PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Homma, T; Kato, A; Sakashita, M; Norton, JE; Suh, LA; Carter, RG; Schleimer, RP				Homma, Tetsuya; Kato, Atsushi; Sakashita, Masafumi; Norton, James E.; Suh, Lydia A.; Carter, Roderick G.; Schleimer, Robert P.			Involvement of Toll-Like Receptor 2 and Epidermal Growth Factor Receptor Signaling in Epithelial Expression of Airway Remodeling Factors	AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY			English	Article						Staphylococcus aureus; remodeling; Toll-like receptor 2; epidermal growth factor receptor; matrix metalloproteinase 1	OBSTRUCTIVE PULMONARY-DISEASE; THYMIC STROMAL LYMPHOPOIETIN; INNATE IMMUNE-RESPONSES; MATRIX METALLOPROTEINASES; MYCOPLASMA-PNEUMONIAE; BRONCHIAL EPITHELIUM; CIGARETTE-SMOKE; INDUCED ASTHMA; MESSENGER-RNA; CUTTING EDGE	Staphylococcus aureus (SA) colonization and infection is common, and may promote allergic or inflammatory airway diseases, such as asthma, cystic fibrosis, and chronic rhinosinusitis by interacting with airway epithelial cells. Airway epithelial cells not only comprise a physical barrier, but also play key roles in immune, inflammatory, repair, and remodeling responses upon encounters with pathogens. To elucidate the impact of SA on epithelial-mediated remodeling of allergic airways, we tested the hypothesis that SA can enhance the remodeling process. Normal human bronchial epithelial (NHBE) cells were stimulated with heat-killed SA (HKSA) or transforming growth factor (TGF) alpha. Cell extracts were collected to measure mRNA (real-time RT-PCR) and signaling molecules (Western blot); supernatants were collected to measure protein (ELISA) after 24 hours of stimulation. Epidermal growth factor receptor (EGFR) signaling inhibition experiments were performed using a specific EGFR kinase inhibitor (AG1478) and TGF-alpha was blocked with an anti-TGF-alpha antibody. HKSA induced both mRNA and protein for TGF-alpha and matrix metalloproteinase (MMP) 1 from NHBE cells by a Toll-like receptor 2-dependent mechanism. Recombinant human TGF-alpha also induced mRNA and protein for MMP-1 from NHBE cells; anti-TGF-alpha antibody inhibited HKSA-induced MMP-1, suggesting that endogenous TGF-alpha mediates the MMP-1 induction by HKSA. HKSA-induced MMP-1 expression was suppressed when a specific EGFR kinase inhibitor was added, suggesting that EGFR signaling was mediating the HKSA-induced MMP-1 release. Exposure or colonization by SA in the airway may enhance the remodeling of tissue through a TGF-alpha-dependent induction of MMP-1 expression, and may thereby promote remodeling in airway diseases in which SA is implicated, such as asthma and chronic rhinosinusitis.	[Homma, Tetsuya; Kato, Atsushi; Sakashita, Masafumi; Norton, James E.; Suh, Lydia A.; Carter, Roderick G.; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Homma, Tetsuya] Showa Univ, Sch Med, Dept Internal Med, Div Resp Med & Allergol, Tokyo 142, Japan	Homma, T (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, 240 East Huron,Room M-230,McGaw Pavilion, Chicago, IL 60611 USA.	tetsuya.homma@northwestern.edu			National Institutes of Health [R37HL068546, R01HL078860, R01AI104733, P01AI106683]; Ernest S. Bazley Foundation; Showa University Research Grant for Young Researchers (Showa University Research Fund)	This work was supported in part by National Institutes of Health grants R37HL068546, R01HL078860, R01AI104733, and P01AI106683, by the Ernest S. Bazley Foundation, and by a Showa University Research Grant for Young Researchers (Showa University Research Fund).	Ancha HR, 2007, INT J BIOCHEM CELL B, V39, P2143, DOI 10.1016/j.biocel.2007.06.003; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Cataldo D, 2000, INT ARCH ALLERGY IMM, V123, P259, DOI 10.1159/000024452; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Wenzel SE, 2003, J ALLERGY CLIN IMMUN, V111, P1345, DOI 10.1067/mai.2003.1464; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Sun Y, 2012, AM J RHINOL ALLERGY, V26, P104, DOI 10.2500/ajra.2012.26.3718; Chizzolini C, 2000, J IMMUNOL, V164, P5952; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Agrawal S, 2003, J IMMUNOL, V171, P4984; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Kumagai K, 1999, J IMMUNOL, V162, P4212; Baginski TK, 2006, AM J RESP CELL MOL, V35, P165, DOI 10.1165/rcmb.2005-0259OC; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; Amayasu H, 2000, ANN ALLERG ASTHMA IM, V84, P594; Van Zele T, 2010, J ALLERGY CLIN IMMUN, V125, P1069, DOI 10.1016/j.jaci.2010.02.020; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Redecke V, 2004, J IMMUNOL, V172, P2739; Lane AP, 2006, AM J RHINOL, V20, P138; Zhang N, 2007, J IMMUNOL, V179, P578; Hirakawa S, 2013, J MED VIROL, V85, P2141, DOI 10.1002/jmv.23718; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Ferreira DS, 2012, CLIN EXP ALLERGY, V42, P1459, DOI 10.1111/j.1365-2222.2012.04047.x; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-03880C; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Mathis C, 2013, AM J PHYSIOL-LUNG C, V304, pL489, DOI 10.1152/ajplung.00181.2012; de Boer WI, 2006, AM J CLIN PATHOL, V125, P184, DOI 10.1039/W1AXKGT7UA37X257; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Asano Kazuhito, 2010, Int J Chron Obstruct Pulmon Dis, V5, P277; Bissonnette EY, 2014, J ASTHMA, V51, P119, DOI 10.3109/02770903.2013.860164; Boguniewicz M, 2001, SEMIN CUTAN MED SURG, V20, P217, DOI 10.1053/sder.2001.29379; Bruce C, 2005, TOXICOL APPL PHARM, V205, P126, DOI 10.1016/j.taap.2004.10.005; Cataldo DD, 2004, LAB INVEST, V84, P418, DOI 10.1038/labinvest.3700063; Chu HW, 2005, J IMMUNOL, V174, P5713; Cunningham AF, 1998, EUR RESPIR J, V11, P345, DOI 10.1183/09031936.98.11020345; Dahlen B, 1999, THORAX, V54, P590; Evdonin AL, 2006, FEBS LETT, V580, P6674, DOI 10.1016/j.febslet.2006.11.024; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Imai K, 2001, AM J RESP CRIT CARE, V163, P786; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Lee YC, 2001, J ALLERGY CLIN IMMUN, V108, P1021, DOI 10.1067/mai.2001.120132; Matsukura S, 2013, INT ARCH ALLERGY IMM, V161, P84, DOI 10.1159/000350455; Mautino G, 1999, AM J RESP CRIT CARE, V160, P324; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Oguma T, 2011, J IMMUNOL, V187, P999, DOI 10.4049/jimmunol.1002257; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Shiomi T, 2011, AM J RESP CELL MOL, V45, P376, DOI 10.1165/rcmb.2010-0234OC; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, pe1; Ye S, 2001, Methods Mol Biol, V151, P367; Zhang QL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-35	64	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1044-1549	1535-4989		AM J RESP CELL MOL	Am. J. Respir. Cell Mol. Biol.	APR	2015	52	4					471	481		10.1165/rcmb.2014-0240OC		11	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	CF0BV	WOS:000352208400008		
J	Waseda, K; Miyahara, N; Taniguchi, A; Kurimoto, E; Ikeda, G; Koga, H; Fujii, U; Yamamoto, Y; Gelfand, EW; Yamamoto, H; Tanimoto, M; Kanehiro, A				Waseda, Koichi; Miyahara, Nobuaki; Taniguchi, Akihiko; Kurimoto, Etsuko; Ikeda, Genyo; Koga, Hikari; Fujii, Utako; Yamamoto, Yasuhiko; Gelfand, Erwin W.; Yamamoto, Hiroshi; Tanimoto, Mitsune; Kanehiro, Arihiko			Emphysema Requires the Receptor for Advanced Glycation End-Products Triggering on Structural Cells	AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY			English	Article						receptor for advanced glycation end-products; elastase; emphysema	OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; INDUCED LUNG INJURY; SOLUBLE RECEPTOR; AIRWAY HYPERRESPONSIVENESS; AGE RECEPTORS; MOUSE MODEL; RAGE; ELASTASE; INFLAMMATION	Pulmonary emphysema is characterized by persistent inflammation and progressive alveolar destruction. The receptor for advanced glycation end-products (RAGE) is a multiligand cell surface receptor reported to be involved in the process of acute alveolar epithelial cell injury. However, studies that address the role of RAGE in pulmonary emphysema are inconclusive. We investigated the role of RAGE in the development of elastase-induced pulmonary inflammation and emphysema in mice. RAGE-sufficient (RAGE(+/+)) mice and RAGE-deficient (RAGE(-/-)) mice were treated with intratracheal elastase on Day 0. Airway inflammation, static lung compliance, lung histology, and the levels of neutrophil-related chemokine and proinflammatory cytokines in bronchoalveolar lavage fluid were determined on Days 4 and 21. Neutrophilia in bronchoalveolar lavage fluid, seen in elastase-treated RAGE(+/+) mice, was reduced in elastase-treated RAGE(-/-) mice on Day 4, and was associated with decreased levels of keratinocyte chemoattractant, macrophage inflammatory protein-2, and IL-1 beta. Static lung compliance values and emphysematous changes in the lung tissue were decreased in RAGE(-/-) mice compared with RAGE(+/+) mice on Day 21 after elastase treatment. Experiments using irradiated, bone marrow-chimeric mice showed that the mice expressing RAGE on radioresistant structural cells, but not hematopoietic cells, developed elastase-induced neutrophilia and emphysematous change in the lung. In contrast, mice expressing RAGE on hematopoietic cells, but not radioresistant structural cells, showed reduced neutrophilia and emphysematous change in the lung. These data identify the importance of RAGE expressed on lung structural cells in the development of elastase-induced pulmonary inflammation and emphysema. Thus, RAGE represents a novel therapeutic target for preventing pulmonary emphysema.	[Waseda, Koichi; Miyahara, Nobuaki; Taniguchi, Akihiko; Kurimoto, Etsuko; Ikeda, Genyo; Koga, Hikari; Fujii, Utako; Tanimoto, Mitsune; Kanehiro, Arihiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol Allergy & Resp Med, Okayama, Okayama 7008558, Japan; [Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [Gelfand, Erwin W.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO USA	Miyahara, N (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol Allergy & Resp Med, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	miyahara@md.okayama-u.ac.jp			Ministry of Education, Science, and Culture of Japan	This work was supported in part by a grant from the Ministry of Education, Science, and Culture of Japan.	Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Ishii Y, 2005, J IMMUNOL, V175, P6968; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Fuchimoto Y, 2011, AM J RESP CELL MOL, V45, P1248, DOI 10.1165/rcmb.2010-0465OC; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Campana L, 2009, J LEUKOCYTE BIOL, V86, P609, DOI 10.1189/jlb.0908576; Ofulue AF, 1999, AM J PHYSIOL-LUNG C, V277, pL97; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; HAYES JA, 1975, J PATHOL, V117, P1, DOI 10.1002/path.1711170102; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; KAPLAN PD, 1973, J LAB CLIN MED, V82, P349; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P1195, DOI 10.1165/rcmb.2011-0170OC; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Robinson AB, 2012, AM J PHYSIOL-LUNG C, V302, pL1192, DOI 10.1152/ajplung.00099.2012; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; BRETT J, 1993, AM J PATHOL, V143, P1699; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Ogawa EN, 2006, AM J RESP CRIT CARE, V174, P400, DOI 10.1164/rccm.200605-699OC; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Waseda K, 2011, AM J RESP CELL MOL, V45, P851, DOI 10.1165/rcmb.2010-0455OC; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Taguchi A, 2000, NATURE, V405, P354; Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Schneider M, 2008, J MOL MED-JMM, V86, P507, DOI 10.1007/s00109-007-0301-3; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; Downward J, 1997, CURR BIOL, V7, pR258, DOI 10.1016/S0960-9822(06)00116-3; Erlandsson Harris Helena, 2004, Eur J Immunol, V34, P1503, DOI 10.1002/eji.200424916; Koga H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-8; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; Matsuse T, 1998, J CLIN PATHOL, V51, P515; Miniati M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-37; Schwenger V, 2006, CONTRIB NEPHROL, V150, P77, DOI 10.1159/000093505; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Winston JT, 1996, ONCOGENE, V12, P127	56	2	2	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1044-1549	1535-4989		AM J RESP CELL MOL	Am. J. Respir. Cell Mol. Biol.	APR	2015	52	4					482	491		10.1165/rcmb.2014-0027OC		10	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	Biochemistry & Molecular Biology; Cell Biology; Respiratory System	CF0BV	WOS:000352208400009		
J	Ryan, AG; Russell, JK; Nichols, ARL; Hess, KU; Porritt, LA				Ryan, Amy G.; Russell, James K.; Nichols, Alexander R. L.; Hess, Kai-Uwe; Porritt, Lucy A.			Experiments and models on H2O retrograde solubility in volcanic systems	AMERICAN MINERALOGIST			English	Article						Rhyolite; hydrous; H2O-solubility; volcanic; experiment; modeling; glass transition; retrograde	BUBBLE-GROWTH; WATER SOLUBILITY; SURFACE-TENSION; SILICATE MELTS; TEMPERATURE-DEPENDENCE; EXPLOSIVE VOLCANISM; GLASS-TRANSITION; RHYOLITIC MAGMA; EMPIRICAL-MODEL; NUCLEATION	We present a suite of 36 high-temperature (900-1100 degrees C) experiments performed on 10 x 10 mm unjacketed cores of rhyolitic obsidian from Hrafntinnuhryggur, Krafla, Iceland, under atmospheric pressure. The obsidian is bubble- and crystal-free with an H2O content of 0.11(4) wt%. The obsidian cores were heated above the glass transition temperature (T-g), held for 0.25-24 h, then quenched. During each experiment the volume of the samples increased as H2O vapor-filled bubbles nucleated and expanded. Uniquely, the bubbles did not nucleate on the surface of the core, nor escape, conserving mass during all experiments. Within each isothermal experimental suite, the cores increased in volume with time until they reached a maximum, after which continued heating caused no change in volume (measured by He-pycnometry). We interpret these T-t conditions as representing thermochemical equilibrium between the melt and exsolved vapor. These experiments are modeled to recover the 1-atm, temperature-dependent solubility of water in the rhyolite melt. Our results define the magnitude of retrograde solubility (-7.1 x 10(-3) wt% H2O per 100 degrees C) and provide estimates of the enthalpy and entropy of the H2O exsolution reaction [Delta H degrees = 17.8 kJ/mol, Delta S degrees = 107 J/(K.mol)]. We conclude by modeling the implications of retrograde solubility for the glass transition temperatures (T-g) of cooling volcanic systems at pressures relevant to volcanic conduits and the Earth's surface. All volcanic systems cool; the effects of retrograde solubility are to allow melts to rehydrate by H2O dissolution as they cool isobarically, thereby depressing T-g and expanding the melt window. Ultimately, the melt is quenched at higher H2O contents and lower temperatures where the isobaric retrograde solubility curve "catches" the evolving T-g.	[Ryan, Amy G.; Russell, James K.; Porritt, Lucy A.] Univ British Columbia, Ctr Expt Studies Lithosphere Earth Ocean & Atmosp, Vancouver, BC V6T 1Z4, Canada; [Nichols, Alexander R. L.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Hess, Kai-Uwe] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany	Ryan, AG (reprint author), Univ British Columbia, Ctr Expt Studies Lithosphere Earth Ocean & Atmosp, Vancouver, BC V6T 1Z4, Canada.	amygryan@yahoo.com			NSERC; German Academic Exchange Service; AmeriCorps; Mineralogical Association of Canada; University of British Columbia	The NSERC Discovery and Discovery Accelerator Supplements programs and the German Academic Exchange Service funded this work via grants held by J.K.R. The senior author acknowledges scholarship and travel funding from AmeriCorps, the Mineralogical Association of Canada, and the University of British Columbia. We are indebted to Hugh Tuffen (Lancaster University, U.K.), who generously donated to us a block of obsidian from Hrafntinnuhryggur, Krafla, Iceland, and to Andre Phillion (University of British Columbia Okanagan, Canada) for access to the floating license for Avizo Fire. We thank Felix von Aulock and an anonymous reviewer for the thorough and constructive reviews, which significantly improved this manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Proussevitch AA, 1998, J GEOPHYS RES-SOL EA, V103, P18223, DOI 10.1029/98JB00906; Gardner JE, 2011, CONTRIB MINERAL PETR, V162, P929, DOI 10.1007/s00410-011-0632-5; REDLICH O, 1949, CHEM REV, V44, P233, DOI 10.1021/cr60137a013; Keating GN, 2005, J VOLCANOL GEOTH RES, V142, P145, DOI 10.1016/j.jvolgeores.2004.10.019; Hess KU, 1996, AM MINERAL, V81, P1297; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SPARKS RSJ, 1978, J VOLCANOL GEOTH RES, V3, P1, DOI 10.1016/0377-0273(78)90002-1; Webster JD, 2011, REV MINERAL GEOCHEM, V73, P247, DOI 10.2138/rmg.2011.73.9; Castro JM, 2008, AM MINERAL, V93, P1816, DOI 10.2138/am.2008.2904; Gonnermann HM, 2003, NATURE, V426, P432, DOI 10.1038/nature02138; TORAMARU A, 1995, J GEOPHYS RES-SOL EA, V100, P1913, DOI 10.1029/94JB02775; Navon O, 1998, EARTH PLANET SC LETT, V160, P763, DOI 10.1016/S0012-821X(98)00126-5; Blower JD, 2001, EARTH PLANET SC LETT, V193, P47, DOI 10.1016/S0012-821X(01)00488-5; Papale P, 2006, CHEM GEOL, V229, P78, DOI 10.1016/j.chemgeo.2006.01.013; Zhang YX, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000216; Carroll MR, 1997, AM MINERAL, V82, P549; Castro JM, 2012, EARTH PLANET SC LETT, V333, P63, DOI 10.1016/j.epsl.2012.04.024; Mangan M, 2000, EARTH PLANET SC LETT, V183, P441, DOI 10.1016/S0012-821X(00)00299-5; Moore G, 1998, AM MINERAL, V83, P36; Liu Y, 2005, J VOLCANOL GEOTH RES, V143, P219, DOI 10.1016/j.jvolgeores.2004.09.019; Gardner JE, 2012, GEOCHIM COSMOCHIM AC, V76, P93, DOI 10.1016/j.gca.2011.10.017; FRIEDMAN I, 1963, J GEOPHYS RES, V68, P6523; BURNHAM CW, 1962, AM J SCI, V260, P721; Russell JK, 2005, J VOLCANOL GEOTH RES, V142, P173, DOI 10.1016/j.jvolgeores.2004.10.017; Grunder A, 2005, J VOLCANOL GEOTH RES, V142, P1, DOI 10.1016/j.jvolgeores.2004.10.010; Newman S, 2002, COMPUT GEOSCI-UK, V28, P597, DOI 10.1016/S0098-3004(01)00081-4; Gardner JE, 2013, J VOLCANOL GEOTH RES, V267, P68, DOI 10.1016/j.jvolgeores.2013.09.007; Bagdassarov N, 2000, AM MINERAL, V85, P33; Mysen BO, 1999, GEOCHIM COSMOCHIM AC, V63, P3799, DOI 10.1016/S0016-7037(99)00216-1; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Hauri E, 2002, CHEM GEOL, V183, P99, DOI 10.1016/S0009-2541(01)00375-8; Dixon JE, 1995, J PETROL, V36, P1607; Kolzenburg S, 2014, J GEOPHYS RES-SOL EA, V119, P5305, DOI 10.1002/2013JB010931; Di Matteo V, 2004, CHEM GEOL, V213, P187, DOI 10.1016/j.chemgeo.2004.08.042; WALKER D, 1981, CONTRIB MINERAL PETR, V76, P455, DOI 10.1007/BF00371487; WESTRICH HR, 1994, B VOLCANOL, V56, P447, DOI 10.1007/BF00302826; HOLTZ F, 1995, AM MINERAL, V80, P94; Giordano D, 2005, J VOLCANOL GEOTH RES, V142, P105, DOI 10.1016/j.jvolgeores.2004.10.015; WESTRICH HR, 1988, J GEOPHYS RES-SOLID, V93, P6503, DOI 10.1029/JB093iB06p06503; Tuffen H, 2009, J VOLCANOL GEOTH RES, V185, P352, DOI 10.1016/j.jvolgeores.2008.10.021; Atlas ZD, 2006, J VOLCANOL GEOTH RES, V153, P221, DOI 10.1016/j.jvolgeores.2005.06.010; Barclay J, 1995, B VOLCANOL, V57, P422, DOI 10.1007/BF00300986; JAUPART C, 1991, EARTH PLANET SC LETT, V102, P413, DOI 10.1016/0012-821X(91)90032-D; EICHELBERGER JC, 1986, NATURE, V323, P598, DOI 10.1038/323598a0; Vollmayr K, 1996, J CHEM PHYS, V105, P4714, DOI 10.1063/1.472326; Quane SL, 2009, GEOLOGY, V37, P471, DOI 10.1130/G25625A.1; von Aulock FW, 2014, LITHOS, V206, P52, DOI 10.1016/j.lithos.2014.07.017; MCMILLAN P, 1986, CONTRIB MINERAL PETR, V94, P178, DOI 10.1007/BF00592934; Wright Heather M. N., 2007, Bulletin of Volcanology, V69, DOI 10.1007/s00445-006-0073-6; Sparks RSJ, 1999, J GEOL SOC LONDON, V156, P217, DOI 10.1144/gsjgs.156.2.0217; Giachetti T, 2013, EARTH PLANET SC LETT, V369, P317, DOI 10.1016/j.epsl.2013.03.041; Anovitz LM, 2008, AM MINERAL, V93, P1166, DOI 10.2138/am.2008.2516; BAGDASSAROV NS, 1992, J VOLCANOL GEOTH RES, V50, P307, DOI 10.1016/0377-0273(92)90099-Y; Cas R.A.F., 1987, VOLCANIC SUCCESSIONS; Castro J, 1999, J STRUCT GEOL, V21, P807, DOI 10.1016/S0191-8141(99)00070-X; Castro JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024029; Deans SR, 2007, RADON TRANSFORM SOME; Dingwell DB, 1997, AM MINERAL, V82, P434; Gardner JE, 2000, GEOCHIM COSMOCHIM AC, V64, P1473, DOI 10.1016/S0016-7037(99)00436-6; Holtz F, 2000, AM MINERAL, V85, P682; Kennedy M, 2010, J ADOLESC ADULT LIT, V54, P299, DOI 10.1598/JAAL.54.4.9; Liu Y, 2000, EARTH PLANET SC LETT, V181, P251, DOI 10.1016/S0012-821X(00)00197-7; Mangan M, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003215; MANLEY CR, 1992, J VOLCANOL GEOTH RES, V53, P27, DOI 10.1016/0377-0273(92)90072-L; McIntosh IM, 2014, EARTH PLANET SC LETT, V401, P1, DOI 10.1016/j.epsl.2014.05.037; Miwa T, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-012-0685-y; Mourtada-Bonnefoi CC, 1999, GEOPHYS RES LETT, V26, P3505, DOI 10.1029/1999GL008368; Mourtada-Bonnefoi CC, 2004, EARTH PLANET SC LETT, V218, P521, DOI [10.1016/S0012-821X(03)00684-8, 10.1016/S00112-821X(03)00684-8]; Mourtada-Bonnefoi C.C., 2002, J GEOPHYS RES, V107; Proussevitch A, 2005, J VOLCANOL GEOTH RES, V143, P89, DOI 10.1016/j.jvolgeores.2004.09.012; PROUSEVITCH AA, 1993, J GEOPHYS RES-SOL EA, V98, P22283, DOI 10.1029/93JB02027; Robert G, 2008, CHEM GEOL, V256, P216, DOI 10.1016/j.chemgeo.2008.06.028; Rust AC, 2007, B VOLCANOL, V69, P825, DOI 10.1007/s00445-006-0111-4; SILVER LA, 1990, CONTRIB MINERAL PETR, V104, P142, DOI 10.1007/BF00306439; STEVENSON RJ, 1994, NEW ZEAL J GEOL GEOP, V37, P345; STOLPER E, 1982, CONTRIB MINERAL PETR, V81, P1, DOI 10.1007/BF00371154; TORAMARU A, 1989, J GEOPHYS RES-SOLID, V94, P17523, DOI 10.1029/JB094iB12p17523; Tuffen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3709; Vona A, 2013, CHEM GEOL, V346, P213, DOI 10.1016/j.chemgeo.2012.10.005; von Aulock FW, 2013, GEOCHIM COSMOCHIM AC, V114, P72, DOI 10.1016/j.gca.2013.03.012; Watkins JM, 2012, GEOLOGY, V40, P699, DOI 10.1130/G33027.1; Yamashita S, 1999, J PETROL, V40, P1497, DOI 10.1093/petrology/40.10.1497; Yoshimura S., 2008, J VOLCANOLOGY GEOTHE, V178, P78; Zhang YX, 1999, REV GEOPHYS, V37, P493, DOI 10.1029/1999RG900012	85	3	3	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	APR	2015	100	4					774	786		10.2138/am-2015-5030		13	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CE9PK	WOS:000352175700012		
J	Ishiyama, T; Kotoda, M; Asano, N; Ikemoto, K; Mitsui, K; Sato, H; Matsukawa, T; Sessler, DI				Ishiyama, T.; Kotoda, M.; Asano, N.; Ikemoto, K.; Mitsui, K.; Sato, H.; Matsukawa, T.; Sessler, D. I.			The effects of Patent Blue dye on peripheral and cerebral oxyhaemoglobin saturations	ANAESTHESIA			English	Article							SENTINEL LYMPH-NODE; CANCER PATIENTS; PULSE OXIMETRY; BLOOD-FLOW; INTERFERENCE; SEVOFLURANE; ISOFLURANE; ANESTHESIA; PROPOFOL; READINGS	We measured the effect of Patent Blue dye on oxyhaemoglobin saturations after injection into breast tissue: 40 women had anaesthesia for breast surgery maintained with sevoflurane or propofol (20 randomly allocated to each). Saturations were recorded with a digital pulse oximeter, in arterial blood samples and with a cerebral tissue oximeter before dye injection and 10, 20, 30, 40, 50, 60, 75, 90, 105 and 120 min afterwards. Patent Blue did not decrease arterial blood oxyhaemoglobin saturation, but it did reduce mean (SD) digital and cerebral oxyhaemoglobin saturations by 1.1 (1.1) % and 6.8 (7.0) %, p < 0.0001 for both. The falsely reduced oximeter readings persisted for at least 2 h. The mean (SD) intra-operative digital pulse oxyhaemoglobin readings were lower with sevoflurane than propofol, 97.8 (1.2) % and 98.8 (1.0) %, respectively, p < 0.0001.	[Ishiyama, T.] Univ Yamanashi, Fac Med, Surg Ctr, Chuo Ku, Yamanashi, Japan; [Kotoda, M.; Asano, N.; Ikemoto, K.; Mitsui, K.; Sato, H.; Matsukawa, T.] Univ Yamanashi, Fac Med, Dept Anesthesiol, Chuo Ku, Yamanashi, Japan; [Sessler, D. I.] Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, Cleveland, OH 44106 USA	Ishiyama, T (reprint author), Univ Yamanashi, Fac Med, Surg Ctr, Chuo Ku, Yamanashi, Japan.	ishiyama@yamanashi.ac.jp					Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; Shibuya K, 2009, J NEUROSURG ANESTH, V21, P40, DOI 10.1097/ANA.0b013e31818b22d5; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Kieckbusch H, 2008, EUR J ANAESTH, V25, P365, DOI 10.1017/S0265021508003578; Gipponi M, 2004, J SURG ONCOL, V85, P102, DOI 10.1002/jso.20022; Chia Y Y, 2001, Acta Anaesthesiol Sin, V39, P27; Hueter L, 2005, EUR J ANAESTH, V22, P475, DOI 10.1017/S0265021505230818; Koivusalo AM, 2002, ACTA ANAESTH SCAND, V46, P411, DOI 10.1034/j.1399-6576.2002.460414.x; Kuroda Y, 1996, ANESTHESIOLOGY, V84, P555, DOI 10.1097/00000542-199603000-00010; Lai Hou-Chuan, 2011, Acta Anaesthesiol Taiwan, V49, P162, DOI 10.1016/j.aat.2011.11.004; McEwan D, 1997, ANAESTH INTENS CARE, V25, P587; MORELL RC, 1993, ANESTHESIOLOGY, V78, P363, DOI 10.1097/00000542-199302000-00022; Murkin JM, 2009, BR J ANAESTH S1, V103, pi3, DOI DOI 10.1093/BJA/AEP299; Pinero A, 2004, ARCH SURG-CHICAGO, V139, P1204, DOI 10.1001/archsurg.139.11.1204; SAITO S, 1995, ACTA ANAESTH SCAND, V39, P268; Szocik J, 2010, MILLERS ANESTHESIA, P1197; Yusim Y, 2007, J CLIN ANESTH, V19, P315, DOI 10.1016/j.jclinane.2005.01.006	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	APR	2015	70	4					429	433		10.1111/anae.12932		5	Anesthesiology	Anesthesiology	CE8YL	WOS:000352129900010		
J	Mikuni, I; Torres, CG; Bakshi, T; Tampo, A; Carlson, BE; Bienengraeber, MW; Kwok, WM				Mikuni, Ikuomi; Torres, Carlos G.; Bakshi, Tania; Tampo, Akihito; Carlson, Brian E.; Bienengraeber, Martin W.; Kwok, Wai-Meng			Enhanced Effects of Isoflurane on the Long QT Syndrome 1-associated A341V Mutant	ANESTHESIOLOGY			English	Article							KCNQ1 POTASSIUM CHANNEL; I-KS; CARDIAC-ARRHYTHMIA; DE-POINTES; LQT1 FORM; MUTATIONS; ANESTHESIA; KVLQT1; GENE; SUBUNITS	Background: The impact of volatile anesthetics on patients with inherited long QT syndrome (LQTS) is not well understood. This is further complicated by the different genotypes underlying LQTS. No studies have reported on the direct effects of volatile anesthetics on specific LQTS-associated mutations. We investigated the effects of isoflurane on a common LQTS type 1 mutation, A341V, with an unusually severe phenotype. Methods: Whole cell potassium currents (IKs) were recorded from HEK293 and HL-1 cells transiently expressing/coexpressing wild-type KCNQ1 (alpha-subunit), mutant KCNQ1, wild-type KCNE1 (beta-subunit), and fusion KCNQ1 + KCNE1. Current was monitored in the absence and presence of clinically relevant concentration of isoflurane (0.54 +/- 0.05 mM, 1.14 vol %). Computer simulations determined the resulting impact on the cardiac action potential. Results: Isoflurane had significantly greater inhibitory effect on A341V + KCNE1 (62.2 +/- 3.4%, n = 8) than on wild-type KCNQ1 + KCNE1 (40.7 +/- 4.5%; n = 9) in transfected HEK293 cells. Under heterozygous conditions, isoflurane inhibited A341V + KCNQ1 + KCNE1 by 65.2 +/- 3.0% (n = 13) and wild-type KCNQ1 + KCNE1 (2: 1 ratio) by 32.0 +/- 4.5% (n = 11). A341V exerted a dominant negative effect on IKs. Similar differential effects of isoflurane were also observed in experiments using the cardiac HL-1 cells. Mutations of the neighboring F340 residue significantly attenuated the effects of isoflurane, and fusion proteins revealed the modulatory effect of KCNE1. Action potential simulations revealed a stimulation frequency-dependent effect of A341V. Conclusions: The LQTS-associated A341V mutation rendered the IKs channel more sensitive to the inhibitory effects of isoflurane compared to wild-type IKs in transfected cell lines; F340 is a key residue for anesthetic action.	[Mikuni, Ikuomi] Asahikawa Med Univ, Dept Anesthesiol & Crit Care Med, Asahikawa, Hokkaido, Japan; [Torres, Carlos G.] Massachusetts Gen Hosp Children, Pediat Residency Program, Boston, MA USA; [Bakshi, Tania] GlaxoSmithKline, Dept Biol Sci, Collegeville, PA USA; [Tampo, Akihito] Asahikawa Med Univ, Dept Emergency Med, Asahikawa, Hokkaido, Japan; [Carlson, Brian E.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Carlson, Brian E.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Kwok, Wai-Meng] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Bienengraeber, Martin W.; Kwok, Wai-Meng] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Kwok, WM (reprint author), Med Coll Wisconsin, Dept Anesthesiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wmkwok@mcw.edu			National Institutes of Health (Bethesda, Maryland) [R01 GM-067675]; Medical College of Wisconsin (Milwaukee, Wisconsin) Diversity Summer Health-related Research Education Program	This study was supported by the National Institutes of Health (Bethesda, Maryland) (grant no. R01 GM-067675 to Dr. Kwok) and the Medical College of Wisconsin (Milwaukee, Wisconsin) Diversity Summer Health-related Research Education Program (to Dr. Torres).	Aizawa K, 2004, ANESTHESIOLOGY, V101, P381, DOI 10.1097/00000542-200408000-00019; Aizawa Y, 2007, J CARDIOVASC ELECTR, V18, P972, DOI 10.1111/j.1540-8167.2007.00889.x; Anastasakis A, 2006, EUROPACE, V8, P241, DOI 10.1093/eurospace/eul012; Shibata S, 2004, J PHARMACOL SCI, V95, P363, DOI 10.1254/jphs.FP0040024; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Kobori A, 2004, J CARDIOVASC ELECTR, V15, P190, DOI 10.1046/j.1540-8167.2004.03112.x; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Booker PD, 2003, BRIT J ANAESTH, V90, P349, DOI 10.1093/bja/aeg061; Katz RI, 2003, CAN J ANAESTH, V50, P398; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Kang JS, 2006, ANESTHESIOLOGY, V104, P1015, DOI 10.1097/00000542-200605000-00018; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Terrenoire C, 2005, CIRC RES, V96, pE25, DOI 10.1161/01.RES.0000160555.58046.9a; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Crotti L, 2007, CIRCULATION, V116, P2366, DOI 10.1161/CIRCULATIONAHA.107.726950; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Plant LD, 2014, P NATL ACAD SCI USA, V111, pE1438, DOI 10.1073/pnas.1323548111; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Michaloudis D, 1996, ANAESTHESIA, V51, P219, DOI 10.1111/j.1365-2044.1996.tb13636.x; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tampo A, 2009, BRIT J PHARMACOL, V156, P432, DOI 10.1111/j.1476-5381.2008.00026.x; Kies SJ, 2005, ANESTHESIOLOGY, V102, P204, DOI 10.1097/00000542-200501000-00029; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Bett GCL, 2006, J PHYSIOL-LONDON, V576, P755, DOI 10.1113/jphysiol.2006.116012; Chen XD, 2002, VASC PHARMACOL, V39, P33, DOI 10.1016/S1537-1891(02)00279-3; Chevalier P, 2001, CARDIOVASC RES, V50, P386, DOI 10.1016/S0008-6363(01)00263-2; Dirschinger RJ, 2012, PEDIATR CARDIOL, V33, P950, DOI 10.1007/s00246-012-0286-8; Donger C, 1997, CIRCULATION, V96, P2778; Heijman J, 2012, CIRC RES, V110, P211, DOI 10.1161/CIRCRESAHA.111.249482; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONHA.105.550111; Imredy JP, 2008, AM J PHYSIOL-HEART C, V295, pH1867, DOI 10.1152/ajpheart.433.2008; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Mikuni I, 2011, BBA-GEN SUBJECTS, V1810, P1285, DOI 10.1016/j.bbagen.2011.07.018; Mikuni I, 2011, P ANN M AM SOC AN CH, pA1200; Nathan AT, 2011, ANESTH ANALG, V112, P1163, DOI 10.1213/ANE.0b013e3182121d57; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Saenen JB, 2008, J MOL CELL CARDIOL, V44, P633, DOI 10.1016/j.yjmcc.2008.01.006; Salata JJ, 1998, MOL PHARMACOL, V54, P220; Saussine M, 2006, PEDIATR ANESTH, V16, P63, DOI 10.1111/j.1460-9592.2005.01593.x; SCHMELING WT, 1991, ANESTH ANALG, V72, P137; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Siebrands CC, 2006, ANESTHESIOLOGY, V105, P511, DOI 10.1097/00000542-200609000-00015; Suzuki A, 2002, ANESTHESIOLOGY, V97, P1209, DOI 10.1097/00000542-200211000-00026; Suzuki A, 2003, ANESTH ANALG, V96, P1308, DOI 10.1213/01.ANE.0000057604.56578.77; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x	63	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	APR	2015	122	4					806	820		10.1097/ALN.0000000000000583		15	Anesthesiology	Anesthesiology	CF0EX	WOS:000352216700013		
J	Kinoshita, H				Kinoshita, Hiroyuki			Another Role of Limb Remote Ischemic Preconditioning in Patients with Lung Cancer	ANESTHESIOLOGY			English	Letter							OXIDATIVE STRESS; MALONDIALDEHYDE; RESECTION; INJURY		Aichi Med Univ, Sch Med, Nagakute, Aichi 48011, Japan	Kinoshita, H (reprint author), Aichi Med Univ, Sch Med, Nagakute, Aichi 48011, Japan.	hkinoshi@aichi-med-u.ac.jp					Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Esme H, 2008, RESPIROLOGY, V13, P112, DOI 10.1111/j.1440-1843.2007.01212.x; Li C, 2014, ANESTHESIOLOGY, V121, P249, DOI 10.1097/ALN.0000000000000266; Dulu A, 2006, CHEST, V130, P73, DOI 10.1378/chest.130.1.73; Misthos P, 2005, EUR J CARDIO-THORAC, V27, P379, DOI 10.1016/j.ejcts.2004.12.023; Elia S, 2005, EUR J CARDIO-THORAC, V27, P382; Peddireddy V, 2012, BIOMARKERS, V17, P261, DOI 10.3109/1354750X.2012.664169	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	APR	2015	122	4					955	956		10.1097/ALN.0000000000000600		3	Anesthesiology	Anesthesiology	CF0EX	WOS:000352216700032		
J	Iinuma, T; Okamoto, Y; Yamamoto, H; Inamine-Sasaki, A; Ohki, Y; Sakurai, T; Funakoshi, U; Yonekura, S; Sakurai, D; Hirahara, K; Nakayama, T				Iinuma, Tomohisa; Okamoto, Yoshitaka; Yamamoto, Heizaburo; Inamine-Sasaki, Ayako; Ohki, Yuji; Sakurai, Toshioki; Funakoshi, Urara; Yonekura, Syuji; Sakurai, Daiju; Hirahara, Kiyoshi; Nakayama, Toshinori			Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							NASAL POLYPS; ALLERGIC INFLAMMATION; CHRONIC SINUSITIS; T-HELPER-2 CELLS; IN-VIVO; EXPRESSION; RESPONSES; ASTHMA; IL-25; TRANSCRIPTION	Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous disease of uncertain pathogenesis. Memory T cells acquire additional functions during the secondary response and play important roles in chronic inflammation. Objective: To investigate characteristics of tissue memory CD4(+) T cells obtained from patients with non-eosinophilic CRSwNP (NECRS) and eosinophilic CRSwNP (ECRS) by focusing on the influence of interleukin (IL)-25. Methods: Pro-allergic cytokines in tissue homogenates were measured using enzyme-linked immunosorbent assays. NP mononuclear cells and CD4(+) T cells were isolated from NPs from patients with CRSwNP. Cytokine expression and CD4(+) T-cell subpopulations were analyzed using enzyme-linked immunosorbent assay, flow cytometry, and real-time polymerase chain reaction. Results: The IL-25 level in NPs increased in patients with ECRS. IL-5 and IL-9 mRNA levels expressed by tissue CD4(+) T cells were significantly elevated in patients with ECRS. Most infiltrating CD4(+) T cells in ECRS and NECRS expressed CD45RO; however, regardless of the atopic status, high IL-17RB levels were detected in CD4(+) T cells from patients with ECRS. IL-17RB mRNA levels expressed by tissue CD4(+) T cells significantly correlated with the number of eosinophils in NPs. Elevation of IL-5 and IL-9 production was found in NP mononuclear cells from patients with ECRS, but not in those from patients with NECRS, by stimulation with IL-25 under T-cell receptor stimulation. Conclusion: Interleukin-25 and a subpopulation of tissue T-helper type 2 and 9 cells that express increased IL-17RB levels could contribute to infiltration of eosinophils in NPs and could have produced the pathologic difference between NECRS and ECRS. (C) 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.	[Iinuma, Tomohisa; Okamoto, Yoshitaka; Yamamoto, Heizaburo; Inamine-Sasaki, Ayako; Ohki, Yuji; Sakurai, Toshioki; Funakoshi, Urara; Yonekura, Syuji; Sakurai, Daiju] Chiba Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Chiba 2608670, Japan; [Iinuma, Tomohisa; Hirahara, Kiyoshi] Chiba Univ, Grad Sch Med, Dept Adv Allergol Airway, Chiba 2608670, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan	Okamoto, Y (reprint author), Chiba Univ, Dept Otolaryngol Head & Neck Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	yokamoto@faculty.chiba-u.jp			Research on Allergic Disease and Immunology of Health Labor Sciences Research Grant in Japan [H26-consignment [Immunity]-General-003]; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency	This work was supported by a Research on Allergic Disease and Immunology of Health Labor Sciences Research Grant in Japan (H26-consignment [Immunity]-General-003) and by a grant from the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency.	Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Kouzaki H, 2013, AM J RESP CELL MOL, V49, P741, DOI 10.1165/rcmb.2012-0304OC; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Hanania NA, 2011, J ALLERGY CLIN IMMUN, V128, pS4, DOI 10.1016/j.jaci.2011.06.048; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Inamine A, 2012, CLIN IMMUNOL, V143, P170, DOI 10.1016/j.clim.2012.01.008; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Cao Ping-Ping, 2009, J Allergy Clin Immunol, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Polzehl D, 2006, ALLERGY, V61, P1275, DOI 10.1111/j.1398-9995.2006.01132.x; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Petersen BC, 2012, NAT MED, V18, P751, DOI 10.1038/nm.2735; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Hurst SD, 2002, J IMMUNOL, V169, P443; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; HAMILOS DL, 1995, J ALLERGY CLIN IMMUN, V96, P537, DOI 10.1016/S0091-6749(95)70298-9; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gevaert P, 2013, ALLERGY, V68, P55, DOI 10.1111/all.12054; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jiang XD, 2011, AM J RHINOL ALLERGY, V25, pE171, DOI 10.2500/ajra.2011.25.3645; Sakuma Y, 2011, AURIS NASUS LARYNX, V38, P583, DOI 10.1016/j.anl.2011.01.007; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Emanuel IA, 2000, OTOLARYNG HEAD NECK, V123, P687, DOI 10.1067/mhn.2000.110961; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P708, DOI DOI 10.1016/J.JACI.2011.08.004; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Jung JS, 2009, CHEST, V135, P1173, DOI 10.1378/chest.08-1595; Lora JM, 2003, J ALLERGY CLIN IMMUN, V112, P1119, DOI 10.1016/j.jaci.2003.08.042; Louahed J, 2000, AM J RESP CELL MOL, V22, P649; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Terrier B, 2010, BLOOD, V116, P4523, DOI 10.1182/blood-2010-02-267542; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Yamamoto H, 2007, ALLERGY, V62, P1451, DOI 10.1111/j.1398-9995.2007.01464.x	45	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	APR	2015	114	4					289	298		10.1016/j.anai.2015.01.013		10	Allergy; Immunology	Allergy; Immunology	CF1NF	WOS:000352312100007		
J	Tanaka, E; Kuroda, S; Horiuchi, S; Tabata, A; El-Bialy, T				Tanaka, Eiji; Kuroda, Shingo; Horiuchi, Shinya; Tabata, Akira; El-Bialy, Tarek			Low-Intensity Pulsed Ultrasound in Dentofacial Tissue Engineering	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Low-intensity pulsed ultrasound; Tissue engineering; Periodontal regeneration; Tissue repair	PERIODONTAL-LIGAMENT CELLS; FOCAL ADHESION KINASE; CYCLOOXYGENASE-2 MESSENGER-RNA; ACTIVATED PROTEIN-KINASES; MESENCHYMAL STEM-CELLS; ROOT RESORPTION; IN-VITRO; RHEUMATOID-ARTHRITIS; TEMPOROMANDIBULAR-JOINT; THERAPEUTIC ULTRASOUND	Oral and maxillofacial diseases affect millions of people worldwide and hence tissue engineering can be considered an interesting and clinically relevant approach to regenerate orofacial tissues after being affected by different diseases. Among several innovations for tissue regeneration, low-intensity pulsed ultrasound (LIPUS) has been used extensively in medicine as a therapeutic, operative, and diagnostic tool. LIPUS is accepted to promote bone fracture repair and regeneration. Furthermore, the effect of LIPUS on soft tissues regeneration has been paid much attention, and many studies have performed to evaluate the potential use of LIPUS to tissue engineering soft tissues. The present article provides an overview about the status of LIPUS stimulation as a tool to be used to enhance regeneration/tissue engineering. This review consists of five parts. Part 1 is a brief introduction of the acoustic description of LIPUS and mechanical action. In Part 2, biological problems in dentofacial tissue engineering are proposed. Part 3 explores biologic mechanisms of LIPUS to cells and tissues in living body. In Part 4, the effectiveness of LIPUS on cell metabolism and tissue regeneration in dentistry are summarized. Finally, Part 5 relates the possibility of clinical application of LIPUS in orthodontics. The present review brings out better understanding of the bioeffect of LIPUS therapy on orofacial tissues which is essential to the successful integration of management remedies for tissue regeneration/engineering. To develop an evidence-based approach to clinical management and treatment of orofacial degenerative diseases using LIPUS, we would like to be in full pursuit of LIPUS biotherapy. Still, there are many challenges for this relatively new strategy, but the up to date achievements using it promises to go far beyond the present possibilities.	[Tanaka, Eiji; Kuroda, Shingo; Horiuchi, Shinya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan; [Tabata, Akira] ITO Co LTD, Tokyo, Japan; [El-Bialy, Tarek] Univ Alberta, Fac Med & Dent, Sch Dent, Div Orthodont, Edmonton, AB, Canada	Tanaka, E (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	etanaka@tokushima-u.ac.jp					Al-Daghreer S, 2013, ULTRASOUND MED BIOL, V39, P1066, DOI 10.1016/j.ultrasmedbio.2012.12.005; Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd.1034; Harle J, 2001, ULTRASOUND MED BIOL, V27, P579, DOI 10.1016/S0301-5629(00)00326-4; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Zhou SX, 2004, J BIOL CHEM, V279, P54463, DOI 10.1074/jbc.M404786200; Mostafa NZ, 2009, ARCH ORAL BIOL, V54, P743, DOI 10.1016/j.archoralbio.2009.04.012; CHAPMAN IV, 1980, ULTRASOUND MED BIOL, V6, P47, DOI 10.1016/0301-5629(80)90063-0; Nagata K, 2013, ANN BIOMED ENG, V41, P1095, DOI 10.1007/s10439-013-0757-y; Claes L, 2007, PROG BIOPHYS MOL BIO, V93, P384, DOI 10.1016/j.pbiomolbio.2006.07.021; Naruse K, 2000, BIOCHEM BIOPH RES CO, V268, P216, DOI 10.1006/bbrc.2000.2094; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Dalla-Bona DA, 2008, ARCH ORAL BIOL, V53, P318, DOI 10.1016/j.archoralbio.2007.11.006; Kurol J, 1996, AM J ORTHOD DENTOFAC, V110, P303, DOI 10.1016/S0889-5406(96)80015-1; Chen YJ, 2003, FEBS LETT, V554, P154, DOI 10.1016/S0014-5793(03)01157-8; DEPALMA AF, 1972, SURG GYNECOL OBSTETR, V134, P755; Padilla F, 2014, ULTRASONICS, V54, P1125, DOI 10.1016/j.ultras.2014.01.004; Romano CL, 2009, ULTRASOUND MED BIOL, V35, P529, DOI 10.1016/j.ultrasmedbio.2008.09.029; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; [Anonymous], 1998, CLIN ORTHOP S, DOI 10.1097/00003086-199810001-00022; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Mukai S, 2005, ULTRASOUND MED BIOL, V31, P1713, DOI 10.1016/j.ultrasmedbio.2005.07.012; Scheven BA, 2009, ARCH ORAL BIOL, V54, P185, DOI 10.1016/j.archoralbio.2008.09.008; Nakashima M, 2003, HUM GENE THER, V14, P591, DOI 10.1089/104303403764539369; Nakamura T, 2011, ANN BIOMED ENG, V39, P2964, DOI 10.1007/s10439-011-0408-0; Tang CH, 2006, MOL PHARMACOL, V69, P2047, DOI 10.1124/mol.105.022160; Leonardi R, 2011, J ORAL PATHOL MED, V40, P587, DOI 10.1111/j.1600-0714.2011.01012.x; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; HOLLENDER L, 1980, EUR J ORTHODONT, V2, P197; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26; Dalla-Bona DA, 2006, ULTRASOUND MED BIOL, V32, P943, DOI 10.1016/j.ultrasmedbio.2006.01.015; Inubushi T, 2013, BONE, V53, P497, DOI 10.1016/j.bone.2013.01.021; El-Bialy TH, 2002, ANN BIOMED ENG, V30, P1251, DOI 10.1114/1.1529196; Al-Daghreer S, 2014, ULTRASOUND MED BIOL, V40, P1187, DOI 10.1016/j.ultrasmedbio.2013.12.016; Trope M, 2008, J ENDODONT, V34, pS13, DOI 10.1016/j.joen.2008.04.001; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Takayama T, 2007, LIFE SCI, V80, P965, DOI 10.1016/j.lfs.2006.11.037; Izumi K, 2004, CELLS TISSUES ORGANS, V176, P134, DOI 10.1159/000075034; YOUNG SR, 1990, ULTRASOUND MED BIOL, V16, P261, DOI 10.1016/0301-5629(90)90005-W; Warden SJ, 2000, CALCIFIED TISSUE INT, V66, P157, DOI 10.1007/s002230010031; Inubushi T, 2008, J PERIODONTOL, V79, P1984, DOI 10.1902/jop.2008.080081 ; Angle SR, 2011, ULTRASONICS, V51, P281, DOI 10.1016/j.ultras.2010.09.004; Nakamura T, 2010, ANN BIOMED ENG, V38, P3363, DOI 10.1007/s10439-010-0104-5; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Leung KS, 2004, CLIN ORTHOP RELAT R, P253; Tanaka E, 2005, HISTOCHEM CELL BIOL, V123, P275, DOI 10.1007/s00418-005-0773-6; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI [10.1359/jbmr.081102, 10.1359/JBMR.081102]; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; LEVANDER E, 1988, EUR J ORTHODONT, V10, P30; El-Bialy T, 2004, AM J ORTHOD DENTOFAC, V126, P186, DOI 10.1016/j.ajodo.2004.02.010; Sameshima GT, 2001, AM J ORTHOD DENTOFAC, V119, P511, DOI 10.1067/mod.2001.113410; Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; DYSON M, 1968, CLIN SCI, V35, P273; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Kojima F, 2004, ARTHRITIS RES THER, V6, pR355, DOI 10.1186/ar1195; Erdogan O, 2006, J ORAL MAXIL SURG, V64, P180, DOI 10.1016/j.joms.2005.10.027; Kokubu T, 1999, BIOCHEM BIOPH RES CO, V256, P284, DOI 10.1006/bbrc.1999.0318; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Kubota E, 1998, J ORAL MAXIL SURG, V56, P192, DOI 10.1016/S0278-2391(98)90868-0; Sato M, 2014, ANN BIOMED ENG, V42, P2156, DOI 10.1007/s10439-014-1081-x; Kardel R, 2003, INT J ORAL MAX SURG, V32, P390, DOI 10.1054/ijom.2002.0357; Schumann D, 2006, BIORHEOLOGY, V43, P431; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Ren LX, 2013, ULTRASONICS, V53, P686, DOI 10.1016/j.ultras.2012.10.008; Audo R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2342; Bosshardt DD, 2005, CELL TISSUE RES, V320, P399, DOI 10.1007/s00441-005-1106-8; BUCKLEY MJ, 1988, BONE MINER, V4, P225; BURCHARDT H, 1978, SURG CLIN N AM, V58, P403; DELIUS M, 1995, ULTRASOUND MED BIOL, V21, P1219, DOI 10.1016/0301-5629(95)00030-5; D'Errico JA, 1999, BONE, V25, P39, DOI 10.1016/S8756-3282(99)00096-4; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; Dyson M, 1983, Ultrasound Med Biol, VSuppl 2, P61; Dyson M., 1985, BIOL EFFECTS ULTRASO, P121; El-Bialy T, 2010, TISSUE ENG PART C-ME, V16, P1315, DOI 10.1089/ten.TEC.2009.0564; El-Bialy T, 2003, ANGLE ORTHOD, V73, P631; El-Bialy T, 2011, J DENT, V39, P693, DOI 10.1016/j.jdent.2011.08.001; El-Bialy T, 2014, ANN BIOMED ENG, V42, P1406, DOI 10.1007/s10439-014-1013-9; El-Bialy TH, 2008, J DENT RES, V87, P953; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Ghassemi-Nejad S, 2011, OSTEOARTHR CARTILAGE, V19, P458, DOI 10.1016/j.joca.2011.01.012; Gu XQ, 2014, ASIAN PAC J TROP MED, V7, P325, DOI 10.1016/S1995-7645(14)60049-3; Hasuike A, 2011, ORAL SURG ORAL MED O, V111, pE12, DOI 10.1016/j.tripleo.2010.09.061; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; Hu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095168; Iashchenko L. V., 1994, VOPR KURORTOL FIZIOT, V2, P20; Ikai H, 2008, J PERIODONTAL RES, V43, P212, DOI 10.1111/j.1600-0765.2007.01016.x; Iwabuchi Y, 2014, J ORAL FACIAL PAIN H, V28, P261, DOI 10.11607/ofph.1156; Kanbe K, 2009, J ORTHOP SCI, V14, P56, DOI 10.1007/s00776-008-1295-6; Kaur H, 2014, BIOMED RES INT, DOI 10.1155/2014/426710; Khan Y., 2008, J BONE JOINT SURG AM, V90, pS138; Li Faqi, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P839; Lim K, 2013, BIOMED RES INT, DOI 10.1155/2013/269724; Matias MA, 2003, ARCH ORAL BIOL, V48, P709, DOI 10.1016/S0003-9969(03)00131-6; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; MORTIMER AJ, 1988, ULTRASOUND MED BIOL, V14, P499, DOI 10.1016/0301-5629(88)90111-1; Oyonarte R, 2013, AUST ORTHOD J, V29, P3; Oyonarte R, 2009, ANGLE ORTHOD, V79, P964, DOI 10.2319/080708-414.1; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414; Pilla A A, 1990, J Orthop Trauma, V4, P246, DOI 10.1097/00005131-199004030-00002; Rees LA, 1954, BRIT DENT J, V96, P125; Rego EB, 2011, J PERIODONTAL RES, V46, P648, DOI 10.1111/j.1600-0765.2011.01384.x; Rego EB, 2010, ULTRASOUND MED BIOL, V36, P907, DOI 10.1016/j.ultrasmedbio.2010.03.008; Rita F. N., 1999, QUINTESSENCE INT, V30, P9; Ritchie R, 2013, ULTRASOUND MED BIOL, V39, P1785, DOI 10.1016/j.ultrasmedbio.2013.04.010; Kim Sang Hun, 2010, J Periodontal Implant Sci, V40, P271, DOI 10.5051/jpis.2010.40.6.271; Saito M, 2004, CALCIFIED TISSUE INT, V75, P384, DOI 10.1007/s00223-004-0292-9; Shiraishi R, 2011, J PERIODONTOL, V82, P1498, DOI 10.1902/jop.2011.100627; Skutek M, 2003, KNEE SURG SPORT TR A, V11, P122, DOI 10.1007/s00167-002-0322-y; Summer W., 1964, ULTRASONIC THERAPY, P63; Takeuchi R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2451; Ten Cate A. R., 2003, PERIODONTIUM ORAL HI, P276; Tsai C L, 1992, Chin J Physiol, V35, P21; Vafaeian B, 2014, ULTRASONICS, V54, P1663, DOI 10.1016/j.ultras.2014.02.024; Wang YJ, 2014, ULTRASONICS, V54, P1581, DOI 10.1016/j.ultras.2014.03.015; Warwick R, 1973, GRAYS ANATOMY; Widegren U, 2000, PFLUG ARCH EUR J PHY, V441, P317, DOI 10.1007/s004240000417; Yoon JH, 2009, BIOTECHNOL LETT, V31, pCP15, DOI 10.1007/s10529-008-9872-5; Yoshida H, 1997, J ORAL PATHOL MED, V26, P356, DOI 10.1111/j.1600-0714.1997.tb00230.x	120	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2015	43	4					871	886		10.1007/s10439-015-1274-y		16	Engineering, Biomedical	Engineering	CE8CM	WOS:000352068700004		
J	Fujita, H				Fujita, Hajime			Cobordism invariance and the well-definedness of local index	ANNALS OF GLOBAL ANALYSIS AND GEOMETRY			English	Article						Cobordism; Analytic index	TORUS FIBRATIONS; DIRAC OPERATORS; LOCALIZATION; MANIFOLDS	In the previous papers, Furuta, Yoshida and the author gave a definition of analytic index theory of Dirac-type operator on open manifolds by making use of some geometric structure on an open covering of the end of the open manifold and a perturbation of the Dirac-type operator. In this paper, we show the cobordism invariance of the index, and as an application we show the well-definedness of the index with respect to the choice of the open covering.	Japan Womens Univ, Dept Math & Phys Sci, Bunkyo Ku, Tokyo 1128681, Japan	Fujita, H (reprint author), Japan Womens Univ, Dept Math & Phys Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	fujitah@fc.jwu.ac.jp			 [23740059];  [26800045]	The author would like to thank Mikio Furuta and Takahiko Yoshida for stimulating discussions. Partly supported by Grant-in-Aid for Young Scientists (B) 23740059 and Young Scientists (B) 26800045	Braverman M, 2002, K-THEORY, V27, P61, DOI 10.1023/A:1020842205711; Braverman M, 2002, P AM MATH SOC, V130, P1095, DOI 10.1090/S0002-9939-01-06250-5; Fujita H, 2010, J MATH SCI-U TOKYO, V17, P1; Fujita H, 2014, COMMUN MATH PHYS, V326, P585, DOI 10.1007/s00220-014-1890-7; Fujita H, 2014, COMMUN MATH PHYS, V327, P665, DOI 10.1007/s00220-014-2039-4; HIGSON N, 1991, TOPOLOGY, V30, P439, DOI 10.1016/0040-9383(91)90024-X; Nicolaescu LI, 1997, P AM MATH SOC, V125, P2797, DOI 10.1090/S0002-9939-97-03975-0; Shubin MA, 1996, GEOM FUNCT ANAL, V6, P370, DOI 10.1007/BF02247891	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0232-704X	1572-9060		ANN GLOB ANAL GEOM	Ann. Glob. Anal. Geom.	APR	2015	47	4					399	414		10.1007/s10455-015-9452-6		16	Mathematics	Mathematics	CF1GL	WOS:000352292200005		
J	Okasaki, M; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Ito, K; Ishiwata, K; Toyohara, J; Inoue, T; Hirai, R; Hagiwara, S; Miwa, A				Okasaki, Momoko; Kubota, Kazuo; Minamimoto, Ryogo; Miyata, Yoko; Morooka, Miyako; Ito, Kimiteru; Ishiwata, Kiichi; Toyohara, Jun; Inoue, Tomio; Hirai, Risen; Hagiwara, Shotaro; Miwa, Akiyoshi			Comparison of C-11-4 '-thiothymidine, C-11-methionine, and F-18-FDG PET/CT for the detection of active lesions of multiple myeloma	ANNALS OF NUCLEAR MEDICINE			English	Article						FDG; Methionine; C-11-4 '-thiothymidine; PET/CT; Multiple myeloma	POSITRON-EMISSION-TOMOGRAPHY; WORKING GROUP; LUNG-CANCER; FDG PET; DIAGNOSIS	Purpose The aims of this study were to evaluate the possibility of using C-11-methionine (C-11-MET) and C-11-4'-thiothymidine (C-11-4DST) whole-body PET/CT for the imaging of amino acid metabolism and DNA synthesis, respectively, when searching for bone marrow involvement in patients with multiple myeloma (MM) and to compare these findings with those for F-18-FDG PET/CT and aspiration cytology. Methods A total of 64 patients with MM, solitary plasmacytoma, monoclonal gammopathy of undetermined significance, or an unspecified diagnosis were prospectively enrolled. All the patients underwent three whole-body PET/CT examinations within a period of 1 week. First, the tracer accumulation was visually evaluated as positive, equivocal, or negative for 55 focal lytic lesions visualized using CT in 24 patients. Second, the percentages of marrow plasma cells as calculated using a bone marrow aspiration smear and tracer accumulation were evaluated in the posterior iliac crests of 36 patients. Results Among the 55 lytic lesions, the C-11-MET and C-11-4DST findings tended to reveal more positive findings than the F-18-FDG findings. Based on the standard criteria for the diagnosis of active myeloma using the percentage of marrow plasma cells, significant differences were found between the F-18-FDG and C-11-MET findings and between the F-18-FDG and C-11-4DST findings, but no significant difference was observed between the C-11-MET and C-11-4DST findings. Conclusion The addition of C-11-MET and C-11-4DST to F-18-FDG when performing PET/CT enabled clearer evaluations of equivocal lesions. Based on cytological diagnostic criteria, C-11-MET and C-11-4DST were more sensitive than F-18-FDG for the detection of active lesions. C-11-MET and C-11-4DST were more useful than F-18-FDG for the detection of active lesions, especially during the early stage of disease.	[Okasaki, Momoko; Kubota, Kazuo; Minamimoto, Ryogo; Miyata, Yoko; Morooka, Miyako] Natl Ctr Global Hlth & Med, Div Nucl Med, Shinjuku Ku, Tokyo 1628655, Japan; [Ito, Kimiteru] Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878551, Japan; [Ishiwata, Kiichi; Toyohara, Jun] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan; [Inoue, Tomio] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Hirai, Risen; Hagiwara, Shotaro; Miwa, Akiyoshi] Natl Ctr Global Hlth & Med, Div Hematol, Shinjuku Ku, Tokyo 1628655, Japan	Okasaki, M (reprint author), Natl Ctr Global Hlth & Med, Div Nucl Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	epiciel324@gmail.com			National Center for Global Health and Medicine [21 A 126, 24 A 203, 25 A 204, 26 A 116]; Japan Society for the Promotion of Science [24791362, 22390241, 26461874]	We thank Masashi Kameyama, Takashi Sato, Shingo Kawaguchi, Takuya Mitsumoto, Fumio Sunaoka, Takaaki Kaneko, Yoshiaki Taguchi, Hiromi Suzuki, Kazuhiko Nakajima, and Kahori Miyake for their excellent technical support. This work was supported by Grants 21 A 126, 24 A 203, 25 A 204 and 26 A 116 from the National Center for Global Health and Medicine (to KK) and Grants-in-Aid for Young Scientists (B) No. 24791362 (to RM) and for Scientific Research (B) No. 22390241 (to JT) and for Scientific Research (C) No. 26461874 (to KK) from the Japan Society for the Promotion of Science.	Durie BGM, 2006, EUR J CANCER, V42, P1539, DOI 10.1016/j.ejca.2005.11.037; Even-Sapir E, 2005, J NUCL MED, V46, P1356; Dankerl A, 2007, RADIOLOGY, V242, P498; Muzi M, 2005, J NUCL MED, V46, P274; Toyohara J, 2011, J NUCL MED, V52, P1322, DOI 10.2967/jnumed.111.088435; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Kyle RA, 2003, MAYO CLIN PROC, V78, P21; Toyohara J, 2008, NUCL MED BIOL, V35, P67, DOI 10.1016/j.nucmedbio.2007.10.001; Rajkumar SV, 2011, NEW ENGL J MED, V365, P474, DOI 10.1056/NEJMc1106428; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Sirohi B, 2004, LANCET, V363, P875, DOI 10.1016/S0140-6736(04)15736-X; Shreve PD, 1999, RADIOGRAPHICS, V19, P61; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199; Bailey Dale L, 2006, POSITRON EMISSION TO; Blade J, 1996, ARCH INTERN MED, V156, P1463, DOI 10.1001/archinte.156.13.1463; Caldarella C, 2012, INT J MOL IMAGING, V2012, DOI 10.1155/2012/175803; Derlin T, 2012, EUR J NUCL MED MOL I, V39, P493, DOI 10.1007/s00259-011-1993-8; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Juweid ME, 2005, J CLIN ONCOL, V23, P4577, DOI 10.1200/JCO.2005.01.904; Kyle A. R., 2004, NEW ENGL J MED, V351, P1860; Mahfouz T, 2005, J CLIN ONCOL, V23, P7857, DOI 10.1200/JCO.2004.00.8581; Minamimoto R, 2012, J NUCL MED, V53, P199, DOI 10.2967/jnumed.111.095539; Morooka M, 2009, J NUCL MED, V50, P1283, DOI 10.2967/jnumed.108.061341; Munshi NC, 2005, CANC PRINCIPLES PRAC, P2155; Nakamoto Y, 2013, EUR J NUCL MED MOL I, V40, P708, DOI 10.1007/s00259-012-2333-3; Nishizawa M, 2010, INT J HEMATOL, V91, P733, DOI 10.1007/s12185-010-0595-8; Schirrmeister H, 2003, CANCER BIOTHER RADIO, V18, P841, DOI 10.1089/108497803770418382; Sood A, 2011, HELL J NUCL MED, V14, P2; Walker RC, 2012, J NUCL MED, V53, P1091, DOI 10.2967/jnumed.111.098830	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2015	29	3					224	232		10.1007/s12149-014-0931-9		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF1BO	WOS:000352278800002		
J	Yoneyama, H; Tsushima, H; Onoguchi, M; Konishi, T; Nakajima, K; Matsuo, S; Kayano, D; Wakabayashi, H; Inaki, A; Kinuya, S				Yoneyama, Hiroto; Tsushima, Hiroyuki; Onoguchi, Masahisa; Konishi, Takahiro; Nakajima, Kenichi; Matsuo, Shinro; Kayano, Daiki; Wakabayashi, Hiroshi; Inaki, Anri; Kinuya, Seigo			Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems	ANNALS OF NUCLEAR MEDICINE			English	Article						SPECT/CT; Sentinel lymph node; Attenuation correction; Scatter correction; Breast cancer	BREAST-CANCER; IDENTIFICATION	Objective Although SPECT/CT systems have been used for sentinel lymph node (SLN) imaging, few studies have focused on optimization of attenuation correction (AC) and scatter correction (SC). While SLNs could be detected in conventional planar images, they sometimes do not appear in SPECT/CT images. The purpose of this study was to investigate the optimal AC and SC and to improve the detectability of SLNs in examinations using SPECT/CT systems. Materials and methods The study group consisted of 56 female patients with breast cancer. In SPECT/CT imaging, four kinds of images were created with and without AC and SC; namely, AC-SC-, AC+SC-, AC-SC+ and AC+SC+. Five nuclear medicine physicians interpreted the planar and SPECT/CT images with five grades of confidence levels (1-5). The detection rate was calculated as the number of patients whose average confidence levels of interpretation were more than 4, divided by the total number of patients. Results The confidence level of interpretation and the detection rate provided by the planar images were 4.76 +/- 0.49 and 94.6 %, respectively. In SPECT/CT imaging, the AC+SC-provided the best detection rate (confidence level of interpretation, 4.81 +/- 0.38; detection rate, 98.2 %), followed by the AC-SC-(4.70 +/- 0.55, 89.3 %), and the AC-SC+ (4.39 +/- 1.2, 78.6 %). The lowest values were obtained for the AC+SC+ (4.36 +/- 1.22, 78.6 %). Regarding the confidence levels of interpretation, significant differences were observed between AC+SC- and AC-SC-, AC+SC- and AC+SC+, AC+SC- and AC-SC+, and between planar images and AC+SC+ (P = 0.0021, 0.0009, 0.0013, and 0.0056, respectively). Conclusions When SPECT/CT was used, AC improved the detection of SLNs. SC caused disappearance of a faint SLN in some cases and should not be performed.	[Yoneyama, Hiroto; Konishi, Takahiro] Kanazawa Univ Hosp, Dept Radiol Technol, Kanazawa, Ishikawa 9208641, Japan; [Tsushima, Hiroyuki] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Ami, Ibaraki 3000394, Japan; [Onoguchi, Masahisa] Kanazawa Univ, Grad Sch Med Sci, Dept Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Nakajima, Kenichi; Matsuo, Shinro; Kayano, Daiki; Wakabayashi, Hiroshi; Inaki, Anri; Kinuya, Seigo] Kanazawa Univ, Grad Sch Med Sci, Dept Biotracer Med, Kanazawa, Ishikawa 9208641, Japan	Yoneyama, H (reprint author), Kanazawa Univ Hosp, Dept Radiol Technol, Takara Machi 13-1, Kanazawa, Ishikawa 9208641, Japan.	kizu@cf6.so-net.ne.jp			 [25931050]	This work was supported by Grants-in-Aid for Scientific Research in Japan (No. 25931050). The authors thank N. Akatani, T. Yamase, Y. Kunida and all the nuclear medicine physicians at Kanazawa University Hospital for their interpretation of lymphoscintigraphy images. We are grateful to M. Tobisaka, M. Kawamura, K. Noto, and all the radiological technologists at Kanazawa University Hospital for providing technical support.	Even-Sapir E, 2003, J NUCL MED, V44, P1413; Lerman H, 2007, J NUCL MED, V48, P201; Buck AK, 2008, J NUCL MED, V49, P1305, DOI 10.2967/jnumed.107.050195; de Nijs R, 2014, NUCL MED COMMUN, V35, P522, DOI 10.1097/MNM.0000000000000079; Funahashi M, 2002, J NUCL CARDIOL, V9, P622, DOI 10.1067/mnc.2002.126682; Husarik DB, 2007, SEMIN NUCL MED, V37, P29, DOI 10.1053/j.semnuclmed.2006.08.001; Laetitia V, 2014, CLIN NUCL MED, V39, P431; Leong L K, 2001, J Nucl Med Technol, V29, P79; Lerman H, 2006, EUR J NUCL MED MOL I, V33, P329, DOI 10.1007/s00259-005-1927-4; Mariani G, 2010, EUR J NUCL MED MOL I, V37, P1959, DOI 10.1007/s00259-010-1390-8; Moncayo VM, 2013, SEMIN NUCL MED, V43, P281, DOI 10.1053/j.semnuclmed.2013.02.004; Noguchi A, 2011, ANN NUCL MED, V25, P221, DOI 10.1007/s12149-010-0459-6; Okuda K, 2014, ANN NUCL MED, V28, P60, DOI 10.1007/s12149-013-0785-6; Patton James A, 2008, J Nucl Med Technol, V36, P1, DOI 10.2967/jnmt.107.046839; Sadrmomtaz A, 2011, WORLD APPL PROGRAM, V1, P143; Takahashi Yasuyuki, 2007, J Nucl Med Technol, V35, P34; van der Ploeg IMC, 2009, EUR J NUCL MED MOL I, V36, P6, DOI 10.1007/s00259-008-0910-2; van der Ploeg IMC, 2009, EUR J NUCL MED MOL I, V36, P903, DOI 10.1007/s00259-008-1050-4; van der Ploeg IMC, 2007, J NUCL MED, V48, P1756, DOI 10.2967/jnumed.107.043372; Williams SB, 1999, J NUCL MED TECHNOL, V27, P309; Yokoi T, 2002, ANN NUCL MED, V16, P11; Yoneyama H, 2014, CLIN NUCL MED, V39, pE1, DOI 10.1097/RLU.0b013e31828da362	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2015	29	3					248	255		10.1007/s12149-014-0939-1		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF1BO	WOS:000352278800005		
J	Takahashi, T; Tanaka, H; Kozono, N; Tanakamaru, Y; Idei, N; Ohashi, N; Ohtsubo, H; Okada, T; Yasunobu, Y; Kaseda, S				Takahashi, Teruyuki; Tanaka, Haruki; Kozono, Nami; Tanakamaru, Yoshiki; Idei, Naomi; Ohashi, Norihiko; Ohtsubo, Hideki; Okada, Takenori; Yasunobu, Yuji; Kaseda, Shunichi			Characteristics of images of angiographically proven normal coronary arteries acquired by adenosine-stress thallium-201 myocardial perfusion SPECT/CT-IQ.SPECT with CT attenuation correction changed stepwise	ANNALS OF NUCLEAR MEDICINE			English	Article						Myocardial perfusion imaging; Attenuation artifact; Computed tomography number conversion software	EMISSION COMPUTED-TOMOGRAPHY; JOINT POSITION STATEMENT; RISK STRATIFICATION; NUCLEAR-CARDIOLOGY; J-ACCESS; DISEASE; SOCIETY; MISREGISTRATION; REREGISTRATION; SCINTIGRAPHY	Objective Although several studies have shown the diagnostic and prognostic value of CT-based attenuation correction (AC) of single photon emission computed tomography (SPECT) images for diagnosing coronary artery disease (CAD), this issue remains a matter of debate. To clarify the characteristics of CT-AC SPECT images that might potentially improve diagnostic performance, we analyzed images acquired using adenosine-stress thallium-201 myocardial perfusion SPECT/CT equipped with IQ.SPECT (SPECT/CT-IQ.SPECT) from patients with angiographically proven normal coronary arteries after changing the CT attenuation correction (CT-AC) in a stepwise manner. Methods We enrolled 72 patients (Male 36, Female 36) with normal coronary arteries according to findings of invasive coronary angiography or CT-angiography within three months after a SPECT/CT study. Projection images were reconstructed at CT-AC values of (-), 40, 60, 80 and 100 % using a CT number conversion program according to our definition and analyzed using polar maps according to sex. Results CT attenuation corrected segments were located from the mid-and apical-inferior spread through the midand apical-septal regions and finally to the basal-anterior and basal-and mid-lateral regions in males, and from the mid-inferior region through the mid-septal and mid-anterior, and mid-lateral regions in females as the CT-AC values increased. Segments with maximal mean counts shifted from the apical-anterior to mid-anterolateral region under both stress and rest conditions in males, whereas such segments shifted from the apical-septal to the mid-anteroseptal region under both stress and rest conditions in females. Conclusions We clarified which part of the myocardium and to which degree CT-AC affects it in adenosine-stress thallium-201 myocardial perfusion SPECT/CT-IQ.SPECT images by changing the CT-AC value stepwise. We also identified sex-specific shifts of segments with maximal mean counts that changed as CT-AC values increased.	[Takahashi, Teruyuki; Tanakamaru, Yoshiki] Hiroshima Red Cross Hosp, Dept Radiol, Hiroshima, Japan; [Takahashi, Teruyuki; Kozono, Nami; Tanakamaru, Yoshiki; Idei, Naomi; Ohashi, Norihiko; Ohtsubo, Hideki; Okada, Takenori; Kaseda, Shunichi] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Tanaka, Haruki] Miyoshi Cent Hosp, Dept Cardiol, Hiroshima 7288502, Japan; [Kozono, Nami] Hiroshima Red Cross Hosp, Dept Med Informat Management, Hiroshima, Japan; [Idei, Naomi; Ohashi, Norihiko; Ohtsubo, Hideki; Okada, Takenori; Kaseda, Shunichi] Hiroshima Red Cross Hosp, Dept Cardiol, Hiroshima, Japan; [Yasunobu, Yuji] Miyoshi Med Assoc Hosp, Dept Cardiol, Hiroshima, Japan	Tanaka, H (reprint author), Miyoshi Cent Hosp, Dept Cardiol, 531 Higashisakeya Cho, Hiroshima 7288502, Japan.	hatot@wa3.so-net.ne.jp					Abdelmoneim SS, 2011, DIABETES VASC DIS RE, V8, P254, DOI 10.1177/1479164111419973; Flotats A, 2011, EUR J NUCL MED MOL I, V38, P201, DOI 10.1007/s00259-010-1586-y; Reyes E, 2010, J NUCL MED, V51, P1036, DOI 10.2967/jnumed.109.073411; Utsunomiya D, 2005, ANN NUCL MED, V19, P485, DOI 10.1007/BF02985576; Nishimura T, 2008, EUR J NUCL MED MOL I, V35, P319, DOI 10.1007/s00259-007-0608-x; Dorbala S, 2013, J NUCL MED, V54, P1485, DOI 10.2967/jnumed.112.105155; LANG TF, 1992, J NUCL MED, V33, P1881; Heller GV, 2004, J NUCL CARDIOL, V11, P229, DOI 10.1016/j.nuclcard.2003.12.001; Malkerneker D, 2007, J NUCL CARDIOL, V14, P314, DOI 10.1016/j.nuclcard.2007.02.005; Marciano C, 2012, EUR J NUCL MED MOL I, V39, P1199, DOI 10.1007/s00259-012-2117-9; Goetze S, 2007, J NUCL MED, V48, P1090, DOI 10.2967/jnumed.107.040535; Phillips LM, 2013, J NUCL CARDIOL, V20, P969, DOI 10.1007/s12350-013-9773-4; Pazhenkottil AP, 2011, J NUCL MED, V52, P196, DOI 10.2967/jnumed.110.080580; Zoghbi GJ, 2008, J AM COLL CARDIOL, V52, P401, DOI 10.1016/j.jacc.2008.04.035; Sharma P, 2012, CLIN NUCL MED, V37, P332, DOI 10.1097/RLU.0b013e31823ea16b; Matsufuji N, 1998, PHYS MED BIOL, V43, P3261, DOI 10.1088/0031-9155/43/11/007; Du Y, 2014, PHYS MED BIOL, V59, P2813, DOI 10.1088/0031-9155/59/11/2813; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Nakajima K, 2007, ANN NUCL MED, V21, P505, DOI 10.1007/s12149-007-0059-2; Cuocolo A, 2011, EUR J NUCL MED MOL I, V38, P1887, DOI 10.1007/s00259-011-1898-6; Genovesi D, 2011, EUR J NUCL MED MOL I, V38, P1890, DOI 10.1007/s00259-011-1855-4; Kennedy JA, 2009, J NUCL MED, V50, P1471, DOI 10.2967/jnumed.109.062141; Klocke FJ, 2003, CIRCULATION, V108, P1404, DOI 10.1161/01.CIR.0000080946.42225.4D; Masood Y, 2005, J NUCL CARDIOL, V12, P676, DOI 10.1016/j.nuclcard.2005.08.006; Matuso S, 2010, CIRC J, V74, P1916; Moroi M, 2012, INT J CARDIOL, V158, P246, DOI 10.1016/j.ijcard.2011.01.040; Nakajima K, 2012, CIRC J, V76, P1313, DOI 10.1253/circj.CJ-12-0260; Nakajima K, 2009, ANN NUCL MED, V23, P373, DOI 10.1007/s12149-009-0248-2; Okuda K, 2011, NUCL MED COMMUN, V32, P1033, DOI 10.1097/MNM.0b013e32834b69e1; Ou XH, 2013, NUCL MED COMMUN, V34, P495, DOI 10.1097/MNM.0b013e328360053a; Patton JA, 2009, SEMIN NUCL MED, V39, P247, DOI 10.1053/j.semnuclmed.2009.03.005; Pirich C, 2014, Q J NUCL MED MOL IMA; Savvopoulos CA, 2014, J NUCL CARDIOL, V21, P519, DOI 10.1007/s12350-014-9867-7; Watanabe Y, 1999, PHYS MED BIOL, V44, P2201, DOI 10.1088/0031-9155/44/9/308	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2015	29	3					256	267		10.1007/s12149-014-0935-5		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF1BO	WOS:000352278800006		
J	Yamamoto, S; Toshito, T; Komori, M; Morishita, Y; Okumura, S; Yamaguchi, M; Saito, Y; Kawachi, N; Fujimaki, S				Yamamoto, Seiichi; Toshito, Toshiyuki; Komori, Masataka; Morishita, Yuki; Okumura, Satoshi; Yamaguchi, Mitsutaka; Saito, Yuichi; Kawachi, Naoki; Fujimaki, Shu			Monitoring of positron using high-energy gamma camera for proton therapy	ANNALS OF NUCLEAR MEDICINE			English	Article						Proton therapy; Positron; Gamma camera; Imaging	EMISSION-TOMOGRAPHY; PET/CT SCANNER; RADIOTHERAPY; RANGE; BEAMS; PERFORMANCE; VERIFICATION; TRANSPORT; DELIVERY; SYSTEM	Purpose In proton therapy, imaging of proton-induced positrons is a useful method to monitor the proton beam distribution after therapy. Usually, a positron emission tomography (PET) system installed in or near the proton beam treatment room is used for this purpose. However, a PET system is sometimes too large and expensive for this purpose. We developed a small field-of-view (FOV) gamma camera for high-energy gamma photons and used it for monitoring the proton-induced positron distribution. Methods The gamma camera used 0.85 mm x 0.85 mm x 10 mm Ce:Gd(3)A(12)Ga(3)O(12) (GAGG) pixels arranged in 20 x 20 matrix to form a scintillator block, which was optically coupled to a 1-inch-square position-sensitive photomultiplier tube (PSPMT). The GAGG detector was encased in a 20-mm thick container and a pinhole collimator was mounted on its front. The gamma camera was set 1.2 m from the 35 cm x 35 cm x 5 cm plastic phan-tom in the proton therapy treatment room, and proton beams were irradiated to the phantom with two proton energies. Results The gamma camera had spatial resolution of similar to 6.7 cm and sensitivity of 3.2 x 10(-7) at 1 m from the collimator surface. For both proton energies, positron distribution in the phantom could be imaged by the gamma camera with 10-min acquisition. The lengths of the range of protons measured from the images were almost identical to the simulation results. Conclusions These results indicate that the developed high-energy gamma camera is useful for imaging positron distributions in proton therapy.	[Yamamoto, Seiichi; Komori, Masataka; Morishita, Yuki; Okumura, Satoshi] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Toshito, Toshiyuki] Nagoya City West Med Ctr, Nagoya Proton Therapy Ctr, Dept Proton Therapy Phys, Nagoya, Aichi, Japan; [Yamaguchi, Mitsutaka; Saito, Yuichi] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gunma, Japan; [Kawachi, Naoki; Fujimaki, Shu] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gunma, Japan	Yamamoto, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	s-yama@met.nagoya-u.ac.jp	Komori, Masataka/I-6259-2014				Jakoby BW, 2011, PHYS MED BIOL, V56, P2375, DOI 10.1088/0031-9155/56/8/004; Oelfke U, 1996, PHYS MED BIOL, V41, P177, DOI 10.1088/0031-9155/41/1/013; Tashima H, 2012, PHYS MED BIOL, V57, P4705, DOI 10.1088/0031-9155/57/14/4705; Bettinardi V, 2011, MED PHYS, V38, P5394, DOI 10.1118/1.3635220; Nishio T, 2006, MED PHYS, V33, P4190, DOI 10.1118/1.2361079; Yamaya T, 2011, PHYS MED BIOL, V56, P1123, DOI 10.1088/0031-9155/56/4/015; BENNETT GW, 1978, SCIENCE, V200, P1151, DOI 10.1126/science.200.4346.1151; Bettinardi V, 2004, EUR J NUCL MED MOL I, V31, P867, DOI 10.1007/s00259-003-1444-2; Parodi K, 2007, INT J RADIAT ONCOL, V68, P920, DOI 10.1016/j.ijrobp.2007.01.063; Kamada K, 2012, J CRYST GROWTH, V352, P88, DOI 10.1016/j.jcrysgro.2011.11.085; Iseki Y, 2003, NUCL INSTRUM METH A, V515, P840, DOI 10.1016/j.nima.2003.07.005; Litzenberg DW, 1999, MED PHYS, V26, P992, DOI 10.1118/1.598491; Smeets J, 2012, PHYS MED BIOL, V57, P3371, DOI 10.1088/0031-9155/57/11/3371; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Perali I, 2014, PHYS MED BIOL, V59, P5849, DOI 10.1088/0031-9155/59/19/5849; DELGUERRA A, 1994, NUCL INSTRUM METH A, V345, P379, DOI 10.1016/0168-9002(94)91016-2; Parodi K, 2002, PHYS MED BIOL, V47, P21, DOI 10.1088/0031-9155/47/1/302; Hishikawa Y, 2002, INT J RADIAT ONCOL, V53, P1388, DOI 10.1016/S0360-3016(02)02887-0; Inaniwa T, 2005, PHYS MED BIOL, V50, P1131, DOI 10.1088/0031-9155/50/6/007; MOYER RA, 1974, J NUCL MED, V15, P59; Yamamoto S, 2012, MED PHYS, V39, P6667	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2015	29	3					268	275		10.1007/s12149-014-0936-4		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF1BO	WOS:000352278800007		
J	Minamoto, T; Takahashi, N; Kitahara, S; Shinozaki, Y; Hirano, T; Hakamata, W; Nishio, T				Minamoto, Takamitsu; Takahashi, Narumi; Kitahara, Sayaka; Shinozaki, Yuko; Hirano, Takako; Hakamata, Wataru; Nishio, Toshiyuki			Saccharification of beta-Chitin From Squid Pen by a Fermentation Method Using Recombinant Chitinase-Secreting Escherichia coli	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Squid pen beta-chitin; Saccharification; Recombinant chitinase; Escherichia coli; Fermentation method	HEXA-N-ACETYLCHITOHEXAOSE; CHITOHEXAOSE; MICE; PURIFICATION; INFECTION; CHITOSAN; CULTURE; TUMOR	Two strains [BL21(DE3) and HMS174(DE3)] of Escherichia coli harboring the recombinant chitinase expression plasmid pVP-Chi, which contains Vibrio parahaemolyticus chitinase gene with an attached signal sequence, were prepared. These E. coli transformants produced a large amount of recombinant chitinase, which hydrolyzes chitin to yield di-N-acetylchitobiose (GlcNAc)(2), under the presence of isopropyl-1-thio-beta-D-galactopyranoside (IPTG), and secreted the enzyme into their culture fluid with the aid of the signal peptide. Cultivation of these E. coli transformants in Luria-Bertani medium containing squid pen beta-chitin and IPTG gave rise to the decomposition of this polysaccharide and the accumulation of (GlcNAc)(2) in the culture fluid. Through these experiments, we confirmed that the use of strain HMS174(DE3) was preferable for the stable accumulation of (GlcNAc)(2) in the culture fluid during cultivation owing to lower (GlcNAc)(2) assimilation compared to BL21(DE3). Next, using E. coli HMS174(DE3) transformants, we conducted saccharification of different forms (fluffy fiber, flake, and powder) of beta-chitin samples prepared from squid pens in Bacterion-N-KS(B)K medium containing 2 % of each sample under the presence of IPTG. In these experiments, (GlcNAc)(2) was isolated with a more than 20 % stoichiometric yield from each culture supernatant through charcoal column chromatography followed by recrystallization.	[Minamoto, Takamitsu; Takahashi, Narumi; Kitahara, Sayaka; Shinozaki, Yuko; Hirano, Takako; Hakamata, Wataru; Nishio, Toshiyuki] Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa 2528510, Japan	Nishio, T (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.	nishio.toshiyuki@nihon-u.ac.jp			Ministry of Education, Science, Sports and Culture (Japan); College of Bioresearch Sciences of Nihon University	We thank Kenichi Koseki and Dr. Kazuhide Totani, Department of Chemical Engineering, Ichinoseki National College of Technology, for providing pens of Japanese common flying squid. This study was supported by a grant for Creative Scientific Research (C) of the Ministry of Education, Science, Sports and Culture (Japan) from 2009 to 2011. To perform this study, grant from College of Bioresearch Sciences of Nihon University was also used.	Rattanakit N, 2003, J BIOSCI BIOENG, V95, P391, DOI 10.1016/S1389-1723(03)80073-7; Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5; Tolaimate A, 2000, POLYMER, V41, P2463, DOI 10.1016/S0032-3861(99)00400-0; TAKIGUCHI Y, 1988, LETT APPL MICROBIOL, V6, P129, DOI 10.1111/j.1472-765X.1988.tb01231.x; SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; Vincentini O, 2005, CARBOHYD POLYM, V62, P338, DOI 10.1016/j.carbpol.2005.08.008; Kadokura K, 2007, BIOSCI BIOTECH BIOCH, V71, P2848, DOI 10.1271/bbb.703891; Wang SL, 2006, ENZYME MICROB TECH, V39, P724, DOI 10.1016/j.enzmictec.2005.12.007; Chaussard G, 2004, BIOMACROMOLECULES, V5, P559, DOI 10.1021/bm.034401t; AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561; Kadokura K, 2007, APPL MICROBIOL BIOT, V75, P357, DOI 10.1007/s00253-006-0831-6; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; KOBAYASHI M, 1990, MICROBIOL IMMUNOL, V34, P413; Marisch K., 2013, PLOS ONE, V8, P1; HUNT S, 1981, COMP BIOCHEM PHYS B, V68, P535, DOI 10.1016/0305-0491(81)90071-7; SHIMAHARA K, 1988, METHOD ENZYMOL, V161, P417; SUZUKI K, 1986, CARBOHYD RES, V151, P403, DOI 10.1016/S0008-6215(00)90359-8; TOKORO A, 1989, MICROBIOL IMMUNOL, V33, P357; TOKORO A, 1988, CHEM PHARM BULL, V36, P784; TSUKADA K, 1990, JPN J CANCER RES, V81, P259	21	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	APR	2015	175	8					3788	3799		10.1007/s12010-015-1547-9		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CE8HC	WOS:000352081500017		
J	Angell, CT; Pedretti, M; Norman, EB				Angell, C. T.; Pedretti, M.; Norman, E. B.			Method for determining individual deposition velocities of radon progeny	APPLIED RADIATION AND ISOTOPES			English	Article						Radon; Radon progeny; Deposition; Jacobi room model	SURFACE CONTAMINATION; CUORE; MODEL	The deposition velocity of radon progeny is used to model the removal of progeny from the air by surfaces in assessing indoor air quality. It can also be used to assess radon-induced background in sensitive, low-background experiments. A single value of the deposition velocity is typically used for all radon progeny for modeling purposes. This paper presents a method for uniquely determining the individual deposition velocities of radon progeny. Measurements demonstrating the method were carried out. (C) 2015 Elsevier Ltd. All rights reserved.	[Angell, C. T.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Pedretti, M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Norman, E. B.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Angell, CT (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	angell.christopher@jaea.go.jp					Amsbaugh JF, 2007, NUCL INSTRUM METH A, V579, P1054, DOI 10.1016/j.nima.2007.05.321; Angell CT, 2012, AM J PHYS, V80, P61, DOI 10.1119/1.3643249; ANAND SJS, 1990, J ENVIRON RADIOACTIV, V11, P235, DOI 10.1016/0265-931X(90)90017-P; Alessandria F, 2013, ASTROPART PHYS, V45, P13, DOI 10.1016/j.astropartphys.2013.02.005; Bellini F, 2010, ASTROPART PHYS, V33, P169, DOI 10.1016/j.astropartphys.2010.01.004; Browne E., 1986, TABLE RADIOACTIVE IS; Clemenza M, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1805-0; GEORGE AC, 1984, HEALTH PHYS, V46, P867, DOI 10.1097/00004032-198404000-00012; Guiseppe VE, 2011, AIP CONF PROC, V1338, P95, DOI [10.1063/1.3590915, 10.1063/1.3579565]; JACOBI W, 1972, HEALTH PHYS, V22, P441, DOI 10.1097/00004032-197205000-00002; Knutson E., 1988, RADON ITS DECAY PROD, P161; Krane K S, 1987, INTRO NUCL PHYS; Leung M, 2005, AIP CONF PROC, V785, P184; Nazaroff W, 1988, RADON ITS DECAY PROD; Nikezic D, 1999, RADIAT PROT DOSIM, V82, P141; Stevanovic N, 2010, J ENVIRON RADIOACTIV, V101, P349, DOI 10.1016/j.jenvrad.2010.02.002; Stevanovic N, 2009, J ENVIRON RADIOACTIV, V100, P585, DOI 10.1016/j.jenvrad.2009.04.007	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	APR	2015	98						34	39		10.1016/j.apradiso.2015.01.006		6	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CF0OW	WOS:000352245100006		
J	Park, MH; Kim, SJ; Jeong, HO; Moon, KM; Son, S; Kim, DH; Kim, HR; Kim, MJ; Yun, HY; Chun, P; Je, NK; Yokozawa, T; Moon, HR; Chung, HY				Park, Min Hi; Kim, Seong Jin; Jeong, Hyoung Oh; Moon, Kyoung Mi; Son, Sujin; Kim, Dae Hyun; Kim, Hye Rim; Kim, Min Jo; Yun, Hwi Young; Chun, Pusoon; Je, Nam Kyung; Yokozawa, Takako; Moon, Hyung Ryong; Chung, Hae Young			Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908)	ARCHIVES OF PHARMACAL RESEARCH			English	Article						MHY908; Skin; Melanogenesis; Tyrosinase inhibitor	TYROSINASE INHIBITORS; EXPRESSION; MECHANISM; SKIN	Tyrosinase inhibitors might have potential use in cosmetic and medicinal products for the prevention of pigmentation disorders. However, only a few inhibitors are currently used due to their cytotoxicity, and lack of selectivity and stability. In this study, we synthesized several tyrosinase inhibitors and investigated their activity. To investigate the action of 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908) specifically in the inhibition of melanogenesis, a mushroom tyrosinase activity assay was performed. We confirmed the inhibitory effect of MHY908 at various melanin concentrations using alpha-MSH-induced melanoma cells. Our results indicate that MHY908 potently inhibited mushroom tyrosinase activity (IC50 = 8.19 mu M) in a dose-dependent manner. Through a docking simulation, we also analyzed its binding mode to inhibit tyrosinase activity. MHY908 also decreased melanin synthesis without inducing cytotoxicity. These results suggest that MHY908 is a good candidate for prevention and treatment of pigmentation disorders.	[Park, Min Hi; Kim, Seong Jin; Jeong, Hyoung Oh; Moon, Kyoung Mi; Son, Sujin; Kim, Dae Hyun; Kim, Hye Rim; Kim, Min Jo; Yun, Hwi Young; Moon, Hyung Ryong; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 609735, South Korea; [Park, Min Hi; Kim, Seong Jin; Jeong, Hyoung Oh; Moon, Kyoung Mi; Son, Sujin; Kim, Dae Hyun; Kim, Hye Rim; Kim, Min Jo; Yun, Hwi Young; Je, Nam Kyung; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea; [Chun, Pusoon; Yokozawa, Takako] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan; [Moon, Hyung Ryong] Inje Univ, Coll Pharm, Gimhae 621749, Gyeongnam, South Korea	Moon, HR (reprint author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 609735, South Korea.	hyjung@pusan.ac.kr			Pusan National University; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2009-0083538]; R&D program of MOTIE/KIAT [N0000697]	This research was supported by the 2014 Post-Doc. Development Program of Pusan National University. This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIP) (No. 2009-0083538) and the R&D program of MOTIE/KIAT (N0000697, Establishment of Infra Structure for Anti-aging Industry Support).	Parvez S, 2007, PHYTOTHER RES, V21, P805, DOI 10.1002/ptr.2184; Khan MTH, 2012, CURR MED CHEM, V19, P2262; No JK, 1999, LIFE SCI, V65, pPL241, DOI 10.1016/S0024-3205(99)00492-0; Karioti A, 2007, BIOORGAN MED CHEM, V15, P2708, DOI 10.1016/j.bmc.2007.01.035; Liang C, 2012, FOOD CHEM, V134, P1146, DOI 10.1016/j.foodchem.2012.03.003; Kim SS, 2013, J ENZYM INHIB MED CH, V28, P685, DOI 10.3109/14756366.2012.670806; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Yoon WJ, 2010, J OLEO SCI, V59, P315, DOI 10.5650/jos.59.315; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Satooka H, 2012, BIOORGAN MED CHEM, V20, P1090, DOI 10.1016/j.bmc.2011.11.030; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Tocco G, 2009, BIOORG MED CHEM LETT, V19, P36, DOI 10.1016/j.bmcl.2008.11.020; Bilodeau ML, 2001, PIGM CELL RES, V14, P328, DOI 10.1034/j.1600-0749.2001.140504.x; Lourdes M., 2013, COSMETIC TECHNOLOGIE, V16, P17; Morris G. M., 2009, J COMPUT CHEM, V16, P2785, DOI DOI 10.1002/JCC.21256; Park MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078815	16	0	0	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	APR	2015	38	4					505	511		10.1007/s12272-014-0532-0		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF0MW	WOS:000352239300008		
J	Tazoe, T; Perez, MA				Tazoe, Toshiki; Perez, Monica A.			Effects of Repetitive Transcranial Magnetic Stimulation on Recovery of Function After Spinal Cord Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Review						Corticospinal tracts; Motor cortex; Neuroplasticity; Rehabilitation	HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; NEUROPATHIC PAIN; CORTICAL PLASTICITY; EXCITABILITY; SPASTICITY; HUMANS; REORGANIZATION; RESPONSES; BACLOFEN	A major goal of rehabilitation strategies after spinal cord injury (SCI) is to enhance the recovery of function. One possible avenue to achieve this goal is to strengthen the efficacy of the residual neuronal pathways. Noninvasive repetitive transcranial magnetic stimulation (rTMS) has been used in patients with motor disorders as a tool to modulate activity of corticospinal, cortical, and subcortical pathways to promote functional recovery. This article reviews a series of studies published during the last decade that used rTMS in the acute and chronic stages of paraplegia and tetraplegia in humans with complete and incomplete SCI. In the studies, rTMS has been applied over the arm and leg representations of the primary motor cortex to target 3 main consequences of SCI: sensory and motor function impairments, spasticity, and neuropathic pain. Although some studies demonstrated that consecutive sessions of rTMS improve aspects of particular functions, other studies did not show similar effects. We discuss how rTMS parameters and postinjury reorganization in the corticospinal tract, motor cortical, and spinal cord circuits might be critical factors in understanding the advantages and disadvantages of using rTMS in patients with SCI. The available data highlight the limited information on the use of rTMS after SCI and the need to further understand the pathophysiology of neuronal structures affected by rTMS to maximize the potential beneficial effects of this technique in humans with SCI. (C) 2015 by the American Congress of Rehabilitation Medicine	[Tazoe, Toshiki; Perez, Monica A.] Univ Pittsburgh, Syst Neurosci Inst, Dept Phys Med & Rehabil, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; [Tazoe, Toshiki] Japanese Soc Promot Sci, Tokyo, Japan	Perez, MA (reprint author), Univ Pittsburgh, Syst Neurosci Inst, Dept Phys Med & Rehabil, Ctr Neural Basis Cognit, 4074 BST3,3501 Fifth Ave, Pittsburgh, PA 15261 USA.	perezmo@pitt.edu			National Institute of Neurological Disorders and Stroke, United States [ROE NS076589]; Department of Veterans Affairs, United States [3397626]; Paralyzed Veterans of America, United States [2955]	Supported by the National Institute of Neurological Disorders and Stroke, United States (grant no. ROE NS076589); Department of Veterans Affairs, United States (grant no. 3397626); and Paralyzed Veterans of America, United States (grant no. 2955).	Perez MA, 2005, J PHYSIOL-LONDON, V568, P343, DOI 10.1113/jphysiol.2005.089904; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Di Lazzaro V, 2010, CLIN NEUROPHYSIOL, V121, P464, DOI 10.1016/j.clinph.2009.11.007; Aydin G, 2005, AM J PHYS MED REHAB, V84, P584, DOI 10.1097/01.phm.0000171173.86312.69; Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Kumru H, 2010, NEUROREHAB NEURAL RE, V24, P435, DOI 10.1177/1545968309356095; Saturno E, 2008, NEUROL RES, V30, P1084, DOI 10.1179/174313208X332968; Moreno-Duarte I, 2014, NEUROIMAGE, V85, P1003, DOI [10.1016/j.neuroimage.2013.05.097, 10.1016/j.neuroimage2013.05.097]; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Touge T, 2001, CLIN NEUROPHYSIOL, V112, P2138, DOI 10.1016/S1388-2457(01)00651-4; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Corbetta M, 2002, P NATL ACAD SCI USA, V99, P17066, DOI 10.1073/pnas.262669099; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; Takei T, 2013, J NEUROSCI, V33, P8850, DOI 10.1523/JNEUROSCI.4032-12.2013; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Mori F, 2009, PROG BRAIN RES, V175, P429, DOI 10.1016/S0079-6123(09)17528-3; TOPKA H, 1991, NEUROLOGY, V41, P1276; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Perez MA, 2005, EXP BRAIN RES, V162, P202, DOI 10.1007/s00221-004-2144-2; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Defrin R, 2007, ARCH PHYS MED REHAB, V88, P1574, DOI 10.1016/j.apmr.2007.07.025; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Bunday KL, 2012, J NEUROPHYSIOL, V107, P2901, DOI 10.1152/jn.00850.2011; Valero-Cabre A, 2001, NEUROREPORT, V12, P3845, DOI 10.1097/00001756-200112040-00048; Garcia-Larrea L, 1999, PAIN, V83, P259; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x; Krummenacher P, 2010, PAIN, V148, P368, DOI 10.1016/j.pain.2009.09.033; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Baker AT, 1985, LANCET, V1, P1106; Barry MD, 2013, J NEUROSCI, V33, P12898, DOI 10.1523/JNEUROSCI.1552-13.2013; Bedrock GM, 1963, PARAPLEGIA, V1, P215; Belci M, 2004, SPINAL CORD, V42, P417, DOI 10.1038/sj.sc.3101613; Benito J, 2012, Top Spinal Cord Inj Rehabil, V18, P106, DOI 10.1310/sci1802-106; Bunday BL, 2014, J NEUROSCI, V34, P7341; Bunday KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076747; BURKE D, 1971, J NEUROL SCI, V14, P199, DOI 10.1016/0022-510X(71)90089-X; Cirillo J, 2013, ABSTR SOC NEUROSCI; Darian-Smith C, 2014, J NEUROSCI, V34, P12267, DOI 10.1523/JNEUROSCI.1593-14.2014; Domingo A, 2012, J NEUROTRAUM, V29, P865, DOI 10.1089/neu.2011.2052; Ellaway PH, 2007, J REHABIL RES DEV, V44, P69, DOI 10.1682/JRRD.2005.08.0140; Fierro B, 2010, EXP BRAIN RES, V203, P31, DOI 10.1007/s00221-010-2206-6; Hill MR, 2010, SPINAL CORD, V48, P438, DOI 10.1038/sc.2009.164; Houze B, 2013, CEREB CORTEX, V23, P2667, DOI 10.1093/cercor/bhs255; Jette F, 2013, NEUROREHAB NEURAL RE, V27, P636, DOI 10.1177/1545968313484810; Kang BS, 2009, ARCH PHYS MED REHAB, V90, P1766, DOI 10.1016/j.apmr.2009.04.008; Kuppuswamy A, 2011, CLIN NEUROPHYSIOL, V122, P2452, DOI 10.1016/j.clinph.2011.04.022; LEVY WJ, 1990, BRAIN RES, V510, P130, DOI 10.1016/0006-8993(90)90738-W; Modugno N, 2001, EXP BRAIN RES, V140, P453, DOI 10.1007/s002210100843; Perez MA, 2012, CORTICAL CONNECTIVIT, P323; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Prut Y, 2003, J NEUROSCI, V23, P9600; Rokyta R, 2012, PHYSIOL RES, V61, pS23; Rosche J, 2002, SPINAL CORD, V40, P261, DOI 10.1038/sj.sc.3101313; Roy FD, 2011, CLIN NEUROPHYSIOL, V122, P1387, DOI 10.1016/j.clinph.2010.11.020; Taube W, 2014, CEREB CORTEX; Tazoe T, 2013, ABSTR SOC NEUROSCI; Thomas CK, 2010, BRAIN, V133, P117, DOI 10.1093/brain/awp285; Yezierski RP, 2005, NEUROSIGNALS, V14, P182, DOI 10.1159/000087657; Yilmaz B, 2014, J SPINAL CORD MED, V37, P397, DOI 10.1179/2045772313Y.0000000172	69	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4		2			S145	S155		10.1016/j.apmr.2014.07.418		11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CE9RA	WOS:000352179900008		
J	Tajima, T; Chosa, E; Kawahara, K; Yamaguchi, N				Tajima, Takuya; Chosa, Etsuo; Kawahara, Katsuhiro; Yamaguchi, Nami			Prospective Comparisons of Femoral Tunnel Enlargement With 3 Different Postoperative Immobilization Periods After Double-Bundle Anterior Cruciate Ligament Reconstruction With Hamstring Grafts	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							SINGLE-BUNDLE; ACL RECONSTRUCTION; ACCELERATED REHABILITATION; PATELLAR TENDON; FOLLOW-UP; FIXATION; AUTOGRAFT; CT	Purpose: To determine the effect of differing postoperative immobilization periods on femoral bone tunnel enlargement and clinical outcome after double-bundle anterior cruciate ligament (ACL) reconstruction with hamstring grafts. Methods: Fifty-one patients undergoing primary double-bundle ACL reconstruction with hamstring grafts were divided into 3 postoperative immobilization protocol groups: 2-day immobilization with the knee in 20 degrees of flexion postoperatively (group A, n = 18); 1-week immobilization (group B, n = 17); and 2-week immobilization (group C, n = 16). Bone tunnel enlargement was determined by computed digital radiographs taken on the first postoperative day and at 24 months in the anteroposterior (AP) and lateral views. Each tunnel diameter was shown as a percentage of the maximum joint width of the proximal tibia on the AP view or a percentage of the maximum diameter of the patella on the lateral view. To determine the incidence of tunnel enlargement, a percentage diameter change of more than 10% was defined as an enlarged tunnel. The standard clinical evaluation was also performed. This study used nonrandomized procedures. Results: In each group there were no significant differences in the incidence and magnitude of anteromedial and posterolateral bone tunnel enlargement on both the AP and lateral views (1-factor analysis of variance). Group C showed significantly less muscle strength in knee extension compared with the contralateral knee (85.3% +/- 18.4%) than group A (93.7% +/- 13.1%, P = .049) and group B (96.8% +/- 12.9%, P = .044). Conclusions: This prospective radiographic study showed that femoral bone tunnel enlargement, in both the anteromedial and posterolateral tunnels, may occur after double-bundle ACL reconstruction with hamstring grafts despite different postoperative immobilization periods, with no significant difference in the incidence and magnitude among groups with differing postoperative immobilization periods. In addition, a 2-week immobilization period after surgery showed harmful effects, such as significantly less quadriceps muscle strength.	[Tajima, Takuya; Chosa, Etsuo; Kawahara, Katsuhiro; Yamaguchi, Nami] Miyazaki Univ, Fac Med, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Miyazaki 8891692, Japan	Tajima, T (reprint author), Miyazaki Univ, Fac Med, Div Orthoped Surg, Dept Med Sensory & Motor Organs, 5200 Kihara, Miyazaki 8891692, Japan.	ttajima@med.miyazaki-u.ac.jp			University of Miyazaki; Japanese Ministry of Education, Culture, Sports, Science and Technology	This study was supported by the University of Miyazaki and Japanese Ministry of Education, Culture, Sports, Science and Technology. The authors report that they have no conflicts of interest in the authorship and publication of this article.	Achtnich A, 2013, ARTHROSCOPY, V29, P1514, DOI 10.1016/j.arthro.2013.06.002; Kawaguchi Y, 2011, KNEE SURG SPORT TR A, V19, P1249, DOI 10.1007/s00167-011-1455-7; Bedi A, 2010, AM J SPORT MED, V38, P1788, DOI 10.1177/0363546510369303; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Wilson TC, 2004, AM J SPORT MED, V32, P543, DOI 10.1177/0363546504263151; Marumo K, 2005, AM J SPORT MED, V33, P1166, DOI 10.1177/0363546504271973; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P2387, DOI 10.2106/JBJS.I.01270; Brophy RH, 2011, J BONE JOINT SURG AM, V93A, P381, DOI [10.2106/JBJS.I.00933, 10.2106/JBJSJ.00933]; Janssen RPA, 2014, KNEE SURG SPORT TR A, V22, P2102, DOI 10.1007/s00167-013-2634-5; Jarvela T, 2008, ARTHROSCOPY, V24, P1349, DOI 10.1016/j.arthro.2008.07.018; Zysk SP, 2004, KNEE SURG SPORT TR A, V12, P98, DOI 10.1007/s00167-003-0426-z; Dunn WR, 2004, AM J SPORT MED, V32, P1906, DOI 10.1177/0363546504265006; Kawahara K, 2012, KNEE SURG SPORT TR A, V20, P1479, DOI 10.1007/s00167-011-1701-z; Webster KE, 2001, KNEE SURG SPORT TR A, V9, P86, DOI 10.1007/s001670100191; Siebold R, 2008, ARTHROSCOPY, V24, P137, DOI 10.1016/j.arthro.2007.11.013; Jansson KA, 1999, KNEE SURG SPORT TR A, V7, P290, DOI 10.1007/s001670050166; Webster KE, 2004, ARTHROSCOPY, V20, P946, DOI 10.1016/j.arthro.2004.06.037; Shino K, 2010, KNEE SURG SPORT TR A, V18, P1164, DOI 10.1007/s00167-009-0979-6; Silva A, 2010, KNEE SURG SPORT TR A, V18, P1189, DOI 10.1007/s00167-010-1046-z; Siebold R, 2010, ARTHROSCOPY, V26, P1066, DOI 10.1016/j.arthro.2009.12.019; Yoo JC, 2009, AM J SPORT MED, V37, P1478, DOI 10.1177/0363546509332432; SHELBOURNE KD, 1990, AM J SPORT MED, V18, P292, DOI 10.1177/036354659001800313; Vadala A, 2007, KNEE SURG SPORT TR A, V15, P365, DOI 10.1007/s00167-006-0219-2; Clatworthy MG, 1999, KNEE SURG SPORT TR A, V7, P138, DOI 10.1007/s001670050138; Cinar BM, 2009, ACTA ORTHOP TRAUMATO, V43, P515, DOI 10.3944/AOTT.2009.515; Dave Lee Yee Han, 2014, Eur J Orthop Surg Traumatol, V24, P217, DOI 10.1007/s00590-013-1175-4; Decarlo M S, 1992, J Orthop Sports Phys Ther, V15, P309; Iorio R, 2007, INT ORTHOP, V31, P49, DOI 10.1007/s00264-006-0118-7; Janssen RPA, 2013, KNEE SURG SPORT TR A, V21, P1977, DOI 10.1007/s00167-012-2234-9; Mae T, 2008, AM J SPORT MED, V36, P1094, DOI 10.1177/0363546508317412; Yasuda K, 2010, ARTHROSCOPY, V26, P212	31	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	APR	2015	31	4					651	658		10.1016/j.arthro.2014.10.015		8	Orthopedics; Surgery	Orthopedics; Surgery	CF0KJ	WOS:000352232400013		
J	Jung, WH; Takeuchi, R; Chun, CW; Lee, JS; Jeong, JH				Jung, Woon-Hwa; Takeuchi, Ryohei; Chun, Chung-Woo; Lee, Jung-Su; Jeong, Jae-Heon			Comparison of Results of Medial Opening-Wedge High Tibial Osteotomy With and Without Subchondral Drilling	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							CARTILAGE REGENERATION; ARTICULAR-CARTILAGE; FOLLOW-UP; ABRASION ARTHROPLASTY; OSTEOARTHRITIC KNEES; VALGUS OSTEOTOMY; GONARTHROSIS; TRANSPLANTATION; BONE	Purpose: The purposes of this study were to compare the results of medial opening-wedge high tibial osteotomy (MOWHTO) with and without subchondral drilling and to assess the formation of fibrocartilage at 2 years postoperatively. Methods: Patients were divided into 2 groups. Thirty knees were treated with osteotomy and subchondral drilling (group 1), and 31 knees were treated with osteotomy alone (group 2). Clinical evaluations were performed by use of Knee Society scores preoperatively and at 2 years postoperatively. For evaluation of cartilage degeneration, the International Cartilage Repair Society grading system was used for arthroscopic grading on initial arthroscopy during high tibial osteotomy. The patients underwent a second-look arthroscopic evaluation of the articular cartilage at the time of removal of the plate, an average of 2 years after the initial osteotomy. For evaluation of formation of fibrocartilage on second-look arthroscopy, the articular cartilage was classified as having either no change from initial surgery (grade I) or white scattering with fibrocartilage, partial coverage with fibrocartilage, or even coverage with fibrocartilage (grade II). In addition, maturation of the appearance of the cartilage was defined. The appearance was considered mature if the chondral defects were evenly covered with fibrocartilage. It was considered immature if there was white scattering or only partial coverage with fibrocartilage. Results: In group 1 the mean Knee Society knee score and function score were 67.3 +/- 8.2 points and 66.5 +/- 14.3 points, respectively, preoperatively. At 2 years postoperatively, they improved to 91.2 +/- 6.4 and 92.8 +/- 10.0, respectively (P = .001 and P = .001, respectively). In group 2 the mean Knee Society knee score and function score were 63.7 +/- 13.9 points and 66.8 +/- 9.1 points, respectively, preoperatively. At 2 years postoperatively, they improved to 92.5 +/- 5.3 points and 92.2 +/- 8.0 points, respectively (P = .001 and P = .001, respectively). There were no significant differences in the postoperative Knee Society knee score and function score at 2 years' follow-up between the groups (P = .389 and P = .806, respectively). Grade II regeneration was achieved in the medial femoral condyle articular cartilage in 100% of knees in group 1 and 94% of knees in group 2 (P = .492). Maturation of the cartilage was found in the medial femoral condyle articular cartilage in 10% of knees in group 1 and 3% of knees in group 2 (P = .354). There was no significant difference in the formation of fibrocartilage between the groups. Conclusions: Subchondral drilling had no effect on the outcome at 2 years after MOWHTO. In addition, there was no significant difference in the formation of fibrocartilage with or without subchondral drilling. Therefore subchondral drilling is not necessary after MOWHTO.	[Jung, Woon-Hwa; Chun, Chung-Woo; Lee, Jung-Su; Jeong, Jae-Heon] Murup Hosp, Dept Orthopaed Surg, Changwon Si 631423, Gyeongnam, South Korea; [Takeuchi, Ryohei] Yokosuka Municipal Hosp, Yokohama, Kanagawa, Japan	Jeong, JH (reprint author), Murup Hosp, Dept Orthopaed Surg, 2-52,3 Ga Jungang Dong, Changwon Si 631423, Gyeongnam, South Korea.	osjjaeheon@naver.com					Floerkemeier S, 2013, KNEE SURG SPORT TR A, V21, P170, DOI 10.1007/s00167-012-2087-2; Jung WH, 2013, ARTHROSCOPY, V29, P1063, DOI 10.1016/j.arthro.2013.02.020; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109; Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011; FUJISAWA Y, 1979, ORTHOP CLIN N AM, V10, P585; Niemeyer P, 2010, ARTHROSCOPY, V26, P1607, DOI 10.1016/j.arthro.2010.05.006; Akizuki S, 1997, ARTHROSCOPY, V13, P9, DOI 10.1016/S0749-8063(97)90204-8; Jung WH, 2014, ARTHROSCOPY, V30, P72, DOI 10.1016/j.arthro.2013.10.008; Kanamiya T, 2002, ARTHROSCOPY, V18, P725, DOI 10.1053/jars.2002.35258; McCulloch PC, 2007, AM J SPORT MED, V35, P411, DOI 10.1177/0363546506295178; Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054; Koshino T, 2003, KNEE, V10, P229, DOI 10.1016/S0968-0160(03)00005-X; Pascale W, 2011, ORTHOPEDICS, V34, pE251, DOI 10.3928/01477447-20110526-06; Kim HA, 2008, RHEUMATOLOGY, V47, P88, DOI 10.1093/rheumatology/kem308; Sterett WI, 2010, AM J SPORT MED, V38, P1420, DOI 10.1177/0363546509360403; Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8; HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332; Wakabayashi S, 2002, ARTHROSCOPY, V18, P272, DOI 10.1053/jars.2002.30488; Takeuchi R, 2009, ARTHROSCOPY, V25, P46, DOI 10.1016/j.arthro.2008.08.015; BERGENUDD H, 1992, ACTA ORTHOP SCAND, V63, P413, DOI 10.3109/17453679209154757; Gebhard F, 2011, ARCH ORTHOP TRAUM SU, V131, P297, DOI 10.1007/s00402-010-1145-9; Hunt Stephen A, 2002, J Am Acad Orthop Surg, V10, P356; KOSHINO T, 1989, ORTHOP CLIN N AM, V20, P227; Koshino T, 2004, KNEE, V11, P439, DOI 10.1016/j.knee.2004.03.005; Lee Su Chan, 2010, Clin Orthop Surg, V2, P47, DOI 10.4055/cios.2010.2.1.47; Matsunaga D, 2007, KNEE, V14, P465, DOI 10.1016/j.knee.2007.06.008; Menche DS, 1996, ARTHROSCOPY, V12, P280, DOI 10.1016/S0749-8063(96)90059-6; ODENBRING S, 1992, CLIN ORTHOP RELAT R, P210; Okahashi K, 2010, TECH KNEE SURG, V9, P95; PEDERSEN MS, 1995, INT ORTHOP, V19, P12; Spahn G, 2012, Z ORTHOP UNFALLCHIR, V150, P272, DOI 10.1055/s-0031-1298388	31	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	APR	2015	31	4					673	679		10.1016/j.arthro.2014.11.035		7	Orthopedics; Surgery	Orthopedics; Surgery	CF0KJ	WOS:000352232400016		
J	Furukawa, Y; Kim, HJ; Hutter, D; Benner, SA				Furukawa, Yoshihiro; Kim, Hyo-Joong; Hutter, Daniel; Benner, Steven A.			Abiotic Regioselective Phosphorylation of Adenosine with Borate in Formamide	ASTROBIOLOGY			English	Article							PRIMITIVE EARTH CONDITIONS; HYDROGEN CYANIDE; PREBIOTIC SYNTHESIS; CHEMICAL EVOLUTION; MINERAL SURFACES; RIBOSE; LIFE; RNA; POLYNUCLEOTIDES; NUCLEOTIDES	Nearly 40 years ago, Schoffstall and his coworkers used formamide as a solvent to permit the phosphorylation of nucleosides by inorganic phosphate to give nucleoside phosphates, which (due to their thermodynamic instability with respect to hydrolysis) cannot be easily created in water by an analogous phosphorylation (the "water problem" in prebiotic chemistry). More recently, we showed that borate could stabilize certain carbohydrates against degradation (the "asphalt problem"). Here, we combine the two concepts to show that borate can work in formamide to guide the reactivity of nucleosides under conditions where they are phosphorylated. Specifically, reaction of adenosine in formamide with inorganic phosphate and pyrophosphate in the presence of borate gives adenosine-5 '-phosphate as the only detectable phosphorylated product, with formylation (as opposed to hydrolysis) being the competing reaction. Key Words: Prebiotic chemistry-Nucleoside phosphates-Phosphorylation-Borate-Formamide. Astrobiology 15, 259-267.	[Furukawa, Yoshihiro] Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan; [Kim, Hyo-Joong; Hutter, Daniel; Benner, Steven A.] Fdn Appl Mol Evolut, Westheimer Inst Sci & Technol, Alachua, FL USA	Furukawa, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Aoba Ku, 6-3 Aza Aoba, Sendai, Miyagi 9808578, Japan.	furukawa@m.tohoku.ac.jp	Furukawa, Yoshihiro/C-6563-2012	Furukawa, Yoshihiro/0000-0001-7241-530X	NASA Exobiology program [NNX08AO23G]; NASA Astrobiology Institute program on Titan (via a subcontract from the Jet Propulsion Laboratory) [NNH08ZDA002C]; Tohoku University	This work was supported in part by the NASA Exobiology program (NNX08AO23G) and the NASA Astrobiology Institute program on Titan (via a subcontract from the Jet Propulsion Laboratory, NNH08ZDA002C). Y.F. is indebted to Tohoku University for travel funds.	Amaral AF, 2008, NEW J CHEM, V32, P2043, DOI 10.1039/b809636h; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SANCHEZ RA, 1967, J MOL BIOL, V30, P223; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; LAHAV N, 1976, J MOL EVOL, V8, P357, DOI 10.1007/BF01739261; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Harrison TM, 2009, ANNU REV EARTH PL SC, V37, P479, DOI 10.1146/annurev.earth.031208.100151; FERRIS JP, 1989, ORIGINS LIFE EVOL B, V19, P153, DOI 10.1007/BF01808149; Kofoed J, 2005, ORG BIOMOL CHEM, V3, P1850, DOI 10.1039/b501512j; ORO J, 1961, ARCH BIOCHEM BIOPHYS, V94, P217, DOI 10.1016/0003-9861(61)90033-9; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; SCHOFFSTALL AM, 1985, ORIGINS LIFE EVOL B, V15, P141, DOI 10.1007/BF01809496; Schreiber U, 2012, ORIGINS LIFE EVOL B, V42, P47, DOI 10.1007/s11084-012-9267-4; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; Lambert JB, 2010, SCIENCE, V327, P984, DOI 10.1126/science.1182669; GERLT JA, 1975, J BIOL CHEM, V250, P5059; HOLM NG, 1993, ORIGINS LIFE EVOL B, V23, P195, DOI 10.1007/BF01581839; Grew ES, 2011, ORIGINS LIFE EVOL B, V41, P307, DOI 10.1007/s11084-010-9233-y; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Perron JT, 2007, NATURE, V447, P840, DOI 10.1038/nature05873; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Furukawa Y, 2013, ORIGINS LIFE EVOL B, V43, P353, DOI 10.1007/s11084-013-9350-5; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; ORO J, 1962, ARCH BIOCHEM BIOPHYS, V96, P293, DOI 10.1016/0003-9861(62)90412-5; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Benner SA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003467; Cockell CS, 1998, J THEOR BIOL, V193, P717, DOI 10.1006/jtbi.1998.0738; Cossetti C, 2010, POLYMERS-BASEL, V2, P211, DOI 10.3390/polym2030211; Prieur BE, 2001, CR ACAD SCI II C, V4, P667, DOI 10.1016/S1387-1609(01)01266-X; Prieur B, 2001, FIRST STEPS IN THE ORIGIN OF LIFE IN THE UNIVERSE, PROCEEDINGS, P103; Rauchfuss H, 2008, CHEMICAL EVOLUTION AND THE ORIGIN OF LIFE, P1; Saladino R, 2003, CHEMBIOCHEM, V4, P514, DOI 10.1002/cbic.200300567; SCHOFFSTALL AM, 1982, ORIGINS LIFE EVOL B, V12, P143, DOI 10.1007/BF00927141; SCHWARTZ AW, 1985, J MOL EVOL, V21, P299, DOI 10.1007/BF02102362; Scorei R, 2012, ORIGINS LIFE EVOL B, V42, P3, DOI 10.1007/s11084-012-9269-2; Scorei R, 2006, ORIGINS LIFE EVOL B, V36, P1, DOI 10.1007/s11084-005-0562-1; Stephenson JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064624; WESTHEIM.FH, 1968, ACCOUNTS CHEM RES, V1, P70, DOI 10.1021/ar50003a002	39	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1531-1074	1557-8070		ASTROBIOLOGY	Astrobiology	APR 1	2015	15	4					259	267		10.1089/ast.2014.1209		9	Astronomy & Astrophysics; Biology; Geosciences, Multidisciplinary	Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics; Geology	CF5XI	WOS:000352630200001		
J	Mousis, O; Chassefiere, E; Holm, NG; Bouquet, A; Waite, JH; Geppert, WD; Picaud, S; Aikawa, Y; Ali-Dib, M; Charlou, JL; Rousselot, P				Mousis, Olivier; Chassefiere, Eric; Holm, Nils G.; Bouquet, Alexis; Waite, Jack Hunter; Geppert, Wolf Dietrich; Picaud, Sylvain; Aikawa, Yuri; Ali-Dib, Mohamad; Charlou, Jean-Luc; Rousselot, Philippe			Methane Clathrates in the Solar System	ASTROBIOLOGY			English	Review							EVOLUTIONARY TURBULENT MODEL; MARTIAN ATMOSPHERE; CARBON-DIOXIDE; GAS HYDRATE; NOBLE-GASES; WATER ICE; MOLECULAR EVOLUTION; TITANS ATMOSPHERE; PRESTELLAR CORES; UMIST DATABASE	We review the reservoirs of methane clathrates that may exist in the different bodies of the Solar System. Methane was formed in the interstellar medium prior to having been embedded in the protosolar nebula gas phase. This molecule was subsequently trapped in clathrates that formed from crystalline water ice during the cooling of the disk and incorporated in this form into the building blocks of comets, icy bodies, and giant planets. Methane clathrates may play an important role in the evolution of planetary atmospheres. On Earth, the production of methane in clathrates is essentially biological, and these compounds are mostly found in permafrost regions or in the sediments of continental shelves. On Mars, methane would more likely derive from hydrothermal reactions with olivine-rich material. If they do exist, martian methane clathrates would be stable only at depth in the cryosphere and sporadically release some methane into the atmosphere via mechanisms that remain to be determined. In the case of Titan, most of its methane probably originates from the protosolar nebula, where it would have been trapped in the clathrates agglomerated by the satellite's building blocks. Methane clathrates are still believed to play an important role in the present state of Titan. Their presence is invoked in the satellite's subsurface as a means of replenishing its atmosphere with methane via outgassing episodes. The internal oceans of Enceladus and Europa also provide appropriate thermodynamic conditions that allow formation of methane clathrates. In turn, these clathrates might influence the composition of these liquid reservoirs. Finally, comets and Kuiper Belt Objects might have formed from the agglomeration of clathrates and pure ices in the nebula. The methane observed in comets would then result from the destabilization of clathrate layers in the nuclei concurrent with their approach to perihelion. Thermodynamic equilibrium calculations show that methane-rich clathrate layers may exist on Pluto as well. Key Words: Methane clathrate-Protosolar nebula-Terrestrial planets-Outer Solar System. Astrobiology 15, 308-326.	[Mousis, Olivier] Aix Marseille Univ, CNRS, LAM, UMR 7326, Marseille, France; [Mousis, Olivier; Picaud, Sylvain; Ali-Dib, Mohamad; Rousselot, Philippe] Univ Franche Comte, Inst UTINAM, CNRS INSU, UMR 6213,Observ Sci Univers THETA, F-25030 Besancon, France; [Chassefiere, Eric] Univ Paris 11, CNRS, Lab GEOPS, UMR 8148, F-91405 Orsay, France; [Holm, Nils G.] Stockholm Univ, Dept Geol Sci, Geochem Sect, S-10691 Stockholm, Sweden; [Bouquet, Alexis] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX USA; [Bouquet, Alexis; Waite, Jack Hunter] SW Res Inst, Space Sci & Engn Div, San Antonio, TX USA; [Geppert, Wolf Dietrich] Stockholm Univ, Dept Phys, AlbaNova Univ Ctr, S-10691 Stockholm, Sweden; [Aikawa, Yuri] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan; [Charlou, Jean-Luc] IFREMER, Ctr Brest, Dept Geosci Marines, F-29280 Plouzane, France	Mousis, O (reprint author), Lab Astrophys Marseille, Pole Etoile Site Chateau Gombert, F-13388 Marseille 13, France.	olivier.mousis@lam.fr			CNES; PNP; Cassini-Huygens JPL [1405851, 1405853]; International Space Science Institute (ISSI) for our team "The Methane Balance-Formation and Destruction Processes on Planets, Their Satellites and in the Interstellar Medium'' [193]; A*MIDEX project - "Investissements d'Avenir" French Government program [ANR-11-IDEX-0001-02]	We wish to thank Dr. Jeffrey Kargel and an anonymous referee for their very constructive comments that helped us strengthen our manuscript. O.M. acknowledges support from CNES. E.C. acknowledges support from PNP. J.H.W. acknowledges support from Cassini-Huygens JPL subcontracts 1405851 and 1405853. The authors gratefully acknowledge support from the International Space Science Institute (ISSI) for our team "The Methane Balance-Formation and Destruction Processes on Planets, Their Satellites and in the Interstellar Medium,'' Team ID 193. This work has been carried out thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR).	Aikawa Y, 2005, ASTROPHYS J, V620, P330, DOI 10.1086/427017; Aikawa Y, 2013, CHEM REV, V113, P8961, DOI 10.1021/cr4003193; Aikawa Y, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201015999; Ali-Dib M, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/125; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Atreya SK, 2006, PLANET SPACE SCI, V54, P1177, DOI 10.1016/j.pss.2006.05.028; Gautier D, 2001, ASTROPHYS J, V550, pL227, DOI 10.1086/319648; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; CRUIKSHANK DP, 1976, SCIENCE, V194, P835; Terada H, 2007, ASTROPHYS J, V667, P303, DOI 10.1086/520951; Oberg KI, 2008, ASTROPHYS J, V678, P1032, DOI 10.1086/533432; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Thomas C, 2008, PLANET SPACE SCI, V56, P1607, DOI 10.1016/j.pss.2008.04.009; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; LEWIS JS, 1972, ICARUS, V16, P241, DOI 10.1016/0019-1035(72)90071-1; Mousis O, 2004, PLANET SPACE SCI, V52, P361, DOI 10.1016/j.pss.2003.06.004; Mousis O, 2009, ASTROPHYS J LETT, V701, pL39, DOI 10.1088/0004-637X/701/1/L39; Chassefiere E, 2013, J GEOPHYS RES-PLANET, V118, P1123, DOI 10.1002/jgre.20089; Sakai N, 2008, ASTROPHYS J, V672, P371, DOI 10.1086/523635; Thomas C, 2009, PLANET SPACE SCI, V57, P42, DOI 10.1016/j.pss.2008.10.003; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Sexton PF, 2011, NATURE, V471, P349, DOI 10.1038/nature09826; Marboeuf U, 2010, ASTROPHYS J, V708, P812, DOI 10.1088/0004-637X/708/1/812; Mousis O, 2010, FARADAY DISCUSS, V147, P509, DOI 10.1039/c003658g; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Owen T, 1999, NATURE, V402, P269, DOI 10.1038/46232; PRASAD SS, 1980, ASTROPHYS J SUPPL S, V43, P1, DOI 10.1086/190665; Notesco G, 2005, ICARUS, V175, P546, DOI 10.1016/j.icarus.2004.12.001; Boogert ACA, 1996, ASTRON ASTROPHYS, V315, pL377; OPPENHEIMER BR, 1995, SCIENCE, V270, P1478, DOI 10.1126/science.270.5241.1478; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Mousis O, 2002, ICARUS, V156, P162, DOI 10.1006/icar.2001.6782; Kasting JF, 1997, SCIENCE, V276, P1213, DOI 10.1126/science.276.5316.1213; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Sakai N, 2009, ASTROPHYS J, V702, P1025, DOI 10.1088/0004-637X/702/2/1025; Mandt KE, 2009, PLANET SPACE SCI, V57, P1917, DOI 10.1016/j.pss.2009.06.005; Sauter EJ, 2006, EARTH PLANET SC LETT, V243, P354, DOI 10.1016/j.epsl.2006.01.041; Thomas C, 2007, ASTRON ASTROPHYS, V474, pL17, DOI 10.1051/0004-6361:20078072; Gough RV, 2011, PLANET SPACE SCI, V59, P238, DOI 10.1016/j.pss.2010.09.018; Hand KP, 2006, ASTROBIOLOGY, V6, P463, DOI 10.1089/ast.2006.6.463; Chastain BK, 2007, PLANET SPACE SCI, V55, P1246, DOI 10.1016/j.pss.2007.02.003; Stern LA, 2001, J PHYS CHEM B, V105, P1756, DOI 10.1021/jp003061s; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; GROSSMAN L, 1972, GEOCHIM COSMOCHIM AC, V36, P597, DOI 10.1016/0016-7037(72)90078-6; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Aikawa Y, 2008, ASTROPHYS J, V674, P984, DOI 10.1086/524096; LEWIS JS, 1980, ASTROPHYS J, V238, P357, DOI 10.1086/157992; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Fonti S, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913178; Mousis O, 2009, ICARUS, V204, P749, DOI 10.1016/j.icarus.2009.07.040; Brown ME, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/6/146; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Mousis O, 2009, ASTROPHYS J, V696, P1348, DOI 10.1088/0004-637X/696/2/1348; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Chassefiere E, 2011, EARTH PLANET SC LETT, V310, P262, DOI 10.1016/j.epsl.2011.08.013; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Langlais B, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002048; Etiope G, 2013, ICARUS, V224, P276, DOI 10.1016/j.icarus.2012.05.009; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Fray N, 2010, J CHEM ENG DATA, V55, P5101, DOI 10.1021/je1006604; Alibert Y, 2005, ASTROPHYS J, V622, pL145, DOI 10.1086/429662; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Chassefiere E, 2009, ICARUS, V204, P137, DOI 10.1016/j.icarus.2009.06.016; Mousis O, 2004, ASTRON ASTROPHYS, V413, P373, DOI 10.1051/0004-6361:20031515; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; Ciesla FJ, 2006, ICARUS, V181, P178, DOI 10.1016/j.icarus.2005.11.009; Alibert Y, 2005, ASTROPHYS J, V626, pL57, DOI 10.1086/431325; Pontoppidan KM, 2005, ASTROPHYS J, V622, P463, DOI 10.1086/427688; Lasue J, 2013, SPACE SCI REV, V174, P155, DOI 10.1007/s11214-012-9946-5; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Mousis O, 2012, ICARUS, V218, P80, DOI 10.1016/j.icarus.2011.12.007; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Kargel JS, 2007, GEOLOGY, V35, P975, DOI 10.1130/G23783A.1; Mousis O, 2009, ASTROPHYS J, V691, P1780, DOI 10.1088/0004-637X/691/2/1780; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5; Mousis O, 2013, ASTROBIOLOGY, V13, P380, DOI 10.1089/ast.2012.0907; Mousis O, 2013, SPACE SCI REV, V174, P213, DOI 10.1007/s11214-012-9942-9; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Buffett B, 2004, EARTH PLANET SC LETT, V227, P185, DOI 10.1016/j.epsl.2004.09.005; Spencer JR, 2002, ASTRON J, V124, P3400, DOI 10.1086/344307; Kargel JS, 1998, ASTROPHYS SPACE SC L, V227, P97; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; KOUCHI A, 1994, ASTRON ASTROPHYS, V290, P1009; Mousis O, 2013, ICARUS, V225, P856, DOI 10.1016/j.icarus.2013.03.008; BARNUN A, 1980, ASTRON ASTROPHYS, V85, P197; Barucci MA, 2011, ICARUS, V214, P297, DOI 10.1016/j.icarus.2011.04.019; Bouquet A., 2015, GEOPHYS RES IN PRESS, DOI 10. 1002/2014GL063013; Carr JS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/102; Chassefiere E, 2011, PLANET SPACE SCI, V59, P207, DOI 10.1016/j.pss.2010.09.004; Chassefiere E, 2013, ICARUS, V223, P878, DOI 10.1016/j.icarus.2013.01.001; Choukroun M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050747,2012; Croft SK, 1995, SPACE SCI S, P879; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; Dartois E, 2011, ICARUS, V212, P950, DOI 10.1016/j.icarus.2010.12.004; Dartois E, 2012, ICARUS, V220, P427, DOI 10.1016/j.icarus.2012.05.021; Durham WB, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001872; Madden ME, 2009, MAR PETROL GEOL, V26, P369, DOI 10.1016/j.marpetgeo.2008.04.002; Emmanuel S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030532; Griffith CA, 2006, SCIENCE, V313, P1620, DOI 10.1126/science.1128245; HERBST E, 1973, ASTROPHYS J, V185, P505, DOI 10.1086/152436; Herri JM, 2012, PLANET SPACE SCI, V73, P376, DOI 10.1016/j.pss.2012.07.028; Holm N. G., 2015, ASTROBIOLOG IN PRESS, V15, DOI [10.1089/ast.2014.1188, DOI 10.1089/AST.2014.1188]; Irvine W. M., 1987, ASTROCHEMISTRY, V120, P245; Irwin P. G. J., 2003, GIANT PLANETS OUR SO; Johnson TV, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/192; Kaminska M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062701; Kargel J. S., 2004, MARS WARMER WETTER P; Kargel J. S., 2000, 31 ST LUN PLAN SCI C; Kennett J. P., 2003, METHANE HYDRATES QUA; Knez C, 2009, ASTROPHYS J, V696, P471, DOI 10.1088/0004-637X/696/1/471; LACY JH, 1991, ASTROPHYS J, V376, P556, DOI 10.1086/170304; Lasue J., 2014, 8 INT C MARS LUN PLA; Lellouch E, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116954; Lopes RMC, 2013, J GEOPHYS RES-PLANET, V118, P416, DOI 10.1002/jgre.20062; Lunine J. I., 2006, METEORITES EARLY SOL, P309; Lyons JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022161; Marboeuf U, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015438; Marboeuf U, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118176; Marion GM, 2014, ICARUS, V236, P1, DOI 10.1016/j.icarus.2014.03.025; Marion GM, 2006, CALPHAD, V30, P248, DOI 10.1016/j.calphad.2006.04.002; Mastrogiuseppe M, 2014, GEOPHYS RES LETT, V41, P1432, DOI 10.1002/2013GL058618; Meslin PY, 2011, PLANET SPACE SCI, V59, P247, DOI 10.1016/j.pss.2010.09.022; Millar TJ, 1997, ASTRON ASTROPHYS SUP, V121, P139, DOI 10.1051/aas:1997118; Mitchell JL, 2009, ICARUS, V203, P250, DOI 10.1016/j.icarus.2009.03.043; Mitri G., 2006, 37 LUN PLAN SCI C LU; Mousis O, 2002, ICARUS, V159, P156, DOI 10.1006/icar.2002.6930; Mousis O, 2008, ASTROPHYS J LETT, V677, pL67, DOI 10.1086/587141; Mousis O, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L7; Mousis O, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/146; Mousis O, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L9; Mousis O, 2014, ICARUS, V239, P39, DOI 10.1016/j.icarus.2014.05.032; Oancea A, 2012, ICARUS, V221, P900, DOI 10.1016/j.icarus.2012.09.020; Owen T., 1977, Journal of Geophysical Research, V82, DOI 10.1029/JS082i028p04635; OWEN T, 1975, ASTROPHYS J, V197, pL37, DOI 10.1086/181771; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Pauzat F, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/29; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Prieto-Ballesteros O, 2006, GEOLOGY, V34, P149, DOI 10.1130/G22311.1; Prieto-Ballesteros O, 2005, ICARUS, V177, P491, DOI 10.1016/j.icarus.2005.02.021; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Renssen H, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000968; Ross RG, 1998, ASTROPHYS SPACE SC L, V227, P33; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Semaniak J, 1998, ASTROPHYS J, V498, P886, DOI 10.1086/305581; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Stansberry JA, 1996, PLANET SPACE SCI, V44, P1051, DOI 10.1016/0032-0633(96)00084-0; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; Talbi D, 1998, CHEM PHYS, V232, P267, DOI 10.1016/S0301-0104(98)00124-4; Thi WF, 2002, ASTRON ASTROPHYS, V394, pL27, DOI 10.1051/0004-6361:20021353; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Visscher C, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/72; Waite J. H., 2014, WORKSH HAB IC WORLDS; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981; Zhang K, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/82; Zolotov M. Y., 2009, EUROPA, P431	166	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1531-1074	1557-8070		ASTROBIOLOGY	Astrobiology	APR 1	2015	15	4					308	326		10.1089/ast.2014.1189		19	Astronomy & Astrophysics; Biology; Geosciences, Multidisciplinary	Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics; Geology	CF5XI	WOS:000352630200007		
J	Akiyama, E; Muto, T; Kusakabe, N; Kataoka, A; Hashimoto, J; Tsukagoshi, T; Kwon, J; Kudo, T; Kandori, R; Grady, CA; Takami, M; Janson, M; Kuzuhara, M; Henning, T; Sitko, ML; Carson, JC; Mayama, S; Currie, T; Thalmann, C; Wisniewski, J; Momose, M; Ohashi, N; Abe, L; Brandner, W; Brandt, TD; Egner, S; Feldt, M; Goto, M; Guyon, O; Hayano, Y; Hayashi, M; Hayashi, S; Hodapp, KW; Ishi, M; Iye, M; Knapp, GR; Matsuo, T; Mcelwain, MW; Miyama, S; Morino, JI; Moro-Martin, A; Nishimura, T; Pyo, TS; Serabyn, G; Suenaga, T; Suto, H; Suzuki, R; Takahashi, YH; Takato, N; Terada, H; Tomono, D; Turner, EL; Watanabe, M; Yamada, T; Takami, H; Usuda, T; Tamura, M				Akiyama, E.; Muto, T.; Kusakabe, N.; Kataoka, A.; Hashimoto, J.; Tsukagoshi, T.; Kwon, J.; Kudo, T.; Kandori, R.; Grady, C. A.; Takami, M.; Janson, M.; Kuzuhara, M.; Henning, T.; Sitko, M. L.; Carson, J. C.; Mayama, S.; Currie, T.; Thalmann, C.; Wisniewski, J.; Momose, M.; Ohashi, N.; Abe, L.; Brandner, W.; Brandt, T. D.; Egner, S.; Feldt, M.; Goto, M.; Guyon, O.; Hayano, Y.; Hayashi, M.; Hayashi, S.; Hodapp, K. W.; Ishi, M.; Iye, M.; Knapp, G. R.; Matsuo, T.; Mcelwain, M. W.; Miyama, S.; Morino, J. -I.; Moro-Martin, A.; Nishimura, T.; Pyo, T. -S.; Serabyn, G.; Suenaga, T.; Suto, H.; Suzuki, R.; Takahashi, Y. H.; Takato, N.; Terada, H.; Tomono, D.; Turner, E. L.; Watanabe, M.; Yamada, T.; Takami, H.; Usuda, T.; Tamura, M.			DISCOVERY OF A DISK GAP CANDIDATE AT 20 AU IN TW HYDRAE	ASTROPHYSICAL JOURNAL LETTERS			English	Article						planetary systems; protoplanetary disks; stars: individual (TW Hydrae); stars: pre-main sequence; techniques: polarimetric	SPECTRAL ENERGY-DISTRIBUTIONS; PROTOPLANETARY DISKS; TAURI STARS; SUBMILLIMETER ARRAY; CIRCUMSTELLAR DISKS; TRANSITION DISKS; SCATTERED-LIGHT; HYA; SIGNATURES; PLANETS	We present a new Subaru/HiCIAO high-contrast H-band polarized intensity (PI) image of a nearby transitional disk associated with TW Hydrae. The scattered light from the disk was detected from 0 ''.2 to 1 ''.5 (11-81 AU) and the PI image shows a clear axisymmetric depression in PI at similar to 0 ''.4 (similar to 20 AU) from the central star, similar to the similar to 80 AU gap previously reported from Hubble Space Telescope images. The azimuthal PI profile also shows that the disk beyond 0 ''.2 is almost axisymmetric. We discuss two possible scenarios explaining the origin of the PI depression: (1) a gap structure may exist at similar to 20 AU from the central star because of a shallow slope seen in the PI profile, and (2) grain growth may be occurring in the inner region of the disk. Multi-band observations at near-infrared and millimeter/submillimeter wavelengths play a complementary role in investigating dust opacity and may help reveal the origin of the gap more precisely.	[Akiyama, E.; Kusakabe, N.; Kandori, R.; Hayashi, M.; Ishi, M.; Iye, M.; Morino, J. -I.; Suto, H.; Suzuki, R.; Takahashi, Y. H.; Takami, H.; Usuda, T.; Tamura, M.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Muto, T.] Kogakuin Univ, Div Liberal Arts, Shinjuku Ku, Tokyo 1638677, Japan; [Kataoka, A.; Kuzuhara, M.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Hashimoto, J.; Wisniewski, J.] Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA; [Tsukagoshi, T.; Momose, M.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Kwon, J.; Takahashi, Y. H.; Tamura, M.] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Kudo, T.; Currie, T.; Ohashi, N.; Egner, S.; Guyon, O.; Hayano, Y.; Nishimura, T.; Pyo, T. -S.; Takato, N.; Terada, H.; Tomono, D.] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Grady, C. A.] Eureka Sci, Oakland, CA 96002 USA; [Takami, M.] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Janson, M.] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, SE-10691 Stockholm, Sweden; [Henning, T.; Carson, J. C.; Brandner, W.; Feldt, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Sitko, M. L.] Space Sci Inst, Boulder, CO 80301 USA; [Sitko, M. L.] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA; [Carson, J. C.] Coll Charleston, Dept Phys & Astron, Charleston, SC 29424 USA; [Mayama, S.] Grad Univ Adv Studies, Ctr Promot Integrated Sci, Shonan Int Village, Miura, Kanagawa 2400115, Japan; [Thalmann, C.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Abe, L.] Univ Nice Sophia Antipolis, Lab Hippolyte Fizeau, UMR6525, F-06108 Nice, France; [Brandt, T. D.; Knapp, G. R.; Turner, E. L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Goto, M.] Univ Munich, Univ Sternwarte Munchen 12, D-81679 Munich, Germany; [Hodapp, K. W.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA; [Matsuo, T.] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Mcelwain, M. W.] NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; [Miyama, S.] Hiroshima Univ, Hiroshima 7398511, Japan; [Moro-Martin, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Moro-Martin, A.] Johns Hopkins Univ, Ctr Astrophys Sci, Baltimore, MD 21218 USA; [Serabyn, G.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Suenaga, T.] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Astron Sci, Mitaka, Tokyo 1818588, Japan; [Turner, E. L.] Univ Tokyo, Kavli Inst Phys & Math Univ, Kashiwa, Chiba 2278568, Japan; [Watanabe, M.] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamada, T.] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Akiyama, E (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	eiji.akiyama@nao.ac.jp	MIYAMA, Shoken/A-3598-2015		KAKENHI [22000005, 23103004, 23740151]; NSF AST [1008440, 1009314]; NASA [NNX09AC73G, NNG13PB64P]; JSPS [23103004, 26800106, 26400224]; U.S. National Science Foundation [1009203]; Ministry of Science and Technology (MoST) of Taiwan [103-2112-M-001-029];  [26.04023]	This work is partially supported by KAKENHI 22000005 (M.T.), KAKENHI 23103004, 23740151 (M.F.), NSF AST 1008440 (C.A.G.), NSF AST 1009314 (J.P.W.), and NASA NNX09AC73G (C.A.G. and M.L.S.). C.A.G. was also supported by NSF AST 1008440 and through the NASA Origins of Solar Systems program on NNG13PB64P. J.K. is supported by Grant-in-Aid for JSPS Fellows (26.04023). T.M. is supported by JSPS KAKENHI grant Numbers 26800106, 23103004, and 26400224. J.C. is supported by a grant from the U.S. National Science Foundation under Award No. 1009203. M.T. is supported by Ministry of Science and Technology (MoST) of Taiwan (grant No. 103-2112-M-001-029).	Andrews SM, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/42; Andrews SM, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/162; Clarke CJ, 2001, MON NOT R ASTRON SOC, V328, P485, DOI 10.1046/j.1365-8711.2001.04891.x; MIYAKE K, 1993, ICARUS, V106, P20, DOI 10.1006/icar.1993.1156; Bergin EA, 2013, NATURE, V493, P644, DOI 10.1038/nature11805; Owen JE, 2011, MON NOT R ASTRON SOC, V412, P13, DOI 10.1111/j.1365-2966.2010.17818.x; Hayano Y, 2008, P SOC PHOTO-OPT INS, V7015, DOI 10.1117/12.789992; Hughes AM, 2008, ASTROPHYS J, V678, P1119, DOI 10.1086/586730; Roberge A, 2005, ASTROPHYS J, V622, P1171, DOI 10.1086/427974; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Krist JE, 2000, ASTROPHYS J, V538, P793, DOI 10.1086/309170; Brauer F, 2008, ASTRON ASTROPHYS, V480, P859, DOI 10.1051/0004-6361:20077759; KENYON SJ, 1987, ASTROPHYS J, V323, P714, DOI 10.1086/165866; STROM KM, 1989, ASTRON J, V97, P1451, DOI 10.1086/115085; Qi CH, 2004, ASTROPHYS J, V616, pL11, DOI 10.1086/421063; DUBRULLE B, 1995, ICARUS, V114, P237, DOI 10.1006/icar.1995.1058; FISCHER O, 1994, ASTRON ASTROPHYS, V284, P187; Wada K, 2009, ASTROPHYS J, V702, P1490, DOI 10.1088/0004-637X/702/2/1490; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Inoue AK, 2008, PUBL ASTRON SOC JPN, V60, P557; Apai D, 2004, ASTRON ASTROPHYS, V415, P671, DOI 10.1051/0004-6361:20034549; Birnstiel T, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219262; Currie T, 2014, ASTROPHYS J LETT, V796, DOI 10.1088/2041-8205/796/2/L30; Debes JH, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/45; Ducourant C, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322075; Fukagawa M, 2013, PUBL ASTRON SOC JPN, V65; Grady CA, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/48; Hashimoto J, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/2/L17; Hashimoto J, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L19; Isella A, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/30; Jang-Condell H, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/153; Jang-Condell H, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/34; Joos F., 2008, P SOC PHOTO-OPT INS, V7016; Mayama S, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L26; Menu J, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322961; Muto T, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L22; Muto T, 2010, ASTROPHYS J, V724, P448, DOI 10.1088/0004-637X/724/1/448; Owen JE, 2011, MON NOT R ASTRON SOC, V411, P1104, DOI 10.1111/j.1365-2966.2010.17750.x; Qi CH, 2006, ASTROPHYS J, V636, pL157, DOI 10.1086/500241; Takami M, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/145; Tamura M, 2006, P SOC PHOTO-OPT INS, V6269, pV2690, DOI 10.1117/12.670742; Tamura M, 2009, AIP CONF PROC, V1158, P11, DOI 10.1063/1.3215811; van Leeuwen F, 2007, ASTROPHYS SPACE SC L, V350, P3; Wada K, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322259; Weinberger AJ, 2002, ASTROPHYS J, V566, P409, DOI 10.1086/338076; Zhu ZH, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/47	46	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	APR 1	2015	802	2							L17	10.1088/2041-8205/802/2/L17		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CE9BL	WOS:000352138300004		
J	Favre, C; Bergin, EA; Cleeves, LI; Hersant, F; Qi, CH; Aikawa, Y				Favre, Cecile; Bergin, Edwin A.; Cleeves, L. Ilsedore; Hersant, Franck; Qi, Chunhua; Aikawa, Yuri			EVIDENCE FOR DCO+ AS A PROBE OF IONIZATION IN THE WARM DISK SURFACE	ASTROPHYSICAL JOURNAL LETTERS			English	Article						astrochemistry; ISM: abundances; protoplanetary disks; stars: formation	PROTOPLANETARY DISKS; DEUTERIUM FRACTIONATION; IMAGING SURVEY; HD 163296; DM TAURI; LY-ALPHA; CHEMISTRY; CO; MOLECULES; DEUTERATION	In this Letter, we model the chemistry of DCO+ in protoplanetary disks. We find that the overall distribution of the DCO+ abundance is qualitatively similar to that of CO but is dominated by a thin layer located at the inner disk surface. To understand its distribution, we investigate the different key gas-phase deuteration pathways that can lead to the formation of DCO+. Our analysis shows that the recent update in the exothermicity of the reaction involving CH2D+ as a parent molecule of DCO+ favors deuterium fractionation in warmer conditions. As a result, the formation of DCO+ is enhanced in the inner warm surface layers of the disk where X-ray ionization occurs. Our analysis points out that DCO+ is not a reliable tracer of the CO snow line as previously suggested. We thus predict that DCO+ is a tracer of active deuterium and, in particular, X-ray ionization of the inner disk.	[Favre, Cecile; Bergin, Edwin A.; Cleeves, L. Ilsedore] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Hersant, Franck] Univ Bordeaux, LAB, UMR 5804, F-33270 Floirac, France; [Hersant, Franck] CNRS, LAB, UMR 5804, F-33270 Floirac, France; [Qi, Chunhua] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Aikawa, Yuri] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan	Favre, C (reprint author), Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48109 USA.	cfavre@umich.edu			National Science Foundation [1008800]	This work was supported by the National Science Foundation under grant 1008800. F.H. thanks the Department of Astronomy (University of Michigan) for its hospitality.	Aikawa Y, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/40; Oberg KI, 2010, ASTROPHYS J, V720, P480, DOI 10.1088/0004-637X/720/1/480; Hersant F, 2009, ASTRON ASTROPHYS, V493, pL49, DOI 10.1051/0004-6361:200811082; Garrod RT, 2006, ASTRON ASTROPHYS, V457, P927, DOI 10.1051/0004-6361:20065560; Flower DR, 2006, ASTRON ASTROPHYS, V449, P621, DOI 10.1051/0004-6361:20054246; Garrod RT, 2008, ASTROPHYS J, V682, P283, DOI 10.1086/588035; Qi CH, 2008, ASTROPHYS J, V681, P1396, DOI 10.1086/588516; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Guilloteau S, 2006, ASTRON ASTROPHYS, V448, pL5, DOI 10.1051/0004-6361:200600005; van Dishoeck EF, 2003, ASTRON ASTROPHYS, V400, pL1, DOI 10.1051/0004-6361:20030091; Bethell TJ, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/78; Cleeves LI, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/5; Cleeves LI, 2014, SCIENCE, V345, P1590, DOI [10.1126/science.1258055, 10.1126/science.1258066]; Dutrey A., 2014, PROTOSTARS PLANETS 6, V317; Fogel JKJ, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/29; Mathews GS, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321600; Oberg KI, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/98; Oberg KI, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/152; Oberg KI, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/162; PAGANI L, 1992, ASTRON ASTROPHYS, V258, P479; Qi CH, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/84; Qi CH, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/34; Roueff E, 2013, J PHYS CHEM A, V117, P9959, DOI 10.1021/jp400119a; Schwarz KR, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/113; SMITH D, 1982, ASTROPHYS J, V263, P123, DOI 10.1086/160487; Tange O., 2011, USENIX MAGAZINE, V36, P42; Teague R, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201425268; WATSON WD, 1976, REV MOD PHYS, V48, P513, DOI 10.1103/RevModPhys.48.513; Wootten A., 1987, IAU S, V120, P311	30	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	APR 1	2015	802	2							L23	10.1088/2041-8205/802/2/L23		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CE9BL	WOS:000352138300010		
J	Koda, J; Yagi, M; Komiyama, Y; Boissier, S; Boselli, A; Bouquin, AYK; Meyer, JD; de Paz, AG; Imanishi, M; Madore, BF; Thilker, DA				Koda, Jin; Yagi, Masafumi; Komiyama, Yutaka; Boissier, Samuel; Boselli, Alessandro; Bouquin, Alexandre Y. K.; Meyer, Jennifer Donovan; Gil de Paz, Armando; Imanishi, Masatoshi; Madore, Barry F.; Thilker, David A.			DISCOVERY OF NEW DWARF GALAXY NEAR THE ISOLATED SPIRAL GALAXY NGC 6503	ASTROPHYSICAL JOURNAL LETTERS			English	Article						galaxies: dwarf; galaxies: individual (NGC 6503); galaxies: irregular; galaxies: stellar content	STAR-FORMATION; BRIGHT SATELLITES; STELLAR EVOLUTION; DISK GALAXIES; SUPRIME-CAM; LOCAL GROUP; LAMBDA-CDM; MILKY-WAY; CALIBRATION; CLUSTERS	We report the discovery of a new dwarf galaxy (NGC 6503-d1) during the Subaru extended ultraviolet disk survey. It is a likely companion of the spiral galaxy NGC 6503. The resolved images, in the B, V, R, i, and H alpha bands, show an irregular appearance due to bright stars with underlying, smooth and unresolved stellar emission. It is classified as the transition type (dwarf irregular (dIrr)/dwarf spheroidal (dSph)) between the dIrr and dSph types. Its structural properties are similar to those of the dwarfs in the Local Group, with an absolute magnitude M-V similar to -10.5, half-light radius r(e) similar to 400 pc, and central surface brightness mu(0,V) similar to 25.2. Despite the low stellar surface brightness environment, one H II region was detected, though its H alpha luminosity is low, indicating an absence of any appreciable O-stars at the current epoch. The presence of multiple stellar populations is indicated by the color-magnitude diagram of similar to 300 bright resolved stars and the total colors of the dwarf, with the majority of its total stellar mass similar to 4 x 10(6) M-circle dot in an old stellar population.	[Koda, Jin] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Yagi, Masafumi; Komiyama, Yutaka] Natl Inst Nat Sci, Natl Astron Observ Japan, Div Opt & Infrared Astron, Mitaka, Tokyo 1818588, Japan; [Boissier, Samuel; Boselli, Alessandro] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Bouquin, Alexandre Y. K.; Gil de Paz, Armando] Univ Complutense Madrid, Dept Astrofis, E-28040 Madrid, Spain; [Bouquin, Alexandre Y. K.; Gil de Paz, Armando] Univ Complutense Madrid, CC Atmosfera, E-28040 Madrid, Spain; [Meyer, Jennifer Donovan] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Imanishi, Masatoshi] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Madore, Barry F.] Carnegie Inst Sci, Pasadena, CA 91101 USA; [Thilker, David A.] Johns Hopkins Univ, Ctr Astrophys Sci, Baltimore, MD 21218 USA	Koda, J (reprint author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.	jin.koda@stonybrook.edu			Caltech under NASA [NAS5-98034]; NASA [NNX14AF74G]; NSF [AST-1211680]	This research used data collected with the Subaru Telescope operated by the National Astronomical Observatory of Japan and with the GALEX operated for NASA by the Caltech under NASA contract NAS5-98034, and used the NASA/IPAC Extragalactic Database (NED) operated by the Jet Propulsion Laboratory, Caltech, under contract with NASA. We thank an anonymous referee for constructive comments, Fumiaki Nakata for help in observations, Eric Greisen for HI data, and the Pan-STARRS1 Surveys collaboration for the photometric catalog. This research is supported by NASA through grant NNX14AF74G. J.K. also acknowledges support from the NSF (AST-1211680).	Thilker DA, 2007, ASTROPHYS J SUPPL S, V173, P538, DOI 10.1086/523853; Tang J, 2014, MON NOT R ASTRON SOC, V445, P4287, DOI 10.1093/mnras/stu2029; Sternberg A, 2003, ASTROPHYS J, V599, P1333, DOI 10.1086/379506; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Geha M, 2006, ASTROPHYS J, V653, P240, DOI 10.1086/508604; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Boylan-Kolchin M, 2012, MON NOT R ASTRON SOC, V422, P1203, DOI 10.1111/j.1365-2966.2012.20695.x; Ibata R, 2007, ASTROPHYS J, V671, P1591, DOI 10.1086/522574; Chen Y, 2014, MON NOT R ASTRON SOC, V444, P2525, DOI 10.1093/mnras/stu1605; Greisen EW, 2009, ASTRON J, V137, P4718, DOI 10.1088/0004-6256/137/6/4718; LEE MG, 1993, ASTROPHYS J, V417, P553, DOI 10.1086/173334; Tolstoy E, 2009, ANNU REV ASTRON ASTR, V47, P371, DOI 10.1146/annurev-astro-082708-101650; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Crnojevic D, 2014, ASTROPHYS J LETT, V795, DOI 10.1088/2041-8205/795/2/L35; de Vaucouleurs G., 1991, 3 REFERENCE CATALOGU; Donovan Meyer J., 2014, APJ UNPUB; Epinat B, 2008, MON NOT R ASTRON SOC, V388, P500, DOI 10.1111/j.1365-2966.2008.13422.x; Espada D, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/20; da Silva RL, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/145; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; Karachentsev ID, 2003, ASTRON ASTROPHYS, V398, P479, DOI 10.1051/0004-6361:20021566; Kravtsov AV, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/2/L31; Magnier EA, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/2/20; McConnachie AW, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/4; McGaugh SS, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/5/77; McQuinn K. B. W., 2015, ARXIV150107313; Merritt A, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/2/L37; Monachesi A, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/179; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Richardson JC, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/76; Schlafly EF, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/158; STETSON PB, 1987, PUBL ASTRON SOC PAC, V99, P191, DOI 10.1086/131977; Tollerud EJ, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L21; Tollerud EJ, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/102; Tonry JL, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/99; Yagi M, 2013, PUBL ASTRON SOC JPN, V65	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	APR 1	2015	802	2							L24	10.1088/2041-8205/802/2/L24		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CE9BL	WOS:000352138300011		
J	Yamada, H; Inomata, S; Tanimoto, H				Yamada, Hiroyuki; Inomata, Satoshi; Tanimoto, Hiroshi			Evaporative emissions in three-day diurnal breathing loss tests on passenger cars for the Japanese market	ATMOSPHERIC ENVIRONMENT			English	Article						Evaporative emissions; Breakthrough emissions; Gasoline passenger car; PTR plus SRI-MS; Ozone formation potential	VOLATILE ORGANIC-COMPOUNDS; CALIFORNIA REFORMULATED GASOLINE; MOTOR-VEHICLES; HYDROCARBON EMISSIONS; OZONE FORMATION; EXHAUST; REACTIVITY; VOC; UNCERTAINTY; SENSITIVITY	Breakthrough emissions that dominate diurnal evaporative emissions from gasoline vehicles were observed in continuous 3-day diurnal breathing loss (DBL) tests. These measurements were conducted on nine vehicles for the Japanese market. Two of these vehicles, made by US and European manufacturers, also meet regulations in their countries of origin. Four vehicles exhibited marked emissions caused by breakthrough emissions during the experimental period, all made by Japanese manufacturers. Using our experimental results, we estimate the total diurnal evaporative emissions from gasoline vehicles in Japan to be 32,792 t y(-1). The compositions of the breakthrough and permeation emissions were analyzed in real time using proton transfer reaction plus switchable reagent ion mass spectrometry to estimate the ozone formation potential for the evaporative emissions. The real-time measurements showed that the adsorption of hydrocarbons in a sealed housing evaporative determination unit can result in underestimation, when concentrations are only monitored before and after a DBL test. The composition analysis gave an estimated maximum incremental reactivity (MIR) 20% higher for the breakthrough emissions than for the gasoline that was tested, while the MIR for the permeation emissions was almost the same as the MIR for the fuel. Evaporative emissions from gasoline vehicles in Japan were found to contribute 4.2% to emissions from stationary sources using a mass-based estimate, or 6.1% of emissions from stationary sources using a MIR-based estimate. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Hiroyuki] Natl Traff Safety & Environm Lab, Chofu, Tokyo 1820012, Japan; [Inomata, Satoshi; Tanimoto, Hiroshi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Yamada, H (reprint author), Natl Traff Safety & Environm Lab, 7-42-27 Jindaiji Higashimachi, Chofu, Tokyo 1820012, Japan.	h-yamada@ntsel.go.jp	Inomata, Satoshi/E-7364-2010; Tanimoto, Hiroshi/E-6779-2010				Carter WPL, 2010, ATMOS ENVIRON, V44, P5324, DOI 10.1016/j.atmosenv.2010.01.026; Martini G, 2014, SCI TOTAL ENVIRON, V487, P506, DOI 10.1016/j.scitotenv.2014.04.053; Adam TW, 2011, ATMOS ENVIRON, V45, P2842, DOI 10.1016/j.atmosenv.2011.03.002; Gentner DR, 2013, ENVIRON SCI TECHNOL, V47, P11837, DOI 10.1021/es401470e; Kirchstetter TW, 1996, ENVIRON SCI TECHNOL, V30, P661, DOI 10.1021/es950406p; Schmitz T, 2000, ATMOS ENVIRON, V34, P4639, DOI 10.1016/S1352-2310(00)00303-4; Wang J, 2013, SCI TOTAL ENVIRON, V445, P110, DOI 10.1016/j.scitotenv.2012.12.044; Chen JJ, 2012, ATMOS ENVIRON, V55, P448, DOI 10.1016/j.atmosenv.2012.02.082; Harley RA, 2000, ENVIRON SCI TECHNOL, V34, P4088, DOI 10.1021/es0009875; Jordan A, 2009, INT J MASS SPECTROM, V286, P32, DOI 10.1016/j.ijms.2009.06.006; Yamada H, 2013, SCI TOTAL ENVIRON, V449, P143, DOI 10.1016/j.scitotenv.2013.01.045; Kirchstetter TW, 1999, ENVIRON SCI TECHNOL, V33, P329, DOI 10.1021/es980374g; Chatani S, 2011, ATMOS ENVIRON, V45, P1383, DOI 10.1016/j.atmosenv.2010.12.036; Carter WPL, 2013, ATMOS ENVIRON, V77, P404, DOI 10.1016/j.atmosenv.2013.05.021; Nakashima Y, 2010, ATMOS ENVIRON, V44, P468, DOI 10.1016/j.atmosenv.2009.11.006; Erickson MH, 2014, ATMOS MEAS TECH, V7, P225, DOI 10.5194/amt-7-225-2014; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; Costagliola MA, 2014, SCI TOTAL ENVIRON, V468, P1043, DOI 10.1016/j.scitotenv.2013.09.025; Gentner DR, 2009, ENVIRON SCI TECHNOL, V43, P4247, DOI 10.1021/es9006228; Automobile Inspection & Registration Information Association, 2013, MONTHL REP VEH NUMB; Burns V.R., 1992, 920323 SAE; California Environmental Protection Agency, 2009, TABL MAX INCR REACT; Dimitriades B, 1996, J AIR WASTE MANAGE, V46, P963; European Environment Agency, 2013, 9 EEA; Farrugia J., 2005, 2005010683 SAE; Inomata S, 2014, CHEM LETT, V43, P538, DOI 10.1246/cl.131105; Japanese Standards Association, 2003, K253622003 JIS; Lough GC, 2005, J AIR WASTE MANAGE, V55, P629; Manufacturers of Emission Controls Association, 2014, RED EV EM LARG SOURC; Martien PT, 2003, ENVIRON SCI TECHNOL, V37, P1598, DOI 10.1021/es026174t; Martini G., 2007, EUR22713EN; MILFORD JB, 1994, J GEOPHYS RES-ATMOS, V99, P3533, DOI 10.1029/93JD03224; Ministry of the Environment Japan, 2011, AIR QUAL MON REP; Ministry of the Environment Japan, 2013, REP VOC EM INV 2012; Olson K.L., 2000, 2000012950 SAE; Perry K.L., 1991, 912429 SAE; Pierson WR, 1999, J AIR WASTE MANAGE, V49, P498; Rubin JI, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006458; Spanel P, 1998, INT J MASS SPECTROM, V181, P1, DOI 10.1016/S1387-3806(98)14114-3; Tsai JH, 2012, ATMOS ENVIRON, V61, P499, DOI 10.1016/j.atmosenv.2012.07.078; U.S. Environmental Protection Agency, 2012, EPA454R12001; Yamada H., 2014, J AUTOMOT ENG, V45, P443; Yamada H, 2013, J AUTOMOT ENG, V44, P165; Yang YJ, 1996, ENVIRON SCI TECHNOL, V30, P196, DOI 10.1021/es950244x; Zielinska B, 1996, ATMOS ENVIRON, V30, P2269, DOI 10.1016/1352-2310(95)00116-6	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	APR	2015	107						166	173		10.1016/j.atmosenv.2015.02.032		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CE6UY	WOS:000351974900017		
J	Matsuda, K; Watanabe, I; Mizukami, K; Ban, S; Takahashi, A				Matsuda, Kazuhide; Watanabe, Ichiro; Mizukami, Kou; Ban, Satomi; Takahashi, Akira			Dry deposition of PM2.5 sulfate above a hilly forest using relaxed eddy accumulation	ATMOSPHERIC ENVIRONMENT			English	Article						Deposition velocity; Aerosol; REA; Complex terrain; EANET	VEGETATIVE CANOPIES; PARTICLE DEPOSITION; TROPICAL FOREST; VELOCITY; FLUX; EXCHANGE; THAILAND; AMMONIA; MODEL; SO2	Sulfur compounds continue to be an important component of atmospheric deposition in East Asia. In order to better understand the dry deposition of PM2.5 sulfate, which is one of the most significant transboundary air pollutants in this region, we measured the dry deposition flux of PM2.5 sulfate above a hilly forest of the Field Museum Tamakyuryo (FM Tama) site in suburban Tokyo. We used the relaxed eddy accumulation (REA) method and took measurements during the summer, from 26 July to 2 August 2013, and the autumn, from 18 to 22 November 2013. We primarily focused on the evaluation of dry deposition above a forest on complex terrain. The total flux and 80% of the runs showed downward flux. The deposition velocities measured by the REA method during times when the wind direction was from a relatively uniform sloping surface over the forest were more reasonable than those measured when the wind direction was from a more complex surface. Using a resistance model that includes the effect of growth of hygroscopic aerosols, we inferred the deposition velocities during two experimental periods. When the fluxes were averaged for a long time (i.e., about 2 weeks) the inferred fluxes and deposition velocities were in reasonable agreement with the measurements. Although averages over long periods showed good agreement, the measured deposition velocities were distributed in a wider range than those inferred by the model. An increased range of deposition velocities was associated with flux footprints from complex terrain. It is possible that the agreements between measured and inferred fluxes or deposition velocities at the site are because the depositions of sulfate are largely controlled by surface factors rather than aerodynamic resistance. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsuda, Kazuhide; Mizukami, Kou; Ban, Satomi; Takahashi, Akira] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan; [Watanabe, Ichiro; Ban, Satomi] Japan Environm Sanitat Ctr, Kawasaki, Kanagawa 2100828, Japan; [Takahashi, Akira] Cent Res Inst Elect Power Ind, Chiba 2701194, Japan	Matsuda, K (reprint author), Tokyo Univ Agr & Technol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	kmatsuda@cc.tuat.ac.jp	Matsuda, Kazuhide/C-2041-2013		JSPS KAKENHI [20120012]; Tokyu Foundation for Better Environment [2014-16]	We gratefully acknowledge the support of Prof. Hiroshi Hara of the Tokyo University of Agriculture and Technology. We also thank Mr. Takafumi Miyake, Mr. Tatsuya Yamazaki, and Ms. Ayaka Hara of the Matsuda Laboratory for their contributions to the experiments presented herein. A part of this work was supported by JSPS KAKENHI (Grant Number 20120012) and The Tokyu Foundation for Better Environment (Grant Number 2014-16).	Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Wyers GP, 1997, ATMOS ENVIRON, V31, P333, DOI 10.1016/S1352-2310(96)00188-4; Baum KA, 2009, ATMOS ENVIRON, V43, P1753, DOI 10.1016/j.atmosenv.2008.12.021; Pryor SC, 2008, TELLUS B, V60, P42, DOI 10.1111/j.1600-0889.2007.00298.x; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; SLINN WGN, 1982, ATMOS ENVIRON, V16, P1785, DOI 10.1016/0004-6981(82)90271-2; Hole LR, 2008, ENVIRON POLLUT, V154, P473, DOI 10.1016/j.envpol.2007.06.061; Endo T, 2011, ATMOS ENVIRON, V45, P1259, DOI 10.1016/j.atmosenv.2010.12.003; Chatani S., 2011, JPN J ATMOS ENV, V46, P101; EANET (Acid Deposition Monitoring Network in East Asia),, 2011, 2 PER REP STAT AC 3, pii; EANET (Acid Deposition Monitoring Network in East Asia), 2010, TECHN MAN DRY DEP FL, P23; Erisman J. W., 1995, STUDIES ENV SCI, V63, P55; Erisman JW, 1997, ATMOS ENVIRON, V31, P321, DOI 10.1016/S1352-2310(96)00223-3; Foken T., 2008, MICROMETEOROLOGY, P105, DOI 10.1007/978-3-540-74666-9_4; Garland J.A., 2001, WATER AIR SOIL POLL, V1, P323, DOI 10.1023/A:1013183911748; Hicks B.B., 1988, MEASURING MODELLING, P541; Horvath L, 2003, ATMOS ENVIRON, V37, P4419, DOI 10.1016/S1352-2310(03)00584-3; Katata G, 2014, ATMOS ENVIRON, V97, P501, DOI 10.1016/j.atmosenv.2013.11.028; Matsuda K, 2012, ATMOS ENVIRON, V54, P282, DOI 10.1016/j.atmosenv.2012.02.022; Matsuda K, 2006, ATMOS ENVIRON, V40, P7557, DOI 10.1016/j.atmosenv.2006.07.003; Matsuda K., 2002, J JAPAN SOC ATMOSPHE, V37, P387; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; Meyers TP, 2006, AGR FOREST METEOROL, V136, P203, DOI 10.1016/j.agrformet.2004.10.005; Milne R, 1999, BOUND-LAY METEOROL, V93, P211, DOI 10.1023/A:1002061514948; Miyashima Y., 2011, J JPN SOC ATMOS ENV, V46, P119; Moravek A, 2013, J GEOPHYS RES-ATMOS, V118, P10210, DOI 10.1002/jgrd.50763; Myles L, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/3/034004; Ruijgrok W, 1997, ATMOS ENVIRON, V31, P399, DOI 10.1016/S1352-2310(96)00089-1; Seinfeld J.H., 2006, ATMOSPHERIC CHEM PHY, P407; Sorimachi A, 2003, ATMOS ENVIRON, V37, P3157, DOI 10.1016/S1352-2310(03)00180-8; Tsai JL, 2010, ATMOS ENVIRON, V44, P1011, DOI 10.1016/j.atmosenv.2009.12.022	31	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	APR	2015	107						255	261		10.1016/j.atmosenv.2015.02.050		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CE6UY	WOS:000351974900026		
J	Sastyin, G; Niimi, R; Yokosawa, K				Sastyin, Gergo; Niimi, Ryosuke; Yokosawa, Kazuhiko			Does object view influence the scene consistency effect?	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Object recognition; Scene perception; Natural image perception; High-level vision	RECOGNITION; CONTEXT; IDENTIFICATION; PERCEPTION; CATEGORIZATION; LANGUAGE; AXIS	Traditional research on the scene consistency effect only used clearly recognizable object stimuli to show mutually interactive context effects for both the object and background components on scene perception (Davenport & Potter in Psychological Science, 15, 559-564, 2004). However, in real environments, objects are viewed from multiple viewpoints, including an accidental, hard-to-recognize one. When the observers named target objects in scenes (Experiments 1a and 1b, object recognition task), we replicated the scene consistency effect (i.e., there was higher accuracy for the objects with consistent backgrounds). However, there was a significant interaction effect between consistency and object viewpoint, which indicated that the scene consistency effect was more important for identifying objects in the accidental view condition than in the canonical view condition. Therefore, the object recognition system may rely more on the scene context when the object is difficult to recognize. In Experiment 2, the observers identified the background (background recognition task) while the scene consistency and object views were manipulated. The results showed that object viewpoint had no effect, while the scene consistency effect was observed. More specifically, the canonical and accidental views both equally provided contextual information for scene perception. These findings suggested that the mechanism for conscious recognition of objects could be dissociated from the mechanism for visual analysis of object images that were part of a scene. The "context" that the object images provided may have been derived from its view-invariant, relatively low-level visual features (e.g., color), rather than its semantic information.	[Sastyin, Gergo; Niimi, Ryosuke; Yokosawa, Kazuhiko] Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, Tokyo 1130033, Japan	Niimi, R (reprint author), Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	niimi@L.u-tokyo.ac.jp	Niimi, Ryosuke/F-1535-2014	Niimi, Ryosuke/0000-0003-1916-9853			Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Davenport JL, 2007, MEM COGNITION, V35, P393, DOI 10.3758/BF03193280; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; LANDAU B, 1993, BEHAV BRAIN SCI, V16, P217; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Ji LJ, 2004, J PERS SOC PSYCHOL, V87, P57, DOI 10.1037/0022-3514.87.1.57; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037//0033-295X.94.2.115; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037//0096-1523.15.3.556; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; HUMPHREY GK, 1993, Q J EXP PSYCHOL-A, V46, P137; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; Marr D., 1982, VISION COMPUTATIONAL, DOI [10.1002/neu.480130612, DOI 10.1002/NEU.480130612]; Mitsumatsu H, 2002, PERCEPTION, V31, P1289, DOI 10.1068/p3421; Munneke J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00552; Newell FN, 1997, PERCEPTION, V26, P1231, DOI 10.1068/p261231; Niimi R, 2009, PERCEPTION, V38, P533, DOI 10.1068/p6161; Palmer S. E., 1981, ATTENTION PERFORM, V9, P135; PALMER SE, 1975, MEM COGNITION, V3, P519; Van Eylen L, 2013, RES AUTISM SPECT DIS, V7, P913, DOI 10.1016/j.rasd.2013.04.005	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	APR	2015	77	3					856	866		10.3758/s13414-014-0817-x		11	Psychology; Psychology, Experimental	Psychology	CF0YR	WOS:000352271100015		
J	Mitsuda, T; Yoshioka, Y				Mitsuda, Takashi; Yoshioka, Yuichi			Taken last, selected first: The sampling bias is also present in the haptic domain	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Gaze bias; Preference; Haptic; Tactile sense; Decision making; Dislike	GAZE BIAS; PREFERENCE; JUDGMENTS; CHOICE; EXPOSURE	When people are presented with a pair of images and asked to identify which one is more attractive, their eye gaze shifts gradually toward the image that they eventually choose. This study examined whether this sampling bias also occurs in other sensory modalities by observing participants' behavior in a haptic preference task. The results indicated that the participants tended to sample the chosen item just prior to making their decision when they were instructed to identify their most preferred item (i.e., the "like" task), but not when they were instructed to identify their least preferred item (i.e., the "dislike" task). This indicates that the sampling bias is a general phenomenon regardless of sensory modality. In addition, the sampling bias in the like task was larger when the difference in preference ratings between the paired items was smaller. However, the sampling bias decreased when the two items were given equal preference ratings, despite there being a longer decision time on those trials. This suggests that the sampling bias is not simply related to task difficulty, but is also related to preference formation and/or selective encoding of task-relevant information.	[Mitsuda, Takashi; Yoshioka, Yuichi] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Shiga 5258577, Japan	Mitsuda, T (reprint author), Ritsumeikan Univ, Coll Informat Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	mitsuda@ci.ritsumei.ac.jp					Grohmann B, 2007, J RETAILING, V83, P237, DOI 10.1016/j.jretai.2006.09.001; Mantonakis A, 2009, PSYCHOL SCI, V20, P1309, DOI 10.1111/j.1467-9280.2009.02453.x; [Anonymous], 2013, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2013.00863; Meloy MG, 2004, ORGAN BEHAV HUM DEC, V93, P114, DOI 10.1016/j.obhdp.2003.12.002; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Peck J, 2003, J MARKETING, V67, P35, DOI 10.1509/jmkg.67.2.35.18612; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Glaholt M. G., 2011, J NEUROSCI PSYCHOL E, V4, P125, DOI [DOI 10.1037/A0020692, 10.1037/a0020692]; Glaholt MG, 2009, VIS COGN, V17, P1228, DOI 10.1080/13506280802362962; Jakesch M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031215; Lindsen JP, 2011, CONSCIOUS COGN, V20, P1781, DOI 10.1016/j.concog.2011.01.008; Mitsuda T, 2014, VIS COGN, V22, P11; Nittono H, 2009, PERCEPT MOTOR SKILL, V109, P79, DOI 10.2466/PMS.109.1.79-94; Schotter ER, 2010, VIS COGN, V18, P1113, DOI 10.1080/13506281003668900; SHAFIR E, 1993, MEM COGNITION, V21, P546, DOI 10.3758/BF03197186; Yamagishi K, 1996, J EXP PSYCHOL LEARN, V22, P493; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	APR	2015	77	3					941	947		10.3758/s13414-014-0803-3		7	Psychology; Psychology, Experimental	Psychology	CF0YR	WOS:000352271100024		
J	Nakamoto, H; Mori, S; Ikudome, S; Unenaka, S; Imanaka, K				Nakamoto, Hiroki; Mori, Shiro; Ikudome, Sachi; Unenaka, Satoshi; Imanaka, Kuniyasu			Effects of sport expertise on representational momentum during timing control	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Representational momentum; Sport expertise; Visuo-motor control	ATTACKING FOREHAND DRIVE; TO-CONTACT ESTIMATION; INTERCEPTIVE ACTIONS; MOTION EXTRAPOLATION; PREDICTION-MOTION; TIME DELAYS; BALL; PERCEPTION; MOVEMENT; ANTICIPATION	Sports involving fast visual perception require players to compensate for delays in neural processing of visual information. Memory for the final position of a moving object is distorted forward along its path of motion (i.e., "representational momentum," RM). This cognitive extrapolation of visual perception might compensate for the neural delay in interacting appropriately with a moving object. The present study examined whether experienced batters cognitively extrapolate the location of a fast-moving object and whether this extrapolation is associated with coincident timing control. Nine expert and nine novice baseball players performed a prediction motion task in which a target moved from one end of a straight 400-cm track at a constant velocity. In half of the trials, vision was suddenly occluded when the target reached the 200-cm point (occlusion condition). Participants had to press a button concurrently with the target arrival at the end of the track and verbally report their subjective assessment of the first target-occluded position. Experts showed larger RM magnitude (cognitive extrapolation) than did novices in the occlusion condition. RM magnitude and timing errors were strongly correlated in the fast velocity condition in both experts and novices, whereas in the slow velocity condition, a significant correlation appeared only in experts. This suggests that experts can cognitively extrapolate the location of a moving object according to their anticipation and, as a result, potentially circumvent neural processing delays. This process might be used to control response timing when interacting with moving objects.	[Nakamoto, Hiroki; Mori, Shiro; Ikudome, Sachi] Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Unenaka, Satoshi] Natl Inst Fitness & Sports Kanoya, Doctors Course, Grad Sch Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Imanaka, Kuniyasu] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Kinesiol, Hachioji, Tokyo 1920397, Japan	Nakamoto, H (reprint author), Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	nakamoto@nifs-k.ac.jp			JSPS KAKENHI [26702025, 25242060]	This work was supported by JSPS KAKENHI Grant Number 26702025 and 25242060.	Akpinar S, 2012, PERCEPT MOTOR SKILL, V115, P581, DOI 10.2466/30.25.27.PMS.115.5.581-593; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Didierjean A, 2005, VIS COGN, V12, P265, DOI 10.1080/13506280444000021; FREYD JJ, 1985, B PSYCHONOMIC SOC, V23, P443; Gilis B, 2008, J EXP PSYCHOL-APPL, V14, P21, DOI 10.1037/1076-898X.14.1.21; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; Gorman AD, 2012, Q J EXP PSYCHOL, V65, P1151, DOI 10.1080/17470218.2011.644306; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3; Singer RN, 1998, RES Q EXERCISE SPORT, V69, P290; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; DeLucia PR, 1998, J EXP PSYCHOL HUMAN, V24, P901, DOI 10.1037/0096-1523.24.3.901; Gray R, 2001, PERCEPTION, V30, P1007, DOI 10.1068/p3220; Reed CL, 1996, J EXP PSYCHOL HUMAN, V22, P839, DOI 10.1037/0096-1523.22.4.839; Munger MP, 2002, VIS COGN, V9, P177, DOI 10.1080/13506280143000386; Hubbard TL, 1997, J EXP PSYCHOL LEARN, V23, P1484, DOI 10.1037/0278-7393.23.6.1484; Marinovic W, 2009, EXP PSYCHOL, V56, P265, DOI 10.1027/1618-3169.56.4.265; VERFAILLIE K, 1991, J EXP PSYCHOL LEARN, V17, P302, DOI 10.1037/0278-7393.17.2.302; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Tresilian JR, 2006, EXP BRAIN RES, V171, P421, DOI 10.1007/s00221-005-0286-5; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; SCHIFF W, 1979, PERCEPTION, V8, P647, DOI 10.1068/p080647; Blattler C, 2010, VIS COGN, V18, P1253, DOI 10.1080/13506281003737119; TRESILIAN JR, 1995, PERCEPT PSYCHOPHYS, V57, P231, DOI 10.3758/BF03206510; HUBBARD TL, 1988, PERCEPT PSYCHOPHYS, V44, P211, DOI 10.3758/BF03206290; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; CAMPBELL FW, 1978, VISION RES, V18, P1297; VOLKMANN FC, 1968, J OPT SOC AM, V58, P562, DOI 10.1364/JOSA.58.000562; Blattler C, 2011, J EXP PSYCHOL HUMAN, V37, P1569, DOI 10.1037/a0023512; BAHILL AT, 1984, AM SCI, V72, P249; Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Blattler C, 2012, VIS COGN, V20, P988, DOI 10.1080/13506285.2012.716799; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; BOOTSMA RJ, 1991, RES Q EXERCISE SPORT, V62, P276; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; FROHLICH C, 1984, AM J PHYS, V52, P325, DOI 10.1119/1.13883; Harrold D, 2002, PERCEPT MOTOR SKILL, V94, P914, DOI 10.2466/PMS.94.3.914-920; Hubbard AW, 1954, RES QUART, V25, P42; Ikudome S, 2013, NEUROREPORT, V24, P879, DOI 10.1097/WNR.0000000000000010; JAGACINSKI RJ, 1983, J EXP PSYCHOL HUMAN, V9, P43, DOI 10.1037/0096-1523.9.1.43; Lee Seung-Min, 2010, IJASS(International Journal of Applied Sports Sciences), V22, P128; Le Runigo C, 2005, HUM MOVEMENT SCI, V24, P429, DOI 10.1016/j.humov.2005.06.008; Marinovic W., 2009, EXP PSYCHOL, V57, P292; Marinovic W, 2012, VISION RES, V60, P73, DOI 10.1016/j.visres.2012.03.010; Neto RMD, 2011, EXP BRAIN RES, V211, P109, DOI 10.1007/s00221-011-2657-4; Neto RMD, 2009, EXP BRAIN RES, V199, P135, DOI 10.1007/s00221-009-1987-y; Nijhawan R, 2009, PHILOS T R SOC A, V367, P1063, DOI 10.1098/rsta.2008.0270; PAYNE VG, 1986, J HUM MOVEMENT STUD, V12, P289; Ripoll H, 1997, J SPORT SCI, V15, P573, DOI 10.1080/026404197367001; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; SELIN C, 1959, RES QUART, V30, P232; Tenenbaum G., 2000, PSYCHOL SPORT EXERC, V1, P117, DOI [10.1016/S1469-0292(00)00008-X, DOI 10.1016/S1469-0292(00)00008-X]; Tyldesley D. A., 1975, J HUMAN MOVEMENT STU, V1, P172; WHITING HTA, 1970, ERGONOMICS, V13, P265, DOI 10.1080/00140137008931141; Williams A. M., 1999, VISUAL PERCEPTION AC; Williams T., 1986, SCI HITTING; Zago M, 2005, NEUROPSYCHOLOGIA, V43, P178, DOI 10.1016/j.neuropsychologia.2004.11.005	60	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	APR	2015	77	3					961	971		10.3758/s13414-014-0818-9		11	Psychology; Psychology, Experimental	Psychology	CF0YR	WOS:000352271100027		
J	Fukata, M; Sekiya, A; Murakami, T; Yokoi, N; Fukata, Y				Fukata, Masaki; Sekiya, Atsushi; Murakami, Tatsuro; Yokoi, Norihiko; Fukata, Yuko			Postsynaptic nanodomains generated by local palmitoylation cycles	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article						DHHC; intrabody; palmitoylation; super-resolution microscopy; synaptic nanodomain	PROTEIN PALMITOYLATION; AMPA RECEPTORS; NEURONAL DEVELOPMENT; EXCITATORY SYNAPSES; PSD-95; DENSITY; IDENTIFICATION; NEUROLIGINS; REVEALS; CBLN1	Precise regulation of protein assembly at specialized membrane domains is essential for diverse cellular functions including synaptic transmission. However, it is incompletely understood how protein clustering at the plasma membrane is initiated, maintained and controlled. Protein palmitoylation, a common post-translational modification, regulates protein targeting to the plasma membrane. Such modified proteins are enriched in these specialized membrane domains. In this review, we focus on palmitoylation of PSD-95, which is a major postsynaptic scaffolding protein and makes discrete postsynaptic nanodomains in a palmitoylation-dependent manner and discuss a determinant role of local palmitoylation cycles in creating highly localized hotspots at the membrane where specific proteins concentrate to organize functional domains.	[Fukata, Masaki; Sekiya, Atsushi; Murakami, Tatsuro; Yokoi, Norihiko; Fukata, Yuko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan; [Fukata, Masaki; Sekiya, Atsushi; Murakami, Tatsuro; Yokoi, Norihiko; Fukata, Yuko] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan	Fukata, M (reprint author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448787, Japan.	mfukata@nips.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [26291045]; Cabinet Office for Funding Program for Next Generation World-Leading Researchers [LS123]	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology [grant number 26291045]; and the Cabinet Office for Funding Program for Next Generation World-Leading Researchers [grant number LS123] to M.F.	Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Chen L, 2000, NATURE, V408, P936; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/nmeth.1293, 10.1038/NMETH.1293]; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; El-Hussein AE, 2000, SCIENCE, V290, P1364; Rao A, 1998, J NEUROSCI, V18, P1217; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08	43	0	0	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	APR	2015	43		2				199	204		10.1042/BST20140238		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CF1GV	WOS:000352293500012		
J	Tsukui, T; Nagano, N; Umemura, M; Kumagai, T; Terai, G; Machida, M; Asai, K				Tsukui, Takahiro; Nagano, Nozomi; Umemura, Myco; Kumagai, Toshitaka; Terai, Goro; Machida, Masayuki; Asai, Kiyoshi			Ustiloxins, fungal cyclic peptides, are ribosomally synthesized in Ustilaginoidea virens	BIOINFORMATICS			English	Article							FALSE SMUT BALLS; RICE PANICLES; GENOME; SEQUENCES; ALIGNMENT; ACCURACY	Motivation: Ustiloxins A and B are toxic cyclic tetrapeptides, Tyr-Val/Ala-Ile-Gly (Y-V/A-I-G), that were originally identified from Ustilaginoidea virens, a pathogenic fungus affecting rice plants. Contrary to our report that ustiloxin B is ribosomally synthesized in Aspergillus flavus, a recent report suggested that ustiloxins are synthesized by a non-ribosomal peptide synthetase in U. virens. Thus, we analyzed the U. virens genome, to identify the responsible gene cluster. Results: The biosynthetic gene cluster was identified from the genome of U. virens based on homologies to the ribosomal peptide biosynthetic gene cluster for ustiloxin B identified from A. flavus. It contains a gene encoding precursor protein having five Tyr-Val-Ile-Gly and three Tyr-Ala-Ile-Gly motifs for ustiloxins A and B, respectively, strongly indicating that ustiloxins A and B from U. virens are ribosomally synthesized.	[Tsukui, Takahiro; Nagano, Nozomi; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350064, Japan; [Umemura, Myco; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan; [Kumagai, Toshitaka] Fermlab Inc, Tokyo 1350021, Japan; [Terai, Goro] INTEC Inc, Tokyo 1368637, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba 2778561, Japan	Umemura, M (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan.	umemura-m@aist.go.jp; asai@k.u-tokyo.ac.jp			commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work was supported by the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan.	Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; KOISO Y, 1994, J ANTIBIOT, V47, P765; KOISO Y, 1992, TETRAHEDRON LETT, V33, P4157, DOI 10.1016/S0040-4039(00)74677-6; Koiso Y, 1998, J ANTIBIOT, V51, P418; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Umemura M, 2014, FUNGAL GENET BIOL, V68, P23, DOI 10.1016/j.fgb.2014.04.011; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Gotoh O, 2000, BIOINFORMATICS, V16, P190, DOI 10.1093/bioinformatics/16.3.190; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Magrane M, 2011, DATABASE-OXFORD, V2011, DOI [DOI 10.1093/DATABASE/BAR009, 10.1093/database/bar009]; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Takeda I., 2014, GENOME ANNOUNC, V2; Umemura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084028; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4849	19	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	APR 1	2015	31	7					981	985		10.1093/bioinformatics/btu753		5	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CF0YC	WOS:000352269500001		
J	Kyoda, K; Tohsato, Y; Ho, KHL; Onami, S				Kyoda, Koji; Tohsato, Yukako; Ho, Kenneth H. L.; Onami, Shuichi			Biological Dynamics Markup Language (BDML): an open format for representing quantitative biological dynamics data	BIOINFORMATICS			English	Article							SINGLE-CELL RESOLUTION; CAENORHABDITIS-ELEGANS; MICROARRAY DATA; C. ELEGANS; MICROSCOPY; SPINDLE; EMBRYOS; MODEL; IMAGE; EMBRYOGENESIS	Motivation: Recent progress in live-cell imaging and modeling techniques has resulted in generation of a large amount of quantitative data (from experimental measurements and computer simulations) on spatiotemporal dynamics of biological objects such as molecules, cells and organisms. Although many research groups have independently dedicated their efforts to developing software tools for visualizing and analyzing these data, these tools are often not compatible with each other because of different data formats. Results: We developed an open unified format, Biological Dynamics Markup Language (BDML; current version: 0.2), which provides a basic framework for representing quantitative biological dynamics data for objects ranging from molecules to cells to organisms. BDML is based on Extensible Markup Language (XML). Its advantages are machine and human readability and extensibility. BDML will improve the efficiency of development and evaluation of software tools for data visualization and analysis.	[Kyoda, Koji; Tohsato, Yukako; Ho, Kenneth H. L.; Onami, Shuichi] RIKEN Quantitat Biol Ctr, Lab Dev Dynam, Kobe, Hyogo 6500047, Japan; [Onami, Shuichi] Japan Sci & Technol Agcy, Natl Biosci Database Ctr, Tokyo 1020081, Japan	Onami, S (reprint author), RIKEN Quantitat Biol Ctr, Lab Dev Dynam, Kobe, Hyogo 6500047, Japan.	sonami@riken.jp			National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	This work was supported by the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST).	Lawrence R, 2004, INFORM SOFTWARE TECH, V46, P753, DOI 10.1016/j.infsof.2004.02.003; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/nmeth.1476, 10.1038/NMETH.1476]; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/nmeth.1896, 10.1038/NMETH.1896]; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Achard F, 2001, BIOINFORMATICS, V17, P115, DOI 10.1093/bioinformatics/17.2.115; Boyle TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-275; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/nmeth.2560, 10.1038/NMETH.2560]; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Britten RD, 2013, MED BIOL ENG COMPUT, V51, P1191, DOI 10.1007/s11517-013-1097-7; Brooks DJ, 2011, IEEE ENG MED BIO, P5670, DOI 10.1109/IEMBS.2011.6091372; Brutzman D., 2007, MORGAN KAUFMANN SERI; Clarke JA, 2007, PROCEEDINGS OF THE HPCMP USERS GROUP CONFERENCE 2007, P322; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Dada JO, 2010, BIOINFORMATICS, V26, P932, DOI 10.1093/bioinformatics/btq069; Hamahashi S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-125; Hedley WJ, 2001, PHILOS T ROY SOC A, V359, P1073, DOI 10.1098/rsta.2001.0817; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Kyoda K, 2013, NUCLEIC ACIDS RES, V41, pD732, DOI 10.1093/nar/gks1107; Martens L., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/MCP.R110.000133-2; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Rayner TF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-489; Spellman PT, 2002, GENOME BIOL, V3; Stoma S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-126; Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130; Tsukada Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000223; Waltemath D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-198	43	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	APR 1	2015	31	7					1044	1052		10.1093/bioinformatics/btu767		9	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CF0YC	WOS:000352269500009		
J	Naito, Y; Hino, K; Bono, H; Ui-Tei, K				Naito, Yuki; Hino, Kimihiro; Bono, Hidemasa; Ui-Tei, Kumiko			CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites	BIOINFORMATICS			English	Article							HUMAN-CELLS; CAS9; SPECIFICITY; NUCLEASES; TOOL; DNA; ALIGNMENT; SYSTEMS	A Summary: CRISPRdirect is a simple and functional web server for selecting rational CRISPR/Cas targets from an input sequence. The CRISPR/Cas system is a promising technique for genome engineering which allows target-specific cleavage of genomic DNA guided by Cas9 nuclease in complex with a guide RNA (gRNA), that complementarily binds to a similar to 20 nt targeted sequence. The target sequence requirements are twofold. First, the 5'-NGG protospacer adjacent motif (PAM) sequence must be located adjacent to the target sequence. Second, the target sequence should be specific within the entire genome in order to avoid off-target editing. CRISPRdirect enables users to easily select rational target sequences with minimized off-target sites by performing exhaustive searches against genomic sequences. The server currently incorporates the genomic sequences of human, mouse, rat, marmoset, pig, chicken, frog, zebrafish, Ciona, fruit fly, silkworm, Caenorhabditis elegans, Arabidopsis, rice, Sorghum and budding yeast.	[Naito, Yuki; Bono, Hidemasa] Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Mishima, Shizuoka 4118540, Japan; [Naito, Yuki; Bono, Hidemasa] Res Org Informat & Syst, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Hino, Kimihiro; Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Naito, Y (reprint author), Res Org Informat & Syst, Database Ctr Life Sci DBCLS, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	y-naito@dbcls.rois.ac.jp		Bono, Hidemasa/0000-0003-4413-0651	Life Science Database Integration Project, National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cell Innovation Program of MEXT	Life Science Database Integration Project, National Bioscience Database Center (NBDC) of Japan Science and Technology Agency (JST) (to Y.N. and H.B.); Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to Y.N. and K.U.-T.); Cell Innovation Program of MEXT (to K.U.-T.).	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Ma M, 2013, BIOMED RES INT, DOI 10.1155/2013/270805; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	21	5	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	APR 1	2015	31	7					1120	1123		10.1093/bioinformatics/btu743		4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CF0YC	WOS:000352269500018		
J	Takeo, T; Horikoshi, Y; Nakao, S; Sakoh, K; Ishizuka, Y; Tsutsumi, A; Fukumoto, K; Kondo, T; Haruguchi, Y; Takeshita, Y; Nakamuta, Y; Tsuchiyama, S; Nakagata, N				Takeo, Toru; Horikoshi, Yuka; Nakao, Satohiro; Sakoh, Kazuhito; Ishizuka, Yuta; Tsutsumi, Aki; Fukumoto, Kiyoko; Kondo, Tomoko; Haruguchi, Yukie; Takeshita, Yumi; Nakamuta, Yuko; Tsuchiyama, Shuuji; Nakagata, Naomi			Cysteine Analogs with a Free Thiol Group Promote Fertilization by Reducing Disulfide Bonds in the Zona Pellucida of Mice	BIOLOGY OF REPRODUCTION			English	Article						assisted reproductive technology; fertilization; in vitro fertilization (IVF); oocyte; zona pellucida	IN-VITRO FERTILIZATION; METHYL-BETA-CYCLODEXTRIN; INTRACYTOPLASMIC SPERM INJECTION; CRYOPRESERVED MOUSE SPERM; EMBRYO DEVELOPMENT; CHOLESTEROL EFFLUX; BOVINE OOCYTES; AMINO-ACIDS; BULL SEMEN; BOAR SEMEN	Archives of cryopreserved sperm harvested from genetically engineered mice, in mouse resource centers, are a readily accessible genetic resource for the scientific community. We previously reported that exposure of oocytes to reduced glutathione (GSH) greatly improves the fertilization rate of frozen-thawed mouse sperm. Application of GSH to in vitro fertilization techniques is widely accepted as a standard protocol to produce sufficient numbers of mice from cryopreserved sperm. However, the detailed mechanism of the enhancement of fertilization mediated by GSH in vitro is not fully understood. Here we focused on the chemical by determining the effects of its amino acid constituents and cysteine analogs on the fertilization of oocytes by frozen-thawed sperm. Furthermore, we determined the stability of these compounds in aqueous solution. We show here that L-cysteine (L-Cys), D-cysteine (D-Cys), or N-acetyl-L-cysteine (NAC) increased the rate of fertilization when added to the medium but did not adversely affect embryo development in vitro or in vivo. The levels of thiol groups of proteins in the zona pellucida (ZP) and the expansion of the ZP were increased by L-Cys, D-Cys, and NAC. These effects were abrogated by the methylation of the thiol group of L-Cys. NAC was the most stable of these compounds in the fertilization medium at 4 degrees C. These results suggest that the thiol groups of cysteine analogs markedly enhance the fertilization rate of mouse oocytes.	[Takeo, Toru; Horikoshi, Yuka; Nakao, Satohiro; Sakoh, Kazuhito; Ishizuka, Yuta; Tsutsumi, Aki; Fukumoto, Kiyoko; Kondo, Tomoko; Haruguchi, Yukie; Takeshita, Yumi; Nakamuta, Yuko; Tsuchiyama, Shuuji; Nakagata, Naomi] Kumamoto Univ, CARD, Div Reprod Engn, Chuo Ku, Kumamoto 8600811, Japan	Nakagata, N (reprint author), Kumamoto Univ, CARD, Div Reprod Engn, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	nakagata@kumamoto-u.ac.jp	Takeo, Toru/A-3119-2010	Takeo, Toru/0000-0002-8103-651X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26860039]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Partially supported by a Grant-in-Aid for Scientific Research on Priority Areas (No. 26860039) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Grant-in-Aid for the Fundamental Technologies Upgrading Program, National BioResource Project (NBRP), from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Partyka A, 2013, CRYOBIOLOGY, V67, P132, DOI 10.1016/j.cryobiol.2013.06.002; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Nakagata N, 2000, MAMM GENOME, V11, P572, DOI 10.1007/s003350010109; QUINN P, 1985, FERTIL STERIL, V44, P493; Bilodeau JF, 2001, THERIOGENOLOGY, V56, P275, DOI 10.1016/S0093-691X(01)00562-3; Yeste M, 2013, REPROD FERT DEVELOP, V25, P1036, DOI 10.1071/RD12230; Michael A, 2007, THERIOGENOLOGY, V68, P204, DOI 10.1016/j.theriogenology.2007.04.053; Eppig JT, 1999, TRENDS GENET, V15, P81, DOI 10.1016/S0168-9525(98)01665-5; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Donahue LR, 2012, MAMM GENOME, V23, P559, DOI 10.1007/s00335-012-9420-4; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Iwamoto K, 1999, J REPROD FERTIL, V117, P395, DOI 10.1530/jrf.0.1170395; Takeo T, 2010, LAB ANIM-UK, V44, P132, DOI 10.1258/la.2009.009074; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Estrada E, 2014, ANDROLOGY-US, V2, P88, DOI 10.1111/j.2047-2927.2013.00144.x; Liu JM, 2012, HUM REPROD, V27, P1411, DOI 10.1093/humrep/des019; Kaeoket K, 2010, ASIAN J ANDROL, V12, P760, DOI 10.1038/aja.2010.48; Sztein JM, 2000, BIOL REPROD, V63, P1774, DOI 10.1095/biolreprod63.6.1774; deMatos DG, 1996, MOL REPROD DEV, V45, P451, DOI 10.1002/(SICI)1098-2795(199612)45:4<451::AID-MRD7>3.3.CO;2-Q; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415; YOSHIDA M, 1993, BIOL REPROD, V49, P89, DOI 10.1095/biolreprod49.1.89; Whitaker BD, 2012, REPROD FERT DEVELOP, V24, P1048, DOI 10.1071/RD12002; Thuwanut P, 2008, THERIOGENOLOGY, V70, P233, DOI 10.1016/j.theriogenology.2008.04.005; Bai J, 2008, THERIOGENOLOGY, V70, P758, DOI 10.1016/j.theriogenology.2008.04.053; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; BROOME JD, 1972, J NATL CANCER I, V49, P579; Caamano JN, 1998, J DAIRY SCI, V81, P369; Deleuze S, 2010, REPROD DOMEST ANIM, V45, pe476, DOI 10.1111/j.1439-0531.2010.01587.x; Gray JE, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109157; Guan M, 2012, MAMM GENOME, V23, P572, DOI 10.1007/s00335-012-9423-1; Ishizuka Y, 2013, THERIOGENOLOGY, V80, P421, DOI 10.1016/j.theriogenology.2013.07.002; Katayama M, 2007, THERIOGENOLOGY, V67, P835, DOI 10.1016/j.theriogenology.2006.10.015; Kito S, 2008, ZYGOTE, V16, P259, DOI 10.1017/S0967199408004619; Kito S, 1997, J REPROD FERTIL, V110, P35; Li XX, 2014, THERIOGENOLOGY, V81, P309, DOI 10.1016/j.theriogenology.2013.09.030; Nabenishi H, 2012, ZYGOTE, V20, P249, DOI 10.1017/S0967199411000220; Nakagata N, 1992, Jikken Dobutsu, V41, P387; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nishizono H, 2004, BIOL REPROD, V71, P973, DOI 10.1095/biolreprod.103.024422; Niwa K, 1993, J Reprod Fertil Suppl, V48, P49; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; Sariozkan S, 2009, CRYOBIOLOGY, V58, P134, DOI 10.1016/j.cryobiol.2008.11.006; SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4; Taguma K, 2009, EXP ANIM TOKYO, V58, P395, DOI 10.1538/expanim.58.395; Takeo T, 2012, CRYOBIOLOGY, V65, P163, DOI 10.1016/j.cryobiol.2012.06.002; Takeo T, 2014, CRYOBIOLOGY, V68, P12, DOI 10.1016/j.cryobiol.2013.10.007; Toyoda Y, 1971, JPN J ANIM REPROD, V16, P147; WHITTING.DG, 1968, NATURE, V220, P592, DOI 10.1038/220592a0; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353	55	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	APR 1	2015	92	4							90	10.1095/biolreprod.114.125443		7	Reproductive Biology	Reproductive Biology	CF7BX	WOS:000352712200008		
J	Hananouchi, T				Hananouchi, Takehito			Prophylactic bioactive screw fixation as an alternative augmentation for femoroplasty	BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK			English	Article						bioactive screw; femoral neck fracture; femoroplasty; osteoporosis	2ND HIP FRACTURE; PROXIMAL FEMUR; BIOMECHANICAL EVALUATION; COMPRESSION FRACTURES; CEMENT AUGMENTATION; BONE-CEMENT; OSTEOPOROSIS; PREVENTION; RISK; VERTEBROPLASTY	Femoroplasty is theoretically a prophylactic surgical procedure for femoral neck fracture. Although bone cement is generally used for augmentation, its distribution cannot be easily controlled. This study investigated whether a bioactive screw is feasible for femoroplasty as an alternative augmentation material. A mechanical test was done to compare the strength of four types of augmentation bioactive screw (Superfixsorb), two bioinert cements, or no intervention in a composite femoral bone. The peak load to fracture under simulated falling was compared among the four groups. The mean peak load to failure in the bioactive screw group (2667 N) was significantly higher than that in the intact group (2391 N) (p=0.028), comparable to that in the Simplex P cement group (2864 N) (p=0.11), and significantly lower than that of the cranioplastic cement group (3022 N) (p=0.006). The strength of a composite femur with the bioactive screw was higher than that of an intact bone and comparable to one cement augmentation. Thus, this bioactive screw can be potentially used as augmentation material for femoroplasty.	Osaka Sangyo Univ, Fac Engn, Dept Mech Engn, Med Engn Lab, Daito 5748530, Japan	Hananouchi, T (reprint author), Osaka Sangyo Univ, Fac Engn, Dept Mech Engn, Med Engn Lab, 3-1-1 Nakagaito, Daito 5748530, Japan.	hana-osaka@umin.net			Japan Osteoporosis Foundation	This study was partially supported by a grant from the Japan Osteoporosis Foundation (brought by Lilly Japan).	Heini PF, 2004, CLIN BIOMECH, V19, P506, DOI 10.1016/j.clinbiomech.2004.01.014; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; COURTNEY AC, 1995, J BONE JOINT SURG AM, V77A, P387; Beckmann J, 2007, MED ENG PHYS, V29, P755, DOI 10.1016/j.medengphy.2006.08.006; Mortensen L, 1998, J CLIN ENDOCR METAB, V83, P396, DOI 10.1210/jc.83.2.396; Sutter EG, 2010, J ORTHOP TRAUMA, V24, P95, DOI 10.1097/BOT.0b013e3181b5c0c6; Beckmann J, 2011, J ORTHOP RES, V29, P1753, DOI 10.1002/jor.21410; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5; Bai B, 1999, SPINE, V24, P1521, DOI 10.1097/00007632-199908010-00004; Belkoff SM, 2000, SPINE, V25, P1061, DOI 10.1097/00007632-200005010-00004; Boonen S, 2004, J AM GERIATR SOC, V52, P1832, DOI 10.1111/j.1532-5415.2004.52506.x; COBEY JC, 1976, CLIN ORTHOP RELAT R, P258; Egan M, 2008, CLIN REHABIL, V22, P272, DOI 10.1177/0269215507081573; Ettinger B, 1998, J MANAGE CARE PHARM, V4, P488; Formiga F, 2005, AGING CLIN EXP RES, V17, P96; Hananouchi T, 2012, OSTEOPOROSIS INT, V23, pS819; Ira P, 2006, ANN RHEUM DIS, V65, P87; Kessenich CR, 2007, CLIN INTERV AGING, V2, P263; Lin JT, 2008, NAT CLIN PRACT RHEUM, V4, P20, DOI 10.1038/ncprheum0702; Nymark T, 2006, OSTEOPOROSIS INT, V17, P1353, DOI 10.1007/s00198-006-0125-y; SCHRODER HM, 1993, CLIN ORTHOP RELAT R, P166; Strauss EJ, 2007, J ORTHOP TRAUMA, V21, P295, DOI 10.1097/BOT.0b013e3180616ba5; Tomita S, 2004, SPINE, V29, P1203, DOI 10.1097/00007632-200406010-00009; van der Steenhoven TJ, 2009, CLIN BIOMECH, V24, P286, DOI 10.1016/j.clinbiomech.2008.11.009; van der Steenhoven TJ, 2011, CLIN BIOMECH, V26, P464, DOI 10.1016/j.clinbiomech.2010.12.009	26	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0013-5585	1862-278X		BIOMED ENG-BIOMED TE	Biomed. Eng.-Biomed. Tech.	APR	2015	60	2					165	169		10.1515/bmt-2014-0169		5	Engineering, Biomedical; Medical Informatics	Engineering; Medical Informatics	CF0GQ	WOS:000352221600008		
J	Inami, K; Sasaki, T; Kumagai, T; Nagata, K				Inami, Keita; Sasaki, Takamitsu; Kumagai, Takeshi; Nagata, Kiyoshi			Simultaneous evaluation of human CYP3A4 and ABCB1 induction by reporter assay in LS174T cells, stably expressing their reporter genes	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						CYP3A4; P-gp; stable cell line; LS174T; reporter assay	VITAMIN-D-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; DRUG-DRUG INTERACTIONS; PREGNANE-X-RECEPTOR; P-GLYCOPROTEIN; TRANSCRIPTIONAL REGULATION; RESPONSE ELEMENTS; MEDIATED PATHWAY; LINE; MDR1	The bioavailability of orally administered therapies are often significantly limited in the human intestine by the metabolic activities of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp). Predicting whether candidate compounds induce CYP3A4 and P-gp is a crucial stage in the drug development process, as drug-drug interactions may result in the induction of intestinal CYP3A4 and P-gp. However, the assay systems needed to evaluate both CYP3A4 and P-gp induction in the intestine are yet to be established. To address this urgent requirement, LS174T cells were used to create two stable cell lines expressing the CYP3A4 or ATP-binding cassette subfamily B member 1 (ABCB1, encoding P-gp) reporter genes. First, these stable cells were tested by treatment with 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), all-trans-retinoic acid (ATRA) and 9-cis-retinoic acid (9-cis RA) that induce CYP3A4 and P-gp in the intestines. All these compounds significantly increased both CYP3A4 and ABCB1 reporter activities in the stable cell lines. To simultaneously assess the induction of CYP3A4 and ABCB1, both stable cells were co-cultivated to measure their reporter activities. The mixed cells showed a significant increase in the CYP3A4 and ABCB1 reporter activities following treatment with 1,25(OH)(2)D-3, ATRA, and 9-cis RA. These activity levels were maintained after passaging more than 20 times and following multiple freeze-thaw cycles. These results demonstrate that our established cell lines can be used to evaluate simultaneously CYP3A4 and ABCB1 induction in the intestines, providing a valuable in vitro model for the evaluation of future drug candidates. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Inami, Keita; Sasaki, Takamitsu; Kumagai, Takeshi; Nagata, Kiyoshi] Tohoku Pharmaceut Univ, Dept Environm & Hlth Sci, Sendai, Miyagi 9818558, Japan	Nagata, K (reprint author), Tohoku Pharmaceut Univ, Dept Environm & Hlth Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	nagataki@tohoku-pharm.ac.jp			Health and Labor Sciences Research Grant for Research on Food Safety from Ministry of Health, Labor and Welfare of Japan [22230301]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by a Health and Labor Sciences Research Grant for Research on Food Safety (No. 22230301) from the Ministry of Health, Labor and Welfare of Japan; and by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities.	Anglicheau D, 2003, NEPHROL DIAL TRANSPL, V18, P2409, DOI 10.1093/ndt/gfg381; Wang K, 2008, BIOCHEM PHARMACOL, V75, P2204, DOI 10.1016/j.bcp.2008.02.030; MCKINNON RA, 1995, GUT, V36, P259, DOI 10.1136/gut.36.2.259; Khan AA, 2009, EUR J PHARM SCI, V37, P115, DOI 10.1016/j.ejps.2009.01.006; Tachibana S, 2009, DRUG METAB DISPOS, V37, P1604, DOI 10.1124/dmd.109.027219; Pfrunder A, 2003, J PHARM PHARMACOL, V55, P59, DOI 10.1211/002235702441; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Galetin A, 2010, DRUG METAB PHARMACOK, V25, P28; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Gupta A, 2008, DRUG METAB DISPOS, V36, P1172, DOI 10.1124/dmd.107.018689; Watkins PB, 1997, ADV DRUG DELIVER REV, V27, P161, DOI 10.1016/S0169-409X(97)00041-0; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Kivisto KT, 2004, FUND CLIN PHARMACOL, V18, P621, DOI 10.1111/j.1472-8206.2004.00291.x; Chen SY, 2010, BIOCHEM PHARMACOL, V79, P270, DOI 10.1016/j.bcp.2009.08.012; Kliewer SA, 2003, J NUTR, V133, p2444S; Lis AP, 1995, TOXICOLOGY, V104, P1, DOI [10.1016/0300-483X(95)03155-9, DOI 10.1016/0300-483X(95)03155-9]; Luos G, 2002, DRUG METAB DISPOS, V30, P795, DOI [10.1124/dmd.30.7.795, DOI 10.1124/DMD.30.7.795]; Noracharttiyapot W, 2006, DRUG METAB PHARMACOK, V21, P99, DOI 10.2133/dmpk.21.99; Pavek P, 2010, BIOCHEM PHARMACOL, V79, P277, DOI 10.1016/j.bcp.2009.08.017; Saeki M, 2008, BIOCHEM PHARMACOL, V76, P531, DOI 10.1016/j.bcp.2008.05.030; Sato W, 2010, DRUG METAB PHARMACOK, V25, P180; Sekimoto M, 2012, BIOL PHARM BULL, V35, P677; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Toriyabe T, 2009, MOL PHARMACOL, V75, P677, DOI 10.1124/mol.108.050575; Zhang L, 2011, CLIN PHARMACOL THER, V89, P481, DOI 10.1038/clpt.2010.359	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	APR	2015	36	3					139	147		10.1002/bdd.1927		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF5WK	WOS:000352627800001		
J	Nakamaru, Y; Emoto, C; Shimizu, M; Yamazaki, H				Nakamaru, Yoshinobu; Emoto, Chie; Shimizu, Makiko; Yamazaki, Hiroshi			Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						teneligliptin; DPP-4 inhibitor; PBPK modeling; drug-drug interaction	MONOOXYGENASE-3	Teneligliptin is a type 2 diabetes drug that has an inhibitory effect on dipeptidyl peptidase-4. The aim of this study was to establish a physiologically based pharmacokinetic (PBPK) model to elucidate in detail the pharmacokinetics of teneligliptin. A PBPK model of teneligliptin was developed using the population-based Simcyp simulator incorporating the results of in vitro and in vivo studies. Model validation was conducted by comparison of simulated teneligliptin plasma concentrations with those from clinical trials. Using the PBPK model, predicted drug-drug interactions with concomitant medication were examined. The robustness of the PBPK model was demonstrated by the accurate simulation of clinically measured plasma concentrations of teneligliptin after oral administration in different ethnic groups, in subjects belonging to different age groups and in patients with kidney or liver impairment; none of these factors were incorporated during model development. The fraction absorbed and intestinal availability of teneligliptin predicted by the model were 0.62 and 0.99, respectively. The predicted ratios of areas under the time-concentration curves (AUCs) in patients with moderate and severe renal impairment who were concomitantly administered ketoconazole, a potent inhibitor of P450 3A4, were, respectively, 2.1- and 2.2-fold those in healthy adults who were given teneligliptin alone. A robust PBPK model reflecting the pharmacokinetic properties of teneligliptin was constructed. The final optimized PBPK model enabled us to elucidate in detail the factors affecting the pharmacokinetics of teneligliptin and to predict changes in exposure in drug-drug interactions or in specific populations. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nakamaru, Yoshinobu; Emoto, Chie; Shimizu, Makiko; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan; [Nakamaru, Yoshinobu] Mitsubishi Tanabe Pharma Co, Kisarazu, Chiba 2920818, Japan	Nakamaru, Y (reprint author), Mitsubishi Tanabe Pharma Co, 1-1-1 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan.	Nakamaru.Yoshinobu@mf.mt-pharma.co.jp; hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261			Harvey JN, 2003, CURR OPIN NEPHROL HY, V12, P317, DOI 10.1097/01.mnh.0000069867.94246.0b; Nakamaru Y, 2014, CLIN THER, V36, P760, DOI 10.1016/j.clinthera.2014.03.002; Jamei M, 2009, AAPS J, V11, P225, DOI 10.1208/s12248-009-9099-y; Nakamaru Y, 2014, XENOBIOTICA, V44, P242, DOI 10.3109/00498254.2013.816891; Jamei M, 2009, EXPERT OPIN DRUG MET, V5, P211, DOI [10.1517/17425250802691074 , 10.1517/17425250802691074]; Koukouritaki SB, 2002, PEDIATR RES, V51, P236, DOI 10.1203/00006450-200202000-00018; Cashman JR, 2002, DRUG METAB DISPOS, V30, P1043, DOI 10.1124/dmd.30.10.1043; Etos T, 2012, DIABETES OBES METAB, V14, P1040, DOI [10.1111/j.1463-1326.2012.01662.x, DOI 10.1111/J.1463-1326.2012.01662.X]; Halabi A, 2013, CLIN PHARM DRUG DEV, V2, P246, DOI 10.1002/cpdd.29; Huang SM, 2013, J PHARM SCI-US, V102, P2912, DOI 10.1002/jps.23570; Rowland Yeos K, 2011, EXPERT REV CLIN PHAR, V4, P261, DOI [10.1586/ecp.10.143., DOI 10.1586/ECP.10.143]; Sinha V, 2014, CLIN PHARMACOL THER, V95, P478, DOI 10.1038/clpt.2014.46	12	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	APR	2015	36	3					148	162		10.1002/bdd.1928		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF5WK	WOS:000352627800002		
J	Nagai, K; Suzuki, S; Yamamura, A; Konishi, H				Nagai, Katsuhito; Suzuki, Sho; Yamamura, Ayumi; Konishi, Hiroki			Change in pharmacokinetic behavior of intravenously administered midazolam due to increased CYP3A2 expression in rats treated with menthol	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						menthol; midazolam; pharmacokinetics; CYP3A; rat	IRRITABLE-BOWEL-SYNDROME; HUMAN CYTOCHROME-P450; DRUG-INTERACTIONS; LIVER-MICROSOMES; PEPPERMINT OIL; METABOLISM; INHIBITION; SUBFAMILY; WARFARIN; ENZYMES	Menthol is used widely as a constituent of functional foods and chemical drugs. The present study investigated changes in the pharmacokinetic behavior of intravenously administered midazolam (MDZ), a probe for CYP3A, when rats were treated with menthol. The study also examined which isoforms of CYP3A1 and 3A2 were menthol-inducible and contributed to the altered disposition of midazolam. Menthol was administered intraperitoneally to rats once daily for 3days at a dose of 10mg/kg, while the control rats received vehicle alone. The pharmacokinetic examination of i.v. administered midazolam revealed that serum midazolam concentrations at each sampling point were lower in the menthol-treated rats than in the control rats. Regarding the pharmacokinetic parameters of the menthol-treated group, the area under the curve (AUC) was decreased significantly and, correspondingly, the elimination rate constant at terminal phase (k(e)) was increased significantly without significant changes in the volume of distribution at steady state (Vd(ss)). The metabolic production of the 1-hydroxylated and 4-hydroxylated forms of MDZ by hepatic microsomes was significantly greater in the menthol-treated rats than in the control rats. The expression levels of mRNA and protein for hepatic CYP3A2 were more than 2.5-fold higher than the control levels when the rats were treated with menthol, whereas no changes were observed in the expression levels of CYP3A1. These results indicate that menthol enhanced the elimination clearance of midazolam by inducing hepatic CYP3A2 and that careful attention should be paid when menthol is ingested in combination with drugs that act as substrates for CYP3A. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nagai, Katsuhito; Suzuki, Sho; Yamamura, Ayumi; Konishi, Hiroki] Osaka Ohtani Univ, Lab Clin Pharm & Therapeut, Fac Pharm, Tondabayashi 5848540, Japan	Nagai, K (reprint author), Osaka Ohtani Univ, Lab Clin Pharm & Therapeut, Fac Pharm, 3-11-1 Nishikiori Kita, Tondabayashi 5848540, Japan.	nagaika@osaka-ohtani.ac.jp					Amjadi MA, 2012, IRAN J PHARM RES, V11, P1073; Venkataramanan R, 2006, LIFE SCI, V78, P2105, DOI 10.1016/j.lfs.2005.12.021; Ramasamy S, 2014, MOLECULES, V19, P2588, DOI 10.3390/molecules19022588; Kato M, 2008, DRUG METAB PHARMACOK, V23, P87, DOI 10.2133/dmpk.23.87; Tang W, 2001, CURR DRUG METAB, V2, P185, DOI 10.2174/1389200013338658; Aiba T, 2005, BIOL PHARM BULL, V28, P311, DOI 10.1248/bpb.28.311; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Durr D, 2000, CLIN PHARMACOL THER, V68, P598, DOI 10.1067/mcp.2000.112240; Miyazawa M, 2011, J OLEO SCI, V60, P127, DOI 10.5650/jos.60.127; Vuppugalla R, 2012, XENOBIOTICA, V42, P1058, DOI 10.3109/00498254.2012.684104; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Hiki N, 2011, CLIN PHARMACOL THER, V90, P221, DOI 10.1038/clpt.2011.110; IMAOKA S, 1990, J PHARMACOL EXP THER, V255, P1385; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Kline RM, 2001, J PEDIATR-US, V138, P125, DOI 10.1067/mpd.2001.109606; GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643; Bus HZ, 2006, CURR DRUG METAB, V7, P231; Coderre Karen, 2010, Pharmacotherapy, V30, P110, DOI 10.1592/phco.30.1.110; Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100; Ghosal A, 1996, DRUG METAB DISPOS, V24, P940; Hoch M, 2013, EUR J CLIN PHARMACOL, V69, P523, DOI 10.1007/s00228-012-1403-6; Hoshino M, 2014, EUR J PHARM SCI, V56, P92, DOI 10.1016/j.ejps.2014.02.011; Juergens U R, 1998, Eur J Med Res, V3, P539; Kassebaum PJ, 2005, ANN PHARMACOTHER, V39, P365, DOI 10.1345/aph.1E537; Kims H, 2006, DRUG METAB DISPOS, V34, P521; Kremers Pierre, 2002, ScientificWorldJournal, V2, P751; Kusudas J, 2012, BIOPHARM DRUG DISPOS, V33, P22; Lis Q, 2009, ONCOLOGY, V77, P335; Mas J, 2006, J CLIN PHARMACOL, V46, P103; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; Paos LH, 2012, AM J CHINESE MED, V40, P57; Pirotta M, 2009, AUST FAM PHYSICIAN, V38, P966; RIBEIRO V, 1992, ARCH BIOCHEM BIOPHYS, V293, P147, DOI 10.1016/0003-9861(92)90377-9; Ruskins WA, 2007, EUR J PHARMACOL, V559, P161; Souidi M, 2005, TOXICOLOGY, V214, P113, DOI 10.1016/j.tox.2005.06.006; THUMMEL KE, 1994, J PHARMACOL EXP THER, V271, P557; Tian X, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/179643; Zhang X, 2010, DRUG METAB DISPOS, V38, P61, DOI 10.1124/dmd.109.028290	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	APR	2015	36	3					174	182		10.1002/bdd.1930		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CF5WK	WOS:000352627800004		
J	Nguyen, NTH; Miwa, M; Tsuruoka, Y; Chikayama, T; Tojo, S				Nguyen, Nhung T. H.; Miwa, Makoto; Tsuruoka, Yoshimasa; Chikayama, Takashi; Tojo, Satoshi			Wide-coverage relation extraction from MEDLINE using deep syntax	BMC BIOINFORMATICS			English	Article						Predicate-argument structures; Biomedical relation extraction; Open information extraction	PROTEIN INTERACTIONS; TEXT	Background: Relation extraction is a fundamental technology in biomedical text mining. Most of the previous studies on relation extraction from biomedical literature have focused on specific or predefined types of relations, which inherently limits the types of the extracted relations. With the aim of fully leveraging the knowledge described in the literature, we address much broader types of semantic relations using a single extraction framework. Results: Our system, which we name PASMED, extracts diverse types of binary relations from biomedical literature using deep syntactic patterns. Our experimental results demonstrate that it achieves a level of recall considerably higher than the state of the art, while maintaining reasonable precision. We have then applied PASMED to the whole MEDLINE corpus and extracted more than 137 million semantic relations. The extracted relations provide a quantitative understanding of what kinds of semantic relations are actually described in MEDLINE and can be ultimately extracted by (possibly type-specific) relation extraction systems. Conclusion: PASMED extracts a large number of relations that have previously been missed by existing text mining systems. The entire collection of the relations extracted from MEDLINE is publicly available in machine-readable form, so that it can serve as a potential knowledge base for high-level text-mining applications.	[Nguyen, Nhung T. H.; Tojo, Satoshi] Japan Adv Inst Sci & Technol, Sch Informat Sci, Kanazawa, Ishikawa, Japan; [Miwa, Makoto] Toyota Technol Inst, Nagoya, Aichi 468, Japan; [Tsuruoka, Yoshimasa; Chikayama, Takashi] Univ Tokyo, Grad Sch Engn, Tokyo, Japan	Nguyen, NTH (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, Kanazawa, Ishikawa, Japan.	nthnhung@jaist.ac.jp					Airola A, 2008, P WORKSH CURR TRENDS, P1, DOI 10.3115/1572306.1572308; Akbik A, 2012, P JOINT WORKSH AUT K, P2; Ananiadou S., 2005, TEXT MINING BIOL BIO; Banko M, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2670; Chowdhary R, 2009, BIOINFORMATICS, V25, P1536, DOI 10.1093/bioinformatics/btp245; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Zhang SD, 2013, J BIOMED INFORM, V46, P1088, DOI 10.1016/j.jbi.2013.08.004; Vazquez M, 2011, MOL INFORM, V30, P506, DOI 10.1002/minf.201100005; Miyao Y, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1017; Clarke SJ, 1997, ASLIB PROC, V49, P184, DOI 10.1108/eb051463; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Baker C., 1998, P 36 ANN M ASS COMP, V1, P86, DOI DOI 10.3115/980845.980860; Bodenreider O., 2004, NUCLEIC ACIDS RES, V32, P267; Bui Q.-C., 2013, P BIONLP SHAR TASK 2, P104; Chou WC, 2006, P FLAC 06; Chun H. -W., 2006, P PAC S BIOC, P4; Cohen KB, 2006, BMC BIOINF S3, V7, P5; Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; Fader A., 2011, P C EMP METH NAT LAN, P1535; Green AM, 1997, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1110; Kim J-D, 2003, BIOINFORMATICS S1, V19, pi180, DOI DOI 10.1093/BIOINFORMATICS/BTG1023; Kingsbury P, 2002, P HLT; Kinoshita S, 2005, BMC BIOINFORM S1, V6, P4; Kipper Karin, 2000, P 17 NAT C ART INT A, P691; Krallinger M, 2011, BMC BIOINFORMATIC S8, V12, P3; Matsuzaki T, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1671; Mausam Schmitz M, 2012, P C EMP METH NAT LAN, P523; McDonald R, 2005, P 43 ANN M ASS COMP, P491, DOI 10.3115/1219840.1219901; Mesquita F., 2013, P EMNLP, P447; MIWA M, 2009, INT J MED INFORM, V78, P39; Miyao Y., 2008, P 46 ANN M ASS COMP, P46; Nebot V, 2014, KNOWL INF SYST, V38, P385; Nedellec C, 2013, ACL, V2013, P1; Nguyen N.T.H., 2013, P 5 INT S LANG BIOL, P51; Noreen E, 1989, COMPUTER INTENSIVE M; Ohta Tomoko, 2004, P INT JOINT WORKSH N, P70, DOI 10.3115/1567594.1567610; Palaga P, 2009, P 12 INT C EXT DAT T, P1140, DOI 10.1145/1516360.1516498; Pyysalo S, 2008, BMC BIOINF S3, V9, P6, DOI DOI 10.1186/1471-2105-9-S3-S6; Pyysalo S, 2013, P BIONLP SHAR TASK 2, P58; Rebholz-Schuhmann Dietrich, 2010, Journal of Bioinformatics and Computational Biology, V8, P163, DOI 10.1142/S0219720010004562; Rinaldi F, 2006, BMC BIOINFORMATICS, V7, P3; Rindflesch Thomas C., 2011, Information Services & Use, V31, DOI 10.3233/ISU-2011-0627; Segura-Bedmar I., 2013, P 7 INT WORKSH SEM E, P341; Van Landeghem S, 2013, PLOS ONE, V8, P55814; Wattarujeekrit T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-155; Xu R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-181; Xu Y., 2013, P NAACL HLT, P868; Yakushiji Akane, 2006, P 2006 C EMP METH NA, P284, DOI 10.3115/1610075.1610116	51	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	APR 1	2015	16								107	10.1186/s12859-015-0538-8		11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	CF6ST	WOS:000352687200001		
J	Sagova-Mareckova, M; Ulanova, D; Sanderova, P; Omelka, M; Kamenik, Z; Olsovska, J; Kopecky, J				Sagova-Mareckova, Marketa; Ulanova, Dana; Sanderova, Petra; Omelka, Marek; Kamenik, Zdenek; Olsovska, Jana; Kopecky, Jan			Phylogenetic relatedness determined between antibiotic resistance and 16S rRNA genes in actinobacteria	BMC MICROBIOLOGY			English	Article						Actinobacteria; 16S rRNA diversity; Resistance genes; Thin layer chromatography; Sequenced genome database; Phylogeny	BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; STREPTOMYCES-FRADIAE; PROTEIN EVOLUTION; GENOME SEQUENCE; SOIL; DIVERSITY; STRAIN; CLUSTER; RECOMBINATION	Background: Distribution and evolutionary history of resistance genes in environmental actinobacteria provide information on intensity of antibiosis and evolution of specific secondary metabolic pathways at a given site. To this day, actinobacteria producing biologically active compounds were isolated mostly from soil but only a limited range of soil environments were commonly sampled. Consequently, soil remains an unexplored environment in search for novel producers and related evolutionary questions. Results: Ninety actinobacteria strains isolated at contrasting soil sites were characterized phylogenetically by 16S rRNA gene, for presence of erm and ABC transporter resistance genes and antibiotic production. An analogous analysis was performed in silico with 246 and 31 strains from Integrated Microbial Genomes (JGI_IMG) database selected by the presence of ABC transporter genes and erm genes, respectively. In the isolates, distances of erm gene sequences were significantly correlated to phylogenetic distances based on 16S rRNA genes, while ABC transporter gene distances were not. The phylogenetic distance of isolates was significantly correlated to soil pH and organic matter content of isolation sites. In the analysis of JGI_IMG datasets the correlation between phylogeny of resistance genes and the strain phylogeny based on 16S rRNA genes or five housekeeping genes was observed for both the erm genes and ABC transporter genes in both actinobacteria and streptomycetes. However, in the analysis of sequences from genomes where both resistance genes occurred together the correlation was observed for both ABC transporter and erm genes in actinobacteria but in streptomycetes only in the erm gene. Conclusions: The type of erm resistance gene sequences was influenced by linkage to 16S rRNA gene sequences and site characteristics. The phylogeny of ABC transporter gene was correlated to 16S rRNA genes mainly above the genus level. The results support the concept of new specific secondary metabolite scaffolds occurring more likely in taxonomically distant producers but suggest that the antibiotic selection of gene pools is also influenced by site conditions.	[Sagova-Mareckova, Marketa; Sanderova, Petra; Kopecky, Jan] Crop Res Inst, Epidemiol & Ecol Microorganisms, Prague, Czech Republic; [Ulanova, Dana] Acad Sci Czech Republic, Inst Microbiol, Vvi, Lab Biol Metab 2, Prague, Czech Republic; [Sanderova, Petra] Charles Univ Prague, Fac Pharm, CS-50165 Hradec Kralove, Czech Republic; [Omelka, Marek] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Math Stat, Prague, Czech Republic; [Kamenik, Zdenek] Acad Sci Czech Republic, Inst Microbiol, Vvi, Lab Fungal Genet & Metab, Prague, Czech Republic; [Olsovska, Jana] Res Inst Brewing & Malting PLC, Analyt & Testing Lab, Prague, Czech Republic; [Ulanova, Dana] Kochi Univ, Ctr Sci Res, Oceanog Sect, IMT MEXT, Kochi 780, Japan	Kopecky, J (reprint author), Crop Res Inst, Epidemiol & Ecol Microorganisms, Prague, Czech Republic.	jkopecky@vurv.cz	Kopecky, Jan/C-7400-2013; Omelka, Marek/I-2447-2014		Ministry of Education, Youth and Sports of the Czech Republic [LH14030, LD13003]; Ministry of Agriculture of the Czech Republic [QJ1210359, MZe RO0414]	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic, grants No. LH14030 and LD13003, and the Ministry of Agriculture of the Czech Republic, projects QJ1210359 and MZe RO0414.	Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Schlatter D, 2009, MICROB ECOL, V57, P413, DOI 10.1007/s00248-008-9433-4; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; EPP JK, 1987, GENE, V53, P73, DOI 10.1016/0378-1119(87)90094-1; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Hohmann C, 2009, J ANTIBIOT, V62, P99, DOI 10.1038/ja.2008.24; Kopecky J, 2011, FEMS MICROBIOL ECOL, V78, P386, DOI 10.1111/j.1574-6941.2011.01173.x; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Sagova-Mareckova M, 2011, APPL ENVIRON MICROB, V77, P7560, DOI 10.1128/AEM.00527-11; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Thaker MN, 2013, NAT BIOTECHNOL, V31, P922, DOI 10.1038/nbt.2685; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Genilloud O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/s10295-010-0882-7; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Sakai M, 2004, J MICROBIOL METH, V59, P81, DOI 10.1016/j.mimet.2004.06.005; Reddy BVB, 2012, APPL ENVIRON MICROB, V78, P3744, DOI 10.1128/AEM.00102-12; Nash KA, 2005, J ANTIMICROB CHEMOTH, V55, P170, DOI 10.1093/jac/dkh523; Cermak L, 2008, APPL SOIL ECOL, V40, P348, DOI 10.1016/j.apsoil.2008.06.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Baltz RH, 2005, NAT PROD REP, V22, P717, DOI 10.1039/b416648p; Doroghazi JR, 2011, J BACTERIOL, V193, P7021, DOI 10.1128/JB.06262-11; Pan YL, 2011, J BACTERIOL, V193, P3150, DOI 10.1128/JB.00344-11; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Chopra I, 2002, J APPL MICROBIOL, V92, p4S, DOI 10.1046/j.1365-2672.92.5s1.13.x; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; Egan S, 2001, ANTON LEEUW INT J G, V79, P127, DOI 10.1023/A:1010296220929; Farnet CM, 2003, Patent, Patent No. [WO 03010193-A2, 03010193]; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gandecha AR, 1996, GENE, V180, P173, DOI 10.1016/S0378-1119(96)00448-9; Gathogo EWN, 2003, J ANTIBIOT, V56, P423; Gonzalez I, 1999, LETT APPL MICROBIOL, V29, P147, DOI 10.1046/j.1365-2672.1999.00580.x; Jensen PR, 2010, J IND MICROBIOL BIOT, V37, P219, DOI 10.1007/s10295-009-0683-z; Jousset A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3573; KAMIMIYA S, 1988, J BACTERIOL, V170, P1800; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mido N, 2004, Patent, Patent No. [JP 2004049100-A1, 2004049100]; Omelka M, 2013, ENVIRONMETRICS, V24, P449, DOI 10.1002/env.2238; Pernodet JL, 1999, MICROBIOL-UK, V145, P2355; ROBERTS AN, 1985, GENE, V35, P259, DOI 10.1016/0378-1119(85)90004-6; Zakalyukina YV, 2007, BIOL BULL+, V34, P329, DOI 10.1134/S1062359007040036; Zoropogui A, 2012, J BACTERIOL, V194, P2098, DOI 10.1128/JB.00161-12	52	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2180			BMC MICROBIOL	BMC Microbiol.	APR 1	2015	15								81	10.1186/s12866-015-0416-6		13	Microbiology	Microbiology	CF5KR	WOS:000352596500002		
J	Takano, K; Fuji, S; Uchida, N; Ogawa, H; Ohashi, K; Eto, T; Sakamaki, H; Morishima, Y; Kato, K; Suzuki, R; Fukuda, T				Takano, K.; Fuji, S.; Uchida, N.; Ogawa, H.; Ohashi, K.; Eto, T.; Sakamaki, H.; Morishima, Y.; Kato, K.; Suzuki, R.; Fukuda, T.			Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT	BONE MARROW TRANSPLANTATION			English	Article							STEM-CELL TRANSPLANTATION; SYSTEMATIC ANALYSIS; COMORBIDITY INDEX; CANCER-RISK; HYPERGLYCEMIA; MARROW; INDIVIDUALS; RECIPIENTS; REMISSION; LEUKEMIA	Diabetes mellitus (DM) is a factor in the hematopoietic cell transplantation-comorbidity index. However, the impact of pre-transplant DM on morbidity and cause-specific non-relapse mortality (NRM) remains unclear. We performed a retrospective study with registry data that included a total of 7626 patients who underwent their first allogeneic hematopoietic SCT (HSCT) between 2007 and 2010. The median age was 44 years (range 0-88). Compared with patients without pre-transplant DM (non-DM group, n = 7248), patients with pre-transplant DM (DM group, n = 378) were older and were more likely to have high-risk disease, a reduced-intensity conditioning regimen and GVHD prophylaxis using tacrolimus. Multivariate analyses showed that pre-transplant DM was associated with increased risks of NRM (hazard ratio (HR) 1.46, 95% confidence interval (CI) 1.21-1.76, P<0.01) and infection-related NRM (HR 2.08, 95% CI 1.58-2.73, P<0.01). The presence of pre-transplant DM was associated with an increased risk of overall mortality in a multivariate analysis (HR 1.55, 95% CI 1.35-1.78, P<0.01). In conclusion, pre-transplant DM was a risk factor for NRM, particularly infection-related mortality, after allogeneic HSCT. To improve the clinical outcome in patients with DM, the benefits of strict infection control and appropriate glycemic control should be explored in future trials.	[Takano, K.; Fuji, S.; Fukuda, T.] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Tokyo 1040045, Japan; [Takano, K.] Oita Univ, Fac Med, Dept Med Oncol & Hematol, Oita 87011, Japan; [Uchida, N.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Ogawa, H.] Hyogo Coll Med, Dept Internal Med, Div Hematol, Kobe, Hyogo, Japan; [Ohashi, K.; Sakamaki, H.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Eto, T.] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Morishima, Y.] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Kato, K.] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol Oncol, Nagoya, Aichi, Japan; [Suzuki, R.] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management Biostat, Nagoya, Aichi 4648601, Japan	Fuji, S (reprint author), Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sfuji@ncc.go.jp			Japanese Ministry of Health, Labor and Welfare; National Cancer Research and Development Fund	This work was supported by grants from the Japanese Ministry of Health, Labor and Welfare and the National Cancer Research and Development Fund. Some of the results were presented at the 32nd Annual Meeting of the Japanese Society of Hematology in Kanazawa, 9 March 2013. We thank the medical, nursing, data-processing, laboratory and clinical staff at the participating centers for their important contributions to this study and their dedicated care of the patients.	Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Hammer MJ, 2009, BIOL BLOOD MARROW TR, V15, P344, DOI 10.1016/j.bbmt.2008.12.488; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sluik D, 2011, AM J EPIDEMIOL, V174, P22, DOI 10.1093/aje/kwr048; Fuji S, 2007, TRANSPLANTATION, V84, P814, DOI 10.1097/01.tp.0000282790.66889.a5; Kurosawa S, 2013, BONE MARROW TRANSPL, V48, P1198, DOI 10.1038/bmt.2013.42; Rammaert B, 2012, DIABETES METAB, V38, P193, DOI 10.1016/j.diabet.2012.01.002; Horan JT, 2011, J CLIN ONCOL, V29, P805, DOI 10.1200/JCO.2010.32.5001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Derr RL, 2008, DIABETES CARE, V31, P1972, DOI 10.2337/dc08-0574; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Gebremedhin E, 2013, INFLAMMATION, V36, P177, DOI 10.1007/s10753-012-9533-7; Kurosawa S, 2013, BONE MARROW TRANSPL, V48, P529, DOI 10.1038/bmt.2012.172; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; Fuji S, 2009, BONE MARROW TRANSPL, V44, P105, DOI 10.1038/bmt.2008.431; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Unick JL, 2011, DIABETES CARE, V34, P2152, DOI 10.2337/dc11-0874; Eijgenraam P, 2013, BRIT J CANCER, V109, P2924, DOI 10.1038/bjc.2013.629; Ginter Emil, 2012, Adv Exp Med Biol, V771, P42; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mercer BN, 2012, INT J CLIN PRACT, V66, P640, DOI 10.1111/j.1742-1241.2012.02924.x; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009	32	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2015	50	4					553	558		10.1038/bmt.2014.315		6	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE9HQ	WOS:000352155300015		
J	Nakasone, H; Fukuda, T; Kanda, J; Mori, T; Yano, S; Kobayashi, T; Miyamura, K; Eto, T; Kanamori, H; Iwato, K; Uchida, N; Mori, S; Nagamura-Inoue, T; Ichinohe, T; Atsuta, Y; Teshima, T; Murata, M				Nakasone, H.; Fukuda, T.; Kanda, J.; Mori, T.; Yano, S.; Kobayashi, T.; Miyamura, K.; Eto, T.; Kanamori, H.; Iwato, K.; Uchida, N.; Mori, S.; Nagamura-Inoue, T.; Ichinohe, T.; Atsuta, Y.; Teshima, T.; Murata, M.		Japan Soc Hematopoietic Cell	Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation	BONE MARROW TRANSPLANTATION			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TOTAL-BODY IRRADIATION; RISK-FACTORS; CHRONIC GRAFT; REGIMEN; JAPAN; BLOOD	The impact of the conditioning intensity and TBI on acute GVHD (aGVHD) is still a matter of debate. We analyzed 6848 adult recipients who received allogeneic hematopoietic cell transplants (HCT) between 2006 and 2011 in Japan. The subjects were divided into groups who had received myeloablative conditioning (MAC) or reduced-intensity conditioning (RIC), either with or without TBI. There was a significant difference in the incidence of aGVHD 2-4 among the different conditioning types: 39% in TBI-MAC, 35% in TBI-RIC and 32% in both no-TBI MAC and no-TBI-RIC (P<0.001). In a multivariate analysis, TBI-MAC, but not no-TBI MAC, was significantly associated with an increased risk of aGVHD 2-4 (hazard ratio (HR) 1.33, P<0.01), whereas TBI-RIC was associated with an increased risk of GVHD 3-4 (HR 1.36, P = 0.048). TBI-MAC and TBI-RIC were significantly associated with skin and gastrointestinal aGVHD. Subgroup analyses demonstrated that not only TBI-MAC, but also TBI-RIC, was significantly associated with aGVHD 2-4 in older patients. Furthermore, high-dose TBI only had an adverse impact on aGVHD 2-4 in HLA-matched HCT. Impacts of intensity and TBI on aGVHD differ by patient backgrounds, and this difference should be considered to establish a risk-adapted strategy for the prevention of aGVHD.	[Nakasone, H.] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Nakasone, H.; Kanda, J.] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Fukuda, T.] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Mori, T.] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Yano, S.] Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, Tokyo, Japan; [Kobayashi, T.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Miyamura, K.] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Eto, T.] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Kanamori, H.] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan; [Iwato, K.] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan; [Iwato, K.] Atom Bomb Survivors, Hiroshima, Japan; [Uchida, N.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Mori, S.] St Lukes Int Hosp, Div Hematol & Oncol, Tokyo, Japan; [Nagamura-Inoue, T.] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo, Japan; [Ichinohe, T.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Atsuta, Y.] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Y.] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Teshima, T.] Hokkaido Univ, Grad Sch Med Sci, Dept Hematol, Sapporo, Hokkaido, Japan; [Murata, M.] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan	Nakasone, H (reprint author), Stanford Univ, Sch Med, Div Blood & Marrow Transplantat, 269 West Campus Dr,CCSR 2210, Stanford, CA 94305 USA.	nakasone-tky@umin.ac.jp			Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor and Welfare	We express our appreciation for the work of all the physicians and data managers at the centers who contributed valuable data on transplantation to the Japan Society for Hematopoietic Cell Transplantation (JSHCT), the Japan Marrow Donor Program (JMDP) and the Japan Cord Blood Bank Network (JCBBN). We also thank all of the members of the Transplant Registry Unified Management committees at JSHCT, JMDP and JCBBN for their dedicated data management. This work was supported in part by a Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor and Welfare (YA).	Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Hill GR, 1997, BLOOD, V90, P3204; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Murata M, 2013, BIOL BLOOD MARROW TR, V19, P1183, DOI 10.1016/j.bbmt.2013.05.003; Perez-Simon JA, 2005, BRIT J HAEMATOL, V130, P394, DOI 10.1111/j.1365-2141.2005.05614.x; Alyea EP, 2005, BLOOD, V105, P1810, DOI 10.1182/blood-2004-05-1947; MacMillan ML, 2009, BLOOD, V113, P2410, DOI 10.1182/blood-2008-07-163238; Powles R, 2010, LANCET ONCOL, V11, P305, DOI 10.1016/S1470-2045(10)70001-2; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Hill GR, 2000, BLOOD, V95, P2754; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Giebel S, 2014, CANCER-AM CANCER SOC, V120, P2760, DOI 10.1002/cncr.28768; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Mohty M, 2015, BIOL BLOOD MARROW TR, V21, P620, DOI 10.1016/j.bbmt.2014.09.010; Rapoport AP, 1999, J CLIN ONCOL, V17, P2446; Shi-Xia Xu, 2011, Clin Transplant, V25, pE187, DOI 10.1111/j.1399-0012.2010.01361.x; Teshima T, 2005, BRIT J HAEMATOL, V130, P575, DOI 10.1111/j.1365-2141.2005.05632.x	23	4	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2015	50	4					559	565		10.1038/bmt.2014.293		7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE9HQ	WOS:000352155300016		
J	Itonaga, H; Sawayama, Y; Taguchi, J; Honda, S; Taniguchi, H; Makiyama, J; Matsuo, E; Sato, S; Ando, K; Imanishi, D; Imaizumi, Y; Yoshida, S; Hata, T; Moriuchi, Y; Fukushima, T; Miyazaki, Y				Itonaga, H.; Sawayama, Y.; Taguchi, J.; Honda, S.; Taniguchi, H.; Makiyama, J.; Matsuo, E.; Sato, S.; Ando, K.; Imanishi, D.; Imaizumi, Y.; Yoshida, S.; Hata, T.; Moriuchi, Y.; Fukushima, T.; Miyazaki, Y.			Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group	BONE MARROW TRANSPLANTATION			English	Article							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ISOLATED EXTRAMEDULLARY RELAPSE; VERSUS-HOST-DISEASE; RETROSPECTIVE ANALYSIS; GROUP EXPERIENCE; LONG-TERM; LEUKEMIA/LYMPHOMA; INTENSITY; FEATURES	Allogeneic hematopoietic SCT (allo-SCT) is a promising therapy that may provide long-term durable remission for adult T-cell leukemia-lymphoma (ATL) patients; however, the incidence of relapse associated with ATL remains high. To determine the clinical features of these patients at relapse, we retrospectively analyzed tumor lesions in 30 or 49 patients who relapsed following allo-SCT or chemotherapy (CHT), respectively, at three institutions in Nagasaki prefecture between 1997 and 2011. A multivariate analysis revealed that the development of abnormal lymphocytes in the peripheral blood of patients at relapse was less frequent after allo-SCT than after CHT (P<0.001). Furthermore, relapse with a new lesion only in the absence of the primary lesion was more frequent in allo-SCT (P = 0.014). Lesions were more frequently observed in the central nervous systems of patients who relapsed with new lesions only (P = 0.005). Thus, the clinical manifestation of relapsed ATL was slightly complex, especially in post-transplant patients. Our results emphasized the need to develop adoptive modalities for early and accurate diagnoses of relapsed ATL.	[Itonaga, H.; Sawayama, Y.; Taguchi, J.; Ando, K.; Imanishi, D.; Imaizumi, Y.; Hata, T.; Miyazaki, Y.] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki, Nagasaki 8528501, Japan; [Itonaga, H.; Taniguchi, H.; Sato, S.; Moriuchi, Y.] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan; [Honda, S.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki, Nagasaki 8528501, Japan; [Makiyama, J.; Matsuo, E.; Yoshida, S.] Natl Hosp Org, Nagasaki Med Ctr, Dept Internal Med, Ohmura, Japan; [Fukushima, T.] Univ Ryukyus, Fac Med, Sch Hlth Sci, Lab Hematoimmunol,Dept Clin Lab Sci, Nishihara, Okinawa 90301, Japan	Sawayama, Y (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.	sawayasu@nagasaki-u.ac.jp			Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the hematologists at the Department of Hematology, Atomic Bomb Disease and Hibakusya Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, for the diagnosis and treatment of patients with ATL. This study was supported in part by a Grant-in-Aid from the Ministry of Health and Welfare of Japan and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Itonaga H, 2013, BIOL BLOOD MARROW TR, V19, P607, DOI 10.1016/j.bbmt.2013.01.011; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Yamaguchi T, 2005, BRIT J DERMATOL, V152, P76, DOI 10.1111/J.1365-2133.2004.06274.X; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; UCHIYAMA T, 1977, BLOOD, V50, P481; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; SHIMOYAMA M, 1991, LEUKEMIA RES, V15, P81; Takasaki Y, 2010, BLOOD, V115, P4337, DOI 10.1182/blood-2009-09-242347; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Tsukasaki K, 2001, BLOOD, V97, P3875, DOI 10.1182/blood.V97.12.3875; Yoshihara S, 2012, BIOL BLOOD MARROW TR, V18, P1800, DOI 10.1016/j.bbmt.2012.05.010; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Yonekura K, 2008, BONE MARROW TRANSPL, V41, P1029, DOI 10.1038/bmt.2008.39; Choi I, 2011, BONE MARROW TRANSPL, V46, P116, DOI 10.1038/bmt.2010.92; Choi SJ, 2004, LEUKEMIA, V18, P1789, DOI 10.1038/sj.leu.2403523; Cook LB, 2014, BLOOD, V123, P3925, DOI 10.1182/blood-2014-02-553602; Firouzi S, 2014, GENOME MED, V6, DOI 10.1186/gm568; Fukushima T, 2011, INT J HEMATOL, V94, P390, DOI 10.1007/s12185-011-0935-3; Fukushima T, 2005, LEUKEMIA, V19, P829, DOI 10.1038/sj.leu.2403682; Fukushima T, 2013, INT J HEMATOL, V97, P485, DOI 10.1007/s12185-013-1307-y; Imaizumi Y, 2003, CLIN CANCER RES, V9, P181; Itonaga H, 2013, BLOOD, V121, P219, DOI 10.1182/blood-2012-07-444372; Itoyama Takahiro, 2001, Blood, V97, P3612, DOI 10.1182/blood.V97.11.3612; Kamimura T, 2012, INT J HEMATOL, V95, P725, DOI 10.1007/s12185-012-1056-3; Kanda J, 2012, BLOOD, V119, P2141, DOI 10.1182/blood-2011-07-368233; Kato K, 2007, BIOL BLOOD MARROW TR, V13, P90, DOI 10.1016/j.bbmt.2006.09.002; Okamura J, 2005, BLOOD, V105, P4143, DOI 10.1182/blood-2004-11-4193; Potenza L, 2006, AM J HEMATOL, V81, P45, DOI 10.1002/ajh.20421; Shigematsu A, 2014, BIOL BLOOD MARROW TR, V20, P801, DOI 10.1016/j.bbmt.2014.02.014; Shiratori S, 2008, BIOL BLOOD MARROW TR, V14, P817, DOI 10.1016/j.bbmt.2008.04.014; Simone CB, 2012, BLOOD, V120, P1816, DOI 10.1182/blood-2012-01-401349; Tanosaki R, 2008, BIOL BLOOD MARROW TR, V14, P702, DOI 10.1016/j.bbmt.2008.03.010; YAMADA Y, 1983, BLOOD, V61, P192; Yoshihara S, 2012, BONE MARROW TRANSPL, V47, P669, DOI 10.1038/bmt.2011.163	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2015	50	4					585	591		10.1038/bmt.2014.308		7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE9HQ	WOS:000352155300020		
J	Yamamoto, H; Uchida, N; Matsuno, N; Kon, A; Nishida, A; Ota, H; Ikebe, T; Nakano, N; Ishiwata, K; Araoka, H; Takagi, S; Tsuji, M; Asano-Mori, Y; Yamamoto, G; Izutsu, K; Masuoka, K; Wake, A; Yoneyama, A; Makino, S; Taniguchi, S				Yamamoto, H.; Uchida, N.; Matsuno, N.; Kon, A.; Nishida, A.; Ota, H.; Ikebe, T.; Nakano, N.; Ishiwata, K.; Araoka, H.; Takagi, S.; Tsuji, M.; Asano-Mori, Y.; Yamamoto, G.; Izutsu, K.; Masuoka, K.; Wake, A.; Yoneyama, A.; Makino, S.; Taniguchi, S.			I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases	BONE MARROW TRANSPLANTATION			English	Letter							STEM-CELL TRANSPLANTATION; SUCCESSFUL ENGRAFTMENT; ADULT RECIPIENTS; BUSULFAN; GRAFTS		[Yamamoto, H.; Uchida, N.; Matsuno, N.; Kon, A.; Nishida, A.; Ota, H.; Ikebe, T.; Nakano, N.; Ishiwata, K.; Takagi, S.; Tsuji, M.; Asano-Mori, Y.; Yamamoto, G.; Izutsu, K.; Masuoka, K.; Wake, A.; Taniguchi, S.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Uchida, N.; Izutsu, K.; Taniguchi, S.] Okinaka Mem Inst Med Res, Tokyo, Japan; [Araoka, H.; Yoneyama, A.] Toranomon Gen Hosp, Dept Infect Dis, Tokyo, Japan; [Makino, S.] Toranomon Gen Hosp, Dept Transfus Med, Tokyo, Japan	Yamamoto, H (reprint author), Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan.	nuchida@toranomon.gr.jp					Alatrash G, 2011, BIOL BLOOD MARROW TR, V17, P1490, DOI 10.1016/j.bbmt.2011.02.007; Barker JN, 2003, BLOOD, V102, P1915, DOI 10.1182/blood-2002-11-3337; Gyurkocza B, 2010, J CLIN ONCOL, V28, P2859, DOI 10.1200/JCO.2009.27.1460; Barrett AJ, 2006, LEUKEMIA, V20, P1661, DOI 10.1038/sj.leu.2404334; Ciurea SO, 2009, BIOL BLOOD MARROW TR, V15, P523, DOI 10.1016/j.bbmt.2008.12.489; El Kourashy S, 2011, BONE MARROW TRANSPL, V46, P1077, DOI 10.1038/bmt.2010.257; Horwitz ME, 2008, BIOL BLOOD MARROW TR, V14, P591, DOI 10.1016/j.bbmt.2008.02.016; Komatsu T, 2007, ANN HEMATOL, V86, P49, DOI 10.1007/s00277-006-0190-5; Miyakoshi S, 2004, CLIN CANCER RES, V10, P3586, DOI 10.1158/1078-0432.CCR-03-0754; Patel P, 2011, BONE MARROW TRANSPL, V46, P1326, DOI 10.1038/bmt.2010.293; PETERS WP, 1987, CANCER RES, V47, P6402; Theilgaard-Monch K, 2001, BONE MARROW TRANSPL, V28, P1073, DOI 10.1038/sj.bmt.1703270; Uchida Naoyuki, 2008, Biol Blood Marrow Transplant, V14, P583, DOI 10.1016/j.bbmt.2008.03.003	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	APR	2015	50	4					607	609		10.1038/bmt.2014.316		3	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE9HQ	WOS:000352155300026		
J	Fujisaki, K; Fujimoto, H; Sangai, T; Nagashima, T; Sakakibara, M; Shiina, N; Kuroda, M; Aoyagi, Y; Miyazaki, M				Fujisaki, Kaoru; Fujimoto, Hiroshi; Sangai, Takafumi; Nagashima, Takeshi; Sakakibara, Masahiro; Shiina, Nobumitsu; Kuroda, Masayuki; Aoyagi, Yasuyuki; Miyazaki, Masaru			Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; Adipocytes; Cell migration; Adipokines	UNILOCULAR FAT-CELLS; GEL MATRIX CULTURE; BREAST-CANCER; ADIPOCYTES; OBESITY; MICROENVIRONMENT; PROGRESSION; PHENOTYPE	The objective of this study is to investigate interactions between adipocytes and breast cancer cells, and identify the responsible factors for the observed effects. In 27 breast cancer patients undergoing mastectomy, mammary adipose tissue was obtained from the breast quadrant bearing the tumor and corresponding non-tumoral quadrant. Isolated normal breast adipocytes (NBAs) and cancer-associated adipocytes (CAAs) were cultured in collagen gels to mimic the in vivo environment. Immunohistochemistry, qRT-PCR, and cell proliferation assays were performed to analyze adipocyte phenotypes. MCF7 and MDA-MB-231 breast cancer cell lines were co-cultured with adipocytes to detect phenotypic changes. Migration of MCF7 and MDA-MB-231 cells was assessed in NBA- and CAA-conditioned media. Cytokine levels in conditioned media were measured by cytokine array. Migration assays were repeated using conditioned media containing neutralizing antibodies. NBAs and CAAs lost their morphological phenotype in culture, acquiring a spindle-like shape, and CAAs showed higher cell proliferation, suggesting reversion to an immature phenotype. In co-cultures with MCF7 or MDA-MB-231 cells, NBAs exhibited increased cell proliferation, indicating acquisition of the immature phenotype of CAAs. MCF7 and MDA-MB-231 showed higher migration in a CAA-conditioned medium than in an NBA-conditioned medium. Cytokine array analysis of conditioned media revealed higher levels of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) in the CAA-conditioned medium. Neutralization experiments using antibodies against IL-6 or MCP-1 showed abrogation of migration-enhancing effects of the CAA-conditioned medium. Adipocytes revert to an immature and proliferative phenotype in the presence of breast cancer cells, and promote cancer cell migration via adipokines including IL-6 and MCP-1.	[Fujisaki, Kaoru; Fujimoto, Hiroshi; Sangai, Takafumi; Nagashima, Takeshi; Sakakibara, Masahiro; Shiina, Nobumitsu; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2600856, Japan; [Kuroda, Masayuki] Chiba Univ Hosp, Ctr Adv Med, Chuo Ku, Chiba 2600856, Japan; [Aoyagi, Yasuyuki] Chiba Univ, Grad Sch Med, Clin Cell Biol & Med, Chuo Ku, Chiba 2600856, Japan	Fujimoto, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.	hifujimonty@chiba-u.jp			MEXT KAKENHI [26461942]	This work was supported by MEXT KAKENHI Grant Number 26461942.	Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; SUGIHARA H, 1988, J LIPID RES, V29, P691; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dirat B, 2010, ENDOCRIN DEV, V19, P45, DOI 10.1159/000316896; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Chen HC, 2002, J LIPID RES, V43, P986; Majed B, 2008, BREAST CANCER RES TR, V111, P329, DOI 10.1007/s10549-007-9785-3; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; SUGIHARA H, 1987, J LIPID RES, V28, P1038; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; RODBELL M, 1964, J BIOL CHEM, V239, P375; Moreno A, 2008, ENDOCR-RELAT CANCER, V15, P257, DOI 10.1677/ERC-07-0202; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Flavell DM, 2005, DIABETES, V54, P582; Kushiro Kyoko, 2012, Cancer Microenviron, V5, P73, DOI 10.1007/s12307-011-0087-2	18	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	APR	2015	150	2					255	263		10.1007/s10549-015-3318-2		9	Oncology	Oncology	CE9ZL	WOS:000352202200003		
J	Oshiro, C; Kagara, N; Naoi, Y; Shimoda, M; Shimomura, A; Maruyama, N; Shimazu, K; Kim, SJ; Noguchi, S				Oshiro, Chiya; Kagara, Naofumi; Naoi, Yasuto; Shimoda, Masafumi; Shimomura, Atsushi; Maruyama, Naomi; Shimazu, Kenzo; Kim, Seung Jin; Noguchi, Shinzaburo			PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients	BREAST CANCER RESEARCH AND TREATMENT			English	Article						Breast cancer; PIK3CA mutation; ctDNA; dPCR; Prognosis	INTERNATIONAL EXPERT CONSENSUS; CIRCULATING TUMOR DNA; PRIMARY THERAPY; HIGHLIGHTS; PLASMA; RESISTANCE; PROGNOSIS; PATHWAY; ORIGIN; CELLS	We attempted to develop a highly sensitive and specific method for the detection of circulating tumor DNA (ctDNA) using a digital PCR (dPCR) assay for PIK3CA mutations (i.e., H1047R, E545K, and E542K) in primary breast cancer patients. The sensitivity of the dPCR assay for the mutant alleles was examined using cell lines with PIK3CA mutations and proved to be 0.01 %. Serum samples were collected pre-operatively from 313 stage I-III breast cancer patients, of whom 110 were found to have PIK3CA mutant tumors. The serum samples from these patients with PIK3CA mutant tumors were subjected to the dPCR assay, and 25 (22.7 %) were found to be positive. No PIK3CA mutant ctDNA was detected in the serum samples of 50 healthy women and 30 breast cancer patients with PIK3CA non-mutant tumors. The patients with PIK3CA mutant ctDNA were dichotomized into mutant ctDNA-high (ctDNA(high)) and ctDNA-low (ctDNA(low)) groups based on the median. The ctDNA(high) patients exhibited significantly shorter recurrence-free survival (RFS; P = 0.0002) and overall survival rates (OS; P = 0.0048) compared to those exhibited by the combined ctDNA(low) patient and ctDNA-free patient group. Multivariate analysis revealed that ctDNA(high) status significantly predicted poor RFS and OS and did so independently of conventional histological parameters. These results suggest that dPCR is a highly sensitive and specific method for the detection of PIK3CA mutant ctDNA and that ctDNA(high) but not ctDNA(low) status is a significant and independent prognostic factor for primary breast cancer patients.	[Oshiro, Chiya; Kagara, Naofumi; Naoi, Yasuto; Shimoda, Masafumi; Shimomura, Atsushi; Maruyama, Naomi; Shimazu, Kenzo; Kim, Seung Jin; Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Suita, Osaka 5650871, Japan	Kagara, N (reprint author), Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, 2-2-E10 Yamadaoka, Suita, Osaka 5650871, Japan.	kagaran@onsurg.med.osaka-u.ac.jp			Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by Grants-in-Aid from the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Becker S, 2009, BREAST CANCER RES TR, V117, P227, DOI 10.1007/s10549-008-0174-3; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Fujita N, 2012, ONCOLOGY-BASEL, V83, P273, DOI 10.1159/000342083; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3007094; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Schwarzenbach H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3446; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Turner NC, 2014, J CLIN ONCOL, V32	26	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-6806	1573-7217		BREAST CANCER RES TR	Breast Cancer Res. Treat.	APR	2015	150	2					299	307		10.1007/s10549-015-3322-6		9	Oncology	Oncology	CE9ZL	WOS:000352202200007		
J	Tsuno, H; Noguchi, M; Okabe, M; Tomihara, K; Yoshida, T; Nikaido, T				Tsuno, Hiroaki; Noguchi, Makoto; Okabe, Motonori; Tomihara, Kei; Yoshida, Toshiko; Nikaido, Toshio			Use of hyperdry amniotic membrane in operations for cleft palate: a study in rats	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article						Amnion; Cleft palate; Cleft repair; Growth of maxilla; Constriction of dental arch; Scarring of wound	SURGICAL DEFECTS; ORAL-MUCOSA; TRANSPLANTATION; REPAIR; CELLS; LIP	The growth of maxillary bone and the development of dentition are often impaired in patients who have had pushback operations for repair of a cleft palate. There has been considerable discussion about the most suitable technique or material used in such repairs to resolve the problem. Hyperdry amniotic membrane, a new preservable material derived from human amnion, has recently been introduced in several procedures. We have evaluated its use during pushback surgery in animal studies to try to correct the inhibition of growth and development of the maxilla. Mucosal defects were created in 3-week-old rats, and then covered with hyperdry amniotic membrane or not. Healing was assessed by histological and morphological examination at 1 week and 7 weeks postoperatively. In the group treated with hyperdry amniotic membrane, submucosal tissue was reconstructed successfully during the early postoperative period. Lateral palatal growth was not inhibited as much, and medial inclination of the teeth was less, after a period of growth using this material. The results suggest that hyperdry amniotic membrane is a suitable new dressing material for use in the treatment of cleft palate. (C) 2015 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.	[Tsuno, Hiroaki; Noguchi, Makoto; Tomihara, Kei] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Oral & Maxillofacial Surg, Toyama 9300194, Japan; [Tsuno, Hiroaki; Okabe, Motonori; Yoshida, Toshiko; Nikaido, Toshio] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Regenerat Med, Toyama 9300194, Japan	Tsuno, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Oral & Maxillofacial Surg, 2630 Sugitani, Toyama 9300194, Japan.	htsuno-tym@umin.ac.jp			Japan society for the promotion of science KAKENHI [24792192]	The authors would like to thank Ms. Furuichi for providing expert technical assistance in this study. This work was supported by the Japan society for the promotion of science KAKENHI (24792192).	Ab Hamid SS, 2014, CELL TISSUE BANK, V15, P15, DOI 10.1007/s10561-012-9353-x; Thomasen H, 2009, GRAEF ARCH CLIN EXP, V247, P1691, DOI 10.1007/s00417-009-1162-y; Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034; Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235; AKLE CA, 1981, LANCET, V2, P1003; Ravishanker R, 2003, BURNS, V29, P369, DOI 10.1016/S0305-4179(02)00304-2; Fujioka M, 1997, CLEFT PALATE-CRAN J, V34, P297, DOI 10.1597/1545-1569(1997)034<0297:MGFAIO>2.3.CO;2; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Rastogi S, 2009, J ORAL MAXIL SURG, V67, P1600, DOI 10.1016/j.joms.2008.12.020; Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033; Fudalej P, 2012, J DENT RES, V91, P47, DOI 10.1177/0022034511425674; Kitagawa K, 2009, AM J OPHTHALMOL, V148, P383, DOI 10.1016/j.ajo.2009.03.030; Kothari CR, 2012, BRIT J ORAL MAX SURG, V50, P545, DOI 10.1016/j.bjoms.2011.09.022; Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222; Murphy FA, 1996, SCIENCE, V273, P746, DOI 10.1126/science.273.5276.746; Noguchi M, 2003, J CRANIO MAXILL SURG, V31, P137, DOI 10.1016/S1010-5182(03)00016-7; Okabe M, 2014, J BIOMED MATER RES A, V102, P862, DOI 10.1002/jbm.a.34753; Rohleder NH, 2013, PLAST RECONSTR SURG, V132, P172, DOI 10.1097/PRS.0b013e3182910b50; Rommel N, 2013, BRIT J ORAL MAX SURG, V51, pE224, DOI 10.1016/j.bjoms.2013.01.016; Ross R B, 1970, Cleft Palate J, V7, P37; Shojaku H, 2011, LARYNGOSCOPE, V121, P1953, DOI 10.1002/lary.22082; Tsuno H, 2012, ORAL SURG ORAL MED O, V17, pe83; UNGER MG, 1976, BRIT J PLAST SURG, V29, P99, DOI 10.1016/0007-1226(76)90103-X; Von den Hoff JW, 2006, CLEFT LIP PALATE DIA, P301	25	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0266-4356	1532-1940		BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	APR	2015	53	4					358	363		10.1016/j.bjoms.2015.01.018		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CE8HX	WOS:000352083800013		
J	Kobayashi, S; Ito, M; Yamamoto, S; Kinugasa, Y; Kotake, M; Saida, Y; Kobatake, T; Yamanaka, T; Saito, N; Moriya, Y				Kobayashi, S.; Ito, M.; Yamamoto, S.; Kinugasa, Y.; Kotake, M.; Saida, Y.; Kobatake, T.; Yamanaka, T.; Saito, N.; Moriya, Y.			Randomized clinical trial of skin closure by subcuticular suture or skin stapling after elective colorectal cancer surgery	BRITISH JOURNAL OF SURGERY			English	Article							SURGICAL-SITE INFECTIONS; SURVEILLANCE; MULTICENTER; OPERATIONS; DISEASE	Background: The best suture method to prevent incisional surgical-site infection (SSI) after clean-contaminated surgery has not been clarified. Methods: Patients undergoing elective colorectal cancer surgery at one of 16 centres were randomized to receive either subcuticular sutures or skin stapling for skin closure. The primary endpoint was the rate of incisional SSI. Secondary endpoints of interest included time required for wound closure, incidence of wound problems, postoperative length of stay, wound aesthetics and patient satisfaction. Results: A total of 1264 patients were enrolled. The cumulative incidence of incisional SSI by day 30 after surgery was similar after subcuticular sutures and stapled closure (8.7 versus 9.8 per cent respectively; P = 0.576). Comparison of cumulative incidence curves revealed that SSI occurred later in the subcuticular suture group (P = 0.019) (hazard ratio 0.66, 95 per cent c.i. 0.45 to 0.97). Wound problems (P = 0.484), wound aesthetics (P = 0.182) and postoperative duration of hospital stay (P = 0.510) did not differ between the groups; subcuticular sutures took 5 min longer than staples (P < 0.001). Patients in the subcuticular suture group were significantly more satisfied with their wound (52.4 per cent versus 42.7 per cent in the staple group; P = 0.002). Conclusion: Compared with skin stapling, subcuticular sutures did not reduce the risk of incisional SSI after colorectal surgery. Registration number: UMIN000004001 (http://www.umin.ac.jp/ctr).	[Kobayashi, S.; Ito, M.; Saito, N.] Natl Canc Ctr Hosp East, Dept Colorectal Surg, Kashiwa, Chiba 2778577, Japan; [Yamamoto, S.; Moriya, Y.] Natl Canc Ctr, Dept Colorectal Surg, Tokyo, Japan; [Kobayashi, S.; Saida, Y.] Toho Univ, Ohashi Med Ctr, Dept Surg, Tokyo, Japan; [Kobayashi, S.] Tokyo Metropolitan Komagome Hosp, Dept Surg, Tokyo, Japan; [Kinugasa, Y.] Shizuoka Canc Ctr, Dept Colon & Rectal Surg, Shizuoka, Japan; [Kotake, M.] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa, Japan; [Kobatake, T.] Natl Hosp Org, Shikoku Canc Ctr, Dept Gastroenterol Surg, Matsuyama, Ehime, Japan; [Yamanaka, T.] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan	Ito, M (reprint author), Natl Canc Ctr Hosp East, Dept Colorectal Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	maito@east.ncc.go.jp					ANGELINI GD, 1984, THORAX, V39, P942, DOI 10.1136/thx.39.12.942; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Kornblith AB, 2011, J CLIN ONCOL, V29, P1022, DOI 10.1200/JCO.2010.29.9859; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; Nichols RL, 2001, EMERG INFECT DIS, V7, P220; Tsujinaka T, 2013, LANCET, V382, P1105, DOI 10.1016/S0140-6736(13)61780-8; Hendriks AAJ, 2001, MED CARE, V39, P270, DOI 10.1097/00005650-200103000-00007; Poon JT, 2009, ANN SURG, V249, P77, DOI 10.1097/SLA.0b013e31819279e3; Delgado-Rodriguez M, 2001, INFECT CONT HOSP EP, V22, P24; Johnson A, 2006, J HOSP INFECT, V64, P30, DOI 10.1016/j.jhin.2006.03.020; Konishi T, 2006, ANN SURG, V244, P758, DOI 10.1097/01.sla.0000219017.78611.49; Singer AJ, 2007, PLAST RECONSTR SURG, V120, P1892, DOI 10.1097/01.prs.0000287275.15511.10; Johnson RG, 1997, ANN SURG, V226, P606, DOI 10.1097/00000658-199711000-00005; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428; Fujita S, 2007, ARCH SURG-CHICAGO, V142, P657, DOI 10.1001/archsurg.142.7.657; Grant AM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1908; Halsted WH, 1890, J HOPKINS HOSP MED J, V1, P13; Lawrence WT, 2002, PHYSL BASIS SURG, P107; LUBOWSKI D, 1985, AUST NZ J SURG, V55, P405, DOI 10.1111/j.1445-2197.1985.tb00910.x; Mangram Alicia J., 1999, Infection Control and Hospital Epidemiology, V20, P247; Martone WJ, 1992, HOSP INFECT, P577; RANABOLDO CJ, 1992, BRIT J SURG, V79, P1172, DOI 10.1002/bjs.1800791122; Shetty A A, 2004, J Orthop Surg (Hong Kong), V12, P191	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	APR	2015	102	5					495	500		10.1002/bjs.9786		6	Surgery	Surgery	CE9AE	WOS:000352134800008		
J	Matsuda, K; Hotta, T; Takifuji, K; Yokoyama, S; Oku, Y; Watanabe, T; Mitani, Y; Ieda, J; Mizumoto, Y; Yamaue, H				Matsuda, K.; Hotta, T.; Takifuji, K.; Yokoyama, S.; Oku, Y.; Watanabe, T.; Mitani, Y.; Ieda, J.; Mizumoto, Y.; Yamaue, H.			Randomized clinical trial of defaecatory function after anterior resection for rectal cancer with high versus low ligation of the inferior mesenteric artery	BRITISH JOURNAL OF SURGERY			English	Article							QUALITY-OF-LIFE; HIGH TIE; COLONIC MOTILITY; J-POUCH; AUTONOMIC DENERVATION; FECAL INCONTINENCE; COLORECTAL-CANCER; SURGERY; LEVEL; ANASTOMOSIS	Background: Defaecatory function is often poor after anterior resection. Denervation of the neorectum following high ligation of the inferior mesenteric artery (IMA) is a possible cause of impaired defaecatory function. The purpose of this randomized clinical trial was to clarify whether the level of ligation of the IMA in patients with rectal cancer affects defaecatory function. Methods: Between 2008 and 2011, patients who underwent anterior resection for rectal cancer were randomized to receive either high or low ligation of the IMA. The primary endpoint was to demonstrate the superiority of low ligation in terms of defaecatory function. Results: One hundred patients were enrolled in the study; 51 were randomized to high ligation of the IMA and 49 to low ligation. There were no differences between the groups in terms of clinical data, except tumour stage, which was more advanced in the high-ligation group (P = 0.046). Nor were there any differences in defaecatory function, self-assessment of defaecation, Faecal Incontinence Quality of Life scale or continence score between groups at 3 months and 1 year. The number of harvested lymph nodes was similar. The rate of symptomatic anastomotic leakage was 16 per cent in the high-ligation group and 10 per cent in the low-ligation group (P = 0.415). Conclusion: The level of ligation of the IMA in patients with rectal cancer did not affect defaecatory function or the incidence of postoperative complications. Registration number: NCT00701012 (http://www.clinicaltrials.gov).	[Matsuda, K.; Hotta, T.; Takifuji, K.; Yokoyama, S.; Oku, Y.; Watanabe, T.; Mitani, Y.; Ieda, J.; Mizumoto, Y.; Yamaue, H.] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Adachi Y, 1998, J CLIN GASTROENTEROL, V26, P179, DOI 10.1097/00004836-199804000-00006; Adachi Y, 2000, HEPATO-GASTROENTEROL, V47, P155; Matzel KE, 1997, INT J COLORECTAL DIS, V12, P82, DOI 10.1007/s003840050086; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Rutegard M, 2012, BRIT J SURG, V99, P127, DOI 10.1002/bjs.7712; Koda K, 2005, DIS COLON RECTUM, V48, P210, DOI 10.1007/s10350-004-0814-6; Seike K, 2007, INT J COLORECTAL DIS, V22, P689, DOI 10.1007/s00384-006-0221-7; Koda K, 2009, J AM COLL SURGEONS, V208, P362, DOI 10.1016/j.jamcollsurg.2008.10.035; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Engel J, 2003, ANN SURG, V238, P203, DOI 10.1097/01.sla.0000080823.38569.b0; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Ho YH, 2002, ANN SURG, V236, P49, DOI 10.1097/00000658-200207000-00009; Lange MM, 2008, DIS COLON RECTUM, V51, P1139, DOI 10.1007/s10350-008-9328-y; Biondo S, 2013, SURGERY, V153, P383, DOI 10.1016/j.surg.2012.08.012; Titu LV, 2008, DIGEST SURG, V25, P148, DOI 10.1159/000128172; SURTEES P, 1990, BRIT J SURG, V77, P618, DOI 10.1002/bjs.1800770607; Lee WY, 2008, SURGERY, V143, P778, DOI 10.1016/j.surg.2008.03.014; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Cirocchi R, 2012, SURG ONCOL, V21, pE111, DOI 10.1016/j.suronc.2012.04.004; CORDER AP, 1992, BRIT J SURG, V79, P680, DOI 10.1002/bjs.1800790730; Hida J, 2013, SURG TODAY, V43, P8, DOI 10.1007/s00595-012-0359-6; Hida J, 1996, DIS COLON RECTUM, V39, P986, DOI 10.1007/BF02054686; Iizuka I, 2004, AM J SURG, V188, P176, DOI 10.1016/j.amjsurg.2003.12.064; Irie M, 1998, SURG TODAY, V28, P626; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Kanemitsu Y, 2006, BRIT J SURG, V93, P609, DOI 10.1002/bjs.5327; Kawamura YJ, 2000, EUR J SURG, V166, P803, DOI 10.1080/110241500447443; Oya M, 2002, SURG TODAY, V32, P111; Shimizu K, 2006, SURGERY, V139, P395, DOI 10.1016/j.surg.2005.08.018; Sobin LH, 2009, TNM CLASSIFICATION M; Tabe Y, 2010, INT J COLORECTAL DIS, V25, P53, DOI 10.1007/s00384-009-0799-7; Tanabe Y, 2002, SURGERY, V132, P471, DOI 10.1067/msy.2002.126511; Uehara K, 2007, DIGEST SURG, V24, P375, DOI 10.1159/000107779	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	APR	2015	102	5					501	508		10.1002/bjs.9739		8	Surgery	Surgery	CE9AE	WOS:000352134800009		
J	Seid, VE; Galvao, FHF; Vaidya, A; Waisberg, DR; Cruz, RJ; Chaib, E; Nahas, SC; Araujo, SEA; D'Albuquerque, LAC; Araki, J				Seid, V. E.; Galvao, F. H. F.; Vaidya, A.; Waisberg, D. R.; Cruz, R. J., Jr.; Chaib, E.; Nahas, S. C.; Araujo, S. E. A.; D'Albuquerque, L. A. C.; Araki, J.			Functional outcome of autologous anorectal transplantation in an experimental model	BRITISH JOURNAL OF SURGERY			English	Article							FECAL INCONTINENCE; AUTOTRANSPLANTATION; RAT	Background: Although anorectal transplantation is a challenging procedure, it is a promising option for patients who have completely lost anorectal function or in whom it failed to develop, as in congenital malformations. The paucity of animal models with which to test functional outcomes was addressed in this study of anorectal manometry in rats. Methods: Wistar rats were assigned randomly to four groups: orthotopic anorectal transplantation, heterotopic transplantation, sham operation, or normal control. Bodyweight and anal pressure were measured immediately before and after operation, and on postoperative days 7 and 14. ANOVA and Tukey's test were used to compare results for bodyweight, anal manometry and length of procedure. Results: Immediately after the procedure, mean(s.d.) anal pressure in the orthotopic group (n=13) dropped from 31.4(13.1) to 1.6(13.1) cmH(2)O (P < 0.001 versus both sham operation (n=13) and normal control (n=15)), with partial recovery on postoperative day 7 (14.9(13.9) cmH(2)O) (P=0.009 versus normal control) and complete recovery on day 14 (23.7(12.2) cmH(2)O). Heterotopic rats (n=14) demonstrated partial functional recovery: mean(s. d.) anal pressure was 26.9(10.9) cmH(2)O before operation and 8.6(6.8) cmH(2)O on postoperative day 14 (P < 0.001 versus both sham and normal control). Conclusion: Orthotopic anorectal transplantation may result in better functional outcomes than heterotopic procedures.	[Seid, V. E.; Galvao, F. H. F.; Waisberg, D. R.; Chaib, E.; D'Albuquerque, L. A. C.] Univ Sao Paulo, Fac Med, Div Liver Transplantat, Lab Liver Transplantat & Expt Surg LEM 37, Sao Paulo, Brazil; [Seid, V. E.; Nahas, S. C.; Araujo, S. E. A.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Div Colorectal Surg, Sao Paulo, Brazil; [Vaidya, A.] Oxford Univ Hosp, Dept Transplant Surg, Oxford, England; [Vaidya, A.] Univ Oxford, Oxford, England; [Cruz, R. J., Jr.] Univ Pittsburgh Med Ctr, Intestinal Rehabil & Transplant Ctr, Pittsburgh, PA USA; [Araki, J.] Univ Tokyo, Dept Plast Surg, Tokyo, Japan	Araki, J (reprint author), Univ Tokyo, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	arakij-pla@h.u-tokyo.ac.jp	D'ALBUQUERQUE, LUIZ/I-4011-2012				Benevento BT, 2002, PHYS THER, V82, P601; Pomahac B, 2012, NEW ENGL J MED, V366, P715, DOI 10.1056/NEJMoa1111432; Vignali A, 2000, DIS COLON RECTUM, V43, P76, DOI 10.1007/BF02237248; DUTHIE HL, 1965, GUT, V6, P64, DOI 10.1136/gut.6.1.64; Siproudhis L, 1999, AM J GASTROENTEROL, V94, P1556, DOI 10.1111/j.1572-0241.1999.01144.x; GIBBONS CP, 1986, LANCET, V1, P886; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Araki J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06312; Araki J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044310; Araki J, 2011, TRANSPL P, V43, P3552, DOI 10.1016/j.transproceed.2011.08.042; Athanasakos EP, 2008, BRIT J SURG, V95, P1394, DOI 10.1002/bjs.6327; Brannstrom M, 2014, LANCET; Galvao FHF, 2012, CLINICS, V67, P971, DOI 10.6061/clinics/2012(08)20; Galvao FHF, 2009, TECH COLOPROCTOL, V13, P55, DOI 10.1007/s10151-009-0459-5; Galvao FHF, 2012, MICROSURG, V32, P77, DOI 10.1002/micr.20958; Galvao FHF, 2013, TRANSPLANTATION, V96, pE3, DOI 10.1097/TP.0b013e3182981167; KIFF ES, 1984, BRIT J SURG, V71, P614, DOI 10.1002/bjs.1800710817; McCarthy MJ, 2007, SPINE, V15, P207; O'Bichere A, 2000, BRIT J SURG, V87, P1534, DOI 10.1046/j.1365-2168.2000.01557.x; PERCY JP, 1981, LANCET, V1, P16	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	APR	2015	102	5					558	562		10.1002/bjs.9762		5	Surgery	Surgery	CE9AE	WOS:000352134800017		
J	Sakamoto, Y; Hirai, N; Tanikawa, T; Yago, M; Ishii, M				Sakamoto, Y.; Hirai, N.; Tanikawa, T.; Yago, M.; Ishii, M.			Population genetic structure and Wolbachia infection in an endangered butterfly, Zizina emelina (Lepidoptera, Lycaenidae), in Japan	BULLETIN OF ENTOMOLOGICAL RESEARCH			English	Article						genetic structure; male killing; mitochondrial DNA; Wolbachia; Zizina emelina	MALE-KILLING WOLBACHIA; CYTOPLASMIC INCOMPATIBILITY; MITOCHONDRIAL-DNA; SEX-RATIO; DROSOPHILA-SIMULANS; CENTRAL-EUROPE; ICE AGES; CONSERVATION; DISPERSAL; HYBRIDIZATION	Zizina emelina (de l'Orza) is listed on Japan's Red Data List as an endangered species because of loss of its principal food plant and habitat. We compared parts of the mitochondrial and nuclear genes of this species to investigate the level of genetic differentiation among the 14 extant populations. We also examined infection of the butterfly with the bacterium Wolbachia to clarify the bacterium's effects on the host population's genetic structure. Mitochondrial and nuclear DNA analyses revealed that haplotype composition differed significantly among most of the populations, and the fixation index F-ST was positively correlated with geographic distance. In addition, we found three strains of Wolbachia, one of which was a male killer; these strains were prevalent in several populations. There was linkage between some host mitochondrial haplotypes and the three Wolbachia strains, although no significant differences were found in a comparison of host mitochondrial genetic diversity with nuclear genetic diversity in Wolbachia-infected or -uninfected populations. These genetic analyses andWolbachia infection findings show that Z. emelina has little migratory activity and that little gene flow occurs among the current populations.	[Sakamoto, Y.; Hirai, N.; Tanikawa, T.; Ishii, M.] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Entomol Lab, Sakai, Osaka 5998531, Japan; [Yago, M.] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Sakamoto, Y (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	sakamoto.yoshiko@nies.go.jp			Japan Society for the Promotion of Science [11J10420, 23510297, 24510331]	We are grateful to Dr T. Hirowatari of the Entomological Laboratory of Kyushu University, Japan, and to Dr J. Y. Uchida of the University of Hawaii for their kind advice and help. We also thank Mr S. Morichi and Mr S. Minohara of the Lepidopterological Society of Japan, Dr T. Kobayashi of the Yamanashi Institute of Environmental Sciences, and Mr Y. Yoshida of the Yokohama Plant Protection Station for collecting samples. Our thanks are also due to our colleagues in our laboratory for their helpful cooperation and comments. This study was supported in part by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS Fellows 11J10420, Grants-in-Aid for Scientific Research 23510297 and 24510331).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Hiroki M, 2002, NATURWISSENSCHAFTEN, V89, P167, DOI 10.1007/s00114-002-0303-5; HOFFMANN AA, 1990, GENETICS, V126, P933; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Braig HR, 1998, J BACTERIOL, V180, P2373; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Jiggins CD, 2001, EVOLUTION, V55, P1631; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; BONNELL ML, 1974, SCIENCE, V184, P908, DOI 10.1126/science.184.4139.908; Ibrahim KM, 1996, HEREDITY, V77, P282; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Jeratthitikul E, 2013, MOL PHYLOGENET EVOL, V66, P316, DOI 10.1016/j.ympev.2012.10.009; HUDSON RR, 1987, GENETICS, V116, P153; TEMPLETON AR, 1992, GENETICS, V132, P619; OBRIEN SJ, 1983, SCIENCE, V221, P459, DOI 10.1126/science.221.4609.459; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; Jiggins FM, 2003, GENETICS, V164, P5; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.2307/3060947; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329; TURELLI M, 1995, GENETICS, V140, P1319; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Smidova A, 2011, FLORA, V206, P151, DOI 10.1016/j.flora.2010.03.003; Weeks AR, 2001, P ROY SOC B-BIOL SCI, V268, P2245, DOI 10.1098/rspb.2001.1797; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Avise JC., 2000, PHYLOGEOGRAPHY HIST; Avise J.C., 1994, MOL MARKERS NATURAL; Bonte D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-16; BRISCOE D. A., 2002, INTRO CONSERVATION G; Dvorakova H, 2010, FLORA, V205, P418, DOI 10.1016/j.flora.2009.12.029; Ellegren H, 1996, MOL ECOL, V5, P3, DOI 10.1111/j.1365-294X.1996.tb00286.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fay JC, 1999, MOL BIOL EVOL, V16, P1003; Forbes SH, 1999, ANIM CONSERV, V2, P223, DOI 10.1111/j.1469-1795.1999.tb00068.x; Fukuda H, 1984, LIFE HIST BUTTERFLIE, VIII; Haig SM, 2001, CONSERV GENET, V2, P25, DOI 10.1023/A:1011561101460; Hamrick J. L., 1996, P281; Huck S, 2012, FLORA, V207, P399, DOI 10.1016/j.flora.2012.03.005; Ikeda H, 2009, BIOL J LINN SOC, V98, P452, DOI 10.1111/j.1095-8312.2009.01283.x; Ishii M., 2009, DECLINE CONSERVATION, VVI, P3; Ishii Minoru, 2008, Transactions of the Lepidopterological Society of Japan, V59, P78; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453; Leturque H, 2003, EVOL ECOL, V17, P67, DOI 10.1023/A:1022405415375; LOGSDON JM, 1995, P NATL ACAD SCI USA, V92, P8507, DOI 10.1073/pnas.92.18.8507; Mano T., 2009, DECLINE CONSERVATION, VVI, P107; Meffe GK, 1997, PRINCIPLES CONSERVAT; Ministry of Environment Japan, 2012, 4 RED DAT LIST THREA; Ministry of Environment Japan, 2006, THREAT WILDL JAP RED, V5, P24; Minohara Shigeru, 2007, Transactions of the Lepidopterological Society of Japan, V58, P421; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nakamura Y., 2010, J INSECT CONSERV, V15, P5; Nakamura Y, 2003, DECLINE CONSERVATION, P171; Nakatani T., 2006, INSECT DNA RES NEWSL, V5, P28; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Negri I, 2006, P R SOC B, V273, P2409, DOI 10.1098/rspb.2006.3592; Nice CC, 2009, BIOL CONSERV, V142, P3137, DOI 10.1016/j.biocon.2009.08.020; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Ohshima I, 2010, MOL PHYLOGENET EVOL, V57, P1026, DOI 10.1016/j.ympev.2010.09.018; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; Primack R.B., 2004, PRIMER CONSERVATION; RIGAUD T, 1991, ENDOCYT CELL RES, V7, P259; Ritter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078107; Saigusa T., 2001, BUTTERFLY DNA RES SO, V6, P15; Saitoh S, 2008, BIOL J LINN SOC, V93, P557, DOI 10.1111/j.1095-8312.2007.00888.x; Sakamoto Y, 2011, ANN ENTOMOL SOC AM, V104, P483, DOI 10.1603/AN09168; Sakamoto Y, 2010, ENTOMOL NEWS, V121, P443, DOI 10.3157/021.121.0505; Schmitt T, 2007, J ZOOL SYST EVOL RES, V45, P39, DOI 10.1111/j.1439-0469.2006.00404.x; Sunose T, 2003, DECLINE CONSERVATION, P1; Suzuki Y., 2007, NATURE INSECTS, P10; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Takei H., 2005, NATURE AND INSECTS, V20, P24; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447; Yagi T, 1999, J MOL EVOL, V48, P42, DOI 10.1007/PL00006443; Yago M, 2008, ZOOTAXA, P15; Yoshio M., 2005, INSECT DNA RES NEWSL, V2, P38	84	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0007-4853	1475-2670		B ENTOMOL RES	Bull. Entomol. Res.	APR	2015	105	2					152	165		10.1017/S0007485314000819		14	Entomology	Entomology	CF7CQ	WOS:000352714100002		
J	Rachman, AN; Chung, TW; Yoshimoto, K; Son, B				Rachman, Asep Nur; Chung, Tae Woong; Yoshimoto, Kazuo; Son, Busoon			Separation of Intrinsic and Scattering Attenuation Using Single Event Source in South Korea	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							FULL SEISMOGRAM ENVELOPE; TIME WINDOW ANALYSIS; SEISMIC ATTENUATION; S-WAVES; SPATIAL-DISTRIBUTION; FREQUENCY Q(LG)(-1); SHEAR-WAVES; ENERGY; CODA; CRUST	Simultaneous use of numerous events in the multiple lapse time window analysis (MLTWA) method is the most effective way to obtain Q(i)(-1) and Q(S)(-1) values. Such simultaneous use of numerous events normally shows a large observational scatter, which may be caused by different radiation pattern and focal depth of each earthquake, and regional alteration of the local structure. To avoid these scattering factors, the current study attempted to use single event source as the input data in MLTWA for South Korea. The direct simulation Monte Carlo (DSMC) method was used to simulate the observations, which showed realistic results when the number of recorded stations was eight or more. The obtained values of seismic albedo (B-0) were less than 0.5, which were in accordance with the same in the previous results. Three envelopes constructed by combination of three regional values of Q(Lg)(-1) at 1 Hz produced regional variations, of which the ones at high frequencies of Q(i)(-1) and at low frequencies of Q(S)(-1) were remarkable. This result, showing the local variation indicated an advantage of the study using single source event over the previous studies in South Korea that involved extensively distributed data. Because DSMC was known to be applicable to 3D structure due to its simple algorithm, the current study also tried to correct radiation pattern of the observations by inserting focal mechanism algorithm to the code of the DSMC method. Such insertion, however, generated extremely low values of Q(S)(-1) because the geometrically shrunk receiver could not capture most of the scattered particles. This receiver problem is most likely to be a major obstacle of the 3D study of DSMC. In addition, the significant depth effect of Q(-1) was identified for the prior MLTWA studies resulting from different measurement range and focal depth.	[Rachman, Asep Nur; Chung, Tae Woong] Sejong Univ, Seoul 143747, South Korea; [Yoshimoto, Kazuo] Yokohama City Univ, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Son, Busoon] Soonchunhyang Univ, Asan Chungnam 336745, South Korea	Rachman, AN (reprint author), Sejong Univ, 209 Neungdong Ro, Seoul 143747, South Korea.	anrachman59@gmail.com; chungtw@sejong.ac.kr; k_yoshi@yokohama-cu.ac.jp; sonbss@sch.ac.kr			CATER by the Center for Atmosphere Sciences and Earthquake Research (CATER) of Korea	This research was supported by funds from CATER 2012-8010 provided by the Center for Atmosphere Sciences and Earthquake Research (CATER) of Korea. Comments and suggestions by two anonymous reviewers greatly helped improve and clarify this manuscript.	Aki K., 1980, QUANTITATIVE SEISMOL; AKI K, 1980, J GEOPHYS RES, V85, P6496, DOI 10.1029/JB085iB11p06496; Ugalde A, 2007, TECTONOPHYSICS, V429, P111, DOI 10.1016/j.tecto.2006.09.010; DAINTY AM, 1981, GEOPHYS RES LETT, V8, P1126, DOI 10.1029/GL008i011p01126; Bianco F, 2002, GEOPHYS J INT, V150, P10, DOI 10.1046/j.1365-246X.2002.01696.x; MITCHELL BJ, 1995, REV GEOPHYS, V33, P441, DOI 10.1029/95RG02074; Hoshiba M, 1997, PHYS EARTH PLANET IN, V104, P15, DOI 10.1016/S0031-9201(97)00055-1; Chung TW, 2003, B SEISMOL SOC AM, V93, P1401, DOI 10.1785/0120020199; Hong TK, 2012, TECTONOPHYSICS, V570, P102, DOI 10.1016/j.tecto.2012.08.034; Giampiccolo E, 2006, GEOPHYS J INT, V165, P211, DOI 10.1111/j.1365-246X.2006.02881.x; MITCHELL BJ, 1994, GEOPHYS J INT, V116, P468, DOI 10.1111/j.1365-246X.1994.tb01809.x; Ryzhik L, 1996, WAVE MOTION, V24, P327, DOI 10.1016/S0165-2125(96)00021-2; Mukhopadhyay S, 2010, PHYS EARTH PLANET IN, V180, P7, DOI 10.1016/j.pepi.2010.03.007; Bianco F, 2005, GEOPHYS J INT, V161, P130, DOI 10.1111/j.1365-246X.2005.02555.x; Canas JA, 1998, J GEOPHYS RES-SOL EA, V103, P15037, DOI 10.1029/98JB00769; WU RS, 1985, GEOPHYS J ROY ASTR S, V82, P57, DOI 10.1111/j.1365-246X.1985.tb05128.x; Carcole E, 2010, GEOPHYS J INT, V180, P268, DOI 10.1111/j.1365-246X.2009.04394.x; SATO H, 1993, GEOPHYS J INT, V112, P141, DOI 10.1111/j.1365-246X.1993.tb01443.x; Chung TW, 2010, B SEISMOL SOC AM, V100, P3183, DOI 10.1785/0120100054; Yoshimoto K, 2000, J GEOPHYS RES-SOL EA, V105, P6153, DOI 10.1029/1999JB900437; FEHLER M, 1992, GEOPHYS J INT, V108, P787, DOI 10.1111/j.1365-246X.1992.tb03470.x; Vargas CA, 2004, GEOPHYS J INT, V158, P609, DOI 10.1111/j.1365-246X.2004.02307.x; Kim KD, 2004, B SEISMOL SOC AM, V94, P1070, DOI 10.1785/0120030137; Hoshiba M, 2001, J SEISMOL, V5, P157, DOI 10.1023/A:1011478202750; Badi G, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041081; Cerveny V., 1971, THEORY SEISMIC HEAD; Chung T. W., 2014, DISASTER ADV, V7, P7; Chung T. W., 2013, J KOREAN SOC EARTH E, V16, P293, DOI [10.7582/GGE.2013.16.4.293, DOI 10.7582/GGE.2013.16.4.293]; Chung TW, 2009, GEOPHYS J INT, V177, P1366, DOI 10.1111/j.1365-246X.2009.04121.x; Chung TW, 2005, B SEISMOL SOC AM, V95, P512, DOI 10.1785/0120030223; Chung TW, 2007, B SEISMOL SOC AM, V97, P2190, DOI 10.1785/0120070066; Chung TW, 2001, B SEISMOL SOC AM, V91, P1867, DOI 10.1785/0120000268; de Lorenzo S, 2013, PHYS EARTH PLANET IN, V218, P19, DOI 10.1016/j.pepi.2013.03.002; Del Pezzo E, 2011, GEOPHYS J INT, V186, P373, DOI 10.1111/j.1365-246X.2011.05053.x; Draper N.R., 1998, APPL REGRESSION ANAL; Feynman R., 1989, FEYNMAN LECT PHYS CO; Hong TK, 2010, B SEISMOL SOC AM, V100, P851, DOI 10.1785/0120090057; HOSHIBA M, 1991, PHYS EARTH PLANET IN, V67, P123, DOI 10.1016/0031-9201(91)90066-Q; Hoshiba M, 1991, PAP METEOROL GEOPHYS, V42, P65, DOI DOI 10.2467/MRIPAPERS.42.65; HOSHIBA M, 1993, J GEOPHYS RES-SOL EA, V98, P15809, DOI 10.1029/93JB00347; Jo E, 2013, J ASIAN EARTH SCI, V66, P204, DOI 10.1016/j.jseaes.2013.01.008; KAMPFMANN W, 1985, PHYS EARTH PLANET IN, V40, P223, DOI 10.1016/0031-9201(85)90132-3; Lee K, 2003, B SEISMOL SOC AM, V93, P2131, DOI 10.1785/0120020176; Lemzikov VK, 2007, J VOLCANOL SEISMOL+, V1, P185, DOI 10.1134/S0742046307030049; MAYEDA K, 1992, J GEOPHYS RES-SOL EA, V97, P6643, DOI 10.1029/91JB03094; Padhy S, 2010, GEOPHYS J INT, V183, P1052, DOI 10.1111/j.1365-246X.2010.04783.x; Sato H, 2012, SEISMIC WAVE PROPAGA; SATO H, 1994, GEOPHYS J INT, V117, P487, DOI 10.1111/j.1365-246X.1994.tb03946.x; Ugalde A, 2010, PHYS EARTH PLANET IN, V181, P73, DOI 10.1016/j.pepi.2010.04.009; Wessel P., 1998, EOS T AGU, V79; Yun S, 2007, B SEISMOL SOC AM, V97, P1012, DOI 10.1785/0120060097; ZENG YH, 1991, J GEOPHYS RES-SOLID, V96, P607, DOI 10.1029/90JB02012	52	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	APR	2015	105	2A					858	872		10.1785/0120140259		15	Geochemistry & Geophysics	Geochemistry & Geophysics	CE7AO	WOS:000351989600027		
J	Sano, H; Tanaka, H; Motoji, Y; Fukuda, Y; Sawa, T; Mochizuki, Y; Ryo, K; Matsumoto, K; Emoto, N; Hirata, K				Sano, Hiroyuki; Tanaka, Hidekazu; Motoji, Yoshiki; Fukuda, Yuko; Sawa, Takuma; Mochizuki, Yasuhide; Ryo, Keiko; Matsumoto, Kensuke; Emoto, Noriaki; Hirata, Ken-ichi			Right Ventricular Function and Right-Heart Echocardiographic Response to Therapy Predict Long-term Outcome in Patients With Pulmonary Hypertension	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							ARTERIAL-HYPERTENSION; GUIDELINES; FAILURE; STRAIN	Background: Right ventricular (RV) dysfunction in pulmonary hypertension (PH) is linked to adverse outcomes, but this response is considered heterogeneous because it can be associated with multiple factors. Methods: RV function of 51 PH patients was calculated by averaging peak speckle-tracking longitudinal strain from RV free-wall (RV-free), and the cutoff for RV dysfunction was predefined as RV-free <= 19%. Right-sided heart remodelling was assessed in terms of RV end-systolic area (RVESA) and right atrial (RA) area (RA-area). Midterm reverse remodelling was defined as a relative decrease in RVESA (DRVESA) and RA-area (DRA-area) of at least 15% at 5.7 +/- 4.0 months after introduction of pulmonary artery hypertension-specific drugs. Longterm outcome was tracked for 3.0 +/- 2.0 years. Results: Patients with midterm RV and RA reverse remodelling showed more favourable long-term outcomes than those without (P = 0.01, P = 0.047, respectively). Sequential Cox models showed that a model based on hemodynamic parameters (chi(2) = 0.3) was improved by the addition of RV-free (chi(2) = 6.4; P = 0.01), and further improved by addition of DRVESA and DRA-area (chi(2) = 28.2; P < 0.001). Furthermore, preservation of baseline RV function and midterm reverse remodelling in right-sided heart was associated with an optimal outcome: a survival rate of 100%. In contrast, absence of midterm reverse remodelling in the right-sided heart of patients with impaired baseline RV function was associated with significantly worse outcome with a survival rate of 33% (P = 0.01). Conclusions: RV function and echocardiographic right-heart reverse remodelling with therapy improves the prediction of long-term outcomes for PH patients over standard hemodynamic indices.	[Sano, Hiroyuki; Tanaka, Hidekazu; Motoji, Yoshiki; Fukuda, Yuko; Sawa, Takuma; Mochizuki, Yasuhide; Ryo, Keiko; Matsumoto, Kensuke; Emoto, Noriaki; Hirata, Ken-ichi] Kobe Univ Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Tanaka, H (reprint author), Kobe Univ Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tanakah@med.kobe-u.ac.jp					Fukui S, 2014, EUR RESPIR J, V43, P1394, DOI 10.1183/09031936.00012914; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Motoji Y, 2013, CIRC J, V77, P756, DOI 10.1253/circj.CJ-12-1083; Chin KM, 2008, AM J CARDIOL, V101, P1669, DOI 10.1016/j.amjcard.2008.01.055; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Iino M, 2008, EUR RADIOL, V18, P792, DOI 10.1007/s00330-007-0829-1; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Han MLK, 2013, CHEST, V143, P1699, DOI 10.1378/chest.12-1594; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640; Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051; Bustamante-Labarta M, 2002, J AM SOC ECHOCARDIOG, V15, P1160, DOI 10.1067/mje.2002.123962; Fukuda Y, 2014, INT J CARDIOVAS IMAG, V30, P1269, DOI 10.1007/s10554-014-0460-6	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	APR	2015	31	4					529	536		10.1016/j.cjca.2015.01.027		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE9EB	WOS:000352145500016		
J	Frigault, MJ; Lee, J; Basil, MC; Carpenito, C; Motohashi, S; Scholler, J; Kawalekar, OU; Guedan, S; McGettigan, SE; Posey, AD; Ang, S; Cooper, LJN; Platt, JM; Johnson, FB; Paulos, CM; Zhao, YB; Kalos, M; Milone, MC; June, CH				Frigault, Matthew J.; Lee, Jihyun; Basil, Maria Ciocca; Carpenito, Carmine; Motohashi, Shinichiro; Scholler, John; Kawalekar, Omkar U.; Guedan, Sonia; McGettigan, Shannon E.; Posey, Avery D., Jr.; Ang, Sonny; Cooper, Laurence J. N.; Platt, Jesse M.; Johnson, F. Brad; Paulos, Chrystal M.; Zhao, Yangbing; Kalos, Michael; Milone, Michael C.; June, Carl H.			Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells	CANCER IMMUNOLOGY RESEARCH			English	Article							INTERLEUKIN-2 GENE-EXPRESSION; CD28 COSTIMULATION; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; SIGNAL-TRANSDUCTION; CLONAL EXPANSION; CLINICAL-TRIAL; TUMOR-CELLS; CHAIN; ACTIVATION	This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-kappa B, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials.	[Frigault, Matthew J.; Lee, Jihyun; Basil, Maria Ciocca; Carpenito, Carmine; Scholler, John; Kawalekar, Omkar U.; Guedan, Sonia; McGettigan, Shannon E.; Posey, Avery D., Jr.; Platt, Jesse M.; Johnson, F. Brad; Zhao, Yangbing; Kalos, Michael; Milone, Michael C.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Ang, Sonny; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Paulos, Chrystal M.] Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Paulos, Chrystal M.] Med Univ S Carolina, Dept Surg, Hollings Canc Ctr, Charleston, SC 29425 USA	June, CH (reprint author), Univ Penn, 3400 Civ Ctr Blvd,8th Floor,Room 08-123, Philadelphia, PA 19104 USA.	cjune@exchange.upenn.edu			NIH [R01CA120409, R01CA105216, 2PN2EY016586, 2P30CA016520, P01CA066726, 3T32-GM007170-36S1]; Abramson Family Cancer Institute; Novartis	This work was supported by funding from NIH grants R01CA120409, R01CA105216, 2PN2EY016586, 2P30CA016520, P01CA066726, 3T32-GM007170-36S1, the Abramson Family Cancer Institute, and Novartis.	Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Haynes NM, 2002, J IMMUNOL, V169, P5780; Finney HM, 2004, J IMMUNOL, V172, P104; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Bonini C, 2011, BIOL BLOOD MARROW TR, V17, pS15, DOI 10.1016/j.bbmt.2010.09.019; Goronzy JJ, 2012, SEMIN IMMUNOL, V24, P365, DOI 10.1016/j.smim.2012.04.003; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Lukens JN, 2009, ALZHEIMERS DEMENT, V5, P463, DOI 10.1016/j.jalz.2009.05.666; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Finney HM, 1998, J IMMUNOL, V161, P2791; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Newrzela S, 2011, MOL MED, V17, P1223, DOI 10.2119/molmed.2010.00193; Geiger TL, 2001, BLOOD, V98, P2364, DOI 10.1182/blood.V98.8.2364; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Hombach A, 2001, J IMMUNOL, V167, P6123; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Ertl HCJ, 2011, CANCER RES, V71, P3175, DOI 10.1158/0008-5472.CAN-10-4035; Kohn DB, 2011, MOL THER, V19, P432, DOI 10.1038/mt.2011.1; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Moeller M, 2004, CANCER GENE THER, V11, P371, DOI 10.1038/sj.cgt.7700710; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; AlvarezVallina L, 1996, EUR J IMMUNOL, V26, P2304, DOI 10.1002/eji.1830261006; Skibinski G, 2001, IMMUNOLOGY, V102, P506, DOI 10.1046/j.1365-2567.2001.01186.x; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Huang X, 2006, BLOOD, V107, P483, DOI 10.1182/blood-2005-05-2133; Arakawa F, 2002, ANTICANCER RES, V22, P4285; Feldhaus AL, 1997, GENE THER, V4, P833, DOI 10.1038/sj.gt.3300456; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Good L, 1997, J BIOL CHEM, V272, P1425; Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; Gyobu H, 2004, CANCER RES, V64, P1490, DOI 10.1158/0008-5472.CAN-03-2780; Hsu C, 2007, BLOOD, V109, P5168, DOI 10.1182/blood-2006-06-029173; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; JUNE CH, 1987, MOL CELL BIOL, V7, P4472; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Loskog A, 2006, LEUKEMIA, V20, P1819, DOI 10.1038/sj.leu.2404366; MCGUIRE KL, 1993, J VIROL, V67, P1590; Nguyen P, 2003, BLOOD, V102, P4320, DOI 10.1182/blood-2003-04-1255; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Shibaguchi H, 2006, ANTICANCER RES, V26, P4067; Teng MWL, 2004, HUM GENE THER, V15, P699, DOI 10.1089/1043034041361235; Teng MWL, 2006, HUM GENE THER, V17, P1134, DOI 10.1089/hum.2006.17.1134; Willemsen RA, 2005, J IMMUNOL, V174, P7853; Yu X, 2000, J IMMUNOL, V164, P3543; Zhao Y, 2010, CANCER RES, V70, P9062	52	5	5	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2326-6066	2326-6074		CANCER IMMUNOL RES	Cancer Immunol. Res.	APR	2015	3	4					356	U131		10.1158/2326-6066.CIR-14-0186		13	Oncology; Immunology	Oncology; Immunology	CF2LT	WOS:000352379500007		
J	Ezaki, J; Hashimoto, K; Asano, T; Kanda, S; Akioka, Y; Hattori, M; Yamamoto, T; Shibata, N				Ezaki, Jiro; Hashimoto, Kazunori; Asano, Tatsuo; Kanda, Shoichiro; Akioka, Yuko; Hattori, Motoshi; Yamamoto, Tomoko; Shibata, Noriyuki			Gonadal Tumor in Frasier Syndrome: A Review and Classification	CANCER PREVENTION RESEARCH			English	Review							SPLICE-SITE MUTATION; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RESISTANT NEPHROTIC SYNDROME; 46,XY PHENOTYPIC MALE; WT1 GENE; IVS9+4C-GREATER-THAN-T MUTATION; DELAYED PUBERTY; RENAL-FAILURE; GONADOBLASTOMA; FEMALE	Frasier syndrome is a rare inherited disease characterized by steroid-resistant nephrotic syndrome, gonadal tumor, and male pseudohermaphroditism (female external genitalia with sex chromosomes XY), which is based on a splice site mutation of Wilms tumor-suppressor gene 1 (WT1). Several unusual Frasier syndrome cases have been reported in which male pseudohermaphroditism was absent. We reviewed 88 Frasier syndrome cases in the literature and classified them into three types (type 1-3) according to external genitalia and sex chromosomes, and described their clinical phenotypes. Type 1 Frasier syndrome is characterized by female external genitalia with 46, XY (n = 72); type 2 by male external genitalia with 46, XY (n = 8); and type 3 by female external genitalia with 46, XX (n = 8). Clinical course differs markedly among the types. Although type 1 is noticed at the mean age of 16 due to mainly primary amenorrhea, type 2 and 3 do not present delayed secondary sex characteristics, making diagnosis difficult. The prevalence of gonadal tumor is high in type 1 (67%) and also found in 3 of the 8 type 2 cases, but not in any type 3 cases, which emphasize that preventive gonadectomy is unnecessary in type 3. On the basis of our findings, we propose a new diagnostic algorithm for Frasier syndrome. (C) 2015 AACR.	[Ezaki, Jiro] Tokyo Womens Med Univ, Med Training Ctr Grad, Tokyo 1628666, Japan; [Ezaki, Jiro; Yamamoto, Tomoko; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo 1628666, Japan; [Hashimoto, Kazunori] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo 1628666, Japan; [Asano, Tatsuo; Kanda, Shoichiro; Akioka, Yuko; Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Yamamoto, Tomoko; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan	Shibata, N (reprint author), Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shibatan@research.twmu.ac.jp					Jeanpierre C, 1998, AM J HUM GENET, V62, P824, DOI 10.1086/301806; Santin S, 2011, CLIN J AM SOC NEPHRO, V6, P1139, DOI 10.2215/CJN.05260610; Subbiah V, 2009, PEDIATR BLOOD CANCER, V53, P1349, DOI 10.1002/pbc.22152; TSUCHIYA K, 1995, AM J HUM GENET, V57, P1400; FRASIER SD, 1964, J PEDIATR-US, V64, P740, DOI 10.1016/S0022-3476(64)80622-3; Pleskacova J, 2010, SEX DEV, V4, P259, DOI 10.1159/000314536; Aucella F, 2006, PEDIATR NEPHROL, V21, P1393, DOI 10.1007/s00467-006-0225-0; BAILEY WA, 1992, AM J DIS CHILD, V146, P1218; Chak WL, 2002, NEPHRON, V91, P526, DOI 10.1159/000064302; Chan W. K. Y., 2006, Hong Kong Medical Journal, V12, P225; Demmer L, 1999, J AM SOC NEPHROL, V10, P2215; Denamur E, 1999, J AM SOC NEPHROL, V10, P2219; Denamur E, 2000, KIDNEY INT, V57, P1868, DOI 10.1046/j.1523-1755.2000.00036.x; Esin S, 2012, ARCH GYNECOL OBSTET, V285, P447, DOI 10.1007/s00404-011-2073-9; Fujita S, 2010, CLIN NEPHROL, V73, P487; Guaragna MS, 2012, ARQ BRAS ENDOCRINOL, V56, P525, DOI 10.1590/S0004-27302012000800011; Hausladen J, 2001, CURR OPIN PEDIATR, V13, P150, DOI 10.1097/00008480-200104000-00011; Hersmus R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040858; Hughes I A, 2006, J Pediatr Urol, V2, P148, DOI 10.1016/j.jpurol.2006.03.004; Ismaili K, 2008, EUR J PEDIATR, V167, P579, DOI 10.1007/s00431-007-0514-z; Jaubert Francis, 2003, Arkhiv Patologii, V65, P40; Joki-Erkkilä Minna M, 2002, J Pediatr Adolesc Gynecol, V15, P145, DOI 10.1016/S1083-3188(02)00147-X; Kanagal DV, 2013, J CLIN DIAGN RES, V9, P2021; Kanemoto K, 2007, PEDIATR NEPHROL, V22, P454, DOI 10.1007/s00467-006-0333-x; Kitsiou-Tzeli S, 2012, HORM-INT J ENDOCRINO, V11, P361; Kohsaka T, 1999, HUM MUTAT, V14, P466, DOI 10.1002/(SICI)1098-1004(199912)14:6<466::AID-HUMU4>3.3.CO;2-Y; Koziell A, 2000, CLIN ENDOCRINOL, V52, P519; Love JD, 2006, J PEDIATR SURG, V41, DOI 10.1016/j.jpedsurg.2006.07.012; Melo KFS, 2002, J CLIN ENDOCR METAB, V87, P2500, DOI 10.1210/jc.87.6.2500; Mestrallet G, 2011, PEDIATR TRANSPLANT, V15, pe53, DOI 10.1111/j.1399-3046.2010.01273.x; Okuhara K, 1999, ENDOCR J, V46, P639, DOI 10.1507/endocrj.46.639; PAGE DC, 1987, DEVELOPMENT, V101, P151; REZNIK VM, 1993, PEDIATR NEPHROL, V7, P551; Saylam K, 2003, EUR J OBSTET GYN R B, V110, P111, DOI 10.1016/S0301-2115(03)00088-5; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Shimoyama H, 2002, EUR J PEDIATR, V161, P81, DOI 10.1007/s00431-001-0867-7; Tajima T, 2003, HORM RES, V60, P302, DOI 10.1159/000074249; Yang YH, 2013, EUR J PEDIATR, V172, P127, DOI 10.1007/s00431-012-1770-0; Yang YH, 2013, GENET MOL RES, V12, P6184, DOI 10.4238/2013.December.4.5	39	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	APR	2015	8	4					271	276		10.1158/1940-6207.CAPR-14-0415		6	Oncology	Oncology	CE8FP	WOS:000352077400004		
J	Kuwano, Y; Nishida, K; Kajita, K; Satake, Y; Akaike, Y; Fujita, K; Kano, S; Masuda, K; Rokutan, K				Kuwano, Y.; Nishida, K.; Kajita, K.; Satake, Y.; Akaike, Y.; Fujita, K.; Kano, S.; Masuda, K.; Rokutan, K.			Transformer 2 beta and miR-204 regulate apoptosis through competitive binding to 3 ' UTR of BCL2 mRNA	CELL DEATH AND DIFFERENTIATION			English	Article							EXONIC SPLICING ENHANCER; SR PROTEIN FAMILY; CARCINOMA-CELLS; GASTRIC-CANCER; EXPRESSION; HUR; SF2/ASF; GENE; PHOSPHORYLATION; PROLIFERATION	RNA-binding proteins and microRNAs are potent post-transcriptional regulators of gene expression. Human transformer 2 beta (Tra2 beta) is a serine/arginine-rich-like protein splicing factor and is now implicated to have wide-ranging roles in gene expression as an RNA-binding protein. RNA immunoprecipitation (RIP) with an anti-Tra2 beta antibody and microarray analysis identified a subset of Tra2 beta-associated mRNAs in HCT116 human colon cancer cells, many of which encoded cell death-related proteins including Bcl-2 (B-cell CLL/lymphoma 2). Tra2 beta knockdown in HCT116 cells decreased Bcl-2 expression and induced apoptosis. Tra2 beta knockdown accelerated the decay of BCL2 alpha mRNA that encodes Bcl-2 and full-length 3' UTR, while it did not affect the stability of BCL2 beta mRNA having a short, alternatively spliced 3' UTR different from BCL2a 3' UTR. RIP assays with anti-Tra2 beta and antiArgonaute 2 antibodies, respectively, showed that Tra2 beta bound to BCL2a 3' UTR, and that Tra2 beta knockdown facilitated association of miR-204 with BCL2a 3' UTR. The consensus sequence (GAA) for Tra2 beta-binding lies within the miR-204-binding site of BCL2 3' UTR. Mutation of the consensus sequence canceled the binding of Tra2 beta to BCL2 3' UTR without disrupting miR-204-binding to BCL2 3' UTR. Transfection of an anti-miR-204 or introduction of three-point mutations into the miR-204-binding site increased BCL2 mRNA and Bcl-2 protein levels. Inversely, transfection of precursor miR-204 reduced their levels. Experiments with Tra2 beta-silenced or overexpressed cells revealed that Tra2 beta antagonized the effects of miR-204 and upregulated Bcl-2 expression. Furthermore, TRA2 beta mRNA expression was significantly upregulated in 22 colon cancer tissues compared with paired normal tissues and positively correlated with BCL2 mRNA expression. Tra2 beta knockdown in human lung adenocarcinoma cells (A549) increased their sensitivity to anticancer drugs. Taken together, our findings suggest that Tra2 beta regulates apoptosis by modulating Bcl-2 expression through its competition with miR-204. This novel function may have a crucial role in tumor growth.	[Kuwano, Y.; Nishida, K.; Kajita, K.; Satake, Y.; Akaike, Y.; Fujita, K.; Kano, S.; Masuda, K.; Rokutan, K.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, Tokushima 7708503, Japan	Kuwano, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Stress Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kuwanoy@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22790649, 24659370]; Takeda Science Foundation	This research was supported by a research grant (nos. 22790649 and 24659370) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.K) and Takeda Science Foundation.	Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Fischer DC, 2004, ONCOL REP, V11, P1085; Lam EKY, 2011, AM J TRANSL RES, V3, P209; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Beil B, 1997, DNA CELL BIOL, V16, P679; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Mukherjee N, 2011, MOL CELL, V43, P327, DOI [10.1016/j.molcel.2011.06.007, 10.1016/j.molce1.2011.06.007]; Qian W, 2011, FEBS LETT, V585, P875, DOI 10.1016/j.febslet.2011.02.017; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Gabriel B, 2009, ACTA OBSTET GYN SCAN, V88, P216, DOI 10.1080/00016340802503021; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Kajita K, 2013, J GASTROENTEROL, V48, P1222, DOI 10.1007/s00535-012-0745-2; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bao W, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-155; Chen ZY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-105; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Imam SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065129; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1365-2443.2004.00709.x; Kurokawa K, 2013, ONCOGENE, V33, P1407; Masuda K, 2013, METHODS MOL BIOL, V1048, P285, DOI 10.1007/978-1-62703-556-9_19; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; Pelisch F, 2010, P NATL ACAD SCI USA, V107, P16119, DOI 10.1073/pnas.1004653107; Sacconi A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.160; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Tsukamoto Y, 2001, AM J PATHOL, V158, P1685, DOI 10.1016/S0002-9440(10)64124-7	47	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	APR	2015	22	5					815	825		10.1038/cdd.2014.176		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CF3XQ	WOS:000352482800010		
J	Kobayashi, K; Toguchida, J; Karin, M; Kato, T				Kobayashi, K.; Toguchida, J.; Karin, M.; Kato, T., Jr.			IKK beta in postnatal perichondrium remotely controls endochondral ossification of the growth plate through downregulation of MCP-5	CELL DEATH AND DIFFERENTIATION			English	Article							KAPPA-B ACTIVATION; LONGITUDINAL BONE-GROWTH; SKELETAL DEVELOPMENT; CRE RECOMBINASE; INFLAMMATORY CYTOKINES; LIVER DEGENERATION; MICE; ALPHA; CHONDROCYTES; EXPRESSION	I kappa B kinase beta (IKK beta) is a catalytic subunit of the IKK complex, which activates nuclear factor-kappa B (NF-kappa B). Although its role in osteoclastogenesis is well established, the role of IKK beta in bone formation is poorly understood. Here, we report that conditional knockout of Ikk beta in limb bud mesenchymal cells results in the upregulation of monocyte chemoattractant protein-5 (MCP-5) in the perichondrium, which in turn inhibits the growth of longitudinal bone by compromising chondrocyte hypertrophy and increasing the apoptosis of chondrocytes within the growth plate. Contrary to expectations, IKK beta in cells of chondrocyte or osteoblast lineage was dispensable for bone growth. On the other hand, ex vivo experiments confirmed the role of MCP-5 in the growth of longitudinal bone. Furthermore, an in vitro study demonstrated that the action of IKK beta on MCP-5 is cell autonomous. Collectively, our results provide evidence for a previously unrecognized role of IKK beta in the regulation of the growth plate that is mediated through stimulation-independent downregulation of MCP-5 in the perichondrium.	[Kobayashi, K.; Toguchida, J.; Kato, T., Jr.] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto 6068507, Japan; [Karin, M.] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Karin, M.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	Kato, T (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Cell Growth & Differentiat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tkato@frontier.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21591941]	We are indebted to Dr. M Hibi (Nagoya University) for critically reading of the manuscript. We also thank Peter Karagiannis (CiRA, Kyoto University) for help in preparing the manuscript. We thank Dr. G Karsenty for permitting us to use the Col1a1-Cre Tg mouse and Dr. S Kato for providing it, and Dr. T Chano for providing the Col2a1-Cre Tg mouse and Dr. T Kitamura (The University of Tokyo) for providing Plat-E cells. Finally, we thank members of the Toguchida Lab, especially M Ikeya, Y Jin, S Sato, S Tamaki, N Takahara and Y Kobayashi, for their help. This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21591941 to TK Jr)	Alvarez J, 2001, DEV DYNAM, V221, P311, DOI 10.1002/dvdy.1141; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; MacRae VE, 2006, J ENDOCRINOL, V189, P319, DOI 10.1677/joe.1.06609; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Longobardi L, 2012, DEV CELL, V23, P71, DOI 10.1016/j.devcel.2012.05.004; Sederquist B, 2014, J MOL ENDOCRINOL, V53, pT35, DOI 10.1530/JME-14-0006; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Li ZW, 2003, J IMMUNOL, V170, P4630; Bakker A, 2003, METH MOLEC MED, V80, P19; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Häcker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Long FX, 1998, DEVELOPMENT, V125, P1067; Marie PJ, CURR OSTEOPOROS REP, V10, P190; Nishimura I, 2011, J BIOL CHEM, V286, P43925, DOI 10.1074/jbc.M111.264192; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Yang F, 2004, J IMMUNOL, V172, P2446	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	APR	2015	22	5					852	861		10.1038/cdd.2014.192		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CF3XQ	WOS:000352482800013		
J	Fister, I; Perc, M; Ljubic, K; Kamal, SM; Iglesias, A; Fister, I				Fister, Iztok, Jr.; Perc, Matjaz; Ljubic, Karin; Kamal, Salahuddin M.; Iglesias, Andres; Fister, Iztok			Particle swarm optimization for automatic creation of complex graphic characters	CHAOS SOLITONS & FRACTALS			English	Article							SURFACE RECONSTRUCTION; FIREFLY ALGORITHMS; DISPATCH	Nature-inspired algorithms are a very promising tool for solving the hardest problems in computer sciences and mathematics. These algorithms are typically inspired by the fascinating behavior at display in biological systems, such as bee swarms or fish schools. So far, these algorithms have been applied in many practical applications. In this paper, we present a simple particle swarm optimization, which allows automatic creation of complex two-dimensional graphic characters. The method involves constructing the base characters, optimizing the modifications of the base characters with the particle swarm optimization algorithm, and finally generating the graphic characters from the solution. We demonstrate the effectiveness of our approach with the creation of simple snowman, but we also outline in detail how more complex characters can be created. (C) 2015 Elsevier Ltd. All rights reserved.	[Fister, Iztok, Jr.; Fister, Iztok] Univ Maribor, Fac Elect Engn & Comp Sci, SI-2000 Maribor, Slovenia; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, SI-2000 Maribor, Slovenia; [Perc, Matjaz; Kamal, Salahuddin M.] King Abdulaziz Univ, Fac Sci, Jeddah, Saudi Arabia; [Ljubic, Karin] Univ Maribor, Fac Med, SI-2000 Maribor, Slovenia; [Iglesias, Andres] Univ Cantabria, Dept Appl Math & Computat Sci, E-39005 Santander, Spain; [Iglesias, Andres] Toho Univ, Fac Sci, Dept Informat Sci, Funabashi, Chiba 2748510, Japan	Perc, M (reprint author), Univ Maribor, Fac Nat Sci & Math, Koroska Cesta 160, SI-2000 Maribor, Slovenia.	matjaz.perc@um.si	Perc, Matjaz/A-5148-2009; Fister, Iztok Jr./G-7024-2011	Perc, Matjaz/0000-0002-3087-541X; Fister, Iztok Jr./0000-0002-6418-1272	Deanship of Scientific Research (DSR), King Abdulaziz University [76-130-35-HiCi]; KAU; Spanish Ministry of Economy and Competitiveness [TIN2012-30768]	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under Grant No. (76-130-35-HiCi). The authors, therefore, acknowledge technical and financial support of KAU. Financial support from the Computer Science National Program of the Spanish Ministry of Economy and Competitiveness, Project Ref. TIN2012-30768 is also acknowledged.	AlRashidi MR, 2009, IEEE T EVOLUT COMPUT, V13, P913, DOI 10.1109/TEVC.2006.880326; Chaturvedi KT, 2008, IEEE T POWER SYST, V23, P1079, DOI 10.1109/TPWRS.2008.926455; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968; Panigrahi BK, 2008, ENERG CONVERS MANAGE, V49, P1407, DOI 10.1016/j.enconman.2007.12.023; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Galvez A, 2008, LECT NOTES COMPUT SC, V5102, P116, DOI 10.1007/978-3-540-69387-1_13; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015; Vanni F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.078103; Galvez A, 2012, INFORM SCIENCES, V192, P174, DOI 10.1016/j.ins.2010.11.007; Fister I, 2013, SWARM EVOL COMPUT, V13, P34, DOI 10.1016/j.swevo.2013.06.001; Jiang Y, 2007, APPL MATH COMPUT, V193, P231, DOI 10.1016/j.amc.2007.03.047; Grigolini P, 2013, CHAOS SOLITON FRACT, V55, P1, DOI 10.1016/j.chaos.2013.06.001; Ciuprina G, 2002, IEEE T MAGN, V38, P1037, DOI 10.1109/20.996266; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Blum Christian, 2008, P43, DOI 10.1007/978-3-540-74089-6_2; Lukovic M, 2014, PHYSICA A, V416, P430, DOI 10.1016/j.physa.2014.08.066; Togelius J, 2011, IEEE T COMP INTEL AI, V3, P172, DOI 10.1109/TCIAIG.2011.2148116; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Zhang YD, 2010, EXPERT SYST APPL, V37, P1911, DOI 10.1016/j.eswa.2009.07.025; Bentley PJ, 2000, EVOLUTIONARY DESIGN AND MANUFACTURE, P161; Berube D, 2007, PRACTICAL RUBY GEMS, P191; Brownlee J., 2011, CLEVER ALGORITHMS NA; Crawford Chris, 1984, ART COMPUTER GAME DE; Eiben A. E., 2003, INTRO EVOLUTIONARY C; Fister I, 2014, SCI WORLD J, DOI 10.1155/2014/121782; Fister I, 2015, APPL MATH COMPUT, V252, P155, DOI 10.1016/j.amc.2014.12.006; Flanagan D., 2008, RUBY PROGRAMMING LAN; Funes P, 1998, ARTIF LIFE, V4, P337, DOI 10.1162/106454698568639; Galvez A, 2013, J APPL MATH, DOI 10.1155/2013/237984; Galvez A, 2012, INFORM SCIENCES, V182, P56, DOI 10.1016/j.ins.2010.09.031; Garey M.R., 1979, COMPUTERS INTRACTABI; Helbing Dirk, 2012, SOCIAL SELF ORG AGEN; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Rosenfeld Simon, 2013, Gene Regul Syst Bio, V7, P23, DOI 10.4137/GRSB.S10885; Russell S. J., 2010, ARTIFICIAL INTELLIGE; Shi Y., 2001, EV COMP 2001 P 2001, V1, P81; Shi Y., 1998, P IEEE INT C EV COMP, V26, P69, DOI DOI 10.1109/ICEC.1998.699146; Sims K, 1994, P 21 ANN C COMP GRAP, P15, DOI 10.1145/192161.192167; Sims K., 1991, ARTIFICIAL EVOLUTION, V25; Still M., 2006, RMAGICK IMAGEMAGICK, P301; Wang K.P., 2003, P 2 INT C MACH LEARN, V3, P1583; Xu K, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185553; Yang XS, 2011, COMM COM INF SC, V136, P53; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	44	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	APR	2015	73						29	35		10.1016/j.chaos.2014.12.019		7	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CE7TG	WOS:000352044100004		
J	Rabajante, JF; Talaue, CO				Fajardo Rabajante, Jomar; Ortega Talaue, Cherryl			Equilibrium switching and mathematical properties of nonlinear interaction networks with concurrent antagonism and self-stimulation	CHAOS SOLITONS & FRACTALS			English	Article							GENE REGULATORY NETWORKS; PLURIPOTENT STEM-CELLS; BIOCHEMICAL REACTION NETWORKS; BIOLOGICAL SWITCHES; COMPLEX NETWORKS; RNA DEGRADATION; MULTISTABILITY; SYSTEMS; MODELS; NOISE	Concurrent decision-making model (CDM) of interaction networks with more than two antagonistic components represents various biological systems, such as gene interaction, species competition and mental cognition. The CDM model assumes sigmoid kinetics where every component stimulates itself but concurrently represses the others. Here we prove generic mathematical properties (e.g., location and stability of steady states) of n-dimensional CDM with either symmetric or asymmetric reciprocal antagonism between components. Significant modifications in parameter values serve as biological regulators for inducing steady state switching by driving a temporal state to escape an undesirable equilibrium. Increasing the maximal growth rate and decreasing the decay rate can expand the basin of attraction of a steady state that contains the desired dominant component. Perpetually adding an external stimulus could shut down multi-stability of the system which increases the robustness of the system against stochastic noise. We further show that asymmetric interaction forming a repressilator-type network generates oscillatory behavior. (C) 2015 Elsevier Ltd. All rights reserved.	[Fajardo Rabajante, Jomar; Ortega Talaue, Cherryl] Univ Philippines Diliman, Inst Math, Quezon City 1101, Philippines; [Fajardo Rabajante, Jomar] Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna 4031, Philippines	Rabajante, JF (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	jfrabajante@up.edu.ph; cherryl@math.upd.edu.ph	Rabajante, Jomar/K-3502-2014	Rabajante, Jomar/0000-0002-0655-0893	Philippine Council for Industry, Energy and Emerging Technology Research and Development (PCIEERD) of the Department of Science and Technology (DOST); University of the Philippines	This work was financially supported by the Philippine Council for Industry, Energy and Emerging Technology Research and Development (PCIEERD) of the Department of Science and Technology (DOST), and by the University of the Philippines. We express our sincere thanks to Baltazar D. Aguda and Ariel L. Babierra for the useful discussion and comments.	Aguda BD, 2008, MODELS OF CELLULAR R; Andersen ME, 2002, ENVIRON HEALTH PERSP, V110, P971; Andrecut M., 2011, Applications of Monte Carlo Methods in Biology- Medicine and Other Fields of Science; Leite MCA, 2010, MATH BIOSCI ENG, V7, P83, DOI 10.3934/mbe.2010.7.83; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Mochizuki A, 2005, J THEOR BIOL, V236, P291, DOI 10.1016/j.jtbi.2005.03.015; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; 't Hoen PAC, 2011, NUCLEIC ACIDS RES, V39, P556, DOI 10.1093/nar/gkq790; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Neumeister H, 2010, J NEUROPHYSIOL, V104, P3180, DOI 10.1152/jn.00574.2010; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Macia J, 2009, J THEOR BIOL, V261, P126, DOI 10.1016/j.jtbi.2009.07.019; Mincheva M, 2008, P IEEE, V96, P1281, DOI 10.1109/JPROC.2008.925474; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Barzel B, 2013, NAT PHYS, V9, P673, DOI 10.1038/NPHYS2741; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Boss WF, 2010, PLANT PHYSIOL, V154, P439, DOI 10.1104/pp.110.161232; SMALE S, 1976, J MATH BIOL, V3, P5, DOI 10.1007/BF00307854; Baumgartner BL, 2011, P NATL ACAD SCI USA, V108, P21087, DOI 10.1073/pnas.1111408109; Bezout E., 1779, THEORIE GENERALE DES; Buse O, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066206; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Chen M, 2013, ACS SYNTH BIOL, V2, P587, DOI 10.1021/sb400044g; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; DeDeo S, 2012, J R SOC INTERFACE, V9, P2131, DOI 10.1098/rsif.2011.0840; Dilao R, 2014, J THEOR BIOL; Faucon PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102873; Ganguly N, 2009, DYNAMICS ON AND OF C; Hanel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036679; Huang S., 2011, BIOESSAYS, V34, P149, DOI DOI 10.1002/BIES.201100031; Huang S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000380; Huguet G, 2014, J VISION, V14, P1; Jeswiet SB, 2011, BEHAV ECOL, V23, P195; Kaarlejarvi E, 2014, OIKOS; KATH WL, 1985, SIAM J APPL MATH, V45, P943, DOI 10.1137/0145057; Kim KH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002344; Kuznetsov A, 2012, CHAOS SOLITON FRACT, V45, P660, DOI 10.1016/j.chaos.2012.02.009; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Li G, 2014, EURASIP J BIOINFORM, V4; Luna B, 2013, MOL BIOSYST, V9, P1765, DOI 10.1039/c3mb70077a; Masuda S, 2013, J MOL CELL BIOL, V5, P354, DOI 10.1093/jmcb/mjt034; Muller S, 2006, J MATH BIOL, V53, P905, DOI 10.1007/s00285-006-0035-9; Neves FS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018701; Pandian GN, 2012, BIOTECHNOL J, V7, P798, DOI 10.1002/biot.201100361; Panovska-Griffiths J, 2012, J R SOC INTERFACE, V10; Pisarchik AN, 2014, PHYS REP; Guantes R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000235; Radde N, 2011, ASIAN J CONTROL, V13, P597, DOI 10.1002/asjc.376; RANALDI R, 1994, J NEUROSCI METH, V53, P163, DOI 10.1016/0165-0270(94)90174-0; Siegal-Gaskins D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002039; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531; Suzuki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027232; Wang JW, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-50; Xu R, 2005, MATH COMPUT MODEL, V41, P159, DOI 10.1016/j.mcm.2004.08.003; Zhou JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014752	78	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	APR	2015	73						166	182		10.1016/j.chaos.2015.01.018		17	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CE7TG	WOS:000352044100018		
J	Done, JM; Holland, GJ; Bruyere, CL; Leung, LR; Suzuki-Parker, A				Done, James M.; Holland, Greg J.; Bruyere, Cindy L.; Leung, L. Ruby; Suzuki-Parker, Asuka			Modeling high-impact weather and climate: lessons from a tropical cyclone perspective	CLIMATIC CHANGE			English	Article							GENESIS POTENTIAL INDEX; HURRICANE FREQUENCY; CHANGING CLIMATE; NORTH-ATLANTIC; SIMULATIONS; VARIABILITY; TEMPERATURE; SENSITIVITY; RESOLUTION; INTENSITY	Although the societal impact of a weather event increases with the rarity of the event, our current ability to assess extreme events and their impacts is limited by not only rarity but also by current model fidelity and a lack of understanding and capacity to model the underlying physical processes. This challenge is driving fresh approaches to assess high-impact weather and climate. Recent lessons learned in modeling high-impact weather and climate are presented using the case of tropical cyclones as an illustrative example. Through examples using the Nested Regional Climate Model to dynamically downscale large-scale climate data the need to treat bias in the driving data is illustrated. Domain size, location, and resolution are also shown to be critical and should be adequate to: include relevant regional climate physical processes; resolve key impact parameters; and accurately simulate the response to changes in external forcing. The notion of sufficient model resolution is introduced together with the added value in combining dynamical and statistical assessments to fill out the parent distribution of high-impact parameters.	[Done, James M.; Holland, Greg J.; Bruyere, Cindy L.] NCAR Earth Syst Lab, Boulder, CO 80307 USA; [Bruyere, Cindy L.] North West Univ, Environm Sci & Management, Potchefstroom, South Africa; [Leung, L. Ruby] Pacific NW Natl Lab, Richland, WA 99352 USA; [Suzuki-Parker, Asuka] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	Done, JM (reprint author), NCAR Earth Syst Lab, POB 3000, Boulder, CO 80307 USA.	done@ucar.edu			National Science Foundation; Willis Research Network; Research Partnership to Secure Energy for America; Climatology and Simulation of Eddies/Eddies Joint Industry Project; Department of Energy Regional and Global Climate Modeling and Integrated Assessment Research programs; DOE by Battelle Memorial Institute [DE-AC05-76RLO1830]; Office of Science of the U.S. Department of Energy [DE-AC02-06CH11357]	NCAR is funded by the National Science Foundation and this work was partially supported by the Willis Research Network, the Research Partnership to Secure Energy for America, and the Climatology and Simulation of Eddies/Eddies Joint Industry Project. LRL was supported by the Department of Energy Regional and Global Climate Modeling and Integrated Assessment Research programs. The Pacific Northwest National Laboratory is operated for DOE by Battelle Memorial Institute under contract DE-AC05-76RLO1830. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-06CH11357. The ideas and concepts benefitted from discussions with: Julie Caron, Bill Collins, Cort Cooper, Rowan Douglas, Sherrie Fredrick, Jim Hack, Jim Hurrell, Rick Katz, Bill Kuo, Bill Large, John Michalakes, Adam Phillips, Erin Towler, Joe Tribbia, Mariana Vertenstein and Jon Wolfe.	Knutson TR, 2007, B AM METEOROL SOC, V88, P1549, DOI 10.1175/BAMS-88-10-1549; Katz RW, 2010, CLIMATIC CHANGE, V100, P71, DOI 10.1007/s10584-010-9834-5; MEARNS LO, 1984, J CLIM APPL METEOROL, V23, P1601, DOI 10.1175/1520-0450(1984)023<1601:EHTECI>2.0.CO;2; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Caron LP, 2011, CLIM DYNAM, V37, P869, DOI 10.1007/s00382-010-0846-7; Davis C, 2008, MON WEATHER REV, V136, P1990, DOI 10.1175/2007MWR2085.1; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Rasmussen R, 2011, J CLIMATE, V24, P3015, DOI 10.1175/2010JCLI3985.1; Xu ZF, 2012, J CLIMATE, V25, P6271, DOI 10.1175/JCLI-D-12-00005.1; Menkes CE, 2012, CLIM DYNAM, V38, P301, DOI 10.1007/s00382-011-1126-x; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Bruyere CL, 2012, J CLIMATE, V25, P8611, DOI 10.1175/JCLI-D-11-00619.1; Gentry MS, 2010, MON WEATHER REV, V138, P688, DOI 10.1175/2009MWR2976.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; JONES RG, 1995, Q J ROY METEOR SOC, V121, P1413, DOI 10.1256/smsqj.52609; Dosio A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015934; Strachan J, 2013, J CLIMATE, V26, P133, DOI 10.1175/JCLI-D-12-00012.1; Large WG, 2006, J CLIMATE, V19, P2325, DOI 10.1175/JCLI3740.1; Giorgi F, 1999, J GEOPHYS RES-ATMOS, V104, P6335, DOI 10.1029/98JD02072; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Emanuel K, 2000, MON WEATHER REV, V128, P1139, DOI 10.1175/1520-0493(2000)128<1139:ASAOTC>2.0.CO;2; Laprise R, 2008, METEOROL ATMOS PHYS, V100, P3, DOI 10.1007/s00703-008-0292-9; Camargo SJ, 2007, TELLUS A, V59, P428, DOI 10.1111/J.1600-0870.2007.00238.X; Munoz E, 2012, J CLIMATE, V25, P4860, DOI 10.1175/JCLI-D-11-00294.1; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Leung LR, 2006, B AM METEOROL SOC, V87, P1747, DOI 10.1175/BAMS-887-12-1747; Caron LP, 2012, CLIM DYNAM, V39, P113, DOI 10.1007/s00382-011-1160-8; Coles S., 2001, INTRO STAT MODELING; Davis C, 2010, CISESI2010030023; Done J, 2011, OFFSH TECHN C HOUST; Emanuel K. A., 2004, P 26 C HURR TROP MET, P240; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Holland GJ, 2010, OFFSH TECHN C HOUST; IPCC SRES SPM, 2000, SUMM POL EM SCEN SPE; Kieu CQ, 2008, J ATMOS SCI, V65, P3419, DOI 10.1175/2008JAS2605.1; Kumar A, 2011, METEOROL ATMOS PHYS, V114, P123, DOI 10.1007/s00703-011-0161-9; Kunreuther H.C., 2009, WAR WEATHER MANAGING, P416; Leduc M, 2009, CLIM DYNAM, V32, P833, DOI 10.1007/s00382-008-0400-z; Mote PW, 2011, EOS T AGU, V92, P31; Schar C, 1996, GEOPHYS RES LETT, V23, P669, DOI 10.1029/96GL00265; Skamarock WC, 2008, 475 NCAR; Suzuki-Parker A, 2012, THESIS, VXIII; Towler E, 2012, ENVIRON MANAGE, V50, P1152, DOI 10.1007/s00267-012-9953-z; Vannitsem S, 2005, J CLIMATE, V18, P229, DOI 10.1175/JCLI3252.1; Weibull W., 1939, P ROYAL SWEDISH I EN, V151, P1; Wilks D.S., 2006, INT GEOPHYS SERIES, V91; Wu LG, 2010, J CLIMATE, V23, P5978, DOI 10.1175/2010JCLI3384.1	54	10	10	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-0009	1573-1480		CLIMATIC CHANGE	Clim. Change	APR	2015	129	3-4					381	395		10.1007/s10584-013-0954-6		15	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CF0AQ	WOS:000352205300003		
J	Hashimoto, K; Tanikawa, K; Nishikawa, J; Chen, Y; Suzuki, T; Koga, M				Hashimoto, Kunihiko; Tanikawa, Kazuko; Nishikawa, Jun; Chen, Yingchao; Suzuki, Toshinobu; Koga, Masafumi			Association of variation range in glycated albumin (GA) with increase but not decrease in plasma glucose: Implication for the mechanism by which GA reflects glycemic excursion	CLINICAL BIOCHEMISTRY			English	Article						HbA1c; Glycated albumin; Maillard reaction; Glycemic excursion; Postprandial hyperglycemia	BLOOD-GLUCOSE; HEMOGLOBIN	Objectives: HbA1c mainly reflects mean plasma glucose (PG), whereas glycated albumin (GA) reflects glycemic excursion in addition to mean PG; the mechanism of the difference between HbA1c and GA is unknown. We hypothesized that a transient increase in PG irreversibly produces stable GA unlike HbA1c. To prove this hypothesis, we investigated diurnal variations in PG, HbA1c, #C fraction (a fraction containing unstable HbA1c and modified hemoglobin on HPLC) and GA in diabetic patients. Design and Methods: Sixteen diabetic patients with poor glycemic control were enrolled in this study. Blood sampling was performed before and after each meal, before bedtime, and before breakfast on the following day; PG, HbA1c, #C fraction, and GA were measured. The variations of these indicators were compared with those in PG. Results: HbA1c showed almost no change regardless of diurnal glycemic variation. Variation range in #C fraction significantly correlated with variation range in PG when PG increased (R=0.746, p < 0.0001) and decreased (R = 0.271, p = 0.035). On the other hand, variation range in GA significantly correlated with variation range in PG when PG increased (R = 0.322, p = 0.021), but not when PG decreased (R = 0.090, p = 0.493). Conclusions: We observed that variation range in GA significantly correlated with variation range in PG when PG increased but not when PG decreased for the first time. It is considered that GA reflects glycemic excursion through this phenomenon. (C) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Hashimoto, Kunihiko; Tanikawa, Kazuko; Nishikawa, Jun; Chen, Yingchao; Suzuki, Toshinobu] NTT West Osaka Hosp, Dept Internal Med, Osaka, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6660195, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, 5-21-1 Higashi Uneno, Kawanishi, Hyogo 6660195, Japan.	m-koga@kawanishi-city-hospital.com					American Diabetes Association, 2014, DIABETES CARE, V37; Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Kouzuma T, 2004, CLIN CHIM ACTA, V346, P135, DOI 10.1016/j.cccn.2004.02.019; DAY JF, 1980, DIABETES, V29, P524, DOI 10.2337/diabetes.29.7.524; Koga M, 2013, CLIN CHIM ACTA, V425, P188, DOI 10.1016/j.cca.2013.07.029; HIGGINS PJ, 1981, J BIOL CHEM, V256, P5204; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; DAVIS JE, 1978, DIABETES, V27, P102, DOI 10.2337/diabetes.27.2.102; Kurebayashi S, 2014, J DIABETES METAB, V5, P343; Ogawa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046517; SHIMA K, 1988, DIABETOLOGIA, V31, P627, DOI 10.1007/BF00264772; Sumitani S, 2015, ANN CLIN BIOCHEM, V52, P76, DOI 10.1177/0004563214522984; Tsutsumi C, 2013, DIABETOL INT, V4, P156	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	APR	2015	48	6					397	400		10.1016/j.clinbiochem.2014.12.021		4	Medical Laboratory Technology	Medical Laboratory Technology	CF4GE	WOS:000352506000006		
J	Koga, M; Saito, H; Kasayama, S				Koga, Masafumi; Saito, Hiroshi; Kasayama, Soji			Patients who showed paradoxical increase in HbA1c levels after intensification of diabetes treatment	CLINICAL BIOCHEMISTRY			English	Article						Glycated albumin; HbA1c; Diabetes treatment; Paradoxical increase	GLYCATED ALBUMIN; GLYCEMIC CONTROL; HEMOGLOBIN; GLUCOSE; MELLITUS	Objectives: When diabetes treatment is started, added, or changed (intensification of treatment) in patients with poor glycemic control, GA (glycated albumin) decreases within a few weeks, while HbA1c increases in some patients, resulting in a discrepancy between changes in GA and HbA1c. In the present study, we investigated the pathophysiology of such discrepancies. Design and methods: Four diabetic patients with poor glycemic control in whom GA showed a decrease while HbA1c showed an increase at a few weeks after intensification of treatment, resulting in a discrepancy between the time course of HbA1c and that of GA, were studied. Results: In all patients HbA1c increased during the course before intensification of treatment; GA measured in two patients before the intensification of treatment also increased. After the intensification of treatment, GA decreased in all patients. On the other hand, HbA1c increased even after the intensification of treatment, but it decreased later in these patients. Conclusions: In patients in whom HbA1c increased in spite of a decrease in GA after the intensification of diabetes treatment, glycemic control got worsened before the intensification of treatment. In such patients, therapeutic effect may be misinterpreted if glycemic control is evaluated by HbA1c, and thus it is preferable to evaluate glycemic control by fasting plasma glucose, GA and fructosamine in such situations. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6660195, Japan; [Saito, Hiroshi] Kinki Cent Hosp, Dept Internal Med, Itami, Hyogo, Japan; [Kasayama, Soji] Nissay Hosp, Dept Med, Osaka, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, 5-21-1 Higashi Uneno, Kawanishi, Hyogo 6660195, Japan.	m-koga@kawanishi-city-hospital.com					Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Koga M, 2013, CLIN CHIM ACTA, V425, P188, DOI 10.1016/j.cca.2013.07.029; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Cohen M P, 1988, J Diabet Complications, V2, P214, DOI 10.1016/S0891-6632(88)80012-6; DAVIS JE, 1978, DIABETES, V27, P102, DOI 10.2337/diabetes.27.2.102; Kohzuma K, 2010, MOL DIAGN THER, V14, P49; Murai J, 2013, ENDOCR J, V60, P409	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	APR	2015	48	6					459	462		10.1016/j.clinbiochem.2014.12.001		4	Medical Laboratory Technology	Medical Laboratory Technology	CF4GE	WOS:000352506000018		
J	Shigematsu, H; Kadoya, T; Masumoto, N; Sasada, T; Emi, A; Ohara, M; Kajitani, K; Okada, M				Shigematsu, Hideo; Kadoya, Takayuki; Masumoto, Norio; Sasada, Tatsunari; Emi, Akiko; Ohara, Masahiro; Kajitani, Keiko; Okada, Morihito			The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial	CLINICAL BREAST CANCER			English	Article						Abraxane; Breast cancer; Cyclophosphamide; Preoperative chemotherapy	DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; PARALLEL HER2-NEGATIVE COHORT; CONTROLLED SUPERIORITY TRIAL; SURGICAL ADJUVANT BREAST; ALBUMIN-BOUND PACLITAXEL; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; CREMOPHOR-FREE; FREE SURVIVAL; OPEN-LABEL	Tri-weekly Abraxane has better outcomes than tri-weekly Cremophor-based taxol, and cyclophosphamide combined with taxane shows an enhanced antitumor effect. We showed excellent efficacy and safety of preoperative chemotherapy with TRI-ABC (tri-weekly Abraxane and cyclophosphamide) followed by FEC (5-fluorouracil, epirubicin and cyclophosphamide) for resectable breast cancer. Further clinical studies should be conducted to compare the tri-weekly Abraxane and cylophosphamide regimen with conventional taxane regimens. Background: It has been reported that tri-weekly Abraxane therapy has better outcomes in recurrent breast cancer than tri-weekly Cremophor-based taxol therapy, and that cyclophosphamide combined with taxane shows an enhanced antitumor effect. We conducted a phase II clinical trial of preoperative chemotherapy with a combination of TRI-ABC. Patients and Methods: From September 2011 to September 2013, 4 cycles of preoperative chemotherapy with TRI-ABC followed by 4 cycles of FEC were administered in patients with resectable breast cancer. In patients with HER2-positive breast cancer, tri-weekly Trastuzumab was administered with TRI-ABC. The primary end point was the pathological complete response (pCR) rate in the breasts and lymph nodes. Results: The treatment outcomes and safety were evaluated in 54 patients who received at least 1 dose of chemotherapy. All patients underwent radical surgery, and the overall pCR rate of 37% (20 of 54) was achieved. The pCR rates according to each subtype were 8% (2 of 24) in hormone receptor (HR)-positive HER2-negative breast cancer, 56% (5 of 9) in HR-positive HER2-positive breast cancer, 63% (5 of 8) in HR-negative HER2-positive breast cancer, and 62% (8 of 13) in triple-negative breast cancer. Multivariate analysis revealed that HR negativity and HER2 positivity were predictive factors of pCR. Clinical response was observed in 49 patients (91%). The safety profile was acceptable. Conclusion: Preoperative chemotherapy with TRI-ABC followed by FEC showed high efficacy and excellent safety. Further clinical studies should be conducted to compare the efficacy of TRI-ABC followed by FEC with conventional taxaneeanthracycline regimens.	[Shigematsu, Hideo; Kadoya, Takayuki; Masumoto, Norio; Emi, Akiko; Kajitani, Keiko; Okada, Morihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Hiroshima 7340037, Japan; [Sasada, Tatsunari] Onomichi Gen Hosp, Dept Surg, Onomichi City, Hiroshima, Japan; [Ohara, Masahiro] Hiroshima Prefectural Hosp, Dept Gastrointestinal Breast & Transplantat Surg, Hiroshima, Japan	Okada, M (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Surg Oncol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7340037, Japan.	morihito1217@gmail.com					Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; von Minckwitz G, 2010, J CLIN ONCOL, V28, P2015, DOI 10.1200/JCO.2009.23.8303; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Yardley D, 2010, BREAST CANCER RES TR, V123, P471, DOI 10.1007/s10549-010-1047-0; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038; Jones SE, 2013, LANCET ONCOL, V14, P1121, DOI 10.1016/S1470-2045(13)70384-X; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Gradishar WJ, 2009, J CLIN ONCOL, V27, P3611, DOI 10.1200/JCO.2008.18.5397; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gianni L, 2014, LANCET ONCOL, V15, P640, DOI 10.1016/S1470-2045(14)70080-4; Ohno S, 2013, BREAST CANCER RES TR, V142, P69, DOI 10.1007/s10549-013-2691-y; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.200502.6187; Chen XS, 2010, ANN ONCOL, V21, P961, DOI 10.1093/annonc/mdq041; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Jones S, 2009, J CLIN ONCOL, V27, P1177, DOI 10.1200/JCO.2008.18.4028; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Earl HM, 2014, LANCET ONCOL, V15, P201, DOI 10.1016/S1470-2045(13)70554-0; Foote M, 2007, BIOTECHNOL ANN REV, V13, P345, DOI 10.1016/S1387-2656(07)13012-X; Rugo HS, 2012, J CLIN ONCOL, V30; Sikov WM, 2009, J CLIN ONCOL, V27, P4693, DOI 10.1200/JCO.2008.21.4163	25	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	APR	2015	15	2					110	116		10.1016/j.clbc.2014.09.010		7	Oncology	Oncology	CE9DP	WOS:000352144200017		
J	Nomiya, T; Akamatsu, H; Harada, M; Ota, I; Hagiwara, Y; Ichikawa, M; Miwa, M; Suzuki, A; Nemoto, K				Nomiya, Takuma; Akamatsu, Hiroko; Harada, Mayumi; Ota, Ibuki; Hagiwara, Yasuhito; Ichikawa, Mayumi; Miwa, Misako; Suzuki, Akihiko; Nemoto, Kenji			Modified Simultaneous Integrated Boost Radiotherapy for Unresectable Locally Advanced Breast Cancer: Preliminary Results of a Prospective Clinical Trial	CLINICAL BREAST CANCER			English	Article						Breast neoplasm; Clinical trial; Radiotherapy; Technique; Unresectable tumor	CONTROL PROBABILITY; TUMOR VOLUME; EXPERIENCE; CARCINOMA; TOLERANCE	Unresectable massive T4 breast tumor cannot be controlled by radiotherapy of <= 70Gy. Modified SIB irradiation technique enables to irradiate >= 100Gy to the tumor, keeping dose to the surrounding healthy tissue within tolerance dose. Huge tumors of all 3 patients enrolled in the clinical trial macroscopically disappeared by modified SIB radiotherapy. Background: The purpose of this study was to evaluate the effect of modified simultaneous integrated boost (SIB) radiotherapy for patients with extensive breast cancer. Patients and Methods: Patients with macroscopic tumor and histologically proven adenocarcinoma of the breast were enrolled in the study. Patients were included whether they had or did not have previous surgery, chemotherapy, hormone therapy, or molecular targeted therapy; patients with past history of thoracic radiotherapy were excluded. Under conditions of not exceeding the tolerance dose for normal tissue, irradiation to the tumor was increased to the maximum possible extent using the modified SIB technique. Results: Three breast cancer patients were treated with the modified SIB technique. All patients were diagnosed as T4b (median maximum diameter of the tumor: 16 cm; range, 15.5-22 cm), and all patients exhibited symptoms because of the extremely large tumor. The median total dose to the part of tumor tissue was 128.8 Gy (range, 110-140 Gy). Total dose to normal tissue was < 72 Gy in all patients. Although large tumors were radioresistant, it was macroscopically confirmed that all tumors eventually disappeared. Although skin defects persisted because of tumor disappearance, there were no Grade >= 3 toxicities due to radiotherapy. Conclusion: Although much care is required in delivering extremely high doses of radiotherapy to the tumor, modified SIB radiotherapy was shown to be effective against extremely large tumors that could not be controlled using conventional radiotherapy. In future, an increase in the number of study patients and establishment of the technique will be required.	[Nomiya, Takuma] Natl Inst Radiol Sci, Dept Radiat Oncol, Chiba 2638555, Japan; [Akamatsu, Hiroko; Harada, Mayumi; Ota, Ibuki; Hagiwara, Yasuhito; Ichikawa, Mayumi; Miwa, Misako; Nemoto, Kenji] Yamagata Univ Hosp, Dept Radiat Oncol, Yamagata, Japan; [Suzuki, Akihiko] Yamagata Univ Hosp, Dept Surg, Yamagata, Japan	Nomiya, T (reprint author), Natl Inst Radiol Sci, Res Ctr, Hosp Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	t_nomiya@nirs.go.jp					Wu PM, 1997, INT J RADIAT ONCOL, V37, P913, DOI 10.1016/S0360-3016(96)00588-3; Brito RA, 2001, J CLIN ONCOL, V19, P628; Bergmann A, 2011, ASIAN PAC J CANCER P, V12, P2939; Ueno NT, 1997, CANCER CHEMOTH PHARM, V40, P321, DOI 10.1007/s002800050664; Thilmann C, 2001, INT J CANCER, V96, P341, DOI 10.1002/ijc.1042; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Studer G, 2004, STRAHLENTHER ONKOL, V180, P233, DOI 10.1007/s00066-004-1171-z; Bentzen SM, 1996, INT J RADIAT ONCOL, V36, P247, DOI 10.1016/S0360-3016(96)00242-8; Berg CD, 1994, SEMIN RADIAT ONCOL, V4, P226, DOI 10.1016/S1053-4296(05)80093-1; BRENNER DJ, 1993, INT J RADIAT ONCOL, V26, P171, DOI 10.1016/0360-3016(93)90189-3; COHEN L, 1981, INT J RADIAT ONCOL, V7, P961; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109; Joiner MC, 2004, INT J RADIAT ONCOL, V58, P871, DOI 10.1016/j.ijrobp.2003.10.036; Koom WS, 2008, HEAD NECK-J SCI SPEC, V30, P159, DOI 10.1002/hed.20667; National Cancer Institute, 2009, NIH PUBLICATION, V09-7473; Nomiya T, 2007, WORLD J GASTROENTERO, V13, P2250; Peponi E, 2010, STRAHLENTHER ONKOL, V186, P35	17	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	APR	2015	15	2					161	167		10.1016/j.clbc.2014.09.011		7	Oncology	Oncology	CE9DP	WOS:000352144200023		
J	Fukada, I; Araki, K; Minatsuki, S; Fujino, T; Hatano, M; Numakura, S; Abe, H; Ushiku, T; Iwase, T; Ito, Y				Fukada, Ippei; Araki, Kazuhiro; Minatsuki, Shun; Fujino, Takeo; Hatano, Masaru; Numakura, Satoe; Abe, Hiroyuki; Ushiku, Tetsuo; Iwase, Takuji; Ito, Yoshinori			Imatinib Alleviated Pulmonary Hypertension Caused by Pulmonary Tumor Thrombotic Microangiopathy in a Patient With Metastatic Breast Cancer	CLINICAL BREAST CANCER			English	Article						Imatinib; Metastatic breast cancer; PDGFR; Pulmonary hypertension; Pulmonary tumor thrombotic microangiopathy (PTTM)	ENDOTHELIAL GROWTH-FACTOR; OF-THE-LITERATURE; GASTRIC-CARCINOMA; TISSUE FACTOR; EXPRESSION; ANGIOGENESIS; OSTEOPONTIN; EMBOLISM		[Fukada, Ippei; Araki, Kazuhiro; Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo 1358550, Japan; [Minatsuki, Shun; Fujino, Takeo; Hatano, Masaru] Tokyo Univ Hosp, Dept Cardiovasc Med, Tokyo 113, Japan; [Numakura, Satoe; Abe, Hiroyuki; Ushiku, Tetsuo] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Breast Surg, Tokyo 1358550, Japan	Fukada, I (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	ippei.fukada@jfcr.or.jp					Shoji M, 1998, AM J PATHOL, V152, P399; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Roberts KE, 2003, AM J MED, V115, P228, DOI 10.1016/S0002-9343(03)00305-X; Ogawa A, 2013, INTERNAL MED, V52, P1927, DOI 10.2169/internalmedicine.52.0718; Takahashi F, 2009, PATHOL INT, V59, P752, DOI 10.1111/j.1440-1827.2009.02439.x; Abe H, 2013, VIRCHOWS ARCH, V462, P523, DOI 10.1007/s00428-013-1403-7; VONHERBAY A, 1990, CANCER, V66, P587, DOI 10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; Chinen K, 2010, PATHOL RES PRACT, V206, P682, DOI 10.1016/j.prp.2010.05.002; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451; SATO Y, 1995, PATHOL INT, V45, P436, DOI 10.1111/j.1440-1827.1995.tb03481.x; Chinen K, 2005, PATHOL INT, V55, P27, DOI 10.1111/j.1440-1827.2005.01783.x; Chinen K, 2009, PATHOL RES PRACT, V205, P63, DOI 10.1016/j.prp.2008.08.002; Geiger R, 2000, J PATHOL, V191, P202; Malani AK, 2007, DIGEST DIS SCI, V52, P555, DOI 10.1007/s10620-006-9232-z; Okubo Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-27; Sakashita N, 2007, PATHOL INT, V57, P383, DOI 10.1111/j.1440-1827.2007.02111.x; SCHRINER RW, 1991, MAYO CLIN PROC, V66, P143; Yokomine T, 2010, J CLIN PATHOL, V63, P376	19	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	APR	2015	15	2					E167	E170		10.1016/j.clbc.2014.10.008		4	Oncology	Oncology	CE9DP	WOS:000352144200012		
J	Ito, T; Sato, N; Yamaguchi, Y; Tazawa, C; Moriya, T; Hirakawa, H; Hayashi, S				Ito, Takako; Sato, Nozomi; Yamaguchi, Yuri; Tazawa, Chika; Moriya, Takuya; Hirakawa, Hisashi; Hayashi, Shin-ichi			Differences in Stemness Properties Associated With the Heterogeneity of Luminal-Type Breast Cancer	CLINICAL BREAST CANCER			English	Article						Cancer stem cells; Estrogen response element activity; Mammosphere; Primary breast cancer; Stemness-related genes	TOPOISOMERASE-II-ALPHA; CELL-PROLIFERATION; GENE-EXPRESSION; PROSPECTIVE IDENTIFICATION; TRANSCRIPTIONAL ACTIVITY; MOLECULAR PORTRAITS; PROTEIN EXPRESSION; HUMAN TUMORS; P53; ESTROGEN	Luminal-type breast cancers are heterogeneous because of the fact that approximately 30% show poor response to endocrine therapy. We investigated the stemness properties of mammospheres prepared from clinical samples by analyzing surface cancer stem cell (CSC) antigens, stemness-related genes, and estrogen response element (ERE) activity. Assessment of mammosphere stemness properties could be a useful and novel approach to the subclassification of luminal-type breast cancer. Background: Luminal-type breast cancers are the most abundant subtype. Endocrine therapies targeting estrogen receptor (ER) or estradiol (E2) synthesis have achieved marked improvement in disease-free and overall survival of ER-positive cancers. However, approximately one-third of these cancers are poorly responsive to endocrine therapies, suggesting nonuniform tumor cell characteristics of this subtype. Recently, the tumorigenesis theory which states that CSCs are capable of self-renewal, tumorigenicity, and therapeutic resistance, became widely accepted. We investigated the relationship between the heterogeneity of luminal-type breast cancer and stemness properties. Materials and Methods: CSC surface markers and expression of stemness-related genes, including Octamer-binding transcription factor 4 (OCT4), Nanog homeobox (NANOG), and Kruppel-like factor 4 (KLF4), were analyzed in clinical samples. ER activities were analyzed using the adenovirus vector carrying the ERE-green fluorescent protein (GFP). We separated the luminal-type breast cancers into 2 groups according to stemness-related gene expression patterns in mammospheres. Results: The group that predominantly expressed NANOG mRNA showed a high percentage of the cells that were positive for CD44 and negative for CD24 and Hoechst (possessing high-stemness properties), younger patient age, higher p53 expression, and tended to show higher histological grade and higher topoisomerase IIa expression. The ERE-GFP assay revealed that the luminal-type breast cancer mammospheres were heterogeneous. Mammospheres from several specimens lacked ER activity and responsiveness to E2 but some retained ER activities. Conclusion: ERE activity differences might be associated with endocrine therapy effectiveness. Mammosphere stemness properties could be a useful and novel criterion for subclassification of luminal-type breast cancers.	[Ito, Takako] Tohoku Univ, Dept Blood & Cell Treatment, Sendai, Miyagi 9808575, Japan; [Sato, Nozomi; Tazawa, Chika; Hayashi, Shin-ichi] Tohoku Univ, Dept Mol & Funct Dynam, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Yamaguchi, Yuri] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan; [Moriya, Takuya] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama, Japan; [Hirakawa, Hisashi] Tohoku Kosai Hosp, Dept Surg, Sendai, Miyagi, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 9808575, Japan	Hayashi, S (reprint author), Tohoku Univ, Dept Mol & Funct Dynam, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	shin@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22790520]; Ministry of Health, Labor and Welfare, Japan [H24-3-006]; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation [09-02]; Smoking Research Foundation	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22790520); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan (H24-3-006); the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (09-02); and a grant from the Smoking Research Foundation.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Li XX, 2008, J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Matsumoto M, 2008, ENDOCR-RELAT CANCER, V15, P451, DOI 10.1677/ERC-07-0227; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Singh SK, 2003, CANCER RES, V63, P5821; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Fritz P, 2005, BREAST CANCER RES, V7, pR374, DOI 10.1186/bcr1012; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; Bane A, 2013, BREAST CANCER RES TR, V140, P195, DOI 10.1007/s10549-013-2591-1; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Yamamoto M, 2014, CANCER SCI, V105, P81, DOI 10.1111/cas.12302; Ezeh UI, 2005, CANCER, V104, P2255, DOI 10.1002/cncr.21432; Nagata T, 2014, BREAST CANCER-TOKYO, V21, P96, DOI 10.1007/s12282-012-0357-y; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Phillips TM, 2006, J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; GERDES J, 1984, J IMMUNOL, V133, P1710; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Gohno T, 2012, CANCER MED-US, V1, P328, DOI 10.1002/cam4.41; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lynch BJ, 1997, HUM PATHOL, V28, P1180, DOI 10.1016/S0046-8177(97)90256-2; Miller KA, 2001, J BIOL CHEM, V276, P42863, DOI 10.1074/jbc.M108130200; Rody A, 2009, BREAST CANCER RES TR, V113, P457, DOI 10.1007/s10549-008-9964-x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; VERONESI U, 1987, ANN SURG, V205, P18	44	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	APR	2015	15	2					E93	E103		10.1016/j.clbc.2014.11.002		11	Oncology	Oncology	CE9DP	WOS:000352144200002		
J	Minamimoto, R; Senda, M; Jinnouchi, S; Terauchi, T; Yoshida, T; Inoue, T				Minamimoto, Ryogo; Senda, Michio; Jinnouchi, Seishi; Terauchi, Takashi; Yoshida, Tsuyoshi; Inoue, Tomio			Detection of Breast Cancer in an FDG-PET Cancer Screening Program: Results of a Nationwide Japanese Survey	CLINICAL BREAST CANCER			English	Article						Asymptomatic subjects; Breast ultrasound; Cancer staging; Mammography; PET/CT	CARCINOMA IN-SITU; POSITRON-EMISSION-TOMOGRAPHY; F-18 FLUORODEOXYGLUCOSE; INCIDENCE RATES; MAMMOGRAPHY; WOMEN; POPULATION; ULTRASOUND; RISK; MRI	"FDGPET cancer screening program" is defined as a cancer screening program using FDG-PET with or without a combination of other tests, that is aimed at the detection of cancer at an early stage. The FDG-PET screening program detected 161 breast cancers in 62.054 asymptomatic subjects, and 83.0% of them was detected at Stage 0 or I. Background: The [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) cancer screening program is defined as cancer screening for asymptomatic subjects using FDG-PET/computed tomography with or without combination of other screening tests. The aim of this study was to analyze the detection rate and effectiveness of the FDG-PET cancer screening program for breast cancer between 2006 and 2009 in Japan. Patients and Methods: A total of 62,054 asymptomatic female subjects underwent FDG-PET cancer screening. We analyzed 473 cases with findings of possible breast cancer in any screening tests. Results: Among 473 possible cases, 161 were verified as breast cancer. The relative sensitivity and positive predictive value (PPV) of FDG-PET for breast cancer were 83.9% and 41.7%, respectively. The relative sensitivity and PPV of mammography (MMG) for breast cancer was less than for FDG-PET; results for breast ultrasonography (US) were close to FDG-PET. The combination of FDG-PET with MMG and US might contribute to increased sensitivity but does not improve PPV. Most breast cancer cases (83.0%) detected using the FDG-PET cancer screening program were stage 0 or I based on the Union for International Cancer Control criteria. Conclusion: The FDG-PET screening program in Japan detected breast cancer at an early stage. A combination of FDG-PET and MMG and/or breast US yields the best results for detecting breast cancer. The FDG-PET cancer-screening program alone cannot detect all breast cancers.	[Minamimoto, Ryogo] Natl Ctr Global Hlth, Div Nucl Med, Dept Radiol, Tokyo, Japan; [Minamimoto, Ryogo; Inoue, Tomio] Yokohama City Univ, Dept Radiol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Senda, Michio] Inst Biomed Res & Innovat, Div Mol Imaging, Kobe, Hyogo, Japan; [Jinnouchi, Seishi] Atsuchi Mem Clin PET Ctr, Atsuchi Mem Inst Radiol, Kagoshima, Japan; [Terauchi, Takashi] Natl Canc Ctr, Div Diagnost Radiol, Tokyo, Japan; [Yoshida, Tsuyoshi] Dept Radiol, Koga Hosp 21 PET Ctr, Kurume, Fukuoka, Japan	Minamimoto, R (reprint author), Natl Ctr Global Hlth & Med, Dept Radiol, Div Nucl Med, Shinjyuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	ryogominamimoto@yahoo.co.jp			National Cancer Center Research and Development Fund [23-A-25]; Japanese Council of PET Imaging: Working Group on Epidemiology Study for PET Cancer Screening, the PET Cancer Screening Research Group of Yokohama City University	This work was supported by the National Cancer Center Research and Development Fund 23-A-25, Japanese Council of PET Imaging: Working Group on Epidemiology Study for PET Cancer Screening, the PET Cancer Screening Research Group of Yokohama City University. The authors express their sincere appreciation and gratitude to Sachiko Yanagida and Yoshihide Nakamura from the Japan Radioisotope Association for management of this survey.	Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Puig-Vives M, 2012, BREAST, V21, P646, DOI 10.1016/j.breast.2012.01.014; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; TABAR L, 1985, LANCET, V1, P829; Chiarelli AM, 2009, J NATL CANCER I, V101, P1236, DOI 10.1093/jnci/djp241; Terauchi T, 2008, ANN NUCL MED, V22, P379, DOI 10.1007/s12149-008-0130-7; Eo JS, 2012, BREAST, V21, P66, DOI 10.1016/j.breast.2011.08.002; Ono K, 2007, ANN NUCL MED, V21, P65; [Anonymous], VIT STAT JAP; Carney PA, 2003, ANN INTERN MED, V138, P168; McCann J, 2004, J MED SCREEN, V11, P117, DOI 10.1258/0969141041732201; Lee JW, 2009, ANN NUCL MED, V23, P685, DOI 10.1007/s12149-009-0291-z; OHUCHI N, 1993, JPN J CANCER RES, V84, P807; Berg WA, 2012, AM J ROENTGENOL, V198, P219, DOI 10.2214/AJR.10.6342; Kaplan SS, 2001, RADIOLOGY, V221, P641, DOI 10.1148/radiol.2213010364; Schilling K, 2011, EUR J NUCL MED MOL I, V38, P23, DOI 10.1007/s00259-010-1588-9; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Ide M, 2006, Q J NUCL MED MOL IM, V50, P23; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; [Anonymous], 2004, GUIDELINE FDG PET CA; Nishizawa S, 2009, J CLIN ONCOL, V27, P1767, DOI 10.1200/JCO.2008.18.2238; Silverstein Melvin J., 2010, Journal of the National Cancer Institute Monographs, P193, DOI 10.1093/jncimonographs/lgq040; Bertagna F, 2014, JPN J RADIOL, V32, P59, DOI 10.1007/s11604-013-0270-0; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Kumar R, 2006, MOL IMAGING BIOL, V8, P355, DOI 10.1007/s11307-006-0060-5; Lynge E, 2014, EUR J CANCER, V50, P185, DOI 10.1016/j.ejca.2013.08.013; Chen YK, 2004, ANTICANCER RES, V24, P4103; ANDERSSON I, 1988, BRIT MED J, V297, P943; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Lord SJ, 2007, EUR J CANCER, V43, P1905, DOI 10.1016/j.ejca.2007.06.007; Ozanne EM, 2011, BREAST CANCER RES TR, V129, P165, DOI 10.1007/s10549-011-1430-5; Corsetti V, 2008, EUR J CANCER, V44, P539, DOI 10.1016/j.ejca.2008.01.009; Eubank WB, 2005, SEMIN NUCL MED, V35, P84, DOI 10.1053/j.semnuclmed.2004.11.001; Avril N, 2000, J CLIN ONCOL, V18, P3495; Caldarella C, 2014, CLIN BREAST CANCER, V14, P241, DOI 10.1016/j.clbc.2013.12.004; Hayashi M, 2008, BREAST CANCER-TOKYO, V15, P224, DOI 10.1007/s12282-008-0051-2; Kojima S, 2007, EUR J CANCER, V43, P1842, DOI 10.1016/j.ejca.2007.05.010; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Minamimoto R, 2013, ANN NUCL MED, V27, P46, DOI 10.1007/s12149-012-0660-x; Minamimoto R, 2007, ANN NUCL MED, V21, P481, DOI 10.1007/s12149-007-0061-8; Minamimoto R, 2011, ANN NUCL MED, V25, P45, DOI 10.1007/s12149-010-0428-0; Murano T, 2011, ANN NUCL MED, V25, P657, DOI 10.1007/s12149-011-0511-1; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Schoder H, 2007, J NUCL MED, V48, p4S; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Suzuki A, 2008, CANCER SCI, V99, P2264, DOI 10.1111/j.1349-7006.2008.00926.x; The Japanese Breast Cancer Society, GEN RUL CLIN PATH RE; van Steenbergen LN, 2009, BREAST CANCER RES TR, V115, P181, DOI 10.1007/s10549-008-0067-5	50	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	APR	2015	15	2					E139	E146		10.1016/j.clbc.2014.09.008		8	Oncology	Oncology	CE9DP	WOS:000352144200007		
J	Yamamoto, Y; Loriot, Y; Beraldi, E; Zhang, F; Wyatt, AW; Al Nakouzi, N; Mo, F; Zhou, TY; Kim, Y; Monia, BP; MacLeod, AR; Fazli, L; Wang, YZ; Collins, CC; Zoubeidi, A; Gleave, M				Yamamoto, Yoshiaki; Loriot, Yohann; Beraldi, Eliana; Zhang, Fan; Wyatt, Alexander W.; Al Nakouzi, Nader; Mo, Fan; Zhou, Tianyuan; Kim, Youngsoo; Monia, Brett P.; MacLeod, A. Robert; Fazli, Ladan; Wang, Yuzhuo; Collins, Colin C.; Zoubeidi, Amina; Gleave, Martin			Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth	CLINICAL CANCER RESEARCH			English	Article							CASTRATION-RESISTANT; IN-VIVO; ANTITUMOR-ACTIVITY; CLUSTERIN; PROGRESSION; SURVIVAL; TUMORS; MICE; INHIBITION; STEROIDOGENESIS	Purpose: Enzalutamide (ENZ) is a potent androgen receptor (AR) antagonist with activity in castration-resistant prostate cancer (CRPC); however, progression to ENZ-resistant (ENZ-R) CRPC frequently occurs with rising serum PSA levels, implicating AR full-length (ARFL) or variants (AR-Vs) in disease progression. Experimental Design: To define functional roles of ARFL and AR-Vs in ENZ-R CRPC, we designed 3 antisense oligonucleotides (ASO) targeting exon-1, intron-1, and exon-8 in AR pre-mRNA to knockdown ARFL alone or with AR-Vs, and examined their effects in three CRPC cell lines and patient-derived xenografts. Results: ENZ-R-LNCaP cells express high levels of both ARFL and AR-V7 compared with CRPC-LNCaP; in particular, ARFL levels were approximately 12-fold higher than AR-V7. Both ARFL and AR-V7 are highly expressed in the nuclear fractions of ENZ-R-LNCaP cells even in the absence of exogenous androgens. In ENZ-R-LNCaP cells, knockdown of ARFL alone, or ARFL plus AR-Vs, similarly induced apoptosis, suppressed cell growth and AR-regulated gene expression, and delayed tumor growth in vivo. In 22Rv1 cells that are inherently ENZ-resistant, knockdown of both ARFL and AR-Vs more potently suppressed cell growth, AR transcriptional activity, and AR-regulated gene expression than knockdown of ARFL alone. Exon-1 AR-ASO also inhibited tumor growth of LTL-313BR patient-derived CRPC xenografts. Conclusions: These data identify the AR as an important driver of ENZ resistance, and while the contributions of ARFL and AR-Vs can vary across cell systems, ARFL is the key driver in the ENZ-R LNCaP model. AR targeting strategies against both ARFL and AR-Vs is a rational approach for AR-dependent CRPC. (C) 2015 AACR.	[Yamamoto, Yoshiaki; Loriot, Yohann; Beraldi, Eliana; Zhang, Fan; Wyatt, Alexander W.; Al Nakouzi, Nader; Mo, Fan; Fazli, Ladan; Wang, Yuzhuo; Collins, Colin C.; Zoubeidi, Amina; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Yamamoto, Yoshiaki; Loriot, Yohann; Beraldi, Eliana; Zhang, Fan; Wyatt, Alexander W.; Al Nakouzi, Nader; Mo, Fan; Fazli, Ladan; Wang, Yuzhuo; Collins, Colin C.; Zoubeidi, Amina; Gleave, Martin] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Yamamoto, Yoshiaki] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 755, Japan; [Zhou, Tianyuan; Kim, Youngsoo; Monia, Brett P.; MacLeod, A. Robert] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA USA	Gleave, M (reprint author), Univ British Columbia, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	m.gleave@ubc.ca			Prostate Cancer Foundation; Prostate Cancer Canada STAR grant from the Safeway Foundation [SP2013-02]; Conquer Cancer Foundation ASCO Young Investigator Award	The work was supported by a Prostate Cancer Foundation and Prostate Cancer Canada STAR grant (SP2013-02) from the Safeway Foundation. Y. Loriot was sponsored by Conquer Cancer Foundation ASCO Young Investigator Award.	Adamo Vincenzo, 2012, Front Endocrinol (Lausanne), V3, P73, DOI 10.3389/fendo.2012.00073; Zhang YX, 2011, MOL CANCER THER, V10, P2309, DOI 10.1158/1535-7163.MCT-11-0329; POTTER GA, 1995, J MED CHEM, V38, P2463, DOI 10.1021/jm00013a022; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zellweger T, 2001, J PHARMACOL EXP THER, V298, P934; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Yang J, 2012, NANOMEDICINE-UK, V7, P1297, DOI 10.2217/NNM.12.14; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Burel SA, 2013, NUCLEIC ACID THER, V23, P213, DOI 10.1089/nat.2013.0422; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Shiota M, 2011, MOL CANCER RES, V9, P1755, DOI 10.1158/1541-7786.MCR-11-0379; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Sowery RD, 2008, BJU INT, V102, P389, DOI 10.1111/j.1464-410X.2008.07618.x; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Leung SYL, 2000, PROSTATE, V44, P156, DOI 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Zanardi TA, 2012, J PHARMACOL EXP THER, V343, P489, DOI 10.1124/jpet.112.197426; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; GLEAVE ME, 1992, CANCER RES, V52, P1598; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Joseph James D, 2013, Cancer Discov, V3, P1020, DOI 10.1158/2159-8290.CD-13-0226; Lee JB, 2012, INT J CANCER, V131, pE781, DOI 10.1002/ijc.27361; Shiota M, 2011, J MOL ENDOCRINOL, V47, pR25, DOI 10.1530/JME-11-0018; Tran C, 2009, SCIENCE, V324, P787	48	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	APR 1	2015	21	7					1675	1687		10.1158/1078-0432.CCR-14-1108		13	Oncology	Oncology	CE8FI	WOS:000352076700022		
J	Urakawa, H; Tsukushi, S; Kozawa, E; Ikuta, K; Hamada, S; Ishiguro, N; Nishida, Y				Urakawa, Hiroshi; Tsukushi, Satoshi; Kozawa, Eiji; Ikuta, Kunihiro; Hamada, Shunsuke; Ishiguro, Naoki; Nishida, Yoshihiro			Postoperative brain metastases in soft tissue sarcomas	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Brain metastasis; Soft tissue sarcoma; Malignant peripheral nerve sheath tumor; Neurofibromatosis-1; Survival	NERVE SHEATH TUMORS; SINGLE INSTITUTION; SURVIVAL; SERIES	Brain metastases (BMs) from soft tissue sarcoma (STS) are rare but lethal. We reviewed 187 consecutive patients with STS treated with definitive surgery in Nagoya University Hospital from 2004 to 2014. There were 10 patients with neurofibromatosis-1 (NF-1). We investigated estimated brain metastasis free survival (BMFS) after surgery and overall survival (OS) after BMs in STS. The factors that affected BMFS were also investigated. Eight of 187 patients (4.3 %) developed BM with a median period of 18.2 (range 8.8-42.6) months after surgery. Seven of 8 BM patients had metastases at other sites. Estimated 5 year BMFS rate after surgery was 95.2 %, and 3 month OS rate after BM was 25.0 %. NF-1 (p < 0.0001), histological subtype of MPNST (p = 0.008), and primary tumor size >= 5 cm (p = 0.021) were significantly associated with increasing incidence of BM. In this study, postoperative BMs were common in patients with NF-1, MPNST, and large tumors. Considering the impact of NF-1 on BMFS, careful follow up for BM is necessary for NF-1 patients with metastases at other sites.	[Urakawa, Hiroshi; Tsukushi, Satoshi; Kozawa, Eiji; Ikuta, Kunihiro; Hamada, Shunsuke; Ishiguro, Naoki; Nishida, Yoshihiro] Nagoya Univ, Dept Orthoped Surg, Grad Sch & Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Urakawa, H (reprint author), Nagoya Univ, Dept Orthoped Surg, Grad Sch & Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	urakawa@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791533]	One or more of the authors (H.U.) has received research funding from the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 24791533 for Scientific Research (C)].	Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; von Mehren M, 2012, J NATL COMPR CANC NE, V10, P951; Barnholtz-Sloan JS, 2012, NEURO-ONCOLOGY, V14, P910, DOI 10.1093/neuonc/nos087; Portera CA, 2001, CANCER, V91, P585, DOI 10.1002/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0; Espat NJ, 2002, CANCER, V94, P2706, DOI 10.1002/cncr.10554; Coindre JM, 2001, CANCER, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Anghileri M, 2006, CANCER, V107, P1065, DOI 10.1002/cncr.22098; Gronchi A, 2010, ANN SURG, V251, P506, DOI 10.1097/SLA.0b013e3181cf87fa; Shweikeh Faris, 2014, Sarcoma, P475175, DOI 10.1155/2014/475175; Chou YS, 2011, J SURG ONCOL, V104, P765, DOI 10.1002/jso.22011; DUCATMAN BS, 1986, CANCER, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Ikuta K, 2014, CLIN EXP METASTAS, V31, P715, DOI 10.1007/s10585-014-9662-5; Ogose A, 1999, JPN J CLIN ONCOL, V29, P245, DOI 10.1093/jjco/29.5.245; Rades D, 2013, STRAHLENTHER ONKOL, V189, P996, DOI 10.1007/s00066-013-0442-y; Salvati M, 2010, J NEURO-ONCOL, V98, P373, DOI 10.1007/s11060-009-0085-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Urakawa H, 2013, AM J CLIN ONCOL-CANC, DOI [10.1097/COC.0b013e318295aea2, DOI 10.1097/COC.0B013E318295AEA2]; WRONSKI M, 1995, ANN SURG ONCOL, V2, P392, DOI 10.1007/BF02306371; Yoshida S, 2000, SURG NEUROL, V54, P160, DOI 10.1016/S0090-3019(00)00293-7	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	APR	2015	32	4					345	351		10.1007/s10585-015-9713-6		7	Oncology	Oncology	CF6BR	WOS:000352642000005		
J	Kanai, H; Sawanobori, E; Koizumi, K; Ohashi, R; Higashida, K				Kanai, Hiroaki; Sawanobori, Emi; Koizumi, Keiichi; Ohashi, Ryuji; Higashida, Kosuke			Pediatric case of crescentic post-streptococcal glomerulonephritis with myeloperoxidase anti-neutrophil cytoplasmic antibody	CLINICAL NEPHROLOGY			English	Article						poststreptococcal glomerulonephritis; diffuse crescentic glomerulonephritis; myeloperoxidase anti-neutrophil cytoplasmic antibodies; methylprednisolone pulse therapy; intravenous cyclophosphamide therapy	IMMUNE-COMPLEX DEPOSITS; ANCA; CHILDREN; VASCULITIS	Post-streptococcal glomerulonephritis (PSGN) generally has a good renal prognosis, and immunosuppressive therapies are not needed. However, a few patients present with severe acute kidney injury and extensive crescent formations. The etiology of such patients is not well known, and involvement of anti-neutrophil cytoplasmic antibodies is rarely reported. A 9-year-old girl with rapidly progressive nephritic syndrome was diagnosed with PSGN. A biopsy showed diffuse crescentic glomerulonephritis with immunoglobulin G and C3 deposits; moreover, humps were observed on electron microscopy. After she was administered methylprednisolone pulse therapy and intravenous cyclophosphamide, followed by prednisolone and azathioprine therapy, her urinary abnormalities improved and renal function normalized. However, the myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) titers gradually increased. We speculated that PSGN may be augmented by increased MPO-ANCA levels. Therefore, the patient is currently being treated with losartan, enalapril, azathioprine, and prednisolone. Although the MPO-ANCA titer remains high, urinary findings show mild proteinuria, and her renal function has been normal for 18 months since onset. A progressive clinical course and severe histological findings may indicate the involvement of ANCA in deterioration of condition in patients with PSGN. Furthermore, in such cases immunosuppressive therapies should be considered even in pediatric PSGN.	[Kanai, Hiroaki; Sawanobori, Emi; Koizumi, Keiichi; Higashida, Kosuke] Univ Yamanashi, Fac Med, Dept Pediat, Chuo, Yamanashi 4093898, Japan; [Ohashi, Ryuji] Nippon Med Coll Hosp, Div Diagnost Pathol, Bunkyo Ku, Tokyo, Japan	Kanai, H (reprint author), Univ Yamanashi, Fac Med, Dept Pediat, Shimokato 1110, Chuo, Yamanashi 4093898, Japan.	hkanai@kind.ocn.ne.jp					CHUGH KS, 1987, INT J ARTIF ORGANS, V10, P189; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; de Groot K, 2009, ANN INTERN MED, V150, P670; Ozaki S, 2012, MOD RHEUMATOL, V22, P394, DOI 10.1007/s10165-011-0525-5; Sumida K, 2012, CLIN NEPHROL, V77, P454, DOI 10.5414/CN107254; El-Husseini AA, 2005, INT UROL NEPHROL, V37, P603, DOI 10.1007/s11255-005-0399-6; Wong W, 2009, PEDIATR NEPHROL, V24, P1021, DOI 10.1007/s00467-008-1086-5; Ardiles LG, 1997, CLIN NEPHROL, V47, P1; Bagga A., 2009, PEDIAT NEPHROLOGY, P815, DOI 10.1007/978-3-540-76341-3_34; Hattori M, 2001, J AM SOC NEPHROL, V12, P1493; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group, 2012, KIDNEY INT S, VS2, P139; Rodriguez-Iturbe B, 2009, PEDIAT NEPHROLOGY, P743, DOI 10.1007/978-3-540-76341-3_30; Singhal P C, 1982, Ann Acad Med Singapore, V11, P36; VOGL W, 1986, NEPHRON, V44, P58, DOI 10.1159/000183913	14	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0301-0430			CLIN NEPHROL	Clin. Nephrol.	APR	2015	83	4					243	248		10.5414/CN108286		6	Urology & Nephrology	Urology & Nephrology	CF0MK	WOS:000352238000007		
J	Yoshino, Y; Seo, K; Koga, I; Kitazawa, T; Ota, Y				Yoshino, Yusuke; Seo, Kazunori; Koga, Ichiro; Kitazawa, Takatoshi; Ota, Yasuo			Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan	CLINICAL RESPIRATORY JOURNAL			English	Article						clinical efficacy; influenza; oseltamivir; peramivir	2009 H1N1 INFLUENZA; NEURAMINIDASE INHIBITOR; ORAL OSELTAMIVIR; INFECTION	BackgroundPeramivir is an intravenously administered neuraminidase inhibitor for influenza. The clinical efficacy of peramivir remains unclear because it is used in a limited number of countries. We compared the clinical efficacy of peramivir with that of oseltamivir in influenza patients during the 2012-2013 season. MethodsThirty-two influenza patients who were hospitalized at Teikyo University Hospital, a teaching hospital in Tokyo, Japan, from October 2012 to March 2013 were enrolled. Among them, 23 and 9 were treated with peramivir and oseltamivir, respectively. The end points of this study were the time to defervescence and survival rate. ResultsThere were no significant differences in the clinical backgrounds of the two groups. However, patients treated with peramivir tended to have a higher incidence of consciousness disturbance [34.8% (8/23) vs 0.00% (0/9), P=0.064]. There were no significant differences between the peramivir and oseltamivir groups with respect to the time to defervescence (30.918.7h vs 34.7 +/- 18.6h) or survival rate [95.7% (22/23) vs 100% (9/9), respectively]. ConclusionsThe clinical efficacy of peramivir is non-inferior to that of oseltamivir, although peramivir tended to be used in patients with serious complications. Intravenous administration of peramivir may be useful for patients with serious complications, such as consciousness disturbances.	[Yoshino, Yusuke; Seo, Kazunori; Koga, Ichiro; Kitazawa, Takatoshi; Ota, Yasuo] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 1738606, Japan	Yoshino, Y (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan.	yyoshino@med.tekyo-u.ac.jp					Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Shobugawa Y, 2012, J INFECT CHEMOTHER, V18, P858, DOI 10.1007/s10156-012-0428-1; Hikita T, 2012, INT J PEDIAT, DOI [10.1155/2012/834181, DOI 10.1155/2012/834181]; Louie JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040261; Mancuso CE, 2010, ANN PHARMACOTHER, V44, P1240, DOI 10.1345/aph.1P031; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-6981	1752-699X		CLIN RESPIR J	Clin. Respir. J.	APR	2015	9	2					228	232		10.1111/crj.12129		5	Respiratory System	Respiratory System	CF4YV	WOS:000352561500014		
J	Inokuchi, R; Manabe, H; Ohta, F; Nakamura, K; Nakajima, S; Yahagi, N				Inokuchi, Ryota; Manabe, Haruki; Ohta, Fumihito; Nakamura, Kensuke; Nakajima, Susumu; Yahagi, Naoki			Granulocyte colony-stimulating factor-producing lung cancer and acute respiratory distress syndrome	CLINICAL RESPIRATORY JOURNAL			English	Article						ARDS; G-CSF; large-cell carcinoma; leukocytosis; lung cancer		Granulocyte colony-stimulating factor (G-CSF)-producing lung cancers are known to cause extreme leukocytosis. However, acute respiratory distress syndrome (ARDS) caused by G-CSF-producing lung cancer is extremely rare. We present a case of G-CSF-producing lung cancer with marked leukocytosis, which rapidly led to severe ARDS after the patient developed pneumonia. The present case suggests that extreme leukocytosis may easily lead to ARDS, triggered by infection. Thus, G-CSF-producing lung cancer with marked leukocytosis should be carefully monitored before surgery and during treatment.	[Inokuchi, Ryota] Shirane Tokushukai Hosp, Dept Emergency & Crit Care Med, Minami Alps, Yamanashi, Japan; [Inokuchi, Ryota; Nakamura, Kensuke; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan; [Manabe, Haruki] Shirane Tokushukai Hosp, Dept Gen Med, Minami Alps, Yamanashi, Japan; [Ohta, Fumihito] Shirane Tokushukai Hosp, Dept Neurosurg, Minami Alps, Yamanashi, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inokuchir-icu@h.u-tokyo.ac.jp					ASANO S, 1977, BLOOD, V49, P845; Wada H, 2011, SURG TODAY, V41, P1161, DOI 10.1007/s00595-010-4426-6; Yamaguchi T, 2012, J SURG RES, V178, P378, DOI 10.1016/j.jss.2011.12.026	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-6981	1752-699X		CLIN RESPIR J	Clin. Respir. J.	APR	2015	9	2					250	252		10.1111/crj.12111		3	Respiratory System	Respiratory System	CF4YV	WOS:000352561500018		
J	Arai, H; Inui, K; Watanabe, K; Watanuki, K; Okudela, K; Tsuboi, M; Masuda, M				Arai, Hiromasa; Inui, Kenji; Watanabe, Keisuke; Watanuki, Kei; Okudela, Koji; Tsuboi, Masahiro; Masuda, Munetaka			Lung abscess combined with chronic osteomyelitis of the mandible successfully treated with video-assisted thoracoscopic surgery	CLINICAL RESPIRATORY JOURNAL			English	Article						lung abscess; osteomyelitis; surgery; VATS		With the progress of antibiotic therapy, the mortality of lung abscess has been improved, and surgical intervention has declined. However, surgery is still required in selected cases that are intractable to antibiotic treatment. Video-assisted thoracoscopic surgery (VATS) is beneficial for treatment and/or diagnosis of pulmonary disease as it provides a less invasive surgical technique and reduces prolongation of post-operative recovery. However, the indication of VATS lobectomy for lung abscess is controversial as a result of particular complications, i.e. wet lung, intrapleural adhesion and ease of bleeding. We herein report a rare combination of lung abscess and osteomyelitis of mandible resulting from the same pathogen successfully treated with VATS lobectomy. We propose VATS lobectomy for lung abscess. This procedure might be the best treatment candidate for selected cases of lung abscess.	[Arai, Hiromasa; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 2360004, Japan; [Inui, Kenji; Watanabe, Keisuke; Tsuboi, Masahiro] Yokohama City Univ, Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa 2360004, Japan; [Watanuki, Kei] Yokohama City Univ, Med Ctr, Div Oral & Maxillofacial Surg, Yokohama, Kanagawa 2360004, Japan; [Okudela, Koji] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan	Arai, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hiromasa@jg7.so-net.ne.jp					Hirshberg B, 1999, CHEST, V115, P746, DOI 10.1378/chest.115.3.746; [Anonymous], J CAN DENT ASS; HUDSON JW, 1993, J ORAL MAXIL SURG, V51, P1294; HAGAN JL, 1983, ANN SURG, V197, P755, DOI 10.1097/00000658-198306000-00015; Kim SG, 2001, ORAL SURG ORAL MED O, V92, P394, DOI 10.1067/moe.2001.117810; DELARUE NC, 1980, CAN J SURG, V23, P297; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; Miller JI, 2005, GEN THORACIC SURG, P1219; vansMerkesteyn JPR, 1997, INT J ORAL MAXILLOF, V26, P450; Yeoh SC, 2005, AUST DENT J, V50, P200, DOI 10.1111/j.1834-7819.2005.tb00361.x; Yu Hyeon, 2011, Semin Intervent Radiol, V28, P75, DOI 10.1055/s-0031-1273942	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-6981	1752-699X		CLIN RESPIR J	Clin. Respir. J.	APR	2015	9	2					253	256		10.1111/crj.12115		4	Respiratory System	Respiratory System	CF4YV	WOS:000352561500019		
J	Kawano, Y; Ohashi, T				Kawano, Yoshiki; Ohashi, Tetsuya			Numerical study on c-axis orientations of sea ice surface grown under calm sea conditions using a particle method and Voronoi dynamics	COLD REGIONS SCIENCE AND TECHNOLOGY			English	Article						Sea ice; Crystal growth; Numerical simulation; C-axis orientations; Flotation of crystal nuclei; Geometric selection	SEMIIMPLICIT METHOD; GREASE ICE; FRAZIL ICE; FRAGMENTATION; CRYSTALS; BREAKING; FLUID; FLOWS	Physical properties of frazil and grease ice depending on their microstructures are not easily measured, while they are important elements for predicting their behavior on the ocean surface. Thus, numerical models considering the effect of the microstructures are required to investigate the ice-water mixture. In this paper, we combined a computational fluid dynamics (CFD) and crystal growth model, and numerically predicted a process of flotation and accumulation of crystal nuclei near the surface of calm sea, and their growth after the accumulation. The results obtained showed that the crystal fabrics and c-axis distributions had good similarity with those of an actual sea ice, and the combined model was effective for dealing with ice-water mixture. Thus far, while we have paid little attention to the details of c-axis distributions within the surface layer of sea ice because of their tedious investigation, the results also indicated that anisotropic growth of crystal nuclei, as well as the flotation and accumulation, strongly affects the c-axis distributions within the horizontal cross-sections of the surface layer of sea ice grown under calm sea conditions. This work would be an important step for the development of numerical models to predict the complex phenomena of sea ice depending on the microstructures, such as behavior of the ice-water mixture on the sea surface. (C) 2014 Elsevier B.V. All rights reserved.	[Kawano, Yoshiki] Asahikawa Coll, Natl Inst Technol, Dept Mech Syst Engn, Asahikawa, Hokkaido 0718142, Japan; [Ohashi, Tetsuya] Kitami Inst Technol, Dept Mech Engn, Kitami, Hokkaido 0908507, Japan	Kawano, Y (reprint author), Asahikawa Coll, Natl Inst Technol, Dept Mech Syst Engn, 2-2 Shunkodai, Asahikawa, Hokkaido 0718142, Japan.	kawano@asahikawa-nct.ac.jp; ohashi@newton.mech.kitami-it.ac.jp			National Institute of Technology, Asahikawa College, Hokkaido, Japan; Calculation Mechanics Laboratory, Kitami Institute of Technology, Hokkaido, Japan	We would like to express my gratitude to Toshiyuki Kawamura and Masafumi Sasaki for insightful discussions. Meaningful comments from two anonymous reviewers improved the quality of the manuscript. This work was financially supported by the National Institute of Technology, Asahikawa College, Hokkaido, Japan, and by the Calculation Mechanics Laboratory, Kitami Institute of Technology, Hokkaido, Japan.	Smedsrud LH, 2006, COLD REG SCI TECHNOL, V44, P171, DOI 10.1016/j.coldregions.2005.11.002; Shao SD, 2003, ADV WATER RESOUR, V26, P787, DOI 10.1016/S0309-1708(03)00030-7; MARTIN S, 1981, ANNU REV FLUID MECH, V13, P379, DOI 10.1146/annurev.fl.13.010181.002115; Cole DM, 2001, ENG FRACT MECH, V68, P1797, DOI 10.1016/S0013-7944(01)00031-5; Lee CJK, 2007, COMPUT STRUCT, V85, P688, DOI 10.1016/j.compstruc.2007.01.019; Koshizuka S, 1998, INT J NUMER METH FL, V26, P751, DOI 10.1002/(SICI)1097-0363(19980415)26:7<751::AID-FLD671>3.0.CO;2-C; Skogseth R, 2009, J GLACIOL, V55, P43; Kawano Y, 2009, COLD REG SCI TECHNOL, V57, P39, DOI 10.1016/j.coldregions.2009.02.001; Maus S, 2012, J GLACIOL, V58, P594, DOI 10.3189/2012JoG11J110; Dempsey DE, 2012, COLD REG SCI TECHNOL, V78, P1, DOI 10.1016/j.coldregions.2012.03.002; Ataie-Ashtiani B, 2006, FLUID DYN RES, V38, P241, DOI 10.1016/j.fluiddyn.2005.12.002; Gotoh H, 2006, COAST ENG, V53, P171, DOI 10.1016/j.coastaleng.2005.10.007; Koshizuka S, 1999, NUCL ENG DES, V189, P423, DOI 10.1016/S0029-5493(98)00270-2; Naumann AK, 2012, CRYOSPHERE, V6, P729, DOI 10.5194/tc-6-729-2012; Koshizuka S, 1996, NUCL SCI ENG, V123, P421; Golden KM, 1998, SCIENCE, V282, P2238, DOI 10.1126/science.282.5397.2238; Schulson EM, 1999, JOM-J MIN MET MAT S, V51, P21, DOI 10.1007/s11837-999-0206-4; Dempsey D.E., 2010, J GEOPHYS RES, V115, P1, DOI DOI 10.1029/2008JC005264); Eicken H., 2003, SEA ICE INTRO ITS PH, P22, DOI DOI 10.1002/9780470757161.CH2; Gow A.J., 1991, MONOGRAPH US ARMY CO, V1-91; Jones K.A., 2012, J GEOPHYS RES, V117, P1; Kawano Y., 2013, P 8 PAC RIM INT C AD, P2839; Kondo M., 2007, P JSME 20 COMP MECH, P463; Koshizuka S., 1995, P 3 WORKSH SUP NUCL, P43; Muller-Stoffels M, 2009, COLD REG SCI TECHNOL, V56, P1, DOI 10.1016/j.coldregions.2008.11.003; Ohashi T, 2004, P 19 INT S OKH SEA S, P180; Petrich C, 2006, COLD REG SCI TECHNOL, V44, P131, DOI 10.1016/j.coldregions.2005.10.001; USHIO S, 1993, J GEOPHYS RES-OCEANS, V98, P20321, DOI 10.1029/93JC01905; Weeks W.F., 1986, GEOPHYSICS SEA ICE, P9; Weeks WF, 1996, JOHANNES WEERTMAN SYMPOSIUM, P337; Weeks W.F., 1998, PHYSICS ICE COVERED, P25; Zhang Y, 1997, J STRUCT GEOL, V19, P875, DOI 10.1016/S0191-8141(97)00016-3	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-232X	1872-7441		COLD REG SCI TECHNOL	Cold Reg. Sci. Tech.	APR	2015	112						29	38		10.1016/j.coldregions.2014.12.012		10	Engineering, Environmental; Engineering, Civil; Geosciences, Multidisciplinary	Engineering; Geology	CF7PJ	WOS:000352748500003		
J	Mori, H; Wakagawa, M; Kuroki, S; Satoh, M				Mori, Hisashi; Wakagawa, Masaki; Kuroki, Shigeki; Satoh, Mitsuru			Counterion mixing effects on conformational transitions of polyelectrolytes 3: coil-globule transition of alkali metal and tetraalkyl ammonium polysulfonates	COLLOID AND POLYMER SCIENCE			English	Article						Polyelectrolytes; Coil-globule transition; Counterion binding; Organic solvents	CHARGE-DENSITY; BINDING; CONDENSATION; GEL; POLY(ACRYLATE)S; IONIZATION; COLLAPSE	The coil-globule transition of alkali metal (M+) and tetraalkyl ammonium (TAA(+)) polysulfonates, i.e., poly(styrene sulfonate)s (PSSM, PSSTAA) and poly(vinyl sulfonate)s (PVSM, PVSTAA), in aqueous organic solvents were investigated in terms of the reduced viscosity and the molar conductivity for the single- and the mixed-counterion systems, respectively. In the single counterion systems, the viscosity and the conductivity significantly decreased with the solvent concentration, and the counterion specificities observed for PSS and PVS were found to be K+ > Cs+ > Na+ > TMA(+)(CH3)(4)N+) a parts per thousand aEuro parts per thousand Li+ a parts per thousand aEuro parts per thousand TEA(+)(C2H5)(4)N+) a parts per thousand aEuro parts per thousand TBA(+) (C4H9)(4)N+) and Cs+ a parts per thousand aEuro parts per thousand K+ > Na+ > Li+ > TMA(+) > TEA(+) > TBA(+), respectively. In the mixed-counterion systems, significant decrements in the viscosity and the conductivity were induced not only for Li+/TAA(+) mixed system but also for Na+/TAA(+). In order to estimate the counterion binding strength, NMR line width of the alkali metal cations (Li-7, Na-23, and Cs-133) as counterions of PVS was also measured to find that strong counterion binding of Na+ as a smaller counterion component may also be induced by mixing with a larger counterion (TBA(+)). All the results were discussed in terms of the size-fitting effect that has been proposed for poly(acrylate)s.	[Mori, Hisashi; Wakagawa, Masaki; Satoh, Mitsuru] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528550, Japan; [Kuroki, Shigeki] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Satoh, M (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528550, Japan.	msatoh@polymer.titech.ac.jp					MAYER U, 1975, MONATSH CHEM, V106, P1235, DOI 10.1007/BF00913599; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; Bodrova AS, 2007, POLYM SCI SER A+, V49, P737, DOI 10.1134/S0965545X07060168; Grochowski P., 2007, BIOPOLYMERS, V89, P93; Gutmann V, 1966, INORG NUCL CHEM LETT, V2, P257, DOI 10.1016/0020-1650(66)80056-9; Hasuike M, 2012, BIOPHYS CHEM, V165, P48, DOI 10.1016/j.bpc.2012.03.004; Hayashi M, 2009, J POLYM SCI POL PHYS, V47, P2122, DOI 10.1002/polb.21809; Khokhlov AR, 1996, MACROMOLECULES, V29, P681, DOI 10.1021/ma946426d; KLEIN JW, 1984, J CHEM PHYS, V80, P1334, DOI 10.1063/1.446814; KOWBLANSKY M, 1981, MACROMOLECULES, V14, P1451, DOI 10.1021/ma50006a060; MANNING GS, 1979, ACCOUNTS CHEM RES, V12, P443, DOI 10.1021/ar50144a004; MANNING GS, 1988, J CHEM PHYS, V89, P3772, DOI 10.1063/1.454899; Minato T, 2004, J POLYM SCI POL PHYS, V42, P4412, DOI 10.1002/polb.20294; Philippova OE, 2013, MACROMOLECULES, V46, P9359, DOI 10.1021/ma401945z; SADEK H, 1983, J ELECTROANAL CHEM, V144, P11, DOI 10.1016/S0022-0728(83)80140-5; Satoh K, 2013, COLLOID POLYM SCI, V291, P1453, DOI 10.1007/s00396-012-2880-y; Vink H, 1981, J CHEM SOC FARADAY T, V1, P77; Wakagawa M, 2009, J POLYM SCI POL PHYS, V47, P2132, DOI 10.1002/polb.21810	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1023	1033		10.1007/s00396-014-3486-3		11	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200003		
J	Suwa, K; Nagasaka, M; Niina, S; Egawa, Y; Seki, T; Anzai, J				Suwa, Keisuke; Nagasaka, Munenari; Niina, Satoshi; Egawa, Yuya; Seki, Toshinobu; Anzai, Jun-ichi			Sugar response of layer-by-layer films composed of poly(vinyl alcohol) and poly(amidoamine) dendrimer bearing 4-carboxyphenylboronic acid	COLLOID AND POLYMER SCIENCE			English	Article						Layer-by-layer film; Dendrimer; Boronic acid; Glucose; Fructose	MULTILAYER FILMS; THIN-FILMS; GLUCOSE; RELEASE; MICROCAPSULES; ASSEMBLIES; CAPSULES; SURFACES; INSULIN; WATER	Multilayered thin films composed of poly(vinyl alcohol) (PVA) and 4-carboxyphenylboronic acid-modified poly(amidoamine) dendrimer (4-PBA-PAMAM) were prepared by a layer-by-layer (LbL) deposition of PVA and 4-PBA-PAMAM on the surface of a quartz plate to study the response of the multilayered films to sugars. PVA/4-PBA-PAMAM films were constructed successfully at pH 7.0-9.0 through the formation of boronate ester bonds between the boronic acid moiety in 4-PBA-PAMAM and 1,3-diol units in PVA, while the film deposition was unsuccessful at pH 6.0 probably owing to weaker affinity between 4-PBA-PAMAM and PVA in the weakly acidic medium. The films were stable in aqueous solutions at pH 7.5 or higher whereas the films decomposed in neutral and acidic solutions, which can be ascribed to lower affinity of neutral trigonal PBA derivatives than that of negatively charged tetragonal PBAs. PVA/4-PBA-PAMAM films decomposed in response to glucose and fructose depending on the concentration as a result of competitive binding of the sugars to 4-PBA-PAMAM in the film. The degree of glucose-induced decomposition of the film was 20-25 % in the presence of 30 mM at pH 7.4 and 9.0. On the other hand, in 10 mM fructose solution, the degree of film decomposition was 90 and 60 % at pH 9.0 and 7.4, respectively. A possible application of the LbL films to sugar-sensitive delivery systems was discussed.	[Suwa, Keisuke; Nagasaka, Munenari; Niina, Satoshi; Anzai, Jun-ichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Egawa, Yuya; Seki, Toshinobu] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Anzai, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	junanzai@mail.pharm.tohoku.ac.jp			Japan Society for Promotion of Science [24390006]	This work was supported in part by Grant-in-Aid (Number 24390006) from the Japan Society for Promotion of Science.	Iost RM, 2012, BIOSENS BIOELECTRON, V31, P1, DOI 10.1016/j.bios.2011.10.040; Watahiki R, 2014, J MATER CHEM B, V2, P5809, DOI 10.1039/c4tb00676c; Chen XY, 2011, BIOMATERIALS, V32, P1759, DOI 10.1016/j.biomaterials.2010.11.002; Dam HH, 2013, LANGMUIR, V29, P7203, DOI 10.1021/la304580x; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Lynn DM, 2007, ADV MATER, V19, P4118, DOI 10.1002/adma.200701748; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Wang B, 2012, J MATER CHEM, V22, P17954, DOI 10.1039/c2jm33070a; Yoshida K, 2014, MAT SCI ENG C-MATER, V34, P384, DOI 10.1016/j.msec.2013.09.045; Kumar BVVSP, 2014, LANGMUIR, V30, P4540, DOI 10.1021/la500407r; Qi W, 2009, BIOMATERIALS, V30, P2799, DOI 10.1016/j.biomaterials.2009.01.027; Bull SD, 2013, ACCOUNTS CHEM RES, V46, P312, DOI 10.1021/ar300130w; Zhang X, 2012, BIOMACROMOLECULES, V13, P92, DOI 10.1021/bm2012696; Ding ZB, 2009, SOFT MATTER, V5, P2302, DOI 10.1039/b901910c; Sato K, 2013, MOLECULES, V18, P8440, DOI 10.3390/molecules18078440; Sato K, 2012, ANAL SCI, V28, P929; Liu XH, 2008, SOFT MATTER, V4, P1688, DOI 10.1039/b804953j; Deshmukh PK, 2013, J CONTROL RELEASE, V166, P294, DOI 10.1016/j.jconrel.2012.12.033; Mawad D, 2012, ADV FUNCT MATER, V22, P5020, DOI 10.1002/adfm.201200999; Byon HR, 2011, CARBON, V49, P457, DOI 10.1016/j.carbon.2010.09.042; De Geest BG, 2006, LANGMUIR, V22, P5070, DOI 10.1021/la053368o; Jang E, 2014, COLLOID POLYM SCI, V292, P1355, DOI 10.1007/s00396-014-3195-y; Suzuki I, 2002, CHEM COMMUN, P164, DOI 10.1039/b108771c; Levy T, 2008, ADV FUNCT MATER, V18, P1586, DOI 10.1002/adfm.200701291; Yoshida K, 2010, J MATER CHEM, V20, P1546, DOI 10.1039/b918226h; Sato K, 2014, LANGMUIR, V30, P9247, DOI 10.1021/la501750s; Anzai J, 1998, SENSOR ACTUAT B-CHEM, V52, P3, DOI 10.1016/S0925-4005(98)00248-2; Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v; Egawa Y, 2014, MATERIALS, V7, P1201, DOI 10.3390/ma7021201; Hoffmann K, 2009, J MEMBRANE SCI, V341, P261, DOI 10.1016/j.memsci.2009.06.017; Kumai M, 2012, ANAL SCI, V28, P121; Manna U, 2010, ACS APPL MATER INTER, V2, P1521, DOI 10.1021/am100139j; Tomita S, 2008, J COLLOID INTERF SCI, V326, P35, DOI 10.1016/j.jcis.2008.06.054; Zhang JW, 2014, COLLOID POLYM SCI, V292, P1235, DOI 10.1007/s00396-014-3188-x; Zhang X, 2014, J MATER CHEM, V22, P16299	35	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1043	1048		10.1007/s00396-014-3490-7		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200005		
J	Yoshioka, Y; Oikawa, D; Shimasaki, T; Teramoto, N; Shibata, M				Yoshioka, Yoshiki; Oikawa, Daisuke; Shimasaki, Toshiaki; Teramoto, Naozumi; Shibata, Mitsuhiro			Gelation behavior and thermal and mechanical properties of polymer network formed by the Diels-Alder reaction of furan- and maleimide-terminated four-arm star-shaped ethylene glycol oligomers	COLLOID AND POLYMER SCIENCE			English	Article						Star polymer; Poly(ethylene glycol); Diels-Alder reaction; Polymer network; Thermo-reversible gel	EPSILON-CAPROLACTONE OLIGOMERS; POLY(STYRENE-CO-FURFURYL METHACRYLATE); ORGANOGELATION BEHAVIOR; BISMALEIMIDE; HYDROGELS; EUGENOL; WATER	Furan-terminated four-arm star-shaped ethylene glycol oligomer (F4EGO (n) ) was synthesized by the esterification reaction of furfuryl alcohol and succinate-terminated four-arm star-shaped ethylene glycol oligomer (S4EGO (n) ) which was prepared by the reaction of succinic anhydride and hydroxy-terminated four-arm star-shaped ethylene glycol oligomer (H4EGO (n) ) having the approximate degree of polymerization per one oligo(ethylene glycol) chain, n = 4 or 11. Also, maleimide-terminated four-arm star-shaped ethylene glycol oligomer (M4EGO (n) ) was synthesized by the reaction of H4EGO (n) and 4-(maleimidophenyl)isocyanate. Solutions of F4EGO(4)/M4EGO(4) and F4EGO(11)/M4EGO(11) in 1,4-dioxane (DOX) or N,N-dimethylformamide (DMF) displayed thermo-reversible sol-gel transitions by the repeated Diels-Alder (DA) reactions at room temperature and retro DA reaction at 80 A degrees C. Although F4EGO(4)/M4EGO(4) was insoluble in water-containing solvents, F4EGO(11)/M4EGO(11) was soluble in DMF/water or DOX/water 1/1, and the solution showed a sol-gel transition but only once or twice. Fourier transform infrared (FT-IR) analysis revealed that the conversion of DA reaction for the F4EGO (n) /M4EGO (n) (n = 4 or 11) film dried at 50 A degrees C (F4EGO (n) -M4EGO (n) ) was 87 % (n = 4) or 90 % (n = 11). The glass transition temperature and tensile strength of F4EGO(4)-M4EGO(4) were higher than those of F4EGO(11)-M4EGO(11). Both F4EGO(4)-M4EGO(4) and F4EGO(11)-M4EGO(11) were swellable to water, DOX/water 1/1, or DMF/water 1/1.	[Yoshioka, Yoshiki; Oikawa, Daisuke; Shimasaki, Toshiaki; Teramoto, Naozumi; Shibata, Mitsuhiro] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan	Shibata, M (reprint author), Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	mitsuhiro.shibata@p.chibakoudai.jp					Acharya AS, 1996, US Patent, Patent No. [5,585,484, 5585484, 5:585-484]; Goiti E, 2004, EUR POLYM J, V40, P219, DOI 10.1016/j.eurpolymj.2003.09.017; Inoue K, 2009, J APPL POLYM SCI, V112, P876, DOI 10.1002/app.29469; Ikeda T, 2013, POLYMER, V54, P3206, DOI 10.1016/j.polymer.2013.04.052; Canadell J, 2010, J POLYM SCI POL CHEM, V48, P3456, DOI 10.1002/pola.24134; Defize T, 2012, MACROMOL CHEM PHYS, V213, P187, DOI 10.1002/macp.201100408; Gandini A, 2013, PROG POLYM SCI, V38, P1, DOI 10.1016/j.progpolymsci.2012.04.002; Furlani TR, 1996, J ORG CHEM, V61, P5492, DOI 10.1021/jo9518011; Inoue K, 2000, PROG POLYM SCI, V25, P453, DOI 10.1016/S0079-6700(00)00011-3; Nijenhuis AJ, 1996, POLYMER, V37, P5849, DOI 10.1016/S0032-3861(96)00455-7; Koehler KC, 2013, BIOMACROMOLECULES, V14, P538, DOI 10.1021/bm301789d; Shibata M, 2013, REACT FUNCT POLYM, V73, P1086, DOI 10.1016/j.reactfunctpolym.2013.05.002; Liu YL, 2006, POLYMER, V47, P2581, DOI 10.1016/j.polymer.2006.02.057; Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k; Adzima BJ, 2008, MACROMOLECULES, V41, P9112, DOI 10.1021/ma801863d; Wei HL, 2010, EUR POLYM J, V46, P1032, DOI 10.1016/j.eurpolymj.2010.01.025; Neda M, 2014, MATER CHEM PHYS, V148, P319, DOI 10.1016/j.matchemphys.2014.07.050; Cameron DJA, 2011, CHEM SOC REV, V40, P1761, DOI 10.1039/c0cs00091d; Wei HL, 2009, POLYMER, V50, P2836, DOI 10.1016/j.polymer.2009.04.032; Ibrahim S, 2012, INT J ELECTROCHEM SC, V7, P2596; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Wei HL, 2010, POLYMER, V51, P1694, DOI 10.1016/j.polymer.2010.02.008; Engberts JBFN, 2006, J ORG CHEM, V71, P4111, DOI 10.1021/jo060127s; Goiti E, 2004, EUR POLYM J, V40, P1451, DOI 10.1016/j.eurpolymj.2004.01.036; Liu YL, 2006, J POLYM SCI POL CHEM, V44, P905, DOI 10.1002/pola.21184; Nakamura T, 2013, J COLLOID INTERF SCI, V404, P8, DOI 10.1016/j.jcis.2013.04.039; Shibata M, 2011, POLYM J, V43, P455, DOI 10.1038/pj.2011.14; Watanabe M, 2006, POLYMER, V47, P4967; Wei HL, 2011, J APPL POLYM SCI, V120, P974, DOI 10.1002/app.33116; Yoshie N, 2010, POLYM DEGRAD STABIL, V95, P826, DOI 10.1016/j.polymdegradstab.2010.01.032; Zhang X, 2006, PROG POLYM SCI, V31, P893, DOI 10.1016/j.progpolymsci.2006.08.009; Zheng C, 2014, ACS APPL MATER INTER, V6, P2753	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1059	1071		10.1007/s00396-014-3492-5		13	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200007		
J	Tsuzuki-Ishi, T; Sawada, H				Tsuzuki-Ishi, Taiki; Sawada, Hideo			Color-changing behavior of fluoroalkyl end-capped 2-methacryloyloxyethanesulfonic acid oligomer/polyaniline nanocomposites, triggered by a variety of basic compounds	COLLOID AND POLYMER SCIENCE			English	Article						Fluorinated oligomer; Polyaniline; Nanocomposite; Chemochromism; UV-vis spectra; Silica particles bearing amino group; Solvatochromism	DOPED POLYANILINE; AMMONIA GAS; CONJUGATED POLYMERS; SENSOR; COMPOSITES; OLIGOMERS; SURFACE; FILMS; POLYMERIZATION; NANOPARTICLES	Fluoroalkyl end-capped 2-(methacryloyloxy)ethanesulfonic acid oligomer [R-F-(MES) (n) -R-F]/polyaniline (PAn) nanocomposites, which were prepared by the polymerization of aniline initiated by ammonium persulfate in the presence of the corresponding oligomer, can cause the smooth color change from green to wine-red (or purple), triggered by a variety of basic compounds such as ammonia, sodium hydroxide, 2-hydroxyethylamine, tris(hydroxymethyl)aminomethane, and silica particles bearing 3-aminopropyl groups (Amino-SiO2) under room temperature. It is found that the R-F-(MES) (n) -R-F/PAn nanocomposites undergo a change in the color when they are exposed to ammonia vapor, and especially, a good reversible color change from green to wine-red color through the chemochromic behavior is observed when they are under air and exposure to ammonia vapor. Purple-colored R-F-(MES) (n) -R-F/PAn/Amino-SiO2 blend hybrids powders, which are prepared by the interaction of R-F-(MES) (n) -R-F/PAn nanocomposites with Amino-SiO2 particles, can cause the solvatochromic response in water, methanol, chloroform, and fluorinated aliphatic solvent to give the color change from blue to colorless (white-gray) in the fluorinated solvent.	[Tsuzuki-Ishi, Taiki; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	hideosaw@cc.hirosaki-u.ac.jp					Airoudj A, 2009, TALANTA, V77, P1590, DOI 10.1016/j.talanta.2008.09.054; Chabukswar VV, 2001, SENSOR ACTUAT B-CHEM, V77, P657, DOI 10.1016/S0925-4005(01)00780-8; Kolla HS, 2005, J AM CHEM SOC, V127, P16770, DOI 10.1021/ja055327k; Ansari MO, 2014, MATER LETT, V114, P159, DOI 10.1016/j.matlet.2013.09.098; Kukla AL, 1996, SENSOR ACTUAT B-CHEM, V37, P135, DOI 10.1016/S0925-4005(97)80128-1; Hong KH, 2004, J APPL POLYM SCI, V92, P37, DOI 10.1002/app.13633; Feast WJ, 1996, POLYMER, V37, P5017, DOI 10.1016/0032-3861(96)00439-9; Yang XJ, 2004, SYNTHETIC MET, V142, P57, DOI 10.1016/j.synthmet.2003.07.012; Durand N, 2011, MACROMOLECULES, V44, P6249, DOI 10.1021/ma200921b; Matsuguchi M, 2003, SENSOR ACTUAT B-CHEM, V94, P46, DOI 10.1016/S0925-4005(03)00325-3; SYED AA, 1991, TALANTA, V38, P815, DOI 10.1016/0039-9140(91)80261-W; Sharma AL, 2013, SENSOR ACTUAT A-PHYS, V198, P107, DOI 10.1016/j.sna.2013.04.026; Durand N, 2011, MACROMOLECULES, V44, P8487, DOI 10.1021/ma2018167; Molapo KM, 2012, INT J ELECTROCHEM SC, V7, P11859; Wessling B, 2010, POLYMERS-BASEL, V2, P786, DOI 10.3390/polym2040786; Athawale AA, 2001, J APPL POLYM SCI, V79, P1994, DOI 10.1002/1097-4628(20010314)79:11<1994::AID-APP1007>3.0.CO;2-R; Jin Z, 2001, SENSOR ACTUAT B-CHEM, V72, P75, DOI 10.1016/S0925-4005(00)00636-5; Kang ET, 1998, PROG POLYM SCI, V23, P277, DOI 10.1016/S0079-6700(97)00030-0; KURAMOTO N, 1995, SYNTHETIC MET, V68, P191, DOI 10.1016/0379-6779(94)02284-6; Chatterjee K, 2013, SENSOR ACTUAT B-CHEM, V181, P544, DOI 10.1016/j.snb.2013.02.042; Chen S, 2013, ACS APPL MATER INTER, V5, P6471; CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6; Drelinkiewicz A, 2014, FUEL, V116, P760, DOI 10.1016/j.fuel.2013.08.079; Duboriz I, 2014, SENSOR ACTUAT B-CHEM, V190, P398, DOI 10.1016/j.snb.2013.09.005; Durand N, 2011, LANGMUIR, V27, P4057, DOI 10.1021/la1048826; Guo S, 2014, EUR POLYM J, V58, P79, DOI 10.1016/j.eurpolymj.2014.04.022; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Huang LM, 2006, ELECTROCHIM ACTA, V51, P5858, DOI 10.1016/j.electacta.2006.03.031; Virji S, 2004, NANO LETT, V4, P491, DOI 10.1021/nl035122e; Kijima K, 2013, J POLYM SCI A, V51, P2555; Menegazzo N, 2011, TALANTA, V85, P1369, DOI 10.1016/j.talanta.2011.06.020; Navarchian AH, 2013, ADV POLYM TECH, V32, DOI 10.1002/adv.21356; Nicho ME, 2001, SENSOR ACTUAT B-CHEM, V76, P18, DOI 10.1016/S0925-4005(01)00562-7; Palaniappan S, 2010, J APPL POLYM SCI, V118, P518, DOI 10.1002/app.32347; Sawada H, 2003, J FLUORINE CHEM, V121, P111, DOI 10.1016/S0022-1139(03)00040-X; Sawada H, 2012, J COLLOID INTERF SCI, V377, P76, DOI 10.1016/j.jcis.2012.03.017; Sawada H, 2006, J APPL POLYM SCI, V100, P1328, DOI 10.1002/app.23787; Sawada H, 2011, J COLLOID INTERF SCI, V359, P461, DOI 10.1016/j.jcis.2011.03.090; Sawada H, 2011, MACROMOLECULES, V44, P1114, DOI 10.1021/ma102532k; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; Sawada H, 2007, EUR POLYM J, V43, P3258, DOI 10.1016/j.eurpolymj.2007.04.050; Sawada H, 2003, J COLLOID INTERF SCI, V263, P1, DOI 10.1016/S0021-9797(03)00335-7; Sawada H, 2010, J COLLOID INTERF SCI, V351, P166, DOI 10.1016/j.jcis.2010.07.008; Sawada H, 2008, POLYM ADVAN TECHNOL, V19, P419, DOI 10.1002/pat.1027; Sawada H, 2000, J FLUORINE CHEM, V105, P219, DOI 10.1016/S0022-1139(00)00279-7; Sawada H, 2001, EUR POLYM J, V37, P1433, DOI 10.1016/S0014-3057(01)00005-2; Sawada H, 2005, COLLOID POLYM SCI, V283, P583, DOI 10.1007/s00396-004-1222-0; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Sawada H, 2011, COLLOID POLYM SCI, V289, P1103, DOI 10.1007/s00396-011-2420-1; Sawada H, 1996, J FLUORINE CHEM, V79, P149, DOI 10.1016/S0022-1139(96)03476-8; Sawada H, 1996, CHEM REV, V96, P1779, DOI 10.1021/cr9411482; Song E, 2013, NANOMATERIALS-BASEL, V3, P498, DOI 10.3390/nano3030498; Wan M, 1995, THIN SOLID FILMS, V258, P188; Wang YM, 2014, INT J MATER RES, V105, P3, DOI 10.3139/146.110996; Zhu Y, 2007, MACROMOL RAPID COMM, V28, P2230, DOI 10.1002/marc.200700468	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1237	1244		10.1007/s00396-015-3506-y		8	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200024		
J	Moriyama, M; Uyama, H; van der Vlies, AJ; Hasegawa, U				Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andre J.; Hasegawa, Urara			Cross-linked catechol-bearing poly(gamma-glutamic acid) self-aggregates with antioxidant activity	COLLOID AND POLYMER SCIENCE			English	Article						Poly(gamma-glutamic acid); Catechol; Nanoparticle; Antioxidant; Drug Delivery System	MUSSEL ADHESIVE PROTEINS; TARGETED DRUG-DELIVERY; POLYMERIC MICELLES; NANOPARTICLES; CANCER; ANGIOGENESIS; RESVERATROL; CARRIER	Reactive oxygen species (ROS) are mainly formed by metabolism of oxygen in the human body and play essential roles in cell signaling, pathogen defense, and homeostasis. However, elevated levels of these species have been linked to inflammatory diseases such as arthritis as well as tumor growth. For this reason, the therapeutic use of antioxidants, compounds capable of inactivating these ROS species, has attracted growing attention. In spite of the ROS-scavenging activity, their low stability as well as poorly controlled pharmacokinetics is a major limitation in antioxidant therapy. To overcome this limitation, we recently reported that polymeric micelles having ROS-scavenging catechol moieties showed increased oxidation stability as compared to the small catechol compound dopamine. This micelles efficiently inhibited angiogenesis by scavenging endogenous ROS. Here, we present the preparation of antioxidant nanoparticles formed by self-assembly of amphiphilic dopamine-grafted poly(gamma-glutamic acid). The nanoparticles formed by interaction of the catechol groups via physical interaction and the size of the nanoparticles could be controlled in the range of 25-130 nm by changing the catechol/carboxylate molar ratio as shown by dynamic light scattering. To improve colloidal stability, the formed nanoparticles were chemically cross-linked by the oxidative coupling of the catechol groups at high pH as shown by atomic force microscopy. The prepared antioxidant nanoparticles were capable of scavenging ROS like H2O2 and may find application in antioxidant therapy.	[Moriyama, Masaki; Uyama, Hiroshi; van der Vlies, Andre J.; Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, Suita, Osaka 5650871, Japan; [van der Vlies, Andre J.] Osaka Univ, Grad Sch Engn, Frontier Res Ctr, Suita, Osaka 5650871, Japan	Hasegawa, U (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	urara.hasegawa@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [26560241]	GAMMA;-PGA was a kind gift from BioLeaders Corp. (Daejeon, Korea). This work was supported by Grant-in-Aid for Challenging Exploratory Research, No. 26560241, from the Japan Society for the Promotion of Science.	Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n; Hecht SS, 1999, CANCER LETT, V137, P123, DOI 10.1016/S0304-3835(98)00326-7; Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n; Cabral H, 2005, J CONTROL RELEASE, V101, P223, DOI 10.1016/j.jconrel.2004.08.022; Moriyama M, 2015, ADV HEALTHC MATER, V4, P569, DOI 10.1002/adhm.201400249; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Gentilini C, 2012, ADV HEALTHC MATER, V1, P308, DOI 10.1002/adhm.201200036; Su J, 2011, J AM CHEM SOC, V133, P11850, DOI 10.1021/ja203077x; van der Leeden MC, 2005, LANGMUIR, V21, P11373, DOI 10.1021/la0515468; Manach C, 2004, AM J CLIN NUTR, V79, P727; Liang HF, 2006, BIOMATERIALS, V27, P2051, DOI 10.1016/j.biomaterials.2005.10.027; Oppermann FB, 1998, POLYM DEGRAD STABIL, V59, P337, DOI 10.1016/S0141-3910(97)00175-4; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Kwon J, 2013, BIOMACROMOLECULES, V14, P1618, DOI 10.1021/bm400256h; Obst M, 2004, BIOMACROMOLECULES, V5, P1166, DOI 10.1021/bm049949u; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Akagi T, 2005, J CONTROL RELEASE, V108, P226, DOI 10.1016/j.jconrel.2005.08.003; ARMSTRONG J, 1976, BRIT J PHARMACOL, V57, P501; LARUE TA, 1964, ANAL CHIM ACTA, V31, P400, DOI 10.1016/S0003-2670(00)88845-5; Park SB, 2014, J BIOMAT SCI-POLYM E, V25, P1875, DOI 10.1080/09205063.2014.953404; Sakuma S, 2009, J CONTROL RELEASE, V133, P125, DOI 10.1016/j.jconrel.2008.09.087; Shima F, 2014, CHEM LETT, V43, P840, DOI 10.1246/cl.140060; Yoshitomi T, 2014, ADV HEALTHC MATER, V3, P1149, DOI 10.1002/adhm.201300576	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1245	1251		10.1007/s00396-015-3516-9		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200025		
J	Yoshida, E				Yoshida, Eri			Cross-linking effect of hydrophobic cores on morphology of giant vesicles formed by amphiphilic random block copolymers	COLLOID AND POLYMER SCIENCE			English	Article						Giant vesicles; Amphiphilic random block copolymer; Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Cross-linking of hydrophobic cores; Ethylene glycol dimethacrylate; Critical packing shape; Morphology transformation; Glass transition temperature	ENDOPLASMIC-RETICULUM MEMBRANE; LATERAL DIFFUSION; RADICAL POLYMERIZATION; PROTEIN TRANSLOCATION; DENSITY-LIPOPROTEIN; MAGNETIC-RESONANCE; ESCHERICHIA-COLI; LIPID-BILAYERS; LIPOSOMES; METHACRYLATE	The cross-linking effect of the hydrophobic cores on the morphology of giant vesicles was explored using amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid), PMAA-b-P(MMA-r-MAA), and ethylene glycol dimethacrylate (EGMA) as the cross-linking agent. Spherical vesicles without cross-linking were transformed into large contorted vesicles with a rough surface by the cross-linking of the P(MMA-r-MAA) blocks with EGMA. An increase in the EGMA ratio promoted a further transformation into huge spherical particles with a smooth surface, followed by smaller partly joined particles. A still higher EGMA ratio caused the joining of particles along with a further decrease in the particle size. The cross-linking of the hydrophobic blocks also dominated the crystallization of the hydrophilic PMAA blocks. The thermal analysis demonstrated that the glass transition temperature of the PMAA blocks increased with the EGMA ratio for the identical PMAA block length. The crystallinity of the hydrophobic cores enhanced that of the hydrophilic surface.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Elston T, 1998, NATURE, V391, P510; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; Sugiura S, 2008, LANGMUIR, V24, P4581, DOI 10.1021/la703509r; Ladha S, 1996, BIOPHYS J, V71, P1364; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; HIGGINS CF, 1994, CURR BIOL, V4, P259, DOI 10.1016/S0960-9822(00)00059-2; KAS J, 1991, BIOPHYS J, V60, P825; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; KWOK R, 1981, BIOPHYS J, V35, P637; Joo KI, 2013, BIOMATERIALS, V34, P3098, DOI 10.1016/j.biomaterials.2013.01.039; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; WAGNER N, 1981, FEBS LETT, V132, P313, DOI 10.1016/0014-5793(81)81187-8; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; Filippov AV, 2011, BIOPHYS CHEM, V85, P585; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P535, DOI 10.1016/B978-0-12-375182-9.10020-X; LINDEN CD, 1973, P NATL ACAD SCI USA, V70, P2271, DOI 10.1073/pnas.70.8.2271; Lodish H, 2013, MOL CELL BIOL, V11; OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023; Pampel A, 2004, J AM CHEM SOC, V126, P9534, DOI 10.1021/ja0474042; SACKMANN E, 1973, BIOCHEMISTRY-US, V12, P5360, DOI 10.1021/bi00750a020; SACKMANN E, 1986, FARADAY DISCUSS, V81, P281, DOI 10.1039/dc9868100281; Sadava DE, 1993, CELL BIOL ORGANELLE, P130; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith CE, 2014, LANGMUIR, V30, P3697, DOI 10.1021/la500412r; STOFFEL W, 1982, H-S Z PHYSIOL CHEM, V363, P19, DOI 10.1515/bchm2.1982.363.1.19; VAZ MJ, 1979, BIOPHYS J, V28, P327; Yoshida E, 2009, COLLOID POLYM SCI, V287, P767, DOI 10.1007/s00396-009-2023-2; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014; Yoshida E, 2015, COLLOID POLYM SCI, V293, P649, DOI 10.1007/s00396-014-3482-7	49	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	APR	2015	293	4					1275	1280		10.1007/s00396-015-3519-6		6	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CE8EL	WOS:000352074200029		
J	Uemura, M; Ishiguro, H				Uemura, Makoto; Ishiguro, Hiroshi			Freezing behavior of adherent neuron-like cells and morphological change and viability of post-thaw cells	CRYOBIOLOGY			English	Article						Nerve cells; Freezing; Thawing; Ice crystals; Microscopic behavior; Morphology; Neurites; Cytoskeleton; Cell viability	NERVE GROWTH-FACTOR; INTRACELLULAR ICE FORMATION; TRAUMATIC BRAIN-INJURY; STRETCH-INJURY; DIRECTIONAL SOLIDIFICATION; PHEOCHROMOCYTOMA CELLS; AXON DEGENERATION; CRYOPRESERVATION; RAT; PRINCIPLES	Freezing of nerve cells forming a neuronal network has largely been neglected, despite the fact that the cryopreservation of nerve cells benefits the study of cells in the areas of medicine and poison screening. Freezing of nerve cells is also attractive for studying cell morphology because of the characteristic long, thread-like neurites extending from the cell body. In the present study, freezing of neuron-like cells adhering to the substrate (differentiated PC12 cells), in physiological saline, was investigated in order to understand the fundamental freezing and thawing characteristics of nerve cells with neurites. The microscopic freezing behavior of cells under different cooling rates was observed. Next, the post-thaw morphological changes in the cells, including the cytoskeleton, were investigated and post-thaw cell viability was evaluated by dye exclusion using propidium iodide. Two categories of morphological changes, beading and shortening of the neurites, were found and quantified. Also, the morphological changes of neurites due to osmotic stress from sodium chloride were studied to gain a better understanding of causation. The results showed that morphological changes and cell death were promoted with a decrease in end temperature during freezing. (C) 2015 Elsevier Inc. All rights reserved.	[Uemura, Makoto; Ishiguro, Hiroshi] Kyushu Inst Technol, Dept Biol Funct & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan	Ishiguro, H (reprint author), Kyushu Inst Technol, Dept Biol Funct & Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	ishiguro@life.kyutech.ac.jp			Japan Society for the Promotion of Science [21360098, 24360083, 23 9393]	This work was supported by Grant-in-Aid for Scientific Research #21360098 and #24360083 (to H.I) and JSPS Fellows #23 9393 (to M.U.) from the Japan Society for the Promotion of Science.	Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Ishiguro H, 2008, INT J HEAT MASS TRAN, V51, P5642, DOI 10.1016/j.ijheatmasstransfer.2008.04.019; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Markin VS, 1999, BIOPHYS J, V76, P2852; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; PIKE CJ, 1992, NEUROREPORT, V3, P769, DOI 10.1097/00001756-199209000-00012; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Ma W, 2006, NEUROSCI LETT, V403, P84, DOI 10.1016/j.neulet.2006.04.064; Paynter SJ, 2008, BRAIN RES BULL, V75, P1, DOI 10.1016/j.brainresbull.2007.08.004; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Al-Noori S, 2000, NEUROSCIENCE, V101, P337, DOI 10.1016/S0306-4522(00)00384-5; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Bakhach J, 2009, ORGANOGENESIS, V5, P119, DOI 10.4161/org.5.3.9583; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Day JG, 2008, MOL BIOTECHNOL, V40, P202, DOI 10.1007/s12033-008-9099-7; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Liu XY, 2001, APPL PHYS LETT, V79, P39, DOI 10.1063/1.1384007; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; FRODL EM, 1994, BRAIN RES, V647, P286, DOI 10.1016/0006-8993(94)91328-5; GASTER RN, 1971, ARCH SURG-CHICAGO, V103, P378; He Xiaoming, 2011, Open Biomed Eng J, V5, P47, DOI 10.2174/1874120701105010047; Hsu M, 2014, J NEURAL TRANSM, V121, P15, DOI 10.1007/s00702-013-1077-y; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; Javois L.C., 1999, IMMUNOCYTOCHEMICAL M; JENSEN S, 1987, CRYOBIOLOGY, V24, P120, DOI 10.1016/0011-2240(87)90014-9; JENSEN S, 1984, J COMP NEUROL, V227, P558, DOI 10.1002/cne.902270407; JOSHI HC, 1985, J CELL BIOL, V101, P697, DOI 10.1083/jcb.101.3.697; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; MCGRATH JJ, 1975, CRYOBIOLOGY, V12, P540, DOI 10.1016/0011-2240(75)90048-6; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Ochs S, 1997, PROG NEUROBIOL, V52, P391, DOI 10.1016/S0301-0082(97)00022-1; Pichugin Y, 2006, CRYOBIOLOGY, V52, P228, DOI 10.1016/j.cryobiol.2005.11.006; RUBINSKY B, 1985, CRYOBIOLOGY, V22, P55, DOI 10.1016/0011-2240(85)90008-2; RUKENSTEIN A, 1983, BRAIN RES, V263, P177, DOI 10.1016/0006-8993(83)91218-0; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625; SOUZU H, 1978, BIOPHYS J, V23, P89; TSUKADA Y, 1994, BIOL PHARM BULL, V17, P370; Uchida T., 2007, CRYOBIOL CRYOTECHNOL, V53, P161; Yamazaki M, 2006, NEUROSCI LETT, V393, P222, DOI 10.1016/j.neulet.2005.09.068; Zhmakin AI, 2008, PHYS-USP+, V51, P231, DOI 10.1070/PU2008v051n03ABEH006449	48	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0011-2240	1090-2392		CRYOBIOLOGY	Cryobiology	APR	2015	70	2					122	135		10.1016/j.cryobiol.2015.01.006		14	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CF6NR	WOS:000352673900007		
J	Eto, T; Takahashi, R; Kamisako, T				Eto, Tomoo; Takahashi, Riichi; Kamisako, Tsutomu			Strain preservation of experimental animals: Vitrification of two-cell stage embryos for multiple mouse strains	CRYOBIOLOGY			English	Article						Strain preservation; Cryopreservation; Vitrification; Cryoprotectant solution; P10; PEPeS; Mouse; Mouse embryos; Multiple mouse strains; Two-cell stage embryos	HUMAN TUBAL FLUID; CRYOPRESERVATION; FERTILIZATION; GENOTYPE; MODELS; MICE	Strain preservation of experimental animals is crucial for experimental reproducibility. Maintaining complete animal strains, however, is costly and there is a risk for genetic mutations as well as complete loss due to disasters or illness. Therefore, the development of effective vitrification techniques for cryopreservation of multiple experimental animal strains is important. We examined whether a vitrification method using cryoprotectant solutions, P10 and PEPeS, is suitable for preservation of multiple inbred and outbred mouse strains. First, we investigated whether our vitrification method using cryoprotectant solutions was suitable for two-cell stage mouse embryos. In vitro development of embryos exposed to the cryoprotectant solutions was similar to that of fresh controls. Further, the survival rate of the vitrified embryos was extremely high (98.1%). Next, we collected and vitrified two-cell stage embryos of 14 mouse strains. The average number of embryos obtained from one female was 7.3-33.3. The survival rate of vitrified embryos ranged from 92.8% to 99.1%, with no significant differences among mouse strains. In vivo development did not differ significantly between fresh controls and vitrified embryos of each strain. For strain preservation using cryopreserved embryos, two offspring for inbred lines and one offspring for outbred lines must be produced from two-cell stage embryos collected from one female. The expected number of surviving fetuses obtained from embryos collected from one female of either the inbred or outbred strains ranged from 2.9 to 19.5. The findings of the present study indicated that this vitrification method is suitable for strain preservation of multiple mouse strains. (C) 2015 The Authors. Published by Elsevier Inc.	[Eto, Tomoo; Takahashi, Riichi; Kamisako, Tsutomu] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan	Eto, T (reprint author), Cent Inst Expt Anim, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa 2100821, Japan.	etoh@ciea.or.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	This study was partially funded by Grant-in Aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Abbott A, 2004, NATURE, V432, P541, DOI 10.1038/432541a; Pedro PB, 2005, J REPROD DEVELOP, V51, P235, DOI 10.1262/jrd.16079; QUINN P, 1985, FERTIL STERIL, V44, P493; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Chou SR, 2000, CELL IMMUNOL, V200, P88, DOI 10.1006/cimm.1999.1624; CULLITON BJ, 1989, SCIENCE, V244, P767; DINNYES A, 1995, MOL REPROD DEV, V40, P429, DOI 10.1002/mrd.1080400406; Edashige K, 1999, CRYOBIOLOGY, V38, P273, DOI 10.1006/cryo.1999.2163; Eto T, 2014, CRYOBIOLOGY, V68, P147, DOI 10.1016/j.cryobiol.2014.01.011; Green EL, 1981, MOUSE BIOMEDICAL RES, P91; Hino T., 2012, ZYGOTE, V19, P315; Horgan B., 1986, MANIPULATION MOUSE E, P97; Horgan B., 1986, MANIPULATION MOUSE E, P135; ITO M, 1992, LAB ANIM SCI, V42, P211; Kasai M., 1997, J MAMM OVA RES, V14, P17, DOI 10.1274/jmor.14.17; Kasai M, 1996, CRYOBIOLOGY, V33, P459, DOI 10.1006/cryo.1996.0046; Kito S, 2004, COMPARATIVE MED, V54, P564; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Mukaida T, 1998, HUM REPROD, V13, P2874; National Research Council, 1996, ROD, P35; Nomura T, 2008, CURR TOP MICROBIOL, V324, P1; Nomura T, 1997, LAB ANIM SCI, V47, P113; Nomura T., 1987, HYBRIDS, P15; SCHMIDT PM, 1987, BIOL REPROD, V37, P1121, DOI 10.1095/biolreprod37.5.1121; SCHMIDT PM, 1985, BIOL REPROD, V32, P507, DOI 10.1095/biolreprod32.3.507; Thorat R, 2012, EXP ANIM TOKYO, V61, P139, DOI 10.1538/expanim.61.139; Toyoda Y, 1971, JPN J ANIM REPROD, V16, P147; Toyoda Y., 1971, JAP J ANIM REPROD, V16, P152; WHITTING.DG, 1971, NATURE, V233, P125, DOI 10.1038/233125a0; Yoshiki A, 1987, Jikken Dobutsu, V36, P379	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0011-2240	1090-2392		CRYOBIOLOGY	Cryobiology	APR	2015	70	2					150	155		10.1016/j.cryobiol.2015.01.008		6	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CF6NR	WOS:000352673900010		
J	Murakami, R; Yajima, Y; Kida, K; Tokura, K; Tojo, M; Hoshino, T				Murakami, Ryo; Yajima, Yuka; Kida, Ken-ichi; Tokura, Katsuyuki; Tojo, Motoaki; Hoshino, Tamotsu			Surviving freezing in plant tissues by oomycetous snow molds	CRYOBIOLOGY			English	Article						Environmental adaptation; Frost resistance; Oomycetes; Stramenopiles; Take advantage of host function	FUNGI	Oomyceteous snow molds, Pythium species, were reported to be less tolerant to chilling and freezing temperatures than other snow mold taxa. However, Pythium species are often found to be pathogenic on mosses in Polar Regions. We investigated the frost resistance of Pythium species from Temperate (Hokkaido, Japan) and Subantarctic Regions. Free mycelia and hyphal swellings, structures for survival, of Pythium iwayamai and Pythium paddicum lost viability within freeze-thaw 3 cycles; however, mycelia in host plants survived the treatment. It was reported that fungi in permafrost are characterized both by the presence of natural cryoprotectants in these ecotopes and by the ability to utilize their inherent mechanisms of protection. It is conceivable that plant substrates or derivatives thereof are natural cryoprotectants, enabling them to provide advantageous conditions to microorganisms under freezing conditions. Our results are the first to experimentally support this hypothesis. (C) 2015 Elsevier Inc. All rights reserved.	[Murakami, Ryo; Hoshino, Tamotsu] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Murakami, Ryo; Yajima, Yuka; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; [Kida, Ken-ichi; Tokura, Katsuyuki; Tojo, Motoaki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan	Hoshino, T (reprint author), Natl Inst Adv Ind Sci & Technol, BRRC, Kagamiyama 3-11-32, Higashihiroshima 7390046, Japan.	tamotsu.hoshino@aist.ga.jp			Japanese Society for the Promotion of Science (JSPS) [23247012, 25291084]	This research was financially supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) (Nos. 23247012 and 25291084) from the Japanese Society for the Promotion of Science (JSPS).	Stakhov VL, 2008, MICROBIOLOGY+, V77, P348, DOI 10.1134/S0026261708030156; Tojo M, 2012, FUNGAL BIOL-UK, V116, P756, DOI 10.1016/j.funbio.2012.04.005; Hoshino T, 2002, CRYOLETTERS, V23, P151; Hoshino T, 2010, MYCOSCIENCE, V51, P98, DOI 10.1007/s10267-009-0013-3; Hoshino T., 2013, ADV MED BIOL, V69, P69; Hoshino T, 2009, MYCOSCIENCE, V50, P26, DOI 10.1007/s10267-008-0452-2; KUSUNOKI M, 1982, Annals of the Phytopathological Society of Japan, V48, P695; MALAJCZUK N, 1977, CAN J MICROBIOL, V23, P1518; Ozerskaya Svetlana, 2009, V16, P85; Smith J. D., 1989, FUNGAL DIS AMENITY T; TAKAYANAGI S, 1989, Scientific Reports of Hokkaido Fisheries Experimental Station, P1; Tojo M., 2012, FUNGAL ECOL, V5, P379	12	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0011-2240	1090-2392		CRYOBIOLOGY	Cryobiology	APR	2015	70	2					208	210		10.1016/j.cryobiol.2015.01.007		3	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CF6NR	WOS:000352673900019		
J	Eiyama, A; Okamoto, K				Eiyama, Akinori; Okamoto, Koji			PINK1/Parkin-mediated mitophagy in mammalian cells	CURRENT OPINION IN CELL BIOLOGY			English	Article							MITOCHONDRIAL QUALITY-CONTROL; PARKIN-MEDIATED MITOPHAGY; UBIQUITIN-LIKE DOMAIN; PINK1-DEPENDENT PHOSPHORYLATION; DEPOLARIZED MITOCHONDRIA; DAMAGED MITOCHONDRIA; REGULATES MITOPHAGY; CATALYTIC-ACTIVITY; ACTIVATE PARKIN; PROTEASE PARL	Mitochondria-specific autophagy (mitophagy) is a fundamental process critical for maintaining mitochondrial fitness in a myriad of cell types. Particularly, mitophagy contributes to mitochondrial quality control by selectively eliminating dysfunctional mitochondria. In mammalian cells, the Ser/Thr kinase PINK1 and the E3 ubiquitin ligase Parkin act cooperatively in sensing mitochondrial functional state and marking damaged mitochondria for disposal via the autophagy pathway. Notably, ubiquitin and deubiquitinases play vital roles in modulating Parkin activity and mitophagy efficiency. In this review, we highlight recent breakthroughs addressing the key issues of how PINK1 activates Parkin in response to mitochondrial malfunction, how Parkin localizes specifically to impaired mitochondria, and how ubiquitination and deubiquitination regulate PINK1/Parkin-mediated mitophagy.	[Eiyama, Akinori; Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Okamoto, K (reprint author), Osaka Univ, Grad Sch Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kokamoto@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25650067, 25291045]; Ministry of Education, Culture, Sports, Science, and Technology [26111513]; JSPS	The authors apologize to the many colleagues whose work could not be cited owing to space limitations. We thank Koji Yamano and Noriko Kondo-Okamoto for their valuable comments on the manuscript. This work was supported in part by Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for JSPS Fellows to AE, Challenging Exploratory Research Grant (25650067) and Scientific Research (B) (25291045) to KO, and by the Ministry of Education, Culture, Sports, Science, and Technology, Grant-in-Aid for Scientific Research on Innovative Areas (26111513) to KO. AE was supported by a JSPS Research Fellowship DC1 for Young Scientists.	Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Ivatt RM, 2014, P NATL ACAD SCI USA, V111, P8494, DOI 10.1073/pnas.1321207111; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Kitada T, 1998, NATURE, V392, P605; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Cornelissen T, 2014, HUM MOL GENET, V23, P5227, DOI 10.1093/hmg/ddu244; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Okatsu K, 2015, J CELL SCI, DOI DOI 10.1242/JCS.161000.IN; Okatsu K, 2015, J CELL BIOL IN PRESS; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Ozawa K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02202; Riley BE, 2013, NAT COMMUN, V4, P1982; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, DOI DOI 10.1016/J.TCB.2014.11.002.; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Spratt D.E, 1983, NAT COMMUN, V4, P1983; Wauer T, 2014, EMBO J, V34, P307; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648	61	9	10	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0955-0674	1879-0410		CURR OPIN CELL BIOL	Curr. Opin. Cell Biol.	APR	2015	33						95	101		10.1016/j.ceb.2015.01.002		7	Cell Biology	Cell Biology	CF0IM	WOS:000352226700015		
J	Kojima, I; Takeda, T; Nakajima, K; Narimatsu, K; Konno, M; Ozawa, T; Ishigami, K				Kojima, Ichiro; Takeda, Tomotaka; Nakajima, Kazunori; Narimatsu, Keishiro; Konno, Michiyo; Ozawa, Takamitsu; Ishigami, Keiichi			Thinning factors influence on custom-made mouthguards thermoforming	DENTAL TRAUMATOLOGY			English	Article						mouthguard; prevention; thermoforming; thinning; air pressure type; vacuum type	SHOCK ABSORPTION ABILITY; MOUTH GUARDS; THICKNESS; DIFFERENCE; OCCLUSION; SPACE; COLOR; SAFE; FIT	The aim of this study was to clarify and quantify factors influencing thinning during a thermoforming using a special simulation model that has three different flat surfaces such as 0 degree, 45 degree and 90 degree against a pressurizing force. Air pressure type samples were made by EVA and acrylic resin blank. Vacuum type samples were also made by EVA. Thickness gauge was employed to measure the thickness. As results, pressure forming showed significantly larger thinning at 45 and 90 degree surfaces and smaller thinning at 0 degree surface, 36% in thinning rate by vacuum forming and 66% by the pressure forming at 90 degree surface, and 17% and 20% at 45 degree surface, and 11% and 2% at 0 degree surfaces. Thinning was increased with the increase in distance from the centre in 0 degree surface and increased with the decrease in height in the vertical surface significantly. The air pressure, the material thickness in EVA (Drufosoft) and difference in material colour did not affect thinning rate. An acrylic resin material showed approximately 10% smaller thinning than EVA (Drufosoft). To retain enough thickness of 3 mm on 90 degree surface corresponding to an incisal labial aspect for pressure laminate type, over 55% reduction is taken into consideration and at least two 3-mm-thickness materials should be laminated. 0 degree surface showed at most 2 % reduction in pressure lamination; post thermoforming occlusal thickness became almost 6 mm with a usual 3 mm plus 3 mm lamination. Therefore, careful occlusal adjustment in an actual mouthguard fabrication to achieve an appropriate 2 mm thickness on this surface should be requested.	[Kojima, Ichiro; Takeda, Tomotaka; Nakajima, Kazunori; Narimatsu, Keishiro; Konno, Michiyo; Ozawa, Takamitsu; Ishigami, Keiichi] Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, Chiba 2618502, Japan	Takeda, T (reprint author), Tokyo Dent Coll, Dept Sports Dent, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	ttakeda@tdc.ac.jp					Ada Council on Access Pairacosa, 2006, J AM DENT ASSOC, V137, P1712; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x; Waked EJ, 2002, QUINTESSENCE INT, V33, P700; Del Rossi G, 2007, DENT TRAUMATOL, V23, P149, DOI 10.1111/j.1600-9657.2006.00436.x; Del Rossi G, 2008, DENT TRAUMATOL, V24, P197, DOI 10.1111/j.1600-9657.2007.00570.x; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Guevara P H, 2001, Gen Dent, V49, P402; Handa Jun, 2011, J Prosthodont Res, V55, P214, DOI 10.1016/j.jpor.2011.02.003; Jagger Robert G, 2010, Prim Dent Care, V17, P143, DOI 10.1308/135576110791654793; Kawarai C, 2004, J SPORTS DENT, V7, P36; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Nakajima K, 2008, DENT TRAUMATOL, V24, P50, DOI 10.1111/j.1600-9657.2006.00398.x; Ozawa T, 2013, SPORTS DENT, V16, P86; Padilla Ray R, 2009, Hawaii Dent J, V40, P6; Padilla R, 1996, J Calif Dent Assoc, V24, P30; Padilla R, 2009, HAWAII DENT J, V4, P6; Padilla R, 2009, HAWAII DENT J, V40, P7; Padilla R R, 1999, J Calif Dent Assoc, V27, P200; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Ranalli DN, 2002, DENT TRAUMATOL, V18, P231, DOI 10.1034/j.1600-9657.2002.00122.x; Rosemergy K, 2001, DENT TECH, V28, P19; Satoh T, 1990, J JPN SOC BIOMECHAN, V14, P68; Takahashi M, 2012, J PROSTHODONT RES, V56, P194, DOI 10.1016/j.jpor.2011.11.002; Takahashi M, 2008, J JPN PROSTHODONT SO, V54, P465; Takahashi M, 2012, J PROSTHODONT RES, V56, P281, DOI 10.1016/j.jpor.2012.03.001; Takeda T, 2004, DENT TRAUMATOL, V20, P150, DOI 10.1111/j.1600-4469.2004.00247.x; Takeda T, 2006, DENT TRAUMATOL, V22, P205, DOI 10.1111/j.1600-9657.2006.00427.x; Takeda T, 2011, DENT TRAUMATOL, V27, P489, DOI 10.1111/j.1600-9657.2011.01029.x; Takeda T, 2008, DENT TRAUMATOL, V24, P360, DOI 10.1111/j.1600-9657.2008.00576.x; Takeda T, 2006, DENT TRAUMATOL, V22, P77, DOI 10.1111/j.1600-9657.2006.00361.x; Waked EJ, 2005, QUINTESSENCE INT, V36, P462; Westerman B, 2002, BRIT J SPORT MED, V36, P51, DOI 10.1136/bjsm.36.1.51; Westerman B, 1995, AUST DENT J, V40, P389; Yamada J, 2006, DENT TRAUMATOL, V22, P139, DOI 10.1111/j.1600-9657.2006.00393.x; Yamada J, 2003, J SPORTS DENT, V6, P42; Yonehata Y, 2003, J PROSTHET DENT, V89, P23, DOI 10.1067/mpr.2003.62	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2015	31	2					103	112		10.1111/edt.12145		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9FC	WOS:000352148400004		
J	Mizuhashi, F; Koide, K; Takahashi, M				Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi			Variations in mouthguard thickness according to fabrication method	DENTAL TRAUMATOLOGY			English	Article						mouthguard; fabrication method; thickness; vacuum-pressure former	GUARDS; PREVENTION	Aim: The purpose of this study was to examine differences in mouthguard thickness according to the method used to form the mouthguard sheet in a combination vacuum-pressure former. Materials and methods: The material used in this study was a mouthguard sheet of 3.8-mm ethylene vinyl acetate. Three forming methods were used: vacuum-forming, vacuum-pressure-forming, and pressure-forming. The sheets were formed when heating causing them to displace 15 mm from baseline. We measured mouthguard thickness at the labial surface of the central incisor, the buccal surface of the first molar, and the occlusal surface of the first molar. Differences in thickness in different regions of mouthguards formed under different conditions were analyzed by two-way analysis of variance and the Bonferroni method. Results: We found that mouthguard thickness differed in different regions of the central incisors and the first molars (P < 0.01). The incisal (cusp) region was thinner than the cervical region. There were significant differences in the thicknesses of vacuum-formed mouthguards and vacuum-pressure-formed mouthguards (P < 0.05), with the vacuum-forming method resulting in thinner guards than the vacuum-pressure-forming method. Mouthguard thickness at the first molar did not differ according to the forming method. Conclusions: Our results suggest that mouthguard thickness at the anterior teeth varies with different forming methods. This information is important when selecting a mouthguard-forming method.	[Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi] Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Mizuhashi, F (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	fumichan@ngt.ndu.ac.jp					Chi Howard H, 2007, Compend Contin Educ Dent, V28, P36; Choy M M, 1998, Hawaii Dent J, V29, P28; Del Rossi G, 2007, DENT TRAUMATOL, V23, P149, DOI 10.1111/j.1600-9657.2006.00436.x; Eccelston JA, 1995, AUSTR DENT J, V40, P389; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Guevara P H, 2001, Gen Dent, V49, P402; Hoffmann J, 1999, ENDOD DENT TRAUMATOL, V15, P157; KERR IL, 1986, SPORTS MED, V3, P415; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Maeda Y, 2001, FABRICATING MANUAL M; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Takahashi F, 2003, J SPORTS DENT, V6, P30; Takahashi F, 2004, J SPORTS DENT, V7, P12; Waked EJ, 2005, QUINTESSENCE INT, V36, P462; Yamada J, 2003, J SPORTS DENT, V6, P42; Yamada Junko, 2007, J Prosthodont, V16, P452, DOI 10.1111/j.1532-849X.2007.00222.x; Yonehata Y, 2003, J PROSTHET DENT, V89, P23, DOI 10.1067/mpr.2003.62	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2015	31	2					130	135		10.1111/edt.12128		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9FC	WOS:000352148400008		
J	Sauriasari, R; Andrajati, R; Azizahwati; Dharmeizar; Saputri, DA; Muris, RU; Manfaatun, A; Amanda, OF; Setiawan, H; Sakano, N; Wang, DH; Ogino, K				Sauriasari, R.; Andrajati, R.; Azizahwati; Dharmeizar; Saputri, D. A.; Muris, R. U.; Manfaatun, A.; Amanda, O. F.; Setiawan, H.; Sakano, N.; Wang, D. H.; Ogino, K.			Marker of lipid peroxidation related to diabetic nephropathy in Indonesian type 2 diabetes mellitus patients	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Diabetes Mellitus; Estimated Glomerular Filtration Rate; Urine Albumin to Creatinine Ratio; 8-iso-PGF(2 alpha)	GLOMERULAR-FILTRATION-RATE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; MESANGIAL CELLS; KIDNEY-FUNCTION; HIGH GLUCOSE; TGF-BETA; MALONDIALDEHYDE; PROTEINURIA; POPULATION	Objective: Even though diabetes patients exhibit an increased oxidative stress, its correlation with diabetic nephropathy is not fully understood. The purpose of this study was to determine whether lipid peroxidation marker correlates well with eGFR and UACR in type 2 diabetes mellitus patients. Methods: We collected urine and serum samples of Indonesian type 2 diabetes mellitus outpatients with normo-and microalbuminuria at a Local Government Clinic (from ages: 39-74 years). Urinary 8-iso-PGF(2 alpha) was measured by ELISA, the serum malondialdehyde by TBARS assay, and urinary albumin by BCG albumin assay. eGFR was calculated using the corrected-Cockcroft-Gault (CG), MDRD, and CKD-EPI equation. Other necessary data were obtained through questionnaires. Results: The results showed that the increasing level of malondialdehyde was mildly correlated with the decline in eGFR (MDRD). In contrary, there was a significant positive correlation between 8-iso-PGF(2 alpha) concentration and eGFR based on the corrected-CG, MDRD study, and CKD-EPI equation (r = 0.457, p < 0.001; r = 0.424, p < 0.001; r = 0.443, p < 0.001). This relationship still persisted in the normoalbuminuric subjects (n = 43) (r = 0.491, p = 0.001; r = 0.461, p = 0.002; r = 0.455, p = 0.002). The multivariate analysis showed that 8-iso-PGF(2 alpha) together with fasting plasma glucose was the most predictive factor for the high 2-quantile eGFR (adjusted OR 1.001, (95% CI, 1.000-1.001)). However, there was no significant correlation between UACR with malondialdehyde (r = 0.268, p = 0.050) and 8-iso-PGF(2 alpha)(r = -0.030, p = 0.808). UACR itself was inversely correlated with eGFR based on the corrected-CG, the MDRD, and CKD-EPI (r = -0.232, p < 0.05; r = -0.228, p < 0.05; r = -0.232, p < 0.05). Conclusions: Increased 8-iso-PGF(2 alpha) and malondialdehyde in type 2 diabetes mellitus patients may play a role in the pathophysiologic significance of diabetic nephropathy, even while considering the effect of potential confounders. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sauriasari, R.; Andrajati, R.; Azizahwati; Saputri, D. A.; Muris, R. U.; Manfaatun, A.; Amanda, O. F.] Univ Indonesia, Fac Pharm, Depok, Indonesia; [Dharmeizar] Ciptomangunkusumo Hosp, Div Renal & Hypertens, Jakarta, Indonesia; [Setiawan, H.; Ogino, K.] Okayama Univ, Dent & Pharmaceut Sci, Grad Sch Med, Dept Publ Hlth, Okayama 7008530, Japan; [Sakano, N.] Okayama Univ, Dent & Pharmaceut Sci, Grad Sch Med, Dept Gerontol Res, Okayama 7008530, Japan; [Wang, D. H.] Okayama Univ Sci, Dept Environm Biochem, Okayama, Japan	Sauriasari, R (reprint author), Univ Indonesia, Fac Pharm, Depok, Indonesia.	rani@farmasi.ui.ac.id			State Institute of Higher Education Operational Assistance Grants (Hibah BOPTN); Ministry of Education Affairs, Republic of Indonesia; Directorate of Research and Public Service, Universitas Indonesia [2918/H2.R12/HKP.05.00/2013]	This work was supported by the State Institute of Higher Education Operational Assistance Grants (Hibah BOPTN), Ministry of Education Affairs, Republic of Indonesia in coordination with the Directorate of Research and Public Service, Universitas Indonesia (#2918/H2.R12/HKP.05.00/2013). We also gratefully appreciate technical contributions from Ms. Yuli, the Center for Radioisotopes and Radiopharmaceuticals, BATAN.	Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Pasaoglu H, 2004, TOHOKU J EXP MED, V203, P211, DOI 10.1620/tjem.203.211; Badr KF, 2005, ANTIOXID REDOX SIGN, V7, P236, DOI 10.1089/ars.2005.7.236; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Schalkwijk CG, 2005, CLIN SCI, V109, P143; Levey AS, 2009, ANN INTERN MED, V150, P604; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004; Basu S, 2009, FREE RADICAL RES, V43, P85, DOI 10.1080/10715760802610851; Iglesias-de la Cruz MC, 2001, KIDNEY INT, V59, P87, DOI 10.1046/j.1523-1755.2001.00469.x; Kedziora-Kornatowska KZ, 1998, NEPHROL DIAL TRANSPL, V13, P2829, DOI 10.1093/ndt/13.11.2829; Li GL, 2012, REJUV RES, V15, P257, DOI 10.1089/rej.2011.1259; Loebstein R, 1998, DIABETES CARE, V21, P1306, DOI 10.2337/diacare.21.8.1306; Mahboob M., 2005, SMJ Singapore Medical Journal, V46, P322; Montero A, 2000, KIDNEY INT, V58, P1963, DOI 10.1046/j.1523-1755.2000.00368.x; Nakatani S, 2014, DIABETES RES CLIN PR, V105, P40, DOI 10.1016/j.diabres.2014.04.019; Ozdemir G, 2005, ANN CLIN BIOCHEM, V42, P99, DOI 10.1258/0004563053492838; Purwantyastuti Kamso S, 2005, MED J INDONES, V14, P71; Richelle M, 1999, FEBS LETT, V459, P259, DOI 10.1016/S0014-5793(99)01259-4; Rostoker G, 2007, J NEPHROL, V20, P576; Sakano N, 2009, FREE RADICAL RES, V43, P183, DOI 10.1080/10715760802663124; Sauriasari R, 2010, HYPERTENS RES, V33, P1129, DOI 10.1038/hr.2010.154; Sharma K, 1994, AM J PHYSIOL, V266, P829; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Terami T, 2013, INT J NEPHROL RENOVA, V22, P233; The National Kidney Disease Education Program (NKDEP) of National Institutes of Health, 2010, IMPROVING THE UNDERS; Triyanti Kuspuji, 2008, Acta Med Indones, V40, P192; US FDA (FDA Food and Drug Administration), 2012, GUIDANCE FOR INDUSTR; YAQOOB M, 1993, CLIN SCI, V85, P557	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	APR	2015	108	1					193	200		10.1016/j.diabres.2014.12.016		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CF1AC	WOS:000352274900034		
J	Kawada, T				Kawada, Tomoyuki			Air pollution and diabetes mellitus	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Letter						Air pollution; Diabetes mellitus; Meta-analysis			Nippon Med Sch, Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Balti EV, 2014, DIABETES RES CLIN PR, V106, P161, DOI 10.1016/j.diabres.2014.08.010; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Park SK, 2014, CURR ENV HLTH REP, V1, P275; Wang B, 2014, EUR J ENDOCRINOL, V171, P173	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	APR	2015	108	1					E7	E7		10.1016/j.diabres.2015.01.002		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CF1AC	WOS:000352274900007		
J	Kuramoto, N; Yabe, D; Kurose, T; Seino, Y				Kuramoto, Naoki; Yabe, Daisuke; Kurose, Takeshi; Seino, Yutaka			A case of hypoglycemia due to illegitimate sexual enhancement medication	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Hypoglycemia; Sexual enhancement medication; Glibenclamide; Sildenafil citrate	PRODUCTS; OUTBREAK	Sexual enhancement medication presents a large market for counterfeit versions. We report here a case of hypoglycemia caused by an illicit sexual enhancement medication containing an extremely large amount of the sulfonylurea drug glibenclamide together with a moderate amount sildenafil citrate. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kuramoto, Naoki; Yabe, Daisuke; Kurose, Takeshi; Seino, Yutaka] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka 5530003, Japan; [Yabe, Daisuke] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Osaka 5530003, Japan	Yabe, D (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, 2-1-7 Fukushima Ku, Osaka 5530003, Japan.	ydaisuke-kyoto@umin.ac.jp	Yabe, Daisuke/J-6682-2014	Yabe, Daisuke/0000-0002-5334-7687			Nagashima K, 2004, DIABETES RES CLIN PR, V66, pS75, DOI 10.1016/j.diabres.2003.12.011; Low MY, 2009, DRUG SAFETY, V32, P1141, DOI 10.2165/11316690-000000000-00000; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Poon W. T., 2009, Hong Kong Medical Journal, V15, P196; Chaubey SK, 2010, MED J AUSTRALIA, V192, P716; Kao SL, 2009, NEW ENGL J MED, V360, P734, DOI 10.1056/NEJMc0807678; Lee TM, 2003, J CLIN ENDOCR METAB, V88, P531, DOI 10.1210/jc.2002-020904; SCHMIDANTOMARCHI H, 1987, J BIOL CHEM, V262, P15840	11	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	APR	2015	108	1					E8	E10		10.1016/j.diabres.2015.02.014		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CF1AC	WOS:000352274900008		
J	Igarashi, Y				Igarashi, Yoshinori			Special Issue: Proceedings of the Endoscopy Forum Japan (EFJ), 2-3 August 2014, Grand Park Otaru, Otaru, Japan Preface	DIGESTIVE ENDOSCOPY			English	Editorial Material									Endoscopy Forum Japan, Org Comm, Toyohashi, Aichi, Japan	Igarashi, Y (reprint author), Endoscopy Forum Japan, Org Comm, Toyohashi, Aichi, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		1	1		10.1111/den.12453		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000001		
J	Yoshinaga, S; Hilmi, IN; Kwek, BEA; Hara, K; Goda, K				Yoshinaga, Shigetaka; Hilmi, Ida Normiha; Kwek, Boon Eu Andrew; Hara, Kazuo; Goda, Kenichi			Current status of endoscopic ultrasound for the upper gastrointestinal tract in Asia	DIGESTIVE ENDOSCOPY			English	Article						endoscopic ultrasound; esophagus; stomach; submucosal tumor; superficial cancer	EARLY GASTRIC-CANCER; SUPERFICIAL ESOPHAGEAL CANCER; SQUAMOUS-CELL CARCINOMA; FINE-NEEDLE-ASPIRATION; SUBMUCOSAL TUMORS; INVASION DEPTH; MAGNIFYING ENDOSCOPY; ULTRASONOGRAPHY; DIAGNOSIS; ACCURACY	We summarize the current status of endoscopic ultrasound (EUS) for the upper gastrointestinal (GI) tract solely in Asia, focusing on the staging of superficial cancers and the diagnosis of submucosal tumors (SMT), by analysis of questionnaire responses and a literature review. EUS for assessing the depth of superficial cancers of the upper GI tract is useful; however, evidence is lacking to support that EUS is superior to other modalities. The current status of EUS varies across different Asian countries, and standardization of the methods used both during the procedure and for depth subclassification is necessary to evaluate the diagnostic accuracy. Although EUS alone is limited in the diagnosis of SMT, EUS-guided fine-needle aspiration is an effective and safe diagnostic tool. Although there is a role for EUS, there are still many limitations both technically and in terms of accessibility.	[Yoshinaga, Shigetaka] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Goda, Kenichi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Hara, Kazuo] Aichi Canc Ctr Hosp, Dept Gastroenterol, Toyohashi, Aichi, Japan; [Hilmi, Ida Normiha] Univ Malaya, Gastroenterol & Hepatol Unit, Kuala Lumpur, Malaysia; [Kwek, Boon Eu Andrew] Changi Gen Hosp, Dept Gastroenterol, Singapore, Singapore	Yoshinaga, S (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	shiyoshi@ncc.go.jp					Abdullah M, 2010, J DIGEST DIS, V11, P28, DOI 10.1111/j.1751-2980.2009.00410.x; Ang Tiing Leong, 2006, Chin J Dig Dis, V7, P191, DOI 10.1111/j.1443-9573.2006.00270.x; Kim JH, 2007, GASTROINTEST ENDOSC, V66, P901, DOI 10.1016/j.gie.2007.06.012; Akahoshi K, 1998, GASTROINTEST ENDOSC, V48, P470, DOI 10.1016/S0016-5107(98)70087-2; Lok KH, 2009, J GASTROINTEST LIVER, V18, P177; DIMAGNO EP, 1980, LANCET, V1, P629; Okada K, 2011, SURG ENDOSC, V25, P841, DOI 10.1007/s00464-010-1279-4; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; Yanai H, 1999, GUT, V44, P361; Kim GH, 2010, J GASTROEN HEPATOL, V25, P506, DOI 10.1111/j.1440-1746.2009.06111.x; Ganpathi IS, 2006, SURG ENDOSC, V20, P559, DOI 10.1007/s00464-005-0309-0; Chiu PWY, 2012, SURG ENDOSC, V26, P3584, DOI 10.1007/s00464-012-2371-8; Mandai K, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/245390; Choi J, 2010, ENDOSCOPY, V42, P705, DOI 10.1055/s-0030-1255617; Matsumoto Y, 2000, J GASTROENTEROL, V35, P326, DOI 10.1007/s005350050356; Yanai H, 1997, GASTROINTEST ENDOSC, V46, P212, DOI 10.1016/S0016-5107(97)70088-9; Mekky MA, 2010, GASTROINTEST ENDOSC, V71, P913, DOI 10.1016/j.gie.2009.11.044; Jung JI, 2014, WORLD J GASTROENTERO, V20, P6322, DOI 10.3748/wjg.v20.i20.6322; Goda K, 2009, DIS ESOPHAGUS, V22, P453, DOI 10.1111/j.1442-2050.2009.00942.x; Attasaranya Siriboon, 2005, Journal of the Medical Association of Thailand, V88, P1660; Esaki M, 2006, GASTROINTEST ENDOSC, V63, P389, DOI 10.1016/j.gie.2005.10.027; FOK M, 1992, WORLD J SURG, V16, P1098; Fukuda M, 2000, WORLD J SURG, V24, P216; Hamada T, 2013, DIGEST DIS SCI, V58, P2634, DOI 10.1007/s10620-013-2717-7; Hasegawa N, 1996, GASTROINTEST ENDOSC, V44, P388, DOI 10.1016/S0016-5107(96)70086-X; He LJ, 2014, WORLD J GASTROENTERO, V20, P1340, DOI 10.3748/wjg.v20.i5.1340; HISANAGA K, 1980, AM J CARDIOL, V46, P837, DOI 10.1016/0002-9149(80)90437-3; Inui K, 2002, GASTROINTEST ENDOSC, V56, pS58, DOI 10.1067/mge.2002.127699; Kawamoto K, 1997, RADIOLOGY, V205, P733; Kikuchi D, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/329385; Kim GH, 2014, SCAND J GASTROENTERO, V49, P347, DOI 10.3109/00365521.2013.867361; Lee HH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-190; Lee MW, 2014, SCAND J GASTROENTERO, V49, P853, DOI 10.3109/00365521.2014.915052; Lee YT, 2002, GASTROINTEST ENDOSC, V56, P842, DOI 10.1067/mge.2002.129611; Mouri Ritsuo, 2009, J Clin Gastroenterol, V43, P318, DOI 10.1097/MCG.0b013e3181775966; Murata Y, 2003, ENDOSCOPY, V35, P429, DOI 10.1055/s-2003-38774; Murata Y, 1996, GASTROINTEST ENDOSC, V44, P23, DOI 10.1016/S0016-5107(96)70224-9; Nishida T, 2013, DIGEST ENDOSC, V25, P479, DOI 10.1111/den.12149; Prachayakul Varayu, 2012, J Med Assoc Thai, V95 Suppl 2, pS61; Puri R, 2012, DIS ESOPHAGUS, V25, P102, DOI 10.1111/j.1442-2050.2011.01223.x; Rong L, 2012, DIGEST ENDOSC, V24, P358, DOI 10.1111/j.1443-1661.2012.01243.x; Sakamoto H, 2010, WORLD J RADIOL, V28, P289; Sekine M, 2015, DIGEST ENDOSC, V27, P44, DOI 10.1111/den.12333; Seo SW, 2013, J DIGEST DIS, V14, P647, DOI 10.1111/1751-2980.12099; Suzuki T, 2011, ISRN GASTROENTEROL, V2011, DOI DOI 10.5402/2011/619128; The Japan Esophageal Society, 2008, JAP CLASS ES CANC, P13; Vu C, 2007, SURG ENDOSC, V21, P1617, DOI 10.1007/s00464-007-9206-z; Yamamoto S, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/194530; Yasuda K, 1990, GASTROINTEST ENDOS S, V36, P17; Yasuda K, 1996, GASTROINTEST ENDOSC, V43, pS29, DOI 10.1016/S0016-5107(96)81511-2; YASUDA K, 1989, GASTROINTEST ENDOSC, V35, P10, DOI 10.1016/S0016-5107(89)72678-X	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		2	10		10.1111/den.12422		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000002		
J	Minami, H; Inoue, H; Isomoto, H; Urabe, S; Nakao, K				Minami, Hitomi; Inoue, Haruhiro; Isomoto, Hajime; Urabe, Shigetoshi; Nakao, Kazuhiko			Clinical application of endoscopic ultrasonography for esophageal achalasia	DIGESTIVE ENDOSCOPY			English	Article						esophageal achalasia; endoscopic ultrasonography; per-oral endoscopic myotomy; inner circular muscle; three-dimensional ultrasonography	LONG-TERM OUTCOMES; BOTULINUM TOXIN; PNEUMATIC DILATION; MYOTOMY POEM; ULTRASOUND; APPEARANCE; WHALEBONE; INJECTION; MOTILITY; LAYERS	Endoscopic ultrasonography (EUS) has been widely used for evaluating the nature of diseases of various organs. The possibility of applying EUS for esophageal motility diseases has not been well discussed despite its versatility. At present, peroral endoscopic myotomy (POEM) for esophageal achalasia and related diseases has brought new attention to esophageal diseases because POEM provides a more direct approach to the inner structures of the esophageal wall. In the present study, we discuss the clinical utility of EUS in evaluating and treating esophageal motility diseases such as esophageal achalasia and related diseases.	[Minami, Hitomi; Isomoto, Hajime; Urabe, Shigetoshi; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki 8528501, Japan; [Inoue, Haruhiro] Showa Univ, Koto Toyosu Hosp, Digest Dis Ctr, Tokyo, Japan	Minami, H (reprint author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	le7novembre@gmail.com					Abdel Khalek M, 2011, J LA STATE MED SOC, V163, P134; ECKARDT VF, 1992, GASTROENTEROLOGY, V103, P1732; Swanstrom LL, 2012, ANN SURG, V256, P659, DOI 10.1097/SLA.0b013e31826b5212; COHEN S, 1995, NEW ENGL J MED, V332, P815, DOI 10.1056/NEJM199503233321211; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Schiano TD, 1996, GASTROINTEST ENDOSC, V44, P151, DOI 10.1016/S0016-5107(96)70132-3; Stavropoulos SN, 2013, SURG ENDOSC, V27, P3322, DOI 10.1007/s00464-013-2913-8; Pasricha PJ, 2007, ENDOSCOPY, V39, P761, DOI 10.1055/s-2007-966764; Iglesias-Garcia J, 2012, ENDOSC ULTRASOUND, V1, P8, DOI 10.7178/eus.01.003; Spiess AE, 1998, JAMA-J AM MED ASSOC, V280, P638, DOI 10.1001/jama.280.7.638; Fusaroli P, 2012, WORLD J GASTROENTERO, V18, P4243, DOI 10.3748/wjg.v18.i32.4243; Mattioli S, 2010, J THORAC CARDIOV SUR, V140, P962, DOI 10.1016/j.jtcvs.2010.07.053; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; Chen WF, 2015, GASTROINTEST ENDOSC, V81, P91, DOI 10.1016/j.gie.2014.06.035; Chen X, 2014, EUR J CARDIOTHORAC S; DEVIERE J, 1989, GASTROENTEROLOGY, V96, P1210; Heller, 1913, MITTGRENZGEBMEDCHIR, V27, P141; LIU JB, 1992, RADIOLOGY, V184, P721; Miller L S, 1995, Gastrointest Endosc Clin N Am, V5, P635; MILLER LS, 1995, GASTROINTEST ENDOSC, V42, P545, DOI 10.1016/S0016-5107(95)70008-0; Moreto M, 2013, DIGEST DIS SCI, V58, P788, DOI 10.1007/s10620-012-2476-x; Nussbaum MS, 2001, SURG LAPARO ENDO PER, V11, P294, DOI 10.1097/00019509-200110000-00002; ODEGAARD S, 1992, GASTROINTEST ENDOSC, V38, P351, DOI 10.1016/S0016-5107(92)70431-3; PASRICHA PJ, 1993, GASTROENTEROLOGY, V105, P1045; PASRICHA PJ, 1993, LANCET, V341, P244, DOI 10.1016/0140-6736(93)90109-T; PONSOT P, 1990, GASTROENTEROLOGY, V98, P253; TANIGUCHI DK, 1993, GASTROINTEST ENDOSC, V39, P146, DOI 10.1016/S0016-5107(93)70054-1; Vaezi MF, 1999, AM J GASTROENTEROL, V94, P1802; Van Dam J, 1998, Endoscopy, V30 Suppl 1, pA48, DOI 10.1055/s-2007-1001467; VANDAM J, 1995, ENDOSCOPY, V27, P185, DOI 10.1055/s-2007-1005659; ZIEGLER K, 1992, ENDOSCOPY, V24, P338, DOI 10.1055/s-2007-1010495; ZIEGLER K, 1990, ENDOSCOPY, V22, P1, DOI 10.1055/s-2007-1012776	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		11	16		10.1111/den.12432		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000003		
J	Hikichi, T; Obara, K; Nakamura, S; Irisawa, A; Ohira, H				Hikichi, Takuto; Obara, Katsutoshi; Nakamura, Shin-ichi; Irisawa, Atsushi; Ohira, Hiromasa			Potential application of interventional endoscopic ultrasonography for the treatment of esophageal and gastric varices	DIGESTIVE ENDOSCOPY			English	Article						coil; cyanoacrylate; endoscopic ultrasonography (EUS); interventional EUS; varix	PROSPECTIVE RANDOMIZED-TRIAL; MULTIPLE SYSTEMIC EMBOLISMS; EUS-GUIDED SCLEROTHERAPY; FINE-NEEDLE-ASPIRATION; COLLATERAL VEINS; PORTAL-HYPERTENSION; FUNDAL VARICES; COIL EMBOLIZATION; CYANOACRYLATE; OBLITERATION	Interventional endoscopic ultrasonography (EUS) has been developed mainly for the treatment of pancreaticobiliary disorders (e.g. cyst drainage for pancreatic pseudocysts, biliary drainage for malignant biliary obstruction, and celiac plexus neurolysis). Recently, the application of interventional EUS has been expanded to a new field, the treatment of gastrointestinal varices. There have been several studies examining this new technique for the treatment of esophageal and gastric varices. In the present review, we have summarized the current status of interventional EUS for the treatment of esophageal and gastric varices (e.g. EUS-guided coil deployment for gastric varices) and clarified the clinical feasibility of this procedure.	[Hikichi, Takuto; Obara, Katsutoshi] Fukushima Med Univ Hosp, Dept Endoscopy, Fukushima, Fukushima 9601295, Japan; [Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Nakamura, Shin-ichi] Tokyo Womens Med Univ Hosp, Dept Gastroenterol, Tokyo, Japan; [Irisawa, Atsushi] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan	Hikichi, T (reprint author), Fukushima Med Univ Hosp, Dept Endoscopy, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	takuto@fmu.ac.jp					de Paulo GA, 2006, GASTROINTEST ENDOSC, V63, P396, DOI 10.1016/j.gie.2005.10.039; Hou MC, 2000, J HEPATOL, V32, P202, DOI 10.1016/S0168-8278(00)80064-1; Binmoeller KF, 2011, GASTROINTEST ENDOSC, V74, P1019, DOI 10.1016/j.gie.2011.06.030; Eisen GM, 2002, GASTROINTEST ENDOSC, V56, P618, DOI 10.1016/S0016-5107(02)70105-3; Levy MJ, 2008, GASTROINTEST ENDOSC, V67, P572, DOI 10.1016/j.gie.2007.06.063; Kanagawa H, 1996, J GASTROEN HEPATOL, V11, P51, DOI 10.1111/j.1440-1746.1996.tb00010.x; SOEHENDRA N, 1986, ENDOSCOPY, V18, P25, DOI 10.1055/s-2007-1013014; Huang YH, 2000, GASTROINTEST ENDOSC, V52, P160, DOI 10.1067/mge.2000.104976; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; Kim T, 1997, HEPATOLOGY, V25, P307; Irisawa A, 2003, J GASTROEN HEPATOL, V18, P309, DOI 10.1046/j.1440-1746.2003.02956.x; VANSTIEGMANN G, 1986, GASTROINTEST ENDOSC, V32, P230, DOI 10.1016/S0016-5107(86)71815-4; Sarin SK, 1997, J HEPATOL, V26, P826, DOI 10.1016/S0168-8278(97)80248-6; Romero-Castro R, 2013, GASTROINTEST ENDOSC, V78, P711, DOI 10.1016/j.gie.2013.05.009; Hikichi T, 2009, J GASTROENTEROL, V44, P322, DOI 10.1007/s00535-009-0001-6; Cameron R, 2013, GASTROINTEST ENDOSC, V77, P846, DOI 10.1016/j.gie.2013.01.028; Irisawa A, 2001, GASTROINTEST ENDOSC, V53, P77, DOI 10.1067/mge.2001.108479; Romero-Castro R, 2007, GASTROINTEST ENDOSC, V66, P402, DOI 10.1016/j.gie.2007.03.008; Lahoti S, 2000, GASTROINTEST ENDOSC, V51, P331, DOI 10.1016/S0016-5107(00)70363-4; Hikichi Takuto, 2007, Fukushima J Med Sci, V53, P11; Irisawa A, 1999, GASTROINTEST ENDOSC, V50, P374, DOI 10.1053/ge.1999.v50.97777; Iso Y, 1997, HEPATO-GASTROENTEROL, V44, P467; Levy MJ, 2013, GASTROINTEST ENDOSC, V78, P722, DOI 10.1016/j.gie.2013.07.004; Palejwala AA, 2000, ENDOSCOPY, V32, pS1; Romero-Castro R, 2010, ENDOSCOPY, V42, pE35, DOI 10.1055/s-0029-1215261; Sanchez-Yague A, 2009, GASTOINTEST ENDOSC, V69, pA; Saracco G, 2007, GASTROINTEST ENDOSC, V65, P345, DOI 10.1016/j.gie.2006.07.009; Tan YM, 2002, GASTROINTEST ENDOSC, V55, P276, DOI 10.1067/mge.2001.118651; Wakatsuki T, 2005, J GASTROEN HEPATOL, V20, P1701	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		17	22		10.1111/den.12436		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000004		
J	Azuma, M; Kusano, C; Gotoda, T				Azuma, Mizutomo; Kusano, Chika; Gotoda, Takuji			Diagnostic potential of endoscopic ultrasonography-elastography for gastric submucosal tumors	DIGESTIVE ENDOSCOPY			English	Letter									[Azuma, Mizutomo] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Kusano, Chika; Gotoda, Takuji] Tokyo Med Univ Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan	Azuma, M (reprint author), Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan.						Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158; Japan Society of Clinical Oncology Japanese Gastric Cancer Association and Japanese Study Group on GIST, 2014, JAP CLIN PRACT GASTR; Saftoiu Adrian, 2006, J Gastrointestin Liver Dis, V15, P161; Sakamoto H, 2011, GASTROINTEST ENDOSC, V73, P227, DOI 10.1016/j.gie.2010.10.011	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		23	23		10.1111/den.12429		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000005		
J	Hirasawa, D; Maeda, Y				Hirasawa, Dai; Maeda, Yuki			Submucosal fibrosis detected by endoscopic ultrasonography may predict incomplete endoscopic submucosal dissection	DIGESTIVE ENDOSCOPY			English	Letter									[Hirasawa, Dai; Maeda, Yuki] Sendai City Med Ctr, Dept Gastroenterol, Sendai, Miyagi, Japan	Hirasawa, D (reprint author), Sendai City Med Ctr, Dept Gastroenterol, Sendai, Miyagi, Japan.						Chonan A, 1995, DIGEST ENDOSC, V7, P220, DOI 10.1111/j.1443-1661.1995.tb00166.x; Chonan A, 1993, GASTROENTEROL ENDOSC, V35, P1269; Hirasawa D, 2004, DIGEST ENDOSC, V16, P315, DOI 10.1111/j.1443-1661.2004.00401.x; Maeda Y, 2011, ENDOSCOPY, V43, pA38; Sabet EA, 2002, DIGEST ENDOSC, V14, P53, DOI 10.1046/j.1443-1661.2002.00169.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		24	24		10.1111/den.12452		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000006		
J	Matsuda, T; Kawano, H; Chiu, HM				Matsuda, Takahisa; Kawano, Hiroshi; Chiu, Han-Mo			Screening colonoscopy: What is the most reliable modality for the detection and characterization of colorectal lesions?	DIGESTIVE ENDOSCOPY			English	Article						adenoma detection rate; chromoendoscopy; colon polyp; image-enhanced endoscopy; screening colonoscopy	RANDOMIZED CONTROLLED-TRIAL; NONNEOPLASTIC COLONIC POLYPS; CAP-ASSISTED COLONOSCOPY; CONVENTIONAL COLONOSCOPY; DIFFERENTIAL-DIAGNOSIS; VIDEOENDOSCOPY SYSTEM; SURVEILLANCE COLONOSCOPY; MISS RATES; AUTOFLUORESCENCE; METAANALYSIS	Colonoscopy is considered the best modality for the detection and treatment of colorectal polyps. However, some polyps still may not be detected. Although conventional white-light endoscopy is the gold standard for the detection of colorectal polyps, up to a fifth of lesions may be missed on screening colonoscopy, especially non-polypoid colorectal neoplasms. Recently, many studies have reported on various endoscopic modalities that improve the detection and characterization of colorectal lesions. Newly developed modalities might be helpful to recognize colorectal lesions; however, careful observation is required to identify flat/depressed lesions as well as hidden polyps during screening and surveillance colonoscopy.	[Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Kawano, Hiroshi] St Marys Hosp, Dept Gastrointestinal Med, Kurume, Fukuoka, Japan; [Chiu, Han-Mo] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Matsuda, T (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tamatsud@ncc.go.jp					Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; van den Broek FJC, 2009, CLIN GASTROENTEROL H, V7, P288, DOI 10.1016/j.cgh.2008.10.025; Matsuda T, 2008, AM J GASTROENTEROL, V103, P1926, DOI 10.1111/j.1572-0241.2008.01931.x; van den Broek FJC, 2009, AM J GASTROENTEROL, V104, P1498, DOI 10.1038/ajg.2009.161; Canto MI, 1999, ENDOSCOPY, V31, P479; Sato R, 2011, ENDOSCOPY, V43, P862, DOI 10.1055/s-0030-1256510; van den Broek FJC, 2009, GASTROINTEST ENDOSC, V69, P124, DOI 10.1016/j.gie.2008.09.040; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Takeuchi Y, 2010, GASTROINTEST ENDOSC, V72, P1006, DOI 10.1016/j.gie.2010.06.055; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Lee YT, 2009, AM J GASTROENTEROL, V104, P41, DOI 10.1038/ajg.2008.56; Su MY, 2006, AM J GASTROENTEROL, V101, P2711, DOI 10.1111/j.1572-0241.2006.00932.x; Aihara H, 2009, GASTROINTEST ENDOSC, V69, P726, DOI 10.1016/j.gie.2008.10.044; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; Rex DK, 2003, AM J GASTROENTEROL, V98, P2000, DOI 10.1016/S0002-9270(03)00625-7; Sano Y, 2009, GASTROINTEST ENDOSC, V69, P278, DOI 10.1016/j.gie.2008.04.066; Uedo N, 2005, GASTROINTEST ENDOSC, V62, P521, DOI 10.1016/j.gie.2005.06.031; Matsushita M, 1998, ENDOSCOPY, V30, P444, DOI 10.1055/s-2007-1001305; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Pasha SF, 2012, AM J GASTROENTEROL, V107, P363, DOI 10.1038/ajg.2011.436; Pohl J, 2011, GUT, V60, P485, DOI 10.1136/gut.2010.229534; Boparai KS, 2009, GASTROINTEST ENDOSC, V70, P947, DOI 10.1016/j.gie.2009.03.1172; Fu KI, 2004, ENDOSCOPY, V36, P1089, DOI 10.1055/s-2004-826039; McCallum AL, 2008, GASTROINTEST ENDOSC, V68, P283, DOI 10.1016/j.gie.2007.10.039; Brown SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006439.pub3; Deenadayalu VP, 2004, AM J GASTROENTEROL, V99, P2138, DOI 10.1111/j.1572-0241.2004.40430.x; Dinesen L, 2012, GASTROINTEST ENDOSC, V75, P604, DOI 10.1016/j.gie.2011.10.017; Hurlstone DP, 2004, GUT, V53, P376, DOI 10.1136/gut.2003.029868; Ikematsu H, 2014, SURG ENDOSC; Parra-Blanco Adolfo, 2006, Gastroenterol Hepatol, V29, P602, DOI 10.1016/S0210-5705(06)71700-9; Jin XF, 2012, J GASTROEN HEPATOL, V27, P882, DOI 10.1111/j.1440-1746.2011.06987.x; Kudo Shin-ei, 2008, Gastrointest Endosc Clin N Am, V18, P581, DOI 10.1016/j.giec.2008.05.013; Kuiper T, 2011, GASTROENTEROLOGY, V140, P1887, DOI 10.1053/j.gastro.2011.03.008; Matsuda Takahisa, 2010, Gastrointest Endosc Clin N Am, V20, P487, DOI 10.1016/j.giec.2010.03.007; Matsuda T, 2010, DIGEST ENDOSC, V22, pS57, DOI 10.1111/j.1443-1661.2010.00967.x; Moriichi K, 2012, BMC GASTROENTEROL, V12, P12; Nakaniwa N, 2005, DIGEST ENDOSC, V17, P235, DOI 10.1111/j.1443-1661.2005.00506.x; Sabbagh LC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-100; Saito Y, 2014, CURR COLORECTAL CANC, V10, P9; Togashi K, 2009, J GASTROENTEROL, V44, P826, DOI 10.1007/s00535-009-0065-3; Uedo N, 2007, DIGEST ENDOSC, V19, P134; Uraoka T, 2014, ENDOSCOPY; Uraoka T, 2013, GASTROINTEST ENDOSC, V77, P480, DOI 10.1016/j.gie.2012.08.037; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		25	29		10.1111/den.12451		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000007		
J	Singh, R; Mangira, D; Kawano, H; Matsuda, T				Singh, Rajvinder; Mangira, Dileep; Kawano, Hiroshi; Matsuda, Takashia			Screening colonoscopy in Australia	DIGESTIVE ENDOSCOPY			English	Article						colorectal cancer; fecal occult blood test; image-enhanced endoscopy; National Bowel Cancer Screening Program; pilot program	RANDOMIZED CONTROLLED-TRIAL; FECAL OCCULT BLOOD; COLORECTAL-CANCER; ADENOMA DETECTION; METAANALYSIS	Colorectal cancer (CRC) is a global epidemic predominantly affecting Western countries. It is the second leading cause of cancer-related deaths in Australia with one in 12 Australians affected by this condition by the age of 85 years. Appropriate preventive measures by screening followed by colonoscopy can detect cancer and precancerous lesions, which are potentially curable. The National Bowel Cancer Screening Program (NBCSP) is a national screening program implemented by the Australian Government aimed at reducing morbidity and mortality from bowel cancer by actively recruiting and screening the target population. The long-term goal of the program is to include the at-risk population (50-74 years of age) in a biennial screening program. Newer technologies could have a potential role in screening programs by enhancing adenoma detection rates. However, until more evidence is available, improving screening uptake and bowel preparation strategies are the prime focus in reducing CRC-related morbidity and mortality.	[Singh, Rajvinder] Lyell McEwin Hosp, Adelaide, SA, Australia; [Singh, Rajvinder] Univ Adelaide, Adelaide, SA, Australia; [Mangira, Dileep] Flinders Med Ctr, Adelaide, SA, Australia; [Kawano, Hiroshi] St Marys Hosp, Tokyo, Japan; [Matsuda, Takashia] Natl Canc Ctr, Tokyo, Japan	Singh, R (reprint author), Lyell McEwin Hosp, Haydown Rd, Elizabeth Vale, SA 5112, Australia.	rajvinder.singh@health.sa.gov.au					AIHW, 2005, HLTH SYST EXP CANC O; Gurudu SR, 2012, GASTROINTEST ENDOSC, V76, P603, DOI 10.1016/j.gie.2012.04.456; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; van den Broek FJC, 2009, GASTROINTEST ENDOSC, V69, P124, DOI 10.1016/j.gie.2008.09.040; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Kaltenbach T, 2008, GASTROENTEROLOGY, V134, P327, DOI 10.1053/j.gastro.2007.10.062; Chiu HM, 2011, DIS COLON RECTUM, V54, P1570, DOI 10.1097/DCR.0b013e318231d667; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Australian Government Department of Health and Ageing, 2005, AUSTR GOV DEP HLTH A; Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, 2012, AUSTR I HLTH WELF CA, V74; Australian Institute of Health and Welfare & Australian Government Department of Health and Ageing, 2008, AUSTR I HLTH WELF CA; Australian Institute of Health and Welfare, 2014, AUSTR I HLTH WELF CA, V84; Australian Institute of Health and Welfare, 2012, AUSTR I HLTH WELF CA, V66; Australian Institute of Health and Welfare, 2012, AUSTR I HLTH WELF CA, V65; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Australian Institute of Health and Welfare, 2012, AUSTR I HLTH WELF CA, V65, P14; Brooker JC, 2002, GASTROINTEST ENDOSC, V56, P333, DOI 10.1067/mge.2002.126908; Commonwealth Department of Health and Family Services Australian Health Technology Advisory Committee, 1997, COL CANC SCREEN AUST; Gralnek IM, 2015, DIGEST ENDOSC, V27, P223, DOI 10.1111/den.12382; Sabbagh LC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-100; Salkeld G, 1996, AUST NZ J PUBL HEAL, V20, P138, DOI 10.1111/j.1753-6405.1996.tb01807.x; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2002, CANC INC 5 CONT WHO; Yang DX, 2014, CANCER-AM CANCER SOC, V120, P2893, DOI 10.1002/cncr.28794; Young GP, 2014, DIG DIS WEEK MAY	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		30	34		10.1111/den.12419		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000008		
J	Oka, S; Tamai, N; Ikematsu, H; Kawamura, T; Sawaya, M; Takeuchi, Y; Uraoka, T; Moriyama, T; Kawano, H; Matsuda, T				Oka, Shiro; Tamai, Naoto; Ikematsu, Hiroaki; Kawamura, Takuji; Sawaya, Manabu; Takeuchi, Yoji; Uraoka, Toshio; Moriyama, Tomohiko; Kawano, Hiroshi; Matsuda, Takahisa			Improved visibility of colorectal flat tumors using image-enhanced endoscopy	DIGESTIVE ENDOSCOPY			English	Article						autofluorescence imaging; chromoendoscopy; colorectal flat tumor; image-enhanced endoscopy; narrow-band imaging	RANDOMIZED CONTROLLED-TRIAL; COLONOSCOPIC POLYPECTOMY; MISS RATE; LESIONS; ADENOMAS; SYSTEM; ACCURACY; CANCER; METAANALYSIS; PREVENTION	Colonoscopy is considered the gold standard for detecting colorectal tumors; however, conventional colonoscopy can miss flat tumors. We aimed to determine whether visualization of colorectal flat lesions was improved by autofluorescence imaging and narrow-band imaging image analysis in conjunction with a new endoscopy system. Eight physicians compared autofluorescent, narrow-band, and chromoendoscopy images to 30 corresponding white-light images of flat tumors. Physicians rated tumor visibility from each image set as follows: +2 (improved), +1 (somewhat improved), 0 (equivalent to white light), -1 (somewhat decreased), and -2 (decreased). The eight scores for each image were totalled and evaluated. Interobserver agreement was also examined. Autofluorescent, narrow-band, and chromoendoscopy images showed improvements of 63.3% (19/30), 6.7% (2/30), and 73.3% (22/30), respectively, with no instances of decreased visibility. Autofluorescence scores were generally greater than narrow-band scores. Interobserver agreement was 0.65 for autofluorescence, 0.80 for narrow-band imaging, and 0.70 for chromoendoscopy. In conclusion, using a new endoscopy system in conjunction with autofluorescent imaging improved visibility of colorectal flat tumors, equivalent to the visibility achieved using chromoendoscopy.	[Oka, Shiro] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima 7348551, Japan; [Tamai, Naoto] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Uraoka, Toshio] Natl Hosp Org Tokyo Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Ikematsu, Hiroaki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Kawamura, Takuji] Kyoto Second Red Cross Hosp, Dept Gastroenterol, Kyoto, Japan; [Sawaya, Manabu] Hirosaki Univ, Dept Gastroenterol & Hematol, Grad Sch Med, Hirosaki, Aomori, Japan; [Takeuchi, Yoji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Moriyama, Tomohiko] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Kawano, Hiroshi] St Marys Hosp, Dept Gastrointestinal Med, Kurume, Fukuoka, Japan	Oka, S (reprint author), Hiroshima Univ Hosp, Dept Endoscopy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	oka4683@hiroshima-u.ac.jp					Reinhart K, 2013, ENDOSCOPY, V45, P350, DOI 10.1055/s-0032-1326348; Inomata H, 2013, WORLD J GASTROENTERO, V19, P7146, DOI 10.3748/wjg.v19.i41.7146; Matsuda T, 2008, AM J GASTROENTEROL, V103, P1926, DOI 10.1111/j.1572-0241.2008.01931.x; Sato R, 2011, ENDOSCOPY, V43, P862, DOI 10.1055/s-0030-1256510; Imagawa H, 2011, GASTROINTEST ENDOSC, V73, P299, DOI 10.1016/j.gie.2010.10.016; Takeuchi Y, 2010, GASTROINTEST ENDOSC, V72, P1006, DOI 10.1016/j.gie.2010.06.055; Bensen S, 1999, AM J GASTROENTEROL, V94, P194; Kudo S, 2000, WORLD J SURG, V24, P1081; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Pasha SF, 2012, AM J GASTROENTEROL, V107, P363, DOI 10.1038/ajg.2011.436; Ikematsu H, 2012, J GASTROENTEROL, V47, P1099, DOI 10.1007/s00535-012-0575-2; Brooker JC, 2002, GASTROINTEST ENDOSC, V56, P333, DOI 10.1067/mge.2002.126908; dos Santos CEO, 2014, DIGEST ENDOSC, DOI [10.1111/den.12346, DOI 10.1111/DEN.12346]; Hurlstone DP, 2004, GUT, V53, P376, DOI 10.1136/gut.2003.029868; Jin XF, 2012, J GASTROEN HEPATOL, V27, P882, DOI 10.1111/j.1440-1746.2011.06987.x; Kaku E, 2011, CLIN GASTROENTEROL H, V9, P503, DOI 10.1016/j.cgh.2011.03.018; Kuiper T, 2011, GASTROENTEROLOGY, V140, P1887, DOI 10.1053/j.gastro.2011.03.008; Moriichi K, 2012, BMC GASTROENTEROL, V12, P12; Nakaniwa N, 2005, DIGEST ENDOSC, V17, P235, DOI 10.1111/j.1443-1661.2005.00506.x; Odagaki T, 2013, DIGEST ENDOSC, V25, P428, DOI 10.1111/j.1443-1661.2012.01400.x; Suzuki H, 2011, DIAGN THER ENDOSC, V2011; Tamai N, 2014, DIGEST ENDOSC, V26, P68, DOI 10.1111/den.12246; Tamai N, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/638391; Uedo N, 2007, DIGEST ENDOSC, V19, pS134, DOI 10.1111/j.1443-1661.2007.00736.x	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		35	39		10.1111/den.12445		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000009		
J	Moriyama, T; Uraoka, T; Esaki, M; Matsumoto, T				Moriyama, Tomohiko; Uraoka, Toshio; Esaki, Motohiro; Matsumoto, Takayuki			Advanced technology for the improvement of adenoma and polyp detection during colonoscopy	DIGESTIVE ENDOSCOPY			English	Article						colon capsule endoscopy; extra-wide-angle-view colonoscopy; full-spectrum endoscopy (R); high-definition colonoscopy; Third Eye((R)) retroscope((R))	RANDOMIZED CONTROLLED-TRIAL; CAP-ASSISTED COLONOSCOPY; WIDE-ANGLE; TRANSPARENT HOOD; WITHDRAWAL TIMES; DETECTION RATES; MISS RATES; MULTICENTER; ENDOSCOPY; IMPACT	Early detection and removal of adenomatous polyps reduces colorectal cancer death. However, many studies have reported that up to 20% of adenomas can be missed during colonoscopy. To improve visualization and reduce the blind spot of the colonic mucosa for an increase in the adenoma detection rate, many endoscopic techniques and technologies have been developed. The benefit of the high-definition endoscope for improving adenoma and polyp detection is marginal. Wide-angle colonoscope has failed to improve adenoma detection compared to standard colonoscopy. Although the cap-assisted colonoscope can reduce cecal intubation times, it does not seem to improve adenoma and polyp detection. The diagnostic accuracy of the colon capsule endoscope is low compared to the conventional colonoscope. Third Eye((R)) retroscope((R)), which provides additional retrograde viewing, has revealed significant improvement in adenoma and polyp detection compared to standard colonoscopy. However, this device increases procedural times. Recently developed full-spectrum endoscopy colonoscope and extra-wide-angle-view colonoscope have demonstrated a significantly lower miss rate of polyps. However, clinical trials are mandatory to determine the efficacy of these novel technologies for cancer screening. In addition, education and training for these novel techniques and technologies should seriously be considered to improve adenoma and polyp detection.	[Moriyama, Tomohiko; Esaki, Motohiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Uraoka, Toshio] Natl Hosp Org Tokyo Med Ctr, Dept Gastroenterol, Tokyo, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 020, Japan	Moriyama, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	morimori@intmed2.med.kyushu-u.ac.jp					Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Kondo S, 2007, AM J GASTROENTEROL, V102, P75, DOI 10.1111/j.1572-0241.2006.00897.x; Rastogi A, 2011, GASTROINTEST ENDOSC, V74, P593, DOI 10.1016/j.gie.2011.04.050; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Ng SC, 2012, AM J GASTROENTEROL, V107, P1165, DOI 10.1038/ajg.2012.135; Harrison M, 2004, AM J GASTROENTEROL, V99, P519, DOI 10.1111/j.1572-0241.2004.04070.x; Rastogi A, 2012, GUT, V61, P402, DOI 10.1136/gutjnl-2011-300187; Buchner AM, 2010, CLIN GASTROENTEROL H, V8, P364, DOI [10.1016/j.cgh.2009.11.009, 10.1016/j.cgh.2009.11009]; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Leufkens AM, 2011, GASTROINTEST ENDOSC, V73, P480, DOI 10.1016/j.gie.2010.09.004; DeMarco DC, 2010, GASTROINTEST ENDOSC, V71, P542, DOI 10.1016/j.gie.2009.12.021; East JE, 2007, AM J GASTROENTEROL, V102, P2529, DOI 10.1111/j.1572-0241.2007.01429.x; Subramanian V, 2011, ENDOSCOPY, V43, P499, DOI 10.1055/s-0030-1256207; Pohl J, 2011, GUT, V60, P485, DOI 10.1136/gut.2010.229534; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; Gralnek IM, 2014, LANCET ONCOL, V15, P353, DOI 10.1016/S1470-2045(14)70020-8; Deenadayalu VP, 2004, AM J GASTROENTEROL, V99, P2138, DOI 10.1111/j.1572-0241.2004.40430.x; desWijkerslooth TR, 2012, GUT, V61, P1426; Fatima H, 2008, CLIN GASTROENTEROL H, V6, P109, DOI 10.1016/j.cgh.2007.10.009; Gralnek IM, 2013, GASTROINTEST ENDOSC, V77, P472, DOI 10.1016/j.gie.2012.12.011; Harada Y, 2009, GASTROINTEST ENDOSC, V69, P637, DOI 10.1016/j.gie.2008.08.029; lesClercq CM, 2014, GUT, V63, P957; Leung FW, 2012, GASTROINTEST ENDOSC, V76, P657, DOI 10.1016/j.gie.2012.04.467; Longcroft-Wheaton G, 2012, ENDOSCOPY, V44, P905, DOI 10.1055/s-0032-1310004; Saito H, 2000, DIS COLON RECTUM, V43, pS78, DOI 10.1007/BF02237230; Uraoka T, 2013, GASTROINTEST ENDOSC, V77, P480, DOI 10.1016/j.gie.2012.08.037; vansRijn JC, 2006, AM J GASTROENTEROL, V101, P343	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		40	44		10.1111/den.12428		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000010		
J	Kawamura, T; Ikematsu, H; Matsuda, T				Kawamura, Takuji; Ikematsu, Hiroaki; Matsuda, Takahisa			New-generation narrow band imaging system for detection of a laterally spreading tumor in the colon	DIGESTIVE ENDOSCOPY			English	Letter									[Kawamura, Takuji] Kyoto Second Red Cross Hosp, Dept Gastroenterol, Kyoto, Japan; [Ikematsu, Hiroaki] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol & Endoscopy, Kashiwa, Chiba, Japan; [Matsuda, Takahisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan	Kawamura, T (reprint author), Kyoto Second Red Cross Hosp, Dept Gastroenterol, Kyoto, Japan.						Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Dinesen L, 2012, GASTROINTEST ENDOSC, V75, P604, DOI 10.1016/j.gie.2011.10.017; Kaku E, 2011, CLIN GASTROENTEROL H, V9, P503, DOI 10.1016/j.cgh.2011.03.018; Leung WK, 2014, DIGEST ENDOSC, V109, P855; vansRijn JC, 2006, AM J GASTROENTEROL, V101, P343	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		45	45		10.1111/den.12416		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000011		
J	Tamai, N; Takeuchi, Y; Tajiri, H				Tamai, Naoto; Takeuchi, Yoji; Tajiri, Hisao			Second-generation autofluorescence imaging for colorectal neoplasia	DIGESTIVE ENDOSCOPY			English	Letter							SYSTEM		[Tamai, Naoto; Tajiri, Hisao] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Tajiri, Hisao] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Takeuchi, Yoji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan	Tamai, N (reprint author), Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan.						Matsuda T, 2008, AM J GASTROENTEROL, V103, P1926, DOI 10.1111/j.1572-0241.2008.01931.x; Takeuchi Y, 2010, GASTROINTEST ENDOSC, V72, P1006, DOI 10.1016/j.gie.2010.06.055; Ide D, 2013, SCAND J GASTROENTERO, V48, P1302, DOI 10.3109/00365521.2013.834073; Odagaki T, 2013, DIGEST ENDOSC, V25, P428, DOI 10.1111/j.1443-1661.2012.01400.x; Tamai N, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/638391	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		46	46		10.1111/den.12417		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000012		
J	Katanuma, A; Isayama, H; Bapaye, A				Katanuma, Akio; Isayama, Hiroyuki; Bapaye, Amol			Endoscopic ultrasonography using new functions for pancreatobiliary diseases: Current status and future perspectives	DIGESTIVE ENDOSCOPY			English	Article						contrast harmonic endoscopic ultrasonography; elastography; endoscopic ultrasonography; pancreatic cystic lesion; tissue harmonic echo	EUS-GUIDED FNA; ULTRASOUND ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; CANCER; MULTICENTER; PANCREAS; ACCESS; TUMOR; ERCP; ASIA	A new endoscopic ultrasound processor (EU-ME2 Premier Plus) has recently been developed. It improves fundamental imaging and enables three new functions; namely, tissue harmonic echo (THE), elastography, and contrast harmonic endoscopic ultrasonography (CH-EUS). However, many aspects regarding the usefulness of these three functions in the diagnosis of pancreatobiliary diseases remain unknown. In connection with and prior to the convening of Endoscopy Forum Japan 2014, endoscopic ultrasonography using EU-ME2 Premier Plus was carried out for pancreatic, bile duct, and gallbladder cases at 12 participating institutions (Japan [n=10]; other Asian countries [n=2]). A questionnaire survey was conducted regarding the usefulness of EU-ME2 Premier Plus for each EUS case. In addition, participants' views were surveyed by asking them to vote as to whether or not the three functions of EU-ME2 Premier Plus were useful for several items under pancreatic, bile duct, and gallbladder indications. According to the participants' views, THE (particularly THE-P mode) is essential for the diagnosis of cystic lesions. Many participants viewed elastography as useful in only extremely limited cases. Although CH-EUS was not considered useful for all cases, its indications covered a broad range. Additional studies are warranted to clarify the functions of EU-ME2 Premier Plus in more detail.	[Katanuma, Akio] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido 0068555, Japan; [Isayama, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Bapaye, Amol] Deenanath Mangeshkar Hosp & Res Ctr, Dept Digest Dis & Endoscopy, Pune, Maharashtra, India	Katanuma, A (reprint author), Teine Keijinkai Hosp, Ctr Gastroenterol, 1-40-1-12 Maeda, Sapporo, Hokkaido 0068555, Japan.	akatanuma@gmail.com					Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158; Puri R, 2012, GASTROINTEST ENDOSC, V75, P900, DOI 10.1016/j.gie.2011.12.026; Napoleon B, 2010, ENDOSCOPY, V42, P564, DOI 10.1055/s-0030-1255537; Kitano M, 2012, AM J GASTROENTEROL, V107, P303, DOI 10.1038/ajg.2011.354; Dhir V, 2012, GASTROINTEST ENDOSC, V75, P354, DOI 10.1016/j.gie.2011.07.075; Saftoiu A, 2011, ENDOSCOPY, V43, P596, DOI 10.1055/s-0030-1256314; Itokawa F, 2011, J GASTROENTEROL, V46, P843, DOI 10.1007/s00535-011-0399-5; Hocke M, 2006, WORLD J GASTROENTERO, V12, P246; Gress FG, 1999, GASTROINTEST ENDOSC, V50, P786, DOI 10.1016/S0016-5107(99)70159-8; Soriano A, 2004, AM J GASTROENTEROL, V99, P492, DOI 10.1111/j.1572-0241.2004.04087.x; Dhir V, 2014, DIGEST ENDOSC, V26, P430, DOI 10.1111/den.12153; KAUFMAN AR, 1989, GASTROINTEST ENDOSC, V35, P214, DOI 10.1016/S0016-5107(89)72761-9; Aslanian H, 2005, AM J GASTROENTEROL, V100, P1381, DOI 10.1111/j.1572-0241.2005.41675.x; Bapaye A, 2013, UNITED EUR GASTROENT, V1, P285, DOI 10.1177/2050640613490928; Bapaye A, 2012, Endoscopy, V44 Suppl 2 UCTN, pE435, DOI 10.1055/s-0032-1325894; Dhir V, 2011, J GASTROEN HEPATOL, V26, P70; Dhir V, 2013, ENDOSCOPY, V45, pE5, DOI 10.1055/s-0032-1326121; Dhir V, 2011, J INTERV GASTROENTER, V1, P153, DOI DOI 10.4161/JIG.1.4.19967; Dhir V, 2013, GASTROINTEST ENDOSC, V1, P103, DOI [10.1177/ 2050640613480145, DOI 10.1177/2050640613480145]; Ishikawa H, 2003, GASTROINTEST ENDOSC, V57, P931, DOI 10.1067/mge.2003.271; Kongkam P, 2013, J GASTROEN HEPATOL, V28, P924, DOI 10.1111/jgh.12198; Lim LG, 2011, J GASTROEN HEPATOL, V26, P1702, DOI 10.1111/j.1440-1746.2011.06884.x; Matsumoto Kazuyuki, 2014, JOP, V15, P274, DOI 10.6092/1590-8577/2385	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		47	54		10.1111/den.12443		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000013		
J	Kitano, M; Kamata, K; Imai, H; Miyata, T; Yasukawa, S; Yanagisawa, A; Kudo, M				Kitano, Masayuki; Kamata, Ken; Imai, Hajime; Miyata, Takeshi; Yasukawa, Satoru; Yanagisawa, Akio; Kudo, Masatoshi			Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases	DIGESTIVE ENDOSCOPY			English	Article						contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS); endoscopic ultrasonography (EUS); pancreatic carcinoma; pancreatobiliary disease	DIFFERENTIAL-DIAGNOSIS; EUS; ULTRASOUND; PANCREAS; TUMORS; ACCURACY; LESIONS; POLYPS; MASSES	The combination of second-generation ultrasound contrast agents and an endoscopic ultrasonography (EUS) system with a broad-band transducer has allowed contrast-enhanced harmonic imaging in the field of EUS. In contrast-enhanced harmonic EUS (CH-EUS), diffuse homogeneous enhancement is obtained in normal parenchyma of the pancreas. The bile duct and pancreatic duct are depicted as non-enhanced ductal structures with strong contrast in comparison to the surrounding parenchyma. CH-EUS identifies pancreatic adenocarcinomas as solid lesions exhibiting hypo-enhancement with a sensitivity and specificity of 88-96% and 88-94%, respectively. In particular, 80-100% of false-negative cases in endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) are correctly classified by CH-EUS, suggesting CH-EUS complements EUS-FNA. Moreover, CH-EUS improves depiction of some subtle lesions in conventional EUS, thus facilitating EUS-FNA. For quantitative perfusion analysis, a time-intensity curve (TIC) for the region of interest can be generated during CH-EUS. The maximum intensity gain and the echo intensity reduction rate from the peak at 1min obtained by TIC can be used for differentiation of pancreatic adenocarcinoma from other tumors. CH-EUS is also useful for differentiation of invasive intraductal papillary mucinous neoplasms (IPMN) from non-invasive IPMN, identification of malignant lesions in the gallbladder, and T- and N-staging of pancreatobiliary tumors.	[Kitano, Masayuki; Kamata, Ken; Imai, Hajime; Miyata, Takeshi; Kudo, Masatoshi] Kinki Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka 5898511, Japan; [Yasukawa, Satoru; Yanagisawa, Akio] Kyoto Prefectural Univ Med, Dept Surg Pathol, Kyoto, Japan	Kitano, M (reprint author), Kinki Univ, Dept Gastroenterol & Hepatol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	m-kitano@med.kindai.ac.jp					Seicean A, 2010, ULTRASCHALL MED, V31, P571, DOI 10.1055/s-0029-1245833; Kitano M, 2004, GUT, V53, P854, DOI 10.1136/gut.2003.029934; Kitano M, 2008, GASTROINTEST ENDOSC, V67, P141, DOI 10.1016/j.gie.2007.07.045; Imazu H, 2012, SCAND J GASTROENTERO, V47, P853, DOI 10.3109/00365521.2012.679686; Gincul R, 2014, ENDOSCOPY, V46, P373, DOI 10.1055/s-0034-1364969; Napoleon B, 2010, ENDOSCOPY, V42, P564, DOI 10.1055/s-0030-1255537; Kitano M, 2012, AM J GASTROENTEROL, V107, P303, DOI 10.1038/ajg.2011.354; Ohno E, 2009, ANN SURG, V249, P628, DOI 10.1097/SLA.0b013e3181a189a8; Gong TT, 2012, GASTROINTEST ENDOSC, V76, P301, DOI 10.1016/j.gie.2012.02.051; Matsubara H, 2011, PANCREAS, V40, P1073, DOI 10.1097/MPA.0b013e31821f57b7; Kanamori A, 2006, AM J GASTROENTEROL, V101, P45, DOI 10.1111/j.1572-0241.2006.00394.x; Park CH, 2013, SURG ENDOSC, V27, P1414, DOI 10.1007/s00464-012-2620-x; Imazu H, 2014, DIGEST DIS SCI, V59, P1909, DOI 10.1007/s10620-014-3115-5; Kitano M, 2008, J MED ULTRASON, V35, P11, DOI 10.1007/s10396-007-0167-6; Imazu H, 2010, SCAND J GASTROENTERO, V45, P732, DOI 10.3109/00365521003690269; Fusaroli P, 2010, CLIN GASTROENTEROL H, V8, P629, DOI 10.1016/j.cgh.2010.04.012; Choi JH, 2013, GASTROINTEST ENDOSC, V78, P484, DOI 10.1016/j.gie.2013.03.1328; Fusaroli P, 2012, J GASTROEN HEPATOL, V27, P1063, DOI 10.1111/j.1440-1746.2012.07115.x; Gheonea DI, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-2; Kitano M, 2009, GASTROINTEST ENDOSC, V69, pAB328; Kitano M, 2011, PANCREATOLOGY, V11, P28, DOI 10.1159/000323493; Kudo M., 2003, CONTRAST HARMONIC IM, P22; Quaia E, 2005, CONTRAST MEDIA ULTRA, P1; Romagnuolo J, 2011, GASTROINTEST ENDOSC, V73, P52, DOI 10.1016/j.gie.2010.09.014; Xia Y, 2010, GASTROINTEST ENDOSC, V72, P637, DOI 10.1016/j.gie.2010.04.013	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		60	67		10.1111/den.12454		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000015		
J	Ohno, E; Kawashima, H; Hashimoto, S; Goto, H; Hirooka, Y				Ohno, Eizaburo; Kawashima, Hiroki; Hashimoto, Senju; Goto, Hidemi; Hirooka, Yoshiki			Current status of tissue harmonic imaging in endoscopic ultrasonography (EUS) and EUS-elastography in pancreatobiliary diseases	DIGESTIVE ENDOSCOPY			English	Article						elasticity imaging; endoscopic ultrasonography (EUS); strain histogram; strain ratio; tissue harmonic imaging (THI)	RADIAL SCANNING ECHOENDOSCOPE; ULTRASOUND ELASTOGRAPHY; CHRONIC-PANCREATITIS; CLINICAL UTILITY; US ELASTOGRAPHY; MASS LESIONS; DIAGNOSIS; DIFFERENTIATION; METAANALYSIS; ELASTICITY	Endoscopic ultrasonography (EUS) has high spatial and contrast resolution, and is thought to be one of the most reliable and efficient diagnostic modalities for pancreatobiliary diseases. Recent progress in EUS, especially in the development of the electronic scanning method, has enabled the application of several utilities and software of a high-end transabdominal ultrasound apparatus as an image-enhanced EUS. Tissue harmonic imaging (THI) is a novel US acquisition method that provides better US images by using second harmonic signals. The potential advantages of THI are improved lateral resolution, reduced side lobe artifact and an increased signal-to-noise ratio. EUS-elastography is another novel technique that provides information about the distributed pattern of tissue hardness. Clinical benefits of EUS-elastography for the differential diagnosis of pancreatic tumors and the evaluation of pancreatic fibrosis have been reported. It is necessary to develop a unified and objective method of imaging and analysis to increase the use of EUS-elastography in the future.	[Ohno, Eizaburo; Kawashima, Hiroki; Goto, Hidemi] Nagoya Univ, Sch Med, Dept Gastroenterol, Nagoya, Aichi 466, Japan; [Goto, Hidemi; Hirooka, Yoshiki] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi 4668550, Japan; [Hashimoto, Senju] Fujita Hlth Univ, Dept Liver Biliary Tract & Pancreas, Toyoake, Aichi, Japan	Hirooka, Y (reprint author), Nagoya Univ Hosp, Dept Endoscopy, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	hirooka@med.nagoya-u.ac.jp	KAWASHIMA, Hiroki/I-7285-2014				Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Saftoiu A, 2008, GASTROINTEST ENDOSC, V68, P1086, DOI 10.1016/j.gie.2008.04.031; Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5; Tsutsumi M, 2007, INT J CLIN ONCOL, V12, P250, DOI 10.1007/s10147-007-0669-7; Janssen J, 2014, ULTRASCHALL MED, V35, P253, DOI 10.1055/s-0033-1355767; Ohno E, 2009, ANN SURG, V249, P628, DOI 10.1097/SLA.0b013e3181a189a8; Nakashima K, 2013, J MED ULTRASON, V40, P359, DOI 10.1007/s10396-013-0457-0; Mei M, 2013, GASTROINTEST ENDOSC, V77, P578, DOI 10.1016/j.gie.2012.09.035; Ortega D, 2001, AM J ROENTGENOL, V176, P653; Iglesias-Garcia J, 2013, ENDOSCOPY, V45, P781, DOI 10.1055/s-0033-1344614; Itoh Y, 2014, J GASTROENTEROL, V49, P1183, DOI 10.1007/s00535-013-0880-4; Itokawa F, 2011, J GASTROENTEROL, V46, P843, DOI 10.1007/s00535-011-0399-5; Shapiro RS, 1998, AM J ROENTGENOL, V171, P1203; Shiina T, 2013, J MED ULTRASON, V40, P309, DOI 10.1007/s10396-013-0490-z; Hirooka Y, 2009, CLIN GASTROENTEROL H, V7, pS63, DOI 10.1016/j.cgh.2009.08.025; Iglesias-Garcia J, 2010, GASTROENTEROLOGY, V139, P1172, DOI 10.1053/j.gastro.2010.06.059; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Flunker S, 2001, GASTROEN CLIN BIOL, V25, P589; Hirooka Y, 2001, DIGEST ENDOSC, V13, pS49, DOI 10.1046/j.1443-1661.2001.0130s1S49.x; Hirooka Y, 2005, GASTROINTEST ENDOSC, V61, pAB282, DOI 10.1016/S0016-5107(05)01447-1; Hirooka Y, 2015, J MED ULTRASON, V42, P151, DOI 10.1007/s10396-014-0571-7; Hirooka Y, 2012, J GASTROENTEROL, V47, P1063, DOI 10.1007/s00535-012-0662-4; Hohl C, 2004, EUR RADIOL, V14, P1109, DOI 10.1007/s00330-003-2191-2; Inui K, 2004, DIGEST ENDOSC, V16, pS240, DOI 10.1111/j.1443-1661.2004.00426.x; Ishikawa H, 2003, GASTROINTEST ENDOSC, V57, P931, DOI 10.1067/mge.2003.271; Itoi T, 2011, DIGEST ENDOSC, V23, P17, DOI 10.1111/j.1443-1661.2011.01132.x; Kawashima H, 2006, J HEPATO-BILIARY-PAN, V13, P69, DOI 10.1007/s00534-005-1060-6; Matsumoto Kazuyuki, 2014, JOP, V15, P274, DOI 10.6092/1590-8577/2385; Mayerle J, 2010, PANCREAS, V39, P1334; Niwa K, 2004, J GASTROEN HEPATOL, V19, P454, DOI 10.1111/j.1440-1746.2003.03317.x; Niwa K, 2003, J GASTROEN HEPATOL, V18, P828, DOI 10.1046/j.1440-1746.2003.03045.x; Pei QS, 2012, PANCREATOLOGY, V12, P402, DOI 10.1016/j.pan.2012.07.013; ROSCH T, 1992, NEW ENGL J MED, V326, P1721, DOI 10.1056/NEJM199206253262601; Rosenthal SJ, 2001, AM J ROENTGENOL, V176, P1393; Uchida H, 2009, PANCREAS, V38, P17, DOI 10.1097/MPA.0b013e318184db78; Uchida H, 2005, GASTROENTEROLOGY, V128, pA536; Ying L, 2013, J GASTROEN HEPATOL, V28, P1434, DOI 10.1111/jgh.12292	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		68	73		10.1111/den.12433		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000016		
J	Kato, H; Yamamoto, N; Yamamoto, K				Kato, Hironari; Yamamoto, Naoki; Yamamoto, Kazuhide			Effectiveness of tissue harmonic echo imaging and contrast-enhanced endoscopic ultrasound for diagnosing mural nodules of intraductal papillary mucinous neoplasms	DIGESTIVE ENDOSCOPY			English	Letter									[Kato, Hironari; Yamamoto, Naoki; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Kato, H (reprint author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.						Kitano M, 2014, DIGEST ENDOSC, V26, P79, DOI 10.1111/den.12179; Kitano M, 2011, DIGEST ENDOSC, V23, P46, DOI 10.1111/j.1443-1661.2011.01146.x; Matsumoto Kazuyuki, 2014, JOP, V15, P274, DOI 10.6092/1590-8577/2385; Spârchez Zeno, 2003, Rom J Gastroenterol, V12, P239	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		74	74		10.1111/den.12438		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000017		
J	Shibukawa, G; Irisawa, A				Shibukawa, Goro; Irisawa, Atsushi			Diagnostic efficacy of a brand-new endoscopic ultrasound processor for early-stage chronic pancreatitis	DIGESTIVE ENDOSCOPY			English	Letter									[Shibukawa, Goro; Irisawa, Atsushi] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan	Shibukawa, G (reprint author), Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan.						Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Itoh Y, 2014, J GASTROENTEROL, V49, P1183, DOI 10.1007/s00535-013-0880-4; Irisawa A, 2007, J GASTROENTEROL, V42, P90, DOI 10.1007/s00535-006-1916-9	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0915-5635	1443-1661		DIGEST ENDOSC	Dig. Endosc.	APR	2015	27			1	SI		75	75		10.1111/den.12430		1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CF5DO	WOS:000352576000018		
J	Bultmann-Mellin, I; Conradi, A; Maul, AC; Dinger, K; Wempe, F; Wohl, AP; Imhof, T; Wunderlich, FT; Bunck, AC; Nakamura, T; Koli, K; Bloch, W; Ghanem, A; Heinz, A; Von Melchner, H; Sengle, G; Sterner-Kock, A				Bultmann-Mellin, Insa; Conradi, Anne; Maul, Alexandra C.; Dinger, Katharina; Wempe, Frank; Wohl, Alexander P.; Imhof, Thomas; Wunderlich, F. Thomas; Bunck, Alexander C.; Nakamura, Tomoyuki; Koli, Katri; Bloch, Wilhelm; Ghanem, Alexander; Heinz, Andrea; Von Melchner, Harald; Sengle, Gerhard; Sterner-Kock, Anja			Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms	DISEASE MODELS & MECHANISMS			English	Article						Latent transforming growth factor beta-binding protein 4; Ltbp-4; Ltbp-4L; Ltbp-4S; Autosomal recessive cutis laxa type 1C; ARCL1C; Elastogenesis; Extracellular matrix; ECM; Fibulin-4; Fibulin-5	BETA-BINDING-PROTEIN; LUNG DEVELOPMENT; LYSYL OXIDASE; IN-VIVO; GROWTH; ELASTOGENESIS; FIBULIN-4; ELASTIN; FIBRILLIN; MATRIX	Recent studies have revealed an important role for LTBP-4 in elastogenesis. Its mutational inactivation in humans causes autosomal recessive cutis laxa type 1C (ARCL1C), which is a severe disorder caused by defects of the elastic fiber network. Although the human gene involved in ARCL1C has been discovered based on similar elastic fiber abnormalities exhibited by mice lacking the short Ltbp-4 isoform (Ltbp4S(-/-)), the murine phenotype does not replicate ARCL1C. We therefore inactivated both Ltbp-4 isoforms in the mouse germline to model ARCL1C. Comparative analysis of Ltbp4S(-/-) and Ltbp4-null (Ltbp4(-/-)) mice identified Ltbp-4L as an important factor for elastogenesis and postnatal survival, and showed that it has distinct tissue expression patterns and specific molecular functions. We identified fibulin-4 as a previously unknown interaction partner of both Ltbp-4 isoforms and demonstrated that at least Ltbp-4L expression is essential for incorporation of fibulin-4 into the extracellular matrix (ECM). Overall, our results contribute to the current understanding of elastogenesis and provide an animal model of ARCL1C.	[Bultmann-Mellin, Insa; Conradi, Anne; Maul, Alexandra C.; Dinger, Katharina; Sterner-Kock, Anja] Univ Cologne, Fac Med, Ctr Expt Med, D-50931 Cologne, Germany; [Dinger, Katharina] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, D-50937 Cologne, Germany; [Wempe, Frank; Von Melchner, Harald] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Wohl, Alexander P.; Imhof, Thomas; Sengle, Gerhard] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Wunderlich, F. Thomas; Sengle, Gerhard] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Imhof, Thomas] Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany; [Wunderlich, F. Thomas] Max Planck Inst Metab Res, D-50931 Cologne, Germany; [Wunderlich, F. Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bunck, Alexander C.] Univ Cologne, Fac Med, Dept Radiol, D-50937 Cologne, Germany; [Nakamura, Tomoyuki] Kansai Med Univ, Dept Pharmacol, Osaka 5708506, Japan; [Koli, Katri] Univ Helsinki, Haartman Inst, Res Programs Unit, Helsinki 00014, Finland; [Koli, Katri] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki 00014, Finland; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiol & Sports Med, D-50933 Cologne, Germany; [Ghanem, Alexander] Univ Bonn, Dept Med Cardiol, D-53127 Bonn, Germany; [Heinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany	Sterner-Kock, A (reprint author), Univ Cologne, Fac Med, Ctr Expt Med, D-50931 Cologne, Germany.	anja.sterner-kock@uk-koeln.de	Bunck, Alexander/M-6389-2014		German Academic Exchange Service DAAD; Deutsche Forschungsgemeinschaft [HE 6190/1-2, SFB 815, SFB829, B12]; Bundesministerium fur Bildung und Forschung [NGFN-plus 01G50858]; UNDP [EU3631500121]; Hochhaus-Stiftung; Maria Pesch-Stiftung; Imhoff-Stiftung	I.B.M. was supported by the German Academic Exchange Service DAAD. A.H. was supported by the Deutsche Forschungsgemeinschaft (grant number HE 6190/1-2). H.v.M. was supported by the Deutsche Forschungsgemeinschaft [grant number SFB 815] and the Bundesministerium fur Bildung und Forschung [grant number NGFN-plus 01G50858]. G.S. was supported by the Deutsche Forschungsgemeinschaft [grant number SFB829/ project B12]. A.S.K. was supported by Hochhaus-, Maria Pesch and Imhoff-Stiftung and by UNDP [grant number EU3631500121]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Annes J, 2004, ANAL BIOCHEM, V327, P45, DOI 10.1016/j.ab.2003.11.029; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; Bunck AC, 2009, INVEST RADIOL, V44, P749, DOI 10.1097/RLI.0b013e3181b2c135; Dabovic B, 2009, J CELL PHYSIOL, V219, P14, DOI 10.1002/jcp.21643; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Kielty CM, 2002, J CELL SCI, V115, P2817; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Hanada K, 2007, CIRC RES, V100, P738, DOI 10.1161/01.RES.0000260181.19449.95; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Ricke-Hoch M, 2014, CARDIOVASC RES, V101, P587, DOI 10.1093/cvr/cvu010; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Torreno-Pina JA, 2014, P NATL ACAD SCI USA, V111, P11037, DOI 10.1073/pnas.1402041111; Sideek MA, 2014, MATRIX BIOL, V34, P114, DOI 10.1016/j.matbio.2013.10.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yamauchi Y, 2010, ACTA HISTOCHEM CYTOC, V43, P131, DOI 10.1267/ahc.10026; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Ghanem A, 2006, ECHOCARDIOGR-J CARD, V23, P900, DOI 10.1111/j.1540-8175.2006.00323.x; Kantola AK, 2010, J CELL PHYSIOL, V223, P727, DOI 10.1002/jcp.22082; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Bleeker GB, 2006, HEART, V92, pI14, DOI 10.1136/hrt.2005.081547; Bultmann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065614; Callewaert B, 2013, HUM MUTAT, V34, P111, DOI 10.1002/humu.22165; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Dabovic B, 2015, J CELL PHYSIOL, V230, P226, DOI 10.1002/jcp.24704; Lowery JW, 2014, CELL MOL LIFE SCI, V71, P3165, DOI 10.1007/s00018-013-1541-8; MIYAZONO K, 1991, CIBA F SYMP, V157, P81; Miyazono K., 1991, CIBA F SYMP, V157, P89; Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004; Schmelzer CEH, 2012, FEBS J, V279, P4191, DOI 10.1111/febs.12012; Schneider JE, 2006, J CARDIOV MAGN RESON, V8, P693, DOI 10.1080/10976640600723664; Seluanov A., 2010, JOVE-J VIS EXP, P2033; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Zheng-Fischhofer Q, 2006, J CELL SCI, V119, P693, DOI 10.1242/jcs.02800	50	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	APR	2015	8	4					403	415		10.1242/dmm.018960		13	Cell Biology; Pathology	Cell Biology; Pathology	CE9KJ	WOS:000352162500008		
J	Watanabe, T; Miyake, M; Shimizu, T; Kamezawa, M; Masutomi, N; Shimura, T; Ohashi, R				Watanabe, Tomoko; Miyake, Manami; Shimizu, Toshinobu; Kamezawa, Miho; Masutomi, Naoya; Shimura, Takesada; Ohashi, Rikiya			Utility of Bilirubins and Bile Acids as Endogenous Biomarkers for the Inhibition of Hepatic Transporters	DRUG METABOLISM AND DISPOSITION			English	Article							DRUG-DRUG INTERACTIONS; SALT EXPORT PUMP; FAMILIAL INTRAHEPATIC CHOLESTASIS; ORGANIC ANION TRANSPORTER; IN-VITRO INHIBITION; INDUCED HYPERBILIRUBINEMIA; HEPATOBILIARY TRANSPORT; HUMAN LIVER; MULTIPLE TRANSPORTERS; BILIARY-EXCRETION	It is useful to identify endogenous substrates for the evaluation of drug-drug interactions via transporters. In this study, we investigated the utility of bilirubins, substrates of OATPs and MRP2, and bile acids and substrates of NTCP and BSEP, as biomarkers for the inhibition of transporters. In rats administered 20 and 80 mg/kg rifampicin, the plasma levels of bilirubin glucuronides were elevated, gradually decreased, and almost returned to the baseline level at 24 hours after administration without an elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). This result indicates the transient inhibition of rOatps and/or rMrp2. Although the correlation between free plasma concentrations and IC50 values of rOatps depended on the substrates used in the in vitro studies, the inhibition of rOatps by rifampicin was confirmed in the in vivo study using valsartan as a substrate of rOatps. In rats administered 10 and 30 mg/kg cyclosporin A, the plasma levels of bile acids were elevated and persisted for up to 24 hours after administration without an elevation of ALT and AST. This result indicates the continuous inhibition of rNtcp and/or rBsep, although there were differences between the free plasma or liver concentrations and IC50 values of rNtcp or rBsep, respectively. This study suggests that the monitoring of bilirubins and bile acids in plasma is useful in evaluating the inhibitory potential of their corresponding transporters.	[Watanabe, Tomoko; Kamezawa, Miho; Shimura, Takesada; Ohashi, Rikiya] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Div Res, Saitama, Japan; [Miyake, Manami; Shimizu, Toshinobu; Masutomi, Naoya] Mitsubishi Tanabe Pharma Corp, Div Res, Safety Res Lab, Chiba, Japan	Watanabe, T (reprint author), Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Div Res, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.	Watanabe.Tomoko@mc.mt-pharma.co.jp					Imamura Y, 2014, DRUG METAB DISPOS, V42, P685, DOI 10.1124/dmd.113.055475; Ito S, 2012, CLIN PHARMACOL THER, V92, P635, DOI 10.1038/clpt.2012.138; Link E, 2008, NEW ENGL J MED, V359, P789; BARRE J, 1985, CLIN CHEM, V31, P60; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; ACOCELLA G, 1965, GASTROENTEROLOGY, V49, P521; Zucker SD, 2001, P NATL ACAD SCI USA, V98, P12671, DOI 10.1073/pnas.231140698; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Hata S, 2003, AM J PHYSIOL-GASTR L, V285, pG829, DOI 10.1152/ajpgi.00352.2002; Chang JH, 2013, MOL PHARMACEUT, V10, P3067, DOI 10.1021/mp4001348; Imamura Y, 2011, CLIN PHARMACOL THER, V89, P81, DOI 10.1038/clpt.2010.232; Cattori V, 2001, PFLUG ARCH EUR J PHY, V443, P188, DOI 10.1007/s004240100697; Jansen PLM, 1999, GASTROENTEROLOGY, V117, P1370, DOI 10.1016/S0016-5085(99)70287-8; Yamashiro W, 2006, DRUG METAB DISPOS, V34, P1247, DOI 10.1124/dmd.105.008938; Maeda K, 2011, CLIN PHARMACOL THER, V90, P575, DOI 10.1038/clpt.2011.142; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Imaoka T, 2013, DRUG METAB DISPOS, V41, P1442, DOI 10.1124/dmd.113.051052; Yoshida K, 2012, CLIN PHARMACOL THER, V91, P1053, DOI 10.1038/clpt.2011.351; Kitamura S, 2008, DRUG METAB DISPOS, V36, P2014, DOI 10.1124/dmd.108.021410; Kamisako T, 1999, HEPATOLOGY, V30, P485, DOI 10.1002/hep.510300220; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Kajosaari LI, 2005, CLIN PHARMACOL THER, V78, P388, DOI 10.1016/j.clpt.2005.07.005; Watanabe T, 2009, DRUG METAB DISPOS, V37, P1471, DOI 10.1124/dmd.108.026062; Shitara Y, 2009, DRUG METAB DISPOS, V37, P1172, DOI 10.1124/dmd.108.025544; Campbell SD, 2004, CHEM-BIOL INTERACT, V150, P179, DOI 10.1016/j.cbi.2004.08.008; Shitara Y, 2012, DRUG METAB PHARMACOK, V27, P368, DOI 10.2133/dmpk.DMPK-11-RG-096; Lau YY, 2006, J PHARMACOL EXP THER, V316, P762, DOI 10.1124/jpet.105.093088; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Ogilvie BW, 2006, DRUG METAB DISPOS, V34, P191, DOI 10.1124/dmd.105.007633; Maurer TS, 2005, DRUG METAB DISPOS, V33, P175, DOI 10.1124/dmd.104.001222; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Fukuda H, 2010, DRUG METAB DISPOS, V38, P1505, DOI 10.1124/dmd.110.033258; Prueksaritanont T, 2014, BRIT J CLIN PHARMACO, V78, P587, DOI 10.1111/bcp.12377; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Lau YY, 2007, CLIN PHARMACOL THER, V81, P194, DOI 10.1038/sj.clpt.6100038; Shingaki T, 2013, J PHARMACOL EXP THER, V347, P193, DOI 10.1124/jpet.113.206425; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Strautnieks SS, 1998, NAT GENET, V20, P233; Chiou WJ, 2014, XENOBIOTICA, V44, P276, DOI 10.3109/00498254.2013.820006; Chowdhury JR, 2001, METABOLIC MOL BASES, P3063; Colombo F, 2012, XENOBIOTICA, V42, P157, DOI 10.3109/00498254.2011.614021; Fattinger K, 2000, HEPATOLOGY, V32, P82, DOI 10.1053/jhep.2000.8539; Gertz M, 2013, PHARM RES-DORDR, V30, P761, DOI 10.1007/s11095-012-0918-y; Kawaguchi A, 1994, Jikken Dobutsu, V43, P37; Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772; LIST AF, 1993, J CLIN ONCOL, V11, P1652; Nakagomi-Hagihara R, 2006, DRUG METAB DISPOS, V34, P862, DOI 10.1124/dmd.105.008888; Wlcek K, 2013, DRUG METAB DISPOS, V41, P1522, DOI 10.1124/dmd.113.051037; Wolkoff AW, 2003, AM J PHYSIOL-GASTR L, V284, pG175, DOI 10.1152/ajpgi.00409.2002	52	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	APR	2015	43	4					459	466		10.1124/dmd.114.061051		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7FC	WOS:000352002400005		
J	Asakura, M; Fujii, H; Atsuda, K; Itoh, T; Fujiwara, R				Asakura, Mitsutoshi; Fujii, Hideaki; Atsuda, Koichiro; Itoh, Tomoo; Fujiwara, Ryoichi			Dipeptidyl Peptidase-4 Greatly Contributes to the Hydrolysis of Vildagliptin in Human Liver	DRUG METABOLISM AND DISPOSITION			English	Article							CLINICAL PHARMACOKINETICS; INHIBITOR VILDAGLIPTIN; SUBSTRATE-SPECIFICITY; IV; PROTEIN; ENZYME; DISPOSITION; METABOLISM; DESIGN; CD26	The major metabolic pathway of vildagliptin in mice, rats, dogs, and humans is hydrolysis at the cyano group to produce a carboxylic acid metabolite M20.7 (LAY151), whereas the major metabolic enzyme of vildagliptin has not been identified. In the present study, we determined the contribution rate of dipeptidyl peptidase-4 (DPP-4) to the hydrolysis of vildagliptin in the liver. We performed hydrolysis assay of the cyano group of vildagliptin using mouse, rat, and human liver samples. Additionally, DPP-4 activities in each liver sample were assessed by DPP-4 activity assay using the synthetic substrate H-glycyl-prolyl-7-amino-4-methylcoumarin (Gly-Pro-AMC). M20.7 formation rates in liver microsomes were higher than those in liver cytosol. M20.7 formation rate was significantly positively correlated with the DPP-4 activity using Gly-Pro-AMC in liver samples (r = 0.917, P < 0.01). The formation of M20.7 in mouse, rat, and human liver S9 fraction was inhibited by sitagliptin, a selective DPP-4 inhibitor. These findings indicate that DPP-4 is greatly involved in vildagliptin hydrolysis in the liver. Additionally, we established stable single expression systems of human DPP-4 and its R623Q mutant, which is the nonsynonymous single-nucleotide polymorphism of human DPP-4, in human embryonic kidney 293 (HEK293) cells to investigate the effect of R623Q mutant on vildagliptin-hydrolyzing activity. M20.7 formation rate in HEK293 cells expressing human DPP-4 was significantly higher than that in control HEK293 cells. Interestingly, R623Q mutation resulted in a decrease of the vildagliptin-hydrolyzing activity. Our findings might be useful for the prediction of interindividual variability in vildagliptin pharmacokinetics.	[Asakura, Mitsutoshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Fujii, Hideaki; Atsuda, Koichiro; Itoh, Tomoo; Fujiwara, Ryoichi] Kitasato Univ, Sch Pharm, Tokyo 1088641, Japan	Fujiwara, R (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	fujiwarar@pharm.kitasato-u.ac.jp					Akabane T, 2012, DRUG METAB PHARMACOK, V27, P181, DOI 10.2133/dmpk.DMPK-11-RG-097; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; He YL, 2007, EUR J CLIN PHARMACOL, V63, P677, DOI 10.1007/s00228-007-0312-6; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; He H, 2009, DRUG METAB DISPOS, V37, P536, DOI 10.1124/dmd.108.023010; He H, 2009, DRUG METAB DISPOS, V37, P545, DOI 10.1124/dmd.108.023002; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; He YL, 2012, CLIN PHARMACOKINET, V51, P147, DOI 10.2165/11598080-000000000-00000; Fukami T, 2012, DRUG METAB PHARMACOK, V27, P466, DOI 10.2133/dmpk.DMPK-12-RV-042; Scheen AJ, 2010, CLIN PHARMACOKINET, V49, P573, DOI 10.2165/11532980-000000000-00000; Golightly LK, 2012, CLIN PHARMACOKINET, V51, P501, DOI 10.2165/11632930-000000000-00000; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Ahren B, 2011, DIABETES OBES METAB, V13, P775, DOI 10.1111/j.1463-1326.2011.01414.x; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Furuta S, 2013, XENOBIOTICA, V43, P432, DOI 10.3109/00498254.2012.731618; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Asakura M, 2014, DRUG METAB PHARMACOK, V29, P463, DOI 10.2133/dmpk.DMPK-14-RG-027; Greene RJ, 2011, XENOBIOTICA, V41, P945, DOI 10.3109/00498254.2011.597455; Karagiannis Thomas, 2014, Ther Adv Drug Saf, V5, P138, DOI 10.1177/2042098614523031; Kurita N, 2014, DIABETES CARE, V37, pE198, DOI 10.2337/dc14-1252; Lee KN, 2009, BIOCHEMISTRY-US, V48, P5149, DOI 10.1021/bi900257m; Metzler WJ, 2008, PROTEIN SCI, V17, P240, DOI 10.1110/ps.073253208; Nagai N, 2010, DRUG METAB PHARMACOK, V25, P3; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l	29	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	APR	2015	43	4					477	484		10.1124/dmd.114.062331		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7FC	WOS:000352002400007		
J	Ando, H; Hisaka, A; Suzuki, H				Ando, Hirotaka; Hisaka, Akihiro; Suzuki, Hiroshi			A New Physiologically Based Pharmacokinetic Model for the Prediction of Gastrointestinal Drug Absorption: Translocation Model	DRUG METABOLISM AND DISPOSITION			English	Article							INTESTINAL 1ST-PASS METABOLISM; SEGREGATED-FLOW MODEL; IN-VITRO; CACO-2 CELLS; BLOOD-FLOW; TRANSIT; RAT; TRANSPORTERS; PERMEABILITY; CYP3A4	This study aimed to construct a new local pharmacokinetic model of gastrointestinal absorption, the translocation model (TLM), using an anatomically relevant, minimally segmented structure to explain linear and nonlinear intestinal absorption, metabolism, and transport. The TLM was based on the concept of a single absorption site that flexibly moves, expands, and shrinks along with the length of the gastrointestinal tract after the intake of an oral dose. The structure of the small intestine is continuous, and various time-and location-dependent issues are freely incorporated in the analysis. Since the model has only one absorption site, understanding and modification of factors affecting absorption are simple. The absorption site is composed of four compartments: solid drug in the lumen, solution drug in the lumen, concentration in the enterocytes, and concentration in the lamina propria. The lamina propria includes the blood capillaries. Blood flow in the absorption site of the lamina propria appropriately accounts for the absorption. In the TLM, the permeability of the apical membrane and that of the basolateral membrane are distinct. By considering plicate, villi, and microvilli expansions of the surface area, the apparent permeability measured in Caco-2 experiments was converted to the effective permeability in vivo. The intestinal availability, bioavailability, and dose product of intestinal availability and absorption rate relationship of the model drugs were well explained using the TLM. The TLM would be a useful tool for the consideration of local pharmacokinetics in the gastrointestinal tract in various situations.	[Ando, Hirotaka; Suzuki, Hiroshi] Tokyo Univ Hosp, Fac Med, Dept Pharm & Pharmacol & Pharmacokinet, Tokyo 113, Japan; [Hisaka, Akihiro] Univ Tokyo, Tokyo, Japan	Hisaka, A (reprint author), 1-8-1 Inohana,Chuo Ku, Chiba 2608675, Japan.	hisaka@chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22136015]	This research was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas HD Physiology Project from the Japanese Ministry of Education, Culture, Sports, Science, and Technology [Grant 22136015].	Agoram B, 2001, ADV DRUG DELIVER REV, V50, pS41, DOI 10.1016/S0169-409X(01)00179-X; Schiller C, 2005, ALIMENT PHARM THERAP, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Maeda K, 2011, CLIN PHARMACOL THER, V90, P263, DOI 10.1038/clpt.2011.108; Yu LX, 1999, INT J PHARM, V186, P119, DOI 10.1016/S0378-5173(99)00147-7; Bruyere A, 2010, MOL PHARMACEUT, V7, P1596, DOI 10.1021/mp100015x; Bergstrand M, 2009, CLIN PHARMACOL THER, V86, P77, DOI 10.1038/clpt.2009.43; Gertz M, 2011, DRUG METAB DISPOS, V39, P1633, DOI 10.1124/dmd.111.039248; Poulin P, 2011, J PHARM SCI-US, V100, P4127, DOI 10.1002/jps.22550; Pang KS, 2012, DRUG METAB DISPOS, V40, P1869, DOI 10.1124/dmd.112.045872; Sugano K, 2009, EXPERT OPIN DRUG MET, V5, P259, DOI [10.1517/17425250902835506 , 10.1517/17425250902835506]; Hisaka A, 2014, DRUG METAB DISPOS, V42, P1640, DOI 10.1124/dmd.114.059147; Englund G, 2006, EUR J PHARM SCI, V29, P269, DOI 10.1016/j.ejps.2006.04.010; Tachibana T, 2010, PHARM RES-DORDR, V27, P442, DOI 10.1007/s11095-009-0026-9; Kajosaari LI, 2005, BASIC CLIN PHARMACOL, V97, P249, DOI 10.1111/j.1742-7843.2005.pto_157.x; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Willmann S, 2004, J MED CHEM, V47, P4022, DOI 10.1021/jm030999b; Sun DX, 2002, PHARMACEUT RES, V19, P1400, DOI 10.1023/A:1020483911355; Henin E, 2012, AAPS J, V14, P155, DOI 10.1208/s12248-012-9324-y; Heikkinen AT, 2012, EUR J PHARM SCI, V47, P375, DOI 10.1016/j.ejps.2012.06.013; Varma MVS, 2010, J MED CHEM, V53, P1098, DOI 10.1021/jm901371v; Ekins S, 1999, J PHARMACOL EXP THER, V291, P424; Yang JS, 2007, CURR DRUG METAB, V8, P676, DOI 10.2174/138920007782109733; Jamei M, 2009, AAPS J, V11, P225, DOI 10.1208/s12248-009-9099-y; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Thomas S, 2008, J PHARM SCI-US, V97, P4557, DOI 10.1002/jps.21305; Petri N, 2003, DRUG METAB DISPOS, V31, P805, DOI 10.1124/dmd.31.6.805; Lin JH, 1999, PHARMACOL REV, V51, P135; Willmann S, 2003, PHARM RES, V20, P1766, DOI 10.1023/B:PHAM.0000003373.72652.c0; Gertz M, 2010, DRUG METAB DISPOS, V38, P1147, DOI 10.1124/dmd.110.032649; Badhan R, 2009, J PHARM SCI-US, V98, P2180, DOI 10.1002/jps.21572; Bergstrand M, 2012, PHARM RES-DORDR, V29, P695, DOI 10.1007/s11095-011-0594-3; Bolger MB, 2009, AAPS J, V11, P353, DOI 10.1208/s12248-009-9111-6; BORNEMANN LD, 1985, EUR J CLIN PHARMACOL, V29, P91, DOI 10.1007/BF00547375; Chen JP, 1997, J PHARMACOL EXP THER, V280, P24; Cong D, 2001, DRUG METAB DISPOS, V29, P1539; Cong D, 2000, DRUG METAB DISPOS, V28, P224; Hisaka A, 2010, DRUG METAB PHARMACOK, V25, P48; Hisaka A, 1998, J PHARMACOKINET BIOP, V26, P495, DOI 10.1023/A:1023294632129; Kalampokis A, 1999, PHARMACEUT RES, V16, P87, DOI 10.1023/A:1018874913372; Kimura T, 2002, BIOL PHARM BULL, V25, P149, DOI 10.1248/bpb.25.149; Ku HY, 2008, DRUG METAB DISPOS, V36, P986, DOI 10.1124/dmd.107.020099; LAVRIJSEN KLM, 1988, ANESTHESIOLOGY, V69, P535, DOI 10.1097/00000542-198810000-00013; Misaka S, 2010, CLIN EXP PHARMACOL P, V37, P290, DOI 10.1111/j.1440-1681.2009.05285.x; Ohura K, 2011, J PHARM SCI-US, V100, P3985, DOI 10.1002/jps.22628; Parker KL, 2005, GOODMAN GILMANS PHAR; Polasek TM, 2010, EUR J CLIN PHARMACOL, V66, P275, DOI 10.1007/s00228-009-0760-2; Rotzinger S, 1998, DRUG METAB DISPOS, V26, P572; SCHULZ R, 1987, N-S ARCH PHARMACOL, V335, P97, DOI 10.1007/BF00165043; Stephens RH, 2001, J PHARMACOL EXP THER, V296, P584; Tam D, 2003, DRUG METAB DISPOS, V31, P373, DOI 10.1124/dmd.31.4.373; WINNE D, 1978, J PHARMACOKINET BIOP, V6, P55, DOI 10.1007/BF01066063	51	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	APR	2015	43	4					590	602		10.1124/dmd.114.060038		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7FC	WOS:000352002400018		
J	Iwao, T; Kodama, N; Kondo, Y; Kabeya, T; Nakamura, K; Horikawa, T; Niwa, T; Kurose, K; Matsunaga, T				Iwao, Takahiro; Kodama, Nao; Kondo, Yuki; Kabeya, Tomoki; Nakamura, Katsunori; Horikawa, Takashi; Niwa, Takuro; Kurose, Kouichi; Matsunaga, Tamihide			Generation of Enterocyte-Like Cells with Pharmacokinetic Functions from Human Induced Pluripotent Stem Cells Using Small-Molecule Compounds	DRUG METABOLISM AND DISPOSITION			English	Article							INTESTINAL EPITHELIAL-CELLS; PREGNANE-X RECEPTOR; GENE-EXPRESSION; ISOMALTASE GENE; DIFFERENTIATION; CYP3A4; IDENTIFICATION; HEPATOCYTES; METABOLISM; INDUCTION	The small intestine plays an important role in all aspects of pharmacokinetics, but there is no system for the comprehensive evaluation of small-intestinal pharmacokinetics, including drug metabolism and absorption. In this study, we aimed to construct an intestinal pharmacokinetics evaluation system and to generate pharmacokinetically functional enterocytes from human induced pluripotent stem cells. Using activin A and fibroblast growth factor 2, we differentiated these stem cells into intestinal stem cell-like cells, and the resulting cells were differentiated into enterocytes in a medium containing epidermal growth factor and small-molecule compounds. The differentiated cells expressed intestinal marker genes and drug transporters. The expression of sucrase-isomaltase, an intestine-specific marker, was markedly increased by small-molecule compounds. The cells exhibited activities of drug-metabolizing enzymes expressed in enterocytes, including CYP1A1/2, CYP2C9, CYP2C19, CYP2D6, CYP3A4/5, UGT, and sulfotransferase. Fluorescence-labeled dipeptide uptake into the cells was observed and was inhibited by ibuprofen, an inhibitor of the intestinal oligopeptide transporter solute carrier 15A1/PEPT1. CYP3A4 mRNA expression level was increased by these compounds and induced by the addition of 1 alpha, 25-dihydroxyvitamin D-3. CYP3A4/5 activity was also induced by 1 alpha, 25-dihydroxyvitamin D-3 in cells differentiated in the presence of the compounds. All these results show that we have generated enterocyte-like cells that have pharmacokinetic functions, and we have identified small-molecule compounds that are effective for promoting intestinal differentiation and the gain of pharmacokinetic functions. Our enterocyte-like cells would be useful material for developing a novel evaluation system to predict human intestinal pharmacokinetics.	[Iwao, Takahiro; Kodama, Nao; Kondo, Yuki; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Nagoya, Aichi 4678603, Japan; [Iwao, Takahiro; Kabeya, Tomoki; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Fac Pharmaceut Sci, Educ Res Ctr Clin Pharm, Nagoya, Aichi 4678603, Japan; [Horikawa, Takashi; Niwa, Takuro] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama, Japan; [Niwa, Takuro] Japan Bioind Assoc, Dept Res & Dev, Tokyo, Japan; [Kurose, Kouichi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan	Matsunaga, T (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	tmatsu@phar.nagoya-cu.ac.jp	Kurose, Kouichi/O-1966-2014	Kurose, Kouichi/0000-0002-7042-0153	Japan Society for the Promotion of Science [23390036, 25860120]; Health and Labour Sciences Research Grants from Japan Health Sciences Foundation [Research on Development of New Drug] [KHB1208]; Nagoya City University [16]	This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science [Grant 23390036, Grant 25860120]; a Health and Labour Sciences Research Grants from Japan Health Sciences Foundation [Research on Development of New Drug, Grant KHB1208]; and a Grant-in-Aid for Research in Nagoya City University [Grant 16].	Iwao T, 2014, DRUG METAB PHARMACOK, V29, P44, DOI 10.2133/dmpk.DMPK-13-RG-005; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Yamanaka H, 2007, DRUG METAB DISPOS, V35, P1642, DOI 10.1124/dmd.107.016097; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Nakamura T, 2002, DRUG METAB DISPOS, V30, P4, DOI 10.1124/dmd.30.1.4; ROBINE S, 1985, P NATL ACAD SCI USA, V82, P8488, DOI 10.1073/pnas.82.24.8488; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Ogaki S, 2013, STEM CELLS, V31, P1086, DOI 10.1002/stem.1344; Zhang QY, 1999, DRUG METAB DISPOS, V27, P804; Sun DX, 2002, PHARMACEUT RES, V19, P1400, DOI 10.1023/A:1020483911355; Kondo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104010; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Thummel KE, 2001, MOL PHARMACOL, V60, P1399; Groneberg DA, 2001, AM J PHYSIOL-GASTR L, V281, pG697; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Teubner W, 2007, BIOCHEM J, V404, P207, DOI 10.1042/BJ20061431; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Schmiedlin-Ren P, 2001, DRUG METAB DISPOS, V29, P1446; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Siissalo S, 2013, CURR DRUG METAB, V14, P102; Glaeser H, 2005, BRIT J CLIN PHARMACO, V59, P199, DOI 10.1111/j.1365-2125.2004.02265.x; Paine MF, 2006, DRUG METAB DISPOS, V34, P880, DOI 10.1124/dmd.105.008672; BOLLER K, 1988, DIFFERENTIATION, V39, P51, DOI 10.1111/j.1432-0436.1988.tb00080.x; Borlak J, 2003, XENOBIOTICA, V33, P927, DOI 10.1080/00498250310001614286; Bourgine J, 2012, DRUG METAB DISPOS, V40, P694, DOI 10.1124/dmd.111.042465; Chougule P, 2012, SCAND J GASTROENTERO, V47, P1334, DOI 10.3109/00365521.2012.708940; Dannenberg LO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-181; Grossmann J, 2003, EUR J CELL BIOL, V82, P262, DOI 10.1078/0171-9335-00312; Gu N, 2007, BIOCHEM BIOPH RES CO, V353, P617, DOI 10.1016/j.bbrc.2006.12.065; Habano W, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-81; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P237, DOI 10.2133/dmpk.DMPK-13-RG-104; Lemieux E, 2011, AM J PHYSIOL-GASTR L, V301, pG719, DOI 10.1152/ajpgi.00508.2010; Martin P, 2008, BRIT J PHARMACOL, V153, P805, DOI 10.1038/sj.bjp.0707601; Omkvist DH, 2010, BRIT J PHARMACOL, V161, P1793, DOI 10.1111/j.1476-5381.2010.01000.x; Pavek P, 2010, BIOCHEM PHARMACOL, V79, P277, DOI 10.1016/j.bcp.2009.08.017; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Takenaka Toru, 2014, Drug Metab Dispos, V42, P1947, DOI 10.1124/dmd.114.059493; van de Kerkhof Esther G, 2008, Drug Metab Dispos, V36, P604	47	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	APR	2015	43	4					603	610		10.1124/dmd.114.062604		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7FC	WOS:000352002400019		
J	Avci-Adali, M; Hann, L; Michel, T; Steinle, H; Stoppelkamp, S; Stang, K; Narita, M; Schlensak, C; Wendel, HP				Avci-Adali, Meltem; Hann, Ludmilla; Michel, Tatjana; Steinle, Heidrun; Stoppelkamp, Sandra; Stang, Katharina; Narita, Miwako; Schlensak, Christian; Wendel, Hans P.			In vitro test system for evaluation of immune activation potential of new single-stranded DNA-based therapeutics	DRUG TESTING AND ANALYSIS			English	Article						aptamers; immune activation; DNA sensing	PLASMACYTOID DENDRITIC CELLS; CPG OLIGODEOXYNUCLEOTIDES; CYTOSOLIC DNA; IFN-ALPHA; APTAMER; CANCER; SELECTION; SENSOR; VIVO; STIMULATION	Aptamers are synthetic single-stranded DNA (ssDNA) molecules with the ability to fold into complex three-dimensional structures. They can bind their targets with a high selectivity and affinity, thus they have an enormous potential as therapeutic agents. However, since aptamers are synthetic and especially since certain sequences can increasingly bind to the pattern recognition receptors of the immune cells when applied in vivo, they can induce an immune activation. Here, we established a real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) based assay to evaluate aptamers-induced immune activation prior to in vivo studies. Human whole blood or plasmacytoid dendritic cell line (PMDC05) were incubated with CpG, R10-60 aptamer, start library, or a CpG containing aptamer. After 2 and 4h, cytokine expression was measured using qRT-PCR to determine immune reaction against different aptamers. CpG containing a phosphorothioate backbone led to a significant up-regulation of CCL-7, IFN-1, IFN-1 in whole blood after 4h. Compared to the samples without ssDNA, significantly higher TNF- expression was detected after the R10-60 aptamer incubation for 4h. The stimulation of PMDC05 cells with different ssDNA enabled more sensitive detection of aptamer sequence specific immune activation. After 4h, CpG led to a significantly higher expression of CCL-8, CXCL-10, IL-1, IL-6, IL-8, IFN-1, and TNF-. R10-60 aptamer caused a significant up-regulation of IL-1, IFN-1, and TNF-. Negative control aptamers did not induce an immune activation. The use of this assay before starting with in vivo studies will facilitate the in vitro prediction of immune activation potential of aptamers. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Avci-Adali, Meltem; Hann, Ludmilla; Michel, Tatjana; Steinle, Heidrun; Stoppelkamp, Sandra; Stang, Katharina; Schlensak, Christian; Wendel, Hans P.] Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, D-72076 Tubingen, Germany; [Narita, Miwako] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Niigata, Japan	Wendel, HP (reprint author), Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, Calwerstr 7-1, D-72076 Tubingen, Germany.	hans-peter.wendel@med.uni-tuebingen.de			European Social Funds in Baden-Wuerttemberg, Germany; MWK-BW, Germany; German Federal Ministry of Education and Research (BMBF)	We thank Prof. Dr. Masuhiro Takahashi (Laboratory of Hematology and Oncology, Graduate School of Health Sciences, Niigata University) for kindly providing the PMDC05 cells. This project was funded by the European Social Funds in Baden-Wuerttemberg, Germany, the MWK-BW, Germany and the German Federal Ministry of Education and Research (BMBF).	Anderson RB, 2008, J LEUKOCYTE BIOL, V83, P381, DOI 10.1189/jlb.0407236; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Bruno JG, 2012, BIOSENS BIOELECTRON, V31, P240, DOI 10.1016/j.bios.2011.10.024; Hornung V, 2002, J IMMUNOL, V168, P4531; Stoltenburg R, 2012, J ANAL METHODS CHEM, DOI 10.1155/2012/415697; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hemmi H, 2000, NATURE, V408, P740; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Yang XJ, 2011, ANALYST, V136, P577, DOI 10.1039/c0an00550a; Song YL, 2013, ANAL CHEM, V85, P4141, DOI 10.1021/ac400366b; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Kim D, 2009, BIOCHEM BIOPH RES CO, V379, P362, DOI 10.1016/j.bbrc.2008.12.063; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Avci-Adali M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068810; Coulais D, 2012, CYTOTHERAPY, V14, P887, DOI 10.3109/14653249.2012.689129; Hu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031970; Mie M, 2013, APPL BIOCHEM BIOTECH, V169, P250, DOI 10.1007/s12010-012-9956-5; Narita M, 2009, LEUKEMIA RES, V33, P1224, DOI 10.1016/j.leukres.2009.03.047; Orava EW, 2013, ACS CHEM BIOL, V8, P170, DOI 10.1021/cb3003557; Schafer R, 2007, ROFO-FORTSCHR RONTG, V179, P1009, DOI 10.1055/s-2007-963409; Shimosato T, 2006, CELL MICROBIOL, V8, P485, DOI 10.1111/j.1462-5822.2005.00640.x; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wu CCN, 2003, HUM GENE THER, V14, P849, DOI 10.1089/104303403765701141; Wu CCN, 2008, CELL IMMUNOL, V251, P78, DOI 10.1016/j.cellimm.2008.04.001; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210; Zhang Z, 2008, CELL MOL LIFE SCI, V65, P1237, DOI 10.1007/s00018-008-7572-x; Zhao QY, 1996, BLOOD, V88, P1788	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-7603	1942-7611		DRUG TEST ANAL	Drug Test. Anal.	APR	2015	7	4					300	308		10.1002/dta.1670		9	Biochemical Research Methods; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CF4MQ	WOS:000352523600004		
J	Kanamori, T; Kanda, K; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Iwata, YT; Inoue, H				Kanamori, Tatsuyuki; Kanda, Koji; Yamamuro, Tadashi; Kuwayama, Kenji; Tsujikawa, Kenji; Iwata, Yuko Togawa; Inoue, Hiroyuki			Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine	DRUG TESTING AND ANALYSIS			English	Article						synthetic cannabinoid; metabolism; hepatocyte; urine	MASS-SPECTROMETRY; PYROLYSIS PRODUCT; CANNABINOIDS; UR-144	The metabolism of (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (XLR-11), a novel synthetic cannabinoid, was studied using a HepaRG cell culture. The HepaRG cells were incubated with the drug for 48 hours and the metabolites were extracted from the culture medium by liquid-liquid extraction. The extract was analyzed by liquid chromatography/mass spectrometry to detect the metabolites. N-(5-Hydroxypentyl) metabolite and N-pentanoic acid metabolite were identified in the culture medium of XLR-11, and several other metabolites, presumably formed by oxidation of the first two metabolites and XLR-11, were detected. The extract of an XLR-11 user's urine was also analyzed; however, the metabolites detected in the urine were different from XLR-11 metabolites in the medium. A metabolic experiment with the thermal degradation product of XLR-11, XLR-11 degradant, using HepaRG cells revealed that the urinary metabolites were almost identical to the XLR-11 degradant metabolites. These findings suggest that most of the XLR-11 was degraded by heating when the user smoked the herbal product containing XLR-11. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Kanamori, Tatsuyuki; Kanda, Koji; Yamamuro, Tadashi; Kuwayama, Kenji; Tsujikawa, Kenji; Iwata, Yuko Togawa; Inoue, Hiroyuki] Natl Res Inst Police Sci, Chem Sect 6 3 1 1, Kashiwa, Chiba 2770882, Japan	Kanamori, T (reprint author), Natl Res Inst Police Sci, Chem Sect 6 3 1 1, Kashiwa, Chiba 2770882, Japan.	kanamori@nrips.go.jp			JSPS KAKENHI [23590866]	This work was supported by JSPS KAKENHI Grant Number 23590866.	Wohlfarth A, 2013, CLIN CHEM, V59, P1638, DOI 10.1373/clinchem.2013.209965; Wiley JL, 2013, NEUROPHARMACOLOGY, V75, P145, DOI 10.1016/j.neuropharm.2013.07.022; Uchiyama N, 2013, FORENSIC SCI INT, V227, P21, DOI 10.1016/j.forsciint.2012.08.047; Adamowicz P, 2013, FORENSIC SCI INT, V233, P320, DOI 10.1016/j.forsciint.2013.10.005; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016; Seely KA, 2012, PROG NEURO-PSYCHOPH, V39, P234, DOI 10.1016/j.pnpbp.2012.04.017; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Grigoryev A, 2013, J ANAL TOXICOL, V37, P265, DOI 10.1093/jat/bkt028; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Barceloux D. G., 2012, MED TOXICOLOGY DRUG, P915; Drug Enforcement Administration Department of justice, 2013, FED REG, V78, P21858; JOHNSON MR, 1981, J CLIN PHARMACOL, V21, pS271; NMS Labs, 2012, NMS LABS TRENDS REP; WEISSMAN A, 1982, J PHARMACOL EXP THER, V223, P516	14	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-7603	1942-7611		DRUG TEST ANAL	Drug Test. Anal.	APR	2015	7	4					341	345		10.1002/dta.1765		5	Biochemical Research Methods; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CF4MQ	WOS:000352523600009		
J	Yamashita, M; Kasaya, T; Takahashi, N; Takizawa, K; Kodaira, S				Yamashita, Mikiya; Kasaya, Takafumi; Takahashi, Narumi; Takizawa, Kaoru; Kodaira, Shuichi			Structural characteristics of the Bayonnaise Knoll caldera as revealed by a high-resolution seismic reflection survey	EARTH PLANETS AND SPACE			English	Letter						Bayonnaise Knoll caldera; Multi-channel seismic reflection survey; Hydrothermal deposit; Back-arc rift; Prestack migration	IZU-BONIN ARC; SUBMARINE SILICIC CALDERA; VELOCITY ANALYSIS; JAPAN; BASIN; CONSTRAINTS; EVOLUTION; VOLCANO; DEPOSIT; ISLAND	The Bayonnaise Knoll caldera is a conical silicic caldera located on the eastern part of the back-arc rift zone of the Izu-Ogasawara arc. Many geological and geophysical surveys have shown that the Bayonnaise Knoll caldera contains hydrothermal sulfide deposits. The Japan Agency for Marine-Earth Science and Technology conducted high-resolution multi-channel seismic reflection surveys across the Bayonnaise Knoll caldera to ascertain details of the crustal structure, such as the configuration of faults around the caldera. A reflection profile of excellent quality was obtained by high-density velocity analysis at about 150-m intervals. We applied prestack depth migration by using the results of the high-density velocity analysis and further analyzed this region. The depth-migrated profile shows many faults, which correspond to bathymetric lineations, on the eastern side of the Bayonnaise Knoll caldera. The velocity structure of the Bayonnaise Knoll caldera resembles that of the Myojin Knoll caldera, which has been well surveyed and is associated with the hydrothermal deposit. The depth-migrated profile shows a clear reflective zone that is distributed asymmetrically to the Bayonnaise Knoll caldera center. These data suggest that caldera formation was controlled by back-arc rifting activity in the Izu-Ogasawara arc. The hydrothermal fluid migration path in the Bayonnaise Knoll caldera is estimated to be the result of faulting and magmatic intrusion on the eastern side of the structure. It is assumed that these fluids formed the Kuroko-type sulfide deposit in the eastern part of the caldera structure.	[Yamashita, Mikiya; Kasaya, Takafumi; Takahashi, Narumi; Takizawa, Kaoru; Kodaira, Shuichi] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Takizawa, Kaoru] Nippon Marine Enterprises Ltd, Yokosuka, Kanagawa 2380004, Japan	Yamashita, M (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	mikiya@jamstec.go.jp					OKINO K, 1994, J GEOMAGN GEOELECTR, V46, P463; Tamura Y, 2002, J PETROL, V43, P1029, DOI 10.1093/petrology/43.6.1029; Tani K, 2008, B VOLCANOL, V70, P547, DOI 10.1007/s00445-007-0153-2; Aoki Y, 2009, J VOLCANOL GEOTH RES, V187, P272, DOI 10.1016/j.jvolgeores.2009.09.004; ALYAHYA K, 1989, GEOPHYSICS, V54, P718, DOI 10.1190/1.1442699; Tsuji T, 2012, J VOLCANOL GEOTH RES, V213, P41, DOI 10.1016/j.jvolgeores.2011.11.007; Kodaira S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004593; Fisher RV, 1991, SEPM SPEC PUBL, V45, P201; Fiske RS, 2001, GEOL SOC AM BULL, V113, P813, DOI 10.1130/0016-7606(2001)113<0813:SSCATF>2.0.CO;2; Fujiwara T, 2009, EARTH PLANETS SPACE, V61, P333; Honsho C, 2013, J GEOPHYS RES-SOL EA, V118, P5147, DOI 10.1002/jgrb.50382; Honsho C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008611; Honsho C, 2010, BUTSURI TANSA, V63, P427; Iizasa K, 1999, SCIENCE, V283, P975, DOI 10.1126/science.283.5404.975; Iizasa K, 2004, OC 04 MTS IEEE TECHN, V2, P991, DOI 10.1109/OCEANS.2004.1405638; Ishizuka O, 2002, J VOLCANOL GEOTHERM, V120, P71; Ishizuka O, 2003, GEOL SOC SPEC PUBL, V219, P187, DOI DOI 10.1144/GSL.SP.2003.219.01.09; Lines LR, 1993, LEADING EDGE, V12, P750, DOI 10.1190/1.1436964; Murakami F., 1996, ISL ARC, V5, P25, DOI 10.1111/j.1440-1738.1996.tb00010.x; Nagaoka N, 1992, P JAMSTEC S DEEP SEA, V8, P237; Naka J, 1995, JAMSTEC J DEEP SEA R, V11, P323; NISHIMURA A, 1992, P OC DRILL PROGR SCI, V0126; Sattlegger J. W., 1974, Geophysical Prospecting, V22, DOI 10.1111/j.1365-2478.1974.tb00087.x; STORK C, 1992, GEOPHYSICS, V57, P404, DOI 10.1190/1.1443255; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; Tanahashi M, 2006, SHIGEN CHISHITSU, V56, P185; Tanahashi M, 2008, RESOUR GEOL, V58, P301, DOI 10.1111/j.1751-3928.2008.00063.x; Taylor B., 1992, P OCEAN DRILLING PRO, V126, P627; Tsuru T, 2008, EARTH PLANETS SPACE, V60, P721; Tsutsui T, 2013, B VOLCANOLOGICAL SOC, V58, P239; Watanabe K, 1994, RESOUR GEOL, V44, P133; Yamashita M, 2007, ISL ARC, V16, P338, DOI 10.1111/j.1440-1738.2007.00594.x	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1880-5981			EARTH PLANETS SPACE	Earth Planets Space	APR 1	2015	67						1	9	45	10.1186/s40623-015-0214-2		9	Geosciences, Multidisciplinary	Geology	CF0WF	WOS:000352264400001		
J	Ishigaki, T; Yoshida, T; Izumi, H; Fujisawa, Y; Shimizu, S; Masuda, K; Asanuma, T; Okabe, H; Nakatani, S				Ishigaki, Takako; Yoshida, Takashi; Izumi, Hiromi; Fujisawa, Yoshihisa; Shimizu, Shoko; Masuda, Kasumi; Asanuma, Toshihiko; Okabe, Hidetoshi; Nakatani, Satoshi			Different Implication of Elevated B-Type Natriuretic Peptide Level in Patients with Heart Failure with Preserved Ejection Fraction and in Those with Reduced Ejection Fraction	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Article						B-type natriuretic peptide; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; echocardiography	VENTRICULAR DIASTOLIC FUNCTION; SPECKLE TRACKING ECHOCARDIOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; 2-DIMENSIONAL STRAIN; DIAGNOSIS; UTILITY; DYSFUNCTION; MECHANICS; IMPACT; TIME	BackgroundThere have been no reports that show significant direct relationship between echocardiographic parameters and B-type natriuretic peptide (BNP) level. This could be due to the heterogeneous pathophysiology of heart failure and a lack of appropriate echocardiographic parameters. We sought to determine the best echocardiographic parameter that described elevated BNP level in patients with heart failure with and without systolic dysfunction. Methods and ResultsWe studied 111 consecutive heart failure patients. They were divided into patients with heart failure and preserved ejection fraction (HFPEF, n=61) and that with heart failure and reduced ejection fraction (HFREF, n=50). Conventional and new echocardiographic parameters including myocardial strains were measured. BNP did not reflect any single echocardiographic parameter in patients with heart failure in total. The ratio of early diastolic transmitral flow velocity and mitral annular velocity had strong positive correlation with BNP level in the HFPEF group but not in the HFREF group. In the group of HFREF, global longitudinal and circumferential strains were positively correlated. Multivariate analysis revealed that predicted factors for BNP value in HFPEF and in HFREF were different. ConclusionHigh BNP level may indicate high filling pressure when ejection fraction is preserved and may indicate myocardial dysfunction when it is reduced.	[Ishigaki, Takako; Masuda, Kasumi; Asanuma, Toshihiko; Nakatani, Satoshi] Osaka Univ, Div Funct Diagnost, Dept Hlth Sci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ishigaki, Takako; Yoshida, Takashi; Izumi, Hiromi; Fujisawa, Yoshihisa; Shimizu, Shoko; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan	Nakatani, S (reprint author), Osaka Univ, Div Funct Diagnost, Dept Hlth Sci, Grad Sch Med, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	nakatani@sahs.med.osaka-u.ac.jp					Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Ammar KA, 2012, ECHOCARDIOGR-J CARD, V29, P861, DOI 10.1111/j.1540-8175.2012.01712.x; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Logeart D, 2002, J AM COLL CARDIOL, V40, P1794, DOI 10.1016/S0735-1097(02)02482-8; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006; MORITA E, 1993, CIRCULATION, V88, P82; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Parekh N, 2009, CURR OPIN CARDIOL, V24, P155, DOI 10.1097/HCO.0b013e328320d82a; Maeder MT, 2009, J AM COLL CARDIOL, V53, P905, DOI 10.1016/j.jacc.2008.12.007; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Troughton RW, 2004, J AM COLL CARDIOL, V43, P416, DOI 10.1016/j.jacc.2003.08.046; Reant P, 2008, J AM COLL CARDIOL, V51, P149, DOI 10.1016/j.jacc.2007.07.088; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Cerisano G, 2005, AM J CARDIOL, V95, P930, DOI 10.1016/j.amjcard.2004.12.029; Dirk JV, 2013, J AM COLL CARDIOL, V61, P1498; JONES CJH, 1990, BRIT HEART J, V63, P215; Krishnaswamy P, 2001, AM J MED, V111, P274, DOI 10.1016/S0002-9343(01)00841-5; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Nakatani Satoshi, 2011, J Cardiovasc Ultrasound, V19, P1, DOI 10.4250/jcu.2011.19.1.1; Tokola H, 2001, CAN J PHYSIOL PHARM, V79, P646, DOI 10.1139/cjpp-79-8-646; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; Wozakowska-Kapłon Beata, 2008, Cardiol J, V15, P525	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	APR	2015	32	4					623	629		10.1111/echo.12707		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CF4AK	WOS:000352490500003		
J	Takauchi, K				Takauchi, Kazuhiro			Endogenous transport price and international R&D rivalry	ECONOMIC MODELLING			English	Article						Transporter; R&D activity; Transport charge; R&D efficiency	TRADE COST REDUCTION; DEVELOPMENT INVESTMENTS; DEVELOPMENT EFFICIENCY; VERTICAL STRUCTURE; MARKET; PRODUCTIVITY; INNOVATION; FIRMS; WAGE	The purpose of this paper is to consider the relationship between monopoly transport prices and an industry's technology level of research and development (R&D). Although R&D efficiency is often considered a key factor to improve the performance of firms in an industry, we demonstrate that this standard view does not always hold in a trade model involving a monopoly transporter. In a one-way duopoly case, an exporter competes with a local firm in the local market but must pay a transport charge to the monopoly transporter to carry its product. We show that higher R&D efficiency may reduce the investments of an exporter. We further investigate a case of two-way trade comprising two symmetric countries. We also show that higher R&D efficiency may reduce the producers' profit. (c) 2014 Elsevier B.V. All rights reserved.	Kansai Univ, Fac Commerce, Suita, Osaka 5648680, Japan	Takauchi, K (reprint author), Kansai Univ, Fac Commerce, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	kazh.takauch@gmail.com					Anderson JE, 2004, J ECON LIT, V42, P691, DOI 10.1257/0022051042177649; Behrens K, 2011, J INT ECON, V85, P280, DOI 10.1016/j.jinteco.2011.06.003; Naylor R, 1998, EUR ECON REV, V42, P1251, DOI 10.1016/S0014-2921(97)00075-5; Clark XM, 2004, J DEV ECON, V75, P417, DOI 10.1016/j.jdeveco.2004.06.005; BRANDER J, 1983, J INT ECON, V15, P313, DOI 10.1016/S0022-1996(83)80008-7; Zhang AM, 2003, J COMP ECON, V31, P444, DOI 10.1016/S0147-5967(03)00055-6; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131; Zhong W, 2011, OMEGA-INT J MANAGE S, V39, P447, DOI 10.1016/j.omega.2010.09.004; Naylor R, 1999, ECON J, V109, P102, DOI 10.1111/1468-0297.00394; Hummels D, 2004, J POLIT ECON, V112, P1384, DOI 10.1086/422562; Wang EC, 2007, RES POLICY, V36, P260, DOI 10.1016/j.respol.2006.11.004; Arya A, 2006, J REGUL ECON, V29, P333, DOI 10.1007/s11149-006-7403-7; Banerjee S, 2003, INT J IND ORGAN, V21, P79, DOI 10.1016/S0167-7187(02)00010-3; Bastos P, 2009, INT J IND ORGAN, V27, P679, DOI 10.1016/j.ijindorg.2009.02.008; Chen C.-T., 2004, INT J BUSINESS, V9, P347; Francois J. F., 2001, REV INT ECON, V9, P249, DOI 10.1111/1467-9396.00277; Ghosh A, 2013, J INT TRADE ECON DEV, V22, P942, DOI 10.1080/09638199.2011.618228; Haaland JI, 2008, J INT ECON, V74, P170, DOI 10.1016/j.jinteco.2007.04.001; Hu JL, 2014, B ECON RES, V66, P55, DOI 10.1111/j.1467-8586.2011.00417.x; Hummels D, 2009, J DEV ECON, V89, P84, DOI 10.1016/j.jdeveco.2008.05.001; Kleinert J., 2011, IAW DISCUSSION PAPER, V74; Leahy D., 1996, REV INT ECON, V4, P322, DOI 10.1111/j.1467-9396.1996.tb00107.x; Leahy D, 1999, OXFORD ECON PAP, V51, P40, DOI 10.1093/oep/51.1.40; Liu Y, 2013, REV INT ECON, V21, P966, DOI 10.1111/roie.12082; Maiti D, 2013, LABOUR ECON, V21, P103, DOI 10.1016/j.labeco.2013.01.001; Manasakis C, 2009, CAN J ECON, V42, P665, DOI 10.1111/j.1540-5982.2009.01523.x; Matsushima N, 2014, TRANSPORT RES B-METH, V67, P382, DOI 10.1016/j.trb.2014.04.010; Matsushima N, 2012, J JPN INT ECON, V26, P142, DOI 10.1016/j.jjie.2012.01.001; MOTTA M., 2004, COMPETITION POLICY T; Mukherjee A, 2013, ECON MODEL, V32, P30, DOI 10.1016/j.econmod.2013.01.020; Mukherjee A, 2007, MANCH SCH, V75, P297, DOI 10.1111/j.1467-9957.2007.01018.x; Mukherjee A, 2008, J ECON, V93, P59, DOI 10.1007/s00712-007-0293-z; Mukherjee A, 2011, INT J IND ORGAN, V29, P232, DOI 10.1016/j.ijindorg.2010.06.001; Pires A. J. G., 2014, J IND COMPET TRADE, V14, P229; SPENCER BJ, 1983, REV ECON STUD, V50, P707, DOI 10.2307/2297771; Takauchi K., 2012, 36843 MPRA; Takauchi K., 2011, EC B, V31, P2319	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	APR	2015	46						36	43		10.1016/j.econmod.2014.12.019		8	Economics	Business & Economics	CE6UW	WOS:000351974700004		
J	Nakamura, T; Takami, H				Nakamura, Tamotsu; Takami, Hiroyuki			Nash bargaining and partial privatization in mixed oligopoly	ECONOMIC MODELLING			English	Article						Nash bargaining; Mixed oligopoly; Partial privatization; Stackelberg equilibrium	OBJECTIVE FUNCTION; MARKET; DUOPOLY; POLICY; MANIPULATION; UNIONS; FIRMS	Neither full nationalization nor full privatization is optimal under moderate conditions in homogenous mixed oligopoly. The result is obtained assuming that a partially-privatized firm maximizes a weighted sum of its profits and the total surplus. If, however, a firm is jointly owned by two different interest parties, the decisions must be made as a result of bargaining between them. This paper shows that the non-optimality result holds even if the privatized firm's strategy is determined by Nash bargaining between the private sector and the public sector. Although partial privatization is optimal for both cases, the optimal degree of partial privatization is different. It is smaller with bargaining than without bargaining. (c) 2015 Elsevier B.V. All rights reserved.	[Nakamura, Tamotsu] Kobe Univ, Grad Sch Econ, Kobe, Hyogo 6578501, Japan; [Takami, Hiroyuki] Oita Univ, Fac Econ, Oita, Japan	Nakamura, T (reprint author), Kobe Univ, Grad Sch Econ, Nada Ku, 2-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	nakamura@econ.kobe-u.ac.jp			Japan Society for the Promotion of Science [23530325]	We would like to thank the editor and an anonymous referee for their useful comments and suggestions. Earlier versions of this paper were presented at the 2012 Spring Meeting of the Japanese Association of Applied Economics, the 2012 Annual Meeting of the Korean Economics and Business Association, and seminars in the University of Florida and Oita University. We are grateful to the participants in these workshops, especially David Denslow, Jon Hamilton, Sang-Ho Lee, Shozo Murata, Richard Romano and Norio Shimoda for their valuable comments. The financial support of Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant no 23530325) is gratefully acknowledged. The usual disclaimer applies.	Megginson WL, 2001, J ECON LIT, V39, P321, DOI 10.1257/jel.39.2.321; Wang LFS, 2011, ECON MODEL, V28, P1465, DOI 10.1016/j.econmod.2011.02.033; Pal D, 1998, SOUTHERN ECON J, V65, P264, DOI 10.2307/1060667; Heywood JS, 2009, B ECON RES, V61, P165, DOI 10.1111/j.1467-8586.2008.00301.x; Fujiwara K, 2007, J ECON, V92, P51, DOI 10.1007/s00712-007-0267-1; Matsumura T, 2010, MANCH SCH, V78, P609, DOI 10.1111/j.1467-9957.2009.02147.x; DEFRAJA G, 1989, OXFORD ECON PAP, V41, P302; Heywood JS, 2010, J ECON, V101, P231, DOI 10.1007/s00712-010-0156-x; Benassi C, 2014, J ECON, V112, P61, DOI 10.1007/s00712-012-0332-2; Chao C. C., 2006, REV INT ECON, V14, P87, DOI 10.1111/j.1467-9396.2006.00562.x; Choi K, 2011, ECON MODEL, V28, P2502, DOI 10.1016/j.econmod.2011.06.025; Dadpay A., 2006, AUST ECON PAP, V45, P269, DOI 10.1111/j.1467-8454.2006.00292.x; DEFRAJA G, 1993, OXFORD ECON PAP, V45, P457; Han LH, 2012, B ECON RES, V64, P125, DOI 10.1111/j.1467-8586.2010.00372.x; Hsu SY, 2014, ECON MODEL, V38, P196, DOI 10.1016/j.econmod.2013.12.025; Jiang L, 2006, CONTEMP ECON POLICY, V24, P395, DOI 10.1093/cep/byj029; Kamijo Y, 2014, ECON MODEL, V39, P101, DOI 10.1016/j.econmod.2014.02.014; Matsumura T, 1998, J PUBLIC ECON, V70, P473, DOI 10.1016/S0047-2727(98)00051-6; White MD, 2002, J ECON BEHAV ORGAN, V49, P487, DOI 10.1016/S0167-2681(02)00009-4; Willner J, 1999, INT J IND ORGAN, V17, P137, DOI 10.1016/S0167-7187(97)00036-2	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	APR	2015	46						315	321		10.1016/j.econmod.2014.12.026		7	Economics	Business & Economics	CE6UW	WOS:000351974700027		
J	Ko, JH; Morita, H				Ko, Jun-Hyung; Morita, Hiroshi			Fiscal sustainability and regime shifts in Japan	ECONOMIC MODELLING			English	Article						Debt-GDP ratio; Fiscal sustainability; Ricardian regime; Dynamic inefficiency; Markov-switching VAR	MONETARY-POLICY; LOST DECADE; BUDGET; DEBT; DEFICITS; RESTRICTIONS; CONSTRAINTS; SOLVENCY; ECONOMY; BURDEN	This paper examines fiscal sustainability conditions in the Japanese economy estimating a Markov-switching vector autoregressive (VAR) model. Three fiscal sustainability conditions are identified in one VAR model: the stance of government, Domar (1944)-type GDP growth, and other factors. The main findings are summarized as follows. First, a regime switch occurred in the early 1990s. In the first regime, it appears that the government adopted the Ricardian stance to past debt levels, while such fiscal reactions are not observed in the second regime. Furthermore, only in the second regime, Domar (1944)-type income growth significantly decreases the debt-GDP ratio. Second, however, the contributions of these two shocks are minor in explaining historical variances of the debt-GDP ratio in both regimes. Third, forecast simulations reveal that the debt-GDP ratio is not sustainable in the second regime. Fourth, counterfactual simulations show that around 2 percent nominal growth or a Ricardian fiscal stance can keep the debt-GDP ratio sustainable. (c) 2015 Elsevier B.V. All rights reserved.	[Ko, Jun-Hyung] Aoyama Gakuin Univ, Dept Econ, Shibuya Ku, Tokyo 1508366, Japan; [Morita, Hiroshi] Hitotsubashi Univ, Grad Sch Econ, Kunitachi, Tokyo 1868603, Japan	Ko, JH (reprint author), Aoyama Gakuin Univ, Dept Econ, Shibuya Ku, 4-4-25 Shibuya, Tokyo 1508366, Japan.	kojunhyung@aoyamagakuin.jp; hiroshi.morita1013@gmail.com					Christiano LJ, 2005, J POLIT ECON, V113, P1, DOI 10.1086/426038; Mendoza EG, 2008, J MONETARY ECON, V55, P1081, DOI 10.1016/j.jmoneco.2008.06.003; Sakuragawa M, 2010, JPN ECON REV, V61, P517, DOI 10.1111/j.1468-5876.2009.00503.x; Ahmed S, 1995, J MONETARY ECON, V36, P351, DOI 10.1016/0304-3932(95)01215-X; BURBIDGE J, 1985, J MONETARY ECON, V16, P45, DOI 10.1016/0304-3932(85)90005-4; Dedola L, 2007, J MONETARY ECON, V54, P512, DOI 10.1016/j.jmoneco.2005.06.006; Domar ED, 1944, AM ECON REV, V34, P798; Bohn H, 2007, J MONETARY ECON, V54, P1837, DOI 10.1016/j.jmoneco.2006.12.012; Sakuragawa M, 2011, J JPN INT ECON, V25, P434, DOI 10.1016/j.jjie.2011.10.002; Sims CA, 1998, INT ECON REV, V39, P949, DOI 10.2307/2527347; HAKKIO CS, 1991, ECON INQ, V29, P429; Doi T, 2011, J JPN INT ECON, V25, P414, DOI 10.1016/j.jjie.2011.09.006; Mountford A, 2009, J APPL ECONOM, V24, P960, DOI 10.1002/jae.1079; Hayashi F, 2002, REV ECON DYNAM, V5, P206, DOI 10.1006/redy.2001.0149; Arai R, 2013, J JPN INT ECON, V30, P59, DOI 10.1016/j.jjie.2013.10.003; Beaudry P, 2006, AM ECON REV, V96, P1293, DOI 10.1257/aer.96.4.1293; Ball L, 1998, J MONEY CREDIT BANK, V30, P699, DOI 10.2307/2601125; Blanchard O., 2001, BE J MACROECON ADV M, V1, P3; BLANCHARD OJ, 1989, AM ECON REV, V79, P655; Bohn H, 1998, Q J ECON, V113, P949, DOI 10.1162/003355398555793; Braun R. A., 2011, IMPLICATIONS G UNPUB; Budina N, 2009, WORLD BANK ECON REV, V23, P119, DOI 10.1093/wber/lhn011; Canzoneri MB, 2001, AM ECON REV, V91, P1221, DOI 10.1257/aer.91.5.1221; Celasun O., 2006, IMF STAFF PAPERS, P3; Corsetti G., 2012, HAS AUSTERITY GONE T, P20; Domar ED, 1945, AM ECON REV, V35, P414; Favero C., 2007, 12822 NBER; HAMILTON JD, 1986, AM ECON REV, V76, P808; Imrohoroglu S., 2011, KEIZAI KENKYU, V62, P44; Imrohoroglu S., 2013, ACHIEVING FISC UNPUB; Inoue T, 2008, J JPN INT ECON, V22, P320, DOI 10.1016/j.jjie.2007.11.002; International Monetary Fund, 2002, ASS SUST; Ito A, 2011, J JPN INT ECON, V25, P380, DOI 10.1016/j.jjie.2011.09.001; Kim C. -J., 1999, STATE SPACE MODELS R, V1; Ko J., 2011, EC B, V31, P2373; Ko J. H., 2015, KEIZAIKENKYU, V7; Ko J. H., 2012, GLOBAL COE HI STAT D, V270; Ko JH, 2013, JPN WORLD ECON, V27, P10, DOI 10.1016/j.japwor.2013.03.001; Muto I, 2012, 12E9 BANK JAP; Nakajima J, 2011, J JPN INT ECON, V25, P225, DOI 10.1016/j.jjie.2011.07.004; Pescatori A., 2011, IMF WORKING PAPERS, V11, P128; Polito V, 2012, EUR ECON REV, V56, P526, DOI 10.1016/j.euroecorev.2011.12.003; Reinhart Carmen M., 2011, NBER WORKING PAPERS; SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017; Tanner E, 2003, APPL ECON, V35, P859, DOI 10.1080/0003684032000056832; TREHAN B, 1991, J MONEY CREDIT BANK, V23, P206, DOI 10.2307/1992777	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	APR	2015	46						364	375		10.1016/j.econmod.2015.02.008		12	Economics	Business & Economics	CE6UW	WOS:000351974700032		
J	Hobbs, RM; La, HM; Makela, JA; Kobayashi, T; Noda, T; Pandolfi, PP				Hobbs, Robin M.; La, Hue M.; Maekelaa, Juho-Antti; Kobayashi, Toshiyuki; Noda, Tetsuo; Pandolfi, Pier Paolo			Distinct germline progenitor subsets defined through Tsc2-mTORC1 signaling	EMBO REPORTS			English	Article						differentiation; germline stem cells; mTORC1	SPERMATOGONIAL STEM-CELLS; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; RETINOIC ACID; SERTOLI-CELLS; MOUSE; DIFFERENTIATION; MTOR; SPERMATOGENESIS; MAINTENANCE	Adult tissue maintenance is often dependent on resident stem cells; however, the phenotypic and functional heterogeneity existing within this self-renewing population is poorly understood. Here, we define distinct subsets of undifferentiated spermatogonia (spermatogonial progenitor cells; SPCs) by differential response to hyperactivation of mTORC1, a key growth-promoting pathway. We find that conditional deletion of the mTORC1 inhibitor Tsc2 throughout the SPC pool using Vasa-Cre promotes differentiation at the expense of self-renewal and leads to germline degeneration. Surprisingly, Tsc2 ablation within a subset of SPCs using Stra8-Cre did not compromise SPC function. SPC activity also appeared unaffected by Amh-Cre-mediated Tsc2 deletion within somatic cells of the niche. Importantly, we find that differentiation-prone SPCs have elevated mTORC1 activity when compared to SPCs with high self-renewal potential. Moreover, SPCs insensitive to Tsc2 deletion are preferentially associated with mTORC1-active committed progenitor fractions. We therefore delineate SPC subsets based on differential mTORC1 activity and correlated sensitivity to Tsc2 deletion. We propose that mTORC1 is a key regulator of SPC fate and defines phenotypically distinct SPC subpopulations with varying propensities for self-renewal and differentiation.	[Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Res Inst, Dept Pathol & Med,Sch Med, Boston, MA 02215 USA; [Hobbs, Robin M.; La, Hue M.; Maekelaa, Juho-Antti] Australian Regenerat Med Inst, Clayton, Vic, Australia; [Hobbs, Robin M.; La, Hue M.; Maekelaa, Juho-Antti] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Kobayashi, Toshiyuki] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan; [Noda, Tetsuo] JFCR Canc Inst, Dept Cell Biol, Tokyo, Japan	Pandolfi, PP (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Res Inst, Dept Pathol & Med,Sch Med, Boston, MA 02215 USA.	robin.hobbs@monash.edu; ppandolf@bidmc.harvard.edu			NIH; NHMRC Project [APP1062197]; Sigrid Juselius Foundation	We would like to thank all members of the Pandolfi and Hobbs laboratories for helpful discussion. We are especially grateful for the experimental assistance and advice of Ai-Leen Chan, Mia De Seram and Antonella Papa. This work was supported by NIH grants to PPP and NHMRC Project Grant APP1062197 to RMH. JM is supported by a fellowship from the Sigrid Juselius Foundation.	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; De Rosa L, 2012, NATURE, V489, P215, DOI 10.1038/489215a; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Tanwar PS, 2012, HUM MOL GENET, V21, P4394, DOI 10.1093/hmg/dds272; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI 10.1073/pnas.0807297105; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Carlone DL, 2012, CELL STEM CELL, V10, P2, DOI 10.1016/j.stem.2011.12.012; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Malagelada C, 2011, J NEUROSCI, V31, P3186, DOI 10.1523/JNEUROSCI.4011-10.2011; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.3.CO;2-7; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI [10.1016/j.devcel.2010.02.018, 10.1016/j.devce1.2010.02.018]; Jijiwa M, 2008, GENES CELLS, V13, P365, DOI 10.1111/j.1365-2443.2008.01171.x; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Gely-Pernot A, 2012, ENDOCRINOLOGY, V153, P438, DOI 10.1210/en.2011-1102; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Kofman AE, 2012, AGING-US, V4, P279; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	APR	2015	16	4					467	480				14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CE9MG	WOS:000352167500010		
J	Oyama, T				Oyama, Tsuneo			Prevention of stricture after large esophageal endoscopic submucosal dissections	ENDOSCOPY			English	Editorial Material							BIODEGRADABLE STENTS; INJECTION; EFFICACY		[Oyama, Tsuneo] Saku Cent Hosp, Dept Gastroenterol, Nagano, Japan	Oyama, T (reprint author), Saku Cent Hosp, Adv Care Ctr Endoscopy, 3400-28 Nakagomi, Saku, Nagano 3850051, Japan.	oyama@coral.ocn.ne.jp					Saito Y, 2008, DIGEST DIS SCI, V53, P330, DOI 10.1007/s10620-007-9873-6; Sakaguchi Y, 2015, ENDOSCOPY, V47, P336, DOI 10.1055/s-0034-1390787; Repici A, 2010, GASTROINTEST ENDOSC, V72, P927, DOI 10.1016/j.gie.2010.07.031; Ezoe Y, 2011, J CLIN GASTROENTEROL, V45, P222, DOI 10.1097/MCG.0b013e3181f39f4e; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Pauli EM, 2012, SURG ENDOSC, V26, P3500, DOI 10.1007/s00464-012-2373-6; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Sato H, 2013, GASTROINTEST ENDOSC, V78, P250, DOI 10.1016/j.gie.2013.01.008; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Iizuka T, 2015, ENDOSCOPY, V47; Oyama Tsuneo, 2005, Clin Gastroenterol Hepatol, V3, pS67, DOI 10.1016/S1542-3565(05)00291-0	12	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	APR	2015	47	4					289	290		10.1055/s-0034-1391733		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CE8PO	WOS:000352106000001		
J	Sakaguchi, Y; Tsuji, Y; Ono, S; Saito, I; Kataoka, Y; Takahashi, Y; Nakayama, C; Shichijo, S; Matsuda, R; Minatsuki, C; Asada-Hirayama, I; Niimi, K; Kodashima, S; Yamamichi, N; Fujishiro, M; Koike, K				Sakaguchi, Yoshiki; Tsuji, Yosuke; Ono, Satoshi; Saito, Itaru; Kataoka, Yosuke; Takahashi, Yu; Nakayama, Chiemi; Shichijo, Satoki; Matsuda, Rie; Minatsuki, Chihiro; Asada-Hirayama, Itsuko; Niimi, Keiko; Kodashima, Shinya; Yamamichi, Nobutake; Fujishiro, Mitsuhiro; Koike, Kazuhiko			Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection	ENDOSCOPY			English	Article							TRIAMCINOLONE INJECTION	Background and study aims: Suitable techniques for the prevention of stricture formation after esophageal endoscopic submucosal dissection (ESD) are still lacking. We investigated the efficacy of polyglycolic acid (PGA) sheets with fibrin glue to prevent post-ESD stricture. Patients and methods: We conducted a pilot study on a total of eight consecutive patients who underwent esophageal ESD that left a mucosal defect of more than three-quarters of the esophageal circumference. PGA sheets were attached to the defect with fibrin glue immediately after the completion of ESD. The primary end-point was the incidence of post-ESD stricture. The secondary endpoints were the number of sessions of endoscopic balloon dilation (EBD) required to resolve any stricture and the rate of complications. Results: There were no adverse events related to the use of PGA sheets and fibrin glue. Post-ESD stricture occurred in 37.5% of the subjects and 0.8 +/- 1.2 sessions of EBD were required. Conclusion: The use of PGA sheets and fibrin glue after esophageal ESD is a novel method that radically decreases the incidence of esophageal stricture and the number of EBD sessions subsequently required. University Hospital Medical Network Clinical Trial Registry (UMIN000011058).	[Sakaguchi, Yoshiki; Tsuji, Yosuke; Ono, Satoshi; Saito, Itaru; Kataoka, Yosuke; Takahashi, Yu; Nakayama, Chiemi; Shichijo, Satoki; Matsuda, Rie; Minatsuki, Chihiro; Asada-Hirayama, Itsuko; Niimi, Keiko; Kodashima, Shinya; Yamamichi, Nobutake; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Tsuji, Yosuke; Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop, Tokyo 1138655, Japan; [Niimi, Keiko] Univ Tokyo, Grad Sch Med, Ctr Epidemiol & Prevent Med, Tokyo 1138655, Japan	Fujishiro, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mtfujish-kkr@umin.ac.jp	Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takahashi, Yu/0000-0002-3066-9501			Ono S, 2014, ENDOSCOPY, V46, pE44, DOI 10.1055/s-0033-1359125; Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; Ono S, 2009, ENDOSCOPY, V41, P661, DOI 10.1055/s-0029-1214867; Ezoe Y, 2011, J CLIN GASTROENTEROL, V45, P222, DOI 10.1097/MCG.0b013e3181f39f4e; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Petersen B, 2004, GASTROINTEST ENDOSC, V60, P327, DOI 10.1016/S0016-5107(04)01564-0; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Ishida T, 2014, DIG ENDOSC, DOI 2910.111/den.12317; Ohki Takeshi, 2014, Gastrointest Endosc Clin N Am, V24, P273, DOI 10.1016/j.giec.2013.11.003; Ono S, 2012, WORLD J GASTROINTEST, V16, P162; Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Yamashina T, 2013, ENDOSCOPY, V45, pE92, DOI 10.1055/s-0032-1326253	15	7	7	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	APR	2015	47	4					336	340		10.1055/s-0034-1390787		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CE8PO	WOS:000352106000010		
J	Iizuka, T; Kikuchi, D; Yamada, A; Hoteya, S; Kajiyama, Y; Kaise, M				Iizuka, Toshiro; Kikuchi, Daisuke; Yamada, Akihiro; Hoteya, Shu; Kajiyama, Yoshiaki; Kaise, Mitsuru			Polyglycolic acid sheet application to prevent esophageal stricture after endoscopic submucosal dissection for esophageal squamous cell carcinoma	ENDOSCOPY			English	Article							FIBRIN GLUE; TRIAMCINOLONE INJECTION; RESECTION; CANCER	Background and study aim: Esophageal stricture following endoscopic submucosal dissection (ESD) can be a serious complication in patients with large mucosal defects. This preliminary study examined the efficacy of using a polyglycolic acid (PGA) sheet with fibrin glue for the prevention of esophageal stricture after ESD. Patients and methods: A total of 15 patients were enrolled. After resection, PGA sheets were placed over the surgical wound. The size of the mucosal defect was estimated by dividing the circumference of the esophagus into 12 parts of equal size. The occurrence of esophageal stricture at 6 weeks, along with the proportion of patients who had PGA sheet remaining in place 1 week and 2 weeks after ESD, and the occurrence of adverse events were investigated. Results: The size of mucosal defects in the 15 patients were 7/12 (n= 4), 8/12 (n= 5), 9/12 (n= 4), 10/12 (n= 1) and 11/12 (n= 1). Esophageal stricture occurred in 1/13 patients (7.7 %; two patients were not included in the analysis because they had required surgical resection during the follow-up period). The PGA sheet remained at 1 week after ESD in 13/15 patients (86.7 %) and at 2 weeks after ESD in 6/15 patients (40 %). No adverse events were observed. Conclusion: PGA sheets may have the potential to prevent esophageal stricture.	[Iizuka, Toshiro; Kikuchi, Daisuke; Yamada, Akihiro; Hoteya, Shu; Kaise, Mitsuru] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo 1058470, Japan; [Iizuka, Toshiro; Kajiyama, Yoshiaki] Juntendo Univ, Dept Upper Gastrointestinal Surg, Tokyo, Japan	Iizuka, T (reprint author), Toranomon Gen Hosp, Dept Gastroenterol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	t-iizuka@toranomon.gr.jp					Ono S, 2014, ENDOSCOPY, V46, pE44, DOI 10.1055/s-0033-1359125; Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Katada C, 2003, GASTROINTEST ENDOSC, V57, P165, DOI 10.1067/mge.2003.73; Hanaoka N, 2012, ENDOSCOPY, V44, P1007, DOI 10.1055/s-0032-1310107; Hashimoto S, 2011, GASTROINTEST ENDOSC, V74, P1389, DOI 10.1016/j.gie.2011.07.070; Yamaguchi N, 2011, GASTROINTEST ENDOSC, V73, P1115, DOI 10.1016/j.gie.2011.02.005; Chung A, 2011, ENDOSCOPY, V43, P1025, DOI 10.1055/s-0030-1257049; Kumar V., 2010, PATHOLOGIC BASIS DIS; Shinozaki T, 2013, JPN J CLIN ONCOL, V43, P33, DOI 10.1093/jjco/hys186; Takeuchi J, 2013, J ORAL MAXIL SURG, V71, pE126, DOI 10.1016/j.joms.2012.08.012; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Ueda K, 2011, J SURG RES, V167, pE71, DOI 10.1016/j.jss.2009.11.009; Uemura K, 2009, HEPATO-GASTROENTEROL, V56, P1538; Yamashina T, 2013, ENDOSCOPY, V45, pE92, DOI 10.1055/s-0032-1326253; Yonezawa H, 2012, BRIT J ORAL MAX SURG, V50, pE43, DOI 10.1016/j.bjoms.2011.09.010	16	5	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	APR	2015	47	4					341	344		10.1055/s-0034-1390770		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CE8PO	WOS:000352106000011		
J	Irino, T; Nunobe, S; Hiki, N; Yamamoto, Y; Hirasawa, T; Ohashi, M; Fujisaki, J; Sano, T; Yamaguchi, T				Irino, Tomoyuki; Nunobe, Souya; Hiki, Naoki; Yamamoto, Yorimasa; Hirasawa, Toshiaki; Ohashi, Manabu; Fujisaki, Junko; Sano, Takeshi; Yamaguchi, Toshiharu			Laparoscopic-endoscopic cooperative surgery for duodenal tumors: a unique procedure that helps ensure the safety of endoscopic submucosal dissection	ENDOSCOPY			English	Article							DELAYED PERFORATION; GASTRIC-CANCER; RESECTION	A new rendezvous-style surgical technique has been developed to ensure the safety of endoscopic submucosal dissection (ESD) for duodenal tumors. The new technique, called "laparoscopicendoscopic cooperative surgery (LECS)," combines ESD with laparoscopic, reinforcing, seromuscular suturing. This case series report describes how three patients with a duodenal tumor were safely treated by LECS. ESD was performed by endoscopy, followed by closure of the mucosal defect using seromuscular suturing by laparoscopy. ESD was successfully completed in all patients. Endoscopic findings after suturing revealed that the mucosal defect was closed appropriately and tightly. None of the three patients experienced delayed perforation or stricture after LECS. LECS for extraction of duodenal tumors seems to be feasible and helps to ensure the safety of ESD in the duodenum.	[Irino, Tomoyuki; Nunobe, Souya; Hiki, Naoki; Ohashi, Manabu; Sano, Takeshi; Yamaguchi, Toshiharu] Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo 1358550, Japan; [Yamamoto, Yorimasa; Hirasawa, Toshiaki; Fujisaki, Junko] Canc Inst Hosp, Dept Gastroenterol, Tokyo 1358550, Japan	Hiki, N (reprint author), Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	naoki.hiki@jfcr.or.jp					Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Hanaoka N, 2010, ENDOSCOPY, V42, P1112, DOI 10.1055/s-0030-1255932; Jung JH, 2013, ENDOSCOPY, V45, P133, DOI 10.1055/s-0032-1326178; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Moreira Coutinho Azevedo Joao Luiz, 2008, Arquivos de Gastroenterologia, V45, P319, DOI 10.1590/S0004-28032008000400011; Inoue T, 2014, DIGEST ENDOSC, V26, P220, DOI 10.1111/den.12104; Mitsui T, 2013, SURG LAPARO ENDO PER, V23, pE217, DOI 10.1097/SLE.0b013e31828e3f94; Shen MY, 2008, HEPATO-GASTROENTEROL, V55, P947; Yamamoto Y, 2014, DIGEST ENDOSC, V26	10	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	APR	2015	47	4					349	351		10.1055/s-0034-1390909		3	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CE8PO	WOS:000352106000013		
J	Billen, J; Mandonx, T; Hashim, R; Ito, F				Billen, Johan; Mandonx, Tine; Hashim, Rosli; Ito, Fuminori			Exocrine glands of the ant Myrmoteras iriodum	ENTOMOLOGICAL SCIENCE			English	Article						Formicidae; intramandibular gland; mandibular gland; metapleural gland; venom gland	L HYMENOPTERA VESPIDAE; INTRAMANDIBULAR GLAND; FORMICINE ANTS; FINE-STRUCTURE; VENOM GLAND	This paper describes the morphological characteristics of nine major exocrine glands in workers of the formicine ant Myrmoteras iriodum. The elongate mandibles reveal along their entire length a conspicuous intramandibular gland, which contains both class-1 and class-3 secretory cells. The secretory cells of the mandibular glands show a peculiar appearance, with a branched end apparatus, which is unusual for ants. The other major glands (pro- and postpharyngeal gland, infrabuccal cavity gland, labial gland, metapleural gland, venom gland and Dufour gland) show common features for formicine ants. The precise function of the glands could not yet be experimentally demonstrated, and to clarify this will depend on the availability of live material of these enigmatic ants in future.	[Billen, Johan; Mandonx, Tine] Univ Leuven, Zool Inst, B-3000 Leuven, Belgium; [Hashim, Rosli] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Ito, Fuminori] Kagawa Univ, Fac Agr, Miki, Kagawa 76107, Japan	Billen, J (reprint author), Univ Leuven, KU Leuven Zool Inst, Naamsestr 59,Box 2466, B-3000 Leuven, Belgium.	johan.billen@bio.kuleuven.be	Hashim, Rosli/A-8555-2010		JSPS [24405010]	We are much indebted to An Vandoren and Alex Vrijdaghs for their skillful help in section preparation and scanning electron microscopy. This study was supported through a Grant-in-Aid for Scientific Research from JSPS (B, Nr 24405010).	Amaral JB, 2006, MICRON, V37, P154; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Billen J, 2002, BELG J ZOOL, V132, P175; Billen J, 2013, ARTHROPOD STRUCT DEV, V42, P173, DOI 10.1016/j.asd.2013.01.001; DELFINO G, 1983, MONIT ZOOL ITAL, V17, P263; AYRE GL, 1967, CAN ENTOMOL, V99, P408; SCHOETERS E, 1994, ZOOMORPHOLOGY, V114, P125, DOI 10.1007/BF00396645; DELFINO G, 1979, MONIT ZOOL ITAL, V13, P221; BAGNERES AG, 1991, EXPERIENTIA, V47, P106, DOI 10.1007/BF02041269; Billen J., 1984, ACTES C INSECTES SOC, V1, P121; Billen J, 2014, MYRMECOL NEWS, V19, P61; Leonardo A. M. C., 1978, Ciencia e Cultura, V30, P835; Eelen D, 2004, ARTHROPOD STRUCT DEV, V33, P471, DOI 10.1016/j.asd.2004.08.001; Gama V., 1982, NATURALIA, V7, P145; Grasso DA, 2004, INSECT SOC, V51, P74, DOI 10.1007/s00040-003-0700-6; HEFETZ A, 1985, Z NATURFORSCH C, V40, P665; HEFETZ A, 1978, BIOCHIM BIOPHYS ACTA, V543, P484, DOI 10.1016/0304-4165(78)90303-3; HOLLDOBLER B, 1984, Psyche (Cambridge), V91, P225, DOI 10.1155/1984/27318; Holldobler B., 1978, Psyche (Cambridge), V85, P285, DOI 10.1155/1978/23867; Holldobler B., 1990, ANTS; Holldobler B., 1985, PSYCHE, V91, P201, DOI 10.1155/1984/70141; Martins LCB, 2011, MICROSC RES TECHNIQ, V74, P763, DOI 10.1002/jemt.20956; MASCHWITZ U, 1964, Z VERGL PHYSIOL, V47, P596, DOI 10.1007/BF00303313; MOFFETT MW, 1986, INSECT SOC, V33, P85, DOI 10.1007/BF02224037; Morgan E. David, 2008, Myrmecological News, V11, P79; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Schoeters E, 1996, NETH J ZOOL, V46, P281; Schoeters E, 1998, ZOOMORPHOLOGY, V118, P245, DOI 10.1007/s004350050073	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					167	173		10.1111/ens.12107		7	Entomology	Entomology	CF5VO	WOS:000352625500004		
J	Wang, QS; Hanatani, I; Takeda, M; Oishi, K; Sakamoto, K				Wang, Qiushi; Hanatani, Ikumi; Takeda, Makio; Oishi, Katsutaka; Sakamoto, Katsuhiko			D2-like dopamine receptors mediate regulation of pupal diapause in Chinese oak silkmoth Antheraea pernyi	ENTOMOLOGICAL SCIENCE			English	Article						adenylate cyclase; cAMP; Lepidoptera; Saturniidae	APIS-MELLIFERA; FUNCTIONAL-CHARACTERIZATION; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; BRAIN; SILKWORM; CLONING; LOCALIZATION; EXPRESSION; BRASSICAE	The present study investigated the pharmacological properties of dopamine receptors that functioned in the termination of pupal diapause in the Chinese oak silkmoth, Antheraea pernyi (Lepidoptera: Saturniidae). Dopamine receptors are classified according to their structure and function into two subfamilies as D1- and D2-like receptors. D1-like receptors activate, whereas D2-like receptors inhibit, adenylate cyclase. We examined the effects of agonists and antagonists selective for D1- and D2-like receptors on the diapause state. As A.pernyi is a long-day species, pupal diapause is maintained during short days and can be terminated by exposure to a long-day photoperiod. The D2-like receptor-selective agonist quinpirole delayed the timing of adult emergence under long days, and the D2-receptor-selective antagonist sulpiride terminated pupal diapause even under a short-day photoperiod. The D1-like receptor-selective agonist and antagonist, SKF-38393 and SCH-23390, respectively, caused no significant effects on diapause pupae. These results suggest that not D1- but D2-like receptors mediated diapause regulation in A.pernyi. This dopamine pathway appeared to block the termination of pupal diapause. Furthermore, the actions of the cAMP analog 8-CPT-cAMP and dopamine receptor antagonists upon diapause pupae were similar, which supports the notion that D2-like receptors involved in diapause of this insect prevent adenylate cyclase from producing cAMP like vertebrate D2-like receptors. Taken together, our findings suggest that dopamine blocked diapause termination through D2-like receptors that inhibited adenylate cyclase in A.pernyi. During short days under which diapause was maintained in pupae, the dopaminergic mechanism might be stimulated to suppress cAMP levels in cells regulating diapause.	[Wang, Qiushi; Hanatani, Ikumi; Takeda, Makio; Sakamoto, Katsuhiko] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan	Sakamoto, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ksakamoto@diamond.kobe-u.ac.jp					Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Blenau W, 1998, J NEUROCHEM, V70, P15; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; PUIROUX J, 1990, ARCH INSECT BIOCHEM, V14, P57, DOI 10.1002/arch.940140202; Missale C, 1998, PHYSIOL REV, V78, P189; Noguchi H, 1997, FEBS LETT, V413, P157, DOI 10.1016/S0014-5793(97)00848-X; Noguchi H, 2001, EUR J BIOCHEM, V268, P774, DOI 10.1046/j.1432-1327.2001.01933.x; Baumann A, 2003, ENCY INSECTS, P91; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BODNARYK RP, 1975, LIFE SCI, V16, P1411, DOI 10.1016/0024-3205(75)90037-5; Denlinger DL, 2011, INSECT ENDOCRINOLOGY, P430; Feng GP, 1996, J NEUROSCI, V16, P3925; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Kot'al V, 2000, J INSECT PHYSL, V46, P887; Mitsumasu K, 2008, INSECT MOL BIOL, V17, P185, DOI 10.1111/j.1365-2583.2008.00792.x; RASENICK MM, 1978, J INSECT PHYSIOL, V24, P137, DOI 10.1016/0022-1910(78)90110-5; RASENICK MM, 1976, J INSECT PHYSIOL, V22, P1453, DOI 10.1016/0022-1910(76)90209-2; Sugimori KS, 1995, FEBS LETT, V362, P131; Tanaka Y, 1950, J SERICULT SCI JAPAN, V19, P429; Tauber MJ, 1986, SEASONAL ADAPTATIONS; Tohno Youhei, 2001, International Journal of Wild Silkmoth & Silk, V6, P17; Wang Q, 2014, ENTOMOLOGIC IN PRESS, DOI [10.1111/ens.12083, DOI 10.1111/ENS.12083]; Williams C M, 1969, Symp Soc Exp Biol, V23, P285; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					193	198		10.1111/ens.12099		6	Entomology	Entomology	CF5VO	WOS:000352625500006		
J	Tsushima, Y; Nakamura, K; Tagami, Y; Miura, K				Tsushima, Yusuke; Nakamura, Kayo; Tagami, Yohsuke; Miura, Kazuki			Mating rates and the prevalence of male-killing Spiroplasma in Harmonia axyridis (Coleoptera: Coccinellidae)	ENTOMOLOGICAL SCIENCE			English	Article						copulation rate; ladybird beetle; male-killer	LADYBIRD BEETLE; MOLECULAR-IDENTIFICATION; COLEOMEGILLA-MACULATA; ADALIA-BIPUNCTATA; MALE-KILLERS; WOLBACHIA; MICROORGANISMS; POPULATION; BACTERIA; INSECTS	Maternally inherited bacteria that kill male but not female hosts during embryogenesis have been widely reported in invertebrates. Harmonia axyridis is one of the species infected by male-killing Spiroplasma. The presence of male-killers in host populations can lead to the occurrence of extremely female-biased sex ratios. Furthermore, infected females may have fewer chances to mate if males can discriminate between infected and uninfected females and prefer the latter. Although there have been many investigations of male-killer infection rates in H.axyridis, little is known about the influence of host mating on male-killer infection dynamics. We investigated copulation rates and changes in infection frequency in a wild population of H.axyridis in western Japan. Almost all infected females collected each year laid fertilized eggs and had therefore mated. Mean infection rates of females collected each year were 13% in 2003, 15% in 2012 and 23% in 2013. Statistical analysis showed that neither the copulation rate nor the infection rate differed significantly among years. These results suggest that the infection rate of H.axyridis with male-killing Spiroplasma is kept approximately constant and that there is no difference in the chance of mating with infected and uninfected females.	[Tsushima, Yusuke; Nakamura, Kayo; Miura, Kazuki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [Tagami, Yohsuke] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Miura, Kazuki] Western Reg Agr Res Ctr, Natl Agr & Food Res Org, Fukuyama, Hiroshima 7218514, Japan	Miura, K (reprint author), Western Reg Agr Res Ctr, Natl Agr & Food Res Org, 6-12-1 Nishifukatsu, Fukuyama, Hiroshima 7218514, Japan.	miurak@affrc.go.jp					C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081; HURST LD, 1991, P ROY SOC B-BIOL SCI, V244, P91, DOI 10.1098/rspb.1991.0056; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Majerus TMO, 1999, INSECT MOL BIOL, V8, P551, DOI 10.1046/j.1365-2583.1999.00151.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407; Randerson JP, 2000, HEREDITY, V84, P152, DOI 10.1046/j.1365-2540.2000.00645.x; Majerus TMO, 2012, EVOL ECOL, V26, P207, DOI 10.1007/s10682-011-9490-x; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; Tagami Y, 2001, J INVERTEBR PATHOL, V78, P267, DOI 10.1006/jipa.2002.5080; Hurst GDD, 1999, PARASITOLOGY, V118, P125, DOI 10.1017/S0031182098003655; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329; Groenenboom MAC, 2002, P ROY SOC B-BIOL SCI, V269, P2509, DOI 10.1098/rspb.2002.2197; Engelstadter J, 2009, HEREDITY, V103, P196, DOI 10.1038/hdy.2009.53; WERREN JH, 1994, J BACTERIOL, V176, P388; Hurst GDD, 1999, INSECT MOL BIOL, V8, P133, DOI 10.1046/j.1365-2583.1999.810133.x; Dixon AFG, 2000, INSECT PREDATOR PREY; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 1996, HEREDITY, V77, P177, DOI 10.1038/hdy.1996.122; Hurst GDD, 1998, ECOL ENTOMOL, V23, P350, DOI 10.1046/j.1365-2311.1998.00131.x; Hurst GDD, 1997, GENET RES, V70, P1, DOI 10.1017/S0016672397002838; Jiggins FM, 2002, EVOLUTION, V56, P2290; LAMB RY, 1979, EVOLUTION, V33, P774, DOI 10.2307/2407801; Majerus TMO, 1998, HEREDITY, V81, P683, DOI 10.1046/j.1365-2540.1998.00438.x; Nakamura K, 2005, ANN ENTOMOL SOC AM, V98, P96, DOI 10.1603/0013-8746(2005)098[0096:POIMMI]2.0.CO;2; Nelder J., 1989, GEN LINEAR MODELS; R Development Core Team, 2013, R LANG ENV STAT COMP; Randerson JP, 1999, J EVOLUTION BIOL, V12, P1110, DOI 10.1046/j.1420-9101.1999.00112.x; Wajnberg Eric, 2008, P402; Williamson DL, 1979, MYCOPLASMAS, P175; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					217	220		10.1111/ens.12113		4	Entomology	Entomology	CF5VO	WOS:000352625500009		
J	Kudo, A; Takamori, H; Watabe, H; Ishikawa, Y; Matsuo, T				Kudo, Ayumi; Takamori, Hisaki; Watabe, Hideaki; Ishikawa, Yukio; Matsuo, Takashi			Variation in morphological and behavioral traits among isofemale strains of Drosophila prolongata (Diptera: Drosophilidae)	ENTOMOLOGICAL SCIENCE			English	Article						aggressive interactions; mating behavior; polymorphism; sexual dimorphism	GRASSHOPPER PODISMA-SAPPORENSIS; BODY-SIZE; SEXUAL SELECTION; ANTIPREDATOR STRATEGIES; AGGRESSIVE-BEHAVIOR; NATURAL-POPULATIONS; COURTSHIP BEHAVIOR; SPERM COMPETITION; GENETIC-BASIS; MELANOGASTER	Drosophila prolongata, a member of the rhopaloa subgroup of the melanogaster species group, occurs in Southeast Asia. Drosophila prolongata is known to have unique and prominent sexual dimorphism, with extraordinarily thick and elongated forelegs only in males. Mating behavior of D.prolongata is also characteristic: males perform leg vibration in their courtship toward females, in which the elongated forelegs play an important role. Comparisons with closely related species suggest that these morphological and behavioral traits have evolved rapidly after the divergence of D.prolongata. In the present study, variation in morphological and behavioral traits was examined among D.prolongata strains derived from single females collected in their natural habitats. Significant variations were detected in the size of various body parts, aggressiveness of interactions between males, and mating behavior. However, no obvious relationship was observed between morphological and behavioral traits. These results suggested that genetic factors contribute to the variation in morphological and behavioral traits in D.prolongata. The strains characterized in this study are useful for studies on the genetic mechanisms underlying the evolution of characteristic traits in D.prolongata.	[Kudo, Ayumi; Ishikawa, Yukio; Matsuo, Takashi] Univ Tokyo, Dept Agr & Environm Biol, Tokyo 1138657, Japan; [Takamori, Hisaki] Tokyo Gakugei Univ, Adv Support Ctr Sci Teachers, Koganei, Tokyo 184, Japan; [Watabe, Hideaki] Hokkaido Univ, Biol Lab, Sapporo, Hokkaido, Japan	Matsuo, T (reprint author), Univ Tokyo, Dept Agr & Environm Biol, Appl Entomol Lab, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	matsuo@utlae.org			JSPS KAKENHI [23128511, 25128702]	This work was supported by JSPS KAKENHI Grant Number 23128511 and 25128702 to TM.	Allen GR, 1996, ANIM BEHAV, V52, P737, DOI 10.1006/anbe.1996.0218; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; SIMMONS LW, 1986, ANIM BEHAV, V34, P1463, DOI 10.1016/S0003-3472(86)80217-2; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Sugano YC, 2007, ETHOLOGY, V113, P301, DOI 10.1111/j.1439-0310.2006.01321.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Narraway C, 2010, J EVOLUTION BIOL, V23, P2550, DOI 10.1111/j.1420-9101.2010.02113.x; Kotiaho J, 1996, EVOLUTION, V50, P1977, DOI 10.2307/2410755; Setoguchi S, 2014, J ETHOL, V32, P91, DOI 10.1007/s10164-014-0399-z; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Miyatake T, 2008, ANIM BEHAV, V75, P113, DOI 10.1016/j.anbehav.2007.04.019; Markow TA, 2002, EVOLUTION, V56, P1725; Hack MA, 1997, ANIM BEHAV, V53, P733, DOI 10.1006/anbe.1996.0310; TODA MJ, 1991, ORIENT INSECTS, V25, P69; Chakir M, 2008, J GENET, V87, P373, DOI 10.1007/s12041-008-0060-0; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brower AVZ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2302; Cabral LG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001986; Chakir M, 2011, ANN SOC ENTOMOL FR, V47, P371; David JR, 2006, HEREDITY, V96, P53, DOI 10.1038/sj.hdy.6800753; Edwards AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r76; Fitzsimmons LP, 2013, BEHAV ECOL SOCIOBIOL, V67, P213, DOI 10.1007/s00265-012-1441-1; FUJISAKI K, 1981, RES POPUL ECOL, V23, P262, DOI 10.1007/BF02515630; GROMKO MH, 1988, BEHAV GENET, V18, P621, DOI 10.1007/BF01082313; Jorge AS, 2011, NEOTROP ENTOMOL, V40, P305, DOI 10.1590/S1519-566X2011000300003; Joron M, 2006, HEREDITY, V97, P157, DOI 10.1038/sj.hdy.6800873; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kimura MT, 2001, TROPICS, V10, P489; Markow TA, 1996, EVOL BIOL, V29, P73; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; MIYATAKE T, 1993, J ETHOL, V11, P63, DOI 10.1007/BF02350007; Moreteau B, 2003, J ZOOL SYST EVOL RES, V41, P64, DOI 10.1046/j.1439-0469.2003.00195.x; Nakayama S, 2009, EVOL ECOL, V23, P711, DOI 10.1007/s10682-008-9266-0; Ohno T, 2007, P R SOC B, V274, P555, DOI 10.1098/rspb.2006.3750; Pavkovic-Lucic S, 2011, REV BRAS ENTOMOL, V55, P583; PYLE DW, 1981, AM NAT, V117, P133, DOI 10.1086/283694; R Core Team, 2013, R LANG ENV STAT COMP; Singh B.K., 1979, Proceedings of the Zoological Society (Calcutta), V30, P31; Stange N, 2012, J COMP PHYSIOL A, V198, P763, DOI 10.1007/s00359-012-0746-x; Sugano Yoshikazu C., 2008, Journal of Orthoptera Research, V17, P243, DOI 10.1665/1082-6467-17.2.243; Suwito Awit, 2012, Treubia, V39, P77; Wong A, 2011, INT J EVOL BIOL, V2011; Yassin A, 2011, J ZOOL SYST EVOL RES, V49, P32, DOI 10.1111/j.1439-0469.2010.00574.x	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					221	229		10.1111/ens.12116		9	Entomology	Entomology	CF5VO	WOS:000352625500010		
J	Kaizuka, J; Iwasa, M				Kaizuka, Jun; Iwasa, Mitsuhiro			Carabid beetles (Coleoptera: Carabidae) in coniferous plantations in Hokkaido, Japan: effects of tree species and environmental factors	ENTOMOLOGICAL SCIENCE			English	Article						abundance; bioindicator; distribution; foliage layer; forest species; soil moisture; specialist	GROUND-BEETLES; ASSEMBLAGES COLEOPTERA; SOUTHWESTERN CHINA; FOREST MANAGEMENT; COMMUNITIES; DIVERSITY; CONSERVATION; SUCCESSION; FRAGMENTATION; INVERTEBRATES	The distribution, species composition and abundance of carabid beetles in monospecific plantations of three different coniferous tree species (Japanese spruce, Sakhalin fir and larch) were investigated by baited pitfall traps in Hokkaido, Japan. In total, 16150 carabid beetles consisting of 31 species in 13 genera were collected in 2011 and 2012. The most predominant species was Pterostichus thunbergiiMorawitz, followed by Synuchus melantho (Bates) and Carabus opaculus (Putzeys). Average numbers of beetles per trap were significantly reduced in larch. Large-sized Carabus species (C.arboreus arboreusLewis and C.opaculus) were collected in large numbers in Japanese spruce. There was no significant difference in diversity and equitability among the three kinds of plantation. The ordination of redundancy analysis showed that medium-sized forest generalists, Pterosticus subovatus (Motschulsky) and P.thunbergii, were highly associated with Japanese spruce and Sakhalin fir, and the forest specialist Synuchus nitidus (Motschulsky) was with Sakhalin fir. In contrast, in larch there was no such associated forest species, and some species of Carabus, Pterostichus and Synuchus were considerably reduced in number, suggesting that larch has unfavorable effects on some forest species. The most important environmental variables influencing carabid assemblages were soil moisture and foliage layer cover. Practices in forest management to minimize the effects of plantations on carabid assemblages are discussed.	[Kaizuka, Jun; Iwasa, Mitsuhiro] Obihiro Univ Agr & Vet Med, Entomol Lab, Obihiro, Hokkaido 0808555, Japan	Iwasa, M (reprint author), Obihiro Univ Agr & Vet Med, Entomol Lab, Obihiro, Hokkaido 0808555, Japan.	iwasa@obihiro.ac.jp					Butterfield J, 1997, ECOGRAPHY, V20, P614, DOI 10.1111/j.1600-0587.1997.tb00430.x; Koivula M, 2002, BIODIVERS CONSERV, V11, P1269, DOI 10.1023/A:1016018702894; Magura T, 2002, EUR J SOIL BIOL, V38, P291, DOI 10.1016/S1164-5563(02)01162-7; Do Yuno, 2012, Baltic Journal of Coleopterology, V12, P65; Magura T, 2003, BIODIVERS CONSERV, V12, P73, DOI 10.1023/A:1021289509500; GREENSLADE PJM, 1964, J ANIM ECOL, V33, P301, DOI 10.2307/2632; Butterfield J, 1995, FOREST ECOL MANAG, V79, P63, DOI 10.1016/0378-1127(95)03620-2; Niemela J, 1997, CONSERV BIOL, V11, P601, DOI 10.1046/j.1523-1739.1997.06008.x; Werner SM, 2000, FOREST ECOL MANAG, V139, P135, DOI 10.1016/S0378-1127(99)00341-2; Duchesne LC, 1999, ENVIRON MONIT ASSESS, V56, P87, DOI 10.1023/A:1005963508085; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Magura T, 2002, FOREST ECOL MANAG, V157, P23, DOI 10.1016/S0378-1127(00)00654-X; DAY KR, 1993, FORESTRY, V66, P37, DOI 10.1093/forestry/66.1.37; Kotze DJ, 1999, BIODIVERS CONSERV, V8, P1339, DOI 10.1023/A:1008945302029; Fahy O, 1998, FOREST ECOL MANAG, V110, P263, DOI 10.1016/S0378-1127(98)00285-0; NIEMELA J, 1993, CONSERV BIOL, V7, P551, DOI 10.1046/j.1523-1739.1993.07030551.x; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Taboada A, 2008, BASIC APPL ECOL, V9, P161, DOI 10.1016/j.baae.2007.01.004; BAGUETTE M, 1993, PEDOBIOLOGIA, V37, P129; Magura T, 2000, BIOL CONSERV, V93, P95, DOI 10.1016/S0006-3207(99)00073-7; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; HALME E, 1993, ANN ZOOL FENN, V30, P17; Koivula M, 2006, FOREST ECOL MANAG, V236, P102, DOI 10.1016/j.foreco.2006.09.004; Niemela J, 2001, EUR J ENTOMOL, V98, P127; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Spence JR, 1996, ANN ZOOL FENN, V33, P173; Koivula M, 2003, ECOGRAPHY, V26, P179, DOI 10.1034/j.1600-0587.2003.03340.x; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; Fuller RJ, 2008, INSECT CONSERV DIVER, V1, P242, DOI 10.1111/j.1752-4598.2008.00032.x; Jukes MR, 2001, FOREST ECOL MANAG, V148, P271, DOI 10.1016/S0378-1127(00)00530-2; Muller MM, 2002, FOREST ECOL MANAG, V166, P165, DOI 10.1016/S0378-1127(01)00671-5; Purtauf T, 2005, OECOLOGIA, V142, P458, DOI 10.1007/s00442-004-1740-y; Baker SC, 2006, AUST J ENTOMOL, V45, P130, DOI 10.1111/j.1440-6055.2006.00526.x; Butterfield J., 1992, ECOLOGY MIXED SPECIE, V11, P255; Cobb TP, 2007, CAN J FOREST RES, V37, P1310, DOI 10.1139/XO6-310; Eyre MD, 1996, ANN ZOOL FENN, V33, P157; Fujita A, 2008, ENTOMOL SCI, V11, P39, DOI 10.1111/j.1479-8298.2007.00243.x; Heliola J, 2001, CONSERV BIOL, V15, P370, DOI 10.1046/j.1523-1739.2001.015002370.x; Hiramatsu S, 2003, REPORT HAKUSAN NATUR, V30, P17; Hiramatsu S, 2004, REP HAKUSAN NAT CONS, V31, P55; Hori S, 2003, B HIST MUSEUM HOKKAI, V31, P15; Ings TC, 1999, FOREST ECOL MANAG, V119, P123, DOI 10.1016/S0378-1127(98)00517-9; Ishitani Masahiro, 1996, Miscellaneous Reports of the Hiwa Museum for Natural History, V34, P1; Kimoto S, 1995, GROUND BEETLES HOKKA; Koivula M, 2004, J INSECT CONSERV, V8, P297, DOI 10.1007/s10841-004-0296-9; Kwiatkowski A, 2011, ZOOKEYS, P447, DOI 10.3897/zookeys.100.1539; Magura T, 2004, LANDSCAPE ECOL, V19, P747, DOI 10.1007/s10980-005-1128-4; Ministry of the Environment, 2006, THREAT WILD LIF JAP, V5; Morimoto K., 2007, ICONOGRAPHIA INSECTO, VII; Niemela J, 1990, NOT ENTOMOL, V69, P169; Niemela J, 1994, PERSPECTIVES INSECT, P29; NIEMALA J, 1992, CAN ENTOMOL, V124, P521; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; Paje J, 1984, OECOLOGIA, V64, P41; R Development Core Team, 2012, R LANG ENV STAT COMP; Thiele HU, 1977, CARABID BEETLES THEI; Ueda A., 2009, Journal of the Japanese Forest Society, V91, P111, DOI 10.4005/jjfs.91.111; Yu XD, 2006, FOREST ECOL MANAG, V231, P169, DOI 10.1016/j.foreco.2006.05.043; Yu XD, 2008, FOREST ECOL MANAG, V255, P2617, DOI 10.1016/j.foreco.2008.01.019; Yu Xiao-Dong, 2002, Acta Ecologica Sinica, V22, P1724; Yu XD, 2007, ENVIRON ENTOMOL, V36, P348, DOI 10.1603/0046-225X(2007)36[348:DOCBCC]2.0.CO;2	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					245	253		10.1111/ens.12104		9	Entomology	Entomology	CF5VO	WOS:000352625500013		
J	Hosoishi, S; Tasen, W; Park, SH; Le Ngoc, A; Kuboki, Y; Ogata, K				Hosoishi, Shingo; Tasen, Wattanachai; Park, Sang-Hyun; Anh Le Ngoc; Kuboki, Yuzuru; Ogata, Kazuo			Annual fire resilience of ground-dwelling ant communities in Hiraodai Karst Plateau grassland in Japan	ENTOMOLOGICAL SCIENCE			English	Article						conservation; disturbance; Formicidae; management; Plagiolepis flavescens; seasonality; Temnothorax spinosior	BIODIVERSITY CONSERVATION; CALCAREOUS GRASSLANDS; NORTHERN AUSTRALIA; AFRICAN SAVANNA; ASSEMBLAGES; FORESTS; FORMICIDAE; MANAGEMENT	The fire resilience of ground-dwelling ant assemblages in grassland subjected to annual fire management was investigated. Study sites consisted of three burnt sites and three unburnt sites in grasslands on the Hiraodai Karst Plateau in Fukuoka Prefecture, Japan. Ground-dwelling ants were sampled by Winkler extraction and collected at 10 days and 1, 2, 3 and 6 months post-fire. In total 33 ant species belonging to 25 genera in six subfamilies were collected from the burnt and unburnt sites. Eight of the 29 ant species collected at burnt sites were restricted to burnt sites, while four of the 25 ant species collected at unburnt sites were restricted to unburnt sites. Non-metric multidimensional scaling and analysis of similarities revealed that the ant assemblages in the burnt sites at 10 days and 1 month post-fire were clearly separated from the assemblages observed at 2, 3 and 6 months post-fire. The results suggested that the ground-dwelling ant fauna in the study area were highly resilient to fire at 2 months post-fire and that the annual fire regime did not have a marked effect on species richness.	[Hosoishi, Shingo; Tasen, Wattanachai; Park, Sang-Hyun; Anh Le Ngoc; Kuboki, Yuzuru; Ogata, Kazuo] Kyushu Univ, Inst Trop Agr, Fukuoka 8128581, Japan; [Tasen, Wattanachai] Kasetsart Univ, Dept Forest Biol, Fac Forestry, Bangkok, Thailand; [Anh Le Ngoc] Hanoi Univ Agr, Dept Entomol, Hanoi, Vietnam	Hosoishi, S (reprint author), Kyushu Univ, Inst Trop Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	hosoishi@gmail.com			Global COE Program (Asian Conservation Ecology as a Basis of Human-nature Mutualism) of MEXT (The Ministry of Education, Culture, Sports, Science and Technology), Japan; JSPS KAKENHI [26440221]	We thank staff at the Hiraodai Natural Observation Center and Hiraodai Countryside Park for their assistance with the field surveys in this study. We also thank the officials of the Fukuoka Prefectural Government for granting us permission to conduct this study in Kitakyushu National Park. We thank Dr Martin Pfeiffer for his valuable comments on this paper. Thanks are also due to Mark Lorenz (Forte Inc.) for improving the English. This work was supported in part by the Global COE Program (Asian Conservation Ecology as a Basis of Human-nature Mutualism) of MEXT (The Ministry of Education, Culture, Sports, Science and Technology), Japan, and JSPS KAKENHI (Grant-in-Aid for Scientific Research (C)) Grant Number 26440221.	Barrow L, 2007, J ARID ENVIRON, V69, P80, DOI 10.1016/j.jaridenv.2006.08.005; van Swaay CAM, 2002, BIOL CONSERV, V104, P315, DOI 10.1016/S0006-3207(01)00196-3; Hellgren EC, 2010, J WILDLIFE MANAGE, V74, P300, DOI 10.2193/2009-090; Parr CL, 2008, AUSTRAL ECOL, V33, P830, DOI 10.1111/j.1442-9993.2008.01848.x; Farji-Brener AG, 2002, DIVERS DISTRIB, V8, P235, DOI 10.1046/j.1472-4642.2002.00133.x; Dekoninck W, 2007, BELG J ZOOL, V137, P137; ANDERSEN AN, 1985, AUST J ECOL, V10, P25, DOI 10.1111/j.1442-9993.1985.tb00860.x; Wikars LO, 2001, FOREST ECOL MANAG, V141, P189, DOI 10.1016/S0378-1127(00)00328-5; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Batary P, 2007, DIVERS DISTRIB, V13, P196, DOI 10.1111/j.1472-4642.2006.00309.x; Verble RM, 2013, ANN ENTOMOL SOC AM, V106, P198, DOI 10.1603/AN12108; [Anonymous], 2001, FUKUOKA PREFECTURAL; Underwood EC, 2010, J INSECT CONSERV, V14, P359, DOI 10.1007/s10841-010-9265-7; Woodcock BA, 2012, BIOL CONSERV, V146, P136, DOI 10.1016/j.biocon.2011.11.033; Ratchford JS, 2005, DIVERS DISTRIB, V11, P487, DOI 10.1111/j.1366-9516.2005.00192.x; Castano-Meneses G, 2003, BIODIVERS CONSERV, V12, P1913, DOI 10.1023/A:1024120600816; Clarke K. R., 2006, PRIMER V6 USER MANUA; Clarke K.R., 2001, CHANGES MARINE COMMU; Gunawardene NR, 2005, J ARID ENVIRON, V63, P725, DOI 10.1016/j.jaridenv.2005.04.016; Holldobler B., 1990, ANTS; Japanese Ant Database Group, 2008, JAP ANT COL IM DAT; Knop E, 2010, RESTORATION ECOLOGY, V19, P151; Masuko K, 1981, NATURE INSECTS, V16, P19; Ogata K, 1986, PULEX, V74, P355; Parr CL, 2002, AFR ENTOMOL, V10, P101; Philpott SM, 2010, ANT ECOLOGY, P137; Touyama Yoshifuni, 1996, Edaphologia, V56, P25; Vanderwoude Cas, 1997, Memoirs of the Museum of Victoria, V56, P671; Vasconcelos HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007762; York Alan, 1994, Memoirs of the Queensland Museum, V36, P231; York A, 2000, AUSTRAL ECOL, V25, P83, DOI 10.1111/j.1442-9993.2000.tb00010.x	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					254	261		10.1111/ens.12117		8	Entomology	Entomology	CF5VO	WOS:000352625500014		
J	Ogawa, N; Maruyama, M; Yoshizawa, K				Ogawa, Naoki; Maruyama, Munetoshi; Yoshizawa, Kazunori			Wing base morphology of Aetalionidae (Hemiptera: Cicadomorpha) and its phylogenetic implications	ENTOMOLOGICAL SCIENCE			English	Editorial Material						Aetalioninae; Biturritiinae; Membracoidea; treehoppers	SUPERFAMILY MEMBRACOIDEA HOMOPTERA; AUCHENORRHYNCHA; INSECTA	The Aetalionidae is a small family belonging to the treehopper superfamily Membracoidea (Hemiptera: Cicadomorpha). Although the wing-base morphology of Cicadomorpha was examined in detail recently, the wing base of this family has not been investigated to date. We examined morphology of the wing-base structure of Aetalionidae. Using the characters selected from the wing base, we inferred the phylogenetic placement of this family and confirmed that it belongs to the superfamily Membracoidea and is likely a sister group of the Membracidae.	[Ogawa, Naoki; Yoshizawa, Kazunori] Hokkaido Univ, Grad Sch Agr, Systemat Entomol, Sapporo, Hokkaido 0608589, Japan; [Maruyama, Munetoshi] Kyushu Univ Museum, Fukuoka, Japan	Ogawa, N (reprint author), Hokkaido Univ, Grad Sch Agr, Systemat Entomol, Sapporo, Hokkaido 0608589, Japan.	ogawa222@res.agr.hokudai.ac.jp	Yoshizawa, Kazunori/A-4268-2012				Dietrich CH, 2001, MOL PHYLOGENET EVOL, V18, P293, DOI 10.1006/mpev.2000.0873; Cryan JR, 2012, SYST ENTOMOL, V37, P7, DOI 10.1111/j.1365-3113.2011.00611.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Cryan JR, 2005, SYST ENTOMOL, V30, P563, DOI 10.1111/j.1365-3113.2004.00285.x; DEITZ LL, 1993, SYST ENTOMOL, V18, P287, DOI 10.1111/j.1365-3113.1993.tb00667.x; Deitz LL, 2010, TREEHOPPERS AETALION; DIETRICH CH, 1993, SYST ENTOMOL, V18, P297, DOI 10.1111/j.1365-3113.1993.tb00668.x; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; WOOD TK, 1993, ANNU REV ENTOMOL, V38, P409, DOI 10.1146/annurev.en.38.010193.002205; Yoshizawa K, 2001, SYST ENTOMOL, V26, P1, DOI 10.1046/j.1365-3113.2001.00133.x; Yoshizawa K, 2012, ENTOMOL SCI, V15, P408, DOI 10.1111/j.1479-8298.2012.00528.x	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					262	265		10.1111/ens.12102		4	Entomology	Entomology	CF5VO	WOS:000352625500015		
J	Yamanaka, A; Morioka, R; Kinugasa, M; Hasegawa, H; Fuchigami, S; Kawasaki, S; Kitazawa, C				Yamanaka, Akira; Morioka, Ritsu; Kinugasa, Masahiro; Hasegawa, Hiroshi; Fuchigami, Soichiro; Kawasaki, Shuhei; Kitazawa, Chisato			Effect of larval brain extracts derived from three swallowtail butterflies, Papilio helenus L., P. machaon L. and P. memnon L., on seasonal morph development of P. xuthus L. (Lepidoptera: Papilionidae)	ENTOMOLOGICAL SCIENCE			English	Editorial Material						butterfly; seasonal diphenism; summer-morph-producing hormone; wing coloration	C-AUREUM L; HORMONAL-CONTROL; NEUROENDOCRINE REGULATION; ARASCHNIA-LEVANA; PRECIS-COENIA; NYMPHALIDAE; FORMS	Adults of the three papilionid butterflies, Papilio helenusL., Papilio machaonL. and Papilio memnonL., exhibit seasonal diphenism comprising spring and summer morphs. To elucidate the physiological mechanism underlying seasonal morph development in papilionid butterflies, we investigated whether a cerebral factor showing summer-morph-producing hormone (SMPH) activity is present in the brain of three Papilio species using an assay system with chilled male short-day pupae of P.xuthusL. When 2% NaCl extracts derived from 20 larval brains of the three species were injected into abdomens of chilled male short-day pupae of P.xuthus, all recipients destined to develop into spring-morph adults developed into summer- and intermediate-morph adults. On the other hand, all recipients injected with distilled water as a control developed into spring-morph adults. These results indicate that a cerebral factor showing SMPH activity is present in the larval brain of the three Papilio species. Additionally, all recipients injected with 2% NaCl extracts derived from 20 adult brains of Bombyx moriL. also developed into summer- and intermediate-morph adults. The results revealed that SMPH or a cerebral factor showing SMPH activity is widely distributed among lepidopteran insects.	[Yamanaka, Akira; Morioka, Ritsu; Hasegawa, Hiroshi; Fuchigami, Soichiro; Kawasaki, Shuhei] Yamaguchi Univ, Fac Sci, Dept Biol & Chem, Yamaguchi 7538512, Japan; [Yamanaka, Akira; Kinugasa, Masahiro] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi 7538512, Japan; [Kitazawa, Chisato] Yamaguchi Univ, Fac Educ, Biol Inst, Yamaguchi 7538512, Japan	Yamanaka, A (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi 7538512, Japan.	yamanaka@yamaguchi-u.ac.jp					KOCH PB, 1987, J INSECT PHYSIOL, V33, P823, DOI 10.1016/0022-1910(87)90030-8; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P987, DOI 10.1016/0022-1910(95)00046-W; ENDO K, 1984, DEV GROWTH DIFFER, V26, P217; ENDO K, 1988, ZOOL SCI, V5, P145; ENDO K, 1985, ZOOL SCI, V2, P755; ENDO K, 1985, J INSECT PHYSIOL, V31, P669, DOI 10.1016/0022-1910(85)90045-9; FUKUDA S, 1966, P JPN ACAD, V42, P1082; Hashimoto K, 1994, B CHIBA COLL HLTH SC, V13, P3; Hidaka T., 1963, Zoological Magazine Tokyo, V72, P77; Ito T, 2001, ZOOL SCI, V18, P1117, DOI 10.2108/zsj.18.1117; Keino H, 1973, ZOOL MAG, V82, P45; MULLER HJ, 1956, NATURWISSENSCHAFTEN, V43, P503; Nijhout HF, 1994, INSECT HORMONES; NYLIN S, 1989, ECOL ENTOMOL, V14, P209, DOI 10.1111/j.1365-2311.1989.tb00771.x; Shapiro A. M., 1976, EVOL BIOL, V9, P259; SHIROZU T, 2006, STANDARD BUTTERFLIES; Smith Kelly C., 1991, Journal of Research on the Lepidoptera, V30, P225; Starnecker G, 1997, NATURWISSENSCHAFTEN, V84, P152, DOI 10.1007/s001140050368; Tanaka A, 2009, INSECT SCI, V16, P125, DOI 10.1111/j.1744-7917.2009.00263.x; Tanaka D, 1997, J INSECT PHYSIOL, V43, P197, DOI 10.1016/S0022-1910(96)00077-7; Yamanaka A, 2000, J INSECT PHYSIOL, V46, P803, DOI 10.1016/S0022-1910(99)00169-9	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					266	270		10.1111/ens.12101		5	Entomology	Entomology	CF5VO	WOS:000352625500016		
J	Komatsu, T; Itino, T; Ueda, S				Komatsu, Takashi; Itino, Takao; Ueda, Shouhei			First report of seed dispersal by ants in Dicentra peregrina (Papaveraceae), an alpine plant in the Japanese Alps	ENTOMOLOGICAL SCIENCE			English	Editorial Material						elaiosome; Mt Norikura; myrmecochory; seed transport	LILIACEAE	Seed dispersal by ants, known as myrmecochory, is commonly observed among various plant taxa. The seeds of these plants have an elaiosome to attract ants. In Japan, myrmecochory has been well studied in several lowland plant species, but not in highland plant species that grow above the tree line. We investigated whether the seeds of Dicentra peregrina, known as the queen of the alpine plants in Japan, are carried by Formica gagatoides ants at 2510m a.s.l. on Mt Norikura, Kita-Alps, Japan. We observed F.gagatoides workers picking up D.peregrina seeds by grasping the elaiosome and carrying the seeds into their nests. We inferred from the observed ant behavior and the seed morphology that D.peregrina is a myrmecochorous species.	[Komatsu, Takashi; Itino, Takao; Ueda, Shouhei] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Itino, Takao] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan	Komatsu, T (reprint author), Shinshu Univ, Fac Sci, Dept Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	corocoro1232000@yahoo.co.jp					HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Gorb E, 2000, ECOL RES, V15, P187, DOI 10.1046/j.1440-1703.2000.00338.x; Ohkawara K, 1996, OECOLOGIA, V106, P500, DOI 10.1007/BF00329708; HIGASHI S, 1989, OIKOS, V54, P389, DOI 10.2307/3565300; KUSMENOGLU S, 1989, PHYTOCHEMISTRY, V28, P2601, DOI 10.1016/S0031-9422(00)98048-8; OHKAWARA K, 1994, OECOLOGIA, V100, P135, DOI 10.1007/BF00317140; NAKANISHI H, 1994, ECOL RES, V9, P1, DOI 10.1007/BF02347236; BERG R Y, 1969, Nytt Magasin for Botanikk (Oslo), V16, P49; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Chiba S, 2006, B BOT SOC NAGANO, V39, P5; Hokkaido Prefecture, 2001, RED DAT BOOK HOKK; Kondoh M, 1976, SCI REPORTS NATURE C, P159; Masuzawa T, 1997, ECOLOGY ALPINE PLANT; Myrmecological Society of Japan, 1991, GUID ID JAP ANTS; NAKANISHI H, 1988, Japanese Journal of Ecology (Tokyo), V38, P169; Niigata Prefecture, 2001, RED DAT BOOK NIIG; Ozeki M, 2008, B NAGANO ENV CONSERV, V4, P55; Takahashi S, 2012, SOCIOBIOLOGY, V59, P1401; Togai R, 2012, JAPANESE J ENV ENTOM, V23, P119; Toyokuni H, 1988, ALPINE FLOWERS JAPAN; Ueda S, 2014, ARI J MYRMECOLOGICAL, V36, P7	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					271	273		10.1111/ens.12110		3	Entomology	Entomology	CF5VO	WOS:000352625500017		
J	Yokoi, T; Watanabe, M				Yokoi, Tomoyuki; Watanabe, Mamoru			Female-biased sleeping aggregations of Amegilla florea urens (Hymenoptera: Apidae)	ENTOMOLOGICAL SCIENCE			English	Editorial Material						arrival time; departure time; overnight; sex; solitary bee	BEES	Although male bees and wasps aggregate in specific sites overnight, few studies have addressed the behaviors of female hymenopterans during the night. It is generally understood that they spend the night in a burrow or nest structure. We found female-biased sleeping aggregations of Amegilla florea urens in populations on Iriomote Island. The sex ratio and number of sleeping individuals in the sex-mixed aggregations changed daily. This species used dead branches as its main sleeping places, and the maximum number of individuals observed per place was 15. Females arrived at the aggregation place later and left it earlier in the morning than did males. Our result suggests that females used the sleeping place regularly but avoided a long stay with males. The use of the same sleeping place by the two sexes may be due to a limited number of sites suitable for sleeping in the forest.	[Yokoi, Tomoyuki; Watanabe, Mamoru] Univ Tsukuba, Fac Life & Environm Sci, Lab Conservat Ecol, Tsukuba, Ibaraki 3058572, Japan	Yokoi, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Lab Conservat Ecol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	tomoyoko@envr.tsukuba.ac.jp					Alcock J, 1998, J KANSAS ENTOMOLOGIC, V71, P77; Alves-dos-Santos I, 2009, GENET MOL RES, V8, P515; Silva MDE, 2011, NEOTROP ENTOMOL, V40, P548, DOI 10.1590/S1519-566X2011000500005; DAFNI A, 1981, ACTA BOT NEERL, V30, P69; EVANS HOWARD E., 1960, BULL SOUTHERN CALIFORNIA ACAD SCI, V59, P30; EVANS HOWARD E., 1964, AMER MIDLAND NATUR, V72, P257, DOI 10.2307/2423504; FREEMAN BE, 1978, ANN ENTOMOL SOC AM, V71, P435; Hirashima Y, 1989, CHECK LIST JAPANESE, VII; LINSLEY E. GORTON, 1962, ANN ENTOMOL SOC AMER, V55, P148; Miyanaga R, 2011, NEW ENTOMOLOGIST, V60, P35; Miyanaga Ryoichi, 1998, Entomological Science, V1, P357; Rayment R, 1935, A CLUSTER OF BEES; Sasaki Y, 2008, CHUGOKU KONTYU, V22, P47; Sugiura Naoto, 1998, Insectarium, V35, P68; Sugiura N, 2000, INSECTARIUM, V37, P411; Wcislo WT, 2003, J KANSAS ENTOMOL SOC, V76, P55	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					274	277		10.1111/ens.12112		4	Entomology	Entomology	CF5VO	WOS:000352625500018		
J	Suzaki, Y; Katsuki, M; Miyatake, T; Okada, Y				Suzaki, Yu; Katsuki, Masako; Miyatake, Takahisa; Okada, Yasukazu			Relationships among male sexually selected traits in the bean bug, Riptortus pedestris (Heteroptera: Alydidae)	ENTOMOLOGICAL SCIENCE			English	Editorial Material						alternative tactics; multiple cues; phenotypic trade-off; sexual selection	CLAVATUS THUNBERG HETEROPTERA; BEETLE ONTHOPHAGUS-TAURUS; MALE HORN DIMORPHISM; FEMALE MATE CHOICE; MALE COMPETITION; LIBRODOR-JAPONICUS; MATING SUCCESS; WATER BOATMAN; ARMED BEETLE; SIZE	Current concepts of sexual selection suggest that male reproductive success is determined by multiple sexual traits. As expression and production of multiple sexual traits are frequently associated with each other, positive or negative correlations among multiple sexual traits ensue. These relationships among traits associated with male reproductive success may be crucial in the evolution of male reproductive strategies. Here, we investigate phenotypic relationships among sexually selected traits in the armed bean bug Riptortus pedestris. In this insect, males with a larger body and weapon are more likely to win male-male competitions, and males with a larger weapon or higher courtship rate are more attractive to females. There was a significant positive correlation between body size and weapon size, whereas the courtship rate had significant negative correlations with body size and weapon size. Our results suggested that there was a phenotypic trade-off between courtship rate and male morphology. In this insect, smaller males may make more effort in courtship behavior as an alternative mating tactic.	[Suzaki, Yu; Miyatake, Takahisa] Okayama Univ, Grad Sch Environm Sci, Okayama 7008530, Japan; [Katsuki, Masako] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Okada, Yasukazu] Univ Tokyo, Fac Arts & Sci, Tokyo, Japan	Suzaki, Y (reprint author), Okayama Univ, Grad Sch Environm Sci, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	gev421204@s.okayama-u.ac.jp					Andersson M., 1994, SEXUAL SELECTION; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; EBERHARD WG, 1991, EVOLUTION, V45, P18, DOI 10.2307/2409478; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Pizzari T, 2007, P R SOC B, V274, P853, DOI 10.1098/rspb.2006.0080; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Candolin U, 2004, EVOLUTION, V58, P1861; Okada K, 2010, EVOL ECOL, V24, P1339, DOI 10.1007/s10682-010-9370-9; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; NUMATA H, 1990, APPL ENTOMOL ZOOL, V25, P144; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Green AJ, 1999, EVOLUTION, V53, P1621, DOI 10.2307/2640909; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Moczek AP, 1999, J EVOLUTION BIOL, V12, P27, DOI 10.1046/j.1420-9101.1999.00004.x; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.2307/2410492; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Yamane T, 2010, P ROY SOC B-BIOL SCI, V277, P1705, DOI 10.1098/rspb.2009.2017; EBERHARD WG, 1982, AM NAT, V119, P420, DOI 10.1086/283920; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2005, P ROY SOC B-BIOL SCI, V272, P47, DOI 10.1098/rspb.2004.2932; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; Hunt J, 2001, P ROY SOC B-BIOL SCI, V268, P2409, DOI 10.1098/rspb.2001.1758; Kamano S, 1991, REARING METHODS INSE, P46; Kikuchi A, 1986, B NATL AGR RES CENT, V6, P33; Kimura S, 2008, JPN J APPL ENTOMOL Z, V52, P13, DOI 10.1303/jjaez.2008.13; Miller CW, 2010, EVOL ECOL, V24, P375, DOI 10.1007/s10682-009-9312-6; Natuhara Y, 1985, SEIKATSU EISEI, V29, P102; NUMATA H, 1986, APPL ENTOMOL ZOOL, V21, P119; Okada K, 2007, ANIM BEHAV, V74, P749, DOI 10.1016/j.anbehav.2006.09.020; Okada K, 2008, ECOL ENTOMOL, V33, P269, DOI 10.1111/j.1365-2311.2007.00965.x; Okada K, 2011, ZOOL SCI, V28, P659, DOI 10.2108/zsj.28.659; Okada Y, 2005, J ETHOL, V23, P99, DOI 10.1007/s10164-004-0134-2; Okada Y, 2012, ANIM BEHAV, V83, P1001, DOI 10.1016/j.anbehav.2012.01.021; R Development Core Team, 2012, R LANG ENV STAT COMP; SAS Institute, 2010, JMP GUID STAT DAT AN; Shuster SM, 2003, MATING SYSTEM STRATE; Suzaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083278; Taylor ML, 2007, CURR BIOL, V17, P959; Thompson JT, 2008, ANIM BEHAV, V76, P113, DOI 10.1016/j.anbehav.2007.12.015; Wagner WE, 2012, P ROY SOC B-BIOL SCI, V279, P2899, DOI 10.1098/rspb.2012.0275	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					278	282		10.1111/ens.12114		5	Entomology	Entomology	CF5VO	WOS:000352625500019		
J	Komatsu, T; Maruyama, M; Hasin, S; Woraguttanon, V; Wiyanan, S; Sakchoowong, W				Komatsu, Takashi; Maruyama, Munetoshi; Hasin, Sasitorn; Woraguttanon, Varawut; Wiyanan, Suthat; Sakchoowong, Watana			Observations of immature and adult stages of the myrmecophilous cetoniine beetle Campsiura nigripennis (Coleoptera: Scarabaeidae)	ENTOMOLOGICAL SCIENCE			English	Editorial Material						Cetoniinae; Elephas maximus; myrmecophily; Oecophylla smaragdina; Thailand	NATIONAL-PARK	Several cetoniine species are known or speculated to be associated with ants, based on their specialized morphological characters. However, there are only a few species where biological information on the larval and adult stages is available. Field observations revealed that Campsiura nigripennis spends the immature stages inside elephant dung, and that adult females fly to elephant dung for oviposition. In addition, adult beetles of C.nigripennis intruded into arboreal nests of Oecophylla smaragdina. Specialized morphological characters appear to allow them to tolerate attacks from the ants. Furthermore, the distribution of the beetle in continental Asia largely overlaps that of the Asian elephant, indicating that dung of elephants, in conjunction with that of other large mammals, is fundamental to the biology of C.nigripennis.	[Komatsu, Takashi] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Maruyama, Munetoshi] Kyushu Univ Museum, Fukuoka, Japan; [Hasin, Sasitorn] Kasetsart Univ, Dept Forest Biol, Fac Forestry, Bangkok, Thailand; [Woraguttanon, Varawut; Wiyanan, Suthat; Sakchoowong, Watana] Dept Natl Pk Wildlife & Plant Conservat, Bangkok, Thailand	Komatsu, T (reprint author), Shinshu Univ, Fac Sci, Dept Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	corocoro1232000@yahoo.co.jp					Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; ALPERT GD, 1994, SOCIOBIOLOGY, V25, P1; Antoine Philippe, 2006, Coleopteres, V12, P337; CAZIER MONT A., 1962, JOUR NEW YORK ENTOMOL SOC, V70, P125; CAZIER MONT A., 1965, J KANS ENTOMOL SOC, V38, P19; Corbet G.B., 1992, MAMMALS INDOMALAYAN; Deloya D, 1988, FOLIA ENTOMOLOGICA M, V75, P77; Grassman Lon I., 1999, Natural History Bulletin of the Siam Society, V47, P77; HORN G.H, 1871, T AM ENTOMOL SOC, V3, P325; JEANNE R L, 1992, Entomologist's Monthly Magazine, V128, P139; Mann W. M., 1920, AnnEnt Soc Amer Columbus, V13; Mawdsley JR, 2011, J NAT HIST, V45, P1257, DOI 10.1080/00222933.2011.552806; Mico E, 2008, SYST ENTOMOL, V33, P128, DOI 10.1111/j.1365-3113.2007.00399.x; Moron Miguel-Angel, 1995, Giornale Italiano di Entomologia, V7, P317; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Ritcher P. 0., 1945, KENTUCKY AGRIC EXPT STA BULL, V476, P1; Sakai K, 2004, CETONIINE BEETLES WO; VEERESH GK, 1985, P INDIAN AS-ANIM SCI, V94, P303; Wheeler WM, 1908, J NEW YORK ENTOMOL S, V16, P68; Yiu Vor, 2010, Hong Kong Entomological Bulletin, V2, P32	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	APR	2015	18	2					288	291		10.1111/ens.12118		4	Entomology	Entomology	CF5VO	WOS:000352625500021		
J	Konishi, H; Fujiya, M; Kohgo, Y				Konishi, Hiroaki; Fujiya, Mikihiro; Kohgo, Yutaka			Host-microbe interactions via membrane transport systems	ENVIRONMENTAL MICROBIOLOGY			English	Review							INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; ULCERATIVE-COLITIS; MURAMYL DIPEPTIDE; SIGNALING PATHWAY; POLYAMINE LEVELS; RESISTANCE GENE; P-GLYCOPROTEIN; MICE	Living organisms take in essential molecules and get rid of wastes effectively through the selective transport of materials. Especially in the digestive tract, advanced transport systems are indispensable for the absorption of nutrients and elimination of waste products. These transport pathways control physiological functions by modulating the ionic environment inside and outside the cells. Moreover, recent studies have shown the importance of the expression of trafficking-related molecules and the population of gut microbiota. We found that the molecules secreted from microorganisms are imported into the cells via transporters or endocytosis and that they activate cell survival pathways of intestinal epithelial cells. These findings indicate that the interactions between the gut microbiota and host cells are mediated, at least partly, by the membrane transport systems. In addition, it is well known that the breakdown of transport systems induces various diseases. This review highlights the significance of the transport systems as the pathogenic molecules and therapeutic targets in gastrointestinal disorders. For example, abnormal expression of the genes encoding membrane transport-related molecules is frequently involved in digestive diseases, such as colorectal cancer and inflammatory bowel disease. We herein review the significance of these molecules as pathogenic and therapeutic targets for digestive diseases.	[Konishi, Hiroaki; Fujiya, Mikihiro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan	Fujiya, M (reprint author), Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan.	fjym@asahikawa-med.ac.jp			Intractable Disease Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare [23590931, 22390148]; Ishidsu Shun Memorial Scholarship Japan	This paper was supported by Grants-in-Aid for Scientific Research, Nos. 23590931 (M. Fujiya) and 22390148 (Y. Kohgo), Intractable Disease Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, and Ishidsu Shun Memorial Scholarship Japan.	Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Weiss TS, 2004, INFLAMM BOWEL DIS, V10, P529, DOI 10.1097/00054725-200409000-00006; Panwala CM, 1998, J IMMUNOL, V161, P5733; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gast.2004.07.024; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Saksena S, 2011, AM J PHYSIOL-GASTR L, V300, pG1115, DOI 10.1152/ajpgi.00027.2011; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Fujiya M, 2011, INFLAMM BOWEL DIS, V17, P907, DOI 10.1002/ibd.21444; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Uemura T, 2010, AM J PHYSIOL-GASTR L, V299, pG517, DOI 10.1152/ajpgi.00169.2010; Andoh A, 2001, INFLAMM BOWEL DIS, V7, P210, DOI 10.1097/00054725-200108000-00005; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088; Ho GT, 2005, GASTROENTEROLOGY, V128, P288, DOI 10.1053/j.gastro.2004.11.019; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; OBAYASHI M, 1992, AM J GASTROENTEROL, V87, P736; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Chidlow JH, 2009, GASTROENTEROLOGY, V136, P575, DOI 10.1053/j.gastro.2008.10.085; Konishi H., 2013, DIGESTIVE DIS WEEK, V2013; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Nguyen HTT, 2009, GASTROENTEROLOGY, V137, P1435, DOI 10.1053/j.gastro.2009.06.043; Noble CL, 2005, GASTROENTEROLOGY, V129, P1854, DOI 10.1053/j.gastro.2005.09.025; Okamoto K, 2012, INT J COLORECTAL DIS, V27, P1039, DOI 10.1007/s00384-012-1416-8; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Sonne S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047729; Weiss TS, 2002, INT J COLORECTAL DIS, V17, P381, DOI 10.1007/s00384-002-0394-7	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	APR	2015	17	4			SI		931	937		10.1111/1462-2920.12632		7	Microbiology	Microbiology	CF4TP	WOS:000352545100002		
J	Kobayashi, K				Kobayashi, Kazuo			Plant methyl salicylate induces defense responses in the rhizobacterium Bacillus subtilis	ENVIRONMENTAL MICROBIOLOGY			English	Article							REGULATOR DEGU CONTROLS; POLY-GAMMA-GLUTAMATE; ARABIDOPSIS-THALIANA; PATHOGEN RESISTANCE; BIOFILM FORMATION; GENE CLONING; BACTERIA; DISEASE; RECRUITMENT; EXPRESSION	Bacillus subtilis is a rhizobacterium that promotes plant growth and health. Cultivation of B.subtilis with an uprooted weed on solid medium produced pleat-like architectures on colonies near the plant. To test whether plants emit signals that affect B.subtilis colony morphology, we examined the effect of plant-related compounds on colony morphology. Bacillussubtilis formed mucoid colonies specifically in response to methyl salicylate, which is a plant-defense signal released in response to pathogen infection. Methyl salicylate induced mucoid colony formation by stimulating poly--glutamic acid biosynthesis, which formed enclosing capsules that protected the cells from exposure to antimicrobial compounds. Poly--glutamic acid synthesis depended on the DegS-DegU two-component regulatory system, which activated DegSU-dependent gene transcription in response to methyl salicylate. Bacillus subtilis did not induce plant methyl salicylate production, indicating that the most probable source of methyl salicylate in the rhizosphere is pathogen-infected plants. Methyl salicylate induced B.subtilis biosynthesis of the antibiotics bacilysin and fengycin, the latter of which exhibited inhibitory activity against the plant pathogenic fungus Fusarium oxysporum. We propose that B.subtilis may sense plants under pathogen attack via methyl salicylate, and express defense responses that protect both B.subtilis and host plants in the rhizosphere.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Kobayashi, K (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	kazuok@bs.naist.jp			JSPS KAKENHI [24580113]; TAKANO Life Science Research Foundation	The author thanks Masayuki Kajikawa (NAIST) for the generous gift of A. thaliana and for the assistance with plant experiments; Tsutomu Kawasaki (NAIST, Kindai University) for the generous gift of P. syringae and for the assistance with plant experiments; and Taku Oshima (NAIST) for the generous gift of E. coli W3100. This work was supported by JSPS KAKENHI Grant Number 24580113 and the TAKANO Life Science Research Foundation.	Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Chen F, 2003, PLANT J, V36, P577, DOI 10.1046/j.1365-313X.2003.01902.x; Ohsawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P2096, DOI 10.1271/bbb.90341; Lakshmanan V, 2013, PLANTA, V238, P657, DOI 10.1007/s00425-013-1920-2; Tsuge K, 1999, ANTIMICROB AGENTS CH, V43, P2183; Piesik D, 2011, J PLANT PHYSIOL, V168, P1534, DOI 10.1016/j.jplph.2011.01.032; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Coutte F, 2010, J APPL MICROBIOL, V109, P480, DOI 10.1111/j.1365-2672.2010.04683.x; Tsuge K, 2005, ANTIMICROB AGENTS CH, V49, P4641, DOI 10.1128/AAC.49.11.4641-4648.2005; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Xu ZH, 2014, APPL ENVIRON MICROB, V80, P2941, DOI 10.1128/AEM.03943-13; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; NAKANO MM, 1992, MOL GEN GENET, V232, P313; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Cavin JF, 1998, APPL ENVIRON MICROB, V64, P1466; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Koumoutsi A, 2007, APPL ENVIRON MICROB, V73, P6953, DOI 10.1128/AEM.00565-07; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Mariappan A, 2012, J MOL MICROB BIOTECH, V22, P114, DOI 10.1159/000338804; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241; Ashiuchi M, 1999, BIOCHEM BIOPH RES CO, V263, P6, DOI 10.1006/bbrc.1999.1298; Ament K, 2010, PLANT J, V62, P124, DOI 10.1111/j.1365-313X.2010.04132.x; KENIG M, 1976, J GEN MICROBIOL, V94, P37; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Hirooka K, 2009, J BACTERIOL, V191, P3685, DOI 10.1128/JB.00202-09; Holopainen JK, 2012, ADV EXP MED BIOL, V739, P17, DOI 10.1007/978-1-4614-1704-0_2; Jousset A, 2011, MOL PLANT MICROBE IN, V24, P352, DOI 10.1094/MPMI-09-10-0208; Koo YJ, 2007, PLANT MOL BIOL, V64, P1, DOI 10.1007/s11103-006-9123-x; Lee B, 2012, ANN BOT-LONDON, V110, P281, DOI 10.1093/aob/mcs055; Nykyri J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003013; SCHROTH MN, 1982, SCIENCE, V216, P1376, DOI 10.1126/science.216.4553.1376; Towe S, 2007, MOL MICROBIOL, V66, P40, DOI 10.1111/j.1365-2958.2007.05891.x	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	APR	2015	17	4			SI		1365	1376		10.1111/1462-2920.12613		12	Microbiology	Microbiology	CF4TP	WOS:000352545100034		
J	Jiang, R; Wang, CY; Hatano, R; Kuramochi, K; Hayakawa, A; Woli, KP				Jiang, Rui; Wang, Chun-ying; Hatano, Ryusuke; Kuramochi, Kanta; Hayakawa, Atsushi; Woli, Krishna P.			Factors controlling the long-term temporal and spatial patterns of nitrate-nitrogen export in a dairy farming watershed	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Nitrate-nitrogen; Land use; Soil type; Denitrification; Soil and water assessment tool	DISSOLVED ORGANIC-CARBON; LAND-USE ANALYSIS; STREAM NITRATE; ADIRONDACK MOUNTAINS; NORTHEASTERN USA; EASTERN HOKKAIDO; STORM EVENTS; NEW-YORK; CATCHMENT; SOIL	It is difficult to investigate the factors that control the riverine nitrate-nitrogen (NO3--N) export in a watershed which gains or losses groundwater. To control the NO3--N contamination in these watersheds, it is necessary to investigate the factors that are related to the export of NO3--N that is only produced by the watershed itself. This study was conducted in the Shibetsu watershed located in eastern Hokkaido, Japan, which gains external groundwater contribution (ExT) and 34 % of the annual NO3--N loading occurs through EXT. The riverine NO3--N exports from 1980 to 2009 were simulated by the SWAT model, and the factors controlling the temporal and spatial patterns of NO3--N exports were investigated without considering the EXT. The results show that hydrological events control NO3--N export at the seasonal scale, while the hydrological and biogeochemical processes are likely to control NO3--N export at the annual scale. There was an integrated effect among the land use, topography, and soil type related to denitrification process, that regulated the spatial patterns of NO3--N export. The spatial distribution of NO3--N export from hydrologic response units (HRUs) identified the agricultural areas with surplus N that are vulnerable to nitrate contamination, A new standard for the N fertilizer application rate including manure application should be given to control riverine NO3--N export. This study demonstrates that applying the SWAT model is an appropriate method to determine the temporal and spatial patterns of NO3--N export from the watershed which includes EXT and to identify the crucial pollution areas within a watershed in which the management practices can be improved to more effectively control NO3--N export to water bodies.	[Jiang, Rui] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Rui] Northwest A&F Univ, Key Lab Plant Nutr & Agrienvironm Northwest China, Minist Agr, Coll Resources & Environm, Yangling 712100, Peoples R China; [Jiang, Rui; Wang, Chun-ying; Hatano, Ryusuke; Kuramochi, Kanta] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Hayakawa, Atsushi] Akita Prefectural Univ, Dept Environm Biol, Akita 0100195, Japan; [Woli, Krishna P.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Jiang, R (reprint author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Room 218,3 Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	haixia992000@hotmail.com			National Natural Science Foundation of China [41201279]; Fundamental Research Funds for the Central Universities [QN2013076]; Strategic International Cooperative Program "Comparative Study of Nitrogen Cycling and its Impact on Water Quality in Agricultural Watersheds in Japan and China"	This study was funded by the National Natural Science Foundation of China (41201279), the Fundamental Research Funds for the Central Universities (QN2013076), and the Strategic International Cooperative Program "Comparative Study of Nitrogen Cycling and its Impact on Water Quality in Agricultural Watersheds in Japan and China".	Alvarez-Cobelas M., 2008, ENVIRON POLLUT, V156, P161; Van Breemen N, 2002, BIOGEOCHEMISTRY, V57, P267, DOI 10.1023/A:1015775225913; Giles J, 2005, NATURE, V433, P791, DOI 10.1038/433791a; Jaynes DB, 2001, J ENVIRON QUAL, V30, P1305; Park JH, 2003, GLOBAL CHANGE BIOL, V9, P1602, DOI 10.1046/j.1529-8817.2003.00686.x; Easton ZM, 2008, J HYDROL, V348, P279, DOI 10.1016/j.jhydrol.2007.10.008; Woli KP, 2004, SCI TOTAL ENVIRON, V329, P61, DOI 10.1016/j.scitotenv.2004.03.006; Caraco NF, 2001, MAR FRESHWATER RES, V52, P119, DOI 10.1071/MF00083; Poor CJ, 2007, J HYDROL, V332, P54, DOI 10.1016/j.jhydrol.2006.06.022; Christopher SF, 2006, GLOBAL CHANGE BIOL, V12, P364, DOI 10.1111/j.1365-2486.2005.01084.x; KEENEY DR, 1993, J ENVIRON QUAL, V22, P267; Inamdar SP, 2004, HYDROL PROCESS, V18, P2651, DOI 10.1002/hyp.5572; Boyer EW, 2002, BIOGEOCHEMISTRY, V57, P137, DOI 10.1023/A:1015709302073; Hayakawa A, 2012, ECOL ENG, V47, P92, DOI 10.1016/j.ecoleng.2012.06.034; Brooks PD, 1999, HYDROL PROCESS, V13, P2177, DOI 10.1002/(SICI)1099-1085(199910)13:14/15<2177::AID-HYP850>3.3.CO;2-M; McNamara JP, 2008, HYDROL PROCESS, V22, P3294, DOI 10.1002/hyp.6920; Conan C, 2003, J ENVIRON QUAL, V32, P2026; BEASLEY DB, 1980, T ASAE, V23, P938; Wagner LE, 2008, J HYDROL, V362, P177, DOI 10.1016/j.jhydrol.2008.08.013; Vidon P, 2009, J HYDROL, V376, P34, DOI 10.1016/j.jhydrol.2009.07.013; Zhou MH, 2013, PLANT SOIL, V362, P149, DOI 10.1007/s11104-012-1269-5; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Harms TK, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000588; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Baron JS, 1997, HYDROL PROCESS, V11, P783, DOI 10.1002/(SICI)1099-1085(199706)11:7<783::AID-HYP519>3.0.CO;2-U; Bicknell B.R., 1993, EPA600R93174 ENV RES; Campbell JL, 2007, SOIL SCI SOC AM J, V71, P1934, DOI 10.2136/sssaj2006.0283; Christopher SF, 2008, BIOGEOCHEMISTRY, V88, P15, DOI 10.1007/s10533-008-9189-4; Creed IF, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007285; Gu JX, 2013, SOIL BIOL BIOCHEM, V60, P134, DOI 10.1016/j.soilbio.2013.01.029; Hatano R, 2005, ECOL ENG, V24, P509, DOI 10.1016/j.ecoleng.2005.01.011; Hayakawa A, 2006, J ENVIRON QUAL, V35, P617, DOI 10.2134/jeq2005.0343; Hayakawa A, 2009, SOIL SCI PLANT NUTR, V55, P800, DOI 10.1111/j.1747-0765.2009.00421.x; Inamdar SP, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004212; Jiang R, 2014, J SOIL WATER CONSERV, V69, P75, DOI 10.2489/jswc.69.1.75; Jiang R, 2012, CATENA, V97, P1, DOI 10.1016/j.catena.2012.04.015; Jiang R, 2014, HYDROL PROCESS, V28, P5105, DOI 10.1002/hyp.9996; Jiang R, 2011, T ASABE, V54, P2171; Jiang R, 2010, SOIL SCI PLANT NUTR, V56, P72, DOI 10.1111/j.1747-0765.2010.00456.x; Mitchell MJ, 1996, WATER AIR SOIL POLL, V88, P355, DOI 10.1007/BF00294111; Puckett L. J., 1995, ENVIRON SCI TECHNOL, V29, P408; Sluijsmans C. M. J, 1978, INFORM AGR, V47; STODDARD JL, 1994, ADV CHEM SER, V237, P223; Tiedje J.M, 1994, AGRON MONOGR, P245; Vithanage I, 2009, THESIS ITC ENSCHEDE; Watmough SA, 2004, ENVIRON SCI TECHNOL, V38, P2383, DOI 10.1021/es0351261; Yevenes MA, 2011, AGR WATER MANAGE, V102, P54, DOI 10.1016/j.agwat.2011.10.006; Young R. A., 1987, 35 USDA; Zhu Q, 2011, J HYDROL, V405, P307, DOI 10.1016/j.jhydrol.2011.05.028; Zhu Q, 2009, GEODERMA, V154, P111, DOI 10.1016/j.geoderma.2009.10.004	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	APR	2015	187	4							206	10.1007/s10661-015-4394-9		16	Environmental Sciences	Environmental Sciences & Ecology	CE8SA	WOS:000352113200032		
J	Riya, S; Zhou, S; Kobara, Y; Sagehashi, M; Terada, A; Hosomi, M				Riya, Shohei; Zhou, Sheng; Kobara, Yuso; Sagehashi, Masaki; Terada, Akihiko; Hosomi, Masaaki			Influence of nitrogen loading and plant nitrogen assimilation on nitrogen leaching and N2O emission in forage rice paddy fields fertilized with liquid cattle waste	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Forage rice; Cattle waste; Nitrogen cycling; Plant uptake; Nitrous oxide; Leaching	AUTOMATED CHAMBER MEASUREMENTS; OXIDE EMISSIONS; CROPPING SYSTEM; WATER; METHANE; CHINA; WHEAT; CH4; REGION; YIELD	Livestock wastewater disposal onto rice paddy fields is a cost- and labor-effective way to treat wastewater and cultivate rice crops. We evaluated the influence of nitrogen loading rates on nitrogen assimilation by rice plants and on nitrogen losses (leaching and N2O emission) in forage rice fields receiving liquid cattle waste (LCW). Four forage rice fields were subjected to nitrogen loads of 107, 258, 522, and 786 kg N ha(-1) (N100, N250, N500, and N750, respectively) using basal fertilizer (chemical fertilizer) (50 kg N ha(-1)) and three LCW topdressings (each 57-284 kg N ha(-1)). Nitrogen assimilated by rice plants increased over time. However, after the third topdressing, the nitrogen content of the biomass did not increase in any treatment. Harvested aboveground biomass contained 93, 60, 33, and 31 % of applied nitrogen in N100, N250, N500, and N750, respectively. The NH4+ concentration in the pore water at a depth of 20 cm was less than 1 mg N L-1 in N100, N250, and N500 throughout the cultivation period, while the NH4+ concentration in N750 increased to 3 mg N L-1 after the third topdressing. Cumulative N2O emissions ranged from -0.042 to 2.39 kg N ha(-1); the highest value was observed in N750, followed by N500. In N750, N2O emitted during the final drainage accounted for 80 % of cumulative N2O emissions. This study suggested that 100-258 kg N ha(-1) is a recommended nitrogen loading rate for nitrogen recovery by rice plants without negative environmental impacts such as groundwater pollution and N2O emission.	[Riya, Shohei; Terada, Akihiko; Hosomi, Masaaki] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan; [Zhou, Sheng] Shanghai Acad Agr Sci, Ecoenvironm Protect Res Inst, Shanghai 201403, Peoples R China; [Kobara, Yuso] Natl Inst Agroenvironm Sci, Organochem Div, Tsukuba, Ibaraki 3058604, Japan; [Sagehashi, Masaki] Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, Wako, Saitama 3510197, Japan	Zhou, S (reprint author), Shanghai Acad Agr Sci, Ecoenvironm Protect Res Inst, 1000 Jinqi Rd, Shanghai 201403, Peoples R China.	zhous@outlook.com	Terada, Akihiko/C-5749-2012	Terada, Akihiko/0000-0002-9258-6912	Strategic International Cooperative Program from the Japanese Science and Technology Agency (JST)	We thank the National Institute for Agro-Environmental Sciences (NIAES) for permission to use their experimental fields. We also thank Mr. Katsuo Abe and Mr. Takahiro Ara for their help in the field management, and Mr. H. Shitara (Saitama Prefecture Agriculture and Forestry Research Center, Saitama Prefecture, Japan) for providing LCW. This study was supported in part by a Strategic International Cooperative Program from the Japanese Science and Technology Agency (JST).	Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Kyaw KM, 2005, BIOL FERT SOILS, V42, P72, DOI 10.1007/s00374-005-0856-5; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311; Nicolaisen MH, 2004, FEMS MICROBIOL ECOL, V49, P359, DOI 10.1016/j.femsec.2004.04.015; Itoh M, 2011, AGR ECOSYST ENVIRON, V141, P359, DOI 10.1016/j.agee.2011.03.019; Kim DG, 2013, AGR ECOSYST ENVIRON, V168, P53, DOI 10.1016/j.agee.2012.02.021; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Qiao J, 2012, AGR ECOSYST ENVIRON, V146, P103, DOI 10.1016/j.agee.2011.10.014; Zhou S, 2008, ECOL ENG, V32, P147, DOI 10.1016/j.ecoleng.2007.10.004; Hooda PS, 2000, SCI TOTAL ENVIRON, V250, P143, DOI 10.1016/S0048-9697(00)00373-9; Zebarth BJ, 2008, CAN J SOIL SCI, V88, P197; Liu C, 2012, BIOGEOSCIENCES, V9, P839, DOI 10.5194/bg-9-839-2012; Yao ZS, 2012, AGR ECOSYST ENVIRON, V152, P1, DOI 10.1016/j.agee.2012.02.004; Bronson KF, 1997, SOIL SCI SOC AM J, V61, P988; Zhou S, 2011, J CHEM ENG JPN, V44, P713, DOI 10.1252/jcej.10we292; Bronson KF, 1997, SOIL SCI SOC AM J, V61, P981; Doi S, 2007, B SHIGA PREFECTURAL; Hua X, 1997, NUTR CYCL AGROECOSYS, V49, P23, DOI 10.1023/A:1009779514395; Ibaraki Prefectural Agricultural Center, 2010, GUID FOOD CROP CULT; Ikeda T, 1995, CROP PHYSL ECOLOGY; IPCC, 2007, CLIMATE CHANGE 2007; IPCC, 2007, CONTRIBUTION WORKING; Ishii H, 2005, B SAITAMA PREFECTURA; Ishikawa M, 2003, PADDY WATER ENVIRON, V1, P27, DOI 10.1007/s10333-002-0007-7; Ishikawa Tetsuya, 2012, Japanese Journal of Crop Science, V81, DOI 10.1626/jcs.81.89; IUSS Working Group WRB, 2006, WORLD SOIL RES REP, V103; Kato H, 2008, JARQ-JPN AGR RES Q, V42, P231; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Kinoshita T, 2013, B TOCHIGI PREFECTURA; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Li S, 2009, J SOIL SEDIMENT, V9, P433, DOI 10.1007/s11368-009-0095-8; Lu J, 2012, AGR ECOSYST ENVIRON, V146, P13, DOI 10.1016/j.agee.2011.10.011; Ma J, 2007, AUST J SOIL RES, V45, P359, DOI 10.1071/SR07039; Matsushima S, 1961, JPN J CROP SCI, V29, P202; Ministry of the Environment, 1997, ENV QUAL STAND GROUN; Mishima S, 2009, NUTR CYCL AGROECOSYS, V83, P1, DOI 10.1007/s10705-008-9193-z; Nishimura S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002207; Razavipour T., 2014, International Journal of Advanced Biological and Biomedical Research, V2, P1379; Riya S, 2012, KAGAKU KOGAKU RONBUN, V38, P290; San-Oh Y, 2008, JARQ-JPN AGR RES Q, V42, P79; Sasada Y, 2011, BIOL FERT SOILS, V47, P949, DOI 10.1007/s00374-011-0601-1; Shen DZ, 1998, ECOL ENG, V11, P121, DOI 10.1016/S0925-8574(98)00028-7; Shimono H, 2007, AGR ECOSYST ENVIRON, V118, P223, DOI 10.1016/j.agee.2006.05.015; Suzuki A, 1997, FERTILIZATION RICE J; Takamura Y, 1976, J SCI SOIL MANURE, V47, P398; Wang DJ, 2004, ENVIRON GEOCHEM HLTH, V26, P221, DOI 10.1023/B:EGAH.0000039584.35434.e0; Wang XT, 2011, PLANT SOIL, V343, P195, DOI 10.1007/s11104-010-0648-z; Zhou S, 2009, WATER AIR SOIL POLL, V201, P135, DOI 10.1007/s11270-008-9933-3; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	53	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	APR	2015	22	8					5762	5771		10.1007/s11356-014-3811-x		10	Environmental Sciences	Environmental Sciences & Ecology	CF0DG	WOS:000352212300015		
J	Luo, PP; He, B; Takara, K; Xiong, YE; Nouer, D; Duan, WL; Fukushi, K				Luo, Pingping; He, Bin; Takara, Kaoru; Xiong, Yin E.; Nouer, Daniel; Duan, Weili; Fukushi, Kensuke			Historical assessment of Chinese and Japanese flood management policies and implications for managing future floods	ENVIRONMENTAL SCIENCE & POLICY			English	Article						Flood management policy; History; Irrigation; Structure measures; No-structure measures; Extreme events	WATER-RESOURCES MANAGEMENT; CLIMATE-CHANGE; LAND-USE; RIVER; RISK; AREA; SEDIMENTATION; URBANIZATION; CHALLENGES; MITIGATION	Floods are among the world's most devastating natural disasters, causing immense damage and accounting for a large number of deaths world-wide. Good flood management policies play an extremely important role in preventing floods. It is well known that China has more than 5000 years of experience in flood management policy beginning with the reign of DaYu and Gun. Although culturally related, Japanese flood management developed differently from that of China. Under rapid development of civil engineering technology, flood management was achieved primarily through the construction of dams, levees and other structures. These structures were never adequate to stop all floods, and recent climate change driven extreme events are ever more frequently overwhelming such infrastructure. It is important to take a historical perspective ofJapanese and Chinese flood management in order to better manage increasingly frequent extreme events and climate change. We present insights taken from an historical overview of Japanese and Chinese flood management policies in order to guide future flood risk management policy. (C) 2015 Elsevier Ltd. All rights reserved.	[Luo, Pingping] Zhejiang Univ, Coll Civil Engn & Architecture, Inst Hydraul Struct Engn & Water Environm, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Pingping] United Nations Univ Inst Adv Study Sustainabil UN, Shibuya Ku, Tokyo, Japan; [Luo, Pingping; Takara, Kaoru] Kyoto Univ, DPRI, Kyoto 6110011, Japan; [He, Bin; Duan, Weili] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing 210008, Peoples R China; [Xiong, Yin E.] Hunan Womens Coll, Foreign Language Dept, Changsha, Hunan, Peoples R China; [Nouer, Daniel] US Agcy Int Dev, Accra, Ghana; [Fukushi, Kensuke] Univ Tokyo, Integrated Res Syst Sustainabil Sci IR3S, Tokyo 1138654, Japan	Luo, PP (reprint author), Zhejiang Univ, Coll Civil Engn & Architecture, Inst Hydraul Struct Engn & Water Environm, Hangzhou 310003, Zhejiang, Peoples R China.	luoping198121@gmail.com; hebin@niglas.ac.cn; duan.scut.cn@gmail.com			United Nations University - Institute for the Advanced Study of Sustainability (UNU-IAS); Japan Institute of Country-ology and Engineering (JICE) [13003];  [24248041]	This study was supported by the project of "Water and Urban Initiative" at the United Nations University - Institute for the Advanced Study of Sustainability (UNU-IAS), the Japan Institute of Country-ology and Engineering (JICE) Grant Number 13003, Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) Grant Number 24248041. "One Hundred Talents Program" of Chinese Academy of Sciences, National Natural Science Foundation of China (No. 41471460), and the Asia-Pacific Network for Global Change Research (APN) CAF2014-RR06(ARCP)-NMY-Wang.	Calder IR, 2007, FOREST ECOL MANAG, V251, P110, DOI 10.1016/j.foreco.2007.06.015; Heidari A, 2009, NAT HAZARD EARTH SYS, V9, P61; Nakamura K, 2006, BIOSCIENCE, V56, P419, DOI 10.1641/0006-3568(2006)056[0419:RAWRLF]2.0.CO;2; Kundzewicz ZW, 1999, HYDROLOG SCI J, V44, P417, DOI 10.1080/02626669909492237; Chen YR, 2011, NAT HAZARDS, V59, P1261, DOI 10.1007/s11069-011-9831-7; Cui BS, 2009, J ENVIRON MANAGE, V90, P3675, DOI 10.1016/j.jenvman.2009.07.010; White MD, 2006, LANDSCAPE URBAN PLAN, V74, P125, DOI 10.1016/j.landurbplan.2004.11.015; Carling PA, 2013, EARTH-SCI REV, V125, P87, DOI 10.1016/j.earscirev.2013.06.002; Duan WL, 2013, SCI TOTAL ENVIRON, V461, P499, DOI 10.1016/j.scitotenv.2013.05.022; Duan WL, 2014, NAT HAZARDS, V73, P1255, DOI 10.1007/s11069-014-1134-3; Nakamura F, 2004, CATENA, V55, P213, DOI 10.1016/S0341-8162(03)00119-X; Luo PP, 2013, ENVIRON SCI-PROC IMP, V15, P1052, DOI 10.1039/c3em30777h; Diao YF, 2010, SCI CHINA TECHNOL SC, V53, P1949, DOI 10.1007/s11431-010-3124-3; Tran P, 2008, NAT HAZARDS, V46, P119, DOI 10.1007/s11069-007-9186-2; Pfister L, 2004, RIVER RES APPL, V20, P229, DOI 10.1002/rra.775; Hayashi S, 2008, J HYDRO-ENVIRON RES, V2, P148, DOI 10.1016/j.jher.2008.10.002; Luo PP, 2011, J ENVIRON MONITOR, V13, P2819, DOI 10.1039/c1em10339c; Duan WL, 2013, CHEMOSPHERE, V93, P946, DOI [10.1016/j.chemosphere.2013.05.060, 10.1016/j.chemoshere.2013.05.060]; Yoshimura C, 2005, RIVER RES APPL, V21, P93, DOI 10.1002/rra.835; Brouwer R, 2004, ECOL ECON, V50, P1, DOI 10.1016/j.ecolecon.2004.01.020; Bean D.I., 2012, EARTH-SCI REV, V114, P156; Bledsoe BP, 2001, J AM WATER RESOUR AS, V37, P255, DOI 10.1111/j.1752-1688.2001.tb00966.x; Browning-Aiken A, 2007, CLIMATIC CHANGE, V85, P323, DOI 10.1007/s10584-007-9302-z; Cao L., 2004, J SHANDONG NORM U HU, V49, P116; Cao SY, 2010, J HYDRO-ENVIRON RES, V4, P3, DOI 10.1016/j.jher.2009.09.003; China National Consultants Group C, 2002, MIT MAN CONTR FLOODS; Dittmann R, 2009, NAT HAZARD EARTH SYS, V9, P1973; Gu H., 2006, HIST FLOOD CONTROL C; Inoue K., 2007, J DISASTER RES, V2, P3; JEIC, 2009, JAP EXP INT COOP JEI; Knight D. W., 2005, RIVER BASIN MODELLIN; Lara A, 2010, NAT HAZARD EARTH SYS, V10, P2081, DOI 10.5194/nhess-10-2081-2010; Li XA, 2010, J HYDROL, V391, P126, DOI 10.1016/j.jhydrol.2010.07.011; Lind N, 2009, STRUCT SAF, V31, P143, DOI 10.1016/j.strusafe.2008.06.013; Linnerooth-Bayer J., 2007, Environmental Hazards, V7, P54, DOI 10.1016/j.envhaz.2007.04.004; Luo P., 2011, WAT RES ENV PROT ISW, P2125; Luo P, 2014, J FLOOD RISK MANAG, V7, P182, DOI 10.1111/jfr3.12038; Luo P., 2010, ASSESSMENT JAPANESE, V53, P61; Mujumdar PP, 2008, PHYS CHEM EARTH, V33, P354, DOI 10.1016/j.pce.2008.02.014; Muller M, 2007, ENVIRON URBAN, V19, P99, DOI 10.1177/0956247807076726; Musiake K, 2009, INT J WATER RESOUR D, V25, P555, DOI 10.1080/07900620903273796; Nakagawa H., 1996, J JAPAN SOC NAT DISA, V15, P151; Needham J., 1995, SHORTER SCI CIVILISA; Nie CJ, 2012, NAT HAZARDS, V61, P425, DOI 10.1007/s11069-011-9926-1; Petersen G., 2009, MANAGING EXTREME FLO, P9; Pottier N, 2005, APPL GEOGR, V25, P1, DOI 10.1016/j.apgeog.2004.11.003; PTTC, 2013, INT SKETCH MAP DUJ W; Rasid H, 2003, NAT HAZARDS, V28, P101, DOI 10.1023/A:1021125916304; Ross L., 1983, J PUBLIC POLICY, V3, P209, DOI 10.1017/S0143814X00006607; Scheuer S, 2013, COMPUT ENVIRON URBAN, V37, P82, DOI 10.1016/j.compenvurbsys.2012.07.007; Simonovic SP, 2003, NAT HAZARDS, V28, P345, DOI 10.1023/A:1022921823614; Takahasi Y., 2011, FLOOD MANAGEMENT JAP; Takahasi Y, 2004, INT J WATER RESOUR D, V20, P97, DOI 10.1080/07900620310001635638; Takara K., 2004, FLOOD CONTROL FUNCTI, P171; Takahasi Y, 2004, GLOBAL ENVIRON CHANG, V14, P63, DOI 10.1016/j.gloenvcha.2003.11.005; Takeuchi K, 2002, WATER INT, V27, P20; Tanaka K, 2005, APPL GEOGR, V25, P201, DOI 10.1016/j.apgeog.2005.07.001; Tingsanchali T., 2012, PROCEDIA ENG, V32, P25; Van de Wiel MJ, 2011, EARTH-SCI REV, V104, P167, DOI 10.1016/j.earscirev.2010.10.004; Wan H., 2013, INT C TOT DIS RISK M, P4; Wan H., 2013, INT C TOT DIS RISK M, P31; Wan XY, 2012, PROCEDIA ENGINEER, V29, P3267, DOI 10.1016/j.proeng.2012.01.478; Wei CC, 2008, J ENVIRON MANAGE, V88, P1624, DOI 10.1016/j.jenvman.2007.08.004; Wu SJ, 2011, NAT HAZARDS, V58, P117, DOI 10.1007/s11069-010-9653-z; Zhai G, 2008, NAT HAZARD EARTH SYS, V8, P1049; Zhao C., 2005, CHINAS FLOOD CONTROL; Zhou K., 1996, CHINA WATER RESOUR, V8, P1	67	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-9011	1873-6416		ENVIRON SCI POLICY	Environ. Sci. Policy	APR	2015	48						265	277		10.1016/j.envsci.2014.12.015		13	Environmental Sciences	Environmental Sciences & Ecology	CF0QA	WOS:000352248100023		
J	Farley, KJ; Meyer, JS; Balistrieri, LS; De Schamphelaere, KAC; Iwasaki, Y; Janssen, CR; Kamo, M; Lofts, S; Mebane, CA; Naito, W; Ryan, AC; Santore, RC; Tipping, E				Farley, Kevin J.; Meyer, Joseph S.; Balistrieri, Laurie S.; De Schamphelaere, Karel A. C.; Iwasaki, Yuichi; Janssen, Colin R.; Kamo, Masashi; Lofts, Stephen; Mebane, Christopher A.; Naito, Wataru; Ryan, Adam C.; Santore, Robert C.; Tipping, Edward			METAL MIXTURE MODELING EVALUATION PROJECT: 2. COMPARISON OF FOUR MODELING APPROACHES	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Biotic ligand model; Concentration addition; Metal bioavailability; Metal toxicity; WHAM-F-TOX	BIOTIC LIGAND MODEL; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; ACUTE TOXICITY; HUMIC SUBSTANCES; DAPHNIA-MAGNA; ION-BINDING; ZINC TOXICITY; AQUATIC BIOTA; SOFT WATERS	As part of the Metal Mixture Modeling Evaluation (MMME) project, models were developed by the National Institute of Advanced Industrial Science and Technology (Japan), the US Geological Survey (USA), HDR|HydroQual (USA), and the Centre for Ecology and Hydrology (United Kingdom) to address the effects of metal mixtures on biological responses of aquatic organisms. A comparison of the 4 models, as they were presented at the MMME workshop in Brussels, Belgium (May 2012), is provided in the present study. Overall, the models were found to be similar in structure (free ion activities computed by the Windermere humic aqueous model [WHAM]; specific or nonspecific binding of metals/cations in or on the organism; specification of metal potency factors or toxicity response functions to relate metal accumulation to biological response). Major differences in modeling approaches are attributed to various modeling assumptions (e.g., single vs multiple types of binding sites on the organism) and specific calibration strategies that affected the selection of model parameters. The models provided a reasonable description of additive (or nearly additive) toxicity for a number of individual toxicity test results. Less-than-additive toxicity was more difficult to describe with the available models. Because of limitations in the available datasets and the strong interrelationships among the model parameters (binding constants, potency factors, toxicity response parameters), further evaluation of specific model assumptions and calibration strategies is needed. Environ Toxicol Chem 2015;34:741-753. (c) 2014 SETAC	[Farley, Kevin J.] Manhattan Coll, Dept Civil & Environm Engn, Riverdale, NY 10471 USA; [Meyer, Joseph S.] ARCADIS US, Lakewood, CO USA; [Balistrieri, Laurie S.] Univ Washington, Sch Oceanog, US Geol Survey, Seattle, WA 98195 USA; [De Schamphelaere, Karel A. C.; Janssen, Colin R.] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium; [Iwasaki, Yuichi] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan; [Kamo, Masashi; Naito, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Lofts, Stephen; Tipping, Edward] Ctr Ecol & Hydrol, Lancaster, England; [Mebane, Christopher A.] US Geol Survey, Boise, ID USA; [Ryan, Adam C.; Santore, Robert C.] HDR HydroQual, Syracuse, NY USA	Farley, KJ (reprint author), Manhattan Coll, Dept Civil & Environm Engn, Riverdale, NY 10471 USA.	Kevin.Farley@manhattan.edu	Kamo, Masashi/C-6049-2015; Lofts, Stephen /K-1849-2012; Janssen, Colin/H-3122-2015; De Schamphelaere, Karel/A-1600-2008; Mebane, Christopher/C-7188-2009	Kamo, Masashi/0000-0002-6972-3333; Lofts, Stephen /0000-0002-3627-851X; Mebane, Christopher/0000-0002-9089-0267	Copper Alliance; International Zinc Association; Nickel Producers Environmental Research Association; Rio Tinto	Funding for this work was provided by the Copper Alliance, International Zinc Association, Nickel Producers Environmental Research Association and Rio Tinto. The authors are especially grateful to E. Van Genderen, W. Adams, R. Dwyer, E. Garman, and J. Gorsuch for sharing their insights and for coordinating the MMME project. The authors also extend their thanks to T. Schmidt (US Geological Survey) and 2 anonymous reviewers for their careful review of the manuscript and their helpful comments and suggestions. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Tipping E, 2005, GEODERMA, V127, P293, DOI 10.1016/j.geoderma.2004.12.003; Balistrieri LS, 2014, SCI TOTAL ENVIRON, V466, P788, DOI 10.1016/j.scitotenv.2013.07.034; Hollis L, 2000, AQUAT TOXICOL, V51, P93, DOI 10.1016/S0166-445X(00)00099-0; Tipping E, 1998, AQUAT GEOCHEM, V4, P3, DOI 10.1023/A:1009627214459; Lofts S, 2011, ENVIRON CHEM, V8, P501, DOI 10.1071/EN11049; PLAYLE RC, 1993, CAN J FISH AQUAT SCI, V50, P2678; Stockdale A, 2010, AQUAT TOXICOL, V100, P112, DOI 10.1016/j.aquatox.2010.07.018; Le TTY, 2013, ENVIRON TOXICOL CHEM, V32, P137, DOI 10.1002/etc.2039; Clifford M, 2010, AQUAT TOXICOL, V98, P1, DOI 10.1016/j.aquatox.2010.01.001; Clifford M, 2009, AQUAT TOXICOL, V91, P26, DOI 10.1016/j.aquatox.2008.09.016; De Schamphelaere KAC, 2002, ENVIRON SCI TECHNOL, V36, P48, DOI 10.1021/es000253s; Mebane CA, 2012, ENVIRON TOXICOL CHEM, V31, P1334, DOI 10.1002/etc.1820; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Birceanu O, 2008, AQUAT TOXICOL, V89, P222, DOI 10.1016/j.aquatox.2008.07.007; Lofts S, 2008, AQUAT GEOCHEM, V14, P337, DOI 10.1007/s10498-008-9040-5; Heijerick DG, 2002, ENVIRON TOXICOL CHEM, V21, P1309, DOI 10.1897/1551-5028(2002)021<1309:PAZTFD>2.0.CO;2; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Tipping E, 2011, ENVIRON CHEM, V8, P225, DOI 10.1071/EN11016; Tipping E, 2013, AQUAT TOXICOL, V142, P114, DOI 10.1016/j.aquatox.2013.08.003; Carbonaro RF, 2011, GEOCHIM COSMOCHIM AC, V75, P2499, DOI 10.1016/j.gca.2011.02.027; Niyogi S, 2008, COMP BIOCHEM PHYS C, V148, P305, DOI 10.1016/j.cbpc.2008.05.015; Norwood WP, 2003, HUM ECOL RISK ASSESS, V9, P795, DOI 10.1080/713610010; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1897/1551-5028(2001)020<2383:BLMOTA>2.0.CO;2; Balistrieri LS, 2015, ENVIRON TOXICOL CHEM, V34, P761, DOI 10.1002/etc.2824; Besser JM, 2015, ENVIRON TOXICOL CHEM, P626; Farley KJ, 2015, ENVIRON TOXICOL CHEM, V34, P821, DOI 10.1002/etc.2837; Farley KJ, 2008, ENVIRON SCI TECHNOL, V42, P838, DOI 10.1021/es0625071; HydroQual, 2007, BIOT LIG MOD WIND IN; Iwasaki Y, 2015, ENVIRON TOXICOL CHEM, V34, P754, DOI 10.1002/etc.2780; Kamo M, 2008, ENVIRON TOXICOL CHEM, V27, P1479, DOI 10.1897/07-425; Lofts S., 2012, USERS GUIDE TO WHAM7; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P799, DOI 10.1002/etc.2787; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P726, DOI 10.1002/etc.2792; Meyer JS, 2007, EFFECTS WATER CHEM B; Naddy RB, 2015, ENVIRON TOXICOL CHEM, V34, P809, DOI 10.1002/etc.2870; Niyogi S, 2004, CAN J FISH AQUAT SCI, V61, P942, DOI 10.1139/F04-044; Santore RC, 2015, ENVIRON TOXICOL CHEM, V34, P777, DOI 10.1002/etc.2869; Santore RC, 2002, COMP BIOCHEM PHYS C, V133, P271, DOI 10.1016/S1532-0456(02)00106-0; Stockdale A, 2014, ECOL INDIC, V37, P341, DOI 10.1016/j.ecolind.2011.11.002; TIPPING E, 1994, COMPUT GEOSCI, V20, P973, DOI 10.1016/0098-3004(94)90038-8; Tipping E, 2015, ENVIRON TOXICOL CHEM, V34, P788, DOI 10.1002/etc.2773; Todd AS, 2009, ENVIRON TOXICOL CHEM, V28, P1233, DOI 10.1897/08-252.1; Van Genderen E, 2015, ENVIRON TOXICOL CHEM, V34, P721, DOI 10.1002/etc.2750	43	11	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	APR	2015	34	4					741	753		10.1002/etc.2820		13	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CE8NY	WOS:000352101100011		
J	Iwasaki, Y; Kamo, M; Narro, W				Iwasaki, Yuichi; Kamo, Masashi; Narro, Wataru			TESTING AN APPLICATION OF A BIOTIC LIGAND MODEL TO PREDICT ACUTE TOXICITY OF METAL MIXTURES TO RAINBOW TROUT	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Ecological risk assessment; Metal bioavailability; Salmonids; Chemical mixtures; Windermere humic aqueous model	ONCORHYNCHUS-MYKISS; SAFE CONCENTRATIONS; CHEMICAL-MIXTURES; FIELD DATA; ZINC; CADMIUM; BINDING; COPPER; MACROINVERTEBRATES; ACCUMULATION	The authors tested the applicability of a previously developed biotic ligand model (BLM) to predict acute toxicity of single metals and metal mixtures (cadmium, lead, and zinc) to rainbow trout fry (Oncorhynchus mykiss) from a single available dataset. The BLM used in the present study hypothesizes that metals inhibit an essential cation (calcium) and organisms die as a result of its deficiency, leading to an assumption that the proportion of metal-binding ligand (f) is responsible for the toxic effects of metals on the survival of rainbow trout. The f value is a function of free-ion concentrations of metals computed by a chemical speciation model, and the function has affinity constants as model parameters. First, the survival effects of single metals were statistically modeled separately (i.e., f-survival relationship) by using the generalized linear mixed model with binomial distribution. The modeled responses of survival rates to f overlapped reasonably irrespective of metals tested, supporting the theoretical prediction from the BLM that f-survival relationships are comparable regardless of metal species. The authors thus developed the generalized linear mixed model based on all data pooled across the single-metal tests. The best-fitted model well predicted the survival responses observed in mixture tests (r=0.97), providing support for the applicability of the BLM to predict effects of metal mixtures. Environ Toxicol Chem 2015;34:754-760. (c) 2014 SETAC	[Iwasaki, Yuichi] Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan; [Iwasaki, Yuichi] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Kamo, Masashi; Narro, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan	Iwasaki, Y (reprint author), Tokyo Inst Technol, Dept Civil Engn, Tokyo 152, Japan.	yuichiwsk@gmail.com	Kamo, Masashi/C-6049-2015	Kamo, Masashi/0000-0002-6972-3333	Promotion of Science (JSPS) Research Fellowships for Young Scientists [11J09736]; JSPS Postdoctoral Fellowships for Research Abroad	The present study was initiated by our participation in the Metal Mixture Modeling Evaluation workshop in Brussels, Belgium, in May 2012. We thank E. Van Genderen and R.L. Dwyer for their kind help and encouragement and anonymous reviewers for insightful comments that greatly improved this manuscript. Y. Iwasaki was funded by Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists (11J09736) and JSPS Postdoctoral Fellowships for Research Abroad.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alsop DH, 2000, ENVIRON TOXICOL CHEM, V19, P1911, DOI 10.1897/1551-5028(2000)019<1911:KAOZAI>2.3.CO;2; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Balistrieri LS, 2014, SCI TOTAL ENVIRON, V466, P788, DOI 10.1016/j.scitotenv.2013.07.034; Jho EH, 2011, ENVIRON TOXICOL CHEM, V30, P1697, DOI 10.1002/etc.556; PLAYLE RC, 1993, CAN J FISH AQUAT SCI, V50, P2678; Le TTY, 2013, ENVIRON TOXICOL CHEM, V32, P137, DOI 10.1002/etc.2039; Meyer JS, 2002, MAR ENVIRON RES, V53, P417, DOI 10.1016/S0141-1136(01)00121-0; Hatano A, 2008, ENVIRON TOXICOL, V23, P372, DOI 10.1002/tox.20348; Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; LAUREN DJ, 1987, CAN J FISH AQUAT SCI, V44, P99, DOI 10.1139/f87-012; Naito W, 2010, SCI TOTAL ENVIRON, V408, P4271, DOI 10.1016/j.scitotenv.2010.06.018; Bryan SE, 2002, COMP BIOCHEM PHYS C, V133, P37, DOI 10.1016/S1532-0456(02)00083-2; Schmidt TS, 2010, ENVIRON TOXICOL CHEM, V29, P2432, DOI 10.1002/etc.302; Mebane CA, 2012, ENVIRON TOXICOL CHEM, V31, P1334, DOI 10.1002/etc.1820; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Clements WH, 2000, ECOL APPL, V10, P626, DOI 10.1890/1051-0761(2000)010[0626:HMSBCI]2.0.CO;2; Hirst H, 2002, FRESHWATER BIOL, V47, P1752, DOI 10.1046/j.1365-2427.2002.00904.x; Borgmann U, 2008, HUM ECOL RISK ASSESS, V14, P266, DOI 10.1080/10807030801934929; Jonker MJ, 2005, ENVIRON TOXICOL CHEM, V24, P2701, DOI 10.1897/04-431R.1; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Paquin PR, 2002, COMP BIOCHEM PHYS C, V133, P3, DOI 10.1016/S1532-0456(02)00112-6; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Zhou DM, 2011, ECOTOX ENVIRON SAFE, V74, P1036, DOI 10.1016/j.ecoenv.2011.01.021; Hogstrand C, 1998, J EXP BIOL, V201, P1809; Chen ZZ, 2010, ENVIRON SCI TECHNOL, V44, P3580, DOI 10.1021/es1003457; Iwasaki Y, 2012, ENVIRON POLLUT, V166, P182, DOI 10.1016/j.envpol.2012.03.028; Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167; European Chemicals Bureau, 2008, EUR UN RISK ASS REP; European Copper Institute, 2008, EUR UN RISK ASS REP; Farley KJ, 2015, ENVIRON TOXICOL CHEM, V34, P741, DOI 10.1002/etc.2820; Hedtke J L, 1982, Fundam Appl Toxicol, V2, P67, DOI 10.1016/S0272-0590(82)80116-4; Hollis L, 2000, ENVIRON TOXICOL CHEM, V19, P2725, DOI 10.1897/1551-5028(2000)019<2725:PEOCAC>2.0.CO;2; Hollis L, 1999, AQUAT TOXICOL, V46, P101, DOI 10.1016/S0166-445X(98)00118-0; Iwasaki Y, 2011, ENVIRON TOXICOL CHEM, V30, P2237, DOI 10.1002/etc.612; Iwasaki Y, 2015, ENVIRON TOXICOL CHEM, V34, P816, DOI 10.1002/etc.2862; Kamo M, 2008, ENVIRON TOXICOL CHEM, V27, P1479, DOI 10.1897/07-425; Kortenkamp A., 2009, STATE ART REPORT MIX; Macdonald A, 2002, COMP BIOCHEM PHYS C, V133, P227, DOI 10.1016/S1532-0456(02)00107-2; McCarty LS, 2006, REGUL TOXICOL PHARM, V45, P104, DOI 10.1016/j.yrtph.2006.03.002; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P799, DOI 10.1002/etc.2787; Noble RB, 2009, ENVIRON TOXICOL CHEM, V28, P997, DOI 10.1897/08-221.1; Playle RC, 2004, AQUAT TOXICOL, V67, P359, DOI 10.1016/j.aquatox.2004.01.017; R Development Core Team, 2013, R LANG ENV STAT COMP; Santore RC, 2002, COMP BIOCHEM PHYS C, V133, P271, DOI 10.1016/S1532-0456(02)00106-0; Schaefer RB, 2013, ENVIRON TOXICOL CHEM, V32, P734, DOI 10.1002/etc.2140; Tsushima K, 2010, CHEMOSPHERE, V80, P563, DOI 10.1016/j.chemosphere.2010.04.031; US Environmental Protection Agency, 2007, 822F07001 EPA; Van Genderen E, 2015, ENVIRON TOXICOL CHEM, V34, P721, DOI 10.1002/etc.2750; Wood CM, 1996, AQUAT TOXICOL, V35, P93, DOI 10.1016/0166-445X(96)00003-3	51	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	APR	2015	34	4					754	760		10.1002/etc.2780		7	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CE8NY	WOS:000352101100012		
J	Iwasaki, Y; Brinkman, SF				Iwasaki, Yuichi; Brinkman, Stephen F.			APPLICATION OF A GENERALIZED LINEAR MIXED MODEL TO ANALYZE MIXTURE TOXICITY: SURVIVAL OF BROWN TROUT AFFECTED BY COPPER AND ZINC	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Windermere humic aqueous model (WHAM) humic acid; Concentration addition; Response addition; Binomial distribution; Random effect	LIGAND BINDING CHARACTERISTICS; ACTIVITY RELATIONSHIPS QICARS; PREDICT METAL TOXICITY; RISK-ASSESSMENT; AQUATIC BIOTA; ECOTOXICOLOGY; ECOLOGY; WATERS	Increased concerns about the toxicity of chemical mixtures have led to greater emphasis on analyzing the interactions among the mixture components based on observed effects. The authors applied a generalized linear mixed model (GLMM) to analyze survival of brown trout (Salmo trutta) acutely exposed to metal mixtures that contained copper and zinc. Compared with dominant conventional approaches based on an assumption of concentration addition and the concentration of a chemical that causes x% effect (ECx), the GLMM approach has 2 major advantages. First, binary response variables such as survival can be modeled without any transformations, and thus sample size can be taken into consideration. Second, the importance of the chemical interaction can be tested in a simple statistical manner. Through this application, the authors investigated whether the estimated concentration of the 2 metals binding to humic acid, which is assumed to be a proxy of nonspecific biotic ligand sites, provided a better prediction of survival effects than dissolved and free-ion concentrations of metals. The results suggest that the estimated concentration of metals binding to humic acid is a better predictor of survival effects, and thus the metal competition at the ligands could be an important mechanism responsible for effects of metal mixtures. Application of the GLMM (and the generalized linear model) presents an alternative or complementary approach to analyzing mixture toxicity. Environ Toxicol Chem 2015;34:816-820. (c) 2015 SETAC	[Iwasaki, Yuichi] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Iwasaki, Yuichi] Toyo Univ, Res Ctr Life & Environm Sci, Gunma, Japan; [Brinkman, Stephen F.] Colorado Pk & Wildlife, Ft Collins, CO USA	Iwasaki, Y (reprint author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	yuichiwsk@gmail.com			Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (JSPS KAKENHI) [239736]; Postdoctoral Fellowships for Research Abroad; Ministry of Education, Culture, Sport, Science, and Technology, Japan [S14111016]	We thank P. Cadmus for connecting dots, and W. Clements, R.L. Dwyer, D.R. Anderson, and K. Terao for their kind support. Insightful comments and edits by J.S. Meyer and 4 anonymous reviewers on earlier versions of this manuscript are greatly appreciated. Y. Iwasaki was funded by the Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (JSPS KAKENHI, Grant Number 239736) and Postdoctoral Fellowships for Research Abroad. The present study was partly supported by a Grant-in-Aid for Strategic Research Base Project for Private Universities, which is funded by the Ministry of Education, Culture, Sport, Science, and Technology, Japan, 2014-2018 (Grant number S14111016).	Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1916, DOI 10.1897/02-568; Kong MY, 2006, BIOMETRICS, V62, P986, DOI 10.1111/j.1541-0420.2006.00579.x; Faust M, 2001, AQUAT TOXICOL, V56, P13, DOI 10.1016/S0166-445X(01)00187-4; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Stockdale A, 2010, AQUAT TOXICOL, V100, P112, DOI 10.1016/j.aquatox.2010.07.018; Antunes PMC, 2012, CHEMOSPHERE, V88, P389, DOI 10.1016/j.chemosphere.2012.02.052; HEWLETT PS, 1959, BIOMETRICS, V15, P591, DOI 10.2307/2527657; Backhaus T, 2012, ENVIRON SCI TECHNOL, V46, P2564, DOI 10.1021/es2034125; Bryan SE, 2002, COMP BIOCHEM PHYS C, V133, P37, DOI 10.1016/S1532-0456(02)00083-2; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Sorensen H, 2007, ENVIRON ECOL STAT, V14, P383, DOI 10.1007/s10651-007-0022-3; BENOIT DA, 1982, WATER RES, V16, P457, DOI 10.1016/0043-1354(82)90171-3; Jonker MJ, 2005, ENVIRON TOXICOL CHEM, V24, P2701, DOI 10.1897/04-431R.1; Brander SM, 2009, ENVIRON TOXICOL CHEM, V28, P1493, DOI 10.1897/08-374.1; Tipping E, 2011, ENVIRON CHEM, V8, P225, DOI 10.1071/EN11016; Tipping E, 2013, AQUAT TOXICOL, V142, P114, DOI 10.1016/j.aquatox.2013.08.003; Howard GJ, 2009, J THEOR BIOL, V259, P469, DOI 10.1016/j.jtbi.2009.03.030; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Norwood WP, 2003, HUM ECOL RISK ASSESS, V9, P795, DOI 10.1080/713610010; Forfait-Dubuc C, 2012, ECOTOXICOLOGY, V21, P1072, DOI 10.1007/s10646-012-0860-0; Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7; Iwasaki Y, 2013, AQUAT TOXICOL, V132, P151, DOI 10.1016/j.aquatox.2013.02.007; Brinkman SF, 2012, ARCH ENVIRON CON TOX, V62, P272, DOI 10.1007/s00244-011-9698-3; Burnham K. P., 2002, MODEL SELECTION MULT; Davies PH, 2002, WATER POLLUTION STUD; De Laender F, 2009, CHEMOSPHERE, V76, P428, DOI 10.1016/j.chemosphere.2009.03.027; Faraway J. J., 2006, EXTENDING LINEAR MOD; FINNEY D.J., 1971, PROBIT ANAL STAT TRE; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Iwasaki Y, 2015, ENVIRON TOXICOL CHEM, V34, P754, DOI 10.1002/etc.2780; Kerr DR, 1996, ENVIRON TOXICOL CHEM, V15, P395, DOI 10.1897/1551-5028(1996)015<0395:MDRUGL>2.3.CO;2; Kortenkamp A., 2009, STATE ART REPORT MIX; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P799, DOI 10.1002/etc.2787; Meyer JS, 2015, ENVIRON TOXICOL CHEM, V34, P726, DOI 10.1002/etc.2792; Newman MC, 1998, ENVIRON HEALTH PERSP, V106, P1419; Noble RB, 2009, ENVIRON TOXICOL CHEM, V28, P997, DOI 10.1897/08-221.1; Ownby DR, 2003, QSAR COMB SCI, V22, P241, DOI 10.1002/qsar.200390018; R Development Core Team, 2013, R LANG ENV STAT COMP; Stephenson GL, 2000, ENVIRON TOXICOL CHEM, V19, P2968, DOI 10.1897/1551-5028(2000)019<2968:UONRTF>2.0.CO;2; Stockdale A, 2014, ECOL INDIC, V37, P341, DOI 10.1016/j.ecolind.2011.11.002; Tipping E, 2015, ENVIRON TOXICOL CHEM, V34, P788, DOI 10.1002/etc.2773; Van Genderen E, 2015, ENVIRON TOXICOL CHEM, V34, P721, DOI 10.1002/etc.2750; Walker JD, 2013, FUNDAMENTAL QSARS ME	44	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	APR	2015	34	4					816	820		10.1002/etc.2862		5	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CE8NY	WOS:000352101100018		
J	Tachimori, Y; Ozawa, S; Numasaki, H; Fujishiro, M; Matsubara, H; Oyama, T; Shinoda, M; Toh, Y; Udagawa, H; Uno, T				Tachimori, Yuji; Ozawa, Soji; Numasaki, Hodaka; Fujishiro, Mitsuhiro; Matsubara, Hisahiro; Oyama, Tsuneo; Shinoda, Masayuki; Toh, Yasushi; Udagawa, Harushi; Uno, Takashi		Japan Esophageal Soc	Comprehensive Registry of Esophageal Cancer in Japan, 2007	ESOPHAGUS			English	Article									[Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Chuo Ku, Tokyo 1040045, Japan; [Ozawa, Soji] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa 25911, Japan; [Numasaki, Hodaka] Osaka Univ, Grad Sch Med, Dept Med Phys & Engn, Osaka, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo, Japan; [Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Oyama, Tsuneo] Saku Gen Hosp, Dept Gastroenterol, Nagano, Japan; [Shinoda, Masayuki] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan; [Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Udagawa, Harushi] Toranomon Gen Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Uno, Takashi] Chiba Univ, Grad Sch Med, Dept Radiol, Chiba, Japan	Tachimori, Y (reprint author), Natl Canc Ctr, Esophageal Surg Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ytachimo@ncc.go.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					101	129		10.1007/s10388-015-0488-2		29	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800001		
J	Tachimori, Y; Ozawa, S; Numasaki, H; Fujishiro, M; Matsubara, H; Oyama, T; Shinoda, M; Toh, Y; Udagawa, H; Uno, T				Tachimori, Yuji; Ozawa, Soji; Numasaki, Hodaka; Fujishiro, Mitsuhiro; Matsubara, Hisahiro; Oyama, Tsuneo; Shinoda, Masayuki; Toh, Yasushi; Udagawa, Harushi; Uno, Takashi		Japan Esophageal Soc	Comprehensive Registry of Esophageal Cancer in Japan, 2008	ESOPHAGUS			English	Article									[Tachimori, Yuji] Natl Canc Ctr, Esophageal Surg Div, Chuo Ku, Tokyo 1040045, Japan; [Ozawa, Soji] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa 25911, Japan; [Numasaki, Hodaka] Osaka Univ, Grad Sch Med, Dept Med Phys & Engn, Osaka, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Tokyo, Japan; [Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Oyama, Tsuneo] Saku Gen Hosp, Dept Gastroenterol, Nagano, Japan; [Shinoda, Masayuki] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan; [Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Udagawa, Harushi] Toranomon Gen Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Uno, Takashi] Chiba Univ, Grad Sch Med, Dept Radiol, Chiba, Japan	Tachimori, Y (reprint author), Natl Canc Ctr, Esophageal Surg Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ytachimo@ncc.go.jp			Ministry of Health, Labour and Welfare of Japan [H26-Cancer Policy-General-014]	This study was supported by Health and Labour Sciences Research Grants for Promotion of Cancer Control Programs (H26-Cancer Policy-General-014) from the Ministry of Health, Labour and Welfare of Japan.		0	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					130	157		10.1007/s10388-015-0489-1		28	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800002		
J	Makuuchi, H; Takubo, K; Yanagisawa, A; Yamamoto, S				Makuuchi, Hiroyasu; Takubo, Kaiyo; Yanagisawa, Akio; Yamamoto, Soichiro			Esophageal malignant melanoma: analysis of 134 cases collected by the Japan Esophageal Society	ESOPHAGUS			English	Article						Esophageal malignant melanoma; Survival rate; Treatment; Superficial malignant melanoma	SURVIVAL	Esophageal malignant melanoma is an extremely rare disease and no scientific society has systematically collected data on it previously. The 141 institutes belonging to the Japan Esophageal Society conducted a questionnaire on the details of esophageal malignant melanoma during the 10-year period from 1998 to 2007. The questionnaire return rate was 92.9 %. In the 10-year period, there were 134 cases of the disease, indicating an incidence of about 13-14 cases per year in Japan. Of these, 70 cases (52.2 %) had invasion extending up to the submucosal layer, while 64 cases (47.8 %) were advanced malignant melanoma. There were 84 cases (62.7 %) of lymph node metastasis and, of these, 25 cases (18.7 %) showed metastasis to distant organs. Endoscopic resection was performed in 7 cases (5.2 %) and surgical resection alone and surgery plus chemotherapy were employed in 102 cases (76.1 %), 21 cases (15.7 %) received chemotherapy or chemoradiotherapy and 4 cases received best supportive care. Of these, 53 cases died within 1 year and the 1-, 3-, 5-year survival rates by the Kaplan-Meier method were 56.9, 28.0 and 26.3 %, respectively. Of the 13 cases surviving 5 years or more, 12 were superficial malignant melanoma and 8 had lymph node metastasis. In principle, the treatment of esophageal malignant melanoma consists of surgical resection, but its indications and adjuvant therapy with new drugs require an extremely thorough rethinking in terms of therapeutic strategy.	[Makuuchi, Hiroyasu; Yamamoto, Soichiro] Tokai Univ, Sch Med, Dept Surg Gastroenterol, Isehara, Kanagawa 2591193, Japan; [Takubo, Kaiyo] Tokyo Metropolitan Geriatr Res Inst, Genome Anal Team, Itabashi Ku, Tokyo 1750015, Japan; [Yanagisawa, Akio] Kyoto Prefectural Univ, Dept Pathol, Kamigyo Ku, Kyoto 6028566, Japan	Makuuchi, H (reprint author), Tokai Univ, Sch Med, Dept Surg Gastroenterol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	makuuchi@is.icc.u-tokai.ac.jp; takubo@tmig.or.jp; yanagisa@koto.kpu-m.ac.jp					Ribas A, 2010, SEMIN ONCOL, V37, P450, DOI 10.1053/j.seminoncol.2010.09.010; Soiffer R, 2003, J CLIN ONCOL, V21, P3343, DOI 10.1200/JCO.2003.07.005; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Long GV, 2012, LANCET ONCOL, V13, P1087, DOI 10.1016/S1470-2045(12)70431-X; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Bauer EH, 1906, ARB PATHOL ANAT I TU, V5, P343; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Fujisawa Y, 2008, SKIN CANC, V23, P267; Fujisawa Y, 2012, SKIN CANC JAPAN, V27, P195; Harada K, 2012, ESOPHAGUS, V9, P118; Ishihara K, 2002, SKIN CANCER, V17, P7; Itami A, 2004, ESOPHAGUS, V1, P135; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P1; Makuuchi Hiroyasu, 2005, Stomach and Intestine (Tokyo), V40, P320; Morita S, 2009, ESOPHAGUS-TOKYO, V6, P249, DOI 10.1007/s10388-009-0204-1; Nakamoto A, 2008, ESOPHAGUS, V5, P233; Okumura T, 2013, ESOPHAGUS-TOKYO, V10, P184, DOI 10.1007/s10388-013-0373-9; Sanbe T, 1960, J JPN BRONCHOESOPHAG, V11, P340; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Seto Y, 1992, JPN J CANC CLIN, V38, P780; Shimada K, 2009, SURGERY, V71, P973; Shomura Y, 1995, J JPN SURG ASS, V56, P544; Sunagawa H, 2005, ESOPHAGUS, V2, P33, DOI 10.1007/s10388-004-0032-2; Tachimori Y, 2014, ESOPHAGUS-TOKYO, V11, P21, DOI 10.1007/s10388-013-0393-5; Yamaguchi Tomohiro, 2004, Japanese Journal of Gastroenterology, V101, P1087	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					158	169		10.1007/s10388-015-0484-6		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800003		
J	Nakao, R; Fujita, Y; Yagi, N; Konishi, E; Yanagisawa, A				Nakao, Ryuta; Fujita, Yasuko; Yagi, Nobuaki; Konishi, Eiichi; Yanagisawa, Akio			Histopathological and immunohistochemical characteristics of superficial squamous cell carcinoma forming droplet infiltration: indicator of lymph node metastasis of the esophagus	ESOPHAGUS			English	Article						Esophageal superficial squamous cell carcinoma; Endoscopic submucosal dissection; Droplet infiltration; Ki-67; CK13	INDEPENDENT PROGNOSTIC-FACTOR; PROLIFERATIVE ACTIVITY; EPITHELIAL NEOPLASMS; EXPRESSION; CANCER; KI-67; RESECTION; PATTERNS; ANTIGEN; PROTEIN	Droplet infiltration (DI) is a tumor infiltration pattern observed in superficial squamous cell carcinoma (SSCC) of the esophagus. Lymph node metastasis (LNM) is related to three reported features of DI (DILFs): longitudinal diameter a parts per thousand currency sign20 mu m (DIsLF); number of constituent cells a parts per thousand currency sign4 (DInLF); distance from the primary focus a parts per thousand yen200 mu m (DIdLF). The aim of this study was to clarify the characteristics of SSCC with high risk of LNM, by analyzing DILF-forming SSCC histopathologically and immunohistochemically. Forty-five SSCC invading the muscularis mucosa or submucosa were divided into two groups with and without above-mentioned three DILFs. The Ki-67 labeling index (LI) and the expression of cytokeratin (CK) 13, 14, 17, and 19 were compared in the paired. The Ki-67 LI was elevated in SSCC with DIsLF and with DInLF (P < 0.001, each), but no significant difference was observed between SSCC with and without DIdLF. The expression of CK13 was decreased in SSCC with DIsLF (P < 0.01) and with DInLF (P < 0.001), but no significant difference was observed between SSCC with and without DIdLF. For CK14, CK17, and CK19, no significant difference was observed between SSCC with and without any DILF. The results indicated that DIsLF and DInLF are not only LNM predictors, but useful morphological markers reflecting excessive cell proliferation, and that the reduced expression of CK13 is closely associated with DIsLF and DInLF formation at the invasive front. Therefore, the elevation of Ki-67 LI and reduced expression of CK13 suggest higher risk of LNM in esophageal SSCC.	[Nakao, Ryuta; Fujita, Yasuko; Konishi, Eiichi; Yanagisawa, Akio] Kyoto Prefectural Univ Med, Dept Surg Pathol, Kamigyo Ku, Kyoto 6028566, Japan; [Nakao, Ryuta] Kyoto First Red Cross Hosp, Dept Pathol, Kyoto, Japan; [Yagi, Nobuaki] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan	Nakao, R (reprint author), Kyoto Prefectural Univ Med, Dept Surg Pathol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	r-nakao@koto.kpu-m.ac.jp					Motoyama S, 2013, SURG TODAY, V43, P638, DOI 10.1007/s00595-012-0295-5; Yamashina T, 2013, AM J GASTROENTEROL, V108, P544, DOI 10.1038/ajg.2013.8; Koike M, 2008, ANN SURG ONCOL, V15, P1977, DOI 10.1245/s10434-008-9901-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; Kawamura T, 1996, CANCER, V77, P843, DOI 10.1002/(SICI)1097-0142(19960301)77:5<843::AID-CNCR6>3.0.CO;2-F; Kwaspen FHL, 1997, HISTOPATHOLOGY, V31, P503, DOI 10.1046/j.1365-2559.1997.2960896.x; Makino T, 2009, BRIT J CANCER, V101, P1298, DOI 10.1038/sj.bjc.6605313; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; Takahashi H, 2010, GASTROINTEST ENDOSC, V72, P255, DOI 10.1016/j.gie.2010.02.040; Eguchi T, 2006, MODERN PATHOL, V19, P475, DOI 10.1038/modpathol.3800557; Center for Cancer Control and Information Services, 2012, CANC STAT JAP 2012, P12; Chino O, 1998, J SURG ONCOL, V67, P18, DOI 10.1002/(SICI)1096-9098(199801)67:1<18::AID-JSO4>3.0.CO;2-P; Chu PG, 2001, HISTOPATHOLOGY, V39, P9, DOI 10.1046/j.1365-2559.2001.01105.x; Egashira H, 2006, ESOPHAGUS, V3, P47, DOI 10.1007/s10388-006-0074-8; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Ikeda G, 1999, CANCER, V86, P1396, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1396::AID-CNCR3>3.0.CO;2-H; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; LAM KY, 1995, VIRCHOWS ARCH, V426, P345; Makuuchi Hiroyasu, 1998, Stomach and Intestine (Tokyo), V33, P993; MALECHA MJ, 1991, VIRCHOWS ARCH A, V418, P249, DOI 10.1007/BF01606063; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Nakanishi Y, 2011, WORLD J SURG, V35, P349, DOI 10.1007/s00268-010-0880-y; Nakayama H, 2011, ESOPHAGUS, V9, P1; Ohashi K, 1997, VIRCHOWS ARCH, V430, P107, DOI 10.1007/BF01008031; Oyama Tsuneo, 2002, Stomach and Intestine (Tokyo), V37, P71; Roh MS, 2004, DIS ESOPHAGUS, V17, P333, DOI 10.1111/j.1442-2050.2004.00436.x; Safadi Rima A, 2010, Head Neck Pathol, V4, P282, DOI 10.1007/s12105-010-0210-6; Sasagawa H, 2012, ESOPHAGUS-TOKYO, V9, P195, DOI 10.1007/s10388-012-0336-6; TAKAHASHI H, 1995, HISTOPATHOLOGY, V26, P45, DOI 10.1111/j.1365-2559.1995.tb00619.x; Takashima Masaki, 2012, J Med Dent Sci, V59, P17; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; Urabe Y, 2011, J GASTROEN HEPATOL, V26, P275, DOI 10.1111/j.1440-1746.2010.06503.x; YOUSSEF EM, 1995, CANCER, V76, P358, DOI 10.1002/1097-0142(19950801)76:3<358::AID-CNCR2820760303>3.0.CO;2-C	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					175	183		10.1007/s10388-014-0459-z		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800005		
J	Yuasa, Y; Okitsu, H; Goto, M; Edagawa, H; Mori, O; Tani, R; Tomibayashi, A; Matsumoto, D; Kuramoto, S; Osaki, K				Yuasa, Yasuhiro; Okitsu, Hiroshi; Goto, Masakazu; Edagawa, Hiroshi; Mori, Osamu; Tani, Ryotaro; Tomibayashi, Atsushi; Matsumoto, Daisuke; Kuramoto, Syunsuke; Osaki, Kyosuke			Preoperative chemoradiotherapy with docetaxel, doxifluridine, and low-dose cisplatin for stage II/III squamous cell carcinoma of the esophagus	ESOPHAGUS			English	Article						Esophageal cancer; Chemoradiotherapy; Neoadjuvant therapy	PHASE-III TRIAL; INDUCTION CHEMOTHERAPY; 5-FLUOROURACIL; CANCER; DCF	Preoperative chemotherapy using 5-fluorouracil and cisplatin is a standard treatment for stage II/III esophageal squamous cell carcinoma (ESCC) in Japan. However, stronger therapies are needed for advanced ESCC. This retrospective study aimed to evaluate the feasibility and safety of neoadjuvant chemoradiotherapy with R-DDP. Patients diagnosed with clinical stage II/III ESCC and initially treated with preoperative R-DDP were enrolled. R-DDP comprised intravenous docetaxel (40 mg m(-2) day(-1) on day 1), oral doxifluridine (800 mg m(-2) day(-1) on days 1-7), low-dose cisplatin (5 mg m(-2) day(-1) on days 1-5), and concurrent radiation (2 Gy day(-1) on days 1-5), which were repeated weekly for 3 weeks (maximum total radiation: 30 Gy). If clinical stage T4 was suspected, another week of the regimen was added (maximum total radiation: 40 Gy). After therapy evaluation, patients underwent esophagectomy with 2 or 3 fields of lymphadenectomy. Between April 2003 and March 2011, 19 eligible patients were enrolled (treatment completion rate: 89.5 %). Complete or partial response was obtained in 17 cases (89.5 %), and 8 cases (42.1 %) involved downstaging. In resected specimens, the primary tumor's histopathological grade was 1, 2, and 3 in 3, 11, and 5 cases. Although 42.1 % of patients developed grade 3+ adverse events, there were no severe perioperative complications. Three- and five-year overall survival rates were 42.1 and 36.1 %, with a 23-month median progression-free survival. Although this treatment had good antitumor effects, it did not necessarily confer prognostic improvements. R-DDP could become a therapeutic strategy for locally advanced ESCC.	[Yuasa, Yasuhiro; Okitsu, Hiroshi; Goto, Masakazu; Edagawa, Hiroshi; Mori, Osamu; Tani, Ryotaro; Tomibayashi, Atsushi; Matsumoto, Daisuke; Kuramoto, Syunsuke] Tokushima Red Cross Hosp, Dept Digest Surg, Komatsushima, Tokushima 7738502, Japan; [Osaki, Kyosuke] Tokushima Red Cross Hosp, Dept Radiol, Komatsushima, Japan	Yuasa, Y (reprint author), Tokushima Red Cross Hosp, Dept Digest Surg, 103 Irinokuchi,Komatsushima Cho, Komatsushima, Tokushima 7738502, Japan.	yuasay0911@gmail.com					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Watanabe M, 2011, DIGESTION, V83, P146, DOI 10.1159/000321797; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Yokota T, 2011, ANTICANCER RES, V31, P3535; Hamamoto Y, 2013, ESOPHAGUS-TOKYO, V10, P205, DOI 10.1007/s10388-013-0384-6; Hsu CH, 1999, ANTICANCER RES, V19, P4463; Japan Esophageal Society, 2008, GUID CLIN PATH STUD; Jun Ohta, 1986, MED FRONTLINE, V41, P528; Okitsu H, 2004, J JPN SURG ASS, V65, P587; Sekiguchi H, 1999, SURG TODAY, V29, P97; Shinoda M, 2010, ASCO ANN M P S15, V28, P4053; Sobin LH, 2009, TNM CLASSIFICATION M; The Japan Esophageal Society, 2012, GUID ES CANC DIAGN T; Toh Y, 2008, GASTROENTEROL SURG, V31, P1653; van Hagen P, 2012, LANCET ONCOL, V366, P2074; Yoshida T, 2010, ESOPHAGUS-TOKYO, V7, P95, DOI 10.1007/s10388-010-0234-8; Yuasa Y, 2010, DIS ESOPHAGUS S97A, V23	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					191	198		10.1007/s10388-014-0460-6		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800007		
J	Takeno, S; Moroga, T; Ono, K; Kawahara, K; Hirano, T; Moriyama, M; Suzuki, M; Maki, K; Yamana, I; Hashimoto, T; Shibata, R; Naito, M; Shiwaku, H; Sasaki, T; Yoshida, Y; Yamashita, Y				Takeno, Shinsuke; Moroga, Toshihiko; Ono, Kiyoshi; Kawahara, Katsunobu; Hirano, Takashi; Moriyama, Munehito; Suzuki, Masashi; Maki, Kenji; Yamana, Ippei; Hashimoto, Tatsuya; Shibata, Ryosuke; Naito, Masayasu; Shiwaku, Hironari; Sasaki, Takamitsu; Yoshida, Yoichiro; Yamashita, Yuichi			Endoscopic mucosal incision for successful treatment of submucosal abscess extending the full length of the esophagus due to fish bone: report of a case	ESOPHAGUS			English	Article						Submucosal abscess; Esophagus; Endoscopic mucosal incision	PERFORATION; MEDIASTINITIS; INGESTION	Submucosal abscess of the esophagus is extremely rare, and treatment has yet to be well established. A 58-year-old man with no relevant past medical history visited an otolaryngological clinic with a chief complaint of throat irritation. Computed tomography revealed submucosal abscess extending the full length of the esophagus after abnormally high white blood cell count and C-reactive protein levels were noted. A fish bone was removed surgically via the right side of the neck, and the submucosal abscess was drained by endoscopic mucosal incision. Oral intake was started on postoperative day 10 and the patient was discharged without any complications. Endoscopic submucosal incision is a useful and less-invasive therapy for treating esophageal submucosal abscess.	[Takeno, Shinsuke; Maki, Kenji; Yamana, Ippei; Hashimoto, Tatsuya; Shibata, Ryosuke; Naito, Masayasu; Shiwaku, Hironari; Sasaki, Takamitsu; Yoshida, Yoichiro; Yamashita, Yuichi] Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Johnan Ku, Fukuoka, Fukuoka 8140180, Japan; [Takeno, Shinsuke; Moroga, Toshihiko; Ono, Kiyoshi; Kawahara, Katsunobu] Oita Univ, Fac Med, Dept Surg 2, Oita 87011, Japan; [Hirano, Takashi; Moriyama, Munehito; Suzuki, Masashi] Oita Univ, Fac Med, Dept Otolaryngol, Oita 87011, Japan	Takeno, S (reprint author), Fukuoka Univ, Fac Med, Dept Surg Gastroenterol, Johnan Ku, Nanakuma 7-45-1, Fukuoka, Fukuoka 8140180, Japan.	takeno@fukuoka-u.ac.jp					Chen Ching Yuan, 2011, Am J Otolaryngol, V32, P253, DOI 10.1016/j.amjoto.2010.02.006; Das D, 2007, EMERG MED J, V24, P48, DOI 10.1136/emj.2006.044388; Eroglu A, 2002, DIS ESOPHAGUS, V15, P93, DOI 10.1046/j.1442-2050.2002.00235.x; Katsetos MC, 2003, SOUTH MED J, V96, P516, DOI 10.1097/01.SMJ.0000047744.34423.0B; Koike Jun, 2010, Tokai J Exp Clin Med, V35, P46; Kunishige Hideyuki, 2008, Gen Thorac Cardiovasc Surg, V56, P427, DOI 10.1007/s11748-008-0266-3; Lee KH, 2003, AM J ROENTGENOL, V180, P1482; Macchi V, 2008, J FORENSIC SCI, V53, P1181, DOI 10.1111/j.1556-4029.2008.00815.x; Nishimaki T, 2001, DIS ESOPHAGUS, V14, P155, DOI 10.1046/j.1442-2050.2001.00175.x; Nozoe T, 1998, HEPATO-GASTROENTEROL, V45, P2190	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					199	202		10.1007/s10388-014-0413-0		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800008		
J	Oshikiri, T; Yasuda, T; Fujino, Y; Tominaga, M				Oshikiri, Taro; Yasuda, Takashi; Fujino, Yasuhiro; Tominaga, Masahiro			Successful conservative management of gastrotracheal fistula after esophagectomy	ESOPHAGUS			English	Article						Esophageal cancer; Esophageal surgery; Fistula; Postoperative care	GASTRO-BRONCHIAL FISTULA; SUBTOTAL ESOPHAGECTOMY; COMPLICATION	Gastro-tracheobronchial fistula following esophagogastrostomy is usually fatal, making conservative treatment inadvisable. A 68-year-old man underwent esophagectomy with gastric conduit reconstruction in the posterior mediastinum and neck anastomosis. Despite anastomotic leakage on postoperative day 8, the patient was stable and was managed conservatively. On day 28, a gastric tube-bronchial fistula was diagnosed by esophagogram, gastrointestinal endoscopy, and bronchoscopy. No inflammatory reaction occurred and the patient remained stable, so conservative management was continued. On day 43, gastrointestinal endoscopy and bronchoscopy showed closure of the hole. The patient progressed well on an oral diet and was discharged. Conservative management is possible in limited cases.	[Oshikiri, Taro; Yasuda, Takashi; Fujino, Yasuhiro; Tominaga, Masahiro] Hyogo Canc Ctr, Dept Surg Gastroenterol, Akashi, Hyogo 6738558, Japan	Oshikiri, T (reprint author), Hyogo Canc Ctr, Dept Surg Gastroenterol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	urotarikishio@gmail.com					Baisi A, 1994, DIS ESOPHAGUS, V7, P209; Bona D, 2007, ANN THORAC SURG, V84, P1036, DOI 10.1016/j.athoracsur.2007.04.043; Massone PPB, 2002, THORAC CARDIOV SURG, V50, P113; Buskens CJ, 2001, ANN THORAC SURG, V72, P221, DOI 10.1016/S0003-4975(01)02701-1; KRON IL, 1989, ANN THORAC SURG, V47, P767; Martin-Smith JD, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-20; Pramesh CS, 2001, DIS ESOPHAGUS, V14, P271, DOI 10.1046/j.1442-2050.2001.00201.x; Union for International Cancer Control (UICC), 2002, TNM CLASSIFICATION M; Ussat S, 2013, DEUT MED WOCHENSCHR, V138, P1406, DOI 10.1055/s-0033-1343238; Yasuda T, 2012, DIS ESOPHAGUS, V25, P687, DOI 10.1111/j.1442-2050.2011.01309.x	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	APR	2015	12	2					203	207		10.1007/s10388-014-0416-x		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF1HG	WOS:000352294800009		
J	Kimura, Y; Pham, NM; Yasuda, K; Nanri, A; Kurotani, K; Kuwahara, K; Akter, S; Sato, M; Hayabuchi, H; Mizoue, T				Kimura, Y.; Pham, N. M.; Yasuda, K.; Nanri, A.; Kurotani, K.; Kuwahara, K.; Akter, S.; Sato, M.; Hayabuchi, H.; Mizoue, T.			Association of adulthood weight gain with circulating adipokine and insulin resistance in the Japanese population	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							BODY-FAT DISTRIBUTION; LEPTIN CONCENTRATIONS; METABOLIC SYNDROME; SERUM ADIPONECTIN; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; OBESE HUMANS; WOMEN; RISK; MEN	BACKGROUND/OBJECTIVES: Although adipokines and insulin resistance are known to be correlated with body fatness, it is unclear whether they are independently related to weight gain experience. We examined the associations of serum adipokines and marker of insulin resistance with past weight gain during adulthood by taking the degree of attained body mass index (BMI) level into consideration. SUBJECTS/METHODS: Subjects were 399 Japanese municipal employees, aged >= 30 years, who participated in a health survey. Serum adipokines were measured using a Luminex suspension bead-based multiplexed array. Weight change during adulthood was calculated as the difference between measured current weight and recalled weight at the age of 20 years. Multiple regression was performed to calculate mean adipokine levels and homeostasis model assessment of insulin resistance (HOMA-IR) according to weight gain (<5 kg, 5-9.9 kg, or >= 10 kg) with adjustment for current BMI. RESULTS: Weight gain from the age of 20 years was significantly and positively associated with leptin levels even after adjustment for current BMI (P for trend <0.001), whereas it was significantly and inversely associated with adiponectin levels in a BMI-adjusted model among subjects aged >= 40 years (P for trend = 0.03). Weight gain was associated with HOMA-IR in a BMI-unadjusted model (P for trend <0.001), but this association was largely attenuated after adjustment for BMI. Resistin, plasminogen activator inhibitor-1 and visfatin were not associated with past weight gain. CONCLUSIONS: Results suggest that a large weight gain during adulthood is associated with higher leptin and lower adiponectin levels independently of the degree of attained BMI level.	[Kimura, Y.] Fukuyama Univ, Fac Life Sci & Biotechnol, Dept Nutr & Life Sci, Fukuyama, Hiroshima 7290292, Japan; [Pham, N. M.; Nanri, A.; Kurotani, K.; Kuwahara, K.; Akter, S.; Mizoue, T.] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Yasuda, K.] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Metab Disorder, Tokyo, Japan; [Sato, M.] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Appl Biol Chem, Fukuoka 812, Japan; [Hayabuchi, H.] Fukuoka Womens Univ, Grad Sch Nutr & Hlth Sci, Fukuoka, Japan	Kimura, Y (reprint author), Fukuyama Univ, Fac Life Sci & Biotechnol, Dept Nutr & Life Sci, 1 Gakuencho, Fukuyama, Hiroshima 7290292, Japan.	kimura@fubac.fukuyama-u.ac.jp			Japan Society for the Promotion of Science [21390213]; Ministry of Education, Culture, Sports, Science and Technology [21790598]; Grant of National Center for Global Health and Medicine; National Center for Global Health and Medicine; National Institute of Biomedical Innovation	We are grateful to the study participants for their cooperation and participation. We also thank Seiko Miyazaki and Yasutaka Horiuchi (Kyushu University); Emi Tanaka, Youko Tsuruda, Misaki Hirose, Meishu Sai, Miho Isayama, Midori Sasaki, Mie Shimomura and Azumi Uehara (Fukuoka Women's University); Yaeko Nagano (retired nurse); and Akiko Hayashi, Yu Teruyama, Kae Saito, Kayoko Washizuka and Yuho Mizoue (National Center for Global Health and Medicine) for their help in data collection. We extend our thanks to Kazuko Nagase and Dai Suzuki (National Center for Global Health and Medicine) for their contributions to measurements of serum adipokines. This study was supported by a Grant-in-Aid for Scientific Research (B) (21390213) from the Japan Society for the Promotion of Science (To Dr Mizoue), a Grant-in-Aid for Young Scientists (B) (21790598) from the Ministry of Education, Culture, Sports, Science and Technology and a Grant of National Center for Global Health and Medicine (To Dr Nanri), a grant from National Center for Global Health and Medicine and a grant from National Institute of Biomedical Innovation (To Dr Yasuda).	Alley DE, 2010, J GERONTOL A-BIOL, V65, P111, DOI 10.1093/gerona/glp177; Nanri A, 2010, INT J OBESITY, V34, P348, DOI 10.1038/ijo.2009.234; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Park KG, 2004, DIABETES RES CLIN PR, V63, P135, DOI 10.1016/j.diabres.2003.09.010; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Peng XD, 2008, CLIN CHIM ACTA, V387, P31, DOI 10.1016/j.cca.2007.08.012; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Tamakoshi K, 2003, INT J OBESITY, V27, P247, DOI 10.1038/sj.ijo.802195; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Suzuki R, 2011, INT J CANCER, V129, P1214, DOI 10.1002/ijc.25744; Aleksandrova K, 2012, CARCINOGENESIS, V33, P1211, DOI [10.1093/carcin/bgs133, 10.1093/carcin/bgs133d]; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003; Nanri A, 2011, J EPIDEMIOL COMMUN H, V65, P1104, DOI 10.1136/jech.2009.097964; Furuhashi M, 2003, CLIN ENDOCRINOL, V59, P507, DOI 10.1046/j.1365-2265.2003.01879.x; Azuma K, 2003, OBES RES, V11, P997, DOI 10.1038/oby.2003.137; Luo JH, 2007, AM J EPIDEMIOL, V166, P752, DOI 10.1093/aje/kwm137; Chen CY, 2012, HYPERTENS RES, V35, P843, DOI 10.1038/hr.2012.42; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Hosono S, 2011, J EPIDEMIOL, V21, P466, DOI 10.2188/jea.JE20110020; Hu FB, 2001, INT J OBESITY, V25, P121, DOI 10.1038/sj.ijo.0801480; de Souza CI, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-97; Janssen I, 2004, ANN EPIDEMIOL, V14, P585, DOI 10.1016/j.annepidem.2004.01.007; Lim U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043502; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Matsushita Y, 2012, OBESITY SILVER SPRIN, V20, P1744; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76; Pham NM, 2012, EUR J CLIN NUTR, V66, P1323, DOI 10.1038/ejcn.2012.169; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Stefanska A, 2010, ADV MED SCI-POLAND, V55, P186, DOI 10.2478/v10039-010-0047-y; Wu HY, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000191; Zimmet P, 1996, BRIT MED J, V313, P965	42	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	APR	2015	69	4					462	466		10.1038/ejcn.2014.257		5	Nutrition & Dietetics	Nutrition & Dietetics	CF0ET	WOS:000352216300009		
J	Okuda, N; Miura, K; Okayama, A; Okamura, T; Abbott, RD; Nishi, N; Fujiyoshi, A; Kita, Y; Nakamura, Y; Miyagawa, N; Hayakawa, T; Ohkubo, T; Kiyohara, Y; Ueshima, H				Okuda, N.; Miura, K.; Okayama, A.; Okamura, T.; Abbott, R. D.; Nishi, N.; Fujiyoshi, A.; Kita, Y.; Nakamura, Y.; Miyagawa, N.; Hayakawa, T.; Ohkubo, T.; Kiyohara, Y.; Ueshima, H.		NIPPON DATA80 Res Grp	Fruit and vegetable intake and mortality from cardiovascular disease in Japan: a 24-year follow-up of the NIPPON DATA80 Study	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; UNITED-KINGDOM; PUBLIC-HEALTH; ALL-CAUSE; MEN; HYPERTENSION; CONSUMPTION; WOMEN	BACKGROUND/OBJECTIVES: There have been few studies on the association of fruit and vegetable (FV) intake with cardiovascular disease (CVD) risk in Asian populations where both dietary habits and disease structure are different from western countries. No study in Asia has found its significant association with stroke. We examined associations of FV intake with mortality risk from total CVD, stroke and coronary heart diseases (CHDs) in a representative Japanese sample. METHODS: A total of 9112 participants aged from 24-year follow-up data in the NIPPON DATA80, of which baseline data were obtained in the National Nutrition Survey Japan in 1980, were studied. Dietary data were obtained from 3-day weighing dietary records. Participants were divided into sex-specific quartiles of energy adjusted intake of FV. Multivariate-adjusted hazard ratios (HRs) were calculated between strata of the total of FV intake, fruit intake and vegetable intake. The adjustment included age, sex, smoking, drinking habit and energy adjusted intakes of sodium and some other food groups. RESULTS: Participants with higher FV intake were older, ate more fish, milk and dairy products and soybeans and legumes and ate less meat. Multivariate-adjusted HR (95% confidence interval; P; P for trend) for the highest versus the lowest quartile of the total of FV intake was 0.74 (0.61-0.91; 0.004; 0.003) for total CVD, 0.80 (0.59-1.09; 0.105; 0.036) for stroke and 0.57 (0.37-0.87; 0.010; 0.109) for CHD. CONCLUSIONS: The results showed that higher total intake of FVs was significantly associated with reduced risk of CVD mortality in Japan.	[Okuda, N.] Univ Human Arts & Sci, Dept Hlth & Nutr, Saitama 3398539, Japan; [Okuda, N.; Fujiyoshi, A.; Miyagawa, N.; Ueshima, H.] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Miura, K.; Abbott, R. D.; Ueshima, H.] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Okayama, A.] Res Inst Strategy Prevent, Tokyo, Japan; [Okamura, T.] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Nishi, N.] Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 162, Japan; [Kita, Y.] Tsuruga Nursing Univ, Dept Nursing Sci, Tsuruga, Fukui, Japan; [Nakamura, Y.] Jichi Med Sch, Dept Publ Hlth, Shimotsuke, Tochigi, Japan; [Hayakawa, T.] Fukushima Med Univ, Dept Hyg & Prevent Med, Fukushima, Japan; [Ohkubo, T.] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Kiyohara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan	Okuda, N (reprint author), Univ Human Arts & Sci, Dept Hlth & Nutr, Iwatsuki Ku, 1288 Umagome, Saitama 3398539, Japan.	nagako_okuda@human.ac.jp	Okamura, Tomonori/L-1693-2013; 	Kita, Yoshikuni/0000-0002-2366-1106	Ministry of Health, Labor and Welfare under the Japanese Association for Cerebro-cardiovascular Disease Control; Research Grant for Cardiovascular Diseases from the Ministry of Health, Labor and Welfare; Health and Labor Sciences Research Grant, Japan [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]	This study was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare under the auspices of the Japanese Association for Cerebro-cardiovascular Disease Control, a Research Grant for Cardiovascular Diseases (7A-2) from the Ministry of Health, Labor and Welfare and a Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health (H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014) and Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022)).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Takachi R, 2008, AM J EPIDEMIOL, V167, P59, DOI 10.1093/aje/kwm263; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Miyagawa N, 2014, ATHEROSCLEROSIS, V232, P384, DOI 10.1016/j.atherosclerosis.2013.11.073; Oyebode O, 2014, J EPIDEMIOL COMMUN H, V68, P856, DOI 10.1136/jech-2013-203500; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Streppel MT, 2014, EUR J CLIN NUTR, V68, P741, DOI 10.1038/ejcn.2014.35; Houston MC, 2011, CURR HYPERTENS REP, V13, P309, DOI 10.1007/s11906-011-0197-8; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Okuda N, 2010, J EPIDEMIOL, V20, pS506, DOI 10.2188/jea.JE20090218; Iso H, 2011, J ATHEROSCLER THROMB, V18, P83; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Okuda N, 2005, ATHEROSCLEROSIS, V178, P371, DOI 10.1016/j.athersclerosis.2004.09.007; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Nakamura K, 2008, J NUTR, V138, P1129; Nagura J, 2009, BRIT J NUTR, V102, P285, DOI 10.1017/S0007114508143586; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Dauchet L, 2006, J NUTR, V136, P2588; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Ceriello A, 2008, DIABETES CARE, V31, pS181, DOI 10.2337/dc08-s245; Chang HY, 2006, AM J CLIN NUTR, V83, P1289; Gibson S, 1990, PRINCIPLES NUTR ASSE; Hu D, 2010, NUTR METAB CARDIOVAS, V20, P394, DOI 10.1016/j.numecd.2010.02.016; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Iwaoka F, 2001, J Nutr Sci Vitaminol (Tokyo), V47, P222; Japanese Ministry of Health and Welfare, 1982, NAT SURV CIRC DIS 19; Japanese Ministry of Health and Welfare, 1982, NAT NUTR SURV JAP 19; Miura Katsuyuki, 2011, EPMA J, V2, P59, DOI 10.1007/s13167-011-0069-y; Ueshima H, 2003, J HUM HYPERTENS, V17, P851, DOI 10.1038/sj.jhh.1001602; Ueshima H, 2006, CIRC J, V70, P1249; Odegaard AO, 2014, AM J CLIN NUTR, V100, P877, DOI 10.3945/ajcn.114.086124; Okayama A, 2006, J HYPERTENS, V24, P459, DOI 10.1097/01.hjh.0000209981.43983.cf; Okuda N, J HYPERTENS, V32, P2385; The Resources Council Science and Technology Agency of Japan, 1963, STAND TABL FOOD COMP; Willet W, 2012, NUTR EPIDEMIOLOGY; Yoshiike N, 1996, J Epidemiol, V6, pS189	44	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	APR	2015	69	4					482	488		10.1038/ejcn.2014.276		7	Nutrition & Dietetics	Nutrition & Dietetics	CF0ET	WOS:000352216300012		
J	Alp, OS; Durlanik, S; Schulz, D; McGrath, M; Grun, JR; Bardua, M; Ikuta, K; Sgouroudis, E; Riedel, R; Zehentmeier, S; Hauser, AE; Tsuneto, M; Melchers, F; Tokoyoda, K; Chang, HD; Thiel, A; Radbruch, A				Alp, Oezen Sercan; Durlanik, Sibel; Schulz, Daniel; McGrath, Mairi; Gruen, Joachim R.; Bardua, Marcus; Ikuta, Koichi; Sgouroudis, Evridiki; Riedel, Rene; Zehentmeier, Sandra; Hauser, Anja E.; Tsuneto, Motokazu; Melchers, Fritz; Tokoyoda, Koji; Chang, Hyun-Dong; Thiel, Andreas; Radbruch, Andreas			Memory CD8(+) T cells colocalize with IL-7(+) stromal cells in bone marrow and rest in terms of proliferation and transcription	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Bone marrow; CD8 T cell; Gene expression; Interleukin-7; Memory cells	SECONDARY LYMPHOID ORGANS; LIVED PLASMA-CELLS; IN-VIVO; HOMEOSTATIC PROLIFERATION; IMMUNOLOGICAL MEMORY; IMMUNE-RESPONSE; RM CELLS; ANTIGEN; SURVIVAL; SITE	It is believed that memory CD8(+) Tcells are maintained in secondary lymphoid tissues, peripheral tissues, and BM by homeostatic proliferation. Their survival has been shown to be dependent on IL-7, but it is unclear where they acquire it. Here we show that in murine BM, memory CD8(+) Tcells individually colocalize with IL-7(+) reticular stromal cells. The Tcells are resting in terms of global transcription and do not express markers of activation, for example, 4-1BB (CD137), IL-2, or IFN-, despite the expression of CD69 on about 30% of the cells. Ninety-five percent of the memory CD8(+) Tcells in BM are in G(0) phase of cell cycle and do not express Ki-67. Less than 1% is in S/M/G(2) of cell cycle, according to propidium iodide staining. While previous publications have estimated the extent of proliferation of CD8(+) memory Tcells on the basis of BrdU incorporation, we show here that BrdU itself induces proliferation of CD8(+) memory Tcells. Taken together, the present results suggest that CD8(+) memory Tcells are maintained as resting cells in the BM in dedicated niches with their survival conditional on IL-7 receptor signaling.	[Alp, Oezen Sercan; Schulz, Daniel; McGrath, Mairi; Bardua, Marcus; Sgouroudis, Evridiki; Riedel, Rene; Chang, Hyun-Dong; Radbruch, Andreas] German Rheumatism Res Ctr DRFZ, Dept Cell Biol, D-10117 Berlin, Germany; [Durlanik, Sibel; Thiel, Andreas] Charite, Berlin Brandenburger Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Gruen, Joachim R.] German Rheumatism Res Ctr, Dept Bioinformat, Berlin, Germany; [Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto 606, Japan; [Zehentmeier, Sandra; Hauser, Anja E.] German Rheumatism Res Ctr, Dept Immunodynam, Berlin, Germany; [Tsuneto, Motokazu; Melchers, Fritz] Max Plank Inst Infect Biol, Dept Lymphocyte Dev, Berlin, Germany; [Tokoyoda, Koji] German Rheumatism Res Ctr, Dept Osteoimmunol, Berlin, Germany	Radbruch, A (reprint author), German Rheumatism Res Ctr DRFZ, Cell Biol, Charitepl 1, D-10117 Berlin, Germany.	radbruch@drfz.de			Deutsche Forschungsgemeinschaft through DFG [1468 IMMUNOBONE]; European Research Council [268987]	We thank Tuula Geske, Heidi Hecker-Kia, Heidi Schliemann for expert technical help, Toralf Kaiser and Jenny Kirsch for cell sorting, and Patrick Thiemann and Manuela Ohde for assistance with animal care. This work was supported by Deutsche Forschungsgemeinschaft through DFG Priority program 1468 IMMUNOBONE (to H.D.C. and A.R.) and European Research Council Advanced Grant IMMEMO (ERC-2010-AdG.20100317 Grant 268987; to A.R.). S.D. and S.Z are members of the International Max Planck Research School for Infectious Diseases and Immunology Berlin (IMPRS-IDI). D.S and R.R are members of Berlin-Brandenburg School for Regenerative Therapies (BSRT).	Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Parretta E, 2008, J IMMUNOL, V180, P7230; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Wherry EJ, 2002, ADV EXP MED BIOL, V512, P165; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Tokoyoda K, 2009, EUR J IMMUNOL, V39, P2095, DOI 10.1002/eji.200939500; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Hauser AE, 2002, J IMMUNOL, V169, P1277; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; GERDES J, 1984, J IMMUNOL, V133, P1710; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Becker TC, 2005, J IMMUNOL, V174, P1269; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lin GHY, 2012, EUR J IMMUNOL, V42, P2861, DOI 10.1002/eji.201242503; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chu Van Trung, 2011, Nat Immunol, V12, P151, DOI 10.1038/ni.1981; Heffner M, 2007, P NATL ACAD SCI USA, V104, P13414, DOI 10.1073/pnas.0706040104; Herndler-Brandstetter D, 2011, J IMMUNOL, V186, P6965, DOI 10.4049/jimmunol.1100243; Kudernatsch RF, 2014, EUR J IMMUNOL, V44, P3532, DOI 10.1002/eji.201344180; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Nygren JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003710; Parretta E, 2005, J IMMUNOL, V174, P7654; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; SLIFKA MK, 1995, J VIROL, V69, P1895; Snell LM, 2012, J IMMUNOL, V188, P5915, DOI 10.4049/jimmunol.1103270; Westendorf K, 2014, EUR J IMMUNOL, V44, P1866, DOI 10.1002/eji.201344323	55	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	APR	2015	45	4					975	987		10.1002/eji.201445295		13	Immunology	Immunology	CF4SZ	WOS:000352543300005		
J	McAlees, JW; Lajoie, S; Dienger, K; Sproles, AA; Richgels, PK; Yang, YF; Khodoun, M; Azuma, M; Yagita, H; Fulkerson, PC; Wills-Karp, M; Lewkowich, IP				McAlees, Jaclyn W.; Lajoie, Stephane; Dienger, Krista; Sproles, Alyssa A.; Richgels, Phoebe K.; Yang, Yanfen; Khodoun, Marat; Azuma, Miyuki; Yagita, Hideo; Fulkerson, Patricia C.; Wills-Karp, Marsha; Lewkowich, Ian P.			Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Airway hyperreactivity; Asthma; Cytokines; PD-1; PD-L1; Th1 response; Th2 response; Th17 response	IMMUNE-RESPONSES; IN-VIVO; FETOMATERNAL TOLERANCE; REGULATORY-CELLS; PD-1; ACTIVATION; EXPRESSION; MICE; INTERLEUKIN-13; INFLAMMATION	Studies examining the role of PD-1 family members in allergic asthma have yielded conflicting results. Using a mouse model of allergic asthma, we demonstrate that blockade of PD-1/PD-L1 has distinct influences on different CD4(+) T-cell subsets. PD-1/PD-L1 blockade enhances airway hyperreactivity (AHR), not by altering the magnitude of the underlying Th2-type immune response, but by allowing the development of a concomitant Th17-type immune response. Supporting differential CD4(+) T-cell responsiveness to PD-1-mediated inhibition, naive PD-1(-/-) mice displayed elevated Th1 and Th17 levels, but diminished Th2 cytokine levels, and ligation of PD-1 in WTcells limited cytokine production by in vitro polarized Th1 and Th17 cells, but slightly enhanced cytokine production by in vitro polarized Th2 cells. Furthermore, PD-1 ligation enhanced Th2 cytokine production by naive Tcells cultured under nonpolarizing conditions. These data demonstrate that different CD4(+) T-cell subsets respond differentially to PD-1 ligation and may explain some of the variable results observed in control of allergic asthma by the PD-1 family members. As the PD-1/PD-L1 axis limits asthma severity by constraining Th17 cell activity, this suggests that severe allergic asthma may be associated with a defective PD-1/PD-L1 regulatory axis in some individuals.	[McAlees, Jaclyn W.; Lajoie, Stephane; Dienger, Krista; Sproles, Alyssa A.; Richgels, Phoebe K.; Yang, Yanfen; Khodoun, Marat; Lewkowich, Ian P.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Khodoun, Marat] Univ Cincinnati, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Khodoun, Marat] Cincinnati Vet Affairs Med Ctr, Dept Res, Cincinnati, OH USA; [Azuma, Miyuki] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Fulkerson, Patricia C.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Wills-Karp, Marsha] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Lewkowich, IP (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Ian.Lewkowich@cchmc.org			Parker B. Francis Fellowship; ATS Unrestricted Research Grant; ALA Biomedical Research Grant; NHLBI [R01 HL67736-09, R01 HL122300]; NIAID [U19 A1070235, R01 A1083315]	Funded by a Parker B. Francis Fellowship (I.P.L., S.L.), an ATS Unrestricted Research Grant (I.P.L.), ALA Biomedical Research Grant (I.P.L.), NHLBI R01 HL67736-09 (M.W.K.), NIAID U19 A1070235 (M.W.K.), NIAID R01 A1083315 (M.W.K.), and NHLBI R01 HL122300 (I.P.L.).	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Yamazaki T, 2002, J IMMUNOL, V169, P5538; Hofer T, 2002, P NATL ACAD SCI USA, V99, P9364, DOI 10.1073/pnas.142284699; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Finkelman FD, 1999, INT IMMUNOL, V11, P1811, DOI 10.1093/intimm/11.11.1811; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Habicht A, 2007, J IMMUNOL, V179, P5211; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Dulos J, 2012, J IMMUNOTHER, V35, P169, DOI 10.1097/CJI.0b013e318247a4e7; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Matsumoto K, 2004, J IMMUNOL, V172, P2530; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Lewkowich IP, 2004, J IMMUNOL METHODS, V286, P123, DOI 10.1016/j.jim.2003.12.010; Lewkowich IP, 2013, MUCOSAL IMMUNOL, V6, P728, DOI 10.1038/mi.2012.111; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Matsumoto K, 2008, BIOCHEM BIOPH RES CO, V365, P170, DOI 10.1016/j.bbrc.2007.10.156; McGee HS, 2010, AM J RESP CELL MOL, V43, P432, DOI 10.1165/rcmb.2009-0258OC; Oflazoglu E, 2004, EUR J IMMUNOL, V34, P3326, DOI 10.1002/eji.200425197; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; vansder Werf N., 2013, PLOS PATHOG, V9; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamazaki Tomohide, 2005, J Immunol, V175, P1586	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	APR	2015	45	4					1019	1029		10.1002/eji.201444778		11	Immunology	Immunology	CF4SZ	WOS:000352543300009		
J	Temizoz, B; Kuroda, E; Ohata, K; Jounai, N; Ozasa, K; Kobiyama, K; Aoshi, T; Ishii, KJ				Temizoz, Burcu; Kuroda, Etsushi; Ohata, Keiichi; Jounai, Nao; Ozasa, Koji; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.			TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						Adjuvant; cGAMP; CpG ODN; IFN-; STING; TLR	CYCLIC GMP-AMP; TOLL-LIKE RECEPTORS; CD4+ T-CELLS; GAMMA PRODUCTION; IMMUNE-RESPONSES; CYTOSOLIC DNA; DI-GMP; CPG; IL-12; INFECTION	Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeutic applications. Here, we show a potent synergism between TLR9 and STING agonists. Together, they make an effective type-1 adjuvant and an anticancer agent. The synergistic effect between CpG ODN (K3) and STING-ligand cyclic GMP-AMP (cGAMP), culminating in NK cell IFN- (type-II IFN) production, is due to the concurrent effects of IL-12 and type-I IFNs, which are differentially regulated by IRF3/7, STING, and MyD88. The combination of CpG ODN with cGAMP is a potent type-1 adjuvant, capable of inducing strong T(h)1-type responses, as demonstrated by enhanced antigen-specific IgG2c and IFN- production, as well as cytotoxic CD8(+) T-cell responses. In our murine tumor models, intratumoral injection of CpG ODN and cGAMP together reduced tumor size significantly compared with the singular treatments, acting as an antigen-free anticancer agent. Thus, the combination of CpG ODN and a STING ligand may offer therapeutic application as a potent type-II IFN inducer.	[Temizoz, Burcu; Kuroda, Etsushi; Ohata, Keiichi; Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, WPI Immunol Frontier Res Ctr iFReC, Osaka 5650871, Japan; [Jounai, Nao; Ozasa, Koji; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat NIBIO, Lab Adjuvant Innovat, Osaka, Japan	Ishii, KJ (reprint author), Osaka Univ, Lab Vaccine Sci, WPI Immunol Frontier Res Ctr iFReC, Osaka 5650871, Japan.	kenishii@biken.osaka-u.ac.jp			Adjuvant Database Grant; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24591145]; Takeda Science Foundation; Regional Strategy Support Program; Japanese Government Scholarship from MEXT	We thank Dr. Cevayir Coban for her comments and critical reading of the manuscript. We also thank the staff of the Animal Resource Center for Infectious Diseases (IFReC and RIMD, Osaka University) for their support in these studies and Prof. Akira's group for providing us the use of their flow cytometer. This study was supported in part by the Adjuvant Database Grant. E.K. received a grant-in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant number 24591145) and Takeda Science Foundation. E.K. was also supported by the Regional Strategy Support Program. B.T. received support in the form of a Japanese Government Scholarship from MEXT.	Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Lankford CSR, 2003, J LEUKOCYTE BIOL, V73, P49, DOI 10.1189/jlb.0602326; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Hornung V, 2002, J IMMUNOL, V168, P4531; Gracie JA, 1996, EUR J IMMUNOL, V26, P1217, DOI 10.1002/eji.1830260605; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Kobiyama K, 2014, P NATL ACAD SCI USA, V111, P3086, DOI 10.1073/pnas.1319268111; Nguyen KB, 2002, J IMMUNOL, V169, P4279; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; MULLER KM, 1993, J IMMUNOL, V150, P5576; Vitale M, 2014, EUR J IMMUNOL, V44, P1582, DOI 10.1002/eji.201344272; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Verthelyi D, 2001, J IMMUNOL, V166, P2372; Hartmann G, 2000, J IMMUNOL, V164, P944; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Chace JH, 1997, CLIN IMMUNOL IMMUNOP, V84, P185, DOI 10.1006/clin.1997.4380; Chu B. R. S., 1997, J EXP MED, V186, P1623; DesTitta A., 2013, P NATL ACAD SCI USA, V110, P19902; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Hogenesch H., 2013, FRONT IMMUNOL, V3, P1; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hunter A., 1997, IMMUNOL LETT, V59, P1; Klinman D. M., 2004, NAT REV IMMUNOL, V4, P1; Tang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061093; Vansde Wetering D., 2009, INT IMMUNOL, V21, P145; Wagner H., 2004, TRENDS IMMUNOL, V25, P1; Way SS, 2007, J IMMUNOL, V178, P4498	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	APR	2015	45	4					1159	1169		10.1002/eji.201445132		11	Immunology	Immunology	CF4SZ	WOS:000352543300021		
J	Shima, A; Nitta, N; Suzuki, F; Laharie, AM; Nozaki, K; Depaulis, A				Shima, Ayako; Nitta, Naoki; Suzuki, Fumio; Laharie, Anne-Marie; Nozaki, Kazuhiko; Depaulis, Antoine			Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						BDNF; epileptogenesis; GABA; granule cell dispersion; mossy fiber sprouting	GRANULE CELL DISPERSION; LHERMITTE-DUCLOS-DISEASE; MAMMALIAN TARGET; HIPPOCAMPAL SCLEROSIS; NEUROTROPHIC FACTOR; TUBEROUS SCLEROSIS; ADULT MICE; RAPAMYCIN SUPPRESSES; DENTATE GYRUS; SOMA SIZE	Recent studies in animal models have suggested that the mammalian target of rapamycin (mTOR) signaling pathway is involved in several features of mesio-temporal lobe epilepsy (MTLE), and that its inhibition could have therapeutic interests. However, it remains controversial whether mTOR activation is the cause or the consequence of MTLE. We previously showed in a mouse model of MTLE associated with hippocampal sclerosis that increased neuronal excitability and brain-derived neurotrophic factor (BDNF) overexpression contribute to the development of morphological features of this form of epilepsy. Here, we addressed whether mTOR activation promotes MTLE epileptogenesis via increasing neuronal excitability and/or BDNF expression or rather mediates neuroplasticity associated with hippocampal sclerosis. In mice injected intrahippocampally with kainate (1nmol), we showed a biphasic increase of phospho-S6 (p-S6) ribosomal protein expression, the downstream product of the mTOR signaling pathway, in the dispersed granule cell layer (GCL) of the dentate gyrus with a second phase lasting up to 6months. Chronic treatment with rapamycin suppressed p-S6 expression, granule cell dispersion and mossy fiber sprouting, but did not reduce cell loss, BDNF overexpression, glutamic acid decarboxylase (GAD)67 expression or the development of hippocampal paroxysmal discharges. Neuronal inhibition by midazolam (2x10mg/kg, i.p.) abolished the increased expression of p-S6 in the dispersed GCL. Our data suggest that activation of the mTOR signaling pathway results from the increased neuronal excitation that develops in the GCL and may contribute to MTLE morphological changes. However, these data do not support the role of this pathway in the development of MTLE or its inhibition as a therapy for this form of epilepsy.	[Shima, Ayako; Nitta, Naoki; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 5202192, Japan; [Shima, Ayako; Suzuki, Fumio] Koto Mem Hosp, Dept Neurosurg, Higashioumi, Shiga, Japan; [Nitta, Naoki; Laharie, Anne-Marie; Depaulis, Antoine] INSERM, U836, Grenoble, France; [Nitta, Naoki; Laharie, Anne-Marie; Depaulis, Antoine] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Depaulis, Antoine] Hop Michallon, CHU Grenoble, Grenoble, France	Nitta, N (reprint author), Shiga Univ Med Sci, Dept Neurosurg, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	nnitta@belle.shiga-med.ac.jp			INSERM; European Union 6th Framework Program for Research and Technological Development, "Life sciences, genomics and biotechnology for health", VALAPODYN [LSHG-CT-2006-037277]	This work was supported by INSERM and by research funds from the European Union 6th Framework Program for Research and Technological Development, "Life sciences, genomics and biotechnology for health", VALAPODYN, contract #LSHG-CT-2006-037277. The authors wish to thank Melanie Langlois, Helene Bernard and Sandrine Saillet for their technical advice and assistance. The authors are grateful to Richard Palmiter for his kind gift of anti-ZnT3 antibody. The authors are also grateful to Satoshi Nakasu, Isabelle Guillemain, Colin Deransart and Christophe Heinrich for fruitful discussions and helpful comments.	Andreska T., 2014, FRONT CELL NEUROSCI, V8, P1; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Langlois M, 2010, J NEUROSCI, V30, P16523, DOI 10.1523/JNEUROSCI.1109-10.2010; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Thom M, 2005, BRAIN, V128, P1344, DOI 10.1093/brain/awh475; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Wong M, 2013, EXP NEUROL, V244, P22, DOI 10.1016/j.expneurol.2011.10.002; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Hamelin S, 2014, NEUROBIOL DIS, V69, P156, DOI [10.1016/j.nbd.2014.05.025, 10.1016/j.nbd2014.05.025]; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Abs E, 2013, ANN NEUROL, V74, P569, DOI 10.1002/ana.23943; Sloviter RS, 1999, EPILEPSIA, V40, pS34, DOI 10.1111/j.1528-1157.1999.tb00876.x; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Blumcke I, 2013, LANCET NEUROL, V12, P844, DOI 10.1016/S1474-4422(13)70175-3; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Mitsuya K, 2009, EPILEPSIA, V50, P1979, DOI 10.1111/j.1528-1167.2009.02055.x; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Troca-Marin JA, 2011, J NEUROSCI, V31, P9445, DOI 10.1523/JNEUROSCI.0011-11.2011; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Appaix F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035169; Cendes F, 2002, CURR PROB E, V17, P513; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; Depaulis A., 2015, REV NEUROL IN PRESS; desLanerolle N C., 2010, NEUROTHERAPEUTICS, V7, P424; Dudek FE, 2010, EPILEPSY CURR, V10, P95, DOI 10.1111/j.1535-7511.2010.01369.x; Fritschy Jean-Marc, 2008, Front Mol Neurosci, V1, P5, DOI 10.3389/neuro.02.005.2008; Gonzalez MI, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00113; Guilhem D, 1996, NEUROSCIENCE, V72, P923, DOI 10.1016/0306-4522(96)00005-X; Guo D., 2013, PLOS ONE, V8; Heck N, 2004, NEUROSCIENCE, V129, P309, DOI 10.1016/j.neuroscience.2004.06.078; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Inoue T, 1998, NEUROSCIENCE, V86, P723, DOI 10.1016/S0306-4522(98)00112-2; Klein S, 2014, EPILEPSY RES, V108, P1719, DOI 10.1016/j.eplepsyres.2014.10.002; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Nitta N, 2008, EPILEPSIA, V49, P1711, DOI 10.1111/j.1528-1167.2008.01595.x; Sullivan S. M., 2012, BRAIN RES, V1319, P165; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tang HY, 2012, BIOCHEM BIOPH RES CO, V420, P199, DOI 10.1016/j.bbrc.2012.02.143; Treiman A. M., 2001, EPILEPSIA S3, V42, P8; VANSVLIET EA, 2012, EPILEPSIA, V53, P1254; Wieser Heinz-Gregor, 2004, Epilepsia, V45, P695; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x	64	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2015	41	7					974	986		10.1111/ejn.12835		13	Neurosciences	Neurosciences & Neurology	CF4SH	WOS:000352540800011		
J	Matsumura, S; Taniguchi, W; Nishida, K; Nakatsuka, T; Ito, S				Matsumura, Shinji; Taniguchi, Wataru; Nishida, Kazuhiko; Nakatsuka, Terumasa; Ito, Seiji			In vivo two-photon imaging of structural dynamics in the spinal dorsal horn in an inflammatory pain model	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						dendrites; glutamate receptors; synaptic plasticity; thy1-YFP mice	SUBSTANTIA-GELATINOSA NEURONS; CENTRAL SENSITIZATION; SYNAPTIC PLASTICITY; CORD; MECHANISMS	Two-photon microscopy imaging has recently been applied to the brain to clarify functional and structural synaptic plasticity in adult neural circuits. Whereas the pain system in the spinal cord is phylogenetically primitive and easily exhibits behavioral changes such as hyperalgesia in response to inflammation, the structural dynamics of dendrites has not been analysed in the spinal cord mainly due to tissue movements associated with breathing and heart beats. Here we present experimental procedures to prepare the spinal cord sufficiently to follow morphological changes of neuronal processes in vivo by using two-photon microscopy and transgenic mice expressing fluorescent protein specific to the nervous system. Structural changes such as the formation of spine-like structures and swelling of dendrites were observed in the spinal dorsal horn within 30min after the multiple-site injections of complete Freund's adjuvant (a chemical irritant) to a leg, and these changes continued for 5h. Both AMPA and N-methyl-D-aspartate receptor antagonists, and gabapentin, a presynaptic Ca2+ channel blocker, completely suppressed the inflammation-induced structural changes in the dendrites in the spinal dorsal horn. The present study first demonstrated by in vivo two-photon microscopy imaging that structural synaptic plasticity occurred in the spinal dorsal horn immediately after the injection of complete Freund's adjuvant and may be involved in inflammatory pain. Furthermore, acute inflammation-associated structural changes in the spinal dorsal horn were shown to be mediated by glutamate receptor activation.	[Matsumura, Shinji; Nishida, Kazuhiko; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Hirakata, Osaka 5731010, Japan; [Taniguchi, Wataru; Nakatsuka, Terumasa] Kansai Univ Hlth Sci, Pain Res Ctr, Kumatori, Osaka, Japan	Ito, S (reprint author), Kansai Med Univ, Dept Med Chem, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	ito@hirakata.kmu.ac.jp			MEXT KAKENHI [24590735, 24590736, 25293137, 26670291]	This study was partially supported by MEXT KAKENHI (24590735 to S.M., 24590736 to K.N., and 25293137 and 26670291 to S.I.). We thank Dr S. Maeda of Kansai Medical University for consulting on statistical analyses.	Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Sonohata M, 2004, J PHYSIOL-LONDON, V555, P515, DOI 10.1113/jphysiol.2003.054932; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Matsumura S, 2010, EUR J NEUROSCI, V32, P798, DOI 10.1111/j.1460-9568.2010.07348.x; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Nakatsuka T, 1999, PAIN, V82, P39, DOI 10.1016/S0304-3959(99)00037-8; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Farrar MJ, 2012, NAT METHODS, V9, P297, DOI [10.1038/nmeth.1856, 10.1038/NMETH.1856]; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Furue H, 2004, NEUROSCI RES, V48, P361, DOI 10.1016/j.neures.2003.12.005; Johannssen HC, 2013, EXP NEUROL, V242, P18, DOI 10.1016/j.expneurol.2012.07.014; Kim SK, 2012, NEURAL PLAST, DOI 10.1155/2012/640259; Nishida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103321	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2015	41	7					987	995		10.1111/ejn.12837		9	Neurosciences	Neurosciences & Neurology	CF4SH	WOS:000352540800012		
J	Kajimoto, T; Morimoto, K; Ogawa, R; Dohi, T; Kita, Y				Kajimoto, Tetsuya; Morimoto, Koji; Ogawa, Ryosuke; Dohi, Toshifumi; Kita, Yasuyuki			Phenyliodine Bis(trifluoroacetate) (PIFA) as an Excellent Promoter of 2-Deoxy-2-phthalimido-1-thioglycosides in the Presence of Triflic Acid in Glycosylation Reactions	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Iodine; Phenyliodine bis(trifluoroacetate); Glycosylation; Thioglycosides	HYPERVALENT IODINE REAGENTS; ONE-POT PROTECTION; N-IODOSUCCINIMIDE; STEREOSELECTIVE GLYCOSIDATION; THIOGLYCOSIDE ACTIVATION; ODORLESS BENZENETHIOLS; MEDIATED ACTIVATION; POLYVALENT IODINE; ORGANIC-SYNTHESIS; BOND FORMATION	A combination of phenyliodine bis(trifluoroacetate) (PIFA) and trifluoromethanesulfonic acid was found to be an effective activator for the glycosylation reaction, of which the glycosyl donor was p-(octyloxy)phenyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-D-glucopyranoside or p-(octyloxy)phenyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-D-galactopyranoside. The reaction proceeded with good yields when naturally occurring and derived alkanols, such as cholestanol, (-)-menthol, 1- and 2-adamantanols and nor-kauranol, were employed as acceptor substrates. Interestingly, the glycosylation reaction of sterically hindered terpenoid alcohols, such as (-)- and (+)-borneols and (+)-fenchyl alcohol, with p-(octyloxy)phenyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-1-thio-D-glucopyranoside afforded the desired -glycoside in quantitative yield. Moreover, the present reaction was useful to synthesize disaccharides of which the non-reducing end was composed of a D-glucosamine or D-galactosamine unit.	[Kajimoto, Tetsuya; Morimoto, Koji; Ogawa, Ryosuke; Dohi, Toshifumi; Kita, Yasuyuki] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga 5258577, Japan	Kita, Y (reprint author), Ritsumeikan Univ, Coll Pharmaceut Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	kita@ph.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS	This work was partially supported by Grants-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformation by Organocatalysts" from The Ministry of Education, Culture, Sports, Science and Technology (MEXT). T. K. acknowledges support from the Grant-in-Aid for Scientific Research (C). K. M. also acknowledges support from the Grant-in-Aid for Young Scientists (B) from the JSPS.	Duschek A, 2011, ANGEW CHEM INT EDIT, V50, P1524, DOI 10.1002/anie.201000873; RAY DG, 1992, J ORG CHEM, V57, P1607, DOI 10.1021/jo00031a054; He HW, 2014, ORG LETT, V16, P3102, DOI 10.1021/ol501211z; Zhu XM, 2009, ANGEW CHEM INT EDIT, V48, P1900, DOI 10.1002/anie.200802036; FUKASE K, 1995, TETRAHEDRON, V51, P4923, DOI 10.1016/0040-4020(95)98690-J; Fukase K, 1996, TETRAHEDRON, V52, P3897, DOI 10.1016/S0040-4020(96)00057-9; Wang CC, 2007, NATURE, V446, P896, DOI 10.1038/nature05730; Crich D, 2000, ORG LETT, V2, P4067, DOI 10.1021/ol006715o; Stang PJ, 1996, CHEM REV, V96, P1123, DOI 10.1021/cr940424+; VEENEMAN GH, 1990, TETRAHEDRON LETT, V31, P1331, DOI 10.1016/S0040-4039(00)88799-7; Wang CC, 2008, NAT PROTOC, V3, P97, DOI 10.1038/nprot.2007.493; Merritt EA, 2009, ANGEW CHEM INT EDIT, V48, P9052, DOI 10.1002/anie.200904689; Tohma H, 2003, TOP CURR CHEM, V224, P209; Tohma H, 2000, CHEM PHARM BULL, V48, P445; Chu AHA, 2014, ORG LETT, V16, P1780, DOI 10.1021/ol5004059; Gonzalez DF, 2012, CHEMCATCHEM, V4, P955, DOI 10.1002/cctc.201200116; Crich D, 2001, J AM CHEM SOC, V123, P9015, DOI 10.1021/ja0111481; Kita Y, 1996, PURE APPL CHEM, V68, P627, DOI 10.1351/pac199668030627; Duron SG, 2004, ORG LETT, V6, P839, DOI 10.1021/ol0400084; Tohma H, 1999, J ORG CHEM, V64, P3519, DOI 10.1021/jo982295t; STORK G, 1989, TETRAHEDRON LETT, V30, P287, DOI 10.1016/S0040-4039(00)95181-5; Tohma H, 2004, ADV SYNTH CATAL, V346, P111, DOI 10.1002/adsc.200303203; Kita Y, 1996, CHEM COMMUN, P2225, DOI 10.1039/cc9960002225; FUKASE K, 1992, TETRAHEDRON LETT, V33, P7165, DOI 10.1016/S0040-4039(00)60863-8; Fleming FF, 2001, J ORG CHEM, V66, P6502, DOI 10.1021/jo0157829; MOOTOO DR, 1988, J AM CHEM SOC, V110, P5583, DOI 10.1021/ja00224a060; Yusubov MS, 2012, CURR ORG SYNTH, V9, P247; Tatai J, 2007, ORG LETT, V9, P4647, DOI 10.1021/ol702139u; Chu AHA, 2013, ORG LETT, V15, P2566, DOI 10.1021/ol401095k; Tohma H, 1998, TETRAHEDRON LETT, V39, P4547, DOI 10.1016/S0040-4039(98)00828-4; Codee JDC, 2003, ORG LETT, V5, P1519, DOI 10.1021/ol034312t; Zhdankin VV, 2008, CHEM REV, V108, P5299, DOI 10.1021/cr800332c; Mukherjee C, 2007, SYNTHESIS-STUTTGART, P683, DOI 10.1055/s-2007-965913; CADDICK S, 1991, J CHEM SOC CHEM COMM, P674, DOI 10.1039/c39910000674; Crich D, 2002, J ORG CHEM, V67, P4640, DOI 10.1021/jo0108818; Dinkelaar J, 2007, J ORG CHEM, V72, P5737, DOI 10.1021/jo070704s; Dohi T, 2009, CHEM COMMUN, P2073, DOI 10.1039/b821747e; Ferrier R. J., 1973, CARBOHYD RES, V27, P65; Fuchigami T, 1998, J CHIN CHEM SOC-TAIP, V45, P131; GAREGG PJ, 1983, CARBOHYD RES, V116, P162, DOI 10.1016/S0008-6215(00)90965-0; HANESSIAN S, 1980, CARBOHYD RES, V80, pC17, DOI 10.1016/S0008-6215(00)84882-X; HANESSIAN S, 1980, CARBOHYD RES, V86, pC3, DOI 10.1016/S0008-6215(00)85913-3; HASEGAWA A, 1991, CARBOHYD RES, V212, P277, DOI 10.1016/0008-6215(91)84066-N; Kajimoto T, 2006, BIOORG MED CHEM LETT, V16, P5736, DOI 10.1016/j.bmcl.2006.08.095; Kajimoto T, 2009, CURR TOP MED CHEM, V9, P13; Kajimoto T, 2007, J CARBOHYD CHEM, V26, P469, DOI 10.1080/07328300701738027; Kita Y, 1999, CHEM COMMUN, P143, DOI 10.1039/a808715f; KONRADSSON P, 1990, J CHEM SOC CHEM COMM, P270, DOI 10.1039/c39900000270; KOSER GF, 1987, TETRAHEDRON LETT, V28, P5431, DOI 10.1016/S0040-4039(00)96746-7; Leong O. T., 1994, NEW J CHEM, V18, P349; Liptak A., 2007, COMPREHENSIVE GLYCOS, V1, P203; Merritt EA, 2011, SYNTHESIS-STUTTGART, P517, DOI 10.1055/s-0030-1258328; Merritt E. A., 2009, ANGEW CHEM, V121, P9214; Motherwell WB, 2002, J CHEM SOC PERK T 1, P2816, DOI 10.1039/b209078c; MUKAIYAMA T, 1979, CHEM LETT, P487, DOI 10.1246/cl.1979.487; Mukhopadhyay B, 2005, TETRAHEDRON LETT, V46, P5923, DOI 10.1016/j.tetlet.2005.06.119; NICOLAOU KC, 1982, J AM CHEM SOC, V104, P2027, DOI 10.1021/ja00371a043; NODE M, 1976, J CHEM SOC PERK T 1, P2237, DOI 10.1039/p19760002237; NUNOMURA S, 1989, TETRAHEDRON LETT, V30, P6713, DOI 10.1016/S0040-4039(00)70658-7; OGAWA T, 1977, CARBOHYD RES, V54, pC17, DOI 10.1016/S0008-6215(00)80569-8; Perion R, 2003, CARBOHYD RES, V338, P2779, DOI 10.1016/j.carres.2003.09.004; Qian WX, 2006, SYNLETT, P709, DOI 10.1055/s-2006-933109; Salmasan RM, 2014, CHEM LETT, V43, P956, DOI 10.1246/cl.140167; SATO S, 1986, CARBOHYD RES, V155, pC6, DOI 10.1016/S0008-6215(00)90163-0; Takeuchi K., 2000, CHEM LETT, P1178; Takeuchi K, 2000, CHEM LETT, P124; Tohma H, 2003, ARKIVOC, P62; TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006; TSAI TYR, 1984, CAN J CHEM, V62, P1403, DOI 10.1139/v84-238; VANCLEVE JW, 1979, CARBOHYD RES, V70, P161, DOI 10.1016/S0008-6215(00)83281-4; Varvoglis A., 1997, HYPERVALENT IODINE O; Wang C., 2006, SYNLETT, P2864; Xia M., 1997, SYNTHETIC COMMUN, V27, P1315, DOI DOI 10.1080/00397919708006059; Yao CH, 2014, TETRAHEDRON, V70, P6757, DOI 10.1016/j.tet.2014.07.068; Zhu X., 2009, ANGEW CHEM, V121, P1932	75	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	APR	2015		10					2138	2142		10.1002/ejoc.201500186		5	Chemistry, Organic	Chemistry	CE8RA	WOS:000352110600007		
J	Moriya, T; Takayama, K; Konakahara, T; Ogiwara, Y; Sakai, N				Moriya, Toshimitsu; Takayama, Kentaro; Konakahara, Takeo; Ogiwara, Yohei; Sakai, Norio			Indium(III)-Catalyzed Reductive Monoalkylation of Electron-Rich Benzenes with Aliphatic Carboxylic Acids Leading to Arylalkane Derivatives	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Indium; Friedel-Crafts alkylation; Carboxylic acids; Reduction; Hydrosiloxanes	FRIEDEL-CRAFTS ALKYLATION; CARBONYL-COMPOUNDS; REAGENTS; BENZYLATION; BROMINATION; BROMIDES; IODINE; ARENES	Described herein is the reaction of electron-rich aromatic compounds with aliphatic carboxylic acids treated with a catalytic amount (5 mol-%) of InI3, 1,1,3,3-tetramethyldisiloxane (TMDS), and molecular iodine. The reductive monoalkylation occurs smoothly to produce the corresponding arylalkane derivatives.	[Moriya, Toshimitsu; Takayama, Kentaro; Konakahara, Takeo; Ogiwara, Yohei; Sakai, Norio] Tokyo Univ Sci RIKADAI, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan	Sakai, N (reprint author), Tokyo Univ Sci RIKADAI, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan.	sakachem@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25410120]	This work was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through a Grant-in-Aid for Scientific Research (C) (No. 25410120). We deeply thank Shin-Etsu Chemical Co., Ltd., for the gift of hydrosilanes.	AIZPURUA JM, 1986, CAN J CHEM, V64, P2342, DOI 10.1139/v86-386; Niggemann M, 2010, ANGEW CHEM INT EDIT, V49, P3684, DOI 10.1002/anie.200907227; Miyai T, 1998, TETRAHEDRON LETT, V39, P6291, DOI 10.1016/S0040-4039(98)01333-1; Calloway NO, 1935, CHEM REV, V17, P327, DOI 10.1021/cr60058a002; [Anonymous], 2011, ANGEW CHEM, V123, P11105; Miyai T, 1999, TETRAHEDRON, V55, P1017, DOI 10.1016/S0040-4020(98)01130-2; Schafer G, 2011, ANGEW CHEM INT EDIT, V50, P10913, DOI 10.1002/anie.201105380; JUNG ME, 1977, J ORG CHEM, V42, P3761, DOI 10.1021/jo00443a033; Kaneko M, 2007, TETRAHEDRON LETT, V48, P7085, DOI 10.1016/j.tetlet.2007.08.011; [Anonymous], 2010, ANGEW CHEM, V122, P3767; Tsuchimoto T, 1997, J ORG CHEM, V62, P6997, DOI 10.1021/jo970599u; Moriya T, 2013, J ORG CHEM, V78, P10642, DOI 10.1021/jo401529j; Moriya T, 2012, ORG LETT, V14, P4842, DOI 10.1021/ol302168q; Augustine JK, 2008, SYNLETT, P2429, DOI 10.1055/s-2008-1078207; Chandrasekhar S, 2009, TETRAHEDRON LETT, V50, P6693, DOI 10.1016/j.tetlet.2009.09.085; Friedel C., 1877, CR HEBD ACAD SCI, V84, P1392; Friedel C., 1877, CR HEBD ACAD SCI, V84, P1450; Guo XK, 2012, SYNLETT, P627, DOI 10.1055/s-0031-1290343; HASHIMOTO Y, 1993, TETRAHEDRON, V49, P5969, DOI 10.1016/S0040-4020(01)87183-0; LECEA B, 1985, TETRAHEDRON, V41, P4657, DOI 10.1016/S0040-4020(01)82361-9; Mendoza O, 2011, TETRAHEDRON LETT, V52, P2235, DOI 10.1016/j.tetlet.2011.01.033; Mosset P, 2013, SYNLETT, V24, P1142, DOI 10.1055/s-0032-1316909; OLAH GA, 1991, ADV SILICON CHEM, V1, P1; Sakai N, 2011, EUR J ORG CHEM, P3178, DOI 10.1002/ejoc.201100161; Yadav J. S., 2005, TETRAHEDRON LETT, V46, P2687	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	APR	2015		10					2277	2281		10.1002/ejoc.201500096		5	Chemistry, Organic	Chemistry	CE8RA	WOS:000352110600024		
J	Matsuyama, Y; Motoyoshi, M; Tsurumachi, N; Shimizu, N				Matsuyama, Yosuke; Motoyoshi, Mitsuru; Tsurumachi, Niina; Shimizu, Noriyoshi			Effects of palate depth, modified arm shape, and anchor screw on rapid maxillary expansion: a finite element analysis	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							ORTHODONTIC MINI-IMPLANTS; STRESS-DISTRIBUTION; SUTURE; MINISCREWS; PLACEMENT; SKELETAL; SUCCESS	Objectives: This study examined the effects of palate depth, modifications of the arm shape, and anchor screw placement in the mid-palatal area on rapid maxillary expansion (RME) using finite element (FE) analysis. Materials and Methods: Three-dimensional FE models were constructed that included the maxilla (cortical and cancellous bone), maxillary sinus, maxillary first molar and first premolar, periodontal membrane, and an RME appliance with arms, bands, and anchor screws. The expansion screws were activated 0.2 mm transversely. Results: The deepest palate model had the smallest lateral displacement of the tooth and expansion of the mid-palatal suture and the greatest strain of the arm among the models with different palate heights. The model with a larger diameter arm had the smallest arm strain among the models with various arm shapes. The model with an anchor screw had the greatest lateral displacement of the tooth and expansion of the mid-palatal suture among all models. Conclusions: For a deeper palate, the arm strain increased and the effect of RME decreased. Modified arm shapes such as a larger diameter arm, arms connected by a diagonal wire, a straight arm, and a shorter arm efficiently expanded the maxillary dental arch. Anchor screws increased the effect of RME, generated more and closer bodily movement of the tooth, and parallel expansion of the mid-palatal suture. The model with an anchor screw without arms decreased the displacement of the teeth compared to the models with arms, so the arms are necessary for effective RME.	[Matsuyama, Yosuke; Motoyoshi, Mitsuru; Tsurumachi, Niina; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dept Orthodont, Tokyo 1018310, Japan	Motoyoshi, M (reprint author), Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	motoyoshi.mitsuru@nihon-u.ac.jp					AlSamak S, 2012, INT J ORAL MAX IMPL, V27, P875; Karagkiolidou A, 2013, AM J ORTHOD DENTOFAC, V143, P767, DOI 10.1016/j.ajodo.2013.01.018; Motoyoshi M, 2007, INT J ORAL MAX IMPL, V22, P779; CHACONAS SJ, 1982, AM J ORTHOD DENTOFAC, V82, P492, DOI 10.1016/0002-9416(82)90318-9; Lee H, 2009, AM J ORTHOD DENTOFAC, V136, P367, DOI 10.1016/j.ajodo.2008.08.023; Lagravere MO, 2006, INT J ORAL MAX SURG, V35, P481, DOI 10.1016/j.ijom.2006.01.025; Akkaya S, 1998, EUR J ORTHODONT, V20, P255, DOI 10.1093/ejo/20.3.255; Nienkemper M, 2012, J OROFAC ORTHOP, V73, P467, DOI 10.1007/s00056-012-0107-y; Boryor A, 2008, J BIOMECH, V41, P376, DOI 10.1016/j.jbiomech.2007.08.016; Provatidis CG, 2008, EUR J ORTHODONT, V30, P437, DOI 10.1093/ejo/cjn046; Natali AN, 2004, DENT MATER, V20, P623, DOI 10.1016/j.dental.2003.08.003; Araugio RMD, 2013, AM J ORTHOD DENTOFAC, V143, P221, DOI 10.1016/j.ajodo.2012.09.016; Ash Jr M.M., 1984, WHEELERS ATLAS TOOTH, P206; Asscherickx K, 2005, ANGLE ORTHOD, V75, P826; Crismani AG, 2006, CLIN ORAL IMPLAN RES, V17, P445, DOI 10.1111/j.1600-0501.2005.01223.x; Dorow Christina, 2005, J Orofac Orthop, V66, P208, DOI 10.1007/s00056-005-0416-5; Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7; Fricke-Zech S, 2012, ANGLE ORTHOD, V82, P145, DOI 10.2319/040311-238.1; Kim YH, 2010, AM J ORTHOD DENTOFAC, V137, P66, DOI 10.1016/j.ajodo.2007.11.036; Lee HK, 2014, EUR J ORTHODONT, V36, P531, DOI 10.1093/ejo/cjs063; Ludwig B, 2013, AM J ORTHOD DENTOFAC, V143, P426, DOI 10.1016/j.ajodo.2012.07.019; Oyama K, 2007, EUR J ORTHODONT, V29, P113, DOI 10.1093/ejo/cjl043; Park Hyo-Sang, 2005, Aust Orthod J, V21, P129; STALEY RN, 1992, CLEFT PALATE-CRAN J, V29, P456, DOI 10.1597/1545-1569(1992)029<0456:CDIMD>2.3.CO;2; TIMMS DJ, 1980, AM J ORTHOD DENTOFAC, V77, P500, DOI 10.1016/0002-9416(80)90129-3; WERTZ RA, 1970, AMER J ORTHODONTICS, V58, P41, DOI 10.1016/0002-9416(70)90127-2	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	APR	2015	37	2					188	193		10.1093/ejo/cju033		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9YY	WOS:000352200800012		
J	Lonnroth, K; Migliori, GB; Abubakar, I; D'Ambrosio, L; de Vries, G; Diel, R; Douglas, P; Falzon, D; Gaudreau, MA; Goletti, D; Ochoa, ERG; Lobue, P; Matteelli, A; Njoo, H; Solovic, I; Story, A; Tayeb, T; van der Werf, MJ; Weil, D; Zellweger, JP; Aziz, MA; Al Lawati, MRM; Aliberti, S; de Onate, WA; Barreira, D; Bhatia, V; Blasi, F; Bloom, A; Bruchfeld, J; Castelli, F; Centis, R; Chemtob, D; Cirillo, DM; Colorado, A; Dadu, A; Dahle, UR; De Paoli, L; Dias, HM; Duarte, R; Fattorini, L; Gaga, M; Getahun, H; Glaziou, P; Goguadze, L; del Granado, M; Haas, W; Jarvinen, A; Kwon, GY; Mosca, D; Nahid, P; Nishikiori, N; Noguer, I; O'Donnell, J; Pace-Asciak, A; Pompa, MG; Popescu, GG; Cordeiro, CR; Ronning, K; Ruhwald, M; Sculier, JP; Simunovic, A; Smith-Palmer, A; Sotgiu, G; Sulis, G; Torres-Duque, CA; Umeki, K; Uplekar, M; van Weezenbeek, C; Vasankari, T; Vitillo, RJ; Voniatis, C; Wanlin, M; Raviglione, MC				Loennroth, Knut; Migliori, Giovanni Battista; Abubakar, Ibrahim; D'Ambrosio, Lia; de Vries, Gerard; Diel, Roland; Douglas, Paul; Falzon, Dennis; Gaudreau, Marc-Andre; Goletti, Delia; Ochoa, Edilberto R. Gonzalez; LoBue, Philip; Matteelli, Alberto; Njoo, Howard; Solovic, Ivan; Story, Alistair; Tayeb, Tamara; van der Werf, Marieke J.; Weil, Diana; Zellweger, Jean-Pierre; Aziz, Mohamed Abdel; Al Lawati, Mohamed R. M.; Aliberti, Stefano; de Onate, Wouter Arrazola; Barreira, Draurio; Bhatia, Vineet; Blasi, Francesco; Bloom, Amy; Bruchfeld, Judith; Castelli, Francesco; Centis, Rosella; Chemtob, Daniel; Cirillo, Daniela M.; Colorado, Alberto; Dadu, Andrei; Dahle, Ulf R.; De Paoli, Laura; Dias, Hannah M.; Duarte, Raquel; Fattorini, Lanfranco; Gaga, Mina; Getahun, Haileyesus; Glaziou, Philippe; Goguadze, Lasha; del Granado, Mirtha; Haas, Walter; Jarvinen, Asko; Kwon, Geun-Yong; Mosca, Davide; Nahid, Payam; Nishikiori, Nobuyuki; Noguer, Isabel; O'Donnell, Joan; Pace-Asciak, Analita; Pompa, Maria G.; Popescu, Gilda G.; Cordeiro, Carlos Robalo; Ronning, Karin; Ruhwald, Morten; Sculier, Jean-Paul; Simunovic, Aleksandar; Smith-Palmer, Alison; Sotgiu, Giovanni; Sulis, Giorgia; Torres-Duque, Carlos A.; Umeki, Kazunori; Uplekar, Mukund; van Weezenbeek, Catharina; Vasankari, Tuula; Vitillo, Robert J.; Voniatis, Constantia; Wanlin, Maryse; Raviglione, Mario C.			Towards tuberculosis elimination: an action framework for low-incidence countries	EUROPEAN RESPIRATORY JOURNAL			English	Article							DRUG-RESISTANT TUBERCULOSIS; LOW-BURDEN-COUNTRY; CALMETTE-GUERIN VACCINATION; COST-EFFECTIVENESS ANALYSIS; CAPTURE-RECAPTURE ANALYSIS; LONG-TERM-CARE; LATENT TUBERCULOSIS; PULMONARY TUBERCULOSIS; UNITED-STATES; BCG VACCINATION	This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-toreach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas: 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.	[Loennroth, Knut; Falzon, Dennis; Matteelli, Alberto; Weil, Diana; Bhatia, Vineet; Dias, Hannah M.; Getahun, Haileyesus; Glaziou, Philippe; Sulis, Giorgia; Uplekar, Mukund] WHO, Global TB Programme, CH-1211 Geneva 27, Switzerland; [Migliori, Giovanni Battista; D'Ambrosio, Lia; Centis, Rosella] Fdn S Maugeri, WHO Collaborating Ctr TB & Lung Dis, IRCCS, Tradate, Italy; [Abubakar, Ibrahim] UCL, TB Sect, London, England; [Abubakar, Ibrahim] Publ Hlth England, London, England; [de Vries, Gerard; van Weezenbeek, Catharina] KNCV TB Fdn, The Hague, Netherlands; [Diel, Roland] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Douglas, Paul] Dept Immigrat & Border Protect, Global Hlth Borders Refugee & Onshore Serv, Sydney, NSW, Australia; [Gaudreau, Marc-Andre; Njoo, Howard] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Montreal, PQ, Canada; [Goletti, Delia] Natl Inst Infect Dis, Rome, Italy; [Ochoa, Edilberto R. Gonzalez] Inst Trop Med Pedro Kouri, Epidemiol Board, Res & Surveillance Grp TB Leprosy & ARI, Havana, Cuba; [LoBue, Philip] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Solovic, Ivan] Catholic Univ, TB Dept, Natl Inst TB Resp Dis & Thorac Surg, Ruzomberok, Slovakia; [Story, Alistair] Find & Treat, London, England; [Tayeb, Tamara] Minist Hlth, Natl TB Control Programme, Riyadh, Saudi Arabia; [van der Werf, Marieke J.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden; [Zellweger, Jean-Pierre] Swiss Lung Assoc, Bern, Switzerland; [Aziz, Mohamed Abdel] WHO Reg Off Eastern Mediterranean, Cairo, Egypt; [Al Lawati, Mohamed R. M.] Minist Hlth, Muscat, Oman; [Aliberti, Stefano] Univ Milano Bicocca, UO Clin Pneumol, AO San Gerardo, Monza, Italy; [de Onate, Wouter Arrazola] Belgian Lung & TB Assoc, Brussels, Belgium; [Barreira, Draurio] Minist Hlth, Brasilia, DF, Brazil; [Blasi, Francesco] Univ Milan, IRCCS Fdn Ca Granda, Dipartimento Fisiopatol Med Chirurg Trapianti, Milan, Italy; [Bloom, Amy] US Agcy Int Dev, Washington, DC 20523 USA; [Bruchfeld, Judith] Karolinska Inst Solna, Inst Med, Infect Dis Unit, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Univ Hosp, Stockholm, Sweden; [Castelli, Francesco] Univ Brescia, Brescia, Italy; [Chemtob, Daniel] Minist Hlth, Jerusalem, Israel; [Cirillo, Daniela M.] IRCCS, San Raffaele Sci Inst, Milan, Italy; [Colorado, Alberto] Advocates Hlth Int, San Diego, CA USA; [Dadu, Andrei] WHO Reg Off Europe, TB & M XDR TB Control Programme, Copenhagen, Denmark; [Dahle, Ulf R.; Ronning, Karin] Norwegian Inst Publ Hlth, Oslo, Norway; [De Paoli, Laura] Med Sans Frontieres, Rome, Italy; [Duarte, Raquel] Gen Directorate Hlth, Lisbon, Portugal; [Fattorini, Lanfranco] Ist Super Sanita, I-00161 Rome, Italy; [Gaga, Mina] Minist Hlth, Athens Chest Hosp, Natl Referral Ctr Mycobacteria, Athens, Greece; [Goguadze, Lasha] Int Federat Red Cross & Red Crescent Soc, Geneva, Switzerland; [del Granado, Mirtha] WHO Reg Off Amer, Washington, DC USA; [Haas, Walter] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Jarvinen, Asko; Vasankari, Tuula] Finnish Lung Hlth Assoc, Helsinki, Finland; [Jarvinen, Asko] Helsinki Univ Cent Hosp, Div Infect Dis, Helsinki, Finland; [Kwon, Geun-Yong] Minist Hlth & Welf, Korea Ctr Dis Control & Prevent KCDC, Seoul, South Korea; [Mosca, Davide] Int Org Migrat, Geneva, Switzerland; [Nahid, Payam] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Nahid, Payam] Amer Thorac Soc, New York, NY USA; [Nishikiori, Nobuyuki] WHO Reg Off Western Pacific, Stop TB & Leprosy Eliminat, Manila, Philippines; [Noguer, Isabel] Inst Salud Carlos III, Madrid, Spain; [O'Donnell, Joan] HSE Hlth Protect Surveillance Ctr, Dublin, Ireland; [Pace-Asciak, Analita] Minist Hlth, Valletta, Malta; [Pompa, Maria G.] Minist Hlth, Rome, Italy; [Popescu, Gilda G.] Pneumol Inst Marius Nasta, Bucharest, Romania; [Cordeiro, Carlos Robalo] Coimbra Univ Hosp, Coimbra, Portugal; [Ruhwald, Morten] State Serum Inst, Copenhagen, Denmark; [Sculier, Jean-Paul] Inst Jules Bordet ULB, Brussels, Belgium; [Simunovic, Aleksandar] Croatian Natl Inst Publ Hlth, Zagreb, Croatia; [Smith-Palmer, Alison] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Biomed Sci, Res Med Educ & Profess Dev Unit,AOU Sassari, I-07100 Sassari, Italy; [Torres-Duque, Carlos A.] Asociac Latinoamer Torax ALAT Fdn Neumol Colombia, Bogota, Colombia; [Umeki, Kazunori] Minist Hlth Labour & Welf, Tokyo, Japan; [Vitillo, Robert J.] Caritas Int, Geneva, Switzerland; [Voniatis, Constantia] Minist Hlth, Nicosia, Cyprus; [Wanlin, Maryse] Fonds Affect Resp FARES, Brussels, Belgium	Raviglione, MC (reprint author), WHO, Global TB Programme, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	raviglionem@who.int	Lonnroth, Knut/L-2339-2014; Matteelli, Alberto/M-8784-2015; Robalo Cordeiro, Carlos Manuel da Silva/I-4864-2012; 	Lonnroth, Knut/0000-0001-5054-8240; Matteelli, Alberto/0000-0001-5109-9248; Robalo Cordeiro, Carlos Manuel da Silva/0000-0002-8264-3856; Duarte, Raquel/0000-0003-2257-3099; Goletti, Delia/0000-0001-8360-4376; Sulis, Giorgia/0000-0001-6641-0094; SOTGIU, Giovanni/0000-0002-1600-4474	European Respiratory Society	This work was supported by core funding from the European Respiratory Society.	Abubakar I, 2012, J INFECT DIS, V205, pS293, DOI 10.1093/infdis/jir886; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Aldridge RW, 2014, EURO SURVEILL, P19; Ali M, 2014, LANCET, V383, P2195, DOI 10.1016/S0140-6736(14)61063-1; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Menzies D, 2008, ANN INTERN MED, V149, P689; Walter ND, 2008, CLIN INFECT DIS, V46, P103, DOI 10.1086/523733; Esposito S, 2014, EUR RESPIR J, V44, P811, DOI 10.1183/09031936.00060414; Fairchild AL, 1998, AM J PUBLIC HEALTH, V88, P1105, DOI 10.2105/AJPH.88.7.1105; Pontali E, 2013, CURR OPIN PULM MED, V19, P266, DOI 10.1097/MCP.0b013e32835f1bf3; Klinkenberg E, 2009, EUR RESPIR J, V34, P1180, DOI 10.1183/09031936.00038009; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Kan B, 2013, INT J TUBERC LUNG D, V17, P597, DOI 10.5588/ijtld.12.0692; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Kamper-Jorgensen Z, 2012, TUBERCULOSIS, V92, P226, DOI 10.1016/j.tube.2012.02.001; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Falzon D, 2013, EUR RESPIR J, V42, P156, DOI 10.1183/09031936.00134712; Jasmer RM, 1999, ANN INTERN MED, V130, P971; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lai RPJ, 2013, EUR J IMMUNOL, V43, P1995, DOI 10.1002/eji.201343632; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; D'Ambrosio L, 2014, EUR RESPIR J, V43, P1410, DOI 10.1183/09031936.00198813; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Borgdorff MW, 1998, AM J EPIDEMIOL, V147, P187; Bamrah S, 2014, INT J TUBERC LUNG D, V18, P912, DOI 10.5588/ijtld.13.0028; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Skripconoka V, 2013, EUR RESPIR J, V41, P1393, DOI 10.1183/09031936.00125812; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Colson PW, 2013, INT J TUBERC LUNG D, V17, P473, DOI 10.5588/ijtld.12.0697; [Anonymous], 1999, MMWR RECOMM REP, V48, P1; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Tiberi S, 2014, EUR RESPIR J, V43, P289, DOI 10.1183/09031936.00122313; Moore-Gillon J, 2010, THORAX, V65, P663, DOI 10.1136/thx.2009.132373; Mor Z, 2008, EUR RESPIR J, V32, P1616, DOI 10.1183/09031936.00042908; Dara M, 2012, EUR RESPIR J, V40, P1081, DOI 10.1183/09031936.00053012; Codecasa LR, 2015, EUR RESPIR J, V45, P292, DOI 10.1183/09031936.00134114; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Arshad S, 2010, EUR RESPIR J, V35, P1336, DOI 10.1183/09031936.00054709; Arinaminpathy N, 2010, J R SOC INTERFACE, V7, P1559, DOI 10.1098/rsif.2010.0072; Baussano I, 2008, EPIDEMIOL PREV, V32, P85; Bernard C, 2013, EURO SURVEILL, V18; Bibi H, 2002, ISRAEL MED ASSOC J, V4, P13; Blasi F, 2013, EUR RESPIR J, V42, P875, DOI 10.1183/09031936.00114513; Cantini Fabrizio, 2014, J Rheumatol Suppl, V91, P56, DOI 10.3899/jrheum.140103; Carvalho Anna C C, 2010, Expert Rev Respir Med, V4, P189, DOI 10.1586/ers.10.7; Centers for Disease Control and Prevention, 2013, REP TUB US 2012; Centers for Disease Control and Prevention, 2013, REG TRAIN MED CONS C; Turner RE, 2013, MMWR-MORBID MORTAL W, V62, P1014; Centers for Disease Control and Prevention(CDC), 1989, MMWR-MORBID MORTAL W, V38, P269; Chemtob D, 2009, SUBST USE MISUSE, V44, P672, DOI 10.1080/10826080802494701; CHEMTOB D, 2000, LUNG BIOL HEALTH DIS, V144, P745; Chemtob D, 2003, INT J TUBERC LUNG D, V7, P959; CLANCY L, 1991, EUR RESPIR J, V4, P1288; Collinson Susan, 2010, Br J Nurs, V19, P36; Cruz AT, 2013, INT J TUBERC LUNG D, V17, P169, DOI 10.5588/ijtld.12.0641; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; D'Ambrosio L, 2014, EUR RESPIR J, V43, P286, DOI 10.1183/09031936.00125813; Dara M, 2013, EXPERT REV ANTI-INFE, V11, P137, DOI [10.1586/eri.12.168, 10.1586/ERI.12.168]; Dara M, 2014, EUR RESPIR J, V43, P24, DOI 10.1183/09031936.00113413; de Vries G, 2014, EURO SURVEILL, V19; de Vries G, 2010, INT J TUBERC LUNG D, V14, P859; de Vries G, 2008, J CLIN MICROBIOL, V46, P3924, DOI 10.1128/JCM.00793-08; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Ducomble T, 2013, EURO SURVEILL, P18; European Centre for Disease Prevention and Control, 2013, INV CONTR TUB INC AF; European Centre for Disease Prevention and Control (ECDC), 2008, FRAM ACT PLAN FIGHT; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2013, TUB SURV MON EUR 201; Evans TG, 2013, VACCINE, V31, pB223, DOI 10.1016/j.vaccine.2012.11.081; Fattorini L, 2012, EUR RESPIR J, V40, P497, DOI 10.1183/09031936.00021012; Fears R, 2010, TUBERCULOSIS, V90, P182, DOI 10.1016/j.tube.2010.03.008; Fortin CF, 2008, REJUV RES, V11, P873, DOI 10.1089/rej.2008.0750; Frick M, 2013, 2013 REP TUB RES FUN; Garie KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026452; Goldblatt D, 2014, INT J TUBERC LUNG D, V18, P1085, DOI 10.5588/ijtld.14.0186; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Guthmann JP, 2013, VACCINE, V31, P5666, DOI 10.1016/j.vaccine.2013.09.059; Haas W, 2011, EURO SURVEILL, V16; Helbling P, 2002, SWISS MED WKLY, V132, P517; Heldal E, 2000, INT J TUBERC LUNG D, V4, P300; Hopewell Philip C, 2014, Ann Am Thorac Soc, V11, P277, DOI 10.1513/AnnalsATS.201401-004AR; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI 10.3201/eid1409.071543; Kamper-Jorgensen Z, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-60; Kirby T, 2013, LANCET INFECT DIS, V13, P836, DOI 10.1016/S1473-3099(13)70276-7; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Laniado-Laborin R, 2012, INT J TUBERC LUNG D, V16, P1418, DOI 10.5588/ijtld.12.0388; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2014, ANN INTERN MED, V161, P670, DOI 10.7326/M14-1888; Lonnroth K, 2010, PRIORITY PUBLIC HLTH; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Manissero D, 2008, VACCINE, V26, P2253, DOI 10.1016/j.vaccine.2008.02.038; Migliori GB, 2013, EUR RESP J S57, V42, P3532; Migliori GB, 2012, LANCET, V380, P955, DOI 10.1016/S0140-6736(12)61183-0; Migliori GB, 2014, EUR RESPIR J, V44, P1412, DOI 10.1183/09031936.00132114; Moore-Gillon J, 2010, THORAX, V65, P571, DOI 10.1136/thx.2009.134247; Nguipdop-Djomo P, 2014, THORAX, V69, P87, DOI 10.1136/thoraxjnl-2013-203931; Nunes C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-30; Organizacion Panamericana de la Salud, 2006, 4 M LOW PREV COUNTR; Paquette K, 2014, INT J TUBERC LUNG D, V18, P1231, DOI 10.5588/ijtld.14.0105; Ploubidis GB, 2012, EUR RESPIR J, V40, P925, DOI 10.1183/09031936.00184011; Raviglione MC, 2013, NAT MED, V19, P263, DOI 10.1038/nm.3129; Reeves A, 2014, LANCET INFECT DIS, V14, P1105; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Sanchini A, 2014, EURO SURVEILL, P19; Sandgren A, 2014, EUR RESPIR J, V43, P1159, DOI 10.1183/09031936.00117213; Sarivalasis A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13860; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Schwartzman K, 2013, INT J TUBERC LUNG D, V17, P1121, DOI 10.5588/ijtld.13.0496; Smieja MJ, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001363; Sotgiu G, 2013, EUR RESP J S57, V42, pP1610; Sotgiu G, 2012, EUR RESPIR J, V40, P500, DOI 10.1183/09031936.00009212; TB CARE I, 2014, INT STAND TUB CAR, V3rd; Tollefson D, INT J TUBERC LUNG DI, V17, P1139; Tuberculosis Coalition for Technical Assistance (TBCTA), 2011, PAT CTR APPR STRAT; Uyemura K, 2002, MECH AGEING DEV, V123, P955, DOI 10.1016/S0047-6374(02)00033-7; van't Hoog AH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-532; van Hest NAH, 2008, EPIDEMIOL INFECT, V136, P1606, DOI 10.1017/S0950268808000496; van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540; Veen J, 2011, EUR RESPIR J, V37, P950, DOI 10.1183/09031936.00019410; Verma G, 2013, INT J TUBERC LUNG D, V17, P1170, DOI 10.5588/ijtld.12.0934; Verver S, 2006, COMPREHENSIVE INT AP; Voniatis C, 2014, EUR RESPIR J, V44, P543, DOI 10.1183/09031936.00044314; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398; WHO, 2013, WHOHTMTB201304; WHO, 2014, WHOHTMTB201409; WHO Stop TB Partnership, 2010, PUBL PRIV MIX TB CAR; World Health Organization, 2015, WHOHTMTB201501; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2014, WHOHTMTB201403; World Health Organization, 2008, WHOHTMTB2008404; World Health Organization, 1998, WHOTB98250; World Health Organization, 2010, WHOHTMTB201016; World Health Organization, 2014, WHOHTMTB201402; World Health Organization, WHO PUBL TUB; World Health Organization, 2011, WHOHTMSTBPSI201121; World Health Organization, 2012, WHOHTMTB20129; World Health Organization & The International Union Against Tuberculosis and Lung Disease, 2011, WHOHTMTB201115; World Health Organization, 2008, WHOHTMTB2007390; World Health Organization, 2013, GUID NUTR CAR SUPP P; World Health Organization, 2014, GLOB STRAT TARG TUB; WHO, 2010, WOR HEALT REP, P1; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, GLOB TB DAT; World Health Organization, 2014, FRAM COND REV TUB PR; World Health Organization, 2008, HLTH MIGR; World Health Organization, 2014, A6711 WHO; World Health Organization, 2008, WHOHTMTB2008400; World Health Organization, 2007, WHOHTMTB2007377; World Health Organization, 2012, PRACT HDB PHARM MED; World Health Organization, 2012, WHOHTMTB201212; World Health Organization, 2008, WHOHTMTB2008399; World Health organization, 2009, WHOHTMTB2009419; World Health Organization, 2010, ROADM ENS QUAL TUB D; World Health Organization, DIS OUTBR; World Health Organization, 2004, WKLY EPIDEMIOL REC, V79, P27; World Health Organization, INTR RAT US NEW DRUG; World Health Organization, 2014, WHOHTMTB201408; World Health Organization (WHO), 2014, WHOHTMTB201413; Zenner D, 2013, INT J TUBERC LUNG D, V17, P573, DOI 10.5588/ijtld.12.0920; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034; Zumla A, 2012, J INFECT DIS, V205, pS141, DOI 10.1093/infdis/jir880	185	24	25	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	APR	2015	45	4					928	952		10.1183/09031936.00214014		25	Respiratory System	Respiratory System	CE7MB	WOS:000352023800008		
J	Fujimoto, D; Shimizu, R; Morimoto, T; Kato, R; Sato, Y; Kogo, M; Ito, J; Teraoka, S; Otoshi, T; Nagata, K; Nakagawa, A; Otsuka, K; Katakami, N; Tomii, K				Fujimoto, Daichi; Shimizu, Ryoko; Morimoto, Takeshi; Kato, Ryoji; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Otoshi, Takehiro; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke			Analysis of advanced lung cancer patients diagnosed following emergency admission	EUROPEAN RESPIRATORY JOURNAL			English	Article							INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; PERFORMANCE STATUS; PROSPECTIVE MULTICENTER; PALLIATIVE CARE; SINGLE-AGENT; OUTCOMES; SURVIVAL; STAGE; ONCOLOGY	Data on prognosis and predictors of overall survival in advanced lung cancer patients diagnosed following emergency admission (DFEA) are currently lacking. We retrospectively analysed data from 771 patients with advanced nonsmall cell lung cancer between April 2004 and April 2012. Of the 771 patients, 103 (13%) were DFEA. DFEA was not an independent predictor of overall survival by multivariate Cox proportional hazard models, whereas good performance status (PS), epidermal growth factor receptor gene mutation, stage IIIB, adenocarcinoma and chemotherapy were independent predictors of overall survival (hazard ratio (95% CI) 0.36 (0.29-0.44), p<0.001; 0.49 (0.38-0.63), p<0.001; 0.64 (0.51-0.80), p<0.001; 0.81 (0.67-0.99), p=0.044; and 0.40 (0.31-0.52), p<0.001, respectively). Good PS just prior to opting for chemotherapy, but not at emergency admission, was a good independent predictor of overall survival in DFEA patients (hazard ratio (95% CI) 0.26 (0.12-0.55); p<0.001). DFEA is relatively common. DFEA and PS at emergency admission were not independent predictors of overall survival, but good PS just prior to opting for chemotherapy was an independent predictor of longer overall survival. Efforts to improve patient PS after admission should be considered vital in such circumstances.	[Fujimoto, Daichi; Shimizu, Ryoko; Kato, Ryoji; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Otoshi, Takehiro; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo 6500047, Japan; [Morimoto, Takeshi] Kobe City Med Ctr Gen Hosp, Clin Res Ctr, Kobe, Hyogo 6500047, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Div Gen Internal Med, Nishinomiya, Hyogo 6638501, Japan	Fujimoto, D (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	daichianzen@yahoo.co.jp			Ethics Committee of Kobe City Medical Center General Hospital	This study was supported by internal funding and the Ethics Committee of Kobe City Medical Center General Hospital.	Adam AK, 2008, EUR RESPIR J, V31, P47, DOI 10.1183/09031936.00031607; Azevedo LCP, 2014, CHEST, V146, P257, DOI 10.1378/chest.13-1870; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Beckett P, 2014, LUNG CANCER, V83, P396, DOI 10.1016/j.lungcan.2013.10.010; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Ellis PM, 2012, CURR ONCOL, V19, pS7, DOI 10.3747/co.19.1069; Blum TG, 2014, EUR RESPIR J, V43, P1254, DOI 10.1183/09031936.00106913; Sabur NF, 2013, RESPIRATION, V85, P36, DOI 10.1159/000342343; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Neal RD, 2007, BRIT J GEN PRACT, V57, P212; Mayer DK, 2011, J CLIN ONCOL, V29, P2683, DOI 10.1200/JCO.2010.34.2816; Berghmans T, 2012, EUR RESPIR J, V39, P9, DOI 10.1183/09031936.00190310; Jung H, 2013, SUPPORT CARE CANCER, V21, P3379, DOI 10.1007/s00520-013-1917-1; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Bonomi MR, 2012, LUNG CANCER, V77, P600, DOI 10.1016/j.lungcan.2012.05.103; Fujimoto D, 2014, CLIN EXP METASTAS, V31, P543, DOI 10.1007/s10585-014-9648-3; Gorham J, 2013, LUNG CANCER, V80, P203, DOI 10.1016/j.lungcan.2012.12.006; Helbekkmo N, 2009, ACTA ONCOL, V48, P1019, DOI 10.1080/02841860902795240; Kelley AS, 2010, NEW ENGL J MED, V363, P781, DOI 10.1056/NEJMe1004139; Kotajima F, 2014, MOL CLIN ONCOL, V2, P322; Lilenbaum RC, 2004, ONCOLOGY-NY, V18, P1321; Meert AP, 2013, EUR RESPIR J, V42, P299, DOI 10.1183/09031936.00008313; Morgan HK, 2011, THORAX, V66, pA146, DOI 10.1136/thoraxjnl-2011-201054c.195; Morth C, 2014, LUNG CANCER, V84, P209, DOI 10.1016/j.lungcan.2014.03.015; Public Health England, 2013, PUBL HLTH ENGL; Slatore CG, 2012, J CLIN ONCOL, V30, P1686, DOI 10.1200/JCO.2011.40.0846; Soares M, 2014, ANN ONCOL, V25, P1829, DOI 10.1093/annonc/mdu234; Soares M, 2007, CHEST, V131, P840, DOI 10.1378/chest.06-2244; Toffart AC, 2011, CHEST, V139, P101, DOI 10.1378/chest.09-2863; Yamaguchi S, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-166	35	1	1	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	APR	2015	45	4					1098	1107		10.1183/09031936.00068114		10	Respiratory System	Respiratory System	CE7MB	WOS:000352023800022		
J	Nakatani, T; Arai, T; Kitaichi, M; Akira, M; Tachibana, K; Sugimoto, C; Hirooka, A; Tsuji, T; Minomo, S; Hayashi, S; Inoue, Y				Nakatani, Takeshi; Arai, Toru; Kitaichi, Masanori; Akira, Masanori; Tachibana, Kazunobu; Sugimoto, Chikatoshi; Hirooka, Aya; Tsuji, Taisuke; Minomo, Shojiro; Hayashi, Seiji; Inoue, Yoshikazu			Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?	EUROPEAN RESPIRATORY JOURNAL			English	Letter							IDIOPATHIC PULMONARY-FIBROSIS; USUAL INTERSTITIAL PNEUMONIA		[Nakatani, Takeshi; Tachibana, Kazunobu; Hirooka, Aya; Tsuji, Taisuke; Minomo, Shojiro; Hayashi, Seiji] Natl Hosp Org, Dept Internal Med, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan; [Arai, Toru; Kitaichi, Masanori; Akira, Masanori; Tachibana, Kazunobu; Sugimoto, Chikatoshi; Inoue, Yoshikazu] Natl Hosp Org, Clin Res Ctr, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan; [Kitaichi, Masanori] Natl Hosp Org, Dept Pathol, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan; [Akira, Masanori] Natl Hosp Org, Dept Radiol, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan	Inoue, Y (reprint author), Natl Hosp Org, Clin Res Ctr, Kinki Chuo Chest Med Ctr, Kita Ku, 1180 Nagasone Cho, Sakai, Osaka 5918555, Japan.	giichi@kch.hosp.go.jp					American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Amitani R, 1992, KOKYU, V11, P693; Becker CD, 2008, MODERN PATHOL, V21, P784, DOI 10.1038/modpathol.2008.56; Beynat-Mouterde C, 2014, EUR RESPIR J, V44, P523, DOI 10.1183/09031936.00214713; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Camus P, 2014, EUR RESPIR J, V44, P289, DOI 10.1183/09031936.00088414; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Akira M, 2009, RADIOLOGY, V251, P271, DOI 10.1148/radiol.2511080917; von der Thusen JH, 2011, MODERN PATHOL, V24, P1633, DOI 10.1038/modpathol.2011.114; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Oda T, 2014, CHEST, V146, P1248, DOI 10.1378/chest.13-2866; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shiota S, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P87; Watanabe Kentaro, 2012, Respir Investig, V50, P88, DOI 10.1016/j.resinv.2012.06.003	14	1	1	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	APR	2015	45	4					1183	1186		10.1183/09031936.00214714		4	Respiratory System	Respiratory System	CE7MB	WOS:000352023800034		
J	Tsuchiya, Y; Murai, S; Yamashita, S				Tsuchiya, Yuichi; Murai, Shin; Yamashita, Shigeru			Dual inhibition of Cdc2 protein kinase activation during apoptosis in Xenopus egg extracts	FEBS JOURNAL			English	Article						apoptosis; Cdc2; Cdc25C; cyclinB; Xenopus egg extracts	PROTEASOME-MEDIATED DEGRADATION; EMBRYONIC-CELL CYCLE; M-PHASE; PHOSPHORYLATION SITES; DOWN-REGULATION; TARGETS CDC25A; MESSENGER-RNAS; PHOSPHATASE; WEE1; LAEVIS	When intracellular damage accumulates in proliferating somatic cells, the cell cycle usually arrests in G(1) or G(2) in a checkpoint-dependent manner, either to repair the damage or to die by apoptosis. In contrast, early embryonic cells lack checkpoint-mediated cell-cycle arrest, and it is not clear whether apoptosis in early embryonic cells occurs at a specific cell cycle stage or at random points. Here, we examined the functional molecular link between the embryonic cell cycle and apoptosis using Xenopus egg extracts. When apoptosis was induced in egg extracts by addition of exogenous cytochromec during cell-cycle progression, cyclinB accumulation was inhibited, Cdc2 was not activated, and the cell cycle arrested at interphase. However, addition of recombinant cyclinB failed to activate Cdc2 due to the strong inhibitory phosphorylation of Cdc2 Tyr15 in apoptotic egg extracts. We found that endogenous Cdc25C, which activates the Cdc2-cyclinB complex by dephosphorylating Cdc2 Tyr15, was inactivated by caspase-mediated cleavage at two sites in the N-terminal regulatory domain. When the hyperactive Cdc25A catalytic fragment was added together with recombinant cyclinB to artificially dephosphorylate Cdc2 Tyr15, M-phase induction was restored in apoptotic egg extracts, indicating that the blockage of cyclinB accumulation and the caspase-mediated inactivation of Cdc25C dually inhibited Cdc2 activation. Apoptosis induction in cytostatic factor-arrested metaphase egg extracts resulted in inactivation of Cdc2 without cyclinB degradation. These results suggest that apoptotic inactivation of Cdc25C plays an important role in arresting the embryonic cell cycle at interphase during apoptosis.	[Tsuchiya, Yuichi; Murai, Shin; Yamashita, Shigeru] Toho Univ, Sch Med, Dept Biochem, Ota Ku, Tokyo 1438540, Japan	Tsuchiya, Y (reprint author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	tsuchiya@med.toho-u.ac.jp			Toho University School of Medicine [20-19]; Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank the members of our laboratory for helpful discussion. We are also grateful to the two anonymous reviewers for valuable scientific suggestions. This work was supported by Project Research Grant 20-19 from Toho University School of Medicine, and in part by Grants-in Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan to Y.T.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Tsuchiya Y, 2005, FEBS J, V272, P2237, DOI 10.1111/j.1742-4658.2005.04648.x; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; St Clair S, 2004, MOL CELL, V16, P725; Kim SH, 1999, DEV BIOL, V212, P381, DOI 10.1006/dbio.1999.9361; Deming Paula, 2006, V322, P379; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; MUELLER PR, 1995, MOL BIOL CELL, V6, P119; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Xiao D, 2004, MOL CANCER THER, V3, P567; IZUMI T, 1992, MOL BIOL CELL, V3, P927; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Chou ST, 2010, J BIOL CHEM, V285, P17833, DOI 10.1074/jbc.M109.078386; Thanasoula M, 2012, EMBO J, V31, P3398, DOI 10.1038/emboj.2012.191; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Audic Y, 2001, MOL CELL BIOL, V21, P1662, DOI 10.1128/MCB.21.5.1662-1671.2001; Casado-Vela J, 2007, PROTEOMICS, V7, P2522, DOI 10.1002/pmic.200700026; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; DusPasquier D, 2011, PLOS ONE, V6; IZUMI T, 1993, MOL BIOL CELL, V4, P1337; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; LESGAC G, 2006, J BIOL CHEM, V281, P24161; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Mazars A, 2009, CELL DEATH DIFFER, V16, P208, DOI 10.1038/cdd.2008.142; McCoy F, 2014, METHODS MOL BIOL, V1133, P119, DOI 10.1007/978-1-4939-0357-3_8; Morley SJ, 2005, CELL DEATH DIFFER, V12, P571, DOI 10.1038/sj.cdd.4401591; Nakajo N, 2011, INT J DEV BIOL, V55, P627, DOI 10.1387/ijdb.113287nn; Okazaki K, 1996, GENE, V178, P111, DOI 10.1016/0378-1119(96)00344-7; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Saitoh Tomohiro, 2009, Reproductive Medicine and Biology, V8, P3, DOI 10.1007/s12522-008-0001-x; Saitoh T, 2009, BIOCHEM BIOPH RES CO, V384, P491, DOI 10.1016/j.bbrc.2009.05.004; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Smith JJ, 2000, J CELL BIOL, V151, P1391, DOI 10.1083/jcb.151.7.1391; Stanford JS, 2005, MOL BIOL CELL, V16, P5749, DOI 10.1091/mbc.E05-06-0541; Tokmakov AA, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-56; Tsuchiya Yuichi, 2007, BMC Biochem, V8, P5, DOI 10.1186/1471-2091-8-5; Tsuchiya Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175927; Ueno H, 2008, DEVELOPMENT, V135, P2023, DOI 10.1242/dev.019893; Wang RN, 2010, P NATL ACAD SCI USA, V107, P19885, DOI 10.1073/pnas.1003528107; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wroble BN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-119; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	APR	2015	282	7					1256	1270		10.1111/febs.13217		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CF0IJ	WOS:000352226400007		
J	Rahman, MM; Tsukamoto, J				Rahman, Mohammed M.; Tsukamoto, Jiro			Opposing effects of substrate quality and site factors on forest floor turnover rates: an example from the tropics	FORESTRY			English	Article							LEAF-LITTER DECOMPOSITION; SUCCESSIONAL STATUS; COMMON GARDEN; RAIN-FOREST; CHEMISTRY; NUTRIENT; CARBON; SOIL; HERBIVORY; LEAVES	In boreal-to-cool temperate regions, there is a consistent relationship between litter quality, litter decay rates in litterbags and forest floor turnover rates across different tree functional types such as conifers and deciduous trees. This is partly due to the synergistic relationship between substrate quality and site conditions (understorey temperatures) in controlling forest floor dynamics. That is, species with higher light penetration have higher understorey temperature and litter of higher quality compared with species with lower light penetration. The findings of our study in Sarawak were partly consistent with this trend, with substrate quality, microbial respiration and mass loss rates of the litter in litterbags being higher for pioneer species from a young secondary forest (YSF) than for climax species from a primary forest (PF). However, the microbial respiration in the forest floor and its turnover rate were lower in the YSF with lower forest floor water content than those in the PF. This discrepancy was explained by the opposing relationship between substrate quality and site conditions (forest floor moisture). That is, in the YSF, the favourable effects of substrate quality on decomposition were overridden by the unfavourable effects of forest floor moisture and the reverse was the case in the PF. It was concluded that the relationship between substrate quality and site factors (synergistic vs. opposing) in controlling decomposition is macroclimate dependent and that the power of substrate quality for predicting forest floor dynamics is lower in the tropics than that in boreal-to-cool temperate regions.	[Rahman, Mohammed M.] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan; [Rahman, Mohammed M.; Tsukamoto, Jiro] Kochi Univ, Educ & Res Ctr Subtrop Field Sci, Kochi 7838502, Japan	Tsukamoto, J (reprint author), Kochi Univ, Educ & Res Ctr Subtrop Field Sci, Kochi 7838502, Japan.	tukamoto@kochi-u.ac.jp			Research Institute for Humanity and Nature [D-04]; Japanese Government [18580148]	This research was financially supported by the Project of the Research Institute for Humanity and Nature (D-04) and the Grant-in-Aid for Scientific Research (grant No. 18580148) from the Japanese Government.	Anderson J. M., 1993, TROPICAL SOIL BIOL F; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x; Quinn JM, 2000, NEW ZEAL J MAR FRESH, V34, P253; Coq S, 2010, ECOLOGY, V91, P2080, DOI 10.1890/09-1076.1; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Luskin MS, 2011, BASIC APPL ECOL, V12, P540, DOI 10.1016/j.baae.2011.06.004; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Prescott CE, 2004, CAN J FOREST RES, V34, P1714, DOI 10.1139/X04-040; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Valachovic YS, 2004, CAN J FOREST RES, V34, P2131, DOI 10.1139/X04-089; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Coulis M, 2009, SOIL BIOL BIOCHEM, V41, P2573, DOI 10.1016/j.soilbio.2009.09.022; REICH PB, 1995, FUNCT ECOL, V9, P65, DOI 10.2307/2390092; Canhoto C, 1996, HYDROBIOLOGIA, V333, P79, DOI 10.1007/BF00017570; Barlow J, 2007, FOREST ECOL MANAG, V247, P91, DOI 10.1016/j.foreco.2007.04.017; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; von Arx G, 2013, J ECOL, V101, P1201, DOI 10.1111/1365-2745.12121; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Mesquita RD, 1998, SOIL BIOL BIOCHEM, V30, P167, DOI 10.1016/S0038-0717(97)00105-3; Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Folin O., 1927, J BIOL CHEM, V27, P239; Gorbacheva T. T., 2006, ENV BIOTECH, V2, P26; HARMON ME, 1990, FOREST ECOL MANAG, V31, P55, DOI 10.1016/0378-1127(90)90111-N; Hashimoto SD, 2005, COMMUN THEOR, V15, P10, DOI 10.1093/ct/15.1.10; Heim A, 2004, BIOGEOCHEMISTRY, V70, P299, DOI 10.1007/s10533-003-0844-5; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kurokawa H, 2008, ECOLOGY, V89, P2645, DOI 10.1890/07-1352.1; Nakagawa M., 2013, COLLAPSE RESTORATION, P3; Perez-Harguindeguy N, 2000, PLANT SOIL, V218, P21, DOI 10.1023/A:1014981715532; Rahman MM, 2013, FORESTRY, V86, P441, DOI 10.1093/forestry/cpt015; Swift M.J., 1979, DECOMPOSITION TERRES; Waterman PG, 1994, ANAL PHENOLIC PLANT; Xuefeng L., 2007, FRONT FOREST CHINA, V2, P417; Zhang D., 2008, J PLANT ECOL, V1, P1	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0015-752X	1464-3626		FORESTRY	Forestry	APR	2015	88	2					190	199		10.1093/forestry/cpu043		10	Forestry	Forestry	CF0BC	WOS:000352206500004		
J	Carrieri, C; Forrest, ARR; Santoro, C; Persichetti, F; Carninci, P; Zucchelli, S; Gustincich, S				Carrieri, Claudia; Forrest, Alistair R. R.; Santoro, Claudio; Persichetti, Francesca; Carninci, Piero; Zucchelli, Silvia; Gustincich, Stefano			Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						antisense transcription; long non-coding RNA; Parkinson's disease; Nurr1; dopaminergic cells	GENE-EXPRESSION; SUBSTANTIA-NIGRA; TERMINAL HYDROLASE; PROMOTER USAGE; CAP ANALYSIS; NURR1; TRANSCRIPTS; NEURONS; MICE; GENOME	Antisense (AS) transcripts are RNA molecules that are transcribed from the opposite strand to sense (S) genes forming S/AS pairs. The most prominent configuration is when a IncRNA is antisense to a protein coding gene. Increasing evidences prove that antisense transcription may control sense gene expression acting at distinct regulatory levels. However, its contribution to brain function and neurodegenerative diseases remains unclear. We have recently identified AS Uchl1 as an antisense to the mouse Ubiquitin carboxy-terminal hydrolase L1 (Uchl1) gene (AS Uchl1), the synthenic locus of UCHL1/PARK5. This is mutated in rare cases of early-onset familial Parkinson's Disease (PD) and loss of UCHL1 activity has been reported in many neurodegenerative diseases. Importantly, manipulation of UchL1 expression has been proposed as tool for therapeutic intervention. AS Uchl1 induces UchL1 expression by increasing its translation. It is the representative member of SINEUPs (SINEB2 sequence to UP-regulate translation), a new functional class of natural antisense IncRNAs that activate translation of their sense genes. Here we take advantage of FANTOM5 dataset to identify the transcription start sites associated to S/AS pair at Uchl1 locus. We show that AS Uchl1 expression is under the regulation of Nurr1, a major transcription factor involved in dopaminergic cells' differentiation and maintenance. Furthermore, AS Uch1 RNA levels are strongly down-regulated in neurochemical models of PD in vitro and in vivo. This work positions AS Uchl1 RNA as a component of Nurr1-dependent gene network and target of cellular stress extending our understanding on the role of antisense transcription in the brain.	[Carrieri, Claudia; Zucchelli, Silvia; Gustincich, Stefano] SISSA, Area Neurosci, Int Sch Adv Studies, I-34014 Trieste, Italy; [Forrest, Alistair R. R.; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Santoro, Claudio; Persichetti, Francesca; Zucchelli, Silvia] Univ Piemonte Orientale, Dipartimento Sci Salute, Novara, Italy	Zucchelli, S (reprint author), Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.	silvia.zucchelli@med.unipmn.it; gustinci@sissa.it		Forrest, Alistair/0000-0003-4543-1675	Italian Ministry of Education, University and Research (FIRB) [prot. RBAP11FRE9]; Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); "Program for Development of Basic Technology to Discover Innovative Biotechnology-Based Drugs" from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	We are indebted to all the members of the SG lab for thought-provoking discussions and to Cristina Leonesi for technical support. We are grateful to SISSA technical and administrative staff, especially to J. Franzot, T. Bigiarini, H. Krmac, Monica Sirk, Simonetta Vetter, and Erica Maran. This work was supported by the Italian Ministry of Education, University and Research (FIRB grant prot. RBAP11FRE9) to SG and FP by the Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies and by the "Program for Development of Basic Technology to Discover Innovative Biotechnology-Based Drugs" from The Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to PC.	Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Barrachina M, 2006, NEUROBIOL DIS, V22, P265, DOI 10.1016/j.nbd.2005.11.005; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Liu H, 2012, EUR J NEUROL, V19, P870, DOI 10.1111/j.1468-1331.2011.03644.x; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Gustincich S, 2003, GENOME RES, V13, P1395, DOI 10.1101/gr.1135303; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Saigoh K, 1999, NAT GENET, V23, P47; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Le W, 1999, J NEUROCHEM, V73, P2218; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Xu PY, 2002, NEUROLOGY, V58, P881; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Lipovich L, 2014, CEREB CORTEX, V24, P1451, DOI 10.1093/cercor/bhs414; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Gibrat C, 2009, J NEUROCHEM, V109, P1469, DOI 10.1111/j.1471-4159.2009.06072.x; Babajko S, 2011, CELLS TISSUES ORGANS, V194, P151, DOI 10.1159/000324466; Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263; Conley AB, 2012, NUCLEIC ACIDS RES, V40, P1438, DOI 10.1093/nar/gkr1010; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Knüppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Ling KH, 2011, CEREB CORTEX, V21, P683, DOI 10.1093/cercor/bhq141; Pardo LM, 2013, NEUROBIOL AGING, V34, P1825, DOI 10.1016/j.neurobiolaging.2013.01.005; Petit S, 2009, J CELL PHYSIOL, V220, P303, DOI 10.1002/jcp.21762; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Scheele C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-74; Spigoni G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008658; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182	63	2	2	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	APR 1	2015	9								114	10.3389/fncel.2015.00114		11	Neurosciences	Neurosciences & Neurology	CF7HZ	WOS:000352728400002		
J	Tanaka, N; Araki, K; Mizokami, D; Miyagawa, Y; Yamashita, T; Tomifuji, M; Ueda, Y; Inoue, M; Matsushita, K; Nomura, F; Shimada, H; Shiotani, A				Tanaka, N.; Araki, K.; Mizokami, D.; Miyagawa, Y.; Yamashita, T.; Tomifuji, M.; Ueda, Y.; Inoue, M.; Matsushita, K.; Nomura, F.; Shimada, H.; Shiotani, A.			Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer	GENE THERAPY			English	Article							SQUAMOUS-CELL CARCINOMA; EXPRESSION; THERAPY; VECTOR; FUSE; FBP; MUTATIONS; TRANSGENE; DISEASE; TARGETS	Far-upstream element-binding protein-interacting repressor (FIR) is a transcription factor that inhibits c-Myc expression and has been shown to have antitumor effects in some malignancies. Here, we evaluated the antitumor effects of FIR using fusion genedeleted Sendai virus (SeV/Delta F) as a nontransmissible vector against head and neck squamous cell carcinoma (HNSCC). Using in vitro and in vivo xenograft mouse models, we observed efficient expression of green fluorescent protein (GFP) following transduction with the SeV/Delta F vector encoding GFP (GFP-SeV/Delta F) into HNSCC cells. In vitro and in vivo studies revealed that administration of the FIR-encoded SeV/Delta F (FIR-SeV/Delta F) vector exerted significant antitumor effects, suppressed c-Myc expression and induced apoptosis in HNSCC. Additionally, the antitumor effects of FIR or the expression of GFP following administration of the FIR- or GFP-SeV/Delta F vector, respectively, were dependent on the multiplicity of infection or titer. Furthermore, the SeV/Delta F vector itself had no cytotoxic effects. Therefore, the SeV/Delta F vector may be safe and useful for the treatment of HNSCC, allowing for high-titer SeV/Delta F vector administration for anticancer gene therapy. In addition, SeV/Delta F vector-mediated FIR gene therapy demonstrated effective tumor suppression in HNSCC, suggesting that this therapy may have the potential for clinical use as a novel strategy for HNSCC treatment.	[Tanaka, N.; Araki, K.; Mizokami, D.; Miyagawa, Y.; Yamashita, T.; Tomifuji, M.; Shiotani, A.] Natl Def Med Coll, Dept Otorhinolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan; [Ueda, Y.; Inoue, M.] DNAVEC Corp, Dept Gene Med, Tsukuba, Ibaraki, Japan; [Matsushita, K.; Nomura, F.] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Matsushita, K.; Nomura, F.] Chiba Univ, Grad Sch Med, Div Clin Genet & Prote, Chiba, Japan; [Shimada, H.] Toho Univ, Sch Med, Dept Surg, Tokyo, Japan	Araki, K (reprint author), Natl Def Med Coll, Dept Otorhinolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	kojaraki@ndmc.ac.jp		Matsushita, Kazuyuki/0000-0001-6742-0761	Special Research Grant on Defense Medicine from the Ministry of Defense of Japan [23592544, 23592545, 25462699, 26462627, 25670723]	We thank Dr T Ota for providing the HSC-3-M3 cell line. A part of this paper was presented in July 2012 at the 8th International Conference on Head and Neck Cancer in Toronto, Canada. This work was supported by a Special Research Grant on Defense Medicine from the Ministry of Defense of Japan, Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Nos. 23592544, 23592545, 25462699 and 26462627) and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI No. 25670723).	Matsushita K, 2013, MOL CANCER RES, V11, P689, DOI 10.1158/1541-7786.MCR-12-0673; Matsushita K, 2012, MOL CANCER RES, V10, P787, DOI 10.1158/1541-7786.MCR-11-0462; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Shirakura M, 2004, GENE THER, V11, P784, DOI 10.1038/sj.gt.3302224; Matsushita K, 2006, CANCER RES, V66, P1409, DOI 10.1158/0008-5472.CAN-04-4459; Hara H, 2011, HUM VACCINES, V7, P639, DOI 10.4161/hv.7.6.15408; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Kitamura A, 2011, CANCER SCI, V102, P1366, DOI 10.1111/j.1349-7006.2011.01931.x; Chung HJ, 2005, MOL CELLS, V20, P157; Matsui T, 1998, ORAL ONCOL, V34, P253; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Perez-Sayans M, 2011, ORAL ONCOL, V47, P688, DOI 10.1016/j.oraloncology.2011.05.016; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Ban H, 2007, GENE THER, V14, P1688, DOI 10.1038/sj.gt.3303032; Chaikhoutdinov I, 2013, ADV EXP MED BIOL, V779, P165, DOI 10.1007/978-1-4614-6176-0_7; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI DOI 10.1172/JCI35700; Inoue M, 2003, J VIROL, V77, P3238, DOI 10.1128/JVI.77.5.3238.3246.2003; Kanzaki S, 2007, AUDIOL NEURO-OTOL, V12, P119, DOI 10.1159/000097798; Li DQ, 2008, LARYNGOSCOPE, V118, P650, DOI 10.1097/MLG.0b013e3181613aba; Matsushita K, 2014, WORLD J GASTROENTERO, V20, P4316, DOI 10.3748/wjg.v20.i15.4316; Matta A., 2009, HEAD NECK ONCOL, V1, P6, DOI DOI 10.1186/1758-3284-1-6; Mizokami D, 2013, LARYNGOSCOPE, V123, P1717, DOI 10.1002/lary.23917; Rahmutulla B, 2014, ONCOTARGET, V5, P2404; Riva C, 1995, ORAL ONCOL, V31B, P384; Roussel ME, 1998, ADV CANCER RES, V74, P1, DOI 10.1016/S0065-230X(08)60763-0; Shiotani A, 2001, GENE THER, V8, P1043, DOI 10.1038/sj.gt.3301486; Tanaka N, 2014, ANTICANCER RES, V34, P3157; Thomas SM, 2009, HUM GENE THER, V20, P1565, DOI 10.1089/hum.2009.163; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	APR	2015	22	4					297	304		10.1038/gt.2014.123		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CE9VN	WOS:000352191600002		
J	Yoshizawa, H; Morishita, Y; Watanabe, M; Ishibashi, K; Muto, S; Kusano, E; Nagata, D				Yoshizawa, H.; Morishita, Y.; Watanabe, M.; Ishibashi, K.; Muto, S.; Kusano, E.; Nagata, D.			TGF-beta(1)-siRNA delivery with nanoparticles inhibits peritoneal fibrosis	GENE THERAPY			English	Article							RNA INTERFERENCE; GENE DELIVERY; DIALYSIS; MEMBRANE; PATHOPHYSIOLOGY; SIRNA; RATS; MICE; THERAPEUTICS; INFLAMMATION	Gene therapies may be promising for the treatment of peritoneal fibrosis (PF) in subjects undergoing peritoneal dialysis (PD). However, a method of delivery of treatment genes to the peritoneum is lacking. We attempted to develop an in vivo small interfering RNA (siRNA) delivery system with liposome-based nanoparticles (NPs) to the peritoneum to inhibit PF. Transforming growth factor (TGF)-beta(1)-siRNAs encapsulated in NPs (TGF-beta(1)-siRNAs-NPs) dissolved in PD fluid were injected into the peritoneum of mice with PF three times a week for 2 weeks. TGF-beta(1)-siRNAs-NPs knocked down TGF-beta(1) expression significantly in the peritoneum and inhibited peritoneal thickening with fibrous changes. TGF-beta(1)-siRNAs-NPs also inhibited the increase of expression of alpha-smooth muscle actin-positive myofibroblasts. These results suggest that the TGF-beta(1)-siRNA delivery system with NPs described here could be an effective therapeutic option for PF in subjects undergoing PD.	[Yoshizawa, H.; Morishita, Y.; Watanabe, M.; Muto, S.; Kusano, E.; Nagata, D.] Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi 3290498, Japan; [Ishibashi, K.] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan	Morishita, Y (reprint author), Jichi Med Univ, Dept Med, Div Nephrol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ymori@jichi.ac.jp			JSPS KAKENHI [25461252]; MEXT-Supported Program for Strategic Research Foundations at Private Universities [S1211029]	We thank Motomu Shimaoka (Professor of Molecular Pathobiology, Mie University School of Medicine) for discussion and comments regarding the manuscript. This work was supported by JSPS KAKENHI (grant number 25461252) and MEXT-Supported Program for Strategic Research Foundations at Private Universities, 20132017 (S1211029).	Morishige T, 2012, ARCH TOXICOL, V86, P1297, DOI 10.1007/s00204-012-0823-5; Hirahara I, 2006, PERITON DIALYSIS INT, V26, P380; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS22; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Motomura Y, 2005, AM J PHYSIOL-GASTR L, V288, pG143, DOI 10.1152/ajpgi.00186.2004; Sledz CA, 2005, BLOOD, V106, P787, DOI 10.1182/blood-2004-12-4643; Ban M, 2013, TOXICOL LETT, V216, P31, DOI 10.1016/j.toxlet.2012.11.003; Margetts PJ, 2002, J AM SOC NEPHROL, V13; Guo H, 2007, GENE THER, V14, P1712, DOI 10.1038/sj.gt.3303040; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Nishino T, 2003, KIDNEY INT, V64, P887, DOI 10.1046/j.1523-1755.2003.00169.x; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Wang XJ, 2013, INT J NANOMED, V8, P1733, DOI 10.2147/IJN.S44211; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Kikuchi A, 1999, HUM GENE THER, V10, P947, DOI 10.1089/10430349950018346; Li XJ, 2012, CHINESE MED J-PEKING, V125, P2219, DOI 10.3760/cma.j.issn.0366-6999.2012.12.024; RONCO C, 1990, PERITON DIALYSIS INT, V10, P119; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Wang X, 2010, NEPHROL DIAL TRANSPL, V25, P399, DOI 10.1093/ndt/gfp480; Yao Q, 2008, NEPHRON EXP NEPHROL, V109, pE71, DOI 10.1159/000142529	31	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	APR	2015	22	4					333	340		10.1038/gt.2014.116		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CE9VN	WOS:000352191600006		
J	Furukawa, MT; Sakamoto, H; Inoue, K				Furukawa, Mari T.; Sakamoto, Hiroshi; Inoue, Kunio			Interaction and colocalization of HERMES/RBPMS with NonO, PSF, and G3BP1 in neuronal cytoplasmic RNP granules in mouse retinal line cells	GENES TO CELLS			English	Article							LONG NONCODING RNA; TAU-MESSENGER-RNA; STRESS GRANULES; PARASPECKLE FORMATION; NUCLEAR-LOCALIZATION; BINDING PROTEINS; GANGLION-CELLS; RGC-5 CELLS; DIFFERENTIATION; TRANSLATION	HERMES, also called RBPMS, is a conserved RNA binding protein with a single RNA recognition motif (RRM) that is abundantly expressed in retinal ganglion cells (RGCs) and in the heart in vertebrates. Here, we identified NonO and PSF as the interacting proteins of HERMES only when the neuronal differentiation of the retinal cell line RGC-5 was induced. Although NonO and PSF are nuclear paraspeckle components, these proteins formed cytoplasmic granules with HERMES in the neurites. G3BP1, a component of stress granules, was also colocalized to the granules, interacting with NonO and HERMES even in the absence of cellular stress. Consistent with a previous report that KIF5 interacts with neuronal granules, the localization of KIF5A overlapped with the cytoplasmic granules in differentiated RGC-5 cells. Thus, our study strongly suggests that the cytoplasmic granule containing HERMES, NonO, PSF, and G3BP1 is a neuronal RNA-protein granule that is transported in neurites during retinal differentiation.	[Furukawa, Mari T.; Sakamoto, Hiroshi; Inoue, Kunio] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan	Inoue, K (reprint author), Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	kunio@kobe-u.ac.jp			JSPS	We thank Drs Akiyasu Kanamori and Azusa Akashi (Graduate School of Medicine, Kobe University) for RGC-5 cells, Dr Shinji Kamata (Biosignal Research Center, Kobe University) for HeLa cells, Drs Masaaki Miyamoto and Ryoko Kusakabe (Radio Isotope Division, Kobe University) for Mass Spectrometry, and Dr Teruaki Takasaki in our laboratory for valuable comments on this manuscript. This work was supported by grants-in-aid for Scientific Research from JSPS. MTF is a JSPS research fellow.	Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Vanderweyde T, 2013, GERONTOLOGY, V59, P524, DOI 10.1159/000354170; Reese BE, 2011, VISION RES, V51, P613, DOI 10.1016/j.visres.2010.07.010; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Martin S, 2013, J NEUROCHEM, V125, P175, DOI 10.1111/jnc.12189; Kim YH, 2012, BIOCHEM BIOPH RES CO, V423, P67, DOI 10.1016/j.bbrc.2012.05.084; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Atlas R, 2007, J NEUROSCI RES, V85, P173, DOI 10.1002/jnr.21099; Balasanyan V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092349; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; Farazi TA, 2014, RNA, V20, P1090, DOI 10.1261/rna.045005.114; Gerber WV, 1999, MECH DEVELOP, V80, P77, DOI 10.1016/S0925-4773(98)00195-6; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Nishimoto Y, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-31; Oster SF, 2004, SEMIN CELL DEV BIOL, V15, P125, DOI 10.1016/j.semcdb.2003.09.006; Piri N, 2006, NEUROSCI LETT, V405, P40, DOI 10.1016/j.neulet.2006.06.049; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; Song HW, 2007, DIFFERENTIATION, V75, P519, DOI 10.1111/j.1432-0436.2006.00155.x	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					257	266		10.1111/gtc.12224		10	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200001		
J	Fukuda, M; Aizawa, Y				Fukuda, Makiha; Aizawa, Yasunori			Hypothetical gene C18orf42 encodes a novel protein kinase A-binding protein	GENES TO CELLS			English	Article							REGULATORY SUBUNIT RII; ANTIGEN PRESENTATION; SYNAPTIC PLASTICITY; ANCHORING PROTEINS; DENDRITIC CELLS; PKA; AKAPS; LOCALIZATION; SPECIFICITY; RECEPTORS	The substrate specificity of cAMP-dependent protein kinase A (PKA) is controlled by its interaction with the A-kinase anchoring protein (AKAP) family. Individual AKAP members are localized to particular intracellular sites and tether PKA specifically to the subcellular compartments where target substrates exist. Here, we report that the human hypothetical gene C18orf42 encodes a novel PKA-binding protein that potentially regulates PKA-AKAP interactions. C18orf42 is expressed preferentially in neural tissues. Functional motif searching predicted that C18orf42 may encode a short protein that contains a putative PKA-binding motif. To confirm this possibility, we applied the CRISPR/Cas9 genome-editing system to incorporate the FLAG tag into the C-terminus of the endogenous C18orf42 protein in the mouse neural cell line Neuro2a. Immunoprecipitation and immunoblotting using anti-FLAG antibody showed translation of the endogenous C18orf42 protein and the physical interaction of the C18orf42 protein with PKA subunits. Immunoprecipitation and pull-down assays showed that C18orf42 binds specifically to the type II regulatory subunits of PKA. Unlike the expression of many AKAPs, that of C18orf42 could block the AKAP-mediated subcellular localization of PKA. These findings suggest that C18orf42 may be a novel PKA signaling gene that serves as an endogenous disruptor peptide for PKA-AKAP interactions.	[Fukuda, Makiha; Aizawa, Yasunori] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Aizawa, Yasunori] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan	Aizawa, Y (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan.	yaizawa@bio.titech.ac.jp			MEXT KAKENHI [24113706]; Promotion Project of Knowledge-based Industrial Clustering of Okinawa Prefecture ('Okinawa International Project for Construction of Intellectual Cluster and Industry based on Advanced Genomic Research'); JSPS KAKENHI [23009635]	The authors thank all the members of Aizawa Laboratory for fruitful discussions, the Support Center for Advanced Medical Sciences, Institute of Health Biosciences, University of Tokushima Graduate School for technical assistance with mass spectrometry, and Professor Hisakazu Mihara and members of his laboratory for assistance with CD spectroscopy. This research was supported by MEXT KAKENHI (grant number 24113706, Y.A.), the Promotion Project of Knowledge-based Industrial Clustering of Okinawa Prefecture ('Okinawa International Project for Construction of Intellectual Cluster and Industry based on Advanced Genomic Research', Y.A.) and JSPS KAKENHI (grant number 23009635, M.F.).	Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Schillace RV, 2011, IMMUNOL CELL BIOL, V89, P650, DOI 10.1038/icb.2010.148; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; DOSKELAND SO, 1978, BIOCHEM BIOPH RES CO, V83, P542, DOI 10.1016/0006-291X(78)91024-0; Kritzer MD, 2012, J MOL CELL CARDIOL, V52, P351, DOI 10.1016/j.yjmcc.2011.05.002; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; CARR DW, 1992, J BIOL CHEM, V267, P13376; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; CARR DW, 1991, J BIOL CHEM, V266, P14188; Troger J, 2012, BRIT J PHARMACOL, V166, P420, DOI 10.1111/j.1476-5381.2011.01796.x; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Feliciello A, 2000, J BIOL CHEM, V275, P303, DOI 10.1074/jbc.275.1.303; GRANOT J, 1980, J BIOL CHEM, V255, P4569; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Kapiloff MS, 2014, J GEN PHYSIOL, V143, P9, DOI 10.1085/jgp.201311020; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Newhall KJ, 2006, CURR BIOL, V16, P321, DOI 10.1016/j.cub.2005.12.031; Nishimura T, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114736; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Schillace RV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004807; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skalhegg Bjorn S., 1997, Frontiers in Bioscience (online), V2, pD331; Webb RJ, 2008, DEV BIOL, V317, P36, DOI 10.1016/j.ydbio.2008.01.045; Yang L., 2014, CURR PROTOC MOL BIOL, V107	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					267	280		10.1111/gtc.12217		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200002		
J	Takeiwa, T; Taniguchi, I; Ohno, M				Takeiwa, Toshihiko; Taniguchi, Ichiro; Ohno, Mutsuhito			Exportin-5 mediates nuclear export of SRP RNA in vertebrates	GENES TO CELLS			English	Article							SIGNAL RECOGNITION PARTICLE; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; RECEPTOR; IDENTIFICATION; NUCLEOLUS; SUBUNITS; DOMAIN; COMPONENTS; MACHINERY	The signal recognition particle is a ribonucleoprotein complex that is essential for the translocation of nascent proteins into the endoplasmic reticulum. It has been shown that the RNA component (SRP RNA) is exported from the nucleus by CRM1 in the budding yeast. However, how SRP RNA is exported in higher species has been elusive. Here, we show that SRP RNA does not use the CRM1 pathway in Xenopus oocytes. Instead, SRP RNA uses the same export pathway as pre-miRNA and tRNA as showed by cross-competition experiments. Consistently, the recombinant Exportin-5 protein specifically stimulated export of SRP RNA as well as of pre-miRNA and tRNA, whereas an antibody raised against Exportin-5 specifically inhibited export of the same RNA species. Moreover, biotinylated SRP RNA can pull down Exportin-5 but not CRM1 from HeLa cell nuclear extracts in a RanGTP-dependent manner. These results, taken together, strongly suggest that the principal export receptor for SRP RNA in vertebrates is Exportin-5 unlike in the budding yeast.	[Takeiwa, Toshihiko; Taniguchi, Ichiro; Ohno, Mutsuhito] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Ohno, M (reprint author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hitoohno@virus.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26113004]	We thank Dr Jun Katahira for the pQE60 plasmid for expressing His-tagged human Exportin-5. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Neo-taxonomy of noncoding RNAs' (No. 26113004 to M.O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Alavian CN, 2004, BIOCHEM BIOPH RES CO, V313, P351, DOI 10.1016/j.bbrc.2003.11.126; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Andersen ES, 2006, NUCLEIC ACIDS RES, V34, pD163, DOI 10.1093/nar/gkj142; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Strub K, 1999, RNA, V5, P1333, DOI 10.1017/S1355838299991045; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Rosenblad MA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-5; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Zwieb C, 2005, RNA, V11, P7, DOI 10.1261/rna.7203605; Rosenblad MA, 2009, RNA BIOL, V6, P508; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BROWN JD, 1994, EMBO J, V13, P4390; Ciufo LF, 2000, CURR BIOL, V10, P1256, DOI 10.1016/S0960-9822(00)00743-0; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Gwizdek C, 2001, J BIOL CHEM, V276, P25910, DOI 10.1074/jbc.M100493200; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HE XP, 1994, J CELL SCI, V107, P903; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Komeili A, 2001, ANNU REV GENET, V35, P341, DOI 10.1146/annurev.genet.35.102401.090720; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Politz JC, 2002, J CELL BIOL, V159, P411, DOI 10.1083/jcb.200208037; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Sommerville J, 2005, J CELL SCI, V118, P1299, DOI 10.1242/jcs.01726; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					281	291		10.1111/gtc.12218		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200003		
J	Doi, A; Fujimoto, A; Sato, S; Uno, T; Kanda, Y; Asami, K; Tanaka, Y; Kita, A; Satoh, R; Sugiura, R				Doi, Akira; Fujimoto, Ayumi; Sato, Shun; Uno, Takaya; Kanda, Yuki; Asami, Keita; Tanaka, Yuriko; Kita, Ayako; Satoh, Ryosuke; Sugiura, Reiko			Chemical genomics approach to identify genes associated with sensitivity to rapamycin in the fission yeast Schizosaccharomyces pombe	GENES TO CELLS			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN TARGET; MEMBRANE TRAFFICKING; ELONGATOR COMPLEX; GROWTH-CONTROL; TOR COMPLEXES; CELL-GROWTH; MTOR; PATHWAY; PROTEIN	Rapamycin and its derivatives have now emerged as an attractive therapeutic strategy with both immunosuppressant and antitumor properties. In addition, rapamycin has been proposed as a calorie restriction mimetic to extend the life span of various organisms. The fission yeast Schizosaccharomyces pombe (S.pombe) serves as a valuable genetic model system to study the mechanism(s) of drug action as well as to determine genetic contexts associated with drug sensitivity or resistance. Here, we identified genes that when deleted modulate the rapamycin-sensitive strains in S.pombe. We carried out a chemical genomics screen for rapamycin-sensitive mutants using the genome-deletion library which covers 95.3% of all nonessential fission yeast genes and confirmed 59 genes to be rapamycin sensitive. Gene Ontology (GO) enrichment analysis showed that strains sensitive to rapamycin are highly enriched in processes regulating tRNA modification and mitochondria as well as other ontologies, including cellular metabolic process, chromatin organization, cell cycle, signaling, translation, transport and other cellular processes. Analysis also showed that components of the Elongator complex are overrepresented in the sensitive strains. Here, the data obtained will provide valuable information for speculation on the actions of rapamycin as well as on TORC signaling, thereby presenting a strategy to enhance sensitivity to rapamycin.	[Doi, Akira; Fujimoto, Ayumi; Sato, Shun; Uno, Takaya; Kanda, Yuki; Asami, Keita; Tanaka, Yuriko; Kita, Ayako; Satoh, Ryosuke; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan; [Doi, Akira] Japan Soc Promot Sci, Tokyo 1028472, Japan	Sugiura, R (reprint author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Kowakae 3-4-1, Higashiosaka, Osaka 5778502, Japan.	sugiurar@phar.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23390021]; MEXT [S1411037]	We would like to thank the Yeast Resource Centre (YGRC/NBRP; http://yeast.lab.nig.ac.jp/nig) for providing strain (h<SUP>-</SUP> tor2-287 leu1) and William Figoni for critical reading of the manuscript. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to R. S. (23390021), and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018) (S1411037). We also would like to express our gratitude to members of the Laboratory of Molecular Pharmacogenomics for their support.	Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Brunn GJ, 1996, EMBO J, V15, P5256; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Lamichhane TN, 2013, MOL CELL BIOL, V33, P2918, DOI 10.1128/MCB.00278-13; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.E03-02-0079; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Bonnefoy N, 1996, MOL GEN GENET, V251, P204; SEHGAL SN, 1975, J ANTIBIOT, V28, P727; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Versees W, 2010, MOL MICROBIOL, V76, P1065, DOI 10.1111/j.1365-2958.2010.07162.x; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Leiber RM, 2010, PLANT CELL, V22, P1898, DOI 10.1105/tpc.109.073007; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099038; Zhang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068738; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Saiki R, 2003, BIOFACTORS, V18, P229; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107730200; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Bauer F, 2012, CELL REPORTS, V1, P424, DOI 10.1016/j.celrep.2012.04.001; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Cherkasova V, 2012, MOL BIOL CELL, V23, P480, DOI 10.1091/mbc.E11-08-0732; Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Augustine JJ, 2007, DRUGS, V67, P369, DOI 10.2165/00003495-200767030-00004; Back JH, 2011, CELL CYCLE, V10, P3849, DOI 10.4161/cc.10.22.18329; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Fernandez-Vazquez J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003647; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Jablonowski D, 2009, EUKARYOT CELL, V8, P1637, DOI 10.1128/EC.00205-09; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Miyatake M, 2007, GENETICS, V175, P1695, DOI 10.1534/genetics.107.070946; Morelon E, 2001, TRANSPLANTATION, V72, P787, DOI 10.1097/00007890-200109150-00008; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI 10.1080/10409230802254911 ; Rallis C, 2014, BIOL OPEN, V3, P161, DOI 10.1242/bio.20147245; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Takahara T, 2013, J BIOCHEM, V154, P1, DOI 10.1093/jb/mvt047; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Van Horn DJ, 1997, RNA, V3, P1434; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 1997, J BACTERIOL, V179, P6325; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P24736, DOI 10.1074/jbc.M102090200; Takeda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022021	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					292	309		10.1111/gtc.12223		18	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200004		
J	Doi, A; Kita, A; Kanda, Y; Uno, T; Asami, K; Satoh, R; Nakano, K; Sugiura, R				Doi, Akira; Kita, Ayako; Kanda, Yuki; Uno, Takaya; Asami, Keita; Satoh, Ryosuke; Nakano, Kentaro; Sugiura, Reiko			Geranylgeranyltransferase Cwg2-Rho4/Rho5 module is implicated in the Pmk1 MAP kinase-mediated cell wall integrity pathway in fission yeast	GENES TO CELLS			English	Article							SCHIZOSACCHAROMYCES-POMBE; PROTEIN; GTPASE; STRESS; LOCALIZATION; CYTOKINESIS; RHO1P; RAS; FARNESYLTRANSFERASE; (1-3)BETA-D-GLUCAN	Pmk1, a fission yeast homologue of mammalian ERK MAPK, regulates cell wall integrity, cytokinesis, RNA granule formation and ion homeostasis. Our screen for vic (viable in the presence of immunosuppressant and chloride ion) mutants identified regulators of the Pmk1 MAPK signaling, including Cpp1 and Rho2, based on the genetic interaction between calcineurin and Pmk1 MAPK. Here, we identified the vic2-1 mutants carrying a mis-sense mutation in the cwg2(+) gene encoding a beta subunit of geranylgeranyltransferase I (GGTase I), which participates in the post-translational C-terminal modification of several small GTPases, allowing their targeting to the membrane. Analysis of the vic2-1/cwg2-v2 mutant strain showed that the localization of Rho1, Rho4, Rho5 and Cdc42, both at the plasma and vacuolar membranes, was impaired in the vic2-1/cwg2-v2 mutant cells. In addition, Rho4 and Rho5 deletion cells exhibited the vic phenotype and cell wall integrity defects, shared phenotypes among the components of the Pmk1 MAPK pathway. Consistently, the phosphorylation of Pmk1 MAPK on heat shock was decreased in the cwg2-v2 mutants, and rho4- and rho5-null cells. Moreover, Rho4 and Rho5 associate with Pck1/Pck2. Possible roles of Cwg2, Rho4 and Rho5 in the Pmk1 signaling will be discussed.	[Doi, Akira; Kita, Ayako; Kanda, Yuki; Uno, Takaya; Asami, Keita; Satoh, Ryosuke; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan; [Doi, Akira] Japan Soc Promot Sci, Tokyo 1028472, Japan; [Nakano, Kentaro] Univ Tsukuba, Grad Sch Life & Environm Sci, Dept Biol Sci, Tsukuba, Ibaraki 3058577, Japan	Sugiura, R (reprint author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Kowakae 3-4-1, Higashiosaka, Osaka 5778502, Japan.	sugiurar@phar.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23390021]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [S1411037]	We would like to thank the Yeast Resource Centre (YGRC/ NBRP; <http://yeast.lab.nig.ac.jp/nig>) for providing reagents; William Figoni for critical reading of the manuscript, and Astellas pharma Inc. for gifts of FK506. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to R. S. (23390021) and MEXT (Ministry of Education, Culture, Sports, Science and Technology)-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018) (S1411037). We also would like to express our gratitude to members of the Laboratory of Molecular Pharmacogenomics for their support.	Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Nakano K, 2003, GENES CELLS, V8, P357, DOI 10.1046/j.1365-2443.2003.00639.x; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200; Nakano K, 2005, FEBS LETT, V579, P5181, DOI 10.1016/j.febslet.2005.08.031; Broadus MR, 2012, MOL BIOL CELL, V23, P4118, DOI 10.1091/mbc.E12-06-0475; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Marshall Christopher J., 1994, Current Opinion in Genetics and Development, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Arellano M, 1997, J CELL SCI, V110, P2547; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/fmc.11.121, 10.4155/FMC.11.121]; Santos B, 2005, EUKARYOT CELL, V4, P1639, DOI 10.1128/EC.4.10.1639-1645.2005; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; DIAZ M, 1993, EMBO J, V12, P5245; Rincon SA, 2014, BIOCHEM SOC T, V42, P201, DOI 10.1042/BST20130155; Takai Y, 2001, PHYSIOL REV, V81, P153; Carver PL, 2004, ANN PHARMACOTHER, V38, P1707, DOI 10.1345/aph.1D301; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; Arellano M, 1998, MOL MICROBIOL, V29, P1357, DOI 10.1046/j.1365-2958.1998.01009.x; Sengar AS, 1997, MOL CELL BIOL, V17, P3508; Calonge TM, 2000, MOL BIOL CELL, V11, P4393; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; RIBAS JC, 1991, J BACTERIOL, V173, P3456; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Rincon SA, 2006, EUKARYOT CELL, V5, P435, DOI 10.1128/EC.5.3.435-446.2006; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Toda T, 1996, MOL CELL BIOL, V16, P6752; [Anonymous], 1991, METHOD ENZYMOL; Arellano M, 1996, EMBO J, V15, P4584; Arellano M, 1999, J CELL SCI, V112, P3569; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; Philips MR, 2005, BIOCHEM SOC T, V33, P657; Sanchez-Mir L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088020; Santos B, 2003, EUKARYOT CELL, V2, P521, DOI 10.1128/EC.2.3.521-533.2003; Satoh R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029683; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sugiura R, 2012, BIOORG MED CHEM LETT, V22, P6735, DOI 10.1016/j.bmcl.2012.08.085; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					310	323		10.1111/gtc.12222		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200005		
J	Zheng, XN; Suzuki, T; Takahashi, C; Nishida, E; Kusakabe, M				Zheng, Xiaona; Suzuki, Toshiyasu; Takahashi, Chika; Nishida, Eisuke; Kusakabe, Morioh			cnrip1 is a regulator of eye and neural development in Xenopus laevis	GENES TO CELLS			English	Article							ENDOCANNABINOID SYSTEM; VERTEBRATE EYE; HOMEOBOX GENE; EMBRYO; CB1	Cannabinoid receptor interacting protein 1 (CNRIP1), which has been originally identified as the binding partner of cannabinoid receptor 1 (CNR1), is evolutionarily conserved throughout vertebrates, but its physiological function has been unknown. Here, we identify a developmental role of CNRIP1 using Xenopus laevis embryos. During early embryogenesis, expression of Xenopus laevis cnrip1 is highly restricted to the animal region of gastrulae where neural and eye induction occur, and afterward it is seen in neural and other tissues with a temporally and spatially regulated pattern. Morpholino-mediated knockdown experiments indicate that cnrip1 has an essential role in early eye and neural development by regulating the onset of expression of key transcription factor genes, sox2, otx2, pax6 and rax. Also, over-expression experiments suggest that cnrip1 has a potential to expand sox2, otx2, pax6 and rax expression. These results suggest an instructive role of Xenopus laevis cnrip1 in early eye and neural development. Furthermore, Xenopus laevis cnr1 knockdown leads to eye defects, which are partly similar to, but milder than, those caused by cnrip1 knockdown, suggesting a possible functional similarity between CNRIP1 and CNR1. This study is the first characterization of an in vivo role of CNRIP1 in the context of whole organisms.	[Zheng, Xiaona; Suzuki, Toshiyasu; Takahashi, Chika; Nishida, Eisuke; Kusakabe, Morioh] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan	Kusakabe, M (reprint author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	morioh@lif.kyoto-u.ac.jp			Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Tetsuro Araki and Isabel de Ridder for initial gene expression analyses, Akira Iimura for helping cDNA cloning, Yuuki Hikita for helping qRT-PCR analysis, and Koichi Miyatake for gene expression analyses and the pCS4-otx2 construct. This work was supported by grants from the Takeda Science Foundation (to M.K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E.N. and M.K.).	Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Chow RL, 1999, DEVELOPMENT, V126, P4213; Niehaus JL, 2007, MOL PHARMACOL, V72, P1557, DOI 10.1124/mol.107.039263; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Kishi M, 2000, DEVELOPMENT, V127, P791; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Keimpema E, 2010, J NEUROSCI, V30, P13992, DOI 10.1523/JNEUROSCI.2126-10.2010; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.0.CO;2-E; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Blume LC, 2013, J NEUROCHEM, V124, P808, DOI 10.1111/jnc.12139; Diaz-Alonso J, 2012, PHILOS T R SOC B, V367, P3229, DOI 10.1098/rstb.2011.0385; DisMarzo V., 2004, NAT REV DRUG DISCOV, V3, P771; Fride E, 2004, NEUROENDOCRINOL LETT, V25, P24; Galve-Roperh I, 2009, EUR ARCH PSY CLIN N, V259, P371, DOI 10.1007/s00406-009-0028-y; Hu SSJ, 2010, J COMP NEUROL, V518, P3848, DOI 10.1002/cne.22429; HUANG S, 1993, J NEUROSCI, V13, P3193; Migliarini Beatrice, 2006, FEBS Lett, V580, P1941; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PANNESE M, 1995, DEVELOPMENT, V121, P707; Psychoyos D, 2012, BIRTH DEFECTS RES B, V95, P137, DOI 10.1002/bdrb.20348; Sive H.L., 2000, EARLY DEV XENOPUS LA	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					324	339		10.1111/gtc.12225		16	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200006		
J	Arai, T; Kano, F; Murata, M				Arai, Tamaki; Kano, Fumi; Murata, Masayuki			Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells	GENES TO CELLS			English	Article							PROTEIN-KINASE-B; DNA-BINDING; FACTOR AFX; PHOSPHATIDYLINOSITOL 3-KINASE; SUBSTRATE-SPECIFICITY; GENE-EXPRESSION; FAMILY-MEMBER; INSULIN; FKHR; PHOSPHORYLATION	Forkhead box O1 (FOXO1) is an important target for insulin. It is widely accepted that insulin-induced phosphorylation of FOXO1 by Akt leads to its nuclear exclusion and results in the inhibition of FOXO1-mediated transcription of the gluconeogenic gene phosphoenolpyruvate carboxykinase 1 (PCK1) in hepatocytes. However, many results that contradict this model have accumulated. Here, we provide a new mechanism for insulin-dependent repression of FOXO1-mediated transcription. We showed insulin-induced translocation of endogenous Ser256-phosphorylated FOXO1, which is essential for regulation of FOXO1-mediated transcription, from nuclear speckles to the nuclear periphery. This insulin-dependent translocation of FOXO1 regulated transcriptional repression of PCK1 concomitant with the formation of the FOXO1-euchromatic histone-lysine N-methyltransferase2 (EHMT2) complex and histone modifications of the PCK1 promoter region. Notably, our results suggest that FOXO1 uses nucleoporin 98kDa NUP98 for this transcriptional regulation. These results provide a new insight into various FOXO1-mediated transcriptional regulation and FOXO1-mediated essential biological pathways.	[Arai, Tamaki; Kano, Fumi; Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kano, Fumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Murata, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	mmurata@bio.c.u-tokyo.ac.jp			JST; PRESTO, Japan Science Technology Agency	This study was supported by grants from the Technology Development Program for Advanced Measurement and Analysis, JST (to M. M) and PRESTO, Japan Science Technology Agency (to F.K).	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad989402; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Kops GJPL, 1999, NATURE, V398, P630; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Huang S, 1996, J CELL BIOL, V133, P719, DOI 10.1083/jcb.133.4.719; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					340	357		10.1111/gtc.12226		18	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200007		
J	Tsuda-Sakurai, K; Seong, KH; Horiuchi, J; Aigaki, T; Tsuda, M				Tsuda-Sakurai, Kayoko; Seong, Ki-Hyeon; Horiuchi, Junjiro; Aigaki, Toshiro; Tsuda, Manabu			Identification of a novel role for Drosophila MESR4 in lipid metabolism	GENES TO CELLS			English	Article							FAT STORAGE; PATHWAY; PROTEIN; GENES; BODY; MELANOGASTER; EXPRESSION; RESISTANCE; GROWTH; CELLS	Drosophila provides a powerful genetic model to analyze lipid metabolism. Drosophila has an adipose-like organ called the fat body, which plays a crucial role in energy homeostasis. Here, we conducted a fat body-specific misexpression screen to identify genes involved in lipid metabolism. We found that over-expression of a nuclear protein with nine C2H2 type zinc-finger motifs and a PHD-finger, Misexpression suppressor of ras 4 (MESR4), reduces lipid accumulation in the fat body, whereas MESR4 knockdown increases it. We further show that MESR4 up-regulates the expression of major lipases, which may account for the reduction in lipid storage in the fat body and the release of free fatty acids (FFAs) in the body. These results suggest that MESR4 acts as an important upstream regulator of energy homeostasis.	[Tsuda-Sakurai, Kayoko] Ochanomizu Univ, Ochadai Acad Prod, Bunkyo Ku, Tokyo 1128610, Japan; [Tsuda-Sakurai, Kayoko; Horiuchi, Junjiro; Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Seong, Ki-Hyeon] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Tsuda, Manabu] Kanagawa Univ Human Serv, Dept Liberal Arts & Human Dev, Yokosuka, Kanagawa 2388522, Japan	Tsuda, M (reprint author), Kanagawa Univ Human Serv, Dept Liberal Arts & Human Dev, 1-10-1 Heiseicho, Yokosuka, Kanagawa 2388522, Japan.	tsuda-l3g@kuhs.ac.jp					Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Ito K, 1997, DEVELOPMENT, V124, P761; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Matsuyama R, 2010, J BIOL CHEM, V285, P18166, DOI 10.1074/jbc.M109.077024; Huang AM, 2000, GENETICS, V156, P1219; Suh JM, 2007, CELL METAB, V6, P195, DOI 10.1016/j.cmet.2007.08.001; Dodson MV, 2011, J LIPIDS, V2011, DOI 10.1155/2011/721686; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Reis T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001206; Yamamoto-Hino M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001254	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	APR	2015	20	4					358	365		10.1111/gtc.12221		8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CF5AD	WOS:000352565200008		
J	Schoenfelder, S; Furlan-Magaril, M; Mifsud, B; Tavares-Cadete, F; Sugar, R; Javierre, BM; Nagano, T; Katsman, Y; Sakthidevi, M; Wingett, SW; Dimitrova, E; Dimond, A; Edelman, LB; Elderkin, S; Tabbada, K; Darbo, E; Andrews, S; Herman, B; Higgs, A; LeProust, E; Osborne, CS; Mitchell, JA; Luscombe, NM; Fraser, P				Schoenfelder, Stefan; Furlan-Magaril, Mayra; Mifsud, Borbala; Tavares-Cadete, Filipe; Sugar, Robert; Javierre, Biola-Maria; Nagano, Takashi; Katsman, Yulia; Sakthidevi, Moorthy; Wingett, Steven W.; Dimitrova, Emilia; Dimond, Andrew; Edelman, Lucas B.; Elderkin, Sarah; Tabbada, Kristina; Darbo, Elodie; Andrews, Simon; Herman, Bram; Higgs, Andy; LeProust, Emily; Osborne, Cameron S.; Mitchell, Jennifer A.; Luscombe, Nicholas M.; Fraser, Peter			The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements	GENOME RESEARCH			English	Article							NUCLEAR LAMINA INTERACTIONS; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; CHROMOSOME CONFORMATION; MOUSE GENOME; IN-VIVO; HI-C; INTERCHROMOSOMAL ASSOCIATIONS; CHROMATIN INTERACTIONS; HYPERSENSITIVE SITES	The mammalian genome harbors up to one million regulatory elements often located at great distances from their target genes. Long-range elements control genes through physical contact with promoters and can be recognized by the presence of specific histone modifications and transcription factor binding. Linking regulatory elements to specific promoters genome-wide is currently impeded by the limited resolution of high-throughput chromatin interaction assays. Here we apply a sequence capture approach to enrich Hi-C libraries for >22,000 annotated mouse promoters to identify statistically significant, long-range interactions at restriction fragment resolution, assigning long-range interacting elements to their target genes genome-wide in embryonic stem cells and fetal liver cells. The distal sites contacting active genes are enriched in active histone modifications and transcription factor occupancy, whereas inactive genes contact distal sites with repressive histone marks, demonstrating the regulatory potential of the distal elements identified. Furthermore, we find that coregulated genes cluster nonrandomly in spatial interaction networks correlated with their biological function and expression level. Interestingly, we find the strongest gene clustering in ES cells between transcription factor genes that control key developmental processes in embryogenesis. The results provide the first genome-wide catalog linking gene promoters to their long-range interacting elements and highlight the complex spatial regulatory circuitry controlling mammalian gene expression.	[Schoenfelder, Stefan; Furlan-Magaril, Mayra; Javierre, Biola-Maria; Nagano, Takashi; Wingett, Steven W.; Dimitrova, Emilia; Dimond, Andrew; Edelman, Lucas B.; Elderkin, Sarah; Tabbada, Kristina; Osborne, Cameron S.; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England; [Mifsud, Borbala; Tavares-Cadete, Filipe; Darbo, Elodie; Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Mifsud, Borbala; Tavares-Cadete, Filipe; Sugar, Robert; Darbo, Elodie; Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England; [Sugar, Robert] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Katsman, Yulia; Sakthidevi, Moorthy; Mitchell, Jennifer A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Wingett, Steven W.; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Herman, Bram; Higgs, Andy; LeProust, Emily] Agilent Technol, Santa Clara, CA 95051 USA; [Luscombe, Nicholas M.] Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	Fraser, P (reprint author), Babraham Inst, Nucl Dynam Programme, Babraham Res Campus, Cambridge CB22 3AT, England.	nicholas.luscombe@ucl.ac.uk; peter.fraser@babraham.ac.uk	Tavares-Cadete, Filipe/G-4962-2015; 	Tavares-Cadete, Filipe/0000-0002-3782-7170; Fraser, Peter/0000-0002-0041-1227; Mifsud, Borbala/0000-0003-3429-3094	Biotechnology and Biological Science Research Council, UK; Medical Research Council, UK; EU, FP7 Epigenesys Network of Excellence; Canadian Institutes of Health Research; Canada Foundation for Innovation; Ontario Ministry of Research and Innovation	We thank Joana Martins and Anne Segonds-Pichon for expert help with MetaCyte data analyses; Sara Borghi for assistance in 3C library generation; Mikhail Spivakov for critical reading of the manuscript; and members of the Fraser and Luscombe groups for stimulating discussions. This work was supported by the Biotechnology and Biological Science Research Council, UK, the Medical Research Council, UK (P.F.), the EU, FP7 Epigenesys Network of Excellence (N.M.L.), the Canadian Institutes of Health Research, and the Canada Foundation for Innovation and the Ontario Ministry of Research and Innovation (J.A.M.).	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/nmeth.2173, 10.1038/NMETH.2173]; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Drissen R, 2010, BLOOD, V115, P3463, DOI 10.1182/blood-2009-07-232876; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Sagai T, 2009, DEVELOPMENT, V136, P1665, DOI 10.1242/dev.032714; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Gibcus JH, 2013, MOL CELL, V49, P773, DOI [10.1016/j.molcel.2013.02.011, 10.1016/j.molce1.2013.02.011]; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Bender MA, 2001, BLOOD, V98, P2022, DOI 10.1182/blood.V98.7.2022; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Ferreira R, 2013, MOL CELL BIOL, V33, P1254, DOI 10.1128/MCB.01525-12; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; Zhou HY, 2014, GENE DEV, V28, P2699, DOI 10.1101/gad.248526.114	79	17	17	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2015	25	4					582	597		10.1101/gr.185272.114		16	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CE9BU	WOS:000352139200012		
J	Inokawa, S; Watanabe, T; Keino, H; Sato, Y; Hirakata, A; Okada, AA; Fukuda, K; Fukushima, A; Umezawa, K				Inokawa, Sosuke; Watanabe, Takayo; Keino, Hiroshi; Sato, Yasuhiko; Hirakata, Akito; Okada, Annabelle A.; Fukuda, Ken; Fukushima, Atsuki; Umezawa, Kazuo			Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1 beta in human corneal fibroblasts	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						NF-kappa B inhibitor; DHMEQ; Corneal fibroblast; Chemokine; ICAM-1	INTERLEUKIN-1-INDUCED COLLAGEN DEGRADATION; INFLAMED HUMAN CORNEAS; PROINFLAMMATORY CYTOKINES; CELLS; INFLAMMATION; KERATOCYTES; NEUTROPHILS; RECEPTOR; CULTURE; ALPHA	Dehydroxymethylepoxyquinomicin (DHMEQ) is derived from the antibiotic, epoxyquinomicin C, and is a novel low molecular weight nuclear factor-kappa B (NF-kappa B) inhibitor. We investigated the effects of DHMEQ on the expression of chemokines and the intercellular adhesion molecule (ICAM)-1 induced by proinflammatory cytokines in cultures of the human corneal fibroblasts (HCFs). The cytotoxicity of DHMEQ on cultured HCFs was evaluated by cell proliferation assays. Cultures were exposed to interleukin (IL)-1 beta, and the production of IL-8 and monocyte chemoattractant protein (MCP)-1 was assessed by enzyme-linked immunosorbent assay. The degree of expression of ICAM-1 was measured by flow cytometry. The translocation of NF-kappa B p65 into the nucleus of HCFs was assessed by immunocytochemistry. DHMEQ was not toxic to cultured HCFs at doses up to 10 mu g/ml. DHMEQ significantly suppressed the production of both IL-8 and MCP-1 in IL-1 beta-stimulated HCFs. In addition, DHMEQ down-regulated ICAM-1 expression in IL-1 beta-stimulated HCFs in a dose-dependent manner. DHMEQ inhibited the IL-1 beta-induced nuclear accumulation of p65, a component of NF-kappa B, in HCFs. The suppression of inflammatory chemokines IL-8 and MCP-1 and inhibition of the expression of ICAM-1 in cultured HCFs by DHMEQ indicates that DHMEQ may have a therapeutic potential for treating ICAM-1 and chemokine-mediated corneal inflammatory disorders.	[Inokawa, Sosuke; Watanabe, Takayo; Keino, Hiroshi; Hirakata, Akito; Okada, Annabelle A.] Kyorin Univ, Sch Med, Dept Ophthalmol, Mitaka, Tokyo 1818611, Japan; [Inokawa, Sosuke] Hiroshima Univ, Sch Med, Dept Ophthalmol, Hiroshima, Japan; [Sato, Yasuhiko] Kyorin Univ, Sch Med, Div Radioisotope Res, Mitaka, Tokyo 1818611, Japan; [Fukuda, Ken; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol, Kochi, Japan; [Umezawa, Kazuo] Aichi Med Univ, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan	Keino, H (reprint author), Kyorin Univ, Sch Med, Dept Ophthalmol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	keino@eye-center.org			Kyorin University, Tokyo, Japan	This work was supported by Grant for Scientific Research from Kyorin University, Tokyo, Japan.	Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; CORY AH, 1991, CANCER COMMUN, V3, P207; Lu Y, 2005, INVEST OPHTH VIS SCI, V46, P2346, DOI 10.1167/iovs.05-0010; Li Q, 2003, J LEUKOCYTE BIOL, V74, P412, DOI 10.1189/jlb.0801757; Funakoshi T, 2012, J CROHNS COLITIS, V6, P215, DOI 10.1016/j.crohns.2011.08.011; Tran MT, 1996, INVEST OPHTH VIS SCI, V37, P987; Kumagai N, 2000, BIOCHEM BIOPH RES CO, V279, P1, DOI 10.1006/bbrc.2000.3890; Kumagai N, 2005, INVEST OPHTH VIS SCI, V46, P114, DOI 10.1167/iovs.04-0922; Smith RS, 1997, AM J PATHOL, V151, P317; Nishio H, 2014, BRIT J CANCER, V110, P2965, DOI 10.1038/bjc.2014.251; Wakamatsu K, 2005, ARTHRITIS RES THER, V7, pR1348, DOI 10.1186/ar1834; Biswas PS, 2004, J IMMUNOL, V172, P3736; Cardile V, 2010, CELL PHYSIOL BIOCHEM, V25, P543, DOI 10.1159/000303058; Fukuda Ken, 2006, Allergol Int, V55, P121, DOI 10.2332/allergolint.55.121; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; GOLDBERG MF, 1994, OPHTHALMOLOGY, V101, P161; Iwata D, 2009, INVEST OPHTH VIS SCI, V51, P2077; Kondo Y, 2008, INVEST OPHTH VIS SCI, V49, P4850, DOI 10.1167/iovs.08-1897; Kosaka T, 2008, NEPHRON EXP NEPHROL, V110, pE17, DOI 10.1159/000150314; Lu Y, 2006, EXP EYE RES, V83, P560, DOI 10.1016/j.exer.2006.02.008; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Nishimura D, 2006, INT J ONCOL, V29, P713; Spandau UHM, 2003, ARCH OPHTHALMOL-CHIC, V121, P825, DOI 10.1001/archopht.121.6.825; Umezawa K, 2002, MOL CELLS, V14, P163; Xue ML, 2003, INVEST OPHTH VIS SCI, V44, P2020, DOI 10.1167/iovs.02-0565	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	APR	2015	253	4					557	563		10.1007/s00417-014-2879-9		7	Ophthalmology	Ophthalmology	CE9YH	WOS:000352199100008		
J	Ho, H; Ozaki, M; Mizoguchi, T; Perera, SA; Su, DH; He, MG; Wong, TY; Nongpiur, ME; Aung, T				Ho, Henrietta; Ozaki, Mineo; Mizoguchi, Takanori; Perera, Shamira A.; Su, Daniel H.; He, Mingguang; Wong, Tien Y.; Nongpiur, Monisha E.; Aung, Tin			Angle-closure glaucoma in Asians: comparison of biometric and anterior segment parameters between Japanese and Chinese subjects	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Glaucoma; Angle closure; Ethnicity; Anterior segment optical coherence tomography	OPTICAL COHERENCE TOMOGRAPHY; ULTRASOUND BIOMICROSCOPY; UVEAL EFFUSION; POPULATION; PREVALENCE; EYE; ASSOCIATION; SINGAPORE	To compare anterior segment parameters in Chinese and Japanese subjects with angle closure using anterior segment optical coherence tomography (ASOCT). One hundred and forty-two Japanese and one hundred and ninety-two Chinese subjects with primary angle closure (PAC) or primary angle-closure glaucoma (PACG) were recruited. All participants underwent A-scan biometry and ASOCT imaging (Visante, Carl Zeiss Meditec, Dublin, CA, USA). Customized software was used to measure ASOCT parameters in horizontal ASOCT scans. The parameters were compared, and multivariate analysis was performed to determine predictors of angle opening distance at 750 mu m from the scleral spur (AOD750). Ethnic difference evaluated by multiple linear regression adjusted for age, gender, spherical equivalent, pupil diameter, and axial length showed that Japanese angle-closure subjects had significantly shallower anterior chamber depth (ACD;beta = -0.3, p < 0.001), smaller anterior chamber area (ACA; beta = -0.21, p = 0.02) and volume (ACV; beta = -0.19, p = 0.01), greater lens vault (LV, beta = 0.3, p < 0.001), lens thickness (LT; beta = 0.48, p < 0.001), greater iris area (IArea; beta = 0.19, p = 0.01), and more curved iris (ICurv; beta = 0.16, p = 0.04). The significant determinants of AOD750 were iris thickness (IT; beta = -0.21, p = 0.04), ICurv (beta = -0.17, p = 0.04), pupil diameter (PD; beta = -0.34, p = 0.001) and ACV (beta = 0.32, p < 0.001) in Japanese; and IT (beta = -0.25, p = 0.001), ACV (beta = 0.37, p < 0.001), PD (beta = -0.26, p = 0.001), and LV (beta = -0.18, p = 0.03) in Chinese. Compared to Chinese, Japanese angle-closure eyes have smaller and more crowded anterior segment with thicker lenses. ACV, IT, and PD are important factors for angle width in both races. These results suggest possible ethnic differences in angle-closure mechanism(s).	[Ho, Henrietta; Perera, Shamira A.; Su, Daniel H.; Wong, Tien Y.; Nongpiur, Monisha E.; Aung, Tin] Singapore Eye Res Inst, Singapore 168751, Singapore; [Ho, Henrietta; Perera, Shamira A.; Su, Daniel H.; Wong, Tien Y.; Nongpiur, Monisha E.; Aung, Tin] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Ozaki, Mineo] Ozaki Eye Hosp, Hyuga, Japan; [Mizoguchi, Takanori] Mizoguchi Eye Clin, Sasebo, Japan; [He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Nongpiur, Monisha E.; Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	Aung, T (reprint author), Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.	aung.tin@snec.com.sg					Amerasinghe N, 2009, INVEST OPHTH VIS SCI, V50, P2626, DOI 10.1167/iovs.08-2582; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; He MG, 2007, OPHTHALMOLOGY, V114, P1513, DOI 10.1016/j.ophtha.2006.11.032; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105; Sakai H, 2005, OPHTHALMOLOGY, V112, P413, DOI 10.1016/j.ophtha.2004.08.026; Klein BEK, 1998, INVEST OPHTH VIS SCI, V39, P1507; Ang LPK, 2004, OPHTHALMOLOGY, V111, P1636, DOI 10.1016/j.ophtha.2004.01.032; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Kumar RS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1647, DOI 10.1001/archophthalmol.2008.514; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Wang DD, 2012, INVEST OPHTH VIS SCI, V53, P3139, DOI 10.1167/iovs.12-9776; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8672, DOI 10.1167/iovs.11-7480; Marchini G, 1998, OPHTHALMOLOGY, V105, P2091, DOI 10.1016/S0161-6420(98)91132-0; Lee RY, 2012, CURR EYE RES, V37, P486, DOI 10.3109/02713683.2012.669006; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wang DD, 2012, CLIN EXP OPHTHALMOL, V40, P542, DOI 10.1111/j.1442-9071.2011.02746.x	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	APR	2015	253	4					601	608		10.1007/s00417-015-2935-0		8	Ophthalmology	Ophthalmology	CE9YH	WOS:000352199100013		
J	Hirooka, K; Saito, W; Namba, K; Takemoto, Y; Mizuuchi, K; Uno, T; Tagawa, Y; Hashimoto, Y; Ishida, S				Hirooka, Kiriko; Saito, Wataru; Namba, Kenichi; Takemoto, Yuko; Mizuuchi, Kazuomi; Uno, Tomoe; Tagawa, Yoshiaki; Hashimoto, Yuki; Ishida, Susumu			Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Choroidal blood flow velocity; Choroidal thickness; Enhanced depth imaging optical coherence tomography; Laser speckle flowgraphy; Vogt-Koyanagi-Harada disease	LASER SPECKLE FLOWGRAPHY; MICROCIRCULATION; CIRCULATION; REGRESSION; DECREASES; HUMANS	To investigate the relationship between circulation hemodynamics and morphology in the choroid during systemic corticosteroid therapy for patients with Vogt-Koyanagi-Harada (VKH) disease. This retrospective case series includes 18 eyes of nine patients with VKH disease (two men and seven women; average age, 40.8 years) who received systemic corticosteroid therapy. Laser speckle flowgraphy (LSFG) and enhanced-depth imaging optical coherence tomography (EDI-OCT) were performed before treatment and at 1 week and 1 and 3 months after treatment. The average values of the mean blur rate (MBR) at the macula and the central choroidal thickness (CCT) were compared at each stage. The changing rates of the average MBR significantly increased at all examinations after the start of treatment compared with the pre-treatment value with resolution of serous retinal detachment (SRD) (P = 0.0002 for all). The CCT decreased significantly at all examinations after the start of treatment compared with the pre-treatment value (P = 0.0002 for all). Changes in MBR and CCT during the 3-month follow-up period correlated significantly (R = -0.5913, P = 0.0097). The best-corrected visual acuity at pre-treatment correlated significantly with the changing rate of the MBR from 0 to 3 months (R = 0.5944, P = 0.0093) but not with CCT. Our data suggest that circulatory disturbances and increased thickness of the choroid relate to the pathogenesis of VKH disease with link mutually. LSFG is useful as an index for evaluating the choroiditis activity of VKH disease as well as EDI-OCT.	[Hirooka, Kiriko; Saito, Wataru; Namba, Kenichi; Takemoto, Yuko; Mizuuchi, Kazuomi; Uno, Tomoe; Tagawa, Yoshiaki; Hashimoto, Yuki; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; [Saito, Wataru; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Saito, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Kita Ku, Nishi 7,Kita 15, Sapporo, Hokkaido 0608638, Japan.	wsaito@med.hokudai.ac.jp					Aizawa Naoko, 2011, Clin Ophthalmol, V5, P1171, DOI 10.2147/OPTH.S22093; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Hashizume K, 2014, ACTA OPHTHALMOL, V92, pE490, DOI 10.1111/aos.12384; Rao Narsing A., 2007, International Ophthalmology, V27, P81, DOI 10.1007/s10792-006-9029-2; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; SUGIURA S, 1978, JPN J OPHTHALMOL, V22, P9; Nakai K, 2012, GRAEF ARCH CLIN EXP, V250, P1089, DOI 10.1007/s00417-011-1910-7; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; Hashimoto Y, 2014, GRAEFES ARCH CLIN EX, DOI [10.1007/s00417-014-2831-z, DOI 10.1007/S00417-014-2831-Z]; Hirooka K, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-73; Hosoda Y, 2014, AM J OPHTHALMOL, V157, P1056, DOI 10.1016/j.ajo.2014.01.015; Kitaichi N, 2008, GRAEF ARCH CLIN EXP, V246, P1641, DOI 10.1007/s00417-008-0869-5; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P1752; Saito M, 2013, BRIT J OPHTHALMOL, V97, P1083, DOI 10.1136/bjophthalmol-2013-303780; Saito M, 2014, CLIN EXP OPHTHALMOL, V42, P139, DOI 10.1111/ceo.12143; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; Takahashi A, 2014, OCUL IMMUNOL INFLAMM, V22, P409, DOI 10.3109/09273948.2014.902075	24	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	APR	2015	253	4					609	617		10.1007/s00417-014-2927-5		9	Ophthalmology	Ophthalmology	CE9YH	WOS:000352199100014		
J	Oh, S; Shida, T; Yamagishi, K; Tanaka, K; So, R; Tsujimoto, T; Shoda, J				Oh, Sechang; Shida, Takashi; Yamagishi, Kazumasa; Tanaka, Kiyoji; So, Rina; Tsujimoto, Takehiko; Shoda, Junichi			Moderate to Vigorous Physical Activity Volume Is an Important Factor for Managing Nonalcoholic Fatty Liver Disease: A Retrospective Study	HEPATOLOGY			English	Article							WEIGHT-LOSS; OXIDATIVE STRESS; EXERCISE; OBESITY; INFLAMMATION; PREVENTION; NAFLD; STRATEGIES; GUIDELINES; MANAGEMENT	Recently, the beneficial effects of increased physical activity (PA) on nonalcoholic fatty liver disease (NAFLD) in obese subjects were reported. However, the optimal strength and volume of PA in lifestyle modification to improve NAFLD pathophysiology and be recommended as an appropriate management of this condition are unclear. The primary goal of this retrospective study was to estimate the beneficial effects of a varying volume of moderate to vigorous intensity PA (MVPA) on the improvement of NAFLD. A total of 169 obese, middle-aged men were enrolled in a 12-week weight reduction program through lifestyle modification consisting of dietary restrictions plus aerobic exercise. Among these obese subjects, 40 performed MVPA for <150 minwk(-1), 42 performed MVPA for 150-250 minwk(-1), and 87 performed MVPA for >250 minwk(-1). The subjects in the MVPA 250 minwk(-1) group, in comparison with those in the MVPA <250 minwk(-1) group, showed significantly attenuated levels of hepatic steatosis (-31.8% versus -23.2%). This attenuation was likely independent of the detectable weight reduction. MVPA for 250 minwk(-1) in comparison with that for <150 minwk(-1) led to a significant decrease in the abdominal visceral adipose tissue severity (-40.6% versus -12.9%), levels of ferritin (-13.6% versus +1.5%), and lipid peroxidation (-15.1% versus -2.8%), and a significant increase in the adiponectin levels (+17.1% versus +5.6%). In association with these changes, the gene expression levels of sterol regulatory element-binding protein-1c and carnitine palmitoyltransferase-1 in peripheral blood mononuclear cells also significantly decreased and increased, respectively. Conclusion: MVPA for 250 minwk(-1) as part of lifestyle management improves NAFLD pathophysiology in obese men. The benefits seem to be acquired through reducing inflammation and oxidative stress levels and altering fatty acid metabolism. (Hepatology 2015;61:1205-1215)	[Oh, Sechang; Shoda, Junichi] Univ Tsukuba, Fac Med, Div Clin Med, Tsukuba, Ibaraki 3058575, Japan; [Shida, Takashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Programs Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Yamagishi, Kazumasa] Univ Tsukuba, Div Publ Hlth Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Tanaka, Kiyoji; So, Rina; Tsujimoto, Takehiko] Univ Tsukuba, Fac Hlth & Sports Sci, Div Sports Med, Tsukuba, Ibaraki 3058575, Japan	Shoda, J (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shodaj@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24390488, 25282212, 25282172, 25293278, 26282191, 26293297, 26670109]	Supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (nos. 24390488,25282212, 25282172, 25293278, 26282191, 26293297, and 26670109).	Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Oh S, 2014, METAB SYNDR RELAT D, V12, P290, DOI 10.1089/met.2013.0143; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Rector RS, 2011, J APPL PHYSIOL, V111, P1828, DOI 10.1152/japplphysiol.00384.2011; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Aigner E, 2008, AM J CLIN NUTR, V87, P1374; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Day CP, 2006, CLIN MED, V6, P19; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Oh S, 2013, MED SCI SPORT EXER, V45, P2214, DOI 10.1249/MSS.0b013e31829afc33; Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488; Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790; Bae JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046819; Bouwens M, 2010, AM J CLIN NUTR, V91, P208, DOI 10.3945/ajcn.2009.28586; Johnson NA, 2012, SEMIN LIVER DIS, V32, P65, DOI 10.1055/s-0032-1306427; Kim SY, 2010, KAPHED, V49, P419; Lemasters JJ, 2009, LIVER BIOL PATHOBIOL, P511, DOI 10.1002/9780470747919.ch33; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; StsGeorge A, 2009, HEPATOLOGY, V50, P68; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365	36	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	APR	2015	61	4					1205	1215		10.1002/hep.27544		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE8NM	WOS:000352099700017		
J	Nagahashi, M; Takabe, K; Liu, RP; Peng, KS; Wang, X; Wang, Y; Hait, NC; Wang, X; Allegood, JC; Yamada, A; Aoyagi, T; Liang, J; Pandak, WM; Spiegel, S; Hylemon, PB; Zhou, HP				Nagahashi, Masayuki; Takabe, Kazuaki; Liu, Runping; Peng, Kesong; Wang, Xiang; Wang, Yun; Hait, Nitai C.; Wang, Xuan; Allegood, Jeremy C.; Yamada, Akimitsu; Aoyagi, Tomoyoshi; Liang, Jie; Pandak, William M.; Spiegel, Sarah; Hylemon, Phillip B.; Zhou, Huiping			Conjugated Bile Acid-Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression	HEPATOLOGY			English	Article							FATTY LIVER-DISEASE; FEEDBACK-REGULATION; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; PATHWAYS; URSODEOXYCHOLATE; LIPOTOXICITY; HEPATOCYTES	Bile acids are important hormones during the feed/fast cycle, allowing the liver to coordinately regulate nutrient metabolism. How they accomplish this has not been fully elucidated. Conjugated bile acids activate both the ERK1/2 and AKT signaling pathways via sphingosine 1-phosphate receptor 2 (S1PR2) in rodent hepatocytes and in vivo. Here, we report that feeding mice a high-fat diet, infusion of taurocholate into the chronic bile fistula rat, or overexpression of the gene encoding S1PR2 in mouse hepatocytes significantly upregulated hepatic sphingosine kinase 2 (SphK2) but not SphK1. Key genes encoding nuclear receptors/enzymes involved in nutrient metabolism were significantly downregulated in livers of S1PR2(-/-) and SphK2(-/-) mice. In contrast, overexpression of the gene encoding S1PR2 in primary mouse hepatocytes differentially increased SphK2, but not SphK1, and mRNA levels of key genes involved in nutrient metabolism. Nuclear levels of sphingosine-1-phosphate, an endogenous inhibitor of histone deacetylases 1 and 2, as well as the acetylation of histones H3K9, H4K5, and H2BK12 were significantly decreased in hepatocytes prepared from S1PR2(-/-) and SphK2(-/-) mice. Conclusion: Both S1PR2(-/-) and SphK2(-/-) mice rapidly developed fatty livers on a high-fat diet, suggesting the importance of conjugated bile acids, S1PR2, and SphK2 in regulating hepatic lipid metabolism. (Hepatology 2015;61:1216-1226)	[Nagahashi, Masayuki; Takabe, Kazuaki; Yamada, Akimitsu; Aoyagi, Tomoyoshi] Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23298 USA; [Nagahashi, Masayuki; Takabe, Kazuaki; Hait, Nitai C.; Allegood, Jeremy C.; Yamada, Akimitsu; Aoyagi, Tomoyoshi; Liang, Jie; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Nagahashi, Masayuki] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan; [Liu, Runping; Peng, Kesong; Wang, Xiang; Wang, Yun; Wang, Xuan; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Liu, Runping; Wang, Yun; Wang, Xuan; Pandak, William M.; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	Takabe, K (reprint author), Virginia Commonwealth Univ, Dept Surg, POB 980011, Richmond, VA 23298 USA.	ktakabe@vcu.edu; hylemon@vcu.edu; hzhou@vcu.edu			National Institutes of Health [R01 DK-057543-11, R37GM043880, R01CA160688]; VA Merit Award; National Science Foundation of China [81070245, 81270489]	Supported by National Institutes of Health grants R01 DK-057543-11 (to P.B.H., H.Z., and K.T.), R37GM043880 (to S.S.), and R01CA160688 (to K.T.); a VA Merit Award (to H.Z. and W.M.P.); and National Science Foundation of China grants 81070245 and 81270489 (to H.Z.). M.N. was a Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad.	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Almeda-Valdes P, 2009, ANN HEPATOL, V8, pS18; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Smith Z, 2013, MOL CELL ENDOCRINOL, V368, P59, DOI 10.1016/j.mce.2012.04.008; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Polyzos SA, 2009, CURR MOL MED, V9, P299; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Malaguarnera M, 2009, J MOL MED-JMM, V87, P679, DOI 10.1007/s00109-009-0464-1; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; HEUMAN DM, 1988, HEPATOLOGY, V8, P358, DOI 10.1002/hep.1840080228; HEUMAN DM, 1991, HEPATOLOGY, V14, P920, DOI 10.1002/hep.1840140527; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Wang Y, 2013, HEPATOLOGY, V57, P1005, DOI 10.1002/hep.26107; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, pe521; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, pe560	38	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	APR	2015	61	4					1216	1226		10.1002/hep.27592		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE8NM	WOS:000352099700018		
J	Inaba, Y; Furutani, T; Kimura, K; Watanabe, H; Haga, S; Kido, Y; Matsumoto, M; Yamamoto, Y; Harada, K; Kaneko, S; Oyadomari, S; Ozaki, M; Kasuga, M; Inoue, H				Inaba, Yuka; Furutani, Tomoko; Kimura, Kumi; Watanabe, Hitoshi; Haga, Sanae; Kido, Yoshiaki; Matsumoto, Michihiro; Yamamoto, Yasuhiko; Harada, Kenichi; Kaneko, Shuichi; Oyadomari, Seiichi; Ozaki, Michitaka; Kasuga, Masato; Inoue, Hiroshi			Growth Arrest and DNA Damage-Inducible 34 Regulates Liver Regeneration in Hepatic Steatosis in Mice	HEPATOLOGY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; OXIDATIVE STRESS; INSULIN ACTION; IN-VIVO; DEPHOSPHORYLATION; METABOLISM; PHOSPHORYLATION; HEPATECTOMY; SUPPRESSION	The liver has robust regenerative potential in response to damage, but hepatic steatosis (HS) weakens this potential. We found that the enhanced integrated stress response (ISR) mediated by phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2) impairs regeneration in HS and that growth arrest and DNA damage-inducible 34 (Gadd34)-dependent suppression of ISR plays a crucial role in fatty liver regeneration. Although mice fed a high-fat diet for 2 weeks developed moderate fatty liver with no increase in eIF2 phosphorylation before 70% hepatectomy, they showed impaired liver regeneration as a result of reduced proliferation and increased death of hepatocytes with increased phosphorylation of eIF2 and ISR. An increased ISR through Gadd34 knockdown induced C/EBP homologous protein (CHOP)-dependent apoptosis and receptor-interacting protein kinase 3-dependent necrosis, resulting in increased hepatocyte death during fatty liver regeneration. Furthermore, Gadd34 knockdown and increased phosphorylation of eIF2 decreased cyclin D1 protein and reduced hepatocyte proliferation. In contrast, enhancement of Gadd34 suppressed phosphorylation of eIF2 and reduced CHOP expression and hepatocyte apoptosis without affecting hepatocyte proliferation, clearly improving fatty liver regeneration. In more severe fatty liver of leptin receptor-deficient db/db mice, forced expression of hepatic Gadd34 also promoted hepatic regeneration after hepatectomy. Conclusion: Gadd34-mediated regulation of ISR acts as a physiological defense mechanism against impaired liver regeneration resulting from steatosis and is thus a possible therapeutic target for impaired regeneration in HS. (Hepatology 2015;61:1343-1356)	[Inaba, Yuka; Furutani, Tomoko; Kimura, Kumi; Watanabe, Hitoshi; Inoue, Hiroshi] Kanazawa Univ, Dept Physiol & Metab, Brain Liver Interface Med Res Ctr, Kanazawa, Ishikawa 9208641, Japan; [Haga, Sanae; Ozaki, Michitaka] Hokkaido Univ, Grad Sch Hlth Sci, Lab Mol & Funct Bioimaging, Sapporo, Hokkaido, Japan; [Kido, Yoshiaki] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan; [Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Div Analyt Biomed Sci, Kobe, Hyogo 657, Japan; [Matsumoto, Michihiro] Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Metab Regulat, Diabet Res Ctr, Tokyo, Japan; [Yamamoto, Yasuhiko] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa 9208641, Japan; [Harada, Kenichi] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9208641, Japan; [Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Kasuga, Masato] Natl Ctr Global Hlth & Med, Tokyo, Japan	Inoue, H (reprint author), Kanazawa Univ, Dept Physiol & Metab, Brain Liver Interface Med Res Ctr, Coll Med Pharmaceut & Hlth Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	inoue-h@staff.kana-zawa-u.ac.jp			JSPS KAKENHI [25126709, 26282022, 26670599, 25861179]; Daininaika-Doumonkai	This work was supported by JSPS KAKENHI (grant nos 25126709, 26282022, and 26670599 [to H.I] and 25861179 [to Y.I.] and by the Daininaika-Doumonkai (grant to H.I.).	Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; desMeijer VE, 2010, BRIT J SURG, V97, P1331; Hamano M., 2013, J GASTROENTEROL, V49, P305, DOI [10.1007/s00535-013-0780-787, DOI 10.1007/S00535-013-0780-787]; Kimura K, 2013, DIABETES, V62, P2266, DOI 10.2337/db12-1701; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Truant S, 2013, ANN SURG, V258, P696, DOI 10.1097/SLA.0b013e3182a61a22; Truant S, 2013, ANN SURG, V258, P702; Vetelainen R, 2007, ANN SURG, V245, P44, DOI 10.1097/01.sla.0000225253.84501.0e	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	APR	2015	61	4					1343	1356		10.1002/hep.27619		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE8NM	WOS:000352099700029		
J	Suzuki, S; Bowman, BN; Ozaki, Y; Mitsunaga, S; Inoko, H; Ranade, S; Shiina, T				Suzuki, Shingo; Bowman, Brett N.; Ozaki, Yuki; Mitsunaga, Shigeki; Inoko, Hidetoshi; Ranade, Swati; Shiina, Takashi			APPLICATION OF SINGLE MOLECULE REAL-TIME (SMRT) SEQUENCING TECHNOLOGY FOR THE FIELD 4 LEVEL GENOTYPING OF CLASSICAL HLA LOCI	HUMAN IMMUNOLOGY			English	Meeting Abstract	40th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI)	OCT 20-24, 2014	Denver, CO	Amer Soc Histocompatibil & Immunogenet					[Suzuki, Shingo; Ozaki, Yuki; Mitsunaga, Shigeki; Inoko, Hidetoshi; Shiina, Takashi] Tokai Univ, Sch Med, Kanagawa 2591100, Japan; [Bowman, Brett N.; Ranade, Swati] Pacific Biosci, Menlo Pk, CA USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	APR	2015	76	4				LBP04	214	214				1	Immunology	Immunology	CF7PS	WOS:000352749400008		
J	Miyadera, H; Kitamura, T; Mizokami, M; Tokunaga, K				Miyadera, Hiroko; Kitamura, Toshio; Mizokami, Masashi; Tokunaga, Katsushi			HLA-PEPTIDE BINDING ANALYSIS BY THE CELL-SURFACE EXPRESSINO ASSAY	HUMAN IMMUNOLOGY			English	Meeting Abstract	40th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI)	OCT 20-24, 2014	Denver, CO	Amer Soc Histocompatibil & Immunogenet					[Miyadera, Hiroko; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Chiba, Japan; [Miyadera, Hiroko; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	APR	2015	76	4				LBP18	225	225				1	Immunology	Immunology	CF7PS	WOS:000352749400022		
J	Gealow, JC; Motomura, M				Gealow, Jeffrey C.; Motomura, Masato			Introduction to the Special Issue on the 2014 Symposium on VLSI Circuits	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Editorial Material									[Gealow, Jeffrey C.] Analog Devices Inc, Commun Div, Wilmington, MA 01887 USA; [Motomura, Masato] Hokkaido Univ, Sapporo, Hokkaido, Japan	Gealow, JC (reprint author), Analog Devices Inc, Commun Div, Wilmington, MA 01887 USA.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	APR	2015	50	4			SI		812	813		10.1109/JSSC.2014.2388082		2	Engineering, Electrical & Electronic	Engineering	CE9HX	WOS:000352156000001		
J	Liang, J; Jalali, MS; Sheikholeslami, A; Kibune, M; Tamura, H				Liang, Joshua; Jalali, Mohammad Sadegh; Sheikholeslami, Ali; Kibune, Masaya; Tamura, Hirotaka			On-Chip Measurement of Clock and Data Jitter With Sub-Picosecond Accuracy for 10 Gb/s Multilane CDRs	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Clock and data recovery; CDR; jitter; jitter measurement; on-chip measurement	CMOS; CIRCUITS; NOISE; TIME	On-chip jitter measurement can be used to optimize the performance of wireline transceivers. In this work, the jitter of random data is measured on-chip by correlating the phase detector outputs from two adjacent CDR lanes. This allows the jitter's auto-correlation function to be estimated, from which the jitter's RMS value and power spectral density are extracted without using any external reference clock. The RMS value of random jitter ranging from 0.85 ps to 1.89 ps, and sinusoidal jitter from 0.89 ps to 5.1 ps is measured in PRBS31 data with less than 0.6 ps of error compared to measurements by an 80 GS/s real-time oscilloscope. Correlating the phase detectors in the CDRs with a third phase detector, which measures the phase difference between the clocks recovered by the two CDRs, allows measurement of the recovered clock jitter. Sinusoidal jitter from 1.8 ps to 5.3 ps is measured in the recovered clock with an error of less than 1 ps.	[Liang, Joshua; Jalali, Mohammad Sadegh; Sheikholeslami, Ali] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Kibune, Masaya; Tamura, Hirotaka] Fujitsu Labs Ltd, Kawasaki, Kanagawa 211, Japan	Liang, J (reprint author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.				NSERC	The authors would like to thank CMC Microsystems for providing test equipment and CAD tools and NSERC for partial funding.	Alon E, 2005, IEEE J SOLID-ST CIRC, V40, P820, DOI 10.1109/JSSC.2004.842853; Analui B, 2005, IEEE J SOLID-ST CIRC, V40, P2689, DOI 10.1109/JSSC.2005.856576; Demir A, 2000, IEEE T CIRCUITS-I, V47, P655, DOI 10.1109/81.847872; Ono G, 2011, IEEE J SOLID-ST CIRC, V46, P3101, DOI 10.1109/JSSC.2011.2168869; Hashimoto T, 2008, 2008 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P166, DOI 10.1109/VLSIC.2008.4585992; Ishida M, 2007, IEEE RAD FREQ INTEGR, P347, DOI 10.1109/RFIC.2007.380898; Ishida M., 2005, ISSCC FEB, P512, DOI 10.1109/ISSCC.2005.1494094; Jenkins KA, 2007, IEEE CUST INTEGR CIR, P157, DOI 10.1109/CICC.2007.4405703; Lee BJ, 2003, IEEE J SOLID-ST CIRC, V38, P1821, DOI 10.1109/JSSC.2003.818290; Lee DC, 2002, IEEE T CIRCUITS-II, V49, P704, DOI 10.1109/TCSII.2002.807265; Leon-Garcia A., 2008, PROBABILITY STAT RAN; Liang J., 2014, IEEE S VLSI CIRC, pC114; Napolitano A., 2012, GEN CYCLOSTATIONARY; Niitsu K, 2012, IEEE J SOLID-ST CIRC, V47, P2701, DOI 10.1109/JSSC.2012.2211655; Nose K, 2006, IEEE J SOLID-ST CIRC, V41, P2911, DOI 10.1109/JSSC.2006.884402; Rezayee A, 2003, ESSCIRC 2003: PROCEEDINGS OF THE 29TH EUROPEAN SOLID-STATE CIRCUITS CONFERENCE, P683, DOI 10.1109/ESSCIRC.2003.1257227; Schaub JD, 2008, PROC EUR SOLID-STATE, P126, DOI 10.1109/ESSCIRC.2008.4681808; Stoica P, 1997, INTRO SPECTRAL ANAL; Toifl T, 2006, IEEE J SOLID-ST CIRC, V41, P954, DOI 10.1109/JSSC.2006.870898	19	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	APR	2015	50	4			SI		845	855		10.1109/JSSC.2014.2378280		11	Engineering, Electrical & Electronic	Engineering	CE9HX	WOS:000352156000004		
J	Yoshioka, K; Saito, R; Danjo, T; Tsukamoto, S; Ishikuro, H				Yoshioka, Kentaro; Saito, Ryo; Danjo, Takumi; Tsukamoto, Sanroku; Ishikuro, Hiroki			Dynamic Architecture and Frequency Scaling in 0.8-1.2 GS/s 7 b Subranging ADC	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Binary search ADC; dynamic architecture and frequency scaling (DAFS); flash ADC; high-speed; power scaling; subranging ADC	NM DIGITAL CMOS	Dynamic Architecture and Frequency Scaling (DAFS) is shown to realize superlinear power scaling in high-speed analog-to-digital converters (ADCs). To achieve both high-speed operation and low power consumption, the ADC architecture is reconfigured between binary search and flash every clock cycle, relying on the conversion delay. The proposed binary search/flash architecture reconfigurable ADC can be implemented with only a small modification to conventional binary search ADCs. By live configuring, the flash operation is adaptively performed when an excess delay is detected. DAFS not only significantly improves the power scaling but also compensates for transistor speed shifts due to process, voltage and temperature (PVT) variations. Therefore, DAFS can be used to improve the design margin of high-speed ADCs. A prototype subranging ADC fabricated in 65 nm CMOS technology operates up to 1220 MS/s and achieves an SNDR of 36.2 dB with a Nyquist input frequency. DAFS is active between 820-1220 MS/s and achieves peak power reduction of 30%, when compared with the power scaling when DAFS is disabled. A peak FoM of 85 fJ/conv. was obtained at 820 MS/s, which is nearly a twofold improvement over that of previously reported subranging ADCs.	[Yoshioka, Kentaro] Toshiba Co Ltd, Wireless Res Lab, Kawasaki, Kanagawa 2128582, Japan; [Saito, Ryo; Ishikuro, Hiroki] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan; [Danjo, Takumi; Tsukamoto, Sanroku] Fujitsu Labs Ltd, Kawasaki, Kanagawa 2118588, Japan	Yoshioka, K (reprint author), Toshiba Co Ltd, Wireless Res Lab, Kawasaki, Kanagawa 2128582, Japan.	yoshioka@iskr.elec.keio.ac.jp					Verbruggen B, 2009, IEEE J SOLID-ST CIRC, V44, P874, DOI 10.1109/JSSC.2009.2012449; Verbruggen B, 2010, IEEE J SOLID-ST CIRC, V45, P2080, DOI 10.1109/JSSC.2010.2061611; [Anonymous], 2012, 80211AD2012 IEEE; [Anonymous], 2013, 80211AC2013 IEEE; PELGROM MJM, 1989, IEEE J SOLID-ST CIRC, V24, P1433, DOI 10.1109/JSSC.1989.572629; Asada Yusuke, 2009, Proceedings of Technical Papers. 2009 IEEE Asian Solid-State Circuits Conference (A-SSCC 2009), DOI 10.1109/ASSCC.2009.5357198; Chung YH, 2015, IEEE T VLSI SYST, V23, P557, DOI 10.1109/TVLSI.2014.2312211; Kull L, 2013, IEEE J SOLID-ST CIRC, V48, P3049, DOI 10.1109/JSSC.2013.2279571; Ohhata Kenichi, 2012, Proceedings of the 2012 IEEE Asian Solid State Circuits Conference (A-SSCC); Proesel J., 2010, P IEEE CUST INT CIRC; SUMANEN L, 2002, P ISCAS, V5, P157; Van der Plas G, 2008, IEEE J SOLID-ST CIRC, V43, P2631, DOI 10.1109/JSSC.2008.2006315; Yang XC, 2014, IEEE T CIRCUITS-I, V61, P2272, DOI 10.1109/TCSI.2014.2333679; Yoshioka K., IEEE T VERY LARGE SC, DOI [10.1109/TVLSI.2014.2307433, DOI 10.1109/TVLSI.2014.2307433]; Yoshioka K., 2014, S IEEE VLSI CIRCUITS, P36	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	APR	2015	50	4			SI		932	945		10.1109/JSSC.2014.2387191		14	Engineering, Electrical & Electronic	Engineering	CE9HX	WOS:000352156000011		
J	Okura, S; Nishikido, O; Sadanaga, Y; Kosaka, Y; Araki, N; Ueda, K; Morishita, F				Okura, Shunsuke; Nishikido, Osamu; Sadanaga, Yusuke; Kosaka, Yasuhiro; Araki, Norihiko; Ueda, Kazuhiro; Morishita, Fukashi			A 3.7 M-Pixel 1300-fps CMOS Image Sensor With 5.0 G-Pixel/s High-Speed Readout Circuit	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Analog-digital integrated circuits; circuit noise; CMOS image sensors; CMOS integrated circuits; CMOSFET circuits; mixed analog digital integrated circuits; sampled data circuits; switched capacitor circuits; very high speed integrated circuits		A 5.0 G-pixel/s readout circuit for 15.3 mm x 8.6 mm optical size, 3.7 M-pixel, 1300 fps, and digital output image sensor for industrial applications is presented. With the column parallel ADC, the speed bottleneck is the vertical analog readout. To achieve a 5.0 G-pixel/s readout rate, a high speed column readout circuit is introduced. The novel pixel readout with the slew-enhancement and the time-interleaved correlated double sampling circuit is introduced to increase the readout rate. Besides, the A/D converter with the delay-and-gray code counter and the distributed digital data transfer schemes are innovated in order to reduce the noise interference to the foreground analog signal settling. The 1 horizontal (1H) readout time is 1.0 mu s.	[Okura, Shunsuke; Nishikido, Osamu; Sadanaga, Yusuke; Kosaka, Yasuhiro; Araki, Norihiko; Ueda, Kazuhiro; Morishita, Fukashi] Renesas Elect Corp, Itami, Hyogo 6640005, Japan	Okura, S (reprint author), Renesas Elect Corp, Itami, Hyogo 6640005, Japan.	shunsuke.okura.fz@renesas.com					Gray F., 1947, U. S. Patent, Patent No. [2,632,058, 2632058]; Guidash R., 1997, EL DEV M 1997 INT IE, P927; Hamamoto T., 2001, IEEE CCD AIS, V1, P165; Honda H., 2013, 2013 S VLSI CIRC VLS, P12; Kagawau K., 2008, 2008 IEEE INT SOL ST, P595; Kleinfelder S, 2001, IEEE J SOLID-ST CIRC, V36, P2049, DOI 10.1109/4.972156; Krymski AI, 2003, IEEE T ELECTRON DEV, V50, P136, DOI 10.1109/TED.2002.806958; Matsuzawa A., 2006, Japanese Patent, Patent No. [2008-92091 A, 200892091]; Okura S., 2014, 2014 S VLSI CIRC JUN, P10; Roel A., 2007, IEEE IM SENS WORKSH, P10; Takahashi H, 2007, IEEE J SOLID-ST CIRC, V42, P2960, DOI 10.1109/JSSC.2007.908719; Takahashi T., 2011, 2011 Symposium on VLSI Circuits. Digest of Technical Papers; Takayanagi I, 2005, IEEE J SOLID-ST CIRC, V40, P2305, DOI 10.1109/JSSC.2005.857375; Toyama T, 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), DOI 10.1109/ISSCC.2011.5746379; Watabe T., 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), DOI 10.1109/ISSCC.2012.6177047	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	APR	2015	50	4			SI		1016	1024		10.1109/JSSC.2014.2387201		9	Engineering, Electrical & Electronic	Engineering	CE9HX	WOS:000352156000017		
J	Arrue, J; Illarramendi, MA; Ayesta, I; Jimenez, F; Zubia, J; Tagaya, A; Koike, Y				Arrue, J.; Illarramendi, M. A.; Ayesta, I.; Jimenez, F.; Zubia, J.; Tagaya, A.; Koike, Y.			Laser-Like Performance of Side-Pumped Dye-Doped Polymer Optical Fibers	IEEE PHOTONICS JOURNAL			English	Article						Amplified spontaneous emission; doped polymer optical fibers; organic dyes	AMPLIFIERS; ILLUMINATION; POWER	Mirrorless graded-index polymer optical fibers doped with the organic dye rhodamine 6G result in very compact broadband fiber lasers in the visible region when pumped from the side. The emission spectrum, threshold, and efficiency obtained on both fiber ends depend on the lengths of the directly illuminated region and of the non-excited ones. The paper analyzes such parameters both experimentally and theoretically for the first time.	[Arrue, J.; Zubia, J.] Univ Basque Country, Dept Commun Engn, Escuela Tecn Super Ingn Bilbao, UPV EHU, Bilbao 48013, Spain; [Illarramendi, M. A.] Univ Basque Country, Dept Appl Phys 1, Escuela Tecn Super Ingn Bilbao, UPV EHU, Bilbao 48013, Spain; [Ayesta, I.; Jimenez, F.] Univ Basque Country, Dept Appl Math, Escuela Tecn Super Ingn Bilbao, UPV EHU, Bilbao 48013, Spain; [Tagaya, A.; Koike, Y.] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2230061, Japan	Jimenez, F (reprint author), Univ Basque Country, Dept Appl Math, Escuela Tecn Super Ingn Bilbao, UPV EHU, Bilbao 48013, Spain.	felipe.jimenez@ehu.es	Koike, Yasuhiro /G-2104-2014; Ayesta Ereno, Igor/H-8945-2015	Ayesta Ereno, Igor/0000-0002-1520-7640			Aiestaran P, 2009, SENSORS-BASEL, V9, P3790, DOI 10.3390/s90503790; Amarasinghe D, 2009, P IEEE, V97, P1637, DOI 10.1109/JPROC.2009.2023250; Kuriki K, 2000, APPL PHYS LETT, V77, P331, DOI 10.1063/1.126967; Xia RD, 2003, ORG ELECTRON, V4, P165, DOI 10.1016/j.orgel.2003.08.009; Clark J, 2010, NAT PHOTONICS, V4, P438, DOI [10.1038/NPHOTON.2010.160, 10.1038/nphoton.2010.160]; Zubia J, 2001, OPT FIBER TECHNOL, V7, P101, DOI 10.1006/ofte.2000.0355; Arrue J, 2011, POLYMERS-BASEL, V3, P1162, DOI 10.3390/polym3031162; Arrue J, 2010, IEEE PHOTONICS J, V2, P521, DOI 10.1109/JPHOT.2010.2050196; Ayesta I, 2011, J LIGHTWAVE TECHNOL, V29, P2629, DOI 10.1109/JLT.2011.2162102; Ayesta I, 2012, J LIGHTWAVE TECHNOL, V30, P3367, DOI 10.1109/JLT.2012.2218216; Bazzana L., 2001, P 16 INT PLAST OPT F, P327; Charas Ana, 2010, Frontiers of Optoelectronics in China, V3, DOI 10.1007/s12200-009-0092-y; Clark J, 2008, J NANOPHOTONICS, V2, DOI 10.1117/1.2902341; De la Rosa-Cruz E, 2001, FIBER INTEGRATED OPT, V20, P457, DOI 10.1080/014680301750413412; Digonnet M. J. F., 1993, RARE EARTH DOPED FIB; Illarramendi M. A., 2014, P SOC PHOTO-OPT INS, V8983; Illarramendi M. A., 2013, OPT EXP, V21, p24 254; Ishigure T, 2002, J LIGHTWAVE TECHNOL, V20, P1449, DOI 10.1109/JLT.2002.801133; Kruhlak RJ, 1999, J OPT SOC AM B, V16, P1749, DOI 10.1364/JOSAB.16.001749; Kuzyk M. G., 2007, POLYM FIBER OPTICS M; Muto S., 1987, Transactions of the Institute of Electronics, Information and Communication Engineers E, VE70; TAGAYA A, 1995, IEEE J QUANTUM ELECT, V31, P2215, DOI 10.1109/3.477749; Tagaya A, 1997, APPL OPTICS, V36, P572, DOI 10.1364/AO.36.000572	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	APR	2015	7	2							7100611	10.1109/JPHOT.2015.2406073		11	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CF0ZU	WOS:000352274100024		
J	Iguchi, S; Yeon, P; Fuketa, H; Ishida, K; Sakurai, T; Takamiya, M				Iguchi, Shunta; Yeon, Pyungwoo; Fuketa, Hiroshi; Ishida, Koichi; Sakurai, Takayasu; Takamiya, Makoto			Wireless Power Transfer With Zero-Phase-Difference Capacitance Control	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Magnetic resonance; power amplifier; wireless power transmission; zero-phase-difference capacitance control	COUPLED RESONATORS; TRANSFER SYSTEMS; TRANSMISSION; ADAPTATION; CONVERTER; DESIGN	Wireless power transfer enables the frequent and ubiquitous charging of electronic devices. However, the variation of the efficiency and the received power with the transmission distance is an outstanding issue. To solve the problem of efficiency degradation of the magnetic resonance at short distances, zero-phase-difference capacitance control (ZPDCC), which is suitable for integration in large scale integrations (LSIs) is proposed in this paper. The proposed ZPDCC achieves adaptive capacitance control by a newly proposed control algorithm with a current-sensing circuit to control variable capacitors at a fixed frequency. Additionally, a theoretical analysis of the total DC-DC power transmission efficiency including a power amplifier, coupled resonators, and a rectifier is demonstrated in this paper. The analysis indicates that the frequency (and capacitance) splitting of is mainly due to the power amplifier; additionally, the efficiency of the power amplifier is maximized at the split peaks when the transmission distance is short. A wireless power transfer system in magnetic resonance with ZPDCC is fabricated in a 3.3 V, 180 nm CMOS. By introducing ZPDCC, the measured at 13.56 MHz increases 1.7 times from 16% to 27% at d = 2.5 mm.	[Iguchi, Shunta; Yeon, Pyungwoo; Fuketa, Hiroshi; Ishida, Koichi; Sakurai, Takayasu; Takamiya, Makoto] Univ Tokyo, Tokyo 1538505, Japan; [Ishida, Koichi] Tech Univ Dresden, D-01069 Dresden, Germany	Iguchi, S (reprint author), Univ Tokyo, Tokyo 1538505, Japan.	shiguchi@iis.u-tokyo.ac.jp			Renesas Electronics Corporation	This work was supported in part by Renesas Electronics Corporation.	Thomas EM, 2012, IEEE T CIRCUITS-I, V59, P2125, DOI 10.1109/TCSI.2012.2185295; Baker MW, 2007, IEEE T BIOMED CIRC S, V1, P28, DOI 10.1109/TBCAS.2007.893180; Ahn D, 2014, IEEE T IND ELECTRON, V61, P2225, DOI 10.1109/TIE.2013.2273472; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Inagaki N, 2014, IEEE T MICROW THEORY, V62, P901, DOI 10.1109/TMTT.2014.2300033; [Anonymous], WID ULTR LOW NOIS VO; Villa JL, 2012, IEEE T IND ELECTRON, V59, P945, DOI 10.1109/TIE.2011.2161055; Staszewski RB, 2006, IEEE T CIRCUITS-II, V53, P220, DOI 10.1109/TCSII.2005.858754; Casanova JJ, 2009, IEEE T CIRCUITS-II, V56, P830, DOI 10.1109/TCSII.2009.2032465; [Anonymous], VIRT MULT SIM SPECTR; Chen QH, 2009, IEEE T BIOMED CIRC S, V3, P23, DOI 10.1109/TBCAS.2008.2006492; Park J, 2011, IEEE T ANTENN PROPAG, V59, P1769, DOI 10.1109/TAP.2011.2123061; Wang GX, 2005, IEEE T CIRCUITS-I, V52, P2109, DOI 10.1109/TCSI.2005.852923; Ahn D, 2014, IEEE T IND ELECTRON, V61, P1193, DOI 10.1109/TIE.2013.2257151; Sample AP, 2011, IEEE T IND ELECTRON, V58, P544, DOI 10.1109/TIE.2010.2046002; Beh TC, 2013, IEEE T IND ELECTRON, V60, P3689, DOI 10.1109/TIE.2012.2206337; [Anonymous], FREQ ALL AM SAT SERV; Moradewicz AJ, 2010, IEEE T IND ELECTRON, V57, P3181, DOI 10.1109/TIE.2010.2051395; Awai I., 2012, P IEEE IMWS IWPT MAY, P105; Brown W. C., 1964, P IRE INT CONV REC M, V12, P8; Ha S., 2014, IEEE S VLSI C IRC PA, P66; Iguchi S, 2013, 2013 IEEE WIRELESS POWER TRANSFER (WPT), P25; Jong G., 1998, IEEE T POWER ELECTR, V13, P1013; Li X., 2014, IEEE S VLSI CIRC JUN, P28; Mori K, 2012, IEEE ANTENN WIREL PR, V11, P1710, DOI 10.1109/LAWP.2013.2239600; Moriwaki Y., 2011, P IEEE 33 INT TEL EN, P1; Narusue Y., 2013, P IEEE RWS JAN, P20; Ogawa K., 2012, P IEEE IMWS IWPT MAY, P155; Salem L., 2014, IEEE INT SOL STAT CI, P88; Sasaki K, 2014, IEEE T MICROW THEORY, V62, P892, DOI 10.1109/TMTT.2013.2280130	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	APR	2015	62	4					938	947		10.1109/TCSI.2015.2388832		10	Engineering, Electrical & Electronic	Engineering	CF1FI	WOS:000352288800002		
J	Ishibuchi, H; Akedo, N; Nojima, Y				Ishibuchi, Hisao; Akedo, Naoya; Nojima, Yusuke			Behavior of Multiobjective Evolutionary Algorithms on Many-Objective Knapsack Problems	IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTATION			English	Article						Evolutionary many-objective optimization; evolutionary multiobjective optimization (EMO); many-objective problems	NONDOMINATED SORTING APPROACH; OPTIMIZATION PROBLEMS; LOCAL SEARCH; NSGA-II; HYPERVOLUME; PERFORMANCE; DECOMPOSITION; DISTANCE; CONSTRAINTS; DOMINANCE	We examine the behavior of three classes of evolutionary multiobjective optimization (EMO) algorithms on many-objective knapsack problems. They are Pareto dominance-based, scalarizing function-based, and hypervolume-based algorithms. NSGA-II, MOEA/D, SMS-EMOA, and HypE are examined using knapsack problems with 2-10 objectives. Our test problems are generated by randomly specifying coefficients (i.e., profits) in objectives. We also generate other test problems by combining two objectives to create a dependent or correlated objective. Experimental results on randomly generated many-objective knapsack problems are consistent with well-known performance deterioration of Pareto dominance-based algorithms. That is, NSGA-II is outperformed by the other algorithms. However, it is also shown that NSGA-II outperforms the other algorithms when objectives are highly correlated. MOEA/D shows totally different search behavior depending on the choice of a scalarizing function and its parameter value. Some MOEA/D variants work very well only on two-objective problems while others work well on many-objective problems with 4-10 objectives. We also obtain other interesting observations such as the performance improvement by similar parent recombination and the necessity of diversity improvement for many-objective knapsack problems.	[Ishibuchi, Hisao; Akedo, Naoya; Nojima, Yusuke] Osaka Prefecture Univ, Dept Comp Sci & Intelligent Syst, Osaka 5998531, Japan	Ishibuchi, H (reprint author), Osaka Prefecture Univ, Dept Comp Sci & Intelligent Syst, Osaka 5998531, Japan.	hisaoi@cs.osakafu-u.ac.jp; naoya.akedo@ci.cs.osakafu-u.ac.jp; nojima@cs.osakafu-u.ac.jp	Ishibuchi, Hisao/B-3599-2009	Ishibuchi, Hisao/0000-0001-9186-6472	Japan Society for the Promotion of Science [24300090]	Manuscript received July 5, 2013; revised November 21, 2013 and February 25, 2014; accepted February 28, 2014. Date of publication April 3, 2014; date of current version March 27, 2015. This work was supported by the Japan Society for the Promotion of Science under Grant-in-Aid for Scientific Research B 24300090.	Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; While L, 2012, IEEE T EVOLUT COMPUT, V16, P86, DOI 10.1109/TEVC.2010.2077298; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Liu HL, 2014, IEEE T EVOLUT COMPUT, V18, P450, DOI 10.1109/TEVC.2013.2281533; Ishibuchi H, 2010, IEEE T EVOLUT COMPUT, V14, P985, DOI 10.1109/TEVC.2010.2043365; Sato H, 2007, LECT NOTES COMPUT SC, V4403, P5; Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Gu FQ, 2012, INT J INNOV COMPUT I, V8, P3677; Ishibuchi H, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P649; Li MQ, 2014, IEEE T EVOLUT COMPUT, V18, P348, DOI 10.1109/TEVC.2013.2262178; [Anonymous], 2010, P 12 ANN C GECCO, DOI 10.1145/1830761.1830837; Russo LMS, 2014, IEEE T EVOLUT COMPUT, V18, P481, DOI 10.1109/TEVC.2013.2281525; Kukkonen S, 2007, IEEE C EVOL COMPUTAT, P3983; Schutze O, 2012, IEEE T EVOLUT COMPUT, V16, P504, DOI 10.1109/TEVC.2011.2161872; Walker DJ, 2013, IEEE T EVOLUT COMPUT, V17, P165, DOI 10.1109/TEVC.2012.2225064; He ZN, 2014, IEEE T EVOLUT COMPUT, V18, P269, DOI 10.1109/TEVC.2013.2258025; Ishibuchi H, 1998, IEEE T SYST MAN CY C, V28, P392, DOI 10.1109/5326.704576; Purshouse RC, 2003, IEEE C EVOL COMPUTAT, P2066; Ishibuchi H, 2011, IEEE C EVOL COMPUTAT, P1465; Khare V, 2003, LECT NOTES COMPUT SC, V2632, P376; Wang R, 2013, IEEE T EVOLUT COMPUT, V17, P474, DOI 10.1109/TEVC.2012.2204264; Kim JH, 2012, IEEE T EVOLUT COMPUT, V16, P20, DOI 10.1109/TEVC.2010.2098412; Thiele L, 2009, EVOL COMPUT, V17, P411, DOI 10.1162/evco.2009.17.3.411; Sindhya K, 2013, IEEE T EVOLUT COMPUT, V17, P495, DOI 10.1109/TEVC.2012.2204403; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Jain H, 2014, IEEE T EVOLUT COMPUT, V18, P602, DOI 10.1109/TEVC.2013.2281534; Ishibuchi H, 2003, IEEE T EVOLUT COMPUT, V7, P204, DOI 10.1109/TEVC.2003.810752; Zitzler E, 1999, IEEE T EVOLUT COMPUT, V3, P257, DOI 10.1109/4235.797969; Zhao SZ, 2012, IEEE T EVOLUT COMPUT, V16, P442, DOI 10.1109/TEVC.2011.2166159; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Ishibuchi H, 2008, EUR J OPER RES, V188, P57, DOI 10.1016/j.ejor.2007.04.007; Qi YT, 2014, EVOL COMPUT, V22, P231, DOI 10.1162/EVCO_a_00109; Saxena DK, 2013, IEEE T EVOLUT COMPUT, V17, P77, DOI 10.1109/TEVC.2012.2185847; Schutze O, 2011, IEEE T EVOLUT COMPUT, V15, P444, DOI 10.1109/TEVC.2010.2064321; Yang SX, 2013, IEEE T EVOLUT COMPUT, V17, P721, DOI 10.1109/TEVC.2012.2227145; Hughes EJ, 2005, IEEE C EVOL COMPUTAT, P222; Coello C.A., 2004, APPL MULTIOBJECTIVE; Corne D., P 2007 GECCO LOND UK, P773; Deb K, 2001, MULTIOBJECTIVE OPTIM; Giagkiozis I, 2013, LECT NOTES COMPUT SC, V7811, P428, DOI 10.1007/978-3-642-37140-0_33; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Ishibuchi H, 2005, LECT NOTES COMPUT SC, V3410, P265; Ishibuchi H., P 2008 GECCO ATL GA, P649; Ishibuchi H., P 2009 IEEE INT C SM, P1820; Ishibuchi H., 2010, P GEN EV COMP C GECC, P519, DOI 10.1145/1830483.1830577; Ishibuchi Hisao, 2012, Parallel Problem Solving from Nature - PPSN XII. Proceedings of the 12th International Conference, DOI 10.1007/978-3-642-32964-7_14; Ishibuchi H., 2008, P 2008 IEEE C EV COM, P2424; Jiang S., 2011, P INT C NAT COMP, P1260; Judt L, 2013, LECT NOTES COMPUT SC, V7811, P96, DOI 10.1007/978-3-642-37140-0_11; Karahan I, 2010, IEEE T EVOLUT COMPUT, V14, P636, DOI 10.1109/TEVC.2009.2033586; Koppen M, 2007, LECT NOTES COMPUT SC, V4403, P727; Moraglio A, 2004, LECT NOTES COMPUT SC, V3102, P1377; Sato Hiroyuki, 2011, Learning and Intelligent Optimization. 5th International Conference, LION 5. Selected Papers, DOI 10.1007/978-3-642-25566-3_7; Singh HK, 2008, LECT NOTES COMPUT SC, V5361, P401; Tan KC, 2005, MULTIOBJECTIVE EVOLU; Tang LX, 2013, IEEE T EVOLUT COMPUT, V17, P20, DOI 10.1109/TEVC.2012.2185702; Wagner T, 2007, LECT NOTES COMPUT SC, V4403, P742; Wagner T, 2010, IEEE T EVOLUT COMPUT, V14, P688, DOI 10.1109/TEVC.2010.2058119; Zitzler E., 2001, SPEA2 IMPROVING STRE	59	5	6	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-778X	1941-0026		IEEE T EVOLUT COMPUT	IEEE Trans. Evol. Comput.	APR	2015	19	2					264	283		10.1109/TEVC.2014.2315442		20	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Computer Science	CF1BF	WOS:000352277900008		
J	Furuhata, M; Daniel, K; Koenig, S; Ordonez, F; Dessouky, M; Brunet, ME; Cohen, L; Wang, XQ				Furuhata, Masabumi; Daniel, Kenny; Koenig, Sven; Ordonez, Fernando; Dessouky, Maged; Brunet, Marc-Etienne; Cohen, Liron; Wang, Xiaoqing			Online Cost-Sharing Mechanism Design for Demand-Responsive Transport Systems	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Cost sharing; demand-responsive transport (DRT) systems; online mechanism design	A-RIDE PROBLEM; DELIVERY PROBLEM; TIME WINDOWS; ALLOCATION; ALGORITHMS; PICKUP	Demand-responsive transport (DRT) systems provide flexible transport services for passengers who request door-to-door rides in shared-ride mode without fixed routes and schedules. DRT systems face interesting coordination challenges. For example, one has to design cost-sharing mechanisms for offering fare quotes to potential passengers so that all passengers are treated fairly. The main issue is how the operating costs of the DRT system should be shared among the passengers (given that different passengers cause different amounts of inconvenience to the other passengers), taking into account that DRT systems should provide fare quotes instantaneously without knowing future ride request submissions. We determine properties of cost-sharing mechanisms that make DRT systems attractive to both the transport providers and passengers, namely online fairness, immediate response, individual rationality, budget balance, and ex-post incentive compatibility. We propose a novel cost-sharing mechanism, which is called Proportional Online Cost Sharing (POCS), which provides passengers with upper bounds on their fares immediately after their ride request submissions despite missing knowledge of future ride request submissions, allowing them to accept their fare quotes or drop out. We examine how POCS satisfies these properties in theory and computational experiments.	[Furuhata, Masabumi; Daniel, Kenny; Ordonez, Fernando; Brunet, Marc-Etienne] Univ So Calif, Los Angeles, CA 90089 USA; [Koenig, Sven; Cohen, Liron] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Ordonez, Fernando] Univ Chile, Dept Ind Engn, Santiago 8370439, Chile; [Dessouky, Maged; Wang, Xiaoqing] Univ So Calif, Dept Ind & Syst Engn, Los Angeles, CA 90089 USA	Furuhata, M (reprint author), DWANGO Corp Ltd, Tokyo 1040061, Japan.	k439bk439b@gmail.com; kenny@algorithmia.io; skoenig@usc.edu; fordon@dii.uchile.cl; maged@usc.edu; marc-etienne.brunet@mail.mcgill.ca; lironcoh@usc.edu; xiaoqinw@usc.edu	Ordonez, Fernando/I-4889-2013	Ordonez, Fernando/0000-0001-7037-6300	METRANS via the California Department of Transportation [09-19]; Federal Highway Administration under the Broad Agency Announcement of Exploratory Advanced Research [DTFH61-10-C-00030]	This paper is based on research supported by METRANS under Grant 09-19 via the California Department of Transportation and follow-up contract DTFH61-10-C-00030 from the Federal Highway Administration under the Broad Agency Announcement of Exploratory Advanced Research.	ANDERSON RC, 1976, SOUTHERN ECON J, V43, P793, DOI 10.2307/1056341; IOACHIM I, 1995, TRANSPORT SCI, V29, P63, DOI 10.1287/trsc.29.1.63; Nanry WP, 2000, TRANSPORT RES B-METH, V34, P107, DOI 10.1016/S0191-2615(99)00016-8; Xiang ZH, 2006, EUR J OPER RES, V174, P1117, DOI 10.1016/j.ejor.2004.09.060; Berbeglia G, 2010, EUR J OPER RES, V202, P8, DOI 10.1016/j.ejor.2009.04.024; Diana M, 2004, TRANSPORT RES B-METH, V38, P539, DOI 10.1016/j.trb.2003.07.001; Quadrifoglio L, 2008, TRANSPORT RES A-POL, V42, P718, DOI 10.1016/j.tra.2008.01.018; Moulin H, 1999, SOC CHOICE WELFARE, V16, P279, DOI 10.1007/s003550050145; Toth P, 1997, TRANSPORT SCI, V31, P60, DOI 10.1287/trsc.31.1.60; Cordeau JF, 2007, ANN OPER RES, V153, P29, DOI 10.1007/s10479-007-0170-8; SAVELSBERGH MWP, 1995, TRANSPORT SCI, V29, P17, DOI 10.1287/trsc.29.1.17; Furuhata M, 2013, TRANSPORT RES B-METH, V57, P28, DOI 10.1016/j.trb.2013.08.012; Frisk M, 2010, EUR J OPER RES, V205, P448, DOI 10.1016/j.ejor.2010.01.015; Brenner J, 2010, LECT NOTES COMPUT SC, V6078, P252, DOI 10.1007/978-3-642-13073-1_23; Cervero R., 1997, PARATRANSIT AM REDEF; Ellis E., 2009, GUIDEBOOK RURAL DEMA; Gendreau M., 2005, SEARCH METHODOLOGIES, P165; Gendreau M., 2003, HDB METAHEURISTICS, V57, P37; Glover F., 1993, ANN OPER RES, V41, P1, DOI DOI 10.1007/BF02078647; Jain K, 2007, ALGORITHMIC GAME THEORY, P385; Kash I., 2013, P INT JOINT C AUT AG, P351; Lemaire J, 1984, ASTIN BULL, V14, P61; Moulin H., 2002, HDB SOCIAL CHOICE WE, V1, P289, DOI 10.1016/S1574-0110(02)80010-8; MOULIN H, 1992, ECONOMETRICA, V60, P1009, DOI 10.2307/2951537; Moulin H., 2013, INT GAME THEORY REV, V15, P1; Parkes DC, 2007, ALGORITHMIC GAME THEORY, P411; d'Orey PM, 2012, IEEE INT C INTELL TR, P140, DOI 10.1109/ITSC.2012.6338703; Reeves C.R., 1993, MODERN HEURISTIC TEC; Shoham Y, 2009, MULTIAGENT SYSTEMS: ALGORITHMIC, GAME-THEORETIC, AND LOGICAL FOUNDATIONS, P1; SHUBIK M, 1962, MANAGE SCI, V8, P325, DOI 10.1287/mnsc.8.3.325; Sprumont Y, 1998, J ECON THEORY, V81, P126, DOI 10.1006/jeth.1998.2408; Tohme F, 1999, J LOGIC COMPUT, V9, P793, DOI 10.1093/logcom/9.6.793; Walsh T, 2011, LECT NOTES ARTIF INT, V6992, P292, DOI 10.1007/978-3-642-24873-3_22; Wang YT, 2002, J MATH ECON, V37, P215, DOI 10.1016/S0304-4068(02)00016-2	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	APR	2015	16	2					692	707		10.1109/TITS.2014.2336212		16	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CF1CZ	WOS:000352282500014		
J	Iryo-Asano, M; Alhajyaseen, WKM; Nakamura, H				Iryo-Asano, Miho; Alhajyaseen, Wael K. M.; Nakamura, Hideki			Analysis and Modeling of Pedestrian Crossing Behavior During the Pedestrian Flashing Green Interval	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Clearance time; microsimulation; pedestrian behavior; pedestrian-vehicle conflicts; signalized crosswalks		Pedestrian-vehicle conflicts are considered one of the most common safety problems at signalized intersections. In Japan, the pedestrian flashing green (PFG) is considered a safe time interval for pedestrians at crosswalks to finish crossing before conflicting vehicle streams are released. In most common phasing schemes, pedestrians have the right-of-way along with left-turning vehicles (in left-hand traffic). By law, pedestrians should not enter a crosswalk during the PFG. However, many of them rush into crosswalks without necessarily heeding approaching turning vehicles, which could increase the probability of severe conflicts. The objective of this paper is to analyze and model the probabilistic behavior of pedestrians after the onset of the PFG, which contains the pedestrians' decision of whether to give up crossing, as well as the pedestrian speed distribution. Empirical data analysis showed that longer crosswalks lead to significantly higher pedestrian stop probabilities. Furthermore, there is a significant difference between the pedestrians' speeds in the first and second halves of crosswalks. The results of a Monte Carlo simulation showed that the estimated models closely represent the overall stochastic behavior of the pedestrians from the onset of the PFG until the completion of crossing.	[Iryo-Asano, Miho] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Alhajyaseen, Wael K. M.] King Fahd Univ Petr & Minerals, Dept Civil & Environm Engn, Dhahran 31262, Saudi Arabia; [Nakamura, Hideki] Nagoya Univ, Grad Sch Environm Studies, Dept Environm Engn & Architecture, Nagoya, Aichi 4648603, Japan	Iryo-Asano, M (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	m-iryo@iis.u-tokyo.ac.jp; waelalhajyaseen@kfupm.edu.sa; nakamura@genv.nagoya-u.ac.jp	Iryo-Asano, Miho/M-5975-2013	Iryo-Asano, Miho/0000-0003-0947-1346	Japan Society for the Promotion of Science	This work was supported by the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (B).	ALABOOD AM, 1986, IEEE T RELIAB, V35, P216, DOI 10.1109/TR.1986.4335408; Alhajyaseen W., 2012, IATSS RES, V36, P66; Alhajyaseen WKM, 2013, TRANSPORT RES C-EMER, V32, P179, DOI 10.1016/j.trc.2012.09.006; Guo HW, 2012, SAFETY SCI, V50, P968, DOI 10.1016/j.ssci.2011.12.027; King MJ, 2009, ACCIDENT ANAL PREV, V41, P485, DOI 10.1016/j.aap.2009.01.008; Lee JYS, 2008, TRANSPORT RES A-POL, V42, P1314, DOI 10.1016/j.tra.2008.06.009; Alhajyaseen WKM, 2013, ACCIDENT ANAL PREV, V50, P175, DOI 10.1016/j.aap.2012.04.006; Avineri E, 2012, ACCIDENT ANAL PREV, V44, P30, DOI 10.1016/j.aap.2010.11.028; Ben Akiva M., 1985, DISCRETE CHOICE ANAL; Dang T., 2013, TRANSPORT RES REC, V2316, P122; Federal Highway Administration, 2009, MAN UN TRAFF CONTR D; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P833, DOI 10.1016/j.aap.2006.12.005; Iryo-Asano M, 2014, PROCEDIA COMPUT SCI, V32, P301, DOI 10.1016/j.procs.2014.05.428; Japan Society of Traffic Engineering, 2006, MAN TRAFF SIGN; LaPlante J., 2007, 3 URB STREET S SEATT, P1; National Police Agency in Japan, 2012, FAT ACC STAT 2011; Suzuki K., 2004, P 24 JPN SOC TRAFF E, P317; Suzuki K., 2006, P 13 WORLD C INT TRA, P1; Wang Yanfeng, 2010, Proceedings of the 2010 International Conference on Intelligent Computation Technology and Automation (ICICTA 2010), DOI 10.1109/ICICTA.2010.185	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	APR	2015	16	2					958	969		10.1109/TITS.2014.2346154		12	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CF1CZ	WOS:000352282500037		
J	Kagawa, T; Ishikawa, H; Kato, T; Sung, C; Uno, Y				Kagawa, Takahiro; Ishikawa, Hironori; Kato, Takayuki; Sung, ChangHyun; Uno, Yoji			Optimization-Based Motion Planning in Joint Space for Walking Assistance With Wearable Robot	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Gait assistance; joint-space planning; linear inverted pendulum model; motion planning; wearable robots	GAIT; REHABILITATION; EXOSKELETON; INDIVIDUALS; PARAPLEGIA; ORTHOSES; HAL	In this paper, we propose an alternative motion planning method for a wearable robot with a variable stride length and walking speed. Trajectories are planned in a joint space rather than a workspace to avoid an ill-posed problem with no solution in inverse kinematics, and to consider the joint's range of motion, maximum velocity, foot clearance, and backward balance. The joint trajectories are represented by minimum jerk trajectories. Two via-points are assigned, and the parameters (angle and angular velocity) at the via-points are determined by applying an inverted pendulum model or optimization to satisfy the constraints. The fastest gait pattern generated by the proposed algorithm was twice as fast as the pattern generated by the workspace-based planning method. We confirmed that the fastest walking pattern of 0.36 m/s was feasible on a treadmill, and a walking pattern of 0.27 m/s was found for walking across the floor with a walker. Furthermore, the proposed method required approximately 65% of the electric power for the workspace-based method for the same walking speed and stride length. These results suggest that the proposed motion planning method is effective at generating a high-speed and efficient gait pattern for a wearable robot.	[Kagawa, Takahiro; Ishikawa, Hironori; Kato, Takayuki; Sung, ChangHyun; Uno, Yoji] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan	Kagawa, T (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan.	kagawa@nuem.nagoya-u.ac.jp; h_ishikawa@nuem.nagoya-u.ac.jp; t_kato@nuem.nagoya-u.ac.jp; s_changhyun@nuem.nagoya-u.ac.jp; uno@nuem.nagoya-u.ac.jp			Tatematsu Foundation;  [26289129];  [26280101];  [25820085]	This work was supported by Grant-in-Aid for Scientific Research (B) Nos. 26289129 and 26280101, Young Scientist (B) No. 25820085, and Tatematsu Foundation.	Alcaraz-Jimenez JJ, 2013, INT J ROBOT RES, V32, P1074, DOI 10.1177/0278364913487566; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Suzuki K, 2007, ADV ROBOTICS, V21, P1441, DOI 10.1163/156855307781746061; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Tanabe S, 2013, NEUROREHABILITATION, V33, P99, DOI 10.3233/NRE-130932; Kajita S, 2003, IEEE INT CONF ROBOT, P1620, DOI 10.1109/ROBOT.2003.1241826; Jarrasse N, 2012, IEEE T ROBOT, V28, P697, DOI 10.1109/TRO.2011.2178151; Kajita S, 1996, IEEE CONTR SYST MAG, V16, P13, DOI 10.1109/37.482132; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/01.wco.000102630.16692.38; Kawamoto H, 2005, ADV ROBOTICS, V19, P717, DOI 10.1163/1568553054455103; Farris RJ, 2011, IEEE T NEUR SYS REH, V19, P652, DOI 10.1109/TNSRE.2011.2163083; Piazzi A, 2000, IEEE T IND ELECTRON, V47, P140, DOI 10.1109/41.824136; Viteckova S, 2013, BIOCYBERN BIOMED ENG, V33, P96, DOI 10.1016/j.bbe.2013.03.005; Cempini M, 2013, IEEE T ROBOT, V29, P236, DOI 10.1109/TRO.2012.2226381; Kubota S, 2013, ARCH PHYS MED REHAB, V94, P1080, DOI 10.1016/j.apmr.2012.12.020; Tejima N, 2000, ADV ROBOTICS, V14, P551; BUTLER PB, 1984, PROSTHET ORTHOT INT, V8, P33; Diaz I., 2011, J ROBOTICS, V2011, P1, DOI DOI 10.1155/2011/759764; FLASH T, 1985, J NEUROSCI, V5, P1688; Ha KH, 2012, IEEE ENG MED BIO, P344, DOI 10.1109/EMBC.2012.6345939; Heruti Rafi, 2003, Int J Low Extrem Wounds, V2, P99, DOI 10.1177/1534734603257249; JEFFERSON RJ, 1990, PROSTHET ORTHOT INT, V14, P103; Kagawa T., 2009, P 2009 INT S ROB HUM, P633; KAGAWA T, 2009, P IEEE RSJ INT C INT, P4067; Kagawa T, 2007, ELECTR ENG JPN, V161, P10, DOI 10.1002/eej.20533; Kagawa T, 2010, HUM MOVEMENT SCI, V29, P964, DOI 10.1016/j.humov.2010.03.007; Kajita S., 1991, Proceedings. 1991 IEEE International Conference on Robotics and Automation (Cat. No.91CH2969-4), DOI 10.1109/ROBOT.1991.131811; Kazerooni H, 2006, INT J ROBOT RES, V25, P561, DOI 10.1177/0278364906065505; Marchal-Crespo L., 2009, J NEUROENG REHABIL, V6, P6, DOI DOI 10.1186/1743-0003-6-20; Pratt J., 2006, P IEEE RAS INT C HUM, P200, DOI DOI 10.1109/ICHR.2006.321385; Quintero H. A., 2012, ASME J MED DEVICES, V6; Raj A. K., 2011, J ROBOT, V2011, P1; Strickland E, 2012, IEEE SPECTRUM, V49, P30, DOI 10.1109/MSPEC.2012.6117830; Sung C., 2013, INT J ADV ROBOT SYST, V10, P1; Sung C, 2013, NATURE INSPIRED MOBILE ROBOTICS, P11; Tanabe Shigeo, 2013, Disabil Rehabil Assist Technol, V8, P84, DOI 10.3109/17483107.2012.688238; Ude A., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.846358; Vukobratovic M., 2004, INT J HUM ROBOT, V1, P157, DOI 10.1142/S0219843604000083; Wang LT, 2013, IEEE INT C INT ROBOT, P965	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	APR	2015	31	2					415	424		10.1109/TRO.2015.2409434		10	Robotics	Robotics	CF2EV	WOS:000352361300015		
J	Tanaka, M; Tanaka, K				Tanaka, Motoyasu; Tanaka, Kazuo			Control of a Snake Robot for Ascending and Descending Steps	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Kinematics; redundancy; snake robot; step climbing; switching constraints	ACTIVE CORD MECHANISM; ARTICULATED BODY; MOBILE ROBOT; LOCOMOTION; DESIGN	This paper proposes control method for a snake robot to ascend and descend steps. In a multiplane step environment, it is necessary for locomotion to transfer from one plane to another. When a snake robot moves, it touches several planes as its body is long and thin. In this paper, we propose a control method to track the trajectory of a snake robot in a step environment. We decomposed the 3-D motion of the robot into two simple models by introducing an assumption that simplifies the model and controller, and derive a model of the robot as a hybrid system with switching. The control method consists of a tracking controller, a method for shifting the robot's part connecting the planes, and active lifting to control the shape of the robot. Ascent and descent experiments confirm the effectiveness of the proposed controller and the method for shifting the connecting part of the robot's body.	[Tanaka, Motoyasu; Tanaka, Kazuo] Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Tokyo 1828585, Japan	Tanaka, M (reprint author), Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Tokyo 1828585, Japan.	mtanaka@uec.ac.jp; ktanaka@mce.uec.ac.jp		Tanaka, Motoyasu/0000-0002-3717-8852	JSPS KAKENHI [26870198]	This work was supported by the JSPS KAKENHI under Grant 26870198.	CHIRIKJIAN GS, 1995, IEEE T ROBOTIC AUTOM, V11, P781, DOI 10.1109/70.478426; Fukushima H, 2012, IEEE T ROBOT, V28, P541, DOI 10.1109/TRO.2012.2183050; Yamada H, 2006, IEEE INT CONF ROBOT, P2890; Kamegawa T, 2004, IEEE INT CONF ROBOT, P5081, DOI 10.1109/ROBOT.2004.1302523; Yamada H, 2013, ADV ROBOTICS, V27, P47, DOI 10.1080/01691864.2013.752318; Morse AS, 1996, IEEE T AUTOMAT CONTR, V41, P1413, DOI 10.1109/9.539424; Liljeback P, 2012, IEEE T CONTR SYST T, V20, P111, DOI 10.1109/TCST.2011.2107516; Date H., 2001, P IEEE INT C INT ROB, P2236; Fjerdingen A. A., 2009, P IEEE RSJ INT C INT, P5665; Granosik G, 2014, J INTELL ROBOT SYST, V75, P147, DOI 10.1007/s10846-013-9985-5; Hatton RL, 2010, AUTON ROBOT, V28, P271, DOI 10.1007/s10514-009-9175-2; Hirose S., 1987, BIOL INSPIRED ROBOTS; HIROSE S, 1995, IEEE CONTR SYST MAG, V15, P5, DOI 10.1109/37.341858; HIROSE S, 1990, INT J ROBOT RES, V9, P99, DOI 10.1177/027836499000900208; Kamegawa T., 2011, P IEEE INT S SAF SEC, P1; Kouno K, 2013, J ROBOT MECHATRON, V25, P559; Liberzon D., 2003, SWITCHING SYSTEMS CO; Liljeback P, 2011, IEEE T AUTOMAT CONTR, V56, P1365, DOI 10.1109/TAC.2010.2088830; Lipkin K., 2007, P IEEE RSJ INT C INT, P1864; Matsuno F, 2000, IEEE DECIS CONTR P, P4791, DOI 10.1109/CDC.2001.914686; Matsuno F., 2005, P IEEE INT C ROB AUT, P3040; Murugendran B, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3643, DOI 10.1109/IROS.2009.5353886; Paap K. L., 1999, Proceedings 1999 IEEE International Symposium on Computational Intelligence in Robotics and Automation. CIRA'99 (Cat. No.99EX375), DOI 10.1109/CIRA.1999.809947; Prautsch P., 2000, Transactions of the Institute of Electrical Engineers of Japan, Part D, V120-D; Scholl K.-U., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844841; Tanaka M, 2014, J INTELL ROBOT SYST, V75, P53, DOI 10.1007/s10846-013-9866-y; Tanaka M, 2014, ADV ROBOTICS, V28, P415, DOI 10.1080/01691864.2013.867285; Tsukano H., 2009, P 9 IFAC S ROB CONTR, P865; Yamada H., 2006, J ROBOTICS MECHATRON, V18, P305; Yamakita M., 2003, P IEEE INT C ROB AUT, V2, P2055, DOI DOI 10.1109/ROBOT.2003.1241896	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	APR	2015	31	2					511	520		10.1109/TRO.2015.2400655		10	Robotics	Robotics	CF2EV	WOS:000352361300024		
J	Tabata, M; Eshima, N; Kiyonari, Y; Takagi, I				Tabata, Minoru; Eshima, Nobuoki; Kiyonari, Yuichi; Takagi, Ichiro			The existence and uniqueness of short-run equilibrium of the Dixit-Stiglitz-Krugman model in an urban-rural setting	IMA JOURNAL OF APPLIED MATHEMATICS			English	Article						Dixit-Stiglitz-Krugman model; short-run equilibrium; fixed point theorem		The Dixit-Stiglitz-Krugman model is one of the most fundamental models in the new economic geography, and is described by the nominal wage equation. We obtain sufficient conditions for the existence and uniqueness of short-run equilibrium of this model, where a short-run equilibrium is defined by a solution of the nominal wage equation under the condition that the worker distribution is given. We construct an iteration scheme to obtain numerical short-run equilibria. No restriction is imposed on the total number of locations where economic activities are conducted.	[Tabata, Minoru; Kiyonari, Yuichi] Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan; [Eshima, Nobuoki] Oita Univ, Dept Stat, Oita 8795593, Japan; [Takagi, Ichiro] Tokai Univ, Dept Econ, Sch Business Studies, Kumamoto 8628652, Japan	Tabata, M (reprint author), Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 5998531, Japan.	mnrtabata@luck.ocn.ne.jp; eshima@med.oita-u.ac.jp; kiyonari444@gmail.com; itakagi@ktmail.tokai-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24540137]	This work is supported by Grant-in-aid for Scientific Research (24540137), Ministry of Education, Culture, Sports, Science and Technology of Japan.	KRUGMAN P, 1980, AM ECON REV, V70, P950; Fujita M., 2002, EC AGGLOMERATION CIT; Fujita M., 1999, SPATIAL EC; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Krugman P., 2008, OFFICIAL WEB SITE NO; Krugman P., 1996, SELF ORG EC; Mossay P, 2006, J URBAN ECON, V59, P389, DOI 10.1016/j.jue.2005.10.007; Pavlidis G., APPL MATH COMPUTATIO, V184, P93; Zeidler E., 1986, NONLINEAR FUNCTIONAL	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0272-4960	1464-3634		IMA J APPL MATH	IMA J. Appl. Math.	APR	2015	80	2					474	493		10.1093/imamat/hxt047		20	Mathematics, Applied	Mathematics	CF1GB	WOS:000352291000011		
J	Sayed, ET; Barakat, NAM; Abdelkareem, MA; Fouad, H; Nakagawa, N				Sayed, Enas Taha; Barakat, Nasser A. M.; Abdelkareem, Mohammad Ali; Fouad, H.; Nakagawa, Nobuyoshi			Yeast Extract as an Effective and Safe Mediator for the Baker's-Yeast-Based Microbial Fuel Cell	INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH			English	Article							ELECTRON-TRANSFER; FE(III)-REDUCING BACTERIUM; SACCHAROMYCES-CEREVISIAE; ELECTRICITY-GENERATION; PLATE; GOLD; MICROORGANISMS; TOXICITY; COLI	Although utilizing the exogenous mediators distinctly enhances the microbial fuel cell (MFC) performance, possibility of microorganisms toxicity, environmental aspect and cost are the main dilemmas facing wide applications. Therefore, successful applying of the yeast extract as a mediator in the bakers-yeast-based (Saccharomyces cerevisiae-based) MFCs would be of great interest as it will overcome all the aforementioned problems. The influence of the yeast extract addition was investigated based on the yeast cell adhesion on the surface of plain and gold-sputtered carbon paper anodes. In the case of plain carbon paper, the addition of the yeast extract considerably enhanced the performance of the yeast-based MFC, which can be attributed to the yeast extract role as growth media or as a mediator; the current and power densities increased from 94 to 190 mA/cm(2) and from 12.9 to 32.6 mW/cm(2), respectively. However, compared with the plain carbon paper, in the case of gold-sputtered anode the performance significantly increased with yeast extract addition, whereas it drastically decreased without yeast extract; the current and power densities increased from 25 to 300 mA/cm(2) and from 2 to 70 mW/cm(2), respectively. The obtained results indicated that yeast extract can be exploited as an effective mediator in the Saccharomyces cerevisiae-based MFCs.	[Sayed, Enas Taha; Barakat, Nasser A. M.; Abdelkareem, Mohammad Ali] Menia Univ, Dept Chem Engn, Fac Engn, Al Minya 61111, Egypt; [Barakat, Nasser A. M.] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, South Korea; [Fouad, H.] King Saud Univ, Dept Appl Sci Med, RCC, Riyadh 11421, Saudi Arabia; [Fouad, H.] Helwan Univ, Biomed Engn Dept, Fac Engn, Helwan 11713, Egypt; [Nakagawa, Nobuyoshi] Gunma Univ, Grad Sch Engn, Dept Chem & Environm Engn, Gunma 3768515, Japan	Sayed, ET (reprint author), Menia Univ, Dept Chem Engn, Fac Engn, Al Minya 61111, Egypt.	e.kasem@mu.edu.eg; nasser@jbnu.ac.kr	Barakat, Nasser/N-3507-2015; 	Barakat, Nasser/0000-0003-0085-5431; Abdelkareem, Mohammad/0000-0003-3248-9843	Deanship of Scientific Research at King Saud University [RG-1435-0052]	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research group (no. RG-1435-0052).	Abdelkareem MA, 2007, J POWER SOURCES, V172, P659, DOI 10.1016/j.jpowsour.2007.05.015; Gil GC, 2003, BIOSENS BIOELECTRON, V18, P327, DOI 10.1016/S0956-5663(02)00110-0; Kim HJ, 2002, ENZYME MICROB TECH, V30, P145, DOI 10.1016/S0141-0229(01)00478-1; Sayed ET, 2012, BIOELECTROCHEMISTRY, V86, P97, DOI 10.1016/j.bioelechem.2012.02.001; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; [Anonymous], 2011, COLLOID SURFACE B; Kim JR, 2005, APPL MICROBIOL BIOT, V68, P23, DOI 10.1007/s00253-004-1845-6; Zhang T, 2007, ELECTROCHEM COMMUN, V9, P349, DOI 10.1016/j.elecom.2006.09.025; Hubenova Y, 2010, BIOELECTROCHEMISTRY, V78, P57, DOI 10.1016/j.bioelechem.2009.07.005; Min B, 2004, ENVIRON SCI TECHNOL, V38, P5809, DOI 10.1021/es0491026; Chaudhuri SK, 2003, NAT BIOTECHNOL, V21, P1229, DOI 10.1038/nbt867; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Hernandez-Sierra JF, 2008, NANOMED-NANOTECHNOL, V4, P237, DOI 10.1016/j.nano.2008.04.005; Pham CA, 2003, FEMS MICROBIOL LETT, V223, P129, DOI 10.1016/S0378-1097(03)00354-9; Prasad D, 2007, BIOSENS BIOELECTRON, V22, P2604, DOI 10.1016/j.bios.2006.10.028; Abdelkareem MA, 2006, J POWER SOURCES, V162, P114, DOI 10.1016/j.jpowsour.2006.07.012; Smith MR, 2013, APPL ENVIRON MICROB, V79, P728, DOI 10.1128/AEM.01737-12; Shukla AK, 2004, CURR SCI INDIA, V87, P455; Masuda M, 2010, BIOELECTROCHEMISTRY, V78, P173, DOI 10.1016/j.bioelechem.2009.08.004; Ringeisen BR, 2007, J POWER SOURCES, V165, P591, DOI 10.1016/j.jpowsour.2006.10.026; Schaetzle O, 2008, ENERG ENVIRON SCI, V1, P607, DOI 10.1039/b810642h; Karamushka VI, 1999, BIOMETALS, V12, P289, DOI 10.1023/A:1009210101628; Kim BH, 1999, J MICROBIOL BIOTECHN, V9, P127; Mourato A., 2011, BIOINORG CHEM APPL, V2011; Sayed E., 2013, KEY ENG MATER, V534, P76; Sayed E., 2013, KEY ENG MATER, V534, P82; Zhang T, 2006, CHEM COMMUN, P2257, DOI 10.1039/b600876c	27	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0888-5885			IND ENG CHEM RES	Ind. Eng. Chem. Res.	APR 1	2015	54	12					3116	3122		10.1021/ie5042325		7	Engineering, Chemical	Engineering	CF0PJ	WOS:000352246400004		
J	Terao, M; Akter, S; Yasin, MG; Nakao, R; Kato, H; Alam, MZ; Katakura, K				Terao, Masashi; Akter, Shirin; Yasin, Md. Golam; Nakao, Ryo; Kato, Hirotomo; Alam, Mohammad Zahangir; Katakura, Ken			Molecular detection and genetic diversity of Babesia gibsoni in dogs in Bangladesh	INFECTION GENETICS AND EVOLUTION			English	Article						Babesia gibsoni; Thrombospondin-related adhesive protein gene (TRAP); Bangladesh; Tandem repeats; Genetic variation; Stray dogs	CANINE BABESIOSIS; ADHESIVE PROTEIN; RIBOSOMAL-RNA; JAPAN; INFECTION; INDIA; TRAP; INVASION; SEQUENCE; REGION	Babesia gibsoni is a tick-borne hemoprotozoan parasite of dogs that often causes fever and hemolytic illness. Detection of B. gibsoni has been predominantly reported in Asian countries, including Japan, Korea, Taiwan, Malaysia, Bangladesh and India. The present study shows the first molecular characterization of B. gibsoni detected from dogs in Bangladesh. Blood samples were collected on FTA (R) Elute cards from 50 stray dogs in Mymensingh District in Bangladesh. DNA eluted from the cards was subjected to nested PCR for the 18S rRNA gene of Babesia species. Approximately 800 bp PCR products were detected in 15 of 50 dogs (30%). Based on restriction fragment length polymorphism (RFLP) and direct sequencing of the PCR products, all parasite isolates were identified as B. gibsoni. Furthermore, the BgTRAP (B. gibsoni thrombospondin-related adhesive protein) gene fragments were detected in 13 of 15 185 rRNA gene PCR positive blood samples. Phylogenetic analysis of the BgTRAP gene revealed that B. gibsoni parasites in Bangladesh formed a cluster, which was genetically different from other Asian B. gibsoni isolates. In addition, tandem repeat analysis of the BgTRAP gene clearly showed considerable genetic variation among Bangladeshi isolates. These results suggested that B. gibsoni parasites in a different genetic clade are endemic in dogs in Bangladesh. Further studies are required to elucidate the origin, distribution, vector and pathogenesis of B. gibsoni parasites circulating in dogs in Bangladesh. (C) 2015 Elsevier B.V. All rights reserved.	[Terao, Masashi; Akter, Shirin; Kato, Hirotomo; Katakura, Ken] Hokkaido Univ, Parasitol Lab, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Akter, Shirin; Yasin, Md. Golam; Alam, Mohammad Zahangir] Bangladesh Agr Univ, Dept Parasitol, Fac Vet Sci, Mymensingh, Bangladesh; [Nakao, Ryo] Hokkaido Univ, Unit Risk Anal & Management, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0600818, Japan	Katakura, K (reprint author), Hokkaido Univ, Parasitol Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	kenkata@vetmed.hokudai.ac.jp	Kato, Hirotomo/A-4820-2012	Kato, Hirotomo/0000-0001-5429-9536	Global Center of Excellence Program for International Collaboration Centers for Zoonosis Control; Ministry of Education, Culture, Sports, Science and Technology of Japan [22405037, 24380163]	This study was supported in part by Global Center of Excellence Program for International Collaboration Centers for Zoonosis Control, and JSPS KAKENHI Grant Numbers 22405037 and 24380163 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We wish to thank staff from Bangladesh Agricultural University and Mymensingh Municipality for their help during field work.	Abd Rani PAM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-141; Alam MZ, 2013, J VET MED SCI, V75, P75, DOI 10.1292/jvms.12-0134; Faber M, 2009, ZOONOSES PUBLIC HLTH, V56, P262, DOI 10.1111/j.1863-2378.2008.01215.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Miyama T, 2005, J VET MED SCI, V67, P467, DOI 10.1292/jvms.67.467; Ghosh S, 2007, PARASITOL RES, V101, pS207, DOI 10.1007/s00436-007-0684-7; Irwin PJ, 2010, VET CLIN N AM-SMALL, V40, P1141, DOI 10.1016/j.cvsm.2010.08.001; Inokuma H, 2004, VET PARASITOL, V121, P341, DOI 10.1016/j.vetpar.2004.03.012; Jefferies R, 2007, VET PARASITOL, V144, P20, DOI 10.1016/j.vetpar.2006.09.022; Zhou JL, 2006, MOL BIOCHEM PARASIT, V148, P190, DOI 10.1016/j.molbiopara.2006.03.015; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Bawm S, 2014, PARASITOL INT, V63, P640, DOI 10.1016/j.parint.2014.04.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bostrom B, 2008, VET PARASITOL, V152, P152, DOI 10.1016/j.vetpar.2007.11.024; ELLIOT DL, 1985, NEW ENGL J MED, V313, P985, DOI 10.1056/NEJM198510173131605; Fukumoto S, 2001, J VET MED SCI, V63, P977, DOI 10.1292/jvms.63.977; Gaffar FR, 2004, MOL BIOCHEM PARASIT, V136, P25, DOI 10.1016/j.molbiopara.2004.02.006; Gelfand Y, 2007, NUCLEIC ACIDS RES, V35, pD80, DOI 10.1093/nar/gkl1013; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Iwakami S, 2014, J VET MED SCI, V76, P1313, DOI 10.1292/jvms.14-0210; Jia HL, 2009, VET PARASITOL, V162, P142, DOI 10.1016/j.vetpar.2009.02.025; Lee CC, 2010, J VET MED SCI, V72, P1329, DOI 10.1292/jvms.10-0093; Lee MJ, 2009, VECTOR-BORNE ZOONOT, V9, P681, DOI 10.1089/vbz.2008.0116; Mandal M, 2014, INFECT GENET EVOL, V27, P325, DOI 10.1016/j.meegid.2014.07.033; Mokhtar AS, 2013, TROP BIOMED, V30, P345; Naitza S, 1998, PARASITOL TODAY, V14, P479, DOI 10.1016/S0169-4758(98)01346-5; Nakao R, 2009, J VET MED SCI, V71, P33, DOI 10.1292/jvms.71.33; Seimenis A, 2014, VET ITAL, V50, P131, DOI 10.12834/VetIt.48.134.3; TALUKDER MH, 2012, J BANGLADESH AGRIC U, V10, P249; Trottein F, 1995, MOL BIOCHEM PARASIT, V74, P129, DOI 10.1016/0166-6851(95)02489-1	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	APR	2015	31						53	60		10.1016/j.meegid.2015.01.011		8	Infectious Diseases	Infectious Diseases	CE9SE	WOS:000352182900008		
J	Chuchaona, W; Khamrin, P; Yodmeeklin, A; Saikruang, W; Kongsricharoern, T; Ukarapol, N; Okitsu, S; Hayakawa, S; Ushijima, H; Maneekarn, N				Chuchaona, Watchaporn; Khamrin, Pattara; Yodmeeklin, Arpaporn; Saikruang, Wilaiporn; Kongsricharoern, Tipachan; Ukarapol, Nuthapong; Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi; Maneekarn, Niwat			Detection and characterization of a novel human parechovirus genotype in Thailand	INFECTION GENETICS AND EVOLUTION			English	Article						Human parechovirus; Genotype; Diarrhea; Children; Thailand	STOOL SAMPLES; ACUTE GASTROENTERITIS; MULTIPLEX PCR; UNITED-STATES; CHILDREN; INFECTIONS; IDENTIFICATION; ENTEROVIRUSES; RECOMBINATION; EPIDEMIOLOGY	Human parechoviruses (HPeV), member in the family Picornaviridae, cause respiratory symptoms primarily in infants and young children. Currently, 16 genotypes have been described based on phylogenetic analysis of VP1 sequences, all of which have a global distribution. The purpose of this study was to investigate the prevalence and genotype distribution of HPeV in Thailand. A total of 171 fecal specimens collected during October 2012 to May 2013 from children with diarrhea in Chiang Mai, Thailand were investigated for HPeV by RT-PCR and sequence analysis. HPeVs were found in 3 out of 171 (1.8%) fecal specimens tested. Of these, one was HPeV1 which is commonly detected in children with gastroenteritis and another one was uncommon HPeV14 genotype. Most interestingly, the sequence of the third HPeV positive sample (CMH-N185-12) did not cluster with any of the known 16 genotypes and therefore is proposed as a candidate HPeV genotype 17. (C) 2015 Elsevier B.V. All rights reserved.	[Chuchaona, Watchaporn; Khamrin, Pattara; Yodmeeklin, Arpaporn; Saikruang, Wilaiporn; Maneekarn, Niwat] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50200, Thailand; [Kongsricharoern, Tipachan] Nakomping Hosp, Pediat Hematol Unit, Chiang Mai, Thailand; [Ukarapol, Nuthapong] Chiang Mai Univ, Dept Pediat, Fac Med, Chiang Mai 50200, Thailand; [Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo, Japan	Khamrin, P (reprint author), Chiang Mai Univ, Dept Microbiol, Fac Med, 110 Intawarorose, Chiang Mai 50200, Thailand.	pattara.k@cmu.ac.th			Faculty of Medicine, Chiang Mai University (Medical research fund); Graduate School of Chiang Mai University, Chiang Mai, Thailand; National Research Council of Thailand (NRCT)	This research was jointly supported by the Research Grants from the Faculty of Medicine, Chiang Mai University (Medical research fund) and Graduate School of Chiang Mai University, Chiang Mai, Thailand, and National Research Council of Thailand (NRCT).	Alam MM, 2012, J CLIN VIROL, V55, P339, DOI 10.1016/j.jcv.2012.08.008; Alam MM, 2015, VIRUSES-BASEL, V7, P378, DOI 10.3390/v7010378; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Ito M, 2010, J CLIN MICROBIOL, V48, P2683, DOI 10.1128/JCM.00086-10; Boivin G, 2005, EMERG INFECT DIS, V11, P103; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Benschop KSM, 2008, J GEN VIROL, V89, P1030, DOI 10.1099/vir.0.83498-0; STANWAY G, 1994, J VIROL, V68, P8232; Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<57::AID-RMV266>3.3.CO;2-8; Joki-Korpela P, 2001, ANN MED, V33, P466, DOI 10.3109/07853890109002095; Oberste MS, 1999, J VIROL, V73, P1941; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Baumgarte Sigrid, 2008, J Clin Microbiol, V46, P242, DOI 10.1128/JCM.01468-07; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chieochansin T, 2011, VIROLOGY, V421, P159, DOI 10.1016/j.virol.2011.09.021; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Huang Y.P., 2014, J MICROBIOL IN PRESS; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129; Levorson RE, 2009, PEDIATR INFECT DIS J, V28, P831, DOI 10.1097/INF.0b013e3181badb6a; Pham Ngan Thi Kim, 2011, J Clin Microbiol, V49, P364, DOI 10.1128/JCM.02151-10; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Pham NTK, 2010, EMERG INFECT DIS, V16, P130, DOI 10.3201/eid1601.091105; Saikruang W, 2014, ARCH VIROL, V159, P3371, DOI 10.1007/s00705-014-2191-3; Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699	31	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	APR	2015	31						300	304		10.1016/j.meegid.2015.02.003		5	Infectious Diseases	Infectious Diseases	CE9SE	WOS:000352182900041		
J	Bouilliart, M; Tomkiewicz, J; Lauesen, P; Okamura, A; Adriaens, D				Bouilliart, M.; Tomkiewicz, J.; Lauesen, P.; Okamura, A.; Adriaens, D.			Between the jaws of the leptocephalus larva: biomechanically approaching a rarely observed organism	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Univ Ghent, B-9000 Ghent, Belgium; Tech Univ Denmark, Odense, Denmark; Billund Aquaculture, Billund, Denmark; IRAGO Inst, Tahara, Aichi, Japan		mathias.bouilliart@ugent.be						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		42.3	E18	E18				1	Zoology	Zoology	CF6HS	WOS:000352658400073		
J	Kitchen, S; Shinzato, C; Harii, S; Satoh, N; Weis, V				Kitchen, S.; Shinzato, C.; Harii, S.; Satoh, N.; Weis, V			Consequences of Hyperthermal Stress on Coral Larvae Undergoing Symbiont Colonization	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Oregon State Univ, Corvallis, OR 97331 USA; Univ Ryukyus, Okinawa Inst Sci & Technol, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan		kitchens@science.oregonstate.edu	Shinzato, Chuya/G-2958-2015					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		113.1	E97	E97				1	Zoology	Zoology	CF6HS	WOS:000352658400386		
J	Kovalik, CM; Toth, LT; Kan, H; Aronson, RB				Kovalik, C. M.; Toth, L. T.; Kan, H.; Aronson, R. B.			Was the Eastern-Pacific Hiatus in Coral Growth a Trans-Pacific Phenomenon?	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Florida Inst Technol, Melbourne, FL USA; Kyushu Univ, Fukuoka 812, Japan		ckovalik2008@my.fit.edu						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		P3.116	E287	E287				1	Zoology	Zoology	CF6HS	WOS:000352658401427		
J	Li, G; Muller, UK; Van Leeuwen, JL; Liu, H				Li, G.; Mueller, U. K.; Van Leeuwen, J. L.; Liu, H.			On the propulsive role of finfold in larval fish swim: a computational study	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Chiba Univ, Chiba, Japan; Calif State Univ Fresno, Fresno, CA 93740 USA; Wageningen Univ, NL-6700 AP Wageningen, Netherlands		reagan@graduate.chiba-u.jp						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		77.5	E111	E111				1	Zoology	Zoology	CF6HS	WOS:000352658400444		
J	Nakata, T; Liu, H; Bomphrey, RJ				Nakata, T.; Liu, H.; Bomphrey, R. J.			Optimization-based study on the aerodynamic performance of flapping wings using a CFD-informed quasi-steady model	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Univ London Royal Vet Coll, London NW1 0TU, England; Chiba Univ, Chiba, Japan		tnakata@rvc.ac.uk						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		81.4	E131	E131				1	Zoology	Zoology	CF6HS	WOS:000352658400525		
J	Ramirez-Otarola, NN; Espinoza, J; Kalergis, AM; Sabat, P				Ramirez-Otarola, N. N.; Espinoza, J.; Kalergis, A. M.; Sabat, P.			Interplay between acclimation temperature and immune challenge on energy expenditure and immune response in the precocial rodent Octodon degus	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Lab Anim Ecophysiol, Rome, Italy; Univ Chile, Santiago, Chile; MIII, Tokyo, Japan; Pont Cathol Univ Chile, Santiago, Chile		nat.rotarola@gmail.com	Sabat, Pablo/E-8829-2012					0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		P2.40	E318	E318				1	Zoology	Zoology	CF6HS	WOS:000352658401552		
J	Ruhr, IM; Bodinier, C; Mager, EM; Esbaugh, AJ; Takei, Y; Grosell, M				Ruhr, I. M.; Bodinier, C.; Mager, E. M.; Esbaugh, A. J.; Takei, Y.; Grosell, M.			The physiological effects of the guanylin peptides on the posterior intestine of Gulf toadfish (Opsanus beta) exposed to hypersalinity	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Univ Miami, Coral Gables, FL 33124 USA; RSMAS, Miami, FL USA; Univ Tokyo, Tokyo 1138654, Japan		iruhr@rsmas.miami.edu						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		83.7	E157	E157				1	Zoology	Zoology	CF6HS	WOS:000352658400628		
J	Yoshida, MA; Ogura, A; Ikeo, K; Kohn, AB; Winters, G; Moroz, LL				Yoshida, M. A.; Ogura, A.; Ikeo, K.; Kohn, A. B.; Winters, G.; Moroz, L. L.			Convergent evolution of brains, eyes and vasculatures in cephalopod molluscs	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Meeting Abstract	Annual Meeting of the Society-for-Integrative-and-Comparative-Biology (SICB)	JAN 03-07, 2015	West Palm Beach, FL	Soc Integrat & Comparat Biol					Univ Florida, Whitney Lab, Gainesville, FL 32611 USA; Natl Inst Genet, Nagahama Inst Biosci & Tech, Nagahama, Shiga, Japan		myoshida0215@gmail.com						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	APR	2015	55			1		S5.8	E207	E207				1	Zoology	Zoology	CF6HS	WOS:000352658401112		
J	Ji, Y; Yamashita, A; Asama, H				Ji, Yonghoon; Yamashita, Atsushi; Asama, Hajime			RGB-D SLAM using vanishing point and door plate information in corridor environment	INTELLIGENT SERVICE ROBOTICS			English	Article						SLAM; RGB-D sensor; Vanishing point; Door plate; Mobile robot		This paper proposes a novel approach to an RGB-D simultaneous localization and mapping (SLAM) system that uses the vanishing point and door plates in a corridor environment simultaneously for navigation. To increase the stability of the SLAM process in such an environment, the vanishing point and door plates are utilized as landmarks for extended Kalman filter-based SLAM (i.e., EKF SLAM). The vanishing point is a semi-global unique feature usually observed in the corridor frontage, and a door plate has strong signature information (i.e., the room number) for the data association process. Thus, using these types of reliable features as landmarks maintains the stability of the SLAM process. A dense 3D map is represented by an octree structure that includes room number information, which can be useful semantic information. The experimental results showed that the proposed scheme yields a better performance than previous SLAM systems.	[Ji, Yonghoon; Yamashita, Atsushi; Asama, Hajime] Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Ji, Y (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ji@robot.t.u-tokyo.ac.jp					Zhang G, 2012, INT J CONTROL AUTOM, V10, P547, DOI 10.1007/s12555-012-0311-y; Shufelt JA, 1999, IEEE T PATTERN ANAL, V21, P282, DOI 10.1109/34.754631; Bosse M, 2003, VISUAL COMPUT, V19, P417, DOI 10.1007/s00371-003-0205-3; Baggio D.L., 2012, MASTERING OPENCV PRA; Horunge A, 2013, AUTON ROBOT, V34, P189; Kawanishi R, 2013, ADV ROBOTICS, V27, P19, DOI 10.1080/01691864.2013.751160; Kim S, 2013, INTEL SERV ROBOT, V6, P89, DOI 10.1007/s11370-012-0125-z; Lee YH, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P936, DOI 10.1109/IROS.2009.5354508; Lemaire T, 2005, P IEEE RSJ INT C INT, P2449; Norling ER, 2008, PERSPECTIVE MADE EAS; Smith Paul, 2006, Bellbird, V1, P17; Thrun S., 2005, PROBABILISTIC ROBOTI; Triebel R, 2006, P IEEE RSJ INT C INT, P2276	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-2776	1861-2784		INTEL SERV ROBOT	Intell. Serv. Robot.	APR	2015	8	2					105	114		10.1007/s11370-015-0166-1		10	Robotics	Robotics	CF0DM	WOS:000352213000004		
J	Yoshino, M; Kin, T; Ito, A; Saito, T; Nakagawa, D; Kamada, K; Mori, H; Kunimatsu, A; Nakatomi, H; Oyama, H; Saito, N				Yoshino, Masanori; Kin, Taichi; Ito, Akihiro; Saito, Toki; Nakagawa, Daichi; Kamada, Kyousuke; Mori, Harushi; Kunimatsu, Akira; Nakatomi, Hirofumi; Oyama, Hiroshi; Saito, Nobuhito			Diffusion tensor tractography of normal facial and vestibulocochlear nerves	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Diffusion tensor tractography; Facial nerve; Vestibulocochlear nerve; Seed region of interest; Fractional anisotropy threshold	FIBER TRACKING; CRANIAL NERVES; VESTIBULAR SCHWANNOMAS; VISUALIZATION; BRAIN; COCHLEAR; BUNDLES	Diffusion tensor tractography (DTT) is not adequately reliable for prediction of facial and vestibulocochlear (VII-VIII) nerve locations, especially relative to a vestibular schwannoma (VS). Furthermore, it is often not possible to visualize normal VII-VIII nerves by DTT (visualization rates were 12.5-63.6 %). Therefore, DTT post-processing was optimized for normal VII-VIII nerve visualization with and without manual noise elimination. DTT examinations of ten patients were evaluated to assess the improvement in performance by modifying seed region of interest (ROI) and fractional anisotropy (FA) threshold. Seed ROI was placed at the porus of the internal auditory meatus, and FA threshold values were either fixed or variable for each patient. DTT visualization of cranial nerves VII-VIII was evaluated and the noise effect was measured. Cranial nerves VII-VIII were visualized in 90 % of patients without using manual noise elimination by modifying the seed ROI and FA threshold. The visualization rate with FA threshold of the upper limit in each patient (100 %) was significantly higher than that with FA threshold of 0.1 (75 %) (). The incidence rate of noise with FA threshold of the upper limit (10 %) was not significantly different than the FA threshold of 0.1 (20 %) (). Seed ROI modification and FA thresholding can improve the visualization of cranial nerve VII-VIII locations in DTT. This technique is promising for its potential to determine the relationship of cranial nerves VII-VIII to VS.	[Yoshino, Masanori; Kin, Taichi; Ito, Akihiro; Nakagawa, Daichi; Nakatomi, Hirofumi; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; [Saito, Toki; Oyama, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Clin Informat Engn, Bunkyo Ku, Tokyo 1138655, Japan; [Kamada, Kyousuke] Asahikawa Med Univ, Dept Neurosurg, Asahikawa, Hokkaido 0788510, Japan; [Mori, Harushi; Kunimatsu, Akira] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan	Yoshino, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ymasa-tky@umin.ac.jp			 [25670618]	We would like to thank Minoru Tanaka for suggesting this investigation. This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (25670618).	Akazawa K, 2010, NEURORADIOLOGY, V52, P723, DOI 10.1007/s00234-010-0670-0; Yoshino M, 2014, INT J COMPUT ASS RAD, V9, P333, DOI 10.1007/s11548-013-0934-3; Gerganov VM, 2011, J NEUROSURG, V115, P1087, DOI 10.3171/2011.7.JNS11495; Chen DQ, 2011, NEUROSURGERY, V68, P1077, DOI 10.1227/NEU.0b013e31820c6cbe; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Stadlbauer A, 2007, NEUROIMAGE, V34, P949, DOI 10.1016/j.neuroimage.2006.08.051; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Andreisek G, 2009, SKELETAL RADIOL, V38, P51, DOI 10.1007/s00256-008-0577-6; Taoka T, 2006, J MAGN RESON IMAGING, V24, P1005, DOI 10.1002/jmri.20725; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Tournier JD, 2002, MAGN RESON MED, V47, P701, DOI 10.1002/mrm.10116; Yamakami I, 2003, NEUROL MED-CHIR, V43, P334, DOI 10.2176/nmc.43.334; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Fujiwara S, 2011, J NEUROIMAGING, V21, pe102, DOI 10.1111/j.1552-6569.2010.00508.x; Roundy N, 2012, J NEUROSURG, V116, P697, DOI 10.3171/2011.12.JNS111404; Byrnes TJD, 2009, J NEUROSURG, V111, P132, DOI 10.3171/2009.2.JNS08930; Cauley KA, 2013, AM J ROENTGENOL, V201, pW326, DOI 10.2214/AJR.12.9230; Hodaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032745; Kabasawa Hiroyuki, 2007, Radiat Med, V25, P462, DOI 10.1007/s11604-007-0169-8; Kamada K, 2005, J NEUROSURG, V102, P664, DOI 10.3171/jns.2005.102.4.0664; Kamada K, 2005, NEUROSURGERY, V57, P121, DOI 10.1227/01.NEU.0000163526.60240.B6; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lori N F, 2002, NMR Biomed, V15, P494, DOI 10.1002/nbm.779; Okada T, 2006, RADIOLOGY, V238, P668, DOI 10.1148/radiol.2382042192; Ozdogmus O, 2004, J ANAT, V205, P65, DOI 10.1111/j.0021-8782.2004.00313.x; Rhoton AL, 2000, NEUROSURGERY, V47, pS93, DOI 10.1097/00006123-200009001-00013; SILVERSTEIN H, 1984, OTOLARYNG HEAD NECK, V92, P207; YAMAKAMI I, 2003, NEUROL MED CHIR, V43, P339	34	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	APR	2015	10	4					383	392		10.1007/s11548-014-1129-2		10	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CE8SI	WOS:000352114000003		
J	Tabrizi, PR; Zoroofi, RA; Yokota, F; Tamura, S; Nishii, T; Sato, Y				Tabrizi, Pooneh R.; Zoroofi, Reza A.; Yokota, Futoshi; Tamura, Satoru; Nishii, Takashi; Sato, Yoshinobu			Acetabular cartilage segmentation in CT arthrography based on a bone-normalized probabilistic atlas	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Acetabular cartilage; CT arthrography; Pelvic bone; Probabilistic atlas; Thickness map	MR-IMAGES; THICKNESS MEASUREMENT; OSTEOARTHRITIC KNEES; ARTICULAR-CARTILAGE; HIP-DYSPLASIA; JOINT; QUANTIFICATION; OBJECTS; VOLUME; MODEL	Determination of acetabular cartilage loss in the hip joint is a clinically significant metric that requires image segmentation. A new semiautomatic method to segment acetabular cartilage in computed tomography (CT) arthrography scans was developed and tested. A semiautomatic segmentation method was developed based on the combination of anatomical and statistical information. Anatomical information is identified using the pelvic bone position and the contact area between cartilage and bone. Statistical information is acquired from CT intensity modeling of acetabular cartilage and adjacent tissue structures. This method was applied to the identification of acetabular cartilages in 37 intra-articular CT arthrography scans. The semiautomatic anatomical-statistical method performed better than other segmentation methods. The semiautomatic method was effective in noisy scans and was able to detect damaged cartilage. The new semiautomatic method segments acetabular cartilage by fully utilizing the statistical and anatomical information in CT arthrography datasets. This method for hip joint cartilage segmentation has potential for use in many clinical applications.	[Tabrizi, Pooneh R.; Zoroofi, Reza A.] Univ Tehran, Sch Elect & Comp Engn, Control & Intelligent Proc Ctr Excellence, Tehran, Iran; [Yokota, Futoshi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tamura, Satoru; Nishii, Takashi; Sato, Yoshinobu] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Tabrizi, PR (reprint author), Univ Tehran, Sch Elect & Comp Engn, Control & Intelligent Proc Ctr Excellence, Tehran, Iran.	proshani@ut.ac.ir					Lee S, 2011, COMPUT VIS IMAGE UND, V115, P1710, DOI 10.1016/j.cviu.2011.05.014; Carr JC, 2001, COMP GRAPH, P67; Williams TG, 2010, IEEE T MED IMAGING, V29, P1541, DOI 10.1109/TMI.2010.2047653; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Yin Y, 2010, IEEE T MED IMAGING, V29, P2023, DOI 10.1109/TMI.2010.2058861; Zhang KL, 2013, MAGN RESON IMAGING, V31, P1731, DOI 10.1016/j.mri.2013.06.005; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Glocker B, 2007, LECT NOTES COMPUT SC, V4792, P536; Fripp J, 2010, IEEE T MED IMAGING, V29, P55, DOI 10.1109/TMI.2009.2024743; Kauffmann C, 2003, IEEE T BIO-MED ENG, V50, P978, DOI 10.1109/TBME.2003.814539; Solloway S, 1997, MAGNET RESON MED, V37, P943, DOI 10.1002/mrm.1910370620; Lane NE, 2007, NEW ENGL J MED, V357, P1413, DOI 10.1056/NEJMcp071112; Mechlenburg I, 2007, OSTEOARTHR CARTILAGE, V15, P366, DOI 10.1016/j.joca.2006.10.005; Tamura S, 2012, OSTEOARTHR CARTILAGE, V20, P646, DOI 10.1016/j.joca.2012.03.015; Yokota F, 2009, LECT NOTES COMPUT SC, V5762, P811; Raynauld JP, 2003, OSTEOARTHR CARTILAGE, V11, P351, DOI 10.1016/S1063-4584(03)00029-3; Nishii T, 2004, OSTEOARTHR CARTILAGE, V12, P650, DOI 10.1016/j.joca.2004.04.009; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Baniasadipour A, 2011, IMAGING SCI J, V59, P253, DOI 10.1179/1743131X10Y.0000000012; Boykov YY, 2001, P ICCV, VI, P12; Cheng YZ, 2007, COMPUT MED IMAG GRAP, V31, P643, DOI 10.1016/j.compinedimag.2007.08.001; Cicuttini F, 2000, RADIOGRAPHY, V6, P79, DOI 10.1053/radi.2000.0239; Dice LR, 1945, ECOLOGY, V26, P299; Khanmohammadi M, 2009, IEICE T INF SYST, VE92D, P2253, DOI 10.1587/transinf.E92.D.2253; Okada T, 2013, LECT NOTES COMPUT SC, V8151, P275, DOI 10.1007/978-3-642-40760-4_35; Tang JS, 2006, IEEE T BIO-MED ENG, V53, P896, DOI 10.1109/TBME.2006.872816	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	APR	2015	10	4					433	446		10.1007/s11548-014-1101-1		14	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CE8SI	WOS:000352114000007		
J	Yamazaki, T; Futai, K; Tomita, T; Sato, Y; Yoshikawa, H; Tamura, S; Sugamoto, K				Yamazaki, Takaharu; Futai, Kazuma; Tomita, Tetsuya; Sato, Yoshinobu; Yoshikawa, Hideki; Tamura, Shinichi; Sugamoto, Kazuomi			3D kinematics of mobile-bearing total knee arthroplasty using X-ray fluoroscopy	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Total knee arthroplasty; Mobile-bearing insert; 3D kinematics; Accuracy validation; 2D/3D registration technique; Clinical application	SINGLE-PLANE FLUOROSCOPY; REPLACEMENT KINEMATICS; REGISTRATION; IMAGES; PROSTHESIS; POSITION; MOTIONS; MODELS; SYSTEM	Total knee arthroplasty (TKA) 3D kinematic analysis requires 2D/3D image registration of X-ray fluoroscopic images and a computer-aided design (CAD) model of the knee implant. However, these techniques cannot provide information on the radiolucent polyethylene insert, since the insert silhouette does not appear clearly in X-ray images. Therefore, it is difficult to obtain the 3D kinematics of the polyethylene insert, particularly the mobile-bearing insert. A technique for 3D kinematic analysis of a mobile-bearing insert used in TKA was developed using X-ray fluoroscopy. The method was tested and a clinical application was evaluated. Tantalum beads and a CAD model of the mobile-bearing TKA insert are used for 3D pose estimation of the mobile-bearing insert used in TKA using X-ray fluoroscopy. The insert model was created using four identical tantalum beads precisely located at known positions in a polyethylene insert using a specially designed insertion device. Finally, the 3D pose of the insert model was estimated using a feature-based 2D/3D registration technique, using the silhouette of beads in fluoroscopic images and the corresponding CAD insert model. In vitro testing for the repeatability of the positioning of the tantalum beads and computer simulations for 3D pose estimation of the mobile-bearing insert were performed. The pose estimation accuracy achieved was sufficient for analyzing mobile-bearing TKA kinematics (RMS error: within 1.0 mm and 1.0, except for medial-lateral translation). In a clinical application, nine patients with mobile-bearing TKA were investigated and analyzed with respect to a deep knee bending motion. A 3D kinematic analysis technique was developed that enables accurate quantitative evaluation of mobile-bearing TKA kinematics. This method may be useful for improving implant design and optimizing TKA surgical techniques.	[Yamazaki, Takaharu; Tamura, Shinichi] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Futai, Kazuma; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan; [Tomita, Tetsuya; Sugamoto, Kazuomi] Osaka Univ, Grad Sch Med, Div Orthopaed Biomat Sci, Suita, Osaka 5650871, Japan; [Sato, Yoshinobu] Osaka Univ, Dept Radiol, Grad Sch Med, Suita, Osaka 5650871, Japan	Yamazaki, T (reprint author), Osaka Univ, Ctr Adv Med Engn & Informat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamazaki@image.med.osaka-u.ac.jp			Global COE Program "in silico medicine" at Osaka University; Ministry of Education, Culture, Sports, Science and Technology, Japan [23700206]	A part of this study was supported by the Global COE Program "in silico medicine" at Osaka University, and by Grants-in-Aid for Hybrid Organ Project and Scientific Research for Young Scientists (B) (23700206) from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Wolterbeek N, 2009, CLIN BIOMECH, V24, P441, DOI 10.1016/j.clinbiomech.2009.02.009; Mahfouz MR, 2003, IEEE T MED IMAGING, V22, P1561, DOI 10.1109/TMI.2003.820027; INSALL JN, 1983, J BONE JOINT SURG AM, V65, P619; HANEISHI H, 1995, IEEE T MED IMAGING, V14, P548, DOI 10.1109/42.414620; Markelj P, 2012, MED IMAGE ANAL, V16, P642, DOI 10.1016/j.media.2010.03.005; WENG JY, 1992, IEEE T PATTERN ANAL, V14, P965, DOI 10.1109/34.159901; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; LAVALLEE S, 1995, IEEE T PATTERN ANAL, V17, P378, DOI 10.1109/34.385980; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310; Dennis DA, 2005, J BIOMECH, V38, P241, DOI 10.1016/j.jbiomech.2004.02.042; Bingham J, 2006, J BIOMECH ENG-T ASME, V128, P588, DOI 10.1115/1.2205865; Canny J, 1986, MACH INTELL, V8, P679, DOI DOI 10.1109/TPAMI.1986.4767851; Chouteau J, 2009, ORTHOP TRAUMATOL-SUR, V95, P254, DOI 10.1016/j.otsr.2009.03.012; Fantozzi S, 2004, KNEE SURG SPORT TR A, V12, P144, DOI 10.1007/s00167-003-0384-5; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Hirokawa S, 2008, MED BIOL ENG COMPUT, V46, P1253, DOI 10.1007/s11517-008-0398-8; Kobashi S., 2005, J ADV COMPUTATIONAL, V9, P181; Komistek RD, 2004, CLIN ORTHOP RELAT R, P207, DOI 10.1097/01.blo.0000147135.60185.39; Luenberger D. G., 1984, LINEAR NONLINEAR PRO; Yamazaki T, 2004, IEEE T MED IMAGING, V23, P602, DOI 10.1109/TMI.2004.826051	20	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	APR	2015	10	4					487	495		10.1007/s11548-014-1093-x		9	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CE8SI	WOS:000352114000012		
J	Maeda, M				Maeda, Masahiko			Preparation of Titania Films with Cohered Nanosized Particles Using Improved Liquid Phase Deposition Process	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						improved LPD; titania; rugged surface; photocatalysis; micro-bubble	TIO2 THIN-FILMS; DEGRADATION; EQUILIBRIA	An improved liquid phase deposition method is proposed for the preparation of titania films with cohered particles. This method involves introducing micro-bubbles into the normal LPD process. The micro-bubble plays a role in the film formation process by not only preventing nucleation in the lateral direction but also creating a hot spot by self-crushing. This results in a rugged surface film with cohered nanosized titania particles possessing anatase crystallinity, even in the as-grown film. The lowering of the transition temperature from the anatase phase to the rutile phase takes place in the films deposited by the improved LPD process. For the films prepared via the improved LPD process, a photocatalytic UV light response was observed even in the as-grown film. Furthermore, its activity increases drastically after a 500 degrees C annealing step, leading to crystallinity improvement and surface area increase.	Kanazawa Inst Technol, Coll Engn, Nonoichi, Ishikawa 9218501, Japan	Maeda, M (reprint author), Kanazawa Inst Technol, Coll Engn, 7-1 Ohgigaoka, Nonoichi, Ishikawa 9218501, Japan.	mmaeda@neptune.kanazawa-it.ac.jp					Koumoto K, 1999, CHEM MATER, V11, P2305, DOI 10.1021/cm990223s; Gutierrez-Tauste D, 2006, J MATER CHEM, V16, P2249, DOI 10.1039/b515367k; Kim C, 2009, ELECTROCHIM ACTA, V54, P5715, DOI 10.1016/j.electacta.2009.05.018; NAGAYAMA H, 1988, J ELECTROCHEM SOC, V135, P2013, DOI 10.1149/1.2096198; Maki H, 2014, J PHYS CHEM C, V118, P11964, DOI 10.1021/jp501162a; Park H, 2002, J PHYS CHEM B, V106, P4775, DOI 10.1021/jp025519r; Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016; Yu JG, 2006, THIN SOLID FILMS, V496, P273, DOI 10.1016/j.tsf.2005.08.352; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Ding YB, 2010, J HAZARD MATER, V175, P96, DOI 10.1016/j.jhazmat.2009.09.037; Niesen TP, 2001, J ELECTROCERAM, V6, P169, DOI 10.1023/A:1011496429540; Deki S, 1996, CHEM LETT, P433, DOI 10.1246/cl.1996.433; Dutschke A, 2003, CHEM MATER, V15, P3501, DOI 10.1021/cm0343610; Lei CX, 2012, J ALLOY COMPD, V513, P552, DOI 10.1016/j.jallcom.2011.11.005; Li D, 2013, T NONFERR METAL SOC, V23, P3306, DOI 10.1016/S1003-6326(13)62868-X; Mallak M, 2007, THIN SOLID FILMS, V515, P8072, DOI 10.1016/j.tsf.2007.03.184; SCHMITT RH, 1960, J AM CHEM SOC, V82, P5292, DOI 10.1021/ja01505a005; WAMSER CA, 1951, J AM CHEM SOC, V73, P409, DOI 10.1021/ja01145a134	18	0	0	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	APR	2015	10	4					2988	2996				9	Electrochemistry	Electrochemistry	CF0GZ	WOS:000352222500015		
J	Wang, BZ; Anzai, J				Wang, Baozhen; Anzai, Jun-ichi			A Facile Electrochemical Detection of Hypochlorite Ion based on Ferrocene Compounds	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Amperometric measurement; ferrocene compounds; hypochlorite ion	SODIUM-HYPOCHLORITE; REDOX PROPERTIES; THIN-FILMS; ACID; WATER; NANOPARTICLES; MULTILAYERS; ELECTRODE; EFFICACY; SURFACE	Cyclic voltammogram (CV) and differential pulse voltammogram (DPV) of ferroceneboronic acid (FcBA), 1,1'-ferrocenediboronic acid (FcDBA), ferrocenecarboxylic acid (FcCA), 1,1'-ferrocenedicarboxylic acid (FcDCA), ferrocenylmethanol (FcM), and ferrocenylethanol (FcE) were recorded on a glassy carbon electrode in the presence of hypochlorite (ClO-) ion. The redox current of the ferrocene compounds in CV and DPV decreased with increasing the concentration of ClO- ion in mu M level. The type of substituent in the ferrocene compounds significantly affected the electrochemical response to ClO- ion. Voltammetric and UV-visible absorption spectroscopic results suggested that the ferrocene compounds were oxidatively decomposed by ClO- ion. Thus, the ferrocene compounds can be used as redox marker for detecting ClO- ion in water.	[Wang, Baozhen] Shandong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Jinan 250012, Shandong, Peoples R China; [Wang, Baozhen; Anzai, Jun-ichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Wang, BZ (reprint author), Shandong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, 44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	pauline_111@m.tohoku.ac.jp					Sun RL, 2014, ORGANOMETALLICS, V33, P4560, DOI 10.1021/om5000453; Tsai TH, 2011, INT J ELECTROCHEM SC, V6, P2672; Ordeig O, 2005, ELECTROANAL, V17, P1641, DOI 10.1002/elan.200403194; Takahashi S, 2013, MATERIALS, V6, P5742, DOI 10.3390/ma6125742; Yap YW, 2007, CELL SIGNAL, V19, P219, DOI 10.1016/j.cellsig.2006.06.013; Walter EHM, 2009, LETT APPL MICROBIOL, V49, P366, DOI 10.1111/j.1472-765X.2009.02670.x; AOKI T, 1983, ANAL CHEM, V55, P209, DOI 10.1021/ac00253a010; Zahn R, 2012, J MATER CHEM, V22, P11073, DOI 10.1039/c2jm30469d; Thiagarajan S, 2011, J ELECTROANAL CHEM, V661, P322, DOI 10.1016/j.jelechem.2011.08.009; Yang YK, 2009, ORG LETT, V11, P859, DOI 10.1021/ol802822t; Wang Q, 2013, DYES PIGMENTS, V99, P733, DOI 10.1016/j.dyepig.2013.06.019; March JG, 2007, TALANTA, V73, P232, DOI 10.1016/j.talanta.2007.03.027; Soldatkin AP, 1997, SENSOR ACTUAT B-CHEM, V43, P99, DOI 10.1016/S0925-4005(97)00144-5; Sato K, 2014, LANGMUIR, V30, P9247, DOI 10.1021/la501750s; Anzai J, 1998, SENSOR ACTUAT B-CHEM, V52, P3, DOI 10.1016/S0925-4005(98)00248-2; Bracamonte MV, 2014, J ELECTROANAL CHEM, V712, P124, DOI 10.1016/j.jelechem.2013.11.018; Brugnoni LI, 2012, J FOOD PROCESS ENG, V35, P104, DOI 10.1111/j.1745-4530.2009.00574.x; Endo T, 2004, J COLLOID INTERF SCI, V269, P364, DOI 10.1016/S0021-9797(03)00674-X; Li XF, 2004, J ELECTROANAL CHEM, V569, P79, DOI 10.1016/j.jelechem.2004.01.036; Liu AH, 2003, LANGMUIR, V19, P4043, DOI 10.1021/la0209740; Sato H, 2006, BIOMACROMOLECULES, V7, P2072, DOI 10.1021/bm060222a; Tang X, 2010, J MEMBRANE SCI, V352, P71, DOI 10.1016/j.memsci.2010.01.063; Yang JC, 2010, J CHEM TECHNOL BIOT, V85, P699, DOI 10.1002/jctb.2359; Zhu Z., 2014, SENSOR ACTUAT B-CHEM, V191, P473	24	2	2	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	APR	2015	10	4					3260	3268				9	Electrochemistry	Electrochemistry	CF0GZ	WOS:000352222500039		
J	Kugishima, Y; Yasuhi, I; Yamashita, H; Fukuda, M; Kuzume, A; Sugimi, S; Umezaki, Y; Suga, S; Kusuda, N				Kugishima, Yukari; Yasuhi, Ichiro; Yamashita, Hiroshi; Fukuda, Masashi; Kuzume, Aldko; Sugimi, So; Umezaki, Yasushi; Suga, Sachie; Kusuda, Nobuko			Risk factors associated with abnormal glucose tolerance in the early postpartum period among Japanese women with gestational diabetes	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						Abnormal glucose tolerance; Gestational diabetes; lnsulinogenic index; Japan; Postpartum period; Risk factors	INSULIN-SECRETION; MELLITUS; SENSITIVITY; CONTRIBUTOR; PREVALENCE; NONOBESE; HISTORY	Objective: To identify the risk factors associated with abnormal glucose tolerance (AGT) on the first postpartum oral glucose tolerance test (OGTT) among Japanese women with gestational diabetes (GDM). Methods: In a retrospective study, data were analyzed from women with GDM who underwent their first postpartum OGTT 6-8 weeks post partum at a center in Omura, Japan, between January I, 2007, and December 31, 2011. Women with diabetes or impaired glucose tolerance were deemed to have postpartum AGT. The association between postpartum AGT and various risk factors was analyzed. Results: Among 169 women who underwent a postpartum OGTT, 58 (34.3%) had AGT. The significant risk factors associated with postpartum AGT in univariate analysis were pre-pregnancy body mass index (P = 0.096), 1-hour plasma glucose (P = 0.006), hemoglobin A(1c), (P< 0.001), insulinogenic index (P = 0.05), an insulinogenic index of less than 0.4 (P = 0.006), and insulin therapy during pregnancy (P <0.001). Independent risk factors identified by multivariate logistic regression models were insulinogenic index (odds ratio [OR] 0.10, 95% confidence interval [CI] 0.01-0.74; P = 0.002), an insulinogenic index of less than 0.4 (OR 5.70,95% CI 1.69-21.66; P = 0.005), and insulin therapy during pregnancy (OR 3.43, 95% CI 1.03-12.55; P = 0.044). Conclusion: Among Japanese women with GDM, a lower insulinogenic index and use of insulin therapy during pregnancy are associated with early postpartum AGT. (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.	[Kugishima, Yukari; Yasuhi, Ichiro; Yamashita, Hiroshi; Fukuda, Masashi; Kuzume, Aldko; Sugimi, So; Umezaki, Yasushi; Suga, Sachie; Kusuda, Nobuko] Natl Hosp Org, Nagasaki Med Ctr, Dept Obstet & Gynecol, Omura, Japan	Yasuhi, I (reprint author), Natl Hosp Org, Nagasaki Med Ctr, Dept Obstet & Gynecol, 1001-1 2 Chome Kubara, Nagasaki 8568562, Japan.	yasuhi@nagasaki-mc.com					Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; KJOS SL, 1990, AM J OBSTET GYNECOL, V163, P93; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Yoshinaga H, 1999, DIABETES RES CLIN PR, V44, P129, DOI 10.1016/S0168-8227(99)00019-4; Ekelund M, 2010, DIABETOLOGIA, V53, P452, DOI 10.1007/s00125-009-1621-3; Cosson E, 2013, DIABETES CARE, V36, P598, DOI 10.2337/dc12-1428; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Kwong S, 2009, DIABETES CARE, V32, P2242, DOI 10.2337/dc09-0900; Russell MA, 2006, OBSTET GYNECOL, V108, P1456, DOI 10.1097/01.AOG.0000245446.85868.73; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Lim S, 2007, DIABETES CARE, V30, P348, DOI 10.2337/dc06-1405; Asano T, 2007, ENDOCR J, V54, P903, DOI 10.1507/endocrj.K07-016; Cao XP, 2008, CHINESE MED J-PEKING, V121, P696; Committee on Obstetric Practice, 2009, OBSTET GYNECOL, V113, P1419, DOI DOI 10.1097/A0G.0B013E3181; DAMM P, 1995, DIABETES CARE, V18, P654, DOI 10.2337/diacare.18.5.654; Kanauchi M, 2002, METABOLISM, V51, P184, DOI 10.1053/meta.2002.29985; KJOS SL, 1995, DIABETES, V44, P586, DOI 10.2337/diabetes.44.5.586; Lawrence JM, 2010, DIABETES CARE, V33, P569, DOI 10.2337/dc09-2095; Miyakoshi Kei, 2011, Diabetes Care, V34, pe8, DOI 10.2337/dc10-1725; O'Sullivan JB, 1979, CARBOHYD METABOL, P429; The Committee on Nutrition and Metabolism of the Japan Society of Obstetrics and Gynaecology, 1984, ACTA OBSTET GYNAECOL, V36, P2055; World Health Organization, 2006, DEF DIAGN DIAB MELL	26	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	APR	2015	129	1					42	45		10.1016/j.ijgo.2014.09.030		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CE9SI	WOS:000352183300011		
J	Sekiguchi, A; Ikeda, T; Okamura, K; Nakai, A				Sekiguchi, Atsuko; Ikeda, Tomoaki; Okamura, Kunihiro; Nakai, Akihito			Safety of induced abortions at less than 12 weeks of pregnancy in Japan	INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS			English	Article						Complication; Dilatation and curettage; First trimester; Incomplete abortion; Induced abortion; Medical abortion; Sharp curettage; Vacuum aspiration	SURVEILLANCE	Objective: To assess the safety of various methods of induced abortion when used before 12 weeks of pregnancy in Japan. Methods: A retrospective study was undertaken of induced abortions conducted between January 1 and December 31, 2012. Questionnaires were sent to 4154 institutions that employed doctors who were licensed to conduct induced abortions. Information was obtained about the numbers of induced abortions performed before 12 weeks, methods, complications, and routine management. Results: Completed questionnaires from 2434 institutions showed that 100 851 induced abortions had been performed. Vacuum aspiration (VA) was used in 20 458 (20.3%) abortions, VA with sharp curettage in 47 148 (46.8%), dilatation and curettage (D&C) in 32 958 (32.7%), and medical abortion in 287 (0.3%). Overall, 358 complications were reported (355.0 per 100 000 procedures). The rate of complications was significantly higher after D&C than after VA and after VA with sharp curettage (P < 0.001 for both). However, incomplete abortion requiring repeat procedures was the only complication that was significantly associated with D&C (P <0.001). Conclusion: D&C can be safely used for induced abortion before 12 weeks of pregnancy, but changing from D&C to VA could reduce incomplete abortions and improve the safety of induced abortions before 12 weeks of pregnancy in Japan. (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.	[Sekiguchi, Atsuko; Nakai, Akihito] Tama Nagayama Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 2068512, Japan; [Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Okamura, Kunihiro] Tohoku Kosai Hosp, Dept Obstet & Gynecol, Sendai, Miyagi, Japan	Sekiguchi, A (reprint author), Tama Nagayama Hosp, Nippon Med Sch, Dept Obstet & Gynecol, Tama Ku, Nagayama 1-7-1, Tokyo 2068512, Japan.	oya-a@nms.ac.jp			Japanese Ministry of Health, Labour and Welfare (Health and Labour Sciences Research Grant)	The present study was supported by funding from the Japanese Ministry of Health, Labour and Welfare (Health and Labour Sciences Research Grant 2013).	Abortion Statistics Department of Health, 2014, AB STAT ENGL WAL 201; Adachi T., 2008, ANN REPORT RES CHILD; Allen Rebecca H, 2007, Contraception, V76, P139; Niinimaki M, 2009, OBSTET GYNECOL, V114, P795, DOI 10.1097/AOG.0b013e3181b5ccf9; Pazol K, 2013, MMWR SURVEILL SUMM, V62, P1; Cates W, 2000, AM J PREV MED, V19, P12, DOI 10.1016/S0749-3797(00)00168-9; Kapp N., 2010, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD007207.pub2; Kulier R., 2001, COCHRANE DB SYST REV, V4; LEAN T H, 1976, International Journal of Gynecology and Obstetrics, V14, P481; PETERSON HB, 1981, AM J OBSTET GYNECOL, V141, P763; UK Department of Health, 2010, STAT B; WHO, 2012, SAF AB TECHN POL GUI; World Health Organization, 2003, SAF AB TECHN POL GUI	13	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0020-7292	1879-3479		INT J GYNECOL OBSTET	Int. J. Gynecol. Obstet.	APR	2015	129	1					54	57		10.1016/j.ijgo.2014.09.032		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CE9SI	WOS:000352183300014		
J	Shi, S; Fan, M; Iwama, K; Li, F; Zhang, Z; Jia, L				Shi, Sh.; Fan, M.; Iwama, K.; Li, F.; Zhang, Z.; Jia, L.			Physiological basis of drought tolerance in potato grown under long-term water deficiency	INTERNATIONAL JOURNAL OF PLANT PRODUCTION			English	Article						Potato; Drought; Physiological response; Reactive oxygen species	OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; POLYETHYLENE-GLYCOL; LIPID-PEROXIDATION; FIELD CONDITIONS; WHEAT; PHOTOSYNTHESIS; ANTIOXIDANTS; CULTIVARS; GENOTYPES	Coping with water shortages without compromising tuber yield is a major challenge for potato (Solanum tuberosum L.) production in northern China. In this study, we used three potato cultivars with different sensitivities to drought to evaluate the effect of long-term drought stress on morphological and physiological characteristics under field conditions during three growing seasons (2009-2011). Our aim was to identify the specific drought tolerance traits of the potato cultivars to enable their cultivation in arid and semi-arid regions. Our results show that the drought-tolerant cultivars had higher tuber yields under conditions of drought due an increased number of tubers per hill and increased individual tuber weight. Compared with the drought-sensitive cultivar Neishu no. 7, the drought-tolerant cultivars Kexin no. 1 and Konyu no. 3 had stronger root systems and a higher capacity for water absorption at later developmental stages and a higher leaf relative water content, which conferred enhanced water retention under drought conditions. Moreover, the levels of superoxide radical and hydrogen peroxide were lower and the activities of antioxidative enzymes, including superoxide dismutase, peroxidase and catalase, were higher in the drought-tolerant cultivars under drought stress conditions. These combined characteristics allowed the cultivars to exhibit different levels of water deficiency. The above agro-morphological and physiological parameters could be used as a basis for breeding potato varieties with enhanced drought tolerance.	[Shi, Sh.; Fan, M.; Jia, L.] Inner Mongolia Agr Univ, Coll Agron, Hohhot 010019, Peoples R China; [Iwama, K.] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Li, F.] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot 010019, Peoples R China; [Zhang, Z.] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010019, Peoples R China	Jia, L (reprint author), Inner Mongolia Agr Univ, Coll Agron, Hohhot 010019, Peoples R China.	nndjialiguo@163.com			Special Fund for Agro-scientific Research in the Public Interest in China [201303104]; Pre-973 Project of China [2012CB126307]; National Natural Science Foundation of China [31460321]	This research was financially supported by the Special Fund for Agro-scientific Research in the Public Interest in China (201303104), the Pre-973 Project of China (2012CB126307) and the National Natural Science Foundation of China (31460321).	Chaitanya KV, 2003, PLANT GROWTH REGUL, V40, P75, DOI 10.1023/A:1023064328384; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Deblonde PMK, 2001, EUR J AGRON, V14, P31, DOI 10.1016/S1161-0301(00)00081-2; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Fu JM, 2001, ENVIRON EXP BOT, V45, P105, DOI 10.1016/S0098-8472(00)00084-8; EPSTEIN E, 1973, AGRON J, V65, P400; Santos I, 1999, CAN J BOT, V77, P70; Ashraf M, 2010, BIOTECHNOL ADV, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Rytter RM, 2012, PLANT SOIL, V350, P205, DOI 10.1007/s11104-011-0896-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Tourneux C, 2003, AGRONOMIE, V23, P169, DOI 10.1051/agro:2002079; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Tambussi EA, 2005, PLANTA, V221, P446, DOI 10.1007/s00425-004-1455-7; Flexas J, 2002, FUNCT PLANT BIOL, V29, P461, DOI 10.1071/PP01119; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Heuer B, 1998, PLANT SCI, V137, P43, DOI 10.1016/S0168-9452(98)00133-2; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Lahlou O, 2005, EUR J AGRON, V22, P159, DOI 10.1016/j.eja.2004.02.004; Alva A. K., 2012, Journal of Crop Improvement, V26, DOI 10.1080/15427528.2011.626891; Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; VOS J, 1989, FIELD CROP RES, V20, P237, DOI 10.1016/0378-4290(89)90068-3; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Iwama K, 2008, POTATO RES, V51, P333, DOI 10.1007/s11540-008-9120-3; Burling K, 2013, ENVIRON EXP BOT, V89, P51, DOI 10.1016/j.envexpbot.2013.01.003; Fidalgo F, 2004, ANN APPL BIOL, V145, P185, DOI 10.1111/j.1744-7348.2004.tb00374.x; Foyer C.H., 2003, PLANT PHYSIOL, V1193, P55; Gopal J, 2007, PLANT CELL REP, V26, P693, DOI 10.1007/s00299-006-0275-6; Iwama K., 2006, HDB POTATO PRODUCTIO; JAGTAP V, 1995, J PLANT PHYSIOL, V145, P195; Jovanovic Z, 2010, EUR J AGRON, V33, P124, DOI 10.1016/j.eja.2010.04.003; Kumar C. N., 1993, PLANT PHYSIOL, V102, P115; MACKERRON DKL, 1986, POTATO RES, V29, P299, DOI 10.1007/BF02359959; Sanchez-Rodriguez E, 2010, PLANT SCI, V178, P30, DOI 10.1016/j.plantsci.2009.10.001; Vreugdenhil D, 2007, POTATO BIOL BIOTECHN	38	0	0	GORGAN UNIV AGRICULTURAL SCIENCES & NATURAL RESOURCES	GORGAN	GORGAN UNIV AGRICULTURAL SCIENCES & NATURAL RESOURCES, JOURNAL OFFICE, VICE-PRESIDENCY RESEARCH, GORGAN, 49138-15739, IRAN	1735-6814	1735-8043		INT J PLANT PROD	Int. J. Plant Prod.	APR	2015	9	2					305	320				16	Agronomy	Agriculture	CF6AQ	WOS:000352639200008		
J	Zeng, J; Phan, CA; Matsui, Y				Zeng, Jing; Chi Anh Phan; Matsui, Yoshiki			The impact of hard and soft quality management on quality and innovation performance: An empirical study	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Soft QM; Hard QM; Quality performance; Innovation	MANUFACTURING STRATEGY; ORGANIZATIONAL INNOVATION; COMPETITIVE ADVANTAGE; FIRM PERFORMANCE; TRADE-OFFS; TQM; MODEL; PERSPECTIVE; VALIDATION; COMPANIES	This study examines the conflicting relationship between quality management (QM) and innovation on a global basis using a multidimensional view of QM. QM is divided into two dimensions: hard QM and soft QM. Quality performance as an intended consequence of QM implementation is also examined as a potential mediator between QM and innovation. A conceptual framework is developed to postulate causal linkages between soft/hard QM, quality performance, and innovation performance. Data collected from 283 plants in eight countries and a technique of structural equation modeling are used to test this framework. The results indicate different paths to innovation from different dimensions of QM. Hard QM affects innovation performance directly and indirectly through its effect on quality performance. Soft QM has indirect effect on innovation performance through its effect on hard QM. This means that quality performance depends directly on hard QM which can be promoted by soft QM. Quality performance shows a partial mediating effect on the relationship between hard QM and innovation performance. Quality and innovation are not a matter of trade-off, but they can coexist in a cumulative improvement model with quality as a foundation. Firms have no need to abandon QM endeavor to achieve innovation. Instead, they should devote continuous efforts to maintain a solid quality system in place integrating a set of QM practices and corresponding performance measures. Managers are advised to emphasize on quality control tools and techniques and use teamwork, training, employee empowerment and problem-solving approaches as an underlying support. (C) 2014 Elsevier B.V. All rights reserved.	[Zeng, Jing] Yokohama Natl Univ, Int Grad Sch Social Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Chi Anh Phan] Vietnam Natl Univ, Univ Econ & Business, Hanoi, Vietnam; [Matsui, Yoshiki] Yokohama Natl Univ, Dept Business Adm, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Zeng, J (reprint author), 20-402,1500 Kamisugeta Cho,Hodogaya Ku, Yokohama, Kanagawa 2400051, Japan.	zengzx1028@yahoo.co.jp; anhpc@yahoo.com; ymatsui@ynu.ac.jp	Matsui, Yoshiki/P-1684-2014	Matsui, Yoshiki/0000-0002-5475-5199	Japan Society for the Promotion of Science [22330112, 25245050]	The authors appreciate the financial support for this research from the Japan Society for the Promotion of Science by Grant-in-Aids for Scientific Research, Nos. 22330112 and 25245050.	Abraham M., 1999, INT J QUALITY RELIAB, V16, P112, DOI 10.1108/02656719910239910; Ahire S. L., 1996, INT J QUALITY RELIAB, V13, P8, DOI 10.1108/02656719610128466; Anderson JC, 1995, DECISION SCI, V26, P637, DOI 10.1111/j.1540-5915.1995.tb01444.x; Anderson M., 1999, INT J QUALITY RELIAB, V16, P859, DOI 10.1108/02656719910289168; Ahire SL, 2001, IEEE T ENG MANAGE, V48, P445, DOI 10.1109/17.969423; Sadikoglu E, 2010, INT J PROD ECON, V127, P13, DOI 10.1016/j.ijpe.2010.02.013; SARAPH JV, 1989, DECISION SCI, V20, P810, DOI 10.1111/j.1540-5915.1989.tb01421.x; Prajogo DI, 2001, TECHNOVATION, V21, P539, DOI 10.1016/S0166-4972(00)00070-5; Abrunhosa A, 2008, TECHNOVATION, V28, P208, DOI 10.1016/j.technovation.2007.08.001; Swink M, 1995, INT J OPER PROD MAN, V15, P4, DOI 10.1108/01443579510090381; Glynn MA, 1996, ACAD MANAGE REV, V21, P1081, DOI 10.2307/259165; Ahire SL, 1996, DECISION SCI, V27, P23, DOI 10.1111/j.1540-5915.1996.tb00842.x; BENNETT RC, 1981, BUS HORIZONS, V24, P51, DOI 10.1016/0007-6813(81)90026-4; Molina LM, 2007, J OPER MANAG, V25, P682, DOI 10.1016/j.jom.2006.04.007; SITKIN SB, 1994, ACAD MANAGE REV, V19, P537, DOI 10.2307/258938; Rahman SU, 2005, OMEGA-INT J MANAGE S, V33, P73, DOI 10.1016/j.omega.2004.03.008; LEONG GK, 1990, OMEGA-INT J MANAGE S, V18, P109, DOI 10.1016/0305-0483(90)90058-H; Martinez-Costa M, 2008, TOTAL QUAL MANAG BUS, V19, P209, DOI 10.1080/14783360701600639; Boyer KK, 2002, PROD OPER MANAG, V11, P9; Kim DY, 2012, J OPER MANAG, V30, P295, DOI 10.1016/j.jom.2012.02.003; Ho DCK, 2001, INT J PROD RES, V39, P529, DOI 10.1080/00207540010005709; Linderman K, 2004, J OPER MANAG, V22, P589, DOI 10.1016/j.jom.2004.07.001; Perdomo-Ortiz J, 2006, TECHNOVATION, V26, P1170, DOI 10.1016/j.technovation.2005.09.008; Forza C, 1998, INT J PROD ECON, V55, P1, DOI 10.1016/S0925-5273(98)00007-3; SPENCER BA, 1994, ACAD MANAGE REV, V19, P446, DOI 10.2307/258935; Mazzola E, 2013, INT J PROD ECON, V144, P256, DOI 10.1016/j.ijpe.2013.02.012; Slater SF, 1998, STRATEGIC MANAGE J, V19, P1001, DOI 10.1002/(SICI)1097-0266(199810)19:10<1001::AID-SMJ996>3.0.CO;2-4; Schmenner RW, 1998, J OPER MANAG, V17, P97, DOI 10.1016/S0272-6963(98)00028-X; Forza C, 1996, INT J OPER PROD MAN, V16, P42, DOI 10.1108/01443579610109839; Kaynak H, 2003, J OPER MANAG, V21, P405, DOI 10.1016/S0272-6963(03)00004-4; Flynn BB, 1995, DECISION SCI, V26, P659, DOI 10.1111/j.1540-5915.1995.tb01445.x; CORBETT C, 1993, CALIF MANAGE REV, V35, P107; Peng DX, 2008, J OPER MANAG, V26, P730, DOI 10.1016/j.jom.2007.11.001; Schonberger RJ, 2007, J OPER MANAG, V25, P403, DOI 10.1016/j.jom.2006.04.003; Dow D, 1999, PROD OPER MANAG, V8, P1; Ahire SL, 2000, J OPER MANAG, V18, P549, DOI 10.1016/S0272-6963(00)00029-2; Arauz R, 2009, TOTAL QUAL MANAG BUS, V20, P1337, DOI 10.1080/14783360903248989; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bowen D., 1992, ORGAN DYN, V24, P39; Byrne B. M., 2001, STRUCTURAL EQUATION; DAFT RL, 1978, ACAD MANAGE J, V21, P193, DOI 10.2307/255754; Deming W. Edwards, 1986, OUT CRISIS; DEWAR RD, 1986, MANAGE SCI, V32, P1422, DOI 10.1287/mnsc.32.11.1422; ETTLIE JE, 1984, MANAGE SCI, V30, P682, DOI 10.1287/mnsc.30.6.682; Ettlie J. E., 1990, ACAD MANAGEMENT EXEC, V4, P7; Feng J., 2006, EUROPEAN J INNOVATIO, V9, P269, DOI DOI 10.1108/14601060610678149; Ferdows K., 1990, J OPERATIONS MANAGEM, V9, P168, DOI 10.1016/0272-6963(90)90094-T; Flynn B. B., 1994, Journal of Operations Management, V11, DOI 10.1016/S0272-6963(97)90004-8; Flynn B.B., 1994, BENCHMARKING QUALITY, V1, P48, DOI 10.1108/14635779410056886; Forza C, 1995, INT J OPER PROD MAN, V15, P69, DOI 10.1108/01443579510090363; Forza C, 2001, INT J PROD ECON, V70, P21, DOI 10.1016/S0925-5273(00)00038-4; Garvin D. A., 1987, HARVARD BUS REV, V65, P202; Gibson B. C., 2004, ACAD MANAGE J, V47, P209; Hoang D. H., 2006, INT J QUALITY RELIAB, V23, P1092, DOI DOI 10.1108/02656710610704230; HUMBLE J, 1989, LONG RANGE PLANN, V22, P46, DOI 10.1016/0024-6301(89)90081-2; Imai M., 1986, KAIZEN KEY JAPANS CO; Jha S., 1996, INT J QUALITY SCI, V1, P19; Kochan T. A., 1995, INT J HUM RESOUR MAN, V6, P201; Martinez-Lorente AR, 2000, INT J PROD RES, V38, P3227, DOI 10.1080/002075400418234; McAdam R., 1998, EUROPEAN J INNOVATIO, P139, DOI 10.1108/14601069810230216; MILLER R, 1995, RES TECHNOL MANAGE, V38, P47; Morgan M., 1993, CREATING WORKFORCE I; Noble MA, 1995, DECISION SCI, V26, P693, DOI 10.1111/j.1540-5915.1995.tb01446.x; Nonaka I., 2009, INNOVATION SCI I CHA, P88; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Pfeifer T., 1998, TOTAL QUAL MANAGE, V9, P191; POWELL TC, 1995, STRATEGIC MANAGE J, V16, P15, DOI 10.1002/smj.4250160105; Prajogo D. I., 2003, International Journal of Quality Reliability Management, V20, DOI 10.1108/02656710310493625; Prajogo D. I., 2004, TECHNOVATION, V24, P443, DOI 10.1016/S0166-4972(02)00122-0; Samson D, 1999, J OPER MANAG, V17, P393, DOI 10.1016/S0272-6963(98)00046-1; Santos-Vijande ML, 2007, TECHNOVATION, V27, P514, DOI 10.1016/j.technovation.2007.05.014; Schroeder R. G., 2001, HIGH PERFORMANCE MAN; Singh P. J., 2004, Journal of Manufacturing Technology Management, V15, DOI 10.1108/17410380410540381; SPREITZER GM, 1995, ACAD MANAGE J, V38, P1442, DOI 10.2307/256865; The Associated Press, 2013, ASS PRESS       0904; Tidd J., 1997, MANAGING INNOVATION; Wilkinson A., 1992, TOTAL QUAL MANAGE, V3, P323, DOI 10.1080/09544129200000038; Zairi M., 1994, TOTAL QUAL MANAGE, V5, P27, DOI 10.1080/09544129400000023	78	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	APR	2015	162						216	226		10.1016/j.ijpe.2014.07.006		11	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CE6RK	WOS:000351965500019		
J	Staeblein, T; Aoki, K				Staeblein, Thomas; Aoki, Katsuki			Planning and scheduling in the automotive industry: A comparison of industrial practice at German and Japanese makers	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Automotive industry; Case study; Planning; Scheduling; Order fulfilment	BUILD-TO-ORDER; MANAGING PRODUCT VARIETY; SUPPLY CHAIN; MASS CUSTOMIZATION; FULFILLMENT; PERFORMANCE; MANAGEMENT; STRATEGIES; SYSTEMS; TOYOTA	Providing customization of products is an important way of attracting customers, but it can increase the complexity of planning and scheduling processes in the order fulfilment system. Thus the question arises, how product variety, manufacturing conditions and managerial practices interact with the planning and scheduling functions of a firm. In order to improve this understanding, we compare the order fulfilment system of German and Japanese auto makers as a sample of industrial practice. From 2007 to 2012 we engaged in a total of 56 interviews related to planning and plant scheduling functions in both sales and operations activities to analyse similarities and differences between German and Japanese auto makers. As part of this research we conducted two in-depth case studies at one German and one Japanese auto maker to map planning and scheduling functions along the order fulfilment process. Additionally, we relate those findings with secondary data sources. Our sample reveals a great variation in manufacturing conditions, product variety, and managerial practices in order fulfilment at Japanese and German auto makers. However, contrary to common perception, planning and scheduling processes differ much less between auto makers even in the light of regional differences concerning order fulfilment, different levels of product variety and mixed-model line manufacturing practice. We conclude with a discussion on variations and similarities between auto makers and the possibility of merging different practices with theoretical advances. (C) 2014 Elsevier B.V. All rights reserved.	[Staeblein, Thomas] Tech Univ Munich, Sch Management, D-80333 Munich, Germany; [Aoki, Katsuki] Meiji Univ, Sch Business Adm, Chiyoda Ku, Tokyo 1018301, Japan	Staeblein, T (reprint author), Tech Univ Munich, Sch Management, Arcisstr 21, D-80333 Munich, Germany.	thomas.staeblein@gmail.com; kaoki@meiji.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [23252009]	The authors are grateful for the cooperation of the German and Japanese auto makers in our study and for the comments of Matthias Holweg and two anonymous reviewers. Our work was supported by Schoichiro Sei and the Japan Society for the Promotion of Science (JSPS KAKENHI Grant no. 23252009).	Pil FK, 1996, IND RELAT, V35, P423, DOI 10.1111/j.1468-232X.1996.tb00414.x; MacDuffie JP, 1996, MANAGE SCI, V42, P350, DOI 10.1287/mnsc.42.3.350; Shah R, 2003, J OPER MANAG, V21, P129, DOI 10.1016/S0272-6963(02)00108-0; Solnon C, 2008, EUR J OPER RES, V191, P912, DOI 10.1016/j.ejor.2007.04.033; Pil FK, 2004, INTERFACES, V34, P394, DOI 10.1287/inte.1040.0092; Lander E, 2007, INT J PROD RES, V45, P3681, DOI 10.1080/00207540701223519; Hines P, 1997, INT J OPER PROD MAN, V17, P46, DOI 10.1108/01443579710157989; Childerhouse P, 2008, INT J PROD ECON, V114, P2, DOI 10.1016/j.ijpe.2007.09.008; Gagne C, 2006, EUR J OPER RES, V174, P1427, DOI 10.1016/j.ejor.2005.02.063; Stadtler H, 2005, EUR J OPER RES, V163, P575, DOI 10.1016/j.ejor.2004.03.001; Holweg M, 2005, J OPER MANAG, V23, P507, DOI 10.1016/j.jom.2004.10.009; Salvador F, 2002, J OPER MANAG, V20, P549, DOI 10.1016/S0272-6963(02)00027-X; Boysen N, 2009, EUR J OPER RES, V192, P349, DOI 10.1016/j.ejor.2007.09.013; Quante R, 2009, OR SPECTRUM, V31, P31, DOI 10.1007/s00291-008-0125-8; Sako M, 1998, J ECON BEHAV ORGAN, V34, P387, DOI 10.1016/S0167-2681(97)00082-6; Christensen WJ, 2005, J OPER MANAG, V23, P470, DOI 10.1016/j.jom.2004.10.007; Cachon GP, 2010, MANAGE SCI, V56, P202, DOI 10.1287/mnsc.1090.1095; Rungtusanatham MJ, 2008, PROD OPER MANAG, V17, P385, DOI 10.3401/poms.1080.0025; Schonberger RJ, 2007, J OPER MANAG, V25, P403, DOI 10.1016/j.jom.2006.04.003; Alford D, 2000, INT J PROD ECON, V65, P99, DOI 10.1016/S0925-5273(99)00093-6; Babbie E. R., 2012, PRACTICE SOCIAL RES; Brabazon PG, 2010, PROD OPER MANAG, V19, P489, DOI 10.3401/poms.1080.01132; Brun A, 2012, INT J PROD ECON, V139, P510, DOI 10.1016/j.ijpe.2012.05.018; Forza C, 2002, INT J PROD ECON, V76, P87, DOI 10.1016/S0925-5273(01)00157-8; Fredriksson P, 2005, IND MARKET MANAG, V34, P695, DOI [10.1016/j.indmarman.2005.05.010, 10.1016/j.indarman.2005.05.010]; Fujimoto T., 1999, EVOLUTION MANUFACTUR; Fujimoto T., 2001, INT J AUTOMOTIVE TEC, V1, P379, DOI 10.1504/IJATM.2001.000047; Gebhardt J., 2003, P INT JOINT C UNC AR; La Forme France-Anne Gruat, 2009, International Journal of Logistics Systems and Management, V5, DOI 10.1504/IJLSM.2009.022502; Hanke J. E., 1995, BUSINESS FORECASTING; Holweg M, 2001, MIT SLOAN MANAGE REV, V43, P74; Howard M., 2004, International Journal of Automotive Technology and Management, V4, DOI 10.1504/IJATM.2004.006288; Iyer A. V., 2009, TOYOTA SUPPLY CHAIN; Kreipl S, 2004, PROD OPER MANAG, V13, P77; LANCASTER K, 1990, MARKET SCI, V9, P189, DOI 10.1287/mksc.9.3.189; Meyr H, 2004, OR SPECTRUM, V26, P447, DOI 10.1007/s00291-004-0168-4; Muffatto M., 1999, Integrated Manufacturing Systems, V10, DOI 10.1108/09576069910247564; Pil F. K., 2004, 2 CENTURY RECONNECTI; Ramdas K, 2003, PROD OPER MANAG, V12, P79; Rother M, 2003, LEARNING SEE VALUE S; Scavarda LF, 2010, INT J OPER PROD MAN, V30, P205, DOI 10.1108/01443571011018716; Slack N., 1995, OPERATIONS MANAGEMEN; Staeblein T., 2011, INT J OPER PROD MAN, V31, P350; Steinbrecher M., 2008, COMPUT INTELL AUTOMO, P103; Tomino Takahiro, 2011, International Journal of Logistics Systems and Management, V9, DOI 10.1504/IJLSM.2011.041506; Tomino T, 2009, INT J PROD ECON, V118, P375, DOI 10.1016/j.ijpe.2008.12.002; Volling T, 2011, INT J PROD ECON, V131, P183, DOI 10.1016/j.ijpe.2011.01.008; Voss S., 2006, INTRO COMPUTATIONAL; Wagner M., 2002, SUPPLY CHAIN MANAG, P123; Womack JP, 1990, MACHINE CHANGED WORL; Yin R. K., 2010, CASE STUDY RES DESIG	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	APR	2015	162						258	272		10.1016/j.ijpe.2014.07.005		15	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CE6RK	WOS:000351965500022		
J	Lo Dico, M				Lo Dico, Mauro			Seize the Day's Eye: The Odes of Horace & Henry James's 'Daisy Miller'	INTERNATIONAL JOURNAL OF THE CLASSICAL TRADITION			English	Article							JAMES,HENRY; POETS		Reitaku Univ, Kashiwa, Chiba 2778686, Japan	Lo Dico, M (reprint author), Reitaku Univ, Fac Bldg A,Room 401,2-1-1 Hikarigaoka, Kashiwa, Chiba 2778686, Japan.	mlodico@reitaku-u.ac.jp					Albers C. E., 1997, READERS GUIDE SHORT; Arac J, 2012, HENRY JAMES REV, V33, P233; Armstrong D., 1986, TAPA, V116, P255, DOI 10.2307/283920; Beach J. W., 1954, METHOD H JAMES; Block E., 1984, ROMAN IMAGES SELECTE, P141; Brink C. O., 1963, HORACE ON POETRY; BUITENHUIS P, 1959, AM QUART, V11, P136, DOI 10.2307/2710670; Byron Lord G. G., 1980, BYRON COMPLETE POETI; Chaucer Geoffrey, 1900, HOUSE FAME LEGEND GO, V3; Cicero Marcus Tullius, 1922, CATILINAM PROMURENA, V1; Dimock Wai Chee, 2006, OTHER CONTINENTS AM; Dimock WC, 2003, HENRY JAMES REV, V24, P215, DOI 10.1353/hjr.2003.0022; Duff J. W., 1934, MINOR LATIN POETS, V1; Dupee F. W., 1956, AU AUTOBIOGRAPHY; Edel L., 1984, LC LIT CRITICISM; Edel L., 1974, HJL H JAMES LETT; Edel L., 1987, LIB H JAMES; Edel L., 1987, CN COMPLETE NOTEBOOK; Edgecombe RS, 2010, NOTES QUERIES, V57, P221, DOI 10.1093/notesj/gjq015; Ferber M., 2007, DICT LIT SYMBOLS; Flaccus Valerius, 1980, ARGONAUTICON LIBROS; Fogelman B., 1989, HENRY JAMES REV, V10, P68; Geismar M., 1963, H JAMES JACOBITES; GILBREATH M, 1988, KEATS-SHELLEY J, V37, P20; Hallam G. H., 1928, CLASSICAL REV, V42, P125; Heilman R., 1960, CASEBOOK H JAMESS TU, P174; Herrick Robert, 1956, POETICAL WORKS R HER; Hocks R. A., 1997, AMBASSADORS CONSCIOU; Hocks R. A., 1980, HENRY JAMES REV, V1, P164; Horace, 2011, ODES BOOK; Horace, 2008, Q HORATIVS FLACCVS O; Hornblower Simon, 2012, OXFORD CLASSICAL DIC, Vfourth; Horne P, 2005, HENRY JAMES REV, V26, P68, DOI 10.1353/hjr.2005.0003; Howard R., 1993, CTW COLLECTED TRAVEL; Howells W. D., 1903, N AM REV, V176, P125; Jacobs J. U., 1983, THEORIA-SPAIN, V58, P51; Jonson Ben, 1938, BARTHOLOMEW FAIR DEV, V6; Kaplan F., 1992, H JAMES IMAGINATION; Keats John, 1988, COMPLETE POEMS; Koprince S., 1995, J SHORT STORY ENGLIS, V25, P21; Koprince S., 1986, ARIZ Q, V42, P293; Krook D., 1962, ORDEAL CONSCIOUSNESS; Langland W., 2006, PIERS PLOWMAN DONALD; Leishman J. B., 1963, THEMES VARIATIONS SH; Levy Leo B., 1957, VERSIONS MELODRAMA S; Lo Dico M., 2012, ILLUMINAZIONI, V20, P3; Lo Dico M., 2013, REITAKU U J, V97, P87; Lukacs Georg, 1971, THEORY NOVEL HISTORI; Magalaner M., 1969, 12 SHORT STORIES; Martin W. R., 1986, ARIZ Q, V42, P305; Martindale J., 1993, HORACE MADE NEW HORA, P50; McCollough J. B., 1975, PAPERS LANGUAGE LIT, V11, P312; Mendelssohn M., 2010, H JAMES CONTEXT, P93; Meyers J, 2007, HENRY JAMES REV, V28, P94, DOI 10.1353/hjr.2007.0004; Nisbet Robin, 1978, COMMENTARY HORACE OD, VII; Nisbet Robin, 1970, COMMENTARY HORACE OD, VI; Ovid Amores, 1994, MEDICAMINA FACIEI FE; Perkins G., 1999, REFERENCE GUIDE AM L, P452; Perosa S, 2008, CAMBRIDGE QUART, V37, P150, DOI 10.1093/camqtly/bfm032; Porphyrio Pomponius, 1894, SCHOLIA ANTIQVA Q HO; Raleigh J. H., 1951, PMLA, V66, P107, DOI 10.2307/459593; Rosenzweig S., 1944, PARTISAN REV, V11, P436; Shakespeare William, 1963, COMPLETE SIGNET CLAS; Sharp M. C., 1963, CONFIDANTE H JAMES E; Stafford W. T., 1983, N NOVELS; Strouse J., 1996, CS COMPLETE STORIES; Suetonius, 1860, PRAETER CAESARUM LIB; Terence, 1926, COMOEDIAE ANDRIA HEA; Tintner A. R., 1994, HENRY JAMES REV, V15, P10; Tintner A. R., 1973, NOTES QUERIES, V20, P250; Tintner Adeline, 1991, COSMOPOLITAN WORLD H; Tintner Adeline R., 1986, MUSEUM WORLD H JAMES; Tintner Adeline R., 1989, POP WORLD H JAMES FA; Vaid K. B., 1964, TECHNIQUE TALES H JA; Vance N., 1997, VICTORIANS ANCIENT R; Walker P. A., 2006, CLHJ 1855 72 COMPLET; Walker P. A., 1999, HJC H JAMES CULTURE; Walker P. A., 2009, CLHJ 1872 6 COMPLETE; Walker P. A., 2012, CLHJ 1876 8 COMPLETE; Wellington J. E., 1956, THESIS FLORIDA STATE; WOOD C, 1977, STUD NOVEL, V9, P33; Wright W. F., 1962, MADNESS ART STUDY H; YACOBI T, 1985, STYLE, V19, P1	83	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1073-0508	1874-6292		INT J CLASS TRADIT	Int. J. Class. Tradit.	APR	2015	22	1					76	99		10.1007/s12138-014-0360-0		24	Humanities, Multidisciplinary; Classics	Arts & Humanities - Other Topics; Classics	CF0DQ	WOS:000352213400003		
J	Okihara, K; Ochiai, A; Kamoi, K; Fujizuka, Y; Miki, T; Ito, K				Okihara, Koji; Ochiai, Atsushi; Kamoi, Kazumi; Fujizuka, Yuji; Miki, Tsuneharu; Ito, Kazuto			Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: Focusing on Asians and Asian countries	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						Asia; proPSA; prostate cancer; PCA3; TMPRSS2:ERG	HEALTH INDEX PHI; MOLECULAR URINE TEST; RADICAL PROSTATECTOMY; GENE FUSIONS; 3 PCA3; MULTICENTER EVALUATION; ACTIVE SURVEILLANCE; ISOFORM P2PSA; TOTAL PSA; BIOPSY	We reviewed the current evidence for three novel prostate tumor markers (PCA3, TMPRSS2:ERG and proPSA) that have been recently reported predominantly in Western countries. We focus our attention on Asian men in both clinical and basic research studies. There have been no reports on the clinical usefulness of these three markers for Asians living in Western countries. In Asian countries, evidence for the clinical usefulness of PCA3 and proPSA-related indices including Prostate Health Index is being accumulated, mainly in Japan. The process for how a novel marker is approved in the clinical setting is also discussed.	[Okihara, Koji; Ochiai, Atsushi; Kamoi, Kazumi; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Kyoto 6028566, Japan; [Fujizuka, Yuji; Ito, Kazuto] Gunma Univ, Grad Sch Med, Dept Urol, Maebashi, Gumma 371, Japan	Okihara, K (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	okihara@koto.kpu-m.ac.jp					Jansen FH, 2010, EUR UROL, V57, P921, DOI 10.1016/j.eururo.2010.02.003; Chevli KK, 2014, J UROLOGY, V191, P1743, DOI 10.1016/j.juro.2013.12.005; Salami SS, 2013, UROL ONCOL-SEMIN ORI, V31, P566, DOI 10.1016/j.urolonc.2011.04.001; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Shen M, 2011, EXP MOL PATHOL, V90, P97, DOI 10.1016/j.yexmp.2010.10.009; Guazzoni G, 2011, EUR UROL, V60, P214, DOI 10.1016/j.eururo.2011.03.052; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Young A, 2012, AM J CLIN PATHOL, V138, P685, DOI 10.1309/AJCPU7PPWUPYG8OH; Leyten GHJM, 2014, EUR UROL, V65, P534, DOI 10.1016/j.eururo.2012.11.014; Guazzoni G, 2012, EUR UROL, V61, P455, DOI 10.1016/j.eururo.2011.10.038; Lazzeri M, 2013, EUR UROL, V63, P986, DOI 10.1016/j.eururo.2013.01.011; Lazzeri M, 2012, J UROLOGY, V188, P1137, DOI 10.1016/j.juro.2012.06.017; Lughezzani G, 2012, J UROLOGY, V188, P1144, DOI 10.1016/j.juro.2012.06.025; Crawford ED, 2012, J UROLOGY, V188, P1726, DOI 10.1016/j.juro.2012.07.023; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; Scattoni V, 2013, J UROLOGY, V190, P496, DOI 10.1016/j.juro.2013.02.3184; Stephan C, 2013, CLIN CHEM, V59, P306, DOI 10.1373/clinchem.2012.195784; Choudhury AD, 2012, EUR UROL, V62, P577, DOI 10.1016/j.eururo.2012.05.054; Heidegger I, 2014, PROSTATE CANCER P D, V17, P70, DOI 10.1038/pcan.2013.50; Cornu JN, 2013, PROSTATE, V73, P242, DOI 10.1002/pros.22563; Aubin SMJ, 2010, J UROLOGY, V184, P1947, DOI 10.1016/j.juro.2010.06.098; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; Gittelman MC, 2013, J UROLOGY, V190, P64, DOI 10.1016/j.juro.2013.02.018; Miyagi Y, 2010, MODERN PATHOL, V23, P1492, DOI 10.1038/modpathol.2010.149; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Lazzeri M, 2013, BJU INT, V112, P313, DOI 10.1111/bju.12217; Stephan C, 2013, CLIN CHEM, V59, P280, DOI 10.1373/clinchem.2012.195560; Ferro M, 2012, CLIN CHIM ACTA, V413, P1274, DOI 10.1016/j.cca.2012.04.017; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Tosoian JJ, 2012, J UROLOGY, V188, P1131, DOI 10.1016/j.juro.2012.06.009; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Ochiai A, 2013, BJU INT, V111, P928, DOI 10.1111/j.1464-410X.2012.11683.x; Perdona S, 2013, PROSTATE, V73, P227, DOI 10.1002/pros.22561; Baade Peter D, 2013, Prostate Int, V1, P47, DOI 10.12954/PI.12014; Ferro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067687; Fossatis N, 2014, BJU INT IN PRESS, DOI [10.1111/bju.12718, DOI 10.1111/BJU.12718]; Friedersdorff F, 2014, CLIN BIOCHEM, V47, P916, DOI 10.1016/j.clinbiochem.2014.02.002; Gjengsto P, 2005, J UROLOGY, V173, P425, DOI 10.1097/01.ju.0000149805.83040.1f; Hansen J, 2013, MOL DIAGN THER, V17, P1, DOI 10.1007/s40291-013-0014-y; Hirama H, 2014, J CANCER RES CLIN, V140, P257, DOI 10.1007/s00432-013-1566-2; Igawa T, 2014, J CLIN LAB ANAL, V28, P315, DOI 10.1002/jcla.21687; Isharwal S, 2011, UROLOGY, V77; Itos K, 2013, WORLD J UROL, V31, P305; Itos K, 2014, INT J CLIN ONCOL, V19, P782; Lees K, 2001, UROLOGY, V76; Les BV, 2010, J UROLOGY, V183, P1355; Lichtensztajns DY, 2014, J UROLOGY, V191, P1; Loeb S, 2013, J UROLOGY, V189, P1702, DOI 10.1016/j.juro.2012.11.149; Lughezzanis G, 2013, EUR UROL; Miyakubo M, 2009, INT J UROL, V16, P561, DOI 10.1111/j.1442-2042.2009.02304.x; Ng CF, 2012, HONG KONG MED J, V18, P459; Ngs CF, 2014, INT UROL NEPHROL, V46, P711; Nichol MB, 2012, BJU INT, V110, P353, DOI 10.1111/j.1464-410X.2011.10751.x; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Rhodes T, 2012, UROLOGY, V79, P655, DOI 10.1016/j.urology.2011.09.056; Suns QP, 2010, J MOL DIAGN, V12, P718; Takahashi H, 2014, PROSTATE, V74, P321, DOI 10.1002/pros.22754; Taos Z, 2010, EXP MOL PATHOL, V89, P58; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Veltri RW, 2006, UROLOGY, V68, P898, DOI 10.1016/j.urology.2006.05.008; Wang JJ, 2012, ASIAN PAC J CANCER P, V13, P4935, DOI 10.7314/APJCP.2012.13.10.4935	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					334	341		10.1111/iju.12701		8	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500002		
J	Kitta, T; Mitsui, T; Kanno, Y; Chiba, H; Moriya, K; Shinohara, N				Kitta, Takeya; Mitsui, Takahiko; Kanno, Yukiko; Chiba, Hiroki; Moriya, Kimihiko; Shinohara, Nobuo			Brain-bladder control network: The unsolved 21st century urological mystery	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						functional brain imaging; functional magnetic resonance imaging; functional near-infrared spectroscopy; micturition; overactive bladder; position emission tomography; single-photon emission computed tomography	PONTINE MICTURITION CENTER; URGE URINARY-INCONTINENCE; OVERACTIVE BLADDER; PERIAQUEDUCTAL GRAY; PARKINSONS-DISEASE; OLDER WOMEN; DETRUSOR OVERACTIVITY; SUPRASPINAL CONTROL; LIMBIC CONNECTIONS; INSULAR CORTEX	A review of functional brain imaging studies of bladder control in participants with normal control and pathological conditions. In the normal condition, bladder and urethral afferents received in the periaqueductal gray relay the information to the insula, the anterior cingulate cortex and the prefrontal cortex. During the storage phase, these superior regions control the pontine micturition center to inhibit voiding. In overactive bladder patients, brain responses are different. Cortical responses become exaggerated, especially in the anterior cingulate cortex and the supplementary motor area. That is what presumably evokes the urgency. The supplementary motor area is activated during contraction of the pelvic floor muscles, and provides protection against incontinence. We believe that functional brain imaging studies are promising not only for the understanding of bladder dysfunction, but also as an aid to the development of therapeutic options for chronic disorders.	[Kitta, Takeya; Mitsui, Takahiko; Kanno, Yukiko; Chiba, Hiroki; Moriya, Kimihiko; Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0608638, Japan	Kitta, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	kitta@fb3.so-net.ne.jp					Griffiths DJ, 2013, ACTA PHYSIOL, V207, P93, DOI 10.1111/apha.12019; DEGROAT WC, 1975, BRAIN RES, V87, P201, DOI 10.1016/0006-8993(75)90417-5; Blok BFM, 2002, UROLOGY, V59, P13, DOI 10.1016/S0090-4295(01)01633-8; Athwal BS, 2001, BRAIN, V124, P369, DOI 10.1093/brain/124.2.369; HOLSTEGE G, 1986, J COMP NEUROL, V250, P449, DOI 10.1002/cne.902500404; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Dasgupta R, 2005, J UROLOGY, V174, P2268, DOI 10.1097/01.ju.0000181806.59363.d1; Griffiths D, 2007, NEUROIMAGE, V37, P1, DOI 10.1016/j.neuroimage.2007.04.061; Nishijima S, 2012, J UROLOGY, V187, P1116, DOI 10.1016/j.juro.2011.10.128; Yamamoto T, 2010, NEUROSCI LETT, V473, P42, DOI 10.1016/j.neulet.2010.02.015; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Tadic SD, 2010, NEUROIMAGE, V51, P1294, DOI 10.1016/j.neuroimage.2010.03.016; Mehnert U, 2008, NEUROIMAGE, V41, P682, DOI 10.1016/j.neuroimage.2008.03.006; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Kitta T, 2006, J UROLOGY, V175, P994, DOI 10.1016/S0022-5347(05)00324-1; BLOK BFM, 1994, NEUROSCI LETT, V166, P93, DOI 10.1016/0304-3940(94)90848-6; Holstege G, 1998, BEHAV BRAIN RES, V92, P103, DOI 10.1016/S0166-4328(97)00182-4; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Sakakibara R, 1999, J NEUROL NEUROSUR PS, V67, P658, DOI 10.1136/jnnp.67.5.658; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Fukuyama H, 1996, NEUROREPORT, V7, P3009, DOI 10.1097/00001756-199611250-00042; Seseke S, 2006, NEUROIMAGE, V31, P1399, DOI 10.1016/j.neuroimage.2006.02.012; Tadic SD, 2008, NEUROIMAGE, V39, P1647, DOI 10.1016/j.neuroimage.2007.10.059; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Kuhtz-Buschbeck JP, 2007, NEUROIMAGE, V35, P449, DOI 10.1016/j.neuroimage.2006.12.032; Zhang H, 2005, NEUROIMAGE, V24, P174, DOI 10.1016/j.neuroimage.2004.08.027; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Tadic SD, 2012, NEUROUROL URODYNAM, V31, P652, DOI 10.1002/nau.21240; ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Blok BFM, 1998, BRAIN, V121, P2033, DOI 10.1093/brain/121.11.2033; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Matsumoto S, 2009, INT J UROL, V16, P760, DOI 10.1111/j.1442-2042.2009.02358.x; Schrum A, 2011, J UROLOGY, V186, P185, DOI 10.1016/j.juro.2011.03.001; Pfisterer MHD, 2006, J UROLOGY, V175, P1777, DOI 10.1016/S0022-5347(05)00985-7; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Nardos R, 2014, NEUROUROL URODYNAM, V33, P493, DOI 10.1002/nau.22458; DasGupta R, 2007, BJU INT, V99, P731, DOI 10.1111/j.1464-410X.2007.06749.x; Araki I, 2000, J UROLOGY, V164, P1640, DOI 10.1016/S0022-5347(05)67048-6; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Herholz K, 1999, DEMENT GERIATR COGN, V10, P494, DOI 10.1159/000017196; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Blok BFM, 1998, BEHAV BRAIN RES, V92, P119, DOI 10.1016/S0166-4328(97)00184-8; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Kuhtz-Buschbeck JP, 2005, J UROLOGY, V174, P1477, DOI 10.1097/01.ju.0000173007.84102.7c; OGAWA S, 1993, BIOPHYS J, V64, P803; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Ans X, 1998, J COMP NEUROL, V401, P455; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barrington FJ, 1925, J EXP PHYSL, V15, P81; Blok BFM, 1997, BRAIN, V120, P111, DOI 10.1093/brain/120.1.111; BLOK BFM, 1995, J COMP NEUROL, V359, P300, DOI 10.1002/cne.903590208; Blok Bertil F M, 2002, Scand J Urol Nephrol Suppl, P11; desGroat W. C., 2013, ACTA PHYSL OXF, V207, P66; Di Gangi Herms A M R, 2006, Neuroimage, V29, P267, DOI 10.1016/j.neuroimage.2005.07.018; Guenot M, 2004, ADV TECH STAND NEUR, V29, P265; Herzog J, 2006, BRAIN, V129, P3366, DOI 10.1093/brain/awl302; HOLSTEGE G, 1979, BRAIN RES, V171, P329, DOI 10.1016/0006-8993(79)90337-8; Holsteges G, 1982, BRAIN RES, V57, P145; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Bharat R, 2005, J COMP NEUROL, V493, P27, DOI 10.1002/cne.20753; Kims DK, 2008, PAIN, V139, P181; Komesu YM, 2011, FEMALE PELVIC MED RE, V17, P50, DOI 10.1097/SPV.0b013e3182065507; LEWIN RICHARD J., 1967, BRAIN RES, V4, P301, DOI 10.1016/0006-8993(67)90160-6; LEWIN RJ, 1965, NEUROLOGY, V15, P1049; Lius Z, 2004, NEUROSCIENCE, V126, P1075; Mouton LJ, 2000, J COMP NEUROL, V428, P389, DOI 10.1002/1096-9861(20001218)428:3<389::AID-CNE2>3.0.CO;2-B; Sakakibara Ryuji, 2012, Neurol Int, V4, pe13, DOI 10.4081/ni.2012.e13; Sakakibara R, 2010, NEUROUROL URODYNAM, V29, P757, DOI 10.1002/nau.20815; Sakakibara R, 2003, NEUROSCIENCE, V120, P871, DOI 10.1016/S0306-4522(03)00319-1; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Stewart W. F., 2003, World Journal of Urology, V20, P327; Tadic SD, 2010, J UROLOGY, V183, P221, DOI 10.1016/j.juro.2009.08.155; YAMAMOTO S, 1995, BRIT J UROL, V76, P272, DOI 10.1111/j.1464-410X.1995.tb07697.x; Yinglings CD, 1976, CLIN NEUROPHYSIOL, V41, P476; Yoshimura N, 2003, BRIT J PHARMACOL, V139, P1425, DOI 10.1038/sj.bjp.0705388	79	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					342	348		10.1111/iju.12721		7	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500003		
J	Kihara, K; Koga, F; Fujii, Y; Masuda, H; Tatokoro, M; Yokoyama, M; Matsuoka, Y; Numao, N; Ishioka, J; Saito, K				Kihara, Kazunori; Koga, Fumitaka; Fujii, Yasuhisa; Masuda, Hitoshi; Tatokoro, Manabu; Yokoyama, Minato; Matsuoka, Yoh; Numao, Noboru; Ishioka, Junichiro; Saito, Kazutaka			Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors: Perioperative outcomes	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						clampless sutureless partial nephrectomy; gasless laparoendoscopic single-port surgery; renal tumor; surgical outcomes	LAPAROSCOPIC PARTIAL NEPHRECTOMY; ROBOTIC PARTIAL NEPHRECTOMY; INCISION ENDOSCOPIC SURGERY; NEPHRON SPARING SURGERY; RADICAL NEPHRECTOMY; CELL CARCINOMA; UROLOGY; COMPLICATIONS; GUIDELINES; EXPERIENCE	ObjectivesTo describe the technical aspects of gasless laparoendoscopic single-port clampless sutureless partial nephrectomy for peripheral renal tumors, and to evaluate its outcomes, including surgical, pathological, and short-term oncological and functional outcomes. MethodsBetween January 2010 and June 2013, 103 patients with peripheral renal tumors suggestive of renal cell carcinoma underwent gasless laparoendoscopic single-port partial nephrectomy. In all cases, an attempt was made to accomplish partial nephrectomy without vascular clamping using ultrasonic coagulating and bipolar sealing devices. Hemostasis was achieved by coagulation and hemostatic agents without reconstructing the renal parenchyma. ResultsOf the 103 patients, gasless laparoendoscopic single-port partial nephrectomy was accomplished without vascular clamping and parenchymal suture in all but two patients (98%). Median operative time and blood loss were 191min and 244mL, respectively. One patient (1%) received allogeneic blood transfusion. The median postoperative time to full recovery was 3days. Three major complications (3%, all grade3 urinary leakage) were observed. Of 92 renal cell carcinoma patients, four (4%) had positive surgical margins, most of which underwent thermal degeneration histologically. In 91 non-metastatic renal cell carcinoma patients, 3-year local recurrence-free, progression-free, cancer-specific and overall survival rates were 100%, 99%, 100%, and 100%, respectively (mean follow-up period, 21months). In the 103 patients, the median percent decrease in estimated glomerular filtration rate 3months after partial nephrectomy was 2.4%. ConclusionsGasless laparoendoscopic single-port clampless sutureless partial nephrectomy can be accomplished in almost all cases of peripheral renal tumors. This surgery is technically feasible and safe, yielding acceptable short-term oncological outcomes and maximal preservation of renal function.	[Kihara, Kazunori; Koga, Fumitaka; Fujii, Yasuhisa; Masuda, Hitoshi; Tatokoro, Manabu; Yokoyama, Minato; Matsuoka, Yoh; Numao, Noboru; Ishioka, Junichiro; Saito, Kazutaka] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo 1138519, Japan	Fujii, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	y-fujii.uro@tmd.ac.jp			Sony Corporation (Tokyo, Japan)	Dr Kihara has received research funding from Sony Corporation (Tokyo, Japan), but the sponsor had no control over the interpretation, writing or publication of this work.	Albertos R, 2008, FUNDAMENTALS LAPAROS; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Chow WH, 2008, CANCER J, V14, P288, DOI 10.1097/PPO.0b013e3181867628; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; Smith GL, 2011, BJU INT, V107, P1054, DOI 10.1111/j.1464-410X.2010.09798.x; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Gettman MT, 2004, UROLOGY, V64, P914, DOI 10.1016/j.urology.2004.06.049; Thompson RH, 2007, J UROLOGY, V177, P471, DOI 10.1016/j.juro.2006.09.036; Bensalah K, 2010, EUR UROL, V57, P466, DOI 10.1016/j.eururo.2009.03.048; White WM, 2010, BJU INT, V105, P1580, DOI 10.1111/j.1464-410X.2009.09033.x; Merseburger AS, 2013, EUR UROL, V64, P277, DOI 10.1016/j.eururo.2013.05.034; Levey AS, 1999, ANN INTERN MED, V130, P461; Rogers CG, 2008, J UROLOGY, V180, P2353, DOI 10.1016/j.juro.2008.08.022; Motzer RJ, 2014, J NATL COMPR CANC NE, V12, P175; GILL IS, 1994, J UROLOGY, V152, P1539; Kaouk JH, 2009, EUR UROL, V55, P1163, DOI 10.1016/j.eururo.2008.12.029; Cindolo L, 2010, J ENDOUROL, V24, P1997, DOI 10.1089/end.2010.0313; Kageyama Y, 2002, JPN J CLIN ONCOL, V32, P417, DOI 10.1093/jjco/hyf087; Kihara K, 2014, VIDEOSURGERY MINIINV, V9, P634, DOI 10.5114/wiitm.2014.44155; Kihara K, 2009, INT J UROL, V16, P791, DOI 10.1111/j.1442-2042.2009.02366.x; Kihara K, 2010, AKTUEL UROL, V41, pS15, DOI 10.1055/s-0029-1224662; Kihara K, 2012, INT J UROL, V19, P886, DOI 10.1111/j.1442-2042.2012.03044.x; Marszaleks M, 2011, EUR UROL, V61, P757; Medeiros LJ, 1997, CANCER, V80, P990, DOI 10.1002/(SICI)1097-0142(19970901)80:5<990::AID-CNCR25>3.0.CO;2-Q; Shikanov S, 2010, BJU INT, V106, P91, DOI 10.1111/j.1464-410X.2009.09010.x; Simon SD, 2003, J UROLOGY, V169, P2059, DOI 10.1097/01.ju.0000058407.28232.38; Terai A, 2004, EUR UROL, V45, P744, DOI 10.1016/j.eururo.2004.02.007; Wszolek MF, 2011, BJU INT, V107, P1886, DOI 10.1111/j.1464-410X.2010.09713.x	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					349	355		10.1111/iju.12687		7	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500004		
J	Omae, K; Kondo, T; Takagi, T; Morita, S; Hashimoto, Y; Kobayashi, H; Iizuka, J; Nozaki, T; Yoshida, K; Tanabe, K				Omae, Kenji; Kondo, Tsunenori; Takagi, Toshio; Morita, Satoru; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Nozaki, Taiji; Yoshida, Kazuhiko; Tanabe, Kazunari			Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						aneurysm; laparoscopy; nephrectomy; robotics; renal neoplasms	LAPAROSCOPIC PARTIAL NEPHRECTOMY; ARTERY PSEUDOANEURYSM; COMPUTED-TOMOGRAPHY; COMPLICATIONS; OUTCOMES; TUMORS	ObjectivesTo investigate the incidence of asymptomatic unruptured renal artery pseudoaneurysm detected by 3-D computed tomography arteriography in the early period after minimally invasive partial nephrectomy, including laparoscopic and robotic partial nephrectomy. MethodsFrom February 2012 to November 2013, 101 patients underwent minimally invasive partial nephrectomy for renal masses. Computed tomography arteriography was carried out 3-4days after surgery; radiologists diagnosed renal artery pseudoaneurysm in a blinded manner. Factors influencing the occurrence of renal artery pseudoaneurysm were analyzed with the logistic regression model. ResultsThe incidence of renal artery pseudoaneurysm was unexpectedly high at 21.7% when detected by computed tomography arteriography during the early period after minimally invasive partial nephrectomy. The renal artery pseudoaneurysm group showed a significantly larger tumor size (P=0.02), significantly higher N component score (P=0.01) and higher incidence of renal sinus exposure or opening of the collecting system (P<0.01) compared with the no renal artery pseudoaneurysm group. Although these aforementioned factors were found to be significant by univariate analysis, multivariate analysis showed that renal sinus exposure was the only significant independent predictive factor for occurrence of renal artery pseudoaneurysm. Tumor-related factors, such as the N component of the nephrometry scoring system or tumor size, did not show an independent influence on the occurrence of renal artery pseudoaneurysm. ConclusionsThe present study shows an unexpectedly high incidence of asymptomatic unruptured renal artery pseudoaneurysm detected by computed tomography arteriography in the early period after minimally invasive partial nephrectomy. Renal sinus exposure is an independent significant factor predicting the occurrence of renal artery pseudoaneurysm. Avoidance of deep excision into the renal sinus could reduce the risk of renal artery pseudoaneurysm. (c) 2015 The Japanese Urological Association	[Omae, Kenji; Kondo, Tsunenori; Takagi, Toshio; Hashimoto, Yasunobu; Kobayashi, Hirohito; Iizuka, Junpei; Nozaki, Taiji; Yoshida, Kazuhiko; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Morita, Satoru] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Tokyo, Japan	Kondo, T (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tkondo@kc.twmu.ac.jp		Omae, Kenji/0000-0003-0109-7425			Albani JM, 2003, UROLOGY, V62, P227, DOI 10.1016/S0090-4295(03)00364-9; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Takagi T, 2014, INT J UROL, V21, P880, DOI 10.1111/iju.12462; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Nadu A, 2009, J UROLOGY, V181, P42, DOI 10.1016/j.juro.2008.09.014; Kaouk JH, 2012, EUR UROL, V62, P553, DOI 10.1016/j.eururo.2012.05.021; Singh D, 2005, J UROLOGY, V174, P2256, DOI 10.1097/01.ju.0000181827.49239.8c; Cohenpour M, 2007, CLIN RADIOL, V62, P1104, DOI 10.1016/j.crad.2007.06.004; Gill IS, 2002, J UROLOGY, V167, P469, DOI 10.1016/S0022-5347(01)69066-9; Tanagho YS, 2013, UROLOGY, V81, P573, DOI 10.1016/j.urology.2012.10.067; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Rogers CG, 2008, EUR UROL, V53, P514, DOI 10.1016/j.eururo.2007.09.047; Montag S, 2011, BJU INT, V107, P1460, DOI 10.1111/j.1464-410X.2010.09645.x; Netsch C, 2010, WORLD J UROL, V28, P519, DOI 10.1007/s00345-010-0572-0; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Nguyen MM, 2008, J UROLOGY, V179, P627, DOI 10.1016/j.juro.2007.09.086; Ghoneim TP, 2011, J UROLOGY, V185, P2061, DOI 10.1016/j.juro.2011.02.049; Ebles JN, 2004, WHO CLASSIFICATION T; Hyams ES, 2011, UROLOGY, V78, P820, DOI 10.1016/j.urology.2011.04.063; Kaouk JH, 2002, J UROLOGY, V167, P75; Nadu A, 2009, J UROLOGY, V181, P7; Ngs CK, 2012, EUR UROL, V61, P67; Nguyen MM, 2008, J UROLOGY, V179, P32; Scowcroft ACE, 2014, INT J CARDIOL, V171, P169, DOI 10.1016/j.ijcard.2013.11.086; Shapiros EY, 2009, UROLOGY, V74, P819; Sobin LH, 2009, TNM CLASSIFICATION M, P255	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					356	361		10.1111/iju.12696		6	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500005		
J	Sato, YT				Sato, Yuzuri Tsurumaki			Editorial Comment to Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database	INTERNATIONAL JOURNAL OF UROLOGY			English	Article							POSTOPERATIVE NOMOGRAM; RECURRENCE		Mushashino Red Cross Hosp, Div Urol, Tokyo, Japan	Sato, YT (reprint author), Mushashino Red Cross Hosp, Div Urol, Tokyo, Japan.	tsurumaki-jua@umin.ac.jp					Kattan MW, 1999, J CLIN ONCOL, V17, P1499; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Hans M, 2003, J UROLOGY, V169, P517; Mithal P, 2015, INT J UROL, V22, P362, DOI 10.1111/iju.12704	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					366	367		10.1111/iju.12733		2	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500008		
J	Nishi, M; Tsuchida, M; Ikeda, M; Matsuda, D; Iwamura, M				Nishi, Morihiro; Tsuchida, Mayumi; Ikeda, Masaomi; Matsuda, Daisuke; Iwamura, Masatsugu			Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction: Long-term results	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						laparoscopy; long-term; pyeloplasty; result; secondary	FAILED OPEN SURGERY; DISMEMBERED PYELOPLASTY; GOLD STANDARD; FOLLOW-UP; ENDOPYELOTOMY; COMPLICATIONS	ObjectiveTo evaluate the long-term results of laparoscopic pyeloplasty in patients with secondary ureteropelvic junction obstruction after failed primary interventions. MethodsBetween August 2000 and October 2012, transperitoneal dismembered laparoscopic pyeloplasty was carried out in 13 patients with a surgical history of failed prior surgical interventions. Perioperative outcomes as well as long-term results were assessed. These outcomes were compared with those of the same procedure carried out for primary ureteropelvic junction obstruction by a single surgeon during the same study period. ResultsLaparoscopic transperitoneal pyeloplasty was completed successfully in all cases without converting to open surgery or requiring blood transfusion. The preoperative symptoms in 12 of 13 patients all disappeared soon after the operation. Asymptomatic severe hydronephrosis found in a 2-year-old boy reduced in size postoperatively. When comparing the primary with the secondary laparoscopic pyeloplasty carried out by the same surgeon, the mean operative time was longer (183 vs 241min, P=0.002), estimated blood loss was larger (33 vs 66mL, P=0.03) and the complication rate was higher (8.8% vs 22.2%, P=0.01) in the secondary group. Success rates were 97.9% and 100% (P=0.41) at a mean follow up of 25.9 and 40.0months (P=0.14) for the primary and secondary groups, respectively. ConclusionsLaparoscopic pyeloplasty is an excellent option for patients who failed previous surgical management. This approach provides durable long-term outcomes comparable with those of primary treatment for ureteropelvic junction obstruction.	[Nishi, Morihiro; Tsuchida, Mayumi; Ikeda, Masaomi; Matsuda, Daisuke; Iwamura, Masatsugu] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa 2520374, Japan	Nishi, M (reprint author), Kitasato Univ, Sch Med, Dept Urol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	uromori2000@yahoo.co.jp					ANDERSON J C, 1949, Br J Urol, V21, P209, DOI 10.1111/j.1464-410X.1949.tb10773.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Moon DA, 2006, UROLOGY, V67, P932, DOI 10.1016/j.urology.2005.11.024; BROOKS JD, 1995, UROLOGY, V46, P791, DOI 10.1016/S0090-4295(99)80345-8; Weise ES, 2006, J ENDOUROL, V20, P813, DOI 10.1089/end.2006.20.813; Juliano RV, 2011, J LAPAROENDOSC ADV S, V21, P399, DOI 10.1089/lap.2010.0281; Inagaki T, 2005, BJU INT, V95, P102, DOI 10.1111/j.1464-410X.2005.05208.x; Sundaram CP, 2003, J UROLOGY, V169, P2037, DOI 10.1097/01.ju.0000067180.78134.da; MOTOLA JA, 1993, J UROLOGY, V149, P453; Eden C, 2004, J UROLOGY, V172, P2308, DOI 10.1097/01.ju.0000143904.17666.0b; BADLANI G, 1986, J UROLOGY, V135, P26; Piaggio LA, 2007, J UROLOGY, V177, P1878, DOI 10.1016/j.juro.2007.01.053; Symons SJ, 2009, J ENDOUROL, V23, P463, DOI 10.1089/end.2008.0208; Pouliot F, 2010, J ENDOUROL, V24, P299, DOI 10.1089/end.2009.0134; Yohannes P, 2002, UROLOGY, V60, P39, DOI 10.1016/S0090-4295(02)01717-X; Niver BE, 2012, UROLOGY, V79, P689, DOI 10.1016/j.urology.2011.10.072; Bansal Punit, 2008, J Minim Access Surg, V4, P76; Basiri A, 2007, J ENDOUROL, V21, P1045, DOI 10.1089/end.2006.0414; Brito AH, 2007, J ENDOUROL, V21, P1481, DOI 10.1089/end.2007.0082; Iwamura M, 2004, INT J UROL, V11, P449, DOI 10.1111/j.1442-2042.2004.00830.x; KLETSCHER BA, 1995, J UROLOGY, V153, P701, DOI 10.1016/S0022-5347(01)67691-2; MERETYK I, 1992, J UROLOGY, V148, P775; Nadler RB, 1996, J UROLOGY, V156, P1094, DOI 10.1016/S0022-5347(01)65712-4; NAKADA SY, 1995, UROLOGY, V46, P257, DOI 10.1016/S0090-4295(99)80205-2; O'Reilly PH, 2001, BJU INT, V87, P287, DOI 10.1046/j.1464-410x.2001.00108.x; PERSKY L, 1977, J UROLOGY, V118, P162; SCHUESSLER WW, 1993, J UROLOGY, V150, P1795; Shadpour P, 2011, UROL J, V8, P31; Shapiro EY, 2009, UROLOGY, V73, P115, DOI 10.1016/j.urology.2008.08.483; VANCANGH PJ, 1994, J UROLOGY, V151, P934	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					368	371		10.1111/iju.12686		4	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500009		
J	Ito, H; Kuroda, S; Kawahara, T; Makiyama, K; Yao, M; Matsuzaki, J				Ito, Hiroki; Kuroda, Shinnosuke; Kawahara, Takashi; Makiyama, Kazuhide; Yao, Masahiro; Matsuzaki, Junichi			Preoperative factors predicting spontaneous clearance of residual stone fragments after flexible ureteroscopy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						computed tomography; helical; kidney stone; lithotripsy; multivariate analysis; ureteroscopy	LASER LITHOTRIPSY; RENAL STONES; SHOCKWAVE LITHOTRIPSY; PELVICALICEAL ANATOMY; URETERAL PERISTALSIS; INTRARENAL STONES; 2 CM; CALCULI; IMPACT; NEPHROLITHOMETRY	ObjectiveTo investigate factors predicting spontaneous clearance of residual renal fragments after flexible ureteroscopy. MethodsAmong 546 patients who underwent lithotripsy with flexible ureteroscopy, 81 had residual renal fragments, as determined by kidney-ureter-bladder films on postoperative day1. The final outcome was determined at 3months after the last flexible ureteroscopy session using non-contrast computed tomography. Patient characteristics and preoperative factors were analyzed using the unpaired t-test and (2)-test. Correlations between the possible predictive factors and the spontaneous clearance of residual renal fragments after flexible ureteroscopy were analyzed using a multivariate logistic regression model with backward selection. ResultsNon-contrast computed tomography at postoperative month3 showed that 33 cases (40.7%) had spontaneous clearance of residual renal fragments, whereas 48 (59.3%) showed non-clearance. Significant differences were found between these cases in terms of stone number, stone location, presence of lower pole calculi and preoperative stent placement. Multivariate assessment showed that stone number (P=0.004), presence of lower pole calculi (P=0.021) and presence of hydronephrosis (P=0.024) were independent predictors of the spontaneous clearance of residual renal fragments after flexible ureteroscopy. ConclusionsStone number, presence of lower pole calculi and presence of hydronephrosis are independent predictive factors of the spontaneous clearance of residual renal fragments after flexible ureteroscopy.	[Ito, Hiroki; Kuroda, Shinnosuke; Matsuzaki, Junichi] Ohguchi East Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Ito, Hiroki; Kawahara, Takashi; Makiyama, Kazuhide; Yao, Masahiro] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360012, Japan	Ito, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Urol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360012, Japan.	pug_daikichi@yahoo.co.jp					Resorlu B, 2012, UROLOGY, V79, P61, DOI 10.1016/j.urology.2011.06.031; Venkatesh R, 2005, J ENDOUROL, V19, P170, DOI 10.1089/end.2005.19.170; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; El-Nahas AR, 2006, J ENDOUROL, V20, P870, DOI 10.1089/end.2006.20.870; Geavlete P, 2014, NAT REV UROL, V11, P373, DOI 10.1038/nrurol.2014.118; Raman JD, 2009, J UROLOGY, V181, P1163, DOI 10.1016/j.juro.2008.10.162; Okhunov Z, 2013, UROLOGY, V81, P1154, DOI 10.1016/j.urology.2012.10.083; Cohen J, 2013, BJU INT, V111, pE127, DOI 10.1111/j.1464-410X.2012.11352.x; Rebuck DA, 2011, UROLOGY, V77, P564, DOI 10.1016/j.urology.2010.06.056; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Altunrende F, 2011, J ENDOUROL, V25, P941, DOI 10.1089/end.2010.0491; Tiselius HG, 2001, EUR UROL, V40, P362, DOI 10.1159/000049803; Takazawa R, 2012, INT J UROL, V19, P264, DOI 10.1111/j.1442-2042.2011.02931.x; Candau C, 2000, EUR UROL, V37, P18, DOI 10.1159/000020093; Breda A, 2008, J UROLOGY, V179, P981, DOI 10.1016/j.juro.2007.10.083; Kinn AC, 2002, UROL RES, V30, P213, DOI 10.1007/s00240-002-0258-1; Streem SB, 1996, J UROLOGY, V155, P1186, DOI 10.1016/S0022-5347(01)66208-6; Natalin RA, 2009, BJU INT, V103, P1128, DOI 10.1111/j.1464-410X.2008.08184.x; Cicerellos E, 2012, ADV UROL, V2012; Haskins AE, 2014, INT J UROL, V21, P1227, DOI 10.1111/iju.12566; Itos H, 2014, BJU INT, DOI [10.1111/bju.12775, DOI 10.1111/BJU.12775]; Itos H, 2012, UROLOGY, V80, P524; Itos H, 2013, J ENDOUROL, V27, P715; Itos H, 2012, J ENDOUROL, V26, P1125; Okhunov Z, 2013, J ENDOUROL, V27, P1303, DOI 10.1089/end.2013.0289; Schatloff O, 2010, J UROLOGY, V183, P1031, DOI 10.1016/j.juro.2009.11.013; Sozen S, 2008, J ENDOUROL, V22, P877, DOI 10.1089/end.2007.0277; vans Diepens M, 2014, PLOS ONE, V9	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					372	377		10.1111/iju.12690		6	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500010		
J	Nishizawa, O; Yoshida, M; Takeda, M; Yokoyama, O; Morisaki, Y; Murakami, M; Viktrup, L				Nishizawa, Osamu; Yoshida, Masaki; Takeda, Masayuki; Yokoyama, Osamu; Morisaki, Yoji; Murakami, Masahiro; Viktrup, Lars			Tadalafil 5mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double-blind, placebo-controlled studies	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						Asia; benign prostatic hyperplasia; lower urinary tract symptoms; prostate; tadalafil	OPEN-LABEL EXTENSION; ERECTILE DYSFUNCTION; JAPANESE MEN; PREVALENCE; AMERICAN; BLADDER; TRIAL; KOREA; BPH	ObjectivesAssess the efficacy and safety of tadalafil 5mg once-daily in Asian men with lower urinary tract symptoms by pooling data from three clinical studies. MethodsData on 1199 Japanese, Korean, and Taiwanese men given tadalafil 5mg (n=601) or placebo (n=598) were pooled from three double-blind, placebo-controlled, 12-week studies. Efficacy measures included International Prostate Symptom Score, and Patient and Clinician Global Impressions of Improvement. These measures were also assessed for patient subgroups (age categories, baseline disease severity and/or prostate volume, prior alpha-blocker treatment). Safety measures included adverse events, including those in selected body systems. Efficacy measure changes throughout treatment were assessed by mixed-effect model repeated-measures analysis; baseline to end-point changes for the total population and subgroups were evaluated by analysis of covariance. ResultsTadalafil 5mg led to significant improvement (vs placebo) in all International Prostate Symptom Scores at all time-points (week4 P0.013 for all measures; week8 P0.005, week12 P<0.001). End-point results for both global impressions scales also favored tadalafil (both P<0.001 vs placebo). Tadalafil efficacy was similar between patient subgroups of varied disease severity (interaction P=0.097), prior alpha-blocker use (P=0.580), and prostate volume (P=0.921). The drug was slightly less effective in older men (interaction P=0.042). No unexpected adverse events were reported, and no meaningful adverse effects were observed in visual, auditory, or cardiovascular systems. ConclusionsTadalafil 5mg once-daily for 12weeks is efficacious and safe in Asian men with lower urinary tract symptoms. Tadalafil is also effective in men of different ages, disease severity, prior alpha-blocker exposure, and prostate volumes.	[Nishizawa, Osamu] Azumi Gen Hosp, Dept Urol, Kitaazumi, Nagano, Japan; [Yoshida, Masaki] Natl Ctr Geriatr & Gerontol, Dept Urol, Obu, Aichi, Japan; [Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Kofu, Yamanashi, Japan; [Yokoyama, Osamu] Univ Fukui, Fac Med Sci, Dept Urol, Fukui, Japan; [Morisaki, Yoji; Murakami, Masahiro] Eli Lilly Japan KK, Med Dev Unit Japan, Kobe, Hyogo, Japan; [Viktrup, Lars] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Murakami, M (reprint author), Eli Lilly Japan KK, Med Dev Unit Japan, Chuo Ku, Sannomiya Plaza Bldg,7-1-5 Isogamidori, Kobe, Hyogo 6510086, Japan.	murakami_masahiro@lilly.com			Eli Lilly; Company (Lilly)	Eli Lilly and Company (Lilly) sponsored and funded this work. The authors thank Scott J Burke and Cindi Wood (inVentiv Health Clinical), and Yukiko Inoue (Eli Lilly Japan K.K.) for their technical/writing assistance.	Porst H, 2011, EUR UROL, V60, P1105, DOI 10.1016/j.eururo.2011.08.005; Roehrborn CG, 2008, J UROLOGY, V180, P1228, DOI 10.1016/j.juro.2008.06.079; Egerdie RB, 2012, J SEX MED, V9, P271, DOI 10.1111/j.1743-6109.2011.02504.x; Giuliano F, 2013, J SEX MED, V10, P857, DOI 10.1111/jsm.12039; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Donatucci CF, 2011, BJU INT, V107, P1110, DOI 10.1111/j.1464-410X.2010.09687.x; Verhamme KMC, 2002, EUR UROL, V42, P323, DOI 10.1016/S0302-2838(02)00354-8; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Bertolotto M, 2009, RADIOL MED, V114, P1106, DOI 10.1007/s11547-009-0449-8; Barry MJ, 2001, UROLOGY, V58, P25, DOI 10.1016/S0090-4295(01)01300-0; Giuliano F, 2013, EUR UROL, V63, P506, DOI 10.1016/j.eururo.2012.09.006; Porst H, 2013, UROLOGY, V82, P667, DOI 10.1016/j.urology.2013.05.005; Minagawa T, 2012, BJU INT, V110, pE259, DOI 10.1111/j.1464-410X.2012.11255.x; AVOLVE, 2010, PRECR INF; BARRY MJ, 1992, J UROLOGY, V148, P1549; Guys W National Institute of Mental Health (U. S.). Psychopharmacology Research Branch. & Early Clinical Drug Evaluation Program, 1976, ECDEU ASSESSMENT MAN; HARNAL D., 2010, PRESCRIBING INFORM; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Kang JY, 2011, PROSTATE CANCER P D, V14, P243, DOI 10.1038/pcan.2011.12; Kims SC, 2011, LUTS, V3, P86; Lees SW, 2014, WORLD J MENS HLTH, V32, P28; Lepor Herbert, 2004, Rev Urol, V6 Suppl 2, pS3; Takeda M, 2014, INT J UROL, V21, P670, DOI 10.1111/iju.12410; Takeda M, 2012, LUTS, V4, P110, DOI 10.1111/j.1757-5672.2012.00144.x; Terai A, 2000, Hinyokika Kiyo, V46, P537; The Japanese Urological Association, 2011, CLIN GUID BEN PROST; TSUKAMOTO T, 1995, J UROLOGY, V154, P391, DOI 10.1016/S0022-5347(01)67059-9; URIEF, 2009, PRECR INF; Yokoyamas O, 2013, INT J UROL, V20, P193; ZALUTIA, 2014, PRECR INF	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					378	384		10.1111/iju.12699		7	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500011		
J	Sato, R; Sadaoka, Y; Nishio, K; Kobori, Y; Yagi, H; Arai, G; Soh, S; Okada, H				Sato, Ryo; Sadaoka, Yuko; Nishio, Kojiro; Kobori, Yoshitomo; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi			Effects of preoperative dutasteride treatment in holmium laser enucleation of the prostate	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						dutasteride; laser therapy; magnetic resonance imaging; prostate; urological surgical procedures	TRANSURETHRAL RESECTION; BLOOD-LOSS; FINASTERIDE; BENIGN; HYPERPLASIA; THERAPY; CANCER; TRIAL	ObjectivesTo investigate factors influencing the degree of difficulty in finding and maintaining an appropriate plane on the surgical capsule of the prostate during holmium laser enucleation of the prostate. MethodsA total of 116 men undergoing holmium laser enucleation of the prostate for benign prostate hyperplasia between January 2010 and September 2013 at our hospital were included in this analysis. The degree of difficulty in finding and maintaining the plane of the surgical capsule of the prostate was retrospectively evaluated and graded by using video-based analysis according to newly defined criteria (gradeI, least difficult; gradeIV, most difficult). Factors influencing the degree of difficulty were investigated. ResultsVideo analysis was possible in 99 of 116 patients. Decapsulation difficulty in decapsulation was deemed as being gradeI in 32 patients, gradeII in 31 patients, gradeIII in 20 patients and gradeIV in 16 patients. Preoperative dutasteride therapy was the only factor associated with an increasing level of difficulty in decapsulation during holmium laser enucleation of the prostate. ConclusionsAlthough preoperative dutasteride therapy effectively reduces intraoperative blood loss, surgeons with limited experience should be careful with the use of dutasteride, because its administration might increase surgical difficulty during holmium laser enucleation of the prostate.	[Sato, Ryo; Sadaoka, Yuko; Nishio, Kojiro; Kobori, Yoshitomo; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi] Dokkyo Med Univ, Dept Urol, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan	Sato, R (reprint author), Dokkyo Med Univ, Dept Urol, Koshigaya Hosp, 1-50 Minami Koshigaya 2 Chome, Koshigaya, Saitama 3438555, Japan.	ryo-sato@dokkyomed.ac.jp					Kuntz RM, 2004, J UROLOGY, V172, P1012, DOI 10.1097/01.ju.0000136218.11998.9e; Iczkowski KA, 2005, UROLOGY, V65, P76, DOI 10.1016/j.urology.2004.08.042; Endo F, 2010, UROLOGY, V76, P1451, DOI 10.1016/j.urology.2010.03.071; Sandfeldt L, 2001, UROLOGY, V58, P972, DOI 10.1016/S0090-4295(01)01408-X; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Gupta N, 2006, BJU INT, V97, P85, DOI 10.1111/j.1464-410X.2006.05862.x; Pareek G, 2003, J UROLOGY, V169, P20, DOI 10.1097/01.ju.0000039923.75777.91; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; El-Hakim A, 2002, BJU INT, V90, P863, DOI 10.1046/j.1464-4096.2002.03071.x; Donohue JF, 2002, J UROLOGY, V168, P2024, DOI 10.1097/01.ju.0000028607.29093.56; Hahn RG, 2007, BJU INT, V99, P587, DOI 10.1111/j.1464-410X.2006.06619.x; Homma Y, 2011, INT J UROL, V18, pE1, DOI 10.1111/j.1442-2042.2011.02861.x; Sutton MT, 2006, PROSTATE, V66, P1194, DOI 10.1002/pros.20444; Suzukis K, 2012, JPN UROL SURG, V25, P2145; Tans AHH, 2003, J UROLOGY, V170, P1270; Yang XJ, 1999, UROLOGY, V53, P696, DOI 10.1016/S0090-4295(98)00579-2	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					385	388		10.1111/iju.12703		4	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500012		
J	Soh, S; Kobori, Y; Shin, T; Suzuki, K; Iwahata, T; Sadaoka, Y; Sato, R; Nishi, M; Iwamura, M; Okada, H				Soh, Shigehiro; Kobori, Yoshitomo; Shin, Takeshi; Suzuki, Keisuke; Iwahata, Toshiyuki; Sadaoka, Yuko; Sato, Ryo; Nishi, Morihiro; Iwamura, Masatsugu; Okada, Hiroshi			Transvesicoscopic ureteral reimplantation: Politano-Leadbetter versus Cohen technique	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						laparoscopic; pneumovesicum; transvesical; ureteral reimplantation; vesicoureteral reflux	LICH-GREGOIR TECHNIQUE; VESICOURETERAL REFLUX; INITIAL-EXPERIENCE; PEDIATRIC-PATIENTS; CHILDREN; ADVANCEMENT	ObjectivesTo compare the outcomes of the Politano-Leadbetter and Cohen techniques in laparoscopic pneumovesicum approach for ureteral reimplantation. MethodsWe retrospectively reviewed the medical records of 24 patients who underwent transvesicoscopic ureteral reimplantation during the period from 2007 to 2014. The patients were treated with either the Cohen or Politano-Leadbetter technique. Operative duration, duration of hospital stay, and success and complication rates were compared. ResultsOperative duration was 1h longer for the Politano-Leadbetter technique than for the Cohen technique (P<0.05). Foley catheters were removed 2-3days after the procedures. The mean hospital stay was 3.6days. Reflux completely resolved in 21 patients (35 ureters, 94.6%), but not in two patients (2 ureters). There was no difference in the success rate or durations of catheterization or hospital stay between patients treated with the Politano-Leadbetter technique and those treated with the Cohen technique. ConclusionsThe Politano-Leadbetter and Cohen techniques are both reliable for transvesicoscopic ureteral reimplantation. Despite a longer operative time, because of the higher surgical complexity, the Politano-Leadbetter ureteral reimplantation offers important physiological advantages over other techniques.	[Soh, Shigehiro; Kobori, Yoshitomo; Shin, Takeshi; Suzuki, Keisuke; Iwahata, Toshiyuki; Sadaoka, Yuko; Sato, Ryo; Okada, Hiroshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Urol, Koshigaya 3438555, Japan; [Nishi, Morihiro; Iwamura, Masatsugu] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 228, Japan	Soh, S (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Urol, 2-1-50 Minami Koshigaya, Koshigaya 3438555, Japan.	ssong@dokkyomed.ac.jp					KENNELLY MJ, 1995, UROLOGY, V46, P393, DOI 10.1016/S0090-4295(99)80226-X; Lakshmanan Y, 2000, J ENDOUROL, V14, P589, DOI 10.1089/08927790050152203; Barrieras D, 1999, J UROLOGY, V162, P1197, DOI 10.1016/S0022-5347(01)68130-8; Chung MS, 2012, J LAPAROENDOSC ADV S, V22, P295, DOI 10.1089/lap.2011.0318; Holmdahl G, 2010, J UROLOGY, V184, P280, DOI 10.1016/j.juro.2010.01.059; Canon SJ, 2007, J UROLOGY, V178, P269, DOI 10.1016/j.juro.2007.03.059; Elder JS, 2006, J UROLOGY, V175, P716, DOI 10.1016/S0022-5347(05)00210-7; Marchini GS, 2011, J UROLOGY, V185, P1870, DOI 10.1016/j.juro.2010.12.069; Yeung CK, 2005, J ENDOUROL, V19, P295, DOI 10.1089/end.2005.19.295; Smith RP, 2011, J UROLOGY, V185, P1876, DOI 10.1016/j.juro.2010.12.072; Kojima Y, 2012, J UROLOGY, V188, P582, DOI 10.1016/j.juro.2012.04.018; Lopez M, 2010, J PEDIATR SURG, V45, P806, DOI 10.1016/j.jpedsurg.2009.12.003; BURBIGE KA, 1991, J UROLOGY, V146, P1352; Castillo OA, 2013, ACTAS UROL ESP, V37, P630, DOI 10.1016/j.acuro.2013.04.007; Chung PHY, 2008, J PEDIATR SURG, V43, P2246, DOI 10.1016/j.jpedsurg.2008.08.057; Emir H, 2012, J PEDIATR UROL, V8, P83, DOI 10.1016/j.jpurol.2010.10.005; Hayashi Y, 2014, INT J UROL, V21, P1016, DOI 10.1111/iju.12483; Heidenreich A, 2004, WORLD J UROL, V22, P96, DOI 10.1007/s00345-0074-0408-x; Kawauchi A, 2003, INT J UROL, V10, P90, DOI 10.1046/j.1442-2042.2003.00570.x; Kawauchi A, 2009, J ENDOUROL, V23, P1875, DOI 10.1089/end.2009.0239; Sakamoto W, 2003, INT J UROL, V10, P94, DOI 10.1046/j.1442-2042.2003.00583.x	21	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					394	399		10.1111/iju.12702		6	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500014		
J	Sasaki, Y; Kohjimoto, Y; Iba, A; Matsumura, N; Hara, I				Sasaki, Yumiko; Kohjimoto, Yasuo; Iba, Akinori; Matsumura, Nagahide; Hara, Isao			Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						animal models; kidney stone; metabolic syndrome; rat; weight loss	TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; NEPHROLITHIASIS; HYPERTENSION; PREVALENCE; REDUCTION; ACID; UROLITHIASIS; ASSOCIATION	ObjectivesTo investigate the effect of weight loss intervention on the urinary stone risk parameters in a rat model of metabolic syndrome. MethodsIn a prevention study, 4-week-old male Otsuka Long-Evans Tokushima Fatty rats were randomly assigned to three groups: control, food-restricted and food-restricted+exercise-trained groups. In a treatment study, 24-week-old male Otsuka Long-Evans Tokushima Fatty rats that had already developed type2 diabetes were randomly assigned to the same three groups. Blood and 24-h urine chemistry were measured after 16weeks. ResultsIn both studies, food-restricted and food-restricted+exercise-trained rats showed significantly higher urinary pH and higher excretion of urinary citrate than control rats. In the prevention study, ion-activity products of calcium oxalate in the food-restricted and food-restricted+exercise-trained groups were significantly lower than that of control rats. In the treatment study, ion-activity products of calcium oxalate index in food-restricted+exercise-trained rats was significantly lower than that of control rats. ConclusionsWeight loss intervention seems to reduce the risk of uric acid stone formation by improving low urine pH and calcium oxalate stone formation by increasing urinary citrate excretion. The present study provides the first theoretical evidence to support weight loss intervention programs for nephrolithiasis patients with metabolic syndrome.	[Sasaki, Yumiko; Kohjimoto, Yasuo; Iba, Akinori; Matsumura, Nagahide; Hara, Isao] Wakayama Med Univ, Dept Urol, Wakayama, Wakayama 6418509, Japan	Kohjimoto, Y (reprint author), Wakayama Med Univ, Dept Urol, 811-1 Kimiidera, Wakayama, Wakayama 6418509, Japan.	ykohji@wakayama-med.ac.jp			Wakayama Medical Award for Young Researchers	This study was partly supported by 2011 Wakayama Medical Award for Young Researchers.	Ando R, 2011, INT J UROL, V18, P131, DOI 10.1111/j.1442-2042.2010.02690.x; Deitel M, 2003, OBES SURG, V13, P329, DOI 10.1381/096089203765887598; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Maalouf NM, 2004, KIDNEY INT, V65, P1422, DOI 10.1111/j.1523-1755.2004.00522.x; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing RR, 2010, ARCH INTERN MED, V170, P1566; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Klisic J, 2002, AM J PHYSIOL-RENAL, V283, pF532, DOI 10.1152/ajprenal.00365.2001; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Kohjimoto Y, 2013, AM J KIDNEY DIS, V61, P923, DOI 10.1053/j.ajkd.2012.12.028; Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; Asplin JR, 1996, SEMIN NEPHROL, V16, P412; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; CHOBANIAN MC, 1987, AM J PHYSIOL, V253, pF1171; DAVIS BR, 1993, ARCH INTERN MED, V153, P1773, DOI 10.1001/archinte.153.15.1773; Ibas A, 2010, BJU INT, V106, P1550; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; NISSIM I, 1995, KIDNEY INT, V47, P96, DOI 10.1038/ki.1995.11	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					404	409		10.1111/iju.12691		6	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500016		
J	Nakajima, A; Ide, H; Kitamura, K; Muto, S; Yamaguchi, R; Horie, S				Nakajima, Akiko; Ide, Hisamitsu; Kitamura, Kosuke; Muto, Satoru; Yamaguchi, Raizo; Horie, Shigeo			Rare case of temporally spontaneous regression of retroperitoneal paraganglioma	INTERNATIONAL JOURNAL OF UROLOGY			English	Article									[Nakajima, Akiko; Ide, Hisamitsu; Kitamura, Kosuke; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan; [Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan	Nakajima, A (reprint author), Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan.	ihisamit@med.teikyo-u.ac.jp					Chang J T, 1988, Taiwan Yi Xue Hui Za Zhi, V87, P1224; Kobayashi T, 2005, J SURG ONCOL, V90, P31, DOI 10.1002/jso.20234; Van der Harst E, 1998, INT J CANCER, V79, P537, DOI 10.1002/(SICI)1097-0215(19981023)79:5<537::AID-IJC16>3.0.CO;2-Z; Yaus KK, 2008, ASIAN J SURG, V31, P32	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					421	422		10.1111/iju.12724		2	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500019		
J	Isotani, S				Isotani, Shuji			Editorial Comment from Dr Isotani to Three-dimensional printing in urological surgery: What are the possibilities?	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan	Isotani, S (reprint author), Teikyo Univ, Sch Med, Dept Urol, Tokyo 173, Japan.	sisotan@med.teikyo-u.ac.jp					Silberstein JL, 2014, UROLOGY, V84, P268, DOI 10.1016/j.urology.2014.03.042; Maddoxs MM, 2015, ANN M AM UR ASS 15 1	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					424	424		10.1111/iju.12742		1	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500021		
J	Kimura, T				Kimura, Takahiro			Immunotherapy of castrate-resistant prostate cancer: Progress and new paradigms	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Kimura, Takahiro] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					426	427				2	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500025		
J	Shinohara, N				Shinohara, Nobuo			How to assess the response to targeted therapies in patients with metastatic renal cell carcinoma	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan							Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Kakizoe M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-390	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					427	428				2	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500029		
J	Uemura, H; Reiter, R				Uemura, Hirotsugu; Reiter, Robert			Treatment of castrate-resistant prostate cancer - What is the best management?	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Uemura, Hirotsugu] Kinki Univ, Fac Med, Dept Urol, Osaka, Japan; [Reiter, Robert] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Prostate Canc Program, Los Angeles, CA 90095 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					427	427				1	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500027		
J	Eto, M; Flanigan, R				Eto, Masatoshi; Flanigan, Robert			What is your choice of treatment for this situation?!	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Eto, Masatoshi] Kumamoto Univ, Fac Life Sci, Dept Urol, Kumamoto, Japan; [Flanigan, Robert] Loyola Univ, Med Ctr, Dept Urol, Maywood, IL 60153 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					428	428				1	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500030		
J	Horie, S				Horie, Shigeo			Testosterone levels, depressive symptoms, and falls in older men	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					428	428				1	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500031		
J	Kakehi, Y; Griebling, TL				Kakehi, Yoshiyuki; Griebling, Tomas L.			Approaches to complicated cases of male lower urinary tract symptoms	INTERNATIONAL JOURNAL OF UROLOGY			English	Meeting Abstract									[Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 760, Japan; [Griebling, Tomas L.] Univ Kansas, Sch Med, Dept Urol, Kansas City, KS USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	APR	2015	22	4					429	429				1	Urology & Nephrology	Urology & Nephrology	CF0JC	WOS:000352228500033		
J	Sasaki, Y; Miwa, K; Yamashita, K; Sunakawa, Y; Shimada, K; Ishida, H; Hasegawa, K; Fujiwara, K; Kodaira, M; Fujiwara, Y; Namiki, M; Matsuda, M; Takeuchi, Y; Katsumata, N				Sasaki, Yasutsuna; Miwa, Keisuke; Yamashita, Keishi; Sunakawa, Yu; Shimada, Ken; Ishida, Hiroo; Hasegawa, Kosei; Fujiwara, Keiichi; Kodaira, Makoto; Fujiwara, Yasuhiro; Namiki, Masayuki; Matsuda, Minami; Takeuchi, Yutaka; Katsumata, Noriyuki			A phase I study of farletuzumab, a humanized anti-folate receptor alpha monoclonal antibody, in patients with solid tumors	INVESTIGATIONAL NEW DRUGS			English	Article						Farletuzumab; Folate receptor alpha; Monoclonal antibody; Pharmacokinetics; Phase I study	FOLATE-BINDING-PROTEIN; OVARIAN-CANCER; GASTRIC-CANCER; TRIAL; CHEMOTHERAPY; PLUS	Farletuzumab is a humanized monoclonal antibody against folate receptor alpha (FRA). The purpose of the study is to assess safety and tolerability, the pharmacokinetic (PK) profile, and preliminary antitumor effect. Patients with ovarian cancer (OC) or FRA-expressing solid tumors who are resistant to standard treatments were eligible for the study. After single-dose administration for PK assessment, farletuzumab was administered by intravenous injection, repeating every week until disease progression. Dose-limiting toxicities (DLTs) were defined as grade 4 hematological and grade 3/4 nonhematological toxicities. Dose escalation was planned in 4 cohorts (50, 100, 200, and 400 mg/m(2)). Fourteen patients with OC and two patients with gastric cancer (GC) received farletuzumab infusion. Neither DLTs nor grade 3/4 toxicities were reported in all cohorts. Major adverse events, including grade 1/2 infusion related reaction (15 patients, 93.8 %), headache (seven patients, 43.8 %), and nausea and decreased appetite (five patients each, 31.3 %), were observed and medically managed. AUC and C-max increased dose-dependently and linear PK profiles were observed. No tumor shrinkage was recorded, but long-term disease stabilization for 25 and 20 months was observed in one patient with clear cell OC (100 mg/m(2)) and one patient with GC (400 mg/m(2)), respectively. No cumulative toxicity occurred in any patient. Farletuzumab was well tolerated in Japanese patients with a similar PK profile as compared with the US population. Long-term disease stabilization was observed in a subpopulation of clear cell OC and GC; both of them were resistant and progressive after standard chemotherapies (ClinicalTrials.gov Identifier: NCT01049061).	[Sasaki, Yasutsuna; Miwa, Keisuke; Yamashita, Keishi; Sunakawa, Yu; Shimada, Ken; Ishida, Hiroo] Saitama Med Univ, Dept Med Oncol, Saitama Int Med Ctr, Ctr Comprehens Canc, Saitama, Japan; [Hasegawa, Kosei; Fujiwara, Keiichi] Saitama Med Univ, Dept Gynecol Oncol, Saitama Int Med Ctr, Ctr Comprehens Canc, Saitama, Japan; [Kodaira, Makoto; Fujiwara, Yasuhiro; Katsumata, Noriyuki] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan; [Namiki, Masayuki; Matsuda, Minami; Takeuchi, Yutaka] Eisai & Co Ltd, Tokyo, Japan	Sasaki, Y (reprint author), Showa Univ, Sch Med, Div Med Oncol, Dept Med,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	yasutsuna@med.showa-u.ac.jp			Eisai Co., Ltd.	The authors express our thanks to the participating patients and all subinvestigators and research coordinators at two clinical sites. The authors also thank the Eisai study team, especially Nozomu Koyanagi for study management. This study was funded by Eisai Co., Ltd.	[Anonymous], VIT STAT JAP; Armstrong DK, 2013, GYNECOL ONCOL, V129, P452, DOI 10.1016/j.ygyno.2013.03.002; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; [Anonymous], 2004, INT J CLIN ONCOL S3, V9, P1; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Konner JA, 2010, CLIN CANCER RES, V16, P5288, DOI 10.1158/1078-0432.CCR-10-0700; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; GARINCHESA P, 1993, AM J PATHOL, V142, P557; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; CAMPBELL IG, 1991, CANCER RES, V51, P5329; Lin JM, 2013, CANCER BIOL THER, V14, P1032, DOI 10.4161/cbt.26106; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Ebel Wolfgang, 2007, Cancer Immun, V7, P6; O'Shannessy DJ, 2013, INT J GYNECOL PATHOL, V32, P258, DOI 10.1097/PGP.0b013e3182774562; Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F; Vergote IB, 2013, INT J GYNECOL CANCER, V8, P11; Wakao F., 2013, CANC STAT JAPAN 2013	20	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	APR	2015	33	2					332	340		10.1007/s10637-014-0180-8		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CF3JK	WOS:000352444600007		
J	Fujisaka, Y; Kurata, T; Tanaka, K; Kudo, T; Okamoto, K; Tsurutani, J; Kaneda, H; Okamoto, I; Namiki, M; Kitamura, C; Nakagawa, K				Fujisaka, Yasuhito; Kurata, Takayasu; Tanaka, Kaoru; Kudo, Toshihiro; Okamoto, Kunio; Tsurutani, Junji; Kaneda, Hiroyasu; Okamoto, Isamu; Namiki, Masayuki; Kitamura, Chifumi; Nakagawa, Kazuhiko			Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors	INVESTIGATIONAL NEW DRUGS			English	Article						Amatuximab; Antibody; Mesothelin; MORAb-009; Phase I study	OVARIAN-CANCER; ADENOCARCINOMAS; EXPRESSION; DIAGNOSIS; PANCREAS; BINDING	Amatuximab is a chimeric monoclonal antibody that targets mesothelin, which is expressed in virtually all mesotheliomas and pancreatic adenocarcinomas. The objective of this study was to determine the dose-limiting toxicity and the maximum tolerated dose. Patients with mesothelioma, pancreatic adenocarcinoma or other mesothelin-positive solid tumors were eligible for this study. Amatuximab was administered weekly as an intravenous infusion in 4-week cycles at progressively increasing doses ranging from 50 to 200 mg/m(2). Seventeen patients received amatuximab. Two dose-limiting toxicities were observed: one at 50 mg/m(2) and one at 200 mg/m(2); the maximum tolerated dose of this study was determined to be 200 mg/m(2). Of the 17 patients, 13 patients (76.5 %) experienced treatment-related adverse events. The most common adverse events were grade 1 fatigue (29.4 %) and pyrexia (23.5 %). The maximum serum concentration and area under the concentration curve values increased in an almost dose-proportional manner. Three patients had stable disease. Amatuximab was generally well tolerated at doses up to 200 mg/m(2). The pharmacokinetic profile of amatuximab in the Japanese population was similar to that seen in the United States population (Clinical Trials.gov Identifier: NCT01018784).	[Fujisaka, Yasuhito; Kurata, Takayasu; Tanaka, Kaoru; Kudo, Toshihiro; Okamoto, Kunio; Tsurutani, Junji; Kaneda, Hiroyasu; Okamoto, Isamu; Nakagawa, Kazuhiko] Kinki Univ Fac Med, Dept Med Oncol, Osaka 5898511, Japan; [Namiki, Masayuki; Kitamura, Chifumi] Eisai & Co Ltd, Bunkyo Ku, Tokyo 1128088, Japan	Fujisaka, Y (reprint author), Osaka Med Coll Hosp, Clin Res Ctr, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	fujisaka_y@poh.osaka-med.ac.jp			Eisai. Co., Ltd.	We gratefully acknowledge the commitment of participating patients, their families, and the study investigators for their invaluable contribution to this research. This study was funded by Eisai. Co., Ltd.	Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Argani P, 2001, CLIN CANCER RES, V7, P3862; Bergan L, 2007, CANCER LETT, V255, P263, DOI 10.1016/j.canlet.2007.04.012; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan R, 2014, CLIN CANC RES; Hassan Raffit, 2007, Cancer Immun, V7, P20; Miettinen M, 2003, AM J SURG PATHOL, V27, P150, DOI 10.1097/00000478-200302000-00002; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	APR	2015	33	2					380	388		10.1007/s10637-014-0196-0		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CF3JK	WOS:000352444600012		
J	Matsuyama, M; Ishii, H; Furuse, J; Ohkawa, S; Maguchi, H; Mizuno, N; Yamaguchi, T; Ioka, T; Ajiki, T; Ikeda, M; Hakamada, K; Yamamoto, M; Yamaue, H; Eguchi, K; Ichikawa, W; Miyazaki, M; Ohashi, Y; Sasaki, Y				Matsuyama, Masato; Ishii, H.; Furuse, J.; Ohkawa, S.; Maguchi, H.; Mizuno, N.; Yamaguchi, T.; Ioka, T.; Ajiki, T.; Ikeda, M.; Hakamada, K.; Yamamoto, M.; Yamaue, H.; Eguchi, K.; Ichikawa, W.; Miyazaki, M.; Ohashi, Y.; Sasaki, Y.			Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer	INVESTIGATIONAL NEW DRUGS			English	Article						Biliary tract cancer; Immunotherapy; Cancer vaccines; Phase II clinical trial; VEGFR2	MULTICENTER; CISPLATIN	Background Elpamotide is an HLA-A*24:02-restricted epitope peptide of vascular endothelial growth factor receptor 2 (VEGFR-2) and induces cytotoxic T lymphocytes (CTLs) against VEGFR-2/KDR. Given the high expression of VEGFR-2 in biliary tract cancer, combination chemoimmunotherapy with elpamotide and gemcitabine holds promise as a new therapy. Patients and Methods Patients with unresectable advanced or recurrent biliary tract cancer were included in this single-arm phase II trial, with the primary endpoint of overall survival. Survival analysis was performed in comparison with historical control data. The patients concurrently received gemcitabine once a week for 3 weeks (the fourth week was skipped) and elpamotide once a week for 4 weeks. Results Fifty-five patients were registered, of which 54 received the regimen and were included in the full analysis set as well as the safety analysis set. Median survival was 10.1 months, which was longer than the historical control, and the 1-year survival rate was 44.4 %. Of these patients, injection site reactions were observed in 64.8 %, in whom median survival was significantly longer (14.8 months) compared to those with no injection site reactions (5.7 months). The response rate was 18.5 %, and all who responded exhibited injection site reactions. Serious adverse reactions were observed in five patients (9 %), and there were no treatment-related deaths. Conclusion Gemcitabine and elpamotide combination therapy was tolerable and had a moderate antitumor effect. For future development of therapies, it will be necessary to optimize the target population for which therapeutic effects could be expected.	[Matsuyama, Masato; Ishii, H.] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Med, Koto Ku, Tokyo 1358550, Japan; [Furuse, J.] Kyorin Univ Sch Med, Dept Med Oncol, Tokyo, Japan; [Ohkawa, S.] Kanagawa Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa, Japan; [Maguchi, H.] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Mizuno, N.] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Yamaguchi, T.] Chiba Canc Ctr, Dept Gastroenterol, Chiba 2608717, Japan; [Ioka, T.] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Ajiki, T.] Kobe Univ Grad Sch Med, Hepatobiliary Pancreat Surg, Kobe, Hyogo, Japan; [Ikeda, M.] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Chiba, Japan; [Hakamada, K.] Hirosaki Univ Grad Sch Med, Dept Surg, Aomori, Japan; [Yamamoto, M.] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan; [Yamaue, H.] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Eguchi, K.] Teikyo Univ Sch Med, Div Med Oncol, Tokyo, Japan; [Ichikawa, W.; Sasaki, Y.] Showa Univ Sch Med, Div Med Oncol, Tokyo, Japan; [Miyazaki, M.] Chiba Univ Grad Sch Med, Dept Gen Surg, Chiba, Japan; [Ohashi, Y.] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan	Matsuyama, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Med, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	mahsanmahsan2000@yahoo.co.jp			OncoTherapy Science Inc.; Fuso Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Co., Ltd.	This work was supported by OncoTherapy Science Inc., Fuso Pharmaceutical Industries Ltd., and Otsuka Pharmaceutical Co., Ltd.	Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Sheth S, 2000, AM J GASTROENTEROL, V95, P1402; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Matsukura N, 2002, JPN J CANCER RES, V93, P842; Ledford H, 2011, NATURE, V471, P561, DOI 10.1038/471561a; Okusaka T, 2006, CANCER CHEMOTH PHARM, V57, P647, DOI 10.1007/s00280-005-0095-3; [Tian Yu 田雨], 2005, Chinese Journal of Cancer Research, V17, P273, DOI 10.1007/s11670-005-0025-2; Yonemoto N, 2007, JPN J CLIN ONCOL, V37, P843, DOI 10.1093/jjco/hym116	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	APR	2015	33	2					490	495		10.1007/s10637-014-0197-z		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CF3JK	WOS:000352444600023		
J	Yoneshima, Y; Okamoto, I; Arimura-Omori, M; Kimura, S; Hidaka-Fujimoto, N; Iwama, E; Harada, T; Takayama, K; Nakanishi, Y				Yoneshima, Yasuto; Okamoto, Isamu; Arimura-Omori, Masako; Kimura, Shinichi; Hidaka-Fujimoto, Noriko; Iwama, Eiji; Harada, Taishi; Takayama, Koichi; Nakanishi, Yoichi			Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement	INVESTIGATIONAL NEW DRUGS			English	Article						Crizotinib; Anaplastic lymphoma kinase (ALK); Complex renal cyst; Non-small cell lung cancer (NSCLC)	POLYCYSTIC KIDNEY-DISEASE; PROGRESSION; RATS	Crizotinib is the first clinically available tyrosine kinase inhibitor that targets anaplastic lymphoma kinase (ALK) and is associated with the development of complex renal cysts. We now describe a 39-year-old woman who developed infected complex renal cysts during crizotinib treatment. After 10 months of such treatment, she presented with a high fever and low back pain. Computed tomography findings were consistent with complex renal cysts and perilesional inflammation. Interventions including cyst drainage and antibiotic administration contributed to diagnosis and management of the infected cysts.	[Yoneshima, Yasuto; Okamoto, Isamu; Arimura-Omori, Masako; Kimura, Shinichi; Hidaka-Fujimoto, Noriko; Iwama, Eiji; Harada, Taishi; Takayama, Koichi; Nakanishi, Yoichi] Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Okamoto, Isamu; Nakanishi, Yoichi] Kyushu Univ Hosp, Ctr Clin & Translat Res, Higashi Ku, Fukuoka 8128582, Japan; [Iwama, Eiji] Kyushu Univ, Dept Comprehens Clin Oncol, Fac Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Okamoto, I (reprint author), Kyushu Univ Hosp, Ctr Clin & Translat Res, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okamotoi@kokyu.med.kyushu-u.ac.jp					Jayapalan S, 2000, J NUTR, V130, P2356; Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Rothenstein JM, 2014, CURR ONCOL, V21, P19, DOI 10.3747/co.21.1740; TADA S, 1983, CLIN RADIOL, V34, P437, DOI 10.1016/S0009-9260(83)80238-4; Whelan TF, 2010, CUAJ-CAN UROL ASSOC, V4, P98; Weickhardt AJ, 2012, CANCER-AM CANCER SOC, V118, P5302, DOI 10.1002/cncr.27450; Cowley BD, 1997, AM J KIDNEY DIS, V29, P265, DOI 10.1016/S0272-6386(97)90039-1; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448	9	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	APR	2015	33	2					510	512		10.1007/s10637-014-0195-1		3	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CF3JK	WOS:000352444600026		
J	Chen, Y; Suzuki, A; Tortorici, MA; Garrett, M; LaBadie, RR; Umeyama, Y; Pithavala, YK				Chen, Ying; Suzuki, Akiyuki; Tortorici, Michael A.; Garrett, May; LaBadie, Robert R.; Umeyama, Yoshiko; Pithavala, Yazdi K.			Axitinib plasma pharmacokinetics and ethnic differences	INVESTIGATIONAL NEW DRUGS			English	Review						Asian; Axitinib; Caucasian; Ethnic Factor; Pharmacokinetics	RENAL-CELL CARCINOMA; TYROSINE KINASE INHIBITOR; RANDOMIZED PHASE-3 TRIAL; ADVANCED SOLID TUMORS; JAPANESE PATIENTS; HEALTHY-VOLUNTEERS; INTERFERON-ALPHA; I TRIAL; SUNITINIB; SORAFENIB	Axitinib, a potent and selective tyrosine kinase inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, showed improved progression-free survival over sorafenib in patients previously treated for advanced renal cell carcinoma in the AXIS trial. Although a few studies had established the efficacy and safety of axitinib in Asian patients, additional evaluation was necessary to obtain regulatory approval in several Asian countries, especially in light of ethnic differences that are known to exist in genetic polymorphisms for metabolizing enzymes such as cytochrome P450 (CYP) 3A5, CYP2C19 and uridine diphosphate glucuronosyltransferase (UGT) 1A1, which are involved in axitinib metabolism. Axitinib plasma pharmacokinetics following single or multiple administration of oral axitinib in Asian (Japanese or Chinese) healthy subjects as well as Asian patients with advanced solid tumors was compared with that obtained in Caucasians. Upon review, the data demonstrated that axitinib can be characterized as not sensitive to ethnic factors based on its pharmacokinetic and pharmacodynamic properties. Axitinib exhibited similar pharmacokinetics in Asian and non-Asian subjects. A pooled population pharmacokinetic analysis indicated lack of a clinically meaningful effect of ethnicity on axitinib disposition. Therefore, dose adjustment for axitinib on the basis of ethnicity is not currently warranted.	[Chen, Ying; Garrett, May; Pithavala, Yazdi K.] Pfizer Inc, Clin Pharmacol, San Diego, CA 92121 USA; [Suzuki, Akiyuki; Umeyama, Yoshiko] Pfizer Japan Inc, Shibuya Ku, Tokyo 1518589, Japan; [Tortorici, Michael A.] CSL Behring Biotherapies Life, Clin Pharmacol & Pharmacometr, King Of Prussia, PA 19406 USA; [LaBadie, Robert R.] Pfizer Inc, Groton, CT 06340 USA	Pithavala, YK (reprint author), Pfizer Inc, Clin Pharmacol, 10555 Sci Ctr Dr, San Diego, CA 92121 USA.	yazdi.pithavala@pfizer.com			Pfizer Inc.	The development of this review manuscript was funded by Pfizer Inc. Writing support was provided by Mariko Nagashima, PhD (Engage Scientific Solutions, Southport, CT, USA), and funded by Pfizer Inc.	Akaza H, 2014, EXPERT OPIN PHARMACO, V15, P283, DOI 10.1517/14656566.2014.868436; [Anonymous], 2012, INL AX PRESCR INF; Rini BI, 2013, LANCET ONCOL, V14, P1233, DOI 10.1016/S1470-2045(13)70464-9; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Tortorici MA, 2011, INVEST NEW DRUG, V29, P1370, DOI 10.1007/s10637-010-9477-4; Rini BI, 2013, J CLIN PHARMACOL, V53, P491, DOI 10.1002/jcph.73; Tanigawa G, 2011, JPN J CLIN ONCOL, V41, P1265, DOI 10.1093/jjco/hyr137; Smith BJ, 2014, DRUG METAB DISPOS, V42, P918, DOI 10.1124/dmd.113.056531; Mukohara T, 2010, CANCER SCI, V101, P963, DOI 10.1111/j.1349-7006.2009.01465.x; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Rini BI, 2009, J CLIN ONCOL, V27, P4462, DOI 10.1200/JCO.2008.21.7034; [Anonymous], 2005, NEX SOR PRESCR INF; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Fujiwara Y, 2012, INVEST NEW DRUG, V30, P1055, DOI 10.1007/s10637-011-9637-1; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Ye DW, 2014, ONCOTARGETS THER, V7, P925, DOI 10.2147/OTT.S41828; Rini BI, 2011, CLIN CANCER RES, V17, P3841, DOI 10.1158/1078-0432.CCR-10-2806; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Pithavala YK, 2010, CANCER CHEMOTH PHARM, V65, P563, DOI 10.1007/s00280-009-1065-y; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/51470-2045(07)70285-1; Chen Y, 2011, INT J CLIN PHARM TH, V49, P679, DOI 10.5414/CP201570; Tomita Y, 2010, JPN J CLIN ONCOL, V40, P1166, DOI 10.1093/jjco/hyq146; Chen Y, 2013, CLIN PHARMACOKINET, V52, P713, DOI 10.1007/s40262-013-0068-3; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Liu G, 2005, J CLIN ONCOL, V23, P5464, DOI 10.1200/JCO.2005.04.143; Garrett M, 2014, BRIT J CLIN PHARMACO, V77, P480, DOI 10.1111/bcp.12206; Hurwitz HI, 2009, CLIN CANCER RES, V15, P4220, DOI 10.1158/1078-0432.CCR-08-2740; Rugo HS, 2005, J CLIN ONCOL, V23, P5474, DOI 10.1200/JCO.2005.04.192; Brennan M, 2012, EUR J CLIN PHARMACOL, V68, P645, DOI 10.1007/s00228-011-1171-8; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Hong MH, 2009, CANCER RES TREAT, V41, P67, DOI 10.4143/crt.2009.41.2.67; Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Hutson TE, 2013, LANCET ONCOL, V14, P1287, DOI 10.1016/S1470-2045(13)70465-0; Chen Y, 2015, CLIN PHARMACOKINET, V54, P397, DOI 10.1007/s40262-014-0207-5; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Tomita Y, 2011, EUR J CANCER, V47, P2592, DOI 10.1016/j.ejca.2011.07.014; Pithavala YK, 2012, INVEST NEW DRUG, V30, P273, DOI 10.1007/s10637-010-9511-6; Pithavala YK, 2012, CANCER CHEMOTH PHARM, V70, P103, DOI 10.1007/s00280-012-1888-9; Yoo C, 2010, JPN J CLIN ONCOL, V40, P980, DOI 10.1093/jjco/hyq073; Crettol S, 2010, CURR PHARM DESIGN, V16, P204; Eto M, 2014, CANCER SCI, V105, P1576, DOI 10.1111/cas.12546; GeelRM van, 2012, ONCOLOGIST, V17, P1081, DOI [10.1634/theoncologist.2012-0055, DOI 10.1634/THEONCOLOGIST.2012-0055]; Gross-Goupil Marine, 2013, Clin Med Insights Oncol, V7, P269, DOI 10.4137/CMO.S10594; Lee SH, 2014, ASIA-PAC J CLIN ONCO, V10, P237, DOI 10.1111/ajco.12163; Liu JY, 2007, ANTI-CANCER DRUG, V18, P693, DOI 10.1097/CAD.0b013e32803a46fe; Mittal K, 2012, BIOL THER, V2, P5, DOI 10.1007/s13554-012-0005-2; Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83; Patson B, 2012, EXPERT OPIN DRUG MET, V8, P259, DOI 10.1517/17425255.2012.652947; U.S. Department of Health and Human Services Food and Drug Administration, 1998, FED REGISTER, V63, P31790; Verzoni Elena, 2014, Pharmgenomics Pers Med, V7, P107, DOI 10.2147/PGPM.S37098; Wang Y, 2014, BRIT J CANCER, V110, P1433, DOI 10.1038/bjc.2014.28; Zhang HL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-249	57	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	APR	2015	33	2					521	532		10.1007/s10637-015-0214-x		12	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CF3JK	WOS:000352444600028		
J	Matsushita, B; Yang, W; Yu, GL; Oyama, Y; Yoshimura, K; Fukushima, T				Matsushita, Bunkei; Yang, Wei; Yu, Gongliang; Oyama, Youichi; Yoshimura, Kazuya; Fukushima, Takehiko			A hybrid algorithm for estimating the chlorophyll-a concentration across different trophic states in Asian inland waters	ISPRS JOURNAL OF PHOTOGRAMMETRY AND REMOTE SENSING			English	Article						Chlorophyll-a concentration; Red-NIR algorithm; Blue-green algorithm; Maximum chlorophyll index; Hybrid algorithm; Asian lakes	TURBID PRODUCTIVE WATERS; NEAR-INFRARED BANDS; REMOTE ESTIMATION; SEMIANALYTICAL MODEL; LAKE KASUMIGAURA; COASTAL WATERS; RED; OCEAN; REFLECTANCE; VALIDATION	The chlorophyll-a (Chl-a) concentration is one of the most important parameters for evaluating the state of water environments, which often vary markedly across both time and space. Here we propose a hybrid algorithm for retrieving the Chl-a values from in situ remote sensing data. This hybrid algorithm contains three individual Chl-a estimation algorithms that were previously developed for clear waters (a blue-green algorithm), turbid waters (a two-band index-based red-near infrared algorithm), and highly turbid waters (a three-band index-based red-near infrared algorithm). The MCI value (maximum chlorophyll index) was used to switch the three algorithms. To evaluate the performance of the proposed hybrid algorithm, we used the in situ remote sensing reflectance and Chl-a values collected from five Asian lakes, the trophic status of which varied from oligotrophic to hypertrophic. The results showed that the hybrid algorithm performed well for a wide variety of optical properties, with the NMAE (normalized mean absolute error) of 13.3%. Our results indicate that the proposed hybrid algorithm has the potential for use as an operational tool for monitoring Chl-a in waters with widely varying trophic conditions without the requirement of reparameterization. (C) 2015 International Society for Photogrammetry and Remote Sensing, Inc. (ISPRS). Published by Elsevier B.V. All rights reserved.	[Matsushita, Bunkei; Oyama, Youichi; Fukushima, Takehiko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yang, Wei] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa 2360001, Japan; [Yu, Gongliang] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Yoshimura, Kazuya] Japan Atom Energy Agcy, Headquarters Fukushima Partnership Operat, Tokyo 1008577, Japan	Matsushita, B (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	matsushita.bunkei.gn@u.tsukuba.ac.jp	Yang, Wei/M-6620-2015; Yoshimura, Kazuya/N-9508-2015	Yang, Wei/0000-0003-3342-7679; Yoshimura, Kazuya/0000-0001-5256-2679	MEXT from Japan [25420555, 23404015]; Ministry of the Environment, Japan [S-9-4-(1)]	This research was supported in part by the Grants-in-Aid for Scientific Research of MEXT from Japan (Nos. 25420555 and 23404015), and also by the Environment Research and Technology Development Fund (S-9-4-(1)) of the Ministry of the Environment, Japan. The authors also would like to thank the two anonymous reviewers for their valuable comments on the manuscript.	Matthews MW, 2012, REMOTE SENS ENVIRON, V124, P637, DOI 10.1016/j.rse.2012.05.032; Odermatt D, 2012, REMOTE SENS ENVIRON, V118, P116, DOI 10.1016/j.rse.2011.11.013; Moses WJ, 2009, IEEE GEOSCI REMOTE S, V6, P845, DOI 10.1109/LGRS.2009.2026657; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; Gurlin D, 2011, REMOTE SENS ENVIRON, V115, P3479, DOI 10.1016/j.rse.2011.08.011; Le CF, 2009, REMOTE SENS ENVIRON, V113, P1175, DOI 10.1016/j.rse.2009.02.005; Matthews MW, 2011, INT J REMOTE SENS, V32, P6855, DOI 10.1080/01431161.2010.512947; Dall'Olmo G, 2005, REMOTE SENS ENVIRON, V96, P176, DOI 10.1016/j.rse.2005.02.007; Le CF, 2013, REMOTE SENS ENVIRON, V129, P75, DOI 10.1016/j.rse.2012.11.001; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Gilerson AA, 2010, OPT EXPRESS, V18, P24109, DOI 10.1364/OE.18.024109; GORDON HR, 1975, APPL OPTICS, V14, P417, DOI 10.1364/AO.14.000417; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Yang W, 2011, REMOTE SENS ENVIRON, V115, P1247, DOI 10.1016/j.rse.2011.01.007; Gitelson AA, 2008, REMOTE SENS ENVIRON, V112, P3582, DOI 10.1016/j.rse.2008.04.015; Moore TS, 2014, REMOTE SENS ENVIRON, V143, P97, DOI 10.1016/j.rse.2013.11.021; Yang W, 2010, IEEE GEOSCI REMOTE S, V7, P655, DOI 10.1109/LGRS.2010.2044364; Yu GL, 2014, REMOTE SENS-BASEL, V6, P3492, DOI 10.3390/rs6043492; AUSTIN RW, 1980, BOUND-LAY METEOROL, V18, P269, DOI 10.1007/BF00122024; Carlson RE, 2007, LAKELINE, V2007, P25; Dall'Olmo G., 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1029/2003GL018065; DEKKER A. G., 1993, THESIS VRIJE U AMSTE; Gitelson AA, 2011, T&F SER REMOTE SENS, P439; Gitelson A., 2009, ENV RES LETT, V4; Gitelson A.A., 1991, T DOKLADY USSR ACAD, V306, P1; Gomez JAD, 2011, ENVIRON MONIT ASSESS, V181, P317, DOI 10.1007/s10661-010-1831-7; Han LH, 1997, REMOTE SENS ENVIRON, V62, P253, DOI 10.1016/S0034-4257(97)00106-5; Jaelani LM, 2013, INT J REMOTE SENS, V34, P8967, DOI 10.1080/01431161.2013.860660; Mueller J.L., 2000, OCEAN OPTICS PROTOCO, V2, P98; O'Reilly J. E., 2000, 2000206892 NASA GODD, V11; SCOR-UNESCO, 1966, MONOGRAPHS OCEANOGRA	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-2716	1872-8235		ISPRS J PHOTOGRAMM	ISPRS-J. Photogramm. Remote Sens.	APR	2015	102						28	37		10.1016/j.isprsjprs.2014.12.022		10	Geography, Physical; Geosciences, Multidisciplinary; Remote Sensing; Imaging Science & Photographic Technology	Physical Geography; Geology; Remote Sensing; Imaging Science & Photographic Technology	CF6KL	WOS:000352665500003		
J	Inaba, M				Inaba, Midori			Individualistic attitudes toward attractive rewards in older people: An experimental study using ultimatum games	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						older people; bargaining; ultimatum game; expectations	SOCIAL DECISION-MAKING; AGE-DIFFERENCES; BEHAVIOR; FAIRNESS; ORIENTATIONS; EXPECTATIONS; PERFORMANCE; PREFERENCES; POWERLESS; ADULTS	This study used an ultimatum game to test the hypothesis that older individuals make more selfish offers when bargaining for highly attractive rewards, regardless of the impacts of others' responses on reward size. Both older and younger individuals separately participated in the experiment and made offers as allocators. The effects of four factors (age, certainty of the allocators' own reward depending on the recipient's response, the recipient's response, and type of rewards to be shared) on participants' offers and expectations of recipients' replies were observed. Older participants demanded higher shares for themselves than younger participants, even under the low certainty condition in the highly attractive reward scenario. Particularly in this scenario, older participants increased their portions immediately after receiving rejections. Moreover, they consistently expected the recipients to accept their offers regardless of the proposed distribution amount or bargaining conditions. It was implied that the high attractiveness of the rewards made it difficult for older individuals to predict the recipient's view of their proposals and thus contributed to them making selfish proposals.	[Inaba, Midori] Univ Electrocommun, Chofu, Tokyo 182, Japan	Inaba, M (reprint author), East Japan Railway Co, Ctr Res & Dev, Safety Res Lab, Kita Ku, Nisshin Cho, Saitama 3318513, Japan.	midori-inaba@jreast.co.jp					MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Wood S, 2005, PSYCHOL AGING, V20, P220, DOI 10.1037/0882-7974.20.2.220; Kim S, 2005, Q J EXP PSYCHOL-A, V58, P120, DOI 10.1080/02724980443000160; ROTH AE, 1991, AM ECON REV, V81, P1068; Xiao E, 2010, J ECON PSYCHOL, V31, P456, DOI 10.1016/j.joep.2010.02.001; Inaba M, 2009, INT J PSYCHOPHYSIOL, V74, P106, DOI 10.1016/j.ijpsycho.2009.08.001; Webster JM, 2003, J SOC PSYCHOL, V143, P209; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; von Hippel W, 2005, PSYCHOL AGING, V20, P519, DOI 10.1037/0882-7974.20.3.519; van Dijk E, 2004, J EXP SOC PSYCHOL, V40, P697, DOI 10.1016/j.jesp.2004.03.002; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.6.1330; KUHLMAN DM, 1976, J PERS SOC PSYCHOL, V34, P69, DOI 10.1037//0022-3514.34.1.69; van Dijk E, 2000, J EXP SOC PSYCHOL, V36, P1, DOI 10.1006/jesp.1999.1392; Fehr E, 2006, AM ECON REV, V96, P1912, DOI 10.1257/aer.96.5.1912; CAMERER C, 1995, J ECON PERSPECT, V9, P209; Handgraaf MJJ, 2008, J PERS SOC PSYCHOL, V95, P1136, DOI 10.1037/0022-3514.95.5.1136; Korniotis GM, 2011, REV ECON STAT, V93, P244, DOI 10.1162/REST_a_00053; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, P219, DOI DOI 10.1093/GER0NB/63.4.P219; Bellante D., 2004, REV FINANCIAL EC, V13, P269, DOI DOI 10.1016/J.RFE.2003.09.010; Chen YW, 2003, EDUC GERONTOL, V29, P627, DOI 10.1080/713844418; Declerck CH, 2009, J ECON PSYCHOL, V30, P335, DOI 10.1016/j.joep.2009.03.002; Engel C., 2011, EXPT EC, V14, P533; Gaines LM, 2005, SELF IDENTITY, V4, P373, DOI 10.1080/15298860500280223; Hertzog C, 1996, PSYCHOL AGING, V11, P497, DOI 10.1037/0882-7974.11.3.497; Peters E., 2011, JUDGM DECIS MAK, P113; Pushkar D, 2000, PSYCHOL AGING, V15, P361, DOI 10.1037//0882-7974.15.2.361; Radvansky GA, 2009, AGING NEUROPSYCHOL C, V16, P22, DOI 10.1080/13825580802187200; Sivanathan N, 2008, ORGAN BEHAV HUM DEC, V105, P135, DOI 10.1016/j.obhdp.2007.10.003; Suleiman R, 1996, J ECON PSYCHOL, V17, P531, DOI 10.1016/S0167-4870(96)00029-3; THALER RH, 1988, J ECON PERSPECT, V2, P195; Touron D. R., 2007, J GERONTOL B-PSYCHOL, V62, P149; Wang M, 2004, PSYCHOL AGING, V19, P536, DOI 10.1037/0882-7974.19.3.536; Willemsen G, 2000, BIOL PSYCHOL, V52, P127, DOI 10.1016/S0301-0511(99)00028-9; Zhu LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070769	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					91	102		10.1111/jpr.12068		12	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300001		
J	Nabeta, T; Wakabayashi, S; Park, SY; Kamigaki, A; Yamazaki, A				Nabeta, Tomohiro; Wakabayashi, Sumino; Park, Shin-Young; Kamigaki, Akiko; Yamazaki, Akira			Young children produce categorical false recall without activation of the lure items	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						false memory; DRM procedure; memory development	NONCONSCIOUS PROCESSES; MEMORY ILLUSION; RECOGNITION; INDUCTION; RESPONSES; MULTIPLE; MODALITY; WORDS; ROLES	Individuals who study a list of words that are all related to another word that is not presented (a lure word) sometimes produce a false memory of having studied the lure word. The false memories are observed in lists of words that are in the same category as (category list) or associated with (associative list) a word that was not presented in an attempt to elicit false recall. The present study investigated whether young children create these types of false recall. Following the study of a categorical list, false recall was elicited in young children to the same degree as in adults, but studying an associative list elicited false recall only in adults. Furthermore, categorically related lure words did not have a priming effect in young children. These results suggest that the categorical false recall is produced via a different mechanism from the associative false recall.	[Nabeta, Tomohiro] Univ East Asia, Shimonoseki, Yamaguchi 7518503, Japan; [Wakabayashi, Sumino] Hiroshima Bunka Gakuen Univ, Hiroshima, Japan; [Park, Shin-Young] Sugiyama Jogakuen Univ, Nisshin, Aichi, Japan; [Kamigaki, Akiko] Kawasaki Coll Allied Hlth Profess, Kawasaki, Kanagawa, Japan; [Yamazaki, Akira] Meijigakuin Univ, Tokyo, Japan	Nabeta, T (reprint author), Univ East Asia, Dept Humanities & Social Sci, Shimonoseki, Yamaguchi 7518503, Japan.	nabeta@toua-u.ac.jp			Japan Society for the Promotion of Science	This work was sponsored by research grants from Japan Society for the Promotion of Science.	UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; Smith SM, 2002, J MEM LANG, V47, P436, DOI 10.1016/S0749-596X(02)00012-8; Loftus EF, 1997, SCI AM, V277, P70; Sloutsky VM, 2004, PSYCHOL SCI, V15, P553, DOI 10.1111/j.0956-7976.2004.00718.x; Smith SM, 2000, MEM COGNITION, V28, P386, DOI 10.3758/BF03198554; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Seamon JG, 1998, PSYCHOL SCI, V9, P20, DOI 10.1111/1467-9280.00004; GELMAN SA, 1988, COGNITIVE PSYCHOL, V20, P65, DOI 10.1016/0010-0285(88)90025-4; Dewhurst SA, 2004, PSYCHOL SCI, V15, P782, DOI 10.1111/j.0956-7976.2004.00756.x; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037//0033-2909.114.1.3; Brainerd CJ, 2002, CHILD DEV, V73, P1363, DOI 10.1111/1467-8624.00477; Kimball DR, 2002, J EXP PSYCHOL GEN, V131, P116, DOI 10.1037//0096-3445.131.1.116; BJORKLUND DF, 1984, CHILD DEV, V55, P952, DOI 10.1111/j.1467-8624.1984.tb03833.x; Cotel SC, 2008, CONSCIOUS COGN, V17, P210, DOI 10.1016/j.concog.2007.01.009; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Gallo D. A., 2003, CONSCIOUS COGN, V13, P159; Hamajima H., 1999, STUDIES INFORMATICS, V11, P175; Howe ML, 2005, PSYCHOL SCI, V16, P927, DOI 10.1111/j.1467-9280.2005.01638.x; Klinger N. N., 1968, CHILD DEV, V38, P1143; Kudoh M., 1999, STUDY FUNDAMENTAL VO; Loftus E. F., 1992, CURRENT DIRECTIONS P, V1, P121, DOI DOI 10.1111/1467-8721.EP10769035; McDermott KB, 1997, PSYCHON B REV, V4, P582, DOI 10.3758/BF03214353; McKone E, 2000, J MEM LANG, V43, P89, DOI 10.1006/jmla.1999.2702; Nabeta T., 2008, JAPANESE J PSYCHOL, V78, P591; Nabeta T., 2009, JAPANESE PSYCHOL REV, V4, P545; Nabeta T, 2006, MEMORY, V14, P307, DOI 10.1080/09658210500277398; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037//0096-3445.106.3.226; Park L, 2005, PSYCHOL SCI, V16, P792, DOI 10.1111/j.1467-9280.2005.01616.x; Robinson K. J., 1997, PSYCHOL SCI, V8, P385; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Toyota H., 1984, JAPANESE PSYCHOL REV, V27, P389; Yamada K., 2009, JAPANESE J PSYCHOL, V80, P90	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					103	112		10.1111/jpr.12069		10	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300002		
J	Nakashima, K; Yanagisawa, K				Nakashima, Ken'ichiro; Yanagisawa, Kuniaki			Subjective socioeconomic status and departmental identity interact to reduce depressive tendencies and negative affective responding for female undergraduates	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						subjective socioeconomic status; group identity; mental health; social exclusion	IN-GROUP IDENTIFICATION; SOCIAL EXCLUSION; MENTAL-HEALTH; REJECTION; BEHAVIOR; MODEL; OSTRACISM; STUDENTS; SUPPORT; FAMILY	How do subjective socioeconomic status (SES) and departmental identity promote the mental health of female undergraduates? We conducted a questionnaire study (Study 1) and an experimental study (Study 2) with undergraduates enrolled in a women's junior college to examine whether subjective SES and group identity have an interactive effect on mental health. Results indicated that in participants with high subjective SES, increased identification with their reference in-group (the academic department) was associated with a decreased tendency for depression (Study 1). These individuals also showed reduced negative affect when responding in situations of social exclusion (Study 2). These effects were absent, or had a reduced intensity in participants with low subjective SES. In sum, subjective SES and departmental identity interact to reduce depressive tendencies and negative affective responding for female undergraduates. Individuals with higher subjective SES may gain more benefits from group identity. We have discussed the implications of these findings.	[Nakashima, Ken'ichiro] Hiroshima Univ, Higashihiroshima 7398524, Japan; [Yanagisawa, Kuniaki] Kyoto Univ, Kyoto 6068501, Japan	Nakashima, K (reprint author), Hiroshima Univ, Grad Sch Educ, Higashihiroshima 7398524, Japan.	kennakashi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [22830128, 25780399]	This work was supported by a Grant-in-Aid (number 22830128) for Research Activity Start-up and a Grant-in-Aid (number 25780399) for Young Scientists (B) from Japan Society for the Promotion of Science.	Aiken L. S., 1991, MULTIPLE REGRESSION; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Twenge JM, 2003, J PERS SOC PSYCHOL, V85, P409, DOI 10.1037/0022-3514.85.3.409; Kawada T, 1999, J OCCUP HEALTH, V41, P154, DOI 10.1539/joh.41.154; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Yanagisawa K, 2013, SOC COGN AFFECT NEUR, V8, P617, DOI 10.1093/scan/nss039; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Chen E, 2012, PERSPECT PSYCHOL SCI, V7, P135, DOI 10.1177/1745691612436694; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; Johnson SE, 2011, J PERS SOC PSYCHOL, V100, P838, DOI 10.1037/a0021956; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756; Seligman MEP, 2008, APPL PSYCHOL-INT REV, V57, P3, DOI 10.1111/j.1464-0597.2008.00351.x; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Knowles ML, 2008, PERS SOC PSYCHOL B, V34, P1200, DOI 10.1177/0146167208320062; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Twenge JM, 2002, J PERS SOC PSYCHOL, V83, P606, DOI 10.1037//0022-3514.83.3.606; Walton GM, 2007, J PERS SOC PSYCHOL, V92, P82, DOI 10.1037/0022-3514.92.1.82; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037//0022-3514.74.3.763; KARASAWA M, 1991, BRIT J SOC PSYCHOL, V30, P293; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Bizumic B, 2009, APPL PSYCHOL-INT REV, V58, P171, DOI 10.1111/j.1464-0597.2008.00387.x; Haslam SA, 2004, STRESS HEALTH, V20, P3, DOI 10.1002/smi.995; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; Nakashima K, 2012, ASIAN J SOC PSYCHOL, V15, P49, DOI 10.1111/j.1467-839X.2011.01361.x; Nakashima K, 2013, ASIAN J SOC PSYCHOL, V16, P271, DOI 10.1111/ajsp.12031; Nesdale D, 2007, INT J BEHAV DEV, V31, P115, DOI 10.1177/0165025407073579; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037//0278-6133.4.3.219; Smart Richman L., 2009, PSYCHOL REV, V116, P365, DOI DOI 10.1037/A0015250; Suzuki S., 1979, JAPANESE J BEHAVIOME, V6, P28; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Takata T., 2000, B RES I NARA U, V8, P145; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; van Dick R., 2002, EUROPEAN J WORK ORG, V11, P129, DOI DOI 10.1080/13594320143000889; Yanagisawa K., 2011, THESIS HIROSHIMA U H	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					113	125		10.1111/jpr.12070		13	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300003		
J	Esposito, G; Nakazawa, J; Venuti, P; Bornstein, MH				Esposito, Gianluca; Nakazawa, Jun; Venuti, Paola; Bornstein, Marc H.			Judgment of infant cry: The roles of acoustic characteristics and sociodemographic characteristics	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						infant cry; perception of cry; tree-based models	AUTISM SPECTRUM DISORDER; TREE-BASED MODELS; DISTRESS VOCALIZATIONS; TYPICAL DEVELOPMENT; YOUNG-CHILDREN; PERCEPTIONS; RESPONSES; INTERVENTION; EXPRESSION; CRIES	Adult judgments of infant cry are determined by both acoustic properties of the cry and listener sociodemographic characteristics. The main purpose of this research was to investigate how these two sources shape adult judgments of infant cry. We systematically manipulated both the acoustic properties of infant cries and contrasted listener sociodemographic characteristics. Then, we asked participants to listen to several acoustic manipulations of infant cries and to judge the level of distress the infant was expressing and the level of distress participants felt when listening. Finally, as a contrasting condition, participants estimated the age of the crying infant. Using tree-based models, we found that judgments of the level of distress the infant was expressing as well as the level of distress listeners felt are mainly accounted for by select acoustic properties of infant cry (proportion of sound/pause, fundamental frequency, and number of utterances), whereas age estimates of a crying infant are determined mainly by listener sociodemographic characteristics (gender and parental status). Implications for understanding infant cry and its effects as well as early caregiver-infant interactions are discussed.	[Esposito, Gianluca; Venuti, Paola] Univ Trento, I-38068 Rovereto, TN, Italy; [Nakazawa, Jun] Chiba Univ, Chiba, Japan; [Bornstein, Marc H.] NICHHD, Rockville, MD USA	Esposito, G (reprint author), Univ Trento, Dept Psychol & Cognit Sci, Corso Bettini 31, I-38068 Rovereto, TN, Italy.	gianluca.esposito@unitn.it	Esposito, Gianluca/K-9353-2013	Esposito, Gianluca/0000-0002-9442-0254	Japan Society for the Promotion of Science [22530694, 24730563, 26285149]; FPR Programme (RIKEN Brain Science Institute); NIH, NICHD (USA)	This research was supported by the Grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (Projects #22530694, #24730563 and #26285149), the FPR Programme (RIKEN Brain Science Institute), and the Intramural Research Programme of the NIH, NICHD (USA).	Lingle S, 2012, CURR ZOOL, V58, P698; Costello TJ, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S66; Newman JD, 2007, BEHAV BRAIN RES, V182, P155, DOI 10.1016/j.bbr.2007.02; ZESKIND PS, 1988, CHILD DEV, V59, P193; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Lingle S, 2005, J ANIM ECOL, V74, P1140, DOI 10.1111/j.1365-2656.2005.01014.x; GUSTAFSON GE, 1990, DEV PSYCHOL, V26, P144, DOI 10.1037//0012-1649.26.1.144; BARR RG, 1991, DEV MED CHILD NEUROL, V33, P601; Benedict L, 2007, CONDOR, V109, P79, DOI 10.1650/0010-5422(2007)109[79:ODWRCT]2.0.CO;2; BORNSTEIN MH, 1989, DEV REV, V9, P171, DOI 10.1016/0273-2297(89)90028-2; De Pisapia N., 2012, NEUROREPORT, V24, P142; Del Vecchio T, 2009, INFANT BEHAV DEV, V32, P117, DOI 10.1016/j.infbeh.2008.10.005; DONATEBARTFIELD E, 1985, INFANT BEHAV DEV, V8, P385, DOI 10.1016/0163-6383(85)90003-7; Esposito G, 2011, RES AUTISM SPECT DIS, V5, P1510, DOI 10.1016/j.rasd.2011.02.013; Esposito G, 2012, RES DEV DISABIL, V33, P1059, DOI 10.1016/j.ridd.2012.01.014; Esposito G, 2014, J AUTISM DEV DISORD, V44, P975, DOI 10.1007/s10803-013-1940-6; Esposito G, 2008, RES AUTISM SPECT DIS, V2, P371, DOI 10.1016/j.rasd.2007.09.003; Esposito G., 2010, EARLY CHILD DEV CARE, V180, P1093, DOI DOI 10.1080/03004430902775633; Esposito G, 2013, RES DEV DISABIL, V34, P2717, DOI 10.1016/j.ridd.2013.05.036; Fox J., 1997, APPL REGRESSION ANAL; Gustafson GE, 2000, CRYING SIGN SYMPTOM, P8; Irwin JR, 2003, INFANCY, V4, P503, DOI 10.1207/S15327078IN0404_06; Joosen KJ, 2013, INFANCY, V18, P414, DOI 10.1111/j.1532-7078.2012.00122.x; Lin HC, 2012, INFANT BEHAV DEV, V35, P887, DOI 10.1016/j.infbeh.2012.08.001; Lin HC, 2007, INFANCY, V11, P175; Newman John D., 2004, P171; Rothganger H, 2003, EARLY HUM DEV, V75, P55, DOI 10.1016/j.earlhumdev.2003.09.003; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Venuti P, 2004, J INTELL DISABIL RES, V48, P338; Zeifman DM, 2003, INF MENTAL HLTH J, V24, P597, DOI 10.1002/imhj.10077; Zeifman DM, 2004, INFANT CHILD DEV, V13, P111, DOI 10.1002/icd.344	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					126	134		10.1111/jpr.12072		9	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300004		
J	Kaneshige, T; Haryu, E				Kaneshige, Toshinori; Haryu, Etsuko			Categorization and understanding of facial expressions in 4-month-old infants	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						infant; facial expression; categorization; affective meaning	7-MONTH-OLD INFANTS; DISCRIMINATION; RECOGNITION; REPRESENTATION; IMITATION; EMOTION	This study examined whether 4-month-olds (N=40) could perceptually categorize happy and angry faces, and show appropriate behavior in response to these faces. During the habituation phase, infants were shown the same type of facial expressions (happy or angry) posed by three models, and their behavior in response to those faces was observed. During the test phase immediately after the habituation phase, infants saw a novel emotional expression and a familiar expression posed by a new model, and their looking times were measured. The results indicated that, although 4-month-olds could perceptually categorize happy and angry faces accurately, they responded positively to both expression types. These findings suggest that, although infants can perceptually categorize facial expressions at 4 months of age, they require further time to learn the affective meanings of the facial expressions.	[Kaneshige, Toshinori; Haryu, Etsuko] Univ Tokyo, Tokyo 1130033, Japan	Kaneshige, T (reprint author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan.	kanesige@yb3.so-net.ne.jp			JSPS KAKENHI [24650131]	This work was supported by JSPS KAKENHI Grant Number 24650131.	SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; LUDEMANN PM, 1988, DEV PSYCHOL, V24, P492, DOI 10.1037//0012-1649.24.4.492; Mareschal D, 2001, TRENDS COGN SCI, V5, P443, DOI 10.1016/S1364-6613(00)01752-6; FIELD TM, 1982, SCIENCE, V218, P179, DOI 10.1126/science.7123230; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; YAMADA H, 1993, APPL COGNITIVE PSYCH, V7, P257, DOI 10.1002/acp.2350070309; CARON RF, 1982, CHILD DEV, V53, P1008, DOI 10.1111/j.1467-8624.1982.tb01365.x; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; Quinn PC, 2011, EMOT REV, V3, P197, DOI 10.1177/1754073910387941; Cohen L. B., 2000, HABIT 2000 NEW PROGR; Ekman P., 1975, UNMASKING FACE GUIDE; FIELD TM, 1983, INFANT BEHAV DEV, V6, P485, DOI 10.1016/S0163-6383(83)90316-8; KESTENBAUM R, 1990, INFANT BEHAV DEV, V13, P497, DOI 10.1016/0163-6383(90)90019-5; Nelson C. A., 1998, PERCEPTUAL DEV VISUA, P287; NELSON CA, 1979, CHILD DEV, V50, P1239, DOI 10.1111/j.1467-8624.1979.tb02493.x; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.1111/j.1467-8624.1985.tb00085.x; NELSON CA, 1987, CHILD DEV, V58, P889, DOI 10.2307/1130530; PHILLIPS RD, 1990, INFANT BEHAV DEV, V13, P71, DOI 10.1016/0163-6383(90)90006-T; Quinn PC, 2008, CHILD DEV, V79, P1633, DOI 10.1111/j.1467-8624.2008.01213.x; Serrano JM, 1995, INFANT BEHAV DEV, V18, P477, DOI 10.1016/0163-6383(95)90036-5	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					135	142		10.1111/jpr.12075		8	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300005		
J	Goss, S; Tamaoka, K				Goss, Seth; Tamaoka, Katsuo			Predicting lexical accent perception in native Japanese speakers: An investigation of acoustic pitch sensitivity and working memory	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						speech perception; lexical accent; pitch sensitivity; verbal working memory	PHONOLOGICAL MEMORY; CONGENITAL AMUSIA; IDENTIFICATION; SPEECH; COMPREHENSION; ASSOCIATION; EXPERIENCE; KNOWLEDGE; NONSPEECH; CHILDREN	Spoken language perception may be constrained by a listener's cognitive resources, including verbal working memory (WM) capacity and basic auditory perception mechanisms. For Japanese listeners, it is unknown how, or even if, these resources are involved in the processing of pitch accent at the word level. The present study examined the extent to which native Japanese speakers could make correctness judgments on and categorize spoken Japanese words by pitch accent pattern, and how verbal WM capacity and acoustic pitch sensitivity related to perception ability. Results showed that Japanese listeners were highly accurate at judging pitch accent correctness (M=93%), but that the more cognitively demanding accent categorization task yielded notably lower performance (M=61%). Of chief interest was the finding that acoustic pitch sensitivity significantly predicted accuracy scores on both perception tasks, while verbal WM had a predictive role only for the categorization of a specific accent pattern. These results indicate first, that task demands greatly influence accuracy and second, that basic cognitive capacities continue to support perception of lexical prosody even in adult listeners.	[Goss, Seth] Ohio State Univ, Columbus, OH 43210 USA; [Tamaoka, Katsuo] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Goss, S (reprint author), Ohio State Univ, Dept East Asian Languages & Literatures, Columbus, OH 43210 USA.	goss.33@osu.edu			Japan Foundation Dissertation Fellowship	The first author was supported financially by a Japan Foundation Dissertation Fellowship while conducting this research.	Adams AM, 1999, INT J PSYCHOL, V34, P364; Amano N., 2000, LEXICAL PROPERTIES J, V7; Amano N., 1999, LEXICAL PROPERTIES J, V1; Ueno T, 2014, J COGNITIVE NEUROSCI, V26, P433, DOI 10.1162/jocn_a_00467; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Otake T, 1999, J PHONETICS, V27, P229, DOI 10.1006/jpho.1999.0095; Roy P, 2004, J SPEECH LANG HEAR R, V47, P223, DOI 10.1044/1092-4388(2004/019); Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; O'Brien I, 2006, APPL PSYCHOLINGUIST, V27, P377, DOI 10.1017/S0142716406060322; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Beckman M. E., 1986, PHONOLOGY YB, V3, P255, DOI [10.1017/S095267570000066X, DOI 10.1017/S095267570000066X]; Boersma Paul, 2008, PRAAT DOING PHONETIC; Bohn OS, 1995, SPEECH PERCEPTION LI, P279; Hirano-Cook E., 2011, THESIS U KANSAS LAWR; Iverson P, 1996, J ACOUST SOC AM, V99, P1130, DOI 10.1121/1.415234; Jincho N, 2008, JPN PSYCHOL RES, V50, P12, DOI 10.1111/j.1468-5884.2007.00358.x; Kaushanskaya M, 2013, APPL PSYCHOLINGUIST, V34, P1005, DOI 10.1017/S0142716412000100; Mandel J., 2009, ADAPTIVE PITCH TEST; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; Semal C, 1996, J ACOUST SOC AM, V100, P1132, DOI 10.1121/1.416298; Shibata T., 2008, UNDERSTANDING 2 LANG, P176; Shibatani Masayoshi, 1990, LANGUAGES JAPAN; Shport I. A., 2008, JAPANESE FOREIGN LAN, P165; Strange W., 2008, PHONOLOGY 2 LANGUAGE, P193; Vance Timothy J., 2008, SOUNDS JAPANESE; Venditti Jennifer, 2005, PROSODIC TYPOLOGY PH, P172; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Wayland R, 2010, J PHONETICS, V38, P654, DOI 10.1016/j.wocn.2010.10.001; Werker J. F., 2005, LANGUAGE LEARNING DE, V1, P197, DOI DOI 10.1080/15475441.2005.9684216; Yuzawa M, 2006, COGNITIVE DEV, V21, P146, DOI 10.1016/j.cogdev.2006.01.003; Yuzawa M., 2002, JAPANESE J PSYCHOL, V73, P258	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	APR	2015	57	2					143	154		10.1111/jpr.12076		12	Psychology, Multidisciplinary	Psychology	CF1DH	WOS:000352283300006		
J	Lim, CW; Yoshinari, T; Layne, J; Chan, SH				Lim, Chee Wei; Yoshinari, Tomoya; Layne, Jeff; Chan, Sheot Harn			Multi-Mycotoxin Screening Reveals Separate Occurrence of Aflatoxins and Ochratoxin A in Asian Rice	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						LC-ESI-MS/MS; regulated multimycotoxins; rice	NATURAL OCCURRENCE; MASS-SPECTROMETRY; COOCCURRENCE; FUMONISINS; GRAINS; MAIZE; MS/MS; FOOD; B-1	The determination of important regulated mycotoxins in rice has been reported previously but not in the individual matrix of white, brown, red, and basmati rice with respect to the matrix effect, recovery, and stability. A total of 190 Asian rices were examined for regulated mycotoxin contamination by the LC-ESI-MS/MS method. Significant variation (p < 0.05) in the matrix effect was observed for fumonisins. Methanol improved the limits of detection (LOD) for HT-2 from 50 mu g/kg to 2.3 mu g/kg by promoting ionization efficiency of the ammonium-adduct. LOD and limits of quantitation ranged from 0.1 to 18 mu g/kg and 0.2-31 mu g/kg, respectively. All analytes degraded by more than 50% on storage, except fumonisins. Acetic acid (1%) provided significant improvement (p < 0.05) in recovery for all analytes in selected white rice from Thailand and China. Mean recovery ranged from 70 to 120%. RSD values were lower than 15% for all analytes. Five AFB1 and single OTA positive samples were detected. No correlation between mycotoxin contamination and rice species (r = 0) exists.	[Lim, Chee Wei; Chan, Sheot Harn] Hlth Sci Author, Food Safety Lab, Appl Sci Grp, Singapore 169078, Singapore; [Yoshinari, Tomoya] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Layne, Jeff] Phenomenex, Torrance, CA 90501 USA	Lim, CW (reprint author), Hlth Sci Author, Food Safety Lab, Appl Sci Grp, 11 Outram Rd, Singapore 169078, Singapore.	Jeff_lim@hsa.gov.sg					Afsah-Hejri L, 2013, COMPR REV FOOD SCI F, V12, P629, DOI 10.1111/1541-4337.12029; Sulyok M, 2007, FOOD ADDIT CONTAM, V24, P1184, DOI 10.1080/02652030701510004; Sulyok M, 2007, ANAL BIOANAL CHEM, V389, P1505, DOI 10.1007/s00216-007-1542-2; Reiter EV, 2010, FOOD CONTROL, V21, P988, DOI 10.1016/j.foodcont.2009.12.014; Bansal J, 2011, FOOD ADDIT CONTAM A, V28, P767, DOI 10.1080/19440049.2011.559279; Madbouly AK, 2012, FOOD ADDIT CONTAM B, V5, P112, DOI 10.1080/19393210.2012.676078; Desjardins AE, 2000, APPL ENVIRON MICROB, V66, P1020, DOI 10.1128/AEM.66.3.1020-1025.2000; Varga E, 2012, ANAL BIOANAL CHEM, V402, P2675, DOI 10.1007/s00216-012-5757-5; Trufelli H, 2011, MASS SPECTROM REV, V30, P491, DOI 10.1002/mas.20298; Firdous S, 2012, FOOD ADDIT CONTAM B, V5, P121, DOI 10.1080/19393210.2012.675360; Tanaka K, 2007, INT J FOOD MICROBIOL, V119, P59, DOI 10.1016/j.ijfoodmicro.2007.08.002; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Nguyen MT, 2007, FOOD CHEM, V105, P42, DOI 10.1016/j.foodchem.2007.03.040; Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Kim EK, 2002, J AGR FOOD CHEM, V50, P3614, DOI 10.1021/jf020058s; Reddy KRN, 2008, TOXIN REV, V27, P287, DOI 10.1080/15569540802432308; Liao CD, 2013, J AGR FOOD CHEM, V61, P4771, DOI 10.1021/jf4000677; Zain ME, 2011, J SAUDI CHEM SOC, V15, P129, DOI 10.1016/j.jscs.2010.06.006; Tang YY, 2013, FOOD ANAL METHOD, V6, P727, DOI 10.1007/s12161-012-9473-8; Asghar MA, 2013, SCI TECH DEV, V32, P110; Aydin A, 2011, ENVIRON MONIT ASSESS, V178, P271, DOI 10.1007/s10661-010-1688-9; Chen YH, 2014, FOOD CHEM, V150, P213, DOI 10.1016/j.foodchem.2013.10.132; Food and Agriculture Organisation of the United Nations (FAO), 1997, FAO FOOD NUTR PAP, V64, P1; Food and Agriculture Organisation of the United Nations (FAO), 2013, FAO RIC MARK MON NOV, V16, P1; Food and Agriculture Organization of the United Nations (FAO), 2003, WORLDW REG MYC FOOD; Food Standards Authority (FSA), SURV RET RIC RANG MY; Fredlund E, 2009, FOOD ADDIT CONTAM A, V26, P527, DOI 10.1080/02652030802562912; Hunter C., SCHEDULED MRM ALGORI; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V56, P245; Khui K. W., 2014, WORLD MYCOT IN PRESS; Lim CW, 2012, ANAL BIOANAL CHEM, V403, P2801, DOI 10.1007/s00216-011-5558-2; Makun Hussaini Anthony, 2011, Mycotoxin Res, V27, P97, DOI 10.1007/s12550-010-0080-5; McCluskey A., 2007, CONTINUING ED ANAEST, V7, P208, DOI 10.1093/bjaceaccp/mkm042; Pantazopoulos P., 2001, UNCERTAINTY ESTIMATE, P17; Riazipour M, 2009, IRAN J PUBLIC HEALTH, V38, P111; Schreiber A., INTELLIGENT USE RETE; Tanaka K, 2004, J FOOD HYG SOC JPN, V45, P63	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	APR 1	2015	63	12					3104	3113		10.1021/acs.jafc.5b00471		10	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Agriculture; Chemistry; Food Science & Technology	CF0OX	WOS:000352245200005		
J	Nagata, Y; Kanasaki, A; Tamaru, S; Tanaka, K				Nagata, Yasuo; Kanasaki, Akane; Tamaru, Shizuka; Tanaka, Kazunari			D-Psicose, an Epimer of D-Fructose, Favorably Alters Lipid Metabolism in Sprague-Dawley Rats	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						D-psicose; rare sugar; 24 h energy expenditure; weight management; lipogenic enzyme	DIETARY D-PSICOSE; SUGAR-SWEETENED BEVERAGES; BODY-FAT ACCUMULATION; HIGH-SUCROSE DIET; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; WEIGHT-GAIN; LIPOGENIC ENZYMES; RARE SUGAR; OBESE RATS	d-Psicose, a C-3 epimer of d-fructose, is known to lower body weight and adipose tissue weight and affect lipid metabolism. The precise mechanism remains unknown. It has been reported that d-psicose has a short half-life and is not metabolized in the body. To determine how d-psicose modifies lipid metabolism, rats were fed diets with or without 3% d-psicose for 4 weeks. Rats were decapitated without fasting every 6 h over a period of 24 h. Changes in serum and liver lipid levels, liver enzyme activity, and gene expression were quantified in experiment 1. Rats fed d-psicose had significantly lower serum insulin and leptin levels. Liver enzyme activities involved in lipogenesis were significantly lowered by the d-psicose diet, whereas gene expression of a transcriptional modulator of fatty acid oxidation was enhanced. In experiment 2, feeding the d-psicose diet gave significantly lower body weight (389 +/- 3 vs 426 +/- 6 g, p < 0.05) and food intake (23.8 +/- 0.2 vs 25.7 +/- 0.4 g/day, p < 0.05) compared to the control diet. Rats fed the d-psicose diet gave significantly higher energy expenditure in the light period and fat oxidation in the dark period compared to rats fed the control diet, whereas carbohydrate oxidation was lower. In summary, these results indicate that the d-psicose diet decreases lipogenesis, increases fatty acid oxidation, and enhances 24 h energy expenditure, leading to d-psicose's potential for weight management.	[Nagata, Yasuo; Kanasaki, Akane; Tamaru, Shizuka; Tanaka, Kazunari] Nagasaki Univ, Dept Nutr, Nagasaki 8512195, Japan; [Nagata, Yasuo] Nagasaki Univ, Univ & Govt Cooperat, Ctr Ind, Nagasaki 8528521, Japan	Nagata, Y (reprint author), Nagasaki Univ, Dept Nutr, 1-1-1 Manabino,Nagayo Cho, Nagasaki 8512195, Japan.	y-nagata@sun.ac.jp					Akimine R, 2007, J BIOCHEM BIOPH METH, V70, P481; MARKWELL MA, 1973, J BIOL CHEM, V248, P3426; Villareal DT, 2005, AM J CLIN NUTR, V82, P923; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI 10.1301/nr.2007.jun.S13-S23; Elliott SS, 2002, AM J CLIN NUTR, V76, P911; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Yagi K, 2009, J CLIN BIOCHEM NUTR, V45, P271, DOI 10.3164/jcbn.08-191; Hossain MA, 2011, BIOCHEM BIOPH RES CO, V405, P7, DOI 10.1016/j.bbrc.2010.12.091; Iida T, 2013, FOOD CHEM, V138, P781, DOI 10.1016/j.foodchem.2012.11.017; Hayashi H, 2002, AM J PHYSIOL-GASTR L, V282, pG69; Baek SH, 2010, J FOOD SCI, V75, pH49, DOI 10.1111/j.1750-3841.2009.01434.x; Matsuo T, 2006, BIOSCI BIOTECH BIOCH, V70, P2081, DOI 10.1271/bbb.60036; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77; Matsuo T, 2009, J CLIN BIOCHEM NUTR, V45, P202, DOI 10.3164/jcbn.09-36; Matsuo T, 2001, ASIA PAC J CLIN NUTR, V10, P233, DOI 10.1046/j.1440-6047.2001.00246.x; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Iida T, 2010, METABOLISM, V59, P206, DOI 10.1016/j.metabol.2009.07.018; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Cox CL, 2012, EUR J CLIN NUTR, V66, P201, DOI 10.1038/ejcn.2011.159; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Ishihara K, 2003, J NUTR, V133, P752; Chung MY, 2012, J AGR FOOD CHEM, V60, P863, DOI 10.1021/jf204050w; Chung YM, 2012, J FOOD SCI, V77, pH53, DOI 10.1111/j.1750-3841.2011.02571.x; Hossain A, 2012, BIOCHEM BIOPH RES CO, V425, P717, DOI 10.1016/j.bbrc.2012.07.135; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ochiai M, 2013, BIOSCI BIOTECH BIOCH, V77, P1123, DOI 10.1271/bbb.130019; Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; KELLEY DS, 1986, BIOCHEM J, V235, P87; WHISTLER RL, 1974, CARBOHYD RES, V34, P200, DOI 10.1016/S0008-6215(00)80385-7; Ochiai M, 2014, INT J FOOD SCI NUTR, V65, P245, DOI 10.3109/09637486.2013.845653; Woods SC, 2003, J NUTR, V133, P1081; Malik VS, 2006, AM J CLIN NUTR, V84, P274; FOLCH J, 1957, J BIOL CHEM, V226, P497; Iida T, 2008, J NUTR SCI VITAMINOL, V54, P511, DOI 10.3177/jnsv.54.511; KELLEY DS, 1984, BIOCHEM J, V217, P543; OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4; Schaefer EJ, 2002, DIABETES CARE, V25, P989, DOI 10.2337/diacare.25.6.989; WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8	42	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	APR 1	2015	63	12					3168	3176		10.1021/jf502535p		9	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Agriculture; Chemistry; Food Science & Technology	CF0OX	WOS:000352245200013		
J	Brockow, K; Kneissl, D; Valentini, L; Zelger, O; Grosber, M; Kugler, C; Werich, M; Darsow, U; Matsuo, H; Morita, E; Ring, J				Brockow, Knut; Kneissl, Daniel; Valentini, Luzia; Zelger, Otto; Grosber, Martine; Kugler, Claudia; Werich, Martina; Darsow, Ulf; Matsuo, Hiroaki; Morita, Eishin; Ring, Johannes			Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Wheat-dependent exercise-induced anaphylaxis; omega-5-gliadin; gluten; anaphylaxis; cofactors; plasma gliadin levels; threshold levels; oral challenge test	RECOMBINANT OMEGA-5 GLIADIN; INTESTINAL PERMEABILITY; ALLERGY; INTENSITY; PEPTIDES; ANTIGENS; TESTS	Background: Oral wheat plus cofactors challenge tests in patients with wheat-dependent exercise-induced anaphylaxis (WDEIA) produce unreliable results. Objective: We sought to confirm WDEIA diagnosis by using oral gluten flour plus cofactors challenge, to determine the amount of gluten required to elicit symptoms, and to correlate these results with plasma gliadin levels, gastrointestinal permeability, and allergologic parameters. Methods: Sixteen of 34 patients with a history of WDEIA and omega 5-gliadin IgE underwent prospective oral challenge tests with gluten with or without cofactors until objective symptoms developed. Gluten reaction threshold levels, plasma gliadin concentrations, gastrointestinal permeability, sensitivities and specificities for skin prick tests, and specific IgE levels were ascertained in patients and 38 control subjects. Results: In 16 of 16 patients (8 female and 8 male patients; age, 23-76 years), WDEIA was confirmed by challenges with gluten alone (n = 4) or gluten plus cofactors (n = 12), including 4 patients with previous negative wheat challenge results. Higher gluten doses or acetylsalicylic acid (ASA) plus alcohol instead of physical exercise were cofactors in 2 retested patients. The cofactors ASA plus alcohol and exercise increased plasma gliadin levels (P < .03). Positive challenge results developed after a variable period of time at peak or when the plateau plasma gliadin level was attained. Positive plasma gliadin threshold levels differed by greater than 100-fold and ranged from 15 to 2111 pg/mL (median, 628 pg/mL). The clinical history, IgE gliadin level, and baseline gastrointestinal level were not predictive of the outcomes of the challenge tests. The challenge-confirmed sensitivity and specificity of gluten skin prick tests was 100% and 96%, respectively. Conclusion: Oral challenge with gluten alone or along with ASA and alcohol is a sensitive and specific test for the diagnosis of WDEIA. Exercise is not an essential trigger for the onset of symptoms in patients with WDEIA.	[Brockow, Knut; Kneissl, Daniel; Grosber, Martine; Kugler, Claudia; Darsow, Ulf; Ring, Johannes] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, D-80802 Munich, Germany; [Valentini, Luzia; Werich, Martina] Charite Univ Med Berlin, Sect Nutr Med, Dept Gastroenterol & Hepatol, Berlin, Germany; [Zelger, Otto] Tech Univ Munich, Dept Prevent Rehabil & Sports Med, D-80802 Munich, Germany; [Matsuo, Hiroaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pathophysiol & Therapeut, Hiroshima 730, Japan; [Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Izumo, Shimane, Japan	Brockow, K (reprint author), Tech Univ Munich, Klinikums Rechts Isar, Klin & Poliklin Dermatol & Allergol Biederstein, Biedersteiner Str 29, D-80802 Munich, Germany.	knut.brockow@lrz.tu-muenchen.de					Choo KJL, 2010, ALLERGY, V65, P1205, DOI 10.1111/j.1398-9995.2010.02424.x; Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; Matsuo H, 2005, J IMMUNOL, V175, P8116; Jacquenet S, 2009, INT ARCH ALLERGY IMM, V149, P74, DOI 10.1159/000176309; Buhner S, 2004, ALLERGY, V59, P1118, DOI 10.1111/j.1398-9995.2004.00631.x; Matsuo H, 2008, ALLERGY, V63, P233, DOI 10.1111/j.1398-9995.2007.01504.x; Yano H, 2002, EUR J APPL PHYSIOL, V87, P358, DOI 10.1007/s00421-002-0653-x; Pals KL, 1997, J APPL PHYSIOL, V82, P571; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; Morisset M, 2003, CLIN EXP ALLERGY, V33, P1046, DOI 10.1046/j.1365-2222.2003.01734.x; Fiedler EM, 2002, ALLERGY, V57, P1090, DOI 10.1034/j.1398-9995.2002.23836_12.x; DOHI M, 1991, J ALLERGY CLIN IMMUN, V87, P34, DOI 10.1016/0091-6749(91)90210-F; Webb LM, 2006, ANN ALLERG ASTHMA IM, V97, P39; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Morita Eishin, 2009, Allergology International, V58, P493, DOI 10.2332/allergolint.09-RAI-0125; Palosuo K, 1999, J ALLERGY CLIN IMMUN, V103, P912, DOI 10.1016/S0091-6749(99)70438-0; Fukunaga A, 2012, ACTA DERM-VENEREOL, V92, P480, DOI 10.2340/00015555-1210; Lamprecht M, 2012, MED SPORT SCI, V59, P47, DOI 10.1159/000342169; ROMANO A, 1995, ALLERGY, V50, P817; Hanakawa Y, 1998, BRIT J DERMATOL, V138, P898; Kohno K, 2013, ALLERGOL INT, V62, P229, DOI 10.2332/allergolint.12-OA-0495; Aihara M, 2002, BRIT J DERMATOL, V146, P466, DOI 10.1046/j.1365-2133.2002.04601.x; Norman K, 2012, EUR J CLIN NUTR, V66, P1116, DOI 10.1038/ejcn.2012.104; Lieberman Phillip, 2010, J Allergy Clin Immunol, V126, P477, DOI 10.1016/j.jaci.2010.06.022; Matsuo H, 2005, CLIN EXP ALLERGY, V35, P461, DOI 10.1111/j.1365-2222.2005.02213.x; Gordins P, 2011, INT ARCH ALLERGY IMM, V155, P93, DOI 10.1159/000318740; Inoue Naoyuki, 2011, Arerugi, V60, P1560; Loibl M, 2009, ALLERGY, V64, P1560, DOI 10.1111/j.1398-9995.2009.02103.x; Matsukura S, 2010, CLIN EXP DERMATOL, V35, P233, DOI 10.1111/j.1365-2230.2009.03709.x; OKAZAKI M, 1992, INTERNAL MED, V31, P1052, DOI 10.2169/internalmedicine.31.1052	31	5	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					977	+		10.1016/j.jaci.2014.08.024		12	Allergy; Immunology	Allergy; Immunology	CF0MQ	WOS:000352238600020		
J	Horimukai, K; Morita, K; Inoue, E; Saito, H; Ohya, Y				Horimukai, Kenta; Morita, Kumiko; Inoue, Eisuke; Saito, Hirohisa; Ohya, Yukihiro			Prevention of atopic dermatitis by moisturizer in neonates Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Horimukai, Kenta; Morita, Kumiko; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan; [Inoue, Eisuke] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan	Horimukai, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan.	saito-hr@ncchd.go.jp					Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Kawada Tomoyuki, 2004, Journal of Nippon Medical School, V71, P167, DOI 10.1272/jnms.71.167; Kawada T, 2015, J ALLERGY CLIN IMMUN, V135, P1088, DOI 10.1016/j.jaci.2014.12.1935	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1088	1089		10.1016/j.jaci.2014.12.1934		3	Allergy; Immunology	Allergy; Immunology	CF0MQ	WOS:000352238600041		
J	Kawada, T				Kawada, Tomoyuki			Prevention of atopic dermatitis by moisturizer in neonates	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Kawada Tomoyuki, 2004, Journal of Nippon Medical School, V71, P167, DOI 10.1272/jnms.71.167; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005	3	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1088	1088		10.1016/j.jaci.2014.12.1935		1	Allergy; Immunology	Allergy; Immunology	CF0MQ	WOS:000352238600040		
J	Pakkarato, S; Chomphoo, S; Kagawa, Y; Owada, Y; Mothong, W; Iamsaard, S; Sawatpanich, T; Kondo, H; Hipkaeo, W				Pakkarato, Sawetree; Chomphoo, Surang; Kagawa, Yoshiteru; Owada, Yuji; Mothong, Wilaiwan; Iamsaard, Sitthichai; Sawatpanich, Tarinee; Kondo, Hisatake; Hipkaeo, Wiphawi			Immunohistochemical analysis of sustentacular cells in the adrenal medulla, carotid body and sympathetic ganglion of mice using an antibody against brain-type fatty acid binding protein (B-FABP)	JOURNAL OF ANATOMY			English	Article						adrenal medulla; brain type-fatty acid-binding protein; immunohistochemistry; light microscopy; sustentacular cell; transmission electron microscopy	SATELLITE GLIAL-CELLS; LOCALIZATION	Little attention has been paid to adrenal sustentacular cells, and several major histology textbooks do not even describe them. This study presents a detailed morphological description of sustentacular cells using immuno-light microscopy and an antibody against brain-type fatty acid-binding protein. The immunopositive sustentacular cells and processes formed lattices with holes of various sizes and compactnesses or openness. In addition, weakly immunostained sheet-like structures with ill-defined contours were often associated with the processes and lattices. In the carotid body, which has traditionally been classified under the name of paraganglia in common with the adrenal medulla, immunostained sustentacular cell processes formed lattices in association with the weakly immunostained sheet-like structures, but the lattices with sheets were more compact and rigid than the adrenal medulla, and appeared like individually distinct compartments. In the ganglion, the immunostained satellite cell processes with the sheets tightly enclosed individual neurons. As a result, the immunostained sheet-like structures were regarded as en-face views of thinly flattened sustentacular cytoplasmic envelopes partially covering the chromaffin cells in the adrenal medulla, and widely in the carotid body in a way rather similar to the satellite cells in the ganglion. In brief, the terminal enclosing portions of adrenal sustentacular cell processes, in cut-views, were too thin/flat to be recognized as distinct lines in immuno-light microscopy because of its resolution limit. They are recognized in en-face views as entities of a substantially spacious extension in immuno-light microscopy.	[Pakkarato, Sawetree; Chomphoo, Surang; Mothong, Wilaiwan; Iamsaard, Sitthichai; Sawatpanich, Tarinee; Kondo, Hisatake; Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand; [Pakkarato, Sawetree] Khon Kaen Univ, Neurosci Res & Dev Grp, Khon Kaen 40002, Thailand; [Kagawa, Yoshiteru; Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan; [Kondo, Hisatake] Keiai Kai Med Corp, Histol Lab, Mizusawa, Iwate, Japan	Hipkaeo, W (reprint author), Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen 40002, Thailand.	wiphawi@kku.ac.th			Faculty of Medicine, Khon Kaen University through WH [I57201]	This work was supported by Faculty of Medicine, Khon Kaen University through WH (No. I57201). The authors thank Miss Y. Polsan and Mr D. Hipkaeo for their technical support. The authors would also like to acknowledge Prof. James A. Will for editing the manuscript via Publication Clinic KKU, Thailand.	Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Belzer V, 2010, NEURON GLIA BIOL, V6, P237, DOI 10.1017/S1740925X1100007X; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Bock P, 1982, PARAGANGLIA HDB MIKR; Fawcett DW, 1994, FAWCETT TXB HISTOLOG; Hamilton WJ, 1972, HUMAN EMBRYOLOGY PRE; Kohn A, 1903, ARCH MIKRO ANAT ENTW, V62, P263, DOI 10.1007/BF02985550; KONDO H, 1971, J ULTRA MOL STRUCT R, V37, P544, DOI 10.1016/S0022-5320(71)80024-2; KONDO H, 1982, CELL TISSUE RES, V227, P291, DOI 10.1007/BF00210887; MASCORRO JA, 1989, J ELECTRON MICR TECH, V12, P323, DOI 10.1002/jemt.1060120405; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Powers JF, 2004, NEUROSCI LETT, V356, P5, DOI 10.1016/j.neulet.2003.10.083; Weiss L, 1983, TXB HISTOLOGY; Williams PL, 1995, GRAYS ANATOMY; Yun X, 2004, TOHOKU J EXP MED, V203, P77, DOI 10.1620/tjem.203.77	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	APR	2015	226	4					348	353		10.1111/joa.12285		6	Anatomy & Morphology	Anatomy & Morphology	CF5GD	WOS:000352584400005		
J	Sugisaki, N; Wakahara, T; Murata, K; Miyamoto, N; Kawakami, Y; Kanehisa, H; Fukunaga, T				Sugisaki, Norihide; Wakahara, Taku; Murata, Koichiro; Miyamoto, Naokazu; Kawakami, Yasuo; Kanehisa, Hiroaki; Fukunaga, Tetsuo			Influence of Muscle Hypertrophy on the Moment Arm of the Triceps Brachii Muscle	JOURNAL OF APPLIED BIOMECHANICS			English	Article						resistance training; elbow; MRI; muscle cross-sectional area	STRUCTURES IN-VIVO; ELBOW JOINT; BIOMECHANICAL ANALYSIS; TRAINING-PROGRAMS; PATELLAR TENDON; HUMAN KNEE; RESISTANCE; TENSION; LENGTH; REST	Although the moment arm of the triceps brachii muscle has been shown to be associated with the muscle's anatomical cross-sectional area, whether training-induced muscle hypertrophy alters the moment arm of the muscle remains unexplored. Therefore, the current study aimed to examine this. Eleven men underwent a 12-week resistance training program for the triceps brachii muscle. The maximum muscle anatomical cross-sectional area (ACSA(max)), the moment arm of the triceps brachii muscle, and the anterior-posterior dimension of the olecranon were measured using a magnetic resonance imaging system before and after intervention. The ACSA(max) (33.6 +/- 11.9%, P < .001) and moment arm (5.5 +/- 4.0%, P = .001) significantly increased after training, whereas the anterior-posterior dimension of the olecranon did not change (P>.05). The change in moment arm was smaller than that expected from the relationship between the ACSAmax and the moment arm before the intervention. The present results indicate that training-induced triceps brachii muscle hypertrophy could increase the muscle moment arm, but its impact can be small or negligible.	[Sugisaki, Norihide] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan; [Wakahara, Taku] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan; [Murata, Koichiro] Obihiro Univ Agr & Vet Med, Dept Human Sci, Obihiro, Hokkaido 080, Japan; [Miyamoto, Naokazu; Kanehisa, Hiroaki; Fukunaga, Tetsuo] Natl Inst Fitness & Sports Kanoya, Dept Sports & Life Sci, Kanoya, Kagoshima, Japan; [Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Sugisaki, N (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan.	sugisaki@chiba-u.jp					HOUSH DJ, 1992, J APPL PHYSIOL, V73, P65; Sugisaki N, 2010, J BIOMECH, V43, P2844, DOI 10.1016/j.jbiomech.2010.06.013; YOUM Y, 1979, J BIOMECH, V12, P245, DOI 10.1016/0021-9290(79)90067-8; Reeves ND, 2009, EXP PHYSIOL, V94, P825, DOI 10.1113/expphysiol.2009.046599; Krevolin JL, 2004, J BIOMECH, V37, P785, DOI 10.1016/j.jbiomech.2003.09.010; Wakahara T, 2012, EUR J APPL PHYSIOL, V112, P1569, DOI 10.1007/s00421-011-2121-y; Kubo K, 2001, J APPL PHYSIOL, V91, P26; AN KN, 1981, J BIOMECH, V14, P659, DOI 10.1016/0021-9290(81)90048-8; Maganaris CN, 2004, EUR J APPL PHYSIOL, V91, P130, DOI 10.1007/s00421-003-1033-x; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Akagi R, 2012, J APPL BIOMECH, V28, P63; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; MORREY BF, 1976, J BONE JOINT SURG AM, V58, P501; KAWAKAMI Y, 1994, EUR J APPL PHYSIOL O, V68, P139, DOI 10.1007/BF00244027; Murray WM, 2002, J BIOMECH, V35, P19, DOI 10.1016/S0021-9290(01)00173-7; Kanehisa H, 2002, EUR J APPL PHYSIOL, V87, P112, DOI 10.1007/s00421-002-0604-6; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; MURRAY WM, 1995, J BIOMECH, V28, P513, DOI 10.1016/0021-9290(94)00114-J; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Cohen J., 1988, STAT POWER ANAL BEHA; Ito Masamitsu, 1998, Journal of Applied Physiology, V85, P1230; Gerbeaux M, 1996, J BIOMECH, V29, P171, DOI 10.1016/0021-9290(95)00032-1; HERZOG W, 1993, J ANAT, V182, P213; Ito M, 2000, J BIOMECH, V33, P215, DOI 10.1016/S0021-9290(99)00154-2; Kawakami Y, 1995, EUR J APPL PHYSIOL O, V72, P37, DOI 10.1007/BF00964112; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Lieber RL, 1992, SKELETAL MUSCLE STRU; LONDON JT, 1981, J BONE JOINT SURG AM, V63, P529; Tsaopoulos DE, 2007, J BIOMECH, V40, P645, DOI 10.1016/j.jbiomech.2006.01.022	29	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	APR	2015	31	2					111	116		10.1123/JAB.2014-0126		6	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	CF1UV	WOS:000352334300006		
J	Sun, DH; Kang, XL; Yu, Q; Cui, K; Qin, XY; Shi, XX; Cai, HQ; Ohachi, T; Sang, YH; Liu, H				Sun, Dehui; Kang, Xueliang; Yu, Qian; Cui, Kun; Qin, Xiaoyong; Shi, Xuxia; Cai, Huaqiang; Ohachi, Tadashi; Sang, Yuanhua; Liu, Hong			Antisite defect elimination through Mg doping in stoichiometric lithium tantalate powder synthesized via a wet-chemical spray-drying method	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						antisite defect elimination; stoichiometric lithium tantalate; magnesium doping; wet-chemical spray drying	OPTICAL PARAMETRIC OSCILLATION; ELECTRON-PROBE MICROANALYZER; NEAR-ZERO BIREFRINGENCE; SINGLE-CRYSTALS; DOPED LINBO3; LITAO3; GROWTH; NANOPARTICLES; FABRICATION; DEVICE	MgO-doped stoichiometric LiTaO3 (MgO:SLT) is one of the most promising nonlinear materials. However, its industrial application is limited by the poor optical quality caused by the nonhomogeneous distribution of magnesium. Herein, an MgO:SLT polycrystalline powder was synthesized with a homogenous magnesium distribution by a wet-chemical spray-drying method. A comparative investigation of the coordination state of Ta ions in MgO:SLT powders synthesized by this method and by a conventional solid-state reaction method was performed by X-ray photoelectron spectroscopy. It is proved that the Ta-Li antisite was completely eliminated as a result of the homogeneous Mg doping in the SLT lattice using the wet-chemical spray-drying method. However, for MgO:LT powder produced by the solid-state reaction method, element analysis after acid treatment shows that some Mg ions did not enter the LT lattice after high-temperature calcination. Also, scanning electron microscopy and transmission electron microscopy energy dispersive spectroscopy verified that some MgO particles still exist in the as-synthesized MgO:LT powder. This synthesis method can be used for mass production of high-quality polycrystalline powders for doped crystal growth and some other doped oxide powder products with high melt point.	[Sun, Dehui; Kang, Xueliang; Sang, Yuanhua; Liu, Hong] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Sun, Dehui; Sang, Yuanhua; Liu, Hong] Innowit Co Ltd, Jinan 250101, Peoples R China; [Yu, Qian; Cai, Huaqiang] China Acad Engn Phys, Inst Chem Mat, Mianyang 621900, Peoples R China; [Cui, Kun; Qin, Xiaoyong; Shi, Xuxia] CETC Deqing Huaying Elect Co Ltd, Deqing 313200, Peoples R China; [Ohachi, Tadashi] Doshisha Univ, IRE Lab, D Egg, Kyoto 6100332, Japan	Sang, YH (reprint author), Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China.	sangyh@sdu.edu.cn; hongliu@sdu.edu.cn			National High Technology Research and Development Program of China (863 Program) [2013AA030501]; NSFC [NSFDYS: 51402172, IRG: 51321091]; Program of Introducing Talents of Discipline to Universities in China (111 Program) [b06015]; China Scholarship Council (CSC)	This work was supported by the National High Technology Research and Development Program of China (863 Program, grant No. 2013AA030501), NSFC (NSFDYS: 51402172, IRG: 51321091), and the Program of Introducing Talents of Discipline to Universities in China (111 Program No. b06015). DS was supported by the China Scholarship Council (CSC). The authors thank Dr Matthew Sale and Peiguang Hu for their contribution on English grammar.	Juvalta F, 2006, J OPT SOC AM B, V23, P276, DOI 10.1364/JOSAB.23.000276; Ishizuki H, 2008, OPT EXPRESS, V16, P16963, DOI 10.1364/OE.16.016963; Kumaragurubaran S, 2005, J CRYST GROWTH, V285, P88, DOI 10.1016/j.jcrysgro.2005.07.053; Kumaragurubaran S, 2006, J CRYST GROWTH, V292, P332, DOI 10.1016/j.jcrysgro.2006.04.080; Gutmann E, 2012, J PHYS CHEM C, V116, P5383, DOI 10.1021/jp210686m; Shumov DP, 2006, J CRYST GROWTH, V287, P296, DOI 10.1016/j.jcrysgro.2005.11.031; Kitamura K, 1998, APPL PHYS LETT, V73, P3073, DOI 10.1063/1.122676; Yu NE, 2004, APPL PHYS LETT, V85, P5134, DOI 10.1063/1.1828211; Devan RS, 2010, J APPL CRYSTALLOGR, V43, P1062, DOI 10.1107/S0021889810026646; Riscob B, 2013, J APPL CRYSTALLOGR, V46, P1854, DOI 10.1107/S0021889813025065; Zeng ZY, 2014, ENERG ENVIRON SCI, V7, P797, DOI 10.1039/c3ee42620c; Riwotzki K, 1998, J PHYS CHEM B, V102, P10129, DOI 10.1021/jp982293c; Baumer C, 2003, J APPL PHYS, V93, P3102, DOI 10.1063/1.1542689; Gao CL, 2008, CRYST GROWTH DES, V8, P3785, DOI 10.1021/cg8004147; CORNEILLE JS, 1994, SURF SCI, V306, P269, DOI 10.1016/0039-6028(94)90071-X; ASHKIN A, 1966, APPL PHYS LETT, V9, P72, DOI 10.1063/1.1754607; Liu YW, 2003, APPL PHYS LETT, V82, P4218, DOI 10.1063/1.1583136; Zheng FF, 2009, J ALLOY COMPD, V477, P688, DOI 10.1016/j.jallcom.2008.10.159; Zhu YQ, 2001, CHEM PHYS LETT, V347, P337, DOI 10.1016/S0009-2614(01)00939-3; Hu PC, 2011, OPT MATER, V33, P1677, DOI 10.1016/j.optmat.2011.05.007; BARNS RL, 1970, J APPL CRYSTALLOGR, V3, P395, DOI 10.1107/S0021889870006490; Bernasconi P, 1999, FERROELECTRICS, V223, P373, DOI 10.1080/00150199908260592; Bhagavannarayana G, 2005, J APPL CRYSTALLOGR, V38, P768, DOI 10.1107/S0021889805023745; Bruner A, 2004, J APPL PHYS, V96, P7445, DOI 10.1063/1.1804616; FAIRBROTHER F, 1956, J CHEM SOC, P4946, DOI 10.1039/jr9560004946; FUKUDA T, 1979, J CRYST GROWTH, V46, P179, DOI 10.1016/0022-0248(79)90054-X; Glazer AM, 2012, J APPL CRYSTALLOGR, V45, P1030, DOI 10.1107/S0021889812035121; Glazer AM, 2010, J APPL CRYSTALLOGR, V43, P1305, DOI 10.1107/S0021889810033868; Hatanaka T, 2000, OPT LETT, V25, P651, DOI 10.1364/OL.25.000651; Katsumata T., 1998, MAT RES B, V29, P559; Kehres J, 2010, J APPL CRYSTALLOGR, V43, P1400, DOI 10.1107/S0021889810041907; KITAMURA K, 1992, J CRYST GROWTH, V116, P327, DOI 10.1016/0022-0248(92)90640-5; Krause B, 2013, J APPL CRYSTALLOGR, V46, P1064, DOI 10.1107/S0021889813014477; LIPPS JERE H., 1967, J PALEONTOL, V41, P492; Liu MN, 2006, SOLID STATE IONICS, V177, P275, DOI 10.1016/j.ssi.2005.11.007; Liu QB, 2012, CRYSTENGCOMM, V14, P5572, DOI 10.1039/c2ce25262g; MIYAZAWA SH, 1971, J CRYST GROWTH, V10, P276, DOI 10.1016/0022-0248(71)90195-3; NEWBURY DE, 1990, ANAL CHEM, V62, pA1159; NEWBURY DE, 1990, ANAL CHEM, V62, pA1245; Ould-Ely T, 2013, CRYSTENGCOMM, V15, P6918, DOI 10.1039/c3ce41264d; Thirurnalairajan S, 2013, CRYST GROWTH DES, V13, P291, DOI 10.1021/cg3014305; Tu SY, 2005, OPT LETT, V30, P2451, DOI 10.1364/OL.30.002451; Yan T, 2011, J APPL CRYSTALLOGR, V44, P158, DOI 10.1107/S0021889810052520	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	APR	2015	48		2				377	385		10.1107/S1600576715002113		9	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CF0JH	WOS:000352229100008		
J	Fukumoto, S; Ushimaru, A; Minamoto, T				Fukumoto, Sou; Ushimaru, Atushi; Minamoto, Toshifumi			A basin-scale application of environmental DNA assessment for rare endemic species and closely related exotic species in rivers: a case study of giant salamanders in Japan	JOURNAL OF APPLIED ECOLOGY			English	Article						Andrias davidianus; Andrias japonicus; Chinese giant salamander; environmental DNA; Japanese giant salamander; Katsura River; real-time PCR	WATER SAMPLES; EDNA	1. To prevent the invasion of exotic species causing a decline in an endangered endemic species, it is important to determine the distribution of both species at an early stage, when the density of the exotic species is still low, and to manage the invasion immediately. However, distinguishing between closely related species is difficult because they share similar characteristics. 2. The identification of DNA fragments sampled from a body of water (environmental DNA) has become a popular technique for rapidly determining the distribution of a target species. In this study, we analysed environmental DNA in water samples from 37 sites across the Katsura River basin in Japan. We used TaqMan real-time PCR to distinguish the Japanese giant salamander Andrias japonicus from the closely related Chinese giant salamander Andrias davidianus, which is known to invade Japanese rivers and hybridize with the Japanese species. 3. In environmental samples, we detected mtDNA of the endemic species at 25 sites and mtDNA of the exotic species at nine sites. The DNA detection sites were concentrated in the upstream region. The exotic species DNA was found beyond the limits of an earlier capturing survey. 4. Synthesis and applications. Using environmental DNA to monitor the two salamander species requires less time and effort than traditional surveys, so a wide-ranging survey can be conducted rapidly. Our results showed that performing three environmental DNA surveys for each site between autumn and winter is desirable for giant salamanders. Further collection of environmental DNA, in combination with conventional population surveys, will provide valuable information that can help protect rare endemic species in a variety of aquatic ecosystems and can help monitor the invasion of exotic species.	[Fukumoto, Sou; Ushimaru, Atushi; Minamoto, Toshifumi] Kobe Univ, Fac Human Dev, Nada Ku, Kobe, Hyogo 6578501, Japan; [Fukumoto, Sou] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Kyoto 6068501, Japan; [Ushimaru, Atushi; Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Minamoto, Toshifumi] Res Inst Human & Nat, Kita Ku, Kyoto, Kyoto 6038047, Japan	Minamoto, T (reprint author), Kobe Univ, Fac Human Dev, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	minamoto@people.kobe-u.ac.jp			JSPS KAKENHI [24657020, 26440238]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4RF-1302]	We are grateful to Dr K. Moji at the Research Institute for Humanity and Nature for permitting us to use the laboratory; to Mr H. Mitsuhashi at the Museum of Nature and Human Activities, Hyogo, for advising us on the research direction; to Dr H. Yamanaka at the Ryukoku University for taking water samples; and to Drs M. Matsui and N. Yoshikawa at Kyoto University and Mr S. Seki at the Kyoto Aquarium for providing animal and water samples. This work was supported by JSPS KAKENHI (Grant Numbers: 24657020 and 26440238) and by the Environment Research and Technology Development Fund (4RF-1302) of the Ministry of the Environment, Japan. There are no conflict of interest to declare.	Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Minamoto T, 2009, APPL ENVIRON MICROB, V75, P6900, DOI 10.1128/AEM.01411-09; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Honjo MN, 2010, APPL ENVIRON MICROB, V76, P161, DOI 10.1128/AEM.02011-09; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Fukumoto S., 2015, DRYAD DIGITAL REPOSI; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Matsui M., 2005, HABITATION CONFIRMAT; Minamoto T, 2009, VET MICROBIOL, V135, P261, DOI 10.1016/j.vetmic.2008.09.081; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; R Development Core Team, 2010, R LANG ENV STAT COMP; Sambrook J, 2001, MOL CLONING LAB MANU; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Uchiyama R., 2002, PHOTOGRAPHIC GUIDE A; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	30	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8901	1365-2664		J APPL ECOL	J. Appl. Ecol.	APR	2015	52	2					358	365		10.1111/1365-2664.12392		8	Ecology	Environmental Sciences & Ecology	CE9BJ	WOS:000352138100010		
J	Atobe, S; Saga, K; Hasegawa, F; Magota, A; Furuhashi, K; Okada, S; Suzuki, T; Imou, K				Atobe, Sueko; Saga, Kiyotaka; Hasegawa, Fumio; Magota, Akinari; Furuhashi, Kenichi; Okada, Shigeru; Suzuki, Toru; Imou, Kenji			The effect of the water-soluble polymer released from Botryococcus braunii Showa strain on solvent extraction of hydrocarbon	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Botryococcus braunii; Chlorophyta; Hydrocarbon; Water-soluble polymer; Sol-gel transition; Differential scanning calorimetry (DSC)	GREEN-ALGA; MICROALGAE; RECOVERY; CULTURES	Hydrocarbons are easily extracted by organic solvents such as n-decane from wet samples of Botryococcus braunii by thermal pretreatment at 90 A degrees C even after being cooled to room temperature. However, hydrocarbon recoveries are not as readily achieved at room temperature from samples pretreated at temperatures lower than 80 A degrees C. This suggests that there is the point of no return for pretreatment temperature that enables effective solvent extraction of hydrocarbons at room temperature from wet algal samples of B. braunii. To elucidate the mechanism of hydrocarbon recovery from B. braunii following thermal pretreatments, we investigated the thermophysical properties of the water phase separated from heated algal slurry. Differential scanning calorimetry (DSC) measurements revealed sol-gel transitions in the water phase of algal slurry after protein denaturation at 64 A degrees C in samples that was pretreated at 70 or 80 A degrees C but not in those pretreated at 90 A degrees C. Furthermore, the pretreated > 70 A degrees C water-soluble polymers revealed polysaccharides composed of galactose, arabinose, and uronic acid. These results suggest that the transition from sol state to gel state of water-soluble polysaccharides in algal slurry prevented hydrocarbon recovery with organic solvents since hydrocarbons were easily recovered from sol state samples pretreated at 70 or 80 A degrees C when the extraction temperature was kept the same as the pretreatment temperature. These results reveal that the presence of water-soluble polymers with gelation ability in the water phase and removal of these polymers in sol state enable effective recovery of hydrocarbons at room temperature after thermal pretreatments.	[Atobe, Sueko; Saga, Kiyotaka; Hasegawa, Fumio; Magota, Akinari; Furuhashi, Kenichi; Okada, Shigeru; Imou, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Suzuki, Toru] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Imou, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aimou@mail.ecc.u-tokyo.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This study was performed as part of a project of the Strategic Development of Next-generation Bioenergy Utilization Technology, "Efficient Production of Hydrocarbon from Microalgae," supported by the New Energy and Industrial Technology Development Organization (NEDO). We would like to thank all the people involved.	AARONSON S, 1982, EXPERIENTIA, V38, P36, DOI 10.1007/BF01944523; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; DOTE Y, 1994, FUEL, V73, P1855, DOI 10.1016/0016-2361(94)90211-9; Atobe S, 2014, BIOSCI BIOT IN PRESS; BENAMOTZ A, 1985, J PHYCOL, V21, P72; Chanda S.K., 1939, J AM CHEM SOC, V1952, P1833; Furuhashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066483; Hang A, 1967, ACTA CHEM SCAND, V21, P691; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; Magota A, 2012, BIORESOURCE TECHNOL, V123, P195, DOI 10.1016/j.biortech.2012.07.095; MIYOSHI E, 1995, MACROMOL SYMP, V99, P83, DOI 10.1002/masy.19950990110; Nelson W.L., 1929, J AM CHEM SOC, V51, P1914, DOI 10.1021/ja01381a045; Nelson WL, 1932, J AM CHEM SOC, V54, P3409, DOI 10.1021/ja01347a063; Nishinari K, 2000, HYDROCOLLOIDS 2; NONOMURA A M, 1988, Japanese Journal of Phycology, V36, P285; Rinaudo M, 1994, FOOD HYDROCOLLOIDS S, P35; Saga K., 2013, J JPN I ENERGY, V92, P1214; Sluiter A, 2008, TECHNICAL REPORT; SWALE E M F, 1968, British Phycological Bulletin, V3, P441; THOMAS WH, 1984, BIOMASS, V5, P181, DOI 10.1016/0144-4565(84)90022-2; Vaquez-Duhalt R, 1991, PHYTOCHEMISTRY, V30, P2919; WAKE LV, 1981, AUST J MAR FRESH RES, V32, P353; WAKE LV, 1980, BIOTECHNOL BIOENG, V22, P1637, DOI 10.1002/bit.260220808; YAMAGUCHI K, 1987, AGR BIOL CHEM TOKYO, V51, P493	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	APR	2015	27	2					755	761		10.1007/s10811-014-0363-x		7	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CF3KA	WOS:000352446200013		
J	Sagara, T; Nishibori, N; Kishibuchi, R; Itoh, M; Morita, K				Sagara, Takefumi; Nishibori, Naoyoshi; Kishibuchi, Reina; Itoh, Mari; Morita, Kyoji			Non-protein components of Arthrospira (Spirulina) platensis protect PC12 cells against iron-evoked neurotoxic injury	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Blue-green algae; Cyanobacteria; Protein-deprived extract; Neuroprotective effect; Iron toxicity; DNA degradation; Polyphenolic compounds	C6 GLIOMA-CELLS; CASPASE-3 CASCADE; OXIDATIVE STRESS; DAMAGE; APOPTOSIS; PHYCOCYANIN; ACTIVATION; EXTRACT; ASSAY; HIPPOCAMPAL	The abnormal accumulation of iron in the brain has been suggested to be toxic to neuronal cells and proposed as a possible cause of neurodegenerative disorders. Particularly, studies on the pathogenesis of neurodegenerative diseases have suggested that the excessive accumulation of iron in the specific brain regions may be responsible for neurodegenerative changes associated with the pathogenesis of Alzheimer's, Parkinson's, and Huntington's diseases. As a part of studies searching for natural substances protecting neuronal cells against the iron-evoked toxic injury, an aqueous extract containing the non-protein components of the cyanobacterium Arthrospira (Spirulina) platensis, designated "the protein-deprived extract", was prepared, and its effect on the iron-evoked damage to PC12 cells was examined in an in vitro model experiment. The protein-deprived extract caused a protective effect against the iron-evoked damage to PC12 cells as a consequence of preventing the free radical-evoked DNA degradation. Further studies showed that the extract has antioxidant and free radical-scavenging activities, which might be based on polyphenolic compounds in the extract. Thus, polyphenolic compounds contained in A. platensis are suggested to be potentially active substances responsible for the protective effect of Arthrospira extract against the iron-evoked neurotoxicity and possibly for the protection of neurodegenerative disorders induced by excessive iron accumulation in the brain.	[Sagara, Takefumi] Shokei Jr Coll, Dept Food & Nutr, Kumamoto 8628678, Japan; [Nishibori, Naoyoshi] Shikoku Jr Coll, Dept Food Sci & Nutr, Lab Cell Biol & Toxicol, Tokushima 7711192, Japan; [Kishibuchi, Reina; Itoh, Mari; Morita, Kyoji] Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima 7711192, Japan	Morita, K (reprint author), Shikoku Univ, Sch Hlth Sci, Dept Nursing, Neuropharmacol Lab, Tokushima 7711192, Japan.	kmorita@shikoku-u.ac.jp			Kohken Co. Inc. (Sapporo, Japan); Shikoku Kakoki Co. Ltd. (Tokushima, Japan)	The authors express their gratitude to DIC Life-Tec Co., Ltd. (Tokyo, Japan) for the donation of S. platensis dry powder. This work was supported in part by the funds provided from Kohken Co. Inc. (Sapporo, Japan) and Shikoku Kakoki Co. Ltd. (Tokushima, Japan).	Chen YC, 2002, BIOCHEM PHARMACOL, V64, P1713, DOI 10.1016/S0006-2952(02)01386-2; Ko CH, 2004, FREE RADICAL BIO MED, V36, P897, DOI 10.1016/j.freeradbiomed.2003.12.020; Li XL, 2009, INT J BIOCHEM CELL B, V41, P1526, DOI 10.1016/j.biocel.2009.01.002; FAUTZ R, 1991, MUTAT RES, V253, P173, DOI 10.1016/0165-1161(91)90130-Z; Khan M, 2005, PHYTOTHER RES, V19, P1030, DOI 10.1002/ptr.1783; Lee JC, 2002, J AGR FOOD CHEM, V50, P6490, DOI 10.1021/jf020388c; Liu RL, 2003, J NEUROCHEM, V85, P492, DOI 10.1046/j.1471-4159.2003.01708.x; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Ou Y, 2010, CHEM-BIOL INTERACT, V185, P94, DOI 10.1016/j.cbi.2010.03.013; Lu J, 2010, BRIT J NUTR, V103, P1573, DOI 10.1017/S0007114509993758; Lu HK, 2006, EUR J APPL PHYSIOL, V98, P220, DOI 10.1007/s00421-006-0263-0; Chen TJ, 2006, TOXICOLOGY, V223, P113, DOI 10.1016/j.tox.2006.03.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Thaakur S, 2010, J NEURAL TRANSM, V117, P1083, DOI 10.1007/s00702-010-0440-5; Bermejo P, 2008, FOOD CHEM, V110, P436, DOI 10.1016/j.foodchem.2008.02.021; Bermejo-Bescos P, 2008, TOXICOL IN VITRO, V22, P496; Bostanci MO, 2010, CELL MOL NEUROBIOL, V30, P389, DOI 10.1007/s10571-009-9461-8; Chen YH, 2007, J AGR FOOD CHEM, V55, P1743, DOI 10.1021/jf063118t; Chu WL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-53; Dartsch PC, 2008, PHYTOTHER RES, V22, P627, DOI 10.1002/ptr.2310; Figueredo YN, 2011, J PHARMACOL SCI, V116, P36, DOI 10.1254/jphs.10273FP; Jagetia GC, 2011, CHEM-BIOL INTERACT, V190, P121, DOI 10.1016/j.cbi.2011.02.009; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; Mao T K, 2000, J Med Food, V3, P135, DOI 10.1089/jmf.2000.3.135; Mao TK, 2005, J MED FOOD, V8, P27, DOI 10.1089/jmf.2005.8.27; Morita K, 2000, CELL BIOL INT, V24, P223, DOI 10.1006/cbir.1999.0494; Morita K, 1999, JPN J PHARMACOL, V79, P121, DOI 10.1254/jjp.79.121; Nahdi A, 2010, J MOL HISTOL, V41, P233, DOI 10.1007/s10735-010-9283-5; Oktar S, 2009, J PHYSIOL BIOCHEM, V65, P339, DOI 10.1007/BF03185928; Park HJ, 2008, ANN NUTR METAB, V52, P322, DOI 10.1159/000151486; Salazar J, 2006, J NEURAL TRANSM-SUPP, P205; Salvador GA, 2010, INT J ALZHEIMERS DIS, V2011, P1; Sohn J, 1998, Korean J Ophthalmol, V12, P77; Stromberg I, 2005, EXP NEUROL, V196, P298, DOI 10.1016/j.expneuorol.2005.08.013; Sun YX, 2011, ENVIRON TOXICOL PHAR, V32, P168, DOI 10.1016/j.etap.2011.04.008; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	APR	2015	27	2					849	855		10.1007/s10811-014-0388-1		7	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CF3KA	WOS:000352446200022		
J	Kato, S; Isono, S; Amemiya, M; Sato, S; Ikeda, A; Okazaki, J; Sato, Y; Ishikawa, T				Kato, Shinichiro; Isono, Shiroh; Amemiya, Megumi; Sato, Shin; Ikeda, Aya; Okazaki, Junko; Sato, Yumi; Ishikawa, Teruhiko			Submental negative pressure application decreases collapsibility of the passive pharyngeal airway in nonobese women	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						obstructive sleep apnea; pathophysiology; pharynx; static mechanics; tissue pressure; closing pressure	OBSTRUCTIVE SLEEP-APNEA; TISSUE PRESSURE; ANESTHETIZED PATIENTS; NERVE-STIMULATION; VOLUME BEHAVIOR; FAT; RABBITS; PATENCY; TONGUE; VELOPHARYNX	The pharyngeal airway is surrounded by soft tissues that are also enclosed by bony structures such as the mandible, maxilla, and cervical spine. The passive pharyngeal airway is therefore structurally analogous to a collapsible tube within a rigid box. Cross-sectional area of the tube is determined by transmural pressure, the pressure difference between intraluminal and extraluminal pressures. Due to a lack of knowledge on the influence of extraluminal soft tissue pressure on the human pharyngeal airway patency, we hypothesized that application of negative external pressure to the submental region decreases collapsibility of the passive pharynx, and that obese individuals have less response to the intervention than nonobese individuals. Static mechanical properties of the passive pharynx were compared before and during application of submental negative pressure in 10 obese and 10 nonobese adult women under general anesthesia and paralysis. Negative pressure was applied through use of a silicone collar covering the entire submental region and a vacuum pump. In nonobese subjects, application of submental negative pressure (-25 and -50 cmH(2)O) significantly decreased closing pressures at the retropalatal airway by 2.3 +/- 3.2 cmH(2)O and 2.0 +/- 3.0 cmH(2)O, respectively, and at the retroglossal airway by 2.9 +/- 2.7 cmH(2)O and 3.7 +/- 2.6 cmH(2)O, respectively, and the intervention stiffened the retroglossal pharyngeal airway wall. No significant mechanical changes were observed during application of submental negative pressure in obese subjects. Conclusively, application of submental negative pressure was found to decreases collapsibility of the passive pharyngeal airway in nonobese Japanese women.	[Kato, Shinichiro; Amemiya, Megumi; Sato, Shin; Ikeda, Aya; Ishikawa, Teruhiko] Chiba Univ Hosp, Dept Anesthesiol, Chiba, Japan; [Isono, Shiroh; Okazaki, Junko; Sato, Yumi] Chiba Univ, Grad Sch Med, Dept Anesthesiol B1, Chiba 2608670, Japan	Isono, S (reprint author), Chiba Univ, Grad Sch Med, Dept Anesthesiol B1, Chuo Ku, 1-8-1 Inohana Cho, Chiba 2608670, Japan.	shirohisono@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [24390363]	Support for this study was provided by Grant-in-Aid 24390363 from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan.	Isono S, 2002, ANESTHESIOLOGY, V97, P780, DOI 10.1097/00000542-200210000-00006; ISONO S, 1993, J APPL PHYSIOL, V75, P148; Isono S, 2005, ANESTHESIOLOGY, V103, P489, DOI 10.1097/00000542-200509000-00010; Rowley JA, 1996, J APPL PHYSIOL, V80, P2171; Watanabe T, 2002, AM J RESP CRIT CARE, V165, P260; Kairaitis K, 2009, J APPL PHYSIOL, V106, P887, DOI 10.1152/japplphysiol.91236.2008; Kairaitis K, 2007, SLEEP, V30, P179; Schwartz AR, 2010, J APPL PHYSIOL, V108, P430, DOI 10.1152/japplphysiol.00919.2009; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931; Saigusa H, 2009, ANESTHESIOLOGY, V110, P885, DOI 10.1097/ALN.0b013e31819b5d57; Simpson L, 2010, SLEEP, V33, P467; Kairaitis K, 2003, J APPL PHYSIOL, V95, P1560, DOI 10.1152/japplphysiol.00432.2003; Mortimore IL, 1998, AM J RESP CRIT CARE, V157, P280; Nashi N, 2007, LARYNGOSCOPE, V117, P1467, DOI 10.1097/MLG.0b013e318068b566; Oliven A, 2010, J APPL PHYSIOL, V109, P1037, DOI 10.1152/japplphysiol.00019.2010; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887; SULLIVAN CE, 1981, LANCET, V1, P862; Basner RC, 2007, NEW ENGL J MED, V356, P1751, DOI 10.1056/NEJMct066953; Isono S, 2012, RESPIROLOGY, V17, P32, DOI 10.1111/j.1440-1843.2011.02093.x; Tsuiki S, 2008, ANESTHESIOLOGY, V108, P1009, DOI 10.1097/ALN.0b013e318173f103; Bailey EF, 2003, J PHYSIOL-LONDON, V548, P563, DOI 10.1113/jphysiol.2002.029298; Brennick MJ, 2004, J PHYSIOL-LONDON, V561, P597, DOI 10.1113/jphysiol.2004.073502; HIDA W, 1995, AM J RESP CRIT CARE, V151, P455; Hoshino Y, 2011, J CLIN ANESTH, V23, P527, DOI 10.1016/j.jclinane.2011.02.004; ISONO S, 2000, LUNG BIOL HEALTH DIS, V147, P261; Isono S, 1997, J APPL PHYSIOL, V82, P1319; Isono S, 2000, AM J RESP CRIT CARE, V162, P832; Isono S, 1997, J APPL PHYSIOL, V83, P851; Isono S, 2003, J APPL PHYSIOL, V95, P2257, DOI 10.1152/japplphysiol.00402.2003; Kairaitis K, 2006, J APPL PHYSIOL, V100, P349, DOI 10.1152/japplphysiol.00560.2005; KOENIG JS, 1988, J APPL PHYSIOL, V64, P2294; Li YR, 2012, RESP CARE, V57, P1098, DOI 10.4187/respcare.00929; Riken Japan, HUM ORG PROP DAT COM; WINTER WC, 1995, J APPL PHYSIOL, V79, P726; WOLIN AD, 1990, J APPL PHYSIOL, V68, P154; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-10550C	36	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	APR 1	2015	118	7					912	920		10.1152/japplphysiol.00158.2014		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CE9CM	WOS:000352141200016		
J	Oki, K; Halievski, K; Vicente, L; Xu, YF; Zeolla, D; Poort, J; Katsuno, M; Adachi, H; Sobue, G; Wiseman, RW; Breedlove, SM; Jordan, CL				Oki, Kentaro; Halievski, Katherine; Vicente, Laura; Xu, Youfen; Zeolla, Donald; Poort, Jessica; Katsuno, Masahisa; Adachi, Hiroaki; Sobue, Gen; Wiseman, Robert W.; Breedlove, S. Marc; Jordan, Cynthia L.			Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						polyglutamine/CAG repeat disease; motoneuron disease; neuromuscular disease; Kennedy disease	AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; SKELETAL-MUSCLE; NEURON DEGENERATION; MYOTONIC-DYSTROPHY; AXONAL-TRANSPORT; BODY-COMPOSITION; CREATINE-KINASE; SLOW-TWITCH; DISEASE	Spinal and bulbar muscular atrophy (SBMA) is characterized by progressive muscle weakness linked to a polyglutamine expansion in the androgen receptor (AR). Current evidence indicates that mutant AR causes SBMA by acting in muscle to perturb its function. However, information about how muscle function is impaired is scant. One fundamental question is whether the intrinsic strength of muscles, an attribute of muscle independent of its mass, is affected. In the current study, we assess the contractile properties of hindlimb muscles in vitro from chronically diseased males of three different SBMA mouse models: a transgenic (Tg) model that broadly expresses a full-length human AR with 97 CAGs (97Q), a knock-in (KI) model that expresses a humanized AR containing a CAG expansion in the first exon, and a Tg myogenic model that overexpresses wild-type AR only in skeletal muscle fibers. We found that hindlimb muscles in the two Tg models (97Q and myogenic) showed marked losses in their intrinsic strength and resistance to fatigue, but were minimally affected in KI males. However, diseased muscles of all three models showed symptoms consistent with myotonic dystrophy type 1, namely, reduced resting membrane potential and deficits in chloride channel mRNA. These data indicate that muscle dysfunction is a core feature of SBMA caused by at least some of the same pathogenic mechanisms as myotonic dystrophy. Thus mechanisms controlling muscle function per se independent of mass are prime targets for SBMA therapeutics.	[Oki, Kentaro; Halievski, Katherine; Vicente, Laura; Xu, Youfen; Zeolla, Donald; Poort, Jessica; Breedlove, S. Marc; Jordan, Cynthia L.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Adachi, Hiroaki] Univ Occupat & Environm Hlth, Sch Med, Dept Neurol, Fukuoka, Japan; [Wiseman, Robert W.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Jordan, CL (reprint author), Michigan State Univ, 108 Giltner Hall,293 Farm Lane, E Lansing, MI 48824 USA.	jordancy@msu.edu	Adachi, Hiroaki/I-2669-2012	Adachi, Hiroaki/0000-0002-9302-4663	National Institutes of Health [R01 NS-045195, DK-095210]	This work was supported by National Institutes of Health Grants R01 NS-045195 (to CLJ) and DK-095210 (to RWW).	Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Kemp MQ, 2011, HUM MOL GENET, V20, P4475, DOI 10.1093/hmg/ddr380; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; FISCHBECK KH, 1991, ADV NEUROL, V56, P209; MARTIN AF, 1981, J BIOL CHEM, V256, P964; Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Sorenson EJ, 2007, AMYOTROPH LATERAL SC, V8, P62, DOI 10.1080/17482960600765040; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; Supinski GS, 2006, J APPL PHYSIOL, V100, P1770, DOI 10.1152/japplphysiol.01288.2005; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Johansen JA, 2009, NEUROBIOL DIS, V34, P113, DOI 10.1016/j.nbd.2008.12.009; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Zuloaga DG, 2008, HORM BEHAV, V54, P758, DOI 10.1016/j.yhbeh.2008.08.004; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chahin N, 2009, MUSCLE NERVE, V40, P126, DOI 10.1002/mus.21310; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Talbert EE, 2013, J APPL PHYSIOL, V114, P1482, DOI 10.1152/japplphysiol.00925.2012; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Battaglia F, 2003, J Clin Neuromuscul Dis, V4, P165, DOI 10.1097/00131402-200306000-00001; Charlet BN, 2002, MOL CELL, V10, P45; Chevrel G, 2006, MUSCLE NERVE, V33, P462, DOI 10.1002/mus.20444; Fu SC, 2013, J FORMOS MED ASSOC, V112, P326, DOI 10.1016/j.jfma.2012.03.008; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Harris-Love MO, 2014, REHABIL RES PRACT, V2014; Inoue K, 2009, EUR J NEUROL, V16, P76, DOI 10.1111/j.1468-1331.2008.02349.x; Jayaraman RC, 2006, BIOMED SIGNAL PROCES, V1, P307, DOI 10.1016/j.bspc.2006.12.002; Johansen JA, 2007, J NEUROENDOCRINOL, V19, P823, DOI 10.1111/j.1365-2826.2007.01592.x; Johansen JA, 2011, NEURODEGENER DIS, V8, P25, DOI 10.1159/000313682; LASPADA AR, 1991, NATURE, V352, P77; Meriggioli MN, 2003, MUSCLE NERVE, V27, P249, DOI 10.1002/mus.10295; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Monks DA, 2004, J COMP NEUROL, V473, P59, DOI 10.1002/cne.20088; Noto Y, 2013, CLIN NEUROPHYSIOL, V124, P1893, DOI 10.1016/j.clinph.2012.12.053; Oki K, 2013, MUSCLE NERVE, V47, P823, DOI 10.1002/mus.23813; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Vermaelen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1723, DOI 10.1152/ajpcell.00398.2006; Westerblad H, 2010, ADV EXP MED BIOL, V682, P279, DOI 10.1007/978-1-4419-6366-6_16	54	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	APR 1	2015	118	7					941	952		10.1152/japplphysiol.00886.2014		12	Physiology; Sport Sciences	Physiology; Sport Sciences	CE9CM	WOS:000352141200019		
J	Iwahata, H; Hashimoto, S; Inoue, M; Inoue, T; Ito, K; Nakaoka, Y; Suzuki, N; Morimoto, Y				Iwahata, Hideyuki; Hashimoto, Shu; Inoue, Masayasu; Inoue, Tomoko; Ito, Keijiro; Nakaoka, Yoshiharu; Suzuki, Nao; Morimoto, Yoshiharu			Neonatal outcomes after the implantation of human embryos vitrified using a closed-system device	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Closed vitrification system; Human blastocyst; Neonatal outcome	IN-VITRO FERTILIZATION; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; VITRIFICATION; CRYOPRESERVATION; BLASTOCYSTS; PREGNANCY; SURVIVAL; IVF; CONTAMINATION	Closed vitrification poses a risk of adversely affecting embryo development, while it may minimize the risk of contamination. We assessed the effects of closed-system human embryo vitrification on fetal development after implantation, neonatal outcome, and clinical safety. This was a retrospective cohort study conducted at a private fertility clinic. A total of 875 vitrified-warmed blastocysts that were single-transferred under hormone-replacement cycles between November 2011 and December 2013 were randomly divided into two groups (closed vitrification, n 313; open vitrification, n 562) after receiving the patients' consent forms. Developmental competence after implantation, including gestational age, birth weight, sex, Apgar score, and anomalies of newborns, after the transfer of blastocysts vitrified by closing vitrification was compared with that obtained in the case of open vitrification. There were no significant differences between the use of closed and open vitrification systems in embryo development after implantation, gestational age, birth weight, sex ratio, Apgar score, and congenital anomalies of newborns. Human embryos can be vitrified using a closed vitrification system without impairment of neonatal development.	[Iwahata, Hideyuki; Hashimoto, Shu; Inoue, Masayasu; Inoue, Tomoko; Ito, Keijiro; Nakaoka, Yoshiharu; Morimoto, Yoshiharu] IVF Namba Clin, Nishi Ku, Osaka 5500015, Japan; [Iwahata, Hideyuki; Hashimoto, Shu; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan	Hashimoto, S (reprint author), IVF Namba Clin, Nishi Ku, 1-17-28 Minami Horie, Osaka 5500015, Japan.	hashimoto@ivfnamba.com			Japan Society for the Promotion of Science [JPS-RFTF 23580397]	This work was supported in part by a grant from the Japan Society for the Promotion of Science (JPS-RFTF 23580397 to S.H.).	AbdelHafez F, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-29; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608; Liebermann J, 2002, REPRODUCTION, V124, P483; [Anonymous], 2010, CRYOBIO PREMARKET NO; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3<342::AID-MRD13>3.0.CO;2-X; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779; Hashimoto S, 2013, J ASSIST REPROD GEN, V30, P371, DOI 10.1007/s10815-012-9928-2; Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Martinez-Burgos M, 2011, FERTIL STERIL, V95, P374, DOI 10.1016/j.fertnstert.2010.07.1089; Bielanski A, 2009, HUM REPROD, V24, P2457, DOI 10.1093/humrep/dep117; Rehman KS, 2007, FERTIL STERIL, V87, P1041, DOI 10.1016/j.fertnstert.2006.11.014; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Vanderzwalmen P, 2009, REPROD BIOMED ONLINE, V19, P700; Isachenko V, 2005, HUM REPROD, V20, P492, DOI 10.1093/humrep/deh605; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Isachenko V, 2007, CRYOBIOLOGY, V54, P305, DOI 10.1016/j.cryobiol.2007.03.003; Loutradi KE, 2008, FERTIL STERIL, V90, P186, DOI 10.1016/j.fertnstert.2007.06.010; Bielanski A, 2006, TRENDS REPROD BIOL, V2, P13; Budinetz TH, 2014, FERTIL STERIL, V102, P753, DOI 10.1016/j.fertnstert.2014.05.030; Chen Y, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-107; Czepulkowski B.H., 1992, HUMAN CYTOGENETICS P, VII; DeMunck N, 2012, HUM REPROD, V27, pi72; Desai NN, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-41; Hashimoto S, 2013, HUM REPROD, V28, P1528, DOI 10.1093/humrep/det059; Hashimoto S, 2008, J REPROD DEVELOP, V54, P370, DOI 10.1262/jrd.20012; Huang JYJ, 2007, FERTIL STERIL, V88, P1093, DOI 10.1016/j.fertnstert.2006.12.066; Koike A, 2008, J FERTIL IMPLANT, V25, P219; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Larman MG, 2011, FERTIL STERIL, V95, P1462, DOI 10.1016/j.fertnstert.2010.12.003; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; Mazur P, 2005, CRYOBIOLOGY, V51, P29, DOI 10.1016/j.cryobiol.2005.04.008; Nedambale TL, 2004, THERIOGENOLOGY, V62, P437, DOI 10.1016/j.theriogenology.2003.10.020; Panagiotidis Y, 2012, HUM REPROD, V27, pi59; Papatheodourou A, 2012, HUM REPROD, V27, pi72; Valojerdi MR, 2005, J ASSIST REPROD GEN, V22, P119, DOI 10.1007/s10815-005-4876-8; Yokota Y, 2000, HUM REPROD, V15, P1802, DOI 10.1093/humrep/15.8.1802	39	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	APR	2015	32	4					521	526		10.1007/s10815-015-0431-4		6	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	CF0GA	WOS:000352219900005		
J	Nagao, S; Ishikawa, H; Yamada, T; Mizutani, Y; Hirota, S				Nagao, Satoshi; Ishikawa, Haruto; Yamada, Takuya; Mizutani, Yasuhisa; Hirota, Shun			Carbon monoxide binding properties of domain-swapped dimeric myoglobin	JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY			English	Article						Myoglobin; Domain swapping; Ligand binding; Active site structure	RESONANCE RAMAN-SPECTROSCOPY; SPERM-WHALE MYOGLOBIN; LIGAND-BINDING; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; CYTOCHROME-C; X-RAY; HEMOGLOBIN; HEME; PATHWAYS	Myoglobin (Mb) is a monomeric oxygen storage hemoprotein, and has been shown to form a domain-swapped dimer. In this study, monomeric and dimeric carbon monoxide (CO)-bound Mb (MbCO) exhibited similar absorption spectra. The CO stretching frequencies of MbCO were observed at 1,932 and 1,944 cm(-1) for both monomeric and dimeric MbCO. The resonance Raman (RR) bands for the stretching between the heme iron and axial ligands were observed at the same frequencies for the monomer and dimer of deoxygenated Mb (deoxyMb) and MbCO, respectively (nu (Fe-His), 220 cm(-1); nu (Fe-C), 507 cm(-1)), showing that the Fe-His bond strength of deoxyMb and the Fe-CO bond strength of MbCO did not change by the dimerization. Time-resolved RR measurements showed that the dynamics of the structural changes at the heme active site after CO photo-dissociation of MbCO was similar between monomeric and dimeric Mb [monomer, (5.2 +/- A 1.8) x 10(6) s(-1); dimer, (6.2 +/- A 1.1) x 10(6) s(-1) at room temperature]. These results show that the heme coordination structure, the protein environment around the bound CO, and the protein relaxation character are similar between monomeric and dimeric MbCO. Although the active site structure was similar between the monomer and dimer, the CO binding rate constant of dimeric Mb [(1.01 +/- A 0.03) x 10(6) M-1 s(-1) at 20 A degrees C] was about twice larger than that of the monomer [(0.52 +/- A 0.02) x 10(6) M-1 s(-1) at 20 A degrees C], presumably due to the expansion of the channel between the Xe3 cavity and the solvent by the dimerization.	[Nagao, Satoshi; Yamada, Takuya; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Ishikawa, Haruto; Mizutani, Yasuhisa] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan	Hirota, S (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Nara 6300192, Japan.	hirota@ms.naist.jp	Ishikawa, Haruto/B-1562-2012	Ishikawa, Haruto/0000-0001-6362-5719	JSPS [24750163, 26288080]; Green Photonics Project at NAIST; MEXT	We give thanks to Mr. Leigh McDowell for his advice during manuscript preparation. This work was partially supported by Grants-in-Aid for Scientific Research from JSPS (Young Scientists B, No. 24750163 (S.N.) and Category B, No. 26288080 (S.H.)). This study was also supported by the Green Photonics Project at NAIST sponsored by MEXT.	ALBEN JO, 1968, BIOCHEMISTRY-US, V7, P175, DOI 10.1021/bi00841a022; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0; FRANZEN S, 1995, BIOCHEMISTRY-US, V34, P1224, DOI 10.1021/bi00004a016; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; SONO M, 1982, J BIOL CHEM, V257, P8308; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Hartmann H, 1996, P NATL ACAD SCI USA, V93, P7013, DOI 10.1073/pnas.93.14.7013; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Parui PP, 2013, BIOCHEMISTRY-US, V52, P8732, DOI 10.1021/bi400986g; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Olson JS, 1996, J BIOL CHEM, V271, P17593; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Hayashi Y, 2012, BIOCHEMISTRY-US, V51, P8608, DOI 10.1021/bi3011303; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Dadusc G, 2001, P NATL ACAD SCI USA, V98, P6110, DOI 10.1073/pnas.101130298; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Chu K, 2000, NATURE, V403, P921; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BANGCHAROENPAURPONG O, 1984, J AM CHEM SOC, V106, P5688, DOI 10.1021/ja00331a045; Blouin GC, 2010, BIOCHEMISTRY-US, V49, P4968, DOI 10.1021/bi100172c; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; Brunori M, 2001, EMBO REP, V2, P674, DOI 10.1093/embo-reports/kve159; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Coughey W S, 1969, Biochemistry, V8, P59; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; FINDSEN EW, 1985, J AM CHEM SOC, V107, P3355, DOI 10.1021/ja00297a056; GIBSON QH, 1956, J PHYSIOL-LONDON, V134, P112; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Ishikawa H, 2001, BIOPHYS J, V80, P1507; Kitagawa T, 1987, STRUCT BONDING BERLI, V64, P71; Mizutani Y, 1997, SCIENCE, V278, P443, DOI 10.1126/science.278.5337.443; Mizutani Y, 2001, J PHYS CHEM B, V105, P10992, DOI 10.1021/jp010923w; Mizutani Y, 2001, CHEM REC, V1, P258, DOI 10.1002/tcr.1012; Murakawa Y, 2012, J AM CHEM SOC, V134, P1434, DOI 10.1021/ja209659w; Nishihara Y, 2004, J AM CHEM SOC, V126, P11877, DOI 10.1021/ja038877w; Olson J S, 1981, Methods Enzymol, V76, P631; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P12301, DOI 10.1021/bi980752u; PHILLIPS SEV, 1978, NATURE, V273, P247, DOI 10.1038/273247a0; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Sakakura M, 2001, J AM CHEM SOC, V123, P4286, DOI 10.1021/ja9944655; Salter MD, 2012, J BIOL CHEM, V287, P33163, DOI 10.1074/jbc.M112.392258; Smith RD, 2010, BIOCHEMISTRY-US, V49, P4977, DOI 10.1021/bi1001739; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; STEIN P, 1980, J AM CHEM SOC, V102, P7795, DOI 10.1021/ja00546a035; Tomita A, 2010, J EXP BIOL, V213, P2748, DOI 10.1242/jeb.042994; Unno M, 1998, J AM CHEM SOC, V120, P2670, DOI 10.1021/ja973293d; Yamada K, 2012, J PHYS CHEM B, V116, P1992, DOI 10.1021/jp2114303; Yeh SR, 1998, ACCOUNTS CHEM RES, V31, P727, DOI 10.1021/ar970084p	65	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-8257	1432-1327		J BIOL INORG CHEM	J. Biol. Inorg. Chem.	APR	2015	20	3					523	530		10.1007/s00775-014-1236-0		8	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	CF0DK	WOS:000352212700007		
J	Ohara, T; Fukuda, H; Tokuda, IT				Ohara, Takayuki; Fukuda, Hirokazu; Tokuda, Isao T.			Phase Response of the Arabidopsis thaliana Circadian Clock to Light Pulses of Different Wavelengths	JOURNAL OF BIOLOGICAL RHYTHMS			English	Article						Arabidopsis thaliana; plant circadian rhythm; phase transition curve; light wavelength; mathematical model; parameter estimation	HIGHER-PLANTS; GENE CIRCUIT; DARK-PULSE; RHYTHMS; CRYPTOCHROMES; PHYTOCHROMES; LUCIFERASE; SYSTEM	Light is known as one of the most powerful environmental time cues for the circadian system. The quality of light is characterized by its intensity and wavelength. We examined how the phase response of Arabidopsis thaliana depends on the wavelength of the stimulus light and the type of light perturbation. Using transgenic A. thaliana expressing a luciferase gene, we monitored the rhythm of the bioluminescence signal. We stimulated the plants under constant red light using 3 light perturbation treatments: (1) increasing the red light intensity, (2) turning on a blue light while turning off the red light, and (3) turning on a blue light while keeping the red light on. To examine the phase response properties, we generated a phase transition curve (PTC), which plots the phase after the perturbation as a function of the phase before the perturbation. To evaluate the effect of the 3 light perturbation treatments, we simulated PTCs using a mathematical model of the plant circadian clock and fitted the simulated PTCs to the experimentally measured PTCs. Among the 3 treatments, perturbation (3) provided the strongest stimulus. The results indicate that the color of the stimulus light and the type of pulse administration affect the phase response in a complex manner. Moreover, the results suggest the involvement of interaction between red and blue light signaling pathways in resetting of the plant circadian clock.	[Ohara, Takayuki; Tokuda, Isao T.] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Fukuda, Hirokazu] Osaka Prefecture Univ, Grad Sch Engn, Osaka, Japan	Tokuda, IT (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	isao@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS) [25293053, 23560446, 25119721]	We thank Mr. Nobuya Okamura for assistance with the phase response experiments. This work was partially supported by a Grant-in-Aid for Scientific Research (no. 25293053 to I.T.T.; no. 23560446 to H.F. and I.T.T.; no. 25119721 to H.F.) from the Japan Society for the Promotion of Science (JSPS).	Foster RG, 2001, PHILOS T ROY SOC B, V356, P1779, DOI 10.1098/rstb.2001.0962; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071<0001:PCPPII>2.0.CO;2; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Bujdoso N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00003; CASAL JJ, 1995, PLANTA, V197, P213; Fukuda Hirokazu, 2011, Environment Control in Biology, V49, P51; Fukuda Hirokazu, 2008, Environment Control in Biology, V46, P123; Fukuda H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01533; Hu W, 2013, P NATL ACAD SCI USA, V110, P1542, DOI 10.1073/pnas.1221738110; Johnson Carl Hirschie, 1992, P209; Nakamichi N, 2004, PLANT CELL PHYSIOL, V45, P57, DOI 10.1093/pcp/pch003; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x	26	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0748-7304	1552-4531		J BIOL RHYTHM	J. Biol. Rhythms	APR	2015	30	2					95	103		10.1177/0748730415576426		9	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CF5FB	WOS:000352581100004		
J	Qin, X; Jiang, Q; Matsuo, Y; Kawane, T; Komori, H; Moriishi, T; Taniuchi, I; Ito, K; Kawai, Y; Rokutanda, S; Izumi, S; Komori, T				Qin, Xin; Jiang, Qing; Matsuo, Yuki; Kawane, Tetsuya; Komori, Hisato; Moriishi, Takeshi; Taniuchi, Ichiro; Ito, Kosei; Kawai, Yosuke; Rokutanda, Satoshi; Izumi, Shinichi; Komori, Toshihisa			Cbfb Regulates Bone Development by Stabilizing Runx Family Proteins	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						CBFB; RUNX2; ENDOCHONDRAL OSSIFICATION; INTRAMEMBRANOUS OSSIFICATION; CCD	CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; PARATHYROID-HORMONE; SKELETAL DEVELOPMENT; BETA INTERACTS; IN-VIVO; GENE; BINDING; EXPRESSION; ENHANCER	Runx family proteins, Runx1, Runx2, and Runx3, play important roles in skeletal development. Runx2 is required for osteoblast differentiation and chondrocyte maturation, and haplodeficiency of RUNX2 causes cleidocranial dysplasia, which is characterized by open fontanelles and sutures and hypoplastic clavicles. Cbfb forms a heterodimer with Runx family proteins and enhances their DNA-binding capacity. Cbfb-deficient (Cbfb(-/-)) mice die at midgestation because of the lack of fetal liver hematopoiesis. We previously reported that the partial rescue of hematopoiesis in Cbfb(-/-) mice revealed the requirement of Cbfb in skeletal development. However, the precise functions of Cbfb in skeletal development still remain to be clarified. We deleted Cbfb in mesenchymal cells giving rise to both chondrocyte and osteoblast lineages by mating Cbfb(fl/fl) mice with Dermo1 Cre knock-in mice. Cbfb(fl/fl/Cre) mice showed dwarfism, both intramembranous and endochondral ossifications were retarded, and chondrocyte maturation and proliferation and osteoblast differentiation were inhibited. The differentiation of chondrocytes and osteoblasts were severely inhibited in vitro, and the reporter activities of Ihh, Col10a1, and Bglap2 promoter constructs were reduced in Cbfb(fl/fl/Cre) chondrocytes or osteoblasts. The proteins of Runx1, Runx2, and Runx3 were reduced in the cartilaginous limb skeletons and calvariae of Cbfb(fl/fl/Cre) embryos compared with the respective protein in the respective tissue of Cbfb(fl/fl) embryos at E15.5, although the reduction of Runx2 protein in calvariae was much milder than that in cartilaginous limb skeletons. All of the Runx family proteins were severely reduced in Cbfb(fl/fl/Cre) primary osteoblasts, and Runx2 protein was less stable in Cbfb(fl/fl/Cre) osteoblasts than Cbfb(fl/fl) osteoblasts. These findings indicate that Cbfb is required for skeletal development by regulating chondrocyte differentiation and proliferation and osteoblast differentiation; that Cbfb plays an important role in the stabilization of Runx family proteins; and that Runx2 protein stability is less dependent on Cbfb in calvariae than in cartilaginous limb skeletons. (c) 2014 American Society for Bone and Mineral Research.	[Qin, Xin; Jiang, Qing; Matsuo, Yuki; Kawane, Tetsuya; Komori, Hisato; Moriishi, Takeshi; Kawai, Yosuke; Rokutanda, Satoshi; Izumi, Shinichi; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Unit Basic Med Sci, Nagasaki 8528588, Japan; [Taniuchi, Ichiro] RIKEN Res Ctr Allergy & Immunol, Lab Transcript Regulat, Yokohama, Kanagawa, Japan; [Ito, Kosei] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, Unit Basic Med Sci, Nagasaki 8528588, Japan; [Kawai, Yosuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Unit Translat Med, Nagasaki 8528588, Japan; [Rokutanda, Satoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Surg, Unit Translat Med, Nagasaki 8528588, Japan	Komori, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Unit Basic Med Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	komorit@nagasaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan [26221310]	We thank Dr D Ornitz for Dermo1-Cre knock-in mice, Dr K von der Mark for Col10a1 promoter construct, and M Mori for technical assistance. This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (#26221310).	Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Zaidi SK, 2001, J CELL SCI, V114, P3093; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; CALLEN DF, 1993, J MED GENET, V30, P828, DOI 10.1136/jmg.30.10.828; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Goto Tomohide, 2004, Congenital Anomalies, V44, P225, DOI 10.1111/j.1741-4520.2004.00043.x; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Kawane T, 2014, J BONE MINER RES, V29, P1960, DOI 10.1002/jbmr.2240; Khan A, 2006, AM J MED GENET A, V140A, P2349, DOI 10.1002/ajmg.a.31479; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Marks SC, 2002, PRINCIPLES BONE BIOL; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	APR	2015	30	4					706	714		10.1002/jbmr.2379		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CE8PB	WOS:000352104400016		
J	Lim, KE; Park, NR; Che, XG; Han, MS; Jeong, JH; Kim, SY; Park, CY; Akiyama, H; Kim, JE; Ryoo, HM; Stein, JL; Lian, JB; Stein, GS; Choi, JY				Lim, Kyung-Eun; Park, Na-Rae; Che, Xiangguo; Han, Min-Su; Jeong, Jae-Hwan; Kim, Shin-Yoon; Park, Clara Yongjoo; Akiyama, Haruhiko; Kim, Jung-Eun; Ryoo, Hyun-Mo; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; Choi, Je-Yong			Core Binding Factor beta of Osteoblasts Maintains Cortical Bone Mass via Stabilization of Runx2 in Mice	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						CBF; OSTEOBLASTS; BONE MASS; POLYUBIQUITINATION; RUNX2	CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTOR; CBF-BETA; SKELETAL DEVELOPMENT; IN-VIVO; DIFFERENTIATION; GENE; EXPRESSION; INTERACTS; MUTATION	Core binding factor beta (Cbf), the partner protein of Runx family transcription factors, enhances Runx function by increasing the binding of Runx to DNA. Null mutations of Cbfb result in embryonic death, which can be rescued by restoring fetal hematopoiesis but only until birth, where bone formation is still nearly absent. Here, we address a direct role of Cbf in skeletal homeostasis by generating osteoblast-specific Cbf-deficient mice (Cbfb(ob/ob)) from Cbfb-floxed mice crossed with mice expressing Cre from the Col1a1 promoter. Cbfb(ob/ob) mice showed normal growth and development but exhibited reduced bone mass, particularly of cortical bone. The reduction of bone mass in Cbfb(ob/ob) mice is similar to the phenotype of mice with haploinsufficiency of Runx2. Although the number of osteoblasts remained unchanged, the number of active osteoblasts decreased in Cbfb(ob/ob) mice and resulted in lower mineral apposition rate. Immunohistochemical and quantitative real-time PCR analyses showed that the expression of osteogenic markers, including Runx2, osterix, osteocalcin, and osteopontin, was significantly repressed in Cbfb(ob/ob) mice compared with wild-type mice. Cbf deficiency also reduced Runx2 protein levels in osteoblasts. The mechanism was revealed by forced expression of Cbf, which increased Runx2 protein levels in vitro by inhibiting polyubiquitination-mediated proteosomal degradation. Collectively, these findings indicate that Cbf stabilizes Runx2 in osteoblasts by forming a complex and thus facilitates the proper maintenance of bone mass, particularly cortical bone. (c) 2015 American Society for Bone and Mineral Research.	[Lim, Kyung-Eun; Park, Na-Rae; Che, Xiangguo; Han, Min-Su; Jeong, Jae-Hwan; Kim, Shin-Yoon; Park, Clara Yongjoo; Choi, Je-Yong] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Plus KNU Biomed Convergence Program BK21, Daegu 700422, South Korea; [Akiyama, Haruhiko] Gifu Univ, Dept Orthopaed, Gifu, Japan; [Kim, Jung-Eun] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Daegu 700422, South Korea; [Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul, South Korea; [Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea; [Stein, Janet L.; Lian, Jane B.; Stein, Gary S.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	Choi, JY (reprint author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu 700422, South Korea.	jechoi@knu.ac.kr			Korean Health Technology R&D Project, Ministry of Health Welfare [A111487]; National Research Foundation of Korea grant, Republic of Korea [2010-0026741]; NIH [R01 AR039588, R37DE012528]	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare (A111487) and the National Research Foundation of Korea grant (2010-0026741), Republic of Korea. This study was also supported in part by NIH grants R01 AR039588 (GSS) and R37DE012528 ARRA Merit Award (JBL).	Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/jbmr.081248, 10.1359/JBMR.081248]; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Dempster DW, 2012, J BONE MINER RES, V28, P2, DOI DOI 10.1002/JBMR.1805; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307; Han MS, 2010, J CELL BIOCHEM, V110, P97, DOI 10.1002/jcb.22516; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; KAMACHI Y, 1990, J VIROL, V64, P4808; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kusuzaki K, 2000, BONE, V27, P655, DOI 10.1016/S8756-3282(00)00383-5; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Ohba S, 2007, FASEB J, V21, P1777, DOI 10.1096/fj.06-7571com; WANG SW, 1993, MOL CELL BIOL, V13, P3324; Yoon WJ, 2013, J CELL PHYSIOL, V228, P2377, DOI 10.1002/jcp.24403	39	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	APR	2015	30	4					715	722		10.1002/jbmr.2397		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CE8PB	WOS:000352104400017		
J	Taniguchi, T; Kato, M; Ueda, S; Yokomatsu, T; Mizoguchi, T; Miki, S; Yoshida, A				Taniguchi, Tomohiko; Kato, Masashi; Ueda, Shuzo; Yokomatsu, Takafumi; Mizoguchi, Tetsu; Miki, Shinji; Yoshida, Akira			Prevalence and Significance of Clinically Unsuspected Pulmonary Embolism: Detection Using Coronary Computed Tomography Angiography	JOURNAL OF CARDIAC SURGERY			English	Article							VENOUS THROMBOEMBOLISM; MULTIDETECTOR CT; BYPASS-SURGERY; CANCER; CHEST; MDCT; PREVENTION; THROMBOSIS; RELEVANCE; SURVIVAL	Background and AimClinically unsuspected pulmonary embolism can be detected using coronary computed tomography (CT), but the clinical significance of unsuspected pulmonary embolism remains unclear. MethodsPulmonary embolism was assessed using consecutive coronary CT from March 2003 to June 2007 to assess 1077 patients. Coronary CT was performed using a 16-row multidetector CT (MDCT) scanner with ECG-gating. A radiologist and a cardiologist retrospectively assessed the images of pulmonary arteries to arrive at a consensus diagnosis. ResultsUnsuspected pulmonary embolism was detected in 32/1,077 (3.0%) patients. No significant difference was observed with regard to death and acute pulmonary embolism between patients with and without unsuspected pulmonary embolism at five years (6.7% vs. 4.1%, p=0.61). Prior cardiac surgery within three months of diagnosis of pulmonary embolism was an independent risk factor for unsuspected pulmonary embolism, which was detected in 10/89 (11%) of such patients. The absence of anticoagulant therapy was a risk factor (p=0.015) for unsuspected pulmonary embolism post-cardiac surgery. Although only one out of 10 patients received anticoagulant therapy, none of the 10 experienced critical events. Five of the 10 patients underwent repeated coronary CT, and the embolus disappeared regardless of its size and location in four of the five patients who did not receive anticoagulant therapy. ConclusionsThe prevalence of unsuspected pulmonary embolism detected using coronary CT was 3.0%. Prior cardiac surgery within three months of diagnosing pulmonary embolism was an independent risk factor for unsuspected pulmonary embolism. The long-term clinical outcomes of patients with unsuspected pulmonary embolism were favorable. doi: 10.1111/jocs.12512 (J Card Surg 2015;30:301-306)	[Taniguchi, Tomohiko; Kato, Masashi; Yokomatsu, Takafumi; Mizoguchi, Tetsu; Miki, Shinji; Yoshida, Akira] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto 6158087, Japan; [Ueda, Shuzo] Mitsubishi Kyoto Hosp, Dept Radiol, Kyoto 6158087, Japan	Taniguchi, T (reprint author), Mitsubishi Kyoto Hosp, Dept Cardiol, Nishikyo Ku, 1 Katsura Gosho Cho, Kyoto 6158087, Japan.	ta2guchi@kuhp.kyoto-u.ac.jp					O'Connell C, 2011, J THROMB HAEMOST, V9, P305, DOI 10.1111/j.1538-7836.2010.04114.x; Gladish GW, 2006, RADIOLOGY, V240, P246, DOI 10.1148/radiol.2401051129; Wittram C, 2004, RADIOGRAPHICS, V24, P1219, DOI 10.1148/rg.245045008; Mueller J, 2007, AM J ROENTGENOL, V189, P414, DOI 10.2214/AJR.06.0736; Dentali F, 2010, THROMB RES, V125, P518, DOI 10.1016/j.thromres.2010.03.016; GOLDHABER SZ, 1995, AM J CARDIOL, V76, P993, DOI 10.1016/S0002-9149(99)80282-3; Ritchie G, 2007, THORAX, V62, P536, DOI 10.1136/thx.2006.062299; Storto ML, 2005, AM J ROENTGENOL, V184, P264; Haller S, 2006, AM J ROENTGENOL, V187, P105, DOI 10.2214/AJR.04.1988; Dentali F, 2011, J THROMB HAEMOST, V9, P1081, DOI 10.1111/j.1538-7836.2011.04259.x; den Exter PL, 2011, J CLIN ONCOL, V29, P2405, DOI 10.1200/JCO.2010.34.0984; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Engelke C, 2006, RADIOLOGY, V239, P563, DOI 10.1148/radiol.2392050118; Franklin JM, 2011, POSTGRAD MED J, V87, P746, DOI 10.1136/pgmj.2011.118497; Goldhaber SZ, 2004, CIRCULATION, V109, P2712, DOI 10.1161/01.CIR.0000132616.89315.34; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lee CK, 2011, INT J CARDIOVAS IMAG, V27, P639, DOI 10.1007/s10554-011-9868-4; Meyer G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1421; O'Connell CL, 2006, J CLIN ONCOL, V24, P4928, DOI 10.1200/JCO.2006.06.5870; Protopapas AD, 2011, J CARDIAC SURG, V26, P181, DOI 10.1111/j.1540-8191.2010.01195.x; Rao G, 1975, Vasc Surg, V9, P37, DOI 10.1177/153857447500900106; Smith TP, 2000, AJR, V74, P1489	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	APR	2015	30	4					301	306		10.1111/jocs.12512		6	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CF4BV	WOS:000352494400001		
J	Kanemitsu, H; Okada, Y; Sakon, Y; Konishi, Y; Nakamura, K; Fukunaga, N; Saji, Y; Koyama, T				Kanemitsu, Hideo; Okada, Yukikatsu; Sakon, Yoshito; Konishi, Yasunobu; Nakamura, Ken; Fukunaga, Naoto; Saji, Yoshiaki; Koyama, Tadaaki			Long-Term Outcomes of Mitral Valve Repair with the Duran Flexible Ring	JOURNAL OF CARDIAC SURGERY			English	Article							DEGENERATIVE DISEASE; REGURGITATION; RECONSTRUCTION; ANNULOPLASTY; CARPENTIER; GUIDELINES	BackgroundMitral annuloplasty is a reliable mitral valve repair technique. There are two types of annuloplasy rings: the rigid ring and the flexible ring. This study sought to examine the long-term results of mitral valve repair using a Duran flexible ring. MethodsWe retrospectively reviewed 226 patients who underwent primary mitral valve repair using the Duran flexible ring for mitral regurgitation between September 1994 and March 2003. Patients' mean age was 56.7 years, and 39% were female. The mean follow-up was 10.6 years (0.04 approximate to 18.3), and echocardiographic follow-up was 83.3% complete. ResultsThere were three early and 25 late deaths. Survival was 89.32.2 for 10 years, and 83.5 +/- 3.2% for 15 years. The 10- and 15-year freedom from reoperation on the mitral valve were 96.4 +/- 1.4 and 95.3 +/- 1.7%, respectively. The 10- and 15-year freedom from moderate or severe mitral regurgitation were 92.5 +/- 2.2 and 73.7 +/- 7.1%, respectively. Cox regression analysis revealed that age, male gender, and isolated anterior leaflet prolapse were predictive of recurrent moderate or severe mitral regurgitation. ConclusionsMitral valve repair for mitral regurgitation using a flexible Duran ring is safe and durable for more than 10 years. doi: 10.1111/jocs.12522 (J Card Surg 2015;30:333-337)	[Kanemitsu, Hideo; Okada, Yukikatsu; Sakon, Yoshito; Konishi, Yasunobu; Nakamura, Ken; Fukunaga, Naoto; Saji, Yoshiaki; Koyama, Tadaaki] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kanemitsu, H (reprint author), Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Surg, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	hideo-k@qf6.so-net.ne.jp					Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Okada Y, 2002, J HEART VALVE DIS, V11, P32; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; David TE, 2005, J THORAC CARDIOV SUR, V130, P1242, DOI 10.1016/j.jtcvs.2005.06.046; Ibrahim MF, 2002, ANN THORAC SURG, V73, P34, DOI 10.1016/S0003-4975(01)03305-7; OKADA Y, 1995, ANN THORAC SURG, V59, P658, DOI 10.1016/0003-4975(94)01008-0; Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI 10.1016/j.athoracsur.2007.12.082; David TE, 2013, CIRCULATION, V127, P1485, DOI 10.1161/CIRCULATIONAHA.112.000699; Chang BC, 2007, J THORAC CARDIOV SUR, V133, P995, DOI 10.1016/j.jtcvs.2006.10.023; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Chung CH, 2007, J HEART VALVE DIS, V16, P536; CARPENTI.A, 1971, J THORAC CARDIOV SUR, V61, P1; DAVID TE, 1989, ANN THORAC SURG, V47, P524; DURAN CMG, 1978, J CARDIOVASC SURG, V19, P417; Hu X, 2011, EUR J CARDIO-THORAC, V40, P480, DOI 10.1016/j.ejcts.2010.11.080	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	APR	2015	30	4					333	337		10.1111/jocs.12522		5	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CF4BV	WOS:000352494400006		
J	Unekawa, M; Tomita, Y; Toriumi, H; Osada, T; Masamoto, K; Kawaguchi, H; Itoh, Y; Kanno, I; Suzuki, N				Unekawa, Miyuki; Tomita, Yutaka; Toriumi, Haruki; Osada, Takashi; Masamoto, Kazuto; Kawaguchi, Hiroshi; Itoh, Yoshiaki; Kanno, Iwao; Suzuki, Norihiro			Hyperperfusion counteracted by transient rapid vasoconstriction followed by long-lasting oligemia induced by cortical spreading depression in anesthetized mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						confocal microscopy; cortical spreading depression; laser Doppler flowmetry; microcirculation; neurovascular coupling; pial arteries	BLOOD-CELL VELOCITY; RAT CEREBRAL-CORTEX; IN-VIVO; INTRAPARENCHYMAL CAPILLARIES; OXYGEN-CONSUMPTION; LOCAL CHANGES; FLOW; HYPEREMIA; BRAIN; POTASSIUM	Cortical spreading depression (CSD) involves mass depolarization of neurons and glial cells accompanied with changes in regional cerebral blood flow (rCBF) and energy metabolism. To further understand the mechanisms of CBF response, we examined the temporal diametric changes in pial arteries, pial veins, and cortical capillaries. In urethane-anesthetized mice, the diameters of these vessels were measured while simultaneously recording rCBF with a laser Doppler flowmeter. We observed a considerable increase in rCBF during depolarization in CSD induced by application of KCl, accompanied by a transient dip of rCBF with marked vasoconstriction of pial arteries, which resembled the response to pin-prick-induced CSD. Arterial constriction diminished or disappeared during the second and third passages of CSD, whereas the rCBF increase was maintained without a transient dip. Long-lasting oligemia with a decrease in the reciprocal of mean transit time of injected dye and mild constriction of pial arteries was observed after several passages of the CSD wave. These results indicate that CSD-induced rCBF changes consist of initial hyperemia with a transient dip and followed by a long-lasting oligemia, partially corresponding to the diametric changes of pial arteries, and further suggest that vessels other than pial arteries, such as intracortical vessels, are involved.	[Unekawa, Miyuki; Tomita, Yutaka; Toriumi, Haruki; Osada, Takashi; Itoh, Yoshiaki; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Tokyo 1608582, Japan; [Masamoto, Kazuto] Univ Electrocommun, Brain Sci Inspired Life Support Res Ctr, Tokyo, Japan; [Masamoto, Kazuto; Kawaguchi, Hiroshi; Kanno, Iwao] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan	Unekawa, M (reprint author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	unekawa.m@z5.keio.jp	Suzuki, Norihiro/J-5125-2013		JSPS KAKENHI Grant [22390182, 26350981, 24500422, 24590732, 23591281]	This work was supported by JSPS KAKENHI Grant Numbers 22390182 (NS), 26350981 (MU), 24500422 (YT), 24590732 (HT), and 23591281 (YI).	Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; Hotta H, 2013, J CEREBR BLOOD F MET, V33, P1440, DOI 10.1038/jcbfm.2013.92; Tomita Y, 2005, J CEREBR BLOOD F MET, V25, P858, DOI 10.1038/sj.jcbfm.9600077; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Schiszler I, 2000, AM J PHYSIOL-HEART C, V279, pH1291; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ayata C, 2013, STROKE, V44, pS87, DOI 10.1161/STROKEAHA.112.680264; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Busija DW, 2008, PROG NEUROBIOL, V86, P379, DOI 10.1016/j.pneurobio.2008.09.008; Fabricius M, 1995, AM J PHYSIOL-HEART C, V269, pH23; FABRICIUS M, 1993, BRAIN RES, V602, P350, DOI 10.1016/0006-8993(93)90701-N; Fordsmann JC, 2013, J NEUROSCI, V33, P2562, DOI 10.1523/JNEUROSCI.2308-12.2013; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255; Hotta H, 2011, J PHYSIOL SCI, V61, P201, DOI 10.1007/s12576-011-0139-x; KOCHER M, 1990, J CEREBR BLOOD F MET, V10, P564; KONOLD P, 1968, PFLUG ARCH EUR J PHY, V301, P285, DOI 10.1007/BF00362638; LACOMBE P, 1992, EXP NEUROL, V117, P278, DOI 10.1016/0014-4886(92)90137-F; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829; Osada T, 2006, NEUROREPORT, V17, P1365, DOI 10.1097/01.wnr.0000227992.00175.fa; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Thrane AS, 2013, J CEREBR BLOOD F MET, V33, P996, DOI 10.1038/jcbfm.2013.63; Tomita M, 2011, NEUROIMAGE, V56, P1001, DOI 10.1016/j.neuroimage.2011.02.078; Tomita M, 2005, J CEREBR BLOOD F MET, V25, P742, DOI 10.1038/sj.jcbfm.9600074; Tomita M, 2003, ACT NEUR S, V86, P219; Tomita Y, 2002, NEUROSCI LETT, V322, P157, DOI 10.1016/S0304-3940(02)00072-1; Tomita Y, 2011, BRAIN RES, V1372, P59, DOI 10.1016/j.brainres.2010.11.014; Unekawa M, 2012, MICROCIRCULATION, V19, P166, DOI 10.1111/j.1549-8719.2011.00143.x; Unekawa M, 2013, J NEUROSCI RES, V91, P578, DOI 10.1002/jnr.23184	43	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2015	35	4					689	698		10.1038/jcbfm.2014.250		10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CE7NF	WOS:000352027900020		
J	Nakaegawa, T; Arakawa, O; Kamiguchi, K				Nakaegawa, Tosiyuki; Arakawa, Osamu; Kamiguchi, Kenji			Investigation of Climatological Onset and Withdrawal of the Rainy Season in Panama Based on a Daily Gridded Precipitation Dataset with a High Horizontal Resolution	JOURNAL OF CLIMATE			English	Article							GENERAL-CIRCULATION MODEL; HEMISPHERE WARM POOL; LOW-LEVEL JET; CENTRAL-AMERICA; SURFACE TEMPERATURE; CARIBBEAN RAINFALL; TROPICAL ATLANTIC; TEMPORAL PATTERNS; REGIONAL ASPECTS; SUMMER MONSOON	The present study investigated the onset and withdrawal dates of the rainy season in Panama by using newly developed, gridded, daily precipitation datasets with a high horizontal resolution of 0.05 degrees based on ground precipitation observations. The onset and withdrawal dates showed very complicated geographical features, although the country of Panama is oriented parallel to latitude lines, and the geographical patterns of the onset and withdrawal dates could simply reflect the latitudinal migration of the intertropical convergence zone, as seen in other regions and countries. An absolute threshold value of 3 mm day 21 (pentad mean precipitation) was used to determine the onset and withdrawal dates. The onset and withdrawal dates obtained from the gridded daily precipitation dataset clearly depicted the migration of the rainy season. The rainy season starts suddenly in pentad 21 (11-15 April) in most of eastern Panama and in pentad 22 (16-20 April) in most of western Panama. The termination of the rainy season begins in Los Santos Province during pentad 67 (27 November-1 December) and expands to both the eastern and western surrounding areas. There is no dry season in the western part of the Caribbean coastal zone. Water vapor fluxes and topography suggest dynamical causes, such as a topographically induced upward mass flux accompanied by high humidity, for the complicated geographical features of the onset and withdrawal dates. An assessment was made of uncertainties in the timing of the onset and withdrawal associated with the definition of these terms.	[Nakaegawa, Tosiyuki; Arakawa, Osamu; Kamiguchi, Kenji] Meteorol Res Inst, Climate Res Dept, Tsukuba, Ibaraki 3050052, Japan	Nakaegawa, T (reprint author), Meteorol Res Inst, Climate Res Dept, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	tnakaega@mri-jma.go.jp			KAKENHI from the Japan Society for the Promotion of Science [23226012]; SOUSEI program from the Ministry of Education, Culture, Sports, and Science, Japan	The present study was initiated by the technical cooperation scheme of the Japan International Cooperation Agency. The precipitation dataset was provided by ETESA. The authors thank Professors Fabrega and Pinzon at the Technological University of Panama for their kind support during TN's stay in Panama and Professor Nakayama of the Kitami Institute of Technology, who paved the way for this research. The authors wish to acknowledge Dr. Rosana Nieto-Ferreira as editor and three anonymous reviewers for their constructive and meaningful comments on this manuscript. This research was conducted as part of an MRI project entitled "Research on the mechanisms and the predictability of extreme climate events." TN was financially supported by KAKENHI Grant 23226012 from the Japan Society for the Promotion of Science, and OA and KK by the SOUSEI program from the Ministry of Education, Culture, Sports, and Science, Japan.	Alfaro E. J., 1999, TOPICOS METEOROLOGIC, V6, P1; Alfaro EJ, 2002, TOPICOS METEOROLOGIC, V9, P88; Amador J. A., 1998, TOPICOS METEOROLOGIC, V5, P91; Xie SP, 2005, J CLIMATE, V18, P5, DOI 10.1175/JCLI-3249.1; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; MITCHELL TP, 1992, J CLIMATE, V5, P1140, DOI 10.1175/1520-0442(1992)005<1140:TACIEC>2.0.CO;2; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Zhang SP, 2008, INT J CLIMATOL, V28, P1563, DOI 10.1002/joc.1659; Wang CZ, 2003, J CLIMATE, V16, P1476, DOI 10.1175/1520-0442-16.10.1476; Amador JA, 2006, PROG OCEANOGR, V69, P101, DOI 10.1016/j.pocean.2006.03.007; Mendez M, 2010, J CLIMATE, V23, P1175, DOI 10.1175/2009JCLI3080.1; Taylor MA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001097; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Wang CZ, 2001, GEOPHYS RES LETT, V28, P1635, DOI 10.1029/2000GL011763; OGALLO LJ, 1989, INT J CLIMATOL, V9, P145, DOI 10.1002/joc.3370090204; Garreaud RD, 2001, INT J CLIMATOL, V21, P1181, DOI 10.1002/joc.687; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Enfield DB, 1999, J CLIMATE, V12, P2093, DOI 10.1175/1520-0442(1999)012<2093:TDOCRO>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Amador JA, 2008, ANN NY ACAD SCI, V1146, P153, DOI 10.1196/annals.1446.012; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; WILLMOTT CJ, 1985, J CLIMATOL, V5, P589; Wang CZ, 2007, CLIM DYNAM, V29, P411, DOI 10.1007/s00382-007-0243-z; Condit R., 2010, TREES PANAMA COSTA R, P11; Cortez-Vazquez M, 2000, ATMOSFERA, V13, P95; Duran-Quesada AM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012455; ETESA, 2014, NAT NETW MET HYDR ST; Fabrega J., 2013, HYDROLL RES LETT, V7, P23, DOI [10.3178/hrl.7.23, DOI 10.3178/HRL.7.23]; Gramzow R. H., 1972, Journal of Applied Meteorology, V11, DOI 10.1175/1520-0450(1972)011<0637:TRPOCA>2.0.CO;2; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; HASTENRATH S, 1978, J ATMOS SCI, V35, P2222, DOI 10.1175/1520-0469(1978)035<2222:OMOTCA>2.0.CO;2; HOREL JD, 1989, J CLIMATE, V2, P1388, DOI 10.1175/1520-0442(1989)002<1388:AIOTAC>2.0.CO;2; IMD, 1943, CLIM ATL AIRM; JMA, 2013, GUID MET OBS STAT; JMA, 2014, HIST REC ONS WITHDR; Kamiguchi Kenji, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.60; Liebmann B, 2007, J CLIMATE, V20, P2037, DOI 10.1175/JCLI4122.1; MAFF, 2003, GLOB DIV IRR ACH SUS, P15; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; Matsumoto J, 1997, ADV ATMOS SCI, V14, P231, DOI 10.1007/s00376-997-0022-0; Murphy MJ, 2014, INT J CLIMATOL, V34, P403, DOI 10.1002/joc.3694; Nakaegawa T, 2014, INT J CLIMATOL, V34, P964, DOI 10.1002/joc.3733; Nakaegawa T., 2014, PAP METEOROL GEOPHYS, V65, P15, DOI [10.2467/mripapers.65.15, DOI 10.2467/MRIPAPERS.65.15]; Nakaegawa T, 2014, THEOR APPL CLIMATOL, V116, P155, DOI 10.1007/s00704-013-0934-9; Schaake J., 2004, 18 C HYDR AM MET SOC, P53; Taylor M. A., 2005, ENCY WORLD CLIMATOLO, P183, DOI DOI 10.1007/1-4020-3266-8; UNESCO, 2008, 9 PHILAC; Utsumi N., 2008, HYDROL RES LETT, V2, P47, DOI [10.3178/hrl.2.47, DOI 10.3178/HRL.2.47]; Yavitt JB, 2004, AUSTRAL ECOL, V29, P177, DOI 10.1111/j.1442-9993.2004.01334.x	56	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	APR	2015	28	7					2745	2763		10.1175/JCLI-D-14-00243.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE6IO	WOS:000351940300015		
J	Matsumura, S; Sugimoto, S; Sato, T				Matsumura, Shinji; Sugimoto, Shiori; Sato, Tomonori			Recent Intensification of the Western Pacific Subtropical High Associated with the East Asian Summer Monsoon	JOURNAL OF CLIMATE			English	Article							SEA-SURFACE TEMPERATURE; NORTH PACIFIC; EL-NINO; CLIMATE; PRECIPITATION; TELECONNECTION; WESTWARD; CLOUDS; MEIYU; FRONT	The summer western Pacific subtropical high (WPSH) has intensified during the past three decades. However, the underlying mechanism is not yet well understood. Here, it is shown that baiu rainband activity in midsummer, which is part of the East Asian summer monsoon, plays an important role in recent intensification in the WPSH along the baiu rainband. In contrast with the WPSH, the summer Okhotsk high, which is located to the north of the baiu rainband, has weakened during the past three decades. The north-south contrasting changes between the two highs reflect a response to northward-moved and enhanced baiu heating, which intensifies the upper-tropospheric ridge, resulting in the baroclinic intensification of the WPSH. Regional climate model experiments also support the observational analysis. Therefore, baiu convective activity in midsummer can act as a major driver for the WPSH intensification. The results here suggest that the mechanism intensifying the summer North Pacific subtropical high clearly differs between the western and eastern Pacific.	[Matsumura, Shinji; Sato, Tomonori] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Sugimoto, Shiori] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Tokyo 158, Japan	Matsumura, S (reprint author), Hokkaido Univ, Fac Environm Earth Sci, Kita 10 Nishi 5, Sapporo, Hokkaido 0600810, Japan.	matsusnj@ees.hokudai.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment [S-8-1(2)]; Research Program on Climate Change Adaptation (RECCA) of the MEXT, Japan	We thank three anonymous reviewers for providing useful comments for the improvement of this paper. We acknowledge support from the Environment Research and Technology Development Fund [S-8-1(2)] of the Ministry of the Environment and the Research Program on Climate Change Adaptation (RECCA) of the MEXT, Japan.	AKIYAMA T, 1973, PAP METEOROL GEOPHYS, V24, P157; Miyasaka T, 2005, J CLIMATE, V18, P5046, DOI 10.1175/JCLI3599.1; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Hong SY, 2004, MON WEATHER REV, V132, P103, DOI 10.1175/1520-0493(2004)132<0103:ARATIM>2.0.CO;2; Enomoto T, 2003, Q J ROY METEOR SOC, V129, P157, DOI 10.1256/gj.01.211; Lu RY, 2009, J CLIMATE, V22, P2058, DOI 10.1175/2008JCLI2444.1; Wang B, 1999, B AM METEOROL SOC, V80, P629, DOI 10.1175/1520-0477(1999)080<0629:COSASM>2.0.CO;2; Chowdary Jasti Sriranga, 2011, Climate Dynamics, V36, DOI 10.1007/s00382-009-0686-5; Du Y, 2011, J CLIMATE, V24, P315, DOI 10.1175/2010JCLI3890.1; Stowasser M, 2007, J CLIMATE, V20, P2378, DOI 10.1175/JCLI4126.1; Kosaka Y, 2012, J CLIMATE, V25, P7574, DOI [10.1175/JCLI-D-12-00009.1, 10.1175/JCLI-D-12-00009.-1]; Xie SP, 2010, J CLIMATE, V23, P3352, DOI 10.1175/2010JCLI3429.1; Huang G, 2010, J CLIMATE, V23, P5294, DOI 10.1175/2010JCLI3577.1; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Lu RY, 2001, J METEOROL SOC JPN, V79, P1229, DOI 10.2151/jmsj.79.1229; Li WH, 2012, NAT GEOSCI, V5, P830, DOI 10.1038/NGEO1590; Xie SP, 2009, J CLIMATE, V22, P730, DOI 10.1175/2008JCLI2544.1; Xiang BQ, 2013, GEOPHYS RES LETT, V40, P2349, DOI 10.1002/grl.50431; Sampe T, 2010, J CLIMATE, V23, P113, DOI 10.1175/2009JCLI3128.1; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Tachibana Y, 2004, J METEOROL SOC JPN, V82, P1399, DOI 10.2151/jmsj.2004.1399; Zhou TJ, 2009, J CLIMATE, V22, P2199, DOI 10.1175/2008JCLI2527.1; Grell GA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015311; Matsumura S, 2012, J CLIMATE, V25, P1305, DOI 10.1175/2011JCLI4116.1; Nakamura M, 2014, J CLIMATE, V27, P7861, DOI 10.1175/JCLI-D-13-00609.1; NINOMIYA K, 1986, J METEOROL SOC JPN, V64, P409; Ninomiya K, 2011, J METEOROL SOC JPN, V89, P151, DOI 10.2151/jmsj.2011-204; Sato T, 2013, WATER RESOUR RES, V49, P7763, DOI 10.1002/2012WR013206; Skamarock W. C., 2008, NCARTN475STR; Sui CH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029204	33	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	APR	2015	28	7					2873	2883		10.1175/JCLI-D-14-00569.1		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE6IO	WOS:000351940300022		
J	Zhu, D; Li, CC; Swanson, AM; Villalba, RM; Guo, JD; Zhang, ZB; Matheny, S; Murakamis, T; Stephenson, JR; Daniel, S; Fukata, M; Hall, RA; Olson, JJ; Neigh, GN; Smith, Y; Rainnie, DG; Van Meir, EG				Zhu, Dan; Li, Chenchen; Swanson, Andrew M.; Villalba, Rosa M.; Guo, Jidong; Zhang, Zhaobin; Matheny, Shannon; Murakamis, Tatsuro; Stephenson, Jason R.; Daniel, Sarah; Fukata, Masaki; Hall, Randy A.; Olson, Jeffrey J.; Neigh, Gretchen N.; Smith, Yoland; Rainnie, Donald G.; Van Meir, Erwin G.			BAI1 regulates spatial learning and synaptic plasticity in the hippocampus	JOURNAL OF CLINICAL INVESTIGATION			English	Article							LONG-TERM POTENTIATION; BRAIN ANGIOGENESIS INHIBITOR-1; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; DENDRITIC SPINES; APOPTOTIC CELLS; EMERGING ROLES; MEMORY; PSD-95; RECEPTOR	Synaptic plasticity is the ability of synapses to modulate the strength of neuronal connections; however, the molecular factors that regulate this feature are incompletely understood. Here, we demonstrated that mice lacking brain-specific angiogenesis inhibitor 1 (BAI1) have severe deficits in hippocampus-dependent spatial learning and memory that are accompanied by enhanced long-term potentiation (LTP), impaired long-term depression (LTD), and a thinning of the postsynaptic density (PSD) at hippocampal synapses. We showed that compared with WT animals, mice lacking Bail exhibit reduced protein levels of the canonical PO component PSD-95 in the brain, which stems from protein destabilization. We determined that BAI1 prevents PSD-95 polyubiquitination and degradation through an interaction with murine double minute 2 (MDM2), the E3 ubiquitin ligase that regulates PSD-95 stability. Restoration of PSD-95 expression in hippocampal neurons in BAI1-deficient mice by viral gene therapy was sufficient to compensate for Bail loss and rescued deficits in synaptic plasticity. Together, our results reveal that interaction of DAM with MDM2 in the brain modulates PSD-95 levels and thereby regulates synaptic plasticity. Moreover, these results suggest that targeting this pathway has therapeutic potential for a variety of neurological disorders.	[Zhu, Dan; Zhang, Zhaobin; Matheny, Shannon; Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Sch Med, Mol Neurooncol Lab, Dept Neurosurg, Atlanta, GA 30322 USA; [Zhu, Dan; Zhang, Zhaobin; Matheny, Shannon; Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Sch Med, Mol Neurooncol Lab, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Zhu, Dan; Zhang, Zhaobin; Matheny, Shannon; Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Li, Chenchen; Guo, Jidong; Daniel, Sarah; Neigh, Gretchen N.; Rainnie, Donald G.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Li, Chenchen; Swanson, Andrew M.; Villalba, Rosa M.; Guo, Jidong; Daniel, Sarah; Smith, Yoland; Rainnie, Donald G.] Yerkes Natl Primate Res Ctr, Div Behav Neurosci & Psychiat Disorders, Atlanta, GA USA; [Swanson, Andrew M.] Emory Univ, Neurosci Grad Program, Atlanta, GA 30322 USA; [Murakamis, Tatsuro; Fukata, Masaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi 4448585, Japan; [Murakamis, Tatsuro; Fukata, Masaki] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi, Japan; [Stephenson, Jason R.; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Neigh, Gretchen N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Smith, Yoland] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	Van Meir, EG (reprint author), Emory Univ, Winship Canc Inst, Dept Neurosurg, 1365C Clifton Rd NE,C5078, Atlanta, GA 30322 USA.	evanmei@emory.edu		Hall, Randy/0000-0002-8318-8728	NIH [CA86335, CA138292]; Southeastern Brain Tumor Foundation; CURE Childhood Cancer Foundation; St. Baldrick's Foundation; National Institute on Drug Abuse (NIDA) [T32 DA015040, DA036316]; National Institute of Neurological Disorders and Stroke (NINDS); Center for Neurodegenerative Disease (CND) [P30NS055077]	We thank Helen Zhang of Emory University's Transgenic Mouse and Gene Targeting Core for help with generation of the Bai1<SUP>-/-</SUP> mouse line; Jason Schroeder and David Weinshenker of Emory University's Rodent Behavioral Core facility for help with the mouse behavior tests; and Xinping Huang of the Emory University Viral Vector Core for packaging the AAV. We thank Christine Blattner (Karlsruher Institut fur Technologie, Karlsruhe, Germany) for the Myc-tagged MDM2 constructs. We thank Emily E. Hardy for help with the marble-burying test. This work was supported by grants from the NIH (CA86335, to E.G. Van Meir and CA138292, to the Winship Cancer Institute); the Southeastern Brain Tumor Foundation (to E.G. Van -Meir); the CURE Childhood Cancer Foundation (to E.G. Van Meir); the St. Baldrick's Foundation (to E.G. Van Meir); the National Institute on Drug Abuse (NIDA) (T32 DA015040 and DA036316, to A.M. Swanson); and the National Institute of Neurological Disorders and Stroke (NINDS) and the Center for Neurodegenerative Disease (CND) (P30NS055077), in support of the Viral Vector and Microscopy Core facilities of Emory University. The spine analysis was performed using software provided by the NINDS/CND.	Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Toma C, 2011, J PSYCHIATR RES, V45, P280, DOI 10.1016/j.jpsychires.2010.09.001; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Fahraeus R, 2014, ONCOGENE, V33, P4365, DOI 10.1038/onc.2013.410; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Klenotic PA, 2010, AM J PATHOL, V176, P2039, DOI 10.2353/ajpath.2010.090782; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Migaud M, 1998, NATURE, V396, P433; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Villalba RM, 2011, J COMP NEUROL, V519, P989, DOI 10.1002/cne.22563; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Cork SM, 2011, J MOL MED, V89, P743, DOI 10.1007/s00109-011-0759-x; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; El-Hussein AE, 2000, SCIENCE, V290, P1364; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Li CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026065; Mori K, 2002, NEUROSCI RES, V43, P69, DOI 10.1016/S0168-0102(02)00018-4; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neigh GN, 2010, J CEREBR BLOOD F MET, V30, P1100, DOI 10.1038/jcbfm.2010.46; Ozkan Abdulkadir, 2012, Vasc Cell, V4, P16, DOI 10.1186/2045-824X-4-16; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Park D, 2010, ADV EXP MED BIOL, V706, P167; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9	66	2	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	APR	2015	125	4					1497	1508		10.1172/JCI74603		12	Medicine, Research & Experimental	Research & Experimental Medicine	CF0QF	WOS:000352248600016		
J	Xie, J; Kim, H; Moreau, LA; Puhalla, S; Garber, J; Al Abo, M; Takeda, S; D'Andrea, AD				Xie, Jenny; Kim, Hyungjin; Moreau, Lisa A.; Puhalla, Shannon; Garber, Judy; Al Abo, Muthana; Takeda, Shunichi; D'Andrea, Alan D.			RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway	JOURNAL OF CLINICAL INVESTIGATION			English	Article							DNA-DAMAGE RESPONSE; CROSS-LINK REPAIR; COMPLEMENTATION GROUP-A; CORE-COMPLEX PROTEIN; DOUBLE-STRAND BREAKS; UBIQUITIN E3 LIGASE; GENOTOXIC STRESS; GENOME STABILITY; BINDING-PROTEIN; SUMO	The Fanconi anemia/BRCA (FA/BRCA) pathway is a DNA repair pathway that is required for excision of DNA interstrand cross-links. The 17 known FA proteins, along with several FA-associated proteins (FAAPs), cooperate in this pathway to detect, unhook, and excise DNA cross-links and to subsequently repair the double-strand breaks generated in the process. In the current study, we identified a patient with FA with a point mutation in FANCA, which encodes a mutant FANCA protein (FANCA(1939S)). FANCA(1939S) failed to bind to the FAAP20 subunit of the FA core complex, leading to decreased stability. Loss of FAAP20 binding exposed a SUMOylation site on FANCA at amino acid residue K921, resulting in E2 SUMO-conjugating enzyme UBC9-mediated SUMOylation, RING finger protein 4-mediated (RNF4-mediated) polyubiquitination, and proteasome-mediated degradation of FANCA. Mutation of the SUMOylation site of FANCA rescued the expression of the mutant protein. Wild-type FANCA was also subject to SUMOylation, RNF4-mediated polyubiquitination, and degradation, suggesting that regulated release of FAAP20 from FANCA is a critical step in the normal FA pathway. Consistent with this model, cells lacking RNF4 exhibited interstrand cross-linker hypersensitivity, and the gene encoding RNF4 was epistatic with the other genes encoding members of the FA/BRCA pathway. Together, the results from our study underscore the importance of analyzing unique patient-derived mutations for dissecting complex DNA repair processes.	[Xie, Jenny; Kim, Hyungjin; Moreau, Lisa A.; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Puhalla, Shannon] Univ Pittsburgh, Sch Med, Dept Med Oncol, Pittsburgh, PA USA; [Garber, Judy] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Al Abo, Muthana; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan	D'Andrea, AD (reprint author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, Mayer 640,450 Brookline Ave, Boston, MA 02215 USA.	Alan_dandrea@dfci.harvard.edu			NIH [5R01DK43889, 4R37HL052725, 5P01HL048546, 5T32CA09361]; DOD [BM110181]; NIH T32 postdoctoral trainee grant; Leukemia and Lymphoma Society career developmental fellowship; Fanconi Anemia Research Fund	We thank the members of the D'Andrea laboratory for helpful discussions and Ronald Hay (University of Dundee, Dundee, United Kingdom) for providing us with anti-RNF4 antibody. This work was supported by NIH grants 5R01DK43889, 4R37HL052725, 5P01HL048546, and 5T32CA09361; DOD BM110181; NIH T32 postdoctoral trainee grant (to J. Xie); Leukemia and Lymphoma Society career developmental fellowship (to H. Kim); and a grant from the Fanconi Anemia Research Fund.	Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Mullen JR, 2001, GENETICS, V157, P103; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kuo CY, 2014, J BIOL CHEM, V289, P20757, DOI 10.1074/jbc.M114.555672; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Jackson SP, 2013, MOL CELL, V49, P795, DOI [10.1016/j.molcel.2013.01.017, 10.1016/j.molce1.2013.01.017]; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Ameziane N, 2008, HUM MUTAT, V29, P159, DOI 10.1002/humu.20625; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Groocock LM, 2014, EMBO REP, V15, P601, DOI 10.1002/embr.201338369; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; AUERBACH AD, 1980, CYTOGENET CELL GENET, V28, P265, DOI 10.1159/000131539; AUERBACH AD, 1979, AM J HUM GENET, V31, P77; Bartek J, 2010, CANCER CELL, V17, P9, DOI 10.1016/j.ccr.2009.12.030; Clauson C, 2013, COLD SPRING HARB PER, V3; Cook CE, 2009, CELL CYCLE, V8, P1080, DOI 10.4161/cc.8.7.8123; Gille JJ, 2012, ANEMIA, V2012; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Hirota K, 2014, GENES CELLS, V19, P743, DOI 10.1111/gtc.12173; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Langevin FPM, 2013, M S-MED SCI, V29, P361, DOI 10.1051/medsci/2013294009; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Levran O, 1997, P NATL ACAD SCI USA, V94, P13051, DOI 10.1073/pnas.94.24.13051; Saito M, 2014, BIOCHEM BIOPH RES CO, V447, P83, DOI 10.1016/j.bbrc.2014.03.106; Savino Maria, 2003, Hum Mutat, V22, P338, DOI 10.1002/humu.9180; Savoia A, 1996, HUM GENET, V97, P599; Wang YC, 2013, MOL CELL, V49, P997, DOI 10.1016/j.molcel.2012.12.010	52	1	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	APR	2015	125	4					1523	1532		10.1172/JCI79325		10	Medicine, Research & Experimental	Research & Experimental Medicine	CF0QF	WOS:000352248600018		
J	Nishikawa, T; Bell, A; Brooks, JM; Setoyama, K; Melis, M; Han, B; Fukumitsu, K; Handa, K; Tian, JM; Kaestner, KH; Vodovotz, Y; Locker, J; Soto-Gutierrez, A; Fox, IJ				Nishikawa, Taichiro; Bell, Aaron; Brooks, Jenna M.; Setoyama, Kentaro; Melis, Marta; Han, Bing; Fukumitsu, Ken; Handa, Kan; Tian, Jianmin; Kaestner, Klaus H.; Vodovotz, Yoram; Locker, Joseph; Soto-Gutierrez, Alejandro; Fox, Ira J.			Resetting the transcription factor network reverses terminal chronic hepatic failure	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CHRONIC LIVER-DISEASE; LONG-TERM; HEPATOCYTE; CIRRHOSIS; NUCLEAR; RATS; EXPRESSION; TRANSPLANTATION; PATHOGENESIS; MECHANISM	The cause of organ failure is enigmatic for many degenerative diseases, including end-stage liver disease. Here, using a CCl4-induced rat model of irreversible and fatal hepatic failure, which also exhibits terminal changes in the extracellular matrix, we demonstrated that chronic injury stably reprograms the critical balance of transcription factors and that diseased and dedifferentiated cells can be returned to normal function by re-expression of critical transcription factors, a process similar to the type of reprogramming that induces somatic cells to become pluripotent or to change their cell lineage. Forced re-expression of the transcription factor HNF4 alpha induced expression of the other hepatocyte-expressed transcription factors; restored functionality in terminally diseased hepatocytes isolated from CCl4-treated rats; and rapidly reversed fatal liver failure in CCl4-treated animals by restoring diseased hepatocytes rather than replacing them with new hepatocytes or stem cells. Together, the results of our study indicate that disruption of the transcription factor network and cellular dedifferentiation likely mediate terminal liver failure and suggest reinstatement of this network has therapeutic potential for correcting organ failure without cell replacement.	[Nishikawa, Taichiro; Brooks, Jenna M.; Setoyama, Kentaro; Melis, Marta; Han, Bing; Fox, Ira J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, UPMC, Dept Surg, Pittsburgh, PA 15213 USA; [Nishikawa, Taichiro; Brooks, Jenna M.; Setoyama, Kentaro; Melis, Marta; Han, Bing; Fox, Ira J.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Nishikawa, Taichiro] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Bell, Aaron; Fukumitsu, Ken; Handa, Kan; Tian, Jianmin; Locker, Joseph; Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Bell, Aaron; Fukumitsu, Ken; Handa, Kan; Soto-Gutierrez, Alejandro] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kaestner, Klaus H.] Univ Penn, Perleman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Kaestner, Klaus H.] Univ Penn, Perleman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Vodovotz, Yoram] McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA	Fox, IJ (reprint author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sotogutierreza@upmc.edu; foxi@upmc.edu			NIDDK [R01 DK48794, R01 DK099320, DK099257]; Department of Defense (DOD) [W81XWH-11-1-0803]	We thank A. Russell and D. Perlmutter for their comments. This work was supported by grants NIDDK R01 DK48794 (to I.J. Fox), Department of Defense (DOD) W81XWH-11-1-0803 (to I.J. Fox), NIDDK R01 DK099320 (to I.J. Fox and J. Locker), and NIDDK DK099257 (to A. Soto-Gutierrez).	Limaye PB, 2008, LAB INVEST, V88, P865, DOI 10.1038/labinvest.2008.56; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Grattagliano I, 2011, CURR DRUG TARGETS, V12, P879; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Ponnazhagan S, 1997, GENE, V190, P203, DOI 10.1016/S0378-1119(96)00576-8; Nagata H, 2003, GASTROENTEROLOGY, V124, P422, DOI 10.1053/gast.2003.50065; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Berasain C, 2003, HEPATOLOGY, V38, P148, DOI 10.1053/jhep.2003.50269; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Kitada T, 2001, J HEPATOL, V35, P613, DOI 10.1016/S0168-8278(01)00171-4; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Lajugie J, 2011, BIOINFORMATICS, V27, P1889, DOI 10.1093/bioinformatics/btr309; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Nam YJ, 2013, NAT MED, V19, P413, DOI 10.1038/nm.3147; Bures J, 1976, TECHNIQUES BASIC EXP, P37; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; JAGO MV, 1969, AM J PATHOL, V56, P405; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; KRAHENBUHL S, 1993, PHARMACOL THERAPEUT, V60, P1, DOI 10.1016/0163-7258(93)90020-E; Lechel A, 2004, J HEPATOL, V41, P491, DOI 10.1016/j.jhep.2004.06.010; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Locker J, 2011, MOL PATHOL LIB, V5, P193, DOI 10.1007/978-1-4419-7107-4_14; Lopez PM, 2006, MT SINAI J MED, V73, P1056; MARTINEZHERNANDEZ A, 1991, HEPATOLOGY, V14, P864, DOI 10.1002/hep.1840140519; Odom Duncan T, 2006, Mol Syst Biol, V2; PESSAYRE D, 1978, GASTROENTEROLOGY, V74, P566; PETERSON JE, 1965, J PATHOL BACTERIOL, V89, P153, DOI 10.1002/path.1700890117; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sladek FM, 2001, NUCL RECEPTORS GENET; VAUBOURDOLLE M, 1989, SCAND J GASTROENTERO, V24, P467, DOI 10.3109/00365528909093076	45	2	2	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	APR	2015	125	4					1533	1544		10.1172/JCI73137		12	Medicine, Research & Experimental	Research & Experimental Medicine	CF0QF	WOS:000352248600019		
J	Tanaka, K; Sasayama, T; Irino, Y; Takata, K; Nagashima, H; Satoh, N; Kyotani, K; Mizowaki, T; Imahori, T; Ejima, Y; Masui, K; Gini, B; Yang, HJ; Hosoda, K; Sasaki, R; Mischel, PS; Kohmura, E				Tanaka, Kazuhiro; Sasayama, Takashi; Irino, Yasuhiro; Takata, Kumi; Nagashima, Hiroaki; Satoh, Naoko; Kyotani, Katsusuke; Mizowaki, Takashi; Imahori, Taichiro; Ejima, Yasuo; Masui, Kenta; Gini, Beatrice; Yang, Huijun; Hosoda, Kohkichi; Sasaki, Ryohei; Mischel, Paul S.; Kohmura, Eiji			Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CELL-PROLIFERATION; KINASE INHIBITORS; PTEN-DEFICIENT; CANCER; GROWTH; RAPAMYCIN; PATHWAY; COMPLEX; CONTRIBUTES; MUTATION	The mechanistic target of rapamycin (mTOR) is hyperactivated in many types of cancer, rendering it a compelling drug-target; however, the impact of mTOR inhibition on metabolic reprogramming in cancer is incompletely understood. Here, by integrating metabolic and functional studies in glioblastoma multiforme (GBM) cell lines, preclinical models, and clinical samples, we demonstrate that the compensatory upregulation of glutamine metabolism promotes resistance to mTOR kinase inhibitors. Metabolomic studies in GBM cells revealed that glutaminase (GLS) and glutamate levels are elevated following mTOR kinase inhibitor treatment. Moreover, these mTOR inhibitor-dependent metabolic alterations were confirmed in a GBM xenograft model. Expression of GLS following mTOR inhibitor treatment promoted GBM survival in an alpha-ketoglutarate-dependent (alpha KG-dependent) manner. Combined genetic and/or pharmacological inhibition of mTOR kinase and GLS resulted in massive synergistic tumor cell death and growth inhibition in tumor-bearing mice. These results highlight a critical role for compensatory glutamine metabolism in promoting mTOR inhibitor resistance and suggest that rational combination therapy has the potential to suppress resistance.	[Tanaka, Kazuhiro; Sasayama, Takashi; Takata, Kumi; Nagashima, Hiroaki; Satoh, Naoko; Mizowaki, Takashi; Imahori, Taichiro; Hosoda, Kohkichi; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo 6500017, Japan; [Irino, Yasuhiro] Kobe Univ, Grad Sch Med, Div Evidenced Based Lab Med, Kobe, Hyogo 6500017, Japan; [Kyotani, Katsusuke] Kobe Univ, Grad Sch Med, Ctr Radiol & Radiat Oncol, Kobe, Hyogo 6500017, Japan; [Ejima, Yasuo; Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiat Oncol, Kobe, Hyogo 6500017, Japan; Kobe Univ Hosp, Kobe, Hyogo, Japan; [Masui, Kenta; Gini, Beatrice; Yang, Huijun; Mischel, Paul S.] UCSD, Ludwig Inst Canc Res, Lab Mol Pathol, La Jolla, CA USA; [Mischel, Paul S.] UCSD, Moores Canc Ctr, La Jolla, CA USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Tanaka, K (reprint author), Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kazutana@med.kobe-u.ac.jp			KAKENHI [24791501, 25462258, 24592126, 25293309]; Ludwig Institute for Cancer Research from the National Institute for Neurological Diseases and Stroke [NS73831]; National Cancer Institute [CA151819]; Takeda Science Foundation; Ben and Catherine Ivy Foundation; Defeat GBM Research Collaborative, a subsidiary of the National Brain Tumor Society	We would like to thank all members of the Brain Tumor Translational Resources staff for biospecimen and biorepository support at Kobe University. We would also like to express our gratitude to Izumi Takayama (Department of Radiation Oncology, Kobe University Graduate School of Medicine) for helping with the TUNEL assay, Yukiko Takeuchi (Division of Evidenced-Based laboratory medicine, Kobe University Graduate School of Medicine) for helping with the GC/MS analysis, and Ryosuke Doi and Mitsuharu Endo (Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine) for helping with the ATP assay. K. Tanaka is supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) (24791501) and the Takeda Science Foundation. T. Sasayama, K. Hosoda, and E. Kohmura are also supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) (25462258, 24592126, and 25293309, respectively). P.S. Mischel is supported by the Ludwig Institute for Cancer Research and grants from the National Institute for Neurological Diseases and Stroke (NS73831), the National Cancer Institute (CA151819), the Ben and Catherine Ivy Foundation, and the Defeat GBM Research Collaborative, a subsidiary of the National Brain Tumor Society.	Andronesi OC, 2012, SCI TRANSL MED, V4, pra4; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Tartaglia MC, 2002, J NEUROL, V249, P1382, DOI 10.1007/s00415-002-0846-6; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Nakamizo S, 2013, J NEURO-ONCOL, V113, P65, DOI 10.1007/s11060-013-1090-x; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8; Simpson NE, 2012, EPIGENETICS-US, V7, P1413, DOI 10.4161/epi.22713; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Huang WJ, 2013, CELL RES, V23, P724, DOI 10.1038/cr.2013.15; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; POPTANI H, 1995, AM J NEURORADIOL, V16, P1593; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gini B, 2013, CLIN CANCER RES, V19, P5722, DOI 10.1158/1078-0432.CCR-13-0527; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rodrigues TB, 2007, J NEUROSCI RES, V85, P3284, DOI 10.1002/jnr.21302; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809; Yoshie T, 2012, CANCER SCI, V103, P1010, DOI 10.1111/j.1349-7006.2012.02262.x	43	4	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	APR	2015	125	4					1591	1602		10.1172/JC178239		12	Medicine, Research & Experimental	Research & Experimental Medicine	CF0QF	WOS:000352248600024		
J	Dahlke, M; Ng, D; Yamaguchi, M; Machineni, S; Berger, S; Canadi, J; Rajman, I; Lloyd, P; Pang, YN				Dahlke, Marion; Ng, Dik; Yamaguchi, Masayuki; Machineni, Surendra; Berger, Sergej; Canadi, Jasna; Rajman, Iris; Lloyd, Peter; Pang, Yinuo			Safety and Tolerability of Serelaxin, a Recombinant Human Relaxin-2 in Development for the Treatment of Acute Heart Failure, in Healthy Japanese Volunteers and a Comparison of Pharmacokinetics and Pharmacodynamics in Healthy Japanese and Caucasian Populations	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						cardiovascular; clinical trials; pharmacodynamics; pharmacokinetics and drug metabolism; clinical pharmacology	TASK-FORCE; COLLABORATION; GUIDELINES; DIAGNOSIS; SOCIETY; AHF	Serelaxin, a recombinant form of the human relaxin-2 hormone, is currently under clinical investigation for treatment of acute heart failure. This double-blind, placebo-controlled, dose-ranging study investigated the effect of Japanese ethnicity on the pharmacokinetics (PK), pharmacodynamics (PD), and safety and tolerability of serelaxin. Japanese healthy subjects (n = 32) received 10, 30, or 100 mu g/kg/day of serelaxin, or placebo, administered as a 48-hour intravenous infusion. A Caucasian cohort (n = 8) receiving 30 mu g/kg/day open-label serelaxin was included for comparison. In all subjects, serum serelaxin concentrations increased rapidly after the start of infusion, approached steady state as early as 4 hours, and declined rapidly upon treatment cessation. Serum exposure to serelaxin increased with increasing doses. Statistical dose proportionality was shown for AUC(inf) over the entire dose range. A significant increase in estimated glomerular filtration rate from baseline to Day 2 (30 and 100 mu g/kg/day) and to Day 3 (10 and 100 mu g/kg/day) was observed compared with placebo. Serelaxin was well tolerated by all subjects. In conclusion, PK, PD, and safety profiles of serelaxin were generally comparable between Japanese and Caucasian subjects, suggesting that no dose adjustment will be required in Japanese subjects during routine clinical use of this agent.	[Dahlke, Marion; Canadi, Jasna; Rajman, Iris] Novartis Pharma AG, CH-4056 Basel, Switzerland; [Ng, Dik; Lloyd, Peter] Novartis Pharma UK, Horsham, W Sussex, England; [Yamaguchi, Masayuki] Novartis Pharma KK, Tokyo, Japan; [Machineni, Surendra] Novartis Pharma India, Bombay, Maharashtra, India; [Berger, Sergej] Focus Clin Drug Dev GmbH, Neuss, Germany; [Pang, Yinuo] Novartis Inst BioMed Res, Cambridge, MA USA	Dahlke, M (reprint author), Novartis Pharma AG, CH-4056 Basel, Switzerland.	marion.dahlke@novartis.com			Corthera Inc., a Novartis affiliate company; Novartis Pharma AG, Basel, Switzerland	This study was funded by Corthera Inc., a Novartis affiliate company. Medical writing and editorial assistance was provided by Kristina Standeven (MediTech Media) and Paul Coyle (Novartis) and was funded by Novartis Pharma AG, Basel, Switzerland.	Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; Ponikowski P, 2014, EUR HEART J, V35, P431, DOI 10.1093/eurheartj/eht459; [Anonymous], 2009, HCUP FACTS FIG STAT; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Cowie M., 2013, BR J CARDIOL S2, V20, pS1; Forman DE, 2009, AM HEART J, V157, P1010, DOI 10.1016/j.ahj.2009.03.010; Gheorghiade M, 2005, AM J CARDIOL, V96, p86G, DOI 10.1016/j.amjcard.2005.07.026; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1998, ICH HARM TRIP GUID E; Kobalava Z, 2013, CIRCULATION, V128; Smith MC, 2006, J AM SOC NEPHROL, V17, P3192, DOI 10.1681/ASN.2005090950	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	APR	2015	55	4					415	422		10.1002/jcph.433		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE9CC	WOS:000352140100008		
J	Kawada, JI; Torii, Y; Kawano, Y; Suzuki, M; Kamiya, Y; Kotani, T; Kikkawa, F; Kimura, H; Ito, Y				Kawada, Jun-ichi; Torii, Yuka; Kawano, Yoshihiko; Suzuki, Michio; Kamiya, Yasuko; Kotani, Tomomi; Kikkawa, Fumitaka; Kimura, Hiroshi; Ito, Yoshinori			Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening	JOURNAL OF CLINICAL VIROLOGY			English	Article						Congenital cytomegalovirus infection; Sensorineural hearing loss; Valganciclovir; Viral load	POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; TIME PCR ASSAY; CMV INFECTION; GANCICLOVIR THERAPY; NATIONWIDE SURVEY; DISEASE; INFANTS; VIRUS; JAPAN	Background: Congenital cytomegalovirus (CMV) infection is the most common non-genetic cause of sensorineural hearing loss (SNHL) in children. However, congenital SNHL without other clinical abnormalities is rarely diagnosed as CMV-related in early infancy. Objectives: The aim of this study was to identify and treat patients with congenital CMV-related SNHL or CMV-related clinical abnormalities other than SNHL. The association between CMV load and SNHL was also evaluated. Study design: Newborns who had abnormal hearing screening results or other clinical abnormalities were screened for congenital CMV infection by PCR of saliva or urine specimens, and identified infected patients were treated with valganciclovir (VGCV) for 6 weeks. The CMV load of patients with or without SNHL was compared at regular intervals during as well as after VGCV treatment. Results: Of 127 infants with abnormal hearing screening results, and 31 infants with other clinical abnormalities, CMV infection was identified in 6 and 3 infants, respectively. After VGCV treatment, 1 case had improved hearing but the other 5 SNHL cases had little or no improvement. Among these 9 patients with or without SNHL at 1 year of age, there was no significant difference in CMV blood or urine load at diagnosis, but both were significantly higher in patients with SNHL during VGCV treatment. Conclusions: Selective CMV screening of newborns having an abnormal hearing screening result would be a reasonable strategy for identification of symptomatic congenital CMV infection. Prolonged detection of CMV in blood could be a risk factor for SNHL. (C) 2015 Elsevier B.V. All rights reserved.	[Kawada, Jun-ichi; Torii, Yuka; Kawano, Yoshihiko; Suzuki, Michio; Kamiya, Yasuko; Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Kotani, Tomomi; Kikkawa, Fumitaka] Nagoya Univ, Grad Sch Med, Dept Obstet & Genecol, Nagoya, Aichi 4648601, Japan; [Kimura, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi 4648601, Japan	Ito, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yoshi-i@med.nagoya-u.ac.jp	Kimura, Hiroshi/I-2246-2012				Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059; Stehel EK, 2008, PEDIATRICS, V121, P970, DOI 10.1542/peds.2006-3441; Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6; Kimberlin DW, 2008, J INFECT DIS, V197, P836, DOI 10.1086/528376; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Whitley RJ, 1997, J INFECT DIS, V175, P1080; Nijman J, 2012, J CLIN VIROL, V54, P121, DOI 10.1016/j.jcv.2012.02.017; Koyano S, 2009, CLIN INFECT DIS, V48, pE93, DOI 10.1086/598506; Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Tanaka-Kitajima N, 2005, PEDIATR INFECT DIS J, V24, P782, DOI 10.1097/01.inf.0000177280.28694.00; Williams EJ, 2014, ARCH DIS CHILD-FETAL, V99, pF230, DOI 10.1136/archdischild-2013-305276; Lombardi G, 2009, EUR J CLIN MICROBIOL, V28, P1465, DOI 10.1007/s10096-009-0806-5; Tanaka N, 2000, J MED VIROL, V60, P455, DOI 10.1002/(SICI)1096-9071(200004)60:4<455::AID-JMV14>3.0.CO;2-Q; Torii Y, 2013, PEDIATR INFECT DIS J, V32, P699, DOI 10.1097/INF.0b013e3182897c36; Bradford RD, 2005, J INFECT DIS, V191, P227, DOI 10.1086/426456; Cannon MJ, 2014, REV MED VIROL, V24, P291, DOI 10.1002/rmv.1790; Ito Y, 2013, PEDIATR INT, V55, P566, DOI 10.1111/ped.12122; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Kimberlin D. W., 2013, IDWEEK 2013 SAN FRAN; Koyano S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000118; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ross SA, 2009, PEDIATR INFECT DIS J, V28, P588, DOI 10.1097/INF.0b013e3181979a27; Tanaka Y., 2014, J JPN PEDIAT SOC, V118, P899; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	APR	2015	65						41	45		10.1016/j.jcv.2015.01.015		5	Virology	Virology	CF6XZ	WOS:000352701500009		
J	Fukumoto, H; Li, TC; Kataoka, M; Hasegawa, H; Wakita, T; Saeki, H; Suzuki, T; Katano, H				Fukumoto, Hitomi; Li, Tian-Cheng; Kataoka, Michiyo; Hasegawa, Hideki; Wakita, Takaji; Saeki, Hidehisa; Suzuki, Tetsuro; Katano, Harutaka			Seroprevalence of trichodysplasia spinulosa-associated polyomavirus in Japan	JOURNAL OF CLINICAL VIROLOGY			English	Article						Trichodysplasia spinulosa-associated polyomavirus; Human polyomavirus; Enzyme-linked immunosorbent assay	MERKEL CELL POLYOMAVIRUS; VIRUS-LIKE PARTICLES; CHILDREN; TRANSPLANTATION; EXPRESSION	Background: Trichodysplasia spinulosa-associated polyomavirus (TSV) was identified in, and shown to be the probable cause of, trichodysplasia spinulosa, a rare skin disease. To date, serological analyses have revealed that TSV infection is common among adults in the general population of Europe and Australia. However, there have been no reports of TSV in Asia. Objective: To study the prevalence of TSV infection in Japan. Study design: TSV-VP1 expressed in a recombinant baculovirus expression system in an insect cell line, Tn5, self-assembled into virus-like particles. Overall, 1000 serum samples were examined by enzyme-linked immunosorbent assays using virus-like particles of TSV as antigen. Participants ranged in age from 0 to 94 years. Results: Overall, 629 of 1000 serum samples (62.9%) were positive for anti-TSV antibodies. The seropositive rate increased with age and the seroprevalence of TSV significantly increased from 17.1% (25/146) in children aged from 0 to 4 years to 78.7% (472/600) in adults aged over 20 years (odds ratio = 0.056,95% confidence interval = 0.035-0.900, P = 0.000, Chi-squared test). TSV seropositivity was not different between sera obtained in 1980 and 2012, and was not associated with sex. Competitive assay demonstrated that TSV antibodies did not cross-react with BK virus or Merkel cell polyomavirus. Conclusions: These results provide evidence that TSV circulates widely in the Japanese population, with primary exposure occurring mainly at early childhood, similar to that previously reported in other countries. (C) 2015 Elsevier B.V. All rights reserved.	[Fukumoto, Hitomi; Kataoka, Michiyo; Hasegawa, Hideki; Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Li, Tian-Cheng; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan; [Fukumoto, Hitomi; Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Bunkyo Ku, Tokyo 1138603, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Katano, H (reprint author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	katano@nih.go.jp			Ministry of Health, Labor and Welfare [H25-Shinko-Ippan-015, H25-Shinko-Shitei-006]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24659212]	This work was partly supported by Health and Labor Sciences Research Grants (no. H25-Shinko-Ippan-015 and H25-Shinko-Shitei-006 to HK) from the Ministry of Health, Labor and Welfare, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 24659212 to HK).	Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; PADGETT BL, 1971, LANCET, V1, P1257; van der Meijden E, 2011, EMERG INFECT DIS, V17, P1355, DOI 10.3201/eid1708.110114; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Tsuzuki S, 2014, INT J CLIN EXP PATHO, V7, P5308; Kazem S, 2013, APMIS, V121, P770, DOI 10.1111/apm.12092; Li TC, 1997, J VIROL, V71, P7207; Sadeghi M, 2014, J CLIN VIROL, V59, P55, DOI 10.1016/j.jcv.2013.11.008; GARDNER SD, 1971, LANCET, V1, P1253; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Siebrasse EA, 2012, EMERG INFECT DIS, V18, P1676, DOI 10.3201/eid1810.120359; Chen TT, 2014, EMERG INFECT DIS, V20, P689, DOI 10.3201/eid2004.131015; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Li TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115646; Li TC, 2003, VIROLOGY, V311, P115, DOI 10.1016/S0042-6822(03)00141-7; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; van der Meijden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081078; WICKHAM TJ, 1993, BIOTECHNOL PROGR, V9, P25, DOI 10.1021/bp00019a004	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-6532	1873-5967		J CLIN VIROL	J. Clin. Virol.	APR	2015	65						76	82		10.1016/j.jcv.2015.02.014		7	Virology	Virology	CF6XZ	WOS:000352701500017		
J	Kubota, T; Miyake, K; Hariya, N; Mochizuki, K				Kubota, T. K; Miyake, K.; Hariya, N.; Mochizuki, K.			Understanding the epigenetics of neurodevelopmental disorders and DOHaD	JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE			English	Review						epigenetics; human; molecular/cellular; newborn/children; pregnancy	METHYLATION-SPECIFIC PCR; DNA METHYLATION; RETT-SYNDROME; MOUSE MODEL; IMAGING EPIGENETICS; PRENATAL EXPOSURE; ANGELMAN-SYNDROME; PREGNANT RATS; PRADER-WILLI; ICF SYNDROME	The Developmental Origins of Health and Disease (DOHaD) hypothesis refers to the concept that 'alnutrition during the fetal period induces a nature of thrift in fetuses, such that they have a higher change of developing non-communicable diseases, such as obesity and diabetes, if they grow up in the current well-fed society.' Epigenetics is a chemical change in DNA and histones that affects how genes are expressed without alterations of DNA sequences. Several lines of evidence suggest that malnutrition during the fetal period alters the epigenetic expression status of metabolic genes in the fetus and that this altered expression can persist, and possibly lead to metabolic disorders. Similarly, mental stress during the neonatal period can alter the epigenetic expression status of neuronal genes in neonates. Moreover, such environmental, stress-induced, epigenetic changes are transmitted to the next generation via an acquired epigenetic status in sperm. The advantage of epigenetic modifications over changes in genetic sequences is their potential reversibility; thus, epigenetic alterations are potentially reversed with gene expression. Therefore, we potentially establish'preemptive medicine,' that, in combination with early detection of abnormal epigenetic status and early administration of epigenetic-restoring drugs may prevent the development of disorders associated with the DOHaD.	[Kubota, T. K; Miyake, K.; Hariya, N.] Univ Yamanashi, Fac Med, Dept Epigenet Med, Chuo Ku, Yamanashi 4093898, Japan; [Mochizuki, K.] Univ Yamanashi, Fac Med, Fac Life & Environm Sci, Dept Local Produce & Food Sci, Kofu, Yamanashi, Japan	Kubota, T (reprint author), Univ Yamanashi, Fuculty Med, Dept Epigenet Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	takeot@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26293245, 25670473]; Ministry of Economy, Trade and Industry (METI)	The research described in this review was partially supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Grants-in-Aid (KAKENHI) for Scientific Research (B) (#26293245 to T.K.), for Exploratory Research (#25670473 to T.K.), and by the Ministry of Economy, Trade and Industry (METI) for "Development of core technologies for innovative drug development based upon IT' in the Project focused on developing key technology of discovering and manufacturing drug for next-generation treatment and diagnosis (the Biological verifying studies to T.K.).	Abel Ted, 2008, Curr Opin Pharmacol, V8, P57, DOI 10.1016/j.coph.2007.12.002; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Vecsler M, 2010, EPIGENETICS-US, V5, P61; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Obi T, 2008, NEUROLOGY, V70, P238, DOI 10.1212/01.wnl.0000299387.59159.db; Lillycrop KA, 2005, J NUTR, V135, P1382; Gluckman PD, 2007, LANCET, V369, P1081, DOI 10.1016/S0140-6736(07)60524-8; Amir RE, 1999, NAT GENET, V23, P185; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Gore AC, 2011, MOL ENDOCRINOL, V25, P2157, DOI 10.1210/me.2011-1210; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; James SJ, 2004, AM J CLIN NUTR, V80, P1611; Kubota T, 1997, NAT GENET, V16, P16; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Martinez D, 2014, CELL METAB, V19, P941, DOI 10.1016/j.cmet.2014.03.026; Nag N, 2009, BEHAV BRAIN RES, V196, P44, DOI 10.1016/j.bbr.2008.07.008; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Ling C, 2014, DRUG DISCOV TODAY, V19, P1015, DOI 10.1016/j.drudis.2014.03.006; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Dong E, 2010, EPIGENETICS-US, V5, P730, DOI 10.4161/epi.5.8.13053; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Anway MD, 2010, SCIENCE, V328, P690; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chunshu Y, 2006, CLIN GENET, V70, P530, DOI 10.1111/j.1399-0004.2006.00712.x; Horsthemke B, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573b; Inoue K, 2001, PRENATAL DIAG, V21, P1133, DOI 10.1002/pd.186; Jones B, 2014, NAT REV GENET, V15, P364, DOI 10.1038/nrg3736; Kerr B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011534; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; KUBOTA T, 1994, AM J MED GENET, V49, P378, DOI 10.1002/ajmg.1320490405; Kubota T, 2004, AM J MED GENET A, V129A, P290, DOI 10.1002/ajmg.a.30135; Kubota T, 2002, CYTOGENET GENOME RES, V99, P276, DOI 10.1159/000071604; leiman SF, 2011, PHARMACEUTICALS, V4, P1183; Lista S, 2013, CURR PHARM DESIGN, V19, P6393; Lumey L H, 1992, Paediatr Perinat Epidemiol, V6, P240, DOI 10.1111/j.1365-3016.1992.tb00764.x; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Miyake K, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-81; Moretti P, 2005, NEUROLOGY, V64, P1088; Popp C, 2011, NATURE, V463, P1101; RIMLAND B, 1988, J CHILD NEUROL, V3, pS68; Sakashita K, 2001, J CLIN INVEST, V108, P1195, DOI 10.1172/JCI13030; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Tee L, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-23; Waddington C. H., 1942, Endeavour London, V1, P18; Wang C, 2014, NEUROSCIENCE, V264, P186, DOI 10.1016/j.neuroscience.2013.09.018; Wang YJ, 2013, EPIGENETICS-US, V8, P756, DOI 10.4161/epi.25202; Wiers CE, 2012, EUR ARCH PSY CLIN N, V262, P271, DOI 10.1007/s00406-011-0261-z; Xu C, 2011, PHARMACEUTICALS, V4, P1578	82	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	2040-1744	2040-1752		J DEV ORIG HLTH DIS	J. Dev. Orig. Health Dis.	APR	2015	6	2					96	104		10.1017/S2040174415000057		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF7LR	WOS:000352738400005		
J	Maeyama, H; Hirasawa, T; Tahara, Y; Obata, C; Kasai, H; Moriishi, K; Mochizuki, K; Kubota, T				Maeyama, H.; Hirasawa, T.; Tahara, Y.; Obata, C.; Kasai, H.; Moriishi, K.; Mochizuki, K.; Kubota, T.			Maternal restraint stress during pregnancy in mice induces 11 beta-HSD1-associated metabolic changes in the livers of the offspring	JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE			English	Article						fatty liver; metabolic syndrome; pregnancy; restraint stress; 11 beta-HSD1	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; INTRAUTERINE GROWTH RESTRICTION; PRENATAL STRESS; FATTY LIVER; DEVELOPMENTAL ORIGINS; INSULIN SENSITIVITY; VISCERAL OBESITY; MESSENGER-RNA; RATS; DISEASE	In rats, maternal exposure to restraint stress during pregnancy can induce abnormalities in the cardiovascular and central nervous systems of the offspring. These effects are mediated by long-lasting hyperactivation of the hypothalamic-pituitary-adrenal axis. However, little is known about the potential effects of stress during pregnancy on metabolic systems. We examined the effect of restraint stress in pregnant mice on the liver function of their offspring. The offspring of stressed mothers showed significantly higher lipid accumulation in the liver after weaning than did the controls; this accumulation was associated with increased expression of lipid metabolism-related proteins such as alanine aminotransferase 2 diglyceride acyltransferase 1, peroxisome proliferator-activated receptor gamma and glucocorticoid receptor. Additionally, we observed increased levels of 11 beta-hydroxysteroid dehydrogenase type 1, an intercellular mediator that converts glucocorticoid from the inactive to the active form, in the foetal and postnatal periods. These results indicate that restraint stress in pregnancy in mice induces metabolic abnormalities via 11 beta-hydroxysteroid dehydrogenase type 1-related pathways in the foetal liver. It is therefore possible that exposure to stress in pregnant women may be a risk factor for metabolic syndromes (e.g. fatty liver) in children.	[Maeyama, H.; Hirasawa, T.; Tahara, Y.; Obata, C.; Kubota, T.] Univ Yamanashi, Dept Epigenet Med, Yamanashi 4093898, Japan; [Kasai, H.; Moriishi, K.] Univ Yamanashi, Dept Microbiol, Chuo Ku, Yamanashi 4093898, Japan; [Mochizuki, K.] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan; [Hirasawa, T.; Obata, C.] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	Hirasawa, T (reprint author), Univ Yamanashi, Dept Epigenet Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	takae@yamanashi.ac.jp			JSPS KAKENHI, Japan [23591491, 25670473]; Japan Science and Technology Agency (JST)	This study was supported by grants for Scientific Research (C) (23591491 to T Hirasawa) and Exploratory Research (25670473 to T Kubota) from JSPS KAKENHI, Japan, and by a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) (to T Hirasawa).	Ahmed A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029531; Alisi A, 2011, INT J ENDOCRINOL, DOI 10.1155/2011/269853; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Anderson A, 2013, DRUGS, V73, P1385, DOI 10.1007/s40265-013-0112-5; Lillycrop KA, 2005, J NUTR, V135, P1382; Gluckman PD, 2007, LANCET, V369, P1081, DOI 10.1016/S0140-6736(07)60524-8; Berthiaume M, 2007, ENDOCRINOLOGY, V148, P2391, DOI 10.1210/en.2006-1199; Torrecilla E, 2012, OBES SURG, V22, P478, DOI 10.1007/s11695-011-0524-9; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Nobili V, 2014, PEDIATR OBES, V9, pE99, DOI 10.1111/j.2047-6310.2013.00209.x; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Arai K, 2004, METABOLISM, V53, P28, DOI 10.1016/j.metabol.2003.08.007; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/CS19980388; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Andrews RC, 2003, J CLIN ENDOCR METAB, V88, P285, DOI 10.1210/jc.2002-021194; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Kim JG, 2013, NEUROSCI LETT, V555, P137, DOI 10.1016/j.neulet.2013.09.031; Harno E, 2013, ENDOCRINOLOGY, V154, P4580, DOI 10.1210/en.2013-1613; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Fujisawa Y, 2007, LIFE SCI, V81, P724, DOI 10.1016/j.lfs.2007.07.002; Gandhi K, 2013, METAB SYNDR RELAT D, V11, P397, DOI 10.1089/met.2013.0049; Godfrey K M, 2001, Public Health Nutr, V4, P611; Hollis G, 2011, DIABETES OBES METAB, V13, P1, DOI 10.1111/j.1463-1326.2010.01305.x; Igosheva N, 2004, J PHYSIOL-LONDON, V557, P273, DOI 10.1113/jphysiol.2003.056911; Igosheva N, 2007, J PHYSIOL-LONDON, V582, P665, DOI 10.1113/jphysiol.2007.130252; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Liu Y, 2008, PHYSIOL GENOMICS, V32, P343, DOI 10.1152/physiolgenomics.00067.2007; Moon SS, 2013, DIABETES RES CLIN PR, V99, P343, DOI 10.1016/j.diabres.2012.12.020; Morley-Fletcher S, 2004, NEUROPHARMACOLOGY, V47, P841, DOI 10.1016/j.neuropharm.2004.06.011; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Rhee SD, 2012, EUR J PHARMACOL, V691, P9, DOI 10.1016/j.ejphar.2012.06.021; Takaya J, 2011, EPIGENETICS-US, V6, P573, DOI 10.4161/epi.6.5.15220; Vicker N, 2007, J STEROID BIOCHEM, V104, P123, DOI 10.1016/j.jsbmb.2007.03.023; Viltart O, 2006, PSYCHONEUROENDOCRINO, V31, P769, DOI 10.1016/j.psyneuen.2006.02.007	44	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	2040-1744	2040-1752		J DEV ORIG HLTH DIS	J. Dev. Orig. Health Dis.	APR	2015	6	2					105	114		10.1017/S2040174415000100		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CF7LR	WOS:000352738400006		
J	Yabe, D; Kuroe, A; Watanabe, K; Iwasaki, M; Hamasaki, A; Hamamoto, Y; Harada, N; Yamane, S; Lee, S; Murotani, K; Deacon, CF; Holst, JJ; Hirano, T; Inagaki, N; Kurose, T; Seino, Y				Yabe, Daisuke; Kuroe, Akira; Watanabe, Koin; Iwasaki, Masahiro; Hamasaki, Akihiro; Hamamoto, Yoshiyuki; Harada, Norio; Yamane, Shunsuke; Lee, Soushou; Murotani, Kenta; Deacon, Carolyn F.; Holst, Jens J.; Hirano, Tsutomu; Inagaki, Nobuya; Kurose, Takeshi; Seino, Yutaka			Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients	JOURNAL OF DIABETES AND ITS COMPLICATIONS			English	Article						Insulin; Glucagon; GLP-1; GIP; Hyperglycemia	IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; PLASMA-GLUCAGON; ADMINISTERED GLUCOSE; ALPHA-CELL; POLYPEPTIDE; PEPTIDE-1; JAPANESE; IMMUNOASSAYS; PATHOGENESIS	Aims: Hypersecretion of glucagon and reduced insulin secretion both contribute to hyperglycemia in type 2 diabetes (T2DM). However, the relative contributions of impaired glucagon and insulin secretions in glucose excursions at the various stages of T2DM development remain to be determined. Methods: The responses of glucagon and insulin as well as those of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) were examined before and after ingestion of glucose or mixed meal in Japanese subjects with normal or impaired glucose tolerance (NGT and IGT) and in non-obese, untreated T2DM of short duration. Results: In OGTT, T2DM showed a rise in glucagon at 0-30 min, unlike NGT and IGT, along with reduced insulin. In MTT, all three groups showed a rise in glucagon at 0-30 min, with that in T2DM being highest, while T2DM showed a significant reduction in insulin. Linear regression analyses revealed that glucose area under the curve (AUC)(0-120) min was associated with glucagon-AUC(0-30) min and insulin-AUC(0-30min) in both OGTT and MTT. Total and biologically intact GIP and GLP-1 levels were similar among the three groups. Conclusions: Disordered early phase insulin and glucagon secretions but not incretin secretion are involved in hyperglycemia after ingestion of nutrients in T2DM of even a short duration. (C) 2015 The authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Yabe, Daisuke; Kuroe, Akira; Watanabe, Koin; Kurose, Takeshi; Seino, Yutaka] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka 5530003, Japan; [Yabe, Daisuke; Iwasaki, Masahiro] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Osaka 5530003, Japan; [Iwasaki, Masahiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med,Chuo Ku, Kobe, Hyogo 6500047, Japan; [Hamasaki, Akihiro; Hamamoto, Yoshiyuki; Harada, Norio; Yamane, Shunsuke; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, Kyoto 6068507, Japan; [Lee, Soushou; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Diabet Metab & Endocrinol, Shinagawa Ku, Tokyo 1428555, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Showa Ku, Nagoya, Aichi 4668560, Japan; [Deacon, Carolyn F.; Holst, Jens J.] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark	Yabe, D (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, 2-1-7 Fukushima Ku, Osaka 5530003, Japan.	ydaisuke-kyoto@umin.ac.jp; seino.yutaka@e2.kepco.co.jp	Yabe, Daisuke/J-6682-2014; 	Yabe, Daisuke/0000-0002-5334-7687; Holst, Jens Juul/0000-0001-6853-3805	Merck, Sharp and Dohme	This study was funded by Merck, Sharp and Dohme. Costs for measurement of glucose, insulin, glucagon, GLP-1 and GIP were covered by the funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalim W., 2014, J CLIN ENDOCRINOLOGY; Christensen M, 2011, DIABETES, V60, P3103, DOI 10.2337/db11-0979; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Yabe D, 2010, J DIABETES INVEST, V1, P56, DOI 10.1111/j.2040-1124.2010.00010.x; Moller JB, 2014, DIABETES CARE, V37, P796, DOI 10.2337/dc13-0598; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Knop FK, 2007, DIABETES, V56, P1951, DOI 10.2337/db07-0100; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; Ahren B, 2001, DIABETOLOGIA, V44, P1998, DOI 10.1007/s001250100003; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Kawamori D, 2010, ADV EXP MED BIOL, V654, P421, DOI 10.1007/978-90-481-3271-3_18; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Bak MJ, 2014, EUR J ENDOCRINOL, V170, P529, DOI 10.1530/EJE-13-0941; Mari A, 2008, DIABETIC MED, V25, P671, DOI 10.1111/j.1464-5491.2008.02441.x; Yamada Y, 2006, DIABETES RES CLIN PR, V74, P222, DOI 10.1016/j.diabres.2006.03.030; Ahren B, 2009, DIABETES, V58, P726, DOI 10.2337/db08-1158; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106; Aulinger BA, 2014, DIABETES, V63, P1079, DOI 10.2337/db13-1455; Bak MJ, 2014, J ENDOCRINOL DIAB, V1, P1; Christensen M, 2014, DIABETES, V63, P1, DOI DOI 10.2337/DB14-0440; DAVIES MJ, 1994, DIABETIC MED, V11, P432; Deacon CF, 2009, BEST PRACT RES CL EN, V23, P425, DOI 10.1016/j.beem.2009.03.006; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; Hoist J.J., 2007, PHYSIOL REV, V87, P1409; KAWAI K, 1987, ENDOCRINOL JAPON, V34, P745; KURAHACHI H, 1977, ENDOCRINOL JAPON, V24, P413; Marroqui L., 2014, NUTR RES REV, P1; Mentis N, 2011, DIABETES, V60, P1270, DOI 10.2337/db10-1332; Nauck M. A., 2010, DIABETOLOGIA, V54, P10; NISHINO T, 1981, CLIN CHEM, V27, P1690; Oh TJ, 2014, CLIN ENDOCRINOL, V80, P221, DOI 10.1111/cen.12167; Raffel LJ, 1996, DIABETES CARE, V19, P864, DOI 10.2337/diacare.19.8.864; Rijkelijkhuizen JM, 2010, METABOLISM, V59, P502, DOI 10.1016/j.metabol.2009.07.039; SEINO Y, 1978, DIABETES, V27, P1145, DOI 10.2337/diabetes.27.12.1145; SEINO Y, 1977, HORM METAB RES, V9, P28; TAMINATO T, 1977, DIABETES, V26, P480, DOI 10.2337/diabetes.26.5.480; UNGER RH, 1976, DIABETES, V25, P136; Yabe D., 2014, EXPERT REV ENDOCRINO, V9, P659	52	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1056-8727	1873-460X		J DIABETES COMPLICAT	J. Diabetes Complications	APR	2015	29	3					413	421		10.1016/j.jdiacomp.2014.12.010		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CE8TN	WOS:000352117100017		
J	Kaizoji, T; Leiss, M; Saichev, A; Sornette, D				Kaizoji, Taisei; Leiss, Matthias; Saichev, Alexander; Sornette, Didier			Super-exponential endogenous bubbles in an equilibrium model of fundamentalist and chartist traders	JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION			English	Article						Financial bubbles; Faster-than-exponential growth; Social imitation; Momentum trading; Chartists; Dotcom bubble	STOCK-MARKET; SPECULATIVE BUBBLES; STATISTICAL-MECHANICS; ECONOMETRIC TESTS; BUSINESS-CYCLE; PRICE DYNAMICS; EXPECTATIONS; DIVERSIFICATION; OVERCONFIDENCE; HETEROGENEITY	We introduce a model of super-exponential financial bubbles with two assets (risky and risk-free), in which fundamentalist and chartist traders co-exist. Fundamentalists form expectations on the return and risk of a risky asset and maximize their constant relative risk aversion expected utility with respect to their allocation on the risky asset versus the risk-free asset. Chartists are subjected to social imitation and follow momentum trading. Allowing for random time-varying herding propensity, we are able to reproduce several well-known stylized facts of financial markets such as a fat-tail distribution of returns and volatility clustering. In particular, we observe transient faster-than-exponential bubble growth with approximate log-periodic behavior and give analytical arguments why this follows from our framework. The model accounts well for the behavior of traders and for the price dynamics that developed during the dotcom bubble in 1995-2000. Momentum strategies are shown to be transiently profitable, supporting these strategies as enhancing herding behavior. (C) 2015 Elsevier B.V. All rights reserved.	[Kaizoji, Taisei] Int Christian Univ, Grad Sch Arts & Sci, Mitaka, Tokyo 1818585, Japan; [Leiss, Matthias; Saichev, Alexander; Sornette, Didier] ETH, Dept Management Technol & Econ, CH-8032 Zurich, Switzerland; [Saichev, Alexander] Nizhnii Novgorod State Univ, Dept Math, Novgorod Oblast, Russia; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, CH-1211 Geneva 4, Switzerland	Leiss, M (reprint author), ETH, Dept Management Technol & Econ, Kreuzpl 5, CH-8032 Zurich, Switzerland.	kaizoji@icu.ac.jp; mleiss@ethz.ch; dsornette@ethz.ch					Brock WA, 1998, J ECON DYN CONTROL, V22, P1235, DOI 10.1016/S0165-1889(98)00011-6; Scheinkman JA, 2003, J POLIT ECON, V111, P1183, DOI 10.1086/378531; Sornette D, 2006, PHYSICA A, V370, P704, DOI 10.1016/j.physa.2006.02.022; Durlauf SN, 1999, P NATL ACAD SCI USA, V96, P10582, DOI 10.1073/pnas.96.19.10582; Al-Anaswah N, 2011, J BANK FINANC, V35, P1073, DOI 10.1016/j.jbankfin.2010.09.021; Hong H, 1999, J FINANC, V54, P2143, DOI 10.1111/0022-1082.00184; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Boswijk HP, 2007, J ECON DYN CONTROL, V31, P1938, DOI 10.1016/j.jedc.2007.01.001; Barberis N, 1998, J FINANC ECON, V49, P307, DOI 10.1016/S0304-405X(98)00027-0; Phillips PCB, 2011, QUANT ECON, V2, P455, DOI 10.3982/QE82; Ofek E, 2003, J FINANC, V58, P1113, DOI 10.1111/1540-6261.00560; Sornette D, 1998, PHYS REP, V297, P239, DOI 10.1016/S0370-1573(97)00076-8; Brunnermeier MK, 2004, J FINANC, V59, P2013, DOI 10.1111/j.1540-6261.2004.00690.x; Jegadeesh N, 2001, J FINANC, V56, P699, DOI 10.1111/0022-1082.00342; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; JEGADEESH N, 1993, J FINANC, V48, P65, DOI 10.2307/2328882; DEBONDT WFM, 1987, J FINANC, V42, P557; Chiarella C, 2009, HANDB FINANC, P277, DOI 10.1016/B978-012374258-2.50009-9; Fama EF, 1998, J FINANC ECON, V49, P283, DOI 10.1016/S0304-405X(98)00026-9; Homm U, 2012, J FINANC ECONOMET, V10, P198, DOI 10.1093/jjfinec/nbr009; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; HAMILTON JD, 1985, J MONETARY ECON, V16, P353, DOI 10.1016/0304-3932(85)90041-8; Lammerding M, 2013, ENERG ECON, V36, P491, DOI 10.1016/j.eneco.2012.10.006; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; Battalio R, 2006, J FINANC, V61, P2071, DOI 10.1111/j.1540-6261.2006.01051.x; Klass OS, 2007, EUR PHYS J B, V55, P143, DOI 10.1140/epjb/e2006-00396-1; Engsted T, 2010, J EMPIR FINANC, V17, P585, DOI 10.1016/j.jempfin.2010.01.003; MODIGLIANI F, 1958, AM ECON REV, V48, P261; DEBONDT WFM, 1990, AM ECON REV, V80, P52; Bouchaud JP, 2000, PHYSICA A, V282, P536, DOI 10.1016/S0378-4371(00)00205-3; MODIGLIANI F, 1963, AM ECON REV, V53, P433; Wermers R, 1999, J FINANC, V54, P581, DOI 10.1111/0022-1082.00118; DEBONDT WFM, 1985, J FINANC, V40, P793; KYLE AS, 1985, ECONOMETRICA, V53, P1315, DOI 10.2307/1913210; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; Gurkaynak RS, 2008, J ECON SURV, V22, P166, DOI 10.1111/j.1467-6419.2007.00530.x; Baxter M., 1995, W5019 NAT BUR EC RES; Binder M., 2013, 1569 ECB; BLACK F, 1986, J FINANC, V41, P529, DOI 10.2307/2328481; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; BLUME LE, 1995, GAME ECON BEHAV, V11, P111, DOI 10.1006/game.1995.1046; Boyer R., 1992, J EVOLUTIONARY EC, V2, P165, DOI 10.1007/BF01202416; Breitung J, 2013, STAT PAP, V54, P911, DOI 10.1007/s00362-012-0497-3; Breitung J., 2014, ECONOMETRIC TESTS SP, V1, pIII; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Brock W.A., 1999, THEORY MARKETS, P109; Brook W.A., 1993, ESTUD EC, V8, P3; Cont R, 2007, LONG MEMORY EC, P289; Corcos A., 2002, Quantitative Finance, V2, DOI 10.1088/1469-7688/2/4/303; De Long B., 1990, J POLITICAL EC, V98, P703; de Vries C.G., 1994, HDB INT MACROECONOMI, P348; DeLong B. J., 1990, J FINANC, V45, P379; DIBA BT, 1988, AM ECON REV, V78, P520; Ding Z., 1993, J EMPIR FINANC, V1, P83, DOI 10.1016/0927-5398(93)90006-D; Dudley W.C., 2010, NPR PLANET MONEY APR; Durlauf S.N., 1997, SANTA FE I STUDIES S, VXXVII; Eymard-Duvernay F., 2005, POSTAUTISTIC EC REV, V34, P22; Fischer E., 2013, PORTFOLIO OPTIMIZATI; Greenspan A., 2002, REMARKS CHARIRMAN AL; Guillaume D. M., 1997, FINANC STOCH, V1, P95, DOI 10.1007/s007800050018; HAMILTON JD, 1989, ECONOMETRICA, V57, P357, DOI 10.2307/1912559; Hamilton JD, 2002, EMPIR ECON, V27, P149, DOI 10.1007/s001810100115; Harras G, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011150; Harras G, 2011, J ECON BEHAV ORGAN, V80, P137, DOI 10.1016/j.jebo.2011.03.003; HARRISON JM, 1978, Q J ECON, V92, P323, DOI 10.2307/1884166; Husler A, 2013, J ECON BEHAV ORGAN, V92, P304, DOI 10.1016/j.jebo.2013.06.005; Jondeau E., 1999, TAIL BEHAVIOR STOCK, V668; Kadilli A., 2013, REGIME SWITCHING APP; Kaizoji T, 2000, PHYSICA A, V287, P493, DOI 10.1016/S0378-4371(00)00388-5; Kaizoji T., 2010, BEHAV MODEL BUBBLE C; KELLY M, 1995, J ECON BEHAV ORGAN, V27, P87, DOI 10.1016/0167-2681(95)00006-E; Kindleberger C. P., 1978, MANIAS PANICS CRASHE; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kirman A.P., 1997, INTERACTION MARKETS; Kirman A.P., 2002, THEORY MARKETS, P109; Orlean A., 1994, ANAL EC CONVENTIONS; Pagan A., 1996, J EMPIR FINANC, V3, P15, DOI DOI 10.1016/0927-5398(95)00020-8; Phan D., 2004, COGNITIVE EC INTERDI; Phillips P.C.B., 2013, INT ECON REV, V52, P201; Shiller R., 2000, IRRATIONAL EXUBERANC; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; SORNETTE D, 1994, J PHYS I, V4, P209, DOI 10.1051/jp1:1994133; Sornette D, 2013, PHYSICA A, V392, P4417, DOI 10.1016/j.physa.2013.05.011; Sornette D., 2010, APPL PHYS FINANCIAL; Sornette D., 2010, BRUSSELS EC REV, V53, P201; Sornette D, 2009, PHYSICA A, V388, P1571, DOI 10.1016/j.physa.2009.01.011; Statman M, 2004, FINANC ANAL J, V60, P44, DOI 10.2469/faj.v60.n4.2636; Stauffer D, 1999, PHYSICA A, V271, P496, DOI 10.1016/S0378-4371(99)00290-3; Wagener F.O.O., 2009, CENDEF WORKING PAPER, V09-10; Weidlich W., 1983, CONCEPTS MODELS QUAN; Yan Wanfeng, 2012, INT J PORTFOLIO ANAL, V1, P59; Yoshikawa H, 2007, RECONSTRUCTING MACRO; Yukalov VI, 2009, J ECON BEHAV ORGAN, V70, P206, DOI 10.1016/j.jebo.2008.12.004	94	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2681	1879-1751		J ECON BEHAV ORGAN	J. Econ. Behav. Organ.	APR	2015	112						289	310		10.1016/j.jebo.2015.02.001		22	Economics	Business & Economics	CF1TK	WOS:000352330600019		
J	Fosdick, R; Fried, E				Fosdick, Roger; Fried, Eliot			Special Invited Collection on the Mechanics of Ribbons and Mobius Bands Foreword	JOURNAL OF ELASTICITY			English	Editorial Material									[Fosdick, Roger] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan	Fosdick, R (reprint author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	fosdick@aem.umn.edu; eliot.fried@oist.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					1	2		10.1007/s10659-015-9516-7		2	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900001		
J	Hinz, DF; Fried, E				Hinz, Denis F.; Fried, Eliot			Translation of Michael Sadowsky's Paper "An Elementary Proof for the Existence of a Developable MOBIUS Band and the Attribution of the Geometric Problem to a Variational Problem	JOURNAL OF ELASTICITY			English	Article						Mobius band; Energy functional; Bending energy		This article is a translation of Michael Sadowsky's original paper "Ein elementarer Beweis fur die Existenz eines abwickelbaren Mobiusschen Bandes und die Zuruckfuhrung des geometrischen Problems auf ein Variationsproblem." which appeared in Sitzungsberichte der Preussischen Akademie der Wissenschaften, physikalisch-mathematische Klasse, 17. Juli 1930.-Mitteilung vom 26. Juni, 412-415. Published on September 12, 1930.	[Hinz, Denis F.; Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan.	dfhinz@gmail.com; eliot.fried@oist.jp					Mobius A.F., 1865, GESAMMELTE WERKE, V2, P484	1	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					3	6		10.1007/s10659-014-9490-5		4	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900002		
J	Hinz, DF; Fried, E				Hinz, Denis F.; Fried, Eliot			Translation and Interpretation of Michael Sadowsky's Paper "Theory of Elastically Bendable Inextensible Bands with Applications to the MOBIUS Band"	JOURNAL OF ELASTICITY			English	Article						Mobius band; Energy functional; Bending energy		This article is a translation of Michael Sadowsky's original paper "Theorie der elastisch biegsamen undehnbaren Bander mit Anwendungen auf das Mobius'sche Band" in 3. internationaler Kongress fur technische Mechanik, Stockholm, 1930. The translation is augmented by an Appendix containing an interpretation of the last section of Sadowsky's original paper, including figures generated from recent numerical simulations.	[Hinz, Denis F.; Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan.	dfhinz@gmail.com; eliot.fried@oist.jp					Hamel G., 1912, LEHRBUCH ELEMENTAREN, V36, p 36; Hamel G., 1927, Z ANGEW MATH MECH, V7, P114; Hamel G., 1927, HDB PHYSIK, V5, P1; Hamel G., 1926, SITZUNGSBER BERL MAT, V25, P3; Kleiman D. M., P NATL ACAD SC UNPUB; Sadowsky M., 1930, SITZUNGSBER PREUSS A, V22, P412	6	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					7	17		10.1007/s10659-014-9492-3		11	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900003		
J	Hinz, DF; Fried, E				Hinz, Denis F.; Fried, Eliot			Translation of Michael Sadowsky's Paper "The Differential Equations of the MOBIUS Band"	JOURNAL OF ELASTICITY			English	Article						Mobius band; Energy functional; Bending energy		This article is a translation of Michael Sadowsky's original paper "Die Differentialgleichungen des Mobiusschen Bandes" in Jahresbericht der Deutschen Mathematiker-Vereinigung 39 (2. Abt. Heft 5/8, Jahresversammlung vom 16. bis 23. September), 49-51 (1929), which is a short version of his paper "Theorie der elastisch biegsamen undehnbaren Bander mit Anwendungen auf das Mobius'sche Band" in 3. internationaler Kongress fur technische Mechanik, Stockholm, 1930.	[Hinz, Denis F.; Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan.	dfhinz@gmail.com; eliot.fried@oist.jp					Sadowsky M., 1930, SITZUNGSBER PREUSS A, V22, P412	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					19	22		10.1007/s10659-014-9491-4		4	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900004		
J	Todres, RE				Todres, Russell E.			Translation of W. Wunderlich's "On a Developable Mobius Band"	JOURNAL OF ELASTICITY			English	Article						Mobius bands; Differential geometry; Developable surfaces		The following is a translation of Walter Wunderlich's article "ber ein abwickelbares Mobiusband", which appeared in the Monatshefte fur Mathematik 66 (1962), 276-289 and was dedicated to Prof. Dr. Paul Funk on the occasion of his 75th birthday. Wunderlich summarizes Sadowsky's work (Sitzber. Preuss. Akad. Wiss. 22:412-415, 1930; Verhandlungen des 3. Internationalen Kongresses fur Technische Mechanik, II (Stockholm, 1930), pp. 444-451, Sveriges Litografiska Tryckerier, Stockholm, 1931) on developable Mobius bands and improves Sadowsky's upper bound of the dimensionally-reduced variational description for determining the configuration of a Mobius band whose width is small in comparison to its length. Attempting to reproduce the equilibrium depiction of a band of finite width, using a rational-algebraic developable, Wunderlich then extends Sadowsky's results by presenting perhaps the first successful model of a closed, analytic, developable Mobius band with associated thinness bounds. This translation makes Wunderlich's work accessible to the broader research community at a time of growing interest in and relevance of thin-walled structural elements.	Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan	Todres, RE (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Okinawa 9040495, Japan.	russell.todres@oist.jp					Klima J., 1936, CAS PEST MAT FYS, V65, P211; Krames J., 1918, SITZBER AKAD WISS WI, V127, P563; Maschke H, 1900, T AM MATH SOC, V1, P39; Mobius F. A, 1865, BER VERH SACHS GES W, V17, P31; Sadowsky M., 1930, VERH 3 INT K TECHN M, VII, P444; Sadowsky M., 1930, SITZUNGSBER PREUSS A, V22, P412; Scheffers G., 1913, EINFUHRUNG THEORIE F, P41; Weyl H., 1913, IDEE RIEMANNSCHEN FL, P26	8	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					23	34		10.1007/s10659-014-9489-y		12	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900005		
J	Kirby, NO; Fried, E				Kirby, Nicholas O.; Fried, Eliot			Gamma-Limit of a Model for the Elastic Energy of an Inextensible Ribbon	JOURNAL OF ELASTICITY			English	Article						Low-dimensional media; Dimensional reduction; Curvature elasticity; Sadowsky functional; Torsion; Sequential lower semicontinuity; Weak convergence		A I"-convergence result involving the elastic bending energy of a narrow inextensible ribbon is established. As a consequence of the result, the energy is reduced to a one-dimensional integral, over the centerline of the ribbon, in which the aspect ratio of the ribbon appears as a small parameter. That integral is observed to increase monotonically with the aspect ratio. The I"-limit of the family of energies is taken in a Sobolev space of centerlines with nonvanishing curvature. In that space, it is shown that the I"-limit is a functional first proposed by Sadowsky in the context of narrow ribbons that form Mobius bands. The results obtained here do not apply to such ribbons, since the centerline of a Mobius band must have at least one inflection point. As a first step toward dealing with such inflection points, a result concerning the lower semicontinuity of the Sadowsky functional with inflection points comprising a set of measure zero within the domain of an arclength parameterization is presented.	[Kirby, Nicholas O.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna Son, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna Son, Okinawa 9040495, Japan.	nokirby@uw.edu; eliot.fried@oist.jp					ADAMS R.A., 2003, SOBOLEV SPACES; Friesecke G, 2002, COMMUN PUR APPL MATH, V55, P1461, DOI 10.1002/cpa.10048; Giomi L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238104; Caratheodory C, 1907, MATH ANN, V64, P95, DOI 10.1007/BF01449883; Braides A., 2002, GAMMA CONVERGENCE BE; Buttazzo G., 1998, ONE DIMENSIONAL VARI; Caratheodory C., 1911, RENDICONTI CIRCOLO M, V32, P197; De Giorgi E., 1975, ATTI ACCAD NAZ  SFMN, V58, P842; Gauss C. F., 1827, COMM SOC REGIAE SCI, V6, P1823; Germain S., 1821, RECHERCHES THEORIE S; Graustein W. C., 1935, DIFFERENTIAL GEOMETR; Poisson S. D., 1812, MEM I FR SMP, V2, P167; Randrup T, 1996, ARCH MATH, V66, P511, DOI 10.1007/BF01268871; Rappaport SM, 2007, J PHYS A-MATH THEOR, V40, P4455, DOI 10.1088/1751-8113/40/17/003; Sadowsky M., 1930, SITZUNGSBER PREUSS A, V22, P412; Starostin E. L., 2007, P APPL MATH MECH, V7; Struik D. J., 1961, LECT CLASSICAL DIFFE; Wheeden R. L., 1977, MEASURE INTEGRAL; Wunderlich W., 1962, MONATSH MATH, V66, P276, DOI [10.1007/BF01299052, DOI 10.1007/BF01299052)]; Yong E. H., 2012, THESIS HARVARD U	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					35	47		10.1007/s10659-014-9475-4		13	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900006		
J	Chen, YC; Fosdick, R; Fried, E				Chen, Yi-Chao; Fosdick, Roger; Fried, Eliot			Representation for a Smooth Isometric Mapping from a Connected Planar Domain to a Surface	JOURNAL OF ELASTICITY			English	Article						Isometric embedding; Rigidity; Representation theorem; 2-d to 3-d		A representation theorem for a smooth isometric mapping of a flat, connected domain in two-dimensional Euclidean point space into a surface in three-dimensional Euclidean point space is presented. The form of the mapping is shown to be necessary and sufficient to describe any such smooth isometry. Importantly, this work is not based upon the hypothesis that the mapped surface is ruled. In general, a mapping from a flat planar domain into a ruled surface is far from being isometric, and the property of being ruled is a partial consequence of our representation theorem.	[Chen, Yi-Chao] Univ Houston, Dept Mech Engn, Houston, TX 77204 USA; [Fosdick, Roger] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA; [Fried, Eliot] Grad Univ, Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan	Fried, E (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan.	chen@uh.edu; fosdick@aem.umn.edu; eliot.fried@oist.jp	Fried, Eliot/B-5836-2015					0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	APR	2015	119	1-2					335	350		10.1007/s10659-015-9521-x		16	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CE9BR	WOS:000352138900017		
J	Yanada, H; Takagi, S; Mamiya, S				Yanada, H.; Takagi, S.; Mamiya, S.			Effects of electrode and filter element shapes on characteristics of charge injection type of electrostatic oil filter	JOURNAL OF ELECTROSTATICS			English	Article						Electrostatic filter; Charge injection; Oil saving; Electrohydrodynamics; Ion drag; Numerical simulation	FILTRATION SPEED	This paper reports on an improvement of the filtration speed of charge injection type of electrostatic oil filter. Numerical simulations of the ion drag flow field and electric field are performed to compare the charge density distribution, ion drag flow pattern, and electric field strength distribution for different electrode and filter element shapes. Filtration experiments are conducted and the experimental results are discussed in relation to the simulation results. It is shown that the numerical simulations used in this study can contribute in predicting a better structure for electrostatic oil filters. (C) 2014 Elsevier B.V. All rights reserved.	[Yanada, H.; Takagi, S.; Mamiya, S.] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan	Yanada, H (reprint author), Toyohashi Univ Technol, Dept Mech Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	yanada@me.tut.ac.jp			Japan Society for the Promotion of Science [22560141, 25420088]	The authors would like express their gratitude to Mr. Y. Miyakawa for his help in the experiments. This work has been financially supported by the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research (C) (No. 22560141 and No. 25420088).	Adamczewski I., 1969, IONIZATION CONDUCTIV, P219; [Anonymous], 1983, F313 ASTM STAND, pF313; Felici N. J., 1971, Direct Current and Power Electronics, V2; Japanese Industrial Standard, 1995, Z8901 JIS; Kitahara A., 1984, ELECT PHENOMENA INTE; Tran KD, 2008, J ADV MECH DES SYST, V2, P971, DOI 10.1299/jamdsm.2.971; Tran K.D., 2009, T JAPAN FLUID POWER, V40, P8; Yanada H, 2011, J ELECTROSTAT, V69, P180, DOI 10.1016/j.elstat.2011.03.007; Yanada Hideki, 2010, Journal of Fluid Science and Technology, V5, DOI 10.1299/jfst.5.617; Yanada H, 2012, J ELECTROSTAT, V70, P117, DOI 10.1016/j.elstat.2011.11.005; Yanada H, 2008, J ADV MECH DES SYST, V2, P119, DOI 10.1299/jamdsm.2.119	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	APR	2015	74						1	7		10.1016/j.elstat.2014.11.006		7	Engineering, Electrical & Electronic	Engineering	CE9TD	WOS:000352185400001		
J	Fukuda, T; Ohashi, N; Matsubara, T; Yahagi, N				Fukuda, Tatsuma; Ohashi, Naoko; Matsubara, Takehiro; Yahagi, Naoki			THE CONTRIBUTIONS OF EMERGENCY PHYSICIANS TO OUT-OF-HOSPITAL CARDIOPULMONARY ARREST: AN ANALYSIS OF THE NATIONAL UTSTEIN REGISTRY DATA	JOURNAL OF EMERGENCY MEDICINE			English	Article						out-of-hospital cardiac arrest; cardiopulmonary resuscitation; emergency services; health policy; database	AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; POPULATION-BASED COHORT; CARDIAC-ARREST; CARDIOVASCULAR CARE; STROKE-FOUNDATION; TASK-FORCE; GUIDELINES; SURVIVAL; PROGNOSIS	Background: Emergency physicians are likely to play an important role in the "chain of survival.'' The relationship between the number of emergency physicians and out-of-hospital cardiopulmonary arrest (OHCA) prognosis is not well understood. Objective: We assessed the impact of the number of emergency physicians on the outcomes of OHCA. Methods: In a nationwide, population-based, observational study, we enrolled 120,721 adults aged >= 18 years with OHCA, from January 1, 2010 to December 31, 2010. We used the countrywide Utstein Registry database coupled with health statistics data surveyed by the Ministry of Health, Labour and Welfare. The primary endpoint was favorable neurological outcomes 1 month after OHCA. Results: During the study period, OHCAoccurred in 25,580 people (21.2%) in an area with the number of emergency physicians/100,000 population < 1.5, in 62,299 people (51.6%) in an area with >= 1.5 and < 3.0 emergency physicians/100,000 population, in 30,948 people (25.6%) in an area with >= 3.0 and <4.5 emergency physicians/100,000 population, and in 1894 people (1.6%) in an area with >= 4.5 emergency physicians/100,000 population. Patient prognosis became more favorable as the number of emergency physicians increased (1-month survival: 5.08% vs. 5.81% vs. 5.90% vs. 8.82%, p < 0.0001; and favorable neurological outcomes: 2.64% vs. 2.84% vs. 3.23% vs. 3.54%, p < 0.0001; for emergency physicians/100,000 population of < 1.5, >= 1.5 and < 3.0, >= 3.0 and < 4.5, and >= 4.5, respectively). The adjusted odds ratio for favorable neurological outcomes per increase of one emergency physician/100,000 population was 1.06 (95% confidence interval 1.01-1.11, p = 0.0163). Conclusion: An increased number of emergency physicians/100,000 population is likely to be associated with improved outcomes. (C) 2015 Elsevier Inc.	[Fukuda, Tatsuma; Ohashi, Naoko; Matsubara, Takehiro; Yahagi, Naoki] Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Tokyo 1138655, Japan	Fukuda, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						CUMMINS RO, 1991, CIRCULATION, V84, P960; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Fukuda T, 2014, AM J EMERG MED, V32, P747, DOI 10.1016/j.ajem.2014.02.039; Cudnik MT, 2012, RESUSCITATION, V83, P862, DOI 10.1016/j.resuscitation.2012.02.006; Tanno K, 2008, AM J EMERG MED, V26, P649, DOI 10.1016/j.ajem.2007.09.019; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Stub D, 2011, HEART, V97, P1489, DOI 10.1136/hrt.2011.226431; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Dumas F, 2012, J AM COLL CARDIOL, V60, P21, DOI 10.1016/j.jacc.2012.03.036; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Callaway CW, 2010, RESUSCITATION, V81, P524, DOI 10.1016/j.resuscitation.2009.12.006; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Fire and Disaster Management Agency Ministry of Internal Affairs and Communications, 2010, CURR STAT EM RESC; Fire and Disaster Management Agency Ministry of Internal Affairs and Communications, 2013, CURR STAT EM RESC; Fire and Disaster Management Agency Ministry of Internal Affairs and Communications, 2010, WHIT PAP FIR SERV; Fukuda T, 2013, RESUSCITATION, V84, P964, DOI 10.1016/j.resuscitation.2013.02.019; Fukuda T, 2014, J CRIT CARE, V29, P840, DOI 10.1016/j.jcrc.2014.03.034; Fukuda T, 2014, INT J CARDIOL, V176, P910, DOI 10.1016/j.ijcard.2014.08.057; Health Statistics Office Vital Health and Social Statistics Division Statistics and Information Department Ministry of Health Labour and Welfare, 2010, SURV PHYS DENT PHARM; Health Statistics Office Vital Health and Social Statistics Division Statistics and Information Department Ministry of Health Labour and Welfare, 2010, SURV MED I 2010; Herlitz J, 2003, HEART, V89, P25, DOI 10.1136/heart.89.1.25; Japan Resuscitation Council (JRC), 2012, JRC GUID 2010; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Office of Emergency and Perinatal Medicine Guidance of Medical Service Division Health Policy Bureau Ministry of Health Labour and Welfare, 2011, EV TERT EM MED CTR 2; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Scolletta S, 2012, CRIT CARE, V16, DOI 10.1186/cc11235; Statistical Research and Training Institute, 2013, JAP STAT YB 2013	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2015	48	4					E81	E92		10.1016/j.jemermed.2014.09.053		12	Emergency Medicine	Emergency Medicine	CE8RU	WOS:000352112600001		
J	Koseki, S; Nakamura, N; Shiina, T				Koseki, Shigenobu; Nakamura, Nobutaka; Shiina, Takeo			Growth Inhibition of Listeria monocytogenes, Salmonella enterica, and Escherichia coli O157:H7 by D-Tryptophan as an Incompatible Solute	JOURNAL OF FOOD PROTECTION			English	Article							COMPATIBLE SOLUTES; ANTIBACTERIAL ACTIVITY; PROTECTION; OSMOLYTES; PEPTIDES; STRESS; RICH	Under osmotic stress, bacterial cells uptake compatible solutes such as glycine-betaine to maintain homeostasis. It is unknown whether incompatible solutes exist that are similar in structure to compatible solutes but have adverse physiological effects on bacterial physiology. The objective of this study was to evaluate solute incompatibility of various amino acids against bacterial growth. Bacterial growth was evaluated by changes in optical density at 595 nm in peptone-yeast-glucose (PYG) broth. Twenty-three amino acids with L and/or D isomers were examined for the effect of bacterial growth inhibition. Among the various amino acids examined, D-tryptophan (similar to 40 mM) in PYG broth supplemented with 0 to 4% (wt/vol) salt inhibited the growth of Listeria monocytogenes, Salmonella enterica, and Escherichia coli 0157:117 at 25 degrees C. D-Tryptophan (30 to 40 mM) completely inhibited the growth of E. coli O157:H7 and Salmonella in the presence of >3% salt, but the growth of L. monocytogenes was not completely inhibited under the same conditions. Low concentrations of salt (0 to 2% NaCl) with D-tryptophan did not significantly inhibit the growth of all bacteria except L. monocytogenes, which was relatively inhibited at 0% NaCl. The effect of D-tryptophan differed depending on the bacterial species, illustrating the difference between gram-positive and gram-negative bacteria. These results indicate that the uptake of D-tryptophan as a compatible solute during osmotic stress may inhibit bacterial growth. The antibacterial effect of D-tryptophan found in this study suggests that D-tryptophan could be used as a novel preservative for controlling bacterial growth in foods.	[Koseki, Shigenobu] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Koseki, Shigenobu; Nakamura, Nobutaka; Shiina, Takeo] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Koseki, S (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	koseki@bpe.agr.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23780150]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Young Scientists (B) 23780150.	Munoz A, 2007, BIOCHEM BIOPH RES CO, V354, P172, DOI 10.1016/j.bbrc.2006.12.173; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; McCann KB, 2005, INT DAIRY J, V15, P133, DOI 10.1016/j.idairyj.2004.06.008; BROWN AD, 1976, BACTERIOL REV, V40, P803; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Chin JP, 2010, P NATL ACAD SCI USA, V107, P7835, DOI 10.1073/pnas.1000557107; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; GALINSKI EA, 1994, FEMS MICROBIOL REV, V15, P95, DOI 10.1016/0168-6445(94)90106-6; Murdock CA, 2002, J APPL MICROBIOL, V93, P850, DOI 10.1046/j.1365-2672.2002.01762.x; Held C, 2010, BIOPHYS CHEM, V152, P28, DOI 10.1016/j.bpc.2010.07.003; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Haug BE, 2001, J PEPT SCI, V7, P190, DOI 10.1002/psc.318; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; Galinski E. A., 1995, ADV MICROBIOL PHYSL, P273, DOI 10.1016/S0065-2911(08)60148-4; R Core Team, 2014, R LANG ENV STAT COMP; Sasaki H, 2007, ANN MICROBIOL, V57, P265; Shahjee HM, 2002, J BIOSCIENCES, V27, P515, DOI 10.1007/BF02705049; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X	20	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	APR	2015	78	4					819	824		10.4315/0362-028X.JFP-14-374		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CF3QM	WOS:000352463600026		
J	Andoh, A				Andoh, Akira			Celebratory message from the Editor-in-Chief on the 50th anniversary of the Journal of Gastroenterology	JOURNAL OF GASTROENTEROLOGY			English	Editorial Material									Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan	Andoh, A (reprint author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan.	andoh@belle.shiga-med.ac.jp					Sugano K, 2015, J GASTROENTEROL, V50, P1, DOI 10.1007/s00535-014-1025-0	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					361	363		10.1007/s00535-015-1045-4		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900001		
J	Watanabe, S; Hashimoto, E; Ikejima, K; Uto, H; Ono, M; Sumida, Y; Seike, M; Takei, Y; Takehara, T; Tokushige, K; Nakajima, A; Yoneda, M; Saibara, T; Shiota, G; Sakaida, I; Nakamuta, M; Mizuta, T; Tsubouchi, H; Sugano, K; Shimosegawa, T				Watanabe, Sumio; Hashimoto, Etsuko; Ikejima, Kenichi; Uto, Hirofumi; Ono, Masafumi; Sumida, Yoshio; Seike, Masataka; Takei, Yoshiyuki; Takehara, Tetsuo; Tokushige, Katsutoshi; Nakajima, Atsushi; Yoneda, Masashi; Saibara, Toshiji; Shiota, Goshi; Sakaida, Isao; Nakamuta, Makoto; Mizuta, Toshihiko; Tsubouchi, Hirohito; Sugano, Kentaro; Shimosegawa, Tooru			Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis	JOURNAL OF GASTROENTEROLOGY			English	Article						NAFLD/NASH guideline; Treatment	PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; II RECEPTOR ANTAGONIST; TERM-FOLLOW-UP; INSULIN-RESISTANCE; JAPANESE PATIENTS; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; NATURAL-HISTORY; RISK-FACTORS	Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in industrialized countries worldwide, and has become a serious public health issue not only in Western countries but also in many Asian countries including Japan. Within the wide spectrum of NAFLD, nonalcoholic steatohepatitis (NASH) is a progressive form of disease, which often develops into liver cirrhosis and increases the risk of hepatocellular carcinoma. In turn, a large proportion of NAFLD/NASH is the liver manifestation of metabolic syndrome, suggesting that NAFLD/NASH plays a key role in the pathogenesis of systemic atherosclerotic diseases. Currently, a definite diagnosis of NASH requires liver biopsy, though various noninvasive measures are under development. The mainstays of prevention and treatment of NAFLD/NASH include dietary restriction and exercise; however, pharmacological approaches are often necessary. Currently, vitamin E and thiazolidinedione derivatives are the most evidence-based therapeutic options, although the clinical evidence for long-term efficacy and safety is limited. This practice guideline for NAFLD/NASH, established by the Japanese Society of Gastroenterology in cooperation with The Japan Society of Hepatology, covers lines of clinical evidence reported internationally in the period starting from 1983 to January 2012, and each clinical question was evaluated using the GRADE system. Based on the primary release of the full version in Japanese, this English summary provides the core essentials of this clinical practice guideline comprising the definition, diagnosis, and current therapeutic recommendations for NAFLD/NASH in Japan.	[Watanabe, Sumio; Hashimoto, Etsuko; Ikejima, Kenichi; Uto, Hirofumi; Ono, Masafumi; Sumida, Yoshio; Seike, Masataka; Takei, Yoshiyuki; Takehara, Tetsuo; Tokushige, Katsutoshi; Nakajima, Atsushi; Yoneda, Masashi; Saibara, Toshiji; Shiota, Goshi; Sakaida, Isao; Nakamuta, Makoto; Mizuta, Toshihiko; Tsubouchi, Hirohito; Sugano, Kentaro; Shimosegawa, Tooru] Japanese Soc Gastroenterol JSGE, Guidelines Comm Creating & Evaluating Evidence Ba, Chuo Ku, Tokyo 1040061, Japan	Watanabe, S (reprint author), Japanese Soc Gastroenterol JSGE, Guidelines Comm Creating & Evaluating Evidence Ba, Chuo Ku, K-8 Bldg 8F,8-9-13 Ginza, Tokyo 1040061, Japan.	sumio@juntendo.ac.jp			Japanese Society of Gastroenterology	This article was supported by a Grant-in-Aid from the Japanese Society of Gastroenterology. The authors thank R. F. Whittier (Mitsui Plant Biotechnology Research Institute) for critical reading of the manuscript and thoughtful discussions and Kazuyoshi Kon (Juntendo University) for great assistance with manuscript preparation. The authors also express special appreciation to Shunhei Yamashina, Reiko Yaginuma, Kyoko Fukuhara, Akira Uchiyama, Tomonori Aoyama (Juntendo University), Seiichi Mawatari, Kohei Oda, Kazuaki Tabu (Kagoshima University), Takeshi Okanoue (Saiseikai Suita Hospital), Naoki Fujita, Motoo Iwasa, Kazushi Sugimoto (Mie University), Takuya Miyagi, Yoshihiro Kamada (Osaka University), Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Yuji Ogawa (Yokohama City University), Haruhisa Nakao, Kiyoaki Ito, Ken Sato and Yukiomi Nakade (Aichi Medical University).	Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Angelico F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005166.pub2; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Nobili V, 2007, DIABETES CARE, V30, P2638, DOI 10.2337/dc07-0281; Fujita N, 2009, CANCER EPIDEM BIOMAR, V18, P424, DOI 10.1158/1055-9965.EPI-08-0725; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Zein CO, 2011, HEPATOLOGY, V54, P1610, DOI 10.1002/hep.24544; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Kaneda H, 2006, J GASTROEN HEPATOL, V21, P1459, DOI 10.1111/j.1440-1746.2006.04447.x; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1067/mpd.2000.106566; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Mahady SE, 2011, J HEPATOL, V55, P1383, DOI 10.1016/j.jhep.2011.03.016; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Farrell GC, 2002, SEMIN LIVER DIS, V22, P185, DOI 10.1055/s-2002-30106; Mencin AA, 2011, CURR OPIN CLIN NUTR, V14, P151, DOI 10.1097/MCO.0b013e328342baec; Roldan-Valadez E, 2008, ANN HEPATOL, V7, P212; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Bellentani S, 2000, ANN INTERN MED, V132, P112; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Georgescu EF, 2009, WORLD J GASTROENTERO, V15, P942, DOI 10.3748/wjg.15.942; Ekstedt M, 2007, J HEPATOL, V47, P135, DOI 10.1016/j.jhep.2007.02.013; Boettcher E, 2012, ALIMENT PHARM THER, V35, P66, DOI 10.1111/j.1365-2036.2011.04912.x; Wang RT, 2003, AM J MED, V115, P554, DOI 10.1016/S0002-9343(03)00449-2; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Baranova A, 2011, ALIMENT PHARM THER, V33, P801, DOI 10.1111/j.1365-2036.2011.04579.x; Angulo P, 2007, ALIMENT PHARM THERAP, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; Yokohama S, 2006, WORLD J GASTROENTERO, V12, P322; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Evans CDJ, 2002, J CLIN PATHOL, V55, P689, DOI 10.1136/jcp.55.9.689; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Tokushige K, 2007, J HEPATOL, V46, P1104, DOI 10.1016/j.jhep.2007.01.028; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; Targher G, 2008, CLIN ENDOCRINOL, V68, P481, DOI 10.1111/j.1365-2265.2007.03068.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Haukeland JW, 2009, SCAND J GASTROENTERO, V44, P853, DOI 10.1080/00365520902845268; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Dam-Larsen S, 2009, SCAND J GASTROENTERO, V44, P1236, DOI 10.1080/00365520903171284; Nar A, 2009, ACTA DIABETOL, V46, P113, DOI 10.1007/s00592-008-0067-2; Abdelmalek MF, 2009, HEPATOLOGY, V50, P1818, DOI 10.1002/hep.23239; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Yalamanchili K, 2010, LIVER TRANSPLANT, V16, P431, DOI 10.1002/lt.22004; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Hou XH, 2011, J GASTROEN HEPATOL, V26, P722, DOI 10.1111/j.1440-1746.2010.06509.x; Tokushige K, 2008, INTERNAL MED, V47, P405, DOI 10.2169/internalmedicine.47.0476; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Hyogo H, 2008, METABOLISM, V57, P1711, DOI 10.1016/j.metabol.2008.07.030; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Socha P, 2009, J PEDIATR GASTR NUTR, V48, P587, DOI 10.1097/MPG.0b013e31818e04d1; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; Shyangdan D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15380; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579; Mummadi RR, 2008, CLIN GASTROENTEROL H, V6, P1396, DOI 10.1016/j.cgh.2008.08.012; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Adams LA, 2004, HEPATOLOGY, V39, P909, DOI 10.1002/hep.20140; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Malik SM, 2009, AM J TRANSPLANT, V9, P782, DOI 10.1111/j.1600-6143.2009.02590.x; Chan HLY, 2007, J GASTROEN HEPATOL, V22, P801, DOI 10.1111/j.1440-1746.2007.04977.x; Harrison SA, 2002, AM J GASTROENTEROL, V97, P2714; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Leuschner UFH, 2010, HEPATOLOGY, V52, P472, DOI 10.1002/hep.23727; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Athyros VG, 2006, CURR MED RES OPIN, V22, P873, DOI 10.1185/030079906X104696; van der Heijden GJ, 2010, OBESITY, V18, P384, DOI 10.1038/oby.2009.274; Radu C, 2008, J GASTROINTEST LIVER, V17, P255; Tokushige K, 2010, J GASTROENTEROL, V45, P960, DOI 10.1007/s00535-010-0237-1; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Ratziu V, 2011, J HEPATOL, V54, P1011, DOI 10.1016/j.jhep.2010.08.030; Bellentani S, 1997, GUT, V41, P845; Bhagat V, 2009, LIVER TRANSPLANT, V15, P1814, DOI 10.1002/lt.21927; Bhatt SP, 2012, DIABETES TECHNOL THE, V14, P828, DOI 10.1089/dia.2011.0277; Dureja P, 2011, TRANSPLANTATION, V91, P684, DOI 10.1097/TP.0b013e31820b6b84; Enjoji M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-29; Fargion S, 2005, ALIMENT PHARM THERAP, V22, P61, DOI 10.1111/j.1365-2036.2005.02599.x; Guha IN, 2006, GUT, V55, P1650, DOI 10.1136/gut.2006.091454; Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x; Hashizume H, 2007, EUR J GASTROEN HEPAT, V19, P827; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Komeda T, 2005, HEPATOL RES, V33, P83, DOI 10.1016/j.hepres.2005.09.009; Li WJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-49; Loria P, 2009, NAT REV GASTRO HEPAT, V6, P236, DOI 10.1038/nrgastro.2009.33; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Obara N, 2008, J GASTROENTEROL, V43, P720, DOI 10.1007/s00535-008-2225-2; Okanoues T, 2009, KANZO, V50, P741; Park H, 2010, CLIN CHIM ACTA, V411, P1735, DOI 10.1016/j.cca.2010.07.012; Rakoski MO, 2010, ALIMENT PHARM THER, V32, P1211, DOI 10.1111/j.1365-2036.2010.04467.x; Riquelme A, 2004, DIGEST DIS SCI, V49, P1012, DOI 10.1023/B:DDAS.0000034564.68307.39; Samy Waleed, 2011, Arab J Gastroenterol, V12, P80, DOI 10.1016/j.ajg.2011.04.008; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sofer E, 2011, METABOLISM, V60, P1278, DOI 10.1016/j.metabol.2011.01.011; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356; Sumida Y, 2006, HEPATOL RES, V36, P315, DOI 10.1016/j.hepres.2006.08.003; Tanaka N, 2011, J GASTROENTEROL, V46, P758, DOI 10.1007/s00535-011-0370-5; Thameem F, 2012, DIABETES, V61, P2385, DOI 10.2337/db11-1078; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9; Uygun A, 2004, ALIMENT PHARM THERAP, V19, P537, DOI 10.1111/j.1365-2036.2004.01888.x; Van Wagner LB, 2011, ANN HEPATOL, V10, P277; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Yoshioka Y, 2004, J GASTROENTEROL, V39, P1215, DOI 10.1007/s00535-004-1475-x	133	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					364	377		10.1007/s00535-015-1050-7		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900002		
J	Endo, H; Sakai, E; Kato, T; Umezawa, S; Higurashi, T; Ohkubo, H; Nakajima, A				Endo, Hiroki; Sakai, Eiji; Kato, Takayuki; Umezawa, Shotaro; Higurashi, Takuma; Ohkubo, Hidenori; Nakajima, Atsushi			Small bowel injury in low-dose aspirin users	JOURNAL OF GASTROENTEROLOGY			English	Review						Low-dose aspirin; Capsule endoscopy; Small bowel injury; Enteric-coated aspirin	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENTERIC-COATED ASPIRIN; PROTON PUMP INHIBITORS; INTESTINAL MUCOSAL INJURY; ENDOSCOPY SCORING INDEX; VIDEO CAPSULE ENDOSCOPY; HEALTHY-VOLUNTEERS; DOUBLE-BLIND; QUANTITATIVE-ANALYSIS; INDUCED ENTEROPATHY	The use of low-dose aspirin (LDA) is well known to be associated with an increased risk of serious upper gastrointestinal complications, such as peptic ulceration and bleeding. Until recently, attention was mainly focused on aspirin-induced damage of the stomach and duodenum. However, recently, there has been growing interest among gastroenterologists on the adverse effects of aspirin on the small bowel, especially as new endoscopic techniques, such as capsule endoscopy (CE) and balloon-assisted endoscopy, have become available for the evaluation of small bowel lesions. Preliminary CE studies conducted in healthy subjects have shown that short-term administration of LDA can induce mild mucosal inflammation of the small bowel. Furthermore, chronic use of LDA results in a variety of lesions in the small bowel, including multiple petechiae, loss of villi, erosions, and round, irregular, or punched-out ulcers. Some patients develop circumferential ulcers with stricture. In addition, to reduce the incidence of gastrointestinal lesions in LDA users, it is important for clinicians to confirm the differences in the gastrointestinal toxicity between different types of aspirin formulations in clinical use. Some studies suggest that enteric-coated aspirin may be more injurious to the small bowel mucosa than buffered aspirin. The ideal treatment for small bowel injury in patients taking LDA would be withdrawal of aspirin, however, LDA is used as an antiplatelet agent in the majority of patients, and its withdrawal could increase the risk of cardiovascular/cerebrovascular morbidity and mortality. Thus, novel means for the treatment of aspirin-induced enteropathy are urgently needed.	[Endo, Hiroki; Sakai, Eiji; Kato, Takayuki; Umezawa, Shotaro; Higurashi, Takuma; Ohkubo, Hidenori; Nakajima, Atsushi] Yokohama City Univ, Sch Med, Dept Gastroenterol & Hepatol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Endo, H (reprint author), Yokohama City Univ, Sch Med, Dept Gastroenterol & Hepatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	endo1978@yokohama-cu.ac.jp					Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Higuchi K, 2009, J CLIN BIOCHEM NUTR, V45, P125, DOI 10.3164/jcbn.SR09-58; WEIL J, 1995, BRIT MED J, V310, P827; Sakurai K, 2004, FREE RADICAL RES, V38, P487, DOI 10.1080/1071576042000209808; Montalto M, 2010, ALIMENT PHARM THER, V32, P209, DOI 10.1111/j.1365-2036.2010.04324.x; Jacobs C, 2013, ALIMENT PHARM THER, V37, P1103, DOI 10.1111/apt.12304; Hirata Y, 2011, SCAND J GASTROENTERO, V46, P803, DOI 10.3109/00365521.2011.568522; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1053/S1542-3565(04)00619-6; Ehrhard F, 2013, EUR J GASTROEN HEPAT, V25, P1265, DOI 10.1097/MEG.0b013e3283640fad; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Chitapanarux T, 2008, DIGEST DIS SCI, V53, P2896, DOI 10.1007/s10620-008-0255-5; Fujimori S, 2010, EUR J CLIN INVEST, V40, P504, DOI 10.1111/j.1365-2362.2010.02290.x; Cryer B, 1999, GASTROENTEROLOGY, V117, P17, DOI 10.1016/S0016-5085(99)70545-7; LANZA FL, 1980, NEW ENGL J MED, V303, P136, DOI 10.1056/NEJM198007173030305; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1053/S1542-3565(04)00603-2; Catanoso M, 2001, SCAND J RHEUMATOL, V30, P77; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832; BJARNASON I, 1986, GUT, V27, P1292, DOI 10.1136/gut.27.11.1292; Kim HK, 2007, DIGEST DIS SCI, V52, P1776, DOI 10.1007/s10620-006-9367-y; Goldstein JL, 2007, ALIMENT PHARM THER, V25, P1211, DOI 10.1111/j.1365-2036.2007.03312.x; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; Endo H, 2011, DIGEST ENDOSC, V23, P56, DOI 10.1111/j.1443-1661.2010.01044.x; Endo H, 2011, J GASTROENTEROL, V46, P894, DOI 10.1007/s00535-011-0410-1; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Sigthorsson G, 1998, GUT, V43, P506; Terano A, 2007, J GASTROENTEROL, V42, P690, DOI 10.1007/s00535-007-2076-2; Banoob DW, 2002, ANN PHARMACOTHER, V36, P163; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Davies NM, 2000, J PHARM PHARM SCI, V3, P137; Twiss IM, 2001, CLIN PHARMACOL THER, V69, P431, DOI 10.1067/mcp.2001.115724; Shiotani A, 2011, SCAND J GASTROENTERO, V46, P281, DOI 10.3109/00365521.2010.533381; Leung WK, 2007, LANCET, V369, P614, DOI 10.1016/S0140-6736(07)60282-7; Yoda Y, 2010, J PHYSIOL PHARMACOL, V61, P287; Park SH, 2007, J CLIN BIOCHEM NUTR, V40, P148, DOI 10.3164/jcbn.40.148; KENT TH, 1969, AM J PATHOL, V54, P237; Maiden L, 2007, CLIN GASTROENTEROL H, V5, P1040, DOI 10.1016/j.cgh.2007.04.031; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Somasundaram S, 1997, GUT, V41, P344; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Mizukami K, 2011, WORLD J GASTROENTERO, V17, P5117, DOI 10.3748/wjg.v17.i46.5117; Shiotani A, 2010, SCAND J GASTROENTERO, V45, P292, DOI 10.3109/00365520903453182; Endo H, 2009, DIGESTION, V79, P44, DOI 10.1159/000204465; Compare D, 2011, EUR J CLIN INVEST, V41, P380, DOI 10.1111/j.1365-2362.2010.02419.x; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Somasundaram S, 2000, ALIMENT PHARM THERAP, V14, P639; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; JENKINS RT, 1987, BRIT J RHEUMATOL, V26, P103; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Awtry EH, 2000, CIRCULATION, V101, P1206; Watari I, 2014, DIGESTION, V89, P225, DOI 10.1159/000358287; Konaka A, 1999, PHARMACOL RES, V40, P517, DOI 10.1006/phrs.1999.0550; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Matsumoto T, 2008, SCAND J GASTROENTERO, V43, P490, DOI 10.1080/00365520701794121; Endo H, 2009, J GASTROENTEROL, V44, P544, DOI 10.1007/s00535-009-0040-z; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P71; Arora G, 2009, CLIN GASTROENTEROL H, V7, P725, DOI 10.1016/j.cgh.2009.03.015; Blondon H, 2000, FUNDAM CLIN PHARM, V14, P155; Dammann HG, 1999, ALIMENT PHARM THERAP, V13, P1109; Endo H, 2012, DIGEST LIVER DIS, V44, P833, DOI 10.1016/j.dld.2012.05.016; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Gralnev IM, 2008, ALIMENT PHARM THERAP, V27, P146, DOI 10.1111/j.1365-2036.2007.03556.x; Kurokawa S, 2014, J GASTROENTEROL, V49, P239, DOI 10.1007/s00535-013-0805-2; Lanas Angel, 2007, Curr Med Res Opin, V23, P163, DOI 10.1185/030079907X162656; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; Manetas M, 2004, GASTROINTEST ENDOSC, V60, P848, DOI 10.1016/S0016-5107(04)02174-1; Mehdizadeh S, 2006, GASTROINTEST ENDOSC, V64, P1014, DOI 10.1016/j.gie.2006.05.026; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; PETROSKI D, 1993, CLIN THER, V15, P314; Stattery J, 1995, GUT, V37, P509; Watari I, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-108	76	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					378	386		10.1007/s00535-014-1028-x		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900003		
J	Kawaguchi, T; Mori, M; Saito, K; Suga, Y; Hashimoto, M; Sako, M; Yoshimura, N; Uo, M; Danjo, K; Ikenoue, Y; Oomura, K; Shinozaki, J; Mitsui, A; Kajiura, T; Suzuki, M; Takazoe, M				Kawaguchi, Takaaki; Mori, Maiko; Saito, Keiko; Suga, Yasuyo; Hashimoto, Masaki; Sako, Minako; Yoshimura, Naoki; Uo, Michihide; Danjo, Keiko; Ikenoue, Yuka; Oomura, Kaori; Shinozaki, Junko; Mitsui, Akira; Kajiura, Takayuki; Suzuki, Manabu; Takazoe, Masakazu			Food antigen-induced immune responses in Crohn's disease patients and experimental colitis mice	JOURNAL OF GASTROENTEROLOGY			English	Article						Crohn's disease; Food antigens; Serum immunoglobulin G; CD4(+) T cell; Experimental colitis	INFLAMMATORY-BOWEL-DISEASE; CD4(+) T-CELLS; SACCHAROMYCES-CEREVISIAE; INTESTINAL PERMEABILITY; ULCERATIVE-COLITIS; ANTIBODIES; DIET; THERAPY; TRIAL; IGG	In Crohn's disease (CD), the involvement of food antigens in immune responses remains unclear. The objective of this study was to detect immune responses against food antigens in CD patients and examine the mechanism in a mouse model of colitis. We enrolled 98 CD patients, 50 ulcerative colitis patients, and 52 healthy controls (HCs) to compare the levels of serum immunoglobulin (Ig)Gs against 88 foods. The presence of serum IgGs against foods was also examined in interleukin (IL)-10 knockout (KO) mice in which CD4(+) T cell activation by antigenic food protein was assessed. Mice transferred with IL-10 KO cells received diets with or without food antigens, and the development of colitis was evaluated. The prevalence of IgGs against various foods, especially vegetables, grains, and nuts, was significantly higher in CD patients than in HCs. Similarly, the prevalence of IgGs against food proteins was higher in IL-10 KO mice than in BALB/c mice. Beta-conglycinin, identified as an antigenic food proteins in IL-10 KO mice, induced CD4(+) T cell production of interferon-gamma and IL-17 through dendritic cell antigen presentation. Elimination of the food antigens ameliorated the development of colitis in mice without altering the composition of their intestinal microbiota. In CD colitis mice, intestinal inflammation via CD4(+) T cell hyperactivation was induced by food antigens associated with high serum IgG levels and was ameliorated by the elimination of food antigens. This disrupted immunological tolerance to food antigen, which might act as an exacerbating factor, remains to be elucidated in CD patients.	[Kawaguchi, Takaaki; Sako, Minako; Yoshimura, Naoki; Takazoe, Masakazu] Tokyo Yamate Med Ctr, IBD Ctr, Tokyo, Japan; [Mori, Maiko; Suga, Yasuyo; Hashimoto, Masaki; Uo, Michihide; Danjo, Keiko; Ikenoue, Yuka; Oomura, Kaori; Mitsui, Akira; Suzuki, Manabu] Ajinomoto Pharmaceut Co Ltd, Res Inst, Pharmacol Res Lab, Kawasaki, Kanagawa, Japan; [Saito, Keiko] Tokyo Yamate Med Ctr, Div Nutr, Tokyo, Japan; [Shinozaki, Junko; Kajiura, Takayuki] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan	Kawaguchi, T (reprint author), Tokyo Yamate Med Ctr, IBD Ctr, Tokyo, Japan.	kawaguchitakaaki@yahoo.co.jp		Uo, Michihide/0000-0003-1876-1003			Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; ADENIS A, 1992, GUT, V33, P678, DOI 10.1136/gut.33.5.678; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; ISSENMAN RM, 1993, CLIN INVEST MED, V16, P187; Rajendran N, 2010, WORLD J GASTROENTERO, V16, P1442, DOI 10.3748/wjg.v16.i12.1442; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Andou A, 2009, GASTROENTEROLOGY, V136, P564, DOI 10.1053/j.gastro.2008.09.062; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Oriuchi T, 2003, J GASTROENTEROL, V38, P942, DOI 10.1007/s00535-003-1177-9; Bentz S, 2010, DIGESTION, V81, P252, DOI 10.1159/000264649; Bernstein Charles N, 2010, Curr Gastroenterol Rep, V12, P495, DOI 10.1007/s11894-010-0144-x; Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2; Ferguson LR, 2010, EXPERT REV CLIN IMMU, V6, P573, DOI [10.1586/eci.10.43, 10.1586/ECI.10.43]; Ikenoue Y, 2005, INT IMMUNOPHARMACOL, V5, P993, DOI 10.1016/j.intimp.2005.01.009; Jenkins T, 1988, CLIN INVEST MED, V11, P151; Klebl FH, 2004, INT J COLORECTAL DIS, V19, P319, DOI 10.1007/s00384-003-0557-1; LERNER A, 1989, ACTA PAEDIATR SCAND, V78, P384, DOI 10.1111/j.1651-2227.1989.tb11097.x; LINDBERG E, 1992, GUT, V33, P909, DOI 10.1136/gut.33.7.909; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Rajendran N, 2011, COLORECTAL DIS, V13, P1009, DOI 10.1111/j.1463-1318.2010.02373.x; Rennick DM, 2000, AM J PHYSIOL-GASTR L, V278, pG829; Sugiura T, 2013, J CROHNS COLITIS, V1, P533; Takagi S, 2006, ALIMENT PHARM THERAP, V24, P1333, DOI 10.1111/j.1365-2036.2006.03120.x; Van Den Bogaerde J, 2002, ALIMENT PHARM THERAP, V16, P1903, DOI 10.1046/j.0269-2813.2002.01360.x; Verma S, 2001, SCAND J GASTROENTERO, V36, P383, DOI 10.1080/003655201300051199	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					394	405		10.1007/s00535-014-0981-8		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900005		
J	Saeki, H; Watanabe, M; Mine, S; Shigaki, H; Oya, S; Ishiyama, A; Tsuchida, T; Fujisaki, J; Baba, H; Maehara, Y; Sano, T				Saeki, Hiroshi; Watanabe, Masayuki; Mine, Shinji; Shigaki, Hironobu; Oya, Shuichiro; Ishiyama, Akiyoshi; Tsuchida, Tomohiro; Fujisaki, Junko; Baba, Hideo; Maehara, Yoshihiko; Sano, Takeshi			Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection	JOURNAL OF GASTROENTEROLOGY			English	Article						Endoscopic submucosal dissection; Submucosal invasion; Lymphatic invasion; Venous invasion; Surgery	SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; PHASE-II TRIAL; MUCOSAL RESECTION; ESOPHAGOGASTRIC JUNCTION; SUBMUCOSAL DISSECTION; MUSCULARIS MUCOSAE; RISK-FACTORS; JAPAN; CHEMORADIOTHERAPY	Additional surgical treatment after non-curative endoscopic resection for superficial esophageal cancer should be considered unless the tumor is pathologically proven to be categorized within the absolute indication of endoscopic resection. However, the significance of this treatment strategy has been poorly evaluated until now. Additional esophagectomy with lymph node dissection was carried out for a total of 34 patients with esophageal cancer pathologically diagnosed as in contact with or invading the muscularis mucosa (pT1a-MM) or submucosa (pSM) and/or accompanying vascular permeation after endoscopic resection. The surgical results, pathological diagnosis after esophagectomy, and outcomes were analyzed. The pathological diagnosis after endoscopic resection revealed pT1a-MM in 7 patients, pSM in 27 patients, and vessel permeation in 24 patients. The approach to esophagectomy was via right and left thoracotomy in 26 patients and 2 patients, respectively, and was transhiatal in 6 patients. Three-field lymph node dissection was performed in 12 patients, and the mean number of dissected lymph nodes was 72 (range 31-132). Pathological lymph node metastasis was noted in 10 patients. Postoperative complications developed in 10 patients, and death due to pulmonary complications was observed in one patient. No postoperative recurrence was observed during the follow-up period (1-87 months). Esophagectomy after endoscopic resection provides favorable disease control for esophageal cancer with pT1a-MM/pSM and/or vessel permeation, while strict consideration is required to determine the indication and procedure for surgery because of its invasiveness.	[Saeki, Hiroshi; Watanabe, Masayuki; Mine, Shinji; Shigaki, Hironobu; Oya, Shuichiro; Ishiyama, Akiyoshi; Tsuchida, Tomohiro; Fujisaki, Junko; Sano, Takeshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Koto Ku, Tokyo 1358550, Japan; [Saeki, Hiroshi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan	Watanabe, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	masayuki.watanabe@jfcr.or.jp					Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Motoyama S, 2013, SURG TODAY, V43, P638, DOI 10.1007/s00595-012-0295-5; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Griffin SM, 2002, J AM COLL SURGEONS, V194, P285, DOI 10.1016/S1072-7515(01)01177-2; Kurokawa Y, 2009, JPN J CLIN ONCOL, V39, P686, DOI 10.1093/jjco/hyp078; Buskens CJ, 2004, GASTROINTEST ENDOSC, V60, P703, DOI 10.1016/S0016-5107(04)02017-6; Kim DU, 2008, J GASTROEN HEPATOL, V23, P619, DOI 10.1111/j.1440-1746.2007.05259.x; Mine S, 2013, BRIT J SURG, V100, P1050, DOI 10.1002/bjs.9170; Shimizu Y, 2002, GASTROINTEST ENDOSC, V56, P387, DOI 10.1067/mge.2002.127100; Gockel I, 2011, EXPERT REV GASTROENT, V5, P371, DOI [10.1586/egh.11.33, 10.1586/EGH.11.33]; Suzuki H, 2010, ENDOSCOPY, V42, P1, DOI 10.1055/s-0029-1243807; Omae M, 2013, GASTRIC CANCER, V16, P147, DOI 10.1007/s10120-012-0162-5; Takahashi H, 2010, GASTROINTEST ENDOSC, V72, P255, DOI 10.1016/j.gie.2010.02.040; Katada C, 2007, ENDOSCOPY, V39, P779, DOI 10.1055/s-2007-966761; Eguchi T, 2006, MODERN PATHOL, V19, P475, DOI 10.1038/modpathol.3800557; Sgourakis G, 2013, WORLD J GASTROENTERO, V19, P1424, DOI 10.3748/wjg.v19.i9.1424; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Araki K, 2002, CANCER, V94, P570, DOI 10.1002/cncr.10190; Egashira H, 2006, ESOPHAGUS, V3, P47, DOI 10.1007/s10388-006-0074-8; Honda Kuniomi, 2012, World J Gastrointest Pathophysiol, V3, P44, DOI 10.4291/wjgp.v3.i2.44; INOUE H, 1992, SURG ENDOSC-ULTRAS, V6, P264, DOI 10.1007/BF02498820; Isomoto H, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-46; Mine S, 2014, ANN SURG ONCOL, V21, P1596, DOI 10.1245/s10434-014-3548-2; Nakajima Y, 2002, JPN J CANCER RES, V93, P305; Natsugoe S, 1998, ONCOLOGY-BASEL, V55, P235, DOI 10.1159/000011857; Stein HJ, 2004, WORLD J SURG, V28, P520, DOI 10.1007/s00268-004-7417-1; Tachibana M, 2003, ARCH SURG-CHICAGO, V138, P1383, DOI 10.1001/archsurg.138.12.1383; Tajima Y, 2000, CANCER, V88, P1285; The Japan Esophageal Society, 2008, JAP CLASS ES CANC; Urabe Y, 2011, J GASTROEN HEPATOL, V26, P275, DOI 10.1111/j.1440-1746.2010.06503.x	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					406	413		10.1007/s00535-014-0983-6		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900006		
J	Shan, J; Oshima, T; Muto, T; Yasuda, K; Fukui, H; Watari, J; Nakanishi, K; Miwa, H				Shan, Jing; Oshima, Tadayuki; Muto, Taichiro; Yasuda, Koubun; Fukui, Hirokazu; Watari, Jiro; Nakanishi, Kenji; Miwa, Hiroto			Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis	JOURNAL OF GASTROENTEROLOGY			English	Article						IL-33; Reflux esophagitis; Inflammation; Epithelial cell	TIGHT JUNCTION PROTEINS; GASTROESOPHAGEAL-REFLUX; BARRIER FUNCTION; PROINFLAMMATORY CYTOKINES; IFN-GAMMA; IN-VIVO; RECEPTOR; CELLS; INTERLEUKIN-33; DISEASE	IL-33 is a new tissue-derived cytokine constitutively expressed in epithelial cells and plays a role in sensing damage caused by inflammatory diseases. The function of IL-33 in the esophageal mucosa has not been previously described. Accordingly, we examined the expression of IL-33 and its role in the pathogenesis of reflux esophagitis (RE). IL-33 in the esophageal mucosa of RE patients and in an in vitro stratified normal esophageal squamous epithelial model was examined at the messenger RNA and protein levels. The correlation of the level of IL-33 and IL-8 or IL-6 was examined. Cell layers were stimulated with bile acids and cytokines. IL-33 was knocked down by small interfering RNA (siRNA). Pharmacological inhibitors and signal transducer and activator of transcription 1 (STAT1) siRNA were used. IL-33 was significantly upregulated in RE patients, and was located in the nuclei of basal and suprabasal layers. Upregulated IL-33 messenger RNA expression was correlated with IL-8 and IL-6 expression. In vitro, IL-33 was upregulated in the nuclei of basal and suprabasal layers by interferon-gamma (IFN gamma), and the upregulation was aggravated by the combination of deoxycholic acid (DCA) and IFN gamma. IL-33 knockdown dampened IFN gamma- and DCA-induced IL-8 and IL-6 production. IFN gamma-induced IL-33 was inhibited by a Janus kinase inhibitor, a p38 mitogen-activated protein kinase inhibitor, and STAT1 siRNA. Nuclear IL-33 is upregulated in erosive mucosa of RE patients and is correlated with IL-8 and IL-6 levels. The normal esophageal epithelial model enables us to show for the first time that epithelial-cell-derived nuclear but not exogenous IL-33 is located upstream of the production of inflammatory cytokines and can aggravate the inflammation.	[Shan, Jing; Oshima, Tadayuki; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Shan, Jing] Third Peoples Hosp Chengdu, Dept Gastroenterol, Chengdu, Peoples R China; [Muto, Taichiro; Yasuda, Koubun; Nakanishi, Kenji] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan	Oshima, T (reprint author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp			Japan Society for the Promotion of Science [25460939]	We thank Noriko Kamiya for excellent technical assistance. This study was supported by a Grant-in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (25460939 to T.O.).	Miwa H, 2010, J GASTROENTEROL, V45, P478, DOI 10.1007/s00535-009-0180-1; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shan J, 2013, J GASTROEN HEPATOL, V28, P823, DOI 10.1111/jgh.12139; Rieder F, 2007, GASTROENTEROLOGY, V132, P154, DOI 10.1053/j.gastro.2006.10.009; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Ma J, 2012, AM J PHYSIOL-GASTR L, V303, pG635, DOI 10.1152/ajpgi.00097.2012; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Nomura K, 2012, LARYNGOSCOPE, V122, P1185, DOI 10.1002/lary.23261; Zhong YQ, 2011, DIGEST DIS SCI, V56, P2865, DOI 10.1007/s10620-011-1696-9; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Rieder F, 2010, AM J PHYSIOL-GASTR L, V298, pG571, DOI 10.1152/ajpgi.00454.2009; Jovov B, 2011, AM J GASTROENTEROL, V106, P1039, DOI 10.1038/ajg.2011.102; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6; Sharma S, 2008, J IMMUNOL, V180, P5477; Chen X, 2011, AM J PHYSIOL-GASTR L, V301, pG203, DOI 10.1152/ajpgi.00096.2011; Chen X, 2012, AM J PHYSIOL-GASTR L, V303, pG199, DOI 10.1152/ajpgi.00454.2011; Corrado G, 1999, EUR J GASTROEN HEPAT, V11, P839, DOI 10.1097/00042737-199908000-00005; Isomoto H, 2007, SCAND J GASTROENTERO, V42, P410, DOI 10.1080/00365520600931469; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Liu L, 2004, J INTERF CYTOK RES, V24, P334, DOI 10.1089/107999004323142196; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Oguro M, 2011, J GASTROENTEROL, V46, P629, DOI 10.1007/s00535-011-0390-1; Oshima T, 2012, LAB INVEST, V92, P22, DOI 10.1038/labinvest.2011.139; Oshima T, 2011, AM J PHYSIOL-CELL PH, V300, pC1422, DOI 10.1152/ajpcell.00376.2010; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Shan J, 2012, AM J PHYSIOL-GASTR L, V303, pG1105, DOI 10.1152/ajpgi.00220.2012	38	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					414	423		10.1007/s00535-014-0988-1		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900007		
J	Sekiguchi, M; Kushima, R; Oda, I; Suzuki, H; Taniguchi, H; Sekine, S; Fukagawa, T; Katai, H				Sekiguchi, Masau; Kushima, Ryoji; Oda, Ichiro; Suzuki, Haruhisa; Taniguchi, Hirokazu; Sekine, Shigeki; Fukagawa, Takeo; Katai, Hitoshi			Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers	JOURNAL OF GASTROENTEROLOGY			English	Article						Early gastric cancer; Lymph node metastasis; Lymphatic involvement; Papillary adenocarcinoma	ENDOSCOPIC MUCOSAL RESECTION; LYMPH-NODE METASTASIS; MONOCLONAL-ANTIBODY; MICROSATELLITE INSTABILITY; RISK-FACTORS; CARCINOMA; INVASION; D2-40; PHENOTYPE; TUMORS	We recently reported that the presence of a papillary adenocarcinoma (pap) component was an independent risk factor for lymphatic involvement in endoscopically resected early gastric cancer (EGC). This study aimed to investigate the potential association between the presence of a pap component in EGC and lymph node metastasis (LNM). In order to evaluate the association between LNM and clinicopathological features, including a pap component, we reviewed 628 surgically resected EGCs at our institution between 2009 and 2012. Clinicopathological features included age, gender, tumor location, macroscopic type, tumor size, histological type, depth, ulcerative findings, and lymphatic and venous involvement. In addition, the association between clinicopathological features and lymphatic involvement was also evaluated. LNM was observed in 52 cases (8.3%). Univariate analyses revealed a significant correlation between a pap component and LNM as well as tumor size, depth, macroscopic type, a poorly differentiated adenocarcinoma component, and lymphatic and venous involvement. The percentage of positive LNM among the EGC cases with a pap component was significantly higher than in those without the component (18.2 vs. 7.3%, P = 0.010). Via multivariate analyses lymphatic involvement was identified as the strongest risk factor for LNM [odds ratio (OR) 14.1] and a pap component was revealed as an independent risk factor for lymphatic involvement (OR 3.1). Our study revealed that EGC cases with a pap component were at higher risk of lymphatic involvement and showed a higher percentage of positive LNM. More attention should be paid to a pap component in EGC.	[Sekiguchi, Masau; Oda, Ichiro; Suzuki, Haruhisa] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Sekiguchi, Masau; Kushima, Ryoji; Taniguchi, Hirokazu] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo 1040045, Japan; [Sekine, Shigeki] Natl Canc Ctr, Mol Pathol Div, Tokyo, Japan; [Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	Kushima, R (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ryoji.kushima@gmail.com					Kim HM, 2011, SURG ENDOSC, V25, P3087, DOI 10.1007/s00464-011-1674-5; Rembacken BJ, 2001, ENDOSCOPY, V33, P709, DOI 10.1055/s-2001-16224; Koseki K, 2000, CANCER, V89, P724, DOI 10.1002/1097-0142(20000815)89:4<724::AID-CNCR2>3.0.CO;2-4; Yamao T, 1996, CANCER, V77, P602, DOI 10.1002/(SICI)1097-0142(19960215)77:4<602::AID-CNCR3>3.0.CO;2-I; Shibata N, 2003, HUM PATHOL, V34, P32, DOI 10.1053/hupa.2003.2; Luinetti O, 1998, HUM PATHOL, V29, P702, DOI 10.1016/S0046-8177(98)90279-9; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Soetikno RM, 2003, GASTROINTEST ENDOSC, V57, P567, DOI 10.1067/mge.2003.130; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Kahn HJ, 2002, LAB INVEST, V82, P1255, DOI 10.1097/01.LAB.0000028824.03032.AB; Arigami T, 2005, BRIT J CANCER, V93, P688, DOI 10.1038/sj.bjc.6602739; Kurihara N, 1998, BRIT J SURG, V85, P835; Yonemura Y, 2006, HUM PATHOL, V37, P1193, DOI 10.1016/j.humpath.2006.04.014; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Shiroshita H, 2004, PATHOL INT, V54, P311, DOI 10.1111/j.1440-1827.2004.01625.x; Ha TK, 2008, ANN SURG ONCOL, V15, P508, DOI 10.1245/s10434-007-9660-9; Arai T, 2013, GASTRIC CANCER, V16, P505, DOI 10.1007/s10120-012-0226-6; Arai Tomio, 2004, Gastric Cancer, V7, P154; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Gotoda T, 2001, BRIT J SURG, V88, P444, DOI 10.1046/j.1365-2168.2001.01725.x; Guo RJ, 2001, PATHOL INT, V51, P240, DOI 10.1046/j.1440-1827.2001.01197.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kaizaki Y, 2013, STOMACH INTESTINE, V48, P1539; Lauwers GY, 2010, WHO CLASSIFICATION T, P48; Nakamoto Jiro, 2007, J Med Invest, V54, P99, DOI 10.2152/jmi.54.99; NISHIDA T, 1995, ONCOLOGY, V52, P340; NOGUCHI Y, 1990, SURGERY, V107, P140; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Oda I, 2005, DIGEST ENDOSC, V17, P54, DOI 10.1111/j.1443-1661.2005.00459.x; Sako Akihiro, 2006, Gastric Cancer, V9, P295, DOI 10.1007/s10120-006-0396-1; Sekiguchi M, 2013, J GASTROENTEROL, V48, P706, DOI 10.1007/s00535-012-0696-7; Song JP, 2002, INT J ONCOL, V21, P1205; Yasuda K, 2000, GASTRIC CANCER, V3, P33, DOI DOI 10.1007/PL00011687	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					424	434		10.1007/s00535-014-0991-6		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900008		
J	Fukui, Y; Uchida, K; Sakaguchi, Y; Fukui, T; Nishio, A; Shikata, N; Sakaida, N; Uemura, Y; Satoi, S; Okazaki, K				Fukui, Yuri; Uchida, Kazushige; Sakaguchi, Yutaku; Fukui, Toshiro; Nishio, Akiyoshi; Shikata, Nobuaki; Sakaida, Noriko; Uemura, Yoshiko; Satoi, Sohei; Okazaki, Kazuichi			Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis	JOURNAL OF GASTROENTEROLOGY			English	Article						type 1 autoimmune pancreatitis; Toll-like receptor 7; M2 macrophage; IgG4-related disease	LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS; REGULATORY T-CELLS; INNATE IMMUNITY; RENAL FIBROSIS; ALTERNATIVE ACTIVATION; MURINE RETROVIRUS; SJOGRENS-SYNDROME; JAPANESE PATIENTS; HEPATIC-FIBROSIS; MICE	High serum immunoglobulin G4 (IgG4) levels and IgG4-positive plasma cell infiltration are characteristic of type 1 autoimmune pancreatitis (AIP). It is unclear whether innate immunity is a cause of type 1 AIP; the possible involvement of microbial infection has been suggested in its pathogenesis. To clarify the pathogenesis of type 1 AIP, we investigated Toll-like receptors (TLRs) in type 1 AIP patients. We studied nine cases of type 1 AIP with ten cases of alcoholic chronic pancreatitis (ACP) and three of the samples from non-tumorous lesion of neuroendocrine tumor (NET) as control subjects. We counted the number of TLR1-11-positive cells immunohistochemically stained with anti-TLR1-11 antibodies. To identify TLR-positive cells in pancreata from type 1 AIP patients, we used a double-immunofluorescence method and counted the numbers of identifiable CD68-, CD163-, CD123-, and CD20-positive cells. In type 1 AIP, TLR7 (8.815 +/- A 1.755), TLR8 (3.852 +/- A 1.489), and TLR10 (3.852 +/- A 0.921) were highly expressed. Only the ratio of TLR7 per monocyte was significantly higher in type 1 AIP (0.053 +/- A 0.012) than in ACP (0.007 +/- A 0.004; p < 0.01) and non-tumorous lesion of NET (0.000 +/- A 0.000; p < 0.01). In type 1 AIP, the CD163 to TLR7 ratio (0.789 +/- A 0.031) was significantly higher both than that of CD123 to TLR7 ratio (0.034 +/- A 0.006; p < 0.001) and CD20 to TLR7 ratio (0.029 +/- A 0.010; p < 0.001). TLR7 might be key pattern-recognition receptors involved in the development of type 1 AIP.	[Fukui, Yuri; Uchida, Kazushige; Sakaguchi, Yutaku; Fukui, Toshiro; Nishio, Akiyoshi; Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hirakata, Osaka 5731010, Japan; [Shikata, Nobuaki; Sakaida, Noriko; Uemura, Yoshiko] Kansai Med Univ, Dept Pathol, Hirakata, Osaka, Japan; [Satoi, Sohei] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan	Okazaki, K (reprint author), Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	uchidak@hirakata.kmu.ac.jp; okazaki@hirakata.kmu.ac.jp		Fukui, Toshiro/0000-0003-1131-4067	Ministry of Culture and Science of Japan [26461038, 23591017, 24591020]; Ministry of Labor and Welfare of Japan; CREST Japan Science and Technology Agency; NEXT-Supported Program for Strategic Research Foundation at Private Universities	This study was partially supported by (1) Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan (26461038, 23591017, 24591020), (2) Grant-in-Aid for "Research for Intractable Diseases" Program from the Ministry of Labor and Welfare of Japan, (3) Grants-in-Aid from CREST Japan Science and Technology Agency, and (4) NEXT-Supported Program for Strategic Research Foundation at Private Universities. The authors thank Professor A-Hon Kwon for surgery of pancreas.	Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Sharif R, 2009, GUT, V58, P813, DOI 10.1136/gut.2008.170423; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Nishio A, 2011, PANCREAS, V40, P95, DOI 10.1097/MPA.0b013e3181f3a5d4; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Hornung V, 2002, J IMMUNOL, V168, P4531; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Koyabu M, 2010, J GASTROENTEROL, V45, P732, DOI 10.1007/s00535-010-0199-3; Chamberlain ND, 2013, ANN RHEUM DIS, V72, P418, DOI 10.1136/annrheumdis-2011-201203; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Sung SA, 2007, NEPHRON EXP NEPHROL, V105, pE1, DOI 10.1159/000096859; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Soga Y, 2009, TOHOKU J EXP MED, V217, P175; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Blum A, 2010, ISR MED ASSOC J, V12, P640; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Kitamoto K, 2009, J PHARMACOL SCI, V111, P285, DOI 10.1254/jphs.09227FP; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Okazaki K, 2010, J GASTROENTEROL, V45, P249, DOI 10.1007/s00535-009-0184-x; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Kusuda T, 2011, PANCREAS, V40, P1120, DOI 10.1097/MPA.0b013e31821fc796; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Davidson TS, 2005, AM J PATHOL, V166, P729, DOI 10.1016/S0002-9440(10)62294-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Maniecki MB, 2006, IMMUNOBIOLOGY, V211, P407, DOI 10.1016/j.imbio.2006.05.019; Jain P, 2007, WORLD J GASTROENTERO, V13, P5741; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Detlefsen S, 2008, AM J SURG PATHOL, V32, P986, DOI 10.1097/PAS.0b013e31815d2583; Asada M, 2010, PANCREAS, V39, P224, DOI 10.1097/MPA.0b013e3181bab5e2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Reed JH, 2013, J BIOL CHEM, V288, P9077, DOI 10.1074/jbc.M112.403303; Masamune A, 2008, J GASTROENTEROL, V43, P352, DOI 10.1007/s00535-008-2162-0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Balmelli Carole, 2007, Immunobiology, V212, P693; BUNNELL CE, 1972, J PEDIATR-US, V80, P465, DOI 10.1016/S0022-3476(72)80506-7; Ding SQ, 2010, HEPATOB PANCREAT DIS, V9, P645; FELDSTEI.JD, 1974, ANN SURG, V180, P85, DOI 10.1097/00000658-197407000-00012; Gantier MP, 2008, J IMMUNOL, V180, P2117; Haruta I, 2010, LAB INVEST, V90, P1757, DOI 10.1038/labinvest.2010.153; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260; Hosaka N, 1996, P NATL ACAD SCI USA, V93, P8558, DOI 10.1073/pnas.93.16.8558; Ito T, 1997, DIGEST DIS SCI, V42, P1458, DOI 10.1023/A:1018862626221; Meagher C, 2008, J IMMUNOL, V180, P7793; Notohara K, 2010, MODERN PATHOL, V23, p367A; Okazaki K, 2001, J GASTROENTEROL, V36, P293, DOI 10.1007/s005350170094; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Qu WM, 2002, CLIN EXP IMMUNOL, V129, P27, DOI 10.1046/j.1365-2249.2002.01881.x; Rizzardi GP, 1997, NEW ENGL J MED, V336, P1836, DOI 10.1056/NEJM199706193362516; Shikhagaie MM, 2014, CLIN EXP ALLERGY, V44, P184, DOI 10.1111/cea.12176; SUZUKI K, 1993, LAB INVEST, V69, P430; Tsubata R, 1996, EUR J IMMUNOL, V26, P2742, DOI 10.1002/eji.1830261129; Uchida K, 2000, AM J GASTROENTEROL, V95, P2788, DOI 10.1016/S0002-9270(00)01980-8; Uchida K, 2012, INT J RHEUMATOL, DOI [10.1155/2012/795026, DOI 10.1155/2012/795026]; Uchida K, 2002, LAB INVEST, V82, P411; Umemura T, 2009, HUM IMMUNOL, V70, P742, DOI 10.1016/j.humimm.2009.05.009; URSING B, 1973, BRIT MED J, V3, P524; Vallance BA, 1998, GASTROENTEROLOGY, V115, P978, DOI 10.1016/S0016-5085(98)70270-7; Watanabe S, 2003, CLIN IMMUNOL, V109, P212, DOI 10.1016/S1521-6616(03)00197-9; WITTE CL, 1968, J AMER MED ASSOC, V203, P1068, DOI 10.1001/jama.203.12.1068; Yamashina M, 2012, PANCREAS, V41, P1255, DOI 10.1097/MPA.0b013e31824a0e58; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	85	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					435	444		10.1007/s00535-014-0977-4		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900009		
J	Miyabe, K; Notohara, K; Nakazawa, T; Hayashi, K; Naitoh, I; Shimizu, S; Kondo, H; Yoshida, M; Yamashita, H; Umemura, S; Hori, Y; Kato, A; Takahashi, S; Ohara, H; Joh, T				Miyabe, Katsuyuki; Notohara, Kenji; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Yoshida, Michihiro; Yamashita, Hiroaki; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Takahashi, Satoru; Ohara, Hirotaka; Joh, Takashi			Comparison study of immunohistochemical staining for the diagnosis of type 1 autoimmune pancreatitis	JOURNAL OF GASTROENTEROLOGY			English	Article						Autoimmune pancreatitis; IgG4-related disease; Lymphoplasmacytic sclerosing pancreatitis; Immunohistochemical staining	FINE-NEEDLE-ASPIRATION; IGG4-RELATED SCLEROSING DISEASE; PLASMA-CELL INFILTRATION; 22-GAUGE NEEDLE; CRITERIA; BIOPSY; CLASSIFICATION; EXPRESSION; LESIONS; TUMOR	Various methods to evaluate immunohistochemical staining (IHC) for the diagnosis of type 1 autoimmune pancreatitis (AIP) have been proposed. Our goal was to determine the most useful IHC method for the diagnosis of AIP. Specimens of AIP (18 patients), chronic pancreatitis (CP, 24 patients), and pancreatic ductal adenocarcinoma (PDA, 45 patients) were evaluated with IHC for immunoglobulin G (IgG), IgG1, IgG4, and CD138 (syndecan-1). The number of IHC-positive cells was counted in 3, 5, and 10 different high-power fields (HPFs) by selecting fields with the most numerous positive cells (hotspot) or by randomly selecting fields in the affected areas (random). We evaluated the mean number of IgG4-positive plasma cells (IgG4+)/HPF (mean IgG4+), the number of fields with > 10 and > 50 IgG4+ (NOF > 10 and NOF > 50 IgG4+), the ratio of IgG4+/IgG+, IgG4+/IgG1+, and IgG4+/CD138+. Analysis with receiver operator characteristic curves revealed that accurate and practical parameters in 3 HPFs were mean IgG4+ with the hotspot method (sensitivity, 88.9; specificity, 92.8 %), mean IgG4+ with the random method (100, 95.7 %), and NOF > 10 IgG4+ with the random method (94.4, 97.1 %). These results were as accurate as results from 5 HPFs to 10 HPFs. The combination of mean IgG4+ and IgG4+/IgG+ did not provide more accurate diagnosis for AIP than a single criterion itself. Mean IgG4+ or NOF > 10 IgG4+ with the random method in 3 HPFs was a useful and simple diagnostic method for AIP. The combined criteria of mean IgG4+ and IgG4+/IgG+ might not be required for accurate diagnosis of AIP.	[Miyabe, Katsuyuki; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Yoshida, Michihiro; Yamashita, Hiroaki; Umemura, Shuichiro; Hori, Yasuki; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Notohara, Kenji] Kurashiki Cent Hosp, Dept Pathol, Kurashiki, Okayama, Japan; [Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi, Japan	Nakazawa, T (reprint author), Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	kmiyabe@med.nagoya-cu.ac.jp; tnakazaw@med.nagoya-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Culture and Science of Japan [23591015, 23790803]; Pancreas Research Foundation of Japan; Aichi Cancer Research Foundation	Kenji Notohara, Takahiro Nakazawa, and Hirotaka Ohara received a Grant-in-Aid from the "Research for Intractable Disease" Program of the Ministry of Health, Labor and Welfare of Japan; and Takahiro Nakazawa and Itaru Naitoh received a Grants-in-Aid for Scientific Research from the Ministry of Culture and Science of Japan (23591015 to Takahiro Nakazawa and 23790803 to Itaru Naitoh). This study was supported in part by a research grant from the Pancreas Research Foundation of Japan and Aichi Cancer Research Foundation.	Ammann RW, 1997, PANCREAS, V14, P215, DOI 10.1097/00006676-199704000-00001; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Zen Y, 2005, HUM PATHOL, V36, P710, DOI 10.1016/j.humpath.2005.05.011; Raina A, 2009, AM J GASTROENTEROL, V104, P2295, DOI 10.1038/ajg.2009.325; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Deheragoda MG, 2007, CLIN GASTROENTEROL H, V5, P1229, DOI 10.1016/j.cgh.2007.04.023; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Nishimori I, 2007, J GASTROENTEROL, V42, P6, DOI 10.1007/s00535-007-2043-y; Koyabu M, 2010, J GASTROENTEROL, V45, P732, DOI 10.1007/s00535-010-0199-3; Mizuno N, 2009, J GASTROENTEROL, V44, P742, DOI 10.1007/s00535-009-0062-6; Chari ST, 2009, CLIN GASTROENTEROL H, V7, P1097, DOI 10.1016/j.cgh.2009.04.020; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Garg PK, 2004, J GASTROEN HEPATOL, V19, P998, DOI 10.1111/j.1400-1746.2004.03426.x; Iwashita T, 2012, CLIN GASTROENTEROL H, V10, P316, DOI 10.1016/j.cgh.2011.09.032; Dhall D, 2010, HUM PATHOL, V41, P643, DOI 10.1016/j.humpath.2009.10.019; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Kojima M, 2007, AM J SURG PATHOL, V31, P521, DOI 10.1097/01.pas.0000213390.55536.47; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Yamamoto H, 2009, AM J SURG PATHOL, V33, P1330; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; SARNER M, 1984, GUT, V25, P756, DOI 10.1136/gut.25.7.756; Detlefsen S, 2008, AM J SURG PATHOL, V32, P986, DOI 10.1097/PAS.0b013e31815d2583; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Varadarajulu S, 2004, ENDOSCOPY, V36, P397, DOI 10.1055/s-2004-814316; Zhang L, 2007, MODERN PATHOL, V20, P23, DOI 10.1038/modpathol.3800689; Rebours V, 2012, CLIN GASTROENTEROL H, V10, P91, DOI 10.1016/j.cgh.2011.09.008; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Bang SJ, 2008, PANCREAS, V36, P84, DOI 10.1097/mpa.0b013e318135483d; Binmoeller KF, 2002, GASTROINTEST ENDOSC, V56, pS86, DOI 10.1067/mge.2002.127698; Carruthers MN, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/259408; Chen TS, 2008, J CLIN PATHOL, V61, P1093, DOI 10.1136/jcp.2008.057869; Cheuk W, 2008, AM J SURG PATHOL, V32, P671, DOI 10.1097/PAS.0b013e318157c068; Detlefsen S, 2009, VIRCHOWS ARCH, V454, P531, DOI 10.1007/s00428-009-0747-5; Imai K, 2011, DIGEST LIVER DIS, V43, P869, DOI 10.1016/j.dld.2011.05.021; Kamisawa T, 2014, DIGEST ENDOSC, V26, P627, DOI 10.1111/den.12289; Kawano M., 2012, INT J RHEUMATOL, V2012; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Miyabe K, 2014, J GASTROENTEROL, V49, P715, DOI 10.1007/s00535-013-0818-x; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Sepehr A, 2008, AM J SURG PATHOL, V32, P1770, DOI 10.1097/PAS.0b013e318185490a	47	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					455	466		10.1007/s00535-014-0980-9		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900011		
J	Kawamoto, T; Ishige, K; Thomas, M; Yamashita-Kashima, Y; Shu, S; Ishikura, N; Ariizumi, S; Yamamoto, M; Kurosaki, K; Shoda, J				Kawamoto, Toru; Ishige, Kazunori; Thomas, Melanie; Yamashita-Kashima, Yoriko; Shu, Sei; Ishikura, Nobuyuki; Ariizumi, Shunichi; Yamamoto, Masakazu; Kurosaki, Kunihiko; Shoda, Junichi			Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab	JOURNAL OF GASTROENTEROLOGY			English	Article						Biliary tract carcinoma; HER family member; Heterodimerization; Pertuzumab; Cell signaling	EPIDERMAL-GROWTH-FACTOR; METASTATIC BREAST-CANCER; TRASTUZUMAB PLUS DOCETAXEL; RECEPTOR TYROSINE KINASES; IN-SITU HYBRIDIZATION; CELL-LINE; PHASE-II; INTRAHEPATIC CHOLANGIOCARCINOMA; CHOLANGIOCELLULAR CARCINOMA; DIMERIZATION INHIBITOR	Pertuzumab is a humanized monoclonal antibody that binds to HER2 at an epitope that prevents HER2 from dimerizing with ligand-activated HER-family receptors. To assess the potential of pertuzumab as a new therapy, the expression status of HER family members was determined in biliary tract carcinoma (BTC), and the antitumor activity of pertuzumab was investigated by assessing the inhibition of BTC cell growth. The expression status of HER family members in 113 archival specimens of BTC was analyzed by using immunohistochemistry and fluorescence in situ hybridization. Using ten BTC cell lines, heregulin-alpha (HRG-alpha) stimulated cell proliferation and its inhibition by pertuzumab was tested in vitro. The phosphorylated HER family proteins and their respective downstream molecules were analyzed. In vivo antitumor activity of pertuzumab was evaluated in a xenograft model. Protein overexpression of HER2 and/or HER3 was observed in 23-34 % of the specimens and gene amplification in 17-27 %. Seven of the ten cell lines showed HER2 and/or HER3 protein overexpression and gene amplification, and HRG-alpha stimulated cell proliferation was observed in four of the ten cell lines. In a BTC cell line co-overexpressing HER2 and HER3, pertuzumab potently inhibited the HRG-alpha stimulated cell proliferation in a dose-dependent manner, and completely blocked the phosphorylation of HER3. Suppression of downstream pathway molecules including p-AKT was also observed. Pertuzumab inhibited the in vivo growth of subcutaneous tumors, and increased the number of apoptotic cancer cells. Pertuzumab exerts potent antitumor activity in BTC cells co-overexpressing HER2 and HER3. Pertuzumab provides a new therapeutic option against BTC.	[Kawamoto, Toru; Ariizumi, Shunichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Ishige, Kazunori] Univ Tsukuba, Fac Med, Dept Gastroenterol, Tsukuba, Ibaraki 3058575, Japan; [Thomas, Melanie] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Yamashita-Kashima, Yoriko; Shu, Sei; Ishikura, Nobuyuki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Prod Res Dept, Kamakura, Kanagawa, Japan; [Kurosaki, Kunihiko] Toho Univ, Dept Legal Med, Sch Med, Fac Med, Tokyo, Japan; [Shoda, Junichi] Univ Tsukuba, Fac Med, Dept Med Sci, Tsukuba, Ibaraki 3058575, Japan	Shoda, J (reprint author), Univ Tsukuba, Fac Med, Dept Med Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	shodaj@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [15590618, 23390318, 24390323]	This study was supported by Grants-in-Aid (Nos. 15590618, 23390318, and 24390323) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Agus DB, 2005, J CLIN ONCOL, V23, P2534, DOI 10.1200/JCO.2005.03.184; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Hurvitz SA, 2013, J CLIN ONCOL, V31, P1157, DOI 10.1200/JCO.2012.44.9694; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Altimari A, 2003, DIGEST LIVER DIS, V35, P332, DOI 10.1016/S1590-8658(03)00077-X; Sirica AE, 2002, SEMIN LIVER DIS, V22, P303, DOI 10.1055/s-2002-34507; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Kiguchi K, 2001, CANCER RES, V61, P6971; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Dixon E, 2005, ANN SURG, V241, P385, DOI 10.1097/sla.0000154118.07704.ef; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Nakagohri T, 2003, WORLD J SURG, V27, P289, DOI 10.1007/s00268-002-6696-7; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Lebeau A, 2001, J CLIN ONCOL, V19, P354; Kalekou H, 2004, J GASTROEN HEPATOL, V19, P812, DOI 10.1111/j.1400-1746.2004.03357.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Ross JS, 1998, STEM CELLS, V16, P413; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Greene FL, 2002, AM JOINT COMMITTEE C, P139; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Huang JL, 2004, AM J SURG, V187, P612, DOI 10.1016/j.amjsurg.2004.01.007; IEMURA A, 1992, J HEPATOL, V15, P288, DOI 10.1016/0168-8278(92)90058-W; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kawamoto Toru, 2007, Gastrointest Cancer Res, V1, P221; Koike N, 1998, INT J ONCOL, V13, P1269; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Sakai K, 2007, CANCER SCI, V98, P1498, DOI 10.1111/j.1349-7006.2007.005853.x; Sirica AE, 1997, AM J PATHOL, V151, P1685; Sirica AE, 2001, J GASTROEN HEPATOL, V16, P363, DOI 10.1046/j.1440-1746.2001.02438.x; Sirica AE, 2008, WORLD J GASTROENTERO, V14, P7033, DOI 10.3748/wjg.14.7033; Sirica AE, 1996, TOXICOL PATHOL, V24, P90; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Wiggers KJ, 2014, J GASTROEN HEPATOL, V29, P1582; Yamashita-Kashima Y, 2011, CLIN CANCER RES, V17, P5060, DOI 10.1158/1078-0432.CCR-10-2927; YUKAWA M, 1993, HUM PATHOL, V24, P37, DOI 10.1016/0046-8177(93)90060-T	56	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	APR	2015	50	4					467	479		10.1007/s00535-014-0984-5		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CF3KH	WOS:000352446900012		
J	Amari, Y; Hamanaka, T; Futa, R				Amari, Yoko; Hamanaka, Teruhiko; Futa, Ryusuke			Pathologic Investigation Failure of Trabeculotomy	JOURNAL OF GLAUCOMA			English	Article						trabeculotomy; trabeculectomy; trabecular meshwork; unconventional routes; pathology	EYES; PERFUSION; GLAUCOMA; ENDOTHELIUM	Purpose: To investigate the reason for failure of trabeculotomy using trabeculectomy (TLE) specimens involving the area of previous trabeculotomy. Materials and Methods: Thirteen TLE specimens from 13 patients with open-angle glaucoma were processed for transmission electron microscopy and light microscopy, involving immunohistochemical staining of thrombomodulin, D2-40 (podoplanin), and CD34. Results: All intraocular pressure after trabeculotomy decreased to normal and then returned to the same or a higher level compared with that before TLE. Eleven and 2 TLE specimens were taken from areas with no peripheral anterior synechia (PAS) and PAS areas, respectively. The 4 types of histologic change in the trabecular meshwork were observed: (1) persistence of a disconnected trabecular meshwork with swelling or degeneration at the cut edge; (2) fusion of the trabecular meshwork; (3) a membrane covering the innermost trabecular meshwork; and (4) pigmented cell invasion into the disconnected trabecular meshwork at the PAS site. Schlemm canal (SC) opening into the anterior chamber and SC occlusion were observed in 2 and 8 eyes, respectively. Conclusions: Opening of SC into the anterior chamber observed in the eyes with failed trabeculotomy suggested that the enhancement of conventional routes may not be important for the intraocular pressure-lowering effect. All 4 types of histologic change in the trabecular meshwork, as mentioned above, may reduce enhancement of the newly created unconventional routes by trabeculotomy.	[Amari, Yoko; Hamanaka, Teruhiko] Japanese Red Cross Med Ctr, Dept Ophthalmol, Tokyo 1508935, Japan; [Futa, Ryusuke] Hikuma Eye Clin, Kumamoto, Japan	Hamanaka, T (reprint author), Japanese Red Cross Med Ctr, Dept Ophthalmol, Shibuya Ku, 4-1-22,Hiro O, Tokyo 1508935, Japan.	hamanaka_teruhiko@med.jrc.or.jp					Allingham RR, 1996, EXP EYE RES, V62, P101, DOI 10.1006/exer.1996.0012; Iwao K, 2011, AM J OPHTHALMOL, V151, P1047, DOI 10.1016/j.ajo.2010.11.028; CAMPBELL DG, 1978, AM J OPHTHALMOL, V86, P317; Hamanaka T, 2011, INVEST OPHTH VIS SCI, V52, P8849, DOI 10.1167/iovs.11-7591; DANNHEIM R, 1972, A GRAEF ARCH KLIN EX, V184, P222, DOI 10.1007/BF00413297; DANNHEIM R, 1969, DOC OPHTHALMOL, V26, P90, DOI 10.1007/BF00943965; EDWARDS J, 1967, EXP EYE RES, V6, P316, DOI 10.1016/S0014-4835(67)80004-6; ELLINGSE.BA, 1971, INVEST OPHTH VISUAL, V10, P705; GRANT WM, 1963, ARCH OPHTHALMOL-CHIC, V69, P783; Harms H, 1970, Bibl Ophthalmol, V81, P121; Ikeda T, 2000, INVEST OPHTH VIS SCI, V41, P3383; Ito Shigeo, 1994, Nippon Ganka Gakkai Zasshi, V98, P811; Mermoud A, 1996, GLAUCOMAS, P1259; Ozdal MPC, 2003, EYE, V17, P467, DOI 10.1038/sj.eye.6700382; Watanabe Y, 2010, INVEST OPHTH VIS SCI, V51, P277, DOI 10.1167/iovs.08-3279; WOLFF SM, 1962, AM J OPHTHALMOL, V54, P547	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1057-0829	1536-481X		J GLAUCOMA	J. Glaucoma	APR-MAY	2015	24	4					316	322		10.1097/IJG.0b013e31829e1d6e		7	Ophthalmology	Ophthalmology	CE9ZQ	WOS:000352202700017		
J	Okada, M; Kamano, M; Uemura, T; Ikeda, M; Nakamura, H				Okada, Mitsuhiro; Kamano, Masayuki; Uemura, Takuya; Ikeda, Mikinori; Nakamura, Hiroaki			Pedicled Adipose Tissue for Treatment of Chronic Digital Osteomyelitis	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Chronic osteomyelitis; digit; pedicled tissue transfer; adipose tissue; digital artery	ISLAND FLAP; PHALANGEAL OSTEOMYELITIS; MUSCLE FLAP; RECONSTRUCTION; FINGER; ARTERY; HAND; ADJUNCT	Purpose To describe a surgical technique (pedicled vascularized tissue transfer) for treating chronic digital osteomyelitis. Methods Adipose tissue was obtained at the level of the proximal phalanx based on anterograde or retrograde flow. After bone debridement, we inserted the vascularized adipose tissue into the dead space. Eight patients were treated with this procedure from 2009 to 2012. One patient had chronic osteomyelitis in the thumb, 4 in the index finger, 2 in the middle finger, and 1 in the ring finger. Foci of chronic osteomyelitis were located at the distal phalanx in 2 patients, at the distal to middle phalanx across the distal interphalangeal joint in 4, at the middle phalanx in 1, and at the proximal phalanx in 1. Mean duration of follow-up was 41 months. We assessed the efficacy of the technique by clinical symptoms and imaging. Results We used retrograde pedicled adipose tissue transfer in 7 patients and anterograde pedicled adipose tissue transfer in 1. The pedicled adipose tissue was successfully transferred from the digit tip to its base. The postoperative courses were uneventful; no additional treatments were required. Postoperative physical data and follow-up images showed no evidence of chronic osteomyelitis. No functional loss was caused by procuring vascularized adipose tissue from the digits. Conclusions Pedicled vascularized tissue transfer based on the digital artery was a reliable and reproducible technique. We recommend it as a treatment option for chronic digital osteomyelitis. Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.	[Okada, Mitsuhiro] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka 5458585, Japan; Takaishi Fujii Hosp, Dept Orthoped Surg, Osaka, Japan	Okada, M (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m-okada@med.osaka-cu.ac.jp					Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305; ANTHONY JP, 1991, PLAST RECONSTR SURG, V88, P311, DOI 10.1097/00006534-199108000-00023; McFadden JA, 1998, J RECONSTR MICROSURG, V14, P309, DOI 10.1055/s-2007-1000182; Kim KS, 2005, PLAST RECONSTR SURG, V116, P1332, DOI 10.1097/01.prs.0000181781.25020.43; NIRANJAN NS, 1994, J HAND SURG-BRIT EUR, V19B, P135, DOI 10.1016/0266-7681(94)90149-X; SUOMINEN S, 1995, MICROSURG, V16, P396, DOI 10.1002/micr.1920160609; KOJIMA T, 1990, BRIT J PLAST SURG, V43, P290, DOI 10.1016/0007-1226(90)90074-A; Yildirim S, 2002, ANN PLAS SURG, V48, P586, DOI 10.1097/00000637-200206000-00004; ASHBELL TS, 1967, PLAST RECONSTR SURG, V39, P311, DOI 10.1097/00006534-196703000-00013; Bene M D, 1994, Plast Reconstr Surg, V93, P552; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; CIRRINCIONE C, 1991, J HAND SURG-AM, V16A, P824; DEVRIES H, 1993, INJURY, V24, P32, DOI 10.1016/0020-1383(93)90079-L; Giuffre JL, 2011, J HAND SURG-AM, V36A, P1273, DOI 10.1016/j.jhsa.2011.05.022; Isenberg JS, 2000, J RECONSTR MICROSURG, V16, P547, DOI 10.1055/s-2000-8393; Kakinoki R, 2004, J HAND SURG-AM, V29A, P49, DOI 10.1016/j.jhsa.2003.10.015; Kim Kwang Seog, 2010, Plast Reconstr Surg, V125, P601, DOI 10.1097/PRS.0b013e3181c82fd7; Li YF, 2005, J HAND SURG-AM, V30A, P1305, DOI 10.1016/j.jhsa.2005.05.012; Mitsunaga N, 2010, J PLAST RECONSTR AES, V63, P1312, DOI 10.1016/j.bjps.2009.07.023; ROSE EH, 1983, PLAST RECONSTR SURG, V72, P848, DOI 10.1097/00006534-198312000-00023; Tay SC, 2004, PLAST RECONSTR SURG, V114, P1450, DOI 10.1097/01.PRS.0000138812.33973.92; Teoh LC, 2003, PLAST RECONSTR SURG, V111, P1905, DOI 10.1097/01.PRS.0000056875.02352.A8	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	APR	2015	40	4					677	684		10.1016/j.jhsa.2014.12.034		8	Orthopedics; Surgery	Orthopedics; Surgery	CF4LQ	WOS:000352521000005		
J	Heianza, Y; Arase, Y; Kodama, S; Hsieh, SD; Tsuji, H; Saito, K; Hara, S; Sone, H				Heianza, Y.; Arase, Y.; Kodama, S.; Hsieh, S. D.; Tsuji, H.; Saito, K.; Hara, S.; Sone, H.			Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16 (TOPICS 16)	JOURNAL OF HUMAN HYPERTENSION			English	Article							INCIDENT HYPERTENSION; GLYCATED HEMOGLOBIN; PLASMA-GLUCOSE; BLOOD-PRESSURE; INSULIN; GLYCEMIA; COHORT; ADULTS; ATHEROSCLEROSIS; A1C	We investigated the effect of elevated concentrations of fasting plasma glucose (FPG) or hemoglobin A1c (HbA1c) on the risk of development of hypertension among apparently healthy Japanese. Studied were 9584 individuals without known diabetes and hypertension. During a 5-year follow-up period, 1098 individuals developed hypertension. Elevated concentrations of FPG, rather than of HbA1c, were significantly predictive of future hypertension. Compared with the lowest quartile category of FPG (<4.9 mmol l(-1)), the second (4.9-<5.2 mmol l(-1)), third (5.2-<5.6 mmol l(-1)) and highest (>= 5.6 mmol l(-1)) quartile categories had age-, sex- and body mass index-adjusted odds ratios (95% confidence interval) of 1.35 (1.10, 1.66), 1.39 (1.13, 1.71) and 1.85 (1.51, 2.28) for hypertension, respectively. In the highest quartile of FPG, the multivariate-adjusted OR was 1.37 (1.10, 1.70) compared with the lowest quartile. Results of these adjusted models showed no significant association across quartile categories of HbA1c concentrations and an increased risk of developing hypertension. The joint effect of hyperglycemia and overweight, older age or prehypertension resulted in further elevated ORs for hypertension than the absence of such an association. Higher FPG levels rather than HbA1c were strongly predictive of future hypertension among Japanese. Hyperglycemia along with older age, overweight and prehypertension contributed to identifying individuals at increased risk of developing hypertension.	[Heianza, Y.; Kodama, S.; Saito, K.; Sone, H.] Niigata Univ, Fac Med, Dept Internal Med, Niigata, Japan; [Heianza, Y.; Arase, Y.; Kodama, S.; Hsieh, S. D.; Tsuji, H.; Saito, K.; Hara, S.; Sone, H.] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan; [Arase, Y.; Hsieh, S. D.; Tsuji, H.; Hara, S.] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan	Sone, H (reprint author), Toranomon Gen Hosp, Hlth Management Ctr, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	sone@med.niigata-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science	All the authors sincerely thank the late Professor and Director Kinori Kosaka, MD, PhD, the Health Management Center, Toranomon Hospital, who established the foundation and framework of this project and was always the foremost pillar of spiritual support of the TOPICS project. This work is financially supported in part by the Ministry of Health, Labour and Welfare, Japan. H Sone and Y Heianza are recipients of a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The sponsors had no role in the design and conduct of the study.	Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Wang WY, 2006, HYPERTENSION, V47, P403, DOI 10.1161/01.HYP.0000200710.29498.80; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Marini MA, 2012, DIABETES CARE, V35, P1144, DOI 10.2337/dc11-2032; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Parikh NI, 2008, ANN INTERN MED, V148, P102; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Barba C, 2004, LANCET, V363, P157; Bjornholt JV, 2003, J HYPERTENS, V21, P1383, DOI 10.1097/01.hjh.0000059085.43904.cc; Bower JK, 2012, DIABETES CARE, V35, P1031, DOI 10.2337/dc11-2248; Boyko EJ, 2008, J HYPERTENS, V26, P1742, DOI 10.1097/HJH.0b013e328306c965; Boyko EJ, 2008, J HUM HYPERTENS, V22, P168, DOI 10.1038/sj.jhh.1002316; Britton KA, 2011, AM J HYPERTENS, V24, P328, DOI 10.1038/ajh.2010.233; Costacou T, 2013, DIABETES CARE, V36, P77, DOI 10.2337/dc12-0708; FagotCampagna A, 1997, INT J EPIDEMIOL, V26, P542, DOI 10.1093/ije/26.3.542; Gupta AK, 2011, HYPERTENS RES, V34, P456, DOI 10.1038/hr.2010.267; HAFFNER SM, 1992, DIABETES CARE, V15, P1277, DOI 10.2337/diacare.15.10.1277; He J, 1999, ARCH INTERN MED, V159, P498, DOI 10.1001/archinte.159.5.498; Kim JH, 2011, DIABETES RES CLIN PR, V94, pE27, DOI 10.1016/j.diabres.2011.07.013; Klein R, 1996, ARCH INTERN MED, V156, P622, DOI 10.1001/archinte.156.6.622; Kroke A, 1999, DIABETES-METAB RES, V15, P99, DOI 10.1002/(SICI)1520-7560(199903/04)15:2<99::AID-DMRR22>3.0.CO;2-H; Levin G, 2010, AM J EPIDEMIOL, V172, P1144, DOI 10.1093/aje/kwq266; Liese AD, 1999, J HYPERTENS, V17, P1169, DOI 10.1097/00004872-199917080-00017; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Liu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048878; Morio M, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-81; Suematsu C, 1999, DIABETES CARE, V22, P228, DOI 10.2337/diacare.22.2.228; Takagi Y, 1998, Nihon Ronen Igakkai Zasshi, V35, P830; Talaei M, 2014, J HYPERTENS, V32, P30, DOI 10.1097/HJH.0b013e32836591d4; Tseng CD, 2012, AM J HYPERTENS, V25, P171, DOI 10.1038/ajh.2011.122; Xun PC, 2012, DIABETES CARE, V35, P1532, DOI 10.2337/dc11-2443	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	APR	2015	29	4					254	259		10.1038/jhh.2014.77		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CF4CW	WOS:000352497200009		
J	Shigeto, J; Itoh, Y; Hirao, S; Ohira, K; Fujita, K; Tsutsumi, Y				Shigeto, Jun; Itoh, Yoshitaka; Hirao, Sakie; Ohira, Kaori; Fujita, Koki; Tsutsumi, Yuji			Simultaneously disrupting AtPrx2, AtPrx25 and AtPrx71 alters lignin content and structure in Arabidopsis stem	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article						Arabidopsis; knockout mutant; lignin biosynthesis; plant peroxidase	CINNAMOYL-COA REDUCTASE; WALL-BOUND PEROXIDASE; DOWN-REGULATION; FORAGE QUALITY; NORWAY SPRUCE; CELL-WALLS; LIGNIFICATION; PLANTS; GENES; BIOSYNTHESIS	Plant class III heme peroxidases catalyze lignin polymerization. Previous reports have shown that at least three Arabidopsis thaliana peroxidases, AtPrx2, AtPrx25 and AtPrx71, are involved in stem lignification using T-DNA insertion mutants, atprx2, atprx25, and atprx71. Here, we generated three double mutants, atprx2/atprx25, atprx2/atprx71, and atprx25/atprx71, and investigated the impact of the simultaneous deficiency of these peroxidases on lignins and plant growth. Stem tissue analysis using the acetyl bromide method and derivatization followed by reductive cleavage revealed improved lignin characteristics, such as lowered lignin content and increased arylglycerol--aryl (-O-4) linkage type, especially -O-4 linked syringyl units, in lignin, supporting the roles of these genes in lignin polymerization. In addition, none of the double mutants exhibited severe growth defects, such as shorter plant stature, dwarfing, or sterility, and their stems had improved cell wall degradability. This study will contribute to progress in lignin bioengineering to improve lignocellulosic biomass.	[Shigeto, Jun; Itoh, Yoshitaka; Hirao, Sakie; Ohira, Kaori; Fujita, Koki; Tsutsumi, Yuji] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Tsutsumi, Y (reprint author), Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan.	y-tsutsu@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Scientific Research [26292097, 25660140, 25850123]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Scientific Research (B) Grant Number 26292097 (Y.T.), JSPS KAKENHI Exploratory Research Grant Number 25660140 (Y.T.), and JSPS KAKENHI Young Scientists (B) Grant Number 25850123 (J.S.).	Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Blee KA, 2003, PHYTOCHEMISTRY, V64, P163, DOI 10.1016/S0031-9422(03)00212-7; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; van Parijs FRD, 2010, PLANT PHYSIOL, V153, P1332, DOI 10.1104/pp.110.154468; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Li YH, 2003, J PLANT RES, V116, P175, DOI 10.1007/s10265-003-0087-5; Poovaiah CR, 2014, PLANT BIOTECHNOL J, V12, P1163, DOI 10.1111/pbi.12225; Kumar L, 2012, BIORESOURCE TECHNOL, V103, P201, DOI 10.1016/j.biortech.2011.09.091; Zeng YN, 2014, CURR OPIN BIOTECH, V27, P38, DOI 10.1016/j.copbio.2013.09.008; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; JUNG HG, 1995, J ANIM SCI, V73, P2774; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Yokoyama R, 2006, J PLANT RES, V119, P189, DOI 10.1007/s10265-006-0261-7; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; van der Rest B, 2006, J EXP BOT, V57, P1399, DOI 10.1093/jxb/erj120; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Cosio C, 2009, J EXP BOT, V60, P391, DOI [10.1093/jxb/ern318, 10.1093/jxb/em318]; Fagerstedt KV, 2010, J INTEGR PLANT BIOL, V52, P186, DOI 10.1111/j.1744-7909.2010.00928.x; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Du J, 2010, J INTEGR PLANT BIOL, V52, P17, DOI 10.1111/j.1744-7909.2010.00901.x; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; Koutaniemi S, 2015, J INTEGR PLANT BIOL, V57, P341, DOI 10.1111/jipb.12333; Li XY, 2013, GENET MOL BIOL, V36, P540, DOI 10.1590/S1415-47572013005000039; Nishiguchi M, 2006, J FOREST RES-JPN, V11, P175, DOI 10.1007/s10310-006-0203-1; O'Connell A, 2002, TRANSGENIC RES, V11, P495, DOI 10.1023/A:1020362705497; Ogawa Y, 2008, PLANT CELL PHYSIOL, V49, P242, DOI 10.1093/pcp/pcm181; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Shigeto J, 2012, FEBS J, V279, P348, DOI 10.1111/j.1742-4658.2011.08429.x; Shigeto J, 2013, J AGR FOOD CHEM, V61, P3781, DOI 10.1021/jf400426g; Shigeto J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105332; Wadenback J, 2008, TRANSGENIC RES, V17, P379, DOI 10.1007/s11248-007-9113-z; Wang Y, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00220	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	APR	2015	57	4			SI		349	356		10.1111/jipb.12334		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CF4BJ	WOS:000352493100005		
J	Wakaki, T				Wakaki, Toshiko			Preference-based argumentation built from prioritized logic programming	JOURNAL OF LOGIC AND COMPUTATION			English	Article						Preference-based argumentation; prioritized logic programming; static preferences; dynamic preferences; order-isomorphisms; argumentation semantics; paraconsistent stable model semantics; answer set semantics; constrained argumentation frameworks; direct consistency	PREFERRED ANSWER SETS; WELL-FOUNDED SEMANTICS; FRAMEWORKS; CIRCUMSCRIPTION; GAMES	In this article, we introduce a new approach of preference-based argumentation frameworks. We first introduce an abstract preference-based argumentation framework (an abstract PAF) which handles static preferences. Naturally extending Dung's acceptability semantics, the semantics of an abstract PAF is given by P-extensions which ensure conflict-freeness w.r.t. the attack relation. Second, as the instantiation of the proposed abstract PAF, we present the non-abstract PAF along with the constrained argumentation framework (CAF) built from a prioritized logic program (PLP). As a result, the proposed framework is able to handle static preferences as well as integrity constraints in argumentation. Third, by providing a hierarchical PLP to deal with dynamic preferences in the context of logic programming, we extend the framework to a dynamic PAF built from a hierarchical PLP to deal with dynamic preferences in the context of argumentation. Fourth, we not only show the correspondence between stable extensions of the non-abstract argumentation framework and paraconsistent stable models of an extended logic program but also show the correspondence between the semantics of such PAFs and the semantics of the underling prioritized logic programs based on the order-preserving mapping functions. Finally, the proposed framework is also applied to interactions between agents in multi-agent systems.	Shibaura Inst Technol, Dept Elect Informat Syst, Minuma Ku, Saitama 3378570, Japan	Wakaki, T (reprint author), Shibaura Inst Technol, Dept Elect Informat Syst, Minuma Ku, 307 Fukasaku, Saitama 3378570, Japan.	twakaki@shibaura-it.ac.jp			JSPS [20500141]	This research is partially supported by Grant-in-Aid for Scientific Research from JSPS, No. 20500141. The author thanks Martin Caminada (the University of Aberdeen) and Chiaki Sakama (Wakayama University) for their valuable and useful comments on this research. The author also would like to thank the anonymous reviewers for their useful comments which have helped the author to improve the quality of this paper.	Amgoud L, 2010, LECT NOTES ARTIF INT, V6379, P56; Amgoud L, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P665; Modgil S, 2009, ARTIF INTELL, V173, P901, DOI 10.1016/j.artint.2009.02.001; Schweimeier R, 2005, THEOR PRACT LOG PROG, V5, P207, DOI 10.1017/S147106840400225X; Bondarenko A, 1997, ARTIF INTELL, V93, P63, DOI 10.1016/S0004-3702(97)00015-5; Eiter T, 2003, THEOR PRACT LOG PROG, V3, P463, DOI 10.1017/S1471068403001753; Brewka G, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P100; Amgoud L, 2002, ANN MATH ARTIF INTEL, V34, P197, DOI 10.1023/A:1014490210693; Delgrande JP, 2003, THEOR PRACT LOG PROG, V3, P129, DOI 10.1017/S1471068402001539; Dung PM, 2007, ARTIF INTELL, V171, P642, DOI 10.1016/j.artint.2007.05.003; Brewka G, 1999, ARTIF INTELL, V109, P297, DOI 10.1016/S0004-3702(99)00015-6; Brewka G, 1996, J ARTIF INTELL RES, V4, P19; Sakama C, 2000, ARTIF INTELL, V123, P185, DOI 10.1016/S0004-3702(00)00054-0; Delgrande J, 2004, COMPUT INTELL-US, V20, P308, DOI 10.1111/j.0824-7935.2004.00240.x; Caminada M, 2007, ARTIF INTELL, V171, P286, DOI 10.1016/j.artint.2007.02.003; Bench-Capon TJM, 2003, J LOGIC COMPUT, V13, P429, DOI 10.1093/logcom/13.3.429; Dung PM, 2006, ARTIF INTELL, V170, P114, DOI 10.1016/j.artint.2005.07.002; Amgoud L, 2011, ANN MATH ARTIF INTEL, V63, P149, DOI 10.1007/s10472-011-9271-9; Brewka G., 2010, P AAAI 2010, P273; Caminada M, 2006, FR ART INT, V144, P121; Coste-Marquis S., 2006, P 10 INT C PRINC KNO, P112; Davey B.A., 2002, INTRO LATTICES ORDER; DUNG PM, 1995, ARTIF INTELL, V77, P321, DOI 10.1016/0004-3702(94)00041-X; DUNG PM, 1993, LOGIC PROGRAMM, P616; Egly U., 2010, ARGUMENT COMPUTATION, V1, P147; Egly U, 2008, LECT NOTES COMPUT SC, V5366, P734, DOI 10.1007/978-3-540-89982-2_67; Eiter T., 1997, LECT NOTES COMPUTER, P364; Gelfond M., 1988, P 5 INT C LOG PROGR, P1070; Gelfond M., 1991, New Generation Computing, V9; Gordon T. F., 1993, THESIS TU DARMSTADT; Inoue K., 1992, THESIS KYOTO U; Inoue K., 2011, LECT NOTES ARTIF INT, V6565, P91; LIFSCHITZ V, 1985, P 9 INT JOINT C ART, P121; MCCARTHY J, 1986, ARTIF INTELL, V28, P89, DOI 10.1016/0004-3702(86)90032-9; Modgil S, 2010, FRONT ARTIF INTEL AP, V216, P347, DOI 10.3233/978-1-60750-619-5-347; Mora I., 1998, P 7 INT WORKSH NONM; Niemela I., 1997, LNCS, V1265, P421; Nieves JC, 2008, THEOR PRACT LOG PROG, V8, P527, DOI 10.1017/S1471068408003359; Prakken H, 2010, ARGUMENT COMPUT, V1, P93; Prakken H, 1997, J APPL NONCLASSICAL, V7, P25; Rahwan I, 2009, ARGUMENTATION IN ARTIFICIAL INTELLIGENCE, P1, DOI 10.1007/978-0-387-98197-0; Sakama C., 2009, LNCS, V6214, P122; Sakama C., 1995, Journal of Logic and Computation, V5, DOI 10.1093/logcom/5.3.265; Sefranek J, 2008, P 12 INT WORKSH NONM, P232; Takahashi T., 2004, P 3 INT JOINT C AUT, P800; Toni F., 2011, LECT NOTES ARTIF INT, V6565, P164; Vreeswijk GAW, 2000, LECT NOTES ARTIF INT, V1919, P239, DOI 10.1007/3-540-40006-0_17; Wakaki T, 2011, LECT NOTES ARTIF INT, V6614, P306, DOI 10.1007/978-3-642-21940-5_18; Wakaki T, 2004, LECT NOTES COMPUT SC, V3132, P356, DOI 10.1007/978-3-540-27775-0_25; Wakaki T., 1997, J ADV COMPUTATIONAL, V1, P121; Wakaki T, 2003, LECT NOTES ARTIF INT, V2850, P259, DOI 10.1007/978-3-540-39813-4_18; Wakaki T, 1997, INT JOINT CONF ARTIF, P182; Wakaki T, 2004, LECT NOTES COMPUT SC, V3229, P706, DOI 10.1007/978-3-540-30227-8_62; Wakaki T, 2011, LECT NOTES ARTIF INT, V7047, P336, DOI 10.1007/978-3-642-25044-6_27; Wakaki T., 2008, LECT NOTES ARTIF INT, V5547, p[32, 254]; Wakabayashi T, 2006, POLYYNES: SYNTHESIS, PROPERTIES, AND APPLICATIONS, P1	56	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0955-792X	1465-363X		J LOGIC COMPUT	J. Logic Comput.	APR	2015	25	2			SI		251	301		10.1093/logcom/exs066		51	Computer Science, Theory & Methods; Logic	Computer Science; Science & Technology - Other Topics	CF1NJ	WOS:000352312500002		
J	Tamura, K				Tamura, Kuniaki			A small model theorem for the hybrid mu-calculus	JOURNAL OF LOGIC AND COMPUTATION			English	Article						Hybrid mu-calculus; small model theorem	ALTERNATING TREE AUTOMATA; PARITY GAMES; COMPLETENESS	In this article, we prove that the hybrid mu-calculus, which is the modal mu-calculus extended with nominals and satisfaction operators in the language of hybrid logic, has the small model property as follows: every satisfiable formula is satisfied in a model whose size is bounded by some function on the size of the formula. The obtained bound on the size of the model is then used to obtain a finite, sound and complete axiomatization for this formal system.	Takasago, Tokyo 3159103, Japan	Tamura, K (reprint author), Takasago, Tokyo 3159103, Japan.	kuniaki.tamura@gmail.com					KOZEN D, 1983, THEOR COMPUT SCI, V27, P333, DOI 10.1016/0304-3975(82)90125-6; Alberucci L, 2009, J SYMBOLIC LOGIC, V74, P1367, DOI 10.2178/jsl/1254748696; Arnold A., 2001, STUDIES LOGIC FDN MA, V146; Blackburn P., 2001, CAMBRIDGE TRACTS THE, V53; Bradfield J., 2001, HDB PROCESS ALGEBRA, P293, DOI 10.1016/B978-044482830-9/50022-9; Emerson E. A., 1991, FOCS, V1991, P368; Gradel E., 2002, LNCS, V2500; Jager G, 2008, J LOGIC ALGEBR PROGR, V76, P270, DOI 10.1016/j.jlap.2008.02.005; Kashima R, 2008, J LOGIC COMPUT, V18, P497, DOI 10.1093/logcom/exm077; Kirsten D, 2002, LECT NOTES COMPUT SC, V2500, P153; Kozen D., 1988, STUDIA LOGICA, V47, P233, DOI 10.1007/BF00370554; Mostowski A. W., 1991, 78 U GDANSK; Sattler U., 2001, LECT NOTES ARTIF INT, V2083, P76; Stirling C., 2001, MODAL TEMPORAL PROPE; STREETT RS, 1989, INFORM COMPUT, V81, P249, DOI 10.1016/0890-5401(89)90031-X; Tarski A., 1955, PAC J MATH, V5, P285; Wilke T, 2001, B BELG MATH SOC-SIM, V8, P359	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0955-792X	1465-363X		J LOGIC COMPUT	J. Logic Comput.	APR	2015	25	2			SI		405	441		10.1093/logcom/exs052		37	Computer Science, Theory & Methods; Logic	Computer Science; Science & Technology - Other Topics	CF1NJ	WOS:000352312500006		
J	Ibaraki, S; Kimura, Y; Nagai, Y; Nishikawa, S				Ibaraki, Soichi; Kimura, Yoshihiro; Nagai, Yu; Nishikawa, Shizuo			Formulation of Influence of Machine Geometric Errors on Five-Axis On-Machine Scanning Measurement by Using a Laser Displacement Sensor	JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							ROTARY AXES; TOOLS; CALIBRATION; MODEL	For on-machine measurement of workpiece position, orientation, and geometry on machine tools, five-axis continuous (scanning) measurement by using a laser displacement sensor has a strong advantage in its efficiency, compared to conventional discrete measurement using a touch-triggered contact probe. In any on-machine measurement schemes, major contributors to their measurement uncertainty are error motions of the machine tool itself. This paper formulates the influence of geometric errors of rotary axis average lines on the measurement uncertainty of the five-axis on-machine measurement by using a laser displacement sensor. To validate the present simulator, experimental comparison of measured and simulated trajectories is conducted on five-axis on-machine measurement of a precision sphere of the precalibrated geometry. For total 28 paths measured on the spherical surface, an error in the simulated trajectories from measured trajectories (properly low-pass filtered) was at maximum 5 mu m. Uncertainty assessment demonstration for more practical application example of a turbine blade measurement is also presented.	[Ibaraki, Soichi; Kimura, Yoshihiro; Nagai, Yu] Kyoto Univ, Dept Micro Engn, Nishigyo Ku, Kyoto 6158530, Japan; [Nishikawa, Shizuo] DMG Mori Seiki Co Ltd, Nakamura Ku, Nagoya, Aichi 4500002, Japan	Ibaraki, S (reprint author), Kyoto Univ, Dept Micro Engn, Nishigyo Ku, Kyoto 6158530, Japan.	ibaraki@prec.kyoto-u.ac.jp					Abe G., 2011, INT J AUTOM TECHNOL, V5, P708; [Anonymous], SENSORS VISION MEASU; Abbaszadeh-Mir Y, 2002, INT J PROD RES, V40, P4781, DOI 10.1080/00207540210164459; Mears L, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.3184085; [Anonymous], 2013, 16907 ISOCDTR; [Anonymous], 2012, 107916 ISODIS; Bringmann B, 2006, CIRP ANN-MANUF TECHN, V55, P531, DOI 10.1016/S0007-8506(07)60475-2; [Anonymous], 2001, 841 ISO; DORSCH RG, 1994, APPL OPTICS, V33, P1306, DOI 10.1364/AO.33.001306; [Anonymous], 2012, 23012012 ISO; [Anonymous], 2012, 1079112012 ISODIS; [Anonymous], 2006, 23072006 ISO; Jung JH, 2006, J MATER PROCESS TECH, V174, P56, DOI 10.1016/j.jmatprotec.2004.12.014; Ibaraki S, 2011, INT J MACH TOOL MANU, V51, P190, DOI 10.1016/j.ijmachtools.2010.11.011; Hong CF, 2011, PRECIS ENG, V35, P1, DOI 10.1016/j.precisioneng.2010.09.004; Hong CF, 2013, PRECIS ENG, V37, P159, DOI 10.1016/j.precisioneng.2012.07.012; [Anonymous], 2010, 230102011 ISO; Ibaraki S, 2013, INT J MACH TOOL MANU, V68, P21, DOI 10.1016/j.ijmachtools.2013.01.001; BARIBEAU R, 1991, APPL OPTICS, V30, P2873, DOI 10.1364/AO.30.002873; Hocken R, 1977, ANN CIRP, V26, P403; Ibaraki S, 2012, INT J AUTOMATION TEC, V6, P110, DOI DOI 10.3929/ETHZ-A-007593181; Ihara Y., 2009, J JPN SOC PRECIS ENG, V75, P1281, DOI 10.2493/jjspe.75.1281; Inasaki I., 1997, SHAPER GENERATION TH; Kimura Y., 2012, INT J AUTOMATION TEC, V6, P724; Ko TJ, 2007, INT J ADV MANUF TECH, V32, P739, DOI 10.1007/s00170-005-0383-4; Nagai Y., 2013, P 7 INT C LEAD EDG M, P313; Nakagawa H., 2003, Journal of the Japan Society of Precision Engineering, V69; Tutunea-Fatan OR, 2005, J MANUF SCI E-T ASME, V127, P60, DOI 10.1115/1.1831285; Schwenke H., 2008, CIRP ANN-MANUF TECHN, V57, P560; Sencer B, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.3123335; Watanabe Y., 2003, P INT C LEAD EDG MAN, P65	31	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1087-1357	1528-8935		J MANUF SCI E-T ASME	J. Manuf. Sci. Eng.-Trans. ASME	APR	2015	137	2							021013	10.1115/1.4029183		11	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CF3ID	WOS:000352440900014		
J	Polngam, P; Chiemchaisri, W; Kaewmanee, A; Chiemchaisri, C; Yamamoto, K				Polngam, Praewpimon; Chiemchaisri, Wilai; Kaewmanee, Anekpracha; Chiemchaisri, Chart; Yamamoto, Kazuo			Chemical characterization in correlation to toxicity evaluation for water reuse of solid waste leachates in the itMBR-RO system	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Solid waste; Leachate; Toxicity; Xenobiotic; MBR; RO	LANDFILL LEACHATE; REMOVAL; NITRITE	This research investigates chemical characterization and toxicity evaluation of solid waste leachates along operating treatment units of the itMBR-RO (inclined tubes membrane bioreactor-reverse osmosis) system. Leachates from solid waste disposal sites contain high pollutant concentrations that pose acute toxicity effects on living organisms. Overall treatment processes could reduce COD, ammonia nitrogen and heavy metals by > 99, > 99 and > 97 %, respectively. The xenobiotic compounds can be effectively removed (83.2-100 %) with the itMBR-RO system. 96 h of toxicity tests revealed that not only was NH3 toxic to the Nile Tilapia (Oreochromis niloticus), there were other pollutants in the leachate synergy such as COD, nitrite and conductivity. Nitrite was the most potent pollutant in the MBR-treated leachates giving an acute toxic effect in combination with ammonia. In conclusion, the itMBR-RO system could completely eliminate acute toxicity of the solid waste leachates; although a few toxic organic compounds still remained in the RO permeate i.e. DEHP, hexadecanoic acid and phenol, 2, 4-bis-(tert-butyl).	[Polngam, Praewpimon; Chiemchaisri, Wilai; Kaewmanee, Anekpracha; Chiemchaisri, Chart] Kasetsart Univ, Fac Engn, Dept Environm Engn, Bangkok 10900, Thailand; [Yamamoto, Kazuo] Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, Tokyo 1130033, Japan	Chiemchaisri, W (reprint author), Kasetsart Univ, Fac Engn, Dept Environm Engn, 50 Phaholyothin Rd, Bangkok 10900, Thailand.	friend_kw@hotmail.com; fengwlc@ku.ac.th; anpc_kmn@yahoo.com; fengccc@ku.ac.th; yamamoto@esu.u-tokyo.ac.jp		Chiemchaisri, Chart/0000-0003-0078-563X	Japan International Cooperation Agency (JICA) under Research and Development of Water Reuse Technology in Tropical Region (Water-Intro) Project, Japan	This research was supported by the Japan International Cooperation Agency (JICA) under Research and Development of Water Reuse Technology in Tropical Region (Water-Intro) Project, Japan.	Renou S, 2008, J HAZARD MATER, V150, P468, DOI 10.1016/j.jhazmat.2007.09.077; Marttinen SK, 2002, CHEMOSPHERE, V46, P851, DOI 10.1016/S0045-6535(01)00150-3; Theepharaksapan S, 2011, BIORESOURCE TECHNOL, V102, P5381, DOI 10.1016/j.biortech.2010.11.091; SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375; LEWIS WM, 1986, T AM FISH SOC, V115, P183, DOI 10.1577/1548-8659(1986)115<183:TONTF>2.0.CO;2; Baun A, 2004, WATER RES, V38, P3845, DOI 10.1016/j.watres.2004.07.006; Boonyaroj V, 2012, BIORESOURCE TECHNOL, V113, P174, DOI 10.1016/j.biortech.2011.12.127; Silva AC, 2004, CHEMOSPHERE, V55, P207, DOI 10.1016/j.chemosphere.2003.10.013; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379; Zhang QQ, 2013, WASTE MANAGE, V33, P2277, DOI 10.1016/j.wasman.2013.07.021; APHA, 1998, STANDARD METHODS EXA; Barrett A Lawlor J, 1995, EC WASTE MANAGEMENT; Chiemchaisri C, 2010, J MATER CYCLES WASTE, V12, P161, DOI 10.1007/s10163-009-0284-y; Chiemchaisri Chart, 2009, International Journal of Environment and Waste Management, V3, DOI 10.1504/IJEWM.2009.024701; Croux P, 2004, J ENVIRON BIOL, V25, P7; Dave G, 2005, AQUAT TOXICOL, V73, P11, DOI 10.1016/j.aquatox.2005.02.006; Deguchi Y, 2007, MUTAT RES-GEN TOX EN, V627, P178, DOI 10.1016/j.mrgentox.2006.11.006; Elmer Perkin, 1996, ATOMIC ABSORPTION SP; Jemec A, 2012, ARCH ENVIRON CON TOX, V62, P210, DOI 10.1007/s00244-011-9703-x; Lorz PM, 2005, PHTHALIC ACID DERIVA; Olivero-Verbel J, 2008, ECOTOX ENVIRON SAFE, V70, P294, DOI 10.1016/j.ecoenv.2007.05.016; Thanh BX, 2013, BIORESOURCE TECHNOL, V141, P25, DOI 10.1016/j.biortech.2013.02.066; Thomas DJL, 2009, J TOXICOL ENV HEAL B, V12, P83, DOI 10.1080/10937400802545292; Tomlin C., 1994, PESTICIDE MANUAL WOR	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					237	248		10.1007/s10163-014-0310-6		12	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000004		
J	Kim, D; Yoshikawa, K; Lee, K; Park, KY				Kim, Daegi; Yoshikawa, Kunio; Lee, Kwanyong; Park, Ki Young			Investigation of the combustion characteristics of municipal solid wastes and their hydrothermally treated products via thermogravimetric analysis	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Renewable energy; Hydrothermal treatment; Municipal solid waste (MSW); Thermogravimetric analysis	BIOLOGICAL TREATMENT; BIOMASS; COAL; COCOMBUSTION; FUELS	This study investigated the hydrothermal treatment of municipal solid waste (MSW) for renewable solid fuel production. The properties of surrogate MSWs were greatly improved by hydrothermal treatment and were similar to those of coal-like fuel substances. These included increases in high heating value, fixed carbon, and carbon content. Furthermore, the combustion behavior of MSWs was studied to clarify the effects of hydrothermal treatment on the combustion behavior of treated MSWs. The treated MSWs were then compared to several types of coal, focusing on the combustion characteristics before and after hydrothermal treatment, by use of a thermogravimetric analyzer. After the hydrothermal treatment, the treated MSWs showed two combustion peaks corresponding to volatile release and char combustion, due to an increase of the fixed carbon. The char burn temperature, resulting in the second burning peak region of the treated MSW, was similar to that of Australian coal. The combustion behavior of MSW following hydrothermal treatment suggests that the MSWs were made more similar to coal during this process.	[Kim, Daegi; Lee, Kwanyong; Park, Ki Young] Konkuk Univ, Dept Civil & Environm Syst Engn, Seoul 143701, South Korea; [Yoshikawa, Kunio] Tokyo Inst Technol, Dept Environm Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Park, KY (reprint author), Konkuk Univ, Dept Civil & Environm Syst Engn, 120 Neungdong Ro, Seoul 143701, South Korea.	daegikim@konkuk.ac.kr; yoshikawa.k.aa@m.titech.ac.jp; enbio@konkuk.ac.kr; kypark@konkuk.ac.kr			Konkuk University	This paper was supported by Konkuk University in 2014.	Alexander PE, 2010, WASTE MANAGE, V30, P707; Heilmann SM, 2010, BIOMASS BIOENERG, V34, P875, DOI 10.1016/j.biombioe.2010.01.032; Muthuraman M, 2010, BIORESOURCE TECHNOL, V101, P2477, DOI 10.1016/j.biortech.2009.11.060; Demirbas A, 2004, PROG ENERG COMBUST, V30, P219, DOI 10.1016/j.pecs.2003.10.004; Baxter L, 2005, FUEL, V84, P1295, DOI 10.1016/j.fuel.2004.09.023; Wagland ST, 2011, WASTE MANAGE, V31, P1176, DOI 10.1016/j.wasman.2011.01.001; Muthuraman M, 2010, APPL ENERG, V87, P141, DOI 10.1016/j.apenergy.2009.08.004; Lu R, 1999, FUEL PROCESS TECHNOL, V59, P35, DOI 10.1016/S0378-3820(99)00011-9; Peng YY, 2010, J ANAL APPL PYROL, V88, P134, DOI 10.1016/j.jaap.2010.03.006; Gani A, 2007, RENEW ENERG, V32, P649, DOI 10.1016/j.renene.2006.02.017; Bayard R, 2010, J HAZARD MATER, V175, P23, DOI 10.1016/j.jhazmat.2009.10.049; Hwang IH, 2012, WASTE MANAGE, V32, P410, DOI 10.1016/j.wasman.2011.10.006; Funke A, 2010, BIOFUEL BIOPROD BIOR, V4, P160, DOI 10.1002/bbb.198; Mursito AT, 2010, FUEL, V89, P635, DOI 10.1016/j.fuel.2009.07.004; Rhen C, 2007, BIOMASS BIOENERG, V31, P66, DOI 10.1016/j.biombioe.2006.06.016; Barrena R, 2009, J HAZARD MATER, V162, P1062; Boxiong S, 2006, ENERG CONVERS MANAGE, V47, P1429; CHEN Y, 1995, ENERG FUEL, V9, P71, DOI 10.1021/ef00049a011; Chung IH, 2009, J KOREAN SOLID WASTE, V26, P626; GHETTI P, 1986, FUEL, V65, P636, DOI 10.1016/0016-2361(86)90356-X; Goto M, 2004, BIORESOURCE TECHNOL, V93, P273; Juniper, 2005, MECH BIOL TREATM GUI; Kim D, 2012, J COMBUST, V2012, P8; Kucukbayrak S, 2001, ENERG CONVERS MANAGE, V42, P613, DOI 10.1016/S0196-8904(00)00073-X; Kumar S, 2010, THESIS AUBURN U; Kuzuhara Y, 2005, BIOMASS BIOENERG, V29, P331, DOI 10.1016/j.biombioe.2004.06.014; Lornage R, 2007, WASTE MANAGE, V27, P1755, DOI 10.1016/j.wasman.2006.10.018; Simsekkus N, 2012, TETRAHEDRON, V68, P949; Tri Mursito A, 2010, FUEL, V89, P3394; Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					258	265		10.1007/s10163-014-0342-y		8	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000006		
J	Takata, M; Watanabe, N; Yamamoto, S				Takata, Mitsuyasu; Watanabe, Nobuhisa; Yamamoto, Shuhsaku			Destruction of organic Cl and Br compounds through incineration enhanced by alkali and alumina addition	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Organic chlorine; Organic bromine; PCBs; Incineration; Destruction	ACTIVATED CARBON; CHLORINE; HEXACHLOROBENZENE	Thermochemical destruction of organic Cl and Br compounds in a combustion system was studied. A Cl compound and three Br compounds, namely, 1,2,3,4-tetrachlorobenzene (TeCB), 1,2,4,5-tetrabromobenzene (TeBB), tetrabromobisphenol A (TBBPA), and decabromodiphenyl ether (DBDE) were used. The samples on a boat were combusted at 600 A degrees C followed by gas combustion at 800, 900, and 1,100 A degrees C. An off-gas was adsorptively collected and introduced into a Cl and Br detector by thermal desorption. The destruction efficiency was evaluated using the organic halogen residual ratio (OX-RR) (mu g g(-1)). Halogenated benzene compounds such as TeCB and TeBB were destructed moderately (OX-RR for these compounds at 800, 900 and 1,100 A degrees C was 112, 35 and 32 mu g g(-1) and 258, 57 and 48 mu g g(-1), respectively); on the other hand, the destruction of TBBPA and DBDE, namely fire retardants, was difficult (OX-RR at 800 A degrees C for these compounds was 7,159 and 718 mu g g(-1), respectively). Addition of an alkali and an alumina to a sample enhanced the destruction of organic compounds drastically by several times. This destruction enhancement occurred at temperature as low as 600 A degrees C. Such chemical halogen control is effective to thermal destruction of organic Cl and Br compounds.	[Takata, Mitsuyasu; Watanabe, Nobuhisa; Yamamoto, Shuhsaku] Osaka Inst Technol, Grad Sch Major Environm Engn, Asahi Ku, Osaka 5358585, Japan	Watanabe, N (reprint author), Osaka Inst Technol, Grad Sch Major Environm Engn, Asahi Ku, Ohmiya 5-16-1, Osaka 5358585, Japan.	nobuhisa.watanabe@oit.ac.jp			Japan Environmental Ministry [3K113025]	This work was supported by the Japan Environmental Ministry under the program "3K113025: Visualization and optimization of thermochemical destruction of organohalogen compounds (Research leader: WATANABE Nobuhisa)".	AHLING B, 1978, SCI TOTAL ENVIRON, V10, P51, DOI 10.1016/0048-9697(78)90049-9; Gao YA, 2010, CHEMOSPHERE, V81, P1012, DOI 10.1016/j.chemosphere.2010.09.008; Fujimori T, 2010, ENVIRON SCI TECHNOL, V44, P7678, DOI 10.1021/es102055v; Nakui H, 2011, CHEMOSPHERE, V85, P151, DOI 10.1016/j.chemosphere.2011.06.042; [Anonymous], 2003, K25413 JIS; Duvall DS, 1980, P EPA 6 ANN RES S CH, P121; Japan Environmental Ministry, 2013, C MAT; Kamarehie B, 2014, J MATER CYCLES WASTE, V16, P711, DOI 10.1007/s10163-013-0185-y; Keqing YK, 2013, CHEMOSPHERE, V93, P1600; Kwak YH, 2011, J MATER CYCLES WASTE, V13, P314, DOI 10.1007/s10163-011-0030-0; Seok J, 2005, J HAZARD MATER, V124, P133, DOI 10.1016/j.hazmat.2005.04.035; Sun YF, 2013, J ENVIRON SCI-CHINA, V25, P213, DOI 10.1016/S1001-0742(12)60032-1; Sun YF, 2012, CHEMOSPHERE, V88, P895, DOI 10.1016/j.chemosphere.2012.03.099; US EPA, 1981, EPA600281022; Vehlow J, 2012, REV ENVIRON SCI BIO, V11, P393, DOI 10.1007/s11157-012-9296-5; Vermeulen I, 2014, J MATER CYCLES WASTE, V16, P167, DOI 10.1007/s10163-013-0160-7; Wang F, 2011, J HAZARD MATER, V192, P1067, DOI 10.1016/j.jhazmat.2011.06.009; Watanabe N, 2003, J MATER CYCLES WASTE, V5, P69, DOI 10.1007/s101630300011; Watanabe N, 2007, J ENV CHEM, V17, P461; Watanabe N, 2007, CHEMOSPHERE, V67, pS198, DOI 10.1016/j.chemosphere.2006.05.100; Watanabe N, 2002, ANAL SCI, V18, P1191, DOI 10.2116/analsci.18.1191	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					282	289		10.1007/s10163-015-0359-x		8	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000008		
J	Lwin, CM; Maung, KN; Hashimoto, S				Lwin, Cherry Myo; Maung, Kyaw Nyunt; Hashimoto, Seiji			Future sewage sludge generation and sewer pipeline extension in economically developing ASEAN countries	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Sewage sludge amount; Per capita GDP; ASEAN; Wastewater treatment plant (WWTP); Environmental public utilities		Levels of future generation of sewage sludge must be ascertained to ensure safe and effective waste management, particularly for economically developing countries such as those of the Association of Southeast Asian Nations (ASEAN), where wastewater treatment will increase profoundly in the near future. This study estimated the quantity of sewage sludge generation in ASEAN during 2010-2050. Parameters used in the scenario analysis include population (P), per-capita gross domestic product (GDP(pc)), rate of population in residences connected to wastewater treatment plants (P (wwtp) %), and sewage sludge generation per capita (SSpc). High sewerage penetration scenarios indicate that the sewage sludge in the ASEAN countries is expected to increase to 24-40 million tonnes per annum (Mt/a) by 2050. Indonesia might contribute the greatest amount of 17.04 Mt/a at mid-century, followed by the Philippines and Vietnam. Because of its small population, Brunei Darussalam will contribute the least. Sewage pipeline length has also been estimated. High-penetration scenarios indicate that the sewer network in ASEAN will surge to 2.3-7 million km long. Because sewage sludge management and development of wastewater infrastructure will play important roles in the ASEAN region, these findings will be informative for wastewater management policies and practices in Southeast Asia.	[Lwin, Cherry Myo] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Maung, Kyaw Nyunt] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Hashimoto, Seiji] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan	Lwin, CM (reprint author), Ritsumeikan Univ, Res Org Sci & Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	14v00918@gst.ritsumei.ac.jp; gr0220vf@ed.ritsumei.ac.jp; shashimo@fc.ritsumei.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-6-4]; Ritsumeikan Global Innovation Research Organization (R-GIRO) Program	This research was supported by the Environment Research and Technology Development Fund (S-6-4) of the Ministry of the Environment, Japan and the Ritsumeikan Global Innovation Research Organization (R-GIRO) Program. We also thank anonymous reviewers of the Journal of Material Cycles and Waste Management for their helpful comments. Without their assistance, this research could not have been completed effectively.	[Anonymous], 2008, STAT OV WAT WAST EUR; [Anonymous], 2001, SIGN ENV; Lundin M, 2004, RESOUR CONSERV RECY, V41, P255, DOI 10.1016/j.resconrec.2003.10.006; He PJ, 2007, WATER PRACT TECHNOL, DOI [10.2166/wpt.2007.083, DOI 10.2166/WPT.2007.083]; Japan Sewage Work Association, 2012, POP COV SEW SYST; Metcalf E., 1991, WASTEWATER ENG TREAT; Milieu Ltd. WRc RPA, 2008, ENV EC SOC IMP US SE; OECD Environmental Data, 2006, ENV DAT 2006 2008; Thia-Eng Chua, 1992, P C WAST MAN COAST A; United Nation for Environmental Program, 2004, STAT WAST MAN S E AS	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					290	302		10.1007/s10163-015-0356-0		13	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000009		
J	Ibarra, RM; Sasaki, M; Goto, M; Quitain, AT; Montes, SMG; Aguilar-Garib, JA				Morales Ibarra, Rodolfo; Sasaki, Mitsuru; Goto, Motonobu; Quitain, Armando T.; Garcia Montes, Saida Mayela; Aguilar-Garib, Juan A.			Carbon fiber recovery using water and benzyl alcohol in subcritical and supercritical conditions for chemical recycling of thermoset composite materials	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Recycling; Composites; Carbon fiber; Subcritical fluids; Supercritical fluids	PROPANOL	Recovery of carbon fibers by recycling thermoset composites is highly desirable from both economic and environmental perspectives. This reduces waste disposal of scrap from production parts and end-of-life products. In this study, benzyl alcohol and water in subcritical and supercritical conditions were used to recover carbon fibers from composite materials for potential reuse in high-performance components. The reaction temperature and time duration were the experimental parameters. The methods were evaluated by measurement of the decomposition rate of epoxy resin, which reached up to 89.1 and 93.7 % with supercritical water and subcritical benzyl alcohol, respectively. The samples were characterized by scanning electron microscopy (SEM). SEM analysis showed complete separation of the composites as indicated by the clean recovered carbon fibers.	[Morales Ibarra, Rodolfo; Sasaki, Mitsuru; Quitain, Armando T.] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Morales Ibarra, Rodolfo; Garcia Montes, Saida Mayela; Aguilar-Garib, Juan A.] Univ Autonoma Nuevo Leon, Doctoral Program Mat Sci, San Nicolas De Los Garza 66450, Nuevo Leon, Mexico; [Sasaki, Mitsuru] Kumamoto Univ, Bioelect Res Ctr, Kumamoto 8608555, Japan; [Goto, Motonobu] Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Aguilar-Garib, Juan A.] Univ Autonoma Nuevo Leon, CIIDIT, San Nicolas De Los Garza 66450, Nuevo Leon, Mexico	Ibarra, RM (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	rodolfomoralesibarra@hotmail.com					Pinero-Hernanz R, 2008, J SUPERCRIT FLUID, V46, P83, DOI 10.1016/j.supflu.2008.02.008; Jiang G, 2009, COMPOS SCI TECHNOL, V69, P192, DOI 10.1016/j.compscitech.2008.10.007; AMBROSE D, 1990, J CHEM THERMODYN, V22, P307, DOI 10.1016/0021-9614(90)90204-4; Goto M, 2009, J SUPERCRIT FLUID, V47, P500, DOI 10.1016/j.supflu.2008.10.011; Bai YP, 2010, MATER DESIGN, V31, P999, DOI 10.1016/j.matdes.2009.07.057; Hyde JR, 2006, COMPOS PART A-APPL S, V37, P2171, DOI 10.1016/j.compositesa.2005.12.006; Pickering SJ, 2000, COMPOS SCI TECHNOL, V60, P509, DOI 10.1016/S0266-3538(99)00154-2; Pickering SJ, 2006, COMPOS PART A-APPL S, V37, P1206, DOI 10.1016/j.compositesa.2005.05.030; Iwaya T, 2008, J MATER SCI, V43, P2452, DOI 10.1007/s10853-007-2017-8; Nakagawa Mitsutoshi, 2009, 5 ISFR OCT 11 14 200, P241; Pinero-Hernanz R, 2008, COMPOS PART A-APPL S, V39, P454, DOI 10.1016/j.compositesa.2008.01.001; Yuyan L, 2009, MAT SCI ENG A-STRUCT, V520, P179	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					369	379		10.1007/s10163-014-0252-z		11	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000016		
J	Kamei, T; Ahmed, A; Horai, H; Ugai, K				Kamei, Takeshi; Ahmed, Aly; Horai, Hideto; Ugai, Keizo			A novel solidification technique for fluorine-contaminated bassanite using waste materials in ground improvement applications	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Gypsum wastes; Recycled bassanite; Ettringite; Solidification agent; Ground improvement	FLY-ASH; RECYCLED BASSANITE; SOFT CLAY; ETTRINGITE; SOILS; STABILIZATION; STRENGTH; SYSTEM	This study investigates the development of solidification technology, based on the formation of ettringite, for fluorine-contaminated bassanite using waste and recycled materials. Recycled bassanite is mixed with coal ash, blast furnace slag and furnace cement type B in varying proportions to obtain the optimal ettringite production, based on the chemical response. Leaching tests are performed on the different admixtures to measure the solubility of fluorine. Scan electron microscope and X-ray diffraction tests are conducted on the samples to explore the formation and intensity of ettringite. The results show that the suggested admixture has a significant effect on the production of ettringite and increasing the cement content in the admixture increases the formation of ettringite. The increase of the ratio of cement in the admixture has a clear effect on the production of ettringite and the reduction of fluorine solubility compared to the case of cement-bassanite mixture. Both size and length of ettringite crystals increase with an increase in the ratio of cement-admixture/bassanite and intensity of ettringite in the material matrix. The solubility of fluorine decreases with the increase of admixture content because of the concomitant increase in the production of ettringite. The dimensions of the ettringite crystals have a significant effect on the reduction of the solubility of fluorine, i.e., an increase in ettringite prisms size decreases the fluorine solubility. The investigated limits of the suggested admixture do not show any adverse effect on the geo-environmental properties in terms of fluorine release. The suggested admixture is recommended as a stabiliser material for soft clay soil because it is environmentally friendly, economical and meets the environmental standards.	[Kamei, Takeshi] Miyazaki Univ, Dept Civil & Environm Engn, Miyazaki 8892192, Japan; [Ahmed, Aly] Beni Suef Univ, Dept Civil Engn, Bani Suwayf, Egypt; [Horai, Hideto] Nikko Co Ltd, Ctr Res & Dev, Business Dev Div, Akashi, Hyogo 6748585, Japan; [Ugai, Keizo] Gunma Univ, Dept Civil & Environm Engn, Kiryu, Gunma 3768515, Japan	Ahmed, A (reprint author), Beni Suef Univ, Dept Civil Engn, POB 62512, Bani Suwayf, Egypt.	kamei@civil.miyazaki-u.ac.jp; aly_76@hotmail.com; hideto.horai@nikko-net.co.jp; ugai@ce.gunma-u.ac.jp					DAMIDOT D, 1992, CEMENT CONCRETE RES, V22, P1179, DOI 10.1016/0008-8846(92)90047-Y; Ahmed A, 2011, COLD REG SCI TECHNOL, V66, P84, DOI 10.1016/j.coldregions.2010.12.004; Ahmed A, 2011, SOILS FOUND, V51, P975, DOI 10.3208/sandf.51.975; Chrysochoou M, 2006, J HAZARD MATER, V136, P20, DOI 10.1016/j.jhazmat.2005.11.008; Ahmed A, 2011, CONSTR BUILD MATER, V25, P208, DOI 10.1016/j.conbuildmat.2010.06.036; Kamei T, 2012, COLD REG SCI TECHNOL, V82, P124, DOI 10.1016/j.coldregions.2012.05.016; Dermatas D, 2003, ENG GEOL, V70, P377, DOI 10.1016/S0013-7952(03)00105-4; SOLEMTISHMACK JK, 1995, CEMENT CONCRETE RES, V25, P658, DOI 10.1016/0008-8846(95)00054-G; Tastan EO, 2011, J GEOTECH GEOENVIRON, V137, P819, DOI 10.1061/(ASCE)GT.1943-5606.0000502; [Anonymous], 2003, C61878 ASTM; Horpibulsuk S, 2012, J MATER CIVIL ENG, V24, P184, DOI 10.1061/(ASCE)MT.1943-5533.0000370; Kamei T, 2013, CONSTR BUILD MATER, V38, P224, DOI 10.1016/j.conbuildmat.2012.08.028; DAMIDOT D, 1993, CEMENT CONCRETE RES, V23, P1195, DOI 10.1016/0008-8846(93)90180-H; Arora S, 2005, J MATER CIVIL ENG, V17, P640, DOI 10.1061/(ASCE)0899-1561(2005)17:6(640); Bin-Shafique S, 2009, J RESOUR CONSERV REC, V54, P666; Brooks R, 2011, J MATER CIVIL ENG, V23, P711, DOI 10.1061/(ASCE)MT.1943-5533.0000214; Cody AM, 2004, CEMENT CONCRETE RES, V34, P869, DOI 10.1016/j.cemconres.2003.10.023; Cokca Erdal, 2009, Geotechnical and Geological Engineering, V27, DOI 10.1007/s10706-008-9250-z; Geliga EA, 2010, UNIMAS E J CIVIL ENG, V1, P1; Kamei T., 2007, GEOTECHNICAL SOC ELE, V2, P245; KAMEI T, 2013, J SOILS FDN, V53, P155; Kamei T., 2008, JAPANESE GEOTECHNICA, V4, P91; Kunitomo H, 2009, P S EFF US COAL ASH, P23; Mackiewicz SM, 2005, P 2005 WORLD COAL AS, P7; Ministry of the Environment Government of Japan (MOE), 2012, SOIL CONT COUNT; Nidzam R M, 2010, P I CIVIL ENG CONSTR, V163, p157~165, DOI DOI 10.1680/COMA.2010.163.3.157; NISHIKAWA T, 1992, CEMENT CONCRETE RES, V22, P6, DOI 10.1016/0008-8846(92)90130-N; Phani BR, 2004, J GEOTECH GEOENVIRON, V130, P764, DOI 10.1061/(ASCE)1090-0241(2004)130:7(764); Rifa A, 2010, GROUND IMPROVEMENT TECHNOLOGIES AND CASE HISTORIES, P469, DOI 10.3850/GI025; Rifai A, 2009, P INT JOINT S GEOD P, P185; Senol A, 2012, P GEOC 2012 STAT ART, V225, P3929; Sobhan K, 2006, J ENV ENG, V129, P943; WHO, 1984, FLUOR FLUOR ENV HLTH, V36; World health organisation (WHO), 2004, FLUOR DRINK WAT BACK, P17; World Health Organization (WHO), 2000, FLUOR AIR QUAL GUID, P9	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	APR	2015	17	2					380	390		10.1007/s10163-014-0251-0		11	Environmental Sciences	Environmental Sciences & Ecology	CF3KS	WOS:000352448000017		
J	Shi, ZH; Si, CJ; Zhao, MH; He, LF; Zhang, M; Suzuki, K				Shi, Zhenghao; Si, Chunjiao; Zhao, Minghua; He, Lifeng; Zhang, Ming; Suzuki, Kenji			An Automatic Method for Lung Segmentation in Thin Slice Computed Tomography Based on Random Walks	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Lung Segmentation; Computed Tomography (CT); Random Walks	CHEST CT IMAGES; AIDED DIAGNOSIS; PULMONARY NODULES; THORACIC CT; BOUNDARY; SCANS	In this paper, a prior knowledge guided random walks is proposed. We combine the entropy rate superpixels with dyadic discrete wavelet transform to automatic obtain the coarse area of seeds and non-seeds by rapidly accounting the location of the lung parenchyma and the background in the anatomy. After random walks performed, a curvature-based approach is followed for amending the segmented lung contour. Experiments on a validation database consisting of 23 chest CT scans suggested that the proposed method was superior to other similar methods for lung segmentation on CT scans.	[Shi, Zhenghao; Si, Chunjiao; Zhao, Minghua] Xian Univ Technol, Sch Comp Sci & Engn, Xian 710048, Peoples R China; [Suzuki, Kenji] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [He, Lifeng] Aichi Prefectual Univ, Nagakute, Aichi 4801198, Japan; [Zhang, Ming] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China	Shi, ZH (reprint author), Xian Univ Technol, Sch Comp Sci & Engn, Xian 710048, Peoples R China.				Nature Science Foundation of Shaanxi province [2014JQ8299]; Nature Science Foundation of Shaanxi Education Department [2013JK1136]; Nature Science Foundation of Science Department of PeiLin count at Xi'an [GX1213]	This work is partially supported by a grant from the Nature Science Foundation of Shaanxi province (2014JQ8299), Nature Science Foundation of Shaanxi Education Department (No. 2013JK1136), the Nature Science Foundation of Science Department of PeiLin count at Xi'an (GX1213). The authors also gratefully acknowledge the helpful comments and suggestions of the reviewers.	Cheng KS, 1996, IEEE T MED IMAGING, V15, P560; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Armato SG, 2004, ACAD RADIOL, V11, P1011, DOI 10.1016/j.xacra.2004.06.005; Armato SG, 1999, RADIOGRAPHICS, V19, P1303; Way TW, 2006, MED PHYS, V33, P2323, DOI 10.1118/1.2207129; Sakellaropoulos P, 2003, PHYS MED BIOL, V48, P787, DOI 10.1088/0031-9155/48/6/307; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Unnikrishnan R, 2007, IEEE T PATTERN ANAL, V29, P929, DOI 10.1109/TPAMI.2007.1046; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415; Li Q, 2005, SEMIN ULTRASOUND CT, V26, P357, DOI 10.1053/j.sult.2005.07.001; Pu J, 2008, COMPUT MED IMAG GRAP, V32, P452, DOI 10.1016/j.compmedimag.2008.04.005; Gurcan MN, 2002, MED PHYS, V29, P2552, DOI 10.1118/1.1515762; HEDLUND LW, 1982, RADIOLOGY, V144, P353; Hu SC, 2014, J BIOL SYST, V22, P1, DOI 10.1142/S0218339014500016; Kim DY, 2003, ACTA RADIOL, V44, P252, DOI 10.1034/j.1600-0455.2003.00061.x; Martin D., 2001, P 8 INT C COMP VIS, V2, P416, DOI 10.1109/ICCV.2001.937655; Masutani Y., 2002, IEEE T MED IMAGING, V21, P17; Meila M., 2005, P 22 INT C MACH LEAR, P577, DOI 10.1145/1102351.1102424; Qin CC, 2014, NEUROCOMPUTING, V129, P378, DOI 10.1016/j.neucom.2013.09.021; Shi Z. H., 2011, ICIC EXPRESS LETT B, V2, P69; Uchiyama Y, 2003, MED PHYS, V30, P2440, DOI 10.1118/1.1597431; Yim Y, 2009, COMPUT BIOL MED, V39, P239, DOI 10.1016/j.compbiomed.2008.12.014; Yim Y, 2008, COMPUT BIOL MED, V38, P845, DOI 10.1016/j.compbiomed.2008.04.012	23	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	APR	2015	5	2					303	308		10.1166/jmihi.2015.1391		6	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	CF4PC	WOS:000352531300018		
J	Yoshimura, R; Kyuka, A; Jinno, M; Nishio, S; Matsusaka, M; Nishida, T; Endo, Y				Yoshimura, Ryoichi; Kyuka, Ayumi; Jinno, Miwa; Nishio, Satomi; Matsusaka, Mamoru; Nishida, Tomoki; Endo, Yasuhisa			Increase in Neuropilin-1 on the Surface of Growth Cones and Putative Raft Domains in Neuronal NG108-15 Cells Co-Cultured with Vascular Smooth Muscle SM-3 Cells	JOURNAL OF MEMBRANE BIOLOGY			English	Article						Co-culture; Autonomic vascular innervation; Axon repellent; Lipid raft; Membrane protein extraction	DEVELOPING SYMPATHETIC NEURONS; LIPID RAFTS; CHOLESTEROL DEPLETION; SYNAPSE FORMATION; PLASMA-MEMBRANE; SEMAPHORIN-III; AXON GUIDANCE; HYBRID-CELLS; MICRODOMAINS; TRAFFICKING	The mechanisms underlying autonomic innervation to its targets involve various chemical factors, but have not yet been elucidated in detail. We constructed a co-culture system of neuronal cells and vascular smooth muscle cells to investigate the mechanisms underlying innervation of the vasculature. A co-culture with the vascular smooth muscle cell line, SM-3 significantly promoted cell viability, neurite extension, and neuropilin-1 (Nrp-1) mRNA expression in the cholinergic neuronal cell line, NG108-15. Furthermore, immunocytochemistry with or without a detergent treatment revealed that a co-culture with SM-3 cells or culturing with the conditioned medium of SM-3 cells translocated Nrp-1 onto the cell surface of growth cones rather than varicosities of NG108-15 cells. Immunofluorescent microscopy combined with a cold detergent treatment or cholesterol depletion revealed that Nrp-1 accumulated in putative raft domains in the plasma membrane of NG108-15 cells co-cultured with SM-3 cells. The results of the present study suggest that some soluble factors from smooth muscle cells may affect the localization of Nrp-1 in cholinergic neuronal cells, which may, in turn, be involved in the autonomic innervation of blood vessels.	[Yoshimura, Ryoichi; Kyuka, Ayumi; Jinno, Miwa; Nishio, Satomi; Matsusaka, Mamoru; Endo, Yasuhisa] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Nishida, Tomoki] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, Osaka, Japan	Yoshimura, R (reprint author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	ryoshimu@kit.ac.jp					Amiya Eisuke, 2014, Ann Vasc Dis, V7, P109, DOI 10.3400/avd.ra.14-00048; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Zylbersztejn K, 2012, J CELL BIOL, V196, P37, DOI 10.1083/jcb.201106113; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Brunet I, 2014, J CLIN INVEST, V124, P3230, DOI 10.1172/JCI75181; Ilangumaran S, 1998, BIOCHEM J, V335, P433; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Berk BC, 2001, PHYSIOL REV, V81, P999; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; BEVAN JA, 1987, CIRC RES, V60, P309; Burnstock Geoffrey, 2008, Neurochem Int, V52, P14, DOI 10.1016/j.neuint.2007.03.007; Chen XL, 2008, TRANSPL INT, V21, P30, DOI 10.1111/j.1432-2277.2007.00570.x; Endo Y, 2004, ZOOL SCI, V21, P1279; ENDO Y, 1991, BIOMED RES-TOKYO, V12, P211; Fujisawa H, 1997, CELL TISSUE RES, V290, P465, DOI 10.1007/s004410050954; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Kamiguchi H, 2006, J NEUROCHEM, V98, P330, DOI 10.1111/j.1471-4159.2006.03888.x; KATO K, 1981, BIOCHIM BIOPHYS ACTA, V660, P30, DOI 10.1016/0005-2744(81)90104-2; Kyuka A, 2006, NEUROSCI RES, V55, pS182; Kyuka A, 2008, NEUROSCI RES, V61, pS161; Long JB, 2009, DEV BIOL, V334, P119, DOI 10.1016/j.ydbio.2009.07.023; Marko SB, 2008, AM J PHYSIOL-HEART C, V294, pH2646, DOI 10.1152/ajpheart.00291.2008; Migas I, 1997, CAN J PHYSIOL PHARM, V75, P1249, DOI 10.1139/cjpp-75-10-11-1249; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; PURO DG, 1976, P NATL ACAD SCI USA, V73, P3544, DOI 10.1073/pnas.73.10.3544; SASAKI Y, 1989, J BIOCHEM-TOKYO, V106, P1009; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2631	1432-1424		J MEMBRANE BIOL	J. Membr. Biol.	APR	2015	248	2					171	178		10.1007/s00232-014-9754-9		8	Biochemistry & Molecular Biology; Cell Biology; Physiology	Biochemistry & Molecular Biology; Cell Biology; Physiology	CF0EB	WOS:000352214500002		
J	Miyata, R; Nomura, K; Kakuki, T; Takano, K; Kohno, T; Konno, T; Sawada, N; Himi, T; Kojima, T				Miyata, Ryo; Nomura, Kazuaki; Kakuki, Takuya; Takano, Ken-ichi; Kohno, Takayuki; Konno, Takumi; Sawada, Norimasa; Himi, Tetsuo; Kojima, Takashi			Irsogladine Maleate Regulates Gap Junctional Intercellular Communication-Dependent Epithelial Barrier in Human Nasal Epithelial Cells	JOURNAL OF MEMBRANE BIOLOGY			English	Article						Irsogladine maleate; GJIC; Tight junctions; Barrier function; Human nasal epithelial cells; TLR3	TIGHT JUNCTIONS; EXPRESSION; PATHWAYS; GROWTH; ALPHA; IL-8	The airway epithelium of the human nasal mucosa acts as the first physical barrier that protects against inhaled substances and pathogens. Irsogladine maleate (IM) is an enhancer of gastric mucosal protective factors via upregulation of gap junctional intercellular communication (GJIC). GJIC is thought to participate in the formation of functional tight junctions. However, the effects of IM on GJIC and the epithelial barrier in human nasal epithelial cells (HNECs) remain unknown. To investigate the effects of IM on GJIC and the tight junctional barrier in HNECs, primary cultures of HNECs transfected with human telomerase reverse transcriptase (hTERT-HNECs) were treated with IM and the GJIC inhibitors oleamide and 18 beta-GA. Some cells were pretreated with IM before treatment with TLR3 ligand poly(I:C) to examine whether IM prevented the changes via TLR3-mediated signal pathways. In hTERT-HNECs, GJIC blockers reduced the expression of tight junction molecules claudin-1, -4, -7, occludin, tricellulin, and JAM-A. IM induced GJIC activity and enhanced the expression of claudin-1, -4, and JAM-A at the protein and mRNA levels with an increase of barrier function. GJIC blockers prevented the increase of the tight junction proteins induced by IM. Furthermore, IM prevented the reduction of JAM-A but not induction of IL-8 and TNF-alpha induced by poly(I:C). In conclusion, IM can maintain the GJIC-dependent tight junctional barrier via regulation of GJIC in upper airway nasal epithelium. Therefore, it is possible that IM may be useful as a nasal spray to prevent the disruption of the epithelial barrier by viral infections and exposure to allergens in human nasal mucosa.	[Miyata, Ryo; Nomura, Kazuaki; Kakuki, Takuya; Takano, Ken-ichi; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608556, Japan; [Miyata, Ryo; Kakuki, Takuya; Kohno, Takayuki; Konno, Takumi; Kojima, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido 0608556, Japan; [Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan	Kojima, T (reprint author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, S1,W17, Sapporo, Hokkaido 0608556, Japan.	ktakashi@sapmed.ac.jp					Ohkuni T, 2011, TOXICOL APPL PHARM, V250, P29, DOI 10.1016/j.taap.2010.09.023; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Kamekura R, 2009, CELL TISSUE RES, V338, P283, DOI 10.1007/s00441-009-0855-1; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Kojima T, 2002, EXP CELL RES, V276, P40, DOI 10.1006/excr.2002.5511; Hiraishi H, 2010, ALIMENT PHARM THER, V31, P824, DOI 10.1111/j.1365-2036.2010.04250.x; Ito T, 1997, PANCREAS, V15, P297, DOI 10.1097/00006676-199710000-00013; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Ohkuni T, 2009, MED MOL MORPHOL, V42, P204, DOI 10.1007/s00795-009-0470-y; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Kojima T, 2013, BIOMED RES INT, DOI 10.1155/2013/947072; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Koizumi JI, 2007, J MEMBRANE BIOL, V218, P1, DOI 10.1007/s00232-007-9029-9; Koizumi JI, 2008, MOL PHARMACOL, V74, P432, DOI 10.1124/mol.107.043711; Kojima T, 2009, HISTOL HISTOPATHOL, V24, P1463; Kurose M, 2007, CELL TISSUE RES, V330, P63, DOI 10.1007/s00441-007-0453-z; Morita H, 2004, EXP CELL RES, V298, P1, DOI 10.1016/j.yexcr.2004.03.046; Ogasawara N, 2010, PHARMACOL RES, V61, P489, DOI 10.1016/j.phrs.2010.03.002; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; Savitri IJ, 2014, J PERIODONTAL RES, DOI [10.1111/jre.12231, DOI 10.1111/JRE.12231]; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, P1213; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/4A6539.2005; Trosko JE, 1998, FRONT BIOSCI, V15, P208; Uchida Y, 2005, BIOCHEM BIOPH RES CO, V333, P502, DOI 10.1016/j.bbrc.2005.05.147; UEDA F, 1991, JPN J PHARMACOL, V57, P321, DOI 10.1254/jjp.57.321	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2631	1432-1424		J MEMBRANE BIOL	J. Membr. Biol.	APR	2015	248	2					327	336		10.1007/s00232-015-9774-0		10	Biochemistry & Molecular Biology; Cell Biology; Physiology	Biochemistry & Molecular Biology; Cell Biology; Physiology	CF0EB	WOS:000352214500018		
J	Imori, S; von Rosen, D				Imori, Shinpei; von Rosen, Dietrich			Covariance components selection in high-dimensional growth curve model with random coefficients	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Covariance components analysis; Generalized information criterion; Growth curve model with random coefficients	LINEAR MIXED MODELS; VARIANCE-COMPONENTS; TESTS; PARAMETERS; REGRESSION; CRITERIA	In this paper, the true number of covariance components in a high-dimensional growth curve model with random coefficients are selected. We propose a selection criterion based on a concept from information theory. The proposed criterion satisfies a consistency property of the true covariance components in our high-dimensional setting. The performance of the proposed methodology is illustrated in a simulation study. (C) 2015 Elsevier Inc. All rights reserved.	[Imori, Shinpei] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [von Rosen, Dietrich] Swedish Univ Agr Sci, Dept Energy & Technol, S-90183 Umea, Sweden; [von Rosen, Dietrich] Linkoping Univ, Dept Math, S-58183 Linkoping, Sweden	Imori, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	imori.stat@gmail.com			JSPS	The authors are grateful to the two reviewers for their helpful suggestion. Shinpei Imori's research is supported by Research Fellowships of the JSPS for Young Scientist.	Akaike H., 1973, 2 INT S INF THEOR, P267; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Kinney SK, 2007, BIOMETRICS, V63, P690, DOI 10.1111/j.1541-0420.2007.00771.x; NISHII R, 1984, ANN STAT, V12, P758, DOI 10.1214/aos/1176346522; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Chen Z, 2003, BIOMETRICS, V59, P762, DOI 10.1111/j.0006-341X.2003.00089.x; Bondell HD, 2010, BIOMETRICS, V66, P1069, DOI 10.1111/j.1541-0420.2010.01391.x; RAO CR, 1965, BIOMETRIKA, V52, P447, DOI 10.2307/2333697; POTTHOFF RF, 1964, BIOMETRIKA, V51, P313; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Fitzmaurice GM, 2007, BIOMETRICS, V63, P942, DOI 10.1111/j.1541-0420.2007.00775.x; Fujikoshi Y, 2000, J MULTIVARIATE ANAL, V75, P245, DOI 10.1006/jmva.2000.1907; Fujikoshi Y, 2013, J MULTIVARIATE ANAL, V122, P239, DOI 10.1016/j.jmva.2013.07.006; Fujikoshi Y, 2014, J MULTIVARIATE ANAL, V123, P184, DOI 10.1016/j.jmva.2013.09.006; LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869; Li ZX, 2014, SCAND J STAT, V41, P482, DOI 10.1111/sjos.12044; Sakurai T., 2013, SANKHYA A, V75, P1; SCHOTT JR, 1985, SANKHYA SER B, V47, P179; Siotani M., 1985, MODERN MULTIVARIATE; VONROSEN D, 1991, COMMUN STAT THEORY, V20, P2791, DOI 10.1080/03610929108830668; Yokoyama T., 1992, HIROSHIMA MATH J, V22, P195	22	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	APR	2015	136						86	94		10.1016/j.jmva.2015.01.010		9	Statistics & Probability	Mathematics	CE9RW	WOS:000352182100007		
J	Sofic, E; Salkovic-Petrisic, M; Tahirovic, I; Sapcanin, A; Mandel, S; Youdim, M; Riederer, P				Sofic, E.; Salkovic-Petrisic, M.; Tahirovic, I.; Sapcanin, A.; Mandel, S.; Youdim, M.; Riederer, P.			Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30	JOURNAL OF NEURAL TRANSMISSION			English	Article						Rat; Oxidative stress; Streptozotocin; Catalase; Sporadic Alzheimer's disease	OXIDATIVE STRESS; INTRACEREBROVENTRICULAR STREPTOZOTOCIN; COGNITIVE IMPAIRMENT; ANTIOXIDANT CAPACITY; INSULIN-RESISTANCE; IN-VITRO; NEURODEGENERATIVE DISORDERS; MULTIFUNCTIONAL DRUGS; GLUCOSE-METABOLISM; DIABETES-MELLITUS	Low intracerebroventricular (icv) doses of streptozotocin (STZ) produce regionally specific brain neurochemical changes in rats that are similar to those found in the brain of patients with sporadic Alzheimer's disease (sAD). Since oxidative stress is thought to be one of the major pathologic processes in sAD, catalase (CAT) activity was estimated in the regional brain tissue of animals treated intracerebroventricularly with STZ and the multitarget iron chelator, antioxidant and MAO-inhibitor M30 [5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinoline]. Five-day oral pre-treatment of adult male Wistar rats with 10 mg/kg/day M30 dose was followed by a single injection of STZ (1 mg/kg, icv). CAT activity was measured colorimetrically in the hippocampus (HPC), brain stem (BS) and cerebellum (CB) of the control, STZ-, M30- and STZ + M30-treated rats, respectively, 4 weeks after the STZ treatment. STZ-treated rats demonstrated significantly lower CAT activity in all three brain regions in comparison to the controls (p < 0.05 for BS and CB, p < 0.01 for HPC). M30 pre-treatment of the control rats did not influence the CAT activity in HPC and CB, but significantly increased it in BS (p < 0.05). M30 pre-treatment of STZ-treated rats significantly increased CAT activity in the HPC in comparison to the STZ treatment alone (p < 0.05) and normalized to the control values. These findings are in line with the assumption that reactive oxygen species contribute to the pathogenesis of STZ in a rat model of sAD and indicate that multifunctional iron chelators such as M30 might also have beneficial effects in this non-transgenic sAD model.	[Sofic, E.; Tahirovic, I.; Sapcanin, A.] Univ Sarajevo, Dept Chem, Fac Sci, Sarajevo 71000, Bosnia & Herceg; [Sofic, E.; Sapcanin, A.] Univ Sarajevo, Fac Pharm, Sarajevo 71000, Bosnia & Herceg; [Salkovic-Petrisic, M.] Univ Zagreb, Dept Pharmacol, HR-10000 Zagreb, Croatia; [Salkovic-Petrisic, M.] Univ Zagreb, Croatian Inst Brain Res, Sch Med, HR-10000 Zagreb, Croatia; [Mandel, S.; Youdim, M.] Eve Topf Ctr Neurodegenerat Dis Res,Techn, Dept Mol Pharmacol, Fac Med, Techn, Haifa, Israel; [Riederer, P.] Univ Hosp, Clin & Polyclin Psychiat Psychosomat & Psychother, Dept Cognit Brain Sci, Ctr Mental Hlth,NCGG,Hosp Wuerzburg, Nagoya, Aichi, Japan	Sofic, E (reprint author), Univ Sarajevo, Dept Chem, Fac Sci, Zmaja Od Bosne 33-35, Sarajevo 71000, Bosnia & Herceg.	esofic@pmf.unsa.ba; ismet_tahirovic@yahoo.com			German Academic Exchange Service (DAAD), Stability Pact Project for South-Eastern Europe	The research was supported by the German Academic Exchange Service (DAAD), Stability Pact Project for South-Eastern Europe.	Agrawal R, 2009, NEUROPHARMACOLOGY, V56, P779, DOI 10.1016/j.neuropharm.2009.01.005; Zheng H, 2005, J NEUROCHEM, V95, P68, DOI 10.1111/j.1471-4159.2005.03340.x; Todorich BM, 2004, ANN NY ACAD SCI, V1012, P171, DOI 10.1196/annals.1306.014; Gal S, 2006, J NEURAL TRANSM-SUPP, P447; Kupershmidt L, 2011, NEUROSCIENCE, V189, P345, DOI 10.1016/j.neuroscience.2011.03.040; Kumar MHV, 2003, CLIN EXP PHARMACOL P, V30, P336; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; de la Monte SM, 2013, EXPERT OPIN DRUG DEL, V10, P1699, DOI 10.1517/17425247.2013.856877; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; GSELL W, 1995, J NEUROCHEM, V64, P1216; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Tiwari V, 2009, PHARMACOL BIOCHEM BE, V93, P183, DOI 10.1016/j.pbb.2009.05.009; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Faller P, 2013, INORG CHEM, V52, P12193, DOI 10.1021/ic4003059; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Sharma M, 2001, PHARMACOL BIOCHEM BE, V70, P325, DOI 10.1016/S0091-3057(01)00611-6; Misra S, 2011, EUR J PHARMACOL, V659, P177, DOI 10.1016/j.ejphar.2011.03.026; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Weinreb O, 2006, J NEURAL TRANSM-SUPP, P457; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; YOUDIM MBH, 1989, AM J CLIN NUTR, V50, P607; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Prickaerts J, 1999, BEHAV BRAIN RES, V102, P73, DOI 10.1016/S0166-4328(98)00158-2; Pathan AR, 2006, LIFE SCI, V79, P2209, DOI 10.1016/j.lfs.2006.07.018; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; Zheng HL, 2005, BIOORGAN MED CHEM, V13, P773, DOI 10.1016/j.bmc.2004.10.037; Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Selvatici R, 2013, NEUROCHEM INT, V63, P112, DOI 10.1016/j.neuint.2013.05.005; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; Kupershmidt L, 2012, ANTIOXID REDOX SIGN, V17, P860, DOI 10.1089/ars.2011.4279; Bandyopadhyay S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065978; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335; Ben Shachar D, 2004, NEUROPHARMACOLOGY, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005; DEISSERO.A, 1970, PHYSIOL REV, V50, P319; GOTZ ME, 1992, DEMENTIA, V3, P213, DOI 10.1159/000107020; Grunblatt E, 2011, J NEURAL TRANSM, V118, P371, DOI 10.1007/s00702-010-0426-3; Khan MB, 2012, NEUROL SCI, V33, P1011, DOI 10.1007/s10072-011-0880-1; Kowaltowski AJ, 2000, FEBS LETT, V473, P177, DOI 10.1016/S0014-5793(00)01526-X; Mechlovich D, 2010, J PHARMACOL EXP THER, V333, P874, DOI 10.1124/jpet.109.164269; Pollak Y, 2013, J NEURAL TRANSM, V120, P37, DOI 10.1007/s00702-012-0795-x; Prakash AK, 2009, J PHARM PHARMACOL, V61, P1665, DOI 10.1211/jpp/61.12.0012; RIEDERER P, 1990, NEW VISTAS DRUG RES, V1, P221; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Salkovic-Petrisic M, 2013, J NEURAL TRANSM, V120, P233, DOI 10.1007/s00702-012-0877-9; Sapcanin A, 2008, NEUROTOX RES, V13, P97; Sapcanin A, 2005, PARKINSONISM RELA S2, V11, P159; Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5; Sofic E, 2006, J NEURAL TRANSM-SUPP, P39; Sofic E, 1991, DEMENTIA, V2, P39, DOI 10.1159/000107173; SOFIC E, 1990, J NEUR TR S, P259; Sofic E, 1988, BIOL PSYCHIAT SYNOPS, P151; Tada-Oikawa S, 1999, FEBS LETT, V442, P65, DOI 10.1016/S0014-5793(98)01618-4; Tahirovic I, 2007, J NEURAL TRANSM-SUPP, P235; Tahirovic I, 2007, NEUROCHEM RES, V32, P1709, DOI 10.1007/s11064-007-9410-1; Tan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061246; Tome ME, 2001, CANCER RES, V61, P2766; Weinreb O, 2004, FASEB J, V18, P1471, DOI 10.1096/fj.04-1916fje	64	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	APR	2015	122	4			SI		559	564		10.1007/s00702-014-1307-y		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CF1HP	WOS:000352295900008		
J	Maekawa, T; Yamashita, S; Nagao, S; Hayashi, N; Ohashi, Y				Maekawa, Tsuyoshi; Yamashita, Susumu; Nagao, Seigo; Hayashi, Nariyuki; Ohashi, Yasuo		Brain-Hypothermia B-HYPO Study Grp	Prolonged Mild Therapeutic Hypothermia versus Fever Control with Tight Hemodynamic Monitoring and Slow Rewarming in Patients with Severe Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						cardiac output; cerebral perfusion; therapeutic hypothermia.; intracranial pressure	HOSPITAL CARDIAC-ARREST; MODERATE HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; EFFICACY; INDUCTION; OUTCOMES; SCALE	Although mild therapeutic hypothermia is an effective neuroprotective strategy for cardiac arrest/resuscitated patients, and asphyxic newborns, recent randomized controlled trials (RCTs) have equally shown good neurological outcome between targeted temperature management at 33 degrees C versus 36 degrees C, and have not shown consistent benefits in patients with traumatic brain injury (TBI). We aimed to determine the effect of therapeutic hypothermia, while avoiding some limitations of earlier studies, which included patient selection based on Glasgow coma scale (GCS), delayed initiation of cooling, short duration of cooling, inter-center variation in patient care, and relatively rapid rewarming. We conducted a multicenter RCT in patients with severe TBI (GCS 4-8). Patients were randomly assigned (2:1 allocation ratio) to either therapeutic hypothermia (32-34 degrees C, n=98) or fever control (35.5-37 degrees C, n=50). Patients with therapeutic hypothermia were cooled as soon as possible for >= 72 h and rewarmed at a rate of <1 degrees C/day. All patients received tight hemodynamic monitoring under intensive neurological care. The Glasgow Outcome Scale was assessed at 6 months by physicians who were blinded to the treatment allocation. The overall rates of poor neurological outcomes were 53% and 48% in the therapeutic hypothermia and fever control groups, respectively. There were no significant differences in the likelihood of poor neurological outcome (relative risk [RR] 1.24, 95% confidence interval [CI] 0.62-2.48, p=0.597) or mortality (RR 1.82, 95% CI 0.82-4.03, p=0.180) between the two groups. We concluded that tight hemodynamic management and slow rewarming, together with prolonged therapeutic hypothermia (32-34 degrees C) for severe TBI, did not improve the neurological outcomes or risk of mortality compared with strict temperature control (35.5-37 degrees C).	[Maekawa, Tsuyoshi] Yamaguchi Univ, Grad Sch Med, Dept Stress & Bioresponse Med, Ube, Yamaguchi 7558505, Japan; [Maekawa, Tsuyoshi; Yamashita, Susumu] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Nagao, Seigo] Kagawa Univ, Fac Med, Dept Neurol Surg, Takamatsu, Kagawa 760, Japan; [Hayashi, Nariyuki] Nihon Univ, Sch Med, Dept Acute Med, Div Emergency & Crit Care Med, Tokyo, Japan; [Ohashi, Yasuo] Univ Tokyo, Fac Med, Sch Integrated Hlth Sci, Tokyo 113, Japan	Maekawa, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Stress & Bioresponse Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	maekawa.tsuyoshi@ymghp.jp			Japanese Ministry of Health, Labour and Welfare [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by grants from Japanese Ministry of Health, Labour and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001), and the Japanese Human Science Association 2002-2004. We thank Takahiro Kiuchi (Director of the UMIN Centre) and Kiyoshi Ichihara (Yamaguchi University Graduate School of Medicine) for their support. We also thank Kees H Polderman (University of Pittsburgh Medical Center) for reviewing our manuscript and for his valuable suggestions.	Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; JENNETT B, 1975, LANCET, V1, P480; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Holzer M, 2002, NEW ENGL J MED, V346, P549; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kasaoka S, 2006, Minimally Invasive Neurosurgery and Multidisciplinary Neurotraumatology, P335, DOI 10.1007/4-431-28576-8_50; MARSHALL LF, 1991, J NEUROSURG, V75, pS14; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; The Japan Society of Neurotraumatology, 2001, GUID MAN SEV HEAD IN	30	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2015	32	7					422	429		10.1089/neu.2013.3197		8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CE4YV	WOS:000351837400002		
J	Shibata, A; Nakagawa, K; Tsuduki, T; Miyazawa, T				Shibata, Akira; Nakagawa, Kiyotaka; Tsuduki, Tsuyoshi; Miyazawa, Teruo			alpha-Tocopherol suppresses antiangiogenic effect of delta-tocotrienol in human umbilical vein endothelial cells	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Angiogenesis; Tocotrienol; Tocopherol; VEGF; HUVEC	COLORECTAL ADENOCARCINOMA CELLS; VITAMIN-E; IN-VITRO; CANCER; ANGIOGENESIS; INHIBITION; ANTIBODIES; THERAPY; VEGF; VIVO	Recently, tocotrienol (T3), a less well-known form of vitamin E, has gained attention as a potent hypocholesterolemic, anticancer and antiangiogenic agent. However, tocopherol (Toc), a commonly consumed form of vitamin E, has been reported to inhibit T3's effects (hypocholesterolemic and anticancer activity). There has been no report on Toc's effect on the antiangiogenic action of T3 during cotreatment The aim of this study is to determine if and to what extent Toc affects the antiangiogenic effects of delta-T3 (the most potent isomer). This was achieved through cotreatment of human umbilical vein endothelial cells (HUVECs) with delta-T3 and Toc (alpha-,beta-,gamma- and delta-isomers). Toc, especially a-Toc, attenuated delta-T3-induced cytotoxicity and tube degradation in cotreated HUVECs, while a-Toc treatments did not exhibit any effects. A rat aortic ring assay also showed inhibition of delta-T3's antiangiogenic effects by a-Toc. Further, in HUVEC study, cell cycle arrest and proapoptotic gene expression (p21, p27, caspase-3 and caspase-9) which were induced by delta-T3 were decreased by ot-Toc treatment. a-Toc also suppressed delta-T3-induced dephosphorylation of vascular endothelial growth factor receptor 2 and Akt pathway proteins. Additionally, uptake of delta-T3 into HUVECs was decreased by a-Toc. Here we demonstrate that a-Toc not only has little antiangiogenic effect on endothelial cells but also reduces the antiangiogenic effects of delta-T3 through modulation of its cellular uptake and of relevant signal transduction pathways. Understanding T3's antiangiogenic effects and interaction with Toc is important for developing medical applications. (C) 2015 Elsevier Inc. All rights reserved.	[Shibata, Akira; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Food & Biodynam Chem Lab, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Tsuduki, Tsuyoshi] Tohoku Univ, Lab Food & Biomol Sci, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan	Nakagawa, K (reprint author), Tohoku Univ, Food & Biodynam Chem Lab, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	nkgw@m.tohoku.ac.jp					Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Shibata A, 2009, J AGR FOOD CHEM, V57, P8696, DOI 10.1021/jf9012899; Schlaeppi JM, 1999, CANCER METAST REV, V18, P473, DOI 10.1023/A:1006358220123; Shibata A, 2008, BIOCHEM PHARMACOL, V76, P330, DOI 10.1016/j.bcp.2008.05.017; Sookwong P, 2007, J AGR FOOD CHEM, V55, P461, DOI 10.1021/jf0621572; Shibata A, 2008, J NUTR, V138, P2136, DOI 10.3945/jn.108.093237; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Qureshi AA, 1996, J NUTR, V126, P389; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Wang K, 2012, J ENDOCRINOL, V212, P243, DOI 10.1530/JOE-11-0296; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Nakagawa K, 2007, J NUTR, V137, P1938; Yap WN, 2010, CANCER LETT, V291, P187, DOI 10.1016/j.canlet.2009.10.012; Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Elisia I, 2013, BIOFACTORS, V39, P663, DOI 10.1002/biof.1132; Guthrie N, 1997, J NUTR, V127, pS544; Hodul PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052526; Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776; Manu MA, 2012, CLIN CANCER RES, V18, P2220; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Shibata A, 2010, BIOCHEM BIOPH RES CO, V397, P214, DOI 10.1016/j.bbrc.2010.05.087; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Wahl O, 2011, CURR MED CHEM, V18, P3136	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	APR	2015	26	4					345	350		10.1016/j.jnutbio.2014.11.010		6	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CF3QN	WOS:000352463700006		
J	Yoshinaga, K; Sasaki, K; Watanabe, H; Nagao, K; Inoue, N; Shirouchi, B; Yanagita, T; Nagai, T; Mizobe, H; Kojima, K; Beppu, F; Gotoh, N				Yoshinaga, Kazuaki; Sasaki, Keiichi; Watanabe, Hiroyuki; Nagao, Koji; Inoue, Nao; Shirouchi, Bungo; Yanagita, Teruyoshi; Nagai, Toshiharu; Mizobe, Hoyo; Kojima, Koichi; Beppu, Fumiaki; Gotoh, Naohiro			Differential effects of triacylglycerol positional isomers containing n-3 series highly unsaturated fatty acids on lipid metabolism in C57BL/6J mice (vol 26, pg 57, 2015)	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Correction									[Yoshinaga, Kazuaki; Nagai, Toshiharu; Mizobe, Hoyo; Kojima, Koichi] Tsukishima Foods Ind Co Ltd, Edogawa Ku, Tokyo 1348520, Japan; [Yoshinaga, Kazuaki; Sasaki, Keiichi; Beppu, Fumiaki; Gotoh, Naohiro] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Watanabe, Hiroyuki] Kochi Univ, Dept Hlth Sci, Kochi, Kochi 7810111, Japan; [Nagao, Koji; Inoue, Nao; Shirouchi, Bungo] Saga Univ, Dept Appl Biochem & Food Sci, Saga, Saga 8408502, Japan; [Yanagita, Teruyoshi] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki, Saga 8428585, Japan	Gotoh, N (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	ngotoh@kaiyodai.ac.jp	GOTOH, Naohiro/O-1975-2014				Yoshinaga K, 2015, J NUTR BIOCHEM, V26, P57, DOI 10.1016/j.jnutbio.2014.09.004	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	APR	2015	26	4					431	432		10.1016/j.jnutbio.2015.01.001		2	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CF3QN	WOS:000352463700015		
J	Kanamoto, T; Kiuchi, Y; Tanito, M; Mizoue, S; Naito, T; Teranishi, S; Hirooka, K; Rimayanti, U				Kanamoto, Takashi; Kiuchi, Yoshiaki; Tanito, Masaki; Mizoue, Shiro; Naito, Tomoko; Teranishi, Shinichiro; Hirooka, Kazuyuki; Rimayanti, Ulfah		Ocular Surface Dis Glaucoma Study	Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							PROSTAGLANDIN ANALOGS; GLAUCOMA MEDICATION; OPHTHALMIC SOLUTION; EFFICACY; LATANOPROST; SAFETY; HYPERTENSION; PREVALENCE; SYMPTOMS; CELLS	Purpose: To evaluate some clinically important features of benzalkonium chloride (BAK) toxicity by comparing tafluprost with 0.001% BAK and travoprost preserved with SofZia applied to the ocular surface of the eyes with glaucoma. Methods: This was a prospective, randomized, observer unmasked, multicenter crossover trial. A total of 195 patients were randomized and 174 patients completed the study at 19 clinics between November 2011 and August 2012. Topical BAK-preserved tafluprost or SofZia-preserved travoprost was newly administered or continued. Superficial punctate keratopathy (SPK), tear break-up time (BUT), the conjunctival hyperemia score, and intraocular pressure (IOP) were compared at the baseline visit, 4, and 12 weeks after the start of therapy. The eye drops were switched to another eye drop after 12 weeks of observation. Results: The total SPK and conjunctival hyperemia scores were significantly lower in the tafluprost compared with those in the travoprost phase (both P=0.038). There were no significant differences in the SPK scores of the superior area (P=0.679), central area (P=0.089), inferior area (P=0.090), and tear BUT (P=0.271). The IOP-lowering effects were similar (P=0.155). Conclusions: SPK, hyperemia score, and tear BUT while using tafluprost with 0.001% BAK were not inferior compared with those caused by travoprost with SofZia.	[Kanamoto, Takashi; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima 7348551, Japan; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan; [Mizoue, Shiro] Ehime Univ, Sch Med, Dept Ophthalmol, Touon, Japan; [Naito, Tomoko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama 7008530, Japan; [Teranishi, Shinichiro] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Ube, Yamaguchi 755, Japan; [Hirooka, Kazuyuki] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa 760, Japan; [Rimayanti, Ulfah] UIN Alauddin Makassar, Fac Hlth Sci, South Sulawesi, Indonesia	Kiuchi, Y (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	ykiuchi@hiroshima-u.ac.jp					Aihara M, 2013, ACTA OPHTHALMOL, V91, pe7, DOI 10.1111/j.1755-3768.2012.02565.x; Tomic M, 2013, BIOMED RES INT, DOI 10.1155/2013/603782; Jaenen N, 2007, EUR J OPHTHALMOL, V17, P341; Kitazawa Y, 2011, EYE, V25, P1161, DOI 10.1038/eye.2011.134; Honrubia F, 2009, BRIT J OPHTHALMOL, V93, P316, DOI 10.1136/bjo.2007.135111; Lewis RA, 2007, J GLAUCOMA, V16, P98, DOI 10.1097/01.ijg.0000212274.50229.c6; Nakagawa S, 2012, INVEST OPHTH VIS SCI, V53, P5154, DOI 10.1167/iovs.12-9685; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Fan BJ, 2010, J CLIN INVEST, V120, P3064, DOI 10.1172/JCI43085; Whitson JT, 2010, J OCUL PHARMACOL TH, V26, P287, DOI 10.1089/jop.2009.0134; Stjernschantz JW, 2001, INVEST OPHTH VIS SCI, V42, P1134; Ghosh S, 2012, CLIN EXP OPHTHALMOL, V40, P675, DOI 10.1111/j.1442-9071.2012.02781.x; Aihara M, 2012, J GLAUCOMA, V21, P60, DOI 10.1097/IJG.0b013e3181fc8129; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Pisella PJ, 2002, BRIT J OPHTHALMOL, V86, P418, DOI 10.1136/bjo.86.4.418; Yamazaki S, 2010, JPN J OPHTHALMOL, V54, P7, DOI 10.1007/s10384-009-0754-8; Kawaguchi I, 2012, JPN J OPHTHALMOL, V56, P346, DOI 10.1007/s10384-012-0155-2; Pellinen P, 2009, OPHTHAL RES, V41, P118, DOI 10.1159/000192082; Ayaki M, 2008, CLIN EXP OPHTHALMOL, V36, P553, DOI 10.1111/j.1442-9071.2008.01803.x; Asada H, 2010, YAKUGAKU ZASSHI, V130, P867; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; DUA HS, 1995, BRIT J OPHTHALMOL, V79, P968, DOI 10.1136/bjo.79.11.968; GASSET AR, 1977, AM J OPHTHALMOL, V84, P169; Horsley M. B., 2009, CLIN OPHTHALMOL, V3, P291; Kanamoto Takashi, 2010, Hiroshima Journal of Medical Sciences, V59, P71; Katz Gregory, 2010, Clin Ophthalmol, V4, P1253, DOI 10.2147/OPTH.S14113; Littell R. C., 1991, SAS SYSTEM LINEAR MO, P205; Miyashiro Michael J, 2010, Clin Ophthalmol, V4, P1355, DOI 10.2147/OPTH.S13460; Mizoguchi Takanori, 2012, Clin Ophthalmol, V6, P1579, DOI 10.2147/OPTH.S33414; Mundorf TK, 2004, CLIN THER, V26, P541, DOI 10.1016/S0149-2918(04)90056-2; Nakano T, 2011, JPN J OPHTHALMOL, V55, P605, DOI 10.1007/s10384-011-0082-7; SHIMMURA S, 1995, BRIT J OPHTHALMOL, V79, P1007, DOI 10.1136/bjo.79.11.1007; Weinreb RN, 2009, INVEST OPHTH VIS SCI, V50, P1497, DOI 10.1167/iovs.08-2843; Yoneda T, 2012, JPN J OPHTHALMOL, V56, P1, DOI 10.1007/s10384-011-0107-2	35	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	APR 1	2015	31	3					156	164		10.1089/jop.2014.0104		9	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	CF9WJ	WOS:000352917600006		
J	Shirai, T				Shirai, Tomohiro			Modifications of intensity-interferometric spectral-domain optical coherence tomography with dispersion cancellation	JOURNAL OF OPTICS			English	Article						optical coherence tomography; intensity correlation; dispersion cancellation; computational imaging	ROTATING POLARIZER; GEOMETRIC PHASE	Intensity-interferometric spectral-domain (SD) optical coherence tomography (OCT) developed recently enables axial-scan-free cross-sectional imaging with group-velocity dispersion cancellation and a factor-of-root 2 resolution improvement. This paper is concerned with a simple and practical method of realizing OCT of this kind. Specifically, we demonstrate theoretically and experimentally that intensity-interferometric SD-OCT can be realized in a simple way by means of a slightly modified conventional SD-OCT setup.	Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Tsukuba, Ibaraki 3058568, Japan	Shirai, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	t.shirai@aist.go.jp			Japan Society for the Promotion of Science (KAKENHI) [25390104]	This research was funded in part by the Japan Society for the Promotion of Science (KAKENHI 25390104). The author is indebted to Ari T Friberg for fruitful discussions regarding the theoretical aspect of I-SD-OCT.	Abouraddy AF, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.053817; Nasr MB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.083601; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI 10.1088/0034-4885/66/2/204; Helen SS, 1998, OPT COMMUN, V154, P249, DOI 10.1016/S0030-4018(98)00292-2; Watanabe Y, 2005, APPL OPTICS, V44, P1387, DOI 10.1364/AO.44.001387; Banaszek K, 2007, OPT COMMUN, V269, P152, DOI 10.1016/j.optcom.2006.07.050; Brezinski M, 2006, OPTICAL COHERENCE TO; Erkmen BI, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.041601; HARIHARAN P, 1994, OPT COMMUN, V110, P13, DOI 10.1016/0030-4018(94)90163-5; Lavoie J, 2009, OPT EXPRESS, V17, P3818, DOI 10.1364/OE.17.003818; Le Gouet J, 2010, OPT LETT, V35, P1001, DOI 10.1364/OL.35.001001; Loudon R., 2000, QUANTUM THEORY LIGHT; Mazurek MD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01582; Nasr MB, 2004, OPT EXPRESS, V12, P1353, DOI 10.1364/OPEX.12.001353; Roy M, 2002, OPT LASER ENG, V37, P631, DOI 10.1016/S0143-8166(01)00146-4; Shirai T, 2014, J OPT SOC AM A, V31, P258, DOI 10.1364/JOSAA.31.000258	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	APR	2015	17	4							045605	10.1088/2040-8978/17/4/045605		7	Optics	Optics	CE7PM	WOS:000352033800023		
J	Tatsumi, Y; Mohri, I; Shimizu, S; Tachibana, M; Ohno, Y; Taniike, M				Tatsumi, Yukako; Mohri, Ikuko; Shimizu, Sachiko; Tachibana, Masaya; Ohno, Yuko; Taniike, Masako			Daytime physical activity and sleep in pre-schoolers with developmental disorders	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						autism spectrum disorder; physical activity; pre-school; sleep	AUTISM SPECTRUM DISORDER; NEURODEVELOPMENTAL DISORDERS; CHILDREN; CHILDHOOD; ACCELEROMETERS; ADOLESCENTS; VALIDATION; BEHAVIORS; SEROTONIN; MELATONIN	AimThis study aims to investigate the association between daytime physical activity (PA) and sleep in pre-schoolers with or without autism spectrum disorders (ASDs). MethodThirty-one pre-school children with ASD and 16 age-matched controls were recruited. Sleep and PA patterns were measured with an Actiwatch for 7 days. After average PA values were calculated for three periods (morning, afternoon and evening) of each day for each child, the days with maximum (active) and minimum (inactive) PA values for these three periods were determined. The Wilcoxon signed-rank test was used to compare sleep following active mornings, afternoons and evenings with that following inactive time periods. ResultsIn control children, sleep onset time following active mornings/afternoons did not differ from that following inactive mornings/afternoons. In contrast, sleep onset following the most inactive morning (median sleep onset time: 9:57 pm) and the most inactive afternoon (median sleep onset time: 10:24 pm) began significantly later than that following the most active mornings (median sleep onset time: 9:21 pm) and the most active afternoons (median sleep onset time: 9:39 pm) in children with ASD. The percentage of sleep for control children following active mornings was significantly higher (median: 93.2%) than that following inactive ones (median: 91.7%). Significant associations were not found between evening PA and sleep in either ASD or control children. ConclusionsA high level of morning and afternoon PA can advance the sleep phase in children with ASD.	[Tatsumi, Yukako; Shimizu, Sachiko; Ohno, Yuko] Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, Suita, Osaka 5650871, Japan; [Mohri, Ikuko; Tachibana, Masaya; Taniike, Masako] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Mohri, Ikuko; Tachibana, Masaya; Taniike, Masako] Osaka Univ, Mol Res Ctr Childrens Mental Dev, Suita, Osaka 5650871, Japan; [Mohri, Ikuko; Tachibana, Masaya; Taniike, Masako] Osaka Univ, Div Dev Sci, Dept Child Dev, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan	Tatsumi, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Math Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	y-tatumi@sahs.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21659265]; Ministry of Education, Culture, Sports, Science, and Technology	This study was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (21659265 to MT) and by Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology for the Osaka University Program for Support of Networking among Present and Future Women Researchers (IM).	Achenbach TM., 1991, MANUAL CHILD BEHAV C; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Farley MA, 2009, AUTISM RES, V2, P109, DOI 10.1002/aur.69; Souders MC, 2009, SLEEP, V32, P1566; Malow B, 2012, J AUTISM DEV DISORD, V42, P1729, DOI 10.1007/s10803-011-1418-3; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Mindell JA, 2010, SLEEP MED, V11, P274, DOI 10.1016/j.sleep.2009.04.012; Anderson GM, 2002, J AM ACAD CHILD PSY, V41, P1513, DOI 10.1097/01.CHI.0000024874.60748.28; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Robinson AM, 2004, CHILD CARE HLTH DEV, V30, P139, DOI 10.1111/j.1365-2214.2004.00395.x; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Ekstedt M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-82; JACOBS BL, 1992, PHYSIOL REV, V72, P165; Wong VCN, 2008, J CHILD NEUROL, V23, P67, DOI 10.1177/0883073807308702; Mindell JA, 2009, SLEEP, V32, P599; Cohen-Zion M, 2004, SLEEP MED REV, V8, P379, DOI 10.1016/j.smrv.2004.06.002; Thompson DA, 2005, PEDIATRICS, V116, P851, DOI 10.1542/peds.2004-2788; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; COLE RJ, 1992, SLEEP, V15, P461; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Nixon GM, 2008, SLEEP, V31, P71; McPherson M, 2011, J OCCUP ENVIRON MED, V53, P716, DOI 10.1097/JOM.0b013e31822282fd; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Appleton RE, 2012, HLTH TECHNOL ASSESS, V16, pi; CLEMENTS J, 1986, J CHILD PSYCHOL PSYC, V27, P399, DOI 10.1111/j.1469-7610.1986.tb01841.x; Gringras P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6664; Hyde M, 2007, J SLEEP RES, V16, P213, DOI 10.1111/j.1365-2869.2007.00588.x; Icasiano F, 2004, J PAEDIATR CHILD H, V40, P696, DOI 10.1111/j.1440-1754.2004.00513.x; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Johnson Kyle P, 2008, Curr Treat Options Neurol, V10, P350, DOI 10.1007/s11940-008-0038-5; Kawamura Y, 2008, PSYCHIAT CLIN NEUROS, V62, P152, DOI 10.1111/j.1440-1819.2008.01748.x; Kulman G, 2000, NEUROENDOCRINOL LETT, V21, P31; Motegi A, 2005, J CHILD HLTH, V64, P39; Nixon GM, 2009, ARCH DIS CHILD, V94, P686, DOI 10.1136/adc.2009.157453; Pesonen AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022958; Stores G, 1996, J CHILD PSYCHOL PSYC, V37, P907, DOI 10.1111/j.1469-7610.1996.tb01489.x; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Suzuki M, 2005, SLEEP BIOL RHYTHMS, V3, P86, DOI 10.1111/j.1479-8425.2005.00166.x; Tordjman S, 2012, PSYCHONEUROENDOCRINO, V37, P1990, DOI 10.1016/j.psyneuen.2012.04.013; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	APR	2015	51	4					396	402		10.1111/jpc.12725		7	Pediatrics	Pediatrics	CF0KE	WOS:000352231900010		
J	Tanaka, H; Sasaki, H; Wada, M; Sato, T; Kazama, T; Nishi, K; Kudo, H; Nakamura, M; Nio, M				Tanaka, Hiromu; Sasaki, Hideyuki; Wada, Motoshi; Sato, Tomoyuki; Kazama, Takuro; Nishi, Kotaro; Kudo, Hironori; Nakamura, Megumi; Nio, Masaki			Postnatal management of prenatally diagnosed biliary cystic malformation	JOURNAL OF PEDIATRIC SURGERY			English	Article						Prenatal diagnosis; Biliary atresia; Choledochal cyst; Biliary cystic malformation	CHOLEDOCHAL CYST; ATRESIA; DILATATION	Purpose: Recent advances in ultrasonography have increased prenatal diagnosis of biliary atresia (BA) and choledochal cyst (CC). These conditions are not easy to distinguish before or just after birth. This study investigated diagnostic and therapeutic problems in prenatal diagnosis of BA and CC. Methods: We retrospectively studied clinical characteristics and progression of hepatobiliary cysts in 10 patients (4 cases of BA, 6 cases of CC) from the time of diagnosis. Chronological changes in cyst size and gallbladder morphology were assessed and measured sequentially by ultrasonography. Results: Three cases of BA were type I cyst and 1 case was type III-d. All cases of CC were type Ia. Cyst size decreased between birth and surgery in BA but increased in CC. The gallbladder appeared atrophic in BA. There was no significant difference in gestational age or cyst size at prenatal diagnosis, changes in cyst size between birth and surgery, and degree of liver fibrosis. Conclusions: BA should be suspected if cyst size decreases before and after birth and the gallbladder atrophies after birth. Cholangiography is the only reliable method to differentiate BA from CC. Neonatal surgery is indicated for CC with icterus and liver dysfunction. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Hiromu; Sasaki, Hideyuki; Wada, Motoshi; Sato, Tomoyuki; Kazama, Takuro; Nishi, Kotaro; Kudo, Hironori; Nakamura, Megumi; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Sendai, Miyagi 9808574, Japan	Nio, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mnio@ped-surg.med.tohoku.ac.jp					Casaccia G, 2002, J PEDIATR SURG, V37, P1191, DOI 10.1053/jpsu.2002.34470; DEWBURY KC, 1980, BRIT J RADIOL, V53, P906; Okada T, 2004, J PEDIATR SURG, V39, P1055, DOI 10.1016/j.jpedsurg.2004.03.054; Chen Chau-Jing, 2003, Asian J Surg, V26, P213, DOI 10.1016/S1015-9584(09)60306-7; Clifton MS, 2006, PEDIATRICS, V117, pE596, DOI 10.1542/peds.2005-1411; GREENHOLZ SK, 1986, J PEDIATR SURG, V21, P1147, DOI 10.1016/0022-3468(86)90029-1; Hasegawa T, 2002, PEDIATR SURG INT, V18, P425, DOI 10.1007/s00383-002-0843-y; Ichida F, 1996, HEPATOL COMMUN, V6, P112; Kasai M, 1976, J JPN SOC PEDIATR SU, V12, P327; Matsubara H, 1997, FETAL DIAGN THER, V12, P306; Natsumi Tanaka, 2010, J PEDIATR SURG, V45, P2119; Ohtsuka Y, 2002, J PEDIATR SURG, V37, P1173, DOI 10.1053/jpsu.2002.34466; Todani I, 1977, AM J SURG, V134, P263; Vijayaraghavan P, 2006, PEDIATR SURG INT, V22, P803, DOI 10.1007/s00383-006-1771-z	14	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2015	50	4					507	510		10.1016/j.jpedsurg.2014.08.002		4	Pediatrics; Surgery	Pediatrics; Surgery	CE9CF	WOS:000352140500001		
J	Kitagawa, N; Shinkai, M; Take, H; Mochizuki, K; Asano, F; Usui, H; Miyagi, H; Kido, T; Kurauchi, N; Osaka, H; Yamashita, S				Kitagawa, N.; Shinkai, M.; Take, H.; Mochizuki, K.; Asano, F.; Usui, H.; Miyagi, H.; Kido, T.; Kurauchi, N.; Osaka, H.; Yamashita, S.			Mediastinoscopic extended thymectomy for pediatric patients with myasthenia gravis	JOURNAL OF PEDIATRIC SURGERY			English	Article						Myasthenia gravis; Children; Endoscopic surgery; Mediastinoscopy	ASSISTED THORACOSCOPIC THYMECTOMY; TERM-FOLLOW-UP; MASSES	Background: Extended thymectomy is indicated for children with myasthenia gravis (MG) when drug-resistance or dependence is seen. We have employed a technique for mediastinoscopic extended thymectomy (MET) on children with MG. Method: A total of 14 children underwent MET at Kanagawa Children's Medical Center between 2005 and 2013. A mediastinal operation field was made by a V-shaped hook infrasternally to extirpate the thymus with adipose tissue around the thymus. Results: The operation time and the amount of blood loss were 182 +/- 44 minutes and 34 +/- 43 ml, respectively. Postoperative complications, in the form of transient paralysis of the right recurrent nerve, occurred in 2 patients. The median length of postoperative hospital stay was 4.5 days. After MET, 6 patients achieved complete remission and 7 patients achieved steroid dose reduction, but no improvement was seen in 1 patient. Conclusions: This procedure offers the advantage of good surgical access for dissection around the bilateral phrenic nerves in extended total thymectomy, while achieving good cosmetic results. (C) 2015 Elsevier Inc. All rights reserved.	[Kitagawa, N.; Shinkai, M.; Take, H.; Mochizuki, K.; Asano, F.; Usui, H.; Miyagi, H.] Kanagawa Childrens Med Ctr, Dept Surg, Yokohama, Kanagawa 2328555, Japan; [Kido, T.] Shion Hosp, Dept Resp Surg, Osaka, Japan; [Kurauchi, N.] Hakodate Municipal Hosp, Dept Surg, Hakodate, Hokkaido, Japan; [Osaka, H.; Yamashita, S.] Kanagawa Childrens Med Ctr, Dept Neurol, Yokohama, Kanagawa, Japan	Kitagawa, N (reprint author), Kanagawa Childrens Med Ctr, Dept Surg, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	norihikok@nifty.com					Cheng C, 2013, ANN THORAC SURG, V95, P1035, DOI 10.1016/j.athoracsur.2012.11.074; YIM APC, 1995, CHEST, V108, P1440, DOI 10.1378/chest.108.5.1440; Lee CY, 2011, SURG ENDOSC, V25, P849, DOI 10.1007/s00464-010-1280-y; Christison-Lagay E, 2013, PEDIATR SURG INT, V29, P583, DOI 10.1007/s00383-013-3284-x; Kido T, 1999, ANN THORAC SURG, V67, P263, DOI 10.1016/S0003-4975(98)01210-7; Kogut KA, 2000, J PEDIATR SURG, V35, P1576, DOI 10.1053/jpsu.2000.18315; Kolski H, 2000, J PEDIATR SURG, V35, P768, DOI 10.1053/jpsu.2000.6065; Lindner A, 1997, J NEUROL, V244, P515, DOI 10.1007/s004150050135; MASAOKA A, 1981, ANN NY ACAD SCI, V377, P755, DOI 10.1111/j.1749-6632.1981.tb33773.x; Parikh K, 2011, PEDIATR SURG INT, V27, P595, DOI 10.1007/s00383-010-2838-4; SUGARBAKER DJ, 1993, ANN THORAC SURG, V56, P653; Wagner AJ, 2006, J PEDIATR SURG, V41, P50, DOI 10.1016/j.jpedsurg.2005.10.006	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2015	50	4					528	530		10.1016/j.jpedsurg.2014.08.012		3	Pediatrics; Surgery	Pediatrics; Surgery	CE9CF	WOS:000352140500006		
J	Uchida, H; Sakamoto, S; Kobayashi, M; Shigeta, T; Matsunami, M; Sasaki, K; Kanazawa, H; Fukuda, A; Kanamori, Y; Miyasaka, M; Nosaka, S; Kawagishi, N; Kasahara, M				Uchida, Hajime; Sakamoto, Seisuke; Kobayashi, Megumi; Shigeta, Takanobu; Matsunami, Masatoshi; Sasaki, Kengo; Kanazawa, Hiroyuki; Fukuda, Akinari; Kanamori, Yutaka; Miyasaka, Mikiko; Nosaka, Shunsuke; Kawagishi, Naoki; Kasahara, Mureo			The degree of spleen stiffness measured on acoustic radiation force impulse elastography predicts the severity of portal hypertension in patients with biliary atresia after portoenterostomy	JOURNAL OF PEDIATRIC SURGERY			English	Article						Acoustic radiation force impulse; Biliary atresia; Pediatric liver transplantation; Portal vein; Spleen stiffness	ORTHOTOPIC LIVER-TRANSPLANTATION; ESOPHAGEAL-VARICES; VEIN RECONSTRUCTION; NONINVASIVE DIAGNOSIS; PROGNOSTIC VALUE; CHILDREN; CIRRHOSIS; RISK; FIBROSIS; DISEASE	Background/purpose: Acoustic radiation focus impulse (ARFI) elastography is a new method for assessing the degree of tissue stiffness. We herein evaluated the degree of spleen stiffness (SS) using ARFI elastography in patients with biliary atresia (BA) after Kasai portoenterostomy (KPE). Methods: We retrospectively collected the liver stiffness (LS) and SS values on ARFI elastography from 43 patients undergoing KPE between September 2010 and November 2013. We analyzed the correlations between these values and variables related to the severity of liver dysfunction and portal hypertension (PHT). The data were expressed as the standard deviation score (z-score) relative to the previously reported normal values for the patient's age. Results: The SS value was significantly associated with the spleen diameter and development of collateral vessels, in comparison to the LS value. Interestingly, there was a significant correlation between SS value and the portal vein (PV) diameter. Thirty patients (69.8%) consequently underwent LT; these patients showed higher SS values and smaller PV diameters than the patients monitored without LT. Conclusions: The degree of SS measured on ARFI elastography can be used to predict the severity of PHT in BA patients after KPE. (C) 2015 Elsevier Inc. All rights reserved.	[Uchida, Hajime; Sakamoto, Seisuke; Kobayashi, Megumi; Shigeta, Takanobu; Matsunami, Masatoshi; Sasaki, Kengo; Kanazawa, Hiroyuki; Fukuda, Akinari; Kasahara, Mureo] Natl Ctr Child Hlth & Dev, Organ Transplantat Ctr, Tokyo, Tokyo 1578535, Japan; [Kanamori, Yutaka] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo, Tokyo 1578535, Japan; [Miyasaka, Mikiko; Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo, Tokyo 1578535, Japan; [Uchida, Hajime; Sasaki, Kengo; Kawagishi, Naoki] Tohoku Univ, Grad Sch Med, Div Transplantat Reconstruct & Endoscop Surg, Sendai, Miyagi 980, Japan	Uchida, H (reprint author), Natl Ctr Child Hlth & Dev, Transplantat Ctr, 2-10-1 Okura, Tokyo, Tokyo 1578535, Japan.	uchida-h@ncchd.go.jp					LERUT J, 1987, ANN SURG, V205, P404, DOI 10.1097/00000658-198704000-00011; McDiarmid SV, 2002, TRANSPLANTATION, V74, P173, DOI 10.1097/00007890-200207270-00006; Noruegas MJ, 2012, PEDIATR RADIOL, V42, P201, DOI 10.1007/s00247-011-2257-2; Megremis SD, 2004, RADIOLOGY, V231, P129, DOI 10.1148/radiol.2311020963; Shah SHA, 1996, AM J GASTROENTEROL, V91, P2580; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; STRONG R, 1988, SURGERY, V104, P104; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; Uchida Y, 2006, AM J TRANSPLANT, V6, P2443, DOI 10.1111/j.1600-6143.2006.01487.x; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; Grieve A, 2013, J PEDIATR SURG, V48, P789, DOI 10.1016/j.jpedsurg.2012.10.010; Toshima T, 2011, J GASTROENTEROL, V46, P705, DOI 10.1007/s00535-010-0365-7; Wanty C, 2013, J PEDIATR GASTR NUTR, V56, P537, DOI 10.1097/MPG.0b013e318282a22c; Hanquinet S, 2013, PEDIATR RADIOL, V43, P545, DOI 10.1007/s00247-012-2595-8; Gana JC, 2011, GASTROENTEROLOGY, V141, P2009, DOI 10.1053/j.gastro.2011.08.049; Gana JC, 2010, J PEDIATR GASTR NUTR, V50, P188, DOI 10.1097/MPG.0b013e3181b64437; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Duche M, 2010, GASTROENTEROLOGY, V139, P1952, DOI 10.1053/j.gastro.2010.07.004; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bueno J, 2007, TRANSPL P, V39, P2278, DOI 10.1016/j.transproceed.2007-07-042; Chongsrisawat V, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-41; Cowles RA, 2008, J PEDIATR SURG, V43, P1605, DOI 10.1016/j.jpedsurg.2008.04.012; de Magnee C, 2011, ANN SURG, V254, P55, DOI 10.1097/SLA.0b013e3182121eb7; Kanazawa H, 2012, J PEDIATR SURG, V47, P523, DOI 10.1016/j.jpedsurg.2011.09.036; Kasai M, 1974, Prog Pediatr Surg, V6, P5; Kimura T, 2000, J PEDIATR SURG, V35, P1597, DOI 10.1053/jpsu.2000.18324; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Marwan IK, 1999, SURGERY, V125, P265, DOI 10.1067/msy.1999.95114; Mitchell A, 2002, TRANSPLANTATION, V73, P1244, DOI 10.1097/00007890-200204270-00009; Nightingale K, 2002, ULTRASONIC IMAGING, V24, P129; Nobili V, 2011, PEDIATR RADIOL, V41, P1232, DOI 10.1007/s00247-011-2143-y; OHUCHI N, 1986, J PEDIATR SURG, V21, P10, DOI 10.1016/S0022-3468(86)80641-8; Shapiro R S, 1997, Liver Transpl Surg, V3, P641; Shinkai M, 2003, J PEDIATR SURG, V38, P1001, DOI 10.1016/S0022-3468(03)00179-9; Soyupak S, 2010, EUR J RADIOL, V75, P245, DOI 10.1016/j.ejrad.2009.03.052	40	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2015	50	4					559	564		10.1016/j.jpedsurg.2014.12.026		6	Pediatrics; Surgery	Pediatrics; Surgery	CE9CF	WOS:000352140500013		
J	Nakao, M; Ueno, T; Oga, A; Kuramitsu, Y; Nakatsu, H; Oka, M				Nakao, Mitsuhiro; Ueno, Tomio; Oga, Atsunori; Kuramitsu, Yasuhiro; Nakatsu, Hiroki; Oka, Masaaki			Proposal of intestinal tissue engineering combined with Bianchi's procedure	JOURNAL OF PEDIATRIC SURGERY			English	Article						Small intestinal tissue engineering; Small intestinal submucosa; Short bowel syndrome; Bianchi's procedure	SHORT-BOWEL SYNDROME; IN-VITRO; STEM-CELLS; SUBMUCOSA SIS; MODEL; TRANSPLANTATION; REGENERATION; REPLACEMENT; EXPERIENCE; EPITHELIUM	Aim: The aim of this study is to examine the feasibility of the small intestinal submucosa (SIS) when the longitudinal staples during Bianchi's procedure are replaced with SIS graft. Methods: The mesentery of the bowel was separated based on the bifurcated vessels in five beagles. A 2 x 7-cm longitudinal half of the bowel was excised and the defect was repaired using SIS with similar blood supply in Bianchi's operation. Six months later, intestinal motility in the SIS-grafted area was recorded. Tissue preparations were obtained from the reorganized area. An organ bath technique with electrical field stimulation was applied. Both the native small intestine and grafted area were morphologically investigated using immunohistochemistry. Main results: All dogs survived and thrived with no anastomotic leakage. Isoperistaltic migrating contractility during fasting was observed through the grafted segment including the reorganized area. The SIS-reorganized tissue contracted in response to an acetylcholine agonist and electrical field stimulation. The mucosa was covered with normal epithelium. Reorganization of neural and smooth muscle cells was observed. Conclusions: SIS has the potential for use as a scaffold that promotes the formation of a physical and physiological neointestine. Our present proposal approaches a novel surgical treatment in patients with short bowel syndrome. (C) 2015 The Authors. Published by Elsevier Inc.	[Nakao, Mitsuhiro; Ueno, Tomio; Nakatsu, Hiroki; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Surg 2, Dept Digest Surg & Surg Oncol, Yamaguchi, Japan; [Oga, Atsunori] Yamaguchi Univ, Grad Sch Med, Dept Mol Pathol, Yamaguchi, Japan; [Kuramitsu, Yasuhiro] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Yamaguchi, Japan	Ueno, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Dept Surg 2, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	tommy@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [22591488]	This research was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (grant no. 22591488 to T.U.).	Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1; Fryer JP, 2008, CURR OPIN ORGAN TRAN, V13, P266, DOI 10.1097/MOT.0b013e3282fd6901; Vanderhoof JA, 1997, GASTROENTEROLOGY, V113, P1767, DOI 10.1053/gast.1997.v113.pm9352883; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sudan D, 2007, ANN SURG, V246, P593, DOI 10.1097/SLA.0b013e318155aa0c; Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ueno T, 2007, J GASTROINTEST SURG, V11, P918, DOI 10.1007/s11605-007-0171-6; Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199; Lee M, 2008, J SURG RES, V147, P168, DOI 10.1016/j.jss.2008.03.012; Qin HH, 2011, J SURG RES, V171, pE21, DOI 10.1016/j.jss.2011.08.001; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Walker SR, 2006, J PEDIATR SURG, V41, P113, DOI 10.1016/j.jpedsurg.2005.10.015; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Ueno T, 2007, SURGERY, V142, P376, DOI 10.1016/j.surg.2007.04.019; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x; BIANCHI A, 1980, J PEDIATR SURG, V15, P145, DOI 10.1016/S0022-3468(80)80005-4; Bianchi A, 1999, EUR J PEDIATR SURG, V9, P256, DOI 10.1055/s-2008-1072258; Demirbilek S, 2003, PEDIATR SURG INT, V19, P588, DOI 10.1007/s00383-003-1025-2; MATSUMOT.T, 1966, ANN SURG, V164, P845; McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144; Nishimura T, 2010, TISSUE ENG PT A, V16, P1761, DOI 10.1089/ten.TEA.2009.0485; Pakarinen MP, 2013, J PEDIATR SURG, V48, P339, DOI 10.1016/j.jpedsurg.2012.11.014; Reinshagen K, 2008, J PEDIATR GASTR NUTR, V47, P573, DOI 10.1097/MPG.0b013e31816232e3; Saday C, 1996, J SURG RES, V62, P184, DOI 10.1006/jsre.1996.0193; Sudan D, 2007, ANN SURG, V246, P601; Thompson J S, 1991, J Invest Surg, V4, P203, DOI 10.3109/08941939109140780; Thompson Jon S, 2012, Curr Probl Surg, V49, P52, DOI 10.1067/j.cpsurg.2011.10.002; Ueno T, 2005, AM J PHYSIOL-GASTR L, V288, pG487, DOI 10.1152/ajpgi.00195.2004; Wang ZQ, 2005, J PEDIATR SURG, V40, P1898, DOI 10.1016/j.jpedsurg.2005.08.031; Wang ZQ, 2003, J PEDIATR SURG, V38, P1596, DOI 10.1016/S0022-3468(03)00567-0; Yang B, 2010, J BIOMED MATER RES A, V93A, P1100, DOI 10.1002/jbm.a.32534	34	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2015	50	4					573	580		10.1016/j.jpedsurg.2014.11.035		8	Pediatrics; Surgery	Pediatrics; Surgery	CE9CF	WOS:000352140500016		
J	Kanazawa, H; Nosaka, S; Miyazaki, O; Sakamoto, S; Fukuda, A; Shigeta, T; Nakazawa, A; Kasahara, M				Kanazawa, Hiroyuki; Nosaka, Shunsuke; Miyazaki, Osamu; Sakamoto, Seisuke; Fukuda, Akinari; Shigeta, Takanobu; Nakazawa, Atsuko; Kasahara, Mureo			The classification based on intrahepatic portal system for congenital portosystemic shunts	JOURNAL OF PEDIATRIC SURGERY			English	Article						Abernethy malformation; Congenital portosystemic shunt; Congenital absence of the portal vein; Shunt occlusion test; Liver transplantation	LIVER-TRANSPLANTATION; ABERNETHY MALFORMATION; VEIN; ABSENCE; CHILDREN; ENCEPHALOPATHY; COMPLICATIONS; HYPERTENSION; MANAGEMENT; STRATEGY	Background/purpose: Liver transplantation was previously indicated as a curative operation for congenital absence of portal vein. Recent advances in radiological interventional techniques can precisely visualize the architecture of the intrahepatic portal system (IHPS). Therefore, the therapeutic approach for congenital portosystemic shunt (CPS) needs to be reevaluated from a viewpoint of radiological appearances. The aim of this study was to propose the IHPS classification which could explain the pathophysiological characteristics and play a complementary role of a therapeutic approach and management for CPS. Methods: Nineteen patients with CPS were retrospectively reviewed. The median age at diagnosis was 6.8 years old. Eighteen of these patients underwent angiography with a shunt occlusion test and were classified based of the severity of the hypoplasia of IHPS. Results: The eighteen cases who could undergo the shunt occlusion test were classified into mild (n=7), moderate (n=6) and severe types (n=5) according to the IHPS classification. The IHPS classification correlated with the portal venous pressure under shunt occlusion, the histopathological findings, postoperative portal venous flow and liver regeneration. Shunt closure resulted in dramatic improvement in the laboratory data and subclinical encephalopathy. Two patients with the severe type suffered from sepsis associated with portal hypertension after treatment, and from the portal flow steal phenomenon because of the development of unexpected collateral vessels. The patients with the severe type had a high risk of postoperative complications after shunt closure in one step, even if the PVP was relatively low during the shunt occlusion test. Conclusion: The IHPS could be visualized by the shunt occlusion test. The IHPS classification reflected the clinicopathological features of CPS, and was useful to determine the therapeutic approach and management for CPS. (C) 2015 Elsevier Inc. All rights reserved.	[Kanazawa, Hiroyuki; Sakamoto, Seisuke; Fukuda, Akinari; Shigeta, Takanobu; Kasahara, Mureo] Natl Ctr Child Hlth & Dev, Transplantat Ctr, Tokyo, Japan; [Nosaka, Shunsuke; Miyazaki, Osamu] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Clin Pathol, Tokyo, Japan	Kanazawa, H (reprint author), Natl Ctr Child Hlth & Dev, Dept Transplant Surg, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	kanazawa-hr@ncchd.go.jp			National Center for Child Health and Development, Japan [24-08, 25-06]	This work was supported in part by a Grant from the National Center for Child Health and Development, Japan (24-08, 25-06).	Abernethy J, 1793, PHILOS T R SOC, V83, P59, DOI 10.1098/rstl.1793.0010; Alvarez AE, 2002, PEDIATR PULM, V34, P391, DOI 10.1002/ppul.10182; Howard ER, 1997, J PEDIATR SURG, V32, P494, DOI 10.1016/S0022-3468(97)90614-X; Wakamoto H, 1999, BRAIN DEV-JPN, V21, P425, DOI 10.1016/S0387-7604(99)00049-2; Kondo F, 2001, J GASTROEN HEPATOL, V16, P1319, DOI 10.1046/j.1440-1746.2001.02576.x; Kobayashi N, 2010, HEPATOL RES, V40, P585, DOI 10.1111/j.1872-034X.2010.00667.x; UFLACKER R, 1987, RADIOLOGY, V165, P721; MORGAN G, 1994, J PEDIATR SURG, V29, P1239, DOI 10.1016/0022-3468(94)90812-5; WOODLE ES, 1990, SURGERY, V107, P475; Sakamoto S, 2012, TRANSPLANTATION, V93, P1282, DOI 10.1097/TP.0b013e318250c157; Kasahara M, 2009, LIVER TRANSPLANT, V15, P1641, DOI 10.1002/lt.21839; Franchi-Abella S, 2010, J PEDIATR GASTR NUTR, V51, P322, DOI 10.1097/MPG.0b013e3181d9cb92; Yagi H, 2004, SURG TODAY, V34, P1049, DOI 10.1007/s00595-004-2851-0; McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023; Blanc T, 2014, ANN SURG, V260, P188, DOI 10.1097/SLA.0000000000000266; Hu GH, 2008, WORLD J GASTROENTERO, V14, P5969, DOI 10.3748/wjg.14.5969; Bernard O, 2012, SEMIN LIVER DIS, V32, P273, DOI 10.1055/s-0032-1329896; BARTON JW, 1989, PEDIATR RADIOL, V20, P113, DOI 10.1007/BF02010653; BARSKY MF, 1989, CAN J SURG, V32, P271; SOMEDA H, 1995, J HEPATOL, V22, P623, DOI 10.1016/0168-8278(95)80218-5; Bruckheimer E, 2013, CARDIOVASC INTER RAD, V36, P1580, DOI 10.1007/s00270-013-0581-7; DUPREY J, 1985, ANN MED INTERNE, V136, P655; Egawa H, 1999, TRANSPLANTATION, V67, P712, DOI 10.1097/00007890-199903150-00012; Imamura H, 2000, JPN CIRC J, V64, P471, DOI 10.1253/jcj.64.471; KERLAN RK, 1982, AM J ROENTGENOL, V139, P1013; Kim T, 2004, AM J ROENTGENOL, V183, P1333; Marois D, 1992, GASTROINTEST RADIOL, V17, P31; Marx M, 2002, EUR J PEDIATR, V161, P660; Ono H, 1998, ACTA PAEDIATR, V87, P631, DOI 10.1080/080352598750014021; Saeki I, 2012, PEDIATR TRANSPLANT, V16, P244, DOI 10.1111/j.1399-3046.2011.01624.x	30	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2015	50	4					688	695		10.1016/j.jpedsurg.2015.01.009		8	Pediatrics; Surgery	Pediatrics; Surgery	CE9CF	WOS:000352140500034		
J	Iwasaki, M; Sato, M; Minagawa, K; Manz, MC; Yoshihara, A; Miyazaki, H				Iwasaki, Masanori; Sato, Misuzu; Minagawa, Kumiko; Manz, Michael C.; Yoshihara, Akihiro; Miyazaki, Hideo			Longitudinal Relationship Between Metabolic Syndrome and Periodontal Disease Among Japanese Adults Aged >= 70 Years: The Niigata Study	JOURNAL OF PERIODONTOLOGY			English	Article						Aged; epidemiology; longitudinal studies; metabolic syndrome X; oral medicine; periodontal diseases	OXIDATIVE STRESS; DIABETES-MELLITUS; REACTIVE OXYGEN; ASSOCIATION; HISAYAMA; INFLAMMATION; MITOCHONDRIA; ADIPONECTIN; DYSFUNCTION; POPULATION	Background: There has been little evaluation in longitudinal epidemiologic studies of the effect of metabolic syndrome (MetS) on periodontal status. The specific aim of this longitudinal study is to investigate whether MetS in the Japanese population could be a risk factor for periodontal disease. Methods: A total of 125 older adults from Japan for whom data were available for the years 2003 to 2006 were selected for the current study. Full-mouth periodontal status, measured as clinical attachment level (CAL), was recorded at baseline and in follow-up examinations. Development of periodontal disease was considered to be >= 2 teeth demonstrating a longitudinal loss of proximal attachment of >= 3 mm at the follow-up dental examination. A multivariable Poisson regression model with robust error variance was used to evaluate the association of MetS defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria with development of periodontal disease. Adjustments for sex, income, education, smoking status, number of teeth at baseline, mean CAL at baseline, pattern of visits to a dentist, and brushing frequency were considered. Results: The prevalence of MetS was 21.6% (27/125). Study participants with MetS were approximately 2.6 times more likely to develop periodontal disease (adjusted relative risk 2.58, 95% confidence interval 1.17 to 5.67) after simultaneous adjustment for other covariates. Conclusions: These findings support the hypothesis that MetS may be a risk factor for periodontal disease in older Japanese individuals. Additional studies with larger, more diverse populations and more complete information are needed to substantiate the findings.	[Iwasaki, Masanori] Kyushu Dent Univ, Div Community Oral Hlth Dev, Kitakyushu, Fukuoka 8038580, Japan; [Iwasaki, Masanori; Sato, Misuzu; Minagawa, Kumiko; Miyazaki, Hideo] Niigata Univ, Dept Oral Hlth Sci, Div Prevent Dent, Grad Sch Med & Dent Sci, Niigata, Japan; [Manz, Michael C.] Univ Michigan, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Manz, Michael C.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Yoshihara, Akihiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Dept Oral Hlth & Welf, Niigata 95021, Japan	Iwasaki, M (reprint author), Kyushu Dent Univ, Div Community Oral Hlth Dev, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r14iwasaki@fa.kyu-dent.ac.jp			Ministry of Health and Welfare of Japan [H10-Iryo-001, H13-Iryo-001, H16-Iryo-020];  [23792504];  [26861827]	This work was supported by Grants-in-Aid from the Ministry of Health and Welfare of Japan (H10-Iryo-001, H13-Iryo-001, and H16-Iryo-020) and Grants-in-Aid for Young Scientists (B) (23792504 and 26861827). The authors report no conflicts of interest related to this study.	Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Bullon P, 2011, FREE RADICAL BIO MED, V50, P1336, DOI 10.1016/j.freeradbiomed.2011.02.018; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Sanders AE, 2009, J CLIN PERIODONTOL, V36, P388, DOI 10.1111/j.1600-051X.2009.01394.x; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Saito T, 2008, J DENT RES, V87, P319; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Dawson DR, 2014, PERIODONTOL 2000, V64, P161, DOI 10.1111/j.1600-0757.2012.00458.x; Bullon P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-122; Grundy SM, 2005, ARTERIOSCL THROM VAS, V25, P2243, DOI 10.1161/01.ATV.0000189155.75833.c7; Morita T, 2010, J PERIODONTOL, V81, P512, DOI 10.1902/jop.2010.090594; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Bullon P, 2009, J DENT RES, V88, P503, DOI 10.1177/0022034509337479; Ohnishi T, 2009, J PERIODONTAL RES, V44, P43, DOI 10.1111/j.1600-0765.2007.01060.x; Kobayashi Y, 2012, J DENT RES, V91, P479, DOI 10.1177/0022034512440707; Canakci CF, 2009, ARCH IMMUNOL THER EX, V57, P205, DOI 10.1007/s00005-009-0026-9; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI 10.1111/jcpe.12064; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Ramirez-Tortosa MC, 2010, NUTR METAB CARDIOVAS, V20, P133, DOI 10.1016/j.numecd.2009.03.003; Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642; Saito T, 1998, NEW ENGL J MED, V339, P482, DOI 10.1056/NEJM199808133390717; Bullon P, 2014, PERIODONTOL 2000, V64, P139, DOI 10.1111/j.1600-0757.2012.00455.x; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Saito T, 2004, J DENT RES, V83, P485; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; D'Aiuto F, 2010, J DENT RES, V89, P1241, DOI 10.1177/0022034510375830; Shimazaki Y, 2007, J DENT RES, V86, P271; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, EDUCATION, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486; Fukui N, 2012, J PERIODONTOL, V83, P1363, DOI 10.1902/jop.2012.110605; Hirotomi T, 2002, COMMUNITY DENT ORAL, V30, P409, DOI 10.1034/j.1600-0528.2002.00005.x; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Ishikawa S, 2007, CIRC J, V71, P26, DOI 10.1253/circj.71.26; Khader Y, 2008, J PERIODONTOL, V79, P2048, DOI 10.1902/jop.2008.080022 ; Kushiyama M, 2009, J PERIODONTOL, V80, P1610, DOI 10.1902/jop.2009.090218; Li P, 2009, J PERIODONTOL, V80, P541, DOI 10.1902/jop.2009.080387; Ministry of Health Labour and Welfare Japan, 2011, SURV DENT DIS; Morita T, 2009, J PUBLIC HEALTH DENT, V69, P248, DOI 10.1111/j.1752-7325.2009.00130.x; Moss KL, 2006, J ORAL MAXIL SURG, V64, P652, DOI 10.1016/j.joms.2005.12.012; Reynolds MA, 2014, PERIODONTOL 2000, V64, P7, DOI 10.1111/prd.12047; The Ministry of Health Labour and Welfare Japan, NAT HLTH NUTR SURV 2; Urashima M., 2005, JMAJ - Japan Medical Association Journal, V48, P441; Veeranna V, 2011, METAB SYNDR RELAT D, V9, P361, DOI 10.1089/met.2011.0032	46	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	APR	2015	86	4					491	498		10.1902/jop.2015.140398		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9ER	WOS:000352147200006		
J	Nam, SH; Jung, HI; Kang, SM; Inaba, D; Kwon, HK; Kim, BI				Nam, Sun-Hei; Jung, Hoi-In; Kang, Si-Mook; Inaba, Daisuke; Kwon, Ho-Keun; Kim, Baek-Il			Validity of Screening Methods for Periodontitis Using Salivary Hemoglobin Level and Self-Report Questionnaires in People with Disabilities	JOURNAL OF PERIODONTOLOGY			English	Article						Disabled persons; hemoglobins; periodontal index; periodontitis; ROC curve; self-report	C-REACTIVE PROTEIN; DEVELOPMENTAL-DISABILITIES; PROTEOMIC ANALYSIS; HEALTH-STATUS; ORAL-HEALTH; DISEASE; POPULATION; INDIVIDUALS; SURVEILLANCE; DIAGNOSIS	Background: The aim of this study is to evaluate the validity of screening methods in predicting periodontitis in people with disabilities using the objective salivary hemoglobin level, a subjective self-report questionnaire, and a combined model of the two methods with demographic characteristics. Methods: The participants were 195 patients with disabilities aged >18 years who were examined using the community periodontal index (CPI), salivary hemoglobin level, and answers to 10 self-report questions (n = 192). Multivariable logistic regression and receiver operating characteristic (ROC) curve analysis were performed to evaluate the validity of the methods and the combined model in predicting the prevalence of >= CPI 3 (probing depth [PD] >= 4 mm) or CPI 4 (PD >= 6 mm). Results: Overall, 75.9% of the study group (148 of 195) were diagnosed with >= CPI 3, and 38.5% of the study group (75 of 195) were diagnosed with CPI 4. The areas under the ROC curve (AUCs) of the salivary hemoglobin level were 0.578 (sensitivity of 41% and specificity of 77%) and 0.662 (sensitivity of 53% and specificity of 75%) for predicting the prevalence of >= CPI 3 and CPI 4, respectively. Multivariable modeling incorporating four different questions for predicting >= CPI 3 or CPI 4 indicated higher AUCs of 0.710 and 0.732, respectively, yielding higher sensitivity (55% for >= CPI 3 and 69% for CPI 4) than that of salivary hemoglobin level. The most useful prediction models for >= CPI 3 or CPI 4 were combined models, which yielded AUCs of 0.773 and 0.807, respectively, with sensitivity values of 70% and specificity values >75%. Conclusion: The salivary hemoglobin level, self-report questionnaire, and the combined method demonstrated screening potential that could predict the population prevalence of >= CPI 3 or CPI 4.	[Nam, Sun-Hei; Jung, Hoi-In; Kwon, Ho-Keun] Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, Oral Sci Res Inst, Seoul 120749, South Korea; [Kang, Si-Mook; Kim, Baek-Il] Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, Oral Sci Res Inst,PLUS Project BK21, Seoul 120749, South Korea; [Inaba, Daisuke] Iwate Med Univ, Div Prevent Dent, Dept Oral Med, Morioka, Iwate 020, Japan	Kim, BI (reprint author), Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, 50-1 Yonsei Ro, Seoul 120749, South Korea.	drkbi@yuhs.ac			National Research Foundation of Korea - Ministry of Education [2013R1A1A2062505]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (Grant 2013R1A1A2062505). Drs. Nam and Jung contributed equally to this work. The authors report no conflicts of interest related to this study.	Anders Patrick L, 2010, Spec Care Dentist, V30, P110, DOI 10.1111/j.1754-4505.2010.00136.x; Waldman HB, 2012, J CLIN NURS, V21, P909, DOI 10.1111/j.1365-2702.2011.03969.x; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; Gilbert AD, 1999, BRIT DENT J, V186, P241, DOI 10.1038/sj.bdj.4800075a; Teles RP, 2009, J PERIODONTAL RES, V44, P411, DOI 10.1111/j.1600-0765.2008.01119.x; Morgan JP, 2012, J AM DENT ASSOC, V143, P838; Ahn HJ, 2011, J ORAL REHABIL, V38, P475, DOI 10.1111/j.1365-2842.2010.02179.x; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Corbet EF, 2009, AUST DENT J, V54, pS27, DOI 10.1111/j.1834-7819.2009.01141.x; Eke PI, 2013, J DENT RES, V92, P1041, DOI 10.1177/0022034513505621; Eke PI, 2007, J PERIODONTOL, V78, P1366, DOI 10.1902/jop.2007.070134; Armitage GC, 2003, J PERIODONTOL, V74, P1237; Blicher B, 2005, J DENT RES, V84, P881; Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; Miller CS, 2006, J AM DENT ASSOC, V137, P322; Tsuchida S, 2012, PROTEOMICS, V12, P2190, DOI 10.1002/pmic.201100655; Lloyd-Sherlock P, 2000, SOC SCI MED, V51, P887, DOI 10.1016/S0277-9536(00)00068-X; Eke PI, 2009, J PERIODONTOL, V80, P1371, DOI 10.1902/jop.2009.080607; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Burnham K. P., 2002, MODEL SELECTION MULT; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Jongh Ad, 2008, Spec Care Dentist, V28, P111, DOI 10.1111/j.1754-4505.2008.00022.x; Duane Brett, 2014, Evid Based Dent, V15, P72, DOI 10.1038/sj.ebd.6401038; Fonteles CSR, 2012, NUTRITION, V28, P744, DOI 10.1016/j.nut.2011.10.005; GRIFFITHS GS, 1988, J CLIN PERIODONTOL, V15, P403, DOI 10.1111/j.1600-051X.1988.tb01593.x; Nomura Y, 2012, J DENT SCI, V7, P379, DOI 10.1016/j.jds.2012.09.005; PINCUS T, 1989, ANN INTERN MED, V110, P259; Polson A M, 1985, J Periodontol, V56, P1; Shepherd Simon, 2011, Evid Based Dent, V12, P76, DOI 10.1038/sj.ebd.6400808; Slade GD, 2007, J PERIODONTOL, V78, P1463, DOI 10.1902/jop.2007.060344; SOCRANSKY SS, 1984, J CLIN PERIODONTOL, V11, P21, DOI 10.1111/j.1600-051X.1984.tb01305.x; Takami Y, 2003, J PERIODONTOL, V74, P1778, DOI 10.1902/jop.2003.74.12.1778; World Health Organization, 1997, OR HLTH SURV BAS MET	36	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	APR	2015	86	4					536	545		10.1902/jop.2015.140457		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9ER	WOS:000352147200011		
J	Wiggins, B; Liu-Shin, L; Yamaguchi, H; Ratnaswamy, G				Wiggins, Brian; Liu-Shin, Lily; Yamaguchi, Hideto; Ratnaswamy, Gayathri			Characterization of Cysteine-Linked Conjugation Profiles of Immunoglobulin G1 and Immunoglobulin G2 Antibody-Drug Conjugates	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						biopharmaceuticals characterization; HPLC (high-performance/pressure liquid chromatography); IgG antibody; mass spectrometry; monoclonal antibody; conjugation; protein structure; calorimetry (DSC)	MONOCLONAL-ANTIBODY; DISULFIDE BOND; LIGHT-CHAIN; LC-MS; REDUCTION; STABILITY; CANCER; IGG; ALKYLATION; MOLECULES	Two US FDA-approved antibody-drug conjugates (ADCs; Kadcyla (R) and Adcetris (R)) have accelerated clinical interest in the potential of targeted cancer therapeutics as the next generation of oncology drugs that are designed to increase efficacy while reducing overall toxicity. Thiol conjugates are produced by partial reduction of the interchain disulfides, followed by conjugation with a drug-linker, resulting in a heterogeneous mix of molecules that differ with respect to the site of conjugation and the number of drugs per antibody. ADCs that have been characterized in this class have an immunoglobulin G1 (IgG1) framework and there is little information available on IgG2 ADCs. As IgG1s and IgG2s differ in the number of disulfides and molecular conformations, each subclass could lead to unique combinations of possible conjugation sites. We conducted in-depth characterization of two ADCs, an IgG1 and an IgG2 conjugated to monomethyl auristatin E. The results demonstrate that the IgG1 monoclonal antibodies favor conjugation to the cysteines between the light and heavy chains, whereas IgG2s demonstrate preference for the hinge region cysteines. The drug-loading distribution and conjugation sites of ADCs have been reported to influence pharmacokinetics, toxicity, and clearance. Therefore, an understanding of the conjugation profiles is important for the selection and engineering of ADCs. (C) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association	[Wiggins, Brian; Liu-Shin, Lily; Ratnaswamy, Gayathri] Agensys Inc, Analyt & Formulat Dev, Santa Monica, CA 90404 USA; [Yamaguchi, Hideto] Astellas Pharma Inc, Biotechnol Lab, Tsukuba, Ibaraki, Japan	Ratnaswamy, G (reprint author), Agensys Inc, Analyt & Formulat Dev, Santa Monica, CA 90404 USA.	gratnaswamy@agensys.com					Liu HC, 2010, ANAL CHEM, V82, P5219, DOI 10.1021/ac100575n; Flygare JA, 2013, CHEM BIOL DRUG DES, V81, P113, DOI 10.1111/cbdd.12085; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Wang XL, 2011, PHARM RES-DORDR, V28, P3128, DOI 10.1007/s11095-011-0503-9; Le LN, 2012, ANAL CHEM, V84, P7479, DOI 10.1021/ac301568f; Adem YT, 2014, BIOCONJUGATE CHEM, V25, P656, DOI 10.1021/bc400439x; Pan LY, 2014, ANAL CHEM, V86, P2657, DOI 10.1021/ac404003q; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Ouellette D, 2009, ANAL BIOCHEM, V389, P107, DOI 10.1016/j.ab.2009.03.027; Bender B, 2014, AAPS J, V16, P994, DOI 10.1208/s12248-014-9618-3; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Wang Y, 2011, ANAL CHEM, V83, P3133, DOI 10.1021/ac200128d; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Montano RF, 2002, J IMMUNOL, V168, P224; Beckley NS, 2013, BIOCONJUGATE CHEM, V24, P1674, DOI 10.1021/bc400182x; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Boswell CA, 2011, BIOCONJUGATE CHEM, V22, P1994, DOI 10.1021/bc200212a; Li XJ, 2013, ANAL BIOCHEM, V436, P93, DOI 10.1016/j.ab.2013.01.020; Liu YD, 2013, MOL IMMUNOL, V54, P217, DOI 10.1016/j.molimm.2012.12.005; Shen Y, 2013, MABS-AUSTIN, V5, P418, DOI 10.4161/mabs.24291; Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y; Zhang QC, 2013, J BIOL CHEM, V288, P34325, DOI 10.1074/jbc.M113.506915	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	APR	2015	104	4					1362	1372		10.1002/jps.24338		11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE9FU	WOS:000352150200017		
J	Kodama, Y; Yatsugi, Y; Kitahara, T; Kurosaki, T; Egashira, K; Nakashima, M; Muro, T; Nakagawa, H; Higuchi, N; Nakamura, T; Sasaki, H				Kodama, Yukinobu; Yatsugi, Yuiko; Kitahara, Takashi; Kurosaki, Tomoaki; Egashira, Kanoko; Nakashima, Mikiro; Muro, Takahiro; Nakagawa, Hiroo; Higuchi, Norihide; Nakamura, Tadahiro; Sasaki, Hitoshi			Quaternary Complexes Modified from pDNA and Poly-L-Lysine Complexes to Enhance pH-Buffering Effect and Suppress Cytotoxicity	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						non-viral gene delivery; plasmid DNA; biocompatibility; biodegradable polymers; nanoparticles	GENE DELIVERY-SYSTEMS; HISTIDINE-RELATED COMPOUNDS; D-GLUTAMIC ACID; IN-VIVO; TRANSFECTION EFFICIENCY; BACILLUS-ANTHRACIS; CATIONIC POLYMERS; CAPSULAR ANTIGEN; MAMMALIAN-CELLS; DNA COMPLEXES	We developed a modified complex of pDNA and poly-L-lysine (PLL) by the addition of poly-L-histidine (PLH) and gamma-polyglutamic acid (gamma-PGA) to enhance its pH-buffering effect and suppress cytotoxicity. The binary and ternary complexes of pDNA with PLL or/and PLH showed particle sizes of approximately 52-76 nm with cationic surface charge. The ternary complexes showed much higher gene expression than the binary complexes with PLL. The mixed solution of PLL and PLH showed higher buffering capacity than PLL solution. The high gene expression of ternary complexes was reduced by bafilomycin A(1). These results indicated the addition of PLH to PLL complexes promoted endosomal escape by enhancing the pH-buffering effect. The binary and ternary complexes showed cytotoxicity and blood agglutination because of their cationic surface charge. We therefore developed quaternary complexes by the addition of anionic gamma-PGA, which was reported to decrease the toxicity of cationic complexes. In fact, quaternary complexes showed no cytotoxicity and blood agglutination. Also, quaternary complexes showed higher gene expression than ternary complexes regardless of their anionic surface charge. Quaternary complexes showed selectively high gene expression in the spleen after their intravenous administration. Thus, we successfully developed the quaternary complexes with high gene expression and no toxicity. (C) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association	[Kodama, Yukinobu; Yatsugi, Yuiko; Kitahara, Takashi; Kurosaki, Tomoaki; Muro, Takahiro; Nakagawa, Hiroo; Higuchi, Norihide; Nakamura, Tadahiro; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan; [Egashira, Kanoko; Nakashima, Mikiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharm Practice, Nagasaki 8528521, Japan	Sasaki, H (reprint author), Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan.	sasaki@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ABE H, 1985, AM J PHYSIOL, V249, pR449; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Cherif MS, 2011, VACCINE, V29, P9038, DOI 10.1016/j.vaccine.2011.09.031; Dekie L, 2000, J CONTROL RELEASE, V65, P187, DOI 10.1016/S0168-3659(99)00235-7; Ogris M, 2002, DRUG DISCOV TODAY, V7, P479, DOI 10.1016/S1359-6446(02)02243-2; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tseng SJ, 2005, BIOCONJUGATE CHEM, V16, P1375, DOI 10.1021/bc050005r; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010; Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Swami A, 2007, INT J PHARM, V335, P180, DOI 10.1016/j.ijpharm.2006.11.033; Yamagata M, 2007, BIOORGAN MED CHEM, V15, P526, DOI 10.1016/j.bmc.2006.09.033; Pichon C, 2001, ADV DRUG DELIVER REV, V53, P75, DOI 10.1016/S0169-409X(01)00221-6; Kichler A, 2003, P NATL ACAD SCI USA, V100, P1564, DOI 10.1073/pnas.0337677100; Trubetskoy VS, 2003, GENE THER, V10, P261, DOI 10.1038/sj.gt.3301888; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; Sutherland MD, 2008, INFECT IMMUN, V76, P899, DOI 10.1128/IAI.01176-07; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Shigeta K, 2007, J CONTROL RELEASE, V118, P262, DOI 10.1016/j.jconrel.2006.12.019; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070; Mukherjee SP, 2010, TOXICOL APPL PHARM, V248, P259, DOI 10.1016/j.taap.2010.08.016; Kurosaki T, 2009, BIOMATERIALS, V30, P2846, DOI 10.1016/j.biomaterials.2009.01.055; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Aoki Y, 2001, CANCER GENE THER, V8, P783, DOI 10.1038/sj.cgt.7700362; Canine BF, 2010, ADV DRUG DELIVER REV, V62, P1524, DOI 10.1016/j.addr.2010.04.001; Cherng JY, 2009, J PHARM PHARM SCI, V12, P346; Farrell LL, 2007, EUR J PHARM BIOPHARM, V65, P388, DOI 10.1016/j.ejpb.2006.11.026; Ito T, 2008, J DRUG TARGET, V16, P276, DOI 10.1080/10611860801900728 ; Jiang Ge, 2006, Yaoxue Xuebao, V41, P439; Kabanov AV, 1999, PHARM SCI TECHNOL TO, V2, P365, DOI 10.1016/S1461-5347(99)00186-8; Kurosaki T, 2013, BIOL PHARM BULL, V36, P1800; Kurosaki T, 2010, MOL PHARM, V8, P913; Kurosaki T, 2009, BIOMATERIALS, V30, P4427, DOI 10.1016/j.biomaterials.2009.04.041; Maruyama K, 2004, BIOMATERIALS, V25, P3267, DOI 10.1016/j.biomaterials.2003.10.004; PATCHORNIK A, 1957, J AM CHEM SOC, V79, P5227, DOI 10.1021/ja01576a043; Singh RS, 2004, CHEM BIOL, V11, P713, DOI 10.1016/j.chembiol.2004.03.026; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Sutherland MD, 2009, INFECT IMMUN, V77, P532, DOI 10.1128/IAI.01009-08; Zhao GX, 2014, J BIOMAT SCI-POLYM E, V25, P519, DOI 10.1080/09205063.2013.879562	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	APR	2015	104	4					1470	1477		10.1002/jps.24364		8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE9FU	WOS:000352150200027		
J	Iga, K				Iga, Katsumi			Use of Three-Compartment Physiologically Based Pharmacokinetic Modeling to Predict Hepatic Blood Levels of Fluvoxamine Relevant for Drug-Drug Interactions	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						bioavailability; compartment model; distribution; drug interactions; fluvoxamine; hepatic blood level; hepatic clearance; pharmacokinetics; physiological model; simulation	IN-VIVO; QUANTITATIVE PREDICTION; CLEARANCE; BIOAVAILABILITY; DISPOSITION; METABOLISM; RAMELTEON	Using a three-compartment physiologically based pharmacokinetic (PBPK) model and a tube model for hepatic extraction kinetics, equations for calculating blood drug levels (C(b)s) and hepatic blood drug levels (C(hb)s, proportional to actual hepatic drug levels), were derived mathematically. Assuming the actual values for total body clearance (CLtot), oral bioavailability (F), and steady-state distribution volume (V-dss), C(b)s, and C(hb)s after intravenous and oral administration of fluvoxamine (strong perpetrator in drug-drug interactions, DDIs), propranolol, imipramine, and tacrine were simulated. Values for C(b)s corresponded to the actual values for all tested drugs, and mean C-hb and maximal C-hb-to-maximal C-b ratio predicted for oral fluvoxamine administration (50 mg twice-a-day administration) were nearly 100 nM and 2.3, respectively, which would be useful for the predictions of the DDIs caused by fluvoxamine. Fluvoxamine and tacrine are known to exhibit relatively large F values despite having CLtot similar to or larger than hepatic blood flow, which may be because of the high liver uptake (almost 0.6) upon intravenous administration. The present method is thus considered to be more predictive of the C-hb for perpetrators of DDIs than other methods. (C) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association	Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kodo Kyotanabe, Kyoto 6100395, Japan	Iga, K (reprint author), Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kodo Kyotanabe, Kyoto 6100395, Japan.	kiga@dwc.doshisha.ac.jp					Ito K, 1998, ANNU REV PHARMACOL, V38, P461, DOI 10.1146/annurev.pharmtox.38.1.461; Kato M, 2008, PHARM RES-DORDR, V25, P1891, DOI 10.1007/s11095-008-9607-2; Hartter S, 2000, CLIN PHARMACOL THER, V67, P1, DOI 10.1067/mcp.2000.104071; Obach RS, 2010, DRUG METAB DISPOS, V38, P1381, DOI 10.1124/dmd.110.034009; Granfors MT, 2004, CLIN PHARMACOL THER, V75, P331, DOI 10.1016/j.clpt.2003.12.005; Hallifax D, 2007, DRUG METAB DISPOS, V35, P1325, DOI 10.1124/dmd.107.015131; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Poulin P, 2002, J PHARM SCI, V91, P1358, DOI 10.1002/jps.10128; Prueksaritanont T, 2013, AAPS J, V15, P629, DOI 10.1208/s12248-013-9470-x; Gibaldi M, 1982, PHARMACOKINETICS REV; Lou GL, 1996, J PSYCHIATR NEUROSCI, V21, P334; Neuhoff S, 2013, J PHARM SCI-US, V102, P3145, DOI 10.1002/jps.23594; Nishimuta H, 2011, DRUG METAB PHARMACOK, V26, P300, DOI [10.2133/dmpk.DMPK-10-SH-119, 10.2133/dmpk.DMPK-10-S11-119]; OLANOFF LS, 1986, CLIN PHARMACOL THER, V40, P408; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; Sateia MJ, 2008, SLEEP MED REV, V12, P319, DOI 10.1016/j.smrv.2007.12.005; Webborn PJH, 2007, XENOBIOTICA, V37, P1090, DOI 10.1080/00498250701557266	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	APR	2015	104	4					1478	1491		10.1002/jps.24320		14	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE9FU	WOS:000352150200028		
J	Nakano, Y; Higuchi, Y; Yoshida, Y; Hisamatsu, T				Nakano, Yoshihiro; Higuchi, Yohei; Yoshida, Yuichi; Hisamatsu, Tamotsu			Environmental responses of the FT/TFL1 gene family and their involvement in flower induction in Fragaria x ananassa	JOURNAL OF PLANT PHYSIOLOGY			English	Article						Cultivated strawberry; Day-length; Flowering; Temperature	LOCUS-T; CULTIVATED STRAWBERRY; FLORAL INITIATION; EVERBEARING HABIT; ARABIDOPSIS; FT; HOMOLOG; SIGNALS; PROTEIN; VESCA	Flowering time control is important for fruit production in Fragaria x ananassa. The flowering inhibition pathway has been extensively elucidated in the woodland strawberry, Fragaria vesca, whereas the factors involved in its promotion remain unclear. In this study, we investigated the environmental responses of F. x ananassa FT and TFL1-like genes, which are considered key floral promoters and repressors in many plants, respectively. A putative floral promoter, FaFT3, was up-regulated in the shoot tip under short-day and/or low growth temperature, in accordance with the result that these treatments promoted flowering. FaFT3 mRNA accumulated before induction of a floral meristem identity gene, FaAP1. FaFT2, a counterpart of FvFT2, expressed in the flower bud of F. vesca, was not induced in the shoot tip differentiating sepal or stamen, suggesting that this gene works at a later stage than stamen formation. In F. vesca, FvFT1 transmits the long-day signal perceived in the leaves to the shoot tip, and induces the potent floral inhibitor FvTFL1. FaFT1 was expressed in the leaves under long-day conditions in F. x ananassa. Expression of FaTFL1 was higher in the shoot tip under long-day than short-day conditions. Independent of day-length, FaTFL1 expression was higher under high temperature than low temperature conditions. These results suggest that FaFT3 induction by short-day or low temperature stimuli is a key step for flowering initiation. As in F. vesca, F. x ananassa floral inhibition pathways depend on FaTFL1 regulation by day-length via FaFT1, and by temperature. (C) 2015 Elsevier GmbH. All rights reserved.	[Nakano, Yoshihiro; Higuchi, Yohei; Hisamatsu, Tamotsu] Natl Agr & Food Res Org NARO, NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan; [Yoshida, Yuichi] Okayama Univ, Grad Sch Nat Sci, Kita Ku, Okayama 7008530, Japan	Hisamatsu, T (reprint author), Natl Agr & Food Res Org NARO, NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan.	tamotsu@affrc.go.jp			JSPS [23380019]	This work was supported by a JSPS Grants-in-aid for Scientific Research: Grant number 23380019.	Akagi H., 1985, B TOCHIGI AGR EXP ST, V31, P29; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Mimida N, 2001, GENES CELLS, V6, P327, DOI 10.1046/j.1365-2443.2001.00425.x; Yoo SJ, 2010, PLANT J, V63, P241, DOI 10.1111/j.1365-313X.2010.04234.x; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Heide OM, 2013, J HORTIC SCI BIOTECH, V88, P1; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Mouhu K, 2013, PLANT CELL, V25, P3296, DOI 10.1105/tpc.113.115055; Kurokura T, 2013, J EXP BOT, V64, P4131, DOI 10.1093/jxb/ert233; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Higuchi Y, 2013, P NATL ACAD SCI USA, V110, P17137, DOI 10.1073/pnas.1307617110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Sonsteby A, 2006, SCI HORTIC-AMSTERDAM, V110, P57, DOI 10.1016/j.scienta.2006.06.012; BROWN T, 1965, EUPHYTICA, V14, P97; Chailakhyan MK, 1936, ACAD SCI USSR, V13, P79; Gaston A, 2013, J EXP BOT, V64, P1837, DOI 10.1093/jxb/ert047; Huang NC, 2012, PLANT J, V72, P175, DOI 10.1111/j.1365-313X.2012.05076.x; ITO HIDEO, 1962, TOHOKU JOUR AGRIC RES, V13, P191; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Koskela EA, 2012, PLANT PHYSIOL, V159, P1043, DOI 10.1104/pp.112.196659; LANG A., 1943, Planta, V33, P653, DOI 10.1007/BF01916588; Morishita Masami, 2012, Horticultural Research (Japan), V11, P301; Randoux M, 2014, NEW PHYTOL, V202, P161, DOI 10.1111/nph.12625; Rantanen M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00271; Taylor DR, 1997, ANN APPL BIOL, V130, P141, DOI 10.1111/j.1744-7348.1997.tb05790.x; Taylor DR, 2002, ACTA HORTIC, P245; THOMPSON P. A., 1960, ANN BOT, V24, P482; Trankner C, 2010, PLANTA, V232, P1309, DOI 10.1007/s00425-010-1254-2; VINCEPRU.D, 1973, PLANTA, V110, P165, DOI 10.1007/BF00384839; Yu DingQun, 2012, Journal of Agricultural Science (Toronto), V4, P51	49	1	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0176-1617	1618-1328		J PLANT PHYSIOL	J. Plant Physiol.	APR 1	2015	177						60	66		10.1016/j.jplph.2015.01.007		7	Plant Sciences	Plant Sciences	CE9GH	WOS:000352151600007		
J	Ishizawa, A; Maeyama, S; Watanabe, TH; Sugama, H; Nakajima, N				Ishizawa, A.; Maeyama, S.; Watanabe, T. -H.; Sugama, H.; Nakajima, N.			Electromagnetic gyrokinetic simulation of turbulence in torus plasmas	JOURNAL OF PLASMA PHYSICS			English	Article							BALLOONING-MODE; TRANSPORT; TOKAMAK	Gyrokinetic simulations of electromagnetic turbulence in magnetically confined torus plasmas including tokamak and heliotron/stellarator are reviewed. Numerical simulation of turbulence in finite beta plasmas is an important task for predicting the performance of fusion reactors and a great challenge in computational science due to multiple spatio-temporal scales related to electromagnetic ion and electron dynamics. The simulation becomes further challenging in non-axisymmetric plasmas. In finite beta plasmas, magnetic perturbation appears and influences some key mechanisms of turbulent transport, which include linear instability and zonal flow production. Linear analysis shows that the ion-temperature gradient (ITG) instability, which is essentially an electrostatic instability, is unstable at low beta and its growth rate is reduced by magnetic field line bending at finite beta. On the other hand, the kinetic ballooning mode (KBM), which is an electromagnetic instability, is destabilized at high beta. In addition, trapped electron modes (TEMs), electron temperature gradient (ETG) modes, and micro-tearing modes (MTMs) can be destabilized. These instabilities are classified into two categories: ballooning parity and tearing parity modes. These parities are mixed by nonlinear interactions, so that, for instance, the ITG mode excites tearing parity modes. In the nonlinear evolution, the zonal flow shear acts to regulate the ITG driven turbulence at low beta. On the other hand, at finite beta, interplay between the turbulence and zonal flows becomes complicated because the production of zonal flow is influenced by the finite beta effects. When the zonal flows are too weak, turbulence continues to grow beyond a physically relevant level of saturation in finite-beta tokamaks. Nonlinear mode coupling to stable modes can play a role in the saturation of finite beta ITG mode and KBM. Since there is a quadratic conserved quantity, evaluating nonlinear transfer of the conserved quantity from unstable modes to stable modes is useful for understanding the saturation mechanism of turbulence.	[Ishizawa, A.; Sugama, H.; Nakajima, N.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Maeyama, S.] Japan Atom Energy Agcy, Kashiwa, Chiba 2778587, Japan; [Watanabe, T. -H.] Nagoya Univ, Nagoya, Aichi 4648602, Japan	Ishizawa, A (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	ishizawa@nifs.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [23561003]; NIFS Collaborative Research Program [NIFS14KNTT027, NIFS14KNST067]	One of the authors A. I. thanks Prof. S. Benkadda and Prof. K. Itoh for their support, and also thanks Prof. Y. Kishimoto for fruitful discussion. This work is supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grant No. 23561003) and by NIFS Collaborative Research Program (NIFS14KNTT027 and NIFS14KNST067). The numerical simulations were carried out on the Plasma Simulator at National Institute for Fusion Science and the Helios Super Computer System at Computational Simulation Center of International Fusion Energy Research Center.	Maeyama S, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4873379; Peeters AG, 2009, COMPUT PHYS COMMUN, V180, P2650, DOI 10.1016/j.cpc.2009.07.001; Hornsby WA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3692094; HAHM TS, 1988, PHYS FLUIDS, V31, P1940, DOI 10.1063/1.866641; RECHESTER AB, 1978, PHYS REV LETT, V40, P38, DOI 10.1103/PhysRevLett.40.38; Dimits AM, 2000, PHYS PLASMAS, V7, P969, DOI 10.1063/1.873896; ANTONSEN TM, 1980, PHYS FLUIDS, V23, P1205, DOI 10.1063/1.863121; Pueschel MJ, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4872327; Pueschel MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4825227; Poli E, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075010; Waltz RE, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3692222; BEER MA, 1995, PHYS PLASMAS, V2, P2687, DOI 10.1063/1.871232; Davidson P. A., 2004, TURBULENCE; Diamond P. H., 2010, MODERN PLASMA PHYS; Hazeltine R. D., 2003, PLASMA CONFINEMENT; Helander P., 2002, COLLISIONAL TRANSPOR; HIROSE A, 1994, PHYS REV LETT, V72, P3993, DOI 10.1103/PhysRevLett.72.3993; Hornsby W. A., 2011, PLASMA PHYS CONTROL, V53; Horton W, 2012, TURBULENT TRANSPORT IN MAGNETIZED PLASMAS, P1, DOI 10.1142/8362; Ishizawa A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053007; Ishizawa A, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4876960; Ishizawa A, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4826201; Jenko F, 2000, COMPUT PHYS COMMUN, V125, P196, DOI 10.1016/S0010-4655(99)00489-0; Maeyama S., 2014, PLASMA FUSION RES, V9; Ishizawa Akihiro, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2403087; Nakata M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3675855; Numata R, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3659035; OHDACHI S, 2010, PLASMA PHYS, V50, P552; Pueschel MJ, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3656965; Pueschel MJ, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3435280; Pueschel MJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3005380; Pueschel MJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.155005; Sugama H, 1996, PHYS PLASMAS, V3, P2379, DOI 10.1063/1.871922; TANG WM, 1980, NUCL FUSION, V20, P1439, DOI 10.1088/0029-5515/20/11/011; Waltz RE, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3449075; Watanabe TH, 2006, NUCL FUSION, V46, P24, DOI 10.1088/0029-5515/46/1/003; Watanabe TH, 2004, PHYS PLASMAS, V11, P1476, DOI 10.1063/1.1669393; Watanabe TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.195002; Wesson J., 2004, TOKAMAKS	39	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	APR	2015	81		2						435810203	10.1017/S0022377815000100		41	Physics, Fluids & Plasmas	Physics	CE9WL	WOS:000352194000033		
J	Numata, R; Loureiro, NF				Numata, Ryusuke; Loureiro, N. F.			Ion and electron heating during magnetic reconnection in weakly collisional plasmas	JOURNAL OF PLASMA PHYSICS			English	Article							ASTROPHYSICAL GYROKINETICS; ACCELERATION	Magnetic reconnection and associated heating of ions and electrons in strongly magnetized, weakly collisional plasmas are studied by means of gyrokinetic simulations. It is shown that an appreciable amount of the released magnetic energy is dissipated to yield (irreversible) electron and ion heating via phase mixing. Electron heating is mostly localized to the magnetic island, not the current sheet, and occurs after the dynamical reconnection stage. Ion heating is comparable to electron heating only in high-beta plasmas, and results from both parallel and perpendicular phase mixing due to finite Larmor radius (FLR) effects; in space, ion heating is mostly localized to the interior of a secondary island (plasmoid) that arises from the instability of the current sheet.	[Numata, Ryusuke] Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Loureiro, N. F.] Univ Lisbon, Inst Super Tecn, Inst Plasmas & Fusao Nucl, P-1049001 Lisbon, Portugal	Numata, R (reprint author), Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, 7-1-28 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	ryusuke.numata@gmail.com	Loureiro, Nuno/E-8719-2011	Loureiro, Nuno/0000-0001-9755-6563	JSPS KAKENHI [24740373]; Fundacao para a Ciencia e a Tecnologia [Pest-OE/SADG/LA0010/2011, IF/00530/2013, PTDC/FIS/118187/2010]	This work was supported by JSPS KAKENHI Grant Number 24740373. This work was carried out using the HELIOS supercomputer system at Computational Simulation Centre of International Fusion Energy Research Centre (IFERC-CSC), Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA. N. F. L. was supported by Fundacao para a Ciencia e a Tecnologia through grants Pest-OE/SADG/LA0010/2011, IF/00530/2013 and PTDC/FIS/118187/2010.	Abel IG, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3046067; Barnes M, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3155085; Loureiro NF, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013102; Fiksel G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.145002; Dahlin JT, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4894484; LANDAU L, 1946, ZH EKSP TEOR FIZ+, V16, P574; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; SPITZER L, 1953, PHYS REV, V89, P977, DOI 10.1103/PhysRev.89.977; Ono Y, 1996, PHYS REV LETT, V76, P3328, DOI 10.1103/PhysRevLett.76.3328; Loureiro NF, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2783986; Drake JF, 2006, NATURE, V443, P553, DOI 10.1038/nature05116; PORCELLI F, 1991, PHYS REV LETT, V66, P425, DOI 10.1103/PhysRevLett.66.425; DORLAND W, 1993, PHYS FLUIDS B-PLASMA, V5, P812, DOI 10.1063/1.860934; Fitzpatrick R, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3374427; Howes GG, 2006, ASTROPHYS J, V651, P590, DOI 10.1086/506172; Hsu SC, 2001, PHYS PLASMAS, V8, P1916, DOI 10.1063/1.1356737; Loureiro NF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.025002; Numata R., 2014, JPS C P, V1; Numata R, 2010, J COMPUT PHYS, V229, P9347, DOI 10.1016/j.jcp.2010.09.006; Numata R, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3659035; Tatsuno T., 2009, PHYS REV LETT, V103; TenBarge J. M., 2014, PHYS PLASMAS, V21	22	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	APR	2015	81		2						305810201	10.1017/S002237781400107X		17	Physics, Fluids & Plasmas	Physics	CE9WL	WOS:000352194000015		
J	Yagi, M				Yagi, M.			Numerical methods used in fusion science numerical modeling	JOURNAL OF PLASMA PHYSICS			English	Article								The dynamics of burning plasma is very complicated physics, which is dominated by multi-scale and multi-physics phenomena. To understand such phenomena, numerical simulations are indispensable. Fundamentals of numerical methods used in fusion science numerical modeling are briefly discussed in this paper. In addition, the parallelization technique such as open multi processing (OpenMP) and message passing interface (MPI) parallel programing are introduced and the loop-level parallelization is shown as an example.	Japan Atom Energy Agcy, Rokkasho Fus Inst, Plasma Theory & Simulat Grp, Rokkasho, Aomori 0393212, Japan	Yagi, M (reprint author), Japan Atom Energy Agcy, Rokkasho Fus Inst, Plasma Theory & Simulat Grp, Rokkasho, Aomori 0393212, Japan.	yagi.masatoshi@jeae.go.jp			7th ITER International School	The author (M. Y.) acknowledges travel funding supported by 7th ITER International School.	Birsall C. K., 2005, PLASMA PHYS VIA COMP; CHAPMAN B., 2008, USING OPENMP; Fletcher C., 1991, COMPUTATIONAL TECHNI; Gear C.W., 1971, NUMERICAL INITIAL VA; Gropp William, 1999, USING MPI; Jardin S.C., 2010, COMPUTATIONAL METHOD; Karniadakis G.E., 2003, PARALLEL SCI COMPUTI; MIYOSHI H, 1994, SUPERCOMP PROC, P685; Press WH, 1992, NUMERICAL RECIPES FO; Ruetsch G, 2013, CUDA FORTRAN SCI ENG, V1st; Suli E, 2003, INTRO NUMERICAL ANAL; Tajima T., 1989, COMPUTATIONAL PLASMA	12	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	APR	2015	81		2						435810201	10.1017/S0022377815000069		12	Physics, Fluids & Plasmas	Physics	CE9WL	WOS:000352194000032		
J	Yoshimura, S; Terasaka, K; Tanaka, E; Aramaki, M; Okamoto, A; Nagaoka, K; Tanaka, MY				Yoshimura, S.; Terasaka, K.; Tanaka, E.; Aramaki, M.; Okamoto, A.; Nagaoka, K.; Tanaka, M. Y.			Exploration of spontaneous vortex formation and intermittent behavior in ECR plasmas: The HYPER-I experiments	JOURNAL OF PLASMA PHYSICS			English	Article							WAVES	HYPER-I (High Density Plasma Experiment-I) is a linear device that combines a wide operation range of plasma production with flexible diagnostics. The plasmas are produced by the electron cyclotron resonance (ECR) heating with parallel injection of right-handed circularly polarized microwaves of 2.45 GHz from the high-field side. The maximum attainable electron density is more than two orders of magnitude higher than the cutoff density of ordinary waves. Spontaneous formation of a variety of largescale flow structures, or vortices, has been observed in the HYPER-I plasmas. Flowvelocity field measurements using directional Langmuir probes (DLPs) and laser-induced fluorescence (LIF) method have clarified the physical processes behind such vortex formations. Recently, a new intermittent behavior of local electron temperature has also been observed. Statistical analysis of the floating potential changes has revealed that the phenomenon is characterized by a stationary Poisson process.	[Yoshimura, S.; Nagaoka, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Terasaka, K.; Tanaka, E.; Tanaka, M. Y.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Aramaki, M.] Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758575, Japan; [Okamoto, A.] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan	Yoshimura, S (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	yshinji@nifs.ac.jp			JSPS [24540544]; NIFS [NIFS13KOAP026, NIFS13KB AP016, NIFS14KBAP024]; NINS	The HYPER-I experiment is performed under the auspices of JSPS KAKENHI Grant Number 24540544, NIFS collaboration research program (NIFS13KOAP026, NIFS13KB AP016, and NIFS14KBAP024), and NINS young scientists collaboration program for cross-disciplinary study.	D'Ippolito DA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3594609; Okamoto A, 2003, PHYS PLASMAS, V10, P2211, DOI 10.1063/1.1571059; ALLEN L, 1994, OPT COMMUN, V112, P141, DOI 10.1016/0030-4018(94)00484-6; Horton W, 1999, REV MOD PHYS, V71, P735, DOI 10.1103/RevModPhys.71.735; Carter TA, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2158929; Wheatland MS, 2002, SOL PHYS, V211, P255, DOI 10.1023/A:1022430308641; Aramaki M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3127581; Aramaki M, 2010, J PHYS CONF SER, V227, DOI 10.1088/1742-6596/227/1/012008; Aschwanden M, 2011, SELF-ORGANIZED CRITICALITY IN ASTROPHYSICS: THE STATISTICS OF NONLINEAR PROCESSES IN THE UNIVERSE, P1, DOI 10.1007/978-3-642-15001-2; Chen F. F., 1984, INTRO PLASMA PHYS CO; Kono M, 2000, PHYS SCRIPTA, VT84, P47, DOI 10.1238/Physica.Topical.084a00047; Lieberman MA, 2005, PRINCIPLES OF PLASMA DISCHARGES AND MATERIALS PROCESSING, 2ND EDITION, P1; Nagaoka K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075001; Nagaoka K, 2001, J PHYS SOC JPN, V70, P131, DOI 10.1143/JPSJ.70.131; TANAKA M, 1991, J PHYS SOC JPN, V60, P1600, DOI 10.1143/JPSJ.60.1600; Tanaka MY, 2004, PHYS SCRIPTA, VT107, P49, DOI 10.1238/Physica.Topical.107a00049; Tanaka MY, 1998, REV SCI INSTRUM, V69, P980, DOI 10.1063/1.1148607; Tanaka MY, 2005, IEEE T PLASMA SCI, V33, P454, DOI 10.1109/TPS.2005.845366; Terasaka K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.036101; Vranjes J, 2006, PLASMA SOURCES SCI T, V15, pS1, DOI 10.1088/0963-0252/15/2/S01; Vranges J., 2002, PHYS REV LETT, V89; Windisch T., 2011, PLASMA PHYS CONTROL, V53; Yoshimura S., 2004, J PLASMA FUSION RES, V6, P610; Yoshimura S., 2014, JPS C P, V1; Yoshimura S., 2009, J PLASMA FUSION RES, V8, P11	25	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	APR	2015	81		2						345810204	10.1017/S0022377814001147		10	Physics, Fluids & Plasmas	Physics	CE9WL	WOS:000352194000022		
J	Kawada, T				Kawada, Tomoyuki			C-reactive protein, depressive symptoms and incident diabetes mellitus with special emphasis on physical activity	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Letter							TELEVISION VIEWING TIME; ADULTS; RISK; INFLAMMATION; ASSOCIATION; BIOMARKERS; DISEASE		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/01.EDE.0000023965.92535.C0; Au B, 2014, J PSYCHOSOM RES, V77, P180, DOI 10.1016/j.jpsychores.2014.07.012; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Jarvie JL, 2014, AM J CARDIOL, V114, P1192, DOI 10.1016/j.amjcard.2014.07.036; Smith L, 2014, DIABETIC MED, V31, P1572, DOI 10.1111/dme.12544; Wiseman AJ, 2014, CANCER CAUSE CONTROL, V25, P1309, DOI 10.1007/s10552-014-0433-z	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	APR	2015	78	4					407	407		10.1016/j.jpsychores.2015.01.004		1	Psychiatry	Psychiatry	CE8VG	WOS:000352121600016		
J	O'Neill, S; Posada-Villa, J; Medina-More, ME; Al-Hamzawi, AO; Tachimori, H; Hu, CY; Lim, C; Bruffaerts, R; Lepine, JP; Matschin, H; DeGirolamo, G; de Jonge, P; Alonso, J; Caldas-de-Almeida, JM; Levinson, D; Kessler, R; Scott, K				O'Neill, Siobhan; Posada-Villa, Jose; Medina-More, Maria-Elena; Al-Hamzawi, Ali Obad; Tachimori, Hisateru; Hu, Chiyi; Lim, Carmen; Bruffaerts, Ronny; Lepine, Jean-Pierre; Matschin, Herbert; DeGirolamo, Giovanni; de Jonge, Peter; Alonso, Jordi; Caldas-de-Almeida, Jose Miguel; Levinson, Daphna; Kessler, Ronald; Scott, Kate			associations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancer (vol 76, pg 207, 2014)	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Correction									[O'Neill, Siobhan] Univ Ulster, Bamford Ctr Mental Hlth & Well Being, Coleraine BT52 1SA, Londonderry, North Ireland; [Posada-Villa, Jose] Colegio Mayor Cundinamarca Univ, Bogota, Colombia; [Medina-More, Maria-Elena] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Al-Hamzawi, Ali Obad] Al Qadisiya Univ, Coll Med, Al Qadisiyah, Iraq; [Tachimori, Hisateru] NIMH, Natl Ctr Neurol & Psychiat, Dept Mental Hlth Policy & Evaluat, Kodaira, Tokyo, Japan; [Hu, Chiyi] Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; [Lim, Carmen; Scott, Kate] Univ Otago, Dept Psychol Med, Otago, New Zealand; [Bruffaerts, Ronny] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven, Belgium; [Lepine, Jean-Pierre] Univ Paris Diderot, Paris, France; [Matschin, Herbert] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Publ Hlth Res Unit, Leipzig, Germany; [DeGirolamo, Giovanni] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy; [de Jonge, Peter] Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Alonso, Jordi] IMIM Hosp del Mar Med Res Inst, Hlth Serv Res Unit, Barcelona, Spain; [Alonso, Jordi] CIBERESP, Madrid, Spain; [Caldas-de-Almeida, Jose Miguel] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr CEDOC, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Levinson, Daphna] Minist Hlth, Mental Hlth Serv, Jerusalem, Israel; [Kessler, Ronald] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA	O'Neill, S (reprint author), Univ Ulster, Bamford Ctr Mental Hlth & Well Being, Coleraine BT52 1SA, Londonderry, North Ireland.	sm.oneill@ulster.ac.uk	Alonso, Jordi/A-5514-2010	Alonso, Jordi/0000-0001-8627-9636			O'Neill S, 2014, J PSYCHOSOM RES, V76, P207, DOI 10.1016/j.jpsychores.2013.12.012	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	APR	2015	78	4					409	409		10.1016/j.jpsychores.2015.01.008		1	Psychiatry	Psychiatry	CE8VG	WOS:000352121600018		
J	Ibrahim, M; Suzuki, A; Yamada, K; Takahashi, S; Yasuda, H; Dohzono, S; Koike, T; Nakamura, H				Ibrahim, Mohammad; Suzuki, Akinobu; Yamada, Kentaro; Takahashi, Shinji; Yasuda, Hiroyuki; Dohzono, Sho; Koike, Tatsuya; Nakamura, Hiroaki			The Relationship Between Cervical and Lumbar Spine Lesions in Rheumatoid Arthritis With a Focus on Endplate Erosion	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						rheumatoid arthritis; endplate erosion; atlantoaxial subluxation; vertical subluxation; vertebral fracture; scoliosis; spondylolisthesis; disease activity	INTERVERTEBRAL DISC; CLASSIFICATION; ASSOCIATION; WINNER; ALPHA; MRI	Study Design: A cross-sectional imaging study. Objective: To investigate the relationship between cervical and lumbar spine lesions in patients with rheumatoid arthritis (RA), and to analyze associated factors in those with concurrent cervical and lumbar endplate erosion (EE). Summary of Background Data: Both the lumbar and cervical spines are often involved in RA, but little is known about the relationship between cervical and lumbar lesions. EE is often found in the spine of RA patients, but its prevalence and associated factors have not been well studied. Methods: We enrolled 201 RA patients in this study. Cervical lesions (horizontal and vertical atlantoaxial dislocation, subaxial subluxation) and lumbar lesions (vertebral fracture, scoliosis, spondylolisthesis) were evaluated on plain radiographs. EE was evaluated on sagittal T1-weighted magnetic resonance images, and graded into 4 categories. The prevalence of each lesion was calculated, and correlations between general cervical and lumbar lesions and between cervical and lumbar EE were analyzed. To assess the clinical condition of RA, we evaluated disease duration, Steinbrocker stage, modified Stanford Health Assessment Questionnaire results, and Disease Activity Score for 28 joints with the erythrocyte sedimentation rate. Factors associated with concurrent lumbar and cervical EE were analyzed using multiple logistic regression analysis. Results: Cervical lesions were found in 42.3% of patients and lumbar lesions in 56.2%. There was no significant correlation between the presence of cervical and the presence of lumbar lesions, but patients with cervical subaxial subluxation were significantly more likely to have lumbar spondylolisthesis. Cervical EE (>= 1 points) was found in 61.2% of patients and lumbar EE in 39.3%. Total cervical EE score was significantly correlated with lumbar EE score. Moderate/high disease activity, Steinbrocker stage IV, and severe cervical or lumbar disk degeneration were associated with concurrent cervical and lumbar EE. Conclusions: Some cervical lesions are significantly associated with lumbar spinal lesions. Concurrent cervical and lumbar EE are related to RA disease activity and peripheral joint deterioration, suggesting that RA activity may play an important role in total spinal involvement.	[Ibrahim, Mohammad; Suzuki, Akinobu; Yamada, Kentaro; Takahashi, Shinji; Yasuda, Hiroyuki; Dohzono, Sho; Koike, Tatsuya; Nakamura, Hiroaki] Osaka City Univ, Dept Orthoped Surg, Grad Sch Med, Osaka 558, Japan	Suzuki, A (reprint author), Osaka City Univ, Dept Orthoped Surg, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 558, Japan.	a-suzuki@msic.med.osaka-cu.ac.jp			Takeda Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Chugai Pharmaceutical; Eisai; Abbott Japan; Teijin Pharma; Banyu Pharmaceutical; Ono Pharmaceutical	T.K.: received research grants and/or speaking fees from Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical, Eisai, Abbott Japan, Teijin Pharma, Banyu Pharmaceutical, and Ono Pharmaceutical. The remaining authors declare no conflict of interest.	Iguchi T, 2002, J SPINAL DISORD TECH, V15, P93; de Souza MC, 2011, CLIN RHEUMATOL, V30, P831, DOI 10.1007/s10067-011-1687-4; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; Anderson J, 2012, ARTHRIT CARE RES, V64, P640, DOI 10.1002/acr.21649; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c; Schwab F, 2003, SPINE, V28, P602, DOI 10.1097/00007632-200303150-00016; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Weiler C, 2005, SPINE, V30, P44; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Sakai T, 2008, SPINE J, V8, P605, DOI 10.1016/j.spince.2007.03.008; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Clark CR, 2005, CERVICAL SPINE; Emery P, 2011, ANN RHEUM DIS, V70, P2126, DOI 10.1136/ard.2011.154500; HEYWOOD AWB, 1986, J BONE JOINT SURG BR, V68, P362; Kawaguchi Y, 2003, J SPINAL DISORD TECH, V16, P38; LAWRENCE JS, 1964, ANN RHEUM DIS, V23, P205, DOI 10.1136/ard.23.3.205; Martin Michael D, 2002, Neurosurg Focus, V13, pE1; Moore RJ, 2000, EUR SPINE J, V9, P92, DOI 10.1007/s005860050217; Paus AC, 2008, SPINE, V33, P2278, DOI 10.1097/BRS.0b013e31817f1a17; PINCUS T, 1983, ARTHRITIS RHEUM, V26, P1346, DOI 10.1002/art.1780261107; SHICHIKAWA K, 1978, INT ORTHOP, V2, P53; Silva I, 2010, ACTA REUMATOL PORT, V35, P456; URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101; Yamada K, 2014, J SPINAL DISORD TECH, V27, pE128, DOI 10.1097/BSD.0b013e3182a22a34; Yamashita T, 2000, MOD RHEUMATOL, V10, P211	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	APR	2015	28	3					E154	E160				7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CF1JP	WOS:000352301700006		
J	Ezawa, M				Ezawa, Motohiko			Photo-Induced Topological Superconductor in Silicene, Germanene, and Stanene	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Silicene; Topological superconductor; Majorana fermion		We investigate the emergence of topological superconductivity in honeycomb system such as silicene, germanene, and stanene. Photo-irradiation induces the Haldane term into the system. By introducing s-wave superconductivity by proximity coupling, the system becomes a topological superconductor. It is a photo-induced topological superconductor. We explicitly determine the topological phase diagram by deriving the four independent 2-band theory and determining the chern number. We also explicitly obtain wave functions of Majorana zero-energy bound states, which appear at the boundary of two distinct topological phases. We can arbitrarily control the position of Majorana fermion by moving the area of photo-irradiation.	Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Ezawa, M (reprint author), Univ Tokyo, Dept Appl Phys, Hongo 7-3-1, Tokyo 1138656, Japan.	ezawa@ap.t.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture [25400317]	I am very much grateful to N. Nagaosa, Y. Tanaka and T. Oka for many helpful discussions on the subject. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture No. 25400317.	Kitagawa T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235108; Alicea J, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076501; Qi XL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184516; Ezawa M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033003; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Liu CC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076802; Ezawa M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.026603; JACKIW R, 1981, NUCL PHYS B, V190, P681, DOI 10.1016/0550-3213(81)90044-4; Leijnse M, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/12/124003; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Ezawa M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155415; Beenakker CWJ, 2013, ANNU REV CONDEN MA P, V4, P113, DOI 10.1146/annurev-conmatphys-030212-184337; Qi XL, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187001; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Ezawa M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02790; Ezawa M, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/27006; Kitaev A. Y., 2001, SOV PHYS USP, V44, P131; Liu CC, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195430; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	APR	2015	28	4					1249	1253		10.1007/s10948-014-2900-x		5	Physics, Applied; Physics, Condensed Matter	Physics	CE8IN	WOS:000352085700009		
J	Athauda, A; Yang, JJ; Li, B; Mizuguchi, Y; Lee, S; Louca, D				Athauda, Anushika; Yang, Junjie; Li, Bing; Mizuguchi, Yoshikazu; Lee, Seunghun; Louca, Despina			The Crystal Structure of Superconducting LaO1-x F (x) BiS2	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						BiS2 layered superconductor; Structural analysis; Neutron scattering; Debye temperature	SPECTRA	Neutron scattering measurements were carried out on polycrystalline samples of LaO1-x F (x) BiS2 to investigate the evolution of the crystal structure with the appearance of superconductivity. It is observed that the BiS2 layer gradually unbuckles as x increases to 0.3 and the orientation of the buckling reverses by x = 0.5. The Debye temperatures were estimated to be similar to 319 and similar to 224 K for the x = 0 and x = 0.5, respectively, indicating significant softening related to structural disorder.	[Athauda, Anushika; Yang, Junjie; Li, Bing; Lee, Seunghun; Louca, Despina] Univ Virginia, Dept Phys, Charlottesville, VA 22904 USA; [Mizuguchi, Yoshikazu] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Hachioji, Tokyo 1920397, Japan	Louca, D (reprint author), Univ Virginia, Dept Phys, 382 McCormick Rd, Charlottesville, VA 22904 USA.	dl4f@Virginia.edu			National Science Foundation [DMR - 1404994]	The work at the University of Virginia has been supported by the National Science Foundation, Grant # DMR - 1404994.	Lee J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205134; Yazici D, 2013, PHILOS MAG, V93, P673, DOI 10.1080/14786435.2012.724185; Mizuguchi Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220510; Miura A, 2014, J SOLID STATE CHEM, V212, P213, DOI 10.1016/j.jssc.2014.01.035; BENI G, 1976, PHYS REV B, V14, P1514, DOI 10.1103/PhysRevB.14.1514; Mizuguchi Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114725; Jeong IK, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104301; Deguchi K, 2012, PHYS SOC JPN, P81; Egami T, 1997, J SUPERCOND, V10, P323, DOI 10.1007/BF02765712; Egami T., 2003, PERGAMON MAT SERIES, V55; Egami T, 2000, J SUPERCOND, V13, P709, DOI 10.1023/A:1007849811903; Kajitani J, 2014, SOLID STATE COMMUN, V181, P1, DOI 10.1016/j.ssc.2013.11.027; Li B, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/47002; Shein I.R., 2012, JETP LETT, V96, P769; Yildrim T, 2013, PHYS REV B, P87	15	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	APR	2015	28	4					1255	1259		10.1007/s10948-014-2918-0		5	Physics, Applied; Physics, Condensed Matter	Physics	CE8IN	WOS:000352085700010		
J	Yanagisawa, T				Yanagisawa, Takashi			Multi-Phase Physics of Multi-Condensate Superconductivity	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Multi-gap superconductor; Frustrated-Josephson coupling; Time-reversal symmetry breaking; Massless excitation modes		Multi-gap superconductors exhibit interesting properties. In N-gap superconductors, the U(1) (N) phase invariance is spontaneously broken. When N is greater than 2, N a parts per thousand yen 3, several interesting phenomena will emerge due to the multi-band effect. Among them, the time-reversal symmetry breaking and the emergence of massless modes are significant. We consider a multi-band model with inter-band frustrated-Josephson couplings for general N. The conditions for the time-reversal symmetry breaking and the existence of massless modes are reduced to a simple form for the Josephson couplings in a separable form which we propose in this paper.	Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan	Yanagisawa, T (reprint author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	t-yanagisawa@aist.go.jp					Babaev E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067001; Stanev V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134522; Lin SZ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177005; Platt C, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180502; Tanaka Y, 2010, SOLID STATE COMMUN, V150, P1980, DOI 10.1016/j.ssc.2010.08.024; Stanev V, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.174520; Dias RG, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/8/085009; Hu X, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064516; Izumov Yu.A., 1990, PHASE TRANSIT, V20, P95; Kobayashi K, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.224516; Koyama T, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.074715; Malti S., 2012, PHYS REV B, VB87; Ota Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.060507; Tanaka Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.114706; Tanaka Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017002; Wilson BJ, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/42/425702; Yanagisawa T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024712; Yanagisawa T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124704; Yanagisawa T, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123014	19	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	APR	2015	28	4					1285	1287		10.1007/s10948-014-2905-5		3	Physics, Applied; Physics, Condensed Matter	Physics	CE8IN	WOS:000352085700015		
J	Maebashi, H; Takada, Y				Maebashi, Hideaki; Takada, Yasutami			Generic Features of an Electron Injected into the Luttinger Liquid	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						One-dimensional electron systems; Luttinger liquid; Spin-charge separation; One-electron spectral function	CHARGE-SPIN SEPARATION; SPECTRAL PROPERTIES; FERMI GAS; MODEL	An extra electron injected into the Luttinger liquid (LL) is not completely separated into spin and charge excitations, but it provides a peak of an electron-like excitation in addition to the two prominent spin- and charge-excitation peaks in the one-electron spectral function of an interacting one-dimensional (1D) system. By a scaling argument based on a renormalization-group scheme, we obtain universal features of this electron-like excitation for low energies and in the vicinity of the Fermi point, which are entirely characterized by the Luttinger parameter K (c) and the renormalized Fermi velocity v (F) at the LL fixed point. The latter quantity v (F) is shown to be given by the slope of the lowest excitation spectrum near the Fermi point in the system with large but finite size. Some of exact results are presented for the 1D Hubbard model at n=0.59 filling.	[Maebashi, Hideaki; Takada, Yasutami] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Maebashi, H (reprint author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	maebashi@issp.u-tokyo.ac.jp			MEXT, Japan [22104011]	This work is partially supported by Innovative Area "Materials Design through Computics: Complex Correlation and Non-Equilibrium Dynamics" (No. 22104011) from MEXT, Japan.	SOLYOM J, 1979, ADV PHYS, V28, P201, DOI 10.1080/00018737900101375; Carmelo JMP, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/41/415103; LUTTINGER JM, 1963, J MATH PHYS, V4, P1154, DOI 10.1063/1.1704046; SHANKAR R, 1994, REV MOD PHYS, V66, P129, DOI 10.1103/RevModPhys.66.129; Essler FHL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205120; TOMONAGA S, 1950, PROG THEOR PHYS, V5, P544; Benthien H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256401; Claessen R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.096402; Carmelo JMP, 2006, J PHYS-CONDENS MAT, V18, P5191, DOI 10.1088/0953-8984/18/22/019; Imambekov A, 2012, REV MOD PHYS, V84, P1253, DOI 10.1103/RevModPhys.84.1253; HALDANE FDM, 1981, J PHYS C SOLID STATE, V14, P2585, DOI 10.1088/0022-3719/14/19/010; Maebashi H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201109; SCHONHAMMER K, 1993, PHYS REV B, V48, P11390, DOI 10.1103/PhysRevB.48.11390; MEDEN V, 1992, PHYS REV B, V46, P15753, DOI 10.1103/PhysRevB.46.15753; Metzner W, 1998, ADV PHYS, V47, P317, DOI 10.1080/000187398243528; Orignac E, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165128; SCHONHAMMER K, 1993, PHYS REV B, V47, P16205, DOI 10.1103/PhysRevB.47.16205; Sing M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125111; Solyom J., 2010, FUNDAMENTALS PHYS SO, V3; SUZUMURA Y, 1980, PROG THEOR PHYS, V63, P51, DOI 10.1143/PTP.63.51; VOIT J, 1993, J PHYS-CONDENS MAT, V5, P8305, DOI 10.1088/0953-8984/5/44/020; VOIT J, 1993, PHYS REV B, V47, P6740, DOI 10.1103/PhysRevB.47.6740; WOYNAROVICH F, 1989, J PHYS A-MATH GEN, V22, P4243, DOI 10.1088/0305-4470/22/19/017	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	APR	2015	28	4					1331	1335		10.1007/s10948-014-2914-4		5	Physics, Applied; Physics, Condensed Matter	Physics	CE8IN	WOS:000352085700024		
J	Obase, K; Jeevanandam, V; Saito, K; Kesner, K; Barry, A; Hollatz, A; Farooqui, F; Addetia, K; Roberts, JD; Ota, T; Balkhy, HH; Yoshida, K; Mor-Avi, V; Lang, RM				Obase, Kikuko; Jeevanandam, Valluvan; Saito, Ken; Kesner, Kimberly; Barry, Aaron; Hollatz, Andrew; Farooqui, Farhan; Addetia, Karima; Roberts, Joseph D.; Ota, Takeyoshi; Balkhy, Husam H.; Yoshida, Kiyoshi; Mor-Avi, Victor; Lang, Roberto M.			Visualization and Measurement of Mitral Valve Chordae Tendineae Using Three-Dimensional Transesophageal Echocardiography from the Transgastric Approach	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						3D transesophageal echocardiography; Transgastric view; Multiplanar reconstruction; Submitral apparatus; Mitral valve chordae tendineae	PAPILLARY-MUSCLE; REGURGITATION; REPAIR; REPLACEMENT; PROLAPSE	Background: The evaluation of the submitral apparatus is challenging from the conventional transesophageal approach. The aim of this study was to test the feasibility of using three-dimensional (3D) transesophageal echocardiographic (TEE) imaging from the transgastric approach to visualize the submitral apparatus and quantify the lengths of the chordae tendineae by using multiplanar reconstruction analysis. Methods: Twenty-two patients who had transgastric full-volume 3D TEE data sets before mitral valve surgery underwent surgical measurement of chordal length. A short-axis plane at the chordal level was extracted from the 3D data set to identify leaflet segments and the corresponding primary chords. Then, for each chord, the optimal plane was selected to visualize and measure the entire chordal length from its origin at the leaflet margin to the papillary muscle tips. Measurements were performed at the phase of the cardiac cycle when chordal length reached its maximum. Measured values were compa red with surgical measurements using linear regression and Bland-Altman analyses. Result: One hundred forty-six primary chords were measured intraoperatively. Three-dimensional TEE imaging was able to measure the lengths of all these chords. The surgical and 3D TEE measurements (mean, 1.96 +/- 0.56 vs 1.93 +/- 0.50 cm, respectively) correlated highly (r=0.93, P <.0001), with a minimal bias of 0.03 cm and narrow limits of agreement from -0.39 to 0.45 cm. Conclusion: Transgastric 3D TEE imaging of the submitral apparatus allows visualization and accurate measurement of chordae tendineae lengths, which may be useful for planning mitral valve repair, including percutaneous transcatheter procedures.	[Obase, Kikuko; Addetia, Karima; Mor-Avi, Victor; Lang, Roberto M.] Univ Chicago, Cardiol Sect, Dept Med, Chicago, IL 60637 USA; [Jeevanandam, Valluvan; Ota, Takeyoshi; Balkhy, Husam H.] Univ Chicago, Cardiothorac Surg, Chicago, IL 60637 USA; [Kesner, Kimberly; Barry, Aaron; Hollatz, Andrew; Farooqui, Farhan; Roberts, Joseph D.] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Obase, Kikuko; Saito, Ken; Yoshida, Kiyoshi] Kawasaki Med Univ, Dept Cardiol, Kurashiki, Okayama, Japan	Obase, K (reprint author), Univ Chicago, Med Ctr, Dept Med, Cardiol Sect,Noninvas Cardiac Imaging Lab, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kikuko_obase@hotmail.com					Kron IL, 2002, ANN THORAC SURG, V74, P600, DOI 10.1016/S0003-4975(02)03749-9; Seeburger J, 2014, J AM COLL CARDIOL, V63, P914, DOI 10.1016/j.jacc.2013.07.090; Mohty D, 2001, CIRCULATION, V104, pI1; Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3; PERIER P, 1984, CIRCULATION, V70, P187; Perier P, 2008, ANN THORAC SURG, V86, P718, DOI 10.1016/j.athoracsur.2008.05.015; von Oppell UO, 2000, ANN THORAC SURG, V70, P2166, DOI 10.1016/S0003-4975(00)02047-6; Carpentier A, 2010, RECONSTRUCTIVE VALVE, P36; Hvass U, 2003, ANN THORAC SURG, V75, P809, DOI 10.1016/S0003-4975(02)04678-7; Komeda M, 2012, J THORAC CARDIOV SUR, V144, P1262, DOI 10.1016/j.jtcvs.2012.06.038; Obase K, 2012, J THORAC CARDIOV SUR, V143, DOI 10.1016/j.jtcvs.2012.01.064	11	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	APR	2015	28	4					449	454		10.1016/j.echo.2015.01.015		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE9DX	WOS:000352145100009		
J	Karasawa, K; Asano, K; Moriyama, S; Ushiki, M; Monya, M; Iida, M; Kuboki, E; Yagita, H; Uchida, K; Nitta, K; Tanaka, M				Karasawa, Kazunori; Asano, Kenichi; Moriyama, Shigetaka; Ushiki, Mikiko; Monya, Misa; Iida, Mayumi; Kuboki, Erika; Yagita, Hideo; Uchida, Keiko; Nitta, Kosaku; Tanaka, Masato			Vascular-Resident CD169-Positive Monocytes and Macrophages Control Neutrophil Accumulation in the Kidney with Ischemia-Reperfusion Injury	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CELL-ASSOCIATED ANTIGENS; BONE-MARROW; ENDOTHELIAL-CELLS; MARGINAL ZONE; RECEPTOR; HOMEOSTASIS; REPAIR; MOUSE; PATHOPHYSIOLOGY; ATHEROSCLEROSIS	Monocytes and kidney-resident macrophages are considered to be involved in the pathogenesis of renal ischemia-reperfusion injury (IRI). Several subsets of nnonocytes and macrophages are localized in the injured tissue, but the pathologic roles of these cells are not fully understood. Here, we show that CD169(+) nnonocytes and macrophages have a critical role in preventing excessive inflammation in IRI by downregulating intercellular adhesion molecule-1 (ICAM-1) expression on vascular endothelial cells. Mice depleted of CD169(+) cells showed enhanced endothelial ICAM-1 expression and developed irreversible renal damage associated with infiltration of a large number of neutrophils. The perivascular localization of CD169(+) monocytes and macrophages indicated direct interaction with blood vessels, and coculture experiments showed that the direct interaction of CD169(+) cell-depleted peripheral blood leukocytes augments the expression levels of ICAM-1 on endothelial cells. Notably, the transfer of Ly6C(lo) monocytes into CD169(+) cell-depleted mice rescued the mice from lethal renal injury and normalized renal ICAM-1 expression levels, indicating that the Ly6C(lo) subset of CD169(+) monocytes has a major role in the regulation of inflammation. Our findings highlight the previously unknown role of CD169(+) monocytes and macrophages in the maintenance of vascular homeostasis and provide new approaches to the treatment of renal IRI.	[Karasawa, Kazunori; Asano, Kenichi; Moriyama, Shigetaka; Ushiki, Mikiko; Monya, Misa; Iida, Mayumi; Kuboki, Erika; Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Immune Regulat, Hachioji, Tokyo 1920392, Japan; [Karasawa, Kazunori; Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo, Japan; [Asano, Kenichi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Tanaka, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Immune Regulat, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	mtanaka@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; Uehara Memorial Foundation; Takeda Science Foundation; Naito Foundation	This work was supported, in part, by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan, the Uehara Memorial Foundation, the Takeda Science Foundation, and the Naito Foundation.	Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Oh DJ, 2008, AM J PHYSIOL-RENAL, V294, pF264, DOI 10.1152/ajprenal.00204.2007; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Thakar CV, 2005, J CLIN INVEST, V115, P3451, DOI 10.1172/JC125461; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Furuichi K, 2008, J IMMUNOL, V181, P8670; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takada Y, 2010, J IMMUNOL, V184, P2671, DOI 10.4049/jimmunol.0804012	46	6	6	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	APR	2015	26	4					896	906		10.1681/ASN.2014020195		11	Urology & Nephrology	Urology & Nephrology	CE7UZ	WOS:000352048700017		
J	Saito, I; Ishioka, K				Saito, Izumi; Ishioka, Keiichi			Mechanism for the Formation of Equatorial Superrotation in Forced Shallow-Water Turbulence with Newtonian Cooling	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							2-DIMENSIONAL DECAYING TURBULENCE; ROTATING SPHERE; BETA-PLANE; GEOSTROPHIC TURBULENCE; GIANT PLANETS; JETS; WAVES; VORTICES; FLOWS	Forced shallow-water turbulence on a rotating sphere with Newtonian cooling is examined with the aim of elucidating the mechanism of the robust formation of equatorial superrotation reported by R. K. Scott and L. M. Polvani. It is shown that the Newtonian cooling term distorts the structure of the Hough modes. This distortion can be visualized as either the westward or eastward tilting of the equiphase line with increasing absolute value of latitude; the structural change of the Hough modes leads to the acceleration of the zonal-mean flow. A statistical analysis based on a weak-nonlinear theory predicts that stochastically excited Hough modes generate a prograde equatorial jet, the profile of which is quantitatively consistent with that of the ensemble-averaged zonal-mean flow obtained in nonlinear time evolutions. The predicted prograde equatorial jet originates mainly from the acceleration produced by Rossby modes, the equiphase line of which is tilted westward by the Newtonian cooling term. This tilt of the equiphase line of the Hough modes is clarified and a comparison between the acceleration mechanism presented in the present paper and that in other numerical studies in which equatorial superrotation emerges is made.	[Saito, Izumi; Ishioka, Keiichi] Kyoto Univ, Div Earth & Planetary Sci, Grad Sch Sci, Kyoto 6068502, Japan	Saito, I (reprint author), Kyoto Univ, Div Earth & Planetary Sci, Grad Sch Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	izumi@kugi.kyoto-u.ac.jp			National Science Foundation [NSF PHY11-25915]	We are grateful to Drs. R. K. Scott, T. J. Dunkerton, J. Y.-K. Cho, M. E. McIntyre, Y.-Y. Hayashi, M. Yamada, S. Yoden, and S. Takehiro for fruitful discussions and instructive comments. We also thank two anonymous reviewers for useful comments and suggestions. The ISPACK numerical library (http://www.gfd-dennou.org/arch/ispack/) was used for the computations and the GFD-DENNOU library (http://www.gfd-dennou.org/arch/dcl/) was used to draw the figures. This research was supported in part by the National Science Foundation under Grant NSF PHY11-25915. Izumi Saito is supported by Grant-in-Aid for JSPS Fellows.	[Anonymous], 2011, SPECULUM, V86, P1, DOI DOI 10.1098/RSTA.2010.0306.FARRELL; Cho JYK, 1996, PHYS FLUIDS, V8, P1531, DOI 10.1063/1.868929; Liu JJ, 2010, J ATMOS SCI, V67, P3652, DOI 10.1175/2010JAS3492.1; Schneider T, 2009, J ATMOS SCI, V66, P579, DOI 10.1175/2008JAS2798.1; Scott RK, 2007, J ATMOS SCI, V64, P3158, DOI 10.1175/JAS4003.1; Theiss J, 2004, J PHYS OCEANOGR, V34, P1663, DOI 10.1175/1520-0485(2004)034<1663:EECCLA>2.0.CO;2; Srinivasan K, 2012, J ATMOS SCI, V69, P1633, DOI 10.1175/JAS-D-11-0200.1; RHINES PB, 1975, J FLUID MECH, V69, P417, DOI 10.1017/S0022112075001504; ANDREWS DG, 1976, J ATMOS SCI, V33, P2031, DOI 10.1175/1520-0469(1976)033<2031:PWIHAV>2.0.CO;2; Dritschel DG, 2008, J ATMOS SCI, V65, P855, DOI 10.1175/2007JAS2227.1; WILLIAMS GP, 1978, J ATMOS SCI, V35, P1399, DOI 10.1175/1520-0469(1978)035<1399:PCBROJ>2.0.CO;2; Okuno A, 2003, PHYS FLUIDS, V15, P56, DOI 10.1063/1.1524188; VALLIS GK, 1993, J PHYS OCEANOGR, V23, P1346, DOI 10.1175/1520-0485(1993)023<1346:GOMFAJ>2.0.CO;2; BUSSE FH, 1983, PURE APPL GEOPHYS, V121, P375, DOI 10.1007/BF02590147; Hayashi YY, 2007, J ATMOS SCI, V64, P4246, DOI 10.1175/2007JAS2209.1; Kitamura Y, 2007, J ATMOS SCI, V64, P3340, DOI [10.1175/JAS4015.1, 10.1175/JAS4015]; LONGUETH.MS, 1968, PHILOS TR R SOC S-A, V262, P511, DOI 10.1098/rsta.1968.0003; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Nozawa T, 1997, PHYS FLUIDS, V9, P2081, DOI 10.1063/1.869327; Philander S. G. H., 1985, J OCEANOGR SOC JAPAN, V41, P345, DOI 10.1007/BF02109241; Scott RK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036060; YODEN S, 1993, J ATMOS SCI, V50, P631, DOI 10.1175/1520-0469(1993)050<0631:ANEOTD>2.0.CO;2	22	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	APR	2015	72	4					1466	1483		10.1175/JAS-D-14-0235.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE8QH	WOS:000352108200012		
J	Itano, T				Itano, Toshihisa			Optimal Excitation of Asymmetric Perturbations on an Axisymmetric Barotropic Vortex: A Linear Singular-Value Analysis	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							ATMOSPHERIC PREDICTABILITY; MULTIPLE STRUCTURE; STABILITY ANALYSIS; TORNADO VORTEX; ROTATING FLUID; TYPHOON HERB; ROSSBY WAVES; VORTICES; INSTABILITY; EYE	Singular vectors on a barotropic circular vortex consisting of three regions of piecewise-constant vorticity are investigated under the L2 norm to reveal the shape and growth rate of possible perturbations that may contribute to the formation of the hierarchal structure seen in natural and artificial vortices. Here, the analytical form of the singular values and the forward and backward singular vectors are derived for comparison with the corresponding eigenvalues and vectors. The results indicate no notable difference between the growing eigenvector and the singular vectors for Michalke and Timme's profile, which is characterized by a ring of high vorticity. In contrast, for Syono's profile, which incorporates a negative vorticity region between a solidly rotating core and potentially rotating surroundings, the pattern of the forward singular vector giving the maximum growth in a specified time interval differs crucially from that of the growing eigenvector: whereas the radial peak of the streamfunction exists solely at the maximum-wind radius of the basic vortex in the growing eigenvector, it shifts outward in the growing forward singular vector. This implies the injection of considerable energy into the outer part of the basic vortex, rather than in the inner ring of the highest wind, facilitating the formation of hierarchal structure concentrated around the core region of the vortex.	Natl Def Acad, Dept Earth & Ocean Sci, Yokosuka, Kanagawa 2398686, Japan	Itano, T (reprint author), Natl Def Acad, Dept Earth & Ocean Sci, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	itano@nda.ac.jp					CHURCH CR, 1977, B AM METEOROL SOC, V58, P900, DOI 10.1175/1520-0477(1977)058<0900:TVSAPU>2.0.CO;2; KLOOSTERZIEL RC, 1991, J FLUID MECH, V223, P1, DOI 10.1017/S0022112091001301; VANHEIJST GJF, 1991, J FLUID MECH, V225, P301, DOI 10.1017/S0022112091002069; GUINN TA, 1993, J ATMOS SCI, V50, P3380, DOI 10.1175/1520-0469(1993)050<3380:HSB>2.0.CO;2; Corbosiero KL, 2006, MON WEATHER REV, V134, P3073, DOI 10.1175/MWR3250.1; Kossin JP, 2004, B AM METEOROL SOC, V85, P151, DOI 10.1175/BAMS-85-2-151; MONJI N, 1985, J METEOROL SOC JPN, V63, P703; Schubert WH, 1999, J ATMOS SCI, V56, P1197, DOI 10.1175/1520-0469(1999)056<1197:PEAECA>2.0.CO;2; CARNEVALE GF, 1994, J FLUID MECH, V259, P305, DOI 10.1017/S0022112094000157; Kossin JP, 2000, J ATMOS SCI, V57, P3893, DOI 10.1175/1520-0469(2001)058<3893:UIBAHS>2.0.CO;2; LIN SJ, 1992, J ATMOS SCI, V49, P1745, DOI 10.1175/1520-0469(1992)049<1745:CDOTLV>2.0.CO;2; Bakas NA, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3072617; Farrell BF, 1996, J ATMOS SCI, V53, P2025, DOI 10.1175/1520-0469(1996)053<2025:GSTPIA>2.0.CO;2; FARRELL BF, 1982, J ATMOS SCI, V39, P1663, DOI 10.1175/1520-0469(1982)039<1663:TIGODI>2.0.CO;2; FLIERL GR, 1988, J FLUID MECH, V197, P349, DOI 10.1017/S0022112088003283; Fujita TT, 1971, 7 C SEV LOC STORMS K, P208; Gent PR, 1986, GEOPHYS ASTRO FLUID, V35, P209, DOI 10.1080/03091928608245893; Heifetz E, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1937064; Itano T, 2013, MON WEATHER REV, V141, P987, DOI 10.1175/MWR-D-12-00122.1; Itano T, 2002, J ATMOS SCI, V59, P3254, DOI 10.1175/1520-0469(2002)059<3254:EONVOT>2.0.CO;2; Kasahara A., 1951, J METEOR SOC JAPAN, V29, P397; Kuo HC, 1999, J ATMOS SCI, V56, P1659, DOI 10.1175/1520-0469(1999)056<1659:APMFTE>2.0.CO;2; Lugovtsov B. A., 1982, TOPICS ATMOSPHERIC O, P299; MICHALKE A, 1967, J FLUID MECH, V29, P647, DOI 10.1017/S0022112067001090; MITSUTA Y, 1987, J GEOPHYS RES-ATMOS, V92, P14827, DOI 10.1029/JD092iD12p14827; Montgomery MT, 2002, J FLUID MECH, V471, P1, DOI [10.1017/S0022112002001647, 10.1017/S002212002001647]; Nolan DS, 1999, J ATMOS SCI, V56, P1282, DOI 10.1175/1520-0469(1999)056<1282:GSAOAD>2.0.CO;2; Oda M, 2005, J ATMOS SCI, V62, P2965, DOI 10.1175/JAS3521.1; PENG MS, 1991, GEOPHYS ASTRO FLUID, V58, P263, DOI 10.1080/03091929108227342; ROTUNNO R, 1978, J FLUID MECH, V87, P761, DOI 10.1017/S0022112078001871; SNOW JT, 1978, J ATMOS SCI, V35, P1660, DOI 10.1175/1520-0469(1978)035<1660:OIIART>2.0.CO;2; STALEY DO, 1979, J ATMOS SCI, V36, P973; STEFFENS JL, 1988, J ATMOS SCI, V45, P254, DOI 10.1175/1520-0469(1988)045<0254:TEOVPS>2.0.CO;2; SYONO S, 1951, J METEOROL, V8, P103, DOI 10.1175/1520-0469(1951)008<0103:OTSOAV>2.0.CO;2; WESKE JR, 1963, PHYS FLUIDS, V6, P1397, DOI 10.1063/1.1710960; Yamaguchi M, 2011, J ATMOS SCI, V68, P2273, DOI 10.1175/2011JAS3727.1; YODEN S, 1993, J ATMOS SCI, V50, P1531, DOI 10.1175/1520-0469(1993)050<1531:FTLSAA>2.0.CO;2; Yoden S, 2007, J METEOROL SOC JPN, V85B, P77, DOI 10.2151/jmsj.85B.77; Yoshizumi S., 1973, J METEOR SOC JAPAN, V51, P475	39	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	APR	2015	72	4					1533	1550		10.1175/JAS-D-13-0169.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE8QH	WOS:000352108200016		
J	Ogawa, S; Nakamura, J				Ogawa, Shigeo; Nakamura, Jiro			Photospectroscopically observed pore-space correlations of a wetting fluid during the drying process in nanoporous Vycor glass	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							POROUS-GLASS; 1/LAMBDA(4) SCATTERING; MESOPOROUS GLASS; DESORPTION; ADSORPTION; SENSOR; LIGHT; WATER	We use light scattering to study spatial correlations in the pore space of Vycor glass upon draining a wetting fluid. We analyze the transmission spectrum of forward-scattered light on the basis of the theory of dielectric constant fluctuation, whereas conventional light scattering analyzes the scattered light at small angles of monochromatic incident light. Assuming that the drained pores, which are surrounded by filled pores, exhibit long-range correlations of a fractal dimension of 2.5, we analytically derive the corresponding turbidity. The slight deviation from the lambda(-4) Rayleigh wavelength dependence directly provides the correlation length of the interconnected network of drained pores. The estimated length, ranging from 0.5 to 18 nm at most, is almost the same order as that indirectly estimated from our previous simple effective Rayleigh scatterer model. (C) 2015 Optical Society of America	[Ogawa, Shigeo; Nakamura, Jiro] Nippon Telegraph & Tel Corp, Energy & Environm Syst Labs, Atsugi, Kanagawa 2430198, Japan	Ogawa, S (reprint author), Nippon Telegraph & Tel Corp, Energy & Environm Syst Labs, 3-1 Morinosato, Atsugi, Kanagawa 2430198, Japan.	ogawa.shigeo@lab.ntt.co.jp					Soprunyuk VP, 2004, J LOW TEMP PHYS, V134, P1043, DOI 10.1023/B:JOLT.0000016728.66743.17; Ogawa S, 2013, J OPT SOC AM A, V30, P2079, DOI 10.1364/JOSAA.30.002079; PAGE JH, 1993, PHYS REV LETT, V71, P1216, DOI 10.1103/PhysRevLett.71.1216; Gruener S, 2012, P NATL ACAD SCI USA, V109, P10245, DOI 10.1073/pnas.1119352109; Ogawa S, 2013, J OPT SOC AM A, V30, P154, DOI 10.1364/JOSAA.30.000154; LI JC, 1994, PHYS REV B, V49, P5911, DOI 10.1103/PhysRevB.49.5911; DEBYE P, 1957, J APPL PHYS, V28, P679, DOI 10.1063/1.1722830; PAGE JH, 1995, PHYS REV E, V52, P2763, DOI 10.1103/PhysRevE.52.2763; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Wallacher D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.052101; Kerker M., 1969, SCATTERING LIGHT OTH, P470; Kerker M., 1969, SCATTERING LIGHT OTH; Maruo YY, 2007, SENSOR ACTUAT B-CHEM, V126, P485, DOI 10.1016/j.snb.2007.03.041; Maruo YY, 2008, SENSOR ACTUAT B-CHEM, V129, P544, DOI 10.1016/j.snb.2007.09.002; Novikov AF, 1995, P SOC PHOTO-OPT INS, V2550, P119, DOI 10.1117/12.221424; Soprunyuk V. P., 2003, PHYS REV B, V67; Tanaka T, 1998, SENSOR ACTUAT B-CHEM, V47, P65, DOI 10.1016/S0925-4005(98)00051-3; Wakeling P. R., 1979, APPL OPTICS, V18, P3208	18	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	APR	2015	32	4					533	537		10.1364/JOSAA.32.000533		5	Optics	Optics	CF0CH	WOS:000352209700005		
J	Yashiki, S				Yashiki, Satoshi			Perturbative analysis of partially coherent illumination for coma aberration measurements	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							SPREAD; EDGES	The theory of coma aberration measurement for aerial image sidelobe peaks is extended from coherent illumination to partial illumination. We prove that the intensity difference between the two peaks is linear to the amount of coma aberration in the partially coherent case. Using weak diffraction approximation, we analytically reveal the coherence dependency of the aberration measurement sensitivity for a single line in a bright field. We confirm that our derived formulas are well matched with the numerical lithography simulation results. These results provide guidelines for the measurement condition; higher aberration sensitivity is available under the higher illumination pupil coherence. (C) 2015 Optical Society of America	Nikon Inc, Core Technol Div, Saitama 3300845, Japan	Yashiki, S (reprint author), Nikon Inc, Core Technol Div, Saitama 3300845, Japan.	Satoshi.Yashiki@nikon.com					HOPKINS HH, 1957, J OPT SOC AM, V47, P508, DOI 10.1364/JOSA.47.000508; Gray RW, 2012, OPT EXPRESS, V20, P16436, DOI 10.1364/OE.20.016436; BARAKAT R, 1965, J OPT SOC AM, V55, P1132, DOI 10.1364/JOSA.55.001132; Born M., 1999, PRINCIPLES OPTICS, P517; GLINDEMANN A, 1989, J MOD OPTIC, V36, P659, DOI 10.1080/09500348914550751; GLINDEMANN A, 1991, J MOD OPTIC, V38, P379, DOI 10.1080/09500349114550381; Goodman J. W., 2005, INTRO FOURIER OPTICS; HOPKINS HH, 1953, PROC R SOC LON SER-A, V217, P408, DOI 10.1098/rspa.1953.0071; HOPKINS HH, 1950, P PHYS SOC LOND B, V63, P737, DOI 10.1088/0370-1301/63/10/301; MOORE GE, 1995, P SOC PHOTO-OPT INS, V2440, P2, DOI 10.1117/12.209244; Shibuya M, 2005, OPT REV, V12, P105, DOI 10.1007/s10043-004-0105-4; Suwa K, 2014, APPL OPTICS, V53, P2494, DOI 10.1364/AO.53.002494	12	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	APR	2015	32	4					669	677		10.1364/JOSAA.32.000669		9	Optics	Optics	CF0CH	WOS:000352209700021		
J	Bisht, NS; Shimizu, R				Bisht, Nandan S.; Shimizu, Ryosuke			Spectral properties of broadband biphotons generated from PPMgSLT under a type-II phase-matching condition	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							ENTANGLED PHOTON-PAIRS; PARAMETRIC DOWNCONVERSION; WAVELENGTH; FIBER; INTERFERENCE	We report the spectral properties of broadband biphotons generated by pulsed type-II spontaneous parametric down-conversion based on a periodically poled MgO-doped stoichiometric LiTaO3 (PPMgSLT). Spectroscopic and interferometric measurements were used to characterize the biphoton source. For the spectroscopic measurements, we used conventional spectroscopy and joint spectral intensity measurements. For the interferometric measurements, sum-and difference-frequency two-photon interference experiments were performed to estimate the spectral correlation and to ensure the broadband nature of biphotons, respectively. When using a picosecond Ti: sapphire as a pump source, the spectral width of biphotons was over 40 nm. Finally, we demonstrated the relationship between the two-photon interference visibility and the symmetricity of the joint spectral distribution. (C) 2015 Optical Society of America	[Bisht, Nandan S.; Shimizu, Ryosuke] Univ Electrocommun, Ctr Frontier Sci & Engn, Chofu, Tokyo 1828585, Japan	Shimizu, R (reprint author), Univ Electrocommun, Ctr Frontier Sci & Engn, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	r-simizu@pc.uec.ac.jp			JSPS KAKENHI [26610082]	The authors thank Rui-Bo Jin and Fumihiro Kaneda for helpful discussion. This work was supported by JSPS KAKENHI Grant Number 26610082.	Kim YH, 2005, OPT LETT, V30, P908, DOI 10.1364/OL.30.000908; Abouraddy AF, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.053817; Grice WP, 1997, PHYS REV A, V56, P1627, DOI 10.1103/PhysRevA.56.1627; Zhu EY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213902; Dolev I, 2009, APPL PHYS B-LASERS O, V96, P423, DOI 10.1007/s00340-009-3502-3; Nasr MB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.083601; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Wang KG, 2006, J PHYS B-AT MOL OPT, V39, pR293, DOI 10.1088/0953-4075/39/18/R01; Hendrych M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023817; Fraine A, 2012, OPT LETT, V37, P1910, DOI 10.1364/OL.37.001910; Chapuran TE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/105001; Fedrizzi A, 2007, OPT EXPRESS, V15, P15377, DOI 10.1364/OE.15.015377; Herbauts I, 2013, OPT EXPRESS, V21, P29013, DOI 10.1364/OE.21.029013; Nasr MB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.183601; Lim HC, 2008, OPT EXPRESS, V16, P22099, DOI 10.1364/OE.16.022099; Jin RB, 2013, OPT EXPRESS, V21, P10659, DOI 10.1364/OE.21.010659; Zhu EY, 2013, OPT LETT, V38, P4397, DOI 10.1364/OL.38.004397; Dauler E, 1999, J RES NATL INST STAN, V104, P1, DOI 10.6028/jres.104.001; Kalashnikov DA, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013803; Kok P, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052104; Lim HC, 2008, OPT EXPRESS, V16, P16052, DOI 10.1364/OE.16.016052; O'Donnell KA, 2007, OPT LETT, V32, P817, DOI 10.1364/OL.32.000817; Poh HS, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043815; Poh HS, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.043816; Shimizu R, 2009, OPT EXPRESS, V17, P16385, DOI 10.1364/OE.17.016385; Tanaka A, 2013, PROC SPIE, V8635, DOI 10.1117/12.2003390; U'Ren AB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.223602; Valencia A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.243601	29	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					550	554		10.1364/JOSAB.32.000550		5	Optics	Optics	CE9CZ	WOS:000352142500020		
J	Saito, K; Tanabe, T; Oyama, Y				Saito, Kyosuke; Tanabe, Tadao; Oyama, Yutaka			Cascaded terahertz-wave generation efficiency in excess of the Manley-Rowe limit using a cavity phase-matched optical parametric oscillator	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							DIFFERENCE-FREQUENCY-GENERATION; CRYSTALS; POWER; GAP	We describe a scheme for efficient terahertz (THz) generation using a cascaded optical parametric oscillator using a GaP sheet cavity. By choosing an appropriate pump wavelength and cavity design, the cascading process contributes to efficient THz-wave generation, resulting in a high output peak power of 1.8 MW and a high photon conversion efficiency of 1.086 at 3 THz. This exceeds the Manley-Rowe limit, and the method described here is applicable to widely tunable and high-power THz-wave generation using an optically isotropic nonlinear optical material, such as GaAs, InP, ZnTe, or GaP. Our simulated data show that high-power THz sources are possible that are suitable for the realization of nonlinear optical effects at THz frequencies. (C) 2015 Optical Society of America.	[Saito, Kyosuke; Oyama, Yutaka] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Tanabe, Tadao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Saito, K (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Ku, 6-6-11-1021 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	k-saito@material.tohoku.ac.jp					Fan KB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217404; SLACK GA, 1975, J APPL PHYS, V46, P89, DOI 10.1063/1.321373; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Schaar JE, 2008, IEEE J SEL TOP QUANT, V14, P354, DOI 10.1109/JSTQE.2008.917957; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; Jepsen PU, 2011, LASER PHOTONICS REV, V5, P124, DOI 10.1002/lpor.201000011; Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Paul JR, 2013, OPT LETT, V38, P3654, DOI 10.1364/OL.38.003654; Saito K, 2014, OPT LETT, V39, P5681, DOI 10.1364/OL.39.005681; Hirori H, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2012.2221685; Liu PX, 2013, J LIGHTWAVE TECHNOL, V31, P2508, DOI 10.1109/JLT.2013.2268876; Merbold H, 2011, OPT EXPRESS, V19, P7262, DOI 10.1364/OE.19.007262; FAUST WL, 1966, PHYS REV LETT, V17, P1265, DOI 10.1103/PhysRevLett.17.1265; Shoji I, 1997, J OPT SOC AM B, V14, P2268, DOI 10.1364/JOSAB.14.002268; Zhang CH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794077; Golomb M. C., 2004, OPT LETT, V29, P2046; Hayashi S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05045; Hirori H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081305; Kulipanov G. N., 2008, TERAHERTZ SCI TECHNO, V1, P107; Rarnian G., 1992, NUCL INSTRUM METH A, V318, P225; Richman S, 2013, PROC SPIE, V8885, DOI 10.1117/12.2030367; Saito K, 2008, J PHYS CHEM SOLIDS, V69, P597, DOI 10.1016/j.jpcs.2007.07.090; [Haiyu Sang 桑海宇], 2006, Chinese Optics Letters, V4, P536; Xie ZD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.083901; YARIV A, 1966, IEEE J QUANTUM ELECT, VQE 2, P418, DOI 10.1109/JQE.1966.1074087	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					617	621		10.1364/JOSAB.32.000617		5	Optics	Optics	CE9CZ	WOS:000352142500029		
J	Yoshikawa, T; Kawamoto, M; Fujihara, T; Tada, K; Sassa, T; Kawabe, Y				Yoshikawa, Toshio; Kawamoto, Masuki; Fujihara, Takashi; Tada, Kazuhiro; Sassa, Takafumi; Kawabe, Yutaka			Long-lived cis state of azocarbazole dye with strong acceptor highly doped in a polymer matrix	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							POLY(METHYL METHACRYLATE); AZO-DYE; EFFICIENCY; FILMS; POLYPHOSPHAZENES; COMPOUND; GRATINGS; LIGHT	In order to investigate the formation mechanism of photoinduced gratings in an azocarbazole dye, 3-[(4-nitro-phenyl)] azo-9H-carbazole-9-ethanol (NACzEtOH), used for dynamic hologram, temporal variation of absorption spectra were observed after optical excitation. From a series of spectra obtained during recovering process, spectral components from two constituents were extracted analytically with a technique based on singular value decomposition. Two components were assigned to trans and cis states, by comparison to the theoretical prediction made with a molecular orbital method. Temporal evolution of two components indicated the existence of long-lived cis state with lifetime of 15 min for the most concentrated case (30 wt.% dye in matrix). The results also showed that cis state relaxed to the initial state without reorientation, suggesting an essential role of cis state population in the dynamic holography system based on azocarbazoles. (C) 2015 Optical Society of America	[Yoshikawa, Toshio; Tada, Kazuhiro; Kawabe, Yutaka] Chitose Inst Sci & Technol, Chitose, Hokkaido 0668655, Japan; [Kawamoto, Masuki] RIKEN, Nano Med Engn Lab, Wako, Saitama 3510198, Japan; [Kawamoto, Masuki; Fujihara, Takashi; Sassa, Takafumi] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Sassa, Takafumi] RIKEN, Adv Device Lab, Wako, Saitama 3510198, Japan	Kawabe, Y (reprint author), Chitose Inst Sci & Technol, 758-65 Bibi, Chitose, Hokkaido 0668655, Japan.	y-kawabe@photon.chitose.ac.jp			program for Strategic Promotion of Innovative Research and Development (SPIRE), Japan Science and Technology Agency (JST)	This work was partially supported by the program for Strategic Promotion of Innovative Research and Development (SPIRE), Japan Science and Technology Agency (JST). We would like to express our gratitude to Prof. Naoto Tsutsumi and Prof. Takeo Sasaki for fruitful discussion.	Kawabe Y, 2012, APPL OPTICS, V51, P6653, DOI 10.1364/AO.51.006653; Tsutsumi N, 2013, OPT EXPRESS, V21, P19880, DOI 10.1364/OE.21.019880; Tsutsumi N, 2012, OPT MATER EXPRESS, V2, P1003; Birabassov R, 1998, APPL OPTICS, V37, P8264, DOI 10.1364/AO.37.008264; Zhang WY, 2002, OPT LETT, V27, P1105, DOI 10.1364/OL.27.001105; Barrett CJ, 1996, J PHYS CHEM-US, V100, P8836, DOI 10.1021/jp953300p; Blanche PA, 2000, J OPT SOC AM B, V17, P729, DOI 10.1364/JOSAB.17.000729; SEKKAT Z, 1992, J APPL PHYS, V71, P1543, DOI 10.1063/1.351228; Nishide J, 2008, MOL CRYST LIQ CRYST, V491, P217, DOI 10.1080/15421400802330424; Cojocariu C, 2004, PURE APPL CHEM, V76, P1479, DOI 10.1351/pac200476071479; Barrett C, 1998, MACROMOLECULES, V31, P4845, DOI 10.1021/ma980155f; Sanchez FC, 1996, CHEMOMETR INTELL LAB, V34, P139, DOI 10.1016/0169-7439(96)00020-2; Kawabe Y, 2013, PROC SPIE, V8817, DOI 10.1117/12.2023446; Kawamoto M, 2010, J PHYS CHEM B, V114, P1227, DOI 10.1021/jp906625a; Li Z, 2001, REACT FUNCT POLYM, V48, P113, DOI 10.1016/S1381-5148(01)00043-8; Naydenova I., 2011, HOLOGRAMS RECORDING; Nikolova L, 2009, POLARIZATION HOLOGRAPHY, P1, DOI 10.1017/CBO9780511581489; Sek D, 2002, SYNTHETIC MET, V127, P89, DOI 10.1016/S0379-6779(01)00603-8; Strang G., 1976, LINEAR ALGEBRA ITS A; Tada K., QUANTUM OPT IN PRESS; WILDES PD, 1971, J AM CHEM SOC, V93, P2004; Zhang L, 2006, REACT FUNCT POLYM, V66, P1404, DOI 10.1016/j.reactfunctpolym.2006.04.003; Zhang L, 2008, POLYMER, V49, P2107, DOI 10.1016/j.polymer.2007.09.038; Zhao Y., 2009, SMART LIGHT RESPONSI	24	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					622	627		10.1364/JOSAB.32.000622		6	Optics	Optics	CE9CZ	WOS:000352142500030		
J	Ochiai, T				Ochiai, Tetsuyuki			Spatially periodic modulation of optical conductivity in doped graphene by two-dimensional diffraction grating	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							FOURIER MODAL METHOD; PLASMONICS; RESONANCES; LIGHT	We show theoretically that the optical conductivity of doped graphene can exhibit a spatially periodic modulation by a diffraction grating. Doped graphene placed above the grating exhibits a periodic electrostatic potential distribution, resulting in a periodic charge-density redistribution inside the graphene. The optical conductivity of doped graphene depends linearly on the Fermi energy, which is proportional to the square root of the charge density. Therefore, the optical conductivity exhibits a spatial-periodic modulation. The periodicity implies a band structure formation of the graphene plasmon polariton. Band engineering of the graphene plasmon polariton is also discussed. (C) 2015 Optical Society of America	Natl Inst Mat Sci, Photon Mat Unit, Tsukuba, Ibaraki 3050044, Japan	Ochiai, T (reprint author), Natl Inst Mat Sci, Photon Mat Unit, Tsukuba, Ibaraki 3050044, Japan.	OCHIAI.Tetsuyuki@nims.go.jp	OCHIAI, Tetsuyuki/H-2701-2011	OCHIAI, Tetsuyuki/0000-0003-2933-0014	JSPS KAKENHI [26390013]	This work was supported by JSPS KAKENHI (Grant No. 26390013).	Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Li LF, 1997, J OPT SOC AM A, V14, P2758, DOI 10.1364/JOSAA.14.002758; Johnson SG, 1999, PHYS REV B, V60, P5751, DOI 10.1103/PhysRevB.60.5751; Nikitin AY, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4760230; Bykov DA, 2013, J LIGHTWAVE TECHNOL, V31, P793, DOI 10.1109/JLT.2012.2234723; Peres NMR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/12/125303; Zhu XL, 2014, NANO LETT, V14, P2907, DOI 10.1021/nl500948p; Gao WL, 2012, ACS NANO, V6, P7806, DOI 10.1021/nn301888e; Zhu XL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799173; Zhan TR, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165416; Ochiai T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125107; Horng J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165113; Tikhodeev SG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045102; NOPONEN E, 1994, J OPT SOC AM A, V11, P2494, DOI 10.1364/JOSAA.11.002494; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Chow E, 2000, NATURE, V407, P983; Ohtaka K, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035109; Pendry J.B., 1974, LOW ENERGY ELECT DIF; Slipchenko TM, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/11/114008; Thongrattanasiri S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047401; Weiss T, 2011, J OPT SOC AM A, V28, P238, DOI 10.1364/JOSAA.28.000238	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					701	707		10.1364/JOSAB.32.000701		7	Optics	Optics	CE9CZ	WOS:000352142500041		
J	Saito, K; Tanabe, T; Oyama, Y				Saito, Kyosuke; Tanabe, Tadao; Oyama, Yutaka			Terahertz-wave detection in a GaP-based hybrid waveguide using a nonlinear optical parametric process	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							THZ GENERATION; UP-CONVERSION; CRYSTAL	We design and simulate a GaP-based hybrid waveguide structure for room temperature terahertz-wave detection by using a nonlinear optical parametric process that is based on the photonic conversion from terahertz to the optical domain. The waveguide structure consists of a GaP rib waveguide for optical pump light, and an Si waveguide for the terahertz wave can provide the conversion from terahertz to the optical frequency domain. Owing to the strong confinement of the terahertz wave into the waveguide, high conversion efficiency of 0.05 W-1 (detection at 4.7 THz) can be achieved. The noise equivalent power for terahertz-wave detection by using an optical single photon detector is estimated to be 12 fW/Hz(1/2), which is higher than that obtained using a commercially available 4.2 K Si bolometer. (C) 2015 Optical Society of America	[Saito, Kyosuke; Oyama, Yutaka] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Tanabe, Tadao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Saito, K (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Yama 6-6-11-1021, Sendai, Miyagi 9808579, Japan.	k-saito@material.tohoku.ac.jp					Tanabe T, 2003, APPL PHYS LETT, V83, P237, DOI 10.1063/1.1592889; Suto K, 2002, J LIGHTWAVE TECHNOL, V20, P705, DOI 10.1109/50.996593; Fallahkhair AB, 2008, J LIGHTWAVE TECHNOL, V26, P1423, DOI 10.1109/JLT.2008.923643; Saito K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3094012; Federici JF, 2005, SEMICOND SCI TECH, V20, pS266, DOI 10.1088/0268-1242/20/7/018; Shi W, 2003, APPL PHYS LETT, V82, P4435, DOI 10.1063/1.1584513; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Chang GQ, 2007, OPT EXPRESS, V15, P16308, DOI 10.1364/OE.15.016308; Ito H, 2008, JPN J APPL PHYS, V47, P6256, DOI 10.1143/JJAP.47.6256; Shoji I, 1997, J OPT SOC AM B, V14, P2268, DOI 10.1364/JOSAB.14.002268; LEY L, 1974, PHYS REV B, V9, P600, DOI 10.1103/PhysRevB.9.600; BAGDADE W, 1968, J PHYS CHEM SOLIDS, V29, P2001, DOI 10.1016/0022-3697(68)90050-4; Boyd R. W., 2008, NONLINEAR OPTICS, P105; Cao H, 2004, OPT LETT, V29, P1751, DOI 10.1364/OL.29.001751; Ding YJ, 2006, SOLID STATE ELECTRON, V50, P1128, DOI 10.1016/j.sse.2006.04.028; Ding YJJ, 2006, OPT EXPRESS, V14, P8311, DOI 10.1364/OE.14.008311; Guo R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2953452; HENRY CH, 1968, PHYS REV, V171, P1058, DOI 10.1103/PhysRev.171.1058; Khan MJ, 2008, OPT LETT, V33, P2725, DOI 10.1364/OL.33.002725; RUSSELL EE, 1967, J OPT SOC AM, V57, P341, DOI 10.1364/JOSA.57.000341; Shi W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177363; Shirley EL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054116; Staus C, 2008, OPT EXPRESS, V16, P13296, DOI 10.1364/OE.16.013296; Xia JS, 2004, OPT ENG, V43, P1953, DOI 10.1117/1.1776188; Yang T, 2008, Progress In Electromagnetics Research Letters, V2, DOI 10.2528/PIERL07122806; Zhong SC, 2011, OPT LASER ENG, V49, P361, DOI 10.1016/j.optlaseng.2010.11.003	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					708	713		10.1364/JOSAB.32.000708		6	Optics	Optics	CE9CZ	WOS:000352142500042		
J	Abe, M; Seki, H; Kowa, M; Sasaki, Y; Miyamoto, K; Omatsu, T				Abe, Masashi; Seki, Hiroki; Kowa, Maya; Sasaki, Yuta; Miyamoto, Katsuhiko; Omatsu, Takashige			High average power, diffraction-limited picosecond output from a sapphire face-cooled Nd:YVO4 slab amplifier	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							LASER-ABLATION; GRAZING-INCIDENCE; BOUNCE AMPLIFIER; ND-YVO4 LASER; 2ND-HARMONIC GENERATION; OPTICAL-VORTEX; HIGH-GAIN; FEMTOSECOND; RADIATION; MIRROR	We demonstrated high average power, diffraction-limited (M-2 similar to 1.1) picosecond output from a sapphire face-cooled Nd:YVO4 slab amplifier at 1064 nm in a multi-pass geometry. Average output power of 44.5 W was achieved at an optical efficiency of 56%. A second harmonic power of 24.1 W was also obtained at an input fundamental power of 36 W, corresponding to a conversion efficiency of 67%. (C) 2015 Optical Society of America	[Abe, Masashi; Seki, Hiroki; Kowa, Maya; Sasaki, Yuta; Miyamoto, Katsuhiko; Omatsu, Takashige] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba 2638522, Japan; [Omatsu, Takashige] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Omatsu, T (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	omatsu@faculty.chiba-u.jp	Miyamoto, Katsuhiko/E-6713-2015	Miyamoto, Katsuhiko/0000-0002-2611-882X	Japan Society for the Promotion of Science [21360026]	The authors acknowledge support from a Grant-in-Aid for Scientific Research (No. 21360026) from the Japan Society for the Promotion of Science.	Agnesi A, 2006, IEEE J QUANTUM ELECT, V42, P772, DOI 10.1109/JQE.2006.878187; Nawata K, 2006, OPT EXPRESS, V14, P10657, DOI 10.1364/OE.14.010657; Toyoda K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.143603; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Omatsu T, 2010, OPT EXPRESS, V18, P17967, DOI 10.1364/OE.18.017967; Nawata K, 2009, OPT EXPRESS, V17, P20816, DOI 10.1364/OE.17.020816; Blows JL, 1998, IEEE PHOTONIC TECH L, V10, P1727, DOI 10.1109/68.730483; Nandakumar P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033026; Hamazaki J, 2010, OPT EXPRESS, V18, P2144, DOI 10.1364/OE.18.002144; Wohlmuth M, 2009, OPT EXPRESS, V17, P17303, DOI 10.1364/OE.17.017303; Agnesi A, 2006, OPT EXPRESS, V14, P9244, DOI 10.1364/OE.14.009244; Momma C, 1996, OPT COMMUN, V129, P134, DOI 10.1016/0030-4018(96)00250-7; PREUSS S, 1995, APPL PHYS A-MATER, V61, P33, DOI 10.1007/BF01538207; Kleinbauer J, 2005, APPL PHYS B-LASERS O, V81, P163, DOI 10.1007/s00340-005-1903-5; Wang ZP, 2002, OPT COMMUN, V202, P217, DOI 10.1016/S0030-4018(02)01074-X; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Meijer J, 2002, CIRP ANN-MANUF TECHN, V51, P531, DOI 10.1016/S0007-8506(07)61699-0; Yu NE, 2004, JPN J APPL PHYS 2, V43, pL1265, DOI 10.1143/JJAP.43.L1265; BERNARD JE, 1994, OPT COMMUN, V109, P109, DOI 10.1016/0030-4018(94)90746-3; Peng RW, 2009, OPT COMMUN, V282, P611, DOI 10.1016/j.optcom.2008.10.049; Hermann S, 2010, APPL PHYS A-MATER, V99, P151, DOI 10.1007/s00339-009-5464-z; Wieger V, 2006, LASER PART BEAMS, V24, P41, DOI 10.1017/S0263034606060083; Nawata K, 2007, OPT EXPRESS, V15, P9123, DOI 10.1364/OE.15.009123; Bermudez JC, 2002, OPT COMMUN, V210, P75, DOI 10.1016/S0030-4018(02)01752-2; Toyoda K, 2012, NANO LETT, V12, P3645, DOI 10.1021/nl301347j; Bernard J. E., 1993, OPT LETT, V18, P971; BROWN AJW, 1992, OPT LETT, V17, P109, DOI 10.1364/OL.17.000109; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Hermann S., 2005, LASER PART BEAMS, V23, P167; Jandeleit J, 1996, APPL PHYS A-MATER, V63, P117, DOI 10.1007/BF01567638; Lee SH, 2003, NUMER HEAT TR A-APPL, V44, P833, DOI 10.1080/10407780390229693; Matsuoka Y, 2007, APPL PHYS A-MATER, V89, P457, DOI 10.1007/s00339-007-4143-1; Morgenweg J, 2012, OPT LETT, V37, P208, DOI 10.1364/OL.37.000208; Okida M, 2007, OPT COMMUN, V277, P125, DOI 10.1016/j.optcom.2007.04.036; Siebold M., 2004, APPL PHYS B, V78, P387; Thomas GM, 2010, OPT EXPRESS, V18, P12663, DOI 10.1364/OE.18.012663; Yan XP, 2009, OPT COMMUN, V282, P1851, DOI 10.1016/j.optcom.2009.01.019; Yoshino T, 2013, J OPT SOC AM B, V30, P894, DOI 10.1364/JOSAB.30.000894	39	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					714	718		10.1364/JOSAB.32.000714		5	Optics	Optics	CE9CZ	WOS:000352142500043		
J	Cavalcanti, EG; Foster, CJ; Fuwa, M; Wiseman, HM				Cavalcanti, Eric G.; Foster, Christopher J.; Fuwa, Maria; Wiseman, Howard M.			Analog of the Clauser-Horne-Shimony-Holt inequality for steering	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							PODOLSKY-ROSEN PARADOX	The Clauser-Horne-Shimony-Holt (CHSH) inequality and its permutations are necessary and sufficient criteria for Bell nonlocality in the simplest Bell-nonlocality scenario: two parties, two measurements per party and two outcomes per measurement. Here we derive an inequality for Einstein-Podolsky-Rosen (EPR)-steering that is an analog of the CHSH, in that it is necessary and sufficient in this same scenario. However, since in the case of steering the device at Bob's site must be specified (as opposed to the Bell case, in which it is a black box), the scenario we consider is that where Alice performs two (black-box) dichotomic measurements, and Bob performs two mutually unbiased qubit measurements. We show that this inequality is strictly weaker than the CHSH, as expected, and use it to decide whether a recent experiment [Phys. Rev. Lett. 110, 130401 (2013)] involving a single-photon split between two parties has demonstrated EPR-steering. (C) 2015 Optical Society of America	[Cavalcanti, Eric G.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Foster, Christopher J.] Univ Queensland, Sch Math & Phys, Brisbane, Qld 4072, Australia; [Fuwa, Maria] Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Wiseman, Howard M.] Griffith Univ, Australian Res Council, Ctr Quantum Dynam, Ctr Quantum Computat & Commun Technol, Brisbane, Qld 4111, Australia	Cavalcanti, EG (reprint author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	e.cavalcanti@physics.usyd.edu.au	Wiseman, Howard/A-7266-2008	Wiseman, Howard/0000-0001-6815-854X	Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS); Advanced Photon Science Alliance (APSA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Australian Research Council (ARC) [CE11000102, DE120100559]; Japanese Society for the Promotion of Science (JSPS); Advanced Leading Graduate Course for Photon Science (ALPS); Australian Research Council [DE120100559, CE110001027]	Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS); Grants-in-aid (GIA); Advanced Photon Science Alliance (APSA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japanese Society for the Promotion of Science (JSPS); Australian Research Council (ARC) (CE11000102, DE120100559); Advanced Leading Graduate Course for Photon Science (ALPS).; This work was partly supported by Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS), Grants-in-aid (GIA), and Advanced Photon Science Alliance (APSA), all commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by Japanese Society for the Promotion of Science (JSPS) and the Australian Research Council (grants CE110001027 and DE120100559). M. F. acknowledges financial support from Advanced Leading Graduate Course for Photon Science (ALPS).	Cavalcanti EG, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032112; Reid MD, 2009, REV MOD PHYS, V81, P1727, DOI 10.1103/RevModPhys.81.1727; Cavalcanti EG, 2009, OPT EXPRESS, V17, P18693, DOI 10.1364/OE.17.018693; Saunders DJ, 2010, NAT PHYS, V6, P845, DOI [10.1038/nphys1766, 10.1038/NPHYS1766]; Schneeloch J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130407; Wiseman HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.140402; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Morin O, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130401; Bennet AJ, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031003; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; REID MD, 1989, PHYS REV A, V40, P913, DOI 10.1103/PhysRevA.40.913; Wittmann B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053030; Bowen WP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.043601; Handchen V, 2012, NAT PHOTONICS, V6, P596, DOI 10.1038/NPHOTON.2012.202; CLAUSER JF, 1969, PHYS REV LETT, V23, P880, DOI 10.1103/PhysRevLett.23.880; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555; Bowles J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.200402; Branciard C, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.010301; Fuwa M., 2015, ARXIV14127790; Hiriart-Urruty J.-B., 2001, FUNDAMENTALS CONVEX; Jevtic S, 2015, J OPT SOC AM B, V32, pA40, DOI 10.1364/JOSAB.32.000A40; Roy A., 2015, ARXIV150304649; Saunders DJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113020; Smith DH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1628; Wiseman H. M., 2010, QUANTUM MEASUREMENT; WISEMAN HM, 1995, QUANTUM SEMICL OPT, V7, P569, DOI 10.1088/1355-5111/7/4/013	27	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	APR 1	2015	32	4					A74	A81		10.1364/JOSAB.32.000A74		8	Optics	Optics	CE9CZ	WOS:000352142500012		
J	Ragaza, JA; Mamauag, REP; Yokoyama, S; Ishikawa, M; Koshio, S				Ragaza, Janice A.; Mamauag, Roger E. P.; Yokoyama, Saichiro; Ishikawa, Manabu; Koshio, Shunsuke			Dietary Soy Peptide Enhances Thermotolerance and Survival of Juvenile Japanese Flounder, Paralichthys olivaceus	JOURNAL OF THE WORLD AQUACULTURE SOCIETY			English	Article							HEAT-SHOCK-PROTEIN; THERMAL TOLERANCE; ARTEMIA-FRANCISCANA; VITAMIN-C; BOVINE-LACTOFERRIN; TEMPERATURE STRESS; VIBRIO-CAMPBELLII; IMMUNE-RESPONSE; FISH; GROWTH	Soy peptide (SP), a soy protein enzymatic hydrolysate, contains bioactive substances that could be utilized as an immune-stimulating feed ingredient. The experiment evaluated the efficacy of dietary SP on promoting growth, and enhancing tolerance and survival to heat stress in juvenile Japanese flounder, Paralichthys olivaceus. Four diets were incorporated with different levels of SP (0, 2, 5, and 10%) and a 6-wk feeding trial ensued. Following the feeding trial, the experimental groups were subjected to heat stress to measure survival rate and heat shock protein 70s (HSP70s) in gill, liver, and skin. Fish fed diets with SP inclusion showed considerable decrease in percent weight gain. Significantly higher lethal time values to 50% mortality (LT50) value were recorded for fish fed 10% SP. Moreover, LT50 values of fish fed 2 and 5% SP were significantly higher compared with fish fed control diet. HSP70s produced in all the tissues were significantly highest in fish fed 10% SP. HSP70s values were significantly higher in fish fed 2 and 5% SP compared with fish fed control diet. A significant reduction in HSP70s among all groups during recovery period was also observed. These results suggest that SP can be used to enhance the immune response and survival of P. olivaceus under heat stress.	[Ragaza, Janice A.] Ateneo Manila Univ, Loyola Sch, Dept Biol Sch Sci & Engn, Quezon City 1108, Manila, Philippines; [Mamauag, Roger E. P.] Southeast Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines; [Yokoyama, Saichiro; Ishikawa, Manabu; Koshio, Shunsuke] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8908580, Japan	Ragaza, JA (reprint author), Ateneo Manila Univ, Loyola Sch, Dept Biol Sch Sci & Engn, Katipunan Ave, Quezon City 1108, Manila, Philippines.	jragaza@ateneo.edu			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government; Management Expenses Grants of the United Graduate School of Agricultural Sciences, Kagoshima University	J. A. R. is grateful to the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government for the scholarship and to Yoshinori Sotoyama for his assistance in the heat stress exposure tests. Gad S. Lim and Jan Lorie Robil are also acknowledged for their contribution to the editing and correction of the manuscript. This research was partially supported by the Management Expenses Grants of the United Graduate School of Agricultural Sciences, Kagoshima University, provided to S. K.	Iwama GK, 1999, AM ZOOL, V39, P901; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Teshima SI, 2004, AQUACULT NUTR, V10, P279, DOI 10.1111/j.1365-2095.2004.00303.x; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; Lewis S, 1999, ECOTOXICOLOGY, V8, P351, DOI 10.1023/A:1008982421299; Wang ZL, 2009, FISH SHELLFISH IMMUN, V26, P639, DOI 10.1016/j.fsi.2008.10.011; Luckenbach JA, 2007, COMP BIOCHEM PHYS A, V146, P95, DOI 10.1016/j.cbpa.2006.09.024; Bagni M, 2005, FISH SHELLFISH IMMUN, V18, P311, DOI 10.1016//j.fsi.2004.08.003; Todgham AE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P133, DOI 10.1086/425205; MALLATT J, 1985, CAN J FISH AQUAT SCI, V42, P630, DOI 10.1139/f85-083; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; Tejpal CS, 2014, J THERM BIOL, V41, P59, DOI 10.1016/j.jtherbio.2014.02.008; Burkhardt-Holm P, 1998, COMP BIOCHEM PHYS A, V120, P35, DOI 10.1016/S1095-6433(98)10007-7; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Sung YY, 2008, CELL STRESS CHAPERON, V13, P59, DOI 10.1007/s12192-008-0011-y; Rho SJ, 2007, J SCI FOOD AGR, V87, P908, DOI 10.1002/jsfa.2808; Ortuno J, 2003, FISH SHELLFISH IMMUN, V14, P145, DOI 10.1006/fsim.2002.0428; Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)0060-X; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Wang WN, 2006, AQUACULTURE, V256, P624, DOI 10.1016/j.aquaculture.2006.02.009; Airaksinen S, 1998, J EXP BIOL, V201, P2543; Baruah K, 2010, FISH SHELLFISH IMMUN, V29, P733, DOI 10.1016/j.fsi.2010.07.011; Werner I, 2007, ENVIRON BIOL FISH, V79, P191, DOI 10.1007/s10641-006-9070-z; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Sakai M, 1999, AQUACULTURE, V172, P63, DOI 10.1016/S0044-8486(98)00436-0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOSSER DD, 1986, J CELL PHYSIOL, V128, P432, DOI 10.1002/jcp.1041280312; Mukhopadhyay I, 2003, J BIOCHEM MOL TOXIC, V17, P249, DOI 10.1002/jbt.10086; Sarma K, 2009, SCI TOTAL ENVIRON, V407, P3668, DOI 10.1016/j.scitotenv.2009.02.031; Franek F, 2000, BIOTECHNOL PROGR, V16, P688, DOI 10.1021/bp0001011; Dalvi RS, 2009, AQUACULTURE, V295, P116, DOI 10.1016/j.aquaculture.2009.06.034; Gupta SK, 2010, AQUACULTURE, V306, P398, DOI 10.1016/j.aquaculture.2010.06.008; Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037; AOAC, 1990, OFFICIAL METHODS ANA; Ashida T, 2009, FISHERIES SCI, V75, P529, DOI 10.1007/s12562-009-0077-1; Barange M, 2009, CLIMATE CHANGE IMPLI, P7; Das P, 2005, AQUAC RES, V36, P525, DOI 10.1111/j.1365-2109.2005.01214.x; Dash G., 2011, CHRON YOUNG SCI, V2, P29; Dunlap DY, 1997, ECOTOX ENVIRON SAFE, V37, P238, DOI 10.1006/eesa.1997.1544; DYER SD, 1991, CAN J ZOOL, V69, P2021, DOI 10.1139/z91-282; Frankenberg MM, 2000, J THERM BIOL, V25, P481, DOI 10.1016/S0306-4565(00)00013-9; GEDAMU L, 1983, BIOSCIENCE REP, V3, P647, DOI 10.1007/BF01172875; Hightower LE, 1999, AM ZOOL, V39, P877; Jiun-Rong C., 1995, J NUTR BIOCH, V6, P310; Karouna-Renier NK, 1999, HYDROBIOLOGIA, V401, P255, DOI 10.1023/A:1003730225536; Kikuchi K, 2008, AVANCES NUTR ACUICOL, P108; Kim YJ, 2008, GENES NUTR, V2, P353, DOI 10.1007/s12263-007-0070-1; Liao T., 2004, AQUA FEEDS FORMULATI, V1, P19; Lindquist S, 1992, Curr Opin Genet Dev, V2, P748, DOI 10.1016/S0959-437X(05)80135-2; Liu YF, 2014, FISH PHYSIOL BIOCHEM, V40, P1031, DOI 10.1007/s10695-013-9903-6; Liyanage R, 2009, EUR J LIPID SCI TECH, V111, P884, DOI 10.1002/ejlt.200800264; Mamauag REP, 2011, AQUACULTURE, V321, P252, DOI 10.1016/j.aquaculture.2011.09.022; Meakin CA, 2014, COMP BIOCHEM PHYS A, V172, P46, DOI 10.1016/j.cbpa.2014.02.016; Moe YY, 2004, AQUACULTURE, V242, P501, DOI 10.1016/j.aquaculture.2004.08.028; MULLER R, 1977, J THERM BIOL, V2, P5, DOI 10.1016/0306-4565(77)90003-1; Park K, 2009, EXP MOL MED, V41, P371, DOI 10.3858/emm.2009.41.6.042; Sarma K, 2010, FISH PHYSIOL BIOCHEM, V36, P85, DOI 10.1007/s10695-008-9293-3; Sharaf-Eldeen K. M, 2006, EGYPTIAN J AQUATIC B, V10, P19; Singh G. P., 2011, International Journal of Virology, V7, P33, DOI 10.3923/ijv.2011.33.38; SIWICKI AK, 1994, VET IMMUNOL IMMUNOP, V41, P125, DOI 10.1016/0165-2427(94)90062-0; Smith TR, 1999, FISH PHYSIOL BIOCHEM, V20, P279, DOI 10.1023/A:1007743329892; Soto D, 2009, CLIMATE CHANGE IMPLI; Takenaka A, 2003, BIOSCI BIOTECH BIOCH, V67, P278, DOI 10.1271/bbb.67.278; Underwood ZE, 2012, J FISH BIOL, V80, P2420, DOI 10.1111/j.1095-8649.2012.03287.x; Yamada K., 1998, Soy Protein Research, Japan, V1, P81; YAMAUCHI F, 1993, J NUTR BIOCHEM, V4, P450, DOI 10.1016/0955-2863(93)90062-2; Yokoyama S, 2006, AQUACULTURE, V255, P507, DOI 10.1016/j.aquaculture.2005.12.001; Yokoyama S, 2005, AQUACULTURE, V249, P367, DOI 10.1016/j.aquaculture.2005.03.024	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-8849	1749-7345		J WORLD AQUACULT SOC	J. World Aquacult. Soc.	APR	2015	46	2					129	138		10.1111/jwas.12183		10	Fisheries	Fisheries	CF5XZ	WOS:000352631900002		
J	Kumasaki, M; Tanaka, K; Otsuka, T				Kumasaki, Mieko; Tanaka, Kuninori; Otsuka, Teruhito			Influence of deteriorated solvent on induction period of Grignard reagent formation	JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY			English	Article						Induction period; Grignard reagent formation reaction; Peroxide; Chemical reaction hazards	CALORIMETRIC BEHAVIORS; GAMMA-BUTYROLACTONE; HYDROXYLAMINE; DECOMPOSITION; RUNAWAY; SCALE	The influence of a degraded solvent on Grignard reagent formation was investigated in terms of heat release behaviour. Since degraded solvent is supposed to contain peroxide by oxidation with air as well as water from atmosphere, peroxide in this study was intentionally produced by the storage of tetrahydrofuran in a pressurized oxygen atmosphere and the induction periods were measured. The induction period which appears prior to the main exothermic reaction increased with increasing amounts of peroxide and water content, respectively. However, there was a difference in heat release behaviour; the reaction including peroxide showed a delay in the heat release and two exothermic peaks, while the solvent that included water simply showed a delay in the start of the reaction. gamma-Butyrolactone was found to be a product derived from peroxide, by component analysis of the oxidized solvent. gamma-Butyrolactone caused an induction period when it was added to the solvent. This work suggests a deteriorated solvent can lead to inappropriate handling which cause a runaway reaction and gives insight to the chemical industry that manages the risk of potentially hazardous chemical reactions.	[Kumasaki, Mieko; Tanaka, Kuninori] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Otsuka, Teruhito] Natl Inst Occupat Safety & Hlth, Tokyo 2040024, Japan	Kumasaki, M (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	kumasaki@ynu.ac.jp					Armarego W. L. F., 2013, PURIFICATION LAB CHE; Bou-Diab L, 2002, J HAZARD MATER, V93, P137, DOI 10.1016/S0304-3894(02)00044-4; DASLER W, 1946, IND ENG CHEM, V18, P52, DOI 10.1021/i560149a017; Ende DJA, 1999, ORG PROCESS RES DEV, V3, P319; Garst JE, 2004, COORDIN CHEM REV, V248, P623, DOI 10.1016/j.ccr.2004.02.018; GUSTIN JL, 1993, J LOSS PREVENT PROC, V6, P275, DOI 10.1016/S0950-4230(05)80001-4; HAMSTEAD AC, 1964, IND ENG CHEM, V56, P37, DOI 10.1021/ie50654a005; Hawkins EGE, 1961, ORGANIC PEROXIDES, P332; Johnson RM, 1970, DETERMINATION ORGANI; Kanoufi F, 2006, J PHYS ORG CHEM, V19, P847, DOI 10.1002/poc.1045; Kito H, 2010, INT J SAF, V9, P43; Kowhakul W, 2006, J LOSS PREVENT PROC, V19, P452, DOI 10.1016/j.jlp.2005.11.004; Kryk H, 2007, CHEM ENG SCI, V62, P5198, DOI 10.1016/j.ces.2007.01.013; Kumasaki M, 2003, J LOSS PREVENT PROC, V16, P507, DOI 10.1016/S0950(03)00086-X; Kumasaki M, 2007, ICHEME S SERIES, V53; Kumasaki M, 2006, J LOSS PREVENT PROC, V19, P307, DOI 10.1016/j.jlp.2005.06.032; Kumasaki M, 2004, J HAZARD MATER, V115, P57, DOI 10.1016/j.jhazmat.2004.06.020; MCDERMOTT DP, 1986, J PHYS CHEM-US, V90, P2569, DOI 10.1021/j100403a006; Mitchell J, 1960, ORG ANALYSIS, V4, P1; Reichardt C., 2011, SOLVENTS SOLVENT EFF; REIN H, 1950, ANGEW CHEM-GER EDIT, V62, P120, DOI 10.1002/ange.19500620505; Serra E, 1997, J LOSS PREVENT PROC, V10, P211, DOI 10.1016/S0950-4230(97)00004-1; Shurvell HF, 1997, VIB SPECTROSC, V15, P137, DOI 10.1016/S0924-2031(97)00031-3; Swern D, 1969, ORGANIC PEROXIDES, V1, P497; Tanaka K, 2013, J THERM ANAL CALORIM, V113, P1395, DOI 10.1007/s10973-013-2995-5; Tilstam U, 2002, ORG PROCESS RES DEV, V6, P906, DOI 10.1021/op022567+; VOZZA JF, 1959, J ORG CHEM, V24, P720, DOI 10.1021/jo01087a619	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1388-6150	1572-8943		J THERM ANAL CALORIM	J. Therm. Anal. Calorim.	APR	2015	120	1					633	639		10.1007/s10973-015-4436-0		7	Thermodynamics; Chemistry, Analytical; Chemistry, Physical	Thermodynamics; Chemistry	CE9BZ	WOS:000352139800073		
J	Shimazaki, Y; Yoshida, A; Yamamoto, T				Shimazaki, Yasuhiro; Yoshida, Atsumasa; Yamamoto, Takanori			Thermal responses and perceptions under distinct ambient temperature and wind conditions	JOURNAL OF THERMAL BIOLOGY			English	Article						Thermal sensation; Thermal comfort; Human energy balance; Air current; Regional skin temperature; Ambient temperature	PHYSIOLOGICAL EQUIVALENT TEMPERATURE; HUMAN-BODY; COMFORT; INDEX	Wind conditions are widely recognized to influence the thermal states of humans. In this study, we investigated the relationship between wind conditions and thermal perception and energy balance in humans. The study participants were exposed for 20 min to 3 distinct ambient temperatures, wind speeds, and wind angles. During the exposure, the skin temperatures as a physiological reaction and mental reactions of the human body were measured and the energy balance was calculated based on the human thermal-load method. The results indicate that the human thermal load is an accurate indicator of human thermal states under all wind conditions. Furthermore, wind speed and direction by themselves do not account for the human thermal experience. Because of the thermoregulation that occurs to prevent heat loss and protect the core of the body, a low skin temperature was maintained and regional differences in skin temperature were detected under cool ambient conditions. Thus, the human thermal load, which represents physiological parameters such as skin-temperature change, adequately describes the mixed sensation of the human thermal experience. (C) 2015 Elsevier Ltd. All rights reserved.	[Shimazaki, Yasuhiro] Okayama Prefectural Univ, Dept Syst Engn Sports, Okayama 7191197, Japan; [Yoshida, Atsumasa] Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan; [Yamamoto, Takanori] Technol Res Inst Osaka Prefecture, Prod Reliabil & Human Life Sci Sect, Izumi, Osaka 5941157, Japan	Shimazaki, Y (reprint author), Okayama Prefectural Univ, Dept Syst Engn Sports, 111 Kuboki, Okayama 7191197, Japan.	shimazaki@ss.oka-pu.ac.jp					Shimazaki Y, 2011, BUILD ENVIRON, V46, P1716, DOI 10.1016/j.buildenv.2011.02.013; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Hardy JD, 1937, P NATL ACAD SCI USA, V23, P624, DOI 10.1073/pnas.23.12.624; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; deDear RJ, 1997, INT J BIOMETEOROL, V40, P141, DOI 10.1007/s004840050035; Givoni B, 2003, ENERG BUILDINGS, V35, P77, DOI 10.1016/S0378-7788(02)00082-8; Nikolopoulou M, 2003, ENERG BUILDINGS, V35, P95, DOI 10.1016/S0378-7788(02)00084-1; Matzarakis A, 1999, INT J BIOMETEOROL, V43, P76, DOI 10.1007/s004840050119; ASHRAE, 2010, 552010 ASHRAE; CLARK RP, 1975, J PHYSIOL-LONDON, V244, P283; Eliasson I, 2000, LANDSCAPE URBAN PLAN, V48, P31, DOI 10.1016/S0169-2046(00)00034-7; Gagge AP, 1971, ASHRAE T           1, V77, P247; Longley ID, 2004, ATMOS ENVIRON, V38, P69, DOI 10.1016/j.atmosenv.2003.09.060; Reiter S, 2010, ENVIRON PLANN B, V37, P857, DOI 10.1068/b35154; Schiller G.E., 1988, ASHRAE T, V94, P280; Siple Paul A., 1945, PROC AMER PHIL SOC, V89, P177; Tuller SE, 1997, INT J BIOMETEOROL, V41, P26, DOI 10.1007/s004840050050; Wong MS, 2010, BUILD ENVIRON, V45, P1880, DOI 10.1016/j.buildenv.2010.02.019; Yang J.H., 2004, J ARCHIT ENV ENG AIJ, V584, P33	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4565			J THERM BIOL	J. Therm. Biol.	APR-MAY	2015	49-50						1	8		10.1016/j.jtherbio.2015.01.005		8	Biology; Zoology	Life Sciences & Biomedicine - Other Topics; Zoology	CE7RJ	WOS:000352039200001		
J	Yamakawa, K; Aihara, M; Ogura, H; Yuhara, H; Hamasaki, T; Shimazu, T				Yamakawa, K.; Aihara, M.; Ogura, H.; Yuhara, H.; Hamasaki, T.; Shimazu, T.			Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						anticoagulant drugs; disseminated intravascular coagulation; meta-analysis; sepsis; thrombomodulin	DISSEMINATED INTRAVASCULAR COAGULATION; RANDOMIZED CONTROLLED-TRIAL; SEPTIC SHOCK; SURVIVING SEPSIS; ANTITHROMBIN-III; DOUBLE-BLIND; PROTEIN-C; EFFICACY; SAFETY; CAMPAIGN	BackgroundAlthough recombinant human soluble thrombomodulin (rhTM) is a widely used novel anticoagulant agent for disseminated intravascular coagulation (DIC) in Japan, its clinical efficacy in sepsis-induced DIC has not been demonstrated convincingly. ObjectiveTo assess the benefits and harms of rhTM in sepsis-induced DIC patients. MethodsWe conducted a systematic review and meta-analysis of rhTM therapy for sepsis-induced DIC for both randomized controlled trials (RCTs) and observational studies (retrospective case-control studies and/or prospective cohort studies) separately. All-cause mortality (28-30days) as efficacy and serious bleeding complications as adverse effect were measured as primary outcomes. We assessed body of evidence quality at the outcome level by using the Grading of Evidence, Assessment, Development and Evaluation (GRADE) approach. ResultsWe analyzed 12 studies (838 patients/3 RCTs; 571 patients/9 observational studies). Pooled relative risk was 0.81 (95% CI, 0.62-1.06) in the RCTs, indicating non-significant reduction in mortality, and 0.59 (95% CI, 0.45-0.77) in the observational studies. Meta-regression analysis revealed a significant negative slope between effect size of rhTM therapy and baseline mortality rate in individual studies (P=0.012), suggesting that probability of a beneficial effect with rhTM therapy increases with increasing baseline risk. Risk of serious bleeding complications was not significantly different between rhTM and control groups. We judged the quality of evidence as moderate for mortality and serious bleeding. ConclusionsThe rhTM was associated with a trend in reduction of mortality at 28-30days in sepsis-induced DIC patients. Further large rigorous trials are needed to confirm or refute these findings before implications for practice are clear.	[Yamakawa, K.; Ogura, H.; Shimazu, T.] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan; [Aihara, M.] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Aomori, Japan; [Yuhara, H.] Tokai Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Hiratsuka, Kanagawa 25912, Japan; [Hamasaki, T.] Natl Cerebral & Cardiovasc Ctr, Off Biostat & Data Management, Osaka, Japan	Yamakawa, K (reprint author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	k.yamakawa0911@gmail.com	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160			Aihara M, 2010, GRADE SYSTEM CLIN PR; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Yamato M, 2013, THER APHER DIAL, V17, P472, DOI 10.1111/1744-9987.12112; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Williams SCP, 2012, NAT MED, V18, P1001, DOI 10.1038/nm0712-1001; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Opal SM, 1999, INFECT DIS CLIN N AM, V13, P285, DOI 10.1016/S0891-5520(05)70075-1; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Yamakawa K, 2013, INTENS CARE MED, V39, P644, DOI 10.1007/s00134-013-2822-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Dellinger R P, 1999, Minerva Anestesiol, V65, P340; Dhainaut JF, 2003, INTENS CARE MED, V29, P894, DOI 10.1007/s00134-003-1731-1; DisNisio M, 2012, THROMB RES, V129, pe177; Kato Takahiro, 2013, Thromb J, V11, P3, DOI 10.1186/1477-9560-11-3; Kudo D, 2012, J JPN SOC INTENSIVE, V19, P359; Levi M, 2013, MINERVA ANESTESIOL, V79, P294; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Mimuro J, 2013, THROMB RES, V131, P436, DOI 10.1016/j.thromres.2013.03.008; Ohryorji T, 2011, JJPN SOC INTENSIVE C, V18, P583; Okamoto T., 2012, CRIT CARE RES PRACT, V2012, DOI DOI 10.1155/2012/614545; Sawano H, 2013, NIHON KYUKYU IGAKUKA, V24, P119; Sha K, 2013, ICU CCU, V37, P137; Takahashi H, 2011, ICU CCU, V35, P581; Umegaki T, 2012, J JPN SOC INTENSIVE, V19, P603; Wada H, 2014, THROMB RES, V134, P924, DOI 10.1016/j.thromres.2014.07.033; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Yada N, 2011, NIHON KYUKYU IGAKUKA, V22, P749; Yamakawa K, 2011, CRIT CARE, V15, DOI 10.1186/cc10228	45	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					508	519		10.1111/jth.12841		12	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700005		
J	Aota, T; Matsumoto, T; Suzuki, K; Imai, H; Katayama, N; Wada, H				Aota, T.; Matsumoto, T.; Suzuki, K.; Imai, H.; Katayama, N.; Wada, H.			Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: comment	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Letter									[Aota, T.; Katayama, N.] Mie Univ, Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Matsumoto, T.] Mie Univ Hosp, Blood Transfus, Tsu, Mie, Japan; [Suzuki, K.; Imai, H.] Mie Univ Hosp, Emergency Crit Care Ctr, Tsu, Mie, Japan; [Wada, H.] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp					Takemitsu T, 2011, THROMB HAEMOSTASIS, V105, P40, DOI 10.1160/TH10-05-0293; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc12783; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wada H, 2014, CRIT CARE, V18, DOI 10.1186/cc13971; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					679	680		10.1111/jth.12822		2	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700026		
J	Tagami, T; Matsui, H; Yasunaga, H				Tagami, T.; Matsui, H.; Yasunaga, H.			Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study: reply	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Letter							HIGH-DOSE ANTITHROMBIN; TRIAL; GUIDELINES; MANAGEMENT; DIAGNOSIS		[Tagami, T.; Matsui, H.; Yasunaga, H.] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan; [Tagami, T.] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Tagami, T (reprint author), Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X			Afshari A, 2007, BRIT MED J, V335, P1248, DOI 10.1136/bmj.39398.682500.25; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI 10.1111/j.1365-2141.2009.07600.x; Iba T, 2014, J THROMB HAEMOST, V12, P1010, DOI 10.1111/jth.12596; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Di Nisio M, 2012, THROMB RES, V129, pE177, DOI 10.1016/j.thromres.2011.08.028; Eid A, 2008, ANESTH ANALG, V107, P1633, DOI 10.1213/ane.0b013e318184621d; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc13163; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Wiedermann CJ, 2006, BLOOD COAGUL FIBRIN, V17, P521, DOI 10.1097/01.mbc.0000245302.18010.40	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					680	682		10.1111/jth.12821		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700027		
J	Iba, T				Iba, T.			Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Letter							OBSERVATIONAL NATIONWIDE; MORTALITY		[Iba, T.] Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Tokyo 1138421, Japan	Iba, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	toshiiba@cf6.so-net.ne.jp					Iba T, 2014, J THROMB HAEMOST, V12, P1010, DOI 10.1111/jth.12596; Hashiguchi N, 2014, CRIT CARE MED, V42, pe598; Iwagami M, 2013, CRIT CARE MED, V42, P1187; Tagami T, 2015, J THROMB HAEMOST, V13, P31, DOI 10.1111/jth.12786; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155	6	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					682	683		10.1111/jth.12853		2	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700028		
J	Wada, H; Aota, T; Matsumoto, T; Suzuki, K; Imai, H; Katayama, N				Wada, H.; Aota, T.; Matsumoto, T.; Suzuki, K.; Imai, H.; Katayama, N.			Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Letter							HUMAN SOLUBLE THROMBOMODULIN; OBSERVATIONAL NATIONWIDE; MORTALITY		[Wada, H.] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Aota, T.; Katayama, N.] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Matsumoto, T.] Mie Univ Hosp, Blood Transfus, Tsu, Mie, Japan; [Suzuki, K.; Imai, H.] Mie Univ Hosp, Emergency Crit Care Ctr, Tsu, Mie, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp					Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Aota T, 2014, J THROMB HAEMOST, DOI [10.1111/jth.12822, DOI 10.1111/JTH.12822]; Tagami T, 2015, J THROMB HAEMOST, V13, P31, DOI 10.1111/jth.12786; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Wada H, 2014, CRIT CARE, V18, DOI 10.1186/cc13971; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					684	685		10.1111/jth.12856		2	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700029		
J	Tagami, T; Matsui, H; Yasunaga, H				Tagami, T.; Matsui, H.; Yasunaga, H.			Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Letter							PROPENSITY-SCORE; OBSERVATIONAL NATIONWIDE; ACUTE-PANCREATITIS; SEPTIC SHOCK; MORTALITY; RISK; MANAGEMENT; DATABASE		[Tagami, T.; Matsui, H.; Yasunaga, H.] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan; [Tagami, T.] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Tagami, T (reprint author), Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X			Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Sheffield KM, 2013, JAMA-J AM MED ASSOC, V310, P812, DOI 10.1001/jama.2013.276205; Iwagami M, 2014, CRIT CARE MED, V42, P1187, DOI 10.1097/CCM.0000000000000150; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Bateman BT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5416; Hamada T, 2013, CRIT CARE, V17, DOI 10.1186/cc13029; Iba T, 2015, J THROMB HAEMOST, V13, P682, DOI 10.1111/jth.12853; Jena AB, 2013, CIRCULATION, V128, P2754, DOI 10.1161/CIRCULATIONAHA.113.004074; Tagami T, 2015, J THROMB HAEMOST, V13, P31, DOI 10.1111/jth.12786; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643; Tagami Takashi, 2014, J Intensive Care, V2, P67, DOI 10.1186/s40560-014-0067-y; Tagami T, 2015, J THROMB HAEMOST, V13, P680, DOI 10.1111/jth.12821; Wada H, 2015, J THROMB HAEMOST, V13, P684, DOI 10.1111/jth.12856; Yamakawa K, 2015, J THROMB HAEMOST, V13, P508, DOI 10.1111/jth.12841; Yasunaga H, 2013, PANCREAS, V42, P260, DOI 10.1097/MPA.0b013e31826495a0	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	APR	2015	13	4					686	688		10.1111/jth.12869		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF1MK	WOS:000352309700030		
J	Yamashita, K; Shinoda, S; Hagiwara, S; Itagaki, H				Yamashita, Kunihiko; Shinoda, Shinsuke; Hagiwara, Saori; Itagaki, Hiroshi			Further development of LLNA:DAE method as stand-alone skin-sensitization testing method and applied for evaluation of relative skin-sensitizing potency between chemicals	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						LLNA; LLNA:DAE; Sensitization; Elicitation; Potency	LYMPH-NODE ASSAY; ISOTOPIC END-POINT; ICCVAM EVALUATION; IRRITANTS; B220	To date, there has been no well-established local lymph node assay (LLNA) that includes an elicitation phase. Therefore, we developed a modified local lymph node assay with an elicitation phase (LLNA:DAE) to discriminate true skin sensitizers from chemicals that gave borderline positive results and previously reported this assay. To develop the LLNA:DAE method as a useful stand-alone testing method, we investigated the complete procedure for the LLNA:DAE method using hexyl cinnamic aldehyde (HCA), isoeugenol, and 2,4-dinitrochlorobenzene (DNCB) as test compounds. We defined the LLNA:DAE procedure as follows: in the dose-finding test, four concentrations of chemical applied to dorsum of the right ear on days 1, 2, and 3 and dorsum of both ears on day 10. Ear thickness and skin irritation score were measured on days 1, 3, 5, 10, and 12. Local lymph nodes were excised and weighed on day 12. The test dose for the primary LLNA:DAE study was selected as the dose that gave the highest left ear lymph node weight in the dose-finding study, or the lowest dose that produced a left ear lymph node of over 4 mg. This procedure was validated using nine different chemicals. Furthermore, qualitative relationship was observed between the degree of elicitation response in the left ear lymph node and the skin sensitizing potency of 32 chemicals tested in this study and the previous study. These results indicated that LLNA:DAE method was as first LLNA method that was able to evaluate the skin sensitizing potential and potency in elicitation response.	[Yamashita, Kunihiko] Daicel Corp, Corp Res Ctr, Aboshi Ku, Himeji, Hyogo 6711283, Japan; [Shinoda, Shinsuke; Hagiwara, Saori] Drug Safety Testing Ctr Co Ltd, Yoshimi Labs, Yoshimi, Saitama 3550166, Japan; [Yamashita, Kunihiko; Itagaki, Hiroshi] Yokohama Natl Univ, Dept Mat Sci & Engn, Fac Engn, Yokohama, Kanagawa 2408501, Japan	Yamashita, K (reprint author), Daicel Corp, Corp Res Ctr, Aboshi Ku, 1239 Shinzaike, Himeji, Hyogo 6711283, Japan.	ku_yamashita@gp.daicel.com					Montelius J, 1998, ACTA DERM-VENEREOL, V78, P433; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Idehara Kenji, 2008, Journal of Pharmacological and Toxicological Methods, V58, P1, DOI 10.1016/j.vascn.2008.03.003; Takeyoshi M, 2001, TOXICOL LETT, V119, P203, DOI 10.1016/S0378-4274(00)00315-5; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Basketter DA, 1996, FOOD CHEM TOXICOL, V34, P985, DOI 10.1016/S0278-6915(96)00059-2; Sailstad DM, 2001, REGUL TOXICOL PHARM, V34, P249, DOI 10.1006/rtph.2001.1496; Kreiling R, 2008, FOOD CHEM TOXICOL, V46, P1896, DOI 10.1016/j.fct.2008.01.019; Yamashita K, 2014, J TOXICOL SCI, V39, P147; Omori Takashi, 2008, Journal of Pharmacological and Toxicological Methods, V58, P11, DOI 10.1016/j.vascn.2008.05.001; Haneke KE, 2001, REGUL TOXICOL PHARM, V34, P274, DOI 10.1006/rtph.2001.1498; Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497; Betts CJ, 2007, J APPL TOXICOL, V27, P506, DOI 10.1002/jat.1269; Gerberick GF, 2002, TOXICOL SCI, V68, P420, DOI 10.1093/toxsci/68.2.420; Gerberick G F, 2000, Am J Contact Dermat, V11, P3; ICCVAM, 2010, NIH PUBL, V10-7514; Karen P.S., 2010, DERMATITIS, V21, P8; Katumura Y., 1996, ENV DERMATOL, V3, P8; KIMBER I, 1986, FOOD CHEM TOXICOL, V24, P585, DOI 10.1016/0278-6915(86)90124-9; Magunusson B., 1969, J INVEST DERMATOL, V52, P268; McGarry HF, 2007, TOXICOLOGY, V238, P71, DOI 10.1016/j.tox.2007.06.002; OECD, 2010, OECD GUID TEST CHEM; OECD, 2002, OECD GUID TEST CHEM; Shaffer MP, 2000, CONTACT DERMATITIS, V43, P150, DOI 10.1034/j.1600-0536.2000.043003150.x; Ulrich P., 2008, MARZULLI MAIBACHAS D, P707; Yamashita K., 2005, AATEX, V11, P136, DOI DOI 10.1016/J.VASCN.2008.03.003	26	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					137	150				14	Toxicology	Toxicology	CF4LN	WOS:000352520700001		
J	Hisaki, T; Kaneko, MAN; Yamaguchi, M; Sasa, H; Kouzuki, H				Hisaki, Tomoka; Kaneko, Maki Aiba Nee; Yamaguchi, Masahiko; Sasa, Hitoshi; Kouzuki, Hirokazu			Development of QSAR models using artificial neural network analysis for risk assessment of repeated-dose, reproductive, and developmental toxicities of cosmetic ingredients	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Artificial neural network; Repeated-dose toxicity; Reproductive/developmental toxicity; QSAR model; NOEL; Cosmetic ingredients	ADVERSE-EFFECT LEVEL; STEM-CELL TEST; IN-VITRO; PREDICTION; CHEMICALS	Use of laboratory animals for systemic toxicity testing is subject to strong ethical and regulatory constraints, but few alternatives are yet available. One possible approach to predict systemic toxicity of chemicals in the absence of experimental data is quantitative structure-activity relationship (QSAR) analysis. Here, we present QSAR models for prediction of maximum "no observed effect level" (NOEL) for repeated-dose, developmental and reproductive toxicities. NOEL values of 421 chemicals for repeated-dose toxicity, 315 for reproductive toxicity, and 156 for developmental toxicity were collected from Japan Existing Chemical Data Base (JECDB). Descriptors to predict toxicity were selected based on molecular orbital (MO) calculations, and QSAR models employing multiple independent descriptors as the input layer of an artificial neural network (ANN) were constructed to predict NOEL values. Robustness of the models was indicated by the root-mean-square (RMS) errors after 10-fold cross-validation (0.529 for repeated-dose, 0.508 for reproductive, and 0.558 for developmental toxicity). Evaluation of the models in terms of the percentages of predicted NOELs falling within factors of 2, 5 and 10 of the in-vivo-determined NOELs suggested that the model is applicable to both general chemicals and the subset of chemicals listed in International Nomenclature of Cosmetic Ingredients (INCI). Our results indicate that ANN models using in silico parameters have useful predictive performance, and should contribute to integrated risk assessment of systemic toxicity using a weight-of-evidence approach. Availability of predicted NOELs will allow calculation of the margin of safety, as recommended by the Scientific Committee on Consumer Safety (SCCS).	[Hisaki, Tomoka; Kaneko, Maki Aiba Nee; Yamaguchi, Masahiko; Sasa, Hitoshi; Kouzuki, Hirokazu] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan	Hisaki, T (reprint author), Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	tomoka.hisaki@to.shiseido.co.jp					Hartung T, 2009, NATURE, V460, P1080, DOI 10.1038/4601080a; Kubinyi H, 1998, J MED CHEM, V41, P2553, DOI 10.1021/jm970732a; Hirota M, 2013, TOXICOL IN VITRO, V27, P1233, DOI 10.1016/j.tiv.2013.02.013; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Leonard JT, 2006, QSAR COMB SCI, V25, P235, DOI 10.1002/qsar.200510161; Pasomsub E, 2010, JPN J INFECT DIS, V63, P87; Brown NA, 1995, ATLA-ALTERN LAB ANIM, V23, P868; Cronin MTD, 2008, QSAR COMB SCI, V27, P91, DOI 10.1002/qsar.200710118; Jagt K., 2004, 21405 EUR; Lapenna S., 2010, 24639 JRC EUR EN; MUMTAZ MM, 1995, TOXICOL LETT, V79, P131, DOI 10.1016/0378-4274(95)03365-R; Piparo E.L., 2010, 24522 JRC EUR EN; Rupp B, 2010, ARCH TOXICOL, V84, P681, DOI 10.1007/s00204-010-0532-x; Spielmann H, 2006, ATLA-ALTERN LAB ANIM, V34, P365; Tilaoui L, 2007, QSAR COMB SCI, V26, P102, DOI 10.1002/qsar.200610060; Veerasamy R., 2011, INT J DRUG DES DIS, V2, P511; Venkatapathy R, 2004, J CHEM INF COMP SCI, V44, P1623, DOI 10.1021/ci049903s; Worth A., 2014, 26797 JRC EUR EN	19	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					163	180				18	Toxicology	Toxicology	CF4LN	WOS:000352520700003		
J	Takeuchi, K; Goto, H; Ito, Y; Sato, M; Matsumoto, S; Senba, T; Yamada, H; Umehara, K				Takeuchi, Kenji; Goto, Hirohiko; Ito, Yuko; Sato, Makoto; Matsumoto, Satoshi; Senba, Tadashi; Yamada, Hideyuki; Umehara, Ken			Dehydroepiandrosterone sulfate and cytochrome P450 inducers alleviate fatty liver in male rats fed an orotic acid-supplemented diet	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Fatty liver; DHEAS; Phenobarbital; PPAR alpha; Constitutive androstane receptor; Cytochrome P450	CONSTITUTIVE ANDROSTANE RECEPTOR; MONOXIDE-BINDING PIGMENT; OMEGA-HYDROXYLATION; HEPATIC STEATOSIS; CHOLINE-DEFICIENT; MICROSOMES; DISEASE; TRIGLYCERIDE; CLOFIBRATE; ENZYMES	The effects of the peroxisome proliferator, dehydroepiandrosterone sulfate (DHEAS), and the typical cytochrome P450 (CYP) inducers phenobarbital (PB) and 3-methylcholanthrene (3-MC) on fatty liver were examined in rats. Treating rats with orotic acid caused marked accumulation of lipid droplets in the liver. This effect of orotic acid was almost eradicated by co-treatment with DHEAS and PB. While DHEAS or PB alone also alleviated fatty liver, treatment with 3-MC caused little effect on a reduction in lipid droplets. Histopathological examinations revealed numerous peroxisomes in the liver of rats treated with DHEAS. In addition, a significant increase in the expression on hepatic CYPs was observed in rats the fatty liver of which was attenuated. Regarding other enzymes associated with hepatic fatty acid oxidation, the expression levels of sirtuin 1, sirtuin 6, and carnitine palmitoyltransferase 1 were also upregulated most markedly by treatment with DHEAS alone. Thus, the attenuation in fatty liver observed in the present study is likely due to peroxisome proliferation and the induction of fatty acid-metabolizing enzymes by DHEAS and typical CYP inducers.	[Takeuchi, Kenji; Umehara, Ken] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Drug Metab, Kawaguchi, Tokushima 7710192, Japan; [Goto, Hirohiko; Ito, Yuko; Sato, Makoto; Matsumoto, Satoshi; Senba, Tadashi] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Toxicol, Kawaguchi, Tokushima 7710192, Japan; [Takeuchi, Kenji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Higashi Ku, Fukuoka 8128582, Japan	Takeuchi, K (reprint author), Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Drug Metab, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan.	Takeuchi.Kenji@otsuka.jp					OMURA T, 1964, J BIOL CHEM, V239, P2370; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Tamasi V, 2009, MOL PHARMACEUT, V6, P1573, DOI 10.1021/mp9001552; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; OMURA T, 1964, J BIOL CHEM, V239, P2379; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; Derdak Z, 2013, J HEPATOL, V58, P785, DOI 10.1016/j.jhep.2012.11.042; ANTONY GJ, 1968, J LIPID RES, V9, P267; Baskin-Bey ES, 2007, WORLD J GASTROENTERO, V13, P5635; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; CLOSE I, 1992, J BIOCHEM TOXICOL, V7, P193, DOI 10.1002/jbt.2570070309; Correia M.A, 1995, RAT HUMAN LIVER CYTO, P607; Goto H, 1998, EXP ANIM TOKYO, V47, P257, DOI 10.1538/expanim.47.257; Goto H, 1998, J VET MED SCI, V60, P513, DOI 10.1292/jvms.60.513; JATLOW P, 1965, AM J PATHOL, V47, P125; Kohalmy K, 2007, DRUG METAB DISPOS, V35, P1495, DOI 10.1124/dmd.107.016303; LU AYH, 1968, J BIOL CHEM, V243, P1331; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; NOVIKOFF PM, 1974, LAB INVEST, V30, P732; REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Takeuchi-Yorimoto A, 2013, TOXICOL APPL PHARM, V268, P264, DOI 10.1016/j.taap.2013.01.027; TAMBURINI PP, 1984, EUR J BIOCHEM, V139, P235, DOI 10.1111/j.1432-1033.1984.tb07999.x; THOMAS PE, 1983, J BIOL CHEM, V258, P4590; Tokushige K, 2013, J GASTROENTEROL, V48, P1392, DOI 10.1007/s00535-013-0766-5; WETTERAU JR, 1984, J BIOL CHEM, V259, P863; Yamada J., 1992, BIOCHIM BIOPHYS ACTA, V1160, P231	38	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					181	191				11	Toxicology	Toxicology	CF4LN	WOS:000352520700004		
J	Tsujita-Inoue, K; Atobe, T; Hirota, M; Ashikaga, T; Kouzuki, H				Tsujita-Inoue, Kyoko; Atobe, Tomomi; Hirota, Morihiko; Ashikaga, Takao; Kouzuki, Hirokazu			In silico risk assessment for skin sensitization using artificial neural network analysis	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Skin sensitization; LLNA; Risk assessment; Artificial neural network; In silico	LYMPH-NODE ASSAY; HUMAN CELL-LINES; TEST H-CLAT; CONTACT ALLERGENS; VITRO ASSAYS; CHEMICALS; POTENCY; IDENTIFICATION; BATTERY; PREDICT	The sensitizing potential of chemicals is usually identified and characterized using in vivo methods such as the murine local lymph node assay (LLNA). Due to regulatory constraints and ethical concerns, alternatives to animal testing are needed to predict the skin sensitization potential of chemicals. For this purpose, an integrated evaluation system employing multiple in vitro and in silico parameters that reflect different aspects of the sensitization process seems promising. We previously reported that LLNA thresholds could be well predicted by using an artificial neural network (ANN) model, designated iSENS ver. 2 (integrating in vitro sensitization tests version 2), to analyze data obtained from in vitro tests focused on different aspects of skin sensitization. Here, we examined whether LLNA thresholds could be predicted by ANN using in silico-calculated descriptors of the three-dimensional structures of chemicals. We obtained a good correlation between predicted LLNA thresholds and reported values. Furthermore, combining the results of the in vitro (iSENS ver. 2) and in silico models reduced the number of chemicals for which the potency category was under-estimated. In conclusion, the ANN model using in silico parameters was shown to be have useful predictive performance. Further, our results indicate that the combination of this model with a predictive model using in vitro data represents a promising approach for integrated risk assessment of skin sensitization potential of chemicals.	[Tsujita-Inoue, Kyoko; Atobe, Tomomi; Hirota, Morihiko; Ashikaga, Takao; Kouzuki, Hirokazu] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan	Tsujita-Inoue, K (reprint author), Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	kyoko.tsujita@to.shiseido.co.jp					Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259; Jowsey IR, 2006, J APPL TOXICOL, V26, P341, DOI 10.1002/jat.1146; Sakaguchi H, 2006, TOXICOL IN VITRO, V20, P774, DOI 10.1016/j.tiv.2005.10.014; Hirota M, 2013, TOXICOL IN VITRO, V27, P1233, DOI 10.1016/j.tiv.2013.02.013; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Python F, 2007, TOXICOL APPL PHARM, V220, P113, DOI 10.1016/j.taap.2006.12.026; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; Aeby P, 2010, TOXICOL IN VITRO, V24, P1465, DOI 10.1016/j.tiv.2010.07.005; Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869; Basketter DA, 2007, CONTACT DERMATITIS, V56, P196, DOI 10.1111/j.1600-0536.2006.01008.x; Api AM, 2008, REGUL TOXICOL PHARM, V52, P3, DOI 10.1016/j.yrtph.2007.10.008; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2; Gerberick GF, 2007, TOXICOL SCI, V97, P417, DOI 10.1093/toxsci/kfm064; Kimber I, 2002, INT IMMUNOPHARMACOL, V2, P201, DOI 10.1016/S1567-5769(01)00173-4; Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007; Suzuki M, 2009, TOXICOL IN VITRO, V23, P687, DOI 10.1016/j.tiv.2009.02.002; Azam P, 2006, TOXICOL APPL PHARM, V212, P14, DOI 10.1016/j.taap.2005.06.018; Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2; Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237; Jaworska J, 2011, ALTEX-ALTERN ANIM EX, V28, P211; Basketter D, 2011, CONTACT DERMATITIS, FIFTH EDITION, P229, DOI 10.1007/978-3-642-03827-3_13; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Tsujita-Inoue K, 2014, TOXICOL IN VITRO, V28, P626, DOI 10.1016/j.tiv.2014.01.003; Basketter DA, 2005, CONTACT DERMATITIS, V53, P260, DOI 10.1111/j.0105-1873.2005.00707.x; Fedorowicz A, 2005, CHEM RES TOXICOL, V18, P954, DOI 10.1021/tx0497806; Lambrechts N., 2010, TOXICOL SCI, V116, P112; MAGNUSSO.B, 1969, J INVEST DERMATOL, V52, P268; Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204; OECD, 2012, OECD ENV HLTH SAFETY, V168, P1; Patlewicz G., 2008, OSAR COMB SCI, V27, P60; Patlewicz G., 2008, JRC SCI TECHNICAL RE; Vacanson M., 2014, EXPERIENTIA S, V104, P89	36	1	1	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					193	209				17	Toxicology	Toxicology	CF4LN	WOS:000352520700005		
J	Miyajima, A; Bamba, M; Muto, T; Hirota, T				Miyajima, Atsushi; Bamba, Masaru; Muto, Takafumi; Hirota, Takashi			Dysfunction of blood pressure regulation in hyperhomocyteinemia model in rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Hyperhomocysteinemia; Homocysteine; Cardiovascular event; Vaso-regulation; Elastic lamellae	PLASMA HOMOCYSTEINE; ELASTIC LAMELLAE; VASO-REGULATION; CROSS-LINKING; AORTA; METHIONINE; HYPERHOMOCYSTEINEMIA; DISEASE; ARTERIOSCLEROSIS; PENICILLAMINE	Hyperhomocysteinemia (HHC) has been reported to be one of risk factors for cardiovascular disease. We investigated the effects of HHC on blood pressure regulation and its association with damage to the thoracic aorta and imbalance of redox in plasma in rats. Rats were fed a methionine enriched diet (Met diet) or a methionine and cholesterol (Met+Chol diet) enriched diet for 16 weeks to create a subchronic HHC model, in which the plasma concentration of homocysteine was about 7 times higher than that of control rats. The increase in systolic blood pressure (Delta-SBP) from sympathetic stimulation by L-epinephrine was 2- to 3-fold larger in HHC model in rats than that in control rats after several weeks of the treatment. These findings suggest that HHC deteriorates vaso-regulatory function, which could bring on an increased risk of cardiovascular events in humans. In addition, some of the elastic lamellae in the aorta were disrupted in the HHC group. However, the content of cross-linkages which give elasticity and mechanical strength in the lamellae, was not significantly different between HHC and control rats. Also plasma concentrations of thiobarbituric acid reactive substance and glutathione as indicators for redox balance in plasma were not different. In conclusion, the deterioration of vaso-regulation in HHC model in rats might be caused by the damage to elastic lamellae in the aorta, and not by oxidative stresses.	[Miyajima, Atsushi; Bamba, Masaru; Muto, Takafumi; Hirota, Takashi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biopharmaceut, Noda, Chiba 2788510, Japan	Hirota, T (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biopharmaceut, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	hirotas5@rs.noda.tus.ac.jp					Refsum H, 1998, ANNU REV MED, V49, P31; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Tawakol A, 1997, CIRCULATION, V95, P1119; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Matthias D, 1996, ATHEROSCLEROSIS, V122, P201, DOI 10.1016/0021-9150(95)05740-4; Charpiot P, 1998, MATRIX BIOL, V17, P559, DOI 10.1016/S0945-053X(98)90108-1; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Sun XH, 2005, ANTICANCER RES, V25, P59; DESHMUKH K, 1969, J BIOL CHEM, V244, P1787; Lang D, 2000, ARTERIOSCL THROM VAS, V20, P422; Miyajima A, 2013, J TOXICOL SCI, V38, P719; Muto T, 2013, J TOXICOL SCI, V38, P707; PARTRIDG.SM, 1966, NATURE, V209, P399, DOI 10.1038/209399b0; Tayama J, 2006, HYPERTENS RES, V29, P403, DOI 10.1291/hypres.29.403; THOMAS J, 1963, NATURE, V200, P651, DOI 10.1038/200651a0; Ungvari Z, 1999, ARTERIOSCL THROM VAS, V19, P1899; Yucel K, 2014, ANADOLU KARDIYOL DER, V14, P357, DOI 10.5152/akd.2014.4689; Zhou SY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-134; Zulli A, 1998, CLIN SCI, V95, P589; Zulli A, 1998, LIFE SCI, V62, P2191, DOI 10.1016/S0024-3205(98)00196-9	25	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					211	221				11	Toxicology	Toxicology	CF4LN	WOS:000352520700006		
J	Okazaki, H; Takeda, S; Ikeda, E; Fukunishi, Y; Ishii, H; Taniguchi, A; Tokuyasu, M; Himeno, T; Kakizoe, K; Matsumoto, K; Shindo, M; Aramaki, H				Okazaki, Hiroyuki; Takeda, Shuso; Ikeda, Erika; Fukunishi, Yoshifumi; Ishii, Hiroyuki; Taniguchi, Aya; Tokuyasu, Miki; Himeno, Taichi; Kakizoe, Kazuhiro; Matsumoto, Kenji; Shindo, Mitsuru; Aramaki, Hironori			Bongkrekic acid as a selective activator of the peroxisome proliferator-activated receptor gamma (PPAR gamma) isoform	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Bongkrekic acid; Peroxisome proliferator-activated receptor gamma; Adenine nucleotide translocase; 15-Lipoxygenase; Apoptosis	PERMEABILITY TRANSITION PORE; 2-HYDROXYLASE FA2H GENE; ISCHEMIC NEURONAL DEATH; LOW-DENSITY-LIPOPROTEIN; BREAST-CANCER CELLS; FATTY-ACIDS; LINOLEIC-ACID; CANNABIDIOL-2',6'-DIMETHYL ETHER; EXPRESSION; OXIDATION	Bongkrekic acid (BKA), an antibiotic isolated from Pseudomonas cocovenans, is an inhibitory molecule of adenine nucleotide translocase. Since this translocase is a core component of the mitochondrial permeability transition pore (MPTP) formed by apoptotic stimuli, BKA has been used as a tool to abrogate apoptosis. However, the other biochemical properties of BKA have not yet been resolved. Although the definition of a fatty acid is a carboxylic acid (-COOH) with a long hydrocarbon chain (tail), when focused on the chemical structure of BKA, the molecule was revealed to be a branched unsaturated tricarboxylic acid that resembled the structure of polyunsaturated fatty acids (PUFAs). Peroxisome proliferator-activated receptors (PPARs) consist of a subfamily of three isoforms: alpha, beta, and gamma, the ligands of which include PUFAs. Using completely synthesized BKA together with simplified BKA derivatives (purity: > 98%), we herein demonstrated the utility of BKA as a selective activator of the human PPAR gamma isoform, which may not be associated with the anti-apoptotic nature of BKA. We also discussed the possible usefulness of BKA.	[Okazaki, Hiroyuki; Aramaki, Hironori] Daiichi Univ Pharm, Drug Innovat Res Ctr, Minami Ku, Fukuoka 8158511, Japan; [Takeda, Shuso; Ikeda, Erika; Ishii, Hiroyuki; Taniguchi, Aya; Tokuyasu, Miki; Himeno, Taichi; Kakizoe, Kazuhiro; Aramaki, Hironori] Daiichi Univ Pharm, Dept Mol Biol, Minami Ku, Fukuoka 8158511, Japan; [Takeda, Shuso] HIU, Fac Pharmaceut Sci, Lab Xenobiot Metab & Environm Toxicol, Kure, Hiroshima 7370112, Japan; [Fukunishi, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, Tokyo 1350064, Japan; [Matsumoto, Kenji; Shindo, Mitsuru] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Okazaki, H (reprint author), Daiichi Univ Pharm, Drug Innovat Res Ctr, Minami Ku, 22-1 Tamagawa Cho, Fukuoka 8158511, Japan.	haramaki@daiichi-cps.ac.jp			Cooperative Research Program of the Network Joint Research Center for Materials and Devices [2014408]; Japan Society for the Promotion of Science (JSPS) KAKENHI [25460182, 25893282]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food industry; JSPS KAKENHI [26293004]	This work was performed under the Cooperative Research Program of the Network Joint Research Center for Materials and Devices [Research No. 2014408, (to H.A.)]. This study was supported in part by a Grant-in-Aid for Scientific Research (C) [25460182, (to S.T.)] and a Grant-in-Aid for Young Scientists (Start-up) [25893282, (to E.I.)] from the Japan Society for the Promotion of Science (JSPS) KAKENHI. This study was also supported in part by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food industry (to M.S.) and a Grant-in-Aid for Scientific Research (B) [26293004, (to M.S.)] from the JSPS KAKENHI.	Takeda S, 2011, BIOL PHARM BULL, V34, P1252; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Okuda K, 2012, CHEM RES TOXICOL, V25, P2253, DOI 10.1021/tx300315h; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; DARET D, 1989, PROSTAGLANDINS, V38, P203, DOI 10.1016/0090-6980(89)90083-X; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Sato Y, 2009, TETRAHEDRON LETT, V50, P4164, DOI 10.1016/j.tetlet.2009.04.129; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Takeda S, 2009, TOXICOLOGY, V259, P25, DOI 10.1016/j.tox.2009.01.024; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Nolte RT, 1998, NATURE, V395, P137; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47; HAASE G, 1969, J LIPID RES, V10, P555; Takeda S, 2009, DRUG METAB DISPOS, V37, P1733, DOI 10.1124/dmd.109.026930; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Takeda S, 2013, J TOXICOL SCI, V38, P305; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321; Favre D, 2011, DIABETES, V60, P3169, DOI 10.2337/db10-1743; HENDERSO.PJ, 1970, J BIOL CHEM, V245, P1319; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Muranyi M, 2005, NEUROSCI LETT, V384, P277, DOI 10.1016/j.neulet.2005.05.011; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Takeda S, 2011, J PHARM SCI-US, V100, P1206, DOI 10.1002/jps.22354; Takeda S, 2014, TOXICOLOGY, V326, P18, DOI 10.1016/j.tox.2014.09.011; WANG T, 1992, J LIPID RES, V33, P525	31	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					223	233				11	Toxicology	Toxicology	CF4LN	WOS:000352520700007		
J	Okamoto, Y; Tobe, T; Ueda, K; Takada, T; Kojima, N				Okamoto, Yoshinori; Tobe, Takao; Ueda, Koji; Takada, Tatsuyuki; Kojima, Nakao			Oral administration of Brazilian propolis exerts estrogenic effect in ovariectomized rats	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Brazilian propolis; Phytoestrogens; Postmenopausal women; Natural products; Oral intake	PROSTATE-CANCER CELLS; ANTIESTROGENIC ACTIVITY; MILLETTIA-PACHYCARPA; EQUINE ESTROGEN; HORMONE-THERAPY; IN-VITRO; METABOLISM; MORTALITY; EXTRACTS; RECEPTOR	Propolis, a natural product derived from plants by honeybees, is a mixture of several hundred chemicals, including flavonoids, coumaric acids, and caffeic acids, some of which show estrogen-like activity. In this study, the estrogenic activity of crude ethanolic extract of Brazilian propolis was determined using several in vitro and in vivo assays. Propolis was found to bind to human estrogen receptors (ERs). Furthermore, propolis induced the expression of estrogen-responsive genes in ER-positive MCF-7 and Ishikawa cells. These in vitro assays suggest that propolis exerts estrogenic activity; therefore, in vivo experiments were conducted using ovariectomized rats. Oral administration of propolis (55 or 550 mg/kg/day for 3 days) significantly increased uterine wet weight and luminal epithelium thickness in comparison with the corresponding values in the corn oil-treated control group. Moreover, propohs induced ductal cell proliferation in the mammary glands. These effects were completely inhibited by full ER antagonist ICI 182,780, confirming that the effects of propolis are mediated by the ER. Our data show that oral intake of propolis induces estrogenic activity in ER-expressing organs in vivo and suggest that Brazilian propolis is a useful dietary source of phytoestrogens and a promising treatment for postmenopausal symptoms.	[Okamoto, Yoshinori; Tobe, Takao; Ueda, Koji; Kojima, Nakao] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Takada, Tatsuyuki] Ritsumeikan Univ, Dept Pharmaceut Sci, Kusatsu, Shiga 5258577, Japan	Kojima, N (reprint author), Meijo Univ, Fac Pharm, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	kojiman@meijo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamada Research Grant	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Yamada Research Grant. We thank the past-laboratory members who worked on this project.	Kanno J, 2003, ENVIRON HEALTH PERSP, V111, P1530, DOI 10.1289/ehp.5780; Beral V, 2011, J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Shimizu K, 2004, ARCH BIOCHEM BIOPHYS, V424, P181, DOI 10.1016/j.abb.2004.02.021; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Tolleson WH, 2002, J AGR FOOD CHEM, V50, P4783, DOI 10.1021/jf025549r; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Li HZ, 2007, INT J ONCOL, V31, P601; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Taylor CK, 2009, NUTR REV, V67, P398, DOI 10.1111/j.1753-4887.2009.00213.x; Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930; Ishimi Y, 2010, J NUTR, V140, p1373S, DOI 10.3945/jn.110.124842; Ito C, 2006, J NAT PROD, V69, P138, DOI 10.1021/np050341w; Liu XP, 2012, LIFE SCI, V91, P415, DOI 10.1016/j.lfs.2012.08.022; Okahashi Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq233; Okamoto Y, 2006, J HEALTH SCI, V52, P186, DOI 10.1248/jhs.52.186; Okamoto Y, 2008, CHEM RES TOXICOL, V21, P1120, DOI 10.1021/tx700428m; Okamoto Y, 2010, TOXICOL LETT, V193, P224, DOI 10.1016/j.toxlet.2010.01.012; Okamoto Y, 2008, INT J CANCER, V122, P2142, DOI 10.1002/ijc.23362; Song YS, 2002, J ETHNOPHARMACOL, V82, P89, DOI 10.1016/S0378-8741(02)00159-9; Tinwell H, 2000, ENVIRON HEALTH PERSP, V108, P631, DOI 10.2307/3434883; van der Woude H, 2005, MOL NUTR FOOD RES, V49, P763, DOI 10.1002/mnfr.200500036	22	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					235	242				8	Toxicology	Toxicology	CF4LN	WOS:000352520700008		
J	Koyama, Y; Matsui, Y; Shimada, Y; Yoneda, M				Koyama, Yosuke; Matsui, Yasuto; Shimada, Yoko; Yoneda, Minoru			Biodistribution of gold nanoparticles in mice and investigation of their possible translocation by nerve uptake around the alveolus	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Nanoparticles; Gold; Biodistribution; ICP-MS; Nerve uptake	IN-VIVO; PARTICLES; MECHANISMS; TOXICITY; RATS	The effect of nanoparticles in the environment on our health is a cause of concern. The greatest concern with respect to the biological effect of nanoparticles is that they remain in the body and invade tissues, overcoming the protective mechanisms of the body. It is generally believed that nanoparticles invading a living body move into the blood and are carried by the bloodstream to all organs. However, some studies have shown that the inhaled nanoparticles directly translocate to the central nervous system by nerve uptake. Here quantification of the amount of migration of nanoparticles to organs in short time spans (1, 3, and 6 hr) was attempted by animal experiments. Furthermore, the possibility of migration of nanoparticles through the nerves that project around the alveolus, including the nodose ganglion and dorsal root ganglion (DRG), was investigated. Gold (Au) nanoparticles (15 nm) were administered to mice by intratracheal instillation and tail vein injection. After tail vein injection, most nanoparticles were distributed in the liver. After intratracheal instillation, approximately 80% of detected nanoparticles remained in the lungs at 1 hr and were believed to be translocated to digestive organs, including the stomach and intestine, at 3 and 6 hr. With respect to quantification in ganglia, the levels in most samples were lower than the limit of quantification of inductively coupled plasma mass spectrometry (ICP-MS). However, Au nanoparticles were detected in DRG in only some samples of intratracheal instillation. Therefore, this suggests the possibility of translocation of nanoparticles to DRG via nerves.	[Koyama, Yosuke; Matsui, Yasuto; Shimada, Yoko; Yoneda, Minoru] Kyoto Univ, Cluster C, Nishikyo Ku, Kyoto 6158540, Japan	Koyama, Y (reprint author), Kyoto Univ, Cluster C, Nishikyo Ku, Kyoto 6158540, Japan.	koyama@risk.env.kyoto-u.ac.jp					Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Lankveld DPK, 2010, BIOMATERIALS, V31, P8350, DOI 10.1016/j.biomaterials.2010.07.045; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Hagens WI, 2007, REGUL TOXICOL PHARM, V49, P217, DOI 10.1016/j.yrtph.2007.07.006; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Khandoga A, 2004, CIRCULATION, V109, P1320, DOI 10.1161/01.CIR.0000118524.62298.E8; Coradeghini R, 2013, TOXICOL LETT, V217, P205, DOI 10.1016/j.toxlet.2012.11.022; Semmler-Behnke M, 2008, SMALL, V4, P2108, DOI 10.1002/smll.200800922; Xie GP, 2010, ARCH TOXICOL, V84, P183, DOI 10.1007/s00204-009-0488-x; ICRP, 1994, ANN ICRP, V24, P1; Kreyling WG, 2013, ACS NANO, V8, P222; Matsui Y, 2009, SPECTROCHIM ACTA B, V64, P796, DOI 10.1016/j.sab.2009.06.017; OECD, 2009, OECD GUID TEST CHEM; Oyabu T, 2007, INHAL TOXICOL, V19, P55, DOI 10.1080/08958370701492995	17	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					243	249				7	Toxicology	Toxicology	CF4LN	WOS:000352520700009		
J	Le Coz, F; Suzuki, N; Nagahori, H; Omori, T; Saito, K				Le Coz, Florian; Suzuki, Noriyuki; Nagahori, Hirohisa; Omori, Takashi; Saito, Koichi			Hand1-Luc Embryonic Stem Cell Test (Hand1-Luc EST): A novel rapid and highly reproducible in vitro test for embryotoxicity by measuring cytotoxicity and differentiation toxicity using engineered mouse ES cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						In vitro; Embryotoxicity; Differentiation; Reporter gene assay; Luciferase activity; Hand1 gene	TRANSCRIPTION FACTOR HAND1; MOLECULAR MARKERS; VALIDATION; HEART; PREDICTION; CHEMICALS; DEFECTS; LINES; GENE	The embryonic stem cell test (EST) is a promising alternative method for evaluating embryotoxicity of test chemicals by measuring cytotoxicity and differentiation toxicity using mouse ES cells. Differentiation toxicity is analyzed by microscopically counting the beating of embryonic bodies after 10 days of culture. However, improvements are necessary to reduce the laborious manipulations involved and the time required to obtain results. We have previously reported the successful stable transfection of ES cells (ES-D3) with the heart and neural crest derivatives expressed transcript 1 (Hand1) gene and the establishment of a 96-well multi-plate-based new EST with luciferase reporter assay 6 days after treatment with test chemicals. Now, we propose an even more rapid and easier EST, named Hand1-Luc EST. We established another cell line to monitor the Hand1 gene expression via a luciferase reporter gene. By mRNA analysis and luciferase assay, we examined in detail the luciferase activity during cell differentiation, which allowed us to reduce the time of measurement from day 6 to day 5 (120 hr). Furthermore, the protocol was improved, with, among others, the measurement of cytotoxicity and differentiation toxicity taking place in the same 96-well round bottom plate instead of two different plates. With the positive control, 5-fluorouracil (5-FU), and 9 test chemicals, data with high reproducibility and very low variation (CV < 50%) in the relevant endpoints were obtained. This study shows that the Hand1-Luc EST could provide an accurate and sensitive short-term test for prediction of embryotoxicants by measuring cytotoxicity and differentiation toxicity from the same sample.	[Le Coz, Florian; Suzuki, Noriyuki; Nagahori, Hirohisa; Saito, Koichi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, Osaka 5548558, Japan; [Omori, Takashi] Doshisha Univ, Fac Culture & Informat Sci, Epidemiol & Biostat Lab, Kyotanabe, Kyoto 6100394, Japan	Saito, K (reprint author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugadenaka 3 Chome, Osaka 5548558, Japan.	saitok5@sc.sumitomo-chem.co.jp			Ministry of Economy, Trade and Industry (METI) of Japan	This study was supported by a research grant from the Ministry of Economy, Trade and Industry (METI) of Japan. We also would like to thank Mitsuhiro Nishida for his technical support.	Verwei M, 2006, TOXICOL LETT, V165, P79, DOI 10.1016/j.toxlet.2006.01.017; Genschow E, 2002, ATLA-ALTERN LAB ANIM, V30, P151; Riebeling C, 2012, CRIT REV TOXICOL, V42, P443, DOI 10.3109/10408444.2012.674483; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Suzuki N, 2011, TOXICOL SCI, V124, P460, DOI 10.1093/toxsci/kfr250; Scholz G, 1999, TOXICOL IN VITRO, V13, P675, DOI 10.1016/S0887-2333(99)00046-6; Baek DH, 2012, J APPL TOXICOL, V32, P617, DOI 10.1002/jat.1747; Wang QC, 2013, DEV BIOL, V374, P264, DOI 10.1016/j.ydbio.2012.12.007; Buesen R, 2009, TOXICOL SCI, V108, P389, DOI 10.1093/toxsci/kfp012; Suzuki N, 2011, J TOXICOL SCI, V36, P569; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209; Bremer S, 2004, CURR PHARM DESIGN, V10, P2733, DOI 10.2174/1381612043383700; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Brown NA, 2002, ATLA-ALTERN LAB ANIM, V30, P177; Morikawa Y, 2004, DEVELOPMENT, V131, P2195, DOI 10.1242/dev.01091; Barbosa AC, 2007, DEV BIOL, V310, P154, DOI 10.1016/j.ydbio.2007.07.036; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Bremer Susanne, 2005, Altern Lab Anim, V33 Suppl 1, P183; de Jong E, 2012, TOXICOL IN VITRO, V26, P970, DOI 10.1016/j.tiv.2012.05.015; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/3073; Hayess K, 2013, TOXICOLOGY, V314, P135, DOI 10.1016/j.tox.2013.09.012; PACIFICI GM, 1995, CLIN PHARMACOKINET, V28, P235, DOI 10.2165/00003088-199528030-00005; Peters AK, 2008, TOXICOL IN VITRO, V22, P1948, DOI 10.1016/j.tiv.2008.09.008; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Spielmann H, 2006, ALTEX-ALTERN TIEREXP, V23, P57; Suzuki N, 2012, J TOXICOL SCI, V37, P845; zur Nieden NI, 2010, TOXICOLOGY, V277, P66, DOI 10.1016/j.tox.2010.08.016	29	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					251	261				11	Toxicology	Toxicology	CF4LN	WOS:000352520700010		
J	Atobe, T; Mori, M; Yamashita, F; Hashida, M; Kouzuki, H				Atobe, Tomomi; Mori, Masaaki; Yamashita, Fumiyoshi; Hashida, Mitsuru; Kouzuki, Hirokazu			Artificial neural network analysis for predicting human percutaneous absorption taking account of vehicle properties	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Percutaneous absorption; Risk assessment; In silico; Artificial neural network; Vehicle	EXCISED HUMAN-SKIN; HUMAN STRATUM-CORNEUM; HAIRLESS MOUSE SKIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN CADAVER SKIN; IN-VITRO; TRANSDERMAL DELIVERY; PENETRATION ENHANCERS; PROPYLENE-GLYCOL; PARTITION-COEFFICIENT	An in silico method for predicting percutaneous absorption of cosmetic ingredients was developed by using artificial neural network (ANN) analysis to predict the human skin permeability coefficient (log K-p), taking account of the physicochemical properties of the vehicle, and the apparent diffusion coefficient (log D). Molecular weight and octanol-water partition coefficient (log P) of chemicals, and log P of the vehicles, were used as molecular descriptors for predicting log K-p and log D of 359 samples, for which literature values of either or both of log K-p and log D were available. Adaptivity of the ANN model was evaluated in comparison with a multiple linear regression model (MLR) by calculating the root-mean-square (RMS) errors. Accuracy and robustness were confirmed by 10-fold cross-validation. The predictive RMS errors of the ANN model were smaller than those of the MLR model (log K-p; 0.675 vs 0.887, log D; 0.553 vs 0.658), indicating superior performance. The predictive RMS errors for log K-p and log D with the ANN model after 10-fold cross-validation analysis were 0.723 and 0.606, respectively. Moreover, we estimated the cumulative amounts of chemicals permeated into the skin during 24 hr (Q24hr) from the values of log K-p and log D by applying Fick's law of diffusion. Our results suggest that this newly established ANN analysis method, taking account of the property of the vehicle, could contribute to non-animal risk assessment of cosmetic ingredients by providing a tool for calculating Q24hr, which is required for evaluating the margin of safety.	[Atobe, Tomomi; Mori, Masaaki; Kouzuki, Hirokazu] Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Yamashita, Fumiyoshi; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan	Kouzuki, H (reprint author), Shiseido Co Ltd, Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	hirokazu.kouzuki@to.shiseido.co.jp					Anigbogu ANC, 1996, J PHARM PHARMACOL, V48, P357; Vaddi HK, 2003, BIOL PHARM BULL, V26, P220, DOI 10.1248/bpb.26.220; ROBERTS MS, 1977, J PHARM PHARMACOL, V29, P677; Hirota M, 2013, TOXICOL IN VITRO, V27, P1233, DOI 10.1016/j.tiv.2013.02.013; Lim CW, 2002, BIOL PHARM BULL, V25, P361, DOI 10.1248/bpb.25.361; MICHAELS AS, 1975, AICHE J, V21, P985, DOI 10.1002/aic.690210522; Roper CS, 1997, FOOD CHEM TOXICOL, V35, P1009, DOI 10.1016/S0278-6915(97)00109-9; ROY SD, 1995, J PHARM SCI, V84, P1190, DOI 10.1002/jps.2600841010; GALEY WR, 1976, J INVEST DERMATOL, V67, P713, DOI 10.1111/1523-1747.ep12598596; SCOTT RC, 1991, J INVEST DERMATOL, V96, P921, DOI 10.1111/1523-1747.ep12475447; ANDERSON BD, 1988, PHARMACEUT RES, V5, P566, DOI 10.1023/A:1015989929342; BLANK IH, 1967, J INVEST DERMATOL, V49, P582, DOI 10.1038/jid.1967.184; Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007; KADIR R, 1987, J PHARM SCI, V76, P774, DOI 10.1002/jps.2600761004; PARDO A, 1990, J PHARM SCI, V79, P573, DOI 10.1002/jps.2600790705; Ghafourian T, 2010, EUR J PHARM SCI, V41, P612, DOI 10.1016/j.ejps.2010.08.014; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; Yamane MA, 1995, J PHARM PHARMACOL, V47, P978; Effendy I, 1996, BRIT J DERMATOL, V135, P428; Naegel A, 2008, EUR J PHARM BIOPHARM, V68, P368, DOI 10.1016/j.ejpb.2007.05.018; ROY SD, 1990, PHARMACEUT RES, V7, P842, DOI 10.1023/A:1015912932416; BLANK IH, 1985, J INVEST DERMATOL, V85, P522, DOI 10.1111/1523-1747.ep12277325; Rim JE, 2009, ANN BIOMED ENG, V37, P1217, DOI 10.1007/s10439-009-9678-1; BARBER ED, 1992, FUND APPL TOXICOL, V19, P493, DOI 10.1016/0272-0590(92)90086-W; HOLMSTROM L, 1992, IEEE T NEURAL NETWOR, V3, P24, DOI 10.1109/72.105415; AUNGST BJ, 1990, PHARMACEUT RES, V7, P712, DOI 10.1023/A:1015859320604; BARRATT MD, 1995, TOXICOL IN VITRO, V9, P27, DOI 10.1016/0887-2333(94)00190-6; BARRY BW, 1985, J PHARM PHARMACOL, V37, P226; BOND JR, 1988, J INVEST DERMATOL, V90, P486, DOI 10.1111/1523-1747.ep12460958; BOND JR, 1988, J INVEST DERMATOL, V90, P810, DOI 10.1111/1523-1747.ep12462031; BRONAUGH RL, 1984, J INVEST DERMATOL, V83, P124, DOI 10.1111/1523-1747.ep12263302; BRONAUGH RL, 1986, J PHARM SCI, V75, P1094, DOI 10.1002/jps.2600751115; BRONAUGH RL, 1986, BRIT J DERMATOL, V115, P1, DOI 10.1111/j.1365-2133.1986.tb06214.x; Chen LJ, 2007, ACTA PHARMACOL SIN, V28, P591, DOI 10.1111/j.1745-7254.2007.00528.x; CHOWHAN ZT, 1978, J PHARM SCI, V67, P1272, DOI 10.1002/jps.2600670921; Cordero JA, 1997, J PHARM SCI, V86, P503, DOI 10.1021/js950346l; Cross SE, 2003, J INVEST DERMATOL, V120, P759, DOI 10.1046/j.1523-1747.2003.12131.x; DOLEZAL P, 1993, PHARMACEUT RES, V10, P1015, DOI 10.1023/A:1018914806761; DUGARD PH, 1986, INT J PHARM, V28, P219, DOI 10.1016/0378-5173(86)90248-6; HADGRAFT J, 1987, INT J PHARM, V39, P149, DOI 10.1016/0378-5173(87)90210-9; HARRISON SM, 1984, J PHARM PHARMACOL, V36, P261; HILTON J, 1994, PHARMACEUT RES, V11, P1396, DOI 10.1023/A:1018931503784; IDSON B, 1975, J PHARM SCI-US, V64, P901, DOI 10.1002/jps.2600640604; JACQUES SL, 1987, J INVEST DERMATOL, V88, P88, DOI 10.1111/1523-1747.ep12465112; JENNER J, 1995, J PHARM PHARMACOL, V47, P206; JOLICOEUR LM, 1992, PHARMACEUT RES, V9, P963, DOI 10.1023/A:1015877621976; KADIR R, 1989, J PHARM SCI, V78, P149, DOI 10.1002/jps.2600780216; KADIR R, 1988, J PHARM SCI, V77, P409, DOI 10.1002/jps.2600770511; KASTING GB, 1993, J PHARM SCI, V82, P551, DOI 10.1002/jps.2600820525; Kasting GB, 1997, J PHARM SCI, V86, P142, DOI 10.1021/js950484a; KNUTSON K, 1993, J CONTROL RELEASE, V24, P95, DOI 10.1016/0168-3659(93)90170-A; KOCH RL, 1987, J INVEST DERMATOL, V88, P582, DOI 10.1111/1523-1747.ep12470195; Lockley DJ, 2002, TOXICOL APPL PHARM, V180, P74, DOI 10.1006/taap.2002.9373; Magnusson BM, 1997, ACTA DERM-VENEREOL, V77, P264; MCAULIFFE DJ, 1991, J INVEST DERMATOL, V96, P758, DOI 10.1111/1523-1747.ep12471711; Megwa SA, 2000, J PHARM PHARMACOL, V52, P929, DOI 10.1211/0022357001774813; MITRAGOTRI S, 1995, J PHARM SCI, V84, P697, DOI 10.1002/jps.2600840607; OECD, 2013, IS CHICK EYE TEST ME; OECD, 2004, IN VITR 3T3 NRU PHOT, V432; OECD, 2014, IN VITR MAMM CELL MI, V487; OECD, 1997, BACT REV MUT TEST; OECD, 2013, IN VITR SKIN IRR REC; OECD, 2013, BOV CORN OP PERM TES; Organisation for Economic Co-operation and Development (OECD), 2004, SKIN ABS IN VITR MET; PERSHING LK, 1993, PHARMACEUT RES, V10, P1745, DOI 10.1023/A:1018974131236; Pongjanyakul T, 2002, J PHARM PHARMACOL, V54, P1345, DOI 10.1211/002235702760345419; Pugh WJ, 2000, INT J PHARM, V197, P203, DOI 10.1016/S0378-5173(00)00326-4; Ross JS, 2000, J CONTROL RELEASE, V67, P211, DOI 10.1016/S0168-3659(00)00210-8; ROY SD, 1994, J PHARM SCI, V83, P1548, DOI 10.1002/jps.2600831106; ROY SD, 1995, J PHARM SCI, V84, P49, DOI 10.1002/jps.2600840112; ROY SD, 1989, PHARMACEUT RES, V6, P825, DOI 10.1023/A:1015944018555; Saini S., 2010, INT J ENG SCI TECHNO, V2, P1526; SALES OD, 1993, PHARMAZIE, V48, P684; SCCS, 2012, SCCS 17 PLEN M 11 DE; SCHALLA W, 1981, BRIT J DERMATOL, V105, P104, DOI 10.1111/j.1365-2133.1981.tb01022.x; SCHEUPLE.RJ, 1973, J INVEST DERMATOL, V60, P286, DOI 10.1111/1523-1747.ep12723090; SCHEUPLE.RJ, 1971, PHYSIOL REV, V51, P702; SCHEUPLE.RJ, 1965, J INVEST DERMATOL, V45, P334, DOI 10.1038/jid.1965.140; SCHEUPLE.RJ, 1974, J INVEST DERMATOL, V62, P353, DOI 10.1111/1523-1747.ep12701619; SCHEUPLE.RJ, 1969, J INVEST DERMATOL, V52, P63; SCOTT RC, 1988, J PHARM PHARMACOL, V40, P128; SINGH P, 1995, J PHARM SCI, V84, P1342, DOI 10.1002/jps.2600841115; SINGH P, 1994, J PHARMACOL EXP THER, V268, P144; Sznitowska M, 1998, J PHARM SCI, V87, P1109, DOI 10.1021/js980018w; Tenjarla SN, 1996, J PHARM PHARMACOL, V48, P1138; Vaddi HK, 2001, CHEM PHARM BULL, V49, P1395, DOI 10.1248/cpb.49.1395; Venkatapathy R, 2004, J CHEM INF COMP SCI, V44, P1623, DOI 10.1021/ci049903s; Walters KA, 1997, FOOD CHEM TOXICOL, V35, P705, DOI 10.1016/S0278-6915(97)00032-X	88	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	APR	2015	40	2					277	294				18	Toxicology	Toxicology	CF4LN	WOS:000352520700012		
J	Nemoto, M; Morita, Y; Niwa, H; Bannai, H; Tsujimura, K; Yamanaka, T; Kondo, T				Nemoto, Manabu; Morita, Yoshinori; Niwa, Hidekazu; Bannai, Hiroshi; Tsujimura, Koji; Yamanaka, Takashi; Kondo, Takashi			Rapid detection of equine coronavirus by reverse transcription loop-mediated isothermal amplification	JOURNAL OF VIROLOGICAL METHODS			English	Article						Reverse transcription loop-mediated isothermal amplification; Equine coronavirus; RT-PCR; Real-time RT-PCR; Diagnosis	RT-LAMP; ASSAY; HORSES	A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed for the rapid detection of equine coronavirus (ECoV). This assay was conducted at 60 degrees C for 40 min. Specificity the RT-LAMP assay was confirmed using several equine intestinal and respiratory pathogens in addition to ECoV. The novel assay failed to cross-react with the other pathogens tested, suggesting it is highly specific for ECoV. Using artificially synthesized ECoV RNA, the 50% detection limit of the RT-LAMP assay was 10(1.8) copies/reaction. This is a 50-fold greater sensitivity than conventional reverse transcription polymerase chain reaction (RT-PCR) assays, but a 4-fold lower sensitivity than quantitative RT-PCR (qRT-PCR) assays. Eighty-two fecal samples collected during ECoV outbreaks were analyzed. ECoV was detected in 59 samples using the RT-LAMP assay, and in 30 and 65 samples using RT-PCR or qRT-PCR assays, respectively. Although the RT-LAMP assay is less sensitive than qRT-PCR techniques, it can be performed without the need for expensive equipment. Thus, the RT-LAMP assay might be suitable for large-scale surveillance and diagnosis of ECoV infection in laboratories with limited resources. (C) 2015 Elsevier B.V. All rights reserved.	[Nemoto, Manabu; Niwa, Hidekazu; Bannai, Hiroshi; Tsujimura, Koji; Yamanaka, Takashi; Kondo, Takashi] Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, Shimotsuke, Tochigi 3290412, Japan; [Morita, Yoshinori] Tokachi Draft Horse Clin, Obihiro, Hokkaido 0800023, Japan	Nemoto, M (reprint author), Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, 1400-4 Shiba, Shimotsuke, Tochigi 3290412, Japan.	nemoto_manabu@epizoo.equinst.go.jp			Japan Racing Association (Tokyo, Japan)	This study was funded by the Japan Racing Association (Tokyo, Japan). Equine coronavirus strain NC99 was kindly provided by Dr. J. S. Guy of North Carolina State University (Raleigh, NC, USA). The authors are grateful to Mr. Akira Kokubun, Ms. Kaoru Makabe, Ms. Akiko Suganuma, Ms. Kazue Arakawa, and Ms. Maiko Tezuka (Epizootic Research Center, Equine Research Institute, Japan Racing Association) for their invaluable technical assistance.	Guy JS, 2000, J CLIN MICROBIOL, V38, P4523; Li PC, 2011, CURR MICROBIOL, V62, P1074, DOI 10.1007/s00284-010-9825-9; Oue Y, 2013, J VET MED SCI, V75, P1261, DOI 10.1292/jvms.13-0056; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Poon LLM, 2004, CLIN CHEM, V50, P1050, DOI 10.1373/clinchem.2004.032011; Pusterla N, 2013, VET MICROBIOL, V162, P228, DOI 10.1016/j.vetmic.2012.10.014; Ren XF, 2011, VIRUS GENES, V42, P229, DOI 10.1007/s11262-011-0570-3; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Oue Y, 2011, VET MICROBIOL, V150, P41, DOI 10.1016/j.vetmic.2011.01.004; Miszczak F, 2014, VET MICROBIOL, V171, P206, DOI 10.1016/j.vetmic.2014.03.031; Chen Q, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-206; de Groot R.J., 2011, CORONAVIRIDAE, P806; Hanaki KI, 2013, J VIROL METHODS, V187, P222, DOI 10.1016/j.jviromet.2012.10.008; Hong Thi Cam Thai, 2004, J Clin Microbiol, V42, P1956; Magdesian KG, 2014, EQUINE INFECT DIS, V2nd, P198; REED L. J., 1938, AMER JOUR HYG, V27, P493; Narita M., 2011, Journal of the Japan Veterinary Medical Association, V64, P535; Nemoto M, 2010, J VET MED SCI, V72, P823; Nemoto M, 2014, ARCH VIROL, V159, P3329, DOI 10.1007/s00705-014-2205-1; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Pyrc K, 2011, J VIROL METHODS, V175, P133, DOI 10.1016/j.jviromet.2011.04.024; Qiao J, 2012, J VET DIAGN INVEST, V24, P174, DOI 10.1177/1040638711425937; Shirato K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-139	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0934	1879-0984		J VIROL METHODS	J. Virol. Methods	APR	2015	215						13	16		10.1016/j.jviromet.2015.02.001		4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology	CF1TD	WOS:000352329900003		
J	Kobayashi, A; Parchi, P; Yamada, M; Brown, P; Saverioni, D; Matsuura, Y; Takeuchi, A; Mohri, S; Kitamoto, T				Kobayashi, Atsushi; Parchi, Piero; Yamada, Masahito; Brown, Paul; Saverioni, Daniela; Matsuura, Yuichi; Takeuchi, Atsuko; Mohri, Shirou; Kitamoto, Tetsuyuki			Transmission Properties of Atypical Creutzfeldt-Jakob Disease: a Clue to Disease Etiology?	JOURNAL OF VIROLOGY			English	Article							GERSTMANN-STRAUSSLER-SYNDROME; PRION PROTEIN; SPONGIFORM ENCEPHALOPATHY; AGENT; SCRAPIE; STRAINS; CJD; CLASSIFICATION; DISINFECTION; INACTIVATION	The genotype at polymorphic codon 129 of the PRNP gene has a profound influence on both phenotypic expression and prion strain susceptibility in humans. For example, while the most common sporadic Creutzfeldt-Jakob disease (CJD) subtype, sporadic CJD-MM1 (M1 strain), induces a single phenotype after experimental transmission regardless of the codon 129 genotype of the recipient animal, the phenotype elicited by sporadic CJD-VV2 (V2 strain), the second most common subtype, varies according to the host codon 129 genotype. In particular, the propagation of the V2 strain in codon 129 methionine homozygotes has been linked only to acquired forms of CJD such as plaque-type dura mater graft-associated CJD (dCJD), a subgroup of iatrogenic CJD with distinctive phenotypic features, but has never been observed in sporadic CJD cases. In the present report, we describe atypical CJD cases carrying codon 129 methionine homozygosity, in a neurosurgeon and in a patient with a medical history of neurosurgery without dural grafting, showing the distinctive phenotypic features and transmission properties of plaque-type dCJD. These findings raise the possibility that the two cases, previously thought to represent sporadic CJD, might actually represent acquired CJD caused by infection with the V2 strain. Thus, careful analyses of phenotypic features and transmission properties in atypical cases may be useful to distinguish acquired from sporadic cases of CJD. IMPORTANCE Susceptibility to and phenotypic expression of Creutzfeldt-Jakob disease (CJD) depend on both the prion strain and genotype at polymorphic codon 129 of the PRNP gene. For example, propagation of the second most common sporadic CJD strain (V2 strain) into codon 129 methionine homozygotes has been linked to plaque-type dura mater graft-associated CJD (dCJD), a subgroup of iatrogenic CJD with distinctive phenotypic features, but has never been observed in sporadic CJD. In the present report, we describe atypical CJD cases in a neurosurgeon and in a patient with a medical history of neurosurgery without dural grafting, showing the distinctive phenotypic features and transmission properties of plaque-type dCJD. These findings raise the possibility that the two cases, previously considered to represent sporadic CJD, might actually represent acquired CJD caused by infection with the V2 strain.	[Kobayashi, Atsushi; Takeuchi, Atsuko; Mohri, Shirou; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi 980, Japan; [Parchi, Piero] IRCCS, Ist Sci Neurol, Bologna, Italy; [Parchi, Piero; Saverioni, Daniela] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Brown, Paul] LFB, Les Ulis, France; [Matsuura, Yuichi] Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan	Kitamoto, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi 980, Japan.	kitamoto@med.tohoku.ac.jp	Parchi, Piero/L-9833-2015	Parchi, Piero/0000-0002-9444-9524	Ministry of Health, Labor and Welfare of Japan; JSPS; MEXT for the Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University; MEXT; Research Committee of Surveillance and Infection Control of Prion Disease, the Ministry of Health, Labor and Welfare of Japan	This study was supported by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (A.K. and S.M.), Grants-in-Aid for Scientific Research from JSPS (A.K. and T.K.), a grant from MEXT for the Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University (T.K.), and a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) from MEXT (T.K.). Research for development of decontamination/disinfection procedures against various sCJD subgroups has been supported by a Grant-in-Aid from the Research Committee of Surveillance and Infection Control of Prion Disease, the Ministry of Health, Labor and Welfare of Japan (T.K.).	Alcalde-Cabero E, 2012, EURO SURVEILL, V17; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; NEVIN S, 1960, BRAIN, V83, P519, DOI 10.1093/brain/83.4.519; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; SCHOENE WC, 1981, ARCH NEUROL-CHICAGO, V38, P473; TATEISHI J, 1991, MICROBIOL IMMUNOL, V35, P163; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; KIMBERLIN RH, 1983, J NEUROL SCI, V59, P355, DOI 10.1016/0022-510X(83)90021-7; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; BROWN P, 1982, NEW ENGL J MED, V306, P1279, DOI 10.1056/NEJM198205273062107; DELISLE MB, 1993, REV NEUROL, V149, P524; DEVILLEMEUR TB, 1994, NEUROPATH APPL NEURO, V20, P111; DOHURA K, 1991, NATURE, V353, P801, DOI 10.1038/353801b0; ElHachimi KH, 1997, CR ACAD SCI III-VIE, V320, P319, DOI 10.1016/S0764-4469(97)82774-6; Foncin JF, 1980, REV NEUROL PARIS, V136, P280; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Hamaguchi T, 2009, EMERG INFECT DIS, V15, P265, DOI 10.3201/eid1502.080749; Ishida C, 2003, NEUROLOGY, V60, P514; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Kobayashi A, 2010, J VIROL, V84, P3230, DOI 10.1128/JVI.02387-09; Kobayashi Atsushi, 2013, Acta Neuropathol Commun, V1, P74, DOI 10.1186/2051-5960-1-74; Kobayashi Atsushi, 2014, Acta Neuropathol Commun, V2, P32, DOI 10.1186/2051-5960-2-32; Kobayashi A, 2009, NEUROPATHOLOGY, V29, P619, DOI 10.1111/j.1440-1789.2008.00973.x; Muramoto T, 2000, NEUROSCI LETT, V288, P179, DOI 10.1016/S0304-3940(00)01232-5; Noguchi-Shinohara M, 2007, NEUROLOGY, V69, P360, DOI 10.1212/01.wnl.0000266624.63387.4a; PALMER MS, 1993, HUM MOL GENET, V2, P541, DOI 10.1093/hmg/2.5.541; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; TAGUCHI F, 1991, ARCH VIROL, V119, P297, DOI 10.1007/BF01310679; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; Yamada M, 2009, NEUROPATHOLOGY, V29, P609, DOI 10.1111/j.1440-1789.2008.00987.x	36	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2015	89	7					3939	3946		10.1128/JVI.03183-14		8	Virology	Virology	CF0ER	WOS:000352216100038		
J	Yamaji, R; Yamada, S; Le, MQ; Li, CJ; Chen, HL; Qurnianingsih, E; Nidom, CA; Ito, M; Sakai-Tagawa, Y; Kawaoka, Y				Yamaji, Reina; Yamada, Shinya; Le, Mai Q.; Li, Chengjun; Chen, Hualan; Qurnianingsih, Ema; Nidom, Chairul A.; Ito, Mutsumi; Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro			Identification of PB2 Mutations Responsible for the Efficient Replication of H5N1 Influenza Viruses in Human Lung Epithelial Cells	JOURNAL OF VIROLOGY			English	Article							TO-PERSON TRANSMISSION; RECEPTOR SPECIFICITY; CAP-BINDING; A VIRUSES; ADAPTIVE MUTATIONS; RNA-POLYMERASE; HUMAN AIRWAY; AMINO-ACIDS; PA SUBUNIT; MICE	Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poultry worldwide, resulting in sporadic infections in humans with approximately 60% mortality. However, efficient transmission of H5N1 viruses among humans has yet to occur, suggesting that further adaptation of H5N1 viruses to humans is required for their efficient transmission among humans. The viral determinants for efficient replication in humans are currently poorly understood. Here, we report that the polymerase PB2 protein of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010, virus 36285) increased the growth ability of an avian H5N1 virus (A/wild bird/Anhui/82/2005, virus Wb/AH82) in human lung epithelial A549 cells (however, the reassortant virus did not replicate more efficiently than human 36285 virus). Furthermore, we demonstrate that the amino acid residues at positions 249, 309, and 339 of the PB2 protein from this human isolate were responsible for its efficient replication in A549 cells. PB2 residues 249G and 339M, which are found in the human H5N1 virus, are rare in H5N1 viruses from both human and avian sources. Interestingly, PB2-249G is found in over 30% of human seasonal H3N2 viruses, which suggests that H5N1 viruses may replicate well in human cells when they acquire this mutation. Our data are of value to H5N1 virus surveillance. IMPORTANCE Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overcome the species barrier between avian species and humans. When H5N1 viruses replicate in human respiratory cells, they can acquire amino acid mutations that allow them to adapt to humans through continuous selective pressure. Several amino acid mutations have been shown to be advantageous for virus adaptation to mammalian hosts. Here, we found that amino acid changes at positions 249, 309, and 339 of PB2 contribute to efficient replication of avian H5N1 viruses in human lung cells. These findings are beneficial for evaluating the pandemic risk of circulating avian viruses and for further functional analysis of PB2.	[Yamaji, Reina; Yamada, Shinya; Ito, Mutsumi; Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Le, Mai Q.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Li, Chengjun; Chen, Hualan] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China; [Qurnianingsih, Ema; Nidom, Chairul A.] Airlangga Univ, Avian Influenza Res Ctr, Surabaya, Indonesia; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Dept Pathobiol Sci, Sch Vet Med, Madison, WI USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Special Pathogens, Int Res Ctr Infect Dis, Tokyo, Japan	Yamada, S (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan.	shinya@ims.u-tokyo.ac.jp; kawaoka@ims.u-tokyo.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by grants-in-aid from the Ministry of Health, Labor and Welfare, Japan, and by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).	Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Kim JH, 2010, J GEN VIROL, V91, P1284, DOI 10.1099/vir.0.018143-0; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827; Beigel H, 2005, NEW ENGL J MED, V353, P1374; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Hu J, 2013, J VIROL, V87, P11063, DOI 10.1128/JVI.00760-13; Kurihara T., 2009, Kawasaki Medical Journal, V35, P307; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; REED L. J., 1938, AMER JOUR HYG, V27, P493; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	47	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2015	89	7					3947	3956		10.1128/JVI.03328-14		10	Virology	Virology	CF0ER	WOS:000352216100039		
J	Yoshikawa, R; Okamoto, M; Sakaguchi, S; Nakagawa, S; Miura, T; Hirai, H; Miyazawa, T				Yoshikawa, Rokusuke; Okamoto, Munehiro; Sakaguchi, Shoichi; Nakagawa, So; Miura, Tomoyuki; Hirai, Hirohisa; Miyazawa, Takayuki			Simian Retrovirus 4 Induces Lethal Acute Thrombocytopenia in Japanese Macaques	JOURNAL OF VIROLOGY			English	Article							AMINO-ACID TRANSPORTER; VIRUS; INFECTION; RECEPTOR; DISEASE; MODELS; FELINE; CELLS; ASCT1; CATS	In 2001-2002, six of seven Japanese macaques (Macaca fuscata) died after developing hemorrhagic syndrome at the Kyoto University Primate Research Institute (KUPRI). While the cause of death was unknown at the time, we detected simian retrovirus 4 (SRV-4) in samples obtained from a similar outbreak in 2008-2011, during which 42 of 43 Japanese macaques died after exhibiting hemorrhagic syndrome. In this study, we isolated SRV-4 strain PRI-172 from a Japanese macaque showing severe thrombocytopenia. When inoculated into four Japanese macaques, the isolate induced severe thrombocytopenia in all within 37 days. We then constructed an infectious molecular clone of strain PRI-172, termed pSR415, and inoculated the clone-derived virus into two Japanese macaques. These animals also developed severe thrombocytopenia in just 31 days after inoculation, and the virus was reisolated from blood, bone marrow, and stool. At necropsy, we observed bleeding from the gingivae and subcutaneous bleeding in all animals. SRV-4 infected a variety of tissues, especially in digestive organs, including colon and stomach, as determined by real-time reverse transcription-PCR (RT-PCR) and immunohistochemical staining. Furthermore, we identified the SRV-4 receptor as ASCT2, a neutral amino acid transporter. ASCT2 mRNA was expressed in a variety of tissues, and the distribution of SRV-4 proviruses in infected Japanese macaques correlated well with the expression levels of ASCT2 mRNA. From these results, we conclude that the causative agent of hemorrhagic syndrome in KUPRI Japanese macaques was SRV-4, and its receptor is ASCT2. IMPORTANCE During two separate outbreaks at the KUPRI, in 2001-2002 and 2008-2011, 96% of Japanese macaques (JM) that developed an unknown hemorrhagic syndrome died. Here, we isolated SRV-4 from a JM developing thrombocytopenia. The SRV-4 isolate and a molecularly cloned SRV-4 induced severe thrombocytopenia in virus-inoculated JMs within 37 days. At necropsy, we observed bleeding from gingivae and subcutaneous bleeding in all affected JMs and reisolated SRV-4 from blood, bone marrow, and stool. The distribution of SRV-4 proviruses in tissues correlated with the mRNA expression levels of ASCT2, which we identified as the SRV-4 receptor. From these results, we conclude that SRV-4 was the causative agent of hemorrhagic syndrome in JMs in KUPRI.	[Yoshikawa, Rokusuke; Sakaguchi, Shoichi; Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Lab Signal Transduct, Kyoto 606, Japan; [Yoshikawa, Rokusuke; Sakaguchi, Shoichi; Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Virol Lab, Kyoto 606, Japan; [Miura, Tomoyuki] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Lab Primate Model, Kyoto 606, Japan; [Okamoto, Munehiro] Kyoto Univ, Ctr Human Evolut Modeling Res, Inuyama, Aichi, Japan; [Hirai, Hirohisa] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Mol Biol Sect, Inuyama, Aichi 484, Japan; [Nakagawa, So] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan	Okamoto, M (reprint author), Kyoto Univ, Ctr Human Evolut Modeling Res, Inuyama, Aichi, Japan.	mokamoto@pri.kyoto-u.ac.jp; takavet@gmail.com	Nakagawa, So/Q-2712-2015	Nakagawa, So/0000-0003-1760-3839	Ministry of Health, Labor and Welfare of Japan [H25-shinkou-ippan-0081]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24300153, 25891023]; Kurata Memorial Hitachi Science and Technology Foundation;  [12J05135]	This work was supported in part by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan (grant H25-shinkou-ippan-0081), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (research project no. 24300153 and no. 25891023), and from The Kurata Memorial Hitachi Science and Technology Foundation. R.Y. was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows (research project no. 12J05135).	Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; Sakaguchi S, 2008, J VET MED SCI, V70, P785, DOI 10.1292/jvms.70.785; COSSET FL, 1995, J VIROL, V69, P7430; STRATTON MR, 1989, CARCINOGENESIS, V10, P899; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Committee on Disease Control Primate Research Institute & University K, 2010, PRIMATE RES, V26, P69, DOI [10.2354/psj.2326.2369, DOI 10.2354/PSJ.2326.2369]; Diehl WE, 2008, J VIROL, V82, P11140, DOI 10.1128/JVI.00269-08; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Fujimto K, 2010, COMPARATIVE MED, V60, P51; FULTZ PN, 1994, VIRUS RES, V32, P205, DOI 10.1016/0168-1702(94)90042-6; Gautam R, 2011, J VIROL, V85, P5889, DOI 10.1128/JVI.02523-10; Isa T, 2009, EXP ANIM TOKYO, V58, P451, DOI 10.1538/expanim.58.451; Kawamoto Y, 2007, PRIMATES, V48, P27, DOI 10.1007/s10329-006-0013-2; Lerche Nicholas W., 2003, Toxicologic Pathology, V31, P103, DOI 10.1080/01926230390174977; MARRACCI GH, 1995, J VIROL, V69, P2621; MARX PA, 1984, SCIENCE, V223, P1083, DOI 10.1126/science.6695196; Montiel NA, 2010, J MED PRIMATOL, V39, P303, DOI 10.1111/j.1600-0684.2010.00412.x; MULLINS JI, 1989, VET IMMUNOL IMMUNOP, V21, P25, DOI 10.1016/0165-2427(89)90127-X; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; Tailor CS, 1999, J VIROL, V73, P4470; Yoshikawa R, 2012, J GEN VIROL, V93, P603, DOI 10.1099/vir.0.036228-0; Yoshikawa Y, 2010, LABIO, V21, P11	26	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2015	89	7					3965	3975		10.1128/JVI.03611-14		11	Virology	Virology	CF0ER	WOS:000352216100041		
J	Amako, Y; Munakata, T; Kohara, M; Siddiqui, A; Peers, C; Harris, M				Amako, Yutaka; Munakata, Tsubasa; Kohara, Michinori; Siddiqui, Aleem; Peers, Chris; Harris, Mark			Hepatitis C Virus Attenuates Mitochondrial Lipid beta-Oxidation by Downregulating Mitochondrial Trifunctional-Protein Expression	JOURNAL OF VIROLOGY			English	Article							ANTIVIRAL SIGNALING PROTEIN; INSULIN-RESISTANCE; CELL-CULTURE; INFECTION; GENOME; ACCUMULATION; REPLICATION; METABOLISM; STEATOSIS; PARTICLES	The course of hepatitis C virus (HCV) infection and disease progression involves alterations in lipid metabolism, leading to symptoms such as hypocholesterolemia and steatosis. Steatosis can be induced by multiple mechanisms, including increases in lipid biosynthesis and uptake, impaired lipoprotein secretion, and/or attenuation of lipid beta-oxidation. However, little is known about the effects of HCV on lipid beta-oxidation. A previous proteomics study revealed that HCV interacted with both the alpha- and beta-subunits of the mitochondrial trifunctional protein (MTP), an enzyme complex which catalyzes the last 3 steps of mitochondrial lipid beta-oxidation for cellular energy production. Here we show that in HCV-infected Huh7.5 cells, lipid beta-oxidation was significantly attenuated. Consistently with this, MTP protein and mRNA levels were suppressed by HCV infection. A loss-of-function study showed that MTP depletion rendered cells less responsive to alpha interferon (IFN-alpha) treatment by impairing IFN-stimulated gene expression. These aspects of host-virus interaction explain how HCV alters host energy homeostasis and how it may also contribute to the establishment of persistent infection in the liver. IMPORTANCE HCV infection triggers metabolic alterations, which lead to significant disease outcomes, such as fatty liver (steatosis). This study revealed that HCV impairs mitochondrial lipid beta-oxidation, which results in low lipid combustion. On the other hand, the HCV-induced defects in metabolic status played an important role in the control of the type I interferon system. Under the conditions of impaired lipid beta-oxidation, host cells were less responsive to the ability of exogenously added IFN-alpha to suppress HCV replication. This suggests that interference with lipid beta-oxidation may assist the virus in the establishment of a long-term, persistent infection. Further understanding of this aspect of virus-host interaction may lead to improvements in the current standard therapy.	[Amako, Yutaka; Harris, Mark] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Peers, Chris] Univ Leeds, Fac Med & Hlth, Leeds, W Yorkshire, England; [Munakata, Tsubasa; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Siddiqui, Aleem] Univ Calif San Diego, Div Infect Dis, Dept Med, San Diego, CA 92103 USA	Amako, Y (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan.	amako-yt@igakuken.or.jp; m.harris@leeds.ac.uk			Wellcome Trust [090805]; European Commission [304072 HCVFAO FP7-PEOPLE-2011-CIG]	This study was supported by a grant to M.H. and C.P. from the Wellcome Trust (grant 090805). Y.A. was the recipient of a Marie Curie Career Integration Grant (304072 HCVFAO FP7-PEOPLE-2011-CIG) from the European Commission.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09; Bose SK, 2014, J VIROL, V88, P4195, DOI 10.1128/JVI.03327-13; Sanyal AJ, 2011, LIVER INT, V31, P23, DOI 10.1111/j.1478-3231.2010.02397.x; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Cloonan SM, 2013, CURR OPIN MICROBIOL, V16, P327, DOI 10.1016/j.mib.2013.05.005; Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590; Ramiere C, 2014, J VIROL, V88, P3246, DOI 10.1128/JVI.02862-13; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Gelman MA, 2011, TRENDS MOL MED, V17, P34, DOI 10.1016/j.molmed.2010.10.005; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Rector RS, 2008, ADV DRUG DELIVER REV, V60, P1488, DOI 10.1016/j.addr.2008.04.014; Sato C, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-112; Venegas V, 2011, CURR PROTOC HUM GENE	46	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2015	89	8					4092	4101		10.1128/JVI.01653-14		10	Virology	Virology	CF0FL	WOS:000352218400007		
J	Yamaji, R; Yamada, S; Le, MQ; Ito, M; Sakai-Tagawa, Y; Kawaoka, Y				Yamaji, Reina; Yamada, Shinya; Le, Mai Q.; Ito, Mutsumi; Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro			Mammalian Adaptive Mutations of the PA Protein of Highly Pathogenic Avian H5N1 Influenza Virus	JOURNAL OF VIROLOGY			English	Article							TO-PERSON TRANSMISSION; A VIRUS; PANDEMIC H1N1; INCREASED VIRULENCE; POLYMERASE COMPLEX; HOST ADAPTATION; AMINO-ACIDS; MICE; SUBUNIT; PB2	Highly pathogenic H5N1 influenza A viruses continue to circulate among avian species and cause sporadic cases of human infection. Therefore, the threat of a pandemic persists. However, the human cases of H5N1 infection have been limited mainly to individuals in close contact with infected poultry. These findings suggest that the H5N1 viruses need to acquire adaptive mutations to gain a replicative advantage in mammalian cells to break through the species barrier. Many amino acid mutations of the polymerase complex have been reported to enhance H5N1 virus growth in mammalian cells; however, the mechanism for H5N1 virus of adaptation to humans remains unclear. Here, we propose that the PA of an H5N1 influenza virus isolated from a human in Vietnam (A/Vietnam/UT36285/2010 [36285]) increased the ability of an avian H5N1 virus (A/chicken/Vietnam/TY31/2005 [Ck/TY31]) to grow in human lung epithelial A549 cells. The five PA amino acid substitutions V44I, V127A, C241Y, A343T, and I573V, which are rare in H5N1 viruses from human and avian sources, enhanced the growth capability of this virus in A549 cells. Moreover, these mutations increased the pathogenicity of the virus in mice, suggesting that they contribute to adaptation to mammalian hosts. Intriguingly, PA-241Y, which 36285 encodes, is conserved in more than 90% of human seasonal H1N1 viruses, suggesting that PA-241Y contributes to virus adaptation to human lung cells and mammalian hosts. IMPORTANCE Many amino acid substitutions in highly pathogenic H5N1 avian influenza viruses have been shown to contribute to adaptation to mammalian hosts. However, no naturally isolated H5N1 virus has caused extensive human-to-human transmission, suggesting that additional, as-yet unidentified amino acid mutations are needed for adaptation to humans. Here, we report that five amino acid substitutions in PA (V44I, V127A, C241Y, A343T, and I573V) contribute to the replicative efficiency of H5N1 viruses in human lung cells and to high virulence in mice. These results are helpful for assessing the pandemic risk of isolates and further our understanding of the mechanism of H5N1 virus adaptation to mammalian hosts.	[Yamaji, Reina; Yamada, Shinya; Ito, Mutsumi; Sakai-Tagawa, Yuko; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo, Japan; [Le, Mai Q.] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo, Japan	Yamada, S (reprint author), Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo, Japan.	shinya@ims.u-tokyo.ac.jp; kawaoka@ims.u-tokyo.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by grants in aid from the Ministry of Health, Labor, and Welfare, Japan.	Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Hu J, 2013, J VIROL, V87, P2660, DOI 10.1128/JVI.02891-12; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Kim JH, 2010, J GEN VIROL, V91, P1284, DOI 10.1099/vir.0.018143-0; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827; Beigel H, 2005, NEW ENGL J MED, V353, P1374; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; REED L. J., 1938, AMER JOUR HYG, V27, P493; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; SanzEzquerro JJ, 1996, J VIROL, V70, P1905; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhu WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033383	39	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	APR	2015	89	8					4117	4125		10.1128/JVI.03532-14		9	Virology	Virology	CF0FL	WOS:000352218400009		
J	Mautner, E; Ashida, C; Greimel, E; Lang, U; Kolman, C; Alton, D; Inoue, W				Mautner, Eva; Ashida, Chie; Greimel, Elfriede; Lang, Uwe; Kolman, Christina; Alton, Daniela; Inoue, Wataru			How Do Mothers of Japan and Austria Differentiate in Quality of Life and Depression? Results from a Cross-Cultural Health Outcomes Survey	JOURNAL OF WOMENS HEALTH			English	Meeting Abstract									[Mautner, Eva] Dept Obstet & Gynaecol, Graz, Styria, Austria; [Ashida, Chie] Shujitsu Univ, Fac Educ, Okayama, Okayama, Japan; [Greimel, Elfriede; Lang, Uwe; Kolman, Christina; Alton, Daniela] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Styria, Austria; [Inoue, Wataru] Hiroshima Univ, Grad Sch Educ, Hiroshima, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	APR 1	2015	24	4				P76	29	30				2	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	CF5YE	WOS:000352632500077		
J	Zhao, YK; Wang, ZH; Iida, I; Huang, RF; Lu, JX; Jiang, JH				Zhao, Youke; Wang, Zhihui; Iida, Ikuho; Huang, Rongfeng; Lu, Jianxiong; Jiang, Jinghui			Studies on pre-treatment by compression for wood drying I: effects of compression ratio, compression direction and compression speed on the reduction of moisture content in wood	JOURNAL OF WOOD SCIENCE			English	Article						Pre-treatment; Compression; Wood drying; Moisture content	PRECOMPRESSED WOOD; LIQUID PENETRATION; RECOVERY; WATER	To remarkably reduce the moisture content (MC) in a short time, pre-treatment by compression for wood drying was systematically studied in terms of effects of compression ratio, compression direction and compression speed on the reduction of MC in Poplar and Chinese fir. The results showed (1) MC reduction was about 108 and 176 % after compression at a ratio of 60 % from water-saturated condition, and it was about 1.8 and 3.0 % every 1 % compression ratio for Poplar and Chinese fir, respectively. (2) Compressions in tangential, radial and 45A degrees direction were very effective in MC reduction, suggesting that pre-treatment by compression is very effective on round wood and timbers of flat grain, vertical grain and in-between vertical and flat grain. Of all the compression directions, the tangential compression showed a maximum MC reduction. (3) For Poplar, when the compression speed was 0.5, 1 and 3 mm/min, MC reduction had no big change; while it became small when the compression speed was 5 and 10 mm/min. For Chinese fir, reduction of MC decreased with the increase in compression speed. After all, the pre-treatment by compression is very effective to reduce the MC for wood drying.	[Zhao, Youke; Wang, Zhihui; Huang, Rongfeng; Lu, Jianxiong; Jiang, Jinghui] Chinese Acad Forestry, Res Inst Wood Ind, Beijing 100091, Peoples R China; [Iida, Ikuho] Kyoto Prefectural Univ, Lab Wood Technol, Sakyo Ku, Kyoto 6068522, Japan	Jiang, JH (reprint author), Chinese Acad Forestry, Res Inst Wood Ind, Dong Xiao Fu 1, Beijing 100091, Peoples R China.	jiangjh@caf.ac.cn			948 Project [2011-4-19]	This work was funded by the 948 Project (2011-4-19).	Cech M. Y., 1971, Forest Products Journal, V21, P41; IIDA I, 1984, MOKUZAI GAKKAISHI, V30, P354; Iida I, 2002, J WOOD SCI, V48, P81, DOI 10.1007/BF00766243; Iida I, 1998, MOKUZAI KOGYO, V53, P446; Iida I, 1998, MOKUZAI KOGYO, V53, P298; Iida I, 1981, NIHON REOROJI GAKK, V9, P162; IIDA I, 1992, MOKUZAI GAKKAISHI, V38, P233; Iida I, 1996, MOKUZAI GAKKAISHI, V42, P581; Imamura Y, 1992, MOKUZAI HOZON, V18, P31; Jiang Z, 2008, WOOD STRUCTURES THEI, P81; Kevin AF, 1995, WOOD FIBER SCI, V27, P278; Liu P, 1997, PROPERTIES WOOD PLAN, P5; Norimoto M, 1984, MOKUZAI KOGYO, V39, P9; Norimoto M, 1980, NIHON REOROJI GAKK, V8, P166; Watanabe U, 1998, J WOOD SCI, V44, P158, DOI 10.1007/BF00526263; Zhao Y, 2004, S 22 ANN M JAP WOOD, P105; Zhao You-ke, 2012, Forestry Studies in China, V14, DOI 10.1007/s11632-012-0201-7	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					113	119		10.1007/s10086-014-1451-x		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200002		
J	Matsuda, Y; Fujiwara, Y; Fujii, Y				Matsuda, Yosuke; Fujiwara, Yuko; Fujii, Yoshihisa			Observation of machined surface and subsurface structure of hinoki (Chamaecyparis obtusa) produced in slow-speed orthogonal cutting using X-ray computed tomography	JOURNAL OF WOOD SCIENCE			English	Article						Chip type; Orthogonal cutting; Surface quality; X-ray computed tomography	VENEER-FORMATION PROCESS; STRESS	X-ray computed tomography (CT) was applied to non-destructive observation of machined surface and subsurface structure of hinoki (Chamaecyparis obtusa) produced in slow-speed orthogonal cutting. The cutting experiments were conducted under several cutting conditions and the chip formations were observed with a high-speed camera to be classified into four chip types. The difference in the quality of the machined surfaces produced in four types of chip formation was investigated. During type 0 chip formation, the workpiece was cut almost exactly at the path of the cutting edge, so no deformation was found on and beneath the machined surface. During type I chip formation, the direction of the fore-split, which is dependent on the arrangement of cells, determined the machined surface. During type II chip formation, the cutting tool sometimes tore part of the workpiece below the path of the cutting edge and the tore part was then compressed by the tool, remaining on the machined surface. During type III chip formation, part of the workpiece above the path of the cutting edge was compressed by the tool, instead of being removed as a chip, so the compression occurred in wide area. The relationship between the formation of the machining defects such as torn grain or the compressed cells and the way chip is separated, deformed, or removed was clarified in this study.	[Matsuda, Yosuke; Fujiwara, Yuko; Fujii, Yoshihisa] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Kyoto 6068502, Japan	Matsuda, Y (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, S-220 Nougakubu Sougohkan,Kitashirawakaoiwake Cho, Kyoto, Kyoto 6068502, Japan.	yosuke@h3news1.kais.kyoto-u.ac.jp					STEWART HA, 1982, WOOD SCI, V14, P106; Franz N. C., 1955, Forest Products Journal, V5, P332; Franz NC, 1958, THESIS U MICHIGAN US; Hayashi D, 1970, MOKUZAI GAKKAISHI, V16, P70; Hoadley R. B., 1968, Forest Products Journal, V18, P48; Inoue H., 1979, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V25, P22; KINOSHITA N, 1984, MOKUZAI GAKKAISHI, V30, P32; KINOSHITA N, 1983, MOKUZAI GAKKAISHI, V29, P877; Kuljich S, 2013, J WOOD SCI, V59, P185, DOI 10.1007/s10086-012-1318-y; McKenzie WM, 1967, P 2 INT WOOD MACH SE, P3; MCKENZIE WM, 1975, WOOD SCI TECHNOL, V9, P213; McKenzie W. M., 1966, Forest Products Journal, V16, P35; Mckenzie W. M., 1969, Forest Products Journal, V19, P43; Palka L. C., 1975, Wood Science, V8, P97; Scholz F, 2001, P 15 INT WOOD MACH S, P419; Stewart H. A., 1971, Wood Science, V3, P193; Sugiyama S., 1975, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V21, P15	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					128	135		10.1007/s10086-014-1457-4		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200004		
J	Ebe, K; Sekino, N				Ebe, Kenichi; Sekino, Noboru			Surface deterioration of wood plastic composites under outdoor exposure	JOURNAL OF WOOD SCIENCE			English	Article						WPCs; Outdoor exposure; Polyethylene carbonyl index; Chalking; Weather factor	FLOUR	Outdoor exposure tests of wood plastic composites (WPCs) were conducted at seven sites in Japan. The tests examined the process of chalking on the surface of the WPCs and the weather factors affecting chalking. Observations using a scanning electron microscope and a polarization optical microscope (POM), analyses of Fourier transform infrared spectroscopy, as well as differential scanning calorimetry showed that the deterioration of both wood and polyolefin elements occurs on the surface of WPCs. The POM observations revealed that surface sanding of WPCs in the manufacturing process promoted more chalking. Furthermore, it became clear that among the weather conditions studied, temperature and global solar radiation had the greatest influence on chalking, as determined from the results of single regression analysis.	[Ebe, Kenichi; Sekino, Noboru] Iwate Univ, Morioka, Iwate 0208550, Japan; [Ebe, Kenichi] Yamagata Res Inst Technol, Yamagata 9902473, Japan	Ebe, K (reprint author), Yamagata Res Inst Technol, 2-2-1 Matsuei, Yamagata 9902473, Japan.	ebek@pref.yamagata.jp; sekino@iwate-u.ac.jp			Council of Promotion for Industrial Technology Collaboration, Nanotechnology and Materials committee, Polymer subcommittee	This study was supported by the Council of Promotion for Industrial Technology Collaboration, Nanotechnology and Materials committee, Polymer subcommittee. The authors wish to thank Mr. Akihiro Oishi of National Institute of Advanced Industrial Science and Technology for the measurement of the FT-IR spectra of PE-CI, and Dr. Takashi Kuriyama of Yamagata University for valuable discussions and his assistance in taking the POM images. We express our gratitude to Dr. Koetsu Takahashi of Yamagata University and Dr. Hisayoshi Kofujita of Iwate University for their valuable comments. We also thank Mr. Katsumi Konno and Mr. Takashi Oichi of Hokkaido Research Organization Industrial Technology Research Department, Dr. Takeshi Yasuda and Dr. Kenichi Shimizu of Tokyo Metropolitan Industrial Technology Research Institute, Mr. Wataru Mizuno of Toyama Industrial Technology Center, Mr. Kimitaka Tahira of Hiroshima Prefectural Technology Research Institute Western Region Industrial Research Center, Dr. Nozomu Tsuruta of Kochi Prefectural Industrial Technology Center, and Mr. Shingo Hamayama of Miyazaki Prefecture Industrial Technology Center, for their cooperation in the outdoor exposure tests.	Kojima Y, 2012, J WOOD SCI, V58, P525, DOI 10.1007/s10086-012-1287-1; Rowell RM, 2007, J POLYM ENVIRON, V15, P229, DOI 10.1007/s10924-007-0069-0; Sekino N, 2014, J WOOD SCI, V60, P141, DOI 10.1007/s10086-013-1384-9; Stark NM, 2006, J APPL POLYM SCI, V100, P3131, DOI 10.1002/app.23035; [Anonymous], 2009, 4002 JWTCS; Kiguchi M, 2007, J WOOD SCI, V53, P234, DOI 10.1007/s10086-006-0838-8; Pendleton DE, 2002, FOREST PROD J, V52, P21; [Anonymous], 2009, 4001 JWTCS; Stark NM, 2006, POLYM DEGRAD STABIL, V91, P3048, DOI 10.1016/j.polymdegradstab.2006.08.003; Stark NM, 2007, POLYM DEGRAD STABIL, V92, P1883, DOI 10.1016/j.polymdegradstab.2007.06.017; Kiguchi M, 2011, P 5 INT WOOD FIBR PO, P1; Kiguchi M, 2010, MOKUZAI HOZON, V36, P150; Kiguchi M, 2010, MOKUZAI HOZON, V36, P52; Kikuchi T, 2012, MOKUZAI KOGYO, V67, P475; Kojima Y, 2011, J WOOD SCI, V57, P408, DOI 10.1007/s10086-011-1197-7; Konno K, 2010, REPORTS HOKKAIDO RES, V309, P155; MURAYAMA M, 1988, KOBUNSHI RONBUNSHU, V45, P789; Ogawa T, 2014, SCI JAPANESE LACQUER, P49; Ohshima A, 2010, ANN M ARCH I JAP MAT, P551; Okamoto T, 2003, MOKUZAI GAKKAISHI, V49, P401; Takatani M, 2008, J SOC MAT SCI JPN, V57, P415, DOI 10.2472/jsms.57.415; Wang WH, 2004, FOREST PROD J, V54, P209	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					143	150		10.1007/s10086-014-1449-4		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200006		
J	Watanabe, K; Korai, H; Matsushita, Y; Hayashi, T				Watanabe, Ken; Korai, Hideaki; Matsushita, Yasuhiro; Hayashi, Tomoyuki			Predicting internal bond strength of particleboard under outdoor exposure based on climate data: comparison of multiple linear regression and artificial neural network	JOURNAL OF WOOD SCIENCE			English	Article						Internal bond strength; Particleboard; Outdoor exposure; Artificial neural network; Multiple linear regression	WOOD; MOISTURE; BOARD; MODEL; DETERIORATION; SAMPLES; TIMBER	The internal bond strength (IB) of a commercial particleboard put under various outdoor exposure conditions were modeled using a multiple linear regression (MLR) and an artificial neural network (ANN). The outdoor exposure data used in this study were collected from the results of past outdoor exposure tests conducted at eight locations across Japan from 2004 to 2011. The data from five locations were used to develop the MLR model and the ANN model for predicting the IB of particleboard under outdoor exposure based on climate data including exposure duration, annual mean temperature, annual sunshine duration, and annual precipitation. The performance of the models was assessed by comparing predicted IB values with measured ones for the remaining three locations. The MLR model gave a high R (2) of 0.87 and a low root mean square error (RMSE) of 0.07 MPa, while the ANN model gave an R (2) of 0.93 and an RMSE of 0.05 MPa. Thus, both models were demonstrated to be applicable to particleboards exposed at different locations in Japan. A statistical test of the MLR model revealed that the IB was influenced negatively by exposure duration, temperature, and precipitation. These influences were confirmed by the sensitivity analysis of the ANN model, and the analysis also showed an additional positive influence of sunshine duration on IB.	[Watanabe, Ken; Korai, Hideaki] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Matsushita, Yasuhiro] SET Software Co Ltd, Chuo Ku, Osaka 5410051, Japan; [Hayashi, Tomoyuki] Akita Prefectural Univ, Inst Wood Technol, Akita 0160876, Japan	Watanabe, K (reprint author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	kenwatanabe@ffpri.affrc.go.jp			Forestry and Forest Products Research Institute [201207]	This study was partially supported by Research grant No. 201207 of Forestry and Forest Products Research Institute. Outdoor exposure tests were conducted at eight locations in Japan as part of a project organized by the Research Working Group on Wood-based Boards from the Japan Wood Research Society. The authors thank all participants in this project.	Wu HW, 2006, DRY TECHNOL, V24, P1541, DOI 10.1080/07373930601047584; Fernandez FG, 2012, COMPOS PART B-ENG, V43, P3528, DOI 10.1016/j.compositesb.2011.11.054; Esteban LG, 2009, INVEST AGRAR-SIST R, V18, P92; Mansfield SD, 2011, HOLZFORSCHUNG, V65, P855, DOI 10.1515/HF.2011.107; Kojima Y, 2012, J WOOD SCI, V58, P525, DOI 10.1007/s10086-012-1287-1; Mansfield SD, 2007, HOLZFORSCHUNG, V61, P707, DOI 10.1515/HF2007.115; Sekino N, 2014, J WOOD SCI, V60, P141, DOI 10.1007/s10086-013-1384-9; [Anonymous], 2003, JIS A 5908; Cook DF, 1997, ENG APPL ARTIF INTEL, V10, P171, DOI 10.1016/S0952-1976(96)00068-1; Esteban LG, 2011, HOLZFORSCHUNG, V65, P209, DOI 10.1515/HF.2011.003; Ozsahin S, 2012, BIORESOURCES, V7, P1053; Korai H, 2013, J WOOD SCI, V59, P24, DOI 10.1007/s10086-012-1291-5; Avramidis S, 2005, WOOD FIBER SCI, V37, P682; Andre N, 2008, WOOD SCI TECHNOL, V42, P521, DOI 10.1007/s00226-008-0204-7; Ceylan I, 2008, DRY TECHNOL, V26, P1469, DOI 10.1080/07373930802412132; Samarasinghe S, 2007, SILVA FENN, V41, P105, DOI 10.14214/sf.309; Cook DF, 2000, ENG APPL ARTIF INTEL, V13, P391, DOI 10.1016/S0952-1976(00)00021-X; Avramidis S, 2007, HOLZ ROH WERKST, V65, P89, DOI 10.1007/s00107-006-0113-0; Korai H, 2012, FOREST PROD J, V62, P184; Esteban LG, 2009, COMPUT STRUCT, V87, P1360, DOI 10.1016/j.compstruc.2009.08.010; Avramidis S, 2005, HOLZFORSCHUNG, V59, P336, DOI 10.1515/HF.2005.055; Avramidis S, 2006, WOOD SCI TECHNOL, V40, P563, DOI 10.1007/s00226-006-0096-3; Esteban LG, 2010, WOOD FIBER SCI, V42, P335; Fahlman SE, 1990, TECHNICAL REPORT CMU; Fernandez FG, 2008, INVEST AGRAR-SIST R, V17, P178; Grafen A, 2002, MODERN STATISTICS FO; Kojima Y, 2011, J WOOD SCI, V57, P408, DOI 10.1007/s10086-011-1197-7; Montgomery DC, 1992, INTRODUCTION TO LINE; NeuralWare, 2009, NEURALWORKS PREDICT; Ozsahin S, 2013, EUR J WOOD WOOD PROD, V71, P769, DOI 10.1007/s00107-013-0737-9; Picton P., 2000, NEURAL NETWORKS; R Core Team, 2013, R LANG ENV STAT COMP; Samarasinghe S, 2006, NEURAL NETWORKS FOR; Sukthomya W, 2005, J INTELL MANUF, V16, P39, DOI 10.1007/s10845-005-4823-7; Watanabe K, 2013, J WOOD SCI, V59, P112, DOI 10.1007/s10086-012-1314-2; Watanabe K, 2014, DRY TECHNOL, V32, P590, DOI 10.1080/07373937.2013.846911	36	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					151	158		10.1007/s10086-014-1446-7		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200007		
J	Ohno, E; Miyafuji, H				Ohno, Emiko; Miyafuji, Hisashi			Production of disaccharides from glucose by treatment with an ionic liquid, 1-ethyl-3-methylimidozolium chloride	JOURNAL OF WOOD SCIENCE			English	Article						Glucose; Ionic liquid; 1-Ethyl-3-methylimidazolium chloride; Oligomerization; Oligosaccharides	CELLULOSE; WOOD; LIQUEFACTION; DISSOLUTION; HYDROLYSIS; BEHAVIOR; DILUTE; BEECH	The detailed reaction behavior of cellulose in an ionic liquid, 1-ethyl-3-methylimidazolium chloride ([C2mim][Cl]), was investigated. Glucose is a component of cellulose; its oligomerization was studied during treatment with [C2mim][Cl] at around 100 A degrees C. Glucose was polymerized to produce oligosaccharides such as disaccharides and trisaccharides. These oligosaccharides, however, disappeared upon prolonging the treatment time. Maltose, nigerose, kojibiose, laminaribiose, isomaltose, and gentiobiose were identified by gas chromatograph-mass spectrometer in the disaccharides produced. The yield of these disaccharides increased as the initial concentration of glucose in [C2mim][Cl] increased. [C2mim][Cl], therefore, is a reagent capable of producing various oligosaccharides from glucose in the absence of a catalyst.	[Ohno, Emiko; Miyafuji, Hisashi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp			 [25450246]	The authors wish to thank Ms. Chihiro Kosaka, the Kyoto Municipal Institute of Industrial Technology and Culture, for her assistance in GC-MS analyses. This research was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 25450246) for which the authors are grateful.	SUGISAWA H, 1966, J FOOD SCI, V31, P561, DOI 10.1111/j.1365-2621.1966.tb01905.x; Ohno E, 2013, J WOOD SCI, V59, P221, DOI 10.1007/s10086-013-1322-x; Pilath HM, 2010, J AGR FOOD CHEM, V58, P6131, DOI 10.1021/jf903598w; Xu AR, 2010, GREEN CHEM, V12, P268, DOI 10.1039/b916882f; Sescousse R, 2010, J PHYS CHEM B, V114, P7222, DOI 10.1021/jp1024203; Vitz J, 2009, GREEN CHEM, V11, P417, DOI 10.1039/b818061j; Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042; Gericke M, 2009, BIOMACROMOLECULES, V10, P1188, DOI 10.1021/bm801430x; Miyafuji H, 2009, J WOOD SCI, V55, P215, DOI 10.1007/s10086-009-1020-x; Cao Y, 2007, CARBOHYD POLYM, V69, P665, DOI 10.1016/j.carbpol.2007.02.001; Zhang JM, 2009, CELLULOSE, V16, P299, DOI 10.1007/s10570-008-9260-2; Yamazaki J, 2006, J WOOD SCI, V52, P527, DOI 10.1007/s10086-005-0798-4; Lan W, 2011, CARBOHYD POLYM, V86, P672, DOI 10.1016/j.carbpol.2011.05.013; Chang VS, 2000, APPL BIOCH ENG BIOTE, V38, P53; Cuissinat C, 2008, CARBOHYD POLYM, V72, P590, DOI 10.1016/j.carbpol.2007.09.029; GOLDSTEIN IS, 1980, TAPPI, V63, P141; HELM RF, 1989, CARBOHYD RES, V185, P249, DOI 10.1016/0008-6215(89)80040-0; Hosoya T, 2007, J WOOD SCI, V53, P351, DOI 10.1007/s10086-006-0854-8; Kohmoto T., 1988, Bifidobacteria and Microflora, V7, P61; Kwan GJ, 2006, J WOOD SCI, V52, P461; Liu CF, 2009, J AGR FOOD CHEM, V57, P1814, DOI 10.1021/jf803097k; Ohno E, 2014, J WOOD SCI, V60, P446; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; THOMPSON A, 1954, J AM CHEM SOC, V76, P1309, DOI 10.1021/ja01634a034	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					165	170		10.1007/s10086-014-1453-8		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200009		
J	Watanabe, H; Yanase, Y; Fujii, Y				Watanabe, Hiroki; Yanase, Yoshiyuki; Fujii, Yoshihisa			Evaluation of larval growth process and bamboo consumption of the bamboo powder-post beetle Dinoderus minutus using X-ray computed tomography	JOURNAL OF WOOD SCIENCE			English	Article						Powder-post beetle; Dinoderus minutus; Bamboo; X-ray computed tomography	COLEOPTERA	The bamboo powder-post beetle Dinoderus minutus is a major pest of felled bamboo in Japan. In this study, X-ray computed tomography (CT) was utilized to non-destructively trace the movement of the larvae of D. minutus inside infested bamboo specimens and to evaluate the bamboo consumption of the larvae. The infested specimens, which had been enclosed with adult D. minutus beetles, were scanned using a microfocus X-ray CT system every 2 to 5 days. Larvae and other stages of the beetles were clearly recognizable in the CT images with a voxel size of 61.9 mu m, and they were distinguishable from the bamboo, insect tunnels, and frass. The larvae were traced until pupation, and the length and volume of their tunnels were measured to evaluate their bamboo consumption. The tunnel length and volume bored by one larva was estimated to be 0.98 mm and 1.06 mm(3) (0.70 mg of oven-dry mass) per day within the average observation period of 22 days, respectively, and the active larval period was estimated to be 39 days in our experimental conditions.	[Watanabe, Hiroki; Yanase, Yoshiyuki; Fujii, Yoshihisa] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Watanabe, H (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawaoiwake Cho, Kyoto 6068502, Japan.	watanabe@h3news1.kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25242032, 26450229]	The authors thank Mr. Shinji Ninomiya of Oita Industrial Research Institute, Japan for assistance in collecting D. minutus and providing information regarding the methods for breeding this beetle. This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25242032 and No. 26450229) from the Japan Society for the Promotion of Science.	Garcia CM, 2009, ENVIRON ENTOMOL, V38, P478, DOI 10.1603/022.038.0222; de Naime Joao M, 2003, J BRAZ FOR SCI, V27, P747; Fuchs A, 2004, INT J PEST MANAGE, V50, P63, DOI 10.1080/0967087032000159300; FUJII Y, 1990, FOREST PROD J, V40, P34; Himmi SK, 2014, J WOOD SCI, V60, P453, DOI 10.1007/s10086-014-1427-x; Hirano Y, 2003, MOKUZAI GAKKAISHI, V49, P437; Imamura Y, 1998, JPN J ENVIRON ENTOMO, V9, P98; Kigawa R, 2009, SCI FOR CONSERV, V48, P223; Nair KSS, 1983, KFRI RESEARCH REPORT; SONE K, 1995, JPN J APPL ENTOMOL Z, V39, P341; Suzuki Kentaro, 1991, House and Household Insect Pests, V13, P59; The Society of House and Household Pests Science Japan, 1995, KAOKU GAICHU JITEN E; Yamano K, 1969, KENCHIKU KONCHU KI I	13	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					171	177		10.1007/s10086-014-1458-3		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200010		
J	Konno, N; Obara, A; Sakamoto, Y				Konno, Naotake; Obara, Ayumi; Sakamoto, Yuichi			Molecular cloning, characterization, and expression analysis of a beta-N-acetylhexosaminidase (LeHex20B) from the shiitake mushroom, Lentinula edodes	JOURNAL OF WOOD SCIENCE			English	Article						Shitake mushroom; Basidiomycete; Chitin; beta-N-acetylhexosaminidase; Glycoside hydrolase family 20	FRUITING BODY; TRICHODERMA-ATROVIRIDE; ASPERGILLUS-NIDULANS; SERRATIA-MARCESCENS; KODAKARAENSIS KOD1; COPRINUS-CINEREUS; CHITIN; GENE; ACETYLGLUCOSAMINIDASE; AUTOLYSIS	We previously reported on a beta-N-acetylhexosaminidase, LeHex20A, belonging to glycoside hydrolase family 20 (GH20), from the fruiting body of Lentinula edodes (shiitake mushroom). In this study, we purified, cloned, and characterized another beta-N-acetylhexosaminidase, LeHex20B, from L. edodes fruiting bodies. The cDNA of LeHex20B includes an open reading frame of 1,686 bp encoding a 20 amino acid signal peptide and a 541 amino acid mature protein. The amino acid sequence identity of LeHex20A and LeHex20B was 57 %, and LeHex20B had high sequence identity to GH20 proteins; thus, LeHex20B belongs to GH family 20. LeHex20B showed beta-N-acetylhexosaminidase activity and catalyzed degradation of chitooligosaccharides (GlcNAc(2-6)) exolytically with N-acetylglucosamine (GlcNAc) production. The maximum LeHex20B activity was observed at pH 5.0 and at 60 A degrees C. LeHex20B had highest catalytic efficiency (k (cat)/K (m)) for GlcNAc(3) and showed high affinity for GlcNAc(3-6). The transcript level of LeHex20A was significantly increased in fruiting bodies after harvest, suggesting that LeHex20A is mainly involved in fruiting body autolysis. On the other hand, LeHex20B was highly expressed in young fruiting bodies and mycelia. Therefore, LeHex20B seems to be mainly involved in elongation of fruiting bodies and mycelia.	[Konno, Naotake; Obara, Ayumi; Sakamoto, Yuichi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Konno, Naotake] Utsunomiya Univ, Dept Appl Biol Chem, Utsunomiya, Tochigi 3218505, Japan	Konno, N (reprint author), Utsunomiya Univ, Dept Appl Biol Chem, 350 Mine Machi, Utsunomiya, Tochigi 3218505, Japan.	konno@cc.utsunomiya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [2510648]	We thank Ms. Akiko Uchidate, Ms. Miyuki Ito, Ms. Junko Kawaguchi, and Ms. Shiho Sato for their help with experiments. We are grateful to Dr. Arend F. van Peer for his suggestion and comments. This research was supported by a Grant-in-Aid for Scientific Research to N. K. (no. 2510648) from the Japan Society for the Promotion of Science (JSPS), by grants for project research (Development of fundamental technology for analysis and evaluation of functional agricultural products and functional foods).	Seidl V, 2006, MICROBIOL-SGM, V152, P2003, DOI 10.1099/mic.0.28897-0; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Kang Y, 2013, J MICROBIOL, V51, P189, DOI 10.1007/s12275-013-2535-9; Sakamoto Y, 2009, CURR GENET, V55, P409, DOI 10.1007/s00294-009-0255-9; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; GOW NAR, 1983, PROTOPLASMA, V115, P52, DOI 10.1007/BF01293580; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Sakamoto Y, 2005, CURR GENET, V48, P195, DOI 10.1007/s00294-005-0002-9; KAMADA T, 1991, PROTOPLASMA, V165, P64, DOI 10.1007/BF01322277; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Drouillard S, 1997, BIOCHEM J, V328, P945; Sakamoto Y, 2011, APPL ENVIRON MICROB, V77, P8350, DOI 10.1128/AEM.05581-11; HSU SC, 1975, APPL MICROBIOL, V29, P422; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Vetter J, 2007, FOOD CHEM, V102, P6, DOI 10.1016/j.foodchem.2006.01.037; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; KAMADA T, 1982, J GEN MICROBIOL, V128, P1041; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; ITEN W, 1970, J GEN MICROBIOL, V61, P301; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Hirano T, 1999, BIOSCI BIOTECH BIOCH, V63, P1223, DOI 10.1271/bbb.63.1223; Intra J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-214; JONES CS, 1980, J BIOL CHEM, V255, P1861; Keyhani NO, 1996, J BIOL CHEM, V271, P33425; Kim S, 2002, BIOSCI BIOTECH BIOCH, V66, P2168, DOI 10.1271/bbb.66.2168; Konno N, 2012, AMB EXPRESS, V2, P29; Konno N, 2011, APPL MICROBIOL BIOT, V91, P1365, DOI 10.1007/s00253-011-3295-2; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; RAST DM, 1991, J GEN MICROBIOL, V137, P2797; Sakamoto Y, 2005, CURR GENET, V47, P244, DOI 10.1007/s00294-005-0563-7; SHIDA M, 1981, J BIOCHEM-TOKYO, V90, P1093; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Tanaka T, 1999, APPL ENVIRON MICROB, V65, P5338; Tanaka T, 2001, J BIOL CHEM, V276, P35629, DOI 10.1074/jbc.M105919200	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					178	184		10.1007/s10086-015-1459-x		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200011		
J	Yamauchi, S; Yamagishi, T; Kirikoshi, K; Yatagai, M				Yamauchi, Shigeru; Yamagishi, Takayuki; Kirikoshi, Kazuko; Yatagai, Mitsuyoshi			Cesium adsorption from aqueous solutions onto Japanese oak charcoal II: effects of metal ions eluted from the charcoal	JOURNAL OF WOOD SCIENCE			English	Article						Cesium; Adsorption; Japanese oak charcoal; Demineralization; Aqueous solution		The major metal elements contained in Japanese oak (Quercus serrata Thunb. and/or Quercus crispula Blume) charcoal (OC) and activated charcoal (AC) were identified by X-ray fluorescence spectroscopy. The eluted amounts of sodium, potassium, magnesium, and calcium ions from OC and AC were measured using ion chromatography. We attempted to demineralize OC and AC by water-washing, and then determined the eluted amounts of the four metal ions from the washed OC and AC. The effects of the water-washing on the adsorption of cesium ions onto OC and AC were investigated with respect to 2.50 x 10(-4) and 2.50 x 10(-5) mol/L aqueous cesium chloride solutions. Remarkably, the washing improved the adsorption ability of OC for cesium ions in solutions whose initial cesium chloride concentration was 2.50 x 10(-5) mol/L, although such effects were not so noticeable in solutions whose initial cesium chloride concentration was 2.50 x 10(-4) mol/L.	[Yamauchi, Shigeru; Yamagishi, Takayuki; Kirikoshi, Kazuko] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Yatagai, Mitsuyoshi] Aroma Lib, Chiyoda Ku, Tokyo 1020072, Japan	Yamauchi, S (reprint author), Akita Prefectural Univ, Inst Wood Technol, 11-1 Kaieisaka, Noshiro, Akita 0160876, Japan.	sigeru@iwt.akita-pu.ac.jp					Caccin M, 2013, J RADIOANAL NUCL CH, V297, P9, DOI 10.1007/s10967-012-2305-x; [Anonymous], 2008, TESTING METHODS IND, P191; Elam W.T.T., 2004, ADV XRAY ANAL, V47, P104; ERSHOV BG, 1993, RADIOCHEMISTRY+, V35, P699; Fujiwara S, 2003, MOKUZAI GAKKAISHI, V49, P333; Fukuyama T, 2004, SCI TOTAL ENVIRON, V318, P187, DOI 10.1016/S0048-9697(03)00366-8; IWASE M, 1985, NIPPON KAGAKU KAISHI, P2271; Kira A, 2001, READOUT, V22, P19; Kobayashi M, 2011, J JPN SOC ATMOS ENV, V46, P217; Morel FMM, 1983, PRINCIPLES AQUATIC C, P184; Narita E, 2013, WOOD CARBONIZATION R, V9, P59; Ramazaev V, 2007, J ENVIRON RADIOACTIV, V92, P123; Rayner-Canham G, 2009, DESCRIPTIVE INORGANI, P544; Sekine T, 1974, CALCULATION CHEM EQU, P216; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Yamane K, 2001, NMCC ANN REPORT, V9, P132; Yamauchi S, 2013, WOOD CARBONIZATION R, V10, P35; Yamauchi S, 2014, J WOOD SCI, V60, P473, DOI 10.1007/s10086-014-1431-1	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					185	191		10.1007/s10086-014-1450-y		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200012		
J	Takashima, Y; Tamura, A; Noseda, N; Tanabe, J; Makino, K; Ishiguri, F; Habu, N; Iizuka, K; Yokota, S				Takashima, Yuya; Tamura, Akira; Noseda, Naoya; Tanabe, Jun; Makino, Kazuko; Ishiguri, Futoshi; Habu, Naoto; Iizuka, Kazuya; Yokota, Shinso			Diversities of decay resistance and n-hexane-extractive contents in seven half-sib families from plus trees in todomatsu (Abies sachalinensis)	JOURNAL OF WOOD SCIENCE			English	Article						Abies sachalinensis; n-Hexane extracts; Decay resistance; Tree breeding	HEARTWOOD EXTRACTIVES; NATURAL DURABILITY; LARCH; WOOD; LIGNIN; CLONES	Todomatsu (Abies sachalinensis) is a commercial plantation species on Hokkaido Island, Japan. In the present study, to improve the decay resistance of todomatsu wood, seven families of 22-year-old todomatsu trees were investigated for family diversities in decay resistance of heartwoods against Fomitopsis palustris and Trametes versicolor and n-hexane-extractive contents in heartwoods. In addition, antifungal activity tests of n-hexane extracts were conducted for F. palustris and T. versicolor. Mean percentages of wood mass loss by F. palustris and T. versicolor were 18.2 and 10.5 %, respectively. Significant differences in mass loss and n-hexane-extractive contents were not found among seven families tested here. The mean value of n-hexane-extractive contents was 6.4 mg/g. By gas chromatography/mass spectrometry analysis, a main component of n-hexane extracts was suggested to be juvabione. Results of the antifungal activity test show that mycelial growth of F. palustris and T. versicolor was strongly inhibited over the concentration of 225 and 150 A mu g per disc, respectively. These concentrations corresponded to about 10.0 and 6.6 mg/g in wood. Thus, it is concluded that the todomatsu trees containing more than 10.0 mg/g of n-hexane extracts should be selected among the families for high decay resistance.	[Takashima, Yuya; Noseda, Naoya; Tanabe, Jun; Makino, Kazuko; Ishiguri, Futoshi; Habu, Naoto; Iizuka, Kazuya; Yokota, Shinso] Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; [Tamura, Akira] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hokkaido Reg Breeding Off, Ebetsu, Hokkaido 0690836, Japan; [Tanabe, Jun] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan	Ishiguri, F (reprint author), Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan.	ishiguri@cc.utsunomiya-u.ac.jp		Ishiguri, Futoshi/0000-0002-1870-4060			Holm T, 1999, J CHROMATOGR A, V842, P221, DOI 10.1016/S0021-9673(98)00706-7; Windeisen E, 2002, HOLZ ROH WERKST, V60, P373, DOI 10.1007/s00107-002-0314-0; [Anonymous], 2010, WOOD PRESERVATIVES P, P27; Gierlinger N, 2004, TREES-STRUCT FUNCT, V18, P230, DOI 10.1007/s00468-003-0300-0; AOYAMA M, 1992, MOKUZAI GAKKAISHI, V38, P101; Curnel Y, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008062; Ericsson T., 2001, Forest Genetics, V8, P73; Gierlinger N, 2004, WOOD FIBER SCI, V36, P387; Hillis WE, 1987, HEARTWOOD TREE EXUDA, P268; Iki T, 2009, MOKUZAI GAKKAISHI, V55, P18; Mertz M, 2011, WOOD AND TRADITIONAL, P227; Sasse J, 1998, THE FORESTS OF JAPAN, P75; Tamura A, 2005, MOKUZAI GAKKAISHI, V51, P257, DOI 10.2488/jwrs.51.257; Srinivasan U, 1999, FOREST PROD J, V49, P82; Venalainen M, 2001, HOLZFORSCHUNG, V55, P1, DOI 10.1515/HF.2001.001; Venalainen M, 2003, ANN FOR SCI, V60, P409, DOI 10.1051/forest:2003033; Yoneyama S, 1989, J HOKKAIDO FOREST PR, V3, P16; YONEYAMA S, 1990, MOKUZAI GAKKAISHI, V36, P777	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	APR	2015	61	2					192	198		10.1007/s10086-014-1448-5		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CF0MD	WOS:000352237200013		
J	Hosoya, K; Minakuchi, H; Wakino, S; Fujimura, K; Hasegawa, K; Komatsu, M; Yoshifuji, A; Futatsugi, K; Shinozuka, K; Washida, N; Kanda, T; Tokuyama, H; Hayashi, K; Itoh, H				Hosoya, Kozi; Minakuchi, Hitoshi; Wakino, Shu; Fujimura, Keiko; Hasegawa, Kazuhiro; Komatsu, Motoaki; Yoshifuji, Ayumi; Futatsugi, Koji; Shinozuka, Keisuke; Washida, Naoki; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi			Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans	KIDNEY INTERNATIONAL			English	Article						ADMA; aldosterone; CKD; insulin resistance; mineralocorticoid receptor	HOMEOSTASIS MODEL ASSESSMENT; CHRONIC-RENAL-FAILURE; ASYMMETRICAL DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; PLASMA-ALDOSTERONE; GLUCOSE-TOLERANCE; US ADULTS; ADIPOCYTES; HYPERINSULINEMIA	In this study, we examined the association between chronic kidney disease (CKD) and insulin resistance. In a patient cohort with nondiabetic stages 2-5 CKD, estimated glomerular filtration rate (eGFR) was negatively correlated and the plasma aldosterone concentration was independently associated with the homeostasis model assessment of insulin resistance. Treatment with the mineralocorticoid receptor blocker spironolactone ameliorated insulin resistance in patients, and impaired glucose tolerance was partially reversed in fifth/sixth nephrectomized rats. In these rats, insulin-induced signal transduction was attenuated, especially in the adipose tissue. In the adipose tissue of nephrectomized rats, nuclear mineralocorticoid receptor expression, expression of the mineralocorticoid receptor target molecule SGK-1, tissue aldosterone content, and expression of the aldosterone-producing enzyme CYP11B2 increased. Mineralocorticoid receptor activation in the adipose tissue was reversed by spironolactone. In the adipose tissue of nephrectomized rats, asymmetric dimethylarginine (ADMA; an uremic substance linking uremia and insulin resistance) increased, the expression of the ADMA-degrading enzymes DDAH1 and DDAH2 decreased, and the oxidative stress increased. All of these changes were reversed by spironolactone. In mature adipocytes, aldosterone downregulated both DDAH1 and DDAH2 expression, and ADMA inhibited the insulin-induced cellular signaling. Thus, activation of mineralocorticoid receptor and resultant ADMA accumulation in adipose tissue has, in part, a relevant role in the development of insulin resistance in CKD.	[Hosoya, Kozi; Minakuchi, Hitoshi; Wakino, Shu; Fujimura, Keiko; Hasegawa, Kazuhiro; Komatsu, Motoaki; Yoshifuji, Ayumi; Futatsugi, Koji; Shinozuka, Keisuke; Washida, Naoki; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan	Wakino, S (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	shuwakino@z8.keio.jp					Garg R, 2014, DIABETES OBES METAB, V16, P268, DOI 10.1111/dom.12224; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Chen J, 2004, ANN INTERN MED, V140, P167; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; Wei YZ, 2009, HYPERTENSION, V53, P158, DOI 10.1161/HYPERTENSIONAHA.108.121954; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Freedman BI, 2010, AM J NEPHROL, V31, P375, DOI 10.1159/000287561; Quinkler M, 2005, CIRCULATION, V112, P1435, DOI 10.1161/CIRULATIONHA.105.539122; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Hitomi H, 2007, HYPERTENSION, V50, P750, DOI 10.1161/HYPERTENSIONAHA.107.093955; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Pham H, 2011, CURR OPIN NEPHROL HY, V20, P640, DOI 10.1097/MNH.0b013e32834b23c1; Freedman BI, 2011, CLIN J AM SOC NEPHRO, V6, P1635, DOI 10.2215/CJN.11491210; Goodfriend TL, 1999, PROSTAG LEUKOTR ESS, V60, P401, DOI 10.1016/S0952-3278(99)80020-9; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Banerjee D, 2011, CLIN CARDIOL, V34, P360, DOI 10.1002/clc.20901; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Wesson DE, 2010, KIDNEY INT, V78, P1128, DOI 10.1038/ki.2010.348; Tain YL, 2010, FREE RADICAL BIO MED, V49, P1088, DOI 10.1016/j.freeradbiomed.2010.06.029; Tahara Y, 2009, DIABETES RES CLIN PR, V84, P224, DOI 10.1016/j.diabres.2009.03.014; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Yamashita K, 2008, J CHROMATOGR A, V1200, P114, DOI 10.1016/j.chroma.2008.05.034; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; Bede T, 1978, KIDNEY INT, V14, P228; BIA MJ, 1981, AM J PHYSIOL, V240, pF257; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; Costa Monica Barros, 2010, J Clin Hypertens (Greenwich), V12, P753, DOI 10.1111/j.1751-7176.2010.00339.x; Feneberg R, 2002, J CLIN ENDOCR METAB, V87, P1965, DOI 10.1210/jc.87.5.1965; Hasegawa K, 2013, FASEB J, V27, P2301, DOI 10.1096/fj.12-226092; Hasegawa K, 2006, ARTERIOSCL THROM VAS, V26, P1488, DOI 10.1161/01.ATV.0000219615.88323.b4; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Jain G, 2009, CLIN J AM SOC NEPHRO, V4, P1685, DOI 10.2215/CJN.01340209; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; Kraus D, 2005, HORM METAB RES, V37, P455, DOI 10.1055/s-870240; Krzyzanowska K, 2008, DIABETES RES CLIN PR, V82, pS122, DOI 10.1016/j.diabres.2008.09.024; Kubo M, 1999, KIDNEY INT, V55, P2450, DOI 10.1046/j.1523-1755.1999.00458.x; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Lastra-Lastra G, 2009, CLIN ENDOCRINOL, V71, P1, DOI 10.1111/j.1365-2265.2008.03498.x; Mejla-Garcia TA, 2013, CELL SIGNAL, V25, P2424; Milagro FI, 2007, J STEROID BIOCHEM, V104, P81, DOI 10.1016/j.jsbmb.2006.10.006; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Nene RJ, 1982, KIDNEY INT, V21, P98; Okubo K, 2005, HYPERTENS RES, V28, P181, DOI 10.1291/hypres.28.181; PLAVINIK FL, 1992, HYPERTENSION, V19, P26; REUBI FC, 1980, CLIN EXP HYPERTENS, V2, P593, DOI 10.3109/10641968009037132; Spoto B, 2007, J NEPHROL, V20, P554; Stiblinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420; Tatematsu S, 2007, J AM SOC NEPHROL, V18, P741, DOI 10.1681/ASN.2006040367; TSAO PS, 1994, CIRCULATION, V89, P2176; Wads T, 2009, ENDOCRINOLOGY, V150, P1662; WILLIAMS GH, 1973, KIDNEY INT, V4, P280, DOI 10.1038/ki.1973.115; Yang ZC, 2009, CELL PHYSIOL BIOCHEM, V24, P115, DOI 10.1159/000227819; Zulian E., 2005, Journal of Endocrinological Investigation, V28, P49	60	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	APR	2015	87	4					749	760		10.1038/ki.2014.348		12	Urology & Nephrology	Urology & Nephrology	CE9QZ	WOS:000352179800013		
J	Khamaisi, M; Toukan, H; Axelrod, JH; Rosenberger, C; Skarzinski, G; Shina, A; Meidan, R; Koesters, R; Rosen, S; Walkinshaw, G; Mimura, I; Nangaku, M; Heyman, SN				Khamaisi, Mogher; Toukan, Hala; Axelrod, Jonathan H.; Rosenberger, Christian; Skarzinski, Galia; Shina, Ahuva; Meidan, Rina; Koesters, Robert; Rosen, Seymour; Walkinshaw, Gail; Mimura, Imari; Nangaku, Masaomi; Heyman, Samuel N.			Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor	KIDNEY INTERNATIONAL			English	Article						endothelin; HIF-1; hypoxia; kidney	RENAL PARENCHYMAL HYPOXIA; SMOOTH-MUSCLE-CELLS; FACTOR-I; KIDNEY-DISEASE; SIGNAL TRANSDUCER; GROWTH-FACTOR; UP-REGULATION; RAT-KIDNEY; EXPRESSION; DEGRADATION	Renal endothelin-converting enzyme (ECE)-1 is induced in experimental diabetes and following radiocontrast administration, conditions characterized by renal hypoxia, hypoxia-inducible factor (HIF) stabilization, and enhanced endothelin synthesis. Here we tested whether ECE-1 might be a HIF-target gene in vitro and in vivo. ECE-1 transcription and expression increased in cultured vascular endothelial and proximal tubular cell lines, subject to hypoxia, to mimosine or cobalt chloride. These interventions are known to stabilize HIF signaling by inhibition of HIF-prolyl hydroxylases. In rats, HIF-prolyl-hydroxylase inhibition by mimosine or FG-4497 increased HIF-1 alpha immunostaining in renal tubules, principally in distal nephron segments. This was associated with markedly enhanced ECE-1 protein expression, predominantly in the renal medulla. A progressive and dramatic increase in ECE-1 immunostaining over time, in parallel with enhanced HIF expression, was also noted in conditional von Hippel-Lindau knockout mice. Since HIF and STAT3 are cross-stimulated, we triggered HIF expression by STAT3 activation in mice, transfected by or injected with a chimeric IL-6/IL-6-receptor protein, and found a similar pattern of enhanced ECE-1 expression. Chromatin immunoprecipitation sequence (ChIP-seq) and PCR analysis in hypoxic endothelial cells identified HIF binding at the ECE-1 promoter and intron regions. Thus, our findings suggest that ECE-1 may be a novel HIF-target gene.	[Khamaisi, Mogher; Toukan, Hala] Rambam Med Ctr, Inst Endocrinol Diabet & Metab, Haifa, Israel; [Khamaisi, Mogher; Toukan, Hala] Technion Israel Inst Technol, RB Rappaport Fac Med, Haifa, Israel; [Axelrod, Jonathan H.] Hebrew Univ Jerusalem, Hadassah Hosp, Goldyne Savad Inst Gene Therapy, IL-91240 Jerusalem, Israel; [Rosenberger, Christian] Charite, Dept Nephrol, Berlin, Germany; [Skarzinski, Galia; Shina, Ahuva; Heyman, Samuel N.] Hebrew Univ Jerusalem, Hadassah Hosp, Dept Med, IL-91240 Jerusalem, Israel; [Meidan, Rina] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Koesters, Robert] Univ Paris 06, Dept Nephrol, Tenon Hosp, Paris, France; [Rosen, Seymour] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Rosen, Seymour] Harvard Univ, Sch Med, Boston, MA USA; [Walkinshaw, Gail] FibroGen, San Francisco, CA USA; [Mimura, Imari; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol, Tokyo 113, Japan; [Mimura, Imari; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Endocrinol, Tokyo 113, Japan	Heyman, SN (reprint author), Hebrew Univ Jerusalem, Hadassah Hosp, Dept Med, POB 24035, IL-91240 Jerusalem, Israel.	heyman@cc.huji.ac.il			Israeli Science Foundation [1473/08]	This work was supported by the Israeli Science Foundation (Grant No. 1473/08).	Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Nakano D, 2012, CLIN EXP PHARMACOL P, V39, P104, DOI 10.1111/j.1440-1681.2011.05517.x; Khamaisi M, 2012, AM J HYPERTENS, V25, P109, DOI 10.1038/ajh.2011.164; Nangaku M, 2007, J MOL MED-JMM, V85, P1325, DOI 10.1007/s00109-007-0278-y; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Ghosh AK, 2009, BLOOD, V113, P5568, DOI 10.1182/blood-2008-10-185686; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Garvin JL, 2011, ANNU REV PHYSIOL, V73, P359, DOI 10.1146/annurev-physiol-012110-142247; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Bushuev VI, 2006, HAEMATOL-HEMATOL J, V91, P744; Heyman SN, 2008, CLIN J AM SOC NEPHRO, V3, P288, DOI 10.2215/CJN.02600607; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; TAKAHASHI K, 1990, DIABETOLOGIA, V33, P306, DOI 10.1007/BF00403325; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Fahling M, 2013, J AM SOC NEPHROL, V24, P1806, DOI 10.1681/ASN.2013030281; Clark BA, 1997, AM J KIDNEY DIS, V30, P82, DOI 10.1016/S0272-6386(97)90568-0; HEYMAN SN, 1992, J AM SOC NEPHROL, V3, P58; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Belaidi E, 2009, J AM COLL CARDIOL, V53, P1309, DOI 10.1016/j.jacc.2008.12.050; Rosenberger C, 2005, KIDNEY INT, V67, P531, DOI 10.1111/j.1523-1755.2005.67110.x; Guan ZR, 2011, CONTRIB NEPHROL, V172, P35, DOI 10.1159/000328720; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; D'Orleans-Juste P, 2003, CAN J PHYSIOL PHARM, V81, P503, DOI 10.1139/Y03-032; Gurbanov K, 1996, AM J PHYSIOL-RENAL, V271, pF1166; Hisada T, 2012, CARDIOVASC RES, V95, P251, DOI 10.1093/cvr/cvs110; Keynan S, 2004, J VASC RES, V41, P131; Khamaisi M, 2008, KIDNEY INT, V74, P91, DOI 10.1038/ki.2008.112; Khamaisi M, 2009, ENDOCRINOLOGY, V150, P1440, DOI 10.1210/en.2008-0524; Lopez-Ongil S, 2002, FREE RADICAL BIO MED, V32, P406, DOI 10.1016/S0891-5849(01)00822-X; Nechemia-Arbely Y, 2013, CLIN EXP PHARMACOL P, V40, P262, DOI 10.1111/1440-1681.12064; Pupilli C, 1997, AM J PHYSIOL-RENAL, V273, pF749; Rosenberger C, 2008, NEPHROL DIAL TRANSPL, V23, P3472, DOI 10.1093/ndt/gfn276; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Schneider Jochen G., 2002, American Journal of Hypertension, V15, P967, DOI 10.1016/S0895-7061(02)03060-1; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Soucy NV, 2004, CHEM RES TOXICOL, V17, P555, DOI 10.1021/tx034193q; Spinella F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011241; Takanashi M, 2004, J CARDIOVASC PHARM, V44, pS268, DOI 10.1097/01.fjc.0000166282.01034.8f; Tang L, 2012, DIABETES RES CLIN PR, V97, P125, DOI 10.1016/j.diabres.2012.01.037; Tipoe George L., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P199, DOI 10.2174/187152506777698290; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012	44	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	APR	2015	87	4					761	770		10.1038/ki.2014.362		10	Urology & Nephrology	Urology & Nephrology	CE9QZ	WOS:000352179800014		
J	Nishiyama, K; Fukushima, K; Jo, T; Miyai, T; Kanda, S; Sugawara, N; Ishizuka, K; Chikamoto, H; Akioka, Y; Hattori, M				Nishiyama, Kei; Fukushima, Kenji; Jo, Tohaku; Miyai, Takayuki; Kanda, Shoichiro; Sugawara, Noriko; Ishizuka, Kiyonobu; Chikamoto, Hiroko; Akioka, Yuko; Hattori, Motoshi			SPECT/CT to diagnose pleuroperitoneal communication-associated hydrothorax in peritoneal dialysis	KIDNEY INTERNATIONAL			English	Editorial Material									[Nishiyama, Kei; Jo, Tohaku; Miyai, Takayuki; Kanda, Shoichiro; Sugawara, Noriko; Ishizuka, Kiyonobu; Chikamoto, Hiroko; Akioka, Yuko; Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Fukushima, Kenji] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Tokyo 1628666, Japan	Hattori, M (reprint author), Tokyo Womens Med Univ, Dept Pediat Nephrol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	hattori@kc.twmu.ac.jp						0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	APR	2015	87	4					866	866		10.1038/ki.2014.266		1	Urology & Nephrology	Urology & Nephrology	CE9QZ	WOS:000352179800039		
J	Sasaki, R; Matsumine, H; Watanabe, Y; Yamato, M; Ando, T				Sasaki, R.; Matsumine, H.; Watanabe, Y.; Yamato, M.; Ando, T.			Surgical procedure of extracting teeth for obtaining dental pulp for regenerative medicine in swine	LABORATORY ANIMALS			English	Article						dental pulp; miniature swine; tooth extraction; experimental model	MINIATURE PIG; ANIMAL-MODEL; STEM-CELLS; IN-VITRO; RATS	Dental pulp is a potential source of cells that can be used in cell replacement therapy for various nerve disorders, including stroke, spinal cord injury, and peripheral nerve defect. However, the validation of an animal model closely related to humans is needed in translational research. The miniature pig is a suitable experimental model in maxillofacial surgery, because its anatomical structure and size are similar to those of humans. However, the swine tooth is extremely long. The routine closed extraction procedure for harvesting dental pulp tissue causes root fracture. This report describes the details of a surgical procedure for tooth extraction. Four healthy 7-8-month-old male NIBS miniature pigs were used. Two mandibular deciduous right incisors (Di1 and Di2) were extracted in order to obtain dental pulp tissue. Gingival envelope incision with vertical-releasing incision was performed, and a full-thickness mucoperiosteal flap was made. The buccal alveolar bone was exposed and removed by osteotomy. Di1 and Di2 were extracted. Dental pulp tissue was obtained from these extracted teeth by splitting hard tissue. In this procedure, 9.8 +/- 2.5x10(5) cells were obtained from the mandibular Di1 and Di2 (n=4).	[Sasaki, R.; Ando, T.] Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Global Ctr Excellence COE Program, Tokyo 1628666, Japan; [Sasaki, R.; Matsumine, H.; Watanabe, Y.; Yamato, M.] Tokyo Womens Med Univ, Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Matsumine, H.] Tokyo Womens Med Univ, Sch Med, Dept Plast Surg, Tokyo 1628666, Japan; [Watanabe, Y.] Tokyo Metropolitan Police Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan	Sasaki, R (reprint author), Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	sasaki@oms.twmu.ac.jp			Global COE program; JSPS KAKENHI [23792386]; Formation of Innovation Center for Fusion of Advanced Technologies project - Special Coordination Funds for Promoting Science and Technology 'Cell Sheet Tissue Engineering Center (CSTEC)'; Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This study was partially supported by the Global COE program, the Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, and JSPS KAKENHI Grant Number 23792386, and the Formation of Innovation Center for Fusion of Advanced Technologies project sponsored by the Special Coordination Funds for Promoting Science and Technology 'Cell Sheet Tissue Engineering Center (CSTEC)'.	Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Iwata T, 2010, J CLIN PERIODONTOL, V37, P1088, DOI 10.1111/j.1600-051X.2010.01597.x; Sasaki R, 2008, TISSUE ENG PT A, V14, P1141, DOI 10.1089/ten.tea.2007.0157; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Li YS, 2013, STEM CELLS DEV, V22, P2047, DOI 10.1089/scd.2012.0615; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Swindle MM, 2013, J INVEST SURG, V26, P63, DOI 10.3109/08941939.2012.693149; Eom TG, 2012, OR SURG OR MED OR PA, V114, P411, DOI 10.1016/j.oooo.2011.10.036; Sasaki R, 2008, EUR J NEUROSCI, V27, P538, DOI 10.1111/j.1460-9568.2008.06026.x; Bui CH, 2003, J ORAL MAXIL SURG, V61, P1379, DOI 10.1016/j.joms.2003.04.001; Goldwaser BR, 2013, J ORAL MAXIL SURG, V71, pE168, DOI 10.1016/j.joms.2012.09.012; Gronthos S, 2002, J DENT RES, V81, P531; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Kuo YR, 2012, PLOS ONE, V7; LOMBARDI T, 1993, ACTA ANAT, V147, P35; Nanci A, 2003, 10 CATES ORAL HISTOL, P192; Peterson LJ, 2003, CONT ORAL MAXILLOFAC, P156; Sasaki R, 2010, LAB ANIM-UK, V44, P359, DOI 10.1258/la.2010.009127; Sugiyama M, 2011, TISSUE ENG PT A, V17, P1303, DOI [10.1089/ten.TEA.2010.0306, 10.1089/ten.tea.2010.0306]; Swindle M. M., 1994, ILAR News, V36, P1; Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1034/j.1399-0020.1999.280613.x	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0023-6772	1758-1117		LAB ANIM-UK	Lab. Anim.	APR	2015	49	2					172	176		10.1177/0023677214560002		5	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CF4VY	WOS:000352552200010		
J	Kawai, A; Araki, N; Sugiura, H; Ueda, T; Yonemoto, T; Takahashi, M; Morioka, H; Hiraga, H; Hiruma, T; Kunisada, T; Matsumine, A; Tanase, T; Hasegawa, T; Takahashi, S				Kawai, Akira; Araki, Nobuhito; Sugiura, Hideshi; Ueda, Takafumi; Yonemoto, Tsukasa; Takahashi, Mitsuru; Morioka, Hideo; Hiraga, Hiroaki; Hiruma, Toru; Kunisada, Toshiyuki; Matsumine, Akihiko; Tanase, Takanori; Hasegawa, Tadashi; Takahashi, Shunji			Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study	LANCET ONCOLOGY			English	Article							SOFT-TISSUE SARCOMA; ANTITUMOR-ACTIVITY; ECTEINASCIDIN 743; III TRIAL; DOXORUBICIN; EFFICACY; SAFETY; LIPOSARCOMA; SCHEDULES; CRITERIA	Background Trabectedin binds to the minor groove of DNA and blocks DNA repair machinery. Preclinical data have shown that trabectedin also modulates the transcription of the oncogenic fusion proteins of translocation-related sarcomas. We aimed to assess the efficacy and safety of trabectedin as second-line therapy or later for patients with advanced translocation-related sarcoma. Methods We did a multicentre randomised open-label study in Japan. Eligible patients had pathological diagnosis of translocation-related sarcoma, were aged 19 years or older, were unresponsive or intolerant to standard chemotherapy regimens, no more than four previous chemotherapy regimens, Eastern Cooperative Oncology Group performance status 0 or 1, adequate bone marrow reserve, renal and liver functions, and had measurable lesions. Patients were randomly assigned (1: 1) by the minimisation method to receive either trabectedin (1.2 mg/m(2) given via a central venous line over 24 h on day 1 of a 21 day treatment cycle) or best supportive care, which was adjusted centrally by pathological subtype. Investigators, patients, and the sponsor were unmasked to the treatment assignment. Progression-free survival and objective responses were assessed by a masked central radiology imaging review. Efficacy was assessed by masked central radiology imaging review. The primary endpoint was progression-free survival for the full analysis set population. Follow-up is ongoing for the patients under study treatment. The study is registered with Japan Pharmaceutical Information Center, number JapicCTI-121850. Findings Between July 11, 2012, and Jan 20, 2014, 76 patients were enrolled and allocated to receive either trabectedin (n= 39) or best supportive care (n= 37). After central review to confirm pathological subtypes, 73 patients (37 in the trabectedin group and 36 in the best supportive care group) were included in the primary efficacy analysis. Median progression-free survival of the trabectedin group was 5.6 months (95% CI 4.1-7.5) and the best supportive care group was 0.9 months (0.7-1.0). The hazard ratio (HR) for progression-free survival of trabectedin versus best supportive care was 0.07 (90% CI 0.03-0.14 and 95% CI 0.03-0.16) by a Cox proportional hazards model (p< 0.0001). The most common drug-related adverse events for patients treated with trabectedin were nausea (32 [89%] of 36), decreased appetite (21 [58%]), decreased neutrophil count (30 [83%]), increased alanine aminotransferase (24 [67%]), and decreased white blood cell count (20 [56%]). Interpretation Trabectedin significantly reduced the risk of disease progression and death in patients with advanced translocation-related sarcoma after standard chemotherapy such as doxorubicin, and should be considered as a new therapeutic treatment option for this patient population.	[Kawai, Akira] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo 1040045, Japan; [Araki, Nobuhito] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthopaed Surg, Osaka, Japan; [Sugiura, Hideshi] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Aichi, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Yonemoto, Tsukasa] Chiba Canc Ctr, Div Orthopaed Surg, Chiba 2608717, Japan; [Takahashi, Mitsuru] Shizuoka Canc Ctr Hosp, Div Orthopaed Surg, Shizuoka, Japan; [Morioka, Hideo] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Hiraga, Hiroaki] Hokkaido Canc Ctr, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Hiruma, Toru] Kanagawa Canc Ctr, Dept Musculoskeletal Tumor Surg, Kanagawa, Japan; [Kunisada, Toshiyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med Mat Musculoskeletal Reconstruct, Okayama, Japan; [Matsumine, Akihiko] Mie Univ, Grad Sch Med, Dept Orthoped Surg, Tsu, Mie, Japan; [Tanase, Takanori] Taiho Parmaceut Co Ltd, Dept Data Sci, Tokyo, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Takahashi, Shunji] Hosp Japanese Fdn Canc Res, Inst Canc, Dept Med Oncol, Tokyo, Japan	Kawai, A (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1Tsukiji, Tokyo 1040045, Japan.	akawai@ncc.go.jp			Taiho Pharmaceutical Co., Ltd.	This study is funded by Taiho Pharmaceutical Co., Ltd. National Institute of Biomedical Innovation (Osaka, Japan) promoted Taiho Pharmaceutical Co., Ltd in the development of trabectedin under orphan designation in Japan. PharmaMar, SA (Madrid, Spain) kindly provided pharmacokinetic data from western patients and reviewed the manuscript. We thank all participating patients and their families, the study investigators, study nurses, study monitors, data manager, and all other members of the study team. We also thank Noriyuki Masuda (Kitasato University School of Medicine, Kanagawa, Japan) who participated as the medical advisor, Hirokazu Watanabe (National Cancer Center Hospital, Tokyo, Japan) who participated as the medical advisor for tumour assessment by RECIST, members of the data monitoring and safety committee (Junji Furuse [Kyorin University School of Medicine, Tokyo, Japan], Yoshiyuki Ueno [Yamagata University Faculty of Medicine, Yamagata, Japan], Hitoshi Arioka [Yokohama Rosai Hospital, Yokohama, Japan] and Makoto Nishio [Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan]), the central pathology assay laboratory (SRL, Inc., Tokyo, Japan) and the central radiology imaging review committee (LISIT, Co., Ltd, Tokyo, Japan, and Musashi Image Joho Co., Ltd, Tokyo, Japan). We thank Tetsuji Asao and Keisuke Ishida (SunFlare Co., Ltd, Tokyo, Japan) for medical writing services, which were funded by Taiho Pharmaceutical Co., Ltd.	Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Lorigan P, 2007, J CLIN ONCOL, V25, P3144, DOI 10.1200/JCO.2006.09.7717; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Miura Y, 2012, PATHOL INT, V62, P16, DOI 10.1111/j.1440-1827.2011.02739.x; Demetri GD, 2009, J CLIN ONCOL, V27, P4188, DOI 10.1200/JCO.2008.21.0088; Grosso F, 2007, LANCET ONCOL, V8, P595, DOI 10.1016/S1470-2045(07)70175-4; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Le Cesne A, 2012, EUR J CANCER, V48, P3036, DOI 10.1016/j.ejca.2012.05.012; Martin-Liberal J, 2013, EXPERT OPIN DRUG SAF, V12, P905, DOI 10.1517/14740338.2013.829037; Freidlin B, 2007, J CLIN ONCOL, V25, P2122, DOI 10.1200/JCO.2006.09.6198; Van Glabbeke M, 2002, EUR J CANCER, V38, P543, DOI 10.1016/S0959-8049(01)00398-7; Antonescu CR, 2006, HISTOPATHOLOGY, V48, P13, DOI 10.1111/j.1365-2559.2005.02285.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Blay JY, 2014, EUR J CANCER, V50, P1137, DOI 10.1016/j.ejca.2014.01.012; Grohar PJ, 2011, NEOPLASIA, V13, P145, DOI 10.1593/neo.101202; Ueda T, 2014, INVEST NEW DRUG, V32, P691, DOI 10.1007/s10637-014-0094-5; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; ESMO/European Sarcoma Network Working Group, 2014, ANN ONCOL, V3, piii102; GlaxoSmithKline, VOTRIENT PRESCR INF; Gronchi A, 2012, ANN ONCOL, V23, P771, DOI 10.1093/annonc/mdr265; Hendriks HR, 1999, ANN ONCOL, V10, P1233, DOI 10.1023/A:1008364727071; Le Cesne A, 2013, EXPERT REV ANTICANC, V13, P11, DOI [10.1586/era.13.49, 10.1586/ERA.13.49]; National Comprehensive Cancer Network (NCCN), 2014, CLIN PRACT GUID ONC; Poindessous V, 2003, CLIN CANCER RES, V9, P2817; Rosing H, 1998, J MASS SPECTROM, V33, P1134, DOI 10.1002/(SICI)1096-9888(1998110)33:11<1134::AID-JMS730>3.0.CO;2-S; Saanna GAI, REV WHO CLASSIFICATI; Sharma S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-385	30	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	APR	2015	16	4					406	416		10.1016/S1470-2045(15)70098-7		11	Oncology	Oncology	CE7LA	WOS:000352020000047		
J	Krug, LM; Kindler, HL; Calvert, H; Manegold, C; Tsao, AS; Fennell, D; Ohman, R; Plummer, R; Eberhardt, WEE; Fukuoka, K; Gaafar, RM; Lafitte, JJ; Hillerdal, G; Chu, Q; Buikhuisen, WA; Lubiniecki, GM; Sun, X; Smith, M; Baas, P				Krug, Lee M.; Kindler, Hedy L.; Calvert, Hilary; Manegold, Christian; Tsao, Anne S.; Fennell, Dean; Ohman, Ronny; Plummer, Ruth; Eberhardt, Wilfried E. E.; Fukuoka, Kazuya; Gaafar, Rabab M.; Lafitte, Jean-Jacques; Hillerdal, Gunnar; Chu, Quincy; Buikhuisen, Wieneke A.; Lubiniecki, Gregory M.; Sun, Xing; Smith, Margaret; Baas, Paul			Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial	LANCET ONCOLOGY			English	Article							HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; CELL LUNG-CANCER; ORAL VORINOSTAT; II TRIAL; COMBINATION; THERAPY; CARBOPLATIN; PACLITAXEL; CISPLATIN	Background Vorinostat is a histone deacetylase inhibitor that changes gene expression and protein activity. On the basis of the clinical benefit reported in patients with malignant pleural mesothelioma treated in a phase 1 study of vorinostat, we designed this phase 3 trial to investigate whether vorinostat given as a second-line or third-line therapy improved patients' overall survival. Methods This double-blind, randomised, placebo-controlled trial was done in 90 international centres. Patients with measurable advanced malignant pleural mesothelioma and disease progression after one or two previous systemic regimens were eligible. After stratification for Karnofsky performance status, histology, and number of previous chemotherapy regimens, patients were randomly assigned (1: 1) by use of an interactive voice response system with a block size of four to either treatment with vorinostat or placebo. Patients received oral vorinostat 300 mg (or matching placebo) twice daily on days 1, 2, 3, 8, 9, 10, 15, 16, and 17 of a 21-day cycle. The primary endpoints were overall survival and safety and tolerability of vorinostat. The primary efficacy comparison was done in the intention-to-treat population, and safety and tolerability was assessed in the treated population. This trial is registered with ClinicalTrials.gov, number NCT00128102. Findings From July 12, 2005, to Feb 14, 2011, 661 patients were enrolled and randomly assigned to receive either vorinostat (n= 329) or placebo (n= 332) and included in the intention-to-treat analysis. Median overall survival for vorinostat was 30.7 weeks (95% CI 26.7-36.1) versus 27.1 weeks (23.1-31.9) for placebo (hazard ratio 0.98, 95% CI 0.83-1.17, p= 0.86). The most common grade 3 or worse adverse events for patients treated with vorinostat were fatigue or malaise (51 [16%] patients in the vorinostat group vs 25 [8%] in the placebo group]) and dyspnoea (35 [11%] vs 45 [14%]). Interpretation In this randomised trial, vorinostat given as a second-line or third-line therapy did not improve overall survival and cannot be recommended as a therapy for patients with advanced malignant pleural mesothelioma.	[Krug, Lee M.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Kindler, Hedy L.] Univ Chicago, Chicago, IL 60637 USA; [Calvert, Hilary] UCL, Inst Canc, London, England; [Manegold, Christian] Heidelberg Univ, Med Ctr, Mannheim, Germany; [Tsao, Anne S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Fennell, Dean] Univ Leicester, Leicester, Leics, England; [Ohman, Ronny] Univ Hosp Skane Lund, Lund, Sweden; [Plummer, Ruth] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Eberhardt, Wilfried E. E.] Univ Duisburg Essen, Ruhrlandklin, Univ Hosp Essen, Essen, Germany; [Fukuoka, Kazuya] Kinki Univ, Fac Med, Osaka, Japan; [Gaafar, Rabab M.] Cairo Univ, Natl Canc Inst, Cairo, Egypt; [Lafitte, Jean-Jacques] Ctr Hosp Reg Univ Lille, Lille, France; [Hillerdal, Gunnar] Karolinska Hosp, S-10401 Stockholm, Sweden; [Chu, Quincy; Baas, Paul] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada; [Buikhuisen, Wieneke A.] Netherlands Canc Inst, Amsterdam, Netherlands; [Buikhuisen, Wieneke A.; Baas, Paul] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lubiniecki, Gregory M.; Sun, Xing; Smith, Margaret] Merck & Co Inc, Kenilworth, NJ USA; [Sun, Xing] Sanofi, Sanofi US, Bridgewater, NJ USA	Krug, LM (reprint author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	krugl@mskcc.org			Merck & Co, Kenilworth, NJ, USA	This study was funded by Merck & Co, Kenilworth, NJ, USA. Editorial assistance was provided by Kristen Lewis of Merck & Co, Kenilworth, NJ, USA. Participating institutions are listed in the appendix.	Vandermeers F, 2009, CLIN CANCER RES, V15, P2818, DOI 10.1158/1078-0432.CCR-08-1579; Scherpereel A, 2011, EUR RESPIR J, V37, P129, DOI 10.1183/09031936.00037310; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Ramalingam SS, 2009, J THORAC ONCOL, V4, P97, DOI 10.1097/JTO.0b013e318191520c; Dubey S, 2010, J THORAC ONCOL, V5, P1655, DOI 10.1097/JTO.0b013e3181ec18db; Zauderer MG, 2014, LUNG CANCER, V84, P271, DOI 10.1016/j.lungcan.2014.03.006; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Vansteenkiste J, 2008, INVEST NEW DRUG, V26, P483, DOI 10.1007/s10637-008-9131-6; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Ramalingam SS, 2010, J CLIN ONCOL, V28, P56, DOI 10.1200/JCO.2009.24.9094; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Byrne MJ, 2004, ANN ONCOL, V15, P257, DOI 10.1093/annonc/mdh059; Krug LM, 2006, CLIN LUNG CANCER, V7, P257, DOI 10.3816/CLC.2006.n.003; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Symanowski J, 2009, J THORAC ONCOL, V4, P149, DOI 10.1097/JTO.0b013e318194f991; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Paik PK, 2010, J THORAC ONCOL, V5, P275, DOI 10.1097/JTO.0b013e3181c5e366; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Cao XBX, 2001, AM J RESP CELL MOL, V25, P562; Chen L, 2007, P AM SOC CLIN ONCO S, V25, P18088; GEHAN EA, 1961, J CHRON DIS, V13, P346, DOI 10.1016/0021-9681(61)90060-1; Krug LM, 2011, P AM SOC CLIN ONCO S, V29, P7028; Neuzil Jiri, 2004, Biochemical and Biophysical Research Communications, V314, P186, DOI 10.1016/j.bbrc.2003.12.074; West AC, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27414	29	6	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	APR	2015	16	4					447	456		10.1016/S1470-2045(15)70056-2		10	Oncology	Oncology	CE7LA	WOS:000352020000051		
J	Ishiki, H; Iwase, S; Shimada, N; Chiba, T; Imai, K				Ishiki, Hiroto; Iwase, Satoru; Shimada, Naoki; Chiba, Tsukuru; Imai, Kohzoh			Panitumumab for locally advanced head and neck squamous-cell carcinoma	LANCET ONCOLOGY			English	Letter							LABEL PHASE-2 TRIAL; CHEMORADIOTHERAPY		[Ishiki, Hiroto; Iwase, Satoru; Shimada, Naoki; Chiba, Tsukuru] Univ Tokyo, Inst Med Sci, Dept Palliat Med, Tokyo, Japan; [Imai, Kohzoh] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo, Japan	Ishiki, H (reprint author), Univ Tokyo, Inst Med Sci, Dept Palliat Med, Tokyo, Japan.	ishiki-tky@umin.ac.jp					Vermorken JB, 2013, LANCET ONCOL, V14, P697, DOI 10.1016/S1470-2045(13)70181-5; Giralt J, 2015, LANCET ONCOL, V16, P221, DOI 10.1016/S1470-2045(14)71200-8; Mesia R, 2015, LANCET ONCOL, V16, P208, DOI 10.1016/S1470-2045(14)71198-2; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; NCCN, 2014, CLIN PRACT GUID TREA; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	APR	2015	16	4					E156	E156				1	Oncology	Oncology	CE7LA	WOS:000352020000006		
J	Sassa, K; Tsuchiya, S; Fukuoka, H; Mikos, M; Doan, L				Sassa, Kyoji; Tsuchiya, Satoshi; Fukuoka, Hiroshi; Mikos, Matjaz; Doan, Loi			Landslides: review of achievements in the second 5-year period (2009-2013)	LANDSLIDES			English	Review						Landslides; Impact factor; Citation; Classification	SUSCEPTIBILITY; RAINFALL; PREDICTION; REGRESSION; MODEL	The international journal Landslides: Journal of International Consortium on Landslides was established in April 2004. The aims of Landslides are to promote landslide science, technology, and capacity building, and to strengthen global cooperation for landslide risk reduction within the United Nations International Strategy for Disaster Risk Reduction (ISDR). The achievements of the first 5 years from the beginning of 2004 (Vol. 1, No. 1) to the mid-2009 (Vol. 6, No. 2) were reviewed in 2009 (Landslides 6: 275-286, 2009). This article presents the review for the second 5-year period from mid-2009 (Vol. 6, No. 3) to the end of 2013 (Vol. 10, No. 6), focusing on the journal's significance and its impact. We include an analysis of the classifications of articles in Landslides.	[Sassa, Kyoji] Int Consortium Landslides, Kyoto 6068226, Japan; [Tsuchiya, Satoshi] Shizuoka Univ, Fac Agr, Suruga Ku, Shizuoka 4228017, Japan; [Fukuoka, Hiroshi] Niigata Univ, Res Inst Nat Hazards & Disaster Recovery, Niigata 9502181, Japan; [Mikos, Matjaz] Univ Ljubljana, Fac Civil & Geodet Engn, SI-1000 Ljubljana, Slovenia; [Doan, Loi] Kyoto Univ, Grad Sch Engn, Kyoto 6158530, Japan	Sassa, K (reprint author), Int Consortium Landslides, Kyoto 6068226, Japan.	sassa@iclhq.org		Mikos, Matjaz/0000-0002-6343-3167			Xu C, 2013, LANDSLIDES, V10, P421, DOI 10.1007/s10346-012-0340-x; Martelloni G, 2012, LANDSLIDES, V9, P485, DOI 10.1007/s10346-011-0308-2; Akgun A, 2012, LANDSLIDES, V9, P93, DOI 10.1007/s10346-011-0283-7; Li ZH, 2010, LANDSLIDES, V7, P125, DOI 10.1007/s10346-009-0190-3; Fanti R, 2013, LANDSLIDES, V10, P409, DOI 10.1007/s10346-012-0329-5; Peng M, 2012, LANDSLIDES, V9, P13, DOI 10.1007/s10346-011-0271-y; Allen SK, 2011, LANDSLIDES, V8, P33, DOI 10.1007/s10346-010-0222-z; Xu C, 2014, LANDSLIDES, V11, P441, DOI 10.1007/s10346-013-0404-6; Yin YP, 2010, LANDSLIDES, V7, P339, DOI 10.1007/s10346-010-0220-1; Mansour MF, 2011, LANDSLIDES, V8, P117, DOI 10.1007/s10346-010-0227-7; Pradhan B, 2010, LANDSLIDES, V7, P13, DOI 10.1007/s10346-009-0183-2; Gigli G, 2014, LANDSLIDES, V11, P1, DOI 10.1007/s10346-012-0374-0; Trigila A, 2010, LANDSLIDES, V7, P455, DOI 10.1007/s10346-010-0213-0; Neuhauser B, 2012, LANDSLIDES, V9, P511, DOI 10.1007/s10346-011-0305-5; Herrera G, 2011, LANDSLIDES, V8, P195, DOI 10.1007/s10346-010-0239-3; Ravanel L, 2010, LANDSLIDES, V7, P493, DOI 10.1007/s10346-010-0206-z; Baum R, 2010, LANDSLIDES, V7, P259, DOI 10.1007/s10346-009-0177-0; Cervi F, 2010, LANDSLIDES, V7, P433, DOI 10.1007/s10346-010-0207-y; Chauhan S, 2010, LANDSLIDES, V7, P411, DOI 10.1007/s10346-010-0202-3; Yagi H, 2009, LANDSLIDES, V6, P335, DOI 10.1007/s10346-009-0182-3; Cui P, 2009, LANDSLIDES, V6, P209, DOI 10.1007/s10346-009-0160-9; Yin YP, 2009, LANDSLIDES, V6, P139, DOI 10.1007/s10346-009-0148-5; Cigna F, 2013, LANDSLIDES, V10, P267, DOI 10.1007/s10346-012-0335-7; Pagano L, 2010, LANDSLIDES, V7, P273, DOI 10.1007/s10346-010-0216-x; Casagli N, 2010, LANDSLIDES, V7, P291, DOI 10.1007/s10346-010-0215-y; Chang DS, 2011, LANDSLIDES, V8, P321, DOI 10.1007/s10346-011-0256-x; Capparelli G, 2011, LANDSLIDES, V8, P67, DOI 10.1007/s10346-010-0228-6; Capparelli G, 2010, LANDSLIDES, V7, P401, DOI 10.1007/s10346-009-0189-9; Cruden D.M., 1996, LANDSLIDES INVESTIGA, P36, DOI DOI 10.1007/BF02590167; Duc D, 2013, LANDSLIDES, V10, P219, DOI 10.1007/s10346-012-0362-4; Erener A, 2010, LANDSLIDES, V7, P55, DOI 10.1007/s10346-009-0188-x; Furumura T, 2011, LANDSLIDES, V8, P333, DOI 10.1007/s10346-011-0279-3; Guzzetti G, 2008, LANDSLIDES, V5, P3; Highland LM, 2008, US GEOLOGICAL SURVEY, P129; Sassa K, 2014, LANDSLIDES, V11, P827, DOI 10.1007/s10346-014-0501-1; Sassa K, 2014, P INT FOR URB LANDSL, P85; Sassa K, 2009, LANDSLIDES, V6, P275, DOI 10.1007/s10346-009-0172-5; Schulz WH, 2009, LANDSLIDES, V6, P181, DOI 10.1007/s10346-009-0157-4; Tang C, 2011, LANDSLIDES, V8, P485, DOI 10.1007/s10346-011-0269-5; Wu CH, 2014, LANDSLIDES, V11, P357, DOI 10.1007/s10346-013-0394-4	40	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	APR	2015	12	2					213	223		10.1007/s10346-015-0567-4		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE9ES	WOS:000352147300001		
J	Inoue, D; Kitaura, J; Matsui, H; Hou, HA; Chou, WC; Nagamachi, A; Kawabata, KC; Togami, K; Nagase, R; Horikawa, S; Saika, M; Micol, JB; Hayashi, Y; Harada, Y; Harada, H; Inaba, T; Tien, HF; Abdel-Wahab, O; Kitamura, T				Inoue, D.; Kitaura, J.; Matsui, H.; Hou, H-A; Chou, W-C; Nagamachi, A.; Kawabata, K. C.; Togami, K.; Nagase, R.; Horikawa, S.; Saika, M.; Micol, J-B; Hayashi, Y.; Harada, Y.; Harada, H.; Inaba, T.; Tien, H-F; Abdel-Wahab, O.; Kitamura, T.			SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS	LEUKEMIA			English	Article							ACUTE MYELOID-LEUKEMIA; PRIMARY MYELODYSPLASTIC SYNDROME; GROWTH-FACTOR-BETA; ASXL1 MUTATIONS; C-MYC; BCL-2-RELATED PROTEINS; EXCESSIVE APOPTOSIS; DISEASE PROGRESSION; GENETIC-BASIS; SELF-RENEWAL	Mutations in ASXL1 are frequent in patients with myelodysplastic syndrome (MDS) and are associated with adverse survival, yet the molecular pathogenesis of ASXL1 mutations (ASXL1-MT) is not fully understood. Recently, it has been found that deletion of Asxl1 or expression of C-terminal-truncating ASXL1-MTs inhibit myeloid differentiation and induce MDS-like disease in mice. Here, we find that SET-binding protein 1 (SETBP1) mutations (SETBP1-MT) are enriched among ASXL1-mutated MDS patients and associated with increased incidence of leukemic transformation, as well as shorter survival, suggesting that SETBP1-MT play a critical role in leukemic transformation of MDS. We identify that SETBP1-MT inhibit ubiquitination and subsequent degradation of SETBP1, resulting in increased expression. Expression of SETBP1-MT, in turn, inhibited protein phosphatase 2A activity, leading to Akt activation and enhanced expression of posterior Hoxa genes in ASXL1-mutant cells. Biologically, SETBP1-MT augmented ASXL1-MT-induced differentiation block, inhibited apoptosis and enhanced myeloid colony output. SETBP1-MT collaborated with ASXL1-MT in inducing acute myeloid leukemia in vivo. The combination of ASXL1-MT and SETBP1-MT activated a stem cell signature and repressed the tumor growth factor-beta signaling pathway, in contrast to the ASXL1-MT-induced MDS model. These data reveal that SETBP1-MT are critical drivers of ASXL1-mutated MDS and identify several deregulated pathways as potential therapeutic targets in high-risk MDS.	[Inoue, D.; Kitaura, J.; Kawabata, K. C.; Togami, K.; Nagase, R.; Horikawa, S.; Saika, M.; Hayashi, Y.; Kitamura, T.] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo 1088639, Japan; [Matsui, H.; Nagamachi, A.; Inaba, T.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Hou, H-A; Chou, W-C; Tien, H-F] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Div Hematol,Dept Internal Med, Taipei, Taiwan; [Micol, J-B; Abdel-Wahab, O.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Harada, Y.; Harada, H.] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan	Kitamura, T (reprint author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH [1K08CA160647-01]; US Department of Defense Postdoctoral Fellow Award in Bone Marrow Failure Research [W81XWH-12-1-0041]; Josie Robertson Investigator Program; Damon Runyon Clinical Investigator Award; Evans Foundation; National Science Council (Taiwan) [100-2314-B-002-057-MY3]	This work is mainly supported by Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan. OA-W is supported by an NIH K08 Clinical Investigator Award (1K08CA160647-01), a US Department of Defense Postdoctoral Fellow Award in Bone Marrow Failure Research (W81XWH-12-1-0041), the Josie Robertson Investigator Program and a Damon Runyon Clinical Investigator Award with support from the Evans Foundation. Clinical studies are partially sponsored by Grant No. 100-2314-B-002-057-MY3 from the National Science Council (Taiwan).	Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Parker JE, 2000, BLOOD, V96, P3932; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Cristobal I, 2011, LEUKEMIA, V25, P606, DOI 10.1038/leu.2010.294; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Oakley K, 2012, BLOOD, V119, P6099, DOI 10.1182/blood-2011-10-388710; Cristobal I, 2010, BLOOD, V115, P615, DOI 10.1182/blood-2009-06-227363; Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Meggendorfer M, 2013, LEUKEMIA, V27, P1852, DOI 10.1038/leu.2013.133; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Wang JP, 2014, BLOOD, V123, P541, DOI 10.1182/blood-2013-05-500272; Yamazaki J, 2013, INT J HEMATOL, V97, P175, DOI 10.1007/s12185-012-1197-4; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Dong M, 2006, BLOOD, V107, P4589, DOI 10.1182/blood-2005-10-4169; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Kon S, 2013, J CLIN INVEST, V123, P1123, DOI 10.1172/JCI63711; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gelsi-Boyer V, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-12; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj/onc/1205400; Hou HA, 2014, AM J HEMATOL, V89, P181, DOI 10.1002/ajh.23611; Imai Y, 2001, ONCOGENE, V20, P88, DOI 10.1038/sj.onc.1204057; Jakubowiak A, 2000, J BIOL CHEM, V275, P40282, DOI 10.1074/jbc.C000485200; Kita-Sasai Y, 2001, BRIT J HAEMATOL, V115, P309, DOI 10.1046/j.1365-2141.2001.03073.x; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Parker JE, 1998, BRIT J HAEMATOL, V103, P1075; RAZA A, 1995, BLOOD, V86, P268; Raza A, 1996, INT J HEMATOL, V63, P265; Thol F, 2013, LEUKEMIA, V27, P2072, DOI 10.1038/leu.2013.145	59	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	APR	2015	29	4					847	857		10.1038/leu.2014.301		11	Oncology; Hematology	Oncology; Hematology	CF5GY	WOS:000352586700012		
J	Kato, K; Okumura, T; Segawa, T; Unno, T; Greenidge, D; Nishioka, T; Mori, K; Tosaka, H; Nagaosa, K				Kato, Kenji; Okumura, Takuya; Segawa, Takuya; Unno, Takahito; Greenidge, Darius; Nishioka, Tetsu; Mori, Koji; Tosaka, Hiroyuki; Nagaosa, Kazuyo			Unveiled groundwater flushing from the deep seafloor in Suruga Bay	LIMNOLOGY			English	Article						Suruga Bay; Submarine groundwater discharge; GETFLOWS simulation modeling; Microbial response	DISCHARGE	Unveiling the submarine groundwater discharge (SGD) to the sea is an essential part of understanding groundwater flux and its ecological impact on marine ecosystems. Numerous studies have been conducted to estimate the SGD by measuring the chemical parameters, such as radioisotopes and heat flow. However, elucidating the SGD from the deep seafloor has not been efficient or effective. The aim of this study is to show the SGD in Suruga Bay (Japan) at a depth of 100 m, which was found based on the previously conducted simulation modeling using GETFLOWS. Suruga Bay is in relatively close proximity to Mt. Fuji, a volcanic mountain that has a large groundwater reservoir at its base. The observation location was indicated by simulation modeling, and a suggested SDG point was revealed through repeated in situ observations. The results of an incubation experiment conducted to estimate the function of springwater, flushing out from the deep sea bottom, suggest that phosphate-rich groundwater may enhance microbial growth. This may lead to the initiation of a microbial food web in deep coastal waters.	[Kato, Kenji; Okumura, Takuya; Segawa, Takuya; Unno, Takahito; Nagaosa, Kazuyo] Shizuoka Univ, Fac Sci, Dept Geosci, Suruga Ward, Shizuoka 4228529, Japan; [Greenidge, Darius] Shizuoka Univ, Int Ctr, Suruga Ward, Shizuoka 4228529, Japan; [Nishioka, Tetsu; Mori, Koji] Geosphere Environm Technol Corp, Chiyoda Ward, Tokyo 1010063, Japan; [Tosaka, Hiroyuki] Univ Tokyo, Sch Engn, Dept Syst Innovat, Bunkyo Ward, Tokyo 1138656, Japan	Kato, K (reprint author), Shizuoka Univ, Fac Sci, Dept Geosci, Suruga Ward, 836 Oya, Shizuoka 4228529, Japan.	skkato@ipc.shizuoka.ac.jp			River Front Research Institute; River Fund from the River Foundation, Japan; Japan Society for the Promotion of Science [23241016, 26257402]	We thank the captain and crew of the Tanseimaru. We also thank Captain S. Hori of Miho Marina Co. Ltd., who supported the field study. This study was partly supported by a research fund supplied by the River Front Research Institute, by the River Fund from the River Foundation, Japan, and by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (nos. 23241016 and 26257402).	Moore WS, 1996, NATURE, V380, P612, DOI 10.1038/380612a0; Post VEA, 2013, NATURE, V504, P71, DOI 10.1038/nature12858; Church TM, 1996, NATURE, V380, P579, DOI 10.1038/380579a0; Tosaka H, 2000, HYDROL PROCESS, V14, P449, DOI 10.1002/(SICI)1099-1085(20000228)14:3<449::AID-HYP948>3.0.CO;2-9; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943; Mallast U, 2013, ENVIRON EARTH SCI, V69, P587, DOI 10.1007/s12665-013-2371-6; Grabe A, 2013, ENVIRON EARTH SCI, V69, P571, DOI 10.1007/s12665-012-1795-8; Katsuki M, 2009, FROM HEADWATERS TO THE OCEAN: HYDROLOGICAL CHANGES AND WATERSHED MANAGEMENT, P625; Mori K, 2010, IAHR INT GROUNDW S; Segawa T, 2014, GEOMICROBIO IN PRESS; Taniguchi M, 2009, FROM HEADWATERS TO THE OCEAN: HYDROLOGICAL CHANGES AND WATERSHED MANAGEMENT, P613; Tosaka H, 2010, IAHR INT GROUNDW S; Winter TC, 1999, HYDROGEOL J, V7, P28, DOI 10.1007/s100400050178; Younger PL, 1996, NATURE, V382, P121, DOI 10.1038/382121a0	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1439-8621	1439-863X		LIMNOLOGY	Limnology	APR	2015	16	2					79	83		10.1007/s10201-014-0445-0		5	Limnology	Marine & Freshwater Biology	CF3LQ	WOS:000352450600001		
J	Takaoka, S				Takaoka, Sadao			Origin and geographical characteristics of ponds in a high mountain region of central Japan	LIMNOLOGY			English	Article						Alpine pond; Japanese Alps; Landslide ecosystem; Mass movement; Wetland biodiversity	ALPINE TREELINE; BIODIVERSITY; LANDSCAPE; DIVERSITY; LANDSLIDE; LAKES; COMMUNITIES; RICHNESS; ALTITUDE; SIZE	This study examines the role of landforms in pond formation in alpine and subalpine regions of central Japan. Mountain ponds larger than ca. 50 m(2) were detected by interpretation of stereo-paired aerial photographs, and mapped in areas over 2000 m (above sea level). The mapped ponds totaled 304 in the 1347 km(2) study area. Mass movement landforms are the major sites of pond basins, comprising 66.5 % of the total number; 65 ponds occur in depressions in displaced masses downslope of ridges, and 137 occur in linear depressions along main ridges. These ponds occur frequently in the snowiest parts of the study area, although geological setting also affects pond formation. The second and third major types of landforms with ponds are of volcanic and glacial origins, accounting for 16.8 and 15.8 % of all ponds, respectively. Nearly 90 % of these mapped ponds have an area smaller than 1000 m(2). The size distribution of ponds varies with origin type. Mass movement landforms have a greater range of pond sizes, including both small (< 1000 m(2)) and medium (1000-6000 m(2)), than do glacial and periglacial landforms. Volcanic landforms have the largest ponds, which exceed 10,000 m(2) in some cases. Ponds on glacial landforms are at higher elevations and may be of uniform age post-glaciation, while other landform types can occur at any elevation and may span a wide range of ages. Landslide ponds may provide better habitats for aquatic species than those originating from other landforms, because they are not subject to the strong acid conditions of volcanic ponds or the longer snow-covered period of ponds on glacial landforms.	Senshu Univ, Dept Geog, Tama Ku, Kawasaki, Kanagawa 2148580, Japan	Takaoka, S (reprint author), Senshu Univ, Dept Geog, Tama Ku, 2-1-1 Higashimita, Kawasaki, Kanagawa 2148580, Japan.	takaoka@isc.senshu-u.ac.jp			JSPS KAKENHI [24300321, 26350404]	This work was supported by JSPS KAKENHI Grant Numbers 24300321 and 26350404. The author is grateful to Professor Yoshihiko Kariya of Senshu University for his valuable comments during the course of this work. The author also benefited from discussions with Dr. Hitoshi Saito of Kanto Gakuin University and members of Research Group for Natural History in Kamikochi. The paper has been improved by reviewers' helpful comments and suggestions.	Alexandrowicz Z, 2010, GEOMORPHOLOGY, V123, P290, DOI 10.1016/j.geomorph.2010.07.020; Malanson GP, 2007, PHYS GEOGR, V28, P378, DOI 10.2747/0272-3646.28.5.378; Resler LM, 2006, PROF GEOGR, V58, P124, DOI 10.1111/j.1467-9272.2006.00520.x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Robinson CT, 2009, ECO MONT, V1, P23; Saito H, 2009, GEOMORPHOLOGY, V109, P108, DOI 10.1016/j.geomorph.2009.02.026; Korup O, 2004, ENG GEOL, V73, P13, DOI 10.1016/j.enggeo.2003.11.003; Hinden H, 2005, AQUAT CONSERV, V15, P613, DOI 10.1002/aqc.751; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Martinez-Sanz C, 2012, J LIMNOL, V71, P154, DOI 10.4081/jlimnol.2012.e16; Aoki K, 2003, Z GEOMORPHOL N F, V130, P195; Branstrator DK, 2010, LAKE ECOSYSTEM ECOLO, P191; Bronmark C, 2005, BIOL LAKES PONDS; Catalan J, 2006, LIMNETICA, V25, P551; CHIGIRA M, 1992, ENG GEOL, V32, P157, DOI 10.1016/0013-7952(92)90043-X; Coe JA, 2009, EARTH SURF PROC LAND, V34, P264, DOI 10.1002/esp.1721; Fukui K, 2012, J JPN SOC SNOW ICE, V74, P213; Fureder L, 2006, HYDROBIOLOGIA, V562, P123, DOI 10.1007/s10750-005-1808-7; Gansert D, 2004, FLORA, V199, P143, DOI 10.1078/0367-2530-00143; Geertsema M, 2007, GEOMORPHOLOGY, V89, P55, DOI 10.1016/j.geomorph.2006.07.019; Hamerlik L, 2014, HYDROBIOLOGIA, V723, P41, DOI 10.1007/s10750-013-1621-7; Harayama S, 2003, QUATERNARY RES, V42, P127; Ilg C, 2014, HYDROBIOLOGIA, V723, P53, DOI 10.1007/s10750-013-1538-1; Iozawa T, 1979, JAPANESE ALPS ATLAS; Iwata S, 2003, QUATERNARY RES, V42, P181; Japan Meteorological Agency, 2012, MESH CLIM DAT 2010; Kariya Y, 2013, J GEOGR CHIGAKU ZASS, V122, P768; Kariya Y, 2009, GEOGRAPHICAL REPORTS, V44, P63; Koizumi T., 1980, B TOKYO GAKUGEI U 3, V31, P93; Mizuno K, 1991, GEOGR REP TOKYO METR, V26, P167; Oikawa O, 2003, QUAT RES TOKYO, V42, P141; Panek T, 2007, STUDIA GEOMORPHOLOGI, V41, P77; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Raab T, 2012, PHYS GEOGR, V33, P305, DOI 10.2747/0272-3646.33.4.305; Sakaguchi Y., 1980, GEOGRAPHY JAPAN, P3; Sato G, 2014, MAP J JPN CARTOGR AS, V52, P1; Swansons FJ, 1986, GEOTECHNICAL SPECIAL, V3, P131; Takada M, 1992, J GEOGR, V101, P594; Takaoka S, 2012, J GEOGR CHIGAKU ZASS, V121, P402; Toro Manuel, 2006, Limnetica, V25, P217; Walker LR, 2013, LANDSLIDE ECOLOGY; WATANABE T, 1989, MT RES DEV, V9, P129, DOI 10.2307/3673476; Watanabe Y, 1995, ANN ENV SCI SHINSHU, V17, P51; Witten IH, 2005, DATA MINING PRACTICA	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1439-8621	1439-863X		LIMNOLOGY	Limnology	APR	2015	16	2					103	112		10.1007/s10201-014-0444-1		10	Limnology	Marine & Freshwater Biology	CF3LQ	WOS:000352450600004		
J	Yamada, Y; Fukuda, T; Omori, K; Nakano, T				Yamada, Yoshihiro; Fukuda, Tatsuya; Omori, Koji; Nakano, Takanori			Origin of particulate organic matter in a river with remarkable water pollution in Shikoku Island, Japan	LIMNOLOGY			English	Article						Particulate organic matter; Water use; Irrigation pond; Kagawa Prefecture; Algae	STABLE-ISOTOPES; PHYTOPLANKTON	This study on the origin of particulate organic matter (POM) in a river under efficient water use for irrigation in a basin was carried out on the Shin River in Kagawa Prefecture, Japan. The organic pollution in the basin where water resources are scarce was studied. The level of POM in the Shin River was significantly influenced by the natural and artificial hydrological environment in the river basin. The degree of organic pollution in the Shin River was high, and most of the organic matter was algae. The delta O-18 of water of the middle and lower reaches of the Shin River was high, and water subjected to evaporation for a lengthy time period in the basin flows into the river. The concentration of organic matter in the Shin increases along with the increase in delta O-18. Algae also increases in the stay waters in the basin of the middle-lower reaches and flows into the Shin. It was thought that the irrigation ponds in the basin were the main sources of water and organic matter for the river. This tendency was notable during the nonirrigation season in that the volume of water in the basin decreased. On the other hand, the proportion of algae in organic matter in the river decreased when there was considerable precipitation.	[Yamada, Yoshihiro] Kagawa Univ, Fac Agr, Kita Ku, Takamatsu, Kagawa 7610795, Japan; [Fukuda, Tatsuya] Ehime Univ, United Grad Sch Agr Sci, Kita Ku, Matsuyama, Kagawa 7610795, Japan; [Omori, Koji] Ehime Univ, Fac Sci, Matsuyama, Ehime 7900862, Japan; [Nakano, Takanori] Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan	Yamada, Y (reprint author), Kagawa Univ, Fac Agr, Kita Ku, 2393 Ikenobe Miki Cho, Takamatsu, Kagawa 7610795, Japan.	yamaday@ag.kagawa-u.ac.jp			Foundation of River and Watershed Environment Management, Japan; Water Resources Environment Center, Japan	This study was supported in part by the River Fund from the Foundation of River and Watershed Environment Management, Japan, and Water Resources Environment Center, Japan. The authors are grateful to Dr. Hideki Hamaoka, Center for Marine Environmental Studies, Ehime University, for assistance with the chemical measurements.	Nakashima S, 2007, LIMNOLOGY, V8, P1, DOI 10.1007/s10201-006-0191-z; DANSGAARD W, 1964, TELLUS, V16, P436; House WA, 1997, SCI TOTAL ENVIRON, V205, P25, DOI 10.1016/S0048-9697(97)00086-7; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Clark I., 1997, ENV ISOTOPES HYDROGE, P328; DESCY JP, 1994, HYDROBIOLOGIA, V289, P139, DOI 10.1007/BF00007415; Fette M, 2005, APPL GEOCHEM, V20, P701, DOI 10.1016/j.apgeochem.2004.11.006; Gibson J. J., 2002, GLOBAL BIOGEOCHEMICA, V16, P10, DOI DOI 10.1029/2001GB001839; Gibson JJ, 2010, J HYDROL, V381, P142, DOI 10.1016/j.jhydrol.2009.11.036; Hatch Lorin K., 2002, Archiv fuer Hydrobiologie Supplement, V141, P85; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Houhou J, 2010, WATER RES, V44, P256, DOI 10.1016/j.watres.2009.09.024; Japan Meteorological Agency, 2013, WEATH STAT WEATH DAT; Kagawa Canal land improvement districts, 2012, AM WAT SUPPL KAG CAN; Kagawa Prefecture, 2012, FLOOD DATA WATER LEV; Machida I, 2003, J JPN SOC HYDROL WAT, V16, P556, DOI 10.3178/jjshwr.16.556; Maruyama J, 2008, J JPN SOC WATER ENV, V31, P463; MURAKAMI T, 1992, Japanese Journal of Limnology, V53, P1; Murakami Tetuo, 1994, Japanese Journal of Limnology, V55, P13; OECD, 1982, EUTR WAT MON ASS CON, DOI [10.1002/iroh.19840690206, DOI 10.1002/IROH.19840690206]; RIEMANN B, 1989, J PLANKTON RES, V11, P1037, DOI 10.1093/plankt/11.5.1037; Sakamoto M., 1966, ARCH HYDROBIOL, V62, P1; Suzuki M., 1985, Journal of the Japanese Forestry Society, V67, P115; Yamada Y, 2010, LIMNOLOGY, V11, P267, DOI 10.1007/s10201-009-0308-2; Yuan F, 2008, CHEM GEOL, V255, P220, DOI 10.1016/j.chemgeo.2008.06.045	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1439-8621	1439-863X		LIMNOLOGY	Limnology	APR	2015	16	2					127	137		10.1007/s10201-015-0446-7		11	Limnology	Marine & Freshwater Biology	CF3LQ	WOS:000352450600006		
J	Qiao, YH; Yamada, T; Kanamori, Y; Kida, R; Shigematsu, M; Fujimoto, Y; Tomonaga, S; Matsui, T; Funaba, M				Qiao, Yuhang; Yamada, Tomoya; Kanamori, Yohei; Kida, Ryosuke; Shigematsu, Mei; Fujimoto, Yusuke; Tomonaga, Shozo; Matsui, Tohru; Funaba, Masayuki			Regulatory expression of components in the BMP pathway in white adipose tissues of cattle	LIVESTOCK SCIENCE			English	Article						BMP; Brown adipocyte; Beige adipocyte; Cattle	ADAPTIVE THERMOGENESIS; BROWN; FAT; ADIPOCYTES; UCP1; MUSCLE; OBESITY; PRDM16; SIGNAL; CELLS	The BMP pathway positively regulates murine brown adipogenesis. We herein examined the mRNA levels of BMPs and activin beta B as well as receptors for the BMP pathway in the adipose tissues of cattle fed diets with a differential ratio of concentrate to roughage or a vitamin A-deficient diet. The expression of activin beta B was significantly increased in the subcutaneous fat depot of animals fed the concentrate diet, while the vitamin A-deficient diet significantly increased the expression of BMP4 in the mesenteric fat depot. The expression of receptors for the BMP pathway, ALK2, ALK3, ActRIIA, and BMPR2, showed a similar pattern to that of BMP4 and activin beta B in response to the dietary treatments. The results of the present study demonstrated that diet modulated the expression of components of the BMP pathway and may be responsible for the regulatory expression of brown/beige adipocyte-related genes in the adipose tissues of cattle. (C) 2015 Elsevier B.V. All rights reserved.	[Qiao, Yuhang; Kanamori, Yohei; Kida, Ryosuke; Shigematsu, Mei; Fujimoto, Yusuke; Tomonaga, Shozo; Matsui, Tohru; Funaba, Masayuki] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Yamada, Tomoya] Natl Inst Livestock & Grassland Sci, Nasushiobara 3292793, Japan	Funaba, M (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	mfunaba@kais.kyoto-u.ac.jp		Tomonaga, Shozo/0000-0003-0888-1407	Japan Society for the Promotion of Science [23580368, 26292137]	This work was supported by a Grant-in-Aid for Scientific Research (nos. 23580368 and 26292137) from The Japan Society for the Promotion of Science.	Xue RD, 2014, AM J PHYSIOL-ENDOC M, V306, pE363, DOI 10.1152/ajpendo.00119.2013; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Duran EM, 2005, FRONT BIOSCI-LANDMRK, V10, P2955, DOI 10.2741/1751; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Sjoholm K, 2006, BIOCHEM BIOPH RES CO, V344, P1308, DOI 10.1016/j.bbrc.2006.04.030; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Bonnet M, 2010, ANIMAL, V4, P1093, DOI 10.1017/S1751731110000601; Yamada T, 2012, MEAT SCI, V90, P807, DOI 10.1016/j.meatsci.2011.11.019; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; ALEXANDER G, 1978, AUST J BIOL SCI, V31, P489; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Asano H, 2013, GEN COMP ENDOCR, V184, P87, DOI 10.1016/j.ygcen.2013.01.006; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Kanamori Y, 2014, J VET MED SCI, V76, P1261, DOI 10.1292/jvms.14-0137; Landis MD, 2002, J ANIM SCI, V80, P591; Miyazono K, 2000, J CELL SCI, V113, P1101; Oelkrug R, 2014, FREE RADICAL BIO MED, V77, P210, DOI 10.1016/j.freeradbiomed.2014.09.004; Schleinitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016155; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Yamada T, 2013, J VET MED SCI, V75, P1021, DOI 10.1292/jvms.13-0071	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1871-1413	1878-0490		LIVEST SCI	Livest. Sci.	APR	2015	174						144	149		10.1016/j.livsci.2015.02.008		6	Agriculture, Dairy & Animal Science	Agriculture	CF1TG	WOS:000352330200018		
J	Endo, M; de Graaff, MA; Ingram, DR; Lim, S; Lev, DC; Riaire-De Bruijn, IH; Somaiah, N; Bovee, JVMG; Lazar, AJ; Nielseni, TO				Endo, Makoto; de Graaff, Marieke A.; Ingram, Davis R.; Lim, Simin; Lev, Dina C.; Riaire-de Bruijn, Inge H.; Somaiah, Neeta; Bovee, Judith V. M. G.; Lazar, Alexander J.; Nielseni, Torsten O.			NY-ESO-1 (CTAG1B) expression in mesenchymal tumors	MODERN PATHOLOGY			English	Article							MYXOID/ROUND CELL LIPOSARCOMA; SYNOVIAL SARCOMA; IMMUNOHISTOCHEMICAL MARKER; ANTIGEN NY-ESO-1; CANCER; TISSUE	New York esophageal squamous cell carcinoma 1 (NY-ESO-1, CTAG1B) is a cancer-testis antigen and currently a focus of several targeted immunotherapeutic strategies. We performed a large-scale immunohistochemical expression study of NY-ESO-1 using tissue microarrays of mesenchymal tumors from three institutions in an international collaboration. A total of 1132 intermediate and malignant and 175 benign mesenchymal lesions were enrolled in this study. Immunohistochemical staining was performed on tissue microarrays using a monoclonal antibody for NY-ESO-1. Among mesenchymal tumors, myxoid liposarcomas showed the highest positivity for NY-ESO-1 (88%), followed by synovial sarcomas (49%), myxofibrosarcomas (35%), and conventional chondrosarcomas (28%). Positivity of NY-ESO-1 in the remaining mesenchymal tumors was consistently low, and no immunoreactivity was observed in benign mesenchymal lesions. On the basis of these findings, nearly 90% of myxoid liposarcomas, as well as a significant proportion of synovial sarcomas, myxofibrosarcomas, and conventional chondrosarcomas are good candidates for immunotherapy targeting NY-ESO-1.	[Endo, Makoto; Lim, Simin; Nielseni, Torsten O.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3Z6, Canada; [Endo, Makoto] Kyushu Univ, Dept Orthopaed Surg, Fukuoka 812, Japan; [de Graaff, Marieke A.; Riaire-de Bruijn, Inge H.; Bovee, Judith V. M. G.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Ingram, Davis R.; Lev, Dina C.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Somaiah, Neeta] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA; [Lazar, Alexander J.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Nielseni, TO (reprint author), Univ British Columbia, Dept Pathol & Lab Med, Room 509-2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	torsten@mail.ubc.ca					Nicholaou T, 2006, IMMUNOL CELL BIOL, V84, P303, DOI 10.1111/j.1440-1711.2006.01446.x; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Demicco EG, 2012, MODERN PATHOL, V25, P212, DOI 10.1038/modpathol.2011.148; Powers MP, 2010, MODERN PATHOL, V23, P1307, DOI 10.1038/modpathol.2010.118; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Terry J, 2007, AM J SURG PATHOL, V31, P240, DOI 10.1097/01.pas.0000213330.71745.39; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Cheng HW, 2009, HUM PATHOL, V40, P1244, DOI 10.1016/j.humpath.2009.01.011; Endo M, 2014, HUM PATHOL, V45, P276, DOI 10.1016/j.humpath.2013.09.003; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Ferrari A, 2004, CANCER, V101, P627, DOI 10.1002/cncr.20386; Hoffman A, 2013, CANCER-AM CANCER SOC, V119, P1868, DOI 10.1002/cncr.27847; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Jungbluth AA, 2001, INT J CANCER, V94, P252, DOI 10.1002/ijc.1451; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; de Graaff MA, 2013, HUM PATHOL, V44, P1597, DOI 10.1016/j.humpath.2013.01.006; Fletcher CDM, 2013, PATHOLOGY GENETICS T; Hemminger JA, 2013, MODERN PATHOL, V26, P282, DOI 10.1038/modpathol.2012.133; Hemminger JA, 2013, MODERN PATHOL, V26, P1204, DOI 10.1038/modpathol.2013.65; Kilpatrick SE, 1996, CANCER, V77, P1450, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1450::AID-CNCR5>3.0.CO;2-G; Lai JP, 2012, MODERN PATHOL, V25, P854, DOI 10.1038/modpathol.2012.31; Meijer Danielle, 2011, Clin Sarcoma Res, V1, P5, DOI 10.1186/2045-3329-1-5; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Nielsen TO, 2003, AM J PATHOL, V163, P1449, DOI 10.1016/S0002-9440(10)63502-X; Pacheco M, 2012, MODERN PATHOL, V25, P222, DOI 10.1038/modpathol.2011.157; Pollack SM, 2012, PLOS ONE, V2012; Pollack SM, 2012, CANCER-AM CANCER SOC, V118, P4564, DOI 10.1002/cncr.27446; Steigen SE, 2008, J HISTOCHEM CYTOCHEM, V56, P139, DOI 10.1369/jhc.7A7333.2007; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Waaijer CJF, 2012, VIRCHOWS ARCH, V461, P475, DOI 10.1007/s00428-012-1300-5; Willems SM, 2008, HISTOPATHOLOGY, V52, P465, DOI 10.1111/j.1365-2559.2008.02967.x	32	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	APR	2015	28	4					587	595		10.1038/modpathol.2014.155		9	Pathology	Pathology	CF1OF	WOS:000352315000013		
J	Fukasawa, Y; Tsuji, J; Fu, SC; Tomii, K; Horton, P; Imai, K				Fukasawa, Yoshinori; Tsuji, Junko; Fu, Szu-Chin; Tomii, Kentaro; Horton, Paul; Imai, Kenichiro			MitoFates: Improved Prediction of Mitochondrial Targeting Sequences and Their Cleavage Sites	MOLECULAR & CELLULAR PROTEOMICS			English	Article							PROTEIN IMPORT; PARKIN RECRUITMENT; EM ALGORITHM; IN-VIVO; MUTATIONS; TOM20; PRESEQUENCES; RECOGNITION; PROTEOMICS; SIGNAL	Mitochondria provide numerous essential functions for cells and their dysfunction leads to a variety of diseases. Thus, obtaining a complete mitochondrial proteome should be a crucial step toward understanding the roles of mitochondria. Many mitochondrial proteins have been identified experimentally but a complete list is not yet available. To fill this gap, methods to computationally predict mitochondrial proteins from amino acid sequence have been developed and are widely used, but unfortunately, their accuracy is far from perfect. Here we describe MitoFates, an improved prediction method for cleavable N-terminal mitochondrial targeting signals (presequences) and their cleavage sites. MitoFates introduces novel sequence features including positively charged amphiphilicity, presequence motifs, and position weight matrices modeling the presequence cleavage sites. These features are combined with classical ones such as amino acid composition and physico-chemical properties as input to a standard support vector machine classifier. On independent test data, MitoFates attains better performance than existing predictors in both detection of presequences and in predicting their cleavage sites. We used MitoFates to look for undiscovered mitochondrial proteins from 42,217 human proteins (including isoforms such as alternative splicing or translation initiation variants). MitoFates predicts 1167 genes to have at least one isoform with a presequence. Five-hundred and eighty of these genes were not annotated as mitochondrial in either UniProt or Gene Ontology. Interestingly, these include candidate regulators of parkin translocation to damaged mitochondria, and also many genes with known disease mutations, suggesting that careful investigation of MitoFates predictions may be helpful in elucidating the role of mitochondria in health and disease. MitoFates is open source with a convenient web server publicly available.	[Fukasawa, Yoshinori; Tsuji, Junko; Fu, Szu-Chin; Tomii, Kentaro; Horton, Paul] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2778561, Japan; [Tomii, Kentaro; Horton, Paul; Imai, Kenichiro] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan	Horton, P (reprint author), Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	horton-p@aist.go.jp; kenichiro.imai@aist.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [3308]; grant of the Platform for Drug Discovery, Informatics, and Structural Life Science;  [12J06550]	This work was supported by a grant of the Platform for Drug Discovery, Informatics, and Structural Life Science, Grants-in-Aid for Scientific Research on Innovative Areas ("Matryoshka-type evolution", No. 3308) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Grant-in-Aid for JSPS Fellows (No. 12J06550).	Ambard-Bretteville F, 2003, BIOCHEM BIOPH RES CO, V311, P966, DOI 10.1016/j.bbrc.2003.10.099; VONHEIJNE G, 1986, EMBO J, V5, P1335; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; ABODERIN AA, 1971, INT J BIOCHEM, V2, P537, DOI 10.1016/0020-711X(71)90023-1; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Terada A, 2013, P NATL ACAD SCI USA, V110, P12996, DOI 10.1073/pnas.1302233110; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; CELEUX G, 1992, COMPUT STAT DATA AN, V14, P315, DOI 10.1016/0167-9473(92)90042-E; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; Boutet Emmanuel, 2007, V406, P89; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Obita T, 2003, J MOL BIOL, V328, P495, DOI 10.1016/S0022-2836(03)00288-2; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/bse0470115, 10.1042/BSE0470115]; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Huang SB, 2009, PLANT PHYSIOL, V150, P1272, DOI 10.1104/pp.109.137885; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Candat A, 2013, ANAL BIOCHEM, V434, P44, DOI 10.1016/j.ab.2012.10.040; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Fukasawa Y., 2014, BMC GENOMICS, V15; Gakh Oleksandr, 2002, Biochimica et Biophysica Acta, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278; Heijne G., 1989, EUR J BIOCHEM, V180, P535, DOI 10.1111/j.1432-1033.1989.tb14679.x; Ieva R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3853; Imai K., 2011, BMC GENOMICS, V12; Imai K. a. M. S., 2005, BIOPHYSICS-USSR, V1, P55, DOI 10.2142/biophysics.1.55; Lee CM, 1999, J BIOL CHEM, V274, P20937, DOI 10.1074/jbc.274.30.20937; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Savojardo C, 2014, BIOINFORMATICS, V30, P2973, DOI 10.1093/bioinformatics/btu411; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Smith AC, 2012, NUCLEIC ACIDS RES, V40, pD1160, DOI 10.1093/nar/gkr1101; Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180; TAKAKUBO F, 1995, AM J HUM GENET, V57, P772; Tien-ho Lin R. F. M., 2011, IEEE ACM T COMPUT BI, V9, P441; Van Driest SL, 2005, MOL GENET METAB, V85, P280, DOI 10.1016/j.ymgme.2005.04.010; Verhagen AM, 2007, CELL DEATH DIFFER, V14, P348, DOI 10.1038/sj.cdd.4402001; Yamamoto H., 2010, P NATL ACAD SCI USA, V108, P91; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	68	5	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	APR	2015	14	4					1113	1126		10.1074/mcp.M114.043083		14	Biochemical Research Methods	Biochemistry & Molecular Biology	CE9WP	WOS:000352194400024		
J	Yoshii, A; Omatsu, T; Katayama, Y; Koyama, S; Mizutani, T; Moriyama, H; Fukuhara, T				Yoshii, Atsushi; Omatsu, Tsutomu; Katayama, Yukie; Koyama, Satoshi; Mizutani, Tetsuya; Moriyama, Hiromitsu; Fukuhara, Toshiyuki			Two types of genetic carrier, the IncP genomic island and the novel IncP-1 beta plasmid, for the aac(2 ')-IIa gene that confers kasugamycin resistance in Acidovorax avenae ssp avenae	MOLECULAR PLANT PATHOLOGY			English	Article						Acidovorax; antibiotic resistance; Burkholderia; genomic island; IncP-1 beta plasmid; kasugamycin; rice	WATER TREATMENT-PLANT; ERWINIA-AMYLOVORA; PROVIDES EVIDENCE; ESCHERICHIA-COLI; ACCESSORY GENES; TRANSPOSON; SEQUENCE; RICE; STREPTOMYCIN; BACKBONE	A unique aminoglycoside antibiotic, kasugamycin (KSM), has been used to control many plant bacterial and fungal diseases in several countries. The emergence of KSM-resistant Acidovorax avenae ssp. avenae and Burkholderia glumae, which cause rice bacterial brown stripe and rice bacterial grain and seedling rot, respectively, is a serious threat for the effective control of these diseases. Previously, we have identified the aac(2')-IIa gene, encoding a KSM 2'-N-acetyltransferase, from both KSM-resistant pathogens. Although all KSM-resistant isolates from both species possess the aac(2')-IIa gene, only A. avenae strain 83 showed higher resistance than other strains. In this research, kinetic analysis indicates that an amino acid substitution from serine to threonine at position 146 of AAC(2')-IIa in strain 83 is not involved in this increased resistance. Whole draft genome analysis of A. avenae 83 shows that the aac(2')-IIa gene is carried by the novel IncP-1 beta plasmid pAAA83, whereas the genetic carrier of other strains, the IncP genomic island, is inserted into their chromosomes. The difference in the nucleotides of the promoter region of aac(2')-IIa between strain 83 and other strains indicates an additional transcription start site and results in the increased transcription of aac(2')-IIa in strain 83. Moreover, biological characterization of pAAA83 demonstrates that it can be transferred by conjugation and maintained in the host cells. These results demonstrate that acquisition of the aac(2')-IIa gene takes place in at least two ways and that the gene module, which includes aac(2')-IIa and the downstream gene, may be an important unit for the dissemination of antibiotic resistance.	[Yoshii, Atsushi] Hokko Chem Ind Co Ltd, Cent Res Labs, Atsugi, Kanagawa 2430023, Japan; [Yoshii, Atsushi; Moriyama, Hiromitsu; Fukuhara, Toshiyuki] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Omatsu, Tsutomu; Katayama, Yukie; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan; [Koyama, Satoshi] Tokyo Univ Agr & Technol, Cooperat Dept Vet Med, Fuchu, Tokyo 1838509, Japan	Yoshii, A (reprint author), Hokko Chem Ind Co Ltd, Cent Res Labs, Toda 2165, Atsugi, Kanagawa 2430023, Japan.	yoshii-a@hokkochem.co.jp	Omatsu, Tsutomu/C-8344-2013; Koyama, Satoshi/C-8369-2013; MORIYAMA, Hiromitsu/F-9256-2013; Fukuhara, Toshiyuki/C-3208-2013	Omatsu, Tsutomu/0000-0001-7860-7409; 			Abe H., 2005, 15 S RES COMM FUNG R, P29; AIBA H, 1981, J BIOL CHEM, V256, P1905; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P182, DOI 10.1094/PHYTO-04-10-0127; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; Szczepanowski R, 2007, ANTIMICROB AGENTS CH, V51, P673, DOI 10.1128/AAC.00802-06; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Xie GL, 2011, J BACTERIOL, V193, P5013, DOI 10.1128/JB.05594-11; Adaskaveg JE, 2011, PLANT DIS, V95, P448, DOI 10.1094/PDIS-09-10-0679; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P192, DOI 10.1094/PHYTO-04-10-0128; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.026570-0; Vivian A, 2001, MICROBIOL-UK, V147, P763; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Francia MV, 1999, J BACTERIOL, V181, P6844; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Domingues S, 2012, MOB GENET ELEMENTS, V2, P211, DOI DOI 10.4161/MGE.22967; Gelder L.D., 2007, MICROBIOL, V153, P452; Goto K., 1956, ANN PHYTOPATHOL SOC, V21, P46; Harada KM, 2006, PLASMID, V56, P11, DOI 10.1016/j.plasmid.2005.12.002; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Hiramatsu M., 1989, P 7 INT C PLANT PATH, P219; Hori T., 2007, ANN PHYTOPATHOL SOC, V73, P278; IKEKAWA T, 1966, J ANTIBIOT, V19, P49; ISHIYAMA T, 1965, J ANTIBIOT, V18, P115; Jurgens AG, 2013, PLANT DIS, V97, P1484, DOI 10.1094/PDIS-02-13-0209-RE; Kamachi K, 2006, MICROBIOL-SGM, V152, P3477, DOI 10.1099/mic.0.29056-0; L'abee-Lund TM, 2000, APPL ENVIRON MICROB, V66, P5533, DOI 10.1128/AEM.66.12.5533-5535.2000; Lavigne JP, 2005, INFECT IMMUN, V73, P7779, DOI 10.1128/IAI.73.11.7779-7783.2005; Leao SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060746; Popowska M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00044; Recchia GD, 1995, MICROBIOL-UK, V141, P3015; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Schluter A, 2005, PLASMID, V54, P135, DOI 10.1016/j.plasmid.2005.03.001; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Song L, 2012, COMPUT BIOL CHEM, V36, P62, DOI 10.1016/j.compbiolchem.2012.01.001; Spadafora VJ, 2010, PHYTOPATHOLOGY, V100, pS166; Sundin GW, 2004, MOL GENET GENOMICS, V270, P462, DOI 10.1007/s00438-003-0945-9; Takeuchi T., 1991, ANN PHYTOPATHOL SOC, V57, P117; Tanaka N., 1965, J ANTIBIOT TOKYO, V19, P65; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; Thorsted PA, 1998, J MOL BIOL, V282, P969, DOI 10.1006/jmbi.1998.2060; TOMINAGA T, 1983, Annals of the Phytopathological Society of Japan, V49, P463; UEMATSU T, 1976, Annals of the Phytopathological Society of Japan, V42, P310; WAKIMOTO S., 1963, Ann. phytopath. Soc., V28, P153; Yoshii A, 2012, APPL ENVIRON MICROB, V78, P5555, DOI 10.1128/AEM.01155-12	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-6722	1364-3703		MOL PLANT PATHOL	Mol. Plant Pathol.	APR	2015	16	3					288	300		10.1111/mpp.12182		13	Plant Sciences	Plant Sciences	CE9GN	WOS:000352152200007		
J	Imada, Y; Kanae, S; Kimoto, M; Watanabe, M; Ishii, M				Imada, Yukiko; Kanae, Shinjiro; Kimoto, Masahide; Watanabe, Masahiro; Ishii, Masayoshi			Predictability of Persistent Thailand Rainfall during the Mature Monsoon Season in 2011 Using Statistical Downscaling of CGCM Seasonal Prediction	MONTHLY WEATHER REVIEW			English	Article							EAST-ASIAN CLIMATE; EL-NINO; INDIAN-OCEAN; DATA ASSIMILATION; BOREAL SUMMER; PACIFIC RIM; DIPOLE MODE; PRECIPITATION; IMPACTS; ENSO	Predictability of above-normal rainfall over Thailand during the rainy season of 2011 was investigated with a one-tier seasonal prediction system based on an atmosphere-ocean coupled general circulation model (CGCM) combined with a statistical downscaling method. The statistical relationship was derived using singular value decomposition analysis (SVDA) between observed regional rainfall and the hindcast of tropical sea surface temperature (SST) from the seasonal prediction system, which has an ability to forecast oceanic variability for lead times up to several months. The downscaled product of 2011 local rainfall was obtained by combining rainfall patterns derived from significant modes of SVDA. This method has the advantage in terms of flexibility that phenomenon-based statistical relationships, such as teleconnections associated with El Nino-Southern Oscillation (ENSO), Indian Ocean dipole (IOD), or the newly recognized central Pacific El Nino, are considered separately in each SVDA mode. The downscaled prediction initialized from 1 August 2011 reproduced the anomalously intense precipitation pattern over Indochina including northern Thailand during the latter half of the rainy season, even though the direct hindcast from the CGCM failed to predict the local rainfall distribution and intensity. Further analysis revealed that this method is applicable to the other recent events such as heavy rainfall during the rainy seasons of 2002 and 2008 in Indochina.	[Imada, Yukiko; Ishii, Masayoshi] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Kanae, Shinjiro] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan; [Kimoto, Masahide; Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Imada, Y (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	yimada@mri-jma.go.jp	Kanae, Shinjiro/E-5606-2010	Kanae, Shinjiro/0000-0002-3176-4957	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Core Research for Evolutionary Science and Technology (CREST); Data Integration and Analysis System (DIAS)	The authors are grateful to J. Luo and anonymous reviewers for their encouraging comments. This work was supported by the Program for Generation of Climate Change Risk Information (SOUSEI project) of the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency (JST), Japan International Cooperation Agency (JICA), Core Research for Evolutionary Science and Technology (CREST), and Data Integration and Analysis System (DIAS).	Wetterhall F, 2005, J HYDROL, V306, P174, DOI 10.1016/j,jhydrol.2004.09.008; Kang IS, 2004, J CLIMATE, V17, P834, DOI 10.1175/1520-0442(2004)017<0834:PPOSMP>2.0.CO;2; Luo JJ, 2012, P NATL ACAD SCI USA, V109, P18701, DOI 10.1073/pnas.1210239109; Tatebe H, 2012, J METEOROL SOC JPN, V90A, P275, DOI 10.2151/jmsj.2012-A14; Kim HM, 2009, SCIENCE, V325, P77, DOI 10.1126/science.1174062; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; HUFFMAN GJ, 1995, J CLIMATE, V8, P1284, DOI 10.1175/1520-0442(1995)008<1284:GPEBOA>2.0.CO;2; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Weng HY, 2007, CLIM DYNAM, V29, P113, DOI 10.1007/s00382-007-0234-0; Yang S, 2014, J CLIMATE, V27, P4451, DOI 10.1175/JCLI-D-13-00471.1; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Yuan Y, 2012, J CLIMATE, V25, P7702, DOI 10.1175/JCLI-D-11-00576.1; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Zhang WJ, 2011, J METEOROL SOC JPN, V89, P563, DOI 10.2151/jmsj.2011-510; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Luo JJ, 2005, J CLIMATE, V18, P4474, DOI 10.1175/JCLI3526.1; Weng HY, 2009, CLIM DYNAM, V32, P663, DOI 10.1007/s00382-008-0394-6; Wang B, 2009, CLIM DYNAM, V33, P93, DOI 10.1007/s00382-008-0460-0; Larkin NK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022738; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Jin EK, 2008, CLIM DYNAM, V31, P647, DOI 10.1007/s00382-008-0397-3; Feddersen H, 2005, TELLUS A, V57, P398, DOI 10.1111/j.1600-0870.2005.00102.x; Saji NH, 2003, CLIMATE RES, V25, P151, DOI 10.3354/cr025151; Chu JL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009424; Hendon HH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040100; Kanae S, 2001, J HYDROMETEOROL, V2, P51, DOI 10.1175/1525-7541(2001)002<0051:IODORP>2.0.CO;2; Kanae S, 2006, J CLIMATE, V19, P1450, DOI 10.1175/JCLI3686.1; Kang H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030730; Komori D., 2012, HYDROL RES LETT, V6, P41, DOI DOI 10.3178/HRL.6.41; Wilby RL, 1999, J HYDROL, V225, P67, DOI 10.1016/S0022-1694(99)00136-5; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035; Yen MC, 2011, J METEOROL SOC JPN, V89A, P259, DOI 10.2151/jmsj.2011-A16	35	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	APR	2015	143	4					1166	1178		10.1175/MWR-D-14-00228.1		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CE8PR	WOS:000352106400010		
J	Ikeda, K; Kiyota, N; Kuroda, H; Sato, DK; Nishiyama, S; Takahashi, T; Misu, T; Nakashima, I; Fujihara, K; Aoki, M				Ikeda, Kensuke; Kiyota, Naoki; Kuroda, Hiroshi; Sato, Douglas Kazutoshi; Nishiyama, Shuhei; Takahashi, Toshiyuki; Misu, Tatsuro; Nakashima, Ichiro; Fujihara, Kazuo; Aoki, Masashi			Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody	MULTIPLE SCLEROSIS JOURNAL			English	Article						Neuromyelitis optica; aquaporin-4; myelin-oligodendrocyte glycoprotein; myelin basic protein; glial fibrillary acidic protein	NMO SPECTRUM DISORDERS; DIAGNOSTIC-CRITERIA	We report a patient with neuromyelitis optica (NMO) presenting anti-myelin-oligodendrocyte glycoprotein (MOG)-seropositive, in whom biomarkers of demyelination and astrocyte damage were measured during an acute attack. A 31-year-old man developed right optic neuritis followed by longitudinally extensive transverse myelitis, fulfilling the criteria for definite NMO. He was anti-MOG-seropositive and anti-aquaporin-4 seronegative. The myelin basic protein level was markedly elevated whereas glial fibrillary acidic protein was not detectable in cerebrospinal fluid during an acute attack. His symptoms quickly improved after high-dose methylprednisolone therapy. This case suggests that NMO patients with anti-MOG may have severe demyelination in the absence of astrocyte injury.	[Ikeda, Kensuke; Kiyota, Naoki; Kuroda, Hiroshi; Sato, Douglas Kazutoshi; Nishiyama, Shuhei; Takahashi, Toshiyuki; Misu, Tatsuro; Nakashima, Ichiro; Fujihara, Kazuo; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 9808574, Japan	Kuroda, H (reprint author), Tohoku Univ, Sch Med, Dept Neurol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	dakuro@med.tohoku.ac.jp	Sato, Douglas/F-2508-2013	Sato, Douglas/0000-0002-7695-6020	KAKENHI of the Ministry of Education, Culture, Sports, Science and Technology of Japan [22229008]; Ministry of Health, Labour and Welfare of Japan	This research was supported by KAKENHI (22229008) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan.	Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Sato DK, 2013, NEUROLOGY, V80, P2210, DOI 10.1212/WNL.0b013e318296ea08; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Fujihara K, 2012, J CLIN EXP NEUROIMMU, V3, P58; Kitley J, 2014, JAMA NEUROL; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184	10	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	APR	2015	21	5					656	659		10.1177/1352458514551455		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CE9LO	WOS:000352165700016		
J	Tanaka, M; Kinoshita, M; Tanaka, K				Tanaka, Masami; Kinoshita, Masako; Tanaka, Keiko			Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders	MULTIPLE SCLEROSIS JOURNAL			English	Letter									[Tanaka, Masami; Kinoshita, Masako] Natl Utano Hosp, Dept Neurol, Kyoto 6168255, Japan; [Tanaka, Keiko] Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa 9200265, Japan	Tanaka, M (reprint author), Natl Utano Hosp, Multiple Sclerosis Ctr, Ukyo Ku, 8 Ondoyama, Kyoto 6168255, Japan.	nra17777@nifty.com					Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Lucey MR, 2005, AM J TRANSPLANT, V5, P1111, DOI 10.1111/j.1600-6143.2005.00808.x; Morita Y, 2008, MOD RHEUMATOL, V18, P379, DOI 10.1007/s10165-008-0071-y; Tanaka K, 2007, MULT SCLER, V13, P850, DOI 10.1177/1352458507076976; Tanaka M, 2009, EUR NEUROL, V62, P167, DOI 10.1159/000227277	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	APR	2015	21	5					669	669		10.1177/1352458514546793		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CE9LO	WOS:000352165700020		
J	Izumi, K; Nakato, R; Zhang, Z; Edmondson, AC; Noon, S; Dulik, MC; Rajagopalan, R; Venditti, CP; Gripp, K; Samanich, J; Zackai, EH; Deardorff, MA; Clark, D; Allen, JL; Dorsett, D; Misulovin, Z; Komata, M; Bando, M; Kaur, M; Katou, Y; Shirahige, K; Krantz, ID				Izumi, Kosuke; Nakato, Ryuichiro; Zhang, Zhe; Edmondson, Andrew C.; Noon, Sarah; Dulik, Matthew C.; Rajagopalan, Ramakrishnan; Venditti, Charles P.; Gripp, Karen; Samanich, Joy; Zackai, Elaine H.; Deardorff, Matthew A.; Clark, Dinah; Allen, Julian L.; Dorsett, Dale; Misulovin, Ziva; Komata, Makiko; Bando, Masashige; Kaur, Maninder; Katou, Yuki; Shirahige, Katsuhiko; Krantz, Ian D.			Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin	NATURE GENETICS			English	Article							DE-LANGE-SYNDROME; BROMODOMAIN PROTEIN BRD4; TRANSCRIPTION ELONGATION; NOVO MUTATIONS; P-TEFB; GENE; LEUKEMIA; CELLS; AF4; ACETYLATION	Transcriptional elongation is critical for gene expression regulation during embryogenesis. The super elongation complex (SEC) governs this process by mobilizing paused RNA polymerase II (RNAP2). Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia). Transcriptome and chromatin immunoprecipitation sequencing (ChIP-seq) analyses demonstrated similar alterations of genome-wide binding of AFF4, cohesin and RNAP2 in CdLS and CHOPS syndrome. Direct molecular interaction of the SEC, cohesin and RNAP2 was demonstrated. These data support a common molecular pathogenesis for CHOPS syndrome and CdLS caused by disturbance of transcriptional elongation due to alterations in genome-wide binding of AFF4 and cohesin.	[Izumi, Kosuke; Edmondson, Andrew C.; Noon, Sarah; Zackai, Elaine H.; Deardorff, Matthew A.; Clark, Dinah; Kaur, Maninder; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Izumi, Kosuke; Nakato, Ryuichiro; Komata, Makiko; Bando, Masashige; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo, Japan; [Zhang, Zhe] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Dulik, Matthew C.; Rajagopalan, Ramakrishnan] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Venditti, Charles P.] NHGRI, US NIH, Bethesda, MD 20892 USA; [Gripp, Karen] Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE USA; [Samanich, Joy] Montefiore Med Ctr, Dept Pediat, Div Genet, Bronx, NY 10467 USA; [Zackai, Elaine H.; Deardorff, Matthew A.; Allen, Julian L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Allen, Julian L.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Dorsett, Dale; Misulovin, Ziva] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Shirahige, Katsuhiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	Krantz, ID (reprint author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	kshirahi@iam.u-tokyo.ac.jp; ian2@mail.med.upenn.edu			MEXT (Ministry of Education, Culture, Sports, Science and Technology); CdLS Foundation; Children's Hospital of Philadelphia; US National Institutes of Health (NIH)/National Institute of Child Health and Development (NICHD) [PO1 HD052860]	We thank K. Nakagawa, S. Watanabe and E. Rappaport for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research (S) and for innovative science from MEXT (Ministry of Education, Culture, Sports, Science and Technology) (K.S.) and by research grants from the CdLS Foundation, development funds from the Children's Hospital of Philadelphia and grant PO1 HD052860 from the US National Institutes of Health (NIH)/National Institute of Child Health and Development (NICHD) (I.D.K.).	Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komata M, 2014, METHODS MOL BIOL, V1164, P33, DOI 10.1007/978-1-4939-0805-9_4; Komori T, 2012, J BIOL CHEM, V287, P19985, DOI 10.1074/jbc.M112.367854; Langmead B., 2009, GENOME BIOL, V10, DOI DOI 10.1186/GB-2009-10-3-R25; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.040696101; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Taki T, 1999, P NATL ACAD SCI USA, V96, P14535, DOI 10.1073/pnas.96.25.14535; Tzschach A, 2006, AM J MED GENET A, V140A, P496, DOI 10.1002/ajmg.a.31105; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005	42	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					338	U82		10.1038/ng.3229		9	Genetics & Heredity	Genetics & Heredity	CE6CH	WOS:000351922900008		
J	Michailidou, K; Beesley, J; Lindstrom, S; Canisius, S; Dennis, J; Lush, MJ; Maranian, MJ; Bolla, MK; Wang, Q; Shah, M; Perkins, BJ; Czene, K; Eriksson, M; Darabi, H; Brand, JS; Bojesen, SE; Nordestgaard, BG; Flyger, H; Nielsen, SF; Rahman, N; Turnbull, C; Fletcher, O; Peto, J; Gibson, L; dos-Santos-Silva, I; Chang-Claude, J; Flesch-Janys, D; Rudolph, A; Eilber, U; Behrens, S; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Khan, S; Aaltonen, K; Ahsan, H; Kibriya, MG; Whittemore, AS; John, EM; Malone, KE; Gammon, MD; Santella, RM; Ursin, G; Makalic, E; Schmidt, DF; Casey, G; Hunter, DJ; Gapstur, SM; Gaudet, MM; Diver, WR; Haiman, CA; Schumacher, F; Henderson, BE; Le Marchand, L; Berg, CD; Chanock, SJ; Figueroa, J; Hoover, RN; Lambrechts, D; Neven, P; Wildiers, H; van Limbergen, E; Schmidt, MK; Broeks, A; Verhoef, S; Cornelissen, S; Couch, FJ; Olson, JE; Hallberg, E; Vachon, C; Waisfisz, Q; Meijers-Heijboer, H; Adank, MA; van der Luijt, RB; Li, JM; Liu, JJ; Humphreys, K; Kang, D; Choi, JY; Park, SK; Yoo, KY; Matsuo, K; Ito, H; Iwata, H; Tajima, K; Guenel, P; Truong, T; Mulot, C; Sanchez, M; Burwinkel, B; Marme, F; Surowy, H; Sohn, C; Wu, AH; Tseng, CC; Van den Berg, D; Stram, DO; Gonzalez-Neira, A; Benitez, J; Zamora, MP; Perez, JIA; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Cross, SS; Reed, MWR; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Lindblom, A; Margolin, S; Teo, SH; Yip, CH; Taib, NAM; Tan, GH; Hooning, MJ; Hollestelle, A; Martens, JWM; Collee, JM; Blot, W; Signorello, LB; Cai, QY; Hopper, JL; Southey, MC; Tsimiklis, H; Apicella, C; Shen, CY; Hsiung, CN; Wu, PE; Hou, MF; Kristensen, VN; Nord, S; Alnaes, GIG; Giles, GG; Milne, RL; McLean, C; Canzian, F; Trichopoulos, D; Peeters, P; Lund, E; Sund, M; Khaw, KT; Gunter, MJ; Palli, D; Mortensen, LM; Dossus, L; Huerta, JM; Meindl, A; Schmutzler, RK; Sutter, C; Yang, R; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Hartman, M; Miao, H; Chia, KS; Chan, CW; Fasching, PA; Hein, A; Beckmann, MW; Haeberle, L; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Ashworth, A; Orr, N; Schoemaker, MJ; Swerdlow, AJ; Brinton, L; Garcia-Closas, M; Zheng, W; Halverson, SL; Shrubsole, M; Long, J; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Brauch, H; Hamann, U; Bruning, T; Radice, P; Peterlongo, P; Manoukian, S; Bernard, L; Bogdanova, NV; Dork, T; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Devilee, P; Tollenaar, RAEM; Seynaeve, C; Van Asperen, CJ; Jakubowska, A; Lubinski, J; Jaworska, K; Huzarski, T; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Slager, S; Toland, AE; Ambrosone, CB; Yannoukakos, D; Kabisch, M; Torres, D; Neuhausen, SL; Anton-Culver, H; Luccarini, C; Baynes, C; Ahmed, S; Healey, CS; Tessier, DC; Vincent, D; Bacot, F; Pita, G; Alonso, MR; Alvarez, N; Herrero, D; Simard, J; Pharoah, PPDP; Kraft, P; Dunning, AM; Chenevix-Trench, G; Hall, P; Easton, DF				Michailidou, Kyriaki; Beesley, Jonathan; Lindstrom, Sara; Canisius, Sander; Dennis, Joe; Lush, Michael J.; Maranian, Mel J.; Bolla, Manjeet K.; Wang, Qin; Shah, Mitul; Perkins, Barbara J.; Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Nielsen, Sune F.; Rahman, Nazneen; Turnbull, Clare; Fletcher, Olivia; Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel; Chang-Claude, Jenny; Flesch-Janys, Dieter; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine; Nevanlinna, Heli; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari; Ahsan, Habibul; Kibriya, Muhammad G.; Whittemore, Alice S.; John, Esther M.; Malone, Kathleen E.; Gammon, Marilie D.; Santella, Regina M.; Ursin, Giske; Makalic, Enes; Schmidt, Daniel F.; Casey, Graham; Hunter, David J.; Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Le Marchand, Loic; Berg, Christine D.; Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Lambrechts, Diether; Neven, Patrick; Wildiers, Hans; van Limbergen, Erik; Schmidt, Marjanka K.; Broeks, Annegien; Verhoef, Senno; Cornelissen, Sten; Couch, Fergus J.; Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.; van der Luijt, Rob B.; Li, Jingmei; Liu, Jianjun; Humphreys, Keith; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Yoo, Keun-Young; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Guenel, Pascal; Truong, Therese; Mulot, Claire; Sanchez, Marie; Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.; Gonzalez-Neira, Anna; Benitez, Javier; Zamora, M. Pilar; Arias Perez, Jose Ignacio; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Lindblom, Annika; Margolin, Sara; Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi; Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.; Collee, J. Margriet; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Hopper, John L.; Southey, Melissa C.; Tsimiklis, Helen; Apicella, Carmel; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker; Giles, Graham G.; Milne, Roger L.; McLean, Catriona; Canzian, Federico; Trichopoulos, Dimitrios; Peeters, Petra; Lund, Eiliv; Sund, Malin; Khaw, Kay-Tee; Gunter, Marc J.; Palli, Domenico; Mortensen, Lotte Maxild; Dossus, Laure; Huerta, Jose-Maria; Meindl, Alfons; Schmutzler, Rita K.; Sutter, Christian; Yang, Rongxi; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Hartman, Mikael; Miao, Hui; Chia, Kee Seng; Chan, Ching Wan; Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Ashworth, Alan; Orr, Nick; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Brinton, Louise; Garcia-Closas, Montserrat; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Brauch, Hiltrud; Hamann, Ute; Bruening, Thomas; Radice, Paolo; Peterlongo, Paolo; Manoukian, Siranoush; Bernard, Loris; Bogdanova, Natalia V.; Doerk, Thilo; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; Van Asperen, Christi J.; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; Mckay, James; Slager, Susan; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Kabisch, Maria; Torres, Diana; Neuhausen, Susan L.; Anton-Culver, Hoda; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel; Simard, Jacques; Pharoah, Paul P. D. P.; Kraft, Peter; Dunning, Alison M.; Chenevix-Trench, Georgia; Hall, Per; Easton, Douglas F.		BOCS; KConFab Investigators; AOCS Grp; NBCS; GENICA Network	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer	NATURE GENETICS			English	Article							CONFER SUSCEPTIBILITY; GENOTYPE IMPUTATION; COMMON VARIANTS; OVARIAN-CANCER; RISK; ESTROGEN; CHEK2-ASTERISK-1100DELC; METAANALYSIS; ALLELES; BRCA1	Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining similar to 14% of the familial risk of the disease. To identify new susceptibility loci, we performed a meta-analysis of 11 GWAS, comprising 15,748 breast cancer cases and 18,084 controls together with 46,785 cases and 42,892 controls from 41 studies genotyped on a 211,155-marker custom array (iCOGS). Analyses were restricted to women of European ancestry. We generated genotypes for more than 11 million SNPs by imputation using the 1000 Genomes Project reference panel, and we identified 15 new loci associated with breast cancer at P < 5 x 10(-8). Combining association analysis with ChIP-seq chromatin binding data in mammary cell lines and ChIA-PET chromatin interaction data from ENCODE, we identified likely target genes in two regions: SETBP1 at 18q12.3 and RNF115 and PDZK1 at 1q21.1. One association appears to be driven by an amino acid substitution encoded in EXO1.	[Michailidou, Kyriaki; Dennis, Joe; Lush, Michael J.; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul P. D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia; [Lindstrom, Sara; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Canisius, Sander] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Maranian, Mel J.; Shah, Mitul; Perkins, Barbara J.; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Pharoah, Paul P. D. P.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Li, Jingmei; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Rahman, Nazneen; Turnbull, Clare; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Fletcher, Olivia; Ashworth, Alan; Orr, Nick; Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Chang-Claude, Jenny; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Nevanlinna, Heli; Muranen, Taru A.; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Muranen, Taru A.; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Ctr Canc Epidemiol & Prevent, Chicago, IL 60637 USA; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Gammon, Marilie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Makalic, Enes; Schmidt, Daniel F.] Melbourne Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Casey, Graham; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Berg, Christine D.] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Brinton, Louise] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Neven, Patrick; Wildiers, Hans; van Limbergen, Erik] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Oncogenet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Div Biomed Genet, Utrecht, Netherlands; [Liu, Jianjun] Genome Inst Singapore, Human Genet Div, Singapore, Singapore; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Surowy, Harald] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Yoo, Keun-Young] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Tajima, Kazuo] Mie Univ Hosp, Epidemiol Ctr Dis Control & Prevent, Tsu, Mie, Japan; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] INSERM, Environm Epidemiol Canc, CESP, Ctr Res Epidemiol & Populat Hlth,U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] Univ Paris Sud, UMRS 1018, Villejuif, France; [Mulot, Claire] Univ Paris Sorbonne Cite, INSERM, UMRS 775, Paris, France; [Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Yang, Rongxi] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara; Yang, Rongxi] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Gonzalez-Neira, Anna; Benitez, Javier; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Zamora, M. Pilar] Hosp Univ La Paz, Med Oncol Serv, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Changning, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Div Canc Studies, Res Oncol, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Sch Med, Dept Surg, Galway, Ireland; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Teo, Soo Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi] Univ Malaya Med Ctr, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Signorello, Lisa B.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hopper, John L.; Apicella, Carmel; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.; Tsimiklis, Helen] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, N-0450 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Dept Clin Mol Biol EpiGen, Oslo, Norway; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [McLean, Catriona] Monash Univ, Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Trichopoulos, Dimitrios] Acad Athens, Bureau Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Peeters, Petra] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra; Gunter, Marc J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Lund, Eiliv] Univ Tromso, Arct Univ Norway, Fac Hlth Sci, Dept Commun Med, Tromso, Norway; [Sund, Malin] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Khaw, Kay-Tee] Univ Cambridge, Cambridge Inst Publ Hlth, Sch Clin Med, Cambridge, England; [Palli, Domenico] Ist Studio Prevenz Oncol, Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Mortensen, Lotte Maxild] Aarhus Univ, Sect Epidemiol, Aarhus, Denmark; [Dossus, Laure] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, Nutr Hormones & Womens Hlth Team, U1018, Villejuif, France; [Dossus, Laure] Univ Paris 11, Villejuif, France; [Huerta, Jose-Maria] CIBER Epidemiol & Salud Publ, Consejeria Sanidad & Polit Social, Dept Epidemiol, Murcia, Spain; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.; Radice, Paolo] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Sutter, Christian] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Nonthaburi, Thailand; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Hlth Syst, Singapore, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chan, Ching Wan] Natl Univ Hlth Syst, Div Gen Surg, Singapore, Singapore; [Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen Nuremberg Metropolit, Univ Hosp Erlangen, Dept Gynecol & Obstet,Univ Breast,Ctr Franconia, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina; Brauch, Hiltrud] German Canc Consortium DKTK, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Sante Environnementale & Sante Travail, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dumont, Martine; Simard, Jacques] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Dumont, Martine; Simard, Jacques] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Winqvist, Robert] Univ Oulu, Dept Clin Chem & Bioctr Oulu, Lab Canc Genet & Tumor Biol, NordLab Oulu,Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu, Finland; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Brauch, Hiltrud] German Canc Res Ctr, Heidelberg, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany; [Radice, Paolo] Ist Nazl Tumori, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Peterlongo, Paolo] Italian Fdn Canc Res Oncol Mol IFOM, Fdn Ist FIRC, Milan, Italy; [Manoukian, Siranoush] Ist Nazl Tumori, Unit Med Genet, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kataja, Vesa] Jyvaskyla Cent Hosp, Cent Finland Hosp Dist, Jyvaskyla, Finland; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Canc Inst, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst Thailand, Bangkok, Thailand; [Gaborieau, Valerie; Brennan, Paul; Mckay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Toland, Amanda E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	Easton, DF (reprint author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	dfe20@medschl.cam.ac.uk	Hartman, Mikael/B-4324-2011; Rahman, Nazneen/D-2802-2013; Hein, Alexander/F-6999-2010; Teo,  Soo-hwang/H-2353-2014; Shrubsole, Martha/K-5052-2015; Hartikainen, Jaana/E-6256-2015; Dork, Thilo/J-8620-2012; Li, Jingmei/I-2904-2012; Garcia-Closas, Montserrat /F-3871-2015; Brinton, Louise/G-7486-2015; Bruning, Thomas/G-8120-2015; Helland, Aslaug/H-3910-2015; Knight, Julia/A-6843-2012; Arndt, Volker/B-4999-2014; Yip, Cheng-Har/B-1909-2010	Evans, Gareth/0000-0002-8482-5784; Rahman, Nazneen/0000-0003-4376-0440; Cox, Angela/0000-0002-5138-1099; dos Santos Silva, Isabel/0000-0002-6596-8798; Dawson, Sarah-Jane/0000-0002-8276-0374; Hein, Alexander/0000-0003-2601-3398; Shrubsole, Martha/0000-0002-5591-7575; Li, Jingmei/0000-0001-8587-7511; Garcia-Closas, Montserrat /0000-0003-1033-2650; Brinton, Louise/0000-0003-3853-8562; Bruning, Thomas/0000-0001-9560-5464; Helland, Aslaug/0000-0002-5520-0275; Arndt, Volker/0000-0001-9320-8684; 	Cancer Research UK [C1287/A10118, C1287/A12014, C1287/A10710, C8197/A16565]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175) (COGS)]; European Union COST programme [BM0606]; European Union [HEALTH-F2-2009-223175]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative [1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative)]	BCAC is funded by Cancer Research UK (C1287/A10118, C1287/A12014) and by the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS). Meetings of the BCAC have been funded by the European Union COST programme (BM0606). Genotyping on the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710, C8197/A16565), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program and the Ministry of Economic Development, Innovation and Export Trade of Quebec, grant PSR-SIIRI-701. Combination of the GWAS data was supported in part by the US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative, grant 1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative). For a full description of funding and acknowledgments, see the the Supplementary Note.	Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Ahsan H, 2014, CANCER EPIDEM BIOMAR, V23, P658, DOI 10.1158/1055-9965.EPI-13-0340; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Udler MS, 2010, GENET EPIDEMIOL, V34, P463, DOI 10.1002/gepi.20504; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Fletcher O, 2011, J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Easton D, 2004, AM J HUM GENET, V74, P1175; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Kim HY, 2013, MOL MED, V19, P253, DOI 10.2119/molmed.2011.00001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Lin WY, 2015, HUM MOL GENET, V24, P285, DOI 10.1093/hmg/ddu431; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Milne RL, 2014, HUM MOL GENET, V23, P6096, DOI 10.1093/hmg/ddu311; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Wang ZH, 2013, NEOPLASIA, V15, P1028, DOI 10.1593/neo.13678	38	8	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					373	U127		10.1038/ng.3242		9	Genetics & Heredity	Genetics & Heredity	CE6CH	WOS:000351922900013		
J	Aung, T; Ozaki, M; Mizoguchi, T; Allingham, RR; Li, Z; Haripriya, A; Nakano, S; Uebe, S; Harder, JM; Chan, ASY; Lee, MC; Burdon, KP; Astakhov, YS; Abu-Amero, KK; Zenteno, JC; Nilgun, Y; Zarnowski, T; Pakravan, M; Abu Safieh, L; Jia, LY; Wang, YX; Williams, S; Paoli, D; Schlottmann, PG; Huang, LL; Sim, KS; Foo, JN; Nakano, M; Ikeda, Y; Kumar, RS; Ueno, M; Manabe, SI; Hayashi, K; Kazama, S; Ideta, R; Mori, Y; Miyata, K; Sugiyama, K; Higashide, T; Chihara, E; Inoue, K; Ishiko, S; Yoshida, A; Yanagi, M; Kiuchi, Y; Aihara, M; Ohashi, T; Sakurai, T; Sugimoto, T; Chuman, H; Matsuda, F; Yamashiro, K; Gotoh, N; Miyake, M; Astakhov, SY; Osman, EA; Al-Obeidan, SA; Owaidhah, O; Al-Jasim, L; Al Shahwan, S; Fogarty, RA; Leo, P; Yetkin, Y; Oguz, C; Kanavi, MR; Beni, AN; Yazdani, S; Akopov, EL; Toh, KY; Howell, GR; Orr, AC; Goh, Y; Meah, WY; Peh, SQ; Kosior-Jarecka, E; Lukasik, U; Krumbiegel, M; Vithana, EN; Wong, TY; Liu, YT; Koch, AEA; Challa, P; Rautenbach, RM; Mackey, DA; Hewitt, AW; Mitchell, P; Wang, JJ; Ziskind, A; Carmichael, T; Ramakrishnan, R; Narendran, K; Venkatesh, R; Vijayan, S; Zhao, PQ; Chen, XY; Guadarrama-Vallejo, D; Cheng, CY; Perera, SA; Husain, R; Ho, SL; Welge-Luessen, UC; Mardin, C; Schloetzer-Schrehardt, U; Hillmer, AM; Herms, S; Moebus, S; Nothen, MM; Weisschuh, N; Shetty, R; Ghosh, A; Teo, YY; Brown, MA; Lischinsky, I; Crowston, JG; Coote, M; Zhao, BW; Sang, JH; Zhang, NH; You, QS; Vysochinskaya, V; Founti, P; Chatzikyriakidou, A; Lambropoulos, A; Anastasopoulos, E; Coleman, AL; Wilson, MR; Rhee, DJ; Kang, JH; May-Bolchakova, I; Heegaard, S; Mori, K; Alward, WLM; Jonas, JB; Xu, L; Liebmann, JM; Chowbay, B; Schaeffeler, E; Schwab, M; Lerner, F; Wang, NL; Yang, ZL; Frezzotti, P; Kinoshita, S; Fingert, JH; Inatani, M; Tashiro, K; Reis, A; Edward, DP; Pasquale, LR; Kubota, T; Wiggs, JL; Pasutto, F; Topouzis, F; Dubina, M; Craig, JE; Yoshimura, N; Sundaresan, P; John, SWM; Ritch, R; Hauser, MA; Khor, CC				Aung, Tin; Ozaki, Mineo; Mizoguchi, Takanori; Allingham, R. Rand; Li, Zheng; Haripriya, Aravind; Nakano, Satoko; Uebe, Steffen; Harder, Jeffrey M.; Chan, Anita S. Y.; Lee, Mei Chin; Burdon, Kathryn P.; Astakhov, Yury S.; Abu-Amero, Khaled K.; Zenteno, Juan C.; Nilguen, Yildirim; Zarnowski, Tomasz; Pakravan, Mohammad; Abu Safieh, Leen; Jia, Liyun; Wang, Ya Xing; Williams, Susan; Paoli, Daniela; Schlottmann, Patricio G.; Huang, Lulin; Sim, Kar Seng; Foo, Jia Nee; Nakano, Masakazu; Ikeda, Yoko; Kumar, Rajesh S.; Ueno, Morio; Manabe, Shin-Ichi; Hayashi, Ken; Kazama, Shigeyasu; Ideta, Ryuichi; Mori, Yosai; Miyata, Kazunori; Sugiyama, Kazuhisa; Higashide, Tomomi; Chihara, Etsuo; Inoue, Kenji; Ishiko, Satoshi; Yoshida, Akitoshi; Yanagi, Masahide; Kiuchi, Yoshiaki; Aihara, Makoto; Ohashi, Tsutomu; Sakurai, Toshiya; Sugimoto, Takako; Chuman, Hideki; Matsuda, Fumihiko; Yamashiro, Kenji; Gotoh, Norimoto; Miyake, Masahiro; Astakhov, Sergei Y.; Osman, Essam A.; Al-Obeidan, Saleh A.; Owaidhah, Ohoud; Al-Jasim, Leyla; Al Shahwan, Sami; Fogarty, Rhys A.; Leo, Paul; Yetkin, Yaz; Oguz, Cilingir; Kanavi, Mozhgan Rezaei; Beni, Afsaneh Nederi; Yazdani, Shahin; Akopov, Evgeny L.; Toh, Kai-Yee; Howell, Gareth R.; Orr, Andrew C.; Goh, Yufen; Meah, Wee Yang; Peh, Su Qin; Kosior-Jarecka, Ewa; Lukasik, Urszula; Krumbiegel, Mandy; Vithana, Eranga N.; Wong, Tien Yin; Liu, Yutao; Koch, Allison E. Ashley; Challa, Pratap; Rautenbach, Robyn M.; Mackey, David A.; Hewitt, Alex W.; Mitchell, Paul; Wang, Jie Jin; Ziskind, Ari; Carmichael, Trevor; Ramakrishnan, Rangappa; Narendran, Kalpana; Venkatesh, Rangaraj; Vijayan, Saravanan; Zhao, Peiquan; Chen, Xueyi; Guadarrama-Vallejo, Dalia; Cheng, Ching Yu; Perera, Shamira A.; Husain, Rahat; Ho, Su-Ling; Welge-Luessen, Ulrich-Christoph; Mardin, Christian; Schloetzer-Schrehardt, Ursula; Hillmer, Axel M.; Herms, Stefan; Moebus, Susanne; Noethen, Markus M.; Weisschuh, Nicole; Shetty, Rohit; Ghosh, Arkasubhra; Teo, Yik Ying; Brown, Matthew A.; Lischinsky, Ignacio; Crowston, Jonathan G.; Coote, Michael; Zhao, Bowen; Sang, Jinghong; Zhang, Nihong; You, Qisheng; Vysochinskaya, Vera; Founti, Panayiota; Chatzikyriakidou, Anthoula; Lambropoulos, Alexandros; Anastasopoulos, Eleftherios; Coleman, Anne L.; Wilson, M. Roy; Rhee, Douglas J.; Kang, Jae Hee; May-Bolchakova, Inna; Heegaard, Steffen; Mori, Kazuhiko; Alward, Wallace L. M.; Jonas, Jost B.; Xu, Liang; Liebmann, Jeffrey M.; Chowbay, Balram; Schaeffeler, Elke; Schwab, Matthias; Lerner, Fabian; Wang, Ningli; Yang, Zhenglin; Frezzotti, Paolo; Kinoshita, Shigeru; Fingert, John H.; Inatani, Masaru; Tashiro, Kei; Reis, Andre; Edward, Deepak P.; Pasquale, Louis R.; Kubota, Toshiaki; Wiggs, Janey L.; Pasutto, Francesca; Topouzis, Fotis; Dubina, Michael; Craig, Jamie E.; Yoshimura, Nagahisa; Sundaresan, Periasamy; John, Simon W. M.; Ritch, Robert; Hauser, Michael A.; Khor, Chiea-Chuen		Blue Mountains Eye Study GWAS Team; Wellcome Trust Case Control Consor	A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome	NATURE GENETICS			English	Article							LOXL1 GENE POLYMORPHISMS; PSEUDOEXFOLIATION SYNDROME; SEQUENCE VARIANTS; JAPANESE POPULATION; UNITED-STATES; GLAUCOMA; DISEASE; GERMAN	Exfoliation syndrome (XFS) is the most common recognizable cause of open-angle glaucoma worldwide. To better understand the etiology of XFS, we conducted a genome-wide association study (GWAS) of 1,484 cases and 1,188 controls from Japan and followed up the most significant findings in a further 6,901 cases and 20,727 controls from 17 countries across 6 continents. We discovered a genome-wide significant association between a new locus (CACNA1A rs4926244) and increased susceptibility to XFS (odds ratio (OR) = 1.16, P = 3.36 x 10(-11)). Although we also confirmed overwhelming association at the LOXL1 locus, the key SNP marker (LOXL1 rs4886776) demonstrated allelic reversal depending on the ancestry group (Japanese: ORA allele = 9.87, P = 2.13 x 10(-217); non-Japanese: ORA allele = 0.49, P = 2.35 x 10(-31)). Our findings represent the first genetic locus outside of LOXL1 surpassing genome-wide significance for XFS and provide insight into the biology and pathogenesis of the disease.	[Aung, Tin; Chan, Anita S. Y.; Lee, Mei Chin; Vithana, Eranga N.; Wong, Tien Yin; Cheng, Ching Yu; Perera, Shamira A.; Husain, Rahat; Ghosh, Arkasubhra; Khor, Chiea-Chuen] Singapore Eye Res Inst, Singapore, Singapore; [Aung, Tin; Chan, Anita S. Y.; Wong, Tien Yin; Perera, Shamira A.; Husain, Rahat] Singapore Natl Eye Ctr, Singapore, Singapore; [Aung, Tin; Wong, Tien Yin; Cheng, Ching Yu; Khor, Chiea-Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Aung, Tin; Li, Zheng; Sim, Kar Seng; Foo, Jia Nee; Toh, Kai-Yee; Goh, Yufen; Meah, Wee Yang; Peh, Su Qin; Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Aung, Tin] Natl Univ Singapore, Duke Univ, Grad Sch Med, Singapore 117548, Singapore; [Ozaki, Mineo] Ozaki Eye Hosp, Hyuga, Japan; [Ozaki, Mineo; Manabe, Shin-Ichi; Hayashi, Ken] Hayashi Eye Hosp, Fukuoka, Japan; [Mizoguchi, Takanori] Mizoguchi Eye Hosp, Sasebo, Japan; [Allingham, R. Rand; Challa, Pratap; Teo, Yik Ying; Hauser, Michael A.] Duke Univ, Ctr Eye, Dept Ophthalmol, Durham, NC 27710 USA; [Haripriya, Aravind; Ramakrishnan, Rangappa; Narendran, Kalpana; Venkatesh, Rangaraj] Aravind Eye Hosp, Intraocular Lens & Cataract Clin, Madurai, Tamil Nadu, India; [Nakano, Satoko; Kubota, Toshiaki] Oita Univ, Fac Med, Dept Ophthalmol, Oita 87011, Japan; [Uebe, Steffen; Krumbiegel, Mandy; Reis, Andre; Pasutto, Francesca] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Harder, Jeffrey M.; Howell, Gareth R.; John, Simon W. M.] Jackson Lab, Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Burdon, Kathryn P.; Fogarty, Rhys A.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Burdon, Kathryn P.; Hewitt, Alex W.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Astakhov, Yury S.; Astakhov, Sergei Y.; Akopov, Evgeny L.; Dubina, Michael] First Pavlov State Med Univ St Petersburg, Dept Ophthalmol, St Petersburg, Russia; [Abu-Amero, Khaled K.; Osman, Essam A.; Al-Obeidan, Saleh A.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Abu-Amero, Khaled K.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Zenteno, Juan C.; Guadarrama-Vallejo, Dalia] Inst Ophthalmol Conde de Valenciana, Dept Genet, Mexico City, DF, Mexico; [Zenteno, Juan C.; Guadarrama-Vallejo, Dalia] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; [Nilguen, Yildirim; Yetkin, Yaz; Oguz, Cilingir] Eskisehir Osmangazi Univ, Dept Ophthalmol, Meselik, Turkey; [Zarnowski, Tomasz; Kosior-Jarecka, Ewa; Lukasik, Urszula] Med Univ Lublin, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland; [Pakravan, Mohammad; Owaidhah, Ohoud; Al-Jasim, Leyla; Al Shahwan, Sami; Kanavi, Mozhgan Rezaei; Beni, Afsaneh Nederi; Yazdani, Shahin] Shahid Beheshti Univ Med Sci, Labbafinejad Med Ctr, Ophthalm Res Ctr, Dept Ophthalmol, Tehran, Iran; [Abu Safieh, Leen; Zhao, Bowen; Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Jia, Liyun; Sang, Jinghong; Zhang, Nihong; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wang, Ya Xing; You, Qisheng; Xu, Liang] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Williams, Susan; Carmichael, Trevor] Univ Witwatersrand, Dept Neurosci, Div Ophthalmol, Johannesburg, South Africa; [Paoli, Daniela] Monfalcone Hosp, Dept Ophthalmol, Gorizia, Italy; [Schlottmann, Patricio G.] Org Med Invest, Buenos Aires, DF, Argentina; [Huang, Lulin; Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China; [Huang, Lulin; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Nakano, Masakazu; Mori, Kazuhiko; Tashiro, Kei] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan; [Ikeda, Yoko; Ueno, Morio; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kumar, Rajesh S.; Shetty, Rohit] Narayana Nethralaya Eye Hosp, Glaucoma Serv, Bangalore, Karnataka, India; [Kazama, Shigeyasu] Shinjo Eye Clin, Miyazaki, Japan; [Ideta, Ryuichi] Ideta Eye Hosp, Kumamoto, Japan; [Mori, Yosai; Miyata, Kazunori] Miyata Eye Hosp, Miyazaki, Japan; [Miyata, Kazunori; Sugimoto, Takako; Chuman, Hideki] Miyazaki Univ, Fac Med, Dept Ophthalmol, Miyazaki, Japan; [Sugiyama, Kazuhisa; Higashide, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan; [Chihara, Etsuo] Sensho Kai Eye Inst, Kyoto, Japan; [Inoue, Kenji] Inouye Eye Hosp, Tokyo, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Dept Med, Asahikawa, Hokkaido, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Engn Combined Res Inst, Asahikawa, Hokkaido, Japan; [Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan; [Yanagi, Masahide; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Aihara, Makoto] Yotsuya Shirato Eye Clin, Tokyo, Japan; [Ohashi, Tsutomu] Ohashi Eye Ctr, Sapporo, Hokkaido, Japan; [Sakurai, Toshiya] Tane Mem Eye Hosp, Osaka, Japan; [Matsuda, Fumihiko; Miyake, Masahiro] Kyoto Univ, Grad Sch Med, INSERM, Ctr Genom Med,U852, Kyoto, Japan; [Yamashiro, Kenji; Gotoh, Norimoto; Miyake, Masahiro; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Leo, Paul] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld, Australia; [Orr, Andrew C.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Liu, Yutao; Koch, Allison E. Ashley; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liu, Yutao] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Rautenbach, Robyn M.; Ziskind, Ari] Univ Stellenbosch, Fac Med & Hlth Sci, Div Ophthalmol, Cape Town, South Africa; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Hewitt, Alex W.; Crowston, Jonathan G.; Coote, Michael] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Vijayan, Saravanan; Sundaresan, Periasamy] Aravind Med Res Fdn, Dept Genet, Madurai, Tamil Nadu, India; [Zhao, Peiquan] Shanghai Jiao Tong Univ, Dept Ophthalmol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Chen, Xueyi; Brown, Matthew A.] Xinjiang Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Urumqi, Xinjiang Uygur, Peoples R China; [Ho, Su-Ling] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore; [Welge-Luessen, Ulrich-Christoph; Mardin, Christian; Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Hillmer, Axel M.] Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore, Singapore; [Herms, Stefan; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Herms, Stefan; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Herms, Stefan] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Herms, Stefan] Univ Basel, Dept Biomed, Human Genet Res Grp, Basel, Switzerland; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Weisschuh, Nicole] Dept Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Ghosh, Arkasubhra] Narayana Nethralaya Fdn, Genes Repair & Regenerat Ophthalm Workstat Res La, Bangalore, Karnataka, India; [Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Lischinsky, Ignacio] Ctr Oftalmol Lischinsky, San Miguel De Tucuman, Argentina; [Crowston, Jonathan G.; Coote, Michael] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; [Vysochinskaya, Vera; Dubina, Michael] St Petersburg Acad Univ, St Petersburg, Russia; [Founti, Panayiota; Anastasopoulos, Eleftherios; Topouzis, Fotis] Aristotle Univ Thessaloniki, Fac Med, Dept Ophthalmol, Amer Hellen Educ Progress Assoc Hosp, GR-54006 Thessaloniki, Greece; [Chatzikyriakidou, Anthoula; Lambropoulos, Alexandros] Aristotle Univ Thessaloniki, Fac Med, Dept Biol & Genet, GR-54006 Thessaloniki, Greece; [Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Ctr Commun Outreach & Policy, Los Angeles, CA 90095 USA; [Wilson, M. Roy] Wayne State Univ, Detroit, MI USA; [Rhee, Douglas J.; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Kang, Jae Hee; Pasquale, Louis R.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [May-Bolchakova, Inna] Mil Hosp Begin, Dept Ophthalmol, Paris, France; [Heegaard, Steffen] Univ Copenhagen, Dept Neurosci & Pharmacol, Eye Pathol Inst, Copenhagen, Denmark; [Heegaard, Steffen] Glostrup Univ Hosp, Dept Ophthalmol, Glostrup, Denmark; [Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Liebmann, Jeffrey M.] NYU, Sch Med, Manhattan Eye Ear & Throat Hosp, New York, NY USA; [Chowbay, Balram] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Schaeffeler, Elke; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Schwab, Matthias] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Lerner, Fabian] Fdn Estudio Glaucoma, Buenos Aires, DF, Argentina; [Frezzotti, Paolo] Univ Siena, Dept Surg, Sect Ophthalmol, I-53100 Siena, Italy; [Inatani, Masaru] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Fukui 910, Japan; [Edward, Deepak P.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY USA	Aung, T (reprint author), Singapore Eye Res Inst, Singapore, Singapore.	aung_tin@yahoo.co.uk; khorcc@gis.a-star.edu.sg	Blackwell, Jenefer/H-3015-2015; Jankowski, Janusz/H-2706-2012; Wang, Jie Jin/P-1499-2014; Mitchell, Paul/P-1498-2014; Reis, Andre/D-2309-2009; Deloukas, Panos/B-2922-2013; Brown, Matthew/E-5749-2010; Hillmer, Axel/N-2927-2014; 	Jankowski, Janusz/0000-0003-2130-9181; Wang, Jie Jin/0000-0001-9491-4898; Reis, Andre/0000-0002-6301-6363; Deloukas, Panos/0000-0001-9251-070X; Brown, Matthew/0000-0003-0538-8211; Nothen, Markus/0000-0002-8770-2464; Hillmer, Axel/0000-0002-3381-7266; Plomin, Robert/0000-0002-0756-3629; Ghosh, Arkasubhra/0000-0002-6570-5891	Biomedical Research Council; Agency for Science, Technology and Research, Singapore; US National Institutes of Health/National Eye Institute grants [NIH/NEI R01 EY020928, NIH/NEI P30 EY014104]; US National Institutes of Health/National Eye Institute [EY11721, EY023512, EY018825]; Harvard Medical School Distinguished Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; National Natural Science Foundation of China [81025006, 81170883]; Department of Science and Technology of Sichuan Province, China [2012SZ0219, 2011jtd0020]; Robert Bosch Stiftung (Stuttgart, Germany); German Cancer Consortium (DKTK), Germany; Ophthalmic Research Institute of Australia; National Health and Medical Research Council (NHMRC) [535044]; European Union (European Social Fund); Greek national funds under act 'Aristia' of the operational program 'Education and Lifelong Learning'; Australian NHMRC Canberra, Australia; NHMRC project [512423, 475604, 529912]; Wellcome Trust, UK, Wellcome Trust Case Control Consortium 2;  [085475/B/08/Z];  [085475/08/Z]	The authors thank the staff and participants of all studies for their important contributions. We thank K.-K. Heng, X.-Y. Chen, H.-M. Soo, S.-Q. Mok, A. Jamuth, N. Foxworth and M. Elbl for technical assistance. This research was funded by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore. J.L.W. acknowledges support from US National Institutes of Health/National Eye Institute grants (NIH/NEI R01 EY020928 and NIH/NEI P30 EY014104). S.W.M.J. acknowledges support from grant EY11721 from the US National Institutes of Health/National Eye Institute and is an investigator of the Howard Hughes Medical Institute. L.R.P. acknowledges support from a Harvard Medical School Distinguished Ophthalmology Scholar Award and the Harvard Glaucoma Center of Excellence. J.H.F. acknowledges support from US National Institutes of Health/National Eye Institute grants (EY023512 and EY018825). Z.Y. acknowledges support from the National Natural Science Foundation of China (81025006 and 81170883), as well as from the Department of Science and Technology of Sichuan Province, China (2012SZ0219 and 2011jtd0020). M.S. acknowledges support from Robert Bosch Stiftung (Stuttgart, Germany) and the German Cancer Consortium (DKTK), Germany. The Australian case cohort was funded by grants from the Ophthalmic Research Institute of Australia and National Health and Medical Research Council (NHMRC) project 535044. The Thessaloniki Eye Study was cofunded by the European Union (European Social Fund) and Greek national funds under act 'Aristia' of the operational program 'Education and Lifelong Learning' (Supplementary Note). Blue Mountains Eye Study (BMES) GWAS and genotyping costs were supported by the Australian NHMRC Canberra, Australia; NHMRC project grants 512423, 475604 and 529912) and the Wellcome Trust, UK, as part of the Wellcome Trust Case Control Consortium 2 (A. Viswanathan, P. McGuffin, P. Mitchell, F. Topouzis, P. Foster; grants 085475/B/08/Z and 085475/08/Z). K.P.B. is an NHMRC Senior Research Fellow, and J.E.C. is an NHMRC Practitioner Fellow. M.A.B. is an NHMRC Principal Research Fellow. A.W.H. is an NHMRC Peter Doherty Fellow.	Challa P, 2008, MOL VIS, V14, P146; Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P1459, DOI 10.1167/iovs.07-1449; Aragon-Martin JA, 2008, MOL VIS, V14, P533; Williams SEI, 2010, MOL VIS, V16, P705; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Fingert JH, 2007, AM J OPHTHALMOL, V144, P974, DOI 10.1016/j.ajo.2007.09.034; Hewitt AW, 2008, HUM MOL GENET, V17, P710, DOI 10.1093/hmg/ddm342; Ramprasad VL, 2008, MOL VIS, V14, P318; Hayashi H, 2008, AM J OPHTHALMOL, V145, P582, DOI 10.1016/j.ajo.2007.10.023; Chen L, 2009, MOL VIS, V15, P2349; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P2372, DOI 10.1167/iovs.10-6268; Mossbock G, 2008, MOL VIS, V14, P857; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Mori K, 2008, MOL VIS, V14, P1037; Wolf C, 2010, J GLAUCOMA, V19, P136, DOI 10.1097/IJG.0b013e31819f9330; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Ozaki M, 2008, INVEST OPHTH VIS SCI, V49, P3976, DOI 10.1167/iovs.08-1805; Yang X, 2008, CELL CYCLE, V7, P521; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Lemmela S, 2009, J HUM GENET, V54, P289, DOI 10.1038/jhg.2009.28; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; Fan BJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-5; Krumbiegel M, 2011, EUR J HUM GENET, V19, P186, DOI 10.1038/ejhg.2010.144; Lee MC, 2014, INVEST OPHTH VIS SCI, V55, P3833, DOI 10.1167/iovs.14-14145; Nakano M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05340; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231; Schlotzer-Schrehardt U, 2001, CURR EYE RES, V22, P154; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Tsou WL, 2011, NEUROBIOL DIS, V43, P533, DOI 10.1016/j.nbd.2011.04.016; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	34	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					387	U145		10.1038/ng.3226		8	Genetics & Heredity	Genetics & Heredity	CE6CH	WOS:000351922900015		
J	Nishikawa, H; Iijima, T; Kajitani, R; Yamaguchi, J; Ando, T; Suzuki, Y; Sugano, S; Fujiyama, A; Kosugi, S; Hirakawa, H; Tabata, S; Ozaki, K; Morimoto, H; Ihara, K; Obara, M; Hori, H; Itoh, T; Fujiwara, H				Nishikawa, Hideki; Iijima, Takuro; Kajitani, Rei; Yamaguchi, Junichi; Ando, Toshiya; Suzuki, Yutaka; Sugano, Sumio; Fujiyama, Asao; Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi; Ozaki, Katsuhisa; Morimoto, Hiroya; Ihara, Kunio; Obara, Madoka; Hori, Hiroshi; Itoh, Takehiko; Fujiwara, Haruhiko			A genetic mechanism for female-limited Batesian mimicry in Papilio butterfly	NATURE GENETICS			English	Article							ALIGNMENT; DOUBLESEX; SUPERGENE; EYESPOT; GENOME; LENGTH; SEX; DNA	In Batesian mimicry, animals avoid predation by resembling distasteful models. In the swallowtail butterfly Papilio polytes, only mimetic-form females resemble the unpalatable butterfly Pachliopta aristolochiae. A recent report showed that a single gene, doublesex (dsx), controls this mimicry(1); however, the detailed molecular mechanisms remain unclear. Here we determined two whole-genome sequences of P. polytes and a related species, Papilio xuthus, identifying a single similar to 130-kb autosomal inversion, including dsx, between mimetic (H-type) and non-mimetic (h-type) chromosomes in P. polytes. This inversion is associated with the mimicry-related locus H, as identified by linkage mapping. Knockdown experiments demonstrated that female-specific dsx isoforms expressed from the inverted H allele (dsx(H)) induce mimetic coloration patterns and simultaneously repress non-mimetic patterns. In contrast, dsx(h) does not alter mimetic patterns. We propose that dsx(H) switches the coloration of predetermined wing patterns and that female-limited polymorphism is tightly maintained by chromosomal inversion.	[Nishikawa, Hideki; Iijima, Takuro; Yamaguchi, Junichi; Ando, Toshiya; Fujiwara, Haruhiko] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Kajitani, Rei; Morimoto, Hiroya; Itoh, Takehiko] Tokyo Inst Technol, Dept Biol Informat, Meguro Ku, Tokyo, Japan; [Ando, Toshiya] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Kobe, Hyogo, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Kashiwa, Chiba, Japan; [Sugano, Sumio] Univ Tokyo, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Fujiyama, Asao] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Fujiyama, Asao] Natl Inst Informat, Principle Informat, Chiyoda Ku, Tokyo, Japan; [Kosugi, Shunichi; Hirakawa, Hideki; Tabata, Satoshi] Kazusa DNA Res Inst, Kisarazu, Japan; [Ozaki, Katsuhisa] JT Biohist Res Hall, Takatsuki, Osaka, Japan; [Ihara, Kunio; Obara, Madoka; Hori, Hiroshi] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648601, Japan	Fujiwara, H (reprint author), Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	haruh@k.u-tokyo.ac.jp		Ando, Toshiya/0000-0003-4558-8904	Ministry of Education, Culture, Sports, Science and Technology of Japan [18017007, 20017007];  [22128005];  [221S0002]	We thank A. Toyoda, Y. Kohara, R. Futahashi, T. Kojima, K.K. Kojima, H. Yoshikawa, M. Hasebe, Y. Kondo, S. Kawamura, H. Maekawa and J.M. Otaki for helpful suggestions on our research. We also thank R. Kurokawa for technical assistance with data analysis in the association study. We also thank T. Kojima for helpful comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas 'Comparative Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan 18017007 and 20017007 (to H.F.), Grant-in-Aid for Scientific Research 22128005 (to H.F.) and KAKENHI for Innovative Areas 221S0002.	Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; An WQ, 1996, MOL CELL BIOL, V16, P3106; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; CLARKE CA, 1972, PHILOS T ROY SOC B, V263, P431, DOI 10.1098/rstb.1972.0006; Kunte K, 2009, EVOLUTION, V63, P2707, DOI 10.1111/j.1558-5646.2009.00752.x; Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Loehlin DW, 2014, NATURE, V507, P172, DOI 10.1038/nature13066; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; CLARKE C. A., 1960, HEREDITY, V14, P175, DOI 10.1038/hdy.1960.15; Golden Kyle, 2007, Journal of Insect Science (Tucson), V7, P1, DOI 10.1673/031.007.5301; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Langmead B., 2009, GENOME BIOL, V10, DOI DOI 10.1186/GB-2009-10-3-R25; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469	28	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					405	U169		10.1038/ng.3241		7	Genetics & Heredity	Genetics & Heredity	CE6CH	WOS:000351922900019		
J	Sakai, D; Andersson, GBJ				Sakai, Daisuke; Andersson, Gunnar B. J.			Stem cell therapy for intervertebral disc regeneration: obstacles and solutions	NATURE REVIEWS RHEUMATOLOGY			English	Review							NUCLEUS PULPOSUS CELLS; LOW-BACK-PAIN; ENDOTHELIAL GROWTH-FACTOR; MAGNETIC-RESONANCE SCANS; IN-VIVO; PROGENITOR CELLS; DEGENERATION MODEL; CANINE MODEL; CHONDROCYTE TRANSPLANTATION; ASYMPTOMATIC SUBJECTS	Intervertebral disc (IVD) degeneration is frequently associated with low back and neck pain, which accounts for disability worldwide. Despite the known outcomes of the IVD degeneration cascade, the treatment of IVD degeneration is limited in that available conservative and surgical treatments do not reverse the pathology or restore the IVD tissue. Regenerative medicine for IVD degeneration, by injection of IVD cells, chondrocytes or stem cells, has been extensively studied in the past decade in various animal models of induced IVD degeneration, and has progressed to clinical trials in the treatment of various spinal conditions. Despite preliminary results showing positive effects of cell-injection strategies for IVD regeneration, detailed basic research on IVD cells and their niche indicates that transplanted cells are unable to survive and adapt in the avascular niche of the IVD. For this therapeutic strategy to succeed, the indications for its use and the patients who would benefit need to be better defined. To surmount these obstacles, the solution will be identified only by focused research, both in the laboratory and in the clinic.	[Sakai, Daisuke] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 2591193, Japan; [Andersson, Gunnar B. J.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Sakai, D (reprint author), Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 2591193, Japan.	daisakai@is.icc.u-tokai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; AO Spine International; AO Foundation	The authors are grateful to M. E. Lenz for her help in preparation of the manuscript. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from AO Spine International and a grant from AO Foundation (D.S.).	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM, V58, P3798, DOI 10.1002/art.24073; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Gorensek M, 2004, CELL MOL BIOL LETT, V9, P363; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157; Iwashina T, 2006, SPINE, V31, P1177, DOI 10.1097/01.brs.0000217687.36874.c4; Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7; Fujita N, 2008, BIOCHEM BIOPH RES CO, V372, P367, DOI 10.1016/j.bbrc.2008.05.044; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034; Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007; Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011; Sheikh H, 2009, J NEUROSURG-SPINE, V10, P265, DOI 10.3171/2008.12.SPINE0835; Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Omlor GW, 2010, EUR SPINE J, V19, P601, DOI 10.1007/s00586-009-1255-7; Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78; Henriksson HB, 2009, SPINE, V34, P141, DOI 10.1097/BRS.0b013e31818f8c20; Jeong JH, 2010, ACTA NEUROCHIR, V152, P1771, DOI 10.1007/s00701-010-0698-2; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Leckie SK, 2013, SPINE J, V13, P263, DOI 10.1016/j.spinee.2012.12.004; Chun HJ, 2012, WORLD NEUROSURG, V78, P364, DOI 10.1016/j.wneu.2011.12.084; Acosta FL, 2011, TISSUE ENG PT A, V17, P3045, DOI 10.1089/ten.tea.2011.0229; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178; Ho G, 2008, CONNECT TISSUE RES, V49, P15, DOI 10.1080/03008200701818595; Hee HT, 2010, J BONE JOINT SURG BR, V92B, P726, DOI 10.1302/0301-620X.92B5.23015; Horner HA, 2001, SPINE, V26, P2543, DOI 10.1097/00007632-200112010-00006; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/01.BRS.0000018788.88555.21; Tran CM, 2013, MATRIX BIOL, V32, P298, DOI 10.1016/j.matbio.2013.03.006; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Wei AQ, 2009, J ORTHOP RES, V27, P374, DOI 10.1002/jor.20567; Xia XP, 2013, SPINE, V38, P597, DOI 10.1097/BRS.0b013e318273a2ea; Wang H, 2014, TISSUE ENG PT A, V20, P908, DOI [10.1089/ten.TEA.2012.0703, 10.1089/ten.tea.2012.0703]; Bendtsen M, 2011, SPINE, V36, pE373, DOI 10.1097/BRS.0b013e3181dce34c; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Vadala G, 2012, J TISSUE ENG REGEN M, V6, P348, DOI 10.1002/term.433; Orozco L, 2011, TRANSPLANTATION, V92, P822, DOI 10.1097/TP.0b013e3182298a15; Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de; Jeong JH, 2009, CYTOTECHNOLOGY, V59, P55, DOI 10.1007/s10616-009-9192-1; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; MacGregor AJ, 2004, ARTHRIT RHEUM-ARTHR, V51, P160, DOI 10.1002/art.20236; Gogate SS, 2011, ARTHRITIS RHEUM-US, V63, P1950, DOI 10.1002/art.30342; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Pattappa G, 2014, EUR CELLS MATER, V27, P124; Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2; Juniper M, 2009, EXPERT OPIN PHARMACO, V10, P2581, DOI 10.1517/14656560903304063; Tam V, 2014, J ORTHOP RES, V32, P819, DOI 10.1002/jor.22605; Malik KM, 2013, SPINE J, V13, P1675, DOI 10.1016/j.spinee.2013.06.063; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770; Ghosh P, 2012, J NEUROSURG-SPINE, V16, P479, DOI 10.3171/2012.1.SPINE11852; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Allon AA, 2010, SPINE J, V10, P1089, DOI 10.1016/j.spinee.2010.09.014; Meisel HJ, 2006, EUR SPINE J, V15, pS397, DOI 10.1007/s00586-006-0169-x; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Li YY, 2014, TISSUE ENG PT A, V20, P1379, DOI [10.1089/ten.TEA.2013.0498, 10.1089/ten.tea.2013.0498]; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Yoshikawa T, 2010, SPINE, V35, pE475, DOI 10.1097/BRS.0b013e3181cd2cf4; Murrell W, 2009, SPINE J, V9, P585, DOI 10.1016/j.spinee.2009.02.011; Zhang YG, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000146534.31120.cf; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Siepe CJ, 2014, SPINE J, V14, P1417, DOI 10.1016/j.spinee.2013.08.028; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI [10.1002/jor.21147, 10.1002/jor.21197]; Hong JH, 2013, SPINE, V38, P75, DOI 10.1097/BRS.0b013e318276450f; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Barczewska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074658; Benneker L M, 2014, Eur Cell Mater, V27, P5; Breivik H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1229; Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179; Cai F., 2014, INT ORTHOP, V39, P149; Carreon LY, 1997, SPINE, V22, P1429, DOI 10.1097/00007632-199707010-00001; Chan D, 2006, EUR SPINE J, V15, pS317, DOI 10.1007/s00586-006-0171-3; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075548; Coric D., 2013, J NEUROSURG-SPINE, V18, P85; Erwin WM, 2013, SPINE, V38, P211, DOI 10.1097/BRS.0b013e318266a80d; Feng GJ, 2011, J NEUROSURG-SPINE, V14, P322, DOI 10.3171/2010.11.SPINE10285; Fujita N, 2014, FASEB J, V28, P2455, DOI 10.1096/fj.13-243741; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3; Haufe SMW, 2006, STEM CELLS DEV, V15, P136, DOI 10.1089/scd.2006.15.136; Henriksson HB, 2012, J TISSUE ENG REGEN M, V6, P738, DOI 10.1002/term.480; Huang B, 2011, SPINE, V36, P2252, DOI 10.1097/BRS.0b013e318209fd85; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Illien-Junger S, 2012, SPINE, V37, P1865, DOI 10.1097/BRS.0b013e3182544a8a; Liu LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026285; Ma C. J., 2014, CURR STEM CELL RES T; Miele Vincent J, 2012, Handb Clin Neurol, V109, P31, DOI 10.1016/B978-0-444-52137-8.00002-4; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Miyamoto T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3182; Mochida J, 1996, SPINE, V21, P1556, DOI 10.1097/00007632-199607010-00014; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; Ozaki S, 1999, J Orthop Sci, V4, P286, DOI 10.1007/s007760050105; Pai RR, 1999, SPINE, V24, P739, DOI 10.1097/00007632-199904150-00002; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413; Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408; Prologo JD, 2012, J VASC INTERV RADIOL, V23, P1084, DOI 10.1016/j.jvir.2012.04.032; Rajasekaran S, 2013, SPINE J, V13, P1309, DOI 10.1016/j.spinee.2013.05.019; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sakai D., 2014, SPINE J; Shiri R, 2010, AM J MED, V123; Sivakamasundari V., 2013, ADV STEM CELLS, V2013; Soukane DM, 2009, EUR SPINE J, V18, P254, DOI 10.1007/s00586-008-0822-7; Subhan R. A., 2014, SCI WORLD J, V2014; Grunhagen T, 2011, ORTHOP CLIN N AM, V42, P465, DOI 10.1016/j.ocl.2011.07.010; Tibiletti M, 2014, EUR SPINE J, V23, pS375, DOI 10.1007/s00586-014-3177-2; Turner S, 2014, EUR SPINE J, V23, P2462, DOI 10.1007/s00586-014-3500-y; Tzaan W.C., 2011, ADV ORTHOP, V2011; URBAN JPG, 1978, BIORHEOLOGY, V15, P203; URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101; Watanabe K, 2003, CONNECT TISSUE RES, V44, P104, DOI 10.1080/03008200390200247; Yang HL, 2010, SPINE J, V10, P802, DOI 10.1016/j.spinee.2010.06.019; Yi Z, 2014, SPINE, V39, pE669, DOI [DOI 10.1097/BRS.0000000000000316, 10.1097/BRS.0000000000000316]; Zhang Yejia, 2011, Spine (Phila Pa 1976), V36, P372, DOI 10.1097/BRS.0b013e3181d10401	130	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4790	1759-4804		NAT REV RHEUMATOL	Nat. Rev. Rheumatol.	APR	2015	11	4					243	256		10.1038/nrrheum.2015.13		14	Rheumatology	Rheumatology	CE7IB	WOS:000352011300008		
J	Horibe, H; Fujimaki, T; Oguri, M; Kato, K; Matsuoka, R; Abe, S; Tokoro, F; Arai, M; Noda, T; Watanabe, S; Yamada, Y				Horibe, Hideki; Fujimaki, Tetsuo; Oguri, Mitsutoshi; Kato, Kimihiko; Matsuoka, Reiko; Abe, Shintaro; Tokoro, Fumitaka; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro; Yamada, Yoshiji			Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals	NEPHROLOGY			English	Article						genetics; interleukin-6; kidney failure; polymorphism; receptors; renal insufficiency	CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; DIABETIC-NEPHROPATHY; SUSCEPTIBILITY LOCI; EXPRESSION; VARIANTS; IDENTIFICATION; INFLAMMATION; POPULATION; HEART	AimVarious loci and genes that confer susceptibility to coronary artery disease (CAD) have been identified in Caucasian populations by genome-wide association studies (GWASs). The aim of the present study was to examine a possible association of chronic kidney disease (CKD) with 29 polymorphisms previously identified as susceptibility loci for CAD by meta-analyses of GWASs. MethodsThe study population comprised 2247 Japanese individuals, including 1588 subjects with CKD [estimated glomerular filtration rate (eGFR) of <60mLmin(-1) 1.73m(-2)] and 659 controls (eGFR of 90mLmin(-1) 1.73m(-2)). The genotypes for 29 polymorphisms of 28 candidate genes were determined. ResultsThe (2) test revealed that rs4845625 (TC) of IL6R, rs4773144 (AG) of COL4A1, rs9319428 (GA) of FLT1, and rs46522 (TC) of UBE2Z were significantly (P<0.05) related to CKD. Multivariable logistic regression analysis with adjustment for age, sex, body mass index, and the prevalence of smoking, hypertension, diabetes mellitus, and dyslipidaemia revealed that rs4845625 of IL6R (P=0.0008; dominant model; odds ratio, 1.49), rs4773144 of COL4A1 (P=0.0252; dominant model; odds ratio, 1.28), and rs9319428 of FLT1 (P=0.0260: additive model; odds ratio, 0.77) were significantly associated with CKD. The serum concentration of creatinine was significantly (P=0.0065) greater and eGFR was significantly (P=0.0009) lower in individuals with the TC or CC genotype of IL6R than in those with the TT genotype. ConclusionThe rs4845625 of IL6R may be a susceptibility locus for CKD in Japanese individuals. Summary at a Glance The authors detected a novel SNP in the IL6R gene that correlates with CKD in a reasonably large Japanese cohort.	[Horibe, Hideki] Gifu Prefectural Tajimi Hosp, Dept Cardiovasc Med, Tajimi, Japan; [Fujimaki, Tetsuo] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe, Japan; [Oguri, Mitsutoshi] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Kato, Kimihiko] Meitoh Hosp, Dept Internal Med, Nagoya, Aichi, Japan; [Kato, Kimihiko; Yamada, Yoshiji] Mie Univ, Dept Human Funct Genom, Life Sci Res Ctr, Tsu, Mie 5148507, Japan; [Matsuoka, Reiko; Abe, Shintaro; Tokoro, Fumitaka; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Japan	Yamada, Y (reprint author), Mie Univ, Dept Human Funct Genom, Life Sci Res Ctr, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	yamada@gene.mie-u.ac.jp			Gifu Prefectural General Medical Center [H24-26]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590746]	This work was supported by a Collaborative Research Grant from the Gifu Prefectural General Medical Center (H24-26 to Y.Y.) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24590746 to Y.Y.).	Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; SUZUKI D, 1995, DIABETES, V44, P1233, DOI 10.2337/diabetes.44.10.1233; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Wang H, 2005, J CLIN ENDOCR METAB, V90, P1123, DOI 10.1210/jc.2004-1606; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Heidet L, 2000, AM J PATHOL, V156, P1901, DOI 10.1016/S0002-9440(10)65063-8; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Yamada Y, 2013, J MED GENET, V50, P410, DOI 10.1136/jmedgenet-2013-101518; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Consortium C. A. D., 2013, NAT GENET, V45, P25; Di Lullo L, 2014, HEART FAIL REV; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; Henrich PC, 2003, BIOCHEM J, V374, P1; Nakai K, 2002, HUM MUTAT, V20, P133, DOI 10.1002/humu.10099; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; PETEN EP, 1992, J EXP MED, V176, P1571, DOI 10.1084/jem.176.6.1571; Shah T, 2013, CIRC-CARDIOVASC GENE, V6, P163, DOI 10.1161/CIRCGENETICS.112.964254; Velez DR, 2008, HUM MOL GENET, V17, P1619, DOI 10.1093/hmg/ddn049; Wolford JK, 2003, MOL GENET METAB, V80, P338, DOI 10.1016/j.ymgme.2003.07.003	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	APR	2015	20	4					273	278		10.1111/nep.12381		6	Urology & Nephrology	Urology & Nephrology	CE8NV	WOS:000352100800008		
J	Okuda, Y; Ishikura, K; Hamada, R; Harada, R; Sakai, T; Hamasaki, Y; Hataya, H; Fukuzawa, R; Ogata, K; Honda, M				Okuda, Yusuke; Ishikura, Kenji; Hamada, Riku; Harada, Ryoko; Sakai, Tomoyuki; Hamasaki, Yuko; Hataya, Hiroshi; Fukuzawa, Ryuji; Ogata, Kentaro; Honda, Masataka			Membranoproliferative glomerulonephritis and C3 glomerulonephritis: Frequency, clinical features, and outcome in children	NEPHROLOGY			English	Article						C3 glomerulopathy; immunofluorescence; immunosuppressant; membranoproliferative glomerulonephritis; methylprednisolone pulse therapy	DENSE DEPOSIT DISEASE; HEMOLYTIC-UREMIC SYNDROME; STAGE RENAL-DISEASE; COMPLEMENT ABNORMALITIES; ALTERNATIVE PATHWAY; JAPANESE CHILDREN; KIDNEY-DISEASE; FOLLOW-UP; GLOMERULOPATHY; RISK	AimC3 glomerulonephritis (C3GN) is a recently described disease that is related to membranoproliferative glomerulonephritis (MPGN). We retrospectively compared the frequencies, clinical characteristics, treatment modalities, and outcomes of C3GN and MPGN in a cohort of Japanese children. MethodsChildren who were pathologically diagnosed with MPGN (type I or III) in our hospital were divided into two groups based on immunofluorescence imaging of renal biopsies: children with MPGN induced by classical complement pathway activation (classical MPGN) and children with C3GN. ResultsOf 14 children with MPGN (five boys), four had classical MPGN, eight had C3GN, and two had unclassifiable glomerulonephritis. Four children with classical MPGN and seven with C3GN received methylprednisolone pulse therapy followed by oral prednisolone for 2 years (MPT+PSL therapy). Subsequently, six of seven children with C3GN received combined therapy (prednisolone, azathioprine, and anticoagulants) for 2 years because they responded poorly to MPT+PSL therapy. At the last follow-up visit, two children with classical MPGN and seven with C3GN had not achieved remission. One child with classical MPGN and five with C3GN had hypocomplementaemia at the last follow-up. None of the children had renal impairment. ConclusionMore than half of the patients previously diagnosed with MPGN fulfilled the criteria for C3GN in children. C3GN may be more refractory than classical MPGN to immunosuppressant therapy. Summary at a Glance The emergence of the term C3 glomerulonephropathy (C3 glomerulonephritis) in recent years is a step on the pathway towards an aetiological classification of glomerular disease, reflecting our increased understanding of disease pathogenesis. Okuda etal. present a retrospective study from two paediatric centres in Japan on the clinical features of C3 glomerulopathy in children re-classified as having this condition.	[Okuda, Yusuke; Ishikura, Kenji; Hamada, Riku; Harada, Ryoko; Hataya, Hiroshi; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Ishikura, Kenji] Tokyo Metropolitan Childrens Med Ctr, Clin Res Support Ctr, Fuchu, Tokyo 1838561, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, Fuchu, Tokyo 1838561, Japan; [Hamasaki, Yuko] Toho Univ, Fac Med, Dept Pediat Nephrol, Tokyo, Japan; [Ogata, Kentaro] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tachikawa Hosp, Div Pathol, Tokyo, Japan; [Sakai, Tomoyuki] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan	Ishikura, K (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	kenzo@ii.e-mansion.com					Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Bomback AS, 2012, CLIN J AM SOC NEPHRO, V7, P748, DOI 10.2215/CJN.12901211; Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Sethi S, 2012, KIDNEY INT, V82, P465, DOI 10.1038/ki.2012.212; Sethi S, 2011, CLIN J AM SOC NEPHRO, V6, P1009, DOI [10.2215/CJN.07110810, 10.2215/CIN.07110810]; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Roccatello D, 2007, AM J KIDNEY DIS, V49, P69, DOI 10.1053/j.ajkd.2006.09.015; D'Agati VD, 2012, KIDNEY INT, V82, P379, DOI 10.1038/ki.2012.80; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; Herlitz LC, 2012, J AM SOC NEPHROL, V23, P1229, DOI 10.1681/ASN.2011121186; Sethi S, 2012, KIDNEY INT, V81, P434, DOI 10.1038/ki.2011.399; Nicolas C, 2014, PEDIATR NEPHROL, V29, P85, DOI 10.1007/s00467-013-2605-6; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213; Alchi B, 2010, PEDIATR NEPHROL, V25, P1409, DOI 10.1007/s00467-009-1322-7; Hou J, 2014, KIDNEY INT, V85, P450, DOI 10.1038/ki.2013.340; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Medjeral-Thomas NR, 2014, CLIN J AM SOC NEPHRO, V9, P46, DOI 10.2215/CJN.04700513; CHAPMAN SJ, 1980, ARCH DIS CHILD, V55, P446; Emre Sevinc, 1995, Acta Paediatrica Japonica, V37, P626; Fervenza FC, 2012, NEPHROL DIAL TRANSPL, V27, P4288, DOI 10.1093/ndt/gfs288; IITAKA K, 1995, PEDIATR NEPHROL, V9, P272; Jennette JC, 2007, HEPTINSTALLS PATHOLO; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kawasaki Y, 2002, ARCH DIS CHILD, V86, P21, DOI 10.1136/adc.86.1.21; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group, 2012, KIDNEY INT S, VS2, P139; Neary JJ, 2002, J AM SOC NEPHROL, V13, P2052, DOI 10.1097/01.ASN.0000022006.49966.F8; West CD, 1999, PEDIATR NEPHROL, V13, P448; Yanagihara T, 2005, PEDIATR NEPHROL, V20, P585, DOI 10.1007/s00467-005-1826-8	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	APR	2015	20	4					286	292		10.1111/nep.12382		7	Urology & Nephrology	Urology & Nephrology	CE8NV	WOS:000352100800010		
J	Obuchi, M; Sumitani, M; Shin, M; Ishii, K; Kogure, T; Miyauchi, S; Yamada, Y				Obuchi, Maiko; Sumitani, Masahiko; Shin, Masahiro; Ishii, Kazuhiko; Kogure, Takamichi; Miyauchi, Satoru; Yamada, Yoshitsugu			Spinal Cord Stimulation Ameliorates Neuropathic Pain-Related Sleep Disorders: A Case Series	NEUROMODULATION			English	Article						Chronic pain; sleep disorder; spinal cord stimulation	BACK SURGERY SYNDROME; ACTIGRAPHY; MEDICINE; QUALITY; RATS	ObjectiveAlthough sleep disorder is one of the most serious comorbidities of refractory chronic pain, it is usually assessed only from the patients' subjective point of view. Therefore, we aimed to objectively evaluate the sleep efficiency of patients with chronic pain. MethodsUsing an actigraph, a highly sensitive accelerometer, we assessed the sleep efficiency of six patients with chronic pain before and after the introduction of spinal cord stimulation (SCS). ResultsWhile pain improved in only five out of six patients after SCS, sleep efficiency improved in all cases. Interestingly, in one case, sleep efficiency improved even though pain intensity remained unchanged. ConclusionWith the use of an actigraph, improvements in sleep of patients with chronic pain undergoing SCS were demonstrated. One case showing improvement in sleep despite pain palliation may suggest that SCS might have independently affected the sleep system, although further studies are necessary.	[Obuchi, Maiko; Kogure, Takamichi; Yamada, Yoshitsugu] Tokyo Univ Hosp, Dept Anesthesiol, Tokyo 113, Japan; [Obuchi, Maiko; Kogure, Takamichi; Yamada, Yoshitsugu] Tokyo Univ Hosp, Pain Relief Ctr, Tokyo 113, Japan; [Sumitani, Masahiko] Tokyo Univ Hosp, Dept Med Engn, Tokyo 113, Japan; [Shin, Masahiro; Ishii, Kazuhiko] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan; [Miyauchi, Satoru] Natl Inst Informat & Communicat Technol, Kobe Adv ICT Res Ctr, Kobe, Hyogo, Japan	Sumitani, M (reprint author), 7-3-1 Hongo, Tokyo 1130033, Japan.	sumitanim-ane@h.u-tokyo.ac.jp					Andres J, 2006, PAIN PRACT, V6, P39; O'Brien EM, 2010, CLIN J PAIN, V26, P310, DOI 10.1097/AJP.0b013e3181c328e9; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Mason P, 2001, SLEEP, V24, P32; Acebo C, 1999, SLEEP, V22, P95; Manca A, 2008, EUR J PAIN, V12, P1047, DOI 10.1016/j.ejpain.2008.01.014; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Kelly GA, 2012, EUR J PAIN, V16, P793, DOI 10.1002/j.1532-2149.2011.00092.x; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Lunde LH, 2010, CLIN J PAIN, V26, P132, DOI 10.1097/AJP.0b013e3181b61923; MATSUI T, 1989, PACE, V12, P718, DOI 10.1111/j.1540-8159.1989.tb02722.x; Ozcelik L, 2007, BRAIN RES, V1135, P201, DOI 10.1016/j.brainres.2006.11.086; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; STILLER CO, 1995, BRAIN RES, V699, P231, DOI 10.1016/0006-8993(95)00911-9; Wills WD, 1991, SENSORY MECH SPINAL	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	APR	2015	18	3					191	193		10.1111/ner.12222		3	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	CF5GW	WOS:000352586500009		
J	Arishima, H; Kikuta, K				Arishima, Hidetaka; Kikuta, Ken-ichiro			Intrathecal Baclofen Pump Implantation in Prone Position for a Cerebral Palsy Patient With Severe Scoliosis: A Case Report	NEUROMODULATION			English	Article						Cerebral palsy; intrathecal baclofen; prone position; pump implantation; scoliosis	CHILDREN; THERAPY	Background and ObjectiveIntrathecal baclofen (ITB) pump implantation for cerebral palsy (CP) patients is usually performed in the lateral position; however, it might be difficult for some patients with severe deformity to take a lateral position during surgery. MethodWe report a case of ITB pump implantation in the prone position for a CP patient who exhibited uncontrollable opisthotonus with severe scoliosis. ResultITB therapy effectively controlled her opisthotonus. ConclusionOur findings suggest that ITB therapy may be useful for CP patients with uncontrollable spasticity, dystonia, or opisthotonus who are not able to take a lateral position for pump implantation due to deformities of their extremities and spine.	[Arishima, Hidetaka; Kikuta, Ken-ichiro] Univ Fukui, Dept Neurosurg, Eiheiji, Fukui 9101193, Japan	Arishima, H (reprint author), Univ Fukui, Dept Neurosurg, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	ari@u-fukui.ac.jp					Motta F, 2011, DEV MED CHILD NEUROL, V53, P443, DOI 10.1111/j.1469-8749.2010.03904.x; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; Mccoy AA, 2006, ARCH PHYS MED REHAB, V87, P1503, DOI 10.1016/j.apmr.2006.07.270; Motta F, 2008, J PEDIATR ORTHOPED, V28, P213, DOI 10.1097/BPO.0b013e3181653b2a; Vles GF, 2013, EUR J PAEDIATR NEURO, V17, P639, DOI 10.1016/j.ejpn.2013.06.003	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	APR	2015	18	3					214	216		10.1111/ner.12203		3	Medicine, Research & Experimental; Clinical Neurology	Research & Experimental Medicine; Neurosciences & Neurology	CF5GW	WOS:000352586500020		
J	Li, BM; Funahashi, S				Li, Bao-Ming; Funahashi, Shintaro			A step forward in the understanding of prefrontal cortical functions	NEUROSCIENCE BULLETIN			English	Editorial Material							WORKING-MEMORY; CORTEX		[Li, Bao-Ming] Nanchang Univ, Inst Life Sci, Nanchang 330031, Peoples R China; [Funahashi, Shintaro] Kyoto Univ, Kokoro Res Ctr, Kyoto 6068501, Japan	Li, BM (reprint author), Nanchang Univ, Inst Life Sci, Nanchang 330031, Peoples R China.	bmli@ncu.edu.cn					FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331; Miller EK, 1996, J NEUROSCI, V16, P5154; Cai Q, 2015, NEUROSCI BULL, V31, P220, DOI 10.1007/s12264-014-1505-5; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Goldman-Rakic P., 1987, HDB PHYSL 1, V5, P373; Ku YX, 2015, NEUROSCI BULL, V31, P175, DOI 10.1007/s12264-014-1503-7; Kuo MF, 2015, NEUROSCI BULL, V31, P198, DOI 10.1007/s12264-014-1501-9; Lee YA, 2015, NEUROSCI BULL, V31, P164, DOI 10.1007/s12264-014-1499-z; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; Luria AR., 1966, HIGHER CORTICAL FUNC; Ma CL, 2015, NEUROSCI BULL, V31, P227, DOI 10.1007/s12264-014-1514-4; Mao P, 2015, NEUROSCI BULL, V31, P235, DOI 10.1007/s12264-014-1506-4; Otani S, 2015, NEUROSCI BULL, V31, P183, DOI 10.1007/s12264-014-1507-3; Wang M, 2015, NEUROSCI BULL, V31, P191, DOI 10.1007/s12264-014-1504-6; Xu NL, 2015, NEUROSCI BULL, V31, P242, DOI 10.1007/s12264-014-1509-1; Zhou Y, 2015, NEUROSCI BULL, V31, P207, DOI 10.1007/s12264-014-1502-8	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	APR	2015	31	2			SI		161	163		10.1007/s12264-015-1516-2		3	Neurosciences	Neurosciences & Neurology	CE9GT	WOS:000352152800001		
J	Lee, YA; Goto, Y				Lee, Young-A; Goto, Yukiori			Prefrontal cortical dopamine from an evolutionary perspective	NEUROSCIENCE BULLETIN			English	Review						neurodevelopment; neoteny; psychiatric disorder; stress; animal model; synaptic plasticity; environmental adaptation	PHENOTYPIC PLASTICITY; NEURAL DEVELOPMENT; GENE-EXPRESSION; FRONTAL-CORTEX; CHRONIC STRESS; NMDA RECEPTOR; ANIMAL-MODELS; SOCIAL BRAIN; SCHIZOPHRENIA; RATS	In this article, we propose the hypothesis that the prefrontal cortex (PFC) acquired neotenic development as a consequence of mesocortical dopamine (DA) innervation, which in turn drove evolution of the PFC into becoming a complex functional system. Accordingly, from the evolutionary perspective, decreased DA signaling in the PFC associated with such adverse conditions as chronic stress may be considered as an environmental adaptation strategy. Psychiatric disorders such as schizophrenia and attention deficit/hyperactivity disorder may also be understood as environmental adaptation or a by-product of such a process that has emerged through evolution in humans. To investigate the evolutionary perspective of DA signaling in the PFC, domestic animals such as dogs may be a useful model.	[Lee, Young-A] Catholic Univ Daegu, Dept Food Sci & Nutr, Gyongsan, South Korea; [Goto, Yukiori] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	Goto, Y (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	goto.yukiori.5c@kyoto-u.ac.jp			Kyoto University; Ito Chubei Foundation; Ichiro Kanehara Foundation; Institute of Life Seizon, Japan	This review was supported by Kyoto University, the Ito Chubei Foundation, the Ichiro Kanehara Foundation, and the Institute of Life & Seizon, Japan.	Burns J, 2006, WORLD PSYCHIATRY, V5, P77; MORRISON JH, 1982, P NATL ACAD SCI-BIOL, V79, P2401, DOI 10.1073/pnas.79.7.2401; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; KALIVAS PW, 1989, BIOL PSYCHIAT, V25, P913, DOI 10.1016/0006-3223(89)90271-0; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; Ladepeche L, 2013, P NATL ACAD SCI USA, V110, P18005, DOI 10.1073/pnas.1310145110; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Granon S, 2000, J NEUROSCI, V20, P1208; POVINELLI DJ, 1995, TRENDS NEUROSCI, V18, P418, DOI 10.1016/0166-2236(95)93939-U; SCHEETZ AJ, 1994, FASEB J, V8, P745; Boutros NN, 2000, INT PSYCHOGERIATR, V12, P513, DOI 10.1017/S1041610200006621; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Puumala T, 1998, NEUROSCIENCE, V83, P489; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Miklosi A, 2007, NEUROREPORT, V18, P467; Bosch MN, 2012, CURR ALZHEIMER RES, V9, P298; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Heyland A, 2004, EVOLUTION, V58, P524, DOI 10.1111/j.0014-3820.2004.tb01676.x; WEINBERGER DR, 1988, ANN NY ACAD SCI, V537, P330, DOI 10.1111/j.1749-6632.1988.tb42117.x; Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Koslowsky M, 1997, APPL PSYCHOL-INT REV, V46, P153, DOI 10.1111/j.1464-0597.1997.tb01222.x; Ersche KD, 2013, MOL PSYCHIATR, V18, P134, DOI 10.1038/mp.2012.31; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Pickup GJ, 2001, PSYCHOL MED, V31, P207; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; BUBSER M, 1990, BEHAV BRAIN RES, V37, P157, DOI 10.1016/0166-4328(90)90091-R; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Denoel M, 2000, P ROY SOC B-BIOL SCI, V267, P1481, DOI 10.1098/rspb.2000.1168; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; ARONS CD, 1992, BRAIN RES, V594, P31, DOI 10.1016/0006-8993(92)91026-B; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Arnsten AFT, 2006, NEUROPSYCHOPHARMACOL, V31, P2376, DOI 10.1038/sj.npp.1301164; Takahashi A, 2010, BEHAV GENET, V40, P366, DOI 10.1007/s10519-009-9312-x; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Cameron SA, 1989, CANADIAN J REHABILIT, V2, P137; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Coppinger R, 1995, DOMESTIC DOG ITS EVO; Crespi B., 2008, BEHAV BRAIN SCI, V31, P261, DOI [10.1017/S0140525X08004214, DOI 10.1017/S0140525X08004214]; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Darwin C., 1859, ORIGIN SPECIES; Hall B K, 2000, Evol Dev, V2, P177, DOI 10.1046/j.1525-142x.2000.00003e.x; Harrington Leigh, 2005, Cogn Neuropsychiatry, V10, P87, DOI 10.1080/13546800344000327; HOLDEN KL, 1988, J CLIN PSYCHOL, V44, P286, DOI 10.1002/1097-4679(198803)44:2<286::AID-JCLP2270440233>3.0.CO;2-1; Jensen P. S., 1997, J AM ACAD CHILD ADOL, V36, p[1672, 1679], DOI 10.1097/00004583-199712000-00015; KALSBEEK A, 1989, EXP BRAIN RES, V78, P279; Krasnova IN, 2007, NEUROTOX RES, V11, P107; Lambe EK, 2000, J NEUROSCI, V20, P8780; LEWIS DA, 1990, PROG NEURO-PSYCHOPH, V14, P371, DOI 10.1016/0278-5846(90)90025-C; Lyons DM, 2010, DEV PSYCHOBIOL, V52, P402, DOI 10.1002/dev.20429; Montgomery SM, 1997, ARCH DIS CHILD, V77, P326; Nakama H, 2011, ADDICTION, V106, P1474, DOI 10.1111/j.1360-0443.2011.03433.x; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; NOONBERG A, 1985, ALCOHOL CLIN EXP RES, V9, P334, DOI 10.1111/j.1530-0277.1985.tb05555.x; Parsons KJ, 2011, J EVOLUTION BIOL, V24, P1640, DOI 10.1111/j.1420-9101.2011.02301.x; Peleg-Raibstein D, 2005, NEUROSCIENCE, V132, P219, DOI 10.1016/j.neuroscience.2004.12.016; RABKIN JG, 1980, PSYCHOL BULL, V87, P408, DOI 10.1037/0033-2909.87.2.408; Reece Albert Stuart, 2007, Immun Ageing, V4, P6, DOI 10.1186/1742-4933-4-6; Reinoso BS, 1996, J NEUROSCI RES, V43, P439, DOI 10.1002/(SICI)1097-4547(19960215)43:4<439::AID-JNR5>3.0.CO;2-G; SAUGSTAD LF, 1989, CLIN GENET, V36, P156; Schmidt K, 2010, J EXP ZOOL PART B, V314B, P166, DOI 10.1002/jez.b.21320; Schmidt U, 1996, NEUROSCIENCE, V74, P453, DOI 10.1016/0306-4522(96)00201-1; Sengupta Pallav, 2013, Int J Prev Med, V4, P624; Shea B. T., 1989, AM J PHYS ANTHROPOL, V32, P69, DOI 10.1002/ajpa.1330320505; Stevens A, 2000, EVOLUTIONARY PSYCHIA; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; vanGent T, 1997, J CHILD PSYCHOL PSYC, V38, P337; Wakahara M, 1996, ZOOL SCI, V13, P765, DOI 10.2108/zsj.13.765; WEHMER F, 1970, NATURE, V227, P622, DOI 10.1038/227622a0; Xiang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-646	93	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	APR	2015	31	2			SI		164	174		10.1007/s12264-014-1499-z		11	Neurosciences	Neurosciences & Neurology	CE9GT	WOS:000352152800002		
J	Otani, S; Bai, J; Blot, K				Otani, Satoru; Bai, Jing; Blot, Kevin			Dopaminergic modulation of synaptic plasticity in rat prefrontal neurons	NEUROSCIENCE BULLETIN			English	Review						prefrontal cortex; synaptic plasticity; long-term memory	LONG-TERM POTENTIATION; BIDIRECTIONAL MODULATION; POSTSYNAPTIC ACTIVATION; NORADRENALINE RELEASE; CORTICAL-NEURONS; D1 RECEPTORS; IN-VITRO; CORTEX; DEPRESSION; STRESS	The prefrontal cortex (PFC) is thought to store the traces for a type of long-term memory - the abstract memory that determines the temporal structure of behavior often termed a "rule" or "strategy". Long-term synaptic plasticity might serve as an underlying cellular mechanism for this type of memory. We therefore studied the induction of synaptic plasticity in rat PFC neurons, maintained in vitro, with special emphasis on the functionally important neuromodulator dopamine. First, the induction of long-term potentiation (LTP) was facilitated in the presence of tonic/background dopamine in the bath, and the dose-dependency of this background dopamine followed an "inverted-U" function, where too high or too low dopamine levels could not facilitate LTP. Second, the induction of long-term depression (LTD) by low-frequency stimuli appeared to be independent of background dopamine, but required endogenous, phasically-released dopamine during the stimuli. Blockade of dopamine receptors during the stimuli and exaggeration of the effect of this endogenously-released dopamine by inhibition of dopamine transporter activity both blocked LTD. Thus, LTD induction also followed an inverted-U function in its dopamine-dependency. We conclude that PFC synaptic plasticity is powerfully modulated by dopamine through inverted-U-shaped dose-dependency.	[Otani, Satoru] Ryotokuji Univ, Ctr Med Educ, Fac Hlth Sci, Chiba, Japan; [Otani, Satoru; Bai, Jing] Juntendo Univ, Chinese Med Res Lab, Sch Med, Tokyo, Japan; [Blot, Kevin] Univ Paris, Dept Pathophysiol, F-75252 Paris, France	Otani, S (reprint author), Ryotokuji Univ, Ctr Med Educ, Fac Hlth Sci, Chiba, Japan.	otani@ryotokuji-u.ac.jp					Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Mingote S, 2004, J NEUROSCI, V24, P2475, DOI 10.1523/JNEUROSCI.4547-03.2004; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Barch DM, 2010, SCHIZOPHRENIA BULL, V36, P919, DOI 10.1093/schbul/sbq068; Keil A, 1999, J NEUROSCI, V19, P7152; Sanchez CJ, 2003, NEUROSCIENCE, V119, P497, DOI 10.1016/S0306-4522(03)00078-2; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460.9568.2004.03278.x; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Touzani K, 2007, P NATL ACAD SCI USA, V104, P5632, DOI 10.1073/pnas.0611554104; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; ALESSI DR, 1995, J BIOL CHEM, V270, P27489; Takahata R, 2000, J NEUROCHEM, V75, P1775, DOI 10.1046/j.1471-4159.2000.0751775.x; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Bai J, 2014, CEREB CORTEX, V24, P945, DOI 10.1093/cercor/bhs376; Funahashi S, 2013, PROG NEUROBIOL, V103, P131, DOI 10.1016/j.pneurobio.2012.04.002; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Morris SH, 1999, J NEUROPHYSIOL, V82, P1927; Otani S, 1999, J NEUROSCI, V19, P9788; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Bohlen von, 2006, NEUROTRANSMITERS NEU; Chen L, 2007, J NEUROPHYSIOL, V97, P2448, DOI 10.1152/jn.00317.2006; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Feenstra MGP, 2000, PROG BRAIN RES, V126, P133; Feenstra MGP, 1999, NEUROSCI LETT, V272, P179, DOI 10.1016/S0304-3940(99)00601-1; Fuster JM, 1995, MEMORY CEREBRAL CORT; Korz V, 2005, J NEUROSCI, V25, P7393, DOI 10.1523/JNEUROSCI.0910-05.2005; Schmidt HD, 2006, BEHAV BRAIN RES, V175, P189, DOI 10.1016/j.bbr.2006.08.009; VANEDEN CG, 1987, NEUROSCIENCE, V22, P849, DOI 10.1016/0306-4522(87)92964-2; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Young CE, 2005, EUR J NEUROSCI, V21, P3310, DOI 10.1111/j.1460-9568.2005.04161.x	37	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	APR	2015	31	2			SI		183	190		10.1007/s12264-014-1507-3		8	Neurosciences	Neurosciences & Neurology	CE9GT	WOS:000352152800004		
J	Yang, L; Hamori, S				Yang, Lu; Hamori, Shigeyuki			Interdependence between the bond markets of CEEC-3 and Germany: A wavelet coherence analysis	NORTH AMERICAN JOURNAL OF ECONOMICS AND FINANCE			English	Article						Bond market; Wavelet coherence; Financial integration; Asset price transmission channel	MULTIRESOLUTION ANALYSES; STOCK	In this study, we investigate the interdependence between the bond markets of CEEC-3 (Poland, the Czech Republic, and Hungary) and Germany by using wavelet transform analysis. First, we find that contagion occurred in these markets during the global financial crisis and European debt crisis, at different degrees and in different directions. Second, we show that the degree of bond market integration was relatively high before 2004 for Poland and Hungary and very high for the Czech Republic throughout the sample period. Finally, we find that the interest rate movements in Poland and the Czech Republic mirrored those in Germany for the entire sample period. Implications for investors and policymakers are also suggested. (c) 2015 Elsevier Inc. All rights reserved.	[Yang, Lu] Zhongnan Univ Econ & Law, Sch Finance, Wuhan 430073, Peoples R China; [Hamori, Shigeyuki] Kobe Univ, Fac Econ, Nada Ku, Kobe, Hyogo 6578501, Japan	Hamori, S (reprint author), Kobe Univ, Fac Econ, Nada Ku, 2-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	kudeyang@gmail.com; hamori@econ.kobe-u.ac.jp					Abad P, 2010, J BANK FINANC, V34, P2851, DOI 10.1016/j.jbankfin.2009.10.009; Aloui C, 2014, ECON MODEL, V36, P421, DOI 10.1016/j.econmod.2013.09.043; Vacha L, 2012, ENERG ECON, V34, P241, DOI 10.1016/j.eneco.2011.10.007; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561; Lee CC, 2013, N AM J ECON FINANC, V26, P28, DOI 10.1016/j.najef.2013.04.003; Christiansen C, 2007, EUR FINANC MANAG, V13, P923, DOI 10.1111/j.1468-036X.2007.00403.x; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Rua A, 2009, J EMPIR FINANC, V16, P632, DOI 10.1016/j.jempfin.2009.02.002; Baggett LW, 1999, J FOURIER ANAL APPL, V5, P563, DOI 10.1007/BF01257191; Greenspan A., 2007, AGE TURBULENCE ADVEN; HARDIN DP, 1992, J APPROX THEORY, V71, P104, DOI 10.1016/0021-9045(92)90134-A; Huang SC, 2011, MATH COMPUT SIMULAT, V81, P2529, DOI 10.1016/j.matcom.2011.04.003; In F, 2013, INTRODUCTION TO WAVELET THEORY IN FINANCE: A WAVELET MULTISCALE APPROACH, P1; Jiang C, 2015, INT REV ECON FINANC, V35, P249, DOI 10.1016/j.iref.2014.10.005; Kim S, 2007, J INT FINANC MARK I, V17, P167, DOI 10.1016/j.intfin.2005.10.004; Kiviaho J., 2012, EUROPEAN FINANCIAL M, V10, P1111; Loh L., 2013, RES INT BUSINESS FIN, V29, P1; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Ramsey R. B., 1998, MACROECON DYN, V2, P49; Ramsey R. B., 1997, J EMPIR FINANC, V4, P341; Yang L., 2013, TRANSITION STUDIES R, V20, P179; Yang L., 2013, J INT FINANC MARK I, V29, P109; Yunus N, 2012, J INT FINANC MARK I, V22, P194, DOI 10.1016/j.intfin.2011.09.001; Zhang TW, 2014, N AM J ECON FINANC, V29, P146, DOI 10.1016/j.najef.2014.06.001	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1062-9408	1879-0860		N AM J ECON FINANC	N. Am. Econ. Financ.	APR	2015	32						124	138		10.1016/j.najef.2015.02.003		15	Business, Finance; Economics	Business & Economics	CF3QW	WOS:000352464600008		
J	Cappa, A; Ascasibar, E; Castejon, F; Tafalla, D; Tabares, F; Ochando, M; Romero, J; de la Cal, E; Martinez, J; Nagasaki, K				Cappa, A.; Ascasibar, E.; Castejon, F.; Tafalla, D.; Tabares, F.; Ochando, M.; Romero, J.; de la Cal, E.; Martinez, J.; Nagasaki, K.			Second harmonic ECRH breakdown experiments in the TJ-II stellarator	NUCLEAR FUSION			English	Article						stellarators; plasma heating and breakdown; ECRH	HEATING ASSISTED STARTUP; PLASMA BREAKDOWN; DIII-D	A summary of the second harmonic ECRH breakdown experiments performed in the TJ-II stellarator is given here. The goal of these experiments is to determine the dependence of second harmonic X-mode plasma breakdown efficiency on several relevant parameters as the EC power, wave polarization, beam injection angle, tokamak-like induced electric field, neutral gas pre-fill pressure and discharge creation time with respect to the ramp-up of the currents in the coils. For each different scenario, the breakdown properties are determined, as well as the initial pressure conditions and the level of initial radiation before the injection of the ECRH power, which plays an essential role in the breakdown process.	[Cappa, A.; Ascasibar, E.; Castejon, F.; Tafalla, D.; Tabares, F.; Ochando, M.; Romero, J.; de la Cal, E.; Martinez, J.] CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain; [Nagasaki, K.] Kyoto Univ, Inst Adv Energy, Kyoto, Japan	Cappa, A (reprint author), CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain.	alvaro.cappa@ciemat.es					Lloyd B, 1996, PLASMA PHYS CONTR F, V38, P1627, DOI 10.1088/0741-3335/38/9/007; LLOYD B, 1991, NUCL FUSION, V31, P2031, DOI 10.1088/0029-5515/31/11/001; Omori T, 2011, FUSION ENG DES, V86, P951, DOI 10.1016/j.fusengdes.2011.02.040; Stober J, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083031; Bae YS, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/2/022001; Cappa A, 2004, NUCL FUSION, V44, P406, DOI 10.1088/0029-5515/44/3/005; Cappa A., 2005, P 15 INT STELL WORKS, pP3; Cappa A, 2001, NUCL FUSION, V41, P363, DOI 10.1088/0029-5515/41/4/302; CARTER MD, 1987, NUCL FUSION, V27, P985, DOI 10.1088/0029-5515/27/6/010; Jackson GL, 2010, FUSION SCI TECHNOL, V57, P27; Kajiwara K, 2005, NUCL FUSION, V45, P694, DOI 10.1088/0029-5515/45/7/019; Nagasaki, 2006, J KOREAN PHYS SOC, V49, pS18; Nagasaki K, 2005, NUCL FUSION, V45, P13, DOI 10.1088/0029-5515/45/1/002; NAVARRO AP, 1991, IEEE T PLASMA SCI, V19, P569, DOI 10.1109/27.90321; Radder J.W., 2002, P 13 INT STELL WORKS, P18	15	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	APR	2015	55	4							043018	10.1088/0029-5515/55/4/043018		12	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE8SB	WOS:000352113300019		
J	Guo, ZB; Diamond, PH; Kosuga, Y; Gurcan, OD				Guo, Z. B.; Diamond, P. H.; Kosuga, Y.; Guercan, O. D.			Turbulence elasticity: a key concept to a unified paradigm of L -> I -> H transition	NUCLEAR FUSION			English	Article						LCO; LIH transition; turbulence elasticity		We present a theory of turbulence elasticity, which follows from delayed response of drift waves (DWs) to zonal flow(ZF) shears. It is shown that when vertical bar < V >(ZF)'vertical bar/Delta omega(k) >= 1, with vertical bar < V >(ZF)'vertical bar the ZF shearing rate and Delta omega(k) the local turbulence decorrelation rate, the ZF evolution equation is converted from a diffusion equation to a telegraph equation. This insight provides a natural framework for understanding temporally periodic ZF structures, e.g., propagation of the ZF/turbulence intensity fronts. Furthermore, by incorporating the elastic property of the DW-ZF turbulence, we propose a unified paradigm of low-confinement-mode to intermediate-confinement-mode to high-confinement-mode (L -> I -> H) transitions. In particular, we predict the onset and termination conditions of the limit cycle oscillations, i.e. the I-mode. The transition from an unstable L-mode to I-mode is predicted to occur when Delta omega(k) < vertical bar < V >(ZF)'vertical bar < < V >(cr)', where < V >(cr)' is a critical flow shearing rate and is derived explicitly. If vertical bar < V >(ExB)'vertical bar > < V >(cr)'(< V >(ExB) is mean E x B shear flow driven by edge radial electrostatic field), the I-mode will terminate and spiral into the H-mode.	[Guo, Z. B.; Diamond, P. H.] NFRI, WCI Ctr Fus Theory, Taejon 305333, South Korea; [Guo, Z. B.] Seoul Natl Univ, Seoul 151744, South Korea; [Diamond, P. H.] Univ Calif San Diego, CMTFO, La Jolla, CA 92093 USA; [Diamond, P. H.] Univ Calif San Diego, CASS, La Jolla, CA 92093 USA; [Kosuga, Y.] Kyushu Univ, IAS, Kasuga, Fukuoka 8168580, Japan; [Kosuga, Y.] Kyushu Univ, RIAM, Kasuga, Fukuoka 8168580, Japan; [Guercan, O. D.] Ecole Polytech, CNRS, LPP, F-91128 Palaiseau, France	Guo, ZB (reprint author), NFRI, WCI Ctr Fus Theory, Taejon 305333, South Korea.	guozhipku@gmail.com	Gurcan, Ozgur/A-1362-2013; Kyushu, RIAM/F-4018-2015	Gurcan, Ozgur/0000-0002-2278-1544; 	WCI Programme of the National Research Foundation of Korea - Ministry of Education, Science and Technology of Korea [WCI 2009-001]; Department of Energy [DE-FG02-04ER54738]; CMTFO; US National Science Foundation [NSF PHY11-25915]; R&D Program through the National Fusion Research Institute of Korea (NFRI) - Government funds	We acknowledge the fruitful interactions at the Festival de Theorie, Aix-en-Provence, 2013. This work was supported by the WCI Programme of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea [WCI 2009-001], the Department of Energy under Award Number DE-FG02-04ER54738 and CMTFO, and the US National Science Foundation under Grant No. NSF PHY11-25915. Z.B. Guo was also supported by the R&D Program through the National Fusion Research Institute of Korea (NFRI) funded by the Government funds.	DIAMOND PH, 1994, PHYS REV LETT, V72, P2565, DOI 10.1103/PhysRevLett.72.2565; Miki K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195002; Schmitz L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155002; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; Dimits AM, 2000, PHYS PLASMAS, V7, P969, DOI 10.1063/1.873896; Estrada T, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124024; Guo ZB, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.041101; Guo ZB, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4894695; Gurcan OD, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4792161; Kosuga Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.105002	10	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	APR	2015	55	4							043022	10.1088/0029-5515/55/4/043022		4	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE8SB	WOS:000352113300023		
J	Hamada, Y; Watari, T; Nishizawa, A; Yamagishi, O; Narihara, K; Ida, K; Kawasumi, Y; Ido, T; Kojima, M; Toi, K				Hamada, Y.; Watari, T.; Nishizawa, A.; Yamagishi, O.; Narihara, K.; Ida, K.; Kawasumi, Y.; Ido, T.; Kojima, M.; Toi, K.		JIPPT-IIU Grp	Microtearing mode (MTM) turbulence in JIPPT-IIU tokamak plasmas	NUCLEAR FUSION			English	Article						microtearing mode; magnetic fluctuations; heavy ion beam probe; electron heat loss	HEAVY-ION BEAM; CROSS-POLARIZATION SCATTERING; DENSITY-FLUCTUATIONS; TEARING MODES; PROBE; STABILITY; TRANSPORT	Magnetic, density and potential fluctuations up to 500 kHz at several spatial points have been observed in the core region of JIPPT-IIU tokamak plasmas using a heavy ion beam probe. The frequency spectra of the density and magnetic oscillations are found to be similar, whereas there are large differences in the phase, coherence and frequency dependences deduced from signals at adjacent sample volumes. These differences allow us to ascribe the detected magnetic fluctuations to the microtearing mode (MTM) by simple dispersion relations of the MTM in collisionless and intermediate regimes. The frequency-integrated level of magnetic fluctuations around 150 kHz (100-200 kHz) is (B) over tilde (r)/B-t approximate to 1 x 10(-4), a level high enough for the ergodization of the magnetic surface and enhanced electron heat loss as derived by Rechester and Rosenbluth (1978 Phys. Rev. Lett. 40 38). This level is consistent with the measurements performed using cross-polarization scattering of microwaves in the Tore Supra tokamak. Our results are the first direct experimental verification of the MTM in the core region of tokamak plasmas, which has been recently observed in gyrokinetic simulations using a very fine mesh in tokamak and ST plasmas.	[Hamada, Y.; Watari, T.; Nishizawa, A.; Yamagishi, O.; Narihara, K.; Ida, K.; Kawasumi, Y.; Ido, T.; Kojima, M.; Toi, K.; JIPPT-IIU Grp] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Hamada, Y.] Sokendai, Grad Univ Adv Study, Hayama, Japan	Hamada, Y (reprint author), Natl Inst Fus Sci, Toki, Gifu 5095292, Japan.	hamada@toki-fs.jp					ADAM JC, 1976, PHYS FLUIDS, V19, P561, DOI 10.1063/1.861489; Doerk H, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694663; MAZZUCATO E, 1976, PHYS REV LETT, V36, P792, DOI 10.1103/PhysRevLett.36.792; Hatch DR, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4789448; RECHESTER AB, 1978, PHYS REV LETT, V40, P38, DOI 10.1103/PhysRevLett.40.38; Guttenfelder W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.155004; FURTH HP, 1963, PHYS FLUIDS, V6, P459, DOI 10.1063/1.1706761; Hamada Y, 2005, NUCL FUSION, V45, P81, DOI 10.1088/0029-5515/45/2/002; Applegate H., 2007, PLASMA PHYS CONTROL, V49, P1113; CATTO PJ, 1981, PHYS FLUIDS, V24, P243, DOI 10.1063/1.863352; Colas L, 1998, NUCL FUSION, V38, P903, DOI 10.1088/0029-5515/38/6/308; Connor J.W., 2006, P 21 IAEA C FUS EN C; CONNOR JW, 1990, PLASMA PHYS CONTR F, V32, P799, DOI 10.1088/0741-3335/32/10/004; COWLEY SC, 1986, PHYS FLUIDS, V29, P3230, DOI 10.1063/1.865841; CROWLEY TP, 1992, NUCL FUSION, V32, P1295, DOI 10.1088/0029-5515/32/8/I01; Diamond P. H., 2010, MODERN PLASMA PHYS; Dickinson D., 2012, PHYS REV LETT, V108; Dickinson D, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/7/074006; DIETZ KJ, 1990, PLASMA PHYS CONTR F, V32, P837, DOI 10.1088/0741-3335/32/11/002; Doerk H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.155003; DRAKE JF, 1980, PHYS REV LETT, V44, P994, DOI 10.1103/PhysRevLett.44.994; FONCK RJ, 1993, PHYS REV LETT, V70, P3736, DOI 10.1103/PhysRevLett.70.3736; Fujisawa A, 1996, NUCL FUSION, V36, P375, DOI 10.1088/0029-5515/36/3/I10; Glad N.T., 1980, PHYS FLUIDS, V21, P1182; Hamada Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.065005; HAMADA Y, 1994, PLASMA PHYS CONTR F, V36, P1743, DOI 10.1088/0741-3335/36/11/004; Hamada Y., 1997, FUSION ENG DES, V34-35, P63; Hamada Y, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025001; Hamada Y., 2011, NUCL FUSION, V51; Hamada Y, 1997, NUCL FUSION, V37, P999, DOI 10.1088/0029-5515/37/7/I08; Hatch D., 2012, PHYS REV LETT, V108; Hazeltine R.D., 1975, PHYS FLUIDS, V18, P1776; Horton W, 2012, TURBULENT TRANSPORT IN MAGNETIZED PLASMAS, P1, DOI 10.1142/8362; KADOTA K, 1980, NUCL FUSION, V20, P209, DOI 10.1088/0029-5515/20/2/010; Kitachi K., 1997, FUSION ENG DES, V34-35, P33; KRALL NA, 1963, PHYS FLUIDS, V6, P254, DOI 10.1063/1.1706723; Manz P, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/3/035010; Mikhailovskii A.B., 1963, ZH EKSP TEOR FIZ, V43, P509; MIKHAILOVSKII AB, 1963, SOV PHYS JETP-USSR, V16, P364; Miyato N, 2005, NUCL FUSION, V45, P425, DOI 10.1088/0029-5515/45/6/003; Predebon I., 2012, PHYS PLASMAS, V20; Rosenbluth M.N., 1962, NUCL FUSION        S, V1, P143; SEKI T, 1992, NUCL FUSION, V32, P2189, DOI 10.1088/0029-5515/32/12/I09; Simcic V.J., 1993, PHYS FLUIDS B-PLASMA, V5, P1579; SIMCIC VJ, 1990, REV SCI INSTRUM, V61, P3061, DOI 10.1063/1.1141727; SLUSHER RE, 1978, PHYS REV LETT, V40, P400, DOI 10.1103/PhysRevLett.40.400; Swarmy A.K., 2014, PHYS PLASMAS, V21; Tang W.M., 1976, PHYS FLUIDS, V20, P430; Toi K., 1992, P 14 INT C PLASM PHY, V1, P519; Told D, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3000132; Wesson J., 1997, TOKAMAKS; Zhang B.Z., 1993, DOEER53267119 U TEX; Zonca F, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/35001; ZOU XL, 1995, PHYS REV LETT, V75, P1090, DOI 10.1103/PhysRevLett.75.1090; Zweben S.J., 1979, PHYS REV LETT, V42, P127	55	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	APR	2015	55	4							043008	10.1088/0029-5515/55/4/043008		10	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE8SB	WOS:000352113300009		
J	Ichiguchi, K; Sakakibara, S; Ohdachi, S; Carreras, BA				Ichiguchi, K.; Sakakibara, S.; Ohdachi, S.; Carreras, B. A.			Multi-scale MHD analysis of LHD plasma with background field changing	NUCLEAR FUSION			English	Article						magnetohydrodynamics; numerical simulation; heliotron; multi-scale; pressure-driven mode	MODES	The mechanism of the partial collapse observed in the experiment with the background magnetic field changing in the Large Helical Device (LHD) is numerically investigated with a nonlinear magnetohydrodynamics (MHD) simulation. Since the different timescales of the perturbations and the background field changing have to be treated simultaneously for the analysis of this plasma, a multi-scale simulation scheme is developed. The effect of the perturbation dynamics on the equilibrium pressure and rotational transform is taken into account in this scheme. The result indicates that the collapse is caused by the destabilization of an infernal-like mode due to the magnetic hill enhanced by the change of the background field. The mechanism of the reduction of the central beta observed after the partial collapse in the experiment is also analysed in relation to the effect of the background field changing.	[Ichiguchi, K.; Sakakibara, S.; Ohdachi, S.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ichiguchi, K.; Sakakibara, S.; Ohdachi, S.] SOKENDAI, Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Carreras, B. A.] Univ Carlos III Madrid, Madrid 28911, Spain	Ichiguchi, K (reprint author), Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	ichiguch@nifs.ac.jp			National Institute for Fusion Science (NIFS) [NIFS13KNST053]; Japan Society for Promotion Science [22560822]; 'Catedras de Excelencia' at Universidad Carlos III de Madrid	This work was supported by budget NIFS13KNST053 of the National Institute for Fusion Science (NIFS) and Grant-in-Aid for Scientific Research (C) 22560822 from the Japan Society for Promotion Science. Super computers, Plasma Simulator in NIFS, and Helios in the Computational Simulation Center of the International Fusion Energy Research Center (IFERC-CSC), were utilized for the numerical calculations. One of the authors (BAC) gratefully acknowledges support of this work by the 'Catedras de Excelencia' at Universidad Carlos III de Madrid.	Ichiguchi K, 1996, NUCL FUSION, V36, P1145, DOI 10.1088/0029-5515/36/9/I04; HIRSHMAN SP, 1986, COMPUT PHYS COMMUN, V43, P143, DOI 10.1016/0010-4655(86)90058-5; Carreras BA, 1998, PHYS PLASMAS, V5, P3700, DOI 10.1063/1.872980; Ichiguchi K, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/5/053021; CHARLTON LA, 1989, PHYS FLUIDS B-PLASMA, V1, P798, DOI 10.1063/1.859004; Ichiguchi K, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/014009; GREENE JM, 1961, PHYS FLUIDS, V4, P875, DOI 10.1063/1.1706420; Ichiguchi K, 2003, NUCL FUSION, V43, P1101, DOI 10.1088/0029-5515/43/10/011; Komori A, 2010, FUSION SCI TECHNOL, V58, P1; MANICKAM J, 1987, NUCL FUSION, V27, P1461, DOI 10.1088/0029-5515/27/9/009; Sakakibara S., 2010, P 23 FUS EN C; STRAUSS HR, 1980, PLASMA PHYS CONTR F, V22, P733, DOI 10.1088/0032-1028/22/7/010	12	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	APR	2015	55	4							043019	10.1088/0029-5515/55/4/043019		8	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE8SB	WOS:000352113300020		
J	Ishizawa, A; Watanabe, TH; Sugama, H; Nunami, M; Tanaka, K; Maeyama, S; Nakajima, N				Ishizawa, A.; Watanabe, T. -H.; Sugama, H.; Nunami, M.; Tanaka, K.; Maeyama, S.; Nakajima, N.			Turbulent transport of heat and particles in a high ion temperature discharge of the Large Helical Device	NUCLEAR FUSION			English	Article						turbulent transport; stellarator and heliotron; gyrokinetic simulation	GRADIENT TURBULENCE; ZONAL FLOWS; SIMULATIONS; SYSTEMS; MODE	Turbulent transport in a high ion temperature discharge of the Large Helical Device (LHD) is investigated by means of electromagnetic gyrokinetic simulations, which include kinetic electrons, magnetic perturbations, and full geometrical effects. Including kinetic electrons enables us to firstly evaluate the particle and the electron heat fluxes caused by turbulence in LHD plasmas. It is found that the electron energy transport reproduces the experimental result, and that the particle flux is negative. The contribution of magnetic perturbation to the transport is small because of very low beta. The turbulence is driven by the ion temperature gradient instability, and the effect of kinetic electrons enhances the growth rate larger than that from the adiabatic electron calculation. The ion energy flux is larger than that observed in the experiment, while the flux is close to the experimental observation when the temperature gradient is reduced 20% in the simulation. This significant sensitivity of the energy flux implies that the profile in the experiment is close to the critical temperature gradient. The critical gradient for turbulent energy flux is similar to that for the linear instability, i.e., the Dimits shift is small. This is because the zonal flow in the LHD is weaker than that in tokamaks.	[Ishizawa, A.; Sugama, H.; Nunami, M.; Tanaka, K.; Nakajima, N.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Watanabe, T. -H.] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Maeyama, S.] Japan Atom Energy Agcy, Kashiwa, Chiba 2778587, Japan	Ishizawa, A (reprint author), Natl Inst Fus Sci, Toki, Gifu 5095292, Japan.	ishizawa@nifs.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23561003, 21560861]; NIFS Collaborative Research Program [NIFS14KNST067, NIFS14KNTT026, NIFS14KNTT027]; K at RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140044]	The authors thank Dr M. Yokoyama and Dr S. Satake for providing the data of neoclassical transport calculation. The work is supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant Nos 23561003 and 21560861 and by the NIFS Collaborative Research Program (NIFS14KNST067, NIFS14KNTT026 and NIFS14KNTT027). This research uses computational resources of the Plasma Simulator at NIFS, Helios at IFERC-CSC and K at RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140044).	Candy J, 2003, J COMPUT PHYS, V186, P545, DOI 10.1016/S0021-9991(03)00079-2; Sugama H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.115001; Jenko F, 2001, PLASMA PHYS CONTR F, V43, pA141, DOI 10.1088/0741-3335/43/12A/310; Peeters AG, 2009, COMPUT PHYS COMMUN, V180, P2650, DOI 10.1016/j.cpc.2009.07.001; Gorler T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.185002; Angioni C, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3155498; Guttenfelder W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.155004; KIM JY, 1993, PHYS FLUIDS B-PLASMA, V5, P4030, DOI 10.1063/1.860623; Dimits AM, 2000, PHYS PLASMAS, V7, P969, DOI 10.1063/1.873896; Helander P, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124009; Told D, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4858899; Sugama H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2149311; Holland C, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3085792; Pueschel MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4825227; Watanabe TH, 2007, NUCL FUSION, V47, P1383, DOI 10.1088/0029-5515/47/9/041; Baumgaertel JA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4771587; Baumgaertel JA, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4791657; BEER MA, 1995, PHYS PLASMAS, V2, P2687, DOI 10.1063/1.871232; Candy J, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1954123; Gorler T, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4904301; Hatch DR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235002; HIRSHMAN SP, 1991, J COMPUT PHYS, V96, P99, DOI 10.1016/0021-9991(91)90267-O; Ishizawa A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053007; Ishizawa A, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4876960; Ishizawa A., 2015, J PLASMA PHYS, V81; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; Maeyama S, 2013, COMPUT PHYS COMMUN, V184, P2462, DOI 10.1016/j.cpc.2013.06.014; Nunami M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4704568; Nunami M., 2011, PLASMA FUSION RES, V6, DOI DOI 10.1585/PFR.6.1403001; Pueschel MJ, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3435280; Pueschel MJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3005380; Sugama H, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3257907; Sugama H, 2004, PHYS PLASMAS, V11, P3068, DOI 10.1063/1.1730294; Tanaka K, 2010, PLASMA FUSION RES, V5, pS2053, DOI DOI 10.1585/PFR.5.S2053; TANG WM, 1980, NUCL FUSION, V20, P1439, DOI 10.1088/0029-5515/20/11/011; Told D, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3000132; Waltz RE, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3449075; Waltz RE, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2436851; Watanabe TH, 2006, NUCL FUSION, V46, P24, DOI 10.1088/0029-5515/46/1/003; Watanabe TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.195002; White AE, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2895408; Xanthopoulos P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.245002; Xanthopoulos P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.035002; Xanthopoulos P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.155001	44	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	APR	2015	55	4							043024	10.1088/0029-5515/55/4/043024		8	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE8SB	WOS:000352113300025		
J	Kawamura, K; Shimoda, Y; Kumata, K; Fujinaga, M; Yui, J; Yamasaki, T; Xie, L; Hatori, A; Wakizaka, H; Kurihara, Y; Ogawa, M; Nengaki, N; Zhang, MR				Kawamura, Kazunori; Shimoda, Yoko; Kumata, Katsushi; Fujinaga, Masayuki; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Hatori, Akiko; Wakizaka, Hidekatsu; Kurihara, Yusuke; Ogawa, Masanao; Nengaki, Nobuki; Zhang, Ming-Rong			In vivo evaluation of a new F-18-labeled PET ligand, [F-18]FEBU, for the imaging of I-2-imidazoline receptors	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Imidazoline receptors; I-2; BU99018; [F-18]FEBU; PET	IMIDAZOLINE BINDING-SITES; PARKINSONS-DISEASE; MAJOR DEPRESSION; RAT-BRAIN; PROTEINS; LOCALIZATION; C-11-BU99008	Introduction: The functions of I-2-imidazoline receptors (I(2)Rs) are unknown, but evidence exists for their involvement in various neuropsychiatric disorders. Although a few positron emission tomography (PET) I2R ligands have been developed, of which [C-11]FTIMD and [C-11]BU99008 were evaluated as PET I2R imaging ligands in monkeys, no human PET imaging study using an I2R-selective PET ligand has been conducted yet. Thus, we synthesized an F-18-labeled I2R-selective ligand (BU99018 or FEBU, Ki for I(2)Rs = 2.6 nM), and evaluated its application using rodents in PET imaging in vivo toward the development of a clinically-useful I2R PET imaging ligand. Methods: [F-18]FEBU was synthesized by the reaction of its precursor and [F-18]Fluoroethyl bromide. A biodistribution and brain PET study were conducted in mice and rats respectively. Results: [F-18]FEBU was successfully synthesized yielding a radioactivity suitable for injection (10.1 +/- 53% at the end of the irradiation (n = 10) based on F-18(-)). The specific activity at end of synthesis (EDS) was 40-147 TBq/mmol (n = 10). The radiochemical purity was >99% at EOS and remained >99% for 90 mm after EOS. In mice brain uptake was relatively high. In the blocking study with the co-injection of the high-affinity I2R ligand BU224 (1 mg/kg b.w.) brain uptake was significantly decreased 30 min post-injection. In the PET studies the radioactivity was highly accumulated in the I2R-rich hypothalamus. Pretreatment with BU224 (1 mg/kg b.w.) significantly decreased the radioactivity in the hypothalamus to 23% of that of the control from 60 to 90 min post-injection. Conclusion: [F-18]FEBU was sufficiently stable as a PET ligand and had a relatively high specific binding affinity for I(2)Rs in rats and mice. (C) 2014 Elsevier Inc. All rights reserved.	[Kawamura, Kazunori; Shimoda, Yoko; Kumata, Katsushi; Fujinaga, Masayuki; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Hatori, Akiko; Kurihara, Yusuke; Ogawa, Masanao; Nengaki, Nobuki; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Chiba 2638555, Japan; [Wakizaka, Hidekatsu] Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Chiba 2638555, Japan; [Kurihara, Yusuke; Ogawa, Masanao; Nengaki, Nobuki] SHI Accelerator Serv Ltd, Tokyo 1410032, Japan	Kawamura, K (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	kawamur@nirs.go.jp			MEXT/JSPS KAKENHI grant [23791466, 26293283]	This work was supported by MEXT/JSPS KAKENHI grant numbers 23791466 and 26293283.	Dardonville C, 2004, MED RES REV, V24, P639, DOI 10.1002/med.20007; BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232; Takei M, 2001, APPL RADIAT ISOTOPES, V55, P229, DOI 10.1016/S0969-8043(00)00392-4; CHAN SLF, 1994, BRIT J PHARMACOL, V112, P1065; Kawamura K, 2012, NUCL MED BIOL, V39, P89, DOI 10.1016/j.nucmedbio.2011.06.001; Eglen RM, 1998, TRENDS PHARMACOL SCI, V19, P381, DOI 10.1016/S0165-6147(98)01244-9; Garcia-Sevilla JA, 1998, NEUROSCI LETT, V247, P95, DOI 10.1016/S0304-3940(98)00265-1; GarciaSevilla JA, 1996, ARCH GEN PSYCHIAT, V53, P803; TESSON F, 1991, J BIOL CHEM, V266, P155; Kealey S, 2013, J NUCL MED, V54, P139, DOI 10.2967/jnumed.112.108258; Reynolds GP, 1996, EUR J PHARMACOL, V301, pR19, DOI 10.1016/0014-2999(96)00196-3; Piletz JE, 2000, DNA CELL BIOL, V19, P319, DOI 10.1089/10445490050043290; Piletz JE, 2000, BIOL PSYCHIAT, V48, P910, DOI 10.1016/S0006-3223(00)00892-1; Bousquet P, 2000, AM J HYPERTENS, V13, p84S, DOI 10.1016/S0895-7061(00)00223-5; Fukumura T, 2007, J LABELLED COMPD RAD, V50, pS202; GargalidisMoudanos C, 1997, NEUROCHEM INT, V30, P31, DOI 10.1016/S0197-0186(96)00035-6; Hudson AL, 2003, ANN NY ACAD SCI, V1009, P302, DOI 10.1196/annals.1304.039; Kawamura K, 2010, NUCL MED BIOL, V37, P625, DOI 10.1016/j.nucmedbio.2010.02.013; Kawamura K, 2012, NUCL MED BIOL, V39, P199, DOI 10.1016/j.nucmedbio.2011.07.008; Kawamura K, 2011, SYNAPSE, V65, P452, DOI 10.1002/syn.20897; Kawamura K, 2013, NUCL MED BIOL, V40, P651, DOI 10.1016/j.nucmedbio.2013.03.004; Lione LA, 1998, EUR J PHARMACOL, V353, P123, DOI 10.1016/S0014-2999(98)00389-6; MartinGomez JI, 1996, NEUROREPORT, V7, P1393, DOI 10.1097/00001756-199605310-00013; MICHEL MC, 1992, TRENDS PHARMACOL SCI, V13, P369; Molderings Gerhard J., 1997, Drugs of the Future, V22, P757; Nutt D J, 1995, Ann N Y Acad Sci, V763, P125, DOI 10.1111/j.1749-6632.1995.tb32397.x; Parker CA, 2014, J NUCL MED, V55, P838, DOI 10.2967/jnumed.113.131854; Robinson ESJ, 2002, EUR J PHARMACOL, V450, P55, DOI 10.1016/S0014-2999(02)02076-9; Roeda D, 2003, J LABELLED COMPD RAD, V46, P1141, DOI 10.1002/jlcr.746; SASTRE M, 1993, J NEUROCHEM, V61, P881, DOI 10.1111/j.1471-4159.1993.tb03599.x; Tyacke RJ, 2012, SYNAPSE, V66, P542, DOI 10.1002/syn.21541; Zhang MR, 2002, APPL RADIAT ISOTOPES, V57, P335, DOI 10.1016/S0969-8043(02)00075-1	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	APR	2015	42	4					406	412		10.1016/j.nucmedbio.2014.12.014		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE9RY	WOS:000352182300012		
J	Kimura, T				Kimura, Tetsuji			Defect (p, q) five-branes	NUCLEAR PHYSICS B			English	Article							MONOPOLES; DYNAMICS	We study a local description of composite five-branes of codimension two. The formulation is constructed by virtue of SL(2, Z) x SL(2, Z) monodromy associated with two-torus. Applying conjugate monodromy transformations to the complex structures of the two-torus, we obtain a field configuration of a defect (p, q) five-brane. This is a composite state of p defect NS5-branes and q exotic 5(2)(2)-branes. We also obtain a new example of hyper-Kahler geometry. This is an ALG space, a generalization of an ALP space which asymptotically has a tri-holomorphic two-torus action. This geometry appears in the conjugate configuration of a single defect KK5-brane. (C) 2015 The Author. Published by Elsevier B.V.	Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan	Kimura, T (reprint author), Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan.	tetsuji@th.phys.titech.ac.jp			Iwanami-Fujukai Foundation	The author would like to thank Shin Sasaki and Masaya Yata for valuable discussions and comments. This work is supported in part by the Iwanami-Fujukai Foundation.	Albertsson C., 2009, JHEP, V0904, P113; Andriot D, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)059; Bergshoeff E, 1997, PHYS LETT B, V410, P131, DOI 10.1016/S0370-2693(97)00946-5; MAHARANA J, 1993, NUCL PHYS B, V390, P3, DOI 10.1016/0550-3213(93)90387-5; GREENE BR, 1990, NUCL PHYS B, V337, P1, DOI 10.1016/0550-3213(90)90248-C; de Boer J, 2013, PHYS REP, V532, P65, DOI 10.1016/j.physrep.2013.07.003; Kikuchi T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.046001; Giveon A, 1999, REV MOD PHYS, V71, P983, DOI 10.1103/RevModPhys.71.983; BUSCHER TH, 1987, PHYS LETT B, V194, P59, DOI 10.1016/0370-2693(87)90769-6; SORKIN RD, 1983, PHYS REV LETT, V51, P87, DOI 10.1103/PhysRevLett.51.87; Kimura T, 2013, NUCL PHYS B, V876, P493, DOI 10.1016/j.nuclphysb.2013.08.017; Bergshoeff EA, 2012, NUCL PHYS B, V856, P210, DOI 10.1016/j.nuclphysb.2011.10.037; Bergshoeff EA, 2007, J HIGH ENERGY PHYS; Berman D.S., ARXIV14096314HEPTH; CALLAN CG, 1991, NUCL PHYS B, V359, P611, DOI 10.1016/0550-3213(91)90074-8; Chatzistavrakidis A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.066004; Cherkis S, 2001, COMMUN MATH PHYS, V218, P333, DOI 10.1007/PL00005558; Cherkis SA, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.084015; Dall'Agata G, 2008, NUCL PHYS B, V799, P80, DOI 10.1016/j.nuclphysb.2008.02.020; de Boer J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.251603; DeWolfe O., 1999, ADV THEOR MATH PHYS, V3, P1785; DeWolfe O., 1999, ADV THEOR MATH PHYS, V3, P1835; Gaiotto D., 2012, JHEP, V1208, P034; Gregory R., 1997, ADV THEOR MATH PHYS, V1, P283; Hanany A, 1997, NUCL PHYS B, V492, P152; Harvey J. A., 2005, JHEP, V0510; Hellerman S, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/01/024; Hori K, 2002, J HIGH ENERGY PHYS; Hull CM, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/10/065; Hull CM, 2007, J HIGH ENERGY PHYS; Jensen S., 2011, J HIGH ENERGY PHYS, V1107; Kimura T., 2014, J HIGH ENERGY PHYS, V1407, P127; Kimura T., ARXIV14113457HEPTH; Kimura T, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2013)126; Kimura T, 2014, NUCL PHYS B, V887, P136, DOI 10.1016/j.nuclphysb.2014.08.004; Kimura T, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2014)128; Kimura T., 2014, PTEP, V2014; Lawrence A, 2006, J HIGH ENERGY PHYS; Okuyama K., 2005, JHEP, V0508; STROMINGER A, 1991, NUCL PHYS B, V353, P565; Tong D., 2002, J HIGH ENERGY PHYS, V0207	41	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	APR	2015	893						1	20		10.1016/j.nuclphysb.2015.01.023		20	Physics, Particles & Fields	Physics	CE7TP	WOS:000352045000001		
J	Matsumoto, T; Yoshida, K				Matsumoto, Takuya; Yoshida, Kentaroh			Yang-Baxter sigma models based on the CYBE	NUCLEAR PHYSICS B			English	Article							INTEGRABILITY	It is known that Yang - Baxter sigma models provide a systematic way to study integrable deformations of both principal chiral models and symmetric coset sigma models. In the original proposal and its subsequent development, the deformations have been characterized by classical r-matrices satisfying the modified classical Yang Baxter equation (mCYBE). In this article, we propose the Yang - Baxter sigma models based on the classical Yang - Baxter equations (CYBE) rather than the mCYBE. This generalization enables us to utilize various kinds of solutions of the CYBE to classify integrable deformations. In particular, it is straightforward to realize partial deformations of the target space without loss of the integrability of the parent theory. (C) 2015 The Authors. Published by Elsevier B.V.	[Matsumoto, Takuya] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Matsumoto, Takuya] Nagoya Univ, Dept Math, Nagoya, Aichi 4648602, Japan; [Yoshida, Kentaroh] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan	Yoshida, K (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	takuya.matsumoto@math.nagoya-u.ac.jp; kyoshida@gauge.scphys.kyoto-u.ac.jp			JSPS Japan-Hungary Research Cooperative Program	We are grateful to Io Kawaguchi for collaboration at the early stage of this work. We appreciate Gleb Arutyunov, Riccardo Borsato, P. Marcos Crichigno, Marc Magro and Benoit Vicedo for valuable comments and discussions. This work is supported in part by JSPS Japan-Hungary Research Cooperative Program.	CHEREDNIK IV, 1981, THEOR MATH PHYS+, V47, P422, DOI 10.1007/BF01086395; Delduc F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.051601; Beisert N, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/25/255204; Sfetsos K, 2014, NUCL PHYS B, V880, P225, DOI 10.1016/j.nuclphysb.2014.01.004; Maldacena J, 1999, INT J THEOR PHYS, V38, P1113, DOI 10.1023/A:1026654312961; Balasubramanian K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.061601; Beisert N, 2012, LETT MATH PHYS, V99, P3, DOI 10.1007/s11005-011-0529-2; JIMBO M, 1985, LETT MATH PHYS, V10, P63, DOI 10.1007/BF00704588; Kawaguchi I, 2011, PHYS LETT B, V705, P251, DOI 10.1016/j.physletb.2011.09.117; Kawaguchi I, 2012, J PHYS CONF SER, V343, DOI 10.1088/1742-6596/343/1/012055; Klimcik C, 2014, LETT MATH PHYS, V104, P1095, DOI 10.1007/s11005-014-0709-y; Metsaev RR, 1998, NUCL PHYS B, V533, P109, DOI 10.1016/S0550-3213(98)00570-7; Hollowood TJ, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/49/495402; Son DT, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.046003; Hashimoto A, 1999, PHYS LETT B, V465, P142, DOI 10.1016/S0370-2693(99)01037-0; Arutyunov G., 2014, J HIGH ENERGY PHYS, V1404; Balog J, 2000, PHYS LETT B, V484, P367, DOI 10.1016/S0370-2693(00)00645-6; Beisert N, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/36/365206; Bena I, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.046002; Catal-Ozer A, 2006, J HIGH ENERGY PHYS; Crichigno P.M., 2014, J HIGH ENERGY PHYS, V1412; Delduc F, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)192; Delduc F., ARXIV14066286HEPTH; Drinfeld V.G., 1986, J SOVIET MATH, V41, p[898, 18]; Drinfeld V.G., 1985, SOV MATH DOKL, V32, P254; FADDEEV LD, 1986, ANN PHYS-NEW YORK, V167, P227, DOI 10.1016/0003-4916(86)90201-0; Frolov S, 2005, J HIGH ENERGY PHYS; Hoare B., ARXIV14111266HEPTH; Hoare B, 2014, J HIGH ENERGY PHYS, V1406; Hollowood T.J., 2014, J HIGH ENERGY PHYS, V1411; Israel D, 2005, FORTSCHR PHYS, V53, P73, DOI 10.1002/prop.200410190; Kameyama T, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2013)146; Kawaguchi I, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2012)082; Kawaguchi I, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2013)013; Kawaguchi I, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2010)032; Kawaguchi I, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2014)153; Kawaguchi I, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2011)094; Kawaguchi I, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2013)024; Kawaguchi I., 2014, JHEP, V1406, P146; Kawaguchi I, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2012)115; Klimcik C., 2002, J HIGH ENERGY PHYS, V0212; Klimcik C, 2009, J MATH PHYS, V50, DOI 10.1063/1.3116242; Lunin O, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/05/033; Maldacena JM, 1999, J HIGH ENERGY PHYS; Matsumoto T., 2014, J HIGH ENERGY PHYS, V1406, P135; Matsumoto T, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2014)163; Matsumoto T., ARXIV14100575HEPTH; Matsumoto T., ARXIV14123658HEPTH; Minahan JA, 2003, J HIGH ENERGY PHYS; Orlando D, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/11/115401; Schafer-Nameki S., 2009, JHEP, V0905; ZAKHAROV VE, 1978, ZH EKSP TEOR FIZ+, V74, P1953	52	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	APR	2015	893						287	304		10.1016/j.nuclphysb.2015.02.009		18	Physics, Particles & Fields	Physics	CE7TP	WOS:000352045000012		
J	Itoyama, H; Maru, N				Itoyama, H.; Maru, Nobuhito			Mass sum rule of the effective action on vacua with broken rigid N=1 supersymmetry	NUCLEAR PHYSICS B			English	Article							U(N) GAUGE-MODEL; PARTIAL BREAKING; DYNAMICAL MODEL; SUPERCONDUCTIVITY; PARTICLES; ANALOGY; ENERGY	We present an extension of the mass sum rule that applies to renormalizable rigid supersymmetric field theories to the case of the N = 1 supersymmetric effective action (the gauged non-linear sigma model) consisting of adjoint scalar superfields and vector superfields possessing a Kahler potential, a set of gauge coupling functions (second prepotential derivatives) and a superpotential, which respectively set their energy scales. The mass sum rule derived is valid for any vacua, including the (metastable) one of broken supersymmetry with the condensates of D-term and/or F-term. We manage to extend these analyses to the cases where superfields in (anti-)fundamental representation are present. The supertrace is shown to vanish in those cases where underlying geometry is special Kahler and theory under concern is anomaly free. Simple phenomenological application is given, providing an upper bound for gaugino masses. We discuss that the effects of the D and/or F condensates can be represented as a set of soft breaking terms with their strengths predicted by the scales. (C) 2015 The Authors. Published by Elsevier B.V.	[Itoyama, H.; Maru, Nobuhito] Osaka City Univ, Grad Sch Sci, Dept Math & Phys, Osaka, Japan; [Itoyama, H.] Osaka City Univ, Adv Math Inst OCAMI, Sumiyoshi Ku, Osaka 5588585, Japan	Itoyama, H (reprint author), Osaka City Univ, Grad Sch Sci, Dept Math & Phys, Osaka, Japan.	itoyama@sci.osaka-cu.ac.jp; nmaru@sci.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23540316, 24540283]	The work of RI. is supported in part by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan No. 23540316. The work of N.M. is supported in part by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan No. 24540283.	Aad G., 2014, J HIGH ENERGY PHYS, V1409, P176; Abel S., 2013, J HIGH ENERGY PHYS, V1311; Abel S., 2011, J HIGH ENERGY PHYS, V1106; Amigo S.D.L., 2009, JHEP, V0901; Nomura Y, 2006, NUCL PHYS B, V745, P29, DOI 10.1016/j.nuclphysb.2006.03.034; Itoyama H, 2012, INT J MOD PHYS A, V27, DOI 10.1142/S0217751X1250159X; NAMBU Y, 1960, PHYS REV LETT, V4, P380, DOI 10.1103/PhysRevLett.4.380; FERRARA S, 1979, PHYS REV D, V20, P403, DOI 10.1103/PhysRevD.20.403; Hsieh K, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.015004; NAMBU Y, 1960, PHYS REV, V117, P648, DOI 10.1103/PhysRev.117.648; NILLES HP, 1984, PHYS REP, V110, P1, DOI 10.1016/0370-1573(84)90008-5; Benakli K, 2011, NUCL PHYS B, V851, P445, DOI 10.1016/j.nuclphysb.2011.06.001; HALL LJ, 1991, NUCL PHYS B, V352, P289, DOI 10.1016/0550-3213(91)90444-3; Kribs GD, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.055010; Antoniadis I, 2006, PHYS LETT B, V634, P302, DOI 10.1016/j.physletb.2006.01.010; NAMBU Y, 1961, PHYS REV, V124, P246, DOI 10.1103/PhysRev.124.246; Benakli K, 2009, NUCL PHYS B, V816, P185, DOI 10.1016/j.nuclphysb.2009.03.002; Kribs GD, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.115010; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; FAYET P, 1978, PHYS LETT B, V78, P417, DOI 10.1016/0370-2693(78)90474-4; Antoniadis I., 2008, ADV STUD THEOR PHYS, V2, P645; Benakli K., 2013, J HIGH ENERGY PHYS, V1306; Blechman A.E., 2008, JHEP, V0806; Blechman AE, 2009, MOD PHYS LETT A, V24, P633, DOI 10.1142/S0217732309030795; Carpenter L.M., ARXIVHEPPH0503093; Carpenter L.M., 2012, J HIGH ENERGY PHYS, V1209, P102; Chacko Z, 2005, NUCL PHYS B, V706, P53, DOI 10.1016/j.nuclphysb.2004.11.021; Chatrchyan S., 2014, JHEP, V1406, P055; Davies R., 2011, J HIGH ENERGY PHYS, V1104, P108; Dudas E., ARXIV13122011HEPPH; Fox P.J., 2002, JHEP, V0208; Frugiuele C, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.015016; Fujiwara K, 2005, PROG THEOR PHYS, V113, P429, DOI 10.1143/PTP.113.429; Fujiwara K, 2005, NUCL PHYS B, V723, P33, DOI 10.1016/j.nuclphysb.2005.06.023; GIRARDELLO L, 1982, NUCL PHYS B, V194, P65, DOI 10.1016/0550-3213(82)90512-0; Goodsell M.D., 2013, J HIGH ENERGY PHYS, V1301; Hisano J, 2007, PHYS LETT B, V644, P256, DOI 10.1016/j.physletb.2006.11.047; Itoyama H, 2010, NUCL PHYS B, V830, P1, DOI 10.1016/j.nuclphysb.2009.12.018; Itoyama H., ARXIV13124157HEPPH; Itoyama Hiroshi, 2013, International Journal of Modern Physics: Conference Series, V21, DOI 10.1142/S2010194513009392; Itoyama H, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.025012; Kribs GD, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.115014; Kribs G.D., 2009, JHEP, V0901; Morita Y., 2013, PTEP PROCES TEH ENER, V2013; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Nelson A.E., 2002, JHEP, V0208; Peskin M E, 1995, INTRO QUANTUM FIELD; POLCHINSKI J, 1982, PHYS REV D, V26, P3661, DOI 10.1103/PhysRevD.26.3661; Unwin J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.095002; Wilson K. G., 1974, Physics Reports. Physics Letters Section C, V12c, DOI 10.1016/0370-1573(74)90023-4	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	APR	2015	893						332	345		10.1016/j.nuclphysb.2015.02.017		14	Physics, Particles & Fields	Physics	CE7TP	WOS:000352045000014		
J	Ohta, H; Ogata, T; Papaioannou, D; Ronianella, VV; Masson, M; Paul, JL				Ohta, Hirokazu; Ogata, Takanari; Papaioannou, Denittrios; Ronianella, Vincenzo V.; Masson, Marc; Paul, Jean-Luc			IRRADIATION OF MINOR ACTINIDE-BEARING URANIUM-PLUTONIUM-ZIRCONIUM ALLOYS UP TO similar to 2.5 at. %, similar to 7 at. % AND similar to 10 at. % BURNUPS	NUCLEAR TECHNOLOGY			English	Article						minor actinides; metal fuel; postirradiation examinations	CONSTITUENT REDISTRIBUTION; FUEL; METAL; BEHAVIOR	An irradiation experiment on minor actinide (MA)-bearing uranium-plutonium-zirconium (U-Pu-Zr) alloys, in which contamination by rare earth (RE) elements was considered, was performed up to similar to 2.5 at. %, similar to 7 at. %, and similar to 10 at. % burnups in the Phenix fast reactor. All the irradiated metal fuel pins were subjected to nondestructive tests such as cladding profilometty and gamma spectroscopy. Then, cross-sectional metallography of the low-burnup and medium-burn up fuel alloys was performed, and the redistribution of the fuel matrix constituents-U, Pu, and Zr-in the low-burnup fuels was analyzed by energy dispersive X-ray spectroscopy. As a result, the irradiation growth of MA-rich and RE-rich precipitates was observed by comparing the low-burnup and medium-burnup fuels. From the postirradiation examinations carried out so far, it was confirmed that the irradiation swelling, the cross-sectional structures, and the migration of matrix constituent in metal fuels containing 5 wt% or less MAs and REs are almost the same as those in conventional U-Pu-Zr fuels.	[Ohta, Hirokazu; Ogata, Takanari] Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, Komae, Tokyo 2018511, Japan; [Papaioannou, Denittrios; Ronianella, Vincenzo V.] Inst Transuranium Elements, European Commiss Joint Res Ctr, D-76125 Karlsruhe, Germany; [Masson, Marc; Paul, Jean-Luc] Cent Phenix Site Marcoule, Commissariat Energie Atom, F-30207 Bagnolssur Sur Ceze, France	Ohta, H (reprint author), Cent Res Inst Elect Power Ind, Nucl Technol Res Lab, 2-11-1 Iwado Kita, Komae, Tokyo 2018511, Japan.	hirota@criepi.denken.or.jp					[Anonymous], 2011, L10010 CRIEPI; Ogata T, 1999, NUCL TECHNOL, V128, P113; Kim YS, 2004, J NUCL MATER, V327, P27, DOI 10.1016/j.jnucmat.2004.01.012; Ohta H, 2009, NUCL TECHNOL, V165, P96; Sohn YH, 2000, J NUCL MATER, V279, P317, DOI 10.1016/S0022-3115(99)00290-1; [Anonymous], 2006, 2006002 JAEA; BATES J. F., 1979, DOETIC11086; Bremier S., 2013, Transactions of the American Nuclear Society, V109; CARMACK J., 2008, INLEXT0813779 GLOB N; Crawford D. C., 1994, Transactions of the American Nuclear Society, V71; Egeland GW, 2013, J NUCL MATER, V432, P539, DOI 10.1016/j.jnucmat.2012.07.028; FISSOLO A, 1994, AM SOC TEST MATER, V1175, P646, DOI 10.1520/STP23964S; HAYES S., 2009, P GLOBAL 2009 PAR FR; Hayes S. L., 2002, Transactions of the American Nuclear Society, V87; HOFMAN G. L., 1994, NUCL MAT A 1, V10A; Kim YS, 2009, J NUCL MATER, V392, P164, DOI 10.1016/j.jnucmat.2009.03.043; KOYAMA T., 2004, T03057 CRIEPI; LEIBOWITZ L., 1976, ANLCENRS761; MEYER M. K., 2001, P TOPL M ACC APPL AC; MILLARD A., 1994, P 16 INT S EFF RAD M, P824; OHTA H., 2009, L08005 CRIEPI; OHTA H., 2011, P FALL M AT EN SOC J; OHTA H., 2009, P GLOBAL 2009 PAR FR; OHTA H., 2010, L09011 CRIEPI; OHTA H., 2012, P TOPL M NUCL FUELS; OHTA H., 2011, J NUCL SCI TECHNOL, V48, P1; OHTA H., 2013, P INT C FAST REACT R, P392; PAUL R. G., 1990, P INT M FAST REACT S, VIV, P129; Pouchou J.L., 1984, RECH AEROSPATIALE, V3, P13; SERAN JL, 1992, AM SOC TEST MATER, V1125, P1209; Yokoo T, 1996, NUCL TECHNOL, V116, P173; Yokoo T, 2001, J NUCL SCI TECHNOL, V38, P444	32	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	APR	2015	190	1					36	51				16	Nuclear Science & Technology	Nuclear Science & Technology	CF6PG	WOS:000352678000004		
J	Okubo, H; Miyake, Y; Tanaka, K; Sasaki, S; Hirota, Y				Okubo, Hitomi; Miyake, Yoshihiro; Tanaka, Keiko; Sasaki, Satoshi; Hirota, Yoshio			Maternal total caffeine intake, mainly from Japanese and Chinese tea, during pregnancy was associated with risk of preterm birth: the Osaka Maternal and Child Health Study	NUTRITION RESEARCH			English	Article						Caffeine; Japanese and Chinese tea; Pregnancy; Preterm birth; Prospective birth cohort	DIET HISTORY QUESTIONNAIRE; DOSE-RESPONSE METAANALYSIS; VALIDITY; WEIGHT; ADULTS; VITAMIN-B-12; CONSUMPTION; EXPOSURE; RECORDS; FOLATE	The relation of maternal caffeine intake with birth outcomes is still inconclusive and has not been examined in Japan, where the sources of caffeine intake are different from those in Western countries. We hypothesized that maternal consumption of total caffeine and culture-specific major sources of caffeine would be associated with birth outcomes among Japanese pregnant. The study subjects were 858 Japanese women who delivered singleton infants. Maternal diet during pregnancy was assessed using a validated, self-administered diet history questionnaire. Birth outcomes considered were low birth weight (LBW; <2500 g), preterm birth (PTB; <37 weeks of gestation), and small for gestational age (SGA; <10th percentile). The main caffeine sources were Japanese and Chinese tea (73.5%), coffee (14.3%), black tea (6.6%), and soft drinks (3.5%). After controlling for confounders, maternal total caffeine intake during pregnancy was significantly associated with an increased risk of PTB (odds ratio per 100 mg/d caffeine increase, 1.28; 95% confidence interval, 1.03-1.58; P for trend = .03). However, no evident relationships were observed between total caffeine intake and risk of LBW or SGA. As for caffeine sources, higher Japanese and Chinese tea consumption was associated with an increased risk of PTB (odds ratio per 1 cup/d increase, 1.14; 95% confidence interval, 1.00-1.30; P for trend = .04), but not LBW or SGA. There were no associations between consumption of the other beverages examined and birth outcomes. In conclusion, this prospective birth cohort in Japan suggests that higher maternal total caffeine intake, mainly in the form of Japanese and Chinese tea, during pregnancy is associated with a greater risk of PTB. (C) 2015 Elsevier Inc. All rights reserved.	[Okubo, Hitomi] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Miyake, Yoshihiro; Tanaka, Keiko] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Hirota, Yoshio] Med Co LTA, Clin Epidemiol Res Ctr, Fukuoka, Japan	Okubo, H (reprint author), Natl Inst Publ Hlth, Dept Hlth Promot, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	okubo@niph.go.jp			Ministry of Education, Culture, Sports, Science and Technology [13770206, 16790351]; Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology; Health Research on Children, Youth and Families from the Ministry of Health, Labour, and Welfare	This work was supported in part by a grant-in-aid (13770206 and 16790351) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology and by Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour, and Welfare.	American College of O. Gynecologists, 2010, OBSTET GYNECOL, V116, P467; Andersson H, 2004, INTAKE CAFFEINE OTHE, V2004; ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447; ARNAUD MJ, 1983, TOXICOL LETT, V16, P271, DOI 10.1016/0378-4274(83)90187-X; Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Moussally K, 2012, ALTERN THER HEALTH M, V18, P36; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Sasaki S, 1998, JPN CIRC J, V62, P431, DOI 10.1253/jcj.62.431; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792; BLAND JM, 1986, LANCET, V1, P307; CARE Study Group, 2008, BMJ-BRIT MED J, V337, pa2332, DOI DOI 10.1136/BMJ.A2332; Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; Committee on Toxicity of Chemicals in Food Consumer Products and the Environment, 2008, STAT REPR EFF CAFF; Elashoff J. D, 2007, NQUERY ADVISOR VERSI; Fortier I, 1993, AM J EPIDEMIOL, V137, P931; GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5; Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x; Itabashi K, 2010, NIHONSHOUNIKAGAKKAIZ, V114, P1271; Knutti R, 1982, Arch Toxicol Suppl, V5, P187; Maslova E, 2010, AM J CLIN NUTR, V92, P1120, DOI 10.3945/ajcn.2010.29789; Miyake Y, 2006, J AFFECT DISORDERS, V96, P133, DOI 10.1016/j.jad.2006.05.024; Miyake Y, 2014, INT ARCH ALLERGY IMM, V135, P221; Santos I S, 1998, Cad Saude Publica, V14, P523, DOI 10.1590/S0102-311X1998000300009; Sasaki S, 1998, J Epidemiol, V8, P203; Science and Technology Agency, 2010, STAND TABL FOOD COMP; Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42; Shiraishi M, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-15; Shiraishi M, 2013, INT J FOOD SCI NUTR, V64, P694, DOI 10.3109/09637486.2013.775225; Statistics and Information Department Minister's Secretariat Ministry of Health Labor and Welfare, 2014, VIT STAT JAP 2012, V1; Yamada M, 2010, PUBLIC HEALTH NUTR, V13, P663, DOI 10.1017/S1368980009992023	36	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	APR	2015	35	4					309	316		10.1016/j.nutres.2015.02.009		8	Nutrition & Dietetics	Nutrition & Dietetics	CF0QN	WOS:000352249400006		
J	Ahn, JH; Choi, JW; Choi, JM; Maeda, T; Fujii, H; Yokozawa, T; Cho, EJ				Ahn, Jae Hyun; Choi, Ji Won; Choi, Ji Myung; Maeda, Takahiro; Fujii, Hajime; Yokozawa, Takako; Cho, Eun Ju			Protective role of oligonol from oxidative stress-induced inflammation in C6 glial cell	NUTRITION RESEARCH AND PRACTICE			English	Article						Oligonol; C6cell; inflammation; nitric oxide; oxidative stress	LITCHI-CHINENSIS SONN.; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; INTESTINAL INFLAMMATION; TRANSCRIPTION FACTOR; LYCHEE FRUIT; EXPRESSION; INOS; ANTIOXIDANT; MECHANISMS	BACKGROUND/OBJECTIVES: Natural products or active components with a protective effect against oxidative stress have attracted significant attention for prevention and treatment of degenerative disease. Oligonol is a low molecular weight polyphenol containing catechin-type monomers and oligomers derived from Litchi chinensis Sonn. We investigated the protective effect and its related mechanism of oligonol against oxidative stress. MATERIALS/METHODS: Oxidative stress in C6 glial cells was induced by hydrogen peroxide (H2O2) and the protective effects of oligonol on cell viability, nitric oxide (NO) and reactive oxygen species (ROS) synthesis, and mRNA expression related to oxidative stress were determined. RESULTS: Treatment with oligonol inhibited NO and ROS formation under cellular oxidative stress in C6 glial cells. In addition, it recovered cell viability in a dose dependent-manner. Treatment with oligonol also resulted in down-regulated mRNA expression related to oxidative stress, nuclear factor kappa-B (NF-kappa B) p65, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS), compared with the control group treated with H2O2. In particular, expression of NF-kappa B p65, COX-2, and iNOS was effectively reduced to the normal level by treatment with 10 mu g/mL and 25 mu g/nnL of oligonol. CONCLUSIONS: These results indicate that oligonol has protective activity against oxidative stress-induced inflammation. Oligonol might be a promising agent for treatment of degenerative diseases through inhibition of ROS formation and NF-kappa B pathway gene expression.	[Ahn, Jae Hyun; Choi, Ji Won; Choi, Ji Myung; Cho, Eun Ju] Pusan Natl Univ, Dept Food Sci & Nutr, Busan 609735, South Korea; [Maeda, Takahiro; Fujii, Hajime] Amino Up Chem Co Ltd, Sapporo, Hokkaido 0040839, Japan; [Yokozawa, Takako] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan	Cho, EJ (reprint author), Pusan Natl Univ, Dept Food Sci & Nutr, Busandaehak Ro 63 Beon Gil, Busan 609735, South Korea.	ejcho@pusan.ac.kr					Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Wang LJ, 2011, FOOD CHEM, V126, P1081, DOI 10.1016/j.foodchem.2010.11.133; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Yang B, 2006, CARBOHYD RES, V341, P634, DOI 10.1016/j.carres.2006.01.004; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ong PKC, 1999, J AGR FOOD CHEM, V47, P665, DOI 10.1021/jf980452j; Jiang GX, 2013, FOOD CHEM, V136, P563, DOI 10.1016/j.foodchem.2012.08.089; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Kidd BL, 2001, BRIT J ANAESTH, V87, P3, DOI 10.1093/bja/87.1.3; Cirino Giuseppe, 2006, Inflammation & Allergy Drug Targets, V5, P115, DOI 10.2174/187152806776383143; Bhoopat L, 2011, J ETHNOPHARMACOL, V136, P55, DOI 10.1016/j.jep.2011.03.061; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dobashi K, 1997, J NEUROCHEM, V68, P1896; Fujii H, 2008, FOOD CHEM TOXICOL, V46, P3553, DOI 10.1016/j.fct.2008.06.005; Gookin JL, 2006, AM J PHYSIOL-GASTR L, V290, pG164, DOI 10.1152/ajpgi.00460.2004; GRANDISON L, 1994, MOL CELL ENDOCRINOL, V106, P9; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kundu JK, 2008, PHOTOCHEM PHOTOBIOL, V84, P399, DOI 10.1111/j.1751-1097.2007.00277.x; lalenti A, 1992, EUR J PHARMACOL, V211, P177; McCafferty DM, 1997, GASTROENTEROLOGY, V112, P1022, DOI 10.1053/gast.1997.v112.pm9041266; Noh JS, 2010, BRIT J NUTR, V104, P1120, DOI 10.1017/S0007114510001819; Noh JS, 2011, BRIT J NUTR, V106, P1013, DOI 10.1017/S0007114511001322; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Peterson U, 2012, MEDIAT INFLAMM, V2012; Sarni-Manchado P, 2000, J AGR FOOD CHEM, V48, P5995, DOI 10.1021/jf000815r; Syapin PJ, 2001, J PHARMACOL EXP THER, V298, P744; Yum HW, 2013, ANTIOXID REDOX SIGN, V19, P102, DOI 10.1089/ars.2012.4626; Zhang XH, 2010, BRIT J PHARMACOL, V159, P928, DOI 10.1111/j.1476-5381.2009.00594.x	31	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	APR	2015	9	2					123	128		10.4162/nrp.2015.9.2.123		6	Nutrition & Dietetics	Nutrition & Dietetics	CF6NC	WOS:000352672400003		
J	Sun, XF; Yamasaki, M; Katsube, T; Shiwaku, K				Sun, Xufeng; Yamasaki, Masayuki; Katsube, Takuya; Shiwaku, Kuninori			Effects of quercetin derivatives from mulberry leaves: Improved gene expression related hepatic lipid and glucose metabolism in short-term high-fat fed mice	NUTRITION RESEARCH AND PRACTICE			English	Article						Mulberry leaves; oxidative stress; beta-oxidation; polyphenolic compounds	GREEN TEA CATECHINS; ALBA L. LEAVES; OXIDATIVE STRESS; BETA-OXIDATION; ACID SYNTHESIS; LIVER; DIET; RECEPTOR; POLYPHENOL; OBESITY	BACKGROUND/OBJECTIVES: Mulberry leaves contain quercetin derivatives, which have the effects of reducing obesity and improving lipid and glucose metabolism in mice with obesity. It is not clear whether or not mulberry leaves can directly affect metabolic disorders, in the presence of obesity, because of the interaction between obesity and metabolic disorders. The aim of the current study was to assess the direct action of quercetin derivatives on metabolic disorders in non-obese conditions in short-term high-fat diet fed mice. MATERIALS/METHODS: C57BL/6N mice were fed a high-fat diet, supplemented with either 0% (control), 1%, or 3% mulberry leaf powder (Mul) or 1% catechin powder for five days. Anthropometric parameters and blood biochemistry were determined, and hepatic gene expression associated with lipid and glucose metabolism was analyzed. RESULTS: Body and white fat weights did not differ among the four groups. Plasma triglycerides, total cholesterol, and free fatty acids in the 1%, 3% Mul and catechin groups did not differ significantly from those of the controls, however, plasma glucose and 8-isoprostane levels were significantly reduced. Liver gene expression of gp91phox, a main component of NADPH oxidase, was significantly down-regulated, and PPAR-alpha, related to beta-oxidation, was significantly up-regulated. FAS and GPAT, involved in lipid metabolism, were significantly down-regulated, and Ehhadh was significantly up-regulated. Glucose-metabolism related genes, L-PK and G6Pase, were significantly down-regulated, while GK was significantly up-regulated in the two Mul groups compared to the control group. CONCLUSIONS: Our results suggest that the Mul quercetin derivatives can directly improve lipid and glucose metabolism by reducing oxidative stress and enhancing beta-oxidation. The 1% Mul and 1% catechin groups had similar levels of polyphenol compound intake (0.4 x 10(-5) vs 0.4 x 10(-5) mole/5 days) and exhibited similar effects, but neither showed dose-dependent effects on lipid and glucose metabolism or oxidative stress.	[Sun, Xufeng; Yamasaki, Masayuki; Shiwaku, Kuninori] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane 6938501, Japan; [Katsube, Takuya] Shimane Inst Ind Technol, Matsue, Shimane 6900816, Japan	Yamasaki, M (reprint author), Shimane Univ, Sch Med, Dept Environm & Prevent Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	myamasak@med.shimane-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21790553, 24790586]	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (21790553 and 24790586 to MY).	Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006; Kajikawa S, 2009, PROSTAG LEUKOTR ESS, V80, P229, DOI 10.1016/j.plefa.2009.02.004; Katsube T, 2006, FOOD CHEM, V97, P25, DOI 10.1016/j.foodchem.2005.03.019; Knekt P, 2002, AM J CLIN NUTR, V76, P560; Ide T, 2001, BBA-MOL CELL BIOL L, V1534, P1, DOI 10.1016/S1388-1981(01)00167-6; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Aoki F, 2007, BIOSCI BIOTECH BIOCH, V71, P206, DOI 10.1271/bbb.60463; Bose M, 2008, J NUTR, V138, P1677; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c; Yamazaki T, 2012, J NUTR BIOCHEM, V23, P123, DOI 10.1016/j.jnutbio.2010.11.006; Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011; Feillet-Coudray C, 2009, FREE RADICAL BIO MED, V46, P624, DOI 10.1016/j.freeradbiomed.2008.11.020; Ruijters EJB, 2013, EUR J PHARMACOL, V715, P147, DOI [10.1016/j.ejphar.2013.05.029, 10.1016/j.ejphar.2013.05.020]; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Enkhmaa B, 2005, J NUTR, V135, P729; Han LK, 2003, PHYTOTHER RES, V17, P1188, DOI 10.1002/ptr.1404; Honda S, 2006, J AGR FOOD CHEM, V54, P9055, DOI 10.1021/jf061788t; Kuda T, 2004, FOOD CHEM TOXICOL, V42, P1695, DOI 10.1016/j.fct.2004.06.007; NEMALI MR, 1988, CANCER RES, V48, P5316; Wang L, 2011, EUR J NUTR, V50, P127, DOI 10.1007/s00394-010-0122-y; Crespy V, 2004, J NUTR, V134, p3431S	25	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	APR	2015	9	2					137	143		10.4162/nrp.2015.9.2.137		7	Nutrition & Dietetics	Nutrition & Dietetics	CF6NC	WOS:000352672400005		
J	He, JP; Miyazaki, J; Wang, N; Tsurui, H; Kobayashi, T				He, Jinping; Miyazaki, Jun; Wang, Nan; Tsurui, Hiromichi; Kobayashi, Takayoshi			Label-free imaging of melanoma with nonlinear photothermal microscopy	OPTICS LETTERS			English	Article							LIVE CELLS; GEOMETRY	Nonlinear photothermal microscopy, in which the intensity of the pump heating beam is modulated at f and the photothermal signal is extracted from the probe beam with a lock-in amplifier referred to 2f, is applied to the imaging of mouse melanoma without any staining. The pump and probe pulses, with central wavelengths of 488 and 632 nm, and a pulse duration of similar to 100 ps, are filtered from a compact commercial supercontinuum fiber laser source. An auto-balanced detector is applied to accumulate the signal and remove the laser noise of the probe. The spatial resolution of the nonlinear photothermal imaging is enhanced by similar to 18% in both theoretical calculations and experiments, compared with a linear photothermal mechanism, and the resolution enhancement is theoretically similar to 42% compared with conventional optical microscopy. This imaging technique shows possibilities for the clinical evaluation of melanoma with a high contrast and spatial resolution. (C) 2015 Optical Society of America	[He, Jinping; Miyazaki, Jun; Wang, Nan; Kobayashi, Takayoshi] Univ Electrocommun, Adv Ultrafast Laser Res Ctr, Chofu, Tokyo 1828585, Japan; [He, Jinping; Miyazaki, Jun; Wang, Nan; Kobayashi, Takayoshi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Tsurui, Hiromichi] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 1138421, Japan; [Kobayashi, Takayoshi] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan; [Kobayashi, Takayoshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650971, Japan	Kobayashi, T (reprint author), Univ Electrocommun, Adv Ultrafast Laser Res Ctr, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	kobayashi@ils.uec.ac.jp					Zharov VP, 2011, NAT PHOTONICS, V5, P110, DOI [10.1038/nphoton.2010.280, 10.1038/NPHOTON.2010.280]; Berciaud S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257402; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; Gaiduk A, 2010, CHEM SCI, V1, P343, DOI 10.1039/c0sc00210k; Galanzha EI, 2009, CANCER RES, V69, P7926, DOI 10.1158/0008-5472.CAN-08-4900; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; Lasne D, 2006, BIOPHYS J, V91, P4598, DOI 10.1529/biophysj.106.089771; Lasne D, 2007, OPT EXPRESS, V15, P14184, DOI 10.1364/OE.15.014184; Dka O., 1989, APPL PHYS A, V48, P415; GUSEV V, 1993, APPL PHYS A-MATER, V57, P229, DOI 10.1007/BF00332594; GUSEV V, 1993, INT J THERMOPHYS, V14, P321, DOI 10.1007/BF00507817; GUSEV V, 1994, MAT SCI ENG B-SOLID, V26, P111, DOI 10.1016/0921-5107(94)90159-7; INGLEHART LJ, 1990, APPL PHYS LETT, V56, P1749, DOI 10.1063/1.103088; Jaeger J. C., 1959, CONDUCTION HEAT SOLI; Kalogiannakis G, 2006, NDT&E INT, V39, P236, DOI 10.1016/j.ndteint.2005.07.003; Kawano S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.042401; Kittler H., 2010, LANCET ONCOL, V62, P751; Mandelis A, 1999, J APPL PHYS, V85, P1811, DOI 10.1063/1.369328; Marchesini R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3080140; Matthews TE, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001604; Mehrmohammadi M., 2013, CURR MOL IMAGING, V2, P89; Nedosekin DA, 2013, J BIOPHOTONICS, V6, P523, DOI 10.1002/jbio.201200242; RAJAKARUNANAYAKE YN, 1986, APPL PHYS LETT, V48, P218, DOI 10.1063/1.96800; Sahraoui AH, 1997, J APPL PHYS, V82, P6209, DOI 10.1063/1.365621; Salnick A, 2000, SOLID STATE COMMUN, V114, P133, DOI 10.1016/S0038-1098(00)00025-9; Tokeshi M, 2001, ANAL CHEM, V73, P2112, DOI 10.1021/ac001479g; WETSEL GC, 1986, CAN J PHYS, V64, P1269; Zhao JH, 2002, OPT LETT, V27, P1755, DOI 10.1364/OL.27.001755; Zonios G, 2010, PHOTOCHEM PHOTOBIOL, V86, P236, DOI 10.1111/j.1751-1097.2009.00630.x	29	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1141	1144		10.1364/OL.40.001141		4	Optics	Optics	CE9HK	WOS:000352154600002		
J	Satozono, H				Satozono, Hiroshi			Elimination of artifacts derived from the residual birefringence of a phase modulator for circular dichroism by retardation domain analysis	OPTICS LETTERS			English	Article							SPECTROSCOPY; CALIBRATION	It is well known that various artifacts interfere with circular dichroism (CD) measurement using the polarization modulation technique. In this report, we propose a simple analysis method for eliminating the artifacts derived from the residual birefringence of a phase modulator. We consider the origin of the artifacts and find that those in CD can be distinguished by analyzing signals as a function of the retardation of the phase modulator using a Mueller matrix method. We experimentally obtain pure CD from a sample with CD and linear dichroism by applying retardation domain analysis. (C) 2015 Optical Society of America	Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Japan	Satozono, H (reprint author), Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, 5000 Hirakuchi, Hamamatsu, Japan.	satozono@crl.hpk.co.jp					Kuroda R, 2001, REV SCI INSTRUM, V72, P3802, DOI 10.1063/1.1400157; Arteaga O, 2012, APPL OPTICS, V51, P6805, DOI 10.1364/AO.51.006805; JENSEN HP, 1978, APPL SPECTROSC, V32, P192, DOI 10.1366/000370278774331567; Provenzano C, 2010, OPT LETT, V35, P1822, DOI 10.1364/OL.35.001822; Berova N., 2000, CIRCULAR DICHROISM P; DiNitto JM, 2013, APPL SPECTROSC, V67, P1200, DOI 10.1366/12-06962; GO N, 1967, J PHYS SOC JPN, V23, P88; Nafie LA, 2000, APPL SPECTROSC, V54, P1634, DOI 10.1366/0003702001948664; SHINDO Y, 1985, REV SCI INSTRUM, V56, P32, DOI 10.1063/1.1138467; Shindo Y, 1995, OPT ENG, V34, P3369, DOI 10.1117/12.213252; Takakuwa T, 1985, ANAL SCI, V1, P215, DOI 10.2116/analsci.1.215	11	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1161	1164		10.1364/OL.40.001161		4	Optics	Optics	CE9HK	WOS:000352154600007		
J	Otsuka, K				Otsuka, Kenju			Laser-diode-pumped thin-slice c-cut Nd:GdVO4 multimode laser with coherent vector fields	OPTICS LETTERS			English	Article							SOLID-STATE LASER; ND-YVO4; BEAM; GENERATION; CRYSTAL	Spontaneous formation of coherent vector fields, which results from synchronization of longitudinal modes of orthogonally polarized transverse modes, has been observed in a laser-diode (LD)-pumped thin-slice c-cut Nd:GdVO4 laser with reflective end faces operating under the multi-longitudinal mode oscillation condition. The suppression of antiphase dynamics inherent to multimode solid-state lasers as well as the enhanced self-mixing interference effect as compared with a linearly polarized multimode laser have been identified. (C) 2015 Optical Society of America	Tokai Univ, Dept Human & Informat Sci, Hiratsuka, Kanagawa 2591292, Japan	Otsuka, K (reprint author), Tokai Univ, Dept Human & Informat Sci, Hiratsuka, Kanagawa 2591292, Japan.	kenju.otsuka@gmail.com					ANDERSON FG, 1994, PHYS REV B, V50, P14802, DOI 10.1103/PhysRevB.50.14802; Kozawa Y, 2005, OPT LETT, V30, P3063, DOI 10.1364/OL.30.003063; Otsuka K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.083903; Yonezawa K, 2006, OPT LETT, V31, P2151, DOI 10.1364/OL.31.002151; Chen YF, 2002, APPL PHYS B-LASERS O, V74, P415, DOI 10.1007/s003400200814; OTSUKA K, 1992, JPN J APPL PHYS 2, V31, pL1546; Sato Y, 2005, IEEE J SEL TOP QUANT, V11, P613, DOI 10.1109/JSTQE.2005.850569; Zhan QW, 2009, ADV OPT PHOTONICS, V1, P1, DOI 10.1364/AOP.1.000001; Otsuka K, 2011, SENSORS-BASEL, V11, P2195, DOI 10.3390/s110202195; Asakawa Y, 1999, JPN J APPL PHYS 2, V38, pL515, DOI 10.1143/JJAP.38.L515; Louvergneaux E, 1998, PHYS REV A, V57, P4899, DOI 10.1103/PhysRevA.57.4899; MartinRegalado J, 1997, APPL PHYS LETT, V70, P3350, DOI 10.1063/1.119167; Miyasaka Y, 2005, OPT EXPRESS, V13, P7928, DOI 10.1364/OPEX.13.007928; OTSUKA K, 1976, IEEE J QUANTUM ELECT, V12, P214, DOI 10.1109/JQE.1976.1069135; Otsuka K, 2009, OPT EXPRESS, V17, P21615, DOI 10.1364/OE.17.021615; OTSUKA K, 1978, IEEE J QUANTUM ELECT, V14, P49, DOI 10.1109/JQE.1978.1069664; OTSUKA K, 1992, PHYS REV A, V46, P1692, DOI 10.1103/PhysRevA.46.1692; Otsuka K, 2013, OPT LETT, V38, P1434, DOI 10.1364/OL.38.001434; Yang K., 2006, IEEE J QUANTUM ELECT, V47, P638; Zhou R., 2010, OPT EXPRESS, V18, P10837	20	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1177	1180		10.1364/OL.40.001177		4	Optics	Optics	CE9HK	WOS:000352154600011		
J	Cai, YF; Ikeda, S; Nakagawa, K; Kikuchi, H; Shimidzu, N; Ishibashi, T				Cai, Yongfu; Ikeda, Soushi; Nakagawa, Katsuji; Kikuchi, Hiroshi; Shimidzu, Naoki; Ishibashi, Takayuki			Strong enhancement of nano-sized circularly polarized light using an aperture antenna with V-groove structures	OPTICS LETTERS			English	Article								We present a new type of aperture antenna with V-groove structures that are made of Au to enhance strong circularly polarized light (CPL). Simulations using the finite element method revealed that strong CPL was enhanced within the aperture with a diameter of 10 nm. The intensity of the electric field was enhanced and was 22,700 times greater than that of the incident light. The channel plasmon polaritons generated in the V-groove structures were responsible for the strong enhancement. The influence of the angle and length of the V-groove on the enhancement of the CPL was investigated. (C) 2015 Optical Society of America	[Cai, Yongfu; Ikeda, Soushi; Ishibashi, Takayuki] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402186, Japan; [Nakagawa, Katsuji] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan; [Kikuchi, Hiroshi; Shimidzu, Naoki] NHK Sci & Technol Res Labs, Setagaya Ku, Tokyo 1578510, Japan	Ishibashi, T (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomiokamachi, Nagaoka, Niigata 9402186, Japan.	t_bashi@mst.nagaokaut.ac.jp			National Institute of Information and Communications Technology (NICT); KAKENHI [26286023]	This research was partially supported by the National Institute of Information and Communications Technology (NICT) and KAKENHI Grants-in-Aid for Scientific Research (B) (26286023).	Satoh T, 2012, NAT PHOTONICS, V6, P662, DOI [10.1038/nphoton.2012.218, 10.1038/NPHOTON.2012.218]; Hassey R, 2006, SCIENCE, V314, P1437, DOI 10.1126/science.1134231; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Biagioni P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.153409; Peng X, 2007, NAT NANOTECHNOL, V2, P361, DOI 10.1038/nnano.2007.142; Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Hendry E, 2010, NAT NANOTECHNOL, V5, P783, DOI [10.1038/nnano.2010.209, 10.1038/NNANO.2010.209]; Moreno E, 2006, OPT LETT, V31, P3447, DOI 10.1364/OL.31.003447; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; Koene B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733292; Beth RA, 1936, PHYS REV, V50, P115, DOI 10.1103/PhysRev.50.115; Biagioni P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2137891; Biagioni P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256801; Nakagawa K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556924; Ogut E, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3371696; Sondergaard T., 2009, NANO LETT, V10, P291; Vernon KC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832441	17	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1298	1301		10.1364/OL.40.001298		4	Optics	Optics	CE9HK	WOS:000352154600042		
J	Tamayama, Y				Tamayama, Yasuhiro			Brewster effect in metafilms composed of bi-anisotropic split-ring resonators	OPTICS LETTERS			English	Article							ELECTROMAGNETIC-WAVES; METAMATERIALS; ANGLE; TERAHERTZ; INDEX	The Brewster effect is extended to single-layer metafilms. In contrast to bulk media, the Brewster effect in metafilms can be realized by tailoring the radiation pattern of a distribution of meta-atoms rather than the effective medium parameters. A metafilm composed of bi-anisotropic split-ring resonators is designed based on the theory, and its characteristics are numerically analyzed. The simulation demonstrates that there exists a condition for which the polarization of the reflected wave becomes independent of the incident polarization at a particular angle of incidence. (C) 2015 Optical Society of America	Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan	Tamayama, Y (reprint author), Nagaoka Univ Technol, Dept Elect Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	tamayama@vos.nagaokaut.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22109004]	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 22109004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akozbek N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205430; Alu A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.123902; Katsarakis N, 2004, APPL PHYS LETT, V84, P2943, DOI 10.1063/1.1695439; Tao H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.147401; Tao H, 2011, IEEE J SEL TOP QUANT, V17, P92, DOI 10.1109/JSTQE.2010.2047847; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/nphoton.2011.154, 10.1038/NPHOTON.2011.154]; Fu CJ, 2005, APPL OPTICS, V44, P3716, DOI 10.1364/AO.44.003716; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Rockstuhl C, 2006, APPL PHYS B-LASERS O, V84, P219, DOI 10.1007/s00340-006-2205-2; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/nmat3431, 10.1038/NMAT3431]; Wang BN, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/11/114003; BASSIRI S, 1988, J OPT SOC AM A, V5, P1450, DOI 10.1364/JOSAA.5.001450; Argyropoulos C, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024304; DOYLE WT, 1980, AM J PHYS, V48, P643, DOI 10.1119/1.12042; FUTTERMAN J, 1995, AM J PHYS, V63, P471, DOI 10.1119/1.17915; Grzegorczyk TM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951050; Johnson R. C., 1992, ANTENNA ENG HDB; LAKHTAKIA A, 1992, OPTIK, V90, P184; Lakhtakia A., 1989, OPTICS NEWS, V15, P14; Sastry G. P., 1987, European Journal of Physics, V8, DOI 10.1088/0143-0807/8/2/009; Shen NH, 2006, J OPT SOC AM B, V23, P904, DOI 10.1364/JOSAB.23.000904; Shu W, 2007, APPL PHYS A-MATER, V87, P297, DOI 10.1007/s00339-006-3832-5; Tamayama Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.193104; Tamayama Y, 2008, OPT EXPRESS, V16, P20869, DOI 10.1364/OE.16.020869; Tanaka T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125423; Watanabe R, 2008, PHYS STATUS SOLIDI B, V245, P2696, DOI 10.1002/pssb.200879899	27	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1382	1385		10.1364/OL.40.001382		4	Optics	Optics	CE9HK	WOS:000352154600063		
J	Goi, K; Oka, A; Kusaka, H; Ogawa, K; Liow, TY; Tu, XG; Lo, GQ; Kwong, DL				Goi, Kazuhiro; Oka, Akira; Kusaka, Hiroyuki; Ogawa, Kensuke; Liow, Tsung-Yang; Tu, Xiaoguang; Lo, Guo-Qiang; Kwong, Dim-Lee			Low-loss partial rib polarization rotator consisting only of silicon core and silica cladding	OPTICS LETTERS			English	Article							COMPACT	We present a low-loss and small-footprint polarization rotator based on mode evolution. The polarization rotator is composed of an asymmetric-rib waveguide and a tapered waveguide, both of which consist only of a silicon core and a silica cladding. The rotator is fabricated under the same design rules as other device blocks, such as rib-waveguide phase shifters for photonic integration. The polarization rotator is fabricated using CMOS-based processes and provides polarization rotations with an on-chip insertion loss lower than 0.5 dB from transverse-electric (TE) to transverse-magnetic (TM) polarization and a loss lower than 1.0 dB from the TM to TE polarization in a 200 nm wavelength range extending over C and L bands. (C) 2015 Optical Society of America	[Goi, Kazuhiro; Oka, Akira; Kusaka, Hiroyuki; Ogawa, Kensuke] Fujikura Ltd, Opt & Elect Lab, Sakura, Chiba 2858550, Japan; [Liow, Tsung-Yang; Tu, Xiaoguang; Lo, Guo-Qiang; Kwong, Dim-Lee] ASTAR, Inst Microelect, Singapore 117685, Singapore	Goi, K (reprint author), Fujikura Ltd, Opt & Elect Lab, 1440 Mutsuzaki, Sakura, Chiba 2858550, Japan.	kazuhiro.goi@jp.fujikura.com					Dai DX, 2011, OPT EXPRESS, V19, P10940, DOI 10.1364/OE.19.010940; Watts MR, 2005, OPT LETT, V30, P138, DOI 10.1364/OL.30.000138; Fukuda H, 2008, OPT EXPRESS, V16, P4872, DOI 10.1364/OE.16.004872; Chen L, 2011, OPT LETT, V36, P469, DOI 10.1364/OL.36.000469; Fukuda H, 2006, OPT EXPRESS, V14, P12401, DOI 10.1364/OE.14.012401; Sacher WD, 2014, OPT EXPRESS, V22, P3777, DOI 10.1364/OE.22.003777; Zhang J, 2010, IEEE J SEL TOP QUANT, V16, P53, DOI 10.1109/JSTQE.2009.2031424; Deng HH, 2005, J LIGHTWAVE TECHNOL, V23, P432, DOI 10.1109/JLT.2004.834477; [Anonymous], FIMMW; Zhang HJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734640; Wang ZC, 2008, J OPT SOC AM B, V25, P747, DOI 10.1364/JOSAB.25.000747; Birk M., 2010, P OPT FIB COMM C SAN; Cao TT, 2013, APPL OPTICS, V52, P990, DOI 10.1364/AO.52.000990; Goi K., 2013, P 18 MICR C TOK JAP; Goi K., 2014, P OPT FIB COMM C SAN; Nielsen T. N., 2014, P OPT FIB COMM C SAN; Oka A., 2014, P OPT COMM C MELB AU; Selvaraja S. K., 2012, P OPT COMM C BUS S K; Vermeulen D, 2012, IEEE PHOTONIC TECH L, V24, P482, DOI 10.1109/LPT.2011.2181944; Yamazaki H, 2011, J LIGHTWAVE TECHNOL, V29, P721, DOI 10.1109/JLT.2010.2101052	20	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1410	1413		10.1364/OL.40.001410		4	Optics	Optics	CE9HK	WOS:000352154600070		
J	Tang, R; Kita, T; Yamada, H				Tang, Rui; Kita, Tomohiro; Yamada, Hirohito			Narrow-spectral-linewidth silicon photonic wavelength-tunable laser with highly asymmetric Mach-Zehnder interferometer	OPTICS LETTERS			English	Article								We propose a narrow-spectral-linewidth silicon photonic wavelength-tunable laser with a novel external wavelength-tunable filter, which consists of two silicon ring resonators with different circumferences and a highly asymmetric Mach-Zehnder interferometer (MZI), the two optical paths of which have significantly different lengths. Calculations and experimental results indicated that the gain difference between longitudinal modes was increased by the highly asymmetric MZI. Consequently, a narrow spectral linewidth of 12 kHz and a stable single-mode oscillation were obtained. (C) 2015 Optical Society of America	[Tang, Rui; Kita, Tomohiro; Yamada, Hirohito] Tohoku Univ, Grad Sch Engn, Dept Commun Engn, Sendai, Miyagi 980, Japan	Kita, T (reprint author), Tohoku Univ, Grad Sch Engn, Dept Commun Engn, Sendai, Miyagi 980, Japan.	tkita@ecei.tohoku.ac.jp			JSPS [25420312]; Strategic Information and Communications R&D Promotion Program (SCOPE), Ministry of Internal Affairs and Communications, Japan	This research was partly supported by Grants-in-Aid for Scientific Research (25420312), JSPS and Strategic Information and Communications R&D Promotion Program (SCOPE), Ministry of Internal Affairs and Communications, Japan.	Nemoto K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.082701; OKOSHI T, 1980, ELECTRON LETT, V16, P630, DOI 10.1049/el:19800437; Hulme JC, 2013, OPT EXPRESS, V21, P19718, DOI 10.1364/OE.21.019718; Debregeas H., 2014, P IEEE INT SEM LAS C, P50; HENRY CH, 1982, IEEE J QUANTUM ELECT, V18, P259, DOI 10.1109/JQE.1982.1071522; Kita T., 2014, P IEEE INT SEM LAS C, P149; Kita Tomohiro, 2014, IEEE Journal of Selected Topics in Quantum Electronics, V20, DOI 10.1109/JSTQE.2013.2295712; Matsumoto T., 2010, OPT FIB COMM C; Ren M., 2013, P INT C SOL STAT SEN, P1424; Sato K., 2014, P EUR C OPT COMM; Seimetz M., 2008, P OPT FIB COMM NAT F; Takeuchi T, 2009, IEICE T ELECTRON, VE92C, P198, DOI 10.1587/transele.E92.C.198; Tang R., 2014, P IEEE INT SEM LAS C, P96	13	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1504	1507		10.1364/OL.40.001504		4	Optics	Optics	CE9HK	WOS:000352154600095		
J	Lobanov, SV; Weiss, T; Gippius, NA; Tikhodeev, SG; Kulakovskii, VD; Konishi, K; Kuwata-Gonokami, M				Lobanov, Sergey V.; Weiss, Thomas; Gippius, Nikolay A.; Tikhodeev, Sergei G.; Kulakovskii, Vladimir D.; Konishi, Kuniaki; Kuwata-Gonokami, Makoto			Polarization control of quantum dot emission by chiral photonic crystal slabs	OPTICS LETTERS			English	Article							SPIN; FLUORESCENCE; INJECTION	We investigate theoretically the polarization properties of the quantum dot's (QDs) optical emission from chiral photonic crystal structures made of achiral materials in the absence of external magnetic field at room temperature. The mirror symmetry of the local electromagnetic field is broken in this system due to the decreased symmetry of the chiral modulated layer. As a result, the radiation of randomly polarized QDs normal to the structure becomes partially circularly polarized. The sign and degree of circular polarization are determined by the geometry of the chiral modulated structure and depend on the radiation frequency. A degree of circular polarization up to 99% can be achieved for randomly distributed QDs, and can be close to 100% for some single QDs. (C) 2015 Optical Society of America	[Lobanov, Sergey V.; Gippius, Nikolay A.] Skolkovo Inst Sci & Technol, Skolkovo 143025, Russia; [Lobanov, Sergey V.; Tikhodeev, Sergei G.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Weiss, Thomas] Univ Stuttgart, Inst Phys 4, D-70550 Stuttgart, Germany; [Weiss, Thomas] Univ Stuttgart, Res Ctr Scope, D-70550 Stuttgart, Germany; [Gippius, Nikolay A.; Tikhodeev, Sergei G.] Russian Acad Sci, AM Prokhorov Gen Phys Inst, Moscow 119991, Russia; [Kulakovskii, Vladimir D.] Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia; [Konishi, Kuniaki] Univ Tokyo, Inst Photon Sci & Technol, Tokyo 1130033, Japan; [Kuwata-Gonokami, Makoto] Univ Tokyo, Photon Sci Ctr, Tokyo 1138656, Japan; [Kuwata-Gonokami, Makoto] Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Lobanov, SV (reprint author), Skolkovo Inst Sci & Technol, Novaya St 100, Skolkovo 143025, Russia.	lobanov@physics.msu.ru			RFBR; Russian Federation Presidential Council for Grants; Dynasty Foundation; EU project SPANGL4Q; Photon Frontier Network Program; KAKENHI [20104002]; Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS through its FIRST Program	This work was supported in part by RFBR, Russian Federation Presidential Council for Grants, the Dynasty Foundation, EU project SPANGL4Q, the Photon Frontier Network Program, KAKENHI (20104002), Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by JSPS through its FIRST Program.	STEGEMEYER H, 1979, ISRAEL J CHEM, V18, P312; Woon KL, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041706; Schmidtke J, 2003, EUR PHYS J B, V31, P179, DOI 10.1140/epjb/e2003-00022-x; Ohno Y, 1999, NATURE, V402, P790; Lobanov SV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155137; Weiss T, 2009, OPT EXPRESS, V17, P8051, DOI 10.1364/OE.17.008051; Maksimov AA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045316; Fiederling R, 1999, NATURE, V402, P787; Konishi K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057402; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; Tikhodeev SG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045102; Whittaker DM, 1999, PHYS REV B, V60, P2610, DOI 10.1103/PhysRevB.60.2610; Jiang X, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056601; Bhattacharya P, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/1/014002; Bykov V. P., 1972, Soviet Physics - JETP, V35; Holub M, 2007, J PHYS D APPL PHYS, V40, pR179, DOI 10.1088/0022-3727/40/11/R01; Rashba E. I., 2000, Physical Review B (Condensed Matter), V62, DOI 10.1103/PhysRevB.62.R16267; Ren QJ, 2012, NANO LETT, V12, P3455, DOI 10.1021/nl3008083	18	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1528	1531		10.1364/OL.40.001528		4	Optics	Optics	CE9HK	WOS:000352154600101		
J	Sasaki, T; Noda, K; Kawatsuki, N; Ono, H				Sasaki, Tomoyuki; Noda, Kohei; Kawatsuki, Nobuhiro; Ono, Hiroshi			Universal polarization terahertz phase controllers using randomly aligned liquid crystal cells with graphene electrodes	OPTICS LETTERS			English	Article							WAVE PLATE; TECHNOLOGY; SHIFTER	We present a universal polarization terahertz (THz) phase controller using a randomly aligned liquid crystal (LC) cell with graphene electrodes. The LC cell was fabricated using a nematic LC and two quartz substrates that were coated with a monolayer of graphene as the transparent electrode. The LC in the cell was prepared without any alignment treatments and was randomly aligned. The size of the random domains and the width of the disclination lines in the LC layer were several tens of microns. These textures disappeared when an alternating voltage was applied to the LC through the graphene layers. Using a THz time domain spectroscopic technique, we investigated the complex transmittance of the LC cell. The LC cell was highly transparent in the THz frequency range, and there was little change in the transmittance with the applied voltage. This indicated that the scattering loss originating in the randomly aligned LC molecules was small for the THz waves. We also demonstrated that the THz phase shift could be controlled by the applied voltage. The amplitude of the phase shift was explained by the ordinary and extraordinary refractive indices of the LC. These LC cells with graphene electrodes can be used to realize universal polarization THz phase controllers because of the random alignment. (C) 2015 Optical Society of America	[Sasaki, Tomoyuki; Noda, Kohei; Ono, Hiroshi] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Kawatsuki, Nobuhiro] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712280, Japan	Sasaki, T (reprint author), Nagaoka Univ Technol, Dept Elect Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	sasaki_tomoy@vos.nagaokaut.ac.jp			Konica Minolta Imaging Science Encouragement Award of the Konica Minolta Science and Technology Foundation	This research was supported by the Konica Minolta Imaging Science Encouragement Award of the Konica Minolta Science and Technology Foundation.	Libon IH, 2000, APPL PHYS LETT, V76, P2821, DOI 10.1063/1.126484; Chopik A, 2014, OPT LETT, V39, P1453, DOI 10.1364/OL.39.001453; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Masson JB, 2006, OPT LETT, V31, P265, DOI 10.1364/OL.31.000265; Weis P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3253414; Yang CS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871255; Zografopoulos DC, 2014, OPT MATER EXPRESS, V4, P449, DOI 10.1364/OME.4.000449; Yang CS, 2014, OPT LETT, V39, P2511, DOI 10.1364/OL.39.002511; Wu Y, 2015, ADV MATER, V27, P1874, DOI 10.1002/adma.201405251; Siegel PH, 2002, IEEE T MICROW THEORY, V50, P910, DOI 10.1109/22.989974; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Vieweg N, 2010, J INFRARED MILLIM TE, V31, P1312, DOI 10.1007/s10762-010-9721-1; Nagai M, 2014, OPT LETT, V39, P146, DOI 10.1364/OL.39.000146; Chen HT, 2006, NATURE, V444, P597, DOI 10.1038/nature05343; Wu Y, 2013, OPT EXPRESS, V21, P21395, DOI 10.1364/OE.21.021395; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dierking I., 2003, TEXTURE LIQUID CRYST; Khoo I. C., 1995, LIQUID CRYSTALS PHYS; Nose T, 1997, APPL OPTICS, V36, P6383, DOI 10.1364/AO.36.006383; Tsai TR, 2003, APPL OPTICS, V42, P2372, DOI 10.1364/AO.42.002372; Tsai TR, 2004, IEEE MICROW WIREL CO, V14, P77, DOI 10.1109/LMWC.2003.819958; Wang L, 2012, OPT MATER EXPRESS, V2, P1314; Yeh P., 1999, OPTICS LIQUID CRYSTA	24	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	APR 1	2015	40	7					1544	1547		10.1364/OL.40.001544		4	Optics	Optics	CE9HK	WOS:000352154600105		
J	Sanuki, T; Yumoto, E; Nishimoto, K; Kodama, N; Kodama, H; Minoda, R				Sanuki, Tetsuji; Yumoto, Eiji; Nishimoto, Kohei; Kodama, Narihiro; Kodama, Haruka; Minoda, Ryosei			Laryngeal Reinnervation Featuring Refined Nerve-Muscle Pedicle Implantation Evaluated via Electromyography and Use of Coronal Images	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						unilateral vocal fold paralysis; laryngeal reinnervation; nerve-muscle pedicle implantation; laryngeal electromyography; coronal reconstructed image	VOCAL FOLD PARALYSIS; RAT THYROARYTENOID MUSCLE; ANSA CERVICALIS; CORD PARALYSIS; ARYTENOID ADDUCTION; INNERVATION; ANASTOMOSIS; DENERVATION; DYSPHONIA; UPDATE	Objective To evaluate the long-term efficacy of laryngeal reinnervation via refined nerve-muscle pedicle (NMP) flap implantation combined with arytenoid adduction to treat unilateral vocal fold paralysis (UVFP), employing laryngeal electromyography (LEMG), coronal imaging, and phonatory function assessment. Study Design Case series with chart review. Setting University hospital. Subjects and Methods We retrospectively reviewed 12 UVFP patients who underwent refined NMP implantation with arytenoid adduction. Videostroboscopy, phonatory functional analysis, LEMG, and coronal imaging were performed before and 2 years after surgery. In LEMG analysis, a 4-point scale was employed to grade motor unit (MU) recruitment: 4+ reflected no recruitment, 3+ greatly decreased recruitment, 2+ moderately decreased recruitment, and 1+ mildly decreased activity, associated with less than the full interference pattern. Coronal images were assessed in terms of differences in thickness and the vertical positions of the vocal folds. Results Phonatory function improved significantly after operation in all patients. In terms of LEMG findings, the preoperative MU recruitment scores were 1+ in no patients, 2+ in 4 patients, 3+ in 1 patient, and 4+ in 7 patients. Postoperative MU recruitment results were 1+ in 6 patients, 2+ in 5 patients, 3+ in 1 patient, and 4+ in no patients. Thinning of the affected fold during phonation was evident preoperatively in 9 of 10 patients. The affected and healthy folds were equal in volume in 4 of 9 patients postoperatively. Conclusion The LEMG findings and coronal imaging suggest that NMP implantation may have enabled successful reinnervation of the laryngeal muscles of UVFP patients.	[Sanuki, Tetsuji; Yumoto, Eiji; Nishimoto, Kohei; Kodama, Narihiro; Kodama, Haruka; Minoda, Ryosei] Kumamoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kumamoto 8608556, Japan	Sanuki, T (reprint author), Kumamoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	otostl0319@fc.kuh.kumamoto-u.ac.jp			JSPS KAKENHI [25293349]	This work was supported by JSPS KAKENHI Grant Number 25293349.	BENNINGER MS, 1994, OTOLARYNG HEAD NECK, V111, P497; Maronian N, 2003, ANN OTO RHINOL LARYN, V112, P314; Miyamaru S, 2008, LARYNGOSCOPE, V118, P1318, DOI 10.1097/MLG.0b013e31816f693f; ISSHIKI N, 1978, ARCH OTOLARYNGOL, V104, P555; Munin MC, 2003, ARCH PHYS MED REHAB, V84, P1150, DOI 10.1016/S0003-9993(03)00146-1; Smith ME, 2008, INT J PEDIATR OTORHI, V72, P1311, DOI [10.1016/j.ijporl.2008.05.004, 10.1016/j.ijport.2008.05.004]; Aoyama T, 2010, ANN OTO RHINOL LARYN, V119, P823; CRUMLEY RL, 1991, LARYNGOSCOPE, V101, P384; Hassan MM, 2011, LARYNGOSCOPE, V121, P1018, DOI 10.1002/lary.21657; ISSHIKI N, 1975, ACTA OTO-LARYNGOL, V80, P465, DOI 10.3109/00016487509121353; KANO S, 1991, ARCH OTOLARYNGOL, V117, P1019; Kumai Y, 2006, LARYNGOSCOPE, V116, P1027, DOI 10.1097/01.MLG.0000217588.46645.FA; Lee WT, 2007, OTOLARYNG HEAD NECK, V136, P450, DOI 10.1016/j.otohns.2006.11.040; Lorenz RR, 2008, ANN OTO RHINOL LARYN, V117, P40; MAY M, 1986, LARYNGOSCOPE, V96, P1196; Miyamaru S, 2009, ACTA OTO-LARYNGOL, V129, P1486, DOI 10.3109/00016480902814280; Sanuki T, 2014, OTOLARYNG HEAD NECK, V150, P625, DOI 10.1177/0194599814520999; TUCKER HM, 1977, ANN OTO RHINOL LARYN, V86, P789; Tucker HM, 1997, J VOICE, V11, P474, DOI 10.1016/S0892-1997(97)80045-8; Yumoto E, 2004, ARCH OTOLARYNGOL, V130, P967, DOI 10.1001/archotol.130.8.967; Yumoto E, 2002, AURIS NASUS LARYNX, V29, P41, DOI 10.1016/S0385-8146(01)00122-5; Yumoto E, 2006, LARYNGOSCOPE, V116, P1657, DOI 10.1097/01.mlg.0000233245.27582.fc; Yumoto E, 2003, ACTA OTO-LARYNGOL, V123, P274, DOI 10.1080/0036554021000028107; Yumoto E, 2010, ARCH OTOLARYNGOL, V136, P965, DOI 10.1001/archoto.2010.155; Yumoto E, 2013, ACTA OTO-LARYNGOL, V133, P187, DOI 10.3109/00016489.2012.726741; Shindo ML, 1996, ANN OTO RHINOL LARYN, V105, P602; Zheng HL, 1996, LARYNGOSCOPE, V106, P1522, DOI 10.1097/00005537-199612000-00015	27	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	APR	2015	152	4					697	705		10.1177/0194599815568945		9	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CF5ET	WOS:000352580000025		
J	Phithakkitnukoon, S; Horanont, T; Witayangkurn, A; Siri, R; Sekimoto, Y; Shibasaki, R				Phithakkitnukoon, Santi; Horanont, Teerayut; Witayangkurn, Apichon; Siri, Raktida; Sekimoto, Yoshihide; Shibasaki, Ryosuke			Understanding tourist behavior using large-scale mobile sensing approach: A case study of mobile phone users in Japan	PERVASIVE AND MOBILE COMPUTING			English	Article						Mobile sensing; Mobility pattern; GPS location traces; Tourist behavior	LENGTH-OF-STAY	This article describes a framework that capitalizes on the large-scale opportunistic mobile sensing approach for tourist behavior analysis. The article describes the use of massive mobile phone GPS location records to study tourist travel behavior, in particular, number of trips made, time spent at destinations, and mode of transportation used. Moreover, this study examined the relationship between personal mobility and tourist travel behavior and offered a number of interesting insights that are useful for tourism, such as tourist flows, top tourist destinations or origins, top destination types, top modes of transportation in terms of time spent and distance traveled, and how personal mobility information can be used to estimate the likelihood in tourist travel behavior, i.e., number of trips, time spent at destinations, and trip distance. Furthermore, the article describes an application developed based on the analysis in this study that allows the user to observe touristic, non-touristic, and commuting trips along with home and workplace locations as well as tourist flows, which can be useful for urban planners, transportation management, and tourism authorities. (C) 2014 Elsevier B.V. All rights reserved.	[Phithakkitnukoon, Santi] Chiang Mai Univ, Fac Engn, Dept Comp Engn, Chiang Mai, Thailand; [Horanont, Teerayut] Thammasat Univ, SIIT, Bangkok, Thailand; [Phithakkitnukoon, Santi; Horanont, Teerayut; Witayangkurn, Apichon; Sekimoto, Yoshihide; Shibasaki, Ryosuke] Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo 1138654, Japan; [Siri, Raktida] Maejo Univ, Sch Tourism Dev, Sansai, Thailand	Phithakkitnukoon, S (reprint author), Chiang Mai Univ, Fac Engn, Dept Comp Engn, Chiang Mai, Thailand.	santi@eng.cmu.ac.th			JSPS (Japan Society for the Promotion of Science) Invitation Fellowship [S-13176]; DIAS (Data Integration and Analysis System); GRENE (Green Net-work of Excellence) project of MEXT (Ministry of Education, Culture, Sports, Science and Technology)	This study has been supported by the JSPS (Japan Society for the Promotion of Science) Invitation Fellowship (S-13176), the DIAS (Data Integration and Analysis System) and GRENE (Green Net-work of Excellence) project of MEXT (Ministry of Education, Culture, Sports, Science and Technology). Special thanks to ZENRIN DataCom CO., LTD for the dataset used in this study.	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Gokovali U, 2007, TOURISM MANAGE, V28, P736, DOI 10.1016/j.tourman.2006.05.004; Alegre J, 2006, TOURISM MANAGE, V27, P1343, DOI 10.1016/j.tourman.2005.06.012; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Breiman L., 2009, ANATOL INT J TOUR HO, V20, P46; Ester M, 1996, KDD, V96, P226; Phithakkitnukoon S, 2010, LECT NOTES COMPUT SC, V6219, P14, DOI 10.1007/978-3-642-14715-9_3; Phithakkitnukoon S., 2012, PLOS ONE, V7; Witayangkurn A., 2013, P INT C COMP URB PLA, P1; Wu LL, 2012, TRANSPORT RES REC, P91, DOI 10.3141/2322-10; Zheng Y., 2008, P 10 INT C UB COMP, P312, DOI DOI 10.1145/1409635.1409677	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-1192	1873-1589		PERVASIVE MOB COMPUT	Pervasive Mob. Comput.	APR	2015	18						18	39		10.1016/j.pmcj.2014.07.003		22	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CF0KK	WOS:000352232600003		
J	Yasuda, K; Abe, H; Koganemaru, G; Ikeda, T; Arimori, K; Ishida, Y				Yasuda, Kazuya; Abe, Hiroshi; Koganemaru, Go; Ikeda, Tetsuya; Arimori, Kazuhiko; Ishida, Yasushi			Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Pramipexole; Parkinsonism; Tremulous jaw movement; Ventrolateral striatum; Apomorphine	TREMULOUS JAW MOVEMENTS; C-FOS EXPRESSION; RECEPTOR AGONISTS; TACRINE; DISEASE; MODEL; HALOPERIDOL; ZONISAMIDE; ROPINIROLE; DRUGS	Objective: Pramipexole is widely prescribed for the treatment of Parkinson's disease. This dopamine (DA) receptor agonist has a higher affinity for D-3 over D-2 receptors. We compared the effect of pramipexole to apomorphine, a non-specific DA receptor agonist, on the suppression of tremulous jaw movements (TJMs) in a rat model, to elucidate the possible ameliorating effect of D-3 receptor activation on parkinsonian tremor. Results: In experiment 1, pilocarpine (4.0 mg/kg) was injected into rats intraperitoneally, and the number of rapid vertical deflections of the lower jaw was counted for 20 min immediately after the injection, to evaluate TJMs. TJMs were reduced by intraperitoneal administration of pramipexole (1.0 mg/kg). In experiment 2, the number of TJMs was counted after the rats received intraperitoneal administration of either apomorphine (0.25, 1.0, 4.0 mg/kg) or vehicle, followed by the micro-infusion of pilocarpine (50 mu g/1 mu L/side) or vehicle into the ventrolateral striatum (VLS) via implanted guide cannulae. In experiment 3, either pramipexole (0.25, 1.0, 4.0 mg/kg) or vehicle was intraperitoneally administered, followed by the micro-infusion of pilocarpine or vehicle into the VLS 30 min later. Pramipexole (1.0 and 4.0 mg/kg) and apomorphine (1.0 and 4.0 mg/kg) significantly reduced the number of TJMs induced by micro-infusion of pilocarpine into the VLS. Conclusions: These findings suggest that activation of D-3, as well as D-2 receptors could play important roles in the suppression of parkinsonian tremor. (C) 2015 Elsevier Inc. All rights reserved.	[Yasuda, Kazuya; Abe, Hiroshi; Koganemaru, Go; Ishida, Yasushi] Miyazaki Univ, Fac Med, Dept Psychiat, Miyazaki, Miyazaki 8891692, Japan; [Yasuda, Kazuya; Arimori, Kazuhiko] Univ Miyazaki Hosp, Dept Pharm, Miyazaki, Miyazaki 8891692, Japan; [Ikeda, Tetsuya] Miyazaki Univ, Fac Med, Div Neurobiol, Miyazaki, Miyazaki 8891692, Japan	Abe, H (reprint author), Miyazaki Univ, Fac Med, Dept Psychiat, 5200 Kihara, Miyazaki, Miyazaki 8891692, Japan.	kazuya_yasuda@med.miyazaki-u.ac.jp; abehiro@med.miyazald-u.ac.jp; go_koganemaru@med.miyazaki-u.ac.jp; ikedat@med.miyazaki-u.ac.jp; arimori@med.miyazaki-u.ac.jp; ishiday@med.miyazaki-u.ac.jp					Brichta L, 2013, TRENDS NEUROSCI, V36, P543, DOI 10.1016/j.tins.2013.06.003; Deuschl G, 2000, J NEUROL, V247, P33; Olanow CW, 2001, NEUROLOGY, V56, pS1; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; Joyce JN, 2007, CURR OPIN PHARMACOL, V7, P100, DOI 10.1016/j.coph.2006.11.004; BASKIN P, 1993, PHARMACOL BIOCHEM BE, V46, P793, DOI 10.1016/0091-3057(93)90203-6; Betz AJ, 2009, NEUROSCIENCE, V163, P97, DOI 10.1016/j.neuroscience.2009.05.040; Coldwell MC, 1999, BRIT J PHARMACOL, V127, P1696, DOI 10.1038/sj.bjp.0702673; Correa M, 2004, BEHAV BRAIN RES, V148, P47, DOI 10.1016/S0166-4328(03)00178-5; Cousins MS, 1997, EUR J PHARMACOL, V322, P137, DOI 10.1016/S0014-2999(97)00008-3; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Koganemaru G, 2014, PHARMACOL BIOCHEM BE, V126, P103, DOI 10.1016/j.pbb.2014.09.015; Malik P, 2004, PHARMACOL BIOCHEM BE, V78, P805, DOI 10.1016/j.pbb.2004.05.019; Mayorga AJ, 1997, PHARMACOL BIOCHEM BE, V56, P273, DOI 10.1016/S0091-3057(96)00225-0; Mayorga AJ, 1999, PSYCHOPHARMACOLOGY, V143, P72, DOI 10.1007/s002130050921; Mayorga AJ, 1999, BRAIN RES, V829, P180, DOI 10.1016/S0006-8993(99)01352-9; MCEVOY JP, 1983, J CLIN PSYCHOPHARM, V3, P288; MCSWAIN ML, 1995, J CLIN PSYCHOPHARM, V15, P284, DOI 10.1097/00004714-199508000-00008; Milian M.J., 2002, J PHARMACOL EXP THER, V303, P791; Miwa H, 2009, PARKINSONISM RELAT D, V15, P30, DOI 10.1016/j.parkreldis.2008.02.008; Miwa H, 2008, PARKINSONISM RELAT D, V14, P33, DOI 10.1016/j.parkreldis.2007.05.008; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Podurgiel S, 2013, PHARMACOL BIOCHEM BE, V105, P105, DOI 10.1016/j.pbb.2013.01.015; Salamone JD, 1998, PROG NEUROBIOL, V56, P591, DOI 10.1016/S0301-0082(98)00053-7; Salamone JD, 2005, BEHAV BRAIN RES, V156, P173, DOI 10.1016/j.bbr.2004.05.019; SALAMONE JD, 1990, PSYCHOPHARMACOLOGY, V102, P529, DOI 10.1007/BF02247136; Simola N, 2004, EXP NEUROL, V189, P182, DOI 10.1016/j.expneurol.2004.05.027; STEINPREIS RE, 1993, PSYCHOPHARMACOLOGY, V111, P99, DOI 10.1007/BF02257414; Wermuth L, 1998, EUR J NEUROL, V5, P235, DOI 10.1046/j.1468-1331.1998.530235.x	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	APR	2015	131						1	5		10.1016/j.pbb.2015.01.012		5	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CE9OL	WOS:000352173200002		
J	Katsuragawa, T; Nojiri, S				Katsuragawa, Taishi; Nojiri, Shin'ichi			Stability and antievaporation of the Schwarzschild-de Sitter black holes in bigravity	PHYSICAL REVIEW D			English	Article							DILATON	We study the stability under the perturbation and the related antievaporation of the Nariai space-time in bigravity. If we impose a specific condition for the solutions and parameters, we obtain asymptotically de Sitter space-time, and show the existence of the Nariai space-time as a background solution. Considering the perturbation around the Nariai space-time up to the first order, we investigate the behavior of the black hole horizon. We show that the antievaporation does not occur on the classical level in the bigravity.	[Katsuragawa, Taishi; Nojiri, Shin'ichi] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Nojiri, Shin'ichi] Nagoya Univ, Kobayashi Maskawa Inst Origin Particles & Univ, Nagoya, Aichi 4648602, Japan	Katsuragawa, T (reprint author), Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan.				Nagoya University Program for Leading Graduate Schools - Ministry of Education of the Japanese Government [N01]; JSPS [22224003, 23540296]	The authors are deeply indebted to Sergei D. Odintsov for constructive advice and discussion in the early stage of this research. Taishi Katsuragawa is partially supported by the Nagoya University Program for Leading Graduate Schools funded by the Ministry of Education of the Japanese Government under Grant No. N01. This work is also supported by the JSPS Grant-in-Aid for Scientific Research (S) Grant No. 22224003 and (C) Grant No. 23540296 (Shin'ichi Nojiri).	Akrami Y, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/10/46; Akrami Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)099; DONOGHUE JF, 1994, PHYS REV D, V50, P3874, DOI 10.1103/PhysRevD.50.3874; Hassan SF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.041101; Bamba K, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/7/075016; Katsuragawa T, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.124007; Volkov MS, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/18/184009; Nojiri S, 2012, PHYS LETT B, V716, P377, DOI 10.1016/j.physletb.2012.08.049; Bousso R, 1998, PHYS REV D, V57, P2436, DOI 10.1103/PhysRevD.57.2436; Nojiri S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.046004; de Rham C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.231101; Volkov MS, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.104022; Aoki K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.124089; Aoki K, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.064051; THOOFT G, 1974, ANN I H POINCARE A, V20, P69; Babichev E, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/15/152001; Babichev E, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.081502; Banados M, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.063515; Berg M, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/12/021; Bousso R, 1997, PHYS REV D, V56, P7788, DOI 10.1103/PhysRevD.56.7788; Damour T, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.104025; de Rham C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.044020; Deffayet C, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/6/065009; Fasiello M, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/12/002; Hassan SF, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2011)009; Hassan SF, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2012)126; HAYWARD JD, 1995, PHYS REV D, V52, P2239, DOI 10.1103/PhysRevD.52.2239; Kluson J, 2013, PHYS LETT B, V726, P918, DOI 10.1016/j.physletb.2013.10.003; Konnig F., 2014, PHYS REV D, V90; Nojiri S, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/12/125003; Nojiri S, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/05/020; Nojiri S, 1997, MOD PHYS LETT A, V12, P2083, DOI 10.1142/S0217732397002132; Nojiri S, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.123512; Nojiri S, 2014, PHYS LETT B, V735, P376, DOI 10.1016/j.physletb.2014.06.070; Rossi N, 2008, EUR PHYS J-SPEC TOP, V163, P291, DOI 10.1140/epjst/e2008-00825-5; Sebastiani L, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.104022; Solomon AR, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/066; Tamanini N, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/02/015; Volkov MS, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2012)035; von Strauss M, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/03/042	40	2	2	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	APR 1	2015	91	8							084001	10.1103/PhysRevD.91.084001		12	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CE8YP	WOS:000352130300003		
J	Inoue, S; Tokita, S; Hashida, M; Sakabe, S				Inoue, Shunsuke; Tokita, Shigeki; Hashida, Masaki; Sakabe, Shuji			Transient changes in electric fields induced by interaction of ultraintense laser pulses with insulator and metal foils: Sustainable fields spanning several millimeters	PHYSICAL REVIEW E			English	Article							FEMTOSECOND LASER; GENERATION; DENSITY	The temporal evolutions of electromagnetic fields generated by the interaction between ultraintense lasers (1.3 x 10(18) and 8.2 x 10(18) W/cm(2)) and solid targets at a distance of several millimeters from the laser-irradiated region have been investigated by electron deflectometry. For three types of foil targets (insulating foil, conductive foil, and insulating foil onto which a metal disk was deposited), transient changes in the fields were observed. We found that the direction, strength, and temporal evolution of the generated fields differ markedly for these three types of targets. The results provide an insight for studying the emission dynamics of laser-accelerated fast electrons.	[Inoue, Shunsuke] Kyoto Univ, Inst Chem Res, Adv Res Ctr Beam Sci, Uji, Kyoto 6110011, Japan; Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan	Inoue, S (reprint author), Kyoto Univ, Inst Chem Res, Adv Res Ctr Beam Sci, Uji, Kyoto 6110011, Japan.	sinoue@laser.kuicr.kyoto-u.ac.jp	Tokita, Shigeki/L-5074-2015		JSPS KAKENHI [25600138, 22654050, 23226002, 24540537, 26800280]; Yamada Science Foundation; Mitsubishi Foundation; Matsuo Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by JSPS KAKENHI Grants No. 25600138, No. 22654050, No. 23226002, No. 24540537, and No. 26800280, the Yamada Science Foundation, the Mitsubishi Foundation, the Matsuo Foundation and a Grant-in-Aid for the Global COE Program "The Next Generation of Physics, Spun from Universality and Emergence" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. S.I. gratefully acknowledges a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows.	Davies JR, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/1/014006; McKenna P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.145001; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; Malka G, 1996, PHYS REV LETT, V77, P75, DOI 10.1103/PhysRevLett.77.75; Quinn K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.194801; HAMSTER H, 1993, PHYS REV LETT, V71, P2725, DOI 10.1103/PhysRevLett.71.2725; Reich C, 2000, PHYS REV LETT, V84, P4846, DOI 10.1103/PhysRevLett.84.4846; Kar S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.105004; Ledingham KWD, 2003, SCIENCE, V300, P1107, DOI 10.1126/science.1080552; Sokollik T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890057; Atzeni S, 1999, PHYS PLASMAS, V6, P3316, DOI 10.1063/1.873571; Kodama R, 2004, NATURE, V432, P1005, DOI 10.1038/nature03133; Kar S, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/5/055001; Bulanov SV, 2002, PLASMA PHYS REP+, V28, P453, DOI 10.1134/1.1478534; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Li YT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165003; Roth M, 2002, PHYS REV SPEC TOP-AC, V5, DOI 10.1103/PhysRevSTAB.5.061301; Chatterjee G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235005; Fothergill J. C., 2007, P IEEE 9 INT C SOL D, P1; Inoue S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.185001; Inoue S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3514084; Inoue S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3612915; Jackel O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103027; Jin Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.265003; KMETEC JD, 1992, PHYS REV LETT, V68, P1527, DOI 10.1103/PhysRevLett.68.1527; Nakajima H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.155001; Norreys PA, 1999, PHYS PLASMAS, V6, P2150, DOI 10.1063/1.873466; Otani K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3652705; Romagnani L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.195001; Tokita S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3226674; Tokita S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.215004; Wilks SC, 2001, PHYS PLASMAS, V8, P542, DOI 10.1063/1.1333697	33	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	APR 1	2015	91	4							043101	10.1103/PhysRevE.91.043101		5	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CE8YW	WOS:000352131100003		
J	Takehiro, S				Takehiro, Shin-ichi			Influence of surface displacement on solid state flow induced by horizontally heterogeneous Joule heating in the inner core of the Earth	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Inner core flows; Elastic anisotropy; Turbulent velocity in the outer core; Interaction between inner and outer core	PKIKP TRAVEL-TIMES; MAGNETIC-FIELD; MAXWELL STRESSES; ANISOTROPY; CONVECTION; ROTATION; IRON	We investigate the influence of surface displacement on fluid motions induced by horizontally heterogeneous Joule heating in the inner core. The difference between the governing equations and those of Takehiro (2011) is the boundary conditions at the inner core boundary (ICB). The temperature disturbance at the ICB coincides with the melting temperature, which varies depending on the surface displacement. The normal component of stress equalizes with the buoyancy induced by the surface displacement. The toroidal magnetic field and surface displacement with the horizontal structure of Y-2(0) spherical harmonics is given. The flow fields are calculated numerically for various amplitudes of surface displacement with the expected values of the parameters of the core. Further, by considering the heat balance at the ICB, the surface displacement amplitude is related to the turbulent velocity amplitude in the outer core, near the ICB. The results show that when the turbulent velocity is on the order of 10(-1)-10(-2) m/s, the flow and stress fields are similar to those of Takehiro (2011), where the surface displacement vanishes. As the amplitude of the turbulent velocity decreases, the amplitude of the surface displacement increases, and counter flows from the polar to equatorial regions emerge around the ICB, while flow in the inner regions is directed from the equatorial to polar regions, and the non-zero radial component of velocity at the ICB remains. When the turbulent velocity is on the order of 10(-4)-10(-5) m/s, the radial component of velocity at the ICB vanishes, the surface counter flows become stronger than the flow in the inner region, and the amplitude of the stress field near the ICB dominates the inner region, which might be unsuitable for explaining the elastic anisotropy in the inner core. (C) 2015 Elsevier B.V. All rights reserved.	Kyoto Univ, Math Sci Res Inst, Sakyo Ku, Kyoto 6068502, Japan	Takehiro, S (reprint author), Kyoto Univ, Math Sci Res Inst, Sakyo Ku, Kyoto 6068502, Japan.	takepiro@gfd-dennou.org					MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Deguen R, 2013, GEOPHYS J INT, V194, P1310, DOI 10.1093/gji/ggt202; Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; POUPINET G, 1983, NATURE, V305, P204, DOI 10.1038/305204a0; Makinen AM, 2011, GEOPHYS J INT, V187, P355, DOI 10.1111/j.1365-246X.2011.05146.x; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; Buffett BA, 2001, NATURE, V413, P60, DOI 10.1038/35092543; Karato S, 1999, NATURE, V402, P871; KARATO S, 1993, SCIENCE, V262, P1708, DOI 10.1126/science.262.5140.1708; Tkalcic H, 2013, NAT GEOSCI, V6, P497, DOI [10.1038/ngeo1813, 10.1038/NGEO1813]; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Alboussiere T, 2010, NATURE, V466, P744, DOI 10.1038/nature09257; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Aurnou J, 1998, J GEOPHYS RES-SOL EA, V103, P9721, DOI 10.1029/97JB03618; Buffett BA, 2010, NATURE, V468, P952, DOI 10.1038/nature09643; Deguen R, 2009, NAT GEOSCI, V2, P418, DOI 10.1038/NGEO522; Gillet N., 2010, NATURE, V465, P77; Loper D. E., 2007, TREATISE GEOPHYS, V2, P187; Souriau A., 2007, TREATISE GEOPHYS, V1, P655; Stacey F. D., 2008, PHYS EARTH, P532; Takehiro SI, 2011, PHYS EARTH PLANET IN, V184, P134, DOI 10.1016/j.pepi.2010.11.002	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	APR	2015	241						15	20		10.1016/j.pepi.2015.02.003		6	Geochemistry & Geophysics	Geochemistry & Geophysics	CF6PY	WOS:000352679800002		
J	Takehiro, S				Takehiro, Shin-ichi			Penetration of Alfven waves into an upper stably-stratified layer excited by magnetoconvection in rotating spherical shells	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Penetration distance; Planetary fluid core; Dynamo; Geomagnetic secular variation	EARTHS CORE; NUMERICAL SIMULATIONS; MAGNETIC-FIELD; OUTERMOST CORE; BOUNDARY; DYNAMOS	The penetration of magneto-hydrodynamic (MHD) disturbances into an upper strongly stratified stable layer excited by magnetoconvection in rotating spherical shells is investigated. An analytic expression for the penetration distance is derived by considering perturbations of a stably stratified rotating MHD Boussinesq fluid in a semi-infinite region, with the rotation axis and a uniform magnetic field tilted relative to the gravity axis. Solutions for the response to MHD disturbances applied at the bottom boundary show that the disturbances propagate as Alfven waves in the stable layer. Their propagation distance is proportional to the Alfven wave speed and inversely proportion to both the arithmetic average of viscosity and magnetic diffusion and the total wavenumber of the disturbance. The derived expression for penetration distance is in good agreement with the numerical results for neutral convection in a rotating spherical shell with an upper stably stratified layer embedded in an axially uniform basic magnetic field. (C) 2015 Elsevier B.V. All rights reserved.	Kyoto Univ, Math Sci Res Inst, Sakyo Ku, Kyoto 6068502, Japan	Takehiro, S (reprint author), Kyoto Univ, Math Sci Res Inst, Sakyo Ku, Kyoto 6068502, Japan.	takepiro@gfd-dennou.org					Alfven H, 1942, NATURE, V150, P405, DOI 10.1038/150405d0; LAY T, 1990, GEOPHYS RES LETT, V17, P2001, DOI 10.1029/GL017i011p02001; GLATZMAIER GA, 1984, J COMPUT PHYS, V55, P461, DOI 10.1016/0021-9991(84)90033-0; BULLARD EC, 1950, PHILOS TR R SOC S-A, V243, P67, DOI 10.1098/rsta.1950.0014; Nakagawa T, 2011, PHYS EARTH PLANET IN, V187, P342, DOI 10.1016/j.pepi.2011.06.001; Finlay CC, 2003, SCIENCE, V300, P2084, DOI 10.1126/science.1083324; Helffrich G, 2013, PHYS EARTH PLANET IN, V223, P2, DOI 10.1016/j.pepi.2013.07.005; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Gubbins D, 2013, PHYS EARTH PLANET IN, V215, P21, DOI 10.1016/j.pepi.2012.11.001; Stanley S, 2008, PHYS EARTH PLANET IN, V168, P179, DOI 10.1016/j.pepi.2008.06.016; Helffrich G, 2004, SCIENCE, V306, P2239, DOI 10.1126/science.1101109; Tanaka S, 2007, EARTH PLANET SC LETT, V259, P486, DOI 10.1016/j.epsl.2007.05.007; Takehiro S, 2001, EARTH PLANET SC LETT, V187, P357, DOI 10.1016/S0012-821X(01)00283-7; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; LUNDQUIST S, 1952, ARK FYS, V5, P297; Christensen DR., 2008, ICARUS, V196, P16; Helffrich G., 2010, NATURE, V468, P808; Ishioka K., 2013, ISPACK 1 0 2; Schaeffer N, 2012, GEOPHYS J INT, V191, P508, DOI 10.1111/j.1365-246X.2012.05611.x; Takehiro S., 2013, HIERACHICAL SPECTRAL; Yukutake T., 1962, B EARTHQ RES I TOKYO, V40, P1	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	APR	2015	241						37	43		10.1016/j.pepi.2015.02.005		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CF6PY	WOS:000352679800004		
J	Kono, Y; Kenney-Benson, C; Shibazaki, Y; Park, C; Shen, GY; Wang, YB				Kono, Yoshio; Kenney-Benson, Curtis; Shibazaki, Yuki; Park, Changyong; Shen, Guoyin; Wang, Yanbin			High-pressure viscosity of liquid Fe and FeS revisited by falling sphere viscometry using ultrafast X-ray imaging	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article						Viscosity; Liquid iron; Liquid iron sulfide; High pressure; Liquid structure	ELASTIC-WAVE VELOCITY; PARIS-EDINBURGH CELL; HIGH-TEMPERATURES; PLANETARY CORES; OUTER CORE; 5 GPA; MELTS; DENSITY; IRON; TRANSITION	The viscosity of liquid Fe and FeS has been extensively studied, yielding results differing by almost a factor of ten (2.4-23.7 mPa s for liquid Fe, 3.6-17.9 mPa s for liquid FeS, and 7.4-35.6 mPa s for the Fe-S eutectic composition), possibly due to the low resolution of slow cameras previously employed (typically 30-60 frames/s) in falling sphere measurements using X-ray radiography. Here we revisit the viscosity of liquid Fe and FeS up to 6.4 GPa using recently developed ultrafast X-ray imaging. In this study, we imaged the falling spheres at a rate of 500 frames/s, which is around 10 times faster than previous viscosity measurements. Our measurements showed that terminal velocity is achieved only in a limited region of falling distance, and that substantial oversampling, using sufficiently high-speed X-ray imaging, is essential to accurately determine the terminal velocity and the resulting viscosity. We obtained a viscosity of 6.1-7.4 mPa s for liquid Fe and 4.7-5.7 mPa s for liquid FeS at pressures to 6.4 GPa along their respective melting curves. The viscosity of liquid FeS is about 25-35% lower than that of liquid Fe between around 2 and 6.4 GPa along their respective melting curves. After correction for the effect of different melting temperatures between Fe and FeS on viscosity, we found that viscosity of liquid FeS is 31-42% lower than that of liquid Fe at 1800 degrees C and 1-6 GPa, suggesting that sulfur markedly decreases viscosity in liquid Fe. (C) 2015 Elsevier B.V. All rights reserved.	[Kono, Yoshio; Kenney-Benson, Curtis; Park, Changyong; Shen, Guoyin] Carnegie Inst Sci, Geophys Lab, HPCAT, Argonne, IL 60439 USA; [Shibazaki, Yuki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Wang, Yanbin] Univ Chicago, Ctr Adv Radiat Sources, GeoSoilEnviroCARS, Chicago, IL 60637 USA	Kono, Y (reprint author), Carnegie Inst Sci, Geophys Lab, HPCAT, 9700 S Cass Ave, Argonne, IL 60439 USA.		Park, Changyong/A-8544-2008	Park, Changyong/0000-0002-3363-5788	DOE-NNSA [DE-NA0001974]; DOE-BES [DE-FG02-99ER45775]; Argonne National Laboratory [DE-AC02-06CH11357]; NSF [EAR-1214376]	We acknowledge two anonymous reviewers for valuable comments. The experiments were carried out at the Sector 16-BM-B, HPCAT at the Advanced Photon Source. This research is supported by DOE-NNSA under Award Nos. DE-NA0001974 and DOE-BES under Award No. DE-FG02-99ER45775. The Advanced Photon Source is a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. YW acknowledges NSF Grant EAR-1214376.	Sanloup C, 2000, EUROPHYS LETT, V52, P151, DOI 10.1209/epl/i2000-00417-3; [Anonymous], 2002, PHYS REV B; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Dorogokupets PI, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024115; Jing ZC, 2014, EARTH PLANET SC LETT, V396, P78, DOI 10.1016/j.epsl.2014.04.015; Perrillat JP, 2010, HIGH PRESSURE RES, V30, P415, DOI 10.1080/08957959.2010.494844; Kono Y, 2010, PHYS EARTH PLANET IN, V183, P196, DOI 10.1016/j.pepi.2010.03.010; Liebske C, 2005, EARTH PLANET SC LETT, V240, P589, DOI 10.1016/j.epsl.2005.10.004; HIXSON RS, 1990, PHYS REV B, V42, P6485, DOI 10.1103/PhysRevB.42.6485; Assael MJ, 2006, J PHYS CHEM REF DATA, V35, P285, DOI 10.1063/1.2149380; Dobson DP, 2000, AM MINERAL, V85, P1838; Weber RC, 2011, SCIENCE, V331, P309, DOI 10.1126/science.1199375; Kono Y, 2014, PHYS EARTH PLANET IN, V228, P269, DOI 10.1016/j.pepi.2013.09.006; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; BARMIN LN, 1970, RUSS J PHYS CH USSR, V44, P1450; Brizard M, 2005, METROLOGIA, V42, P298, DOI 10.1088/0026-1394/42/4/015; Fax&eacute;n H., 1925, ARK MAT ASTRON FYS, V19, P1; Kono Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6091; Kono Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024302; LeBlanc GE, 1996, GEOPHYS RES LETT, V23, P213, DOI 10.1029/96GL00216; Maude A.D., 1961, British Journal of Applied Physics, V12, DOI 10.1088/0508-3443/12/6/306; Morard G, 2007, EARTH PLANET SC LETT, V263, P128, DOI 10.1016/j.epsl.2007.09.009; Nishida K, 2011, AM MINERAL, V96, P864, DOI 10.2138/am.2011.3616; Sanloup C, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000808; SHARP WE, 1969, J GEOPHYS RES, V74, P1645, DOI 10.1029/JB074i006p01645; STRONG HM, 1973, METALL TRANS, V4, P2657, DOI 10.1007/BF02644272; Terasaki H, 2001, EARTH PLANET SC LETT, V190, P93, DOI 10.1016/S0012-821X(01)00374-0; Terasaki H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027147; Terasaki H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014321; Urakawa S, 2001, AM MINERAL, V86, P578; Urakawa S., 1998, REV HIGH PRESSURE SC, V7, P286	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201	1872-7395		PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	APR	2015	241						57	64		10.1016/j.pepi.2015.02.006		8	Geochemistry & Geophysics	Geochemistry & Geophysics	CF6PY	WOS:000352679800006		
J	Zhang, GB; Zhang, WX; Yu, HY; Ma, J; Xu, H; Yagi, K				Zhang, Guangbin; Zhang, Wenxuan; Yu, Haiyang; Ma, Jing; Xu, Hua; Yagi, Kazuyuki			Fraction of CH4 oxidized in paddy field measured by stable carbon isotopes	PLANT AND SOIL			English	Article						Stable carbon isotopes; Paddy field; CH4 oxidation; CH4 production; Rhizosphere; Soil-water interface	METHANE OXIDATION; RICE FIELD; SEASONAL-VARIATION; EMISSION; PATHWAYS; CO2; FERTILIZATION; SIGNATURE; FLUX; C-13	Estimating the fraction of CH4 that is oxidized (F (ox)) in paddy field using the stable carbon isotope natural abundance (SCINA) method and discussing the availabilities of delta (CH4)-C-13 ((original)) (newly produced delta (CH4)-C-13) and delta (CH4)-C-13 ((oxidized)) (oxidized delta (CH4)-C-13) in the method. CH4 fluxes from a continuously flooded paddy field and via rice plants, CH4 concentrations in soil pore water and floodwater, CH4 production rates of soil slurries and rice roots, and their stable carbon isotopes (delta C-13) were measured during the rice growing season through field and incubation experiments. The estimation of F (ox) in the rhizosphere was the most efficient by using anaerobically produced delta (CH4)-C-13 of the soil as delta (CH4)-C-13 ((original)) and delta (CH4)-C-13 emitted from the field minus transport fractionation factor (epsilon (transport) = -12.82 aEuro degrees) as delta (CH4)-C-13 ((oxidized)). So, rhizospheric F (ox) was measured to be about 10-60 %, relatively high in the first half of the season. As porewater CH4 was potentially affected by CH4 oxidation and transport in field conditions, its delta (CH4)-C-13 poorly represented delta (CH4)-C-13 ((original)) or delta (CH4)-C-13 ((oxidized)). However, porewater delta (CH4)-C-13 was 10-22 aEuro degrees lower than floodwater delta (CH4)-C-13, indicating that around 30-60 % of the CH4 was oxidized at the soil-water interface when porewater CH4 released into the atmosphere. Anaerobically produced CH4 was highly C-13-depleted than aerobically produced CH4, F (ox) at the soil and root surfaces in lab conditions could be estimated when using the corresponding delta (CH4)-C-13 as delta (CH4)-C-13 ((original)) and delta (CH4)-C-13 ((oxidized)), and it was about 5-50 % and almost 100 %, respectively. The use of delta (CH4 (original))-C-13 and delta (CH4 (oxidized))-C-13 in estimating F (ox) in paddy field should be dependent on different CH4-oxidizing zones in different conditions.	[Zhang, Guangbin; Zhang, Wenxuan; Yu, Haiyang; Ma, Jing; Xu, Hua] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Wenxuan; Yu, Haiyang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yagi, Kazuyuki] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan	Zhang, GB (reprint author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210008, Jiangsu, Peoples R China.	gbzhang@issas.ac.cn; hxu@issas.ac.cn	zhang, guangbin/M-1698-2015	zhang, guangbin/0000-0002-9651-6110	"Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB15020103]; Ministry of Science and Technology of China [2013BAD11B02]; National Natural Sciences Foundation of China [41271259, 41201243]; Jiangsu Province Science Foundation for Youths [BK2012497]	The authors are grateful to our anonymous reviewers for their very helpful comments and revision of the manuscript. This study was financially supported by the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDB15020103), the Ministry of Science and Technology of China (2013BAD11B02), the National Natural Sciences Foundation of China (41271259, 41201243), and the Jiangsu Province Science Foundation for Youths (BK2012497).	Alberto MCR, 2000, CHEMOSPHERE GLOBAL C, V2, P57, DOI DOI 10.1016/S1465-9972(99)00044-6; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Zhang GB, 2013, BIOGEOSCIENCES, V10, P3375, DOI 10.5194/bg-10-3375-2013; COLEMAN DD, 1981, GEOCHIM COSMOCHIM AC, V45, P1033, DOI 10.1016/0016-7037(81)90129-0; Kruger M, 2003, GLOBAL CHANGE BIOL, V9, P773, DOI 10.1046/j.1365-2486.2003.00576.x; Zhang GB, 2011, NUTR CYCL AGROECOSYS, V89, P81, DOI 10.1007/s10705-010-9378-0; CONRAD R, 1991, BIOL FERT SOILS, V12, P28, DOI 10.1007/BF00369384; Tyler SC, 1997, GLOBAL BIOGEOCHEM CY, V11, P323, DOI 10.1029/97GB01624; Kruger M, 2001, GLOBAL CHANGE BIOL, V7, P49, DOI 10.1046/j.1365-2486.2001.00395.x; Chanton JP, 2005, ORG GEOCHEM, V36, P753, DOI 10.1016/j.orggeochem.2004.10.007; Kruger M, 2002, GLOBAL CHANGE BIOL, V8, P265, DOI 10.1046/j.1365-2486.2002.00476.x; SCHUTZ H, 1989, BIOGEOCHEMISTRY, V7, P33; Bilek RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1029, DOI 10.1029/1999GB900040; Cai ZC, 2009, METHANE NITROUS OXID; Cao YaCheng, 2008, Acta Pedologica Sinica, V45, P249; Chanton J, 2000, GLOBAL BIOGEOCHEM CY, V14, P51, DOI 10.1029/1999GB900087; Chanton JP, 2008, ENVIRON SCI TECHNOL, V42, P7818, DOI 10.1021/es801221y; Conrad R, 2005, SOIL BIOL BIOCHEM, V37, P2099, DOI 10.1016/j.soilbio.2005.03.012; Denman KL, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Groot TT, 2003, BIOGEOCHEMISTRY, V64, P355, DOI 10.1023/A:1024921714852; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Popp TJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P1063, DOI 10.1029/1999GB900060; STEVENS CM, 1988, J GEOPHYS RES-ATMOS, V93, P725, DOI 10.1029/JD093iD01p00725; Zhang GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001696; [张广斌 Zhang Guangbin], 2009, [土壤学报, Acta Pedologica Sinica], V46, P676; Zhang GB, 2012, SOIL BIOL BIOCHEM, V52, P108, DOI 10.1016/j.soilbio.2012.04.017; Zhang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073982; Zhang XY, 2012, PEDOSPHERE, V22, P13, DOI 10.1016/S1002-0160(11)60187-2	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	APR	2015	389	1-2					349	359		10.1007/s11104-014-2365-5		11	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	CE9HB	WOS:000352153600025		
J	Hamada, Y; Sato, H; Otagaki, S; Okada, K; Abe, K; Matsumoto, S				Hamada, Yuka; Sato, Hideto; Otagaki, Shungo; Okada, Kazuma; Abe, Kazuyuki; Matsumoto, Shogo			Breeding depression of red flesh apple progeny containing both functional MdMYB10 and MYB110a_JP genes	PLANT BREEDING			English	Article						Malus; MdMYB; type 1; type 2; anthocyanin	TRANSCRIPTION FACTORS; ANTIOXIDANT ACTIVITY; SKIN COLOR; FRUIT; ANTHOCYANINS; EXPRESSION	In apple, two MYB transcription factors MdMYB10 (R-6:MdMYB10) and MdMYB110a have been shown to be responsible for the type 1 and type 2 red flesh traits, respectively. While type 1 red-fleshed apples are characterized by a red coloration not only in fruit flesh but also in vegetative tissues such as leaves and flowers, red pigmentation in type 2 red-fleshed apples is limited at the fruit flesh. We have searched cultivars containing both functional MdMYB10 and MdMYB110a and then tried to breed newcultivars containing both functional genes by cross-pollination of Geneva' (type 1) and Pink Pearl' (type 2). The cultivar having both genes should exhibit superior characteristics, such as a stable red flesh trait throughout fruit maturity, as type 1 reduces its colouring until maturity, whereas type 2 increases until maturity. We could not identify red-fleshed cultivars having both genes; moreover, only one plant of 80 F-1 progeny having both genes died in its juvenile stage. From the results, it was suggested that some sort of breeding depression must have occurred. We analysed the expression patterns of the genes within two F-1 plants having either MdMYB10 or MdMYB110a gene and found that the expression pattern of MdMYB110a was different from that observed in JPP35' (Jonathan'xPink Pearl'). The MdMYB110a gene in the No. 2804 F-1 plant derived from Pink Pearl'xGeneva' was expressed in the flesh from the beginning of the red coloration through maturity, and seemed to cause upregulation, not only the latter half, but also the first half of the gene in the anthocyanin pathway.	[Hamada, Yuka; Sato, Hideto; Otagaki, Shungo; Matsumoto, Shogo] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Okada, Kazuma; Abe, Kazuyuki] NARO Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan	Matsumoto, S (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	shogo@agr.nagoya-u.ac.jp			Adaptable and Seamless Technology Transfer Program (A-STEP) from the Japan Science and Technology Agency (JST); Japan Society for Bioscience, Biotechnology, and Agrochemistry	We are indebted to Dr. K. Shiratake for his useful suggestions. This research was supported by Adaptable and Seamless Technology Transfer Program (A-STEP) from the Japan Science and Technology Agency (JST) and research fund from the Japan Society for Bioscience, Biotechnology, and Agrochemistry. We declare that we have no conflict of interest of the submitted paper.	Espley RV, 2013, PLANT BIOTECHNOL J, V11, P408, DOI 10.1111/pbi.12017; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Ishimizu T, 1999, THEOR APPL GENET, V98, P961, DOI 10.1007/s001220051156; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; Umemura H, 2013, PLANTA, V238, P65, DOI 10.1007/s00425-013-1875-3; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; THOMAS MR, 1993, THEOR APPL GENET, V86, P173, DOI 10.1007/BF00222076; Toufektsian MC, 2008, J NUTR, V138, P747; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Nikiforova SV, 2013, MOL BIOL EVOL, V30, P1751, DOI 10.1093/molbev/mst092; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; BROOTHAERTS W, 1995, PLANT MOL BIOL, V27, P499, DOI 10.1007/BF00019317; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Deacon N, 2012, RED FLESHED APPLES L; desNettancourt D, 1977, MONOGRAPHS THEORETIC, P28; DONG YH, 1995, J AM SOC HORTIC SCI, V120, P95; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Long SS, 2010, TREE GENET GENOMES, V6, P161, DOI 10.1007/s11295-009-0237-6; Matsumoto S, 2014, INT J AGRON; Sekido K, 2010, HORTSCIENCE, V45, P534; Umemura H, 2011, HORTSCIENCE, V46, P1098; VansNocker S., 2012, EUPHYTICA, V185, P281; Volz RK, 2009, ACTA HORTIC, V814, P337; Warner G, 2010, TOTALLY RED NEW APPL	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0179-9541	1439-0523		PLANT BREEDING	Plant Breed.	APR	2015	134	2					239	246		10.1111/pbr.12255		8	Agronomy; Biotechnology & Applied Microbiology; Plant Sciences	Agriculture; Biotechnology & Applied Microbiology; Plant Sciences	CF5BR	WOS:000352570400015		
J	Tsuji, H; Tachibana, C; Tamaki, S; Taoka, K; Kyozuka, J; Shimamoto, K				Tsuji, Hiroyuki; Tachibana, Chika; Tamaki, Shojiro; Taoka, Ken-ichiro; Kyozuka, Junko; Shimamoto, Ko			Hd3a promotes lateral branching in rice	PLANT JOURNAL			English	Article						meristem action; organ development; rice (Oryza sativa L; ); florigen; florigen activation complex; branching	FLOWERING-LOCUS-T; 14-3-3 PROTEINS; PLANT ARCHITECTURE; MERISTEM IDENTITY; FLORAL INDUCTION; AXILLARY BUDS; INTEGRATOR FT; ARABIDOPSIS; FLORIGEN; GENE	Accumulating evidence indicates that the FLOWERING LOCUST (FT) protein is the mobile floral signal known as florigen. A rice FT homolog, Heading date3a (Hd3a), is transported from the phloem to shoot apical cells, where it interacts with 14-3-3 proteins and transcription factor OsFD1 to form a florigen activation complex (FAC) that activates a rice homolog of the floral identity gene APETALA1. Recent studies showed that florigen has roles in plant development beyond flowering; however, the exact nature of these roles is not well understood. It is not clear whether FT is transported to organs outside the shoot apex, and whether FAC formation is required for processes other than flowering. We show here that the Hd3a protein accumulates in axillary meristems to promote branching, and that FAC formation is required. Analysis of transgenic plants revealed that Hd3a promotes branching through lateral bud outgrowth. Hd3a protein produced in the phloem reached the axillary meristem in the lateral bud, and its transport was required for promotion of branching. Moreover, mutant Hd3a proteins defective in FAC formation but competent with respect to transport did not promote branching. Finally, we show that Hd3a promotes branching independently from strigolactone and FC1, a transcription factor that inhibits branching in rice. Together, these results suggest that Hd3a functions as a mobile signal for branching in rice. Significance Statement Accumulating evidence indicates that FLOWERING LOCUS T (FT) protein is the mobile floral signal florigen. Recent studies highlight that florigen may play multiple roles beyond flowering, whereas importance of mobile nature and molecular mechanism underling pleiotropic function remain unknown. We show here that phloem-expressed Hd3a protein accumulated in the distant axillary meristems to promote branching and that FAC formation was required, suggesting that Hd3a functions as a mobile signal for branching in rice.	[Tsuji, Hiroyuki; Tachibana, Chika; Tamaki, Shojiro; Taoka, Ken-ichiro; Shimamoto, Ko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Mol Genet Lab, Nara 6300192, Japan; [Kyozuka, Junko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Tsuji, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Mol Genet Lab, 8916-5 Takayama, Nara 6300192, Japan.	tsujih@bs.naist.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN);  [26113713]	We thank E. Kawano, M. Kanda, S. Toyoda, Y. Tamaki, Y. Konomi and J. Naritomi for technical assistance, and members of the Laboratory of Plant Molecular Genetics at Nara Institute of Science and Technology for discussions. This work was supported in part by a Grant-in-Aid for Young Scientists (A), a Grant-in-Aid for Scientific Research on Innovative Areas (number 26113713) and a grant from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) to H.T.	Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Tsuji H, 2013, CURR OPIN PLANT BIOL, V16, P228, DOI 10.1016/j.pbi.2013.01.005; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Luo L, 2012, PLANT CELL PHYSIOL, V53, P1793, DOI 10.1093/pcp/pcs122; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Lu SJ, 2012, PLANT MOL BIOL REP, V30, P1461, DOI 10.1007/s11105-012-0468-9; Niwa M, 2013, PLANT CELL, V25, P1228, DOI 10.1105/tpc.112.109090; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Tsuji H, 2013, PLANT CELL PHYSIOL, V54, P385, DOI 10.1093/pcp/pct005; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Gao XC, 2010, PLANT PHYSIOL, V153, P728, DOI 10.1104/pp.110.156711; Kobayashi K, 2010, PLANT CELL PHYSIOL, V51, P47, DOI 10.1093/pcp/pcp166; Asano T, 2002, PLANT CELL PHYSIOL, V43, P668, DOI 10.1093/pcp/pcf083; Lee R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3884	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	APR	2015	82	2					256	266		10.1111/tpj.12811		11	Plant Sciences	Plant Sciences	CF5FG	WOS:000352581600007		
J	Shinohara, H; Matsubayashi, Y				Shinohara, Hidefumi; Matsubayashi, Yoshikatsu			Reevaluation of the CLV3-receptor interaction in the shoot apical meristem: dissection of the CLV3 signaling pathway from a direct ligand-binding point of view	PLANT JOURNAL			English	Article						CLAVATA; CLV3; CLV1; BAM1; receptor kinase; peptide hormone; ligand-receptor interaction; shoot apical meristem; arabinosylation; Arabidopsis thaliana	STEM-CELL FATE; RECEPTOR-LIKE KINASE; GENE-EXPRESSION MAP; ORGAN DEVELOPMENT; ARABIDOPSIS; CLAVATA2; REVEALS; WUSCHEL; SPECIFICATION; REGULATOR	The CLAVATA signaling pathway is a key component of the network that controls stem cell renewal and differentiation in Arabidopsis thaliana. CLAVATA3 (CLV3) is a post-translationally arabinosylated secreted peptide signal that regulates WUSHEL (WUS) transcription to affect the balance of stem cell differentiation and proliferation in the shoot apical meristem (SAM). Known membrane-localized receptors involved in the perception of CLV3 signaling include CLV1, the CLV2/CORYNE (CRN) complex and RPK2. The CLV3 peptide can directly bind to CLV1; however, it is unclear whether the CLV3 peptide directly binds to CLV2 or RPK2. In this study, we re-evaluated the direct interaction between CLV3 and its receptors by photoaffinity labeling with photoactivatable arabinosylated CLV3. We showed that CLV2 and RPK2 exhibited no direct binding to the CLV3 peptide. Further analysis showed that the receptor kinase BAM1 directly binds the CLV3 peptide. A loss-of-function clv1 bam1 double mutant exhibited a large number of stem cells that accumulated in the SAM and was insensitive to exogenous treatment with the arabinosylated CLV3 peptide. WUS gene transcripts were up-regulated, and the region of WUS expression was enlarged at the SAM in the clv1 bam1 double mutant. These results indicate that CLV1 and BAM1 are direct receptors that are sufficient to affect the regulatory network controlling stem cell number in the SAM. In contrast, the CLV2/CRN complex and RPK2 are not involved in direct ligand interactions but may act as co-receptors. Significance Statement We re-evaluated the direct interaction between CLV3 and its receptors by photoaffinity labeling. The receptor kinase BAM1 could directly bind CLV3 peptide as well as CLV1. A loss-of-function clv1 bam1 double mutant exhibited a large number of stem cells that accumulated in the SAM and was insensitive to arabinosylated CLV3. These results indicate that CLV1 and BAM1 are direct receptors that are sufficient to affect the regulatory network controlling stem cell number in the SAM.	[Shinohara, Hidefumi; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Shinohara, H (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	shino@bio.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23012020];  [25221105];  [25840111];  [26113520]	We thank Ms Mari Ogawa-Ohnishi for preparing the HaloTag-fused receptor kinases. We also thank Dr Miyuki Nakata and Dr Kiyoshi Tatematsu for providing technical advice regarding the in situ hybridization. This research was supported by Grants-in-Aid for Scientific Research for Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (number 23012020 to H.S.), a Grant-in-Aid for Scientific Research (S) (number 25221105 to Y.M.), a Grant-in-Aid for Young Scientists (B) (number 25840111 to H.S.) and a Grant-in-Aid for Scientific Research on Innovative Areas (number 26113520 to H.S.).	Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; CLARK SE, 1993, DEVELOPMENT, V119, P397; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Nimchuk ZL, 2011, PLANT CELL, V23, P851, DOI 10.1105/tpc.110.075622; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Depuydt S, 2013, P NATL ACAD SCI USA, V110, P7074, DOI 10.1073/pnas.1222314110; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Yadav RK, 2014, DEVELOPMENT, V141, P2735, DOI 10.1242/dev.106104; Shinohara H, 2013, PLANT CELL PHYSIOL, V54, P369, DOI 10.1093/pcp/pcs174; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Lenhard M, 2002, DEVELOPMENT, V129, P3195; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Shinohara H, 2012, PLANT J, V70, P845, DOI 10.1111/j.1365-313X.2012.04934.x; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Durbak A., 2012, GENETICS, V189, P177; Fletcher Jennifer C., 1999, Science (Washington D C), V283, P1911, DOI 10.1126/science.283.5409.1911; Lisso J, 2005, NUCLEIC ACIDS RES, V33, P2685, DOI 10.1093/nar/gki566; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Song XF, 2012, MOL PLANT, V5, P515, DOI 10.1093/mp/ssr120	30	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	APR	2015	82	2					328	336		10.1111/tpj.12817		9	Plant Sciences	Plant Sciences	CF5FG	WOS:000352581600012		
J	Kawahara, Y; Kitamura, Y				Kawahara, Yuki; Kitamura, Yoshie			Changes in cell size and number and in rhizodermal development contribute to root tip swelling of Hyoscyamus albus roots subjected to iron deficiency	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Hyoscyamus albus; Root morphology; Fe deficiency; Confocal laser-scanning microscopy; Cell number; Cell size; Root hair	SUGAR-BEET ROOTS; STRESS-RESPONSE; ARABIDOPSIS; AUXIN; ASSIMILATION; RIBOFLAVIN; PLANTS	Root tip swelling is a common phenomenon observed when plant roots are subjected to Fe deficiency. We analysed whether an increase in cell number or an enlargement of cell width was involved in this phenomenon. Root tips of Hyoscyamus albus cultured with or without Fe were stained with fluorescent SYTO14 and analysed by confocal laser-scanning microscopy. Time-course and position-based examination revealed that the inhibition of longitudinal cell elongation and acceleration of transverse cell enlargement under Fe deficiency started from the tips and then extended towards the base during the time-course period. An increase in cell number also occurred behind the tips. In addition, the development of rhizodermal protrusions was observed on the surface of roots subjected to Fe deficiency. These results indicated that changes in cell size and number and in root hair development were all involved in root tip swelling. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Kawahara, Yuki; Kitamura, Yoshie] Nagasaki Univ, Grad Sch Fisheries Sci Environm Studies, Nagasaki 8528521, Japan	Kitamura, Y (reprint author), Nagasaki Univ, Grad Sch Fisheries Sci Environm Studies, Lab Environm & Funct Bot, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	k-yoshie@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [24580479]	We wish to thank Ms. Yukina Kosasa for her technical help. We also appreciate the English language editing by Dr. Nicholas Walton (Norwich, UK). This work was supported by a Grant-in-Aid (C, 24580479) from the Japan Society for the Promotion of Science.	Lopez-Millan AF, 2000, PLANT PHYSIOL, V124, P885, DOI 10.1104/pp.124.2.885; Vorwieger A, 2007, PLANTA, V226, P147, DOI 10.1007/s00425-006-0476-9; Landsberg EC, 1996, PROTOPLASMA, V194, P69, DOI 10.1007/BF01273169; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Zaharieva TB, 2004, PLANT SCI, V166, P1045, DOI 10.1016/j.plantsci.2003.12.017; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; LINDSAY WL, 1982, J PLANT NUTR, V5, P821, DOI 10.1080/01904168209363012; Thimm O, 2001, PLANT PHYSIOL, V127, P1030, DOI 10.1104/pp.127.3.1030; MAUREL C, 1991, PLANT PHYSIOL, V97, P212, DOI 10.1104/pp.97.1.212; Kobayashi T, 2014, PLANT SCI, V224, P36, DOI 10.1016/j.plantsci.2014.04.002; Donnini S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-268; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Higa A, 2008, PLANT PHYSIOL BIOCH, V46, P452, DOI 10.1016/j.plaphy.2008.01.004; Khandakar J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00331; LANDSBERG EC, 1986, PLANT PHYSIOL, V82, P511, DOI 10.1104/pp.82.2.511; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nemoto Keiichirou, 2009, Plant Signal Behav, V4, P1145; Rellan-Alvarez R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-120; Rodriguez-Celma J, 2011, J PROTEOME RES, V10, P2590, DOI 10.1021/pr2000623	19	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	APR	2015	89						107	111		10.1016/j.plaphy.2015.02.018		5	Plant Sciences	Plant Sciences	CF1TW	WOS:000352331800013		
J	Takemoto, H; Ito, M; Asada, Y; Kobayashi, Y				Takemoto, Hiroaki; Ito, Michiho; Asada, Yoshihisa; Kobayashi, Yoshinori			Inhalation Administration of the Sesquiterpenoid Aristolen-1(10)-en-9-ol from Nardostachys chinensis Has a Sedative Effect via the GABAergic System	PLANTA MEDICA			English	Article						Nardostachys chinensis; Valerianaceae; aristolen-1(10)-en-9-ol; inhalation administration; sedation; GABAergic system	STRESS; BENZODIAZEPINES; COMPONENTS; ROOTS; OIL	Spikenard, the dried roots of Nardostachys chinensis, contains sesquiterpenoids and is widely used as an herbal tranquilizer. We previously demonstrated that spikenard vapor showed a sedative effect when administered by inhalation, and we identified hydrocarbon sesquiterpenoids as active components. Here we investigated the other components that contribute to the effects of spikenard. Six oxygenated sesquiterpenoids, including aristolane-and guaiane-types, were isolated from an acetone extract of spikenard. We evaluated the sedative activities of these oxygenated compounds using an inhalation administration method in a caffeine-treated excitatory mouse model. We identified aristolen-1(10)-en-9-ol and patchouli alcohol as highly effective sedative components. These compounds inhibited locomotion in mice by approximately 60% at a dose of 300 mu g/cage. In addition, aristolen-1(10)-en-9-ol prolonged pentobarbital-induced sleep to the same extent as 1 mg/kg diazepam. This effect completely disappeared with the administration of the GABAA-benzodiazepine receptor antagonist flumazenil (3 mg/kg), suggesting that the sedative effect of aristolen-1(10)-en-9-ol is expressed via the GABAergic system. Furthermore, differently from diazepam, inhalation of aristolen-1(10)-en-9-ol for 1 h did not affect the motor coordination in the rota-rod test. In the present study, we identified active components and provided evidence supporting the traditional sedative use of spikenard. Our research suggests that aristolen-1(10)-en-9-ol may be an effective aromatherapy, providing mild sedation.	[Takemoto, Hiroaki; Kobayashi, Yoshinori] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Ito, Michiho] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Asada, Yoshihisa] Tokyo Univ Sci, Fac Pharmaceut Sci, Tokyo 162, Japan	Ito, M (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacognosy, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068501, Japan.	michihoi@pharm.kyoto-u.ac.jp					Takemoto H, 2008, J NAT MED, V62, P41, DOI 10.1007/s11418-007-0177-0; Ito K, 2011, J NAT MED-TOKYO, V65, P336, DOI 10.1007/s11418-010-0502-x; Sah SP, 2011, PHYTOMEDICINE, V18, P1269, DOI 10.1016/j.phymed.2011.06.009; Zhang Y, 2005, J NAT PROD, V68, P1131, DOI 10.1021/np050125n; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Leuner B, 2013, NEUROSCIENCE, V251, P108, DOI 10.1016/j.neuroscience.2012.04.021; Kobayashi Y, 2005, AROMA RES, V6, P40; Licata SC, 2009, PSYCHOPHARMACOLOGY, V203, P539, DOI 10.1007/s00213-008-1401-7; LOEFFLER PM, 1992, J ORAL MAXIL SURG, V50, P989, DOI 10.1016/0278-2391(92)90061-4; Takemoto H, 2009, J NAT MED, V63, P380, DOI 10.1007/s11418-009-0340-x; Takemoto H, 2014, BIOL PHARM BULL, V37, P1050, DOI 10.1248/bpb.b14-00136; Tanaka K, 2008, J NAT MED, V62, P112, DOI 10.1007/s11418-007-0199-7	12	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	APR	2015	81	5					343	347		10.1055/s-0035-1545725		5	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CF6DV	WOS:000352647800001		
J	Isobe, M; Ogawa, K; Shimizu, A; Osakabe, M; Kub, S; Toi, K				Isobe, Mitsutaka; Ogawa, Kunihiro; Shimizu, Akihiro; Osakabe, Masaki; Kub, Shin; Toi, K.		LHD Expt Grp	Observation of MHD Instabilities Driven by Energetic Electrons in the Large Helical Device	PLASMA SCIENCE & TECHNOLOGY			English	Article						LHD; ECRH; energetic electron; MHD instability	INTERNAL KINK INSTABILITY; D TOKAMAK; PLASMAS; MODES	Coherent magnetic fluctuations in an acoustic range of frequency have been regularly observed in low-density (n(e) < 0.2 x 10(19) m(-3)) plasmas with strong second harmonic electron cyclotron resonance heating (ECRH) on the Large Helical Device. Hard X-ray measurements indicated that energetic electrons are generated in these ECRH discharges. The magnetic fluctuations are suppressed in higher density discharges where energetic electrons are not present. The ECRH power modulation experiment indicated that the observed magnetohydrodynamic (MHD) mode has an acoustic nature rather than an Alfvenic nature.	[Isobe, Mitsutaka; Ogawa, Kunihiro; Shimizu, Akihiro; Osakabe, Masaki; Kub, Shin; Toi, K.; LHD Expt Grp] Natl Inst Nat Sci, Toki, Gifu 5095292, Japan; [Isobe, Mitsutaka] Grad Univ Adv Studies SOKENDAI, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Kub, Shin] Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648463, Japan	Isobe, M (reprint author), Natl Inst Nat Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.				Japan Society for the Promotion of Science [20656150]; JSPS-NRE-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]; JSPS-NRE-NSFC A3 Foresight Program in the field of Plasma Physics (NRE) [2012K2A2A6000443]	*supported by the Grant-in-Aid for Encouragement of Scientists from the Japan Society for the Promotion of Science (No. 20656150). This work was also partly supported by the JSPS-NRE-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328 and NRE: No. 2012K2A2A6000443)	Chen W, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.185004; Chen W, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113010; Ding XT, 2002, NUCL FUSION, V42, P491, DOI 10.1088/0029-5515/42/5/301; Sabot R, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085033; Gorelenkov NN, 2007, PHYS LETT A, V370, P70, DOI 10.1016/j.physleta.2007.05.113; Gorelenkov NN, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3097920; Breizman BN, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/5/054001; Chen W, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075022; Wong KL, 2000, PHYS REV LETT, V85, P996, DOI 10.1103/PhysRevLett.85.996; Fasoli A, 2007, NUCL FUSION, V47, pS264, DOI 10.1088/0029-5515/47/6/S05; Deng CB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.025003; Toi K, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024008; MCGUIRE K, 1983, PHYS REV LETT, V50, P891, DOI 10.1103/PhysRevLett.50.891; TURNBULL AD, 1993, PHYS FLUIDS B-PLASMA, V5, P2546, DOI 10.1063/1.860742; Valovic M, 2000, NUCL FUSION, V40, P1569, DOI 10.1088/0029-5515/40/9/101; Zonca F, 2007, NUCL FUSION, V47, P1588, DOI 10.1088/0029-5515/47/11/022; Cesario R, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075034; Chen W, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.044501; Chen W, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063010; Chen W, 2008, CHINESE PHYS LETT, V25, P3708, DOI 10.1088/0256-307X/25/10/052; Ding XT, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043015; Heidbrink W W, 1994, NUCL FUSION, V34, P536; Isobe M, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084007; Macor A, 2009, PHYS REV LETT, V102; Maget P, 2005, 32 EPS C PLASM PHY C, V29C; Nguyen C, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3008048; Shimizu Akihiro, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1015; Smeulders P, 2002, 29 EPS C PLASM PHY B, V26B; Snipes JA, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/072001; Yamada H, 2009, FUSION ENG DES, V84, P186, DOI 10.1016/j.fusengdes.2009.01.068; Yan LW, 2001, CHINESE PHYS LETT, V18, P1227, DOI 10.1088/0256-307X/18/9/323	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1009-0630			PLASMA SCI TECHNOL	Plasma Sci. Technol.	APR	2015	17	4					276	279		10.1088/1009-0630/17/4/03		4	Physics, Fluids & Plasmas	Physics	CE8YV	WOS:000352131000003		
J	Gasser, A; Brogi, S; Urayama, K; Nishi, T; Kurose, H; Tafi, A; Ribeiro, N; Desaubry, L; Nebigil, CG				Gasser, Adeline; Brogi, Simone; Urayama, Kyoji; Nishi, Toshishide; Kurose, Hitoshi; Tafi, Andrea; Ribeiro, Nigel; Desaubry, Laurent; Nebigil, Canan G.			Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHARACTERIZATION; IDENTIFICATION; ANTAGONISTS; ANGIOGENESIS; LIGANDS; CELLS; BV8; SURVIVAL	Prokineticins are angiogenic hormones that activate two G protein-coupled receptors: PKR1 and PKR2. PKR1 has emerged as a critical mediator of cardiovascular homeostasis and cardioprotection. Identification of non-peptide PKR1 agonists that contribute to myocardial repair and collateral vessel growth hold promises for treatment of heart diseases. Through a combination of in silico studies, medicinal chemistry, and pharmacological profiling approaches, we designed, synthesized, and characterized the first PKR1 agonists, demonstrating their cardioprotective activity against myocardial infarction (MI) in mice. Based on high throughput docking protocol, 250,000 compounds were computationally screened for putative PKR1 agonistic activity, using a homology model, and 10 virtual hits were pharmacologically evaluated. One hit internalizes PKR1, increases calcium release and activates ERK and Akt kinases. Among the 30 derivatives of the hit compound, the most potent derivative, IS20, was confirmed for its selectivity and specificity through genetic gain- and loss-of-function of PKR1. Importantly, IS20 prevented cardiac lesion formation and improved cardiac function after MI in mice, promoting proliferation of cardiac progenitor cells and neovasculogenesis. The preclinical investigation of the first PKR1 agonists provides a novel approach to promote cardiac neovasculogenesis after MI.	[Gasser, Adeline; Urayama, Kyoji; Nishi, Toshishide; Nebigil, Canan G.] Univ Strasbourg, CNRS, Biotechnol & Cell Signaling Lab, UMR 7242, Illkirch Graffenstaden, France; [Brogi, Simone] Univ Siena, European Res Ctr Drug Discovery & Dev NatSynDrugs, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Chem, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Pharm, I-53100 Siena, Italy; [Nishi, Toshishide; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan; [Ribeiro, Nigel; Desaubry, Laurent] Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France	Desaubry, L (reprint author), Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France.	desaubry@unistra.fr; nebigil@unistra.fr		brogi, simone/0000-0001-9375-6242	Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale en France (FRM); Region Alsace; Laboratory of Excellence, Medalis	This work was supported by Centre National de la Recherche Scientifique (CNRS), Fondation pour la Recherche Medicale en France (FRM), Region Alsace, and Laboratory of Excellence, Medalis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Giovani S, 2014, BIOORG MED CHEM LETT, V24, P3582, DOI 10.1016/j.bmcl.2014.05.044; Congiu C, 2014, EUR J MED CHEM, V81, P334, DOI 10.1016/j.ejmech.2014.05.030; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; [Anonymous], CPHMODELS 3 2 SERV; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Urayama K, 2009, CARDIOVASC RES, V81, P28, DOI 10.1093/cvr/cvn251; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Gemma S, 2014, RSC ADV, V4, P4769, DOI 10.1039/c3ra45933k; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Jones G, 1995, J COMPUT AID MOL DES, V9, P532, DOI 10.1007/BF00124324; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7; Miserey-Lenkei S, 2002, J BIOL CHEM, V277, P5891, DOI 10.1074/jbc.M108398200; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Cappelli A, 2013, EUR J MED CHEM, V63, P85, DOI 10.1016/j.ejmech.2013.01.044; Carroll C, 2013, United States patent, Patent No. [WO2013179024A1, US20130324576, 2013179024]; Dai WM, 2011, J RECEPT SIG TRANSD, V31, P229, DOI 10.3109/10799893.2011.578141; DeVita RJ, 2007, CURR TOP MED CHEM, V7, P1433, DOI 10.2174/156802607782194789; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Guazzi M, 2014, PROG CARDIOVASC DIS, V56, P508, DOI 10.1016/j.pcad.2013.11.003; Jacoby Edgar, 2006, ChemMedChem, V1, P761; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Li YY, 2010, CURR MED CHEM, V17, P1167; Nebigil CG, 2009, TRENDS CARDIOVAS MED, V19, P55, DOI 10.1016/j.tcm.2009.04.007; Nguyen T, 2013, J DEV BIOL, V1, P20; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Zhou QY, 2014, United States patent, Patent No. [WO2010077976A3, US8722896B2, 2010077976]	48	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121027	10.1371/journal.pone.0121027		20	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600053		
J	Kawashima, M; Uchino, M; Yokoi, N; Uchino, Y; Dogru, M; Komuro, A; Sonomura, Y; Kato, H; Kinoshita, S; Mimura, M; Tsubota, K				Kawashima, Motoko; Uchino, Miki; Yokoi, Norihiko; Uchino, Yuichi; Dogru, Murat; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Kinoshita, Shigeru; Mimura, Masaru; Tsubota, Kazuo			Associations between Subjective Happiness and Dry Eye Disease: A New Perspective from the Osaka Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISPLAY TERMINAL USERS; RISK-FACTORS; SJOGRENS-SYNDROME; DIAGNOSTIC-TESTS; OCULAR SURFACE; PREVALENCE; SYMPTOMS; POPULATION; IMPACT	Importance Dry eye disease has become an important health problem. A lack of concordance between self-reported symptoms and the outcome of dry eye examinations has raised questions about dry eye disease. Objective To explore the association between subjective happiness and objective and subjective symptoms of dry eye disease. Design The study adopted a cross-sectional design. Setting All the employees of a company in Osaka, Japan. Participants 672 Japanese office workers using Visual Display Terminals (age range: 26-64 years). Methods The dry eye measurement tools included the Schirmer test, conjunctivocorneal staining, the tear film break-up time, as well as the administration of a dry eye symptoms questionnaire. Happiness was measured by the Subjective Happiness Scale. Main Outcome Measures Dry eye examination parameters, dry eye symptoms questionnaires, and the Subjective Happiness Scale score. Results Of the 672 workers, 561 (83.5%) completed the questionnaires and examinations. The mean Subjective Happiness Scale score was 4.91 (SD = 1.01). This score was inversely correlated with the dry eye symptom score (r = -0.188, p < 0.001), but was not associated with objective findings which include conjunctivocorneal staining, low Schirmer test score, or low tear film break-up time. The level of subjective happiness was the lowest in the group without objective results, but reported subjective symptoms of dry eyes (p < 0.05). Conclusions and Relevance There is evidence of the relationship between subjective happiness and self-reported symptoms of dry eyes. Findings of this study revealed a new perspective on dry eye disease, including the potential for innovative treatments of a specific population with dry eye disease.	[Kawashima, Motoko; Uchino, Miki; Uchino, Yuichi; Dogru, Murat; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yokoi, Norihiko; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Kawashima, M (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	motoko-k@a3.keio.jp			Ministry of Education, Science, Sports and Culture [2279192]; Santen Pharmaceutical Co., Ltd.; Santen Pharmaceutical Co., Ltd, Osaka	This study was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture, and Grant-in-Aid for Young Scientists (B), 2279192, 2010. Part of this study was sponsored by Santen Pharmaceutical Co., Ltd. Provision of facilities, transport of equipment were supported by Santen Pharmaceutical Co., Ltd, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-111; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; TODA I, 1993, ACTA OPHTHALMOL, V71, P347; Kim KW, 2011, INVEST OPHTH VIS SCI, V52, P7954, DOI 10.1167/iovs.11-8050; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Vriezekolk JE, 2005, J RHEUMATOL, V32, P2351; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; Smith JA, 2007, OCUL SURF, V5, P93; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Friedman NJ, 2010, CURR OPIN OPHTHALMOL, V21, P310, DOI 10.1097/ICU.0b013e32833a8c15; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Li MY, 2011, CURR EYE RES, V36, P1, DOI 10.3109/02713683.2010.519850; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Wen W, 2012, CORNEA, V31, P686, DOI 10.1097/ICO.0b013e3182261590; Takeyachi Y, 2003, SPINE, V28, P1461, DOI 10.1097/00007632-200307010-00018; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; Adatia FA, 2004, CAN J OPHTHALMOL, V39, P767; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; DeGargino JP, 2004, CHILDRENS HLTH ENV G; Fairchild CJ, 2008, OPTOMETRY VISION SCI, V85, P699, DOI 10.1097/OPX.0b013e3181824e0d; Mattei D, 2004, PSYCHOL REP, V94, P288; Pouyeh B, 2012, AM J OPHTHALMOL, V153, P1061, DOI 10.1016/j.ajo.2011.11.030; Rajagopalan K, 2005, VALUE HEALTH, V8, P168, DOI 10.1111/j.1524-4733.2005.03074.x; Savini Giacomo, 2008, Clin Ophthalmol, V2, P31; Shimai Satoshi, 2004, Nihon Koshu Eisei Zasshi, V51, P845; Shimazaki J., 2007, J EYE, V24, P181; Tse MM, 2012, J ADV NURS, V68, P312, DOI 10.1111/j.1365-2648.2011.05738.x; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123299	10.1371/journal.pone.0123299		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600141		
J	Maejima, R; Iijima, K; Kaihovaara, P; Hatta, W; Koike, T; Imatani, A; Shimosegawa, T; Salaspuro, M				Maejima, Ryuhei; Iijima, Katsunori; Kaihovaara, Pertti; Hatta, Waku; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru; Salaspuro, Mikko			Effects of ALDH2 Genotype, PPI Treatment and L-Cysteine on Carcinogenic Acetaldehyde in Gastric Juice and Saliva after Intragastric Alcohol Administration	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HELICOBACTER-PYLORI INFECTION; CHRONIC ATROPHIC GASTRITIS; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE 2; ETHANOL-METABOLISM; STOMACH-CANCER; ALDH2-DEFICIENT SUBJECTS; MICROBIAL-PRODUCTION; RISK	Acetaldehyde (ACH) associated with alcoholic beverages is Group 1 carcinogen to humans (IARC/WHO). Aldehyde dehydrogenase (ALDH2), a major ACH eliminating enzyme, is genetically deficient in 30-50% of Eastern Asians. In alcohol drinkers, ALDH2-deficiency is a well-known risk factor for upper aerodigestive tract cancers, i.e., head and neck cancer and esophageal cancer. However, there is only a limited evidence for stomach cancer. In this study we demonstrated for the first time that ALDH2 deficiency results in markedly increased exposure of the gastric mucosa to acetaldehyde after intragastric administration of alcohol. Our finding provides concrete evidence for a causal relationship between acetaldehyde and gastric carcinogenesis. A plausible explanation is the gastric first pass metabolism of ethanol. The gastric mucosa expresses alcohol dehydrogenase (ADH) enzymes catalyzing the oxidation of ethanol to acetaldehyde, especially at the high ethanol concentrations prevailing in the stomach after the consumption of alcoholic beverages. The gastric mucosa also possesses the acetaldehyde-eliminating ALDH2 enzyme. Due to decreased mucosal ALDH2 activity, the elimination of ethanol-derived acetaldehyde is decreased, which results in its accumulation in the gastric juice. We also demonstrate that ALDH2 deficiency, proton pump inhibitor (PPI) treatment, and L-cysteine cause independent changes in gastric juice and salivary acetaldehyde levels, indicating that intragastric acetaldehyde is locally regulated by gastric mucosal ADH and ALDH2 enzymes, and by oral microbes colonizing an achlorhydric stomach. Markedly elevated acetaldehyde levels were also found at low intragastric ethanol concentrations corresponding to the ethanol levels of many foodstuffs, beverages, and dairy products produced by fermentation. A capsule that slowly releases L-cysteine effectively eliminated acetaldehyde from the gastric juice of PPI-treated ALDH2-active and ALDH2-deficient subjects. These results provide entirely novel perspectives for the prevention of gastric cancer, especially in established risk groups.	[Maejima, Ryuhei; Iijima, Katsunori; Hatta, Waku; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Kaihovaara, Pertti; Salaspuro, Mikko] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland	Iijima, K (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan.	kiijima@med.tohoku.ac.jp			Astra Zeneca PLC; Biohit Oyj.; Eisai Co., Ltd.; Takeda Pharmaceutical Co., Ltd	KI has received unrestricted grants from Astra Zeneca PLC, Biohit Oyj., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd, for his department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2013, WORLD J GASTROENTERO, V19, P2560, DOI 10.3748/wjg.v19.i16.2560; Li H, 2009, ANN HUM GENET, V73, P335, DOI 10.1111/j.1469-1809.2009.00517.x; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Yokoyama A, 2008, ALCOHOL CLIN EXP RES, V32, P1607, DOI 10.1111/j.1530-0277.2008.00739.x; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; Yin SJ, 1997, GASTROENTEROLOGY, V112, P766, DOI 10.1053/gast.1997.v112.pm9041238; Kurkivuori J, 2007, ORAL ONCOL, V43, P181, DOI 10.1016/j.oraloncology.2006.02.005; Salaspuro VJ, 2006, CANCER EPIDEM BIOMAR, V15, P146, DOI 10.1158/1055-9965.EPI-05-0248; Shin CM, 2011, INT J EPIDEMIOL, V40, P1047, DOI 10.1093/ije/dyr067; Dong YJ, 1996, ALCOHOL, V13, P257, DOI 10.1016/0741-8329(95)02052-7; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Vakevainen S, 2001, ALCOHOL CLIN EXP RES, V25, P829, DOI 10.1111/j.1530-0277.2001.tb02286.x; Lee CH, 2008, INT J CANCER, V122, P1347, DOI 10.1002/ijc.23264; [Anonymous], 2012, IARC MONOGRAPHS EV E, V100E, P471; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/jic.11426; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Vakevainen S, 2000, ALIMENT PHARM THERAP, V14, P1511, DOI 10.1046/j.1365-2036.2000.00858.x; Salaspuro M, 2011, J DIGEST DIS, V12, P51, DOI 10.1111/j.1751-2980.2011.00480.x; Vakevainen S, 2000, ALCOHOL CLIN EXP RES, V24, P873, DOI 10.1111/j.1530-0277.2000.tb02068.x; Xue FB, 2001, WORLD J GASTROENTERO, V7, P801; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Wu AH, 2000, CANCER EPIDEM BIOMAR, V9, P1051; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Cao HX, 2010, ASIAN PAC J CANCER P, V11, P1073; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Hellstrom PM, 2014, GASTROENTEROLOGY S1, V146; Helminen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074418; Hui YH, 2004, HDB FOOD BEVERAGE FE; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Iijima K, 2010, DIGEST DIS SCI, V55, P1349, DOI 10.1007/s10620-009-0853-x; Lee SL, 2006, ALCOHOL CLIN EXP RES, V30, P1132, DOI 10.1111/j.1530-0277.2006.00139.x; Linderborg K, 2011, ALCOHOL CLIN EXP RES, V35, P515; LINDROS KO, 1980, PHARMACOL BIOCHEM BE, V13, P119; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3175; Nieminen MT, 2013, CANCER EPIDEM BIOMAR, V22, P69, DOI 10.1158/1055-9965.EPI-12-0908; Oikawa T, 2010, SCAND J GASTROENTERO, V45, P1338, DOI 10.3109/00365521.2010.495419; Rabl Walter, 1994, Blutalkohol, V31, P76; ROINE RP, 1992, LIFE SCI, V51, P1333, DOI 10.1016/0024-3205(92)90632-Y; Salaspuro M., 2009, SCAND J GASTROENTERO, V5, P121; Salaspuro V, 2004, INT J CANCER, V111, P480, DOI 10.1002/ijc.20293; Salaspuro V, 2002, INT J CANCER, V97, P361, DOI 10.1002/ijc.1620; SIPPONEN P, 1985, INT J CANCER, V35, P173; SPRINCE H, 1975, AGENTS ACTIONS, V5, P164, DOI 10.1007/BF02027359; Uno K, 2011, AM J GASTROENTEROL, V106, P1923, DOI 10.1038/ajg.2011.282; Vakevainen S, 2002, SCAND J GASTROENTERO, V37, P648, DOI 10.1080/00365520212500; Wang H., 2014, AM J MAR SCI, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE; Wang XQ, 2012, J AM COLL NUTR, V31, P375; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yokoyama A, 2007, J GASTROEN HEPATOL, V22, P210, DOI 10.1111/j.1440-1746.2006.04377.x	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120397	10.1371/journal.pone.0120397		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600032		
J	Mohamed, RH; Sutoh, Y; Itoh, Y; Otsuka, N; Miyatake, Y; Ogasawara, K; Kasahara, M				Mohamed, Rania Hassan; Sutoh, Yoichi; Itoh, Yasushi; Otsuka, Noriyuki; Miyatake, Yukiko; Ogasawara, Kazumasa; Kasahara, Masanori			The SKINT1-Like Gene Is Inactivated in Hominoids But Not in All Primate Species: Implications for the Origin of Dendritic Epidermal T Cells	PLOS ONE			English	Article							VARIABLE REGION GENES; GAMMA-DELTA; ANTIGEN RECEPTORS; BOVINE SKIN; DIVERSITY; SURVEILLANCE; EXPRESSION; SELECTION; PHYLOGENOMICS; REPERTOIRE	Dendritic epidermal T cells, which express an invariant V.5V delta 1 T-cell receptor and account for 95% of all resident T cells in the mouse epidermis, play a critical role in skin immune surveillance. These gamma delta T cells are generated by positive selection in the fetal thymus, after which they migrate to the skin. The development of dendritic epidermal T cells is critically dependent on the Skint1 gene expressed specifically in keratinocytes and thymic epithelial cells, suggesting an indispensable role for Skint1 in the selection machinery for specific intraepithelial lymphocytes. Phylogenetically, rodents have functional SKINT1 molecules, but humans and chimpanzees have a SKINT1-like (SKINT1L) gene with multiple inactivating mutations. In the present study, we analyzed SKINT1L sequences in representative primate species and found that all hominoid species have a common inactivating mutation, but that Old World monkeys such as olive baboons, green monkeys, cynomolgus macaques and rhesus macaques have apparently functional SKINT1L sequences, indicating that SKINT1L was inactivated in a common ancestor of hominoids. Interestingly, the epidermis of cynomolgus macaques contained a population of dendritic-shaped gamma delta T cells expressing a semi-invariant V.10/V delta 1 T-cell receptor. However, this population of macaque T cells differed from rodent dendritic epidermal T cells in that their V.10/V delta 1 T-cell receptors displayed junctional diversity and expression of V.10 was not epidermis-specific. Therefore, macaques do not appear to have rodent-type dendritic epidermal T cells despite having apparently functional SKINT1L. Comprehensive bioinformatics analysis indicates that SKINT1L emerged in an ancestor of placental mammals but was inactivated or lost multiple times in mammalian evolution and that Skint1 arose by gene duplication in a rodent lineage, suggesting that authentic dendritic epidermal T cells are presumably unique to rodents.	[Mohamed, Rania Hassan; Sutoh, Yoichi; Otsuka, Noriyuki; Miyatake, Yukiko; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 52021, Japan	Kasahara, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	mkasaha@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; 	Mohamed, Rania/0000-0001-7391-9550	JSPS KAKENHI [24390091]; Ministry of Higher Education and Scientific Research of Egypt	This work was supported by JSPS KAKENHI Grant Number 24390091. RHM was supported by a stipend from the Ministry of Higher Education and Scientific Research of Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Kazen AR, 2011, P NATL ACAD SCI USA, V108, pE332, DOI 10.1073/pnas.1105105108; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri.797; Yoshida S, 2012, J IMMUNOL, V188, P3972, DOI 10.4049/jimmunol.1102886; Afrache H, 2012, IMMUNOGENETICS, V64, P781, DOI 10.1007/s00251-012-0619-z; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Song S, 2012, P NATL ACAD SCI USA, V109, P14942, DOI 10.1073/pnas.1211733109; Ebert LM, 2006, J IMMUNOL, V176, P4331; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; FOSTER CA, 1990, J EXP MED, V171, P997, DOI 10.1084/jem.171.4.997; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Hein WR, 1997, IMMUNOLOGY, V91, P58, DOI 10.1046/j.1365-2567.1997.00224.x; HUCK S, 1988, EMBO J, V7, P719; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; KLEIN MH, 1987, P NATL ACAD SCI USA, V84, P6884, DOI 10.1073/pnas.84.19.6884; Kuhnlein P, 1996, EUR J IMMUNOL, V26, P3092, DOI 10.1002/eji.1830261240; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spetz AL, 1996, AM J PATHOL, V149, P665; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; Witherden DA, 2011, TRENDS IMMUNOL, V32, P265, DOI 10.1016/j.it.2011.03.005	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							UNSP e0123258	10.1371/journal.pone.0123258		15	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600140		
J	Saito, K; Fukumoto, E; Yamada, A; Yuasa, K; Yoshizaki, K; Iwamoto, T; Saito, M; Nakamura, T; Fukumoto, S				Saito, Kan; Fukumoto, Emiko; Yamada, Aya; Yuasa, Kenji; Yoshizaki, Keigo; Iwamoto, Tsutomu; Saito, Masahiro; Nakamura, Takashi; Fukumoto, Satoshi			Interaction between Fibronectin and beta 1 Integrin Is Essential for Tooth Development	PLOS ONE			English	Article							DENTAL-PULP CELLS; EPITHELIAL-MESENCHYMAL INTERACTIONS; IMMUNOFLUORESCENT LOCALIZATION; RECEPTOR ACTIVATOR; MATRIX PROTEINS; GENE-EXPRESSION; BINDING DOMAIN; MESSENGER-RNA; RAT INCISOR; IN-VIVO	The dental epithelium and extracellular matrix interact to ensure that cell growth and differentiation lead to the formation of teeth of appropriate size and quality. To determine the role of fibronectin in differentiation of the dental epithelium and tooth formation, we analyzed its expression in developing incisors. Fibronectin mRNA was expressed during the presecretory stage in developing dental epithelium, decreased in the secretory and early maturation stages, and then reappeared during the late maturation stage. The binding of dental epithelial cells derived from postnatal day-1 molars to a fibronectin-coated dish was inhibited by the RGD but not RAD peptide, and by a beta 1 integrin-neutralizing antibody, suggesting that fibronectin-beta 1 integrin interactions contribute to dental epithelial-cell binding. Because fibronectin and beta 1 integrin are highly expressed in the dental mesenchyme, it is difficult to determine precisely how their interactions influence dental epithelial differentiation in vivo. Therefore, we analyzed beta 1 integrin conditional knockout mice (Int beta 1(lox-/lox-)/K14-Cre) and found that they exhibited partial enamel hypoplasia, and delayed eruption of molars and differentiation of ameloblasts, but not of odontoblasts. Furthermore, a cyst-like structure was observed during late ameloblast maturation. Dental epithelial cells from knockout mice did not bind to fibronectin, and induction of ameloblastin expression in these cells by neurotrophic factor-4 was inhibited by treatment with RGD peptide or a fibronectin siRNA, suggesting that the epithelial interaction between fibronectin and beta 1 integrin is important for ameloblast differentiation and enamel formation.	[Saito, Kan; Fukumoto, Emiko; Yamada, Aya; Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 980, Japan; [Saito, Masahiro] Tohoku Univ, Grad Sch Dent, Dept Restorat Dent, Operat Dent, Sendai, Miyagi 980, Japan; [Yuasa, Kenji] St Marys Hosp, Pediat Dent, Kurume, Fukuoka, Japan; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont, Fukuoka 812, Japan; [Iwamoto, Tsutomu] Univ Tokushima, Grad Sch, Dept Pediat Dent, Tokushima 770, Japan	Saito, K (reprint author), Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 980, Japan.	kanta@dent.tohoku.ac.jp		Saito, Kan/0000-0002-2151-6204; Nakamura, Takashi/0000-0001-9904-1037	Ministry of Education, Science, Culture of Japan [20679006]; NEXT program [LS010, 24792294, 21792054]	This work was supported by Grants-in-Aid from the Ministry of Education, Science (20679006), Culture of Japan, and the NEXT program (LS010), Grant-in-Aid for Young Scientists (24792294), Grant-in-Aid for Scientific Research (21792054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Pulkkinen L, 1998, AM J HUM GENET, V63, P1376, DOI 10.1086/302116; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Mizuno M, 2008, INT ENDOD J, V41, P933, DOI 10.1111/j.1365-2591.2008.01420.x; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; YOSHIBA N, 1994, ARCH ORAL BIOL, V39, P395, DOI 10.1016/0003-9969(94)90169-4; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Mohazab L, 2013, J CELL SCI, V126, P732, DOI 10.1242/jcs.112599; Mizuno M, 2003, J CELL BIOCHEM, V88, P1112, DOI 10.1002/jcb.10466; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Wang Y, 2013, DEV BIOL, V382, P27, DOI 10.1016/j.ydbio.2013.08.003; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Castaneda B, 2011, J CELL PHYSIOL, V226, P74, DOI 10.1002/jcp.22305; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; BERNFIELD M, 1982, DEV BIOL, V90, P291, DOI 10.1016/0012-1606(82)90378-5; Salmivirta K, 1996, DEV DYNAM, V205, P104, DOI 10.1002/(SICI)1097-0177(199602)205:2<104::AID-AJA2>3.0.CO;2-M; Chen B, 2009, J DENT RES, V88, P539, DOI 10.1177/0022034509338008; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; Faraldo MM, 2001, EMBO REP, V2, P431; Fukumoto E, 2003, J DENT RES, V82, P17; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Khan SZ, 2013, AUST ENDOD J, V39, P137, DOI 10.1111/j.1747-4477.2012.00351.x; Kreiborg S, 1999, J CRAN GENET DEV BIO, V19, P75; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LESOT H, 1981, DEV BIOL, V82, P371, DOI 10.1016/0012-1606(81)90460-7; LESOT H, 1992, DIFFERENTIATION, V49, P109, DOI 10.1111/j.1432-0436.1992.tb00775.x; Miyazaki Y, 1998, ARCH ORAL BIOL, V43, P367, DOI 10.1016/S0003-9969(98)00014-4; Modolo F, 2004, ORAL DIS, V10, P277, DOI 10.1111/j.1601-0825.2004.01028.x; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; Narani N, 2007, EUR J ORAL SCI, V115, P288, DOI 10.1111/j.1600-0722.2007.00467.x; Nishiguchi M, 2007, ARCH ORAL BIOL, V52, P237, DOI 10.1016/j.archoralbio.2006.09.016; Sakai T, 1996, ARCH ORAL BIOL, V41, P885, DOI 10.1016/S0003-9969(96)00014-3; SAWADA T, 1995, ARCH ORAL BIOL, V40, P1029, DOI 10.1016/0003-9969(95)00073-X; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069343; THESLEFF I, 1989, International Journal of Developmental Biology, V33, P91; THESLEFF I, 1979, DEV BIOL, V70, P116, DOI 10.1016/0012-1606(79)90011-3; Wang P, 2000, Chin J Dent Res, V3, P55; Wang SK, 2013, HUM MOL GENET; WIKTORJEDRZEJCZAK W, 1994, ENDOCRINOLOGY, V134, P1932, DOI 10.1210/en.134.4.1932; WU CY, 1995, J CELL SCI, V108, P821; YAMADA S, 1994, INT J DEV BIOL, V38, P553; Yang Y, 1998, EUR J IMMUNOL, V28, P995, DOI 10.1002/(SICI)1521-4141(199803)28:03<995::AID-IMMU995>3.0.CO;2-D; Yoshida T, 2012, J DENT RES, V91, P1154, DOI 10.1177/0022034512462722	51	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							UNSP e0121667	10.1371/journal.pone.0121667		21	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600078		
J	Takayasu, M; Sato, K; Sano, Y; Yamada, K; Miura, W; Takayasu, H				Takayasu, Misako; Sato, Kazuya; Sano, Yukie; Yamada, Kenta; Miura, Wataru; Takayasu, Hideki			Rumor Diffusion and Convergence during the 3.11 Earthquake: A Twitter Case Study	PLOS ONE			English	Article							EPIDEMICS; NETWORKS; SEARCH	We focus on Internet rumors and present an empirical analysis and simulation results of their diffusion and convergence during emergencies. In particular, we study one rumor that appeared in the immediate aftermath of the Great East Japan Earthquake on March 11, 2011, which later turned out to be misinformation. By investigating whole Japanese tweets that were sent one week after the quake, we show that one correction tweet, which originated from a city hall account, diffused enormously. We also demonstrate a stochastic agentbased model, which is inspired by contagion model of epidemics SIR, can reproduce observed rumor dynamics. Our model can estimate the rumor infection rate as well as the number of people who still believe in the rumor that cannot be observed directly. For applications, rumor diffusion sizes can be estimated in various scenarios by combining our model with the real data.	[Takayasu, Misako; Sato, Kazuya; Miura, Wataru; Takayasu, Hideki] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Sano, Yukie] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba, Japan; [Sano, Yukie] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Yamada, Kenta] Waseda Inst Adv Study, Shinjuku Ku, Tokyo, Japan; [Yamada, Kenta] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Yamada, Kenta] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Takayasu, Hideki] Sony Comp Sci Labs Inc, Shinagawa, Tokyo, Japan; [Takayasu, Hideki] Meiji Inst Adv Study Math Sci, Kawasaki, Kanagawa, Japan	Takayasu, M (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	takayasu@dis.titech.ac.jp; sano@sk.tsukuba.ac.jp			JSPS KAKENHI [24540395, 26310207, 25750130]	This work was partly supported by JSPS KAKENHI Grant Number 24540395 (MT), 26310207 (MT), and 25750130 (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport Gordon W., 1948, PSYCHOL RUMOR; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Ni SJ, 2011, PHYSICA A, V390, P4528, DOI 10.1016/j.physa.2011.07.042; [Anonymous], 2011, REPORT JAPAN MINISTR; Lu LY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123005; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; GOFFMAN W, 1964, NATURE, V204, P225, DOI 10.1038/204225a0; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Starbird K, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P241; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Ettredge M, 2005, COMMUN ACM, V48, P87, DOI 10.1145/1096000.1096010; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; DiFonzo N., 2008, WATERCOOLER EFFECT I; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Gruhl D., 2005, P 11 ACM SIGKDD INT, P78, DOI 10.1145/1081870.1081883; Maki DP, 1973, MTH MODELS APPL EMPH; Nicholas D., 2013, NATURE, V493, P135, DOI [10.1038/493135a, DOI 10.1038/493135A]; O'Connor B, 2010, ICWSM, V11, P122; Piccardi C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026113; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Sadilek A., 2012, P 26 AAAI C ART INT, P136; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [DOI 10.1145/1772690.1772777, 10.1145/1772690.177277712]; Shigyo A, 2011, BROADCAST RES   0802; Yamada K, UNDERSTANDING UNPUB	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121443	10.1371/journal.pone.0121443		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600073		
J	Uchida, H; Sumimoto, K; Ferriols, VME; Imou, K; Saga, K; Furuhashi, K; Matsunaga, S; Okada, S				Uchida, Hidenobu; Sumimoto, Koremitsu; Ferriols, Victor Marco Emmanuel; Imou, Kenji; Saga, Kiyotaka; Furuhashi, Kenichi; Matsunaga, Shigeki; Okada, Shigeru			Isolation and Characterization of Two Squalene Epoxidase Genes from Botryococcus braunii, Race B	PLOS ONE			English	Article							RNA-SEQ DATA; SACCHAROMYCES-CEREVISIAE; EUPHORBIA-TIRUCALLI; REFERENCE GENOME; BIOSYNTHESIS; CLONING; EXPRESSION; TRITERPENE; PLANT; IDENTIFICATION	The B race of the green microalga Botryococcus braunii produces triterpene hydrocarbons, botryococcenes and methylsqualenes that can be processed into jet fuels with high heating values. In this alga, squalene is also converted into membrane sterols after 2,3-epoxidation. In the present study, cDNA clones of two distinct squalene epoxidases (BbSQE-I and -II) were isolated. Predicted amino acid sequences encoded on these genes are 45% identical with each other. Introduction of BbSQE-I or -II into Saccharomyces cerevisie erg1 mutants resulted in the complementation of ergosterol auxotrophy. The relative expression level of SQE-II increased 3.5-fold from the early stage to the middle phase of a culture period of 42 days, while that of SQE-I was almost constant throughout the culture period. Southern blot analyses suggested that these genes are single-copied genes. This is the first report on the isolation of functional SQEs that are encoded in duplicated loci in the algal genome.	[Uchida, Hidenobu; Sumimoto, Koremitsu; Ferriols, Victor Marco Emmanuel; Matsunaga, Shigeki; Okada, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Uchida, Hidenobu; Sumimoto, Koremitsu; Matsunaga, Shigeki; Okada, Shigeru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan; [Ferriols, Victor Marco Emmanuel] Univ Philippines Visayas, Inst Aquaculture, Iloilo 5023, Philippines; [Imou, Kenji; Saga, Kiyotaka; Furuhashi, Kenichi] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Tokyo 1138657, Japan	Okada, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan.	aokada@mail.ecc.u-tokyo.ac.jp			Japan Science and Technology Agency, CREST; Strategic Development of Next-generation Bioenergy Utilization Technology entitled, "Efficient Production of Hydrocarbon from Microalgae", New Energy and Industrial Technology Development Organization (NEDO)	This work was financially supported by Japan Science and Technology Agency (http://www.jst.go.jp/), CREST. The RNAseq was financially supported by the Strategic Development of Next-generation Bioenergy Utilization Technology entitled, "Efficient Production of Hydrocarbon from Microalgae" by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html). All of the founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Uchida H, 2007, PLANTA, V226, P1109, DOI 10.1007/s00425-007-0557-4; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Matsushima D, 2012, PLANT SCI, V185, P309, DOI 10.1016/j.plantsci.2012.01.002; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17; Uchida H, 2009, PLANTA, V229, P1243, DOI 10.1007/s00425-009-0906-6; Niehaus TD, 2012, J BIOL CHEM, V287, P8163, DOI 10.1074/jbc.M111.316059; Favre B, 1997, GENE, V189, P119, DOI 10.1016/S0378-1119(96)00844-X; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; KOSUGA K, 1995, BBA-GENE STRUCT EXPR, V1260, P345, DOI 10.1016/0167-4781(94)00245-X; Landl KM, 1996, YEAST, V12, P609, DOI 10.1002/(SICI)1097-0061(199605)12:6<609::AID-YEA949>3.0.CO;2-B; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lipinski M, 2009, CENT EUR J BIOL, V4, P163, DOI 10.2478/s11535-009-0002-8; Metzger P, 1999, CHEM MICROALGAE, P205; Milne I, 2012, BRIEF BIOINFORM, V14, P193; NONOMURA A M, 1988, Japanese Journal of Phycology, V36, P285; POULTER CD, 1990, ACCOUNTS CHEM RES, V23, P70, DOI 10.1021/ar00171a003; Ruckenstuhl C, 2005, BIOCHEM SOC T, V33, P1197; Sato Y, 2003, TETRAHEDRON LETT, V44, P7035, DOI 10.1016/S0040-4039(03)01784-2; Weiss TL, 2010, J PHYCOL, V46, P534, DOI 10.1111/j.1529-8817.2010.00820.x	38	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0122649	10.1371/journal.pone.0122649		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CE9AM	WOS:000352135600118		
J	Tsukada, S; Tomobe, A; Abe, Y; Gunji, T				Tsukada, Satoru; Tomobe, Akira; Abe, Yoshimoto; Gunji, Takahiro			Synthesis of poly(3-(4-ethoxysulfonylphenoxy)-2-methylpropyl) silsesquioxane and its application as a proton-conducting membrane	POLYMER JOURNAL			English	Article							ORGANIC HYBRID MEMBRANES; FUEL-CELL APPLICATIONS; SOL-GEL METHOD; HIGH-TEMPERATURE; ACID; 3-AMINOPROPYLTRIETHOXYSILANE; POLYSILSESQUIOXANES; TRANSPORT; DESIGN; FILMS	polysilsesquioxane-based organic-inorganic hybrid membrane was prepared and applied as a proton-conducting membrane for fuel cells. poly(STES-ran-MTES), a random copolymer of ethyl 4-(2-methyl-3-triethoxysilylpropoxy) benzenesulfonate (STES) and triethoxy(methyl) silane (MTES) was synthesized by hydrolysis and condensation in the presence of hydrochloric acid under a nitrogen stream. The molecular weight was 7500-7600 g mol(-1), and the percentage of hydrolyzed ethoxysulfonyl group was 32-50%. A poly(STES-ran-MTES) membrane was prepared by heating for several days, which showed thermal resistivity up to 200 degrees C and proton conductivity of 2.0 x 10(-5) to 1.1 x 10(-3) S cm(-1) at room temperature. By contrast, a membrane of a block copolymer, poly(SPES-block-PMS), showed proton conductivity of 2.5 x 10(-3) S cm(-1). The proton conductivity of the poly(3-(4-ethoxysulfonylphenoxy)-2-methylpropyl) silsesquioxane (SPES) membrane increased from 2.7 x 10(-3) S cm(-1) at 25 degrees C to 1.0x10(-2) S cm(-1) at 110 degrees C. The proton conductivity of the SPES membrane increased from 2.7 x 10-3 S cm(-1) at relative humidity (RH)=25-30% to 2.0 x 10(-3) S cm(-1) at RH=60% and 1.4 x 10(-1) S cm(-1) at RH=90%. The mixture of SPES and poly(vinyl alcohol), poly(ethylene oxide) or polyoctahedralpolysilsesquioxane showed proton conductivities of 2.7 x 10(-3), 1.5 x 10(-3) and 2.5 x 10(-3) S cm(-1), respectively, at 25 degrees C and RH=25-30%. The open-circuit voltage of the SPES membrane was 0.92 V.	[Tsukada, Satoru; Tomobe, Akira; Abe, Yoshimoto; Gunji, Takahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan	Gunji, T (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	gunji@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401, 24102008A02]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas `New Polymeric Materials Based on Element-Blocks (no. 2401)' (24102008A02) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abe Y, 2004, PROG POLYM SCI, V29, P149, DOI 10.1016/j.progpolymsci.2003.08.003; Aparicio M, 2006, J SOL-GEL SCI TECHN, V40, P309, DOI 10.1007/s10971-006-8370-2; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; Deluca NW, 2006, J POLYM SCI POL PHYS, V44, P2201, DOI 10.1002/polb.20861; Fujita S, 2013, CHEM MATER, V25, P1584, DOI 10.1021/cm303950u; Kaneko Y, 2014, CHEM-EUR J, V20, P9394, DOI 10.1002/chem.201402011; Hickner MA, 2004, CHEM REV, V104, P4587, DOI 10.1021/cr020711a; Kreuer KD, 2004, CHEM REV, V104, P4637, DOI 10.1021/cr020715f; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mehta V, 2003, J POWER SOURCES, V114, P32, DOI 10.1016/S0378-7753(02)00542-6; Takamura N, 1999, J POLYM SCI POL CHEM, V37, P1017, DOI 10.1002/(SICI)1099-0518(19990401)37:7<1017::AID-POLA16>3.3.CO;2-6; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Gunji T, 2012, INT J POLYM SCI, DOI 10.1155/2012/568301; Gunji T., 2007, KOUBUNSHI RONBUNSHU, V10, P750; Gunji T, 2010, POLYM J, V42, P684, DOI 10.1038/pj.2010.52; Ibrahim AC, 2012, NEW J CHEM, V36, P1218, DOI 10.1039/c2nj40017k; Khiterer M, 2006, CHEM MATER, V18, P3665, DOI 10.1021/cm060440a; Lannasch P., 2005, FUEL CELL, V5, P248; Shao YY, 2007, J POWER SOURCES, V167, P235, DOI 10.1016/j.jpowsour.2007.02.065; Tezuka T., 2009, J ELECTROCHEM SOC, V156, P174; Tezuka T, 2008, SOLID STATE IONICS, V179, P1151, DOI 10.1016/j.ssi.2008.02.021; Tezuka T, 2006, J AM CHEM SOC, V128, P16470, DOI 10.1021/ja066345k	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					287	293		10.1038/pj.2014.112		7	Polymer Science	Polymer Science	CF4OH	WOS:000352528900001		
J	Nobukawa, S; Aoki, Y; Fukui, Y; Kiyama, A; Yoshimura, H; Tachikawa, Y; Yamaguchi, M				Nobukawa, Shogo; Aoki, Yoshihiko; Fukui, Yoshiharu; Kiyama, Ayumi; Yoshimura, Hiroshi; Tachikawa, Yutaka; Yamaguchi, Masayuki			The effect of flexible chains on the orientation dynamics of small molecules dispersed in polymer films during stretching	POLYMER JOURNAL			English	Article							BIREFRINGENCE DISPERSION; DIELECTRIC-RELAXATION; CELLULOSE ESTERS; POLYSTYRENE; TEMPERATURE; ANISOTROPY; BLENDS; NMR	The effect of flexible chains on the orientation dynamics of small additive molecules in cellulose acetate propionate (CAP) films is investigated during stretching using birefringence and polarized Fourier-transform infrared (FT-IR) spectra measurements. The orientation birefringence is enhanced by additives such as ethylene 2,6-naphthalate (C2Np) and hexamethylene 2,6-naphthalate (C6Np) oligomers, suggesting that the additives orient parallel to the CAP chain as a result of an intermolecular orientation correlation referred to as the nematic interaction (NI). At a high drawing temperature, the orientation of C2Np is stronger than that of C6Np, indicating that the flexible alkyl chain has reduced the intermolecular NI with CAP. By contrast, C6Np orients along the stretching direction at low temperatures. Polarized FT-IR spectra show that the orientation of the rigid portions of C6Np is delayed relative to those of the flexible groups and the matrix CAP chain. Consequently, the contribution of C6Np to birefringence and its wavelength dependence become stronger as the draw ratios increase.	[Nobukawa, Shogo; Aoki, Yoshihiko; Fukui, Yoshiharu; Kiyama, Ayumi; Yamaguchi, Masayuki] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan; [Yoshimura, Hiroshi] DIC Corp, Chiba Plant, Chiba, Japan; [Tachikawa, Yutaka] DIC Corp, Cent Res Labs, Chiba, Japan	Nobukawa, S (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	nobukawa@jaist.ac.jp			Kyoto Technoscience Center;  [25870268]	This work was partially supported by a Grant-in-Aid for Young Scientists B (25870268) and by a grant from the Kyoto Technoscience Center in 2013.	Abd Manaf ME, 2013, OPT MATER, V35, P1443, DOI 10.1016/j.optmat.2013.02.019; Abd Manaf ME, 2011, POLYMERS-BASEL, V3, P955, DOI 10.3390/polym3020955; Yamaguchi M, 2009, MACROMOLECULES, V42, P9034, DOI 10.1021/ma901676j; DOI M, 1989, MACROMOLECULES, V22, P1488, DOI 10.1021/ma00193a082; HAINS PJ, 1975, POLYMER, V16, P725, DOI 10.1016/0032-3861(75)90188-3; Nobukawa S, 2010, MACROMOLECULES, V43, P6099, DOI 10.1021/ma100969j; Abd Manaf ME, 2011, MACROMOLECULES, V44, P3942, DOI 10.1021/ma200317g; Lodge TP, 2000, MACROMOLECULES, V33, P5278, DOI 10.1021/ma9921706; Korus J, 1997, ACTA POLYM, V48, P369, DOI 10.1002/actp.1997.010480904; Cho CK, 2000, J ADHES SCI TECHNOL, V14, P1131, DOI 10.1163/156856100743130; Choudhury RP, 2012, MACROMOLECULES, V45, P879, DOI 10.1021/ma202012h; Cimrova V, 1999, MACROMOLECULES, V32, P8496, DOI 10.1021/ma991030t; Doi M, 1986, THEORY POLYM DYNAMIC; Harding GF, 1986, OPTICAL PROPERTIES P; Iwasaki S, 2012, POLYMER, V53, P3287, DOI 10.1016/j.polymer.2012.05.025; Kono H, 2004, POLYMER, V45, P2843, DOI 10.1016/j.polymer.2004.01.075; Maeda A, 2011, NIHON REOROJI GAKK, V39, P159; McCrum N. G., 1967, ANELASTIC DIELECTRIC; Nobukawa S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40570; Nobukawa S, 2013, J APPL POLYM SCI, V130, P3465, DOI 10.1002/app.39609; SAITO H, 1987, J POLYM SCI POL PHYS, V25, P1629, DOI 10.1002/polb.1987.090250806; Tagaya A, 2006, MACROMOLECULES, V39, P3019, DOI 10.1021/ma0527000; Tagaya A, 2001, APPL OPTICS, V40, P3677, DOI 10.1364/AO.40.003677; Taniguchi N, 2004, MACROMOLECULES, V37, P7832, DOI 10.1021/ma048788j; Uchiyama A, 2012, POLYM J, V44, P995, DOI 10.1038/pj.2012.52; Uchiyama A, 2003, JPN J APPL PHYS 1, V42, P3503, DOI 10.1143/JJAP.42.3503; Ward I. M., 1977, J POLYM SCI       PS, V58, P1; Williams G, 2001, MACROMOLECULES, V34, P7197, DOI 10.1021/ma010335g; Yamaguchi M., 2010, OPTICAL PROPERTIES C	29	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					294	301		10.1038/pj.2014.126		8	Polymer Science	Polymer Science	CF4OH	WOS:000352528900002		
J	Tadano, T; Zhu, R; Muroga, Y; Hoshi, T; Sasaki, D; Hagiwara, T; Sawaguchi, T				Tadano, Tsuyoshi; Zhu, Rui; Muroga, Yoshio; Hoshi, Toru; Sasaki, Daisuke; Hagiwara, Toshiki; Sawaguchi, Takashi			Characteristics of novel transparent poly(methyl methacrylate)/silica nanoparticle hybrid film prepared based on entanglement-agglomeration transition mechanism	POLYMER JOURNAL			English	Article							POLYMER NANOCOMPOSITES; PARTICLES; DISPERSIONS; SPHERES; STABILITY; MOLECULES	Using polydisperse poly(methyl methacrylate) (PMMA) and SiO2 nanoparticles with an average particle diameter of similar to 15 nm, transparent PMMA/SiO2 hybrid films could be fabricated based on the agglomeration mechanism of nanoparticles in the suspension. The calculated distance between the particles in the transparent films was similar to 30 nm, corresponding to the actual measured value of 31 nm obtained from the small-angle X-ray scattering intensity. Upon heating the transparent hybrid films to 140 degrees C, above the glass-transition temperature of PMMA, the transmittance of UV light decreased significantly with the heating time for hybrid films with M-w= 9.6 x 10(4) and a critical molecular weight (M-c) of 3x10(4) or greater, at which PMMA chains show effective entanglement. However, for hybrid films with M-w= 0.3 x 10(4) and with the Mc or a lower molecular weight, the initial high transmittance was sustained over the entire wavelength range even after a long period of heating, and no agglomeration of the SiO2 nanoparticles was observed. Such molecular weight dependence was also observed for monodisperse PMMA/SiO2 hybrid films, leading to an examination of the difference in the rates of polymer chain entanglement and disentanglement.	[Tadano, Tsuyoshi] NIKKA SEIKO CO LTD, Setagaya Ku, Tokyo, Japan; [Zhu, Rui] Nihon Univ, Grad Sch Sci & Technol, Dept Mat & Appl Chem, Tokyo 1018308, Japan; [Muroga, Yoshio; Hoshi, Toru; Sasaki, Daisuke; Hagiwara, Toshiki; Sawaguchi, Takashi] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo 1018308, Japan	Sawaguchi, T (reprint author), Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, 1-8-14 Kandasurugadai, Tokyo 1018308, Japan.	sawaguchi.takashi@nihon-u.ac.jp					Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074; ASAKURA S, 1954, J CHEM PHYS, V22, P1255; Tadano T, 2014, CHEM LETT, V43, P705, DOI 10.1246/cl.140049; Hsu JC, 2010, OPT REV, V17, P553, DOI 10.1007/s10043-010-0099-z; Zhu R, 2011, MACROMOLECULES, V44, P6103, DOI 10.1021/ma2001965; DEHEK H, 1981, J COLLOID INTERF SCI, V84, P409, DOI 10.1016/0021-9797(81)90232-0; DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L; Meth JS, 2011, MACROMOLECULES, V44, P8301, DOI 10.1021/ma201714u; Vaia RA, 2007, CHEM MATER, V19, P2736, DOI 10.1021/cm062693+; Tadano T, 2014, POLYM J, V46, P342, DOI 10.1038/pj.2014.6; VINCENT B, 1986, COLLOID SURFACE, V18, P261, DOI 10.1016/0166-6622(86)80317-1; ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618; Bhattachaya S. N., 2008, POLYM NANOCONPOSITES; De Gennes P. G., 1979, SCALING CONCEPTS POL, P76; DEHEK H, 1979, J COLLOID INTERF SCI, V70, P592, DOI 10.1016/0021-9797(79)90067-5; Ferry J. D., 1980, VISCOELASTIC PROPERT, P377; FLEER GJ, 1984, ACS SYM SER, V240, P245; Krishnamoorti R., 2001, ACS S SERIES, V804; Sugimoto H, 2006, POLYMER, V47, P3754, DOI 10.1016/j.polymer.2006.04.002; Thuzyo K., 1965, KOLLOID Z Z POLYM, V201, P66; Verwey E. J. W., 1942, CHEM WEEKBL, V39, P563; Verwey E. J. W., 1948, THEORY STABILITY LYO; Winey K., 2007, MRS B	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					311	319		10.1038/pj.2014.130		9	Polymer Science	Polymer Science	CF4OH	WOS:000352528900004		
J	Watanabe, M; Hatano, R; Koizumi, C				Watanabe, Masashi; Hatano, Ryou; Koizumi, Chiho			Spontaneous formation of interdigitated array pattern in wrinkled gold films deposited on poly(dimethylsiloxane) elastomer	POLYMER JOURNAL			English	Article							SURFACE-ACOUSTIC-WAVE; THIN-FILMS; NEGATIVE DIELECTROPHORESIS; ELECTRODES; MICROELECTRODES; CELLS; FABRICATION; BIOSENSORS; SUBSTRATE; PERFORMANCE	In this study, we attempted to produce a gold coating on a glass slide with an interdigitated array (IDA) pattern through a series of processes including spontaneous pattern formation as a key step instead of using photolithographic micromachining processes. In the first step, a gold film was formed by sputter deposition onto a strip of poly(dimethylsiloxane) (PDMS) elastomer. As part of the deposition process, the strip was heated because of the excess kinetic energy of the sputtered atoms. As the strip cooled to room temperature after the deposition, it thermally shrunk, causing the gold film to wrinkle because of buckling instability. Most of the wrinkles were oriented in a direction perpendicular to the lengthwise direction of the strip. In the second step, a glass strip that was narrower than the PDMS strip was placed on the PDMS strip. Sputter deposition of gold was repeated, resulting in the formation of wrinkles with an IDA pattern. Finally, this pattern was replicated on an elastomeric stamp surface that was then used for patterning a gold coating on a glass slide using microcontact printing techniques.	[Watanabe, Masashi; Hatano, Ryou; Koizumi, Chiho] Shinshu Univ, Fac Textile Sci & Technol, Ueda, Nagano 3868567, Japan	Watanabe, M (reprint author), Shinshu Univ, Fac Textile Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	mwatana@shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25410223]	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research (C), No. 25410223).	Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Loo YL, 2002, APPL PHYS LETT, V81, P562, DOI 10.1063/1.1493226; Bowden N, 1998, NATURE, V393, P146; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Chen YC, 2013, ACS NANO, V7, P3306, DOI 10.1021/nn4000034; [Anonymous], 2004, KAG BINR KIS HEN KAI; Chen X, 2004, J APPL MECH-T ASME, V71, P597, DOI 10.1115/1.1756141; Chung JY, 2009, ADV MATER, V21, P1358, DOI 10.1002/adma.200803209; WHITE RM, 1965, APPL PHYS LETT, V7, P314, DOI 10.1063/1.1754276; Sultan E, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2936922; Lin PC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743939; Kurosawa MK, 2000, ULTRASONICS, V38, P15, DOI 10.1016/S0041-624X(99)00087-6; Parashkov R, 2005, P IEEE, V93, P1321, DOI 10.1109/JPROC.2005.850304; Jeong JW, 2010, THIN SOLID FILMS, V518, P6343, DOI 10.1016/j.tsf.2010.01.056; Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Ho WO, 1999, ANAL CHEM, V71, P1940, DOI 10.1021/ac981367d; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ionescu RE, 2008, BIOSENS BIOELECTRON, V24, P489, DOI 10.1016/j.bios.2008.06.021; Guttenberg Z, 2005, LAB CHIP, V5, P308, DOI 10.1039/b412712a; SANDERSON DG, 1985, ANAL CHEM, V57, P2388, DOI 10.1021/ac00289a050; Casper MD, 2013, SOFT MATTER, V9, P7797, DOI 10.1039/c3sm50966d; Yasukawa T, 2012, ANAL CHEM, V84, P8830, DOI 10.1021/ac302239k; Chung JY, 2011, ADV MATER, V23, P349, DOI 10.1002/adma.201001759; Chikae M, 2006, ELECTROCHEM COMMUN, V8, P1375, DOI 10.1016/j.elecom.2006.06.019; Yoo PJ, 2002, ADV MATER, V14, P1383, DOI 10.1002/1521-4095(20021002)14:19<1383::AID-ADMA1383>3.0.CO;2-D; Kim SK, 2004, BIOSENS BIOELECTRON, V20, P887, DOI 10.1016/j.bios.2004.04.004; Ino K, 2009, ELECTROPHORESIS, V30, P3406, DOI 10.1002/elps.200900244; TOMMOY M, 1995, ANAL CHEM, V67, P1510, DOI 10.1021/ac00105a005; Berggren C, 2001, ELECTROANAL, V13, P173, DOI 10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO;2-B; Watanabe M, 2012, MACROMOLECULES, V45, P7128, DOI 10.1021/ma301143m; Lange K, 2008, ANAL BIOANAL CHEM, V391, P1509, DOI 10.1007/s00216-008-1911-5; Varshney M, 2009, BIOSENS BIOELECTRON, V24, P2951, DOI 10.1016/j.bios.2008.10.001; Son SU, 2006, SENSOR ACTUAT A-PHYS, V130, P267, DOI 10.1016/j.sna.2006.02.028; Breid D, 2011, SOFT MATTER, V7, P4490, DOI 10.1039/c1sm05152k; Yamamoto M, 2012, ELECTROCHIM ACTA, V82, P35, DOI 10.1016/j.electacta.2012.02.109; BELMONT C, 1994, J APPL ELECTROCHEM, V24, P719, DOI 10.1007/BF00578085; Daniel D, 2003, ELECTROCHEM COMMUN, V5, P782, DOI 10.1016/j.elecom.2003.07.004; Du ZF, 2011, J MATER SCI-MATER EL, V22, P418, DOI 10.1007/s10854-010-0152-5; Ho KC, 2003, SENSOR ACTUAT B-CHEM, V93, P370, DOI 10.1016/S0925-4005(03)00209-0; Hyun DC, 2010, ADV MATER, V22, P2642, DOI 10.1002/adma.201000277; Jo MC, 2013, SENSOR ACTUAT A-PHYS, V196, P1, DOI 10.1016/j.sna.2013.03.028; Molina-Lopez F, 2012, SENSOR ACTUAT B-CHEM, V166, P212, DOI 10.1016/j.snb.2012.02.042; Morgan D. P., 1985, SURFACE WAVE DEVICES; NIWA O, 1995, ELECTROANAL, V7, P606, DOI 10.1002/elan.1140070702; Ohzono T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132202; Saalmink M, 2006, LANGMUIR, V22, P1016, DOI 10.1021/la052513v; Shih TK, 2007, APPL SURF SCI, V253, P9381, DOI 10.1016/j.apsusc.2007.05.073; Shim JS, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/3/035002; Sielmann CJ, 2013, IEEE SENS J, V13, P4005, DOI 10.1109/JSEN.2013.2264930; Strobl CJ, 2004, APPL PHYS LETT, V85, P1427, DOI 10.1063/1.1787159; TAKAHASHI M, 1992, J ELECTROANAL CHEM, V335, P253, DOI 10.1016/0022-0728(92)80246-Z; TANG WC, 1990, SENSOR ACTUAT A-PHYS, V21, P328, DOI 10.1016/0924-4247(90)85065-C; Tomcik P, 2005, ANAL BIOANAL CHEM, V383, P864, DOI 10.1007/s00216-005-0055-0; Watanabe M, 2005, J POLYM SCI POL PHYS, V43, P1532, DOI 10.1002/polb.20464; Watanabe M, 2012, SOFT MATTER, V8, P1563, DOI 10.1039/c2sm06669f; Watanabe M, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40767; Watanabe M., 2014, J POLYM SCI B, DOI [10.1002/polb23599, DOI 10.1002/POLB23599]; Zaccheo BA, 2009, ANAL CHEM, V81, P5757, DOI 10.1021/ac900585g; Zhang AL, 2012, FERROELECTRICS, V432, P22, DOI 10.1080/00150193.2012.707595; Zhang AL, 2012, CHEM ENG PROCESS, V62, P145, DOI 10.1016/j.cep.2012.07.014	60	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					320	327		10.1038/pj.2014.116		8	Polymer Science	Polymer Science	CF4OH	WOS:000352528900005		
J	Tokuda, K; Noda, M; Maruyama, T; Kotera, M; Nishino, T				Tokuda, Kaya; Noda, Miki; Maruyama, Tatsuo; Kotera, Masaru; Nishino, Takashi			A low-fouling polymer surface prepared by controlled segregation of poly(ethylene oxide) and its functionalization with biomolecules	POLYMER JOURNAL			English	Article							PROTEIN ADSORPTION; ADHESION; POLYSTYRENE	A polyethylene terephthalate polymer surface was modified by dip coating in a polymer mixture composed of methacrylate-based terpolymers containing both perfluoroalkyl (R-f) groups and poly(ethylene oxide) (PEO) side chains, vinylidenefluoridetetrafluoroethylene copolymers ((CH2CF2)(80)(CF2CF2)(20)) and poly(methyl methacrylate). The terpolymers contained Rf groups with various numbers of carbons. After the dip coating, both the Rf groups and the PEO chains predominantly segregated on the top surface. The modified surfaces were characterized with X-ray photoelectron spectroscopy, protein adsorption, thrombogenesis and cell adhesion. The results indicate that because of the surface-segregated PEO chains, the surfaces exhibited resistance to nonspecific protein adsorption, antithrombogenicity and resistance to cell adhesion. In addition, covalent conjugation of biotin with the PEO termini enabled selective immobilization of streptavidin from a mixed protein solution on the dip-coated surface.	[Tokuda, Kaya; Noda, Miki; Maruyama, Tatsuo; Kotera, Masaru; Nishino, Takashi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Nishino, T (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan.	tnishino@kobe-u.ac.jp	Maruyama, Tatsuo/A-1744-2013	Maruyama, Tatsuo/0000-0003-2428-1911			YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Yu Q, 2010, LANGMUIR, V26, P8582, DOI 10.1021/la904663m; Peterbauer T, 2006, LAB CHIP, V6, P857, DOI 10.1039/b601803c; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Yuan X, 2009, ANAL CHEM, V81, P1549, DOI 10.1021/ac802282c; LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306; Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59; Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0; Pillai S, 2009, BIOMACROMOLECULES, V10, P2759, DOI 10.1021/bm900589r; Kassis CM, 1996, MACROMOLECULES, V29, P3247, DOI 10.1021/ma951782x; LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4; Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l; CZUHA M, 1975, ANAL CHEM, V47, P1836, DOI 10.1021/ac60361a021; George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012; HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826; Lens JP, 1997, J BIOMAT SCI-POLYM E, V8, P963, DOI 10.1163/156856297X00128; PARK IJ, 1994, J APPL POLYM SCI, V54, P1449, DOI 10.1002/app.1994.070541008; Qie Y. X., 1996, J APPL POLYM SCI, V61, P2373; Sung D., 2004, LANGMUIR, V25, P11289; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tokuda K., 2013, P ADHESION 13, P61; Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106	23	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					328	333		10.1038/pj.2014.131		6	Polymer Science	Polymer Science	CF4OH	WOS:000352528900006		
J	Nakai, Y; Yoshikawa, M				Nakai, Yoshitaro; Yoshikawa, Masakazu			Cellulose as a membrane material for optical resolution	POLYMER JOURNAL			English	Article							MOLECULARLY IMPRINTED MATERIALS; RESONANCE SPR SPECTROSCOPY; POLYION COMPLEX MEMBRANES; RACEMIC AMINO-ACIDS; CHIRAL SEPARATION; PERVAPORATION SEPARATION; RECOGNITION ABILITY; NANOFIBER MEMBRANES; AGAROSE MEMBRANES; VAPOR PERMEATION	In the present study, cellulose, one of the most abundant natural polymers, was adopted as a membrane material for optical resolution. The membrane was prepared from cellulose, and it selectively transported L-glutamic acid (L-Glu) from racemic mixtures of Glu with a concentration gradient as the driving force. A molecularly imprinted cellulose membrane, which was constructed from cellulose and L-Glu, showed D-glutamic acid (D-Glu) permselectivity, which is thought to be due to a strong interaction between L-Glu and the molecularly imprinted cellulose membrane. The performance of both membranes was significantly dependent on LiCl, which was used to dissolve cellulose into an N, N-dimethylactamide (DMAc) solvent. The permselectivity increased with the LiCl concentration and asymptotically reached a maximum value at higher LiCl concentrations. The affinity constant of LiCl for the LiCl recognition sites in both membranes was 65 mol(-1) dm(3).	[Nakai, Yoshitaro; Yoshikawa, Masakazu] Kyoto Inst Technol, Dept Biomol Engn, Kyoto 6068585, Japan	Yoshikawa, M (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Kyoto 6068585, Japan.	masahiro@kit.ac.jp					Wang HD, 2007, J MEMBRANE SCI, V297, P262, DOI 10.1016/j.memsci.2007.03.055; Sueyoshi Y, 2010, J MEMBRANE SCI, V357, P90, DOI 10.1016/j.memsci.2010.04.005; Yoshikawa M, 2003, MACROMOL BIOSCI, V3, P487, DOI 10.1002/mabi.200350016; Piletsky SA, 1999, J MEMBRANE SCI, V157, P263, DOI 10.1016/S0376-7388(99)00007-1; MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010; [Anonymous], INT CRITICAL TABLES, p[43, 1028]; Iwamoto Y, 2010, DESALIN WATER TREAT, V17, P268, DOI 10.5004/dwt.2010.1728; Iwamoto Yuki, 2010, Membrane, V35, P201; Izumi Jun-Ichiro, 1997, Membrane, V22, P149; Kawasaki T, 2013, DESALIN WATER TREAT, V51, P5080, DOI 10.1080/19443994.2013.768832; Kim CW, 2005, J POLYM SCI POL PHYS, V43, P1673, DOI 10.1002/polb.20475; Kondo Yoshiko, 2001, Membrane, V26, P228; Ma CO, 2011, CHIRALITY, V23, P379, DOI 10.1002/chir.20935; Masaki Kumi, 2001, Membrane, V26, P155; MASAWAKI T, 1992, J CHEM ENG JPN, V25, P33, DOI 10.1252/jcej.25.33; MICHAELS AS, 1962, IND ENG CHEM PROC DD, V1, P14, DOI 10.1021/i260001a003; Matsuura Takanori, 2006, Membrane, V31, P281; Shiomi K, 2013, SEP PURIF TECHNOL, V118, P300, DOI 10.1016/j.seppur.2013.07.004; Sueyoshi Y., 2012, Sustainable Agriculture Research, V1, P42; Sueyoshi Y, 2011, WASTE BIOMASS VALORI, V2, P303, DOI 10.1007/s12649-011-9066-6; Taki K, 1999, J POLYM SCI POL PHYS, V37, P1035, DOI 10.1002/(SICI)1099-0488(19990515)37:10<1035::AID-POLB8>3.0.CO;2-L; Taniwaki K, 2003, ANAL CHIM ACTA, V489, P191, DOI 10.1016/S0003-2670(03)00760-8; Weast R.C., 1988, CRC HDB CHEM PHYS; Yoshikawa M, 2002, BIOSEPARATION, V10, P277; Yoshikawa Masakazu, 2008, Membrane, V33, P118; Yoshikawa M, 2002, J MEMBRANE SCI, V205, P293, DOI 10.1016/S0376-7388(02)00131-X; Yoshikawa M, 2007, MACROMOL SYMP, V249, P557, DOI 10.1002/masy.200750436; Yoshikawa M, 1999, J APPL POLYM SCI, V72, P493, DOI 10.1002/(SICI)1097-4628(19990425)72:4<493::AID-APP5>3.0.CO;2-U; Yoshikawa M, 2000, J MEMBRANE SCI, V178, P75, DOI 10.1016/S0376-7388(00)00478-6; Yoshikawa M, 2006, MACROMOL BIOSCI, V6, P210, DOI 10.1002/mabi.200500187; Yoshikawa M, 2004, J MEMBRANE SCI, V243, P89, DOI 10.1016/j.memsci.2004.05.033; Yoshikawa Masakazu, 2004, Membrane, V29, P384; Yoshikawa Masakazu, 2007, Membrane, V32, P40; Yoshikawa M, 1998, ACS SYM SER, V703, P170; Yoshikawa M, 2007, POLYM J, V39, P1193, DOI 10.1295/polymj.PJ2007080	35	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					334	339		10.1038/pj.2014.106		6	Polymer Science	Polymer Science	CF4OH	WOS:000352528900007		
J	Yang, YY; Ogasawara, S; Li, G; Kato, SJ				Yang, Yaoyao; Ogasawara, Shin; Li, Guang; Kato, Shinji			Dendrimer-stabilized Pd polymer composites: drastic suppression of Pd leaching and fine catalysis sustainability	POLYMER JOURNAL			English	Article							CROSS-COUPLING REACTIONS; SUBNANOMETER PALLADIUM CLUSTERS; AQUEOUS-MEDIA; ENCAPSULATED NANOPARTICLES; POLY(METHYL METHACRYLATE); HETEROGENEOUS CATALYSIS; MICROPOROUS POLYMERS; AMBIENT CONDITIONS; ARYL CHLORIDES; SUZUKI	The effects of the ligand used for fabricating palladium (Pd)-incorporated porous polymer composites on their catalytic performances were examined from the perspective of catalysis sustainability. To perform this research, poly(amidoamine) (PAMAM) dendrimers, which were generation zero (G0) and higher, up to G6, the breakdown structure of G0 (that is, the half (G0h) and quarter (G0q)) and a typical small molecule (that is, N, N-dimethyl ethylenediamine (DMEn)) were utilized as ligands. The catalytic performances of the polymer composites were investigated using the aqueous Suzuki-Miyaura carbon cross-coupling reaction as a model reaction. Concerning the efficiency, recyclability and Pd-leaching behavior of the catalytic reaction, polymer composites that were fabricated with PAMAM dendrimers (that is, G1 and higher generations) proved to possess the potential for application as sustainable heterogeneous catalysts.	[Yang, Yaoyao; Li, Guang] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China; [Yang, Yaoyao; Ogasawara, Shin; Kato, Shinji] Kawamura Inst Chem Res, Polymer Chem Lab, Sakura, Chiba 2858668, Japan	Kato, SJ (reprint author), Kawamura Inst Chem Res, Polymer Chem Lab, Sakura, Chiba 2858668, Japan.	shinji-kato@ma.dic.co.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23550172]	Some of the transmission electron microscopy (TEM) images were obtained at the Graduate School of Materials Science, Nara Institute of Science and Technology, with the support of Kyoto-Advanced Nanotechnology Network. We thank Professor Atsushi Ikeda for helpful discussions. We also thank Dr Masafumi Uota for helpful discussions and technical support. We gratefully acknowledge analytical support from the Analysis Center at the DIC Corporation. This research was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 23550172) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kong LR, 2011, ACS APPL MATER INTER, V3, P35, DOI 10.1021/am101077a; TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117; Aymonier C, 2003, CHEM MATER, V15, P4874, DOI [10.1021/cm031049h, 10.1021/cm034019h]; Bronstein LM, 2011, CHEM REV, V111, P5301, DOI 10.1021/cr2000724; Bernechea M, 2009, INORG CHEM, V48, P4491, DOI 10.1021/ic9002753; Esumi K, 1998, LANGMUIR, V14, P3157, DOI 10.1021/la980162x; Balanta A, 2011, CHEM SOC REV, V40, P4973, DOI 10.1039/c1cs15195a; Fang PP, 2011, ANGEW CHEM INT EDIT, V50, P12184, DOI 10.1002/anie.201103465; Jin MJ, 2010, ANGEW CHEM INT EDIT, V49, P1119, DOI 10.1002/anie.200905626; Shin JY, 2007, CHEM COMMUN, P5238, DOI 10.1039/b711237h; Phan NTS, 2006, ADV SYNTH CATAL, V348, P609, DOI 10.1002/adsc.200505473; Gil-Molto J, 2005, TETRAHEDRON, V61, P12168, DOI 10.1016/j.tet.2005.08.122; Yamamoto K, 2009, NAT CHEM, V1, P397, DOI [10.1038/nchem.288, 10.1038/NCHEM.288]; Fujii S, 2010, LANGMUIR, V26, P6230, DOI 10.1021/la9039545; Gatard S, 2011, TETRAHEDRON LETT, V52, P1842, DOI 10.1016/j.tetlet.2011.02.015; Agostini G, 2010, LANGMUIR, V26, P11204, DOI 10.1021/la1005117; Zhang ZP, 2003, J MATER CHEM, V13, P641, DOI 10.1039/b212428a; Agostini G, 2009, J PHYS CHEM C, V113, P10485, DOI 10.1021/jp9023712; Scott RWJ, 2005, J PHYS CHEM B, V109, P692, DOI 10.1021/jp0469665; Cho JK, 2006, J AM CHEM SOC, V128, P6276, DOI 10.1021/ja057480k; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Esumi K, 2004, LANGMUIR, V20, P237, DOI 10.1021/la035440t; Durand J, 2008, EUR J INORG CHEM, P3577, DOI 10.1002/ejic.200800569; Yang YY, 2014, J PHYS CHEM C, V118, P5872, DOI 10.1021/jp5001607; Okamoto K, 2005, J AM CHEM SOC, V127, P2125, DOI 10.1021/ja047095f; Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w; Ornelas C, 2008, CHEM-EUR J, V14, P50, DOI 10.1002/chem.200701410; Wang S, 2013, J AM CHEM SOC, V135, P11849, DOI 10.1021/ja403822d; Astruc D, 2007, INORG CHEM, V46, P1884, DOI 10.1021/ic062183h; Zhao MQ, 1998, J AM CHEM SOC, V120, P4877, DOI 10.1021/ja980438n; Myers VS, 2011, CHEM SCI, V2, P1632, DOI 10.1039/c1sc00256b; Yamada YMA, 2012, J AM CHEM SOC, V134, P3190, DOI 10.1021/ja210772v; Diallo AK, 2007, ANGEW CHEM INT EDIT, V46, P8644, DOI 10.1002/anie.200703067; Urraca JL, 2011, J AM CHEM SOC, V133, P9220, DOI 10.1021/ja202908z; Yang YY, 2013, J MATER CHEM A, V1, P3700, DOI 10.1039/c3ta01407j; Davies IW, 2001, J AM CHEM SOC, V123, P10139, DOI 10.1021/ja016877v; Scott RWJ, 2004, CHEM MATER, V16, P5682, DOI 10.1021/cm049279z; Gaikwad AV, 2007, CHEM-EUR J, V13, P6908, DOI 10.1002/chem.200700105; Ranganath KVS, 2010, ANGEW CHEM INT EDIT, V49, P7786, DOI 10.1002/anie.201002782; Chandler BD, 2006, TOP ORGANOMETAL CHEM, V20, P97, DOI 10.1007/3418_033; Cassol CC, 2005, J AM CHEM SOC, V127, P3298, DOI 10.1021/ja0430043; Ogasawara S, 2010, J AM CHEM SOC, V132, P4608, DOI 10.1021/ja9062053; Astruc D, 2010, MOLECULES, V15, P4947, DOI 10.3390/molecules15074947; de Vries JG, 2006, DALTON T, P421, DOI 10.1039/b506276b; Hasegawa G, 2011, POLYMER, V52, P4644, DOI 10.1016/j.polymer.2011.08.028; Heigl N, 2009, ANAL CHEM, V81, P5655, DOI 10.1021/ac900375z; Inasaki T, 2007, SYNLETT, P3209, DOI 10.1055/s-2007-1000816; Kahat T., 2007, NEW J CHEM, V31, P1218; Kibata T, 2013, CHEM COMMUN, V49, P167, DOI 10.1039/c2cc37038g; Mejias N, 2010, EUR J ORG CHEM, P5090, DOI 10.1002/ejoc.201000671; NAKAO Y, 1993, J CHEM SOC CHEM COMM, P826, DOI 10.1039/c39930000826; O'Connor NA, 2007, J AM CHEM SOC, V129, P1680, DOI 10.1021/ja067276c; Ornelas C, 2008, ADV SYNTH CATAL, V350, P837, DOI 10.1002/adsc.200700584; Scott RWJ, 2005, J AM CHEM SOC, V127, P1380, DOI 10.1021/ja044446h; Yanagihara N, 1999, LANGMUIR, V15, P3038, DOI 10.1021/la9815401	55	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					340	347		10.1038/pj.2014.133		8	Polymer Science	Polymer Science	CF4OH	WOS:000352528900008		
J	Yokoyama, A; Karasawa, M; Kiyota, R; Taniguchi, M; Hirano, Y; Ohta, Y; Yokozawa, T				Yokoyama, Akihiro; Karasawa, Makoto; Kiyota, Ryohei; Taniguchi, Masahisa; Hirano, Yuta; Ohta, Yoshihiro; Yokozawa, Tsutomu			Polymerization of 4,6-diaminoisophthalic acid-type monomers bearing anthranilic acid ester and isatoic anhydride moieties	POLYMER JOURNAL			English	Article							LADDER POLYMER; POLY(IPTYCENE)		[Yokoyama, Akihiro] Seikei Univ, Fac Sci & Technol, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan; [Karasawa, Makoto; Kiyota, Ryohei; Taniguchi, Masahisa; Hirano, Yuta; Ohta, Yoshihiro; Yokozawa, Tsutomu] Kanagawa Univ, Dept Mat & Life Chem, Yokohama, Kanagawa, Japan	Yokoyama, A (reprint author), Seikei Univ, Fac Sci & Technol, Dept Mat & Life Sci, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	ayokoyama@st.seikei.ac.jp			JSPS KAKENHI [20550114]	This work was partially supported by JSPS KAKENHI Grant Number 20550114.	Chen ZH, 2006, MACROMOLECULES, V39, P3202, DOI 10.1021/ma052451f; Thomas SW, 2005, J AM CHEM SOC, V127, P17976, DOI 10.1021/ja056241u; Yokozawa T, 2009, CHEM REV, V109, P5595, DOI 10.1021/cr900041c; Perepichka DF, 2003, J AM CHEM SOC, V125, P10190, DOI 10.1021/ja036193i; AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; Babel A, 2003, J AM CHEM SOC, V125, P13656, DOI 10.1021/ja0371810; Yokoyama A, 2007, MACROMOLECULES, V40, P4093, DOI 10.1021/ma061357b; Zhang AM, 2006, ORG LETT, V8, P803, DOI 10.1021/ol0526322; Hu WP, 2001, J ORG CHEM, V66, P2881, DOI 10.1021/jo010043d; Oyaizu K, 2002, MACROMOLECULES, V35, P67, DOI 10.1021/ma010961d; WEGENER S, 1993, MACROMOLECULES, V26, P3037, DOI 10.1021/ma00064a007; Yokoyama A, 2013, CHEM LETT, V42, P641, DOI 10.1246/cl.130143	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	APR	2015	47	4					348	351		10.1038/pj.2014.105		4	Polymer Science	Polymer Science	CF4OH	WOS:000352528900009		
J	Shiono, A; Hosaka, A; Watanabe, C; Teramae, N; Nemoto, N; Ohtani, H				Shiono, Ai; Hosaka, Akihiko; Watanabe, Chuichi; Teramae, Norio; Nemoto, Nobukatsu; Ohtani, Hajime			Thermoanalytical characterization of polymers: A comparative study between thermogravimetry and evolved gas analysis using a temperature-programmable pyrolyzer	POLYMER TESTING			English	Article						TG (DTG) and EGA; Comparative study; Temperature-programmable pyrolyzer-MS; 15 Representative polymers; Sample mass; Heating rate vs peak temperature	MASS-SPECTROMETRY; THERMAL-DECOMPOSITION; INTERFACE; CHROMATOGRAPHY; POLYSTYRENE; DEGRADATION; KINETICS; EGA	Evolved gas analysis (EGA) was carried out on 15 synthetic polymer samples using z temperature programmable pyrolyzer as a heating unit which was on-line coupled with z MS detector. A deactivated stainless steel tube and a vent free adapter were used to couple the pyrolyzer with the MS detector, and they were placed in a GC oven at 300 degrees C to avoic condensation of evolved gases with high boiling point. Thermograms of polystyrenE measured by this system (Py-EGA-MS) showed shifts of the peak temperature to the higher temperature region as the sample mass increased. It was found that the S/N ratio: of EGA thermograms were 420-fold superior to those of differential thermogravimetr) (DTG) thermograms for the same sample mass of 0.20 mg. Since a good linear relationship was obtained between peak temperatures obtained by Py-EGA-MS and DTG, it can bE concluded that Py-EGA-MS can be used to obtain reliable data on thermal properties o samples with high sensitivity and using less sample.(C) 2015 Elsevier Ltd. All rights reserved	[Shiono, Ai; Hosaka, Akihiko; Watanabe, Chuichi; Teramae, Norio] Frontier Labs Ltd, Koriyama, Fukushima 9638862, Japan; [Teramae, Norio] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Nemoto, Nobukatsu] Nihon Univ, Dept Chem Biol & Appl Chem, Coll Engn, Koriyama, Fukushima 9638642, Japan; [Ohtani, Hajime] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Hosaka, A (reprint author), Frontier Labs Ltd, 1-8-14 Saikon, Koriyama, Fukushima 9638862, Japan.	hosaka@frontier-lab.com					Peterson JD, 2001, MACROMOL CHEM PHYSIC, V202, P775, DOI 10.1002/1521-3935(20010301)202:6<775::AID-MACP775>3.0.CO;2-G; Statheropoulos M, 1998, THERMOCHIM ACTA, V322, P167, DOI 10.1016/S0040-6031(98)00496-1; Materazzi S, 2006, TALANTA, V68, P489, DOI 10.1016/j.talanta.2005.04.055; Materazzi S, 2006, TALANTA, V69, P781, DOI 10.1016/j.talanta.2005.12.007; Ozawa T, 2000, THERMOCHIM ACTA, V355, P35, DOI 10.1016/S0040-6031(00)00435-4; Gronli M, 1999, IND ENG CHEM RES, V38, P2238, DOI 10.1021/ie980601n; Mayer ZA, 2012, J ANAL APPL PYROL, V94, P170, DOI 10.1016/j.jaap.2011.12.008; Yu SZ, 2002, COMPOS PART A-APPL S, V33, P289, DOI 10.1016/S1359-835X(01)00107-5; Encinar JM, 2008, FUEL PROCESS TECHNOL, V89, P678, DOI 10.1016/j.fuproc.2007.12.011; Gomez EF, 2014, POLYM DEGRAD STABIL, V102, P195, DOI 10.1016/j.polymdegradstab.2014.01.008; Arii T., 2006, J MASS SPECTROM SOC, V54, P243; Celiz LL, 2014, J THERM ANAL CALORIM, V116, P1435, DOI 10.1007/s10973-014-3817-0; Chalmers J.M., 2008, COMPREHENSIVE ANAL C, V53; Dimitrov N, 2013, POLYM DEGRAD STABIL, V98, P972, DOI 10.1016/j.polymdegradstab.2013.02.013; Hatakeyama T., 1994, THERM ANAL, P50; Kim BH, 2012, J ANAL APPL PYROL, V98, P236, DOI 10.1016/j.jaap.2012.09.010; Klampfl CW, 2013, TRAC-TREND ANAL CHEM, V50, P53, DOI 10.1016/j.trac.2013.04.012; Raemaekers KGH, 1997, THERMOCHIM ACTA, V295, P1, DOI 10.1016/S0040-6031(97)00097-X; Saraji-Bozorgzad MR, 2011, J THERM ANAL CALORIM, V105, P691, DOI 10.1007/s10973-011-1383-2; Shin T, 2011, PYROLYSIS-GC/MS DATA BOOK OF SYNTHETIC POLYMERS: PYROGRAMS, THERMOGRAMS AND MS OF PYROLYZATES, P1; Tsugoshi T, 2006, TALANTA, V70, P186, DOI 10.1016/j.talanta.2006.01.035; Watanabe C, 2002, LC GC N AM, V20, P374; Watanabe C, 2011, ANAL SCI, V27, P1087; Watanabe C., 2001, AM LAB, V33, P14; Yang J, 2001, POLYM DEGRAD STABIL, V73, P455, DOI 10.1016/S0141-3910(01)00129-X; Yuzawa T, 2009, ANAL SCI, V25, P1057	26	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9418	1873-2348		POLYM TEST	Polym. Test	APR	2015	42						54	61		10.1016/j.polymertesting.2014.12.011		8	Materials Science, Characterization & Testing; Polymer Science	Materials Science; Polymer Science	CE7UM	WOS:000352047300008		
J	Sago, H; Sekizawa, A				Sago, Haruhiko; Sekizawa, Akihiko		Japan NIPT Consortium	Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience	PRENATAL DIAGNOSIS			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; WOMEN; ANEUPLOIDY; AGE	ObjectiveTo report the 1-year experience of a nationwide demonstration project to introduce noninvasive prenatal testing of aneuploidy from maternal plasma and discuss how to implement this program in Japan. MethodsThe test was conducted to detect aneuploidy in high-risk pregnant women with adequate genetic counseling. The clinical data, test results, and pregnancy outcomes were recorded. ResultsOf the 7740 women tested, 142 (1.8%) had positive results, 7594 (98.1%) had negative results, and four (0.1%) had results that were not reportable. Of the 142 women who tested positive, 13 cases resulted in intrauterine fetal death, and three cases refused to undergo the invasive procedure. Of the 126 positive cases confirmed on karyotyping, a normal karyotype was observed for trisomy 21 in three cases, trisomy 18 in eight cases, and trisomy 13 in two cases. In the follow-up study of the negative cases (n=1638), only one false-negative case of trisomy 18 was detected. ConclusionsWe described our nationwide 1-year experience with noninvasive prenatal genetic testing. It is expected that the present data will stimulate a debate regarding prenatal genetic testing and hopefully lead to improvements in the perinatal care system with respect to genetic counseling in Japan. (c) 2014 John Wiley & Sons, Ltd.	[Sago, Haruhiko; Sekizawa, Akihiko] Japan NIPT Consortium, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 142, Japan	Sekizawa, A (reprint author), Japan NIPT Consortium, Tokyo, Japan.	sekizawa@med.showa-u.ac.jp			National Center for Child Health and Development, Japan [24-3]	Supported by the Grant of the National Center for Child Health and Development 24-3, Japan.	Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Yotsumoto J, 2012, PRENATAL DIAG, V32, P674, DOI 10.1002/pd.3886; Onda T, 1996, PRENATAL DIAG, V16, P713, DOI 10.1002/(SICI)1097-0223(199608)16:8<713::AID-PD933>3.0.CO;2-X; Larion S, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.038; Sasaki A, 2011, PRENATAL DIAG, V31, P1007, DOI 10.1002/pd.2816; Suzumori N, 2014, PRENATAL DIAG, V34, P1055, DOI 10.1002/pd.4427	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-3851	1097-0223		PRENATAL DIAG	Prenat. Diagn.	APR	2015	35	4					331	336		10.1002/pd.4539		6	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CF4BN	WOS:000352493500004		
J	Tabuchi, T; Fujiwara, T				Tabuchi, Takahiro; Fujiwara, Takeo			Are secondhand smoke-related diseases of children associated with parental smoking cessation? Determinants of parental smoking cessation in a population-based cohort study	PREVENTIVE MEDICINE			English	Article						Smoking cessation; Tobacco smoke pollution; Japan	GENERAL-POPULATION; CLINICAL-TRIALS; FOLLOW-UP; PREGNANCY; BEHAVIOR; PREDICTORS; JAPAN; RISK; PATTERNS; EXPOSURE	Objective. Little is known about whether secondhand smoke (SHS)-related diseases of young children, such as asthma, induce parental smoking cessation during the early child-rearing period. Our objective was therefore to show the association in addition to other potential determinants of parental cessation. Methods. We analyzed data from the Longitudinal Survey of Newborns in the 21st Century in Japan, from 0.5 years (N = 47,015) to 4.5 years (N = 39,817), having selected participants whose parents smoked at baseline (maternal smoking N = 8,037; paternal smoking N = 28,486). Multivariable log-binomial regression models were used to calculate the prevalence ratios for parental smoking cessation according to the onset of SHS-related diseases of their children, using inverse probability weight to account for non-response at follow-up. Results. A total of 16.7% of smoking mothers and 14.5% of smoking fathers had stopped smoking at follow-up. The onset of SHS-related children's diseases was not statistically significantly associated with either maternal or paternal smoking cessation after multivariable adjustments. Strong determinants were, for example, number of cigarettes smoked per day and partner's smoking status during follow-up. Conclusion. SHS-related children's diseases were not associated with parental smoking cessation. It may therefore be necessary to provide additional support for parental smoking cessation within their child's medical care setting. (C) 2015 Elsevier Inc. All rights reserved.	[Tabuchi, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, Osaka 5378511, Japan; [Tabuchi, Takahiro; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo 1578535, Japan	Tabuchi, T (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, 3-3 Nakamichi 1 Chome, Osaka 5378511, Japan.	tabuti-ta@mc.pref.osaka.jp; fujiwara-tk@ncchd.go.jp			Ministry of Health, Labour and Welfare [H25-010]; Ministry of Education, Culture, Sports, Science and Technology (KAKENHI) [21119003, 14517690]	This study was supported by the Ministry of Health, Labour and Welfare (Grant; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H25-010)) and the Ministry of Education, Culture, Sports, Science and Technology (KAKENHI Grant number; 21119003 and 14517690). We thank Dr Jun Ito and Ms Manami Ochi for their assistance in database formation and valuable comments. We also thank Dr Julia Mortimer for her English language editing.	Ives SP, 2008, EUR J CARDIOV PREV R, V15, P329, DOI 10.1097/HJR.0b013e3282f37a58; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Tong Van T., 2009, Morbidity and Mortality Weekly Report, V58, P1; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Caraballo RS, 2001, AM J EPIDEMIOL, V153, P807, DOI 10.1093/aje/153.8.807; Halterman JS, 2007, J ASTHMA, V44, P83, DOI 10.1080/02770900601180545; Cooley ME, 2009, LUNG CANCER, V66, P218, DOI 10.1016/j.lungcan.2009.01.021; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; Stewart DW, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301062; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Yasuda T, 2013, J OBSTET GYNAECOL RE, V39, P1505, DOI 10.1111/jog.12098; Pollak KI, 2010, ETHNIC HEALTH, V15, P47, DOI 10.1080/13557850903398293; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Yamakawa M, 2013, JAMA PEDIATR, V167, P919, DOI 10.1001/jamapediatrics.2013.2230; Stein RJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e66; Hagimoto A, 2010, ADDICTION, V105, P164, DOI 10.1111/j.1360-0443.2009.02735.x; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Blackburn C, 2005, SOC SCI MED, V61, P517, DOI 10.1016/j.socscimed.2004.12.009; Kaneita Y, 2006, PREV MED, V42, P210, DOI 10.1016/j.ypmed.2005.11.017; Chamberlain C., 2013, COCHRANE DB SYST REV, V10; Eriksen M, 2012, TOBACCO ATLAS; Hauge LJ, 2013, NICOTINE TOB RES, V15, P428, DOI 10.1093/ntr/nts147; Ministry of Health Labour and Welfare, 2013, LONG SURV NEWB 21 CE; Ministry of Health Labour and Welfare Japan, 2014, NAT HLTH NUTR SURV; Nafstad P, 1996, PUBLIC HEALTH, V110, P379, DOI 10.1016/S0033-3506(96)80012-6; Ohga A, 2005, JPN J MATERN HLTH, V45, P423; Park E. W., 2012, COCHRANE DB SYST REV, V7; Pattemore Philip Keith, 2013, Front Pediatr, V1, P20, DOI 10.3389/fped.2013.00020; Rattan D, 2013, BJOG-INT J OBSTET GY, V120, P288, DOI 10.1111/1471-0528.12027; Royal College of Physicians, 2010, PASS SMOK CHILDR REP; U.S. Department of Health and Human Services Centers for Disease Control Office on Smoking and Health, 2006, HLTH CONS INV SMOK R	34	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	APR	2015	73						81	87		10.1016/j.ypmed.2015.01.028		7	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	CE9SB	WOS:000352182600017		
J	Akiyama, T				Akiyama, Tsuyoshi			Jean Delay Prize for Professor Mitsumoto Sato	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Editorial Material									NTT Med Ctr, Tokyo, Japan	Akiyama, T (reprint author), NTT Med Ctr, Tokyo, Japan.						Sartorius N, 2014, SCHIZOPHRENIA B; Sato M, 2013, 6 INT M WPA ANT SECT; Tatum AL, 1929, J PHARMACOL EXP THER, V36, P401	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					178	178		10.1111/pcn.12241		1	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200001		
J	Hayashi, T				Hayashi, Teruo			Conversion of psychological stress into cellular stress response: Roles of the sigma-1 receptor in the process	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						endoplasmic reticulum stress; oxidative stress; psychological stress; sigma-1 receptor	ENDOPLASMIC-RETICULUM STRESS; AMYOTROPHIC-LATERAL-SCLEROSIS; UNFOLDED PROTEIN RESPONSE; ER STRESS; NEUROPSYCHIATRIC DISORDERS; XBP1-116C/G POLYMORPHISM; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; PREFRONTAL CORTEX; BIPOLAR DISORDER	Psychiatrists empirically recognize that excessive or chronic psychological stress can result in long-lasting impairments of brain functions that partly involve neuronal cell damage. Recent studies begin to elucidate the molecular pathways activated/inhibited by psychological stress. Activation of the hypothalamic-pituitary-adrenal axis under psychological stress causes inflammatory oxidative stresses in the brain, in part due to elevation of cytokines. Psychological stress or neuropathological conditions (e.g., accumulation of -amyloids) trigger cellular stress responses', which promote upregulation of molecular chaperones to protect macromolecules from degradation. The unfolded protein response, the endoplasmic reticulum (ER)-specific cellular stress response, has been recently implicated in the pathophysiology of neuropsychiatric disorders and the pharmacology of certain clinically used drugs. The sigma-1 receptor is an ER protein whose ligands are shown to exert antidepressant-like and neuroprotective actions. Recent studies found that the sigma-1 receptor is a novel ligand-operated ER chaperone that regulates bioenergetics, free radical generation, oxidative stress, unfolded protein response and cytokine signaling. The sigma-1 receptor also regulates morphogenesis of neuronal cells, such as neurite outgrowth, synaptogenesis, and myelination, which can be perturbed by cellular stress. The sigma-1 receptor may thus contribute to a cellular defense system that protects nervous systems against chronic psychological stress. Findings from sigma receptor research imply that not only cell surface monoamine effectors but also intracellular molecules, especially those at the ER, may provide novel therapeutic targets for future drug developments.	Seiwakai Nishikawa Hosp, Hamada, Shimane 6970052, Japan	Hayashi, T (reprint author), Seiwakai Nishikawa Hosp, 293-2 Minato Machi, Hamada, Shimane 6970052, Japan.	thayashi2r@gmail.com					Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Gu HF, 2012, ATHEROSCLEROSIS, V223, P69, DOI 10.1016/j.atherosclerosis.2012.01.021; Ortega-Roldan JL, 2013, J BIOL CHEM, V288, P21448, DOI 10.1074/jbc.M113.450379; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Chuang DM, 2005, ANN NY ACAD SCI, V1053, P195, DOI 10.1196/annals.1344.018; Kishi T, 2010, NEUROPHARMACOLOGY, V58, P1168, DOI 10.1016/j.neuropharm.2010.02.013; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Li LA, 2010, NEUROPHARMACOLOGY, V59, P323, DOI 10.1016/j.neuropharm.2010.02.009; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Kim B, 2009, PSYCHIAT RES, V168, P209, DOI 10.1016/j.psychres.2008.05.010; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; Lester HA, 2012, BIOL PSYCHIAT, V72, P907, DOI 10.1016/j.biopsych.2012.05.020; Gold PW, 2013, MOL PSYCHIATR, V18, P154, DOI 10.1038/mp.2012.167; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/003-073; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Hayashi T, 2012, J BIOL CHEM, V287, P43156, DOI 10.1074/jbc.M112.380444; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Tagashira H, 2014, BBA-GEN SUBJECTS, V1840, P3320, DOI 10.1016/j.bbagen.2014.08.012; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Chu TT, 2010, J HUM GENET, V55, P285, DOI 10.1038/jhg.2010.24; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Mancuso R, 2012, NEUROTHERAPEUTICS, V9, P814, DOI 10.1007/s13311-012-0140-y; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Ono Y, 2014, NEUROSCI LETT, V559, P174, DOI 10.1016/j.neulet.2013.12.005; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Miyatake R, 2004, BIOL PSYCHIAT, V55, P85, DOI 10.1016/j.biopsych.2003.07.008; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Harding HP, 1999, NATURE, V397, P271; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Mitsuda T, 2011, BIOCHEM BIOPH RES CO, V415, P519, DOI 10.1016/j.bbrc.2011.10.113; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Kowalczyk M, 2014, CELL STRESS CHAPERON, V19, P205, DOI 10.1007/s12192-013-0446-7; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Mori T, 2012, J PHARMACOL EXP THER, V341, P663, DOI 10.1124/jpet.111.190868; Ritsner MS, 2014, PSYCHIAT CLIN NEUROS, V68, P432, DOI 10.1111/pcn.12150; Allahtavakoli M, 2011, BRAIN RES BULL, V85, P219, DOI 10.1016/j.brainresbull.2011.03.019; Maurice T, 2003, PHARMACOL BIOCHEM BE, V74, P869, DOI 10.1016/S0091-3057(03)00002-9; Smith EM, 1999, J NEUROIMMUNOL, V100, P140, DOI 10.1016/S0165-5728(99)00206-4; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; Tsai SY, 2012, SYNAPSE, V66, P42, DOI 10.1002/syn.20984; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; BLAKE MJ, 1993, ENDOCRINOLOGY, V132, P1063, DOI 10.1210/en.132.3.1063; Bown CD, 2002, BIPOLAR DISORD, V4, P145, DOI 10.1034/j.1399-5618.2002.t01-1-40201.x; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cheng D, 2014, AM J MED GENET B, V165, P665, DOI 10.1002/ajmg.b.32271; Currie S, 2010, P R SOC B, V277, P905, DOI 10.1098/rspb.2009.1562; D'Ambrosi N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00279; Ghafourifar P, 2008, FRONT BIOSCI-LANDMRK, V13, P3116, DOI 10.2741/2913; Hayashi A, 2009, INT J NEUROPSYCHOPH, V12, P33, DOI 10.1017/S1461145708009358; Hayashi A, 2008, BIOCHEM BIOPH RES CO, V376, P758, DOI 10.1016/j.bbrc.2008.09.059; Kakiuchi C, 2004, PSYCHIAT CLIN NEUROS, V58, P438, DOI 10.1111/j.1440-1819.2004.01280.x; Kusumi Ichiro, 2005, Neurosci Lett, V391, P7, DOI 10.1016/j.neulet.2005.08.023; Liu YH, 2011, J PSYCHIATR RES, V45, P269, DOI 10.1016/j.jpsychires.2010.06.010; Maletic Vladimir, 2014, Front Psychiatry, V5, P98, DOI 10.3389/fpsyt.2014.00098; Manie SN, 2014, AM J PHYSIOL-CELL PH, V307, pC901, DOI 10.1152/ajpcell.00292.2014; Matsuno K, 1996, EUR J PHARMACOL, V312, P267, DOI 10.1016/0014-2999(96)00497-9; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nagane A, 2014, PSYCHIAT RES, V218, P101, DOI 10.1016/j.psychres.2014.04.013; Nevell L, 2014, PSYCHONEUROENDOCRINO, V43, P62, DOI 10.1016/j.psyneuen.2014.01.013; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Noda Y, 2000, NEUROPSYCHOPHARMACOL, V23, P276, DOI 10.1016/S0893-133X(00)00103-2; Omi T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.301; Punyiczki M, 1998, ANN NY ACAD SCI, V851, P67, DOI 10.1111/j.1749-6632.1998.tb08978.x; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Ruscher K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045118; Sanchez Sadie, 2014, Occup Environ Med, V71 Suppl 1, pA68, DOI 10.1136/oemed-2014-102362.213; So J, 2007, BIOL PSYCHIAT, V62, P141, DOI 10.1016/j.biopsych.2006.10.014; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Takebayashi M, 2004, PHARMACOPSYCHIATRY, V37, pS208, DOI 10.1055/s-2004-832679; Vassilopoulos D, 2006, ANN NY ACAD SCI, V1088, P132, DOI 10.1196/annals.1366.031; Villard V, 2011, J PHARMACOL SCI, V115, P279, DOI 10.1254/jphs.10191FP; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Weigelt K, 2011, BRAIN BEHAV IMMUN, V25, P1162, DOI 10.1016/j.bbi.2011.03.006; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zhao J, 2014, INVEST OPHTH VIS SCI, V55, P3375, DOI 10.1167/iovs.13-12823	101	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					179	191		10.1111/pcn.12262		13	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200002		
J	Funakoshi, A; Miyamoto, Y				Funakoshi, Akiko; Miyamoto, Yuki			Significant factors in family difficulties for fathers and mothers who use support services for children with hikikomori	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						family difficulties; hikikomori; social withdrawal		AimsHikikomori is a new psychosociological phenomenon among youth, of almost complete withdrawal from social interaction, and it has received considerable attention in community mental health in Japan. The aims of the present study were to identify the influential factors of family difficulties of parents who use support services for children with hikikomori, and compare them between fathers and mothers. MethodsData were collected from 110 parents (55 couples) of children with hikikomori with regard to family difficulties, quality of life, and depression variables via self-report questionnaires. To assess the influential factors of Family Difficulties for parents with children with hikikomori, hierarchical multiple linear regression analysis was carried out for gender. ResultsWhile 94.5% of mothers received some kind of family support, only 61.9% of fathers received it. For both genders, the number of services that the fathers received was significantly correlated with marital cooperation, and the number of services that the mothers received was significantly correlated with support resource utilization. ConclusionsIt is necessary for fathers to receive more support, and it is important for professionals to encourage parents to address their difficulties together.	[Funakoshi, Akiko] Mie Prefectural Coll Nursing, Psychiat & Mental Hlth Nursing, Tsu, Mie 5140116, Japan; [Miyamoto, Yuki] Univ Tokyo, Dept Psychiat Nursing, Grad Sch Med, Tokyo, Japan	Funakoshi, A (reprint author), Mie Prefectural Coll Nursing, Psychiat & Mental Hlth Nursing, I-1-1 Yumegaoka, Tsu, Mie 5140116, Japan.	akiko.funakoshi@mcn.ac.jp					Amagaya M, 2004, HOKENSHI J, V60, P660; Podolski CL, 2001, J CLIN CHILD PSYCHOL, V30, P503, DOI 10.1207/S15374424JCCP3004_07; Koyama A, 2010, PSYCHIAT RES, V176, P69, DOI 10.1016/j.psychres.2008.10.019; Lee YS, 2013, PSYCHIAT CLIN NEUROS, V67, P193, DOI 10.1111/pcn.12043; Kato TA, 2012, SOC PSYCH PSYCH EPID, V47, P1061, DOI 10.1007/s00127-011-0411-7; Herrenkohl TI, 2012, J ADOLESCENT HEALTH, V51, P129, DOI 10.1016/j.jadohealth.2011.11.003; Division of Mental Health and Protection of Substance Abuse, 1997, WHOMSAMNHPSF974; Funakoshi A, 2012, J MIE PREFECT COLL N, V15, P39; Funakoshi A, 2011, JPN J CHILD ADOLESC, V52, P18; Kobayashi S, 2003, SEISHIN IGAKU, V45, P749; Kondo N., 2001, JPN B SOC PSYCHIAT, V10, P193; Kondo N, 2013, INT J SOC PSYCHIAT, V59, P70; Kurita I, 2004, HOKURIKU KOSYUEISEI, V30, P87; Malagon A, 2010, INT J SOC PSYCHIATR, V56, P558, DOI 10.1177/0020764009376612; Ministry of Health Labour and Welfare, 2010, GUID ASS SUPP HIK; Narabayashi R., 2003, SEISHIN IGAKU, V45, P221; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Research Group on Community Mental Health Activities for Hikikomori, 2004, GUID SOC WITHDR; Sakamoto N, 2005, INT J PSYCHIAT MED, V35, P191, DOI 10.2190/7WEQ-216D-TVNH-PQJ1; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Suwa M, 2003, PSYCHIAT CLIN NEUROS, V57, P586, DOI 10.1046/j.1440-1819.2003.01172.x; Suwa Mami, 2002, Psychiatria et Neurologia Japonica, V104, P1228; Takahata T., 2003, SEISHIN IGAKU, V45, P299; Tasaki M, 1997, WHOQOL MAN WHOQOL NO; Teo AR, 2013, INT J SOC PSYCHIATR, V59, P339, DOI 10.1177/0020764012437128; Watts J, 2002, LANCET, V359, P1131, DOI 10.1016/S0140-6736(02)08186-2; Yoshida K, 2005, SEISHIN IGAKU, V47, P655	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					210	219		10.1111/pcn.12230		10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200005		
J	Shimane, T; Matsumoto, T; Wada, K				Shimane, Takuya; Matsumoto, Toshihiko; Wada, Kiyoshi			Clinical behavior of Japanese community pharmacists for preventing prescription drug overdose	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						addiction psychiatry; drug overdose; pharmacist; prescription drug misuse; suicidology	SUICIDE; ABUSE	AimPrescription drug abuse, including benzodiazepines, is a growing health problem in Japan. This study examined the community pharmacist's clinical behavior regarding patients who overdose on prescribed drugs, and explored the possibility of overdose prevention by community pharmacists. MethodsWe surveyed all registered community pharmacies with dispensing functions (n=1867) in the Saitama Pharmaceutical Association. An anonymous self-administered questionnaire was mailed to each pharmacy. Respondents were asked about clinical behavior such as medication counseling and referral to the prescriber if prescription drug overdose was identified. ResultsAmong respondents, 26% of community pharmacists reported clinical experience of working with patients who overdosed on prescribed drugs in the previous year. Half of respondents evaluated their practice such as medication counseling and referral to the prescriber as good'. On multivariate analysis, a poor' self-evaluation of referral to the prescriber was significantly associated with the following perceptions: insufficient confidence in communication with prescribers' (odds ratio [OR], 2.7; 95% confidence interval [95%CI]: 1.4-5.3), and to avoid trouble with prescribers' (OR, 1.7; 95%CI: 1.0-2.7). ConclusionJapanese community pharmacists could prevent prescription drug abuse in their practice, but the pharmacists who have insufficient confidence in communication with prescribers and who are afraid of trouble with a prescriber, reported poor self-evaluation for referral to the prescribers. All prescribers should understand the importance of referral by community pharmacists, to assist community pharmacists in playing a critical role in prevention of prescription drug abuse.	[Shimane, Takuya; Matsumoto, Toshihiko; Wada, Kiyoshi] Natl Ctr Neurol & Psychiat, Dept Drug Dependence Res, Tokyo, Japan	Shimane, T (reprint author), Natl Ctr Neurol & Psychiat, Dept Drug Dependence Res, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan.	shimane@ncnp.go.jp			Ministry of Health, Labour and Welfare of Japan	All authors declare that they have no conflicts of interest. This study was supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. We greatly appreciate the input of the Occupational Ability Committee of the Saitama Pharmaceutical Association and the pharmacists who collaborated in this study.	Aseltine RH, 2004, AM J PUBLIC HEALTH, V94, P446, DOI 10.2105/AJPH.94.3.446; Cabinet Office Government of Japan, 2012, WHIT PAP SUIC PREV J; Chen PT, 2007, SHINSHU MED J, V55, P327; Hale KM, 2009, J AM PHARM ASSOC, V49, P589, DOI 10.1331/JAPhA.2009.09531; Hirokawa S, 2012, PSYCHIAT CLIN NEUROS, V66, P292, DOI 10.1111/j.1440-1819.2012.02343.x; Kehoe WA, 2008, ANN PHARMACOTHER, V42, P270, DOI 10.1345/aph.1K523; Kodaka M, 2013, CRISIS, V34, P420, DOI 10.1027/0227-5910/a000219; Matsumoto Toshihiko, 2011, Seishin Shinkeigaku Zasshi, V113, P1184; Matsumoto Toshihiko, 2010, Japanese Journal of Alcohol Studies & Drug Dependence, V45, P530; Ookura R, 2008, NIHON KYUKYU IGAKUKA, V19, P901; Sheridan J, 1996, BRIT MED J, V313, P272; Shimane T, 2013, YAKUGAKU ZASSHI, V133, P617; Shimane T, 2012, JAPANESE J PSYCHIAT, V87, P87; Someya F, 2009, YAKUGAKU ZASSHI, V129, P1137; Takei A, 2007, JAPANESE J GEN HOSP, V19, P211; The Ministry of Health Labour and Welfare of Japan, 2012, SURV MED CAR ACT PUB; Tommasello AC, 2004, HARM REDUCT J, V1, P3, DOI 10.1186/1477-7517-1-3	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					220	227		10.1111/pcn.12232		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200006		
J	Kitamura, H; Egawa, J; Someya, T				Kitamura, Hideaki; Egawa, Jun; Someya, Toshiyuki			Developmental prosopagnosia referred to outpatient psychiatric service	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter							EPILEPTIC SEIZURE; WITHDRAWAL; ADDICTION		[Kitamura, Hideaki; Egawa, Jun; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan	Kitamura, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	kitamura@med.niigata-u.ac.jp					De Vries TJ, 2002, J NEUROSCI, V22, P3321; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Ouyang HD, 2012, SCI WORLD J, DOI 10.1100/2012/940613; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; AKAOKA H, 1991, J NEUROSCI, V11, P3830; Basu D, 2009, AM J ADDICTION, V18, P417, DOI [10.3109/10550490903077697, 10.1080/10550490903077697]; Mattoo SK, 2009, PSYCHIAT CLIN NEUROS, V63, P580, DOI 10.1111/j.1440-1819.2009.01980.x; Parkar S R, 2006, Indian J Psychiatry, V48, P121, DOI 10.4103/0019-5545.31604; Pathan Hasan, 2012, Br J Pain, V6, P11, DOI 10.1177/2049463712438493	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					238	239		10.1111/pcn.12233		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200008		
J	Takehara, H; Suzuki, Y; Someya, T				Takehara, Hiromi; Suzuki, Yutaro; Someya, Toshiyuki			QT prolongation associated with memantine in Alzheimer's disease	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Takehara, Hiromi; Suzuki, Yutaro; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan	Takehara, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	yutaro@med.niigata-u.ac.jp					Gupta A, 2007, AM HEART J, V153, P891, DOI 10.1016/j.ahj.2007.01.040	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2015	69	4					239	240		10.1111/pcn.12236		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF0II	WOS:000352226200010		
J	Moriya, Y; Kasahara, Y; Hall, FS; Sakakibara, Y; Uhl, GR; Tomita, H; Sora, I				Moriya, Yuki; Kasahara, Yoshiyuki; Hall, F. Scott; Sakakibara, Yasufumi; Uhl, George R.; Tomita, Hiroaki; Sora, Ichiro			Sex differences in the effects of adolescent social deprivation on alcohol consumption in mu-opioid receptor knockout mice	PSYCHOPHARMACOLOGY			English	Article						mu-Opioid receptor (MOP); Knockout (KO) mice; Social isolation; Stress; Sex-dependent manner; Abuse; Alcoholism	POPULATION-BASED SAMPLE; GENDER-DIFFERENCES; C57BL/6J MICE; WISTAR RATS; ETHANOL-CONSUMPTION; NUCLEUS-ACCUMBENS; VENTRAL STRIATUM; LABORATORY RATS; FORCED SWIM; FEMALE RATS	Evidence based on clinical and experimental animal studies indicates that adolescent social deprivation influences alcohol consumption in a sex-dependent manner, perhaps by influencing stress responses. However, the mechanisms underlying the interaction between these phenomena remain to be elucidated. Since the mu-opioid receptor (MOP) has been reported to have key roles in social stress responses as well as the reinforcing/addictive effects of ethanol, MOP is a candidate molecule that may link adolescent social deprivation and subsequent alterations in alcohol consumption. To evaluate the involvement of MOP and social isolation-induced changes in alcohol consumption, as well as the effect of sex differences on responses to social isolation, alcohol consumption was assessed using a two-bottle home-cage consumption procedure (8 % ethanol vs. water) in MOP knockout (MOP-KO) and wild type (WT) mice of both sexes exposed to adolescent social deprivation or reared socially. Isolation rearing had no effects upon alcohol consumption of WT mice, whereas it significantly altered alcohol consumption in both male and female MOP-KO mice. Interestingly, social isolation affected ethanol consumption differently in male and female mice. Ethanol consumption was increased in male MOP-KO mice, but decreased in female MOP-KO mice, by isolation rearing. These results indicate that disturbances of MOP function influence the effects of isolation rearing on ethanol consumption in a sex-dependent manner. Consequently, this suggests the possibility that genetic variation that influences MOP function may have differential roles in alcoholism in men and women, and alcoholism treatments that target MOP function may be differentially effective in males and females.	[Moriya, Yuki; Kasahara, Yoshiyuki; Sakakibara, Yasufumi; Tomita, Hiroaki; Sora, Ichiro] Tohoku Univ, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Moriya, Yuki; Kasahara, Yoshiyuki; Sakakibara, Yasufumi; Tomita, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Disaster Psychiat, Sendai, Miyagi 980, Japan; [Moriya, Yuki; Kasahara, Yoshiyuki; Sakakibara, Yasufumi; Tomita, Hiroaki] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Sendai, Miyagi 980, Japan; [Tomita, Hiroaki] Tohoku Univ, Tohoku Med Megabank Org ToMMo, Sendai, Miyagi 980, Japan; [Hall, F. Scott; Uhl, George R.] NIDA, Mol Neurobiol Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Sora, Ichiro] Kobe Univ, Grad Sch Med, Dept Psychiat, Chuo Ku, Kobe, Hyogo 6570017, Japan	Sora, I (reprint author), Kobe Univ, Grad Sch Med, Dept Psychiat, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6570017, Japan.	sora@med.kobe-u.ac.jp	Hall, Frank/C-3036-2013	Hall, Frank/0000-0002-0822-4063	Japan Society for the Promotion Science (JSPS) KAKENHI [254961]; Intramural Research Grant for Collaboration on Special Project Research from IRIDeS, Tohoku University, JSPS [24116007]; MHLW of Japan; Ministry of Health, Labour and Welfare of Japan; Global COE Program (Basic & Translational Research Center for Global Brain Science) from MEXT of Japan; Intramural Research Program of the National Institute on Drug Abuse, NIH/DHHS, USA	This work was supported by a Japan Society for the Promotion Science (JSPS) KAKENHI Grant-in-Aid for JSPS Fellows (254961); by an Intramural Research Grant for Collaboration on Special Project Research from IRIDeS, Tohoku University, JSPS Grant-in-Aid for scientific research on innovative areas (24116007); by a Grant-in-Aid for Health and Labour Science Research (Research on Pharmaceutical and Medical Safety) from MHLW of Japan; by a Grant from the Ministry of Health, Labour and Welfare of Japan; by the Global COE Program (Basic & Translational Research Center for Global Brain Science) from MEXT of Japan; and through funding from the Intramural Research Program of the National Institute on Drug Abuse, NIH/DHHS, USA (GRU and FSH).	Anderson RI, 2013, NEUROSCIENCE, V249, P214, DOI 10.1016/j.neuroscience.2012.12.028; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; VANDERSCHUREN LJMJ, 1995, EUR J PHARMACOL, V276, P257, DOI 10.1016/0014-2999(95)00040-R; Terenius L, 1996, ALCOHOL, V13, P31, DOI 10.1016/0741-8329(95)02037-3; Hall FS, 2012, PHYSIOL BEHAV, V107, P623, DOI 10.1016/j.physbeh.2012.05.014; Wei J, 2014, MOL PSYCHIATR, V19, P588, DOI 10.1038/mp.2013.83; Hardie TL, 2008, AM J ADDICTION, V17, P319, DOI 10.1080/10550490802139010; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; WILKINSON LS, 1994, NEUROPSYCHOPHARMACOL, V10, P61; Chaplin TM, 2008, ALCOHOL CLIN EXP RES, V32, P1242, DOI 10.1111/j.1530-0277.2008.00679.x; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; Zubieta JK, 2002, J NEUROSCI, V22, P5100; Trezza V, 2011, DEV COGN NEUROS-NETH, V1, P444, DOI 10.1016/j.dcn.2011.05.007; Morris PLP, 2001, ADDICTION, V96, P1565, DOI 10.1046/j.1360-0443.2001.961115654.x; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Dahan A, 2008, ANESTH ANALG, V107, P83, DOI 10.1213/ane.0b013e31816a66a4; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Zubieta JK, 1999, AM J PSYCHIAT, V156, P842; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; Kozlov AP, 2013, PHARMACOL BIOCHEM BE, V103, P773, DOI 10.1016/j.pbb.2012.11.008; Chester JA, 2006, ALCOHOL ALCOHOLISM, V41, P44, DOI 10.1093/alcalc/agh242; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P1136, DOI 10.1111/j.1530-0277.1999.tb04270.x; Jarjour S, 2009, ALCOHOL CLIN EXP RES, V33, P1033, DOI 10.1111/j.1530-0277.2009.00924.x; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Melon LC, 2013, PHARMACOL BIOCHEM BE, V104, P177, DOI 10.1016/j.pbb.2013.01.005; Gianoulakis C, 2001, J PSYCHIATR NEUROSCI, V26, P304; Trigo JM, 2010, DRUG ALCOHOL DEPEN, V108, P183, DOI 10.1016/j.drugalcdep.2009.10.011; Schienle A, 2005, NEUROREPORT, V16, P277, DOI 10.1097/00001756-200502280-00015; Kendler KS, 2002, PSYCHOL MED, V32, P1187, DOI 10.1017/S0033291702006219; Siviy SM, 2011, NEUROSCI BIOBEHAV R, V35, P1821, DOI 10.1016/j.neubiorev.2011.03.006; Job MO, 2007, BIOL PSYCHIAT, V62, P627, DOI 10.1016/j.biopsych.2006.11.016; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; Hall FS, 2001, PSYCHOPHARMACOLOGY, V154, P43, DOI 10.1007/s002130000622; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129; Advani T, 2007, INT J NEUROPSYCHOPH, V10, P595, DOI 10.1017/S1461145706007401; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Balldin J, 2003, ALCOHOL CLIN EXP RES, V27, P1142, DOI 10.1097/01.ALC.0000075548.83053.A9; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Prescott CA, 1999, AM J PSYCHIAT, V156, P34; Averna S, 2001, ADDICT BEHAV, V26, P363, DOI 10.1016/S0306-4603(00)00112-X; Caseras X, 2007, BIOL PSYCHIAT, V62, P464, DOI 10.1016/j.biopsych.2006.10.030; Cruz FC, 2008, PSYCHOPHARMACOLOGY, V201, P459, DOI 10.1007/s00213-008-1307-4; Diaz SL, 2006, SYNAPSE, V60, P132, DOI 10.1002/syn.20279; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405; Enoch MA, 2012, CURR PSYCHIAT REP, V14, P150, DOI 10.1007/s11920-011-0252-9; Fuchs PN, 1999, BRAIN RES, V821, P480, DOI 10.1016/S0006-8993(99)01060-4; GENTSCH C, 1982, BEHAV BRAIN RES, V4, P45, DOI 10.1016/0166-4328(82)90163-2; Hall FS, 2013, SEROTONIN BIOSYNTHES, P168; Hall FS, 1998, PSYCHOPHARMACOLOGY, V139, P210, DOI 10.1007/s002130050706; Hall FS, 1998, J NEUROSCI METH, V79, P47, DOI 10.1016/S0165-0270(97)00155-6; Hall FS, 2006, CURR PSYCHIAT REV, V2, P27, DOI DOI 10.2174/157340006775101526; Hall FS, 2013, J ALCOHOLISM DRUG DE, V1; Hall FS, 1998, PSYCHOPHARMACOLOGY, V139, P203, DOI 10.1007/s002130050705; He DY, 2005, J NEUROSCI, V25, P619, DOI 10.1523/JNEUROSCI.3959-04.2005; Heinrichs SC, 2006, CURR PROTOC NEUROSCI, V8, DOI DOI 10.1002/0471142301.NS0804S34; Herz A, 1997, PSYCHOPHARMACOLOGY, V129, P99, DOI 10.1007/s002130050169; Iwamoto E T, 1985, Alcohol Drug Res, V6, P327; Komatsu H, 2011, PHARMACOL BIOCHEM BE, V99, P676, DOI 10.1016/j.pbb.2011.06.008; Lodge DJ, 2003, BEHAV BRAIN RES, V141, P113, DOI 10.1016/S0166-4328(02)00328-5; Longoni R, 1998, BEHAV PHARMACOL, V9, P9; Lopez MF, 2011, ALCOHOL, V45, P355, DOI 10.1016/j.alcohol.2010.08.017; Marinelli PW, 2003, PSYCHOPHARMACOLOGY, V169, P60, DOI 10.1007/s00213-003-1490-2; Matsuda T, 2001, Nihon Shinkei Seishin Yakurigaku Zasshi, V21, P71; McCall Nora M, 2013, Front Integr Neurosci, V7, P100, DOI 10.3389/fnint.2013.00100; McCool BA, 2009, ALCOHOL CLIN EXP RES, V33, P273, DOI 10.1111/j.1530-0277.2008.00830.x; Milner TA, 2013, SYNAPSE, V67, P757, DOI 10.1002/syn.21683; Olive MF, 2001, J NEUROSCI, V21, part. no.; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Ramachandra V, 2011, ALCOHOL CLIN EXP RES, V35, P929, DOI 10.1111/j.1530-0277.2010.01423.x; Rodefer JS, 1999, PSYCHOPHARMACOLOGY, V141, P436, DOI 10.1007/s002130050854; Sasaki K, 2014, BR J PHARM; SCHENK S, 1990, ALCOHOL, V7, P321, DOI 10.1016/0741-8329(90)90090-Y; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sora I, 1997, EUR J PHARMACOL, V324, pR1, DOI 10.1016/S0014-2999(97)10016-4; Soyka Michael, 2013, Evid Based Ment Health, V16, P71, DOI 10.1136/eb-2013-101304; Uhart M, 2009, ADDICT BIOL, V14, P43, DOI 10.1111/j.1369-1600.2008.00131.x; ULM RR, 1995, J CLIN PSYCHIAT, V56, P5; Varlinskaya EI, 2009, ALCOHOL CLIN EXP RES, V33, P991, DOI 10.1111/j.1530-0277.2009.00920.x; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; WOLFFGRAMM J, 1990, PSYCHOPHARMACOLOGY, V101, P233, DOI 10.1007/BF02244132	89	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	APR	2015	232	8					1471	1482		10.1007/s00213-014-3784-y		12	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF1HB	WOS:000352294200012		
J	Sugita, T; Kanamaru, M; Iizuka, M; Sato, K; Tsukada, S; Kawamura, M; Homma, I; Izumizaki, M				Sugita, Toshihisa; Kanamaru, Mitsuko; Iizuka, Makito; Sato, Kanako; Tsukada, Setsuro; Kawamura, Mitsuru; Homma, Ikuo; Izumizaki, Masahiko			Breathing is affected by dopamine D2-like receptors in the basolateral amygdala	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Amygdala; Respiration; Dopamine D2 receptor; Respiratory rate; Autoreceptor; Emotions	PARKINSONS-DISEASE; CENTRAL NUCLEUS; PANIC DISORDER; RATS; ANXIETY; FEAR; PRAMIPEXOLE; ANTAGONISTS; MODULATION; PHYSIOLOGY	The precise mechanisms underlying how emotions change breathing patterns remain unclear, but dopamine is a candidate neurotransmitter in the process of emotion-associated breathing. We investigated whether basal dopamine release occurs in the basolateral amygdala (BLA), where sensory-related inputs are received and lead to fear or anxiety responses, and whether D1- and D2-like receptor antagonists affect breathing patterns and dopamine release in the BLA. Adult male mice (C57BL/6N) were perfused with artificial cerebrospinal fluid, a D1-like receptor antagonist (SCH 23390), or a D2-like receptor antagonist ((S)-(-)-sulpiride) through a microdialysis probe in the BLA. Respiratory variables were measured using a double-chamber plethysmograph. Dopamine release was measured by an HPLC. Perfusion of (S)-(-)-sulpiride in the BLA, not SCH 23390, specifically decreased respiratory rate without changes in local release of dopamine. These results suggest that basal dopamine release in the BLA, at least partially, increases respiratory rates only through post-synaptic D2-like receptors, not autoreceptors, which might be associated with emotional responses. (C) 2014 Elsevier B.V. All rights reserved.	[Sugita, Toshihisa; Kanamaru, Mitsuko; Iizuka, Makito; Sato, Kanako; Tsukada, Setsuro; Homma, Ikuo; Izumizaki, Masahiko] Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan; [Sugita, Toshihisa; Sato, Kanako; Tsukada, Setsuro; Kawamura, Mitsuru] Showa Univ, Sch Med, Dept Neurol, Tokyo, Japan	Kanamaru, M (reprint author), Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	emikko-n.n-snow.4@forest.ocn.ne.jp; mitsuko@med.showa-u.ac.jp; iizukam@med.showa-u.ac.jp; oxfordox38pb@yahoo.co.jp; giantgreen1999@yahoo.co.jp; kawa@med.showa-u.ac.jp; ihomma@medshowa-u.ac.jp; masahiko@med.showa-u.ac.jp					Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; Saha S, 2000, NEUROSCIENCE, V99, P613, DOI 10.1016/S0306-4522(00)00240-2; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; TAKAYAMA K, 1991, NEUROSCI LETT, V134, P62, DOI 10.1016/0304-3940(91)90509-R; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; de Oliveira AR, 2011, NEUROBIOL LEARN MEM, V95, P37, DOI 10.1016/j.nlm.2010.10.005; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Diaz MR, 2011, NEUROPSYCHOPHARMACOL, V36, P1090, DOI 10.1038/npp.2010.246; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; de la Mora MP, 2010, PROG NEUROBIOL, V90, P198, DOI 10.1016/j.pneurobio.2009.10.010; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Missale C, 1998, PHYSIOL REV, V78, P189; Nardi AE, 2009, RESP PHYSIOL NEUROBI, V167, P133, DOI 10.1016/j.resp.2008.07.011; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; BASS C, 1985, J PSYCHOSOM RES, V29, P599, DOI 10.1016/0022-3999(85)90069-8; Blom EH, 2014, PSYCHOPHYSIOLOGY, V51, P412, DOI 10.1111/psyp.12188; Braun AR, 1997, J NEURAL TRANSM, V104, P341, DOI 10.1007/BF01277656; BULL DR, 1991, NEUROSCI LETT, V134, P41, DOI 10.1016/0304-3940(91)90504-M; CAMACHOOCHOA M, 1995, NEUROSCI LETT, V196, P97; Davis M, 2000, AMYGDALA, V2, P213; HU XT, 1994, SYNAPSE, V17, P43, DOI 10.1002/syn.890170106; Kanamaru M, 2009, AM J PHYSIOL-REG I, V297, pR34, DOI 10.1152/ajpregu.90802.2008; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; Onimaru H, 2007, NEUROSCIENCE, V144, P387, DOI 10.1016/j.neuroscience.2006.09; Paxinos G, 2001, MOUSE BRAIN STEREOTA; PLUM F, 1992, ARCH NEUROL-CHICAGO, V49, P441; ROYBYRNE PP, 1986, BIOL PSYCHIAT, V21, P849, DOI 10.1016/0006-3223(86)90253-2; Sugita T, 2013, J PHYSIOL SCI, V63, pS221; Suzuki T, 2002, EUR J PHARMACOL, V435, P59, DOI 10.1016/S0014-2999(01)01563-1; Thiel CM, 2001, NEUROPSYCHOBIOLOGY, V43, P192, DOI 10.1159/000054889; Tsuchiya N, 2012, EXP PHYSIOL, V97, P228, DOI 10.1113/expphysiol.2011.062703; Verner TA, 2008, BRAIN RES, V1208, P128, DOI 10.1016/j.brainres.2008.02.028	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	APR	2015	209				SI		23	27		10.1016/j.resp.2014.09.020		5	Physiology; Respiratory System	Physiology; Respiratory System	CE9OC	WOS:000352172300005		
J	Iizuka, M; Tomita, K; Takeshima, R				Iizuka, Makito; Tomita, Kazuhide; Takeshima, Reiko			Experience-oriented tobacco-use prevention lecture using a COPD-simulation mask for junior high school students	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Chronic obstructive pulmonary disease (COPD); Pseudo experience; Psychological effects; Adolescents	EXPIRATORY-FLOW LIMITATION; OBSTRUCTIVE PULMONARY-DISEASE; NATURAL-HISTORY; EXERCISE	We recently developed a mask that simulates the experience of having one of the major diseases caused by tobacco smoking: chronic obstructive pulmonary disease (COPD). Here we examined the effects of a tobacco-use prevention lecture accompanied by a pseudo-COPD experience created with this mask on adolescents' attitude toward smoking. Junior high school students (12-13 years old, n = 165) in Japan were the subjects. The students attended a 30-min tobacco-use prevention lecture with slides and movie clips and engaged in a light exercise session wearing the COPD-simulation mask for 15 min. Before and after the lecture, the students' attitudes toward smoking were evaluated by the Kano test for social nicotine dependence (KTSND). The total KTSND scores decreased significantly from 9.9 +/- 4.4 (mean +/- SD, n = 149) to 7.5 +/- 5.3 (n = 144). Ninety-eight students wore the COPD mask, and their modified Borg scale scores increased significantly from 0.7 +/- 1.0 to 3.2 +/- 2.1 after exercise (P < 0.0001). To the questionnaire item "Do you think you understand the suffering of individuals with COPD?", 24 and 51 students answered "definitely yes" and "yes", whereas 16, 4 and 1 answered "Cannot say," "no" and "definitely no", respectively. The KTSND scores were significantly smaller in the former affirmative group compared to the latter negative group (P < 0.05). Of the 98 students who wore the simulation mask, 83 reported being satisfied with this pseudo-COPD experience. The tobacco-use prevention lecture with the pseudo-COPD experience created by the simulation mask was effective and safe. (C) 2014 Elsevier B.V. All rights reserved.	[Iizuka, Makito; Takeshima, Reiko] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Ibaraki 3050394, Japan; [Tomita, Kazuhide] Ibaraki Prefectural Univ Hlth Sci, Dept Phys Therapy, Ibaraki 3050394, Japan	Iizuka, M (reprint author), Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	iizukam@med.showa-u.ac.jp; tomitak@ipu.ac.jp; takesima@ipu.ac.jp			Ibaraki Prefectural University of Health Sciences	This work was supported by a grant-in-aid for research of regional contributions from Ibaraki Prefectural University of Health Sciences.	Aliverti A, 2008, RESP PHYSIOL NEUROBI, V163, P90, DOI 10.1016/j.resp.2008.07.025; Aliverti A, 2002, J APPL PHYSIOL, V92, P1953, DOI 10.1152/japplphysiol.01222.2000; Aliverti A, 2007, RESPIROLOGY, V12, P478, DOI 10.1111/j.1440-1843.2007.01106.x; Amagai K., 2011, JPN J TOB CONTROL, V6, P71; Dobbins M, 2008, PREV MED, V46, P289, DOI 10.1016/j.ypmed.2007.10.003; FLETCHER C, 1977, BRIT MED J, V1, P1645; Gingiss PM, 2006, PREV SCI, V7, P197, DOI 10.1007/s11121-006-0038-1; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Asari T., 2012, SAPPORO J HLTH SCI, V1, P105; Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P1; Committee for the Second Edition of the COPD Guidelines of the Japanese Respiratory Society, 2004, GUID DIAGN TREATM CO, V2nd; Endo A., 2008, JPN J TOB CONTROL, V3, P48; Global Initiative for Chronic Obstructive Lung Disease, 2014, GLOB STRAT DIAGN MAN; Huang BY, 2011, INT DENT J, V61, P152, DOI 10.1111/j.1875-595X.2011.00032.x; Iandelli I, 2002, J APPL PHYSIOL, V92, P1943, DOI 10.1152/japplphysiol.00393.2000; Iizuka M., 2011, JPN J TOB CONTROL, V6, P10; Iizuka M., 2011, JPN J TOB CONTROL, V6, P62; Jeong J.H., 2007, TUBERC RESP DIS, V62, P365; Kayser B, 1997, J APPL PHYSIOL, V83, P936; Kendrick K R, 2000, J Emerg Nurs, V26, P216, DOI 10.1067/men.2000.107012; Liu J., 2014, BIOL PSYCH IN PRESS; Organization WH, 2014, 10 LEAD CAUS DEATH W; Otani T, 2009, ANN EPIDEMIOL, V19, P815, DOI 10.1016/j.annepidem.2009.03.016; Parshall Mark B, 2012, BMC Emerg Med, V12, P6, DOI 10.1186/1471-227X-12-6; Raherison C, 2009, Eur Respir Rev, V18, P213, DOI 10.1183/09059180.00003609; Sezai I., 2009, JPN J TOB CONTROL, V4, P91; Tahlil T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-367; Takeuchi A., 2008, NIHON SHISHUBYO GAKK, V50, P185, DOI 10.2329/perio.50.185; Yoshii Chiharu, 2006, Journal of UOEH, V28, P45	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	APR	2015	209				SI		28	32		10.1016/j.resp.2014.09.012		5	Physiology; Respiratory System	Physiology; Respiratory System	CE9OC	WOS:000352172300006		
J	Patil, P; Uechi, T; Kenmochi, N				Patil, Prakash; Uechi, Tamayo; Kenmochi, Naoya			Incomplete splicing of neutrophil-specific genes affects neutrophil development in a zebrafish model of poikiloderma with neutropenia	RNA BIOLOGY			English	Article						poikiloderma with neutropenia; RNA disease; splicing; U6 biogenesis; zebrafish; CHT; caudal haematopoietic tissue; CRISPR; clustered regularly interspaced short palindromic repeats; GFP; green fluorescent protein; hpf; hours post fertilization; MO; morpholino antisense oligo; MPN1; mutated in poikiloderma with neutropenia; PN; poikiloderma with neutropenia; snRNPs; small nuclear ribonucleoproteins; sqRT-PCR; semi-quantitative reverse transcription and polymerase chain reaction; USB1; U Six Biogenesis 1	CLERICUZIO-TYPE POIKILODERMA; SMALL NUCLEAR-RNA; ROTHMUND-THOMSON-SYNDROME; EXOCRINE PANCREAS; MUTANT ZEBRAFISH; C16ORF57; EXPRESSION; MUTATION; PROTEIN; DIFFERENTIATION	Poikiloderma with neutropenia (PN) is a rare inherited disorder characterized by poikiloderma, facial dysmorphism, pachyonychia, short stature and neutropenia. The molecular testing of PN patients has identified mutations in the C16orf57 gene, which encodes a protein referred to as USB1 (U Six Biogenesis 1). In this study, we developed a zebrafish model of PN by the microinjection of morpholino antisense oligos to suppress usb1 gene function. Severe morphological defects, including a bent tail, thin yolk extension and reduced body length, were predominant in the Usb1-suppressed embryos (morphants). We also observed significantly decreased number of neutrophils in the morphants by Sudan Black staining. Interestingly, the splicing of genes involved in neutrophil differentiation and development, such as mpx, ncf1, ela3l and npsn, was aberrant in the morphants. However, the splicing of haematopoietic precursors and erythroid-specific genes was unaltered. Importantly, the neutrophil defects were almost completely rescued by co-injection of ela3l mRNA, the most markedly affected gene in the morphants. Our study demonstrated a possible role of USB1 in modulating the tissue-specific gene splicing that eventually leads to the impaired development of neutrophils. This zebrafish model could serve as a valuable tool to investigate the causative role of USB1 in PN pathogenesis.	[Patil, Prakash; Uechi, Tamayo; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	Kenmochi, N (reprint author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	kenmochi@med.miyazaki-u.ac.jp			JSPS KAKENHI [2591003, 24591556]; Takeda Science Foundation	This work was supported by JSPS KAKENHI Grants 2591003 (N.K.) and 24591556 (T.U.) and a grant from the Takeda Science Foundation (T.U.).	Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Tanaka A, 2010, AM J MED GENET A, V152A, P1347, DOI 10.1002/ajmg.a.33455; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Shchepachev V, 2012, CELL REP, V2, P855, DOI 10.1016/j.celrep.2012.08.031; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Concolino D, 2010, AM J MED GENET A, V152A, P2588, DOI 10.1002/ajmg.a.33600; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325; Farruggia P, 2014, J PEDIAT HEMATOL ONC, V36, P297, DOI 10.1097/MPH.0b013e31829f35e7; Van Hove JLK, 2005, AM J MED GENET A, V132A, P152, DOI 10.1002/ajmg.a.30430; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/2007-06-095398; Clericuzio C, 2011, AM J MED GENET A, V155A, P337, DOI 10.1002/ajmg.a.33807; Hilcenko C, 2013, BLOOD, V121, P1028, DOI 10.1182/blood-2012-10-461491; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Volpi L, 2010, AM J HUM GENET, V86, P72, DOI 10.1016/j.ajhg.2009.11.014; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Rodgers W, 2013, BRIT J DERMATOL, V168, P665, DOI 10.1111/bjd.12016; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Rosel TD, 2011, EMBO J, V30, P1965, DOI 10.1038/emboj.2011.106; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Mostefai R, 2008, AM J MED GENET A, V146A, P2762, DOI 10.1002/ajmg.a.32524; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Arnold AW, 2010, BRIT J DERMATOL, V163, P866, DOI 10.1111/j.1365-2133.2010.09929.x; Mroczek S, 2012, GENE DEV, V26, P1911, DOI 10.1101/gad.193169.112; Piard J, 2012, EUR J MED GENET, V55, P8, DOI 10.1016/j.ejmg.2011.07.004; Chantorn R, 2012, PEDIATR DERMATOL, V29, P463, DOI 10.1111/j.1525-1470.2011.01513.x; Clericuzio C, 1991, AM J HUM GENET, V49, pA661; Colombo EA, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-7; Dereure O, 2011, ANN DERMATOL VENER, V138, P362, DOI 10.1016/j.annder.2011.01.026; Domitrovich AM, 2003, NUCLEIC ACIDS RES, V31, P2344, DOI 10.1093/nar/gkg331; English MA, 2012, DEV DYNAM, V241, P879, DOI 10.1002/dvdy.23774; Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Koparir A, 2014, AM J MED GENET A, V165A, P2535; Larizza L, 2013, EUR J HUM GENET, V21; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; Martin CS, 2011, GENOME MED, V3, DOI 10.1186/gm299; North TE, 2003, DEV DYNAM, V228, P568, DOI 10.1002/dvdy.10393; Rios Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001271; Shchepachev V, 2013, FEBS LETT, V587, P1858, DOI 10.1016/j.febslet.2013.05.005; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Will MC, 2001, CURR OPIN CELL BIOL, V13, P290	50	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1547-6286	1555-8584		RNA BIOL	RNA Biol.	APR	2015	12	4					426	434		10.1080/15476286.2015.1017240		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CF6GE	WOS:000352654300007		
J	Izumi, M; Zheng, L; Sakai, Y; Goto, H; Sakata, M; Nakamoto, Y; Nguyen, HLT; Kagayama, T; Shimizu, K; Araki, S; Kobayashi, TC; Kambe, T; Gu, DC; Guo, J; Liu, J; Li, YC; Sun, LL; Prassides, K; Kubozono, Y				Izumi, Masanari; Zheng, Lu; Sakai, Yusuke; Goto, Hidenori; Sakata, Masafumi; Nakamoto, Yuki; Nguyen, Huyen L. T.; Kagayama, Tomoko; Shimizu, Katsuya; Araki, Shingo; Kobayashi, Tatsuo C.; Kambe, Takashi; Gu, Dachun; Guo, Jing; Liu, Jing; Li, Yanchun; Sun, Liling; Prassides, Kosmas; Kubozono, Yoshihiro			Emergence of double-dome superconductivity in ammoniated metal-doped FeSe	SCIENTIFIC REPORTS			English	Article							X-RAY; DIFFRACTION	The pressure dependence of the superconducting transition temperature (T-c) and unit cell metrics of tetragonal (NH3)(y)Cs0.4FeSe were investigated in high pressures up to 41 GPa. The T-c decreases with increasing pressure up to 13 GPa, which can be clearly correlated with the pressure dependence of c (or FeSe layer spacing). The T-c vs. c plot is compared with those of various (NH3)(y)MxFeSe (M: metal atoms) materials exhibiting different T-c and c, showing that the T-c is universally related to c. This behaviour means that a decrease in two-dimensionality lowers the T-c. No superconductivity was observed down to 4.3 K in (NH3)(y)Cs0.4FeSe at 11 and 13 GPa. Surprisingly, superconductivity re-appeared rapidly above 13 GPa, with the T-c reaching 49 K at 21 GPa. The appearance of a new superconducting phase is not accompanied by a structural transition, as evidenced by pressure-dependent XRD. Furthermore, T-c slowly decreased with increasing pressure above 21 GPa, and at 41 GPa superconductivity disappeared entirely at temperatures above 4.9 K. The observation of a double-dome superconducting phase may provide a hint for pursuing the superconducting coupling-mechanism of ammoniated/non-ammoniated metal-doped FeSe.	[Izumi, Masanari; Zheng, Lu; Sakai, Yusuke; Goto, Hidenori; Sakata, Masafumi; Nguyen, Huyen L. T.; Kubozono, Yoshihiro] Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan; [Sakata, Masafumi; Nguyen, Huyen L. T.; Kubozono, Yoshihiro] Okayama Univ, Res Ctr New Funct Mat Energy Prod Storage & Trans, Okayama 7008530, Japan; [Sakata, Masafumi; Prassides, Kosmas] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Sakata, Masafumi; Nakamoto, Yuki; Kagayama, Tomoko; Shimizu, Katsuya] Osaka Univ, Ctr Sci & Technol Extreme Condit, Osaka 5608531, Japan; [Araki, Shingo; Kobayashi, Tatsuo C.; Kambe, Takashi] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Gu, Dachun; Sun, Liling] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Gu, Dachun; Guo, Jing; Sun, Liling] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Liu, Jing; Li, Yanchun] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China; [Prassides, Kosmas] Tohoku Univ, WPI Res Ctr, Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Kubozono, Y (reprint author), Okayama Univ, Surface Sci Res Lab, Okayama 7008530, Japan.	kubozono@cc.okayama-u.ac.jp	KUBOZONO, Yoshihiro/B-2091-2011; Zheng, Lu/G-8629-2015; Prassides, Kosmas/C-9804-2009; Goto, Hidenori/C-2102-2015; KAMBE, Takashi/B-2117-2011; KOBAYASHI, Tatsuo/B-1527-2011		MEXT [22244045, 24654105, 26105004, 26400361]; LEMSUPER project (JST-EU Superconductor Project) of the Japan Science and Technology Agency (JST); Program for Promoting the Enhancement of Research Universities; NSF of China [91321207]; 973 project [2011CBA00100]; EPSRC [EP/K027255];  [2013B1145]	This study was partly supported by Grants-in-Aid (22244045, 24654105, 26105004 and 26400361) from MEXT, from the LEMSUPER project (JST-EU Superconductor Project) of the Japan Science and Technology Agency (JST), and by the Program for Promoting the Enhancement of Research Universities. The work in China was supported by the NSF of China (Grant No. 91321207) and 973 project (Grant No. 2011CBA00100). The XRD measurements at SPring-8 were supported by 2013B1145. K.P. thanks the EPSRC for support (EP/K027255).	Zheng L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.094521; Sun LL, 2012, NATURE, V483, P67, DOI 10.1038/nature10813; Guo J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.197001; Ying TP, 2013, J AM CHEM SOC, V135, P2951, DOI 10.1021/ja312705x; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Guo JQ, 2010, AGR ISSUES POLICIES, P1; Mizuguchi Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.102001; Sedlmaier SJ, 2014, J AM CHEM SOC, V136, P630, DOI 10.1021/ja411624q; Hatakeda T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.123705; Lee CH, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.083704; Burrard-Lucas M, 2013, NAT MATER, V12, P15, DOI [10.1038/nmat3464, 10.1038/NMAT3464]; Margadonna S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064506; Cai P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2592; Ding XX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2913; Fan DW, 2014, PHYSICA B, V451, P53, DOI 10.1016/j.physb.2014.06.023; Lu XF, 2013, PHYS REV B, V89; Sakai Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.144509; Shimizu K, 2005, J PHYS SOC JPN, V74, P1345, DOI 10.1143/JPSJ.74.1345; Ye GJ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134501; Ying TP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00426	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 1	2015	5								9477	10.1038/srep09477		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CE7OH	WOS:000352030700001		
J	Shindo, Y; Unsinger, J; Burnham, CA; Green, JM; Hotchkiss, RS				Shindo, Yuichiro; Unsinger, Jacqueline; Burnham, Cary-Ann; Green, Jonathan M.; Hotchkiss, Richard S.			INTERLEUKIN-7 AND ANTI-PROGRAMMED CELL DEATH 1 ANTIBODY HAVE DIFFERING EFFECTS TO REVERSE SEPSIS-INDUCED IMMUNOSUPPRESSION	SHOCK			English	Article						Candida; endotoxin; innate immunity; adaptive immunity; shock	IMPROVES SURVIVAL; IMMUNE DYSFUNCTION; INTERFERON-GAMMA; FUNGAL SEPSIS; SEPTIC SHOCK; MURINE MODEL; T-CELLS; PD-1; IMMUNOTHERAPY; INFECTION	Sepsis remains a major cause of morbidity and mortality in most intensive care units. Protracted sepsis can evolve into a state of profound immunosuppression characterized by secondary infections, frequently with opportunistic-type pathogens. Immunoadjuvant therapy is currently being evaluated as a novel treatment for patients with sepsis. Two of the most promising immunoadjuvants are interleukin-7 (IL-7) and anti-programmed cell death 1 antibody (anti-PD-1). Both IL-7 and anti-PD-1 have been reported to boost host immunity and improve outcomes in patients with viral infections and cancer. The purpose of this study was to define the immunological mechanisms of action of IL-7 and anti-PD-1 in the two-hit sepsis model of cecal ligation and puncture followed by Candida albicans. In addition, we examined whether combined treatment with IL-7 and anti-PD-1 provided any additive beneficial effects in reversing immune dysfunction. The present findings demonstrated that IL-7 and anti-PD-1 had differing effects on innate and adaptive immune functions. Compared with anti-PD-1, IL-7 increased lymphocyte proliferation; expression of lymphocyte adhesion molecules, lymphocyte function-associated antigen 1, and very late antigen-4; interferon-gamma production; and CD28 expression on splenic CD8(+) T cells. In contrast, anti-PD-1 seemed to have a greater effect on major histocompatibility complex class II expression on splenic macrophages and dendritic cells than IL-7. Combined treatment with IL-7 and anti-PD-1 produced additive effects on CD28 expression, lymphocyte proliferation, and splenic secretion of interferon-gamma. In conclusion, the present study shows differences in immunomodulatory actions between IL-7 and anti-PD-1 and provides a potential rationale for combining IL-7 and anti-PD-1 in the therapy of sepsis.	[Shindo, Yuichiro; Green, Jonathan M.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, St Louis, MO 63100 USA; [Shindo, Yuichiro] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Unsinger, Jacqueline] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63100 USA; [Burnham, Cary-Ann] Washington Univ, Sch Med, Dept Pathol & Immunol & Pediat, St Louis, MO 63100 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol Med & Surg, St Louis, MO 63100 USA	Shindo, Y (reprint author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Campus Box 8052,660 South Euclid Ave, St Louis, MO 63100 USA.	yshindo@dom.wustl.edu			National Institutes of Health [GM44118, GM09839]	This work was supported in part by the National Institutes of Health (grant no. GM44118 and grant no. GM09839).	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI 10.1056/NEJMra1208623; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Hotchkiss RS, 2014, NEW ENGL J MED, V371, P380, DOI 10.1056/NEJMcibr1404664; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Kasten KR, 2010, SHOCK, V34, P327, DOI 10.1097/SHK.0b013e3181e14c2e; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Levy Y, 2012, CLIN INFECT DIS, V55, P291, DOI 10.1093/cid/cis383; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Delsing CE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-166; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359; Unsinger J, 2012, J INFECT DIS, V206, P606, DOI 10.1093/infdis/jis383; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Bryant-Hudson KM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/924619; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Davis CG, 2011, BIOCHEM BIOPH RES CO, V414, P37, DOI 10.1016/j.bbrc.2011.09.017; Declerck S, 2014, FUTURE ONCOL, V10, P91, DOI [10.2217/fon.13.166, 10.2217/FON.13.166]; Fisicaro P, 2010, GASTROENTEROLOGY, V138, pe1, DOI [10.1053/j.gastro.2009.09.052, DOI 10.1053/J.GASTRO.2009.09.052]; Gerdes J, 1990, Semin Cancer Biol, V1, P199; Inoue S, 2011, SHOCK, V36, P38, DOI 10.1097/SHK.0b013e3182168cce; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Murphey ED, 2004, SHOCK, V21, P415, DOI 10.1079/01.shk.0000124930.42937.6a; Seo YB, 2014, J VIROL, V88, P8998, DOI 10.1128/JVI.00534-14; Sherwood ER, 2013, CRIT CARE, V17, DOI 10.1186/cc13143; Vivar N, 2011, J INFECT DIS, V203, P1658, DOI 10.1093/infdis/jir156; Wohler J, 2009, MOL IMMUNOL, V46, P2424, DOI 10.1016/j.molimm.2009.04.004; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	41	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2015	43	4					334	343		10.1097/SHK.0000000000000317		10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CF0GW	WOS:000352222200006		
J	Cho, Y; Sugita, S; Kameda, S; Miura, YN; Ishibashi, K; Ohno, S; Kamata, S; Arai, T; Morota, T; Namiki, N; Matsui, T				Cho, Yuichiro; Sugita, Seiji; Kameda, Shingo; Miura, Yayoi N.; Ishibashi, Ko; Ohno, Sohsuke; Kamata, Shunichi; Arai, Tomoko; Morota, Tomokatst; Namiki, Noriyuki; Matsui, Takafumi			High-precision potassium measurements using laser-induced breakdown spectroscopy under high vacuum conditions for in situ K-Ar dating of planetary surfaces	SPECTROCHIMICA ACTA PART B-ATOMIC SPECTROSCOPY			English	Article						Laser-induced breakdown spectroscopy; In situ K-Ar dating; Geochronology; Planetary exploration; Potassium measurement	CHEMCAM INSTRUMENT SUITE; MARS; CHRONOLOGY; STRATIGRAPHY; SYSTEM; LIBS; AGES; UNIT	We conducted a series of laser induced breakdown spectroscopy (LIBS) experiments for K measurements under high vacuum conditions (10(-6) Pa) for the purpose of developing in-situ isochron type K-Ar dating instruments for planetary missions. Unlike whole rock measurement methods, isochron measurements require LIBS experiments in a vacuum chamber because simultaneous Ar isotopic measurements are necessary. However, detailed examination of detection limits and accuracy of this method at low pressures has not been examined extensively before. In this study, the capability of K measurements under high vacuum conditions was examined using LIBS. A compact Czerny-Turner type spectrometer equipped with a charge-coupled device (CCD) as a detector was employed. Twenty-three geologic standard samples were measured using the LIBS method. The second strongest K emission line at 769.89 nm was used for calibration because the strongest emission line at 766.49 nm may suffer from strong interference from another emission line. A calibration curve was constructed for K using internal normalization with the oxygen line at 777 nm and well fitted by a power-law function. Based on the prediction band method, the detection limit and the quantitation limit were estimated to be 300 and 800 ppm, respectively. The 1 sigma relative uncertainty of the K calibration was 20% for 1 wt.% K2O and 40% for 3000 ppm K2O. If the amount of Ar is measured with 15% error for the 3.5 billion years rocks containing 1 and 0.3 wt.% K2O, the K-Ar ages would be determined with 10% and 20% 1 sigma errors, respectively. This level of precision will significantly improve the current Martian chronology, which has uncertainty about a factor of two to four. These results indicate that the concentration of K can be measured quantitatively under high vacuum conditions using a combination of instruments that have previously been carried in planetary missions, which suggests the viability of building in situ isochron K-Ar dating instruments with LIBS. (C) 2015 Elsevier B.V. All rights reserved.	[Cho, Yuichiro; Kameda, Shingo] Rikkyo Univ, Dept Phys, Toshima, Tokyo 1718501, Japan; [Cho, Yuichiro; Sugita, Seiji] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Miura, Yayoi N.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Ishibashi, Ko; Ohno, Sohsuke; Arai, Tomoko; Matsui, Takafumi] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Kamata, Shunichi] Hokkaido Univ, Grad Sch Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Morota, Tomokatst] Nagoya Univ, Dept Earth & Environm Sci, Nagoya, Aichi 4648601, Japan; [Namiki, Noriyuki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Cho, Y (reprint author), Rikkyo Univ, Dept Phys, 3-34-1 Nishi Ikebukuro, Toshima, Tokyo 1718501, Japan.	cho@rikkyo.ac.jp			Institute of Space and Aeronautical Science (ISAS)/Japan Aerospace Exploration Agency (JAXA); Japan Society for the Promotion of Science (JSPS) [26247092]	The authors gratefully acknowledge assistance from Dr. Takehiko Yagi and Dr. Hirotada Gotou of the University of Tokyo for preparing pellet samples with a high-pressure cubic press at the Institute of Solid Sate Physics, University of Tokyo. We thank Noboru Imai and Shigeko Togashi of Institute of Geology and Geoinformation, AIST, for providing many of the standard samples. This study was funded by the Institute of Space and Aeronautical Science (ISAS)/Japan Aerospace Exploration Agency (JAXA) and by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid in Scientific Research Grant Number 26247092. Y. Cho was supported by a Grant-in-Aid for JSPS Fellows.	Anderson F.S., 2012, LUNAR PLANET SCI, VXLIII, P2844; Ng CW, 1997, APPL SPECTROSC, V51, P976, DOI 10.1366/0003702971941638; Meslin PY, 2013, SCIENCE, V341, DOI 10.1126/science.1238670; Morota T, 2011, EARTH PLANET SC LETT, V302, P255, DOI 10.1016/j.epsl.2010.12.028; Salle B, 2006, SPECTROCHIM ACTA B, V61, P301, DOI 10.1016/j.sab.2006.02.003; Hahn DW, 2012, APPL SPECTROSC, V66, P347, DOI 10.1366/11-06574; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Hiesinger H, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001985; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Mermet JM, 2010, SPECTROCHIM ACTA B, V65, P509, DOI 10.1016/j.sab.2010.05.007; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; Neukum G, 2010, EARTH PLANET SC LETT, V294, P204, DOI 10.1016/j.epsl.2009.09.006; Wiens RC, 2013, SPECTROCHIM ACTA B, V82, P1, DOI 10.1016/j.sab.2013.02.003; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; Clegg SM, 2014, APPL SPECTROSC, V68, P925, DOI 10.1366/13-07386; Knight AK, 2000, APPL SPECTROSC, V54, P331, DOI 10.1366/0003702001949591; Aragon C., 2008, ACTA B, V63, P893; Araki H, 2008, ADV SPACE RES, V42, P317, DOI 10.1016/j.asr.2007.05.042; Basaltic Volcanism Study Project, 1981, BAS VOLC TERR PLAN; Bogard DD, 2009, METEORIT PLANET SCI, V44, P3; Cho Y., 2013, LUNAR PLANET SCI, VXLIV, P1505; Cho Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051838; Cho Y., 2011, 2011 PERC PLAN GEOL, pP30; Cho Y., 2012, INT WORKSH INSTR PLA, P1093; Cohen B.A., 2013, LUNAR PLANET SCI, VXLIV, P2363; Cohen B.A., 2012, LUNAR PLANET SCI, VXLIII, P1267; Corsi M, 2005, APPL SPECTROSC, V59, P853, DOI 10.1366/0003702054411607; Cousin A., 2013, LUNAR PLANET SCI, VXLIV, P1409; Cremers D. A., 2006, HDB LASER INDUCED BR; Devismes D., 2013, EPSC, VVIII, P71; Doran PT, 2004, EARTH-SCI REV, V67, P313, DOI 10.1016/j.earscirev.2004.04.001; Farley KA, 2013, GEOCHIM COSMOCHIM AC, V110, P1, DOI 10.1016/j.gca.2013.02.010; Farley KA, 2014, SCIENCE, V343, DOI 10.1126/science.1247166; GOVINDARAJU K, 1994, GEOSTANDARD NEWSLETT, V18, P1; Karunatillake S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002859; Lasue J, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003898; Mermet JM, 2008, SPECTROCHIM ACTA B, V63, P166, DOI 10.1016/j.sab.2007.11.029; Neulcum G., 1983, METEROITENBOMBARDEME; Shannon MA, 1998, APPL SURF SCI, V127, P218, DOI 10.1016/S0169-4332(97)00635-1; Stipe CB, 2012, SPECTROCHIM ACTA B, V70, P45, DOI 10.1016/j.sab.2012.04.010; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; Swindle T.D., 2003, LUNAR PLANET SCI, VXXXIV, P1488; Talboys DL, 2009, PLANET SPACE SCI, V57, P1237, DOI 10.1016/j.pss.2009.02.012	49	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0584-8547			SPECTROCHIM ACTA B	Spectroc. Acta Pt. B-Atom. Spectr.	APR 1	2015	106						28	35		10.1016/j.sab.2015.02.002		8	Spectroscopy	Spectroscopy	CE6WG	WOS:000351978300005		
J	Tsao, Y; Lin, PT; Hu, TY; Lu, XG				Tsao, Yu; Lin, Payton; Hu, Ting-yao; Lu, Xugang			Ensemble environment modeling using affine transform group	SPEECH COMMUNICATION			English	Article						Ensemble modeling; Environment modeling; Prior knowledge; Maximum a posteriori; Model selection; Cohort selection	ROBUST SPEECH RECOGNITION; HIDDEN MARKOV-MODELS; RAPID SPEAKER ADAPTATION; LINEAR-REGRESSION; CONVOLUTIVE DISTORTIONS; INFORMATION CRITERION; JOINT COMPENSATION; VARIABLE SELECTION; HMM ADAPTATION; ELIMINATION	The ensemble speaker and speaking environment modeling (ESSEM) framework was designed to provide online optimization for enhancing workable systems under real-world conditions. In the ESSEM framework, ensemble models are built in the offline phase to characterize specific environments based on local statistics prepared from those particular conditions. In the online phase, a mapping function is computed based on the incoming testing data to perform model adaptation. Previous studies utilized linear combination (LC) and linear combination with a correction bias (LCB) as simple mapping functions that only apply one weighting coefficient on each model. In order to better utilize the ensemble models, this study presents a generalized affine transform group (ATG) mapping function for the ESSEM framework. Although ATG characterizes unknown testing conditions more precisely using a larger amount of parameters, over-fitting issues occur when the available adaptation data is especially limited. This study handles over-fitting issues with three optimization processes: maximum a posteriori (MAP) criterion, model selection (MS), and cohort selection (CS). Experimental results showed that ATG along with the three optimization processes enabled the ESSEM framework to allow unsupervised model adaptation using only one utterance to provide consistent performance improvements. (C) 2015 Elsevier B.V. All rights reserved.	[Tsao, Yu; Lin, Payton; Hu, Ting-yao] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei, Taiwan; [Lu, Xugang] Natl Inst Informat & Commun Technol, Spoken Language Commun Lab, Kyoto, Japan	Tsao, Y (reprint author), 128,Acad Rd,Sect 2, Taipei 11529, Taiwan.	yu.tsao@citi.sinica.edu.tw			National Science Council of Taiwan [NSC101-2221-E-001-020-MY3]	This work was supported by the National Science Council of Taiwan under contracts NSC101-2221-E-001-020-MY3.	Yu D, 2013, INT CONF ACOUST SPEE, P7893; Hilger F, 2006, IEEE T AUDIO SPEECH, V14, P845, DOI 10.1109/TSA.2005.857792; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Yuan M, 2006, J ROY STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; O'Shaughnessy D, 2008, PATTERN RECOGN, V41, P2965, DOI 10.1016/j.patcog.2008.05.008; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Lee CH, 1998, SPEECH COMMUN, V25, P29, DOI 10.1016/S0167-6393(98)00028-4; Li JY, 2014, IEEE-ACM T AUDIO SPE, V22, P745, DOI 10.1109/TASLP.2014.2304637; Siohan O, 2002, COMPUT SPEECH LANG, V16, P5, DOI 10.1006/csla.2001.0181; [Anonymous], 2007, 202050 ETSI ES; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; Hu Y, 2006, LECT NOTES COMPUT SC, V4274, P346; Yu K, 2006, IEEE T AUDIO SPEECH, V14, P1694, DOI 10.1109/TSA.2005.858555; REYNOLDS DA, 1995, IEEE T SPEECH AUDI P, V3, P72, DOI 10.1109/89.365379; Seltzer ML, 2013, INT CONF ACOUST SPEE, P7398, DOI 10.1109/ICASSP.2013.6639100; Li JY, 2009, COMPUT SPEECH LANG, V23, P389, DOI 10.1016/j.csl.2009.02.001; Gemello R, 2007, SPEECH COMMUN, V49, P827, DOI 10.1016/j.specom.2006.11.005; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kuhn R, 2000, IEEE T SPEECH AUDI P, V8, P695, DOI 10.1109/89.876308; Kim DY, 1998, SPEECH COMMUN, V24, P39, DOI 10.1016/S0167-6393(97)00061-7; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Yao KS, 2012, 2012 IEEE WORKSHOP ON SPOKEN LANGUAGE TECHNOLOGY (SLT 2012), P366; Shinoda K, 2001, IEEE T SPEECH AUDI P, V9, P276, DOI 10.1109/89.906001; AuYeung S.-K., 2004, P INT C SPOK LANG PR, P161; Burnham K. P., 2002, MODEL SELECTION MULT; Chesta C., 1999, P EUR C SPEECH COMM, P211; Cotter SF, 2001, SIGNAL PROCESS, V81, P1849, DOI 10.1016/S0165-1684(01)00064-0; Deng L, 2004, COMMUN ACM, V47, P69, DOI 10.1145/962081.962108; Gales M. J. F., 1997, COMPUTER SPEECH LANG, V25, P75; Gales MJF, 2000, IEEE T SPEECH AUDI P, V8, P417, DOI 10.1109/89.848223; Gong YF, 2005, IEEE T SPEECH AUDI P, V13, P975, DOI 10.1109/TSA.2005.851963; Hayter A.J., 2006, PROBABILITY DENSITY; Hazen TJ, 2000, SPEECH COMMUN, V31, P15, DOI 10.1016/S0167-6393(99)00059-X; Hirsch G., 2001, EXPT FRAMEWORK PERFO; Hu Y., 2007, P INTERSPEECH, P1042; Huo Q, 2000, IEEE T SPEECH AUDI P, V8, P200; Jeong Y, 2012, IEEE T AUDIO SPEECH, V20, P2352, DOI 10.1109/TASL.2012.2202649; Jeong Y, 2014, SPEECH COMMUN, V58, P1, DOI 10.1016/j.specom.2013.10.001; Junqua J.-C., 1996, ROBUSTNESS AUTOMATIC; Kosaka T, 1996, COMPUT SPEECH LANG, V10, P55, DOI 10.1006/csla.1996.0004; LEGGETTER CJ, 1995, COMPUT SPEECH LANG, V9, P171, DOI 10.1006/csla.1995.0010; Li B, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P526; Li J., 2011, P ICML 11 WORKSH LEA; Li JY, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1660; Li JY, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P1656; Liao H, 2013, INT CONF ACOUST SPEE, P7947; Liu S., 2014, P IC ASSP 14, P195; Lu X., 2014, P INT 14, P885; Mak B, 2006, INT CONF ACOUST SPEE, P229; Neto J, 1995, P EUROSPEECH 1995, P2171; NORMAN DA, 1984, INT J MAN MACH STUD, V21, P365, DOI 10.1016/S0020-7373(84)80054-1; Ochiai T., 2014, P IC ASSP 14, P6349; Padmanabhan M, 1998, IEEE T SPEECH AUDI P, V6, P71, DOI 10.1109/89.650313; Parihar N., 2004, P EUSIPCO, P553; Parihar N., 2002, I SIGNAL INFORM PROC; PAUL DB, 1992, P WORKSH SPEECH NAT, P357, DOI 10.3115/1075527.1075614; Rahim MG, 1996, IEEE T SPEECH AUDI P, V4, P19; Rosenberg A. E., 1992, P INT C SPOK LANG PR, V1, P599; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sankar A., 1996, SPEECH AUDIO PROCESS, V4, P190; Siohan O, 2001, IEEE T SPEECH AUDI P, V9, P417, DOI 10.1109/89.917687; Surendran AC, 1999, IEEE T SPEECH AUDI P, V7, P643, DOI 10.1109/89.799689; SUTTER JM, 1993, MICROCHEM J, V47, P60, DOI 10.1006/mchj.1993.1012; Tsao Y., 2012, P ICASSP, P705; Tsao Y, 2014, IEEE-ACM T AUDIO SPE, V22, P403, DOI 10.1109/TASLP.2013.2292362; Tsao Y, 2014, COMPUT SPEECH LANG, V28, P709, DOI 10.1016/j.csl.2013.11.005; Tsao Y, 2014, IEICE T INF SYST, VE97D, P1477, DOI 10.1587/transinf.E97.D.1477; Tsao Y., 2015, SIGNAL PROCESS LETT, V22, P351; Tsao Y, 2009, INT CONF ACOUST SPEE, P3833, DOI 10.1109/ICASSP.2009.4960463; Tsao Y, 2009, IEEE T AUDIO SPEECH, V17, P1025, DOI 10.1109/TASL.2009.2016231; Tuske Z, 2011, INT CONF ACOUST SPEE, P5204; Watanabe S, 2014, J SIGNAL PROCESS SYS, V74, P341, DOI 10.1007/s11265-013-0785-8; Wu J, 2006, IEEE T AUDIO SPEECH, V14, P2147, DOI 10.1109/TASL.2006.872616	75	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	APR	2015	68						55	68		10.1016/j.specom.2014.12.007		14	Acoustics; Computer Science, Interdisciplinary Applications	Acoustics; Computer Science	CF0PD	WOS:000352245800005		
